PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Alkhouri, N; Mansoor, S; Giammaria, P; Liccardo, D; Lopez, R; Nobili, V				Alkhouri, Naim; Mansoor, Sana; Giammaria, Paola; Liccardo, Daniela; Lopez, Rocio; Nobili, Valerio			The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							SIMPLE NONINVASIVE INDEX; INSULIN-RESISTANCE; DIABETES-MELLITUS; ADOLESCENTS; OBESITY; BIOPSY; SYSTEM	Background: Noninvasive hepatic fibrosis scores that predict the presence of advanced fibrosis have been developed and validated in adult patients with NAFLD. The aims of our study were to assess the utility of commonly used adult fibrosis scores in pediatric NAFLD and to develop a pediatric specific fibrosis score that can predict advanced fibrosis. Methods: Consecutive children with biopsy-proven NAFLD were included. Fibrosis was determined by an experienced pathologist (F0-4). Advanced fibrosis was defined as fibrosis stage >= 3. The following adult fibrosis scores were calculated for each child: AST/ALT ratio, AST/platelet ratio index (APRI), NAFLD fibrosis score (NFS), and FIB-4 Index. Multivariable logistic regression analysis was performed to build a new pediatric model for predicting advanced fibrosis. Results: Our cohort consisted of 242 children with a mean age of 12.4 +/- 3.1 years and 63% were female. 36 (15%) subjects had advanced fibrosis. APRI and FIB-4 were higher in patients with advanced fibrosis compared to those with fibrosis stage 0-2; however, AST/ALT ratio and NFS were not different between the two groups. We used our data to develop a new model to predict advanced fibrosis which included: ALT, alkaline phosphatase, platelet counts and GGT. The multivariable logistic regression model (z) was defined as follows: z = 1.1+(0.34*sqrt(ALT))+(0.002*alkaline phosphatase) - (1.1*log(platelets) - (0.02*GGT). This value was then converted into a probability distribution (p) with a value between 0 to 100 by the following formula: p = 100xexp(z)/[1+exp(z)]. The AUCROC for this model was 0.74 (95% CI: 0.66, 0.82). This was found to be significantly better than APRI, NAFLD Fibrosis Score and FIB-4 Index. Conclusion: Noninvasive hepatic fibrosis scores developed in adults had poor performance in diagnosing advanced fibrosis in children with NAFLD. We developed a new pediatric NAFLD fibrosis score with improved performance characteristics.	[Alkhouri, Naim; Mansoor, Sana] Cleveland Clin, Dept Pediat Gastroenterol & Hepatol, Cleveland, OH 44106 USA; [Alkhouri, Naim] Cleveland Clin, Inst Digest Dis, Cleveland, OH 44106 USA; [Lopez, Rocio] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Giammaria, Paola; Liccardo, Daniela; Nobili, Valerio] Bambino Gesu Pediat Hosp, Liver Unit, Rome, Italy	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; IRCCS Bambino Gesu	Alkhouri, N (corresponding author), Cleveland Clin, Dept Pediat Gastroenterol & Hepatol, Cleveland, OH 44106 USA.	alkhoun@ccf.org	Nobili, Valerio/K-8670-2018	nobili, valerio/0000-0002-4570-3979; Lopez, Ana Rocio/0000-0002-4319-420X; Liccardo, Daniela/0000-0002-0311-5204				Aggarwal A, 2013, CURRENT PEDIAT REV, V9; Alkhouri Naim, 2012, Gastroenterol Hepatol (N Y), V8, P661; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2013, GASTROENTEROLOGY, V145, P782, DOI 10.1053/j.gastro.2013.06.057; Angulo P, 2010, HEPATOLOGY, V51, P373, DOI 10.1002/hep.23521; [Anonymous], 1987, Natl Inst Health Consens Dev Conf Consens Statement, V6, P1; [Anonymous], 1992, Pediatrics, V89, P525; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chan DFY, 2004, INT J OBESITY, V28, P1257, DOI 10.1038/sj.ijo.0802734; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Genuth S, 2003, DIABETES CARE, V26, P3160; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kuczmarski RJ, 2000, ADV DATA, V314, P1; Manco M, 2008, J PEDIATR GASTR NUTR, V46, P224, DOI 10.1097/MPG.0b013e31814b1d5b; Mansoor S, 2013, AM J GASTROENTEROL, V108, pS624, DOI 10.14309/00000434-201310001-02055; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nobili V, 2006, ALIMENT PHARM THER, V24, P1553, DOI 10.1111/j.1365-2036.2006.03161.x; Nobili V, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-21; Nobili V, 2006, HEPATOLOGY, V44, P458, DOI 10.1002/hep.21262; Poynard T, 2007, ALIMENT PHARM THER, V25, P733, DOI 10.1111/j.1365-2036.2007.03252.x; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yang HR, 2012, WORLD J GASTROENTERO, V18, P1525, DOI 10.3748/wjg.v18.i13.1525	29	49	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104558	10.1371/journal.pone.0104558	http://dx.doi.org/10.1371/journal.pone.0104558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121514	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000043
J	Boeve, JL; Rozenberg, R; Shinohara, A; Schmidt, S				Boeve, Jean-Luc; Rozenberg, Raoul; Shinohara, Akihiko; Schmidt, Stefan			Toxic Peptides Occur Frequently in Pergid and Argid Sawfly Larvae	PLOS ONE			English	Article							D-AMINO ACIDS; HYMENOPTERA; CATTLE; OCTAPEPTIDE; LOPHYROTOMIN; INSECTA; SHEEP	Toxic peptides containing D-amino acids are reported from the larvae of sawfly species. The compounds are suspected to constitute environmental contaminants, as they have killed livestock grazing in areas with congregations of such larvae, and related larval extracts are deleterious to ants. Previously, two octapeptides (both called lophyrotomin) and three heptapeptides (pergidin, 4-valinepergidin and dephosphorylated pergidin) were identified from three species in the family Pergidae and one in Argidae. Here, the hypothesis of widespread occurrence of these peptides among sawflies was tested by LC-MS analyses of single larvae from eight pergid and 28 argid species, plus nine outgroup species. At least two of the five peptides were detected in most sawfly species, whereas none in any outgroup taxon. Wherever peptides were detected, they were present in each examined specimen of the respective species. Some species show high peptide concentrations, reaching up to 0.6% fresh weight of 4-valinepergidin (1.75 mg/larva) in the pergid Pterygophorus nr turneri. All analyzed pergids in the subfamily Pterygophorinae contained pergidin and 4-valinepergidin, all argids in Arginae contained pergidin and one of the two lophyrotomins, whereas none of the peptides was detected in any Perginae pergid or Sterictiphorinae argid (except in Schizocerella pilicornis, which contained pergidin). Three of the four sawfly species that were previously known to contain toxins were reanalyzed here, resulting in several, often strong, quantitative and qualitative differences in the chemical profiles. The most probable ecological role of the peptides is defense against natural enemies; the poisoning of livestock is an epiphenomenon.	[Boeve, Jean-Luc] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Rozenberg, Raoul] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, Louvain, Belgium; [Shinohara, Akihiko] Natl Museum Nat & Sci, Dept Zool, Tsukuba, Ibaraki, Japan; [Schmidt, Stefan] Staatl Nat Wissenschaft Sammlungen Baye, Zool Staatssammlung, Munich, Germany	Royal Belgian Institute of Natural Sciences; Universite Catholique Louvain; National Museum of Nature and Science	Boeve, JL (corresponding author), Royal Belgian Inst Nat Sci, Brussels, Belgium.	Jean-Luc.Boeve@naturalsciences.be						BIRK IM, 1989, ARCH MICROBIOL, V151, P411, DOI 10.1007/BF00416599; Boeve JL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-198; BREWER D, 1979, EXPERIENTIA, V35, P294, DOI 10.1007/BF01964306; Burrows DW, 1997, ENTOMOPHAGA, V42, P299, DOI 10.1007/BF02769822; CALLOW L. L., 1955, QUEENSLAND AGRIC JOUR, V81, P155; Center TD, 2012, BIOCONTROL, V57, P151, DOI 10.1007/s10526-011-9390-6; Cuda J. P, 2004, BIOL CONTROL INVASIV, P439; DADSWELL LP, 1985, AUST VET J, V62, P94, DOI 10.1111/j.1751-0813.1985.tb14148.x; Dutra F, 1997, VET HUM TOXICOL, V39, P281; Fusetani N., 2009, V46, P1, DOI 10.1007/978-3-540-87895-7_1; KANNAN R, 1988, TOXICON, V26, P224, DOI 10.1016/0041-0101(88)90177-8; KOJIRI K, 1989, J ANTIBIOT, V42, P489, DOI 10.7164/antibiotics.42.489; Laroche FB, 1999, MELALEUCA MAGEMENT P; Le Bourgeois Thomas, 2009, Insectes, V153, P17; LEONARD GJ, 1972, TOXICON, V10, P597, DOI 10.1016/0041-0101(72)90121-3; MacLeod JK, 2000, AUST J CHEM, V53, P293, DOI 10.1071/CH99146; Malm T, 2015, CLADISTICS, V31, P1, DOI 10.1111/cla.12069; McKenzie R. A., 1985, Plant toxicology. Proceedings of the Australia-U.S.A. poisonous plants symposium, Brisbane, Australia, May 14-18, 1984., P524; MORROW PA, 1976, OECOLOGIA, V24, P193, DOI 10.1007/BF00345473; Oelrichs P.B., 1983, Toxicon Supplement, P321; OELRICHS PB, 1977, LLOYDIA, V40, P209; Oelrichs PB, 2001, TOXICON, V39, P1933, DOI 10.1016/S0041-0101(01)00144-1; Oelrichs PB, 1999, TOXICON, V37, P537, DOI 10.1016/S0041-0101(98)00192-5; Petre CA, 2007, J INSECT PHYSIOL, V53, P668, DOI 10.1016/j.jinsphys.2007.04.007; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; Purcell M. F., 2005, Australian Entomologist, V32, P37; ROBERTS F. H. S., 1932, Queensland Agricultural Journal, V37, P41; Rodel MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081950; Santana ANC, 1998, BRAZ J MED BIOL RES, V31, P1335, DOI 10.1590/S0100-879X1998001000015; Schmidt S, 2014, MOL PHYLOGENET EVOL, V74, P111, DOI 10.1016/j.ympev.2014.02.002; Schmidt S, 2010, J INSECT PHYSIOL, V56, P1770, DOI 10.1016/j.jinsphys.2010.07.006; Schulmeister S, 2003, BIOL J LINN SOC, V79, P245, DOI 10.1046/j.1095-8312.2003.00233.x; Sela M, 1997, FASEB J, V11, P449; Sewald N., 2002, PEPTIDES CHEM BIOL; Soares MP, 2008, PESQUI VET BRASIL, V28, P169, DOI 10.1590/S0100-736X2008000300007; Soares MP, 2001, TOXICON, V39, P669, DOI 10.1016/S0041-0101(00)00192-6; Tessele B, 2012, PESQUI VET BRASIL, V32, P1095, DOI 10.1590/S0100-736X2012001100004; THAMSBORG SM, 1987, VET REC, V121, P253, DOI 10.1136/vr.121.11.253; Van Driesche R., 2002, BIOL CONTROL INVASIV; WILLIAMS DH, 1983, J CHEM SOC PERK T 1, P1869, DOI 10.1039/p19830001869	40	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105301	10.1371/journal.pone.0105301	http://dx.doi.org/10.1371/journal.pone.0105301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121515	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000113
J	Leo, M; Cazzato, D; De Marco, T; Distante, C				Leo, Marco; Cazzato, Dario; De Marco, Tommaso; Distante, Cosimo			Unsupervised Eye Pupil Localization through Differential Geometry and Local Self-Similarity Matching	PLOS ONE			English	Article							FACE-RECOGNITION	The automatic detection and tracking of human eyes and, in particular, the precise localization of their centers (pupils), is a widely debated topic in the international scientific community. In fact, the extracted information can be effectively used in a large number of applications ranging from advanced interfaces to biometrics and including also the estimation of the gaze direction, the control of human attention and the early screening of neurological pathologies. Independently of the application domain, the detection and tracking of the eye centers are, currently, performed mainly using invasive devices. Cheaper and more versatile systems have been only recently introduced: they make use of image processing techniques working on periocular patches which can be specifically acquired or preliminarily cropped from facial images. In the latter cases the involved algorithms must work even in cases of non-ideal acquiring conditions (e.g in presence of noise, low spatial resolution, non-uniform lighting conditions, etc.) and without user's awareness (thus with possible variations of the eye in scale, rotation and/or translation). Getting satisfying results in pupils' localization in such a challenging operating conditions is still an open scientific topic in Computer Vision. Actually, the most performing solutions in the literature are, unfortunately, based on supervised machine learning algorithms which require initial sessions to set the working parameters and to train the embedded learning models of the eye: this way, experienced operators have to work on the system each time it is moved from an operational context to another. It follows that the use of unsupervised approaches is more and more desirable but, unfortunately, their performances are not still satisfactory and more investigations are required. To this end, this paper proposes a new unsupervised approach to automatically detect the center of the eye: its algorithmic core is a representation of the eye's shape that is obtained through a differential analysis of image intensities and the subsequent combination with the local variability of the appearance represented by self-similarity coefficients. The experimental evidence of the effectiveness of the method was demonstrated on challenging databases containing facial images. Moreover, its capabilities to accurately detect the centers of the eyes were also favourably compared with those of the leading state-of-the-art methods.	[Leo, Marco; Cazzato, Dario; De Marco, Tommaso; Distante, Cosimo] Natl Res Council Italy, Inst Opt, Lecce, Italy; [Cazzato, Dario] Univ Salento, Fac Engn, Lecce, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Salento	Leo, M (corresponding author), Natl Res Council Italy, Inst Opt, Lecce, Italy.	marco.leo@cnr.it	Cazzato, Dario/O-4780-2019; Leo, Marco/AAG-6296-2019; Distante, Cosimo/M-7996-2013	Cazzato, Dario/0000-0002-5472-9150; Leo, Marco/0000-0001-5636-6130; Distante, Cosimo/0000-0002-1073-2390				Asteriadis S, 2009, PATTERN RECOGN, V42, P1388, DOI 10.1016/j.patcog.2009.01.009; BioID, 2001, TECHN RES; Campadelli P, 2009, INT J PATTERN RECOGN, V23, P359, DOI 10.1142/S0218001409007259; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Coutinho FL, 2013, INT J COMPUT VISION, V101, P459, DOI 10.1007/s11263-012-0541-8; Cristinacce D., 2004, P BRIT MACH VIS C, P546, DOI DOI 10.5244/C.18.30; DAUGMAN JG, 1993, IEEE T PATTERN ANAL, V15, P1148, DOI 10.1109/34.244676; Georghiades AS, 2001, IEEE T PATTERN ANAL, V23, P643, DOI 10.1109/34.927464; Hansen DW, 2010, IEEE T PATTERN ANAL, V32, P478, DOI 10.1109/TPAMI.2009.30; He ZF, 2009, IEEE T PATTERN ANAL, V31, P1670, DOI 10.1109/TPAMI.2008.183; Jesorsky O, 2001, LECT NOTES COMPUT SC, V2091, P90; KROON B., 2008, P 2008 INT C CONT BA, P379; Leo M, 2013, J ELECTRON IMAGING, V22, DOI 10.1117/1.JEI.22.3.033033; Lichtenauer J, 2005, PROC CVPR IEEE, P649; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Markus N, 2014, PATTERN RECOGN, V47, P578, DOI 10.1016/j.patcog.2013.08.008; Maver J, 2010, IEEE T PATTERN ANAL, V32, P1211, DOI 10.1109/TPAMI.2009.105; Mishra AK, 2011, IEEE T PATTERN ANAL, V33, P310, DOI 10.1109/TPAMI.2010.83; Niu ZH, 2006, INT C PATT RECOG, P1216; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; Proenca H, 2010, IEEE T PATTERN ANAL, V32, P1529, DOI 10.1109/TPAMI.2009.66; Shah S, 2009, IEEE T INF FOREN SEC, V4, P824, DOI 10.1109/TIFS.2009.2033225; SMI SensoMotoric Instruments iXH, 2012, MOB HEAD MOUNT EY GA; Timm F, 2011, VISAPP 2011: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON COMPUTER VISION THEORY AND APPLICATIONS, P125; Valenti R., 2008, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2008.4587529; Valenti R, 2012, IEEE T PATTERN ANAL, V34, P1785, DOI 10.1109/TPAMI.2011.251; Van Ginkel M, 1999, P SCAND C IM AN, V2, P545; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wildes RP, 1997, P IEEE, V85, P1348, DOI 10.1109/5.628669; Zhu ZW, 2005, COMPUT VIS IMAGE UND, V98, P124, DOI 10.1016/j.cviu.2004.07.012	30	39	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e102829	10.1371/journal.pone.0102829	http://dx.doi.org/10.1371/journal.pone.0102829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122452	Green Submitted, Green Published, gold			2022-12-27	WOS:000341017000006
J	Niazi, A; Manzoor, S; Asari, S; Bejai, S; Meijer, J; Bongcam-Rudloff, E				Niazi, Adnan; Manzoor, Shahid; Asari, Shashidar; Bejai, Sarosh; Meijer, Johan; Bongcam-Rudloff, Erik			Genome Analysis of Bacillus amyloliquefaciens Subsp plantarum UCMB5113: A Rhizobacterium That Improves Plant Growth and Stress Management	PLOS ONE			English	Article							RAPE BRASSICA-NAPUS; SIGNAL PEPTIDES; FUNCTIONAL-CHARACTERIZATION; MICROBIAL INTERACTIONS; SYSTEMIC RESISTANCE; BIOFILM FORMATION; AMYLOID FIBERS; GENE CLUSTERS; SUBTILIS; IDENTIFICATION	The Bacillus amyloliquefaciens subsp. plantarum strain UCMB5113 is a Gram-positive rhizobacterium that can colonize plant roots and stimulate plant growth and defense based on unknown mechanisms. This reinforcement of plants may provide protection to various forms of biotic and abiotic stress. To determine the genetic traits involved in the mechanism of plant-bacteria association, the genome sequence of UCMB5113 was obtained by assembling paired-end Illumina reads. The assembled chromosome of 3,889,532 bp was predicted to encode 3,656 proteins. Genes that potentially contribute to plant growth promotion such as indole-3-acetic acid (IAA) biosynthesis, acetoin synthesis and siderophore production were identified. Moreover, annotation identified putative genes responsible for non-ribosomal synthesis of secondary metabolites and genes supporting environment fitness of UCMB5113 including drug and metal resistance. A large number of genes encoding a diverse set of secretory proteins, enzymes of primary and secondary metabolism and carbohydrate active enzymes were found which reflect a high capacity to degrade various rhizosphere macromolecules. Additionally, many predicted membrane transporters provides the bacterium with efficient uptake capabilities of several nutrients. Although, UCMB5113 has the possibility to produce antibiotics and biosurfactants, the protective effect of plants to pathogens seems to be indirect and due to priming of plant induced systemic resistance. The availability of the genome enables identification of genes and their function underpinning beneficial interactions of UCMB5113 with plants.	[Niazi, Adnan; Manzoor, Shahid; Bongcam-Rudloff, Erik] Swedish Univ Agr Sci, SLU Global Bioinformat Ctr, Dept Anim Breeding & Genet, Uppsala, Sweden; [Asari, Shashidar; Bejai, Sarosh; Meijer, Johan] Swedish Univ Agr Sci, Uppsala Bioctr, Linnean Ctr Plant Biol, Dept Plant Biol, Uppsala, Sweden; [Manzoor, Shahid] Univ Punjab, Lahore, Pakistan	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; University of Punjab	Niazi, A (corresponding author), Swedish Univ Agr Sci, SLU Global Bioinformat Ctr, Dept Anim Breeding & Genet, Uppsala, Sweden.	Adnan.Niazi@slu.se		Bongcam-Rudloff, Erik/0000-0002-1947-8288; Niazi, Adnan/0000-0003-0311-5279	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Carl Tryggers Stiftelse; Nilsson-Ehle Stiftelsen; Helge-Ax:son Johnsons Stiftelse; Swedish University of Agricultural Sciences (SLU); Higher Education Commission of Pakistan (HEC)	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Carl Tryggers Stiftelse; Nilsson-Ehle Stiftelsen; Helge-Ax:son Johnsons Stiftelse; Swedish University of Agricultural Sciences (SLU); Higher Education Commission of Pakistan (HEC)(Higher Education Commission of Pakistan)	This work was supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), Carl Tryggers Stiftelse, Nilsson-Ehle Stiftelsen, Helge-Ax:son Johnsons Stiftelse, the Swedish University of Agricultural Sciences (SLU) and the Higher Education Commission of Pakistan (HEC). Funding for plant growth facilities were provided in part by KFI-VR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Daim IA, 2014, PLANT SOIL, V379, P337, DOI 10.1007/s11104-014-2063-3; BEECHER DJ, 1994, APPL ENVIRON MICROB, V60, P1646, DOI 10.1128/AEM.60.5.1646-1651.1994; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Butcher RA, 2007, P NATL ACAD SCI USA, V104, P1506, DOI 10.1073/pnas.0610503104; Chen XH, 2007, NAT BIOTECHNOL, V25, P1007, DOI 10.1038/nbt1325; Chen XH, 2006, J BACTERIOL, V188, P4024, DOI 10.1128/JB.00052-06; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Choudhary DK, 2009, MICROBIOL RES, V164, P493, DOI 10.1016/j.micres.2008.08.007; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Chu F, 2006, MOL MICROBIOL, V59, P1216, DOI 10.1111/j.1365-2958.2005.05019.x; Collemare J, 2012, EFFECTORS PLANT MICR, P377; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Danielsson J, 2007, MICROB ECOL, V54, P134, DOI 10.1007/s00248-006-9181-2; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DSOUZA C, 1994, P NATL ACAD SCI USA, V91, P9397, DOI 10.1073/pnas.91.20.9397; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ghelardi E, 2012, APPL ENVIRON MICROB, V78, P6540, DOI 10.1128/AEM.01341-12; Gonzalez-Pastor JE, 2003, SCIENCE, V301, P510, DOI 10.1126/science.1086462; HAMOEN LW, 1995, MOL MICROBIOL, V15, P55, DOI 10.1111/j.1365-2958.1995.tb02220.x; Harvie DR, 2006, MOL MICROBIOL, V59, P1341, DOI 10.1111/j.1365-2958.2006.05029.x; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; JACOB J, 1994, FEMS MICROBIOL LETT, V120, P13; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kasim WA, 2013, J PLANT GROWTH REGUL, V32, P122, DOI 10.1007/s00344-012-9283-7; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; KENIG M, 1976, J GEN MICROBIOL, V94, P37, DOI 10.1099/00221287-94-1-37; Kloepper JW, 2004, PHYTOPATHOLOGY, V94, P1259, DOI 10.1094/PHYTO.2004.94.11.1259; Kobayashi K, 2012, MOL MICROBIOL, V85, P51, DOI 10.1111/j.1365-2958.2012.08094.x; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Lee SJ, 2004, J MICROBIOL BIOTECHN, V14, P525; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Manzoor S., 2013, GENOME ANNOUNC, V1; Meilhoc E, 2010, MOL PLANT MICROBE IN, V23, P748, DOI 10.1094/MPMI-23-6-0748; Miethke M, 2006, MOL MICROBIOL, V61, P1413, DOI 10.1111/j.1365-2958.2006.05321.x; Osman Mohammed E. H., 2013, International Journal of Plant Biology, V4, P29, DOI 10.4081/pb.2013.e8; Ostrowski A, 2011, J BACTERIOL, V193, P4821, DOI 10.1128/JB.00223-11; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Premono M.E., 1996, INDONES J CROP SCI, V11, P13, DOI DOI 10.4067/S0718-95162013005000001; Reva ON, 2004, FEMS MICROBIOL ECOL, V48, P249, DOI 10.1016/j.femsec.2004.02.003; ROBERTS WK, 1988, J GEN MICROBIOL, V134, P169; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; SAKAGUCHI R, 1988, BIOCHIM BIOPHYS ACTA, V950, P441, DOI 10.1016/0167-4781(88)90142-X; Sakamoto JJ, 2001, J BIOL CHEM, V276, P47046, DOI 10.1074/jbc.M106205200; Santhanagopalan V, 2006, GENE, V369, P119, DOI 10.1016/j.gene.2005.10.030; Sarosh BR, 2009, PLANT MOL BIOL, V70, P31, DOI 10.1007/s11103-009-9455-4; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Steinborn G, 2005, ARCH MICROBIOL, V183, P71, DOI 10.1007/s00203-004-0743-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Tschen M, 1990, FORUM MIKROBIOL, V3, P156; Tugrul T, 2005, WORLD J MICROB BIOT, V21, P851, DOI 10.1007/s11274-004-5958-y; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Whipps JM, 2001, J EXP BOT, V52, P487, DOI 10.1093/jexbot/52.suppl_1.487; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Yoo JS, 2006, BIOORG MED CHEM LETT, V16, P4889, DOI 10.1016/j.bmcl.2006.06.058; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zimbro MJ, 2009, DIFCO BBL MANUAL MAN, P879; ZIMMERMAN SB, 1987, J ANTIBIOT, V40, P1677, DOI 10.7164/antibiotics.40.1677; Zuber P, 2009, ANNU REV MICROBIOL, V63, P575, DOI 10.1146/annurev.micro.091208.073241	66	66	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104651	10.1371/journal.pone.0104651	http://dx.doi.org/10.1371/journal.pone.0104651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119988	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600074
J	Posnien, N; Zeng, V; Schwager, EE; Pechmann, M; Hilbrant, M; Keefe, JD; Damen, WGM; Prpic, NM; McGregor, AP; Extavour, CG				Posnien, Nico; Zeng, Victor; Schwager, Evelyn E.; Pechmann, Matthias; Hilbrant, Maarten; Keefe, Joseph D.; Damen, Wim G. M.; Prpic, Nikola-Michael; McGregor, Alistair P.; Extavour, Cassandra G.			A Comprehensive Reference Transcriptome Resource for the Common House Spider Parasteatoda tepidariorum	PLOS ONE			English	Article							POLYCISTRONIC MESSENGER-RNA; OPEN READING FRAMES; ACHAEARANEA-TEPIDARIORUM; MAMMALIAN-CELLS; GENES; EXPRESSION; PEPTIDES; GENOME; SEGMENTATION; EVOLUTION	Parasteatoda tepidariorum is an increasingly popular model for the study of spider development and the evolution of development more broadly. However, fully understanding the regulation and evolution of P. tepidariorum development in comparison to other animals requires a genomic perspective. Although research on P. tepidariorum has provided major new insights, gene analysis to date has been limited to candidate gene approaches. Furthermore, the few available EST collections are based on embryonic transcripts, which have not been systematically annotated and are unlikely to contain transcripts specific to post-embryonic stages of development. We therefore generated cDNA from pooled embryos representing all described embryonic stages, as well as post-embryonic stages including nymphs, larvae and adults, and using Illumina HiSeq technology obtained a total of 625,076,514 100-bp paired end reads. We combined these data with 24,360 ESTs available in GenBank, and 1,040,006 reads newly generated from 454 pyrosequencing of a mixed-stage embryo cDNA library. The combined sequence data were assembled using a custom de novo assembly strategy designed to optimize assembly product length, number of predicted transcripts, and proportion of raw reads incorporated into the assembly. The de novo assembly generated 446,427 contigs with an N50 of 1,875 bp. These sequences obtained 62,799 unique BLAST hits against the NCBI non-redundant protein data base, including putative orthologs to 8,917 Drosophila melanogaster genes based on best reciprocal BLAST hit identity compared with the D. melanogaster proteome. Finally, we explored the utility of the transcriptome for RNA-Seq studies, and showed that this resource can be used as a mapping scaffold to detect differential gene expression in different cDNA libraries. This resource will therefore provide a platform for future genomic, gene expression and functional approaches using P. tepidariorum.	[Posnien, Nico; Prpic, Nikola-Michael] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Dept Dev Biol, Gottingen, Germany; [Zeng, Victor; Schwager, Evelyn E.; Extavour, Cassandra G.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Pechmann, Matthias] Univ Cologne, Cologne Bioctr, Inst Dev Biol, D-50931 Cologne, Germany; [Hilbrant, Maarten; Keefe, Joseph D.; McGregor, Alistair P.] Oxford Brookes Univ, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Damen, Wim G. M.] Univ Jena, Dept Genet, Jena, Germany	University of Gottingen; Harvard University; University of Cologne; Oxford Brookes University; Friedrich Schiller University of Jena	Posnien, N (corresponding author), Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Dept Dev Biol, GZMB Ernst Caspari Haus, Gottingen, Germany.	nposnie@gwdg.de; extavour@oeb.harvard.edu	Extavour, Cassandra G/I-4567-2012; Posnien, Nico/D-1639-2012	Extavour, Cassandra G/0000-0003-2922-5855; McGregor, Alistair/0000-0002-2908-2420; Posnien, Nico/0000-0003-0700-5595	European Union via the Marie Curie RTN ZOONET [MRTN-CT-2004-005624]; Deutsche Forschungsgemeinschaft (DFG) [PR 1109/1-1, PR 1109/6-1]; Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (GGNB); Gottingen Centre for Molecular Biosciences (GZMB); University of Gottingen (GAU); Volkswagen foundation [85 983]; Harvard Stem Cell Institute [SG-0057-10-00]; Ellison Medical Foundation New Scholar Award [AG-NS-07010-10]; National Science Foundation (NSF) [IOS-0817678, IOS-1257217]; DFG fellowship [SCHW 1557/1-1]	European Union via the Marie Curie RTN ZOONET; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (GGNB); Gottingen Centre for Molecular Biosciences (GZMB); University of Gottingen (GAU); Volkswagen foundation(Volkswagen); Harvard Stem Cell Institute; Ellison Medical Foundation New Scholar Award(Lawrence Ellison Foundation); National Science Foundation (NSF)(National Science Foundation (NSF)); DFG fellowship(German Research Foundation (DFG))	MH was funded by the European Union via the Marie Curie RTN ZOONET (MRTN-CT-2004-005624) to WGMD. The work of NMP is supported by the Deutsche Forschungsgemeinschaft (DFG; grant numbers PR 1109/1-1 and PR 1109/6-1 to NMP). Additional financial backing to NMP has been received from the Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (GGNB), the Gottingen Centre for Molecular Biosciences (GZMB), and the University of Gottingen (GAU). The work of NP is partially supported by the Volkswagen foundation (85 983). The work of CGE and VZ is funded by Harvard Stem Cell Institute Seed Grant SG-0057-10-00 to CGE, Ellison Medical Foundation New Scholar Award AG-NS-07010-10 to CGE and National Science Foundation (NSF) Grants IOS-0817678 and IOS-1257217 to GCE. The work of EES is supported by DFG fellowship SCHW 1557/1-1 to EES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama-Oda Y, 2003, DEVELOPMENT, V130, P1735, DOI 10.1242/dev.00390; Akiyama-Oda Y, 2006, DEVELOPMENT, V133, P2347, DOI 10.1242/dev.02400; Basrai MA, 1997, GENOME RES, V7, P768, DOI 10.1101/gr.7.8.768; Brown JB, 2014, DIVERSITY DYNAMICS D; Cao ZJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3602; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chiara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080961; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Clarke TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-365; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Croucher PJP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-862; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Farzana L, 2008, DEV GENES EVOL, V218, P181, DOI 10.1007/s00427-008-0207-2; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; FELSENSTEIN J, 1978, SYST ZOOL, V27, P27, DOI 10.2307/2412810; Fernandes-Pedrosa MD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-279; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; GILBERT DG, 2005, DROSPEGE PUBLIC DATA; Gilbert DG, 2007, NUCLEIC ACIDS RES, V35, pD480, DOI 10.1093/nar/gkl997; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; Grigorian M, 2013, DEV GENES EVOL, V223, P103, DOI 10.1007/s00427-012-0428-2; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; He QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081357; Hilbrant M, 2012, DEVELOPMENT, V139, P2655, DOI 10.1242/dev.078204; Hill CA, 2005, TRENDS PARASITOL, V21, P151, DOI 10.1016/j.pt.2005.02.004; Jackson BM, 2014, G3-GENES GENOM GENET, V4, P733, DOI 10.1534/g3.113.009522; Janssen R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-374; Jiang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040532; Kanayama M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1510; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lorenzini DM, 2006, DEV COMP IMMUNOL, V30, P545, DOI 10.1016/j.dci.2005.09.001; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; McGregor AP, 2008, BIOESSAYS, V30, P487, DOI 10.1002/bies.20744; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mittmann B, 2012, DEV GENES EVOL; Nossa CW, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-9; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Oda H, 2007, DEVELOPMENT, V134, P2195, DOI 10.1242/dev.004598; Odegaard F, 2000, BIOL J LINN SOC, V71, P583, DOI 10.1006/bijl.2000.0468; Oliver JL, 1996, J MOL EVOL, V43, P216, DOI 10.1007/PL00006080; Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936; Pechmann M, 2009, P NATL ACAD SCI USA, V106, P1468, DOI 10.1073/pnas.0811150106; Prosdocimi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021634; Prpic Nikola-Michael, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.emo103; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; R Core Team, 2018, R LANG ENV STAT COMP; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roch F, 2000, DEVELOPMENT, V127, P97; Sanggaard K. W., 2014, NAT COMMUN, V5; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shigenobu S, 2010, INSECT MOL BIOL, V19, P47, DOI 10.1111/j.1365-2583.2009.00944.x; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Telford MJ, 2005, CURR BIOL, V15, pR296, DOI 10.1016/j.cub.2005.04.001; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; Xu AG, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000843; Yamazaki K, 2005, ZOOL SCI, V22, P177, DOI 10.2108/zsj.22.177; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zeng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061479; Zeng V, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas048; Zeng V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-581; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-95; Zhu JG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-117	79	44	45	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104885	10.1371/journal.pone.0104885	http://dx.doi.org/10.1371/journal.pone.0104885			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118601	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600099
J	Su, JH; Li, JD; Zheng, HX; You, YA; Luo, XN; Li, YG; Li, XQ; Ma, XS; Li, JJ; Dou, YX; Cai, XP				Su, Junhong; Li, Jidong; Zheng, Haixue; You, Yanan; Luo, Xuenong; Li, Yungang; Li, Xueqiang; Ma, Xusheng; Li, Junjun; Dou, Yongxi; Cai, Xuepeng			Adjuvant Effects of L. acidophilus LW1 on Immune Responses to the Foot- and-Mouth Disease Virus DNA Vaccine in Mice	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; IFN-GAMMA; DENDRITIC CELLS; LACTOBACILLUS; IMMUNIZATION; EXPRESSION; IMMUNOGENICITY; PROTECTION; INFLUENZA; EPITOPES	The adjuvant effects of Lactobacillus acidophilus on DNA vaccination are not fully understood. It has been hypothesized that swine-derived Lactobacillus acidophilus SW1 (LASW1) could function as an immune adjuvant to enhance antigen-specific immune responses after foot-and-mouth disease (FMD) DNA vaccination in mice. To evaluate the effect of oral LASW1 on the immune response to a DNA vaccine (pRC/CMV-vp1) harboring FMD VP1 gene, anti-FMDV antibody and its isotypes, T-cell proliferation, and cytokine detection were investigated. The results showed that LASW1 was able to enhance FMDV-specific antibody levels and FMDV-neutralizing antibodies. After a booster vaccine, the anti-FMDV antibody titers and FMDV-neutralizing antibodies levels induced by pRC/CMV-vp1 were higher in mice treated with LSAW1 than in the group immunized with pRC/CMV-vp1 alone (the control). Using T-cell proliferation, the stimulation index of the LASW1 group was significantly higher in response to ConA and 146S antigen (P<0.05) than in the control group. Importantly, higher concentrations of IFN-gamma and IFN-gamma-producing cells were also observed in splenocytes isolated from the experimental LASW1 mice, indicating that INF-gamma secretion is important to the immune response to LASW1. The results indicate that LASW1 is a promising immune adjuvant in DNA vaccination against FMD when administrated orally.	[Su, Junhong; Li, Jidong; Zheng, Haixue; You, Yanan; Luo, Xuenong; Li, Xueqiang; Ma, Xusheng; Li, Junjun; Dou, Yongxi; Cai, Xuepeng] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China; [Li, Jidong] Ningxia Univ, Sch Agr, Yinchuan, Peoples R China; [Li, Yungang] Anim Dis Prevent & Control, Shandong Prov Ctr, Jinan, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Ningxia University	Dou, YX (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Peoples R China.	salahu333@126.com; caixp@vip.163.com	YD, Zh/HGA-5541-2022; Su, Junhong/ABG-1496-2021	YD, Zh/0000-0001-6795-9978; zheng, hai xue/0000-0001-6850-1379; su, Junhong/0000-0002-3719-5134	Special Fund for Agro-scientific Research in the Public Interest [201303059]; National High Technology Research and Development Program (863 program) of China [2011AA10A211]; China Agriculture Research System [CARS-40-10]	Special Fund for Agro-scientific Research in the Public Interest; National High Technology Research and Development Program (863 program) of China(National High Technology Research and Development Program of China); China Agriculture Research System	The work was supported by Special Fund for Agro-scientific Research in the Public Interest (No. 201303059), the National High Technology Research and Development Program (863 program) of China (No. 2011AA10A211) and the earmarked fund for China Agriculture Research System (No. CARS-40-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benvenisti L, 2001, VACCINE, V19, P3885, DOI 10.1016/S0264-410X(01)00125-6; Cross ML, 2002, FEMS IMMUNOL MED MIC, V34, P245, DOI 10.1111/j.1574-695X.2002.tb00632.x; Davis HL, 1997, CURR OPIN BIOTECH, V8, P635, DOI 10.1016/S0958-1669(97)80041-9; de Vrese M, 2005, EUR J NUTR, V44, P406, DOI 10.1007/s00394-004-0541-8; Gackowska L, 2006, J PHYSIOL PHARMACOL, V57, P13; GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245; Garcia-Briones MM, 2004, VIROLOGY, V322, P264, DOI 10.1016/j.virol.2004.01.027; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Kim H, 2012, MOL CELLS, V33, P479, DOI 10.1007/s10059-012-2266-5; Kim JJ, 2001, VACCINE, V19, P2496, DOI 10.1016/S0264-410X(00)00479-5; Li YG, 2007, VACCINE, V25, P902, DOI 10.1016/j.vaccine.2006.09.034; OIE, 2012, MANUAL DIAGNOSTIC TE; Olivares M, 2007, NUTRITION, V23, P254, DOI 10.1016/j.nut.2007.01.004; Ouwehand A., 2002, European Journal of Nutrition, V41; Parida S, 2009, EXPERT REV VACCINES, V8, P347, DOI 10.1586/14760584.8.3.347; Pouwels PH, 1996, J BIOTECHNOL, V44, P183, DOI 10.1016/0168-1656(95)00140-9; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; SNAPPER CM, 1988, J IMMUNOL, V140, P2121; Song XM, 2009, VACCINE, V27, P51, DOI 10.1016/j.vaccine.2008.10.030; Su BW, 2008, VACCINE, V26, P5111, DOI 10.1016/j.vaccine.2008.03.089; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; WANG B, 1993, P NATL ACAD SCI USA, V90, P4156, DOI 10.1073/pnas.90.9.4156; WANG B, 1995, HUM GENE THER, V6, P407, DOI 10.1089/hum.1995.6.4-407; Ward G, 1997, J VIROL, V71, P7442, DOI 10.1128/JVI.71.10.7442-7447.1997; Wells JM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S17; West CE, 2008, PEDIAT ALLERG IMM-UK, V19, P53, DOI 10.1111/j.1399-3038.2007.00583.x; Wong HT, 2000, VIROLOGY, V278, P27, DOI 10.1006/viro.2000.0607; Xie F, 2012, CARBOHYD POLYM, V87, P1713, DOI 10.1016/j.carbpol.2011.09.080; Yadav S, 2005, VACCINE, V23, P3005, DOI 10.1016/j.vaccine.2004.12.005; Young HA, 1997, BLOOD, V89, P583, DOI 10.1182/blood.V89.2.583; Zeuthen LH, 2006, CLIN VACCINE IMMUNOL, V13, P365, DOI 10.1128/CVI.13.3.365-375.2006; Zhang HY, 2003, VACCINE, V21, P4704, DOI 10.1016/S0264-410X(03)00519-X; Zhang W, 2008, VACCINE, V26, P3655, DOI 10.1016/j.vaccine.2008.04.070; Zheng HX, 2012, VIRUS GENES, V44, P80, DOI 10.1007/s11262-011-0670-0	34	14	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104446	10.1371/journal.pone.0104446	http://dx.doi.org/10.1371/journal.pone.0104446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119375	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600057
J	Chambers, JC; Abbott, J; Zhang, WH; Turro, E; Scott, WR; Tan, ST; Afzal, U; Afaq, S; Loh, M; Lehne, B; O'Reilly, P; Gaulton, KJ; Pearson, RD; Li, XZ; Lavery, A; Vandrovcova, J; Wass, MN; Miller, K; Sehmi, J; Oozageer, L; Kooner, IK; Al-Hussaini, A; Mills, R; Grewal, J; Panoulas, V; Lewin, AM; Northwood, K; Wander, GS; Geoghegan, F; Li, YR; Wang, J; Aitman, TJ; McCarthy, MI; Scott, J; Butcher, S; Elliott, P; Kooner, JS				Chambers, John C.; Abbott, James; Zhang, Weihua; Turro, Ernest; Scott, William R.; Tan, Sian-Tsung; Afzal, Uzma; Afaq, Saima; Loh, Marie; Lehne, Benjamin; O'Reilly, Paul; Gaulton, Kyle J.; Pearson, Richard D.; Li, Xinzhong; Lavery, Anita; Vandrovcova, Jana; Wass, Mark N.; Miller, Kathryn; Sehmi, Joban; Oozageer, Laticia; Kooner, Ishminder K.; Al-Hussaini, Abtehale; Mills, Rebecca; Grewal, Jagvir; Panoulas, Vasileios; Lewin, Alexandra M.; Northwood, Korrinne; Wander, Gurpreet S.; Geoghegan, Frank; Li, Yingrui; Wang, Jun; Aitman, Timothy J.; McCarthy, Mark I.; Scott, James; Butcher, Sarah; Elliott, Paul; Kooner, Jaspal S.			The South Asian Genome	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; SEQUENCING DATA; RISK-FACTORS; HYPERINSULINEMIA; ANNOTATION; ALBINISM; PROTEIN	The genetic sequence variation of people from the Indian subcontinent who comprise one-quarter of the world's population, is not well described. We carried out whole genome sequencing of 168 South Asians, along with whole-exome sequencing of 147 South Asians to provide deeper characterisation of coding regions. We identify 12,962,155 autosomal sequence variants, including 2,946,861 new SNPs and 312,738 novel indels. This catalogue of SNPs and indels amongst South Asians provides the first comprehensive map of genetic variation in this major human population, and reveals evidence for selective pressures on genes involved in skin biology, metabolism, infection and immunity. Our results will accelerate the search for the genetic variants underlying susceptibility to disorders such as type-2 diabetes and cardiovascular disease which are highly prevalent amongst South Asians.	[Chambers, John C.; Zhang, Weihua; Turro, Ernest; Scott, William R.; Afzal, Uzma; Afaq, Saima; Loh, Marie; Lehne, Benjamin; O'Reilly, Paul; Lavery, Anita; Al-Hussaini, Abtehale; Lewin, Alexandra M.; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, London, England; [Chambers, John C.; Panoulas, Vasileios; Elliott, Paul; Kooner, Jaspal S.] Imperial Coll Healthcare NHS Trust, London, England; [Chambers, John C.; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, MRC HPA, Ctr Environm & Hlth, London, England; [Zhang, Weihua; Tan, Sian-Tsung; Miller, Kathryn; Sehmi, Joban; Oozageer, Laticia; Kooner, Ishminder K.; Mills, Rebecca; Grewal, Jagvir; Geoghegan, Frank; Kooner, Jaspal S.] Ealing Hosp NHS Trust, Southall, Middx, England; [Abbott, James; Wass, Mark N.; Butcher, Sarah] Univ London Imperial Coll Sci Technol & Med, Ctr Integrat Syst Biol & Bioinformat, London, England; [Turro, Ernest] Univ Cambridge, Cambridge, England; [Tan, Sian-Tsung; Sehmi, Joban; Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, NHLI, London, England; [Gaulton, Kyle J.; Pearson, Richard D.; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Li, Xinzhong] Univ London Imperial Coll Sci Technol & Med, Inst Clin Sci, London, England; [Li, Xinzhong] Royal Brompton & Harefield Hosp NHS Trust, London, England; [Vandrovcova, Jana; Northwood, Korrinne; Aitman, Timothy J.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, London, England; [Wander, Gurpreet S.] Dayanand Med Coll & Hosp, Hero DMC Heart Inst, Ludhiana, Punjab, India; [Li, Yingrui; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [McCarthy, Mark I.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; University of Cambridge; Imperial College London; University of Oxford; Wellcome Centre for Human Genetics; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Imperial College London; Dayanand Medical College & Hospital; Beijing Genomics Institute (BGI); University of Oxford; University of Oxford	Chambers, JC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Norfolk Pl, London, England.	john.chambers@ic.ac.uk; p.elliott@imperial.ac.uk; j.kooner@imperial.ac.uk	Li, Yingrui/K-1064-2015; li, xin/HHS-9461-2022; zhang, weihua/GXV-1334-2022; Wass, Mark/H-3398-2019; Wang, Jun/C-8434-2016; McCarthy, Mark/M-3763-2015; Wang, Jun/B-9503-2016	Wass, Mark/0000-0001-5428-6479; Abbott, James/0000-0001-7701-4249; O'Reilly, Paul/0000-0001-7515-0845; Wang, Jun/0000-0002-8540-8931; Turro, Ernest/0000-0002-1820-6563; Hughes, Rebecca/0000-0003-2110-5234; Lavery, Anita/0000-0002-3805-6777; McCarthy, Mark/0000-0002-4393-0510; Elliott, Paul/0000-0002-7511-5684; Loh, Marie/0000-0003-3626-8466; Aitman, Timothy/0000-0002-7875-4502; Scott, William/0000-0001-5467-114X; Wang, Jun/0000-0002-2113-5874; Lewin, Alexandra/0000-0003-0081-7582	Imperial College Healthcare NHS Trust cBRC; BBSRC [BB/G000352/1] Funding Source: UKRI; MRC [MC_U120061454, MR/K002414/1, G0801056] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G000352/1] Funding Source: researchfish; Medical Research Council [MC_U120061454, MR/K002414/1, G0801056] Funding Source: researchfish; National Institute for Health Research [ACF-2009-18-005, NF-SI-0611-10099, ACF-2010-21-047, NF-SI-0611-10136] Funding Source: researchfish	Imperial College Healthcare NHS Trust cBRC; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Whole genome sequencing to discover genetic variants underlying type-2 diabetes, coronary heart disease and related phenotypes amongst Indian Asians. Imperial College Healthcare NHS Trust cBRC 2011-13 (JS Kooner [PI], JC Chambers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ARMSTRONG BK, 1995, DERMATOL CLIN, V13, P583, DOI 10.1016/S0733-8635(18)30064-0; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Back K, 2012, J ENDOCRINOL, V215, P89, DOI 10.1530/JOE-12-0261; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Branicki W, 2008, J HUM GENET, V53, P966, DOI 10.1007/s10038-008-0338-3; Brenner M, 2008, PHOTOCHEM PHOTOBIOL, V84, P539, DOI 10.1111/j.1751-1097.2007.00226.x; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Castro A, 2010, ATHEROSCLEROSIS, V209, P201, DOI 10.1016/j.atherosclerosis.2009.09.072; Chambers JC, 2001, CIRCULATION, V104, P145, DOI 10.1161/01.CIR.104.2.145; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Christiansen J, 2009, J MOL ENDOCRINOL, V43, P187, DOI 10.1677/JME-09-0016; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Forouhi NG, 2006, DIABETOLOGIA, V49, P2580, DOI 10.1007/s00125-006-0393-2; Forshew T, 2005, CLIN GENET, V68, P182, DOI 10.1111/j.1399-0004.2005.00460.x; Grant JR, 2011, BIOINFORMATICS, V27, P2300, DOI 10.1093/bioinformatics/btr372; Gupta R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-440; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hoshina T, 2011, J CLIN IMMUNOL, V31, P309, DOI 10.1007/s10875-010-9498-y; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ingley E, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-21; Jimenez-Marin Angeles, 2009, BMC Proc, V3 Suppl 4, pS6, DOI 10.1186/1753-6561-3-S4-S6; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; John TJ, 2011, LANCET, V377, P252, DOI 10.1016/S0140-6736(10)61265-2; Johnson HM, 2011, J CLIN CELL IMMUNOL, V2; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Leduc MS, 2008, J LIPID RES, V49, P2648, DOI 10.1194/jlr.M800155-JLR200; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacGregor S, 2011, NAT GENET, V43, P1114, DOI 10.1038/ng.958; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1988, BRIT HEART J, V60, P390; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mondal M, 2012, GENE, V511, P470, DOI 10.1016/j.gene.2012.09.012; Neuman JA, 2013, BRIEF BIOINFORM, V14, P46, DOI 10.1093/bib/bbs013; Patel V, 2011, LANCET, V377, P413, DOI 10.1016/S0140-6736(10)61188-9; Patterson N, 2010, HUM MOL GENET, V19, P411, DOI 10.1093/hmg/ddp505; Prudente S, 2009, NAT REV ENDOCRINOL, V5, P682, DOI 10.1038/nrendo.2009.215; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LH, 2012, J MICROBIOL IMMUNOL, V45, P411, DOI 10.1016/j.jmii.2012.08.017	47	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e102645	10.1371/journal.pone.0102645	http://dx.doi.org/10.1371/journal.pone.0102645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115870	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000341230400006
J	Jia, XZ; Li, JB; Shi, DJ; Zhao, Y; Dong, YC; Ju, HY; Yang, JF; Sun, JH; Li, X; Ren, H				Jia, Xiuzhi; Li, Jingbo; Shi, Dejing; Zhao, Yu; Dong, Yucui; Ju, Huanyu; Yang, Jinfeng; Sun, Jianhua; Li, Xia; Ren, Huan			Grouping Annotations on the Subcellular Layered Interactome Demonstrates Enhanced Autophagy Activity in a Recurrent Experimental Autoimmune Uveitis T Cell Linel	PLOS ONE			English	Article							GENE-EXPRESSION; ONTOLOGY	Human uveitis is a type of T cell-mediated autoimmune disease that often shows relapse-remitting courses affecting multiple biological processes. As a cytoplasmic process, autophagy has been seen as an adaptive response to cell death and survival, yet the link between autophagy and T cell-mediated autoimmunity is not certain. In this study, based on the differentially expressed genes (GSE19652) between the recurrent versus monophasic T cell lines, whose adoptive transfer to susceptible animals may result in respective recurrent or monophasic uveitis, we proposed grouping annotations on a subcellular layered interactome framework to analyze the specific bioprocesses that are linked to the recurrence of T cell autoimmunity. That is, the subcellular layered interactome was established by the Cytoscape and Cerebral plugin based on differential expression, global interactome, and subcellular localization information. Then, the layered interactomes were grouping annotated by the ClueGO plugin based on Gene Ontology and Kyoto Encyclopedia of Genes and Genomes databases. The analysis showed that significant bioprocesses with autophagy were orchestrated in the cytoplasmic layered interactome and that mTOR may have a regulatory role in it. Furthermore, by setting up recurrent and monophasic uveitis in Lewis rats, we confirmed by transmission electron microscopy that, in comparison to the monophasic disease, recurrent uveitis in vivo showed significantly increased autophagy activity and extended lymphocyte infiltration to the affected retina. In summary, our framework methodology is a useful tool to disclose specific bioprocesses and molecular targets that can be attributed to a certain disease. Our results indicated that targeted inhibition of autophagy pathways may perturb the recurrence of uveitis.	[Jia, Xiuzhi; Zhao, Yu; Dong, Yucui; Ju, Huanyu; Yang, Jinfeng; Ren, Huan] Harbin Med Univ, Dept Immunol, Harbin, Peoples R China; [Jia, Xiuzhi; Zhao, Yu; Dong, Yucui; Ju, Huanyu; Yang, Jinfeng; Ren, Huan] Key Lab Heilongjiang Prov, Harbin, Peoples R China; [Jia, Xiuzhi; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Li, Jingbo] Harbin Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Harbin, Peoples R China; [Shi, Dejing] Harbin Med Univ, Affiliated Hosp 4, Dept Ophthalmol, Harbin, Peoples R China; [Sun, Jianhua] Blood Ctr Hei Long Jiang Prov, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Li, X (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	lixia@ems.hrbmu.edu.cn; renhuan@ems.hrbmu.edu.cn	li, xia/HHZ-7468-2022; Ren, Huan/O-5727-2017; Yang, Jinfeng/GSN-6506-2022	Ren, Huan/0000-0001-7114-2012	Heilongjiang Provincial Education Department [12521180]; Heilongjiang Province Postdoctoral Project [LBH-Z12179]; China Postdoctoral Project [2013M541411]; Heilongjiang Provincial Health Office [2011-208]; Fund of "Spring Sunshine Program'' [Z2010003]; Harbin Science and Technology Bureau [RC2011XK003008]; Key Laboratory of Neurobiology, General Colleges and Universities in Heilongjiang Province of China [2012HLJKLNT-10]	Heilongjiang Provincial Education Department; Heilongjiang Province Postdoctoral Project; China Postdoctoral Project; Heilongjiang Provincial Health Office; Fund of "Spring Sunshine Program''; Harbin Science and Technology Bureau; Key Laboratory of Neurobiology, General Colleges and Universities in Heilongjiang Province of China	This work was supported by the Fund of Heilongjiang Provincial Education Department (12521180), the Fund of Heilongjiang Province Postdoctoral Project (LBH-Z12179), the Fund of China Postdoctoral Project (2013M541411), the Fund of Heilongjiang Provincial Health Office (2011-208), the Fund of "Spring Sunshine Program'' (Z2010003), the Fund of Harbin Science and Technology Bureau (RC2011XK003008), and Open Topic of Key Laboratory of Neurobiology, General Colleges and Universities in Heilongjiang Province of China (2012HLJKLNT-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyenko A, 2012, NUCLEIC ACIDS RES, V40, pD821, DOI 10.1093/nar/gkr1062; Alirezaei M, 2009, AUTOPHAGY, V5, P152, DOI 10.4161/auto.5.2.7348; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barsky A, 2007, BIOINFORMATICS, V23, P1040, DOI 10.1093/bioinformatics/btm057; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; CABEZAARVELAIZ Y, 1993, DNA CELL BIOL, V12, P881, DOI 10.1089/dna.1993.12.881; Caspi RR, 2011, INVEST OPHTH VIS SCI, V52, P1873, DOI 10.1167/iovs.10-6909; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Diedrichs-Mohring M, 2008, INT IMMUNOL, V20, P365, DOI 10.1093/intimm/dxm148; Dreger M, 2003, MASS SPECTROM REV, V22, P27, DOI 10.1002/mas.10047; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Gianchecchi E, 2014, AUTOIMMUN REV, V13, P231, DOI 10.1016/j.autrev.2013.10.007; Greenhalgh T, 2012, BRIT J GEN PRACT, V62, P541, DOI 10.3399/bjgp12X656900; Jia XZ, 2011, MOL VIS, V17, P1493; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaufmann U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049008; Ke Y, 2008, INVEST OPHTH VIS SCI, V49, P3999, DOI 10.1167/iovs.07-1468; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li YJ, 2011, DIABETES RES CLIN PR, V94, P242, DOI 10.1016/j.diabres.2011.07.027; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Quintero-Ronderos P, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/593720; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Sun M, 2010, INVEST OPHTH VIS SCI, V51, P383, DOI 10.1167/iovs.09-3514; SuttorpSchulten MSA, 1996, BRIT J OPHTHALMOL, V80, P844, DOI 10.1136/bjo.80.9.844; Swampillai AL, 2011, CLIN ONCOL R COLL RA; Tang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014207; Tanida I, 2006, AUTOPHAGY, V2, P264, DOI 10.4161/auto.2871; von Toerne C, 2010, MOL IMMUNOL, V48, P272, DOI 10.1016/j.molimm.2010.07.017; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wildner G, 2013, AUTOIMMUN REV, V12, P1070, DOI 10.1016/j.autrev.2013.04.001; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036589; Zhu WL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006288	38	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104404	10.1371/journal.pone.0104404	http://dx.doi.org/10.1371/journal.pone.0104404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116327	gold, Green Submitted, Green Published			2022-12-27	WOS:000341230400047
J	Lyabin, DN; Doronin, AN; Eliseeva, IA; Guens, GP; Kulakovskiy, IV; Ovchinnikov, LP				Lyabin, Dmitry N.; Doronin, Alexander N.; Eliseeva, Irina A.; Guens, Gelena P.; Kulakovskiy, Ivan V.; Ovchinnikov, Lev P.			Alternative Forms of Y-Box Binding Protein 1 and YB-1 mRNA	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSLATION; CELLS; TRANSCRIPTION; INITIATION; DATABASE; SITES	The multifunctional eukaryotic protein YB-1 (Y-box binding protein 1) plays a role in DNA reparation, transcription regulation, splicing, and mRNA translation, thereby participating in many crucial events in cells. Its effect is dependent mostly on its amount, and hence, on regulation of its synthesis. Published data on regulation of synthesis of YB-1 mediated by its mRNA 5' UTR, and specifically on the 5' UTR length and the presence of TOP-like motifs in this region, are contradictory. Here we report that 5' UTRs of major forms of human, rabbit, and mouse YB-1 mRNAs are about 140 nucleotides long and contain no TOP-like motifs mentioned in the literature. Also, we have found that YB-1 specifically interacts with the 5' UTR of its own mRNA within a region of about 100 nucleotides upstream from the start codon. Apart from YB-1, translation of YB-1 mRNA in a cell free system gives an additional product with an extended N-terminus and lower electrophoretic mobility. The start codon for synthesis of the additional product is AUC at position -(60-58) of the same open reading frame as that for the major product. Also, in the cell there is an alternative YB-1 mRNA with exon 1 replaced by a part of intron 1; YB-1 synthesized in vitro from this mRNA contains, instead of its N-terminal A/P domain, 10-11 amino acids encoded by intron 1.	[Lyabin, Dmitry N.; Doronin, Alexander N.; Eliseeva, Irina A.; Ovchinnikov, Lev P.] Russian Acad Sci, Inst Prot Res, Pushchino 142292, Moscow Region, Russia; [Guens, Gelena P.] Moscow State Univ Med & Dent, Dept Oncol & Radiat Therapy, Moscow, Russia; [Kulakovskiy, Ivan V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Kulakovskiy, Ivan V.] Russian Acad Sci, Vavilov Inst Gen Genet, Dept Computat Syst Biol, Moscow, Russia	Russian Academy of Sciences; Moscow State University of Medicine & Dentistry; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Vavilov Institute of General Genetics	Ovchinnikov, LP (corresponding author), Russian Acad Sci, Inst Prot Res, Pushchino 142292, Moscow Region, Russia.	ovchinn@vega.protres.ru	Kulakovskiy, Ivan/A-1462-2014; Doronin, Alexander/AAO-1453-2020; Ovchinnikov, Lev/L-2397-2015; Irina, Eliseeva/J-8175-2015; Lyabin, Dmitry/K-3178-2013	Kulakovskiy, Ivan/0000-0002-6554-8128; Doronin, Alexander/0000-0002-7149-8550; Guens, Gelena/0000-0001-8708-2712	Russian Academy of Sciences, Russian Foundation for Basic Research [14-04-01838, 14-04-00027, 14-04-31517]	Russian Academy of Sciences, Russian Foundation for Basic Research(Russian Academy of SciencesRussian Foundation for Basic Research (RFBR))	This work was supported by Programs on "Molecular and Cell Biology'' and "Basic Sciences to Medicine'' of the Russian Academy of Sciences, Russian Foundation for Basic Research [# 14-04-01838, # 14-04-00027, # 14-04-31517]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; David JJ, 2012, EXP BIOL MED, V237, P593, DOI 10.1258/ebm.2012.011137; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Eliseeva IA, 2013, TRANSLATION, V1, DOI 10.4161/trla.27469; Eliseeva IA, 2012, RNA BIOL, V9, P1473, DOI 10.4161/rna.22711; Evdokimova V, 2012, SEMIN CANCER BIOL, V22, P437, DOI 10.1016/j.semcancer.2012.04.007; EVDOKIMOVA VM, 1995, J BIOL CHEM, V270, P3186, DOI 10.1074/jbc.270.7.3186; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Fukuda T, 2004, NUCLEIC ACIDS RES, V32, P611, DOI 10.1093/nar/gkh223; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Kanamori-Katayama M, 2011, GENOME RES, V21, P1150, DOI 10.1101/gr.115469.110; Lasham A, 2013, BIOCHEM J, V449, P11, DOI 10.1042/BJ20121323; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Lyabin DN, 2013, BIOCHEMISTRY-MOSCOW+, V78, P651, DOI 10.1134/S0006297913060102; Lyabin DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052527; Lyabin DN, 2011, RNA BIOL, V8, P883, DOI 10.4161/rna.8.5.16022; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; POKROVSKAYA ID, 1994, ANAL BIOCHEM, V220, P420, DOI 10.1006/abio.1994.1360; Skabkina OV, 2005, MOL CELL BIOL, V25, P3317, DOI 10.1128/MCB.25.8.3317-3323.2005; Skabkina OV, 2003, J BIOL CHEM, V278, P18191, DOI 10.1074/jbc.M209073200; Yamashita R, 2012, NUCLEIC ACIDS RES, V40, pD150, DOI 10.1093/nar/gkr1005	24	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104513	10.1371/journal.pone.0104513	http://dx.doi.org/10.1371/journal.pone.0104513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116735	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400053
J	Abendano, N; Tyukalova, L; Barandika, JF; Balseiro, A; Sevilla, IA; Garrido, JM; Juste, RA; Alonso-Hearn, M				Abendano, Naiara; Tyukalova, Lyudmila; Barandika, Jesse F.; Balseiro, Ana; Sevilla, Iker A.; Garrido, Joseba M.; Juste, Ramon A.; Alonso-Hearn, Marta			Mycobacterium Avium subsp Paratuberculosis Isolates Induce In Vitro Granuloma Formation and Show Successful Survival Phenotype, Common Anti-Inflammatory and Antiapoptotic Responses within Ovine Macrophages Regardless of Genotype or Host of Origin	PLOS ONE			English	Article							GENE-EXPRESSION; BOVINE MACROPHAGES; INTRACELLULAR SURVIVAL; EXPERIMENTAL-INFECTION; JOHNES-DISEASE; STRAINS; CATTLE; CELLS; MONOCYTES; DISTINCT	The analysis of the early macrophage responses, including bacterial growth within macrophages, represents a powerful tool to characterize the virulence of clinical isolates of Mycobcaterium avium susbp. paratuberculosis (Map). The present study represents the first assessment of the intracellular behaviour in ovine monocyte-derived macrophages (MDMs) of Map isolates representing distinct genotypes (C, S and B), and isolated from cattle, sheep, goat, fallow deer, deer, and wild boar. Intracellular growth and survival of the selected isolates in ovine MDMs was assessed by quantification of CFUs inside of the host cells at 2 h p.i. (day 0) and 7 d p.i. using an automatic liquid culture system (Bactec MGIT 960). Variations in bacterial counts over 7 days from the baseline were small, in a range between 1.63 to 1.05-fold. After 7 d of infection, variations in the estimated log(10) CFUs between all the tested isolates were not statistically significant. In addition, ovine MDMs exhibited enhanced anti-inflammatory, antiapoptotic and antidestructive responses when infected with two ovine isolates of distinct genotype (C and S) or with two C-type isolates from distinct hosts (cattle and sheep); which correlated with the successful survival of these isolates within ovine MDMs. A second objective was to study, based on an in vitro granuloma model, latter stages of the infection by investigating the capacity of two Map isolates from cattle and sheep to trigger formation of microgranulomas. Upon 10 d p.i., both Map isolates were able to induce the formation of granulomas comparable to the granulomas observed in clinical specimens with respect to the cellular components involved. In summary, our results demonstrated that Map isolates from cattle, sheep, goats, deer, fallow-deer and wild boar were able not only to initiate but also to establish a successful infection in ovine macrophages regardless of genotype.	[Abendano, Naiara; Tyukalova, Lyudmila; Barandika, Jesse F.; Sevilla, Iker A.; Garrido, Joseba M.; Juste, Ramon A.; Alonso-Hearn, Marta] NEIKER Tecnalia, Basque Inst Agr Res & Dev, Dept Anim Hlth, Bizkaia, Spain; [Balseiro, Ana] SERIDA, Reg Govt Principal Asturias, Dept Agr, Dept Anim Hlth, Deva, Asturias, Spain	Servicio Regional Investigacion Desarrollo Agroalimentario - SERIDA	Alonso-Hearn, M (corresponding author), NEIKER Tecnalia, Basque Inst Agr Res & Dev, Dept Anim Hlth, Technol Pk Bizkaia, Bizkaia, Spain.		Abendaño, Naiara/L-3535-2017; Sevilla, Iker A/O-6060-2014; GARRIDO, JOSEBA M/L-3202-2014; Balseiro, Ana/O-1794-2019; Juste, Ramon/C-3570-2008	Abendaño, Naiara/0000-0001-9719-0688; Sevilla, Iker A/0000-0003-3968-3390; Balseiro, Ana/0000-0002-5121-7264; Juste, Ramon/0000-0001-6037-5873; Alonso-Hearn, Marta/0000-0001-5979-347X; Joseba M., Garrido/0000-0002-7559-0653	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA); European Funds for Regional Development (FEDER) [RTA2011-00049]; department of Agriculture of the Basque Government	Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA)(Instituto de Investigacion Agropecuaria (INIA)); European Funds for Regional Development (FEDER)(European Commission); department of Agriculture of the Basque Government	Financial support for this work was provided by a grant from the Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (INIA) and by European Funds for Regional Development (FEDER) (RTA2011-00049). Naiara Abendano has a fellowship from the department of Agriculture of the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendano N, 2013, VET MICROBIOL, V163, P325, DOI 10.1016/j.vetmic.2012.12.042; Abendano N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/908348; Abendano N, 2012, J CLIN MICROBIOL, V50, P2609, DOI 10.1128/JCM.00441-12; ADURIZ JJ, 1995, VET MICROBIOL, V45, P211, DOI 10.1016/0378-1135(95)00037-B; Bakker D, 2000, VET QUART, V22, P200, DOI 10.1080/01652176.2000.9695058; Bermudez LE, 2010, INFECT IMMUN, V78, P3570, DOI 10.1128/IAI.01411-09; Birkness KA, 2007, IMMUNOL CELL BIOL, V85, P160, DOI 10.1038/sj.icb.7100019; COLLINS DM, 1990, J CLIN MICROBIOL, V28, P1591, DOI 10.1128/JCM.28.7.1591-1596.1990; Coussens PM, 2003, INFECT IMMUN, V71, P6487, DOI 10.1128/IAI.71.11.6487-6498.2003; Emile JF, 1997, J PATHOL, V181, P25, DOI 10.1002/(SICI)1096-9896(199701)181:1<25::AID-PATH747>3.0.CO;2-Z; Fernandez M, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-5; Harriff MJ, 2008, APPL ENVIRON MICROB, V74, P275, DOI 10.1128/AEM.01480-07; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Hostetter J, 2003, COMP IMMUNOL MICROB, V26, P269, DOI 10.1016/S0147-9571(02)00070-X; Janagama HK, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-10; Juste RA, 2005, J VET DIAGN INVEST, V17, P354, DOI 10.1177/104063870501700409; Kabara E, 2010, BRIEF FUNCT GENOMICS, V9, P220, DOI 10.1093/bfgp/elq009; Kapoor N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053657; Lay G, 2007, J PATHOL, V211, P76, DOI 10.1002/path.2092; MacHugh DE, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-25; Murphy JT, 2006, PHYSIOL GENOMICS, V28, P67, DOI 10.1152/physiolgenomics.00098.2006; Nielsen SS, 2009, PREV VET MED, V88, P1, DOI 10.1016/j.prevetmed.2008.07.003; Olivier M, 2001, VET IMMUNOL IMMUNOP, V82, P139, DOI 10.1016/S0165-2427(01)00330-0; Ott SL, 1999, PREV VET MED, V40, P179, DOI 10.1016/S0167-5877(99)00037-9; Peterson K, 2006, SMALL RUMINANT RES, V65, P136, DOI 10.1016/j.smallrumres.2005.05.037; Puissegur MP, 2007, J IMMUNOL, V178, P3161, DOI 10.4049/jimmunol.178.5.3161; Puissegur MP, 2004, CELL MICROBIOL, V6, P423, DOI 10.1111/j.1462-5822.2004.00371.x; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Seitzer U, 2003, CELLS TISSUES ORGANS, V174, P110, DOI 10.1159/000071151; Sergeant E, 2001, AUST VET J, V79, P484, DOI 10.1111/j.1751-0813.2001.tb13021.x; Sevilla I, 2005, REV SCI TECH OIE, V24, P1061, DOI 10.20506/rst.24.3.1634; Sevilla I, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-18; Sommer S, 2009, VET IMMUNOL IMMUNOP, V128, P44, DOI 10.1016/j.vetimm.2008.10.294; Stevenson K, 2002, J CLIN MICROBIOL, V40, P1798, DOI 10.1128/JCM.40.5.1798-1804.2002; Theus SA, 2005, J INFECT DIS, V191, P453, DOI 10.1086/425936; Verna AE, 2007, ZOONOSES PUBLIC HLTH, V54, P243, DOI 10.1111/j.1863-2378.2007.01058.x; Weiss DJ, 2004, VET PATHOL, V41, P326, DOI 10.1354/vp.41-4-326; Weiss DJ, 2002, INFECT IMMUN, V70, P5556, DOI 10.1128/IAI.70.10.5556-5561.2002; Whittington RJ, 2001, MOL CELL PROBE, V15, P139, DOI 10.1006/mcpr.2001.0346; Woo SR, 2006, VET IMMUNOL IMMUNOP, V110, P109, DOI 10.1016/j.vetimm.2005.09.010	42	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104238	10.1371/journal.pone.0104238	http://dx.doi.org/10.1371/journal.pone.0104238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111300	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100043
J	Bergstrom, JH; Berg, KA; Rodriguez-Pineiro, AM; Stecher, B; Johansson, MEV; Hansson, GC				Bergstrom, Joakim H.; Berg, Katarina A.; Rodriguez-Pineiro, Ana M.; Stecher, Baerbel; Johansson, Malin E. V.; Hansson, Gunnar C.			AGR2, an Endoplasmic Reticulum Protein, Is Secreted into the Gastrointestinal Mucus	PLOS ONE			English	Article							ANTERIOR GRADIENT 2; SMALL-INTESTINE; MOUSE STOMACH; MUCIN; LAYERS; GENE; HOMEOSTASIS; EXPRESSION; TERMINUS; DISEASE	The MUC2 mucin is the major constituent of the two mucus layers in colon. Mice lacking the disulfide isomerase-like protein Agr2 have been shown to be more susceptible to colon inflammation. The Agr2(-/-) mice have less filled goblet cells and were now shown to have a poorly developed inner colon mucus layer. We could not show AGR2 covalently bound to recombinant MUC2 N- and C-termini as have previously been suggested. We found relatively high concentrations of Agr2 in secreted mucus throughout the murine gastrointestinal tract, suggesting that Agr2 may play extracellular roles. In tissue culture (CHO-K1) cells, AGR2 is normally not secreted. Replacement of the single Cys in AGR2 with Ser (C81S) allowed secretion, suggesting that modification of this Cys might provide a mechanism for circumventing the KTEL endoplasmic reticulum retention signal. In conclusion, these results suggest that AGR2 has both intracellular and extracellular effects in the intestine.	[Bergstrom, Joakim H.; Berg, Katarina A.; Rodriguez-Pineiro, Ana M.; Johansson, Malin E. V.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden; [Stecher, Baerbel] Ludwig Maximilians Univ Munchen, Max von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany	University of Gothenburg; University of Munich	Hansson, GC (corresponding author), Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden.	gunnar.hansson@medkem.gu.se	Stecher, Bärbel/A-2911-2015; Johansson, Malin E. V./HCH-7451-2022; Hansson, Gunnar C/A-1236-2009; Rodriguez-Pineiro, Ana M./AAF-6353-2020; Stecher, Barbel/B-9940-2019; Hansson, Gunnar C./AAF-7324-2019	Stecher, Bärbel/0000-0002-7445-5193; Hansson, Gunnar C/0000-0002-1900-1869; Hansson, Gunnar C./0000-0002-1900-1869; Johansson, Malin E. V./0000-0002-4237-6677	Swedish Research Council; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUA-ALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; National Institute of Allergy and Infectious Diseases [U01AI095473]; German Research Foundation [DFG STE1971/4-1]; Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); IngaBritt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUA-ALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); German Research Foundation(German Research Foundation (DFG)); Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swedish Research Council, The Swedish Cancer Foundation, The Knut and Alice Wallenberg Foundation, IngaBritt and Arne Lundberg Foundation, Sahlgren's University Hospital (LUA-ALF), Wilhelm and Martina Lundgren's Foundation, Torsten och Ragnar Soderbergs Stiftelser, The Sahlgrenska Academy, the National Institute of Allergy and Infectious Diseases (U01AI095473, the content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH), German Research Foundation (DFG STE1971/4-1), and The Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley L, 1996, DEVELOPMENT, V122, P2739; Chevet E, 2013, ONCOGENE, V32, P2499, DOI 10.1038/onc.2012.346; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Ermund A, 2013, AM J PHYSIOL-GASTR L, V305, pG341, DOI 10.1152/ajpgi.00046.2013; Godl K, 2002, J BIOL CHEM, V277, P47248, DOI 10.1074/jbc.M208483200; Gupta A, 2013, J BIOL CHEM, V288, P4321, DOI 10.1074/jbc.M112.433086; Gupta A, 2012, J BIOL CHEM, V287, P4773, DOI 10.1074/jbc.M111.301531; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; HANSSON GC, 1994, BIOCHEM BIOPH RES CO, V198, P181, DOI 10.1006/bbrc.1994.1026; Higa A, 2011, J BIOL CHEM, V286, P44855, DOI 10.1074/jbc.M111.275529; Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson MEV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012238; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kumar A, 2011, P NATL ACAD SCI USA, V108, P13588, DOI 10.1073/pnas.1108472108; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Lidell ME, 2003, BIOCHEM J, V372, P335, DOI 10.1042/BJ20030003; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Patel P, 2013, J MOL BIOL, V425, P929, DOI 10.1016/j.jmb.2012.12.009; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Rodriguez-Pineiro AM, 2013, AM J PHYSIOL-GASTR L, V305, pG348, DOI 10.1152/ajpgi.00047.2013; Ryu J, 2013, BIOCHEM BIOPH RES CO, V430, P610, DOI 10.1016/j.bbrc.2012.11.105; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Verma S, 2012, DEV BIOL, V369, P249, DOI 10.1016/j.ydbio.2012.06.030; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zheng W, 2006, GENES IMMUN, V7, P11, DOI 10.1038/sj.gene.6364263	28	40	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104186	10.1371/journal.pone.0104186	http://dx.doi.org/10.1371/journal.pone.0104186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111734	Green Submitted, Green Published, gold			2022-12-27	WOS:000341105100035
J	He, Y; Meng, YL; Gong, H; Chen, SB; Zhang, B; Ding, WX; Luo, QM; Li, AA				He, Yong; Meng, Yunlong; Gong, Hui; Chen, Shangbin; Zhang, Bin; Ding, Wenxiang; Luo, Qingming; Li, Anan			An Automated Three-Dimensional Detection and Segmentation Method for Touching Cells by Integrating Concave Points Clustering and Random Walker Algorithm	PLOS ONE			English	Article							NUCLEI; BRAIN; ATLAS; GPU	Characterizing cytoarchitecture is crucial for understanding brain functions and neural diseases. In neuroanatomy, it is an important task to accurately extract cell populations' centroids and contours. Recent advances have permitted imaging at single cell resolution for an entire mouse brain using the Nissl staining method. However, it is difficult to precisely segment numerous cells, especially those cells touching each other. As presented herein, we have developed an automated three-dimensional detection and segmentation method applied to the Nissl staining data, with the following two key steps: 1) concave points clustering to determine the seed points of touching cells; and 2) random walker segmentation to obtain cell contours. Also, we have evaluated the performance of our proposed method with several mouse brain datasets, which were captured with the micro-optical sectioning tomography imaging system, and the datasets include closely touching cells. Comparing with traditional detection and segmentation methods, our approach shows promising detection accuracy and high robustness.	[He, Yong; Meng, Yunlong; Gong, Hui; Chen, Shangbin; Zhang, Bin; Ding, Wenxiang; Luo, Qingming; Li, Anan] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China; [He, Yong; Meng, Yunlong; Gong, Hui; Chen, Shangbin; Zhang, Bin; Ding, Wenxiang; Luo, Qingming; Li, Anan] Huazhong Univ Sci & Technol, MoE Key Lab Biomed Photon, Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Li, AA (corresponding author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China.	aali@mail.hust.edu.cn		Luo, Qingming/0000-0002-6725-9311	National Nature Science Foundation of China [81171067, 61102122]; 863 Program [2012AA020401, 2012AA020404]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Program(National High Technology Research and Development Program of China)	This work was supported by the National Nature Science Foundation of China (Grant Nos. 81171067, 61102122) (URL: http://www.nsfc.gov.cn/) and 863 Program (Grant Nos. 2012AA020401, 2012AA020404) (URL: http://www.863.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; Bagci U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057105; Bai XZ, 2009, PATTERN RECOGN, V42, P2434, DOI 10.1016/j.patcog.2009.04.003; Bashar MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035550; Bolz J, 2003, ACM T GRAPHIC, V22, P917, DOI 10.1145/882262.882364; Chang H, 2007, PATTERN RECOGN LETT, V28, P1781, DOI 10.1016/j.patrec.2007.05.008; Daszykowski M, 2001, CHEMOMETR INTELL LAB, V56, P83, DOI 10.1016/S0169-7439(01)00111-3; Ding W, 2013, J MICROSC-OXFORD, V251, P168, DOI 10.1111/jmi.12058; Dufour A, 2005, IEEE T IMAGE PROCESS, V14, P1396, DOI 10.1109/TIP.2005.852790; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fernandez G., 1995, Image Analysis and Processing. 8th International Conference, ICIAP '95. Proceedings, P229; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; Han J. H., 1990, Proceedings. Third International Conference on Computer Vision (Cat. No.90CH2934-8), P71, DOI 10.1109/ICCV.1990.139496; Indhumathi C, 2011, J MICROSC-OXFORD, V243, P60, DOI 10.1111/j.1365-2818.2010.03482.x; KOTHARI S, 2009, IEEE INT S BIOM IM N, P795; Kruger J, 2003, ACM T GRAPHIC, V22, P908, DOI 10.1145/882262.882363; Kumar S, 2006, PATTERN RECOGN, V39, P1088, DOI 10.1016/j.patcog.2005.11.014; Li AA, 2010, SCIENCE, V330, P1404, DOI 10.1126/science.1191776; Li G, 2008, J MICROSC-OXFORD, V231, P47, DOI 10.1111/j.1365-2818.2008.02016.x; Li G, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-40; Liu TM, 2008, NEUROINFORMATICS, V6, P5, DOI 10.1007/s12021-007-9005-7; Ljosa V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000603; Mosaliganti KR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002780; Osten P, 2013, NAT METHODS, V10, P515, DOI [10.1038/NMETH.2477, 10.1038/nmeth.2477]; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pal SK, 2000, INT J REMOTE SENS, V21, P2269, DOI 10.1080/01431160050029567; Parvin B, 2007, IEEE T IMAGE PROCESS, V16, P615, DOI 10.1109/TIP.2007.891154; Qi X, 2012, IEEE T BIO-MED ENG, V59, P754, DOI 10.1109/TBME.2011.2179298; Rodriguez R, 2005, COMPUT BIOL MED, V35, P665, DOI 10.1016/j.compbiomed.2004.06.003; Stalling D., 2005, VISUAL HDB, V38, P749, DOI DOI 10.1016/B978-012387582-2/50040-X; Stegmaier J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090036; Wahlby C, 2004, J MICROSC-OXFORD, V215, P67, DOI 10.1111/j.0022-2720.2004.01338.x; Wen Q, 2009, I S BIOMED IMAGING, P9, DOI 10.1109/ISBI.2009.5192970; Wu JP, 2014, NEUROIMAGE, V87, P199, DOI 10.1016/j.neuroimage.2013.10.036; Zhang B, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 AND 2, P476	37	8	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104437	10.1371/journal.pone.0104437	http://dx.doi.org/10.1371/journal.pone.0104437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111442	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100058
J	Huang, CY; Chang, CW; Chen, CR; Chuang, CY; Chiang, CS; Shu, WY; Fan, TC; Hsu, IC				Huang, Chao-Ying; Chang, Cheng-Wei; Chen, Chaang-Ray; Chuang, Chun-Yu; Chiang, Chi-Shiun; Shu, Wun-Yi; Fan, Tai-Ching; Hsu, Ian C.			Extremely Low-Frequency Electromagnetic Fields Cause G1 Phase Arrest through the Activation of the ATM-Chk2-p21 Pathway	PLOS ONE			English	Article							HZ MAGNETIC-FIELD; GENE-EXPRESSION; ATAXIA-TELANGIECTASIA; DNA-DAMAGE; ELF-MF; CELLS; PROLIFERATION; EXPOSURE; RADIATION; P21	In daily life, humans are exposed to the extremely low-frequency electromagnetic fields (ELF-EMFs) generated by electric appliances, and public concern is increasing regarding the biological effects of such exposure. Numerous studies have yielded inconsistent results regarding the biological effects of ELF-EMF exposure. Here we show that ELF-EMFs activate the ATM-Chk2-p21 pathway in HaCaT cells, inhibiting cell proliferation. To present well-founded results, we comprehensively evaluated the biological effects of ELF-EMFs at the transcriptional, protein, and cellular levels. Human HaCaT cells from an immortalized epidermal keratinocyte cell line were exposed to a 1.5 mT, 60 Hz ELF-EMF for 144 h. The ELF-EMF could cause G1 arrest and decrease colony formation. Protein expression experiments revealed that ELF-EMFs induced the activation of the ATM/Chk2 signaling cascades. In addition, the p21 protein, a regulator of cell cycle progression at G1 and G2/M, exhibited a higher level of expression in exposed HaCaT cells compared with the expression of sham-exposed cells. The ELF-EMF-induced G1 arrest was diminished when the CHK2 gene expression (which encodes checkpoint kinase 2; Chk2) was suppressed by specific small interfering RNA (siRNA). These findings indicate that ELF-EMFs activate the ATM-Chk2-p21 pathway in HaCaT cells, resulting in cell cycle arrest at the G1 phase. Based on the precise control of the ELF-EMF exposure and rigorous sham-exposure experiments, all transcriptional, protein, and cellular level experiments consistently supported the conclusion. This is the first study to confirm that a specific pathway is triggered by ELF-EMF exposure.	[Huang, Chao-Ying; Chang, Cheng-Wei; Chen, Chaang-Ray; Chuang, Chun-Yu; Chiang, Chi-Shiun; Hsu, Ian C.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Shu, Wun-Yi] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Fan, Tai-Ching] Natl Synchrotron Radiat Res Ctr, Instrumentat Dev Div, Magnet Grp, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; National Synchrotron Radiation Research Center	Hsu, IC (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	ichsu@mx.nthu.edu.tw	Chiang, Chi-Shiun/A-9562-2008	Chiang, Chi-Shiun/0000-0002-2581-4129; Migliaccio, Antimo/0000-0002-4197-2055; Chen, Chaang-Ray/0000-0003-2106-8699	National Science Council, Taiwan [NSC 101-2112 M-007-003-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The authors would like to thank the National Science Council, Taiwan, for supporting this research financially under Contract (Grant number: NSC 101-2112 M-007-003-MY3, http://web1.most.gov.tw/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121; Trillo MA, 2012, INT J ONCOL, V40, P1405, DOI 10.3892/ijo.2012.1347; [Anonymous], 2002, INT J POSTCOLONIAL S, V4, DOI DOI 10.1029/2001WR000759; Martinez MA, 2012, CELL PHYSIOL BIOCHEM, V29, P675, DOI 10.1159/000178457; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Cayrol C, 1998, ONCOGENE, V16, P311, DOI 10.1038/sj.onc.1201543; Chang CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073311; Chen GD, 2012, BIOELECTROMAGNETICS, V33, P550, DOI 10.1002/bem.21724; Cheng WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038650; Chiang CS, 1997, CANCER RES, V57, P3899; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Fedrowitz M, 2012, INT J RADIAT BIOL, V88, P425, DOI 10.3109/09553002.2012.660555; Gluck B, 2001, CELL MOL BIOL NOISY, V47; HARPER JW, 1993, CELL, V75, P805; Henderson B, 2006, CELL STRESS CHAPERON, V11, P227, DOI 10.1379/CSC-196.1; HONG JH, 1994, RADIAT RES, V140, P17, DOI 10.2307/3578563; Huang CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029241; Huwiler SG, 2012, BIOELECTROMAGNETICS, V33, P488, DOI 10.1002/bem.21709; Ivancsits S, 2005, MUTAT RES-GEN TOX EN, V583, P184, DOI 10.1016/j.mrgentox.2005.03.011; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; Luceri C, 2005, RADIAT RES, V164, P277, DOI 10.1667/RR3426.1; Lupke M, 2006, BBA-MOL CELL RES, V1763, P402, DOI 10.1016/j.bbamcr.2006.03.003; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Manni V, 2002, BIOELECTROMAGNETICS, V23, P298, DOI 10.1002/bem.10023; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sesto A, 2002, P NATL ACAD SCI USA, V99, P2965, DOI 10.1073/pnas.052678999; Simko M, 2007, CURR MED CHEM, V14, P1141, DOI 10.2174/092986707780362835; Stronati L, 2004, BIOELECTROMAGNETICS, V25, P41, DOI 10.1002/bem.10141; Takao J, 2002, PHOTODERMATOL PHOTO, V18, P5, DOI 10.1034/j.1600-0781.2002.180102.x; Tsai ML, 2009, RADIAT RES, V171, P716, DOI 10.1667/RR1625.1; Valery C, 2001, J INVEST DERMATOL, V117, P1471, DOI 10.1046/j.0022-202x.2001.01607.x; Van Den Heuvel R, 2001, TOXICOL IN VITRO, V15, P351, DOI 10.1016/S0887-2333(01)00035-2; Vianale G, 2008, BRIT J DERMATOL, V158, P1189, DOI 10.1111/j.1365-2133.2008.08540.x; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wang SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069182; Wang SC, 2011, INT J RADIAT BIOL, V87, P432, DOI 10.3109/09553002.2011.538128; Wei M, 2000, TOXICOL APPL PHARM, V162, P166, DOI 10.1006/taap.1999.8825; Yoon K, 2004, MOL CELL BIOL, V24, P10650, DOI 10.1128/MCB.24.24.10650-10660.2004; Zhou J, 2011, BONE, V49, P753, DOI 10.1016/j.bone.2011.06.026	47	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104732	10.1371/journal.pone.0104732	http://dx.doi.org/10.1371/journal.pone.0104732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111195	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100094
J	Xu, H; Li, HQ; Liu, J; Zhu, D; Wang, Z; Chen, AQ; Zhao, Q				Xu, Hong; Li, Haiqing; Liu, Jun; Zhu, Dan; Wang, Zhe; Chen, Anqing; Zhao, Qiang			Meta-Analysis of Apolipoprotein E Gene Polymorphism and Susceptibility of Myocardial Infarction	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; RISK-FACTORS; HEART-DISEASE; EPSILON-2/EPSILON-3/EPSILON-4 GENOTYPE; ASSOCIATION; POPULATION; ATHEROSCLEROSIS; CHOLESTEROL; PHENOTYPE; ALLELES	A number of case-control studies have been conducted to clarify the association between ApoE polymorphisms and myocardial infarction (MI); however, the results are inconsistent. This meta-analysis was performed to clarify this issue using all the available evidence. Searching in PubMed retrieved all eligible articles. A total of 33 studies were included in this meta-analysis, including 18752 MI cases and 18963 controls. The pooled analysis based on all included studies showed that the MI patients had a decreased frequency of the epsilon 2 allele (OR = 0.78, 95% CI = 0.70-0.87) and an increased frequency of the epsilon 4 allele (OR = 1.15, 95% CI = 1.10-1.20); The results also showed a decreased susceptibility of MI in the epsilon 2 epsilon 3 vs. epsilon 3 epsilon 3 analysis (OR = 0.79, 95% CI = 0.68-0.90) and in the epsilon 2 vs. epsilon 3 analysis (OR = 0.78, 95% CI = 0.69-0.89), an increased susceptibility of MI in the epsilon 3 epsilon 4 vs. epsilon 3 epsilon 3 analysis (OR = 1.26, 95% CI = 1.12-1.41), in the epsilon 4 vs. epsilon 3 analysis (OR = 1.22, 95% CI = 1.12-1.32) and in the epsilon 4 epsilon 4 vs. epsilon 3 epsilon 3 analysis (OR = 1.59, 95% CI = 1.15-2.19). However, there were no significant associations among polymorphisms and MI for the following genetic models: frequency of the epsilon 3 allele (OR = 0.99, 95% CI = 0.96-1.02); epsilon 2 epsilon 2 vs. epsilon 3 epsilon 3 analysis (OR = 0.73, 95% CI = 0.40-1.32); or epsilon 2 epsilon 4 vs. epsilon 3 epsilon 3 analysis (OR = 1.10, 95% CI = 0.99-1.21). Our results suggested that the epsilon 4 allele of ApoE is a risk factor for the development of MI and the epsilon 2 allele of ApoE is a protective factor in the development of MI.	[Xu, Hong; Li, Haiqing; Liu, Jun; Zhu, Dan; Wang, Zhe; Chen, Anqing; Zhao, Qiang] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Cardiac Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Chen, AQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Cardiac Surg, Shanghai 200030, Peoples R China.	chenanqing2008@163.com; zq11607@rjh.com.cn			National Natural Science Foundation of China [81200093]; Shanghai College [82013011900002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai College	This study was supported by the National Natural Science Foundation of China (NO. 81200093) and the 2012 Shanghai College Special Research Funding for Outstanding Young Teachers (NO. 82013011900002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasvee K, 2006, SCAND J CLIN LAB INV, V66, P191, DOI 10.1080/00365510600564881; Al-Bustan SA, 2009, MED PRIN PRACT, V18, P294, DOI 10.1159/000215727; Atabek ME, 2012, J CLIN RES PEDIATR E, V4, P8, DOI 10.4274/jcrpe.521; Bahri R, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-46; Bai X, 2001, Zhonghua Yi Xue Za Zhi, V81, P340; Batalla A, 2000, CLIN CHEM, V46, P1910; Baum L, 2006, CLIN CHEM LAB MED, V44, P274, DOI 10.1515/CCLM.2006.047; Benes P, 2000, MOL GENET METAB, V69, P137, DOI 10.1006/mgme.1999.2957; Chaudhary R, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-36; CUMMING AM, 1984, CLIN GENET, V25, P310; DALLONGEVILLE J, 1992, J LIPID RES, V33, P447; EICHNER JE, 1993, AM J CARDIOL, V71, P160, DOI 10.1016/0002-9149(93)90732-R; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Freitas EM, 2002, J CARDIOVASC RISK, V9, P59, DOI 10.1097/00043798-200202000-00009; Gu JY, 2014, ARCH MED RES, V45, P76, DOI 10.1016/j.arcmed.2013.10.002; Hergenc Gulay, 1995, Journal of Biomedical Science, V2, P46, DOI 10.1007/BF02257924; Jin YZ, 2014, GENET TEST MOL BIOMA, V18, P330, DOI 10.1089/gtmb.2013.0404; Keavney B, 2004, INT J EPIDEMIOL, V33, P1002, DOI 10.1093/ije/dyh275; Keavney B, 2003, LANCET, V361, P396, DOI 10.1016/S0140-6736(03)12386-0; Kim IJ, 1999, YONSEI MED J, V40, P377, DOI 10.3349/ymj.1999.40.4.377; Koch W, 2008, INT J CARDIOL, V125, P116, DOI 10.1016/j.ijcard.2007.01.012; Kolovou G, 2002, CURR MED RES OPIN, V18, P118, DOI 10.1185/030079902125000444; Kolovou GD, 2003, ANGIOLOGY, V54, P51, DOI 10.1177/000331970305400107; Kolovou GD, 2009, INT J CARDIOL, V133, P264, DOI 10.1016/j.ijcard.2007.11.024; Kumar P, 2003, ANN CLIN BIOCHEM, V40, P382, DOI 10.1258/000456303766477020; Lahiri DK, 2004, NEUROBIOL AGING, V25, P651, DOI 10.1016/j.neurobiolaging.2003.12.024; Lambert JC, 2000, HUM MOL GENET, V9, P57, DOI 10.1093/hmg/9.1.57; LENZEN HJ, 1986, CLIN CHEM, V32, P778; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; LUC G, 1994, ARTERIOSCLER THROMB, V14, P1412, DOI 10.1161/01.ATV.14.9.1412; Mamotte Cyril D.S., 2002, Eur J Intern Med, V13, P250, DOI 10.1016/S0953-6205(02)00030-4; Marques-Vidal P, 2003, AM J CARDIOL, V92, P1102, DOI 10.1016/j.amjcard.2003.06.008; Martinelli N, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-41; Nakai K, 1998, CORONARY ARTERY DIS, V9, P329, DOI 10.1097/00019501-199809060-00002; Onrat ST, 2012, MOL BIOL REP, V39, P9257, DOI 10.1007/s11033-012-1799-1; Ozaki K, 2005, CELL MOL LIFE SCI, V62, P1804, DOI 10.1007/s00018-005-5098-z; Ranjith N, 2004, Cardiovasc J S Afr, V15, P111; Raslova K, 2001, METABOLISM, V50, P24, DOI 10.1053/meta.2001.19499; Scaglione L, 1999, NUTR METAB CARDIOVAS, V9, P118; SCOTT J, 1985, HUM GENET, V71, P144; Shin MH, 2014, ATHEROSCLEROSIS, V232, P180, DOI 10.1016/j.atherosclerosis.2013.11.027; Singh NK, 2014, NEUROL SCI; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; Szpakowicz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095513; Takeuchi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046385; Tanguturi P, 2013, BIOCHEM GENET, V51, P398, DOI 10.1007/s10528-013-9572-2; UTERMANN G, 1984, HUM GENET, V65, P237, DOI 10.1007/BF00286509; Wang JH, 2011, HEART, V97, P1542, DOI 10.1136/heartjnl-2011-300342; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088118; Yin YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066924; Zende PD, 2013, J CLIN DIAGN RES, V7, P2149, DOI 10.7860/JCDR/2013/6195.3455; Zhang RJ, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-47; Zhu SL, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-21	54	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104608	10.1371/journal.pone.0104608	http://dx.doi.org/10.1371/journal.pone.0104608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111308	Green Submitted, gold, Green Published			2022-12-27	WOS:000341105100082
J	Bera, A; Perkins, EM; Zhu, J; Zhu, H; Desai, P				Bera, Alakesh; Perkins, Edward M.; Zhu, Jian; Zhu, Heng; Desai, Prashant			DNA Binding and Condensation Properties of the Herpes Simplex Virus Type 1 Triplex Protein VP19C	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; CAPSID PROTEIN; IDENTIFICATION; MATURATION; VP23; REPLICATION; PROTAMINE; VIRIONS; DOMAINS; PACKING	Herpesvirus capsids are regular icosahedrons with a diameter of a 125 nm and are made up of 162 capsomeres arranged on a T = 16 lattice. The capsomeres (VP5) interact with the triplex structure, which is a unique structural feature of herpesvirus capsid shells. The triplex is a heterotrimeric complex; one molecule of VP19C and two of VP23 form a three-pronged structure that acts to stabilize the capsid shell through interactions with adjacent capsomeres. VP19C interacts with VP23 and with the major capsid protein VP5 and is required for the nuclear localization of VP23. Mutation of VP19C results in the abrogation of capsid shell synthesis. Analysis of the sequence of VP19C showed the N-terminus of VP19C is very basic and glycine rich. It was hypothesized that this domain could potentially bind to DNA. In this study an electrophoretic mobility shift assay (EMSA) and a DNA condensation assay were performed to demonstrate that VP19C can bind DNA. Purified VP19C was able to bind to both a DNA fragment of HSV-1 origin as well as a bacterial plasmid sequence indicating that this activity is non-specific. Ultra-structural imaging of the nucleo-protein complexes revealed that VP19C condensed the DNA and forms toroidal DNA structures. Both the DNA binding and condensing properties of VP19C were mapped to the N-terminal 72 amino acids of the protein. Mutational studies revealed that the positively charged arginine residues in this N-terminal domain are required for this binding. This DNA binding activity, which resides in a non-conserved region of the protein could be required for stabilization of HSV-1 DNA association in the capsid shell.	[Bera, Alakesh; Desai, Prashant] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Viral Oncol Program, Baltimore, MD USA; [Perkins, Edward M.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Perkins, Edward M.] Johns Hopkins Univ, Integrated Imaging Ctr, Baltimore, MD USA; [Zhu, Jian; Zhu, Heng] Johns Hopkins Univ, HiT Ctr, Baltimore, MD USA; [Zhu, Jian; Zhu, Heng] Johns Hopkins Univ, Dept Pharmacol & Mol Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Bera, A (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Hematol & Med Oncol, Dept Med, San Antonio, TX 78229 USA.	bera@uthscsa.edu	Bera, Alakesh/J-5429-2019	Bera, Alakesh/0000-0002-2690-8178; Perkins, Edward/0000-0002-3077-7422	NIH Public Health Service [AI033077, AI061382, AI070740]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107530, R01AI033077, R01AI061382, R21AI070740] Funding Source: NIH RePORTER	NIH Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Public Health Service grants AI033077 and AI061382 (PD) and AI070740 (HZ and PD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson WE, 2006, J VIROL, V80, P1537, DOI 10.1128/JVI.80.3.1537-1548.2006; Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M; Bhella D, 2000, J MOL BIOL, V295, P155, DOI 10.1006/jmbi.1999.3344; Bloomfield VA, 1996, CURR OPIN STRUC BIOL, V6, P334, DOI 10.1016/S0959-440X(96)80052-2; BOOY FP, 1991, CELL, V64, P1007, DOI 10.1016/0092-8674(91)90324-R; BRAUN DK, 1984, J VIROL, V50, P645, DOI 10.1128/JVI.50.2.645-648.1984; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; Brown JC, 2011, CURR OPIN VIROL, V1, P142, DOI 10.1016/j.coviro.2011.06.003; Cardone G, 2012, ADV EXP MED BIOL, V726, P423, DOI 10.1007/978-1-4614-0980-9_19; Casamayor A, 2003, MOL CELL BIOL, V23, P2762, DOI 10.1128/MCB.23.8.2762-2777.2003; Caspar D.t, 1962, COLD SPRING HARB SYM, P1; CHOWDHURY SI, 1994, VIRUS RES, V33, P67, DOI 10.1016/0168-1702(94)90018-3; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; DESAI P, 1993, J VIROL, V67, P1357, DOI 10.1128/JVI.67.3.1357-1364.1993; Desai P, 1996, VIROLOGY, V220, P516, DOI 10.1006/viro.1996.0341; Donnelly M, 2007, J VIROL, V81, P2283, DOI 10.1128/JVI.01677-06; GIBSON W, 1971, P NATL ACAD SCI USA, V68, P2818, DOI 10.1073/pnas.68.11.2818; GIBSON W, 1984, J VIROL, V50, P145, DOI 10.1128/JVI.50.1.145-154.1984; GOLDIN AL, 1981, J VIROL, V38, P50, DOI 10.1128/JVI.38.1.50-58.1981; Homa FL, 1997, REV MED VIROL, V7, P107, DOI 10.1002/(SICI)1099-1654(199707)7:2<107::AID-RMV191>3.0.CO;2-M; HUD NV, 1993, BIOCHEM BIOPH RES CO, V193, P1347, DOI 10.1006/bbrc.1993.1773; Hudson JR, 1997, GENOME RES, V7, P1169, DOI 10.1101/gr.7.12.1169; KNIGHT JD, 1991, P NATL ACAD SCI USA, V88, P3204, DOI 10.1073/pnas.88.8.3204; Krishnamoorthy G, 2003, NUCLEIC ACIDS RES, V31, P5425, DOI 10.1093/nar/gkg738; Lewis Susan E., 1996, Methods (Orlando), V10, P301, DOI 10.1006/meth.1996.0107; Li XJ, 2009, J VIROL, V83, P2531, DOI 10.1128/JVI.02209-08; Li Y, 2012, J GEN VIROL, V93, P1869, DOI 10.1099/vir.0.042697-0; NEWCOMB WW, 1993, J MOL BIOL, V232, P499, DOI 10.1006/jmbi.1993.1406; Okoye ME, 2006, J VIROL, V80, P929, DOI 10.1128/JVI.80.2.929-940.2006; Person S, 1998, VIROLOGY, V242, P193, DOI 10.1006/viro.1997.9005; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Rixon FJ, 1996, J GEN VIROL, V77, P2251, DOI 10.1099/0022-1317-77-9-2251; Sole M, 2007, J VIROL, V81, P8367, DOI 10.1128/JVI.00819-07; Spencer JV, 1998, J VIROL, V72, P3944, DOI 10.1128/JVI.72.5.3944-3951.1998; Steven AC, 1997, HERPESVIRUS CAPSID A, P312; Trus BL, 1996, J MOL BIOL, V263, P447, DOI 10.1016/S0022-2836(96)80018-0; Wood LJ, 1997, J VIROL, V71, P179, DOI 10.1128/JVI.71.1.179-190.1997; Zhao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041825; Zhou ZH, 1999, J VIROL, V73, P3210, DOI 10.1128/JVI.73.4.3210-3218.1999; Zhou ZH, 2000, SCIENCE, V288, P877, DOI 10.1126/science.288.5467.877; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576	41	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104640	10.1371/journal.pone.0104640	http://dx.doi.org/10.1371/journal.pone.0104640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121591	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000051
J	Bjorner, S; Fitzpatrick, PA; Li, YY; Allred, C; Howell, A; Ringberg, A; Olsson, H; Miller, CJ; Axelson, H; Landberg, G				Bjorner, Sofie; Fitzpatrick, Paul A.; Li, Yaoyong; Allred, Craig; Howell, Anthony; Ringberg, Anita; Olsson, Hakan; Miller, Crispin J.; Axelson, Hakan; Landberg, Goran			Epithelial and Stromal MicroRNA Signatures of Columnar Cell Hyperplasia Linking Let-7c to Precancerous and Cancerous Breast Cancer Cell Proliferation	PLOS ONE			English	Article							PANCREATIC-CANCER; TARGET PREDICTION; EXPRESSION; LESIONS; FIBROBLASTS; GROWTH; CONTRIBUTES; PRECURSORS; MECHANISM; MIR-132	Columnar cell hyperplasia (CCH) is the earliest histologically identifiable breast lesion linked to cancer progression and is characterized by increased proliferation, decreased apoptosis and elevated oestrogen receptor alpha (ER alpha) expression. The mechanisms underlying the initiation of these lesions have not been clarified but might involve early and fundamental changes in cancer progression. MiRNAs are key regulators of several biological processes, acting by influencing the post-transcriptional regulation of numerous targets, thus making miRNAs potential candidates in cancer initiation. Here we have defined novel epithelial as well as stromal miRNA signatures from columnar cell hyperplasia lesions compared to normal terminal duct lobular units by using microdissection and miRNA microarrays. Let-7c were among the identified downregulated epithelial miRNAs and its functions were delineated in unique CCH derived cells and breast cancer cell line MCF-7 suggesting anti-proliferative traits potentially due to effects on Myb and ER alpha. MiR-132 was upregulated in the stroma surrounding CCH compared to stoma surrounding normal terminal duct lobular units (TDLUs), and overexpression of miR-132 in immortalized fibroblasts and in fibroblasts co-cultured with epithelial CCH cells caused substantial expression changes of genes involved in metabolism, DNA damage and cell motility. The miRNA signatures identified in CCH indicate early changes in the epithelial and stromal compartment of CCH and could represent early key alterations in breast cancer progression that potentially could be targeted in novel prevention or treatment schedules.	[Bjorner, Sofie; Landberg, Goran] Lund Univ, Skane Univ Hosp, Ctr Mol Pathol, Dept Lab Med Malmo, Malmo, Sweden; [Bjorner, Sofie; Howell, Anthony; Landberg, Goran] Univ Manchester, Christie Natl Hlth Serv Fdn Trust, Manchester Acad Hlth Sci Ctr, Paterson Inst Canc Res,Inst Canc Sci,Breakthrough, Manchester, Lancs, England; [Bjorner, Sofie; Fitzpatrick, Paul A.; Landberg, Goran] Univ Gothenburg, Sahlgrenska Canc Ctr, Dept Biomed, Gothenburg, Sweden; [Li, Yaoyong; Miller, Crispin J.] Paterson Inst Canc Res, Canc Res UK Appl Computat Biol & Bioinformat Grp, Manchester M20 9BX, Lancs, England; [Allred, Craig] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Ringberg, Anita] Lund Univ, SUS Malmo, Inst Clin Sci Malmo, Dept Plast & Reconstruct Surg, Malmo, Sweden; [Olsson, Hakan] Lund Univ, Skane Univ Hosp, Inst Clin Sci Lund, Dept Oncol, Malmo, Sweden; [Axelson, Hakan] Lund Univ, Dept Lab Med Malmo, Malmo, Sweden	Lund University; Skane University Hospital; Christie NHS Foundation Trust; Paterson Institute for Cancer Research; University of Manchester; University of Gothenburg; Paterson Institute for Cancer Research; Washington University (WUSTL); Lund University; Lund University; Skane University Hospital; Lund University	Landberg, G (corresponding author), Lund Univ, Skane Univ Hosp, Ctr Mol Pathol, Dept Lab Med Malmo, Malmo, Sweden.	goran.landberg@gu.se		Olsson, Hakan/0000-0002-8794-9635; Howell, Anthony/0000-0002-6233-719X; Miller, Crispin/0000-0003-4341-1283; Fitzpatrick, Paul/0000-0002-7590-1546	Swedish Cancer Society; Breakthrough Breast Cancer; Cancer Research UK [15675] Funding Source: researchfish	Swedish Cancer Society(Swedish Cancer Society); Breakthrough Breast Cancer; Cancer Research UK(Cancer Research UK)	This study was supported by grants from the Swedish Cancer Society and Breakthrough Breast Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, BRIT J CANCER, V107, P1354, DOI 10.1038/bjc.2012.383; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berglund P, 2005, CANCER RES, V65, P9727, DOI 10.1158/0008-5472.CAN-04-3984; Calin GA, 2006, ONCOGENE, V25, P6202, DOI 10.1038/sj.onc.1209910; Dabbs DJ, 2006, MODERN PATHOL, V19, P344, DOI 10.1038/modpathol.3800538; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Egeblad M, 2008, DIS MODEL MECH, V1, P155, DOI 10.1242/dmm.000596; Holm C, 2006, JNCI-J NATL CANCER I, V98, P671, DOI 10.1093/jnci/djj185; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Lee S, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1367; Lee S, 2007, AM J PATHOL, V171, P252, DOI 10.2353/ajpath.2007.061010; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Madar S, 2009, CARCINOGENESIS, V30, P20, DOI 10.1093/carcin/bgn232; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; McDermott AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087032; Mishra A, 2009, NEUROBIOL DIS, V36, P26, DOI 10.1016/j.nbd.2009.06.010; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Park JK, 2011, BIOCHEM BIOPH RES CO, V406, P518, DOI 10.1016/j.bbrc.2011.02.065; Qin B, 2012, BMB REP, V45, P464, DOI 10.5483/BMBRep.2012.45.8.033; Quintana AM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-30; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rasanen K, 2010, EXP CELL RES, V316, P2713, DOI 10.1016/j.yexcr.2010.04.032; Recavarren RA, 2010, INT J CLIN EXP PATHO, V3, P87; Schnitt SJ, 2003, ADV ANAT PATHOL, V10, P113, DOI 10.1097/00125480-200305000-00001; Simpson PT, 2005, AM J SURG PATHOL, V29, P734, DOI 10.1097/01.pas.0000157295.93914.3b; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Verissimo F, 2006, ONCOGENE, V25, P4172, DOI 10.1038/sj.onc.1209449; WELLINGS SR, 1975, J NATL CANCER I, V55, P231; Yang D, 2011, ONCOGENE, V30, P4590, DOI [10.1038/onc.2011.541, 10.1038/onc.2011.166]; Yates T, 2008, NUCLEIC ACIDS RES, V36, pD780, DOI 10.1093/nar/gkm779; Zearo S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-200; Zhang SY, 2011, CARCINOGENESIS, V32, P1183, DOI 10.1093/carcin/bgr105	39	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105099	10.1371/journal.pone.0105099	http://dx.doi.org/10.1371/journal.pone.0105099			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122196	Green Accepted, Green Published, gold			2022-12-27	WOS:000341017000097
J	Burnham, ME; Esnault, S; Roti, ECR; Bates, ME; Bertics, PJ; Denlinger, LC				Burnham, Mandy E.; Esnault, Stephane; Roti, Elon C. Roti; Bates, Mary E.; Bertics, Paul J.; Denlinger, Loren C.			Cholesterol Selectively Regulates IL-5 Induced Mitogen Activated Protein Kinase Signaling in Human Eosinophils	PLOS ONE			English	Article							BLOOD-CELL COUNT; LIPID RAFTS; DIFFERENTIAL REGULATION; FILIPIN-III; FATTY-ACIDS; TNF-ALPHA; P38 MAPK; AIRWAY; EXPRESSION; APOPTOSIS	Eosinophils function contributes to human allergic and autoimmune diseases, many of which currently lack curative treatment. Development of more effective treatments for eosinophil-related diseases requires expanded understanding of eosinophil signaling and biology. Cell signaling requires integration of extracellular signals with intracellular responses, and is organized in part by cholesterol rich membrane microdomains (CRMMs), commonly referred to as lipid rafts. Formation of these organizational membrane domains is in turn dependent upon the amount of available cholesterol, which can fluctuate widely with a variety of disease states. We tested the hypothesis that manipulating membrane cholesterol content in primary human peripheral blood eosinophils (PBEos) would selectively alter signaling pathways that depend upon membrane-anchored signaling proteins localized within CRMMs (e.g., mitogen activated protein kinase [MAPK] pathway), while not affecting pathways that signal through soluble proteins, like the Janus Kinase/Signal Transducer and Activator of Transcription [JAK/STAT] pathway. Cholesterol levels were increased or decreased utilizing cholesterol-chelating methyl-bcyclodextrin (M beta CD), which can either extract membrane cholesterol or add exogenous membrane cholesterol depending on whether M beta CD is preloaded with cholesterol. Human PBEos were pretreated with M beta CD (cholesterol removal) or M beta CD+Cholesterol (M beta CD+Chol; cholesterol delivery); subsequent IL-5-stimulated signaling and physiological endpoints were assessed. M beta CD reduced membrane cholesterol in PBEos, and attenuated an IL-5-stimulated p38 and extracellular-regulated kinase 1/2 phosphorylation (p-p38, p-ERK1/2), and an IL-5-dependent increase in interleukin-1b (IL-1b) mRNA levels. In contrast, M beta CD+Chol treatment elevated PBEos membrane cholesterol levels and basal p-p38, but did not alter IL-5-stimulated phosphorylation of ERK1/2, STAT5, or STAT3. Furthermore, M beta CD+Chol pretreatment attenuated an IL-5-induced increase in cell survival at 48 hours, measured as total cellular metabolism. The reduction in cell survival following cholesterol addition despite unaltered STAT phosphorylation contradicts the current dogma in which JAK/STAT activation is sufficient to promote eosinophil survival, and suggests an additional, unidentified mechanism critically regulates IL-5-mediated human PBEos survival.	[Burnham, Mandy E.; Bates, Mary E.; Bertics, Paul J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI USA; [Esnault, Stephane; Roti, Elon C. Roti; Denlinger, Loren C.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Denlinger, LC (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Madison, WI 53706 USA.	lcd@medicine.wisc.edu	Esnault, Stephane/AAO-4712-2020; Esnault, Stephane/AAJ-4511-2020	Esnault, Stephane/0000-0001-7238-8671; 	National Institutes of Health [P01HL088594, 5T32DK007665, UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (grants P01HL088594, 5T32DK007665, and UL1TR000427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves SS, 2008, CURR MOL MED, V8, P350, DOI 10.2174/156652408785161023; Akuthota P, 2012, AM J RESP CELL MOL, V46, P188, DOI 10.1165/rcmb.2010-0335OC; Al-Shawwa B, 2006, J ASTHMA, V43, P231, DOI 10.1080/02770900600567056; Andina N, 2009, J ALLERGY CLIN IMMUN, V123, P603, DOI 10.1016/j.jaci.2008.12.004; Bates ME, 2004, AM J RESP CELL MOL, V30, P736, DOI 10.1165/rcmb.2003-0234OC; Bates ME, 2000, J BIOL CHEM, V275, P10968, DOI 10.1074/jbc.275.15.10968; BITTMAN R, 1972, P NATL ACAD SCI USA, V69, P3795, DOI 10.1073/pnas.69.12.3795; Bochner BS, 2005, J ALLERGY CLIN IMMUN, V115, P953, DOI 10.1016/j.jaci.2005.02.032; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Brooks AR, 1996, J BIOL CHEM, V271, P9090, DOI 10.1074/jbc.271.15.9090; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Burnham ME, 2013, J IMMUNOLOG IN PRESS; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Chen YL, 2006, BIOCHEM BIOPH RES CO, V346, P160, DOI 10.1016/j.bbrc.2006.05.093; Cheung PFY, 2008, J IMMUNOL, V180, P5625, DOI 10.4049/jimmunol.180.8.5625; Dendele B, 2014, CHEM-BIOL INTERACT, V207, P41, DOI 10.1016/j.cbi.2013.11.002; Esnault S, 2012, CLIN EXP ALLERGY, V42, P1756, DOI 10.1111/j.1365-2222.2012.04060.x; Esnault S, 2002, BLOOD, V99, P4048, DOI 10.1182/blood.V99.11.4048; Ferreiro I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-144; Ge BX, 2003, J BIOL CHEM, V278, P2286, DOI 10.1074/jbc.M210918200; Gozgit JM, 2008, J BIOL CHEM, V283, P32334, DOI 10.1074/jbc.M803813200; HASSALL DG, 1992, CYTOMETRY, V13, P381, DOI 10.1002/cyto.990130408; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Hou LF, 2013, EUR J EPIDEMIOL, V28, P735, DOI 10.1007/s10654-013-9842-7; Ip WK, 2005, IMMUNOPHARM IMMUNOT, V27, P371, DOI 10.1080/08923970500240925; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kankaanranta H, 1999, J PHARMACOL EXP THER, V290, P621; Kranenburg O, 2001, CURR BIOL, V11, P1880, DOI 10.1016/S0960-9822(01)00582-6; Lei JT, 2008, J LEUKOCYTE BIOL, V84, P499, DOI 10.1189/jlb.1207828; Leitinger B, 2002, J CELL SCI, V115, P963; Liu GT, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/421389; Liu LY, 2002, J IMMUNOL, V169, P6452, DOI 10.4049/jimmunol.169.11.6452; Lucero HA, 2004, ARCH BIOCHEM BIOPHYS, V426, P208, DOI 10.1016/j.abb.2004.03.020; McDermott EP, 2002, J BIOL CHEM, V277, P7808, DOI 10.1074/jbc.M108133200; MCGOOKEY DJ, 1983, J CELL BIOL, V96, P1273, DOI 10.1083/jcb.96.5.1273; Mendelsohn AR, 2002, P NATL ACAD SCI USA, V99, P6871, DOI 10.1073/pnas.072290599; MILHAUD J, 1992, BIOCHIM BIOPHYS ACTA, V1105, P307, DOI 10.1016/0005-2736(92)90209-5; Monahan J, 1997, J IMMUNOL, V159, P4024; MULLER CP, 1984, CYTOMETRY, V5, P42, DOI 10.1002/cyto.990050108; Oda E, 2012, HEART VESSELS, V27, P377, DOI 10.1007/s00380-011-0157-x; Pazdrak K, 1998, J EXP MED, V188, P421, DOI 10.1084/jem.188.3.421; Pelicci G, 1996, ONCOGENE, V13, P633; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Rockett BD, 2012, J LIPID RES, V53, P674, DOI 10.1194/jlr.M021782; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Schley PD, 2007, J NUTR, V137, P548, DOI 10.1093/jn/137.3.548; SEDGWICK JB, 1992, J IMMUNOL, V149, P3710; SEDGWICK JB, 1991, AM REV RESPIR DIS, V144, P1274, DOI 10.1164/ajrccm/144.6.1274; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; Shim WS, 2006, DIABETES RES CLIN PR, V73, P284, DOI 10.1016/j.diabres.2006.02.001; Siddiqui S, 2005, AM J KIDNEY DIS, V46, P1065, DOI 10.1053/j.ajkd.2005.09.001; Stout BA, 2004, J IMMUNOL, V173, P6409, DOI 10.4049/jimmunol.173.10.6409; Stulnig TM, 2003, INT ARCH ALLERGY IMM, V132, P310, DOI 10.1159/000074898; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Szabo G, 2007, J IMMUNOL, V178, P1243, DOI 10.4049/jimmunol.178.3.1243; ten Hove W, 2007, MOL IMMUNOL, V44, P2492, DOI 10.1016/j.molimm.2006.10.009; Tuluc F, 2003, INT IMMUNOPHARMACOL, V3, P1775, DOI 10.1016/j.intimp.2003.08.002; Vidal R, 2011, METHODS MOL BIOL, V793, P241, DOI 10.1007/978-1-61779-328-8_16; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Weller PF, 1997, J ALLERGY CLIN IMMUN, V100, P283, DOI 10.1016/S0091-6749(97)70237-9; Wong CK, 2002, CLIN EXP IMMUNOL, V128, P483, DOI 10.1046/j.1365-2249.2002.01880.x; YAMAGUCHI Y, 1991, BLOOD, V78, P2542; Yao XL, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00037; Yao XL, 2012, AM J PHYSIOL-LUNG C, V302, pL206, DOI 10.1152/ajplung.00110.2011; Yao XL, 2011, J IMMUNOL, V186, P576, DOI 10.4049/jimmunol.1001534; Yao XL, 2010, AM J RESP CRIT CARE, V182, P1228, DOI 10.1164/rccm.201002-0308OC; Yiallouros PK, 2012, CLIN EXP ALLERGY, V42, P423, DOI 10.1111/j.1365-2222.2011.03940.x; Zhu XD, 2002, J LEUKOCYTE BIOL, V72, P1046; Zhu YM, 2011, J IMMUNOL, V186, P516, DOI 10.4049/jimmunol.1000955; Zhuang LY, 2005, J CLIN INVEST, V115, P959; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	72	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103122	10.1371/journal.pone.0103122	http://dx.doi.org/10.1371/journal.pone.0103122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121926	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000011
J	Guo, ZN; Xing, YQ; Liu, J; Wang, S; Yan, S; Jin, H; Yang, Y				Guo, Zhen-Ni; Xing, Yingqi; Liu, Jia; Wang, Shuang; Yan, Shuo; Jin, Hang; Yang, Yi			Compromised Dynamic Cerebral Autoregulation in Patients with a Right-to-Left Shunt: A Potential Mechanism of Migraine and Cryptogenic Stroke	PLOS ONE			English	Article							PATENT FORAMEN OVALE; SPREADING DEPRESSION; BLOOD-PRESSURE; RISK-FACTORS; PREVALENCE; AURA; FLOW	Background and Purpose: The relationship between right-to-left shunts (RLS) and migraine and cryptogenic stroke is not well understood. In this study, we investigated whether RLS are associated with impairment of dynamic cerebral autoregulation (dCA), which may play a role in migraine and cryptogenic stroke. Methods: Sixty-six migraineurs were enrolled in the study, including 36 non-RLS patients and 30 RLS patients. Non-invasive continuous cerebral blood flow velocity and arterial blood pressure were recorded simultaneously from each patient by using transcranial Doppler and servo-controlled plethysmograph, respectively. Transfer function analysis was applied to derive autoregulatory parameters of gain, phase difference (PD), and autoregulation index. Results: The PD in migraineurs with RLS was 50.6 +/- 22.9 degrees, which was significantly lower than that observed in the non-RLS group (67.2 +/- 18.2 degrees, P < 0.001). The PD in the large RLS group (45.4 +/- 22.6 degrees) was significantly lower than that of the small RLS group (64.9 +/- 17.1 degrees, P < 0.01) and non-RLS group (P < 0.001); however, the PD in the small RLS group was similar to that of the non-RLS group. The PD in the permanent group (48.8 +/- 19.9 degrees) was similar to that of the latent group (52.6 +/- 26.1 degrees), and both were significantly lower than that of the non-RLS group (P < 0.05). The autoregulation index results were similar to the PD findings. Conclusions: dCA is impaired in migraineurs with large RLS, and this may represent a potential mechanism linking RLS, migraine, and cryptogenic stroke.	[Guo, Zhen-Ni; Wang, Shuang; Yan, Shuo; Jin, Hang; Yang, Yi] Jilin Univ, Norman Bethune Hosp 1, Dept Neurol, Neurosci Ctr, Changchun, Peoples R China; [Xing, Yingqi] Jilin Univ, Norman Bethune Hosp 1, Ctr Neurovasc Ultrasound, Changchun, Peoples R China; [Liu, Jia] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Jilin University; Jilin University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Yang, Y (corresponding author), Jilin Univ, Norman Bethune Hosp 1, Dept Neurol, Neurosci Ctr, Changchun, Peoples R China.	doctor_yangyi@hotmail.com		Yang, Yi/0000-0002-9729-8522; Xing, Yingqi/0000-0002-7403-5789	Center for Neurovascular Ultrasound, the First Norman Bethune Hospital of Jilin University	Center for Neurovascular Ultrasound, the First Norman Bethune Hospital of Jilin University	This study was supported by Jie Zhang and Yang-Yang Zhou from the Center for Neurovascular Ultrasound, the First Norman Bethune Hospital of Jilin University.	CABANES L, 1993, STROKE, V24, P1865, DOI 10.1161/01.STR.24.12.1865; Caplan LR, 1998, ARCH NEUROL-CHICAGO, V55, P1475, DOI 10.1001/archneur.55.11.1475; Dawson SL, 2003, CEREBROVASC DIS, V16, P69, DOI 10.1159/000070118; Del Sette M, 1998, CEREBROVASC DIS, V8, P327, DOI 10.1159/000015875; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; FLORENCE G, 1994, AM J PHYSIOL, V266, pR1136, DOI 10.1152/ajpregu.1994.266.4.R1136; Giardini A, 2007, INT J CARDIOL, V120, P357, DOI 10.1016/j.ijcard.2006.10.012; Haubrich C, 2004, STROKE, V35, P848, DOI 10.1161/01.STR.0000120729.99039.B6; LAURITZEN M, 1984, J CEREBR BLOOD F MET, V4, P546, DOI 10.1038/jcbfm.1984.79; Mahony PJ, 2000, STROKE, V31, P476, DOI 10.1161/01.STR.31.2.476; Muller M, 2005, STROKE, V36, P1886, DOI 10.1161/01.STR.0000177886.94134.92; Nozari A, 2010, ANN NEUROL, V67, P221, DOI 10.1002/ana.21871; Pezzini A, 2011, STROKE, V42, P17, DOI 10.1161/STROKEAHA.110.592246; Reinhard M, 2012, STROKE, V43, P987, DOI 10.1161/STROKEAHA.111.644674; Saeed NP, 2013, CEREBROVASC DIS, V35, P257, DOI 10.1159/000347075; Schwerzmann M, 2005, NEUROLOGY, V65, P1415, DOI 10.1212/01.wnl.0000179800.73706.20; Sharma A, 2011, ECHOCARDIOGR-J CARD, V28, P913, DOI 10.1111/j.1540-8175.2011.01460.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; WEBSTER MWI, 1988, LANCET, V2, P11; Yang Y, 2012, EUR J NEUROL, V19, P1367, DOI 10.1111/j.1468-1331.2012.03793.x; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	22	22	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104849	10.1371/journal.pone.0104849	http://dx.doi.org/10.1371/journal.pone.0104849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121485	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000064
J	Luchting, B; Rachinger-Adam, B; Zeitler, J; Egenberger, L; Mohnle, P; Kreth, S; Azad, SC				Luchting, Benjamin; Rachinger-Adam, Banafscheh; Zeitler, Julia; Egenberger, Lisa; Moehnle, Patrick; Kreth, Simone; Azad, Shahnaz Christina			Disrupted TH17/Treg Balance in Patients with Chronic Low Back Pain	PLOS ONE			English	Article							REGULATORY T-CELLS; CHRONIC CONSTRICTION; SELF-TOLERANCE; NERVE INJURY; SPINAL-CORD; DEPRESSION; TH17; INFILTRATION; EXPRESSION; SEVERITY	Chronic low back pain (CLBP) is a leading cause of disability and costs in health care systems worldwide. Despite extensive research, the exact pathogenesis of CLBP, particularly the individual risk of chronification remains unclear. To investigate a possible role of the adaptive immune system in the pathophysiology of CLBP, we analyzed T cell related cytokine profiles, T cell related mRNA expression patterns and the distribution of T cell subsets in 37 patients suffering from nonspecific CLBP before and after multimodal therapy in comparison to 25 healthy controls. Serum patterns of marker cytokines were analyzed by Luminex technology, mRNA expression of cytokines and specific transcription factors was measured by real-time PCR, and distribution of TH1-, TH2-, TH17- and regulatory T cell (Tregs) subsets was determined by multicolor flow cytometry. We found that CLBP patients exhibit an increased number of anti-inflammatory Tregs, while pro-inflammatory TH17 cells are decreased, resulting in an altered TH17/Treg ratio. Accordingly, FoxP3 and TGF-b-mRNA expression was elevated, while expression of IL-23 was reduced. Serum cytokine analyses proved to be unsuitable to monitor the adaptive immune response in CLBP patients. We further show that even after successful therapy with lasting reduction of pain, T cell subset patterns remained altered after a follow-up period of 6 months. These findings suggest an involvement of TH17/Treg cells in the pathogenesis of CLBP and emphasize the importance of these cells in the crosstalk of pain and immune response.	[Luchting, Benjamin; Rachinger-Adam, Banafscheh; Zeitler, Julia; Egenberger, Lisa; Moehnle, Patrick; Kreth, Simone; Azad, Shahnaz Christina] Univ Munich, Dept Anesthesiol & Pain Med, Munich, Germany	University of Munich	Luchting, B (corresponding author), Univ Munich, Dept Anesthesiol & Pain Med, Munich, Germany.	benjamin.luchting@med.uni-muenchen.de	Möhnle, Patrick/C-9243-2018	Möhnle, Patrick/0000-0003-4769-7100; Kreth, Simone/0000-0002-0073-2098; Luchting, Benjamin/0000-0002-8919-9874	Hella-Langer-Stiftung, Germany	Hella-Langer-Stiftung, Germany	This work was supported by grants from the Hella-Langer-Stiftung, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali B, 2007, CLIN EXP IMMUNOL, V148, P32, DOI 10.1111/j.1365-2249.2007.03356.x; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Austin PJ, 2012, PAIN, V153, P1916, DOI 10.1016/j.pain.2012.06.005; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Becker A, 2012, SPINE, V37, P701, DOI 10.1097/BRS.0b013e31822b01bd; Becker A, 2010, SPINE, V35, P1714, DOI 10.1097/BRS.0b013e3181cd656f; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Breen EC, 2011, CLIN VACCINE IMMUNOL, V18, P1229, DOI 10.1128/CVI.05032-11; Brucklacher-Waldert V, 2009, J IMMUNOL, V183, P5494, DOI 10.4049/jimmunol.0901000; Cheng L, 2013, INJURY, V44, P1805, DOI 10.1016/j.injury.2013.04.010; Chouker A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010752; Chowdhury F, 2009, J IMMUNOL METHODS, V340, P55, DOI 10.1016/j.jim.2008.10.002; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; DeLeo JA, 2001, PAIN, V90, P1, DOI 10.1016/S0304-3959(00)00490-5; Edit V, 2013, RHEUMATOL INT, V33, P587, DOI 10.1007/s00296-012-2398-0; Fischer CP, 2007, SCAND J MED SCI SPOR, V17, P580, DOI 10.1111/j.1600-0838.2006.00602.x; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Homey B, 2006, HAUTARZT, V57, P730, DOI 10.1007/s00105-006-1199-3; Hong M, 2013, NEUROIMMUNOMODULAT, V20, P39, DOI 10.1159/000343100; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; Huckans M, 2014, BRAIN BEHAV, V4, P123, DOI 10.1002/brb3.200; Kleinschnitz C, 2006, EXP NEUROL, V200, P480, DOI 10.1016/j.expneurol.2006.03.014; Koch A, 2007, INFLAMM RES, V56, P32, DOI 10.1007/s00011-007-6088-4; Ledderose Carola, 2011, BMC Res Notes, V4, P427, DOI 10.1186/1756-0500-4-427; Lenz M, 2013, PAIN, V154, P2142, DOI 10.1016/j.pain.2013.06.039; Licciardone JC, 2012, J AM OSTEOPATH ASSOC, V112, P783; Liu Hai-hong, 2006, Zhonghua Nan Ke Xue, V12, P330; Liu HH, 2006, ZHONGHUA NAN KE XUE, V12, P336; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Miller AH, 2010, BRAIN BEHAV IMMUN, V24, P1, DOI 10.1016/j.bbi.2009.09.009; Perkins NM, 2000, NEUROSCIENCE, V101, P745, DOI 10.1016/S0306-4522(00)00396-1; Raison CL, 2011, CURR PSYCHIAT REP, V13, P467, DOI 10.1007/s11920-011-0232-0; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Schinkel C, 2006, CLIN J PAIN, V22, P235, DOI 10.1097/01.ajp.0000169669.70523.f0; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; SULLIVAN MJL, 1992, PAIN, V50, P5, DOI 10.1016/0304-3959(92)90107-M; Tian Peng, 2009, Orthop Surg, V1, P317, DOI 10.1111/j.1757-7861.2009.00052.x; Torres-Harding Susan, 2008, Bull IACFS ME, V16, P19; Venet F, 2010, J IMMUNOL METHODS, V357, P55, DOI 10.1016/j.jim.2010.02.005; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang H, 2008, CLIN J PAIN, V24, P273, DOI 10.1097/AJP.0b013e31816111d3; Whiteside TL, 2012, CANCER IMMUNOL IMMUN, V61, P283, DOI 10.1007/s00262-011-1171-7; Xing Q, 2013, ARCH DERMATOL RES, V305, P715, DOI 10.1007/s00403-013-1367-0	47	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104883	10.1371/journal.pone.0104883	http://dx.doi.org/10.1371/journal.pone.0104883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122126	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000068
J	Ruder, C; Haase, T; Krost, A; Langwieser, N; Peter, J; Kamann, S; Zohlnhofer, D				Rueder, Constantin; Haase, Tobias; Krost, Annalena; Langwieser, Nicole; Peter, Jan; Kamann, Stefanie; Zohlnhoefer, Dietlind			Combinatorial G-CSF/AMD3100 Treatment in Cardiac Repair after Myocardial Infarction	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; ENDOTHELIAL PROGENITOR CELLS; HEMATOPOIETIC STEM-CELLS; BONE-MARROW-CELLS; ANGIOGENESIS IN-VIVO; G-CSF; PERIPHERAL-BLOOD; MOUSE HEART; RAT MODEL; MOBILIZATION	Aims: Several studies suggest that circulating bone marrow derived stem cells promote the regeneration of ischemic tissues. For hematopoietic stem cell transplantation combinatorial granulocyte-colony stimulating factor (G-CSF)/Plerixafor (AMD3100) administration was shown to enhance mobilization of bone marrow derived stem cells compared to G-CSF monotherapy. Here we tested the hypothesis whether combinatorial G-CSF/AMD3100 therapy has beneficial effects in cardiac recovery in a mouse model of myocardial infarction. Methods: We analyzed the effect of single G-CSF (250 mu g/kg/day) and combinatorial G-CSF/AMD3100 (100 mu g/kg/day) treatment on cardiac morphology, vascularization, and hemodynamics 28 days after permanent ligation of the left anterior descending artery (LAD). G-CSF treatment started directly after induction of myocardial infarction (MI) for 3 consecutive days followed by a single AMD3100 application on day three after MI in the G-CSF/AMD3100 group. Cell mobilization was assessed by flow cytometry of blood samples drawn from tail vein on day 0, 7, and 14. Results: Peripheral blood analysis 7 days after MI showed enhanced mobilization of white blood cells (WBC) and endothelial progenitor cells (EPC) upon G-CSF and combinatorial G-CSF/AMD3100 treatment. However, single or combinatorial treatment showed no improvement in survival, left ventricular function, and infarction size compared to the saline treated control group 28 days after MI. Furthermore, no differences in histology and vascularization of infarcted hearts could be observed. Conclusion: Although the implemented treatment regimen caused no adverse effects, our data show that combinatorial G-CSF/AMD therapy does not promote myocardial regeneration after permanent LAD occlusion.	[Rueder, Constantin; Haase, Tobias; Krost, Annalena; Langwieser, Nicole; Peter, Jan; Kamann, Stefanie; Zohlnhoefer, Dietlind] Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany; [Rueder, Constantin; Haase, Tobias; Zohlnhoefer, Dietlind] Campus Virchow Klinikum, Dept Cardiol, Charite, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ruder, C (corresponding author), Berlin Brandenburg Ctr Regenerat Therapies BCRT, Berlin, Germany.	constantinrueder@hotmail.com		Haase, Tobias/0000-0002-7220-602X	Berlin-Brandenburg Center for Regenerative Therapies (BCRT)	Berlin-Brandenburg Center for Regenerative Therapies (BCRT)	Work was funded by the Berlin-Brandenburg Center for Regenerative Therapies (BCRT). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Badorff C, 2003, CIRCULATION, V107, P1024, DOI 10.1161/01.CIR.0000051460.85800.BB; Barron HV, 2000, CIRCULATION, V102, P2329, DOI 10.1161/01.CIR.102.19.2329; Basu S, 2005, BLOOD, V106, P485, DOI 10.1182/blood-2004-10-4145; Bocchi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017750; Brave M, 2010, ONCOLOGY-BASEL, V78, P282, DOI 10.1159/000315736; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Calandra G, 2008, BONE MARROW TRANSPL, V41, P331, DOI 10.1038/sj.bmt.1705908; Capoccia BJ, 2006, BLOOD, V108, P2438, DOI 10.1182/blood-2006-04-013755; Cheng ZK, 2008, CARDIOVASC RES, V80, P425, DOI 10.1093/cvr/cvn202; Deten A, 2005, CARDIOVASC RES, V65, P52, DOI 10.1016/j.cardiores.2004.11.009; Dubois C, 2010, J AM COLL CARDIOL, V55, P2232, DOI 10.1016/j.jacc.2009.10.081; England TJ, 2009, BRAIN RES REV, V62, P71, DOI 10.1016/j.brainresrev.2009.09.002; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gorog DA, 2003, J MOL CELL CARDIOL, V35, P705, DOI 10.1016/S0022-2828(03)00082-8; Gruh I, 2006, CIRCULATION, V113, P1326, DOI 10.1161/CIRCULATIONAHA.105.559005; Guo Y, 2006, STEM CELLS, V24, P850, DOI 10.1634/stemcells.2005-0457; Guo YR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0288-y; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Hasegawa H, 2006, J AM COLL CARDIOL, V47, P842, DOI 10.1016/j.jacc.2005.09.048; Hu J, 2002, HUM GENE THER, V13, P2041, DOI 10.1089/10430340260395893; Huang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029246; Jujo K, 2010, P NATL ACAD SCI USA, V107, P11008, DOI 10.1073/pnas.0914248107; Lian WS, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-26; Lichtenauer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052101; Maekawa Y, 2004, J AM COLL CARDIOL, V44, P1510, DOI 10.1016/j.jacc.2004.05.083; Miki T, 2004, CLIN EXP PHARMACOL P, V31, P873, DOI 10.1111/j.1440-1681.2004.04130.x; Minatoguchi S, 2004, CIRCULATION, V109, P2572, DOI 10.1161/01.CIR.0000129770.93985.3E; Misao Y, 2006, CARDIOVASC RES, V71, P455, DOI 10.1016/j.cardiores.2006.05.002; Moazzami K., 2013, COCHRANE DB SYST REV, V5; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Ohtsuka M, 2004, FASEB J, V18, P851, DOI 10.1096/fj.03-0637fje; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Pitchford SC, 2009, CELL STEM CELL, V4, P62, DOI 10.1016/j.stem.2008.10.017; Powell TM, 2005, ARTERIOSCL THROM VAS, V25, P296, DOI 10.1161/01.ATV.0000151690.43777.e4; Ripa RS, 2007, CIRCULATION, V116, pI24, DOI 10.1161/CIRCULATIONAHA.106.678649; ROBERTS AW, 1995, STEM CELLS, V13, P512, DOI 10.1002/stem.5530130508; ROBERTS R, 1976, CIRCULATION, V53, P204; Ruder C, 2014, COMBINATORI IN PRESS; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sanganalmath SK, 2011, BASIC RES CARDIOL, V106, P709, DOI 10.1007/s00395-011-0183-y; Shepherd RM, 2006, BLOOD, V108, P3662, DOI 10.1182/blood-2006-06-030577; Steendijk P, 2001, AM J PHYSIOL-HEART C, V281, pH755, DOI 10.1152/ajpheart.2001.281.2.H755; Stein A, 2010, THROMB HAEMOSTASIS, V103, P638, DOI 10.1160/TH09-09-0657; Stroncek DF, 1997, TRANSFUSION MED, V7, P19, DOI 10.1046/j.1365-3148.1997.d01-75.x; Sugano Y, 2005, CARDIOVASC RES, V65, P446, DOI 10.1016/j.cardiores.2004.10.008; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Takamiya M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025265; Theiss HD, 2011, STEM CELL RES, V7, P244, DOI 10.1016/j.scr.2011.05.003; Tura O, 2010, J THROMB HAEMOST, V8, P1614, DOI 10.1111/j.1538-7836.2010.03900.x; Werneck-De-Castro JPS, 2006, BASIC RES CARDIOL, V101, P494, DOI 10.1007/s00395-006-0605-4; Yu RYL, 2005, BLOOD, V105, P1777, DOI 10.1182/blood-2004-08-3171; Zaruba MM, 2008, CARDIOVASC RES, V77, P722, DOI 10.1093/cvr/cvm080; Zohlnhofer D, 2008, CARDIOVASC DRUG THER, V22, P343, DOI 10.1007/s10557-008-6114-y; Zohlnhofer D, 2006, JAMA-J AM MED ASSOC, V295, P1003, DOI 10.1001/jama.295.9.1003	58	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104644	10.1371/journal.pone.0104644	http://dx.doi.org/10.1371/journal.pone.0104644			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121738	Green Submitted, Green Published, gold			2022-12-27	WOS:000341017000052
J	Rutten, B; Tersteeg, C; Vrijenhoek, JEP; van Holten, TC; Elsenberg, EHAM; Mak-Nienhuis, EM; de Borst, GJ; Jukema, JW; Pijls, NHJ; Waltenberger, J; van Zonneveld, AJ; Moll, FL; McClellan, E; Stubbs, A; Pasterkamp, G; Hoefer, I; de Groot, PG; Roest, M				Rutten, Bert; Tersteeg, Claudia; Vrijenhoek, Joyce E. P.; van Holten, Thijs C.; Elsenberg, Ellen H. A. M.; Mak-Nienhuis, Elske M.; de Borst, Gert Jan; Jukema, J. Wouter; Pijls, Nico H. J.; Waltenberger, Johannes; van Zonneveld, Anton Jan; Moll, Frans L.; McClellan, Elizabeth; Stubbs, Andrew; Pasterkamp, Gerard; Hoefer, Imo; de Groot, Philip G.; Roest, Mark			Increased Platelet Reactivity Is Associated with Circulating Platelet-Monocyte Complexes and Macrophages in Human Atherosclerotic Plaques	PLOS ONE			English	Article							P-SELECTIN; EXPRESSION; ENDARTERECTOMY; CLOPIDOGREL; ADHESION; ACTIVATION; DEFICIENT; TRIGGERS; PROTEIN; ARREST	Objective: Platelet reactivity, platelet binding to monocytes and monocyte infiltration play a detrimental role in atherosclerotic plaque progression. We investigated whether platelet reactivity was associated with levels of circulating platelet-monocyte complexes (PMCs) and macrophages in human atherosclerotic carotid plaques. Methods: Platelet reactivity was determined by measuring platelet P-selectin expression after platelet stimulation with increasing concentrations of adenosine diphosphate (ADP), in two independent cohorts: the Circulating Cells cohort (n = 244) and the Athero-Express cohort (n = 91). Levels of PMCs were assessed by flow cytometry in blood samples of patients who were scheduled for percutaneous coronary intervention (Circulating Cells cohort). Monocyte infiltration was semi-quantitatively determined by histological examination of atherosclerotic carotid plaques collected during carotid endarterectomy (Athero-Express cohort). Results: We found increased platelet reactivity in patients with high PMCs as compared to patients with low PMCs (median (interquartile range): 4153 (1585-11267) area under the curve (AUC) vs. 9633 (3580-21565) AUC, P<0.001). Also, we observed increased platelet reactivity in patients with high macrophage levels in atherosclerotic plaques as compared to patients with low macrophage levels in atherosclerotic plaques (mean +/- SD; 8969 +/- 3485 AUC vs. 7020 +/- 3442 AUC, P = 0.02). All associations remained significant after adjustment for age, sex and use of drugs against platelet activation. Conclusion: Platelet reactivity towards ADP is associated with levels of PMCs and macrophages in human atherosclerotic carotid plaques.	[Rutten, Bert; Tersteeg, Claudia; van Holten, Thijs C.; Mak-Nienhuis, Elske M.; de Groot, Philip G.; Roest, Mark] Univ Med Ctr Utrecht, Lab Clin Chem & Hematol, Utrecht, Netherlands; [Tersteeg, Claudia; Vrijenhoek, Joyce E. P.; Elsenberg, Ellen H. A. M.; Mak-Nienhuis, Elske M.; Pasterkamp, Gerard; Hoefer, Imo] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [Vrijenhoek, Joyce E. P.; de Borst, Gert Jan; Moll, Frans L.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Vrijenhoek, Joyce E. P.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Pijls, Nico H. J.] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands; [Waltenberger, Johannes] Maastricht Univ, Dept Cardiol, Med Ctr, Maastricht, Netherlands; [van Zonneveld, Anton Jan] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [van Zonneveld, Anton Jan] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [McClellan, Elizabeth; Stubbs, Andrew] Erasmus Univ, Med Ctr, Dept Bioinformat, Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Catharina Hospital; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC	Roest, M (corresponding author), Univ Med Ctr Utrecht, Lab Clin Chem & Hematol, Utrecht, Netherlands.	M.Roest@umcutrecht.nl	Jukema, J. Wouter/ABD-6503-2021; van Zonneveld, Anton Jan/D-8060-2018; Tersteeg, Claudia/V-3758-2018	Jukema, J. Wouter/0000-0002-3246-8359; van Zonneveld, Anton Jan/0000-0002-1676-7738; Tersteeg, Claudia/0000-0002-6380-6349; Rutten, Bart/0000-0002-9834-6346	project CIRCULATING CELLS [01C-102]; Dutch Heart Foundation	project CIRCULATING CELLS; Dutch Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project CIRCULATING CELLS (grant 01C-102), and supported by the Dutch Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bouman HJ, 2010, J THROMB HAEMOST, V8, P482, DOI 10.1111/j.1538-7836.2009.03733.x; Braun OO, 2008, THROMB HAEMOSTASIS, V100, P626, DOI 10.1160/TH08-05-0313; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Burger PC, 2003, BLOOD, V101, P2661, DOI 10.1182/blood-2002-07-2209; Can MM, 2010, THROMB RES, V125, pE132, DOI 10.1016/j.thromres.2009.11.005; Davies JA, 2009, ACTA HAEMATOL-BASEL, V121, P98, DOI 10.1159/000214848; Dawood BB, 2012, BLOOD, V120, P5041, DOI 10.1182/blood-2012-07-444281; Frenette PS, 2000, J EXP MED, V191, P1413, DOI 10.1084/jem.191.8.1413; Furman MI, 1998, J AM COLL CARDIOL, V31, P352, DOI 10.1016/S0735-1097(97)00510-X; Furman MI, 2001, J AM COLL CARDIOL, V38, P1002, DOI 10.1016/S0735-1097(01)01485-1; Gawaz M, 1998, CIRCULATION, V98, P1164, DOI 10.1161/01.CIR.98.12.1164; GOLDSTEIN MR, 1995, JAMA-J AM MED ASSOC, V274, P1505, DOI 10.1001/jama.1995.03530190019015; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hechler B, 2008, CIRCULATION, V118, P754, DOI 10.1161/CIRCULATIONAHA.108.788927; Hellings WE, 2007, J VASC SURG, V46, P1147, DOI 10.1016/j.jvs.2007.08.018; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Jones CI, 2007, J THROMB HAEMOST, V5, P1756, DOI 10.1111/j.1538-7836.2007.02632.x; Jukema JW, 2013, CLIN RES CARDIOL; KARANAS YL, 1995, ANN PLAS SURG, V35, P525, DOI 10.1097/00000637-199511000-00015; Klinkhardt U, 2003, CLIN PHARMACOL THER, V73, P232, DOI 10.1067/mcp.2003.13; Leppanen A, 1999, J BIOL CHEM, V274, P24838, DOI 10.1074/jbc.274.35.24838; Li D, 2012, ARTERIOSCL THROM VAS, V32, pE81, DOI 10.1161/ATVBAHA.111.239095; Liu D, 2014, J EXP MED; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Martins PAD, 2006, J LEUKOCYTE BIOL, V79, P499, DOI 10.1189/jlb.0605318; Massberg S, 2002, J EXP MED, V196, P887, DOI 10.1084/jem.20012044; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; van Bladel ER, 2014, BLOOD; Van Holten TC, 2012, J THROMB HAEMOST, V10, P1177, DOI 10.1111/j.1538-7836.2012.04703.x; Verhoeven BAN, 2004, EUR J EPIDEMIOL, V19, P1127, DOI 10.1007/s10564-004-2304-6; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; von Hundelshausen P, 2005, BLOOD, V105, P924, DOI 10.1182/blood-2004-06-2475; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772	38	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105019	10.1371/journal.pone.0105019	http://dx.doi.org/10.1371/journal.pone.0105019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122139	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000089
J	Tieu, HV; Suntarattiwong, P; Puthanakit, T; Chotpitayasunondh, T; Chokephaibulkit, K; Sirivichayakul, S; Buranapraditkun, S; Rungrojrat, P; Chomchey, N; Tsiouris, S; Hammer, S; Nandi, V; Ananworanich, J				Tieu, Hong-Van; Suntarattiwong, Piyarat; Puthanakit, Thanyawee; Chotpitayasunondh, Tawee; Chokephaibulkit, Kulkanya; Sirivichayakul, Sunee; Buranapraditkun, Supranee; Rungrojrat, Patcharawee; Chomchey, Nitiya; Tsiouris, Simon; Hammer, Scott; Nandi, Vijay; Ananworanich, Jintanat		Thai TB Px Study Grp	Comparing Interferon-Gamma Release Assays to Tuberculin Skin Test in Thai Children with Tuberculosis Exposure	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; LATENT TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; INFECTION; DIAGNOSIS; PERFORMANCE; METAANALYSIS; CHALLENGES; DISEASE; UTILITY	Background: Data on the performance of interferon-gamma release assays (IGRAs), QuantiFERON TB Gold In-tube (QFNGIT) and T-Spot. TB, in diagnosing tuberculosis (TB) are limited in Southeast Asia. This study aims to compare the performances of the two IGRAs and TST in Thai children with recent TB exposure. Methods: This multicenter, prospective study enrolled children with recent exposure to active TB adults. Children were investigated for active TB. TST was performed and blood collected for T-Spot. TB and QFNGIT. Results: 158 children were enrolled (87% TB-exposed and 13% active TB, mean age 7.2 years). Only 3 children had HIV infection. 66.7% had TST >= 10 mm, while 38.6% had TST >= 15 mm. 32.5% had positive QFNGIT; 29.9% had positive T-Spot. TB. QFNGIT and T-Spot. TB positivity was higher among children with active TB compared with TB-exposed children. No indeterminate IGRA results were detected. No statistically significant differences between the performances of the IGRAs and TST at the two cut-offs with increasing TB exposure were detected. Concordance for positive IGRAs and TST ranged from 42-46% for TST >= 10 mm and 62-67% for TST >= 15 mm. On multivariable analyses, exposure to household primary/secondary caregiver with TB was associated with positive QFNGIT. Higher TB contact score and active TB were associated with positive T-Spot. TB. Conclusions: Both QFNGIT and T-Spot. TB performed well in our Thai pediatric study population. No differences in the performances between tests with increasing TB exposure were found. Due to accessibility and low cost, using TST may more ideal than IGRAs in diagnosing latent and active TB in healthy children in Thailand and other similar settings.	[Tieu, Hong-Van; Nandi, Vijay] New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Infect Dis Prevent, New York, NY 10021 USA; [Tieu, Hong-Van; Tsiouris, Simon; Hammer, Scott] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY USA; [Suntarattiwong, Piyarat; Chotpitayasunondh, Tawee] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [Puthanakit, Thanyawee] Chulalongkorn Univ, Fac Med, Dept Pediat, Bangkok 10330, Thailand; [Puthanakit, Thanyawee; Ananworanich, Jintanat] Thai Red Cross AIDS Res Ctr, HIV Netherlands Australia Thailand Res Collaborat, Bangkok, Thailand; [Chokephaibulkit, Kulkanya] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pediat, Bangkok 10700, Thailand; [Sirivichayakul, Sunee; Buranapraditkun, Supranee; Ananworanich, Jintanat] Chulalonglongkorn Univ, Dept Med, Fac Med, Bangkok, Thailand; [Rungrojrat, Patcharawee; Chomchey, Nitiya; Ananworanich, Jintanat] Thai Red Cross AIDS Res Ctr, SEARCH, Bangkok, Thailand; [Ananworanich, Jintanat] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA	New York Blood Center; Columbia University; Chulalongkorn University; Thai Red Cross Society; Mahidol University; Chulalongkorn University; Thai Red Cross Society; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Tieu, HV (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Infect Dis Prevent, New York, NY 10021 USA.	htieu@nybloodcenter.org	Ananworanich, Jintanat/AAC-6348-2021	Ananworanich, Jintanat/0000-0003-1369-3224; Puthanakit, Thanywee/0000-0003-1873-1867	Tibotec REACH Initiative; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA031035] Funding Source: NIH RePORTER	Tibotec REACH Initiative; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by a competitive, investigator-initiated research grant from Tibotec REACH Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, THAI TUBERCULOUS TRE; Bergamini BM, 2009, PEDIATRICS, V123, pe419, DOI 10.1542/peds.2008-1722; Blandinieres A, 2013, J INFECTION, V67, P391, DOI 10.1016/j.jinf.2013.06.011; Connell TG, 2006, THORAX, V61, P616, DOI 10.1136/thx.2005.048033; Critselis E, 2012, J PEDIATR-US, V161, P632, DOI 10.1016/j.jpeds.2012.04.007; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Immunotec O TSpot, TB PACK INS; Kampmann B, 2009, EUR RESPIR J, V33, P1374, DOI 10.1183/09031936.00153408; Lalvani A, 2007, CURR OPIN INFECT DIS, V20, P264, DOI 10.1097/QCO.0b013e32813e3fd8; Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915; Mandalakas AM, 2008, INT J TUBERC LUNG D, V12, P417; Mandalakas AM, 2011, INT J TUBERC LUNG D, V15, P1018, DOI 10.5588/ijtld.10.0631; Mandalakas AM, 2013, PEDIATR INFECT DIS J, V32, pE111, DOI 10.1097/INF.0b013e31827d77b7; Marais BJ, 2007, J INFECT DIS, V196, pS76, DOI 10.1086/518659; Marais BJ, 2008, PEDIATR PULM, V43, P322, DOI 10.1002/ppul.20787; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Oberdorfer P, 2007, 5 WORLD C WORLD SOC; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Perez-Porcuna TSM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097992; Roy RB, 2012, AM J RESP CRIT CARE, V186, P378, DOI 10.1164/rccm.201201-0026OC; Sollai S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S6; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Thomas TA, 2010, PEDIATRICS, V126, pE1522, DOI 10.1542/peds.2010-0885; Tsiouris SJ, 2006, INT J TUBERC LUNG D, V10, P939; Uluk T, 2013, PEDIATR INFECT DIS J, V32, P187, DOI 10.1097/INF.0b013e31827412fc; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	33	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105003	10.1371/journal.pone.0105003	http://dx.doi.org/10.1371/journal.pone.0105003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121513	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000085
J	Tran, BX; Nong, VM; Maher, RM; Nguyen, PK; Luu, HN				Tran, Bach Xuan; Nong, Vuong Minh; Maher, Rachel Marie; Nguyen, Phuong Khanh; Luu, Hoat Ngoc			A Systematic Review of Scope and Quality of Health Economic Evaluation Studies in Vietnam	PLOS ONE			English	Review							METHADONE-MAINTENANCE TREATMENT; EVIDENCE-BASED DECISION; POSITIVE DRUG-USERS; COST-EFFECTIVENESS; ASIA-PACIFIC; ROTAVIRUS VACCINATION; PREVENTION; PROGRAMS; THERAPY; CANCER	Introduction: The application of health economic evaluation (HEE) evidence can play an important role in strategic planning and policy making. This study aimed to assess the scope and quality of existing research, with the goal of elucidating implications for improving the use of HEE evidence in Vietnam. Methods: A comprehensive search strategy was developed to search medical online databases (Medline, Google Scholar, and Vietnam Medical Databases) to select all types of HEE studies except cost-only analyses. Two researchers assessed the quality of selected studies using the Quality of Health Economic Studies (QHES) instrument. Results: We selected 26 studies, including 6 published in Vietnam. The majority of these studies focused on infectious diseases (14 studies), with HIV being the most common topic (5 studies). Most papers were cost-effectiveness studies that measured health outcomes using DALY units. Using QHES, we found that the overall quality of HEE studies published internationally was much higher (mean score 88.7+13.3) than that of those published in Vietnam (mean score 67.3+22.9). Lack of costing perspectives, reliable data sources and sensitivity analysis were the main shortcomings of the reviewed studies. Conclusion: This review indicates that HEE studies published in Vietnam are limited in scope and number, as well as by several important technical errors or omissions. It is necessary to formalize the process of health economic research in Vietnam and to institutionalize the links between researchers and policy-makers. Additionally, the quality of HEE should be enhanced through education about research techniques, and the implementation of standard HEE guidelines.	[Tran, Bach Xuan] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Tran, Bach Xuan; Nong, Vuong Minh; Maher, Rachel Marie; Luu, Hoat Ngoc] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Nguyen, Phuong Khanh] Hlth Strategy & Policy Inst, Minist Hlth, Hanoi, Vietnam	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Hanoi Medical University	Tran, BX (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	bach@jhu.edu		Nong, Vuong/0000-0003-3331-4738				Acharya A., 2003, MAKING CHOICES HLTH; Tran BX, 2012, GLOB PUBLIC HEALTH, V7, P1080, DOI 10.1080/17441692.2012.736259; Tran BX, 2012, AIDS CARE, V24, P283, DOI 10.1080/09540121.2011.608420; Casey GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023723; Cook J, 2008, VACCINE, V26, P6305, DOI 10.1016/j.vaccine.2008.09.040; Danielsson N, 2004, ARCH DIS CHILD-FETAL, V89, pF546, DOI 10.1136/adc.2003.047837; Desai PR, 2012, PHARMACOECONOMICS, V30, P749, DOI 10.2165/11590140-000000000-00000; Duc AH, 2011, HEALTH POLICY PLANN, V26, P210, DOI 10.1093/heapol/czq045; Vuong DA, 2012, WORLD NEUROSURG, V77, P321, DOI 10.1016/j.wneu.2011.05.050; Fischer TK, 2005, J INFECT DIS, V192, P1720, DOI 10.1086/497339; Gavaza P, 2012, PHARMACOECONOMICS, V30, P925, DOI 10.2165/11589450-000000000-00000; Gavaza P, 2010, PHARMACOECONOMICS, V28, P539, DOI 10.2165/11536170-000000000-00000; Ha NT, 2012, Y HC PHONG 22, VXXII - 2, P54; Higashi H, 2012, ADDICTION, V107, P658, DOI 10.1111/j.1360-0443.2011.03632.x; Higashi H, 2011, APPL HEALTH ECON HEA, V9, P183, DOI 10.2165/11539640-000000000-00000; Holmes CB, 2010, JAMA-J AM MED ASSOC, V304, P313, DOI 10.1001/jama.2010.993; Huong NTM, 2001, AM J PUBLIC HEALTH, V91, P825, DOI 10.2105/AJPH.91.5.825; Jirawattanapisal T, 2009, VALUE HEALTH, V12, pS4, DOI 10.1111/j.1524-4733.2009.00620.x; Kien VD, 2012, TP CHI NGHIEN CU KHO, V79, P127; Kim JJ, 2008, VACCINE, V26, P4015, DOI 10.1016/j.vaccine.2008.05.038; Kim SY, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-29; Lindholm L, 2003, SCAND J PUBLIC HEALT, V31, P66, DOI 10.1080/14034950310015130; Love RR, 2002, J CLIN ONCOL, V20, P2559, DOI 10.1200/JCO.2002.08.169; LT Th, 2003, Y HC THC HANH, V11, P38; Morel CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058205; Nga CN, 2003, PHAN TICH CHI PHI HI, V8, P62; Ofman Joshua J, 2003, J Manag Care Pharm, V9, P53; Peterson LE, 2009, PHYS THER, V89, P733, DOI 10.2522/ptj.20080326; Sivalal S, 2009, INT J TECHNOL ASSESS, V25, P196, DOI 10.1017/S0266462309090631; Sn ND, 2008, Y HC PHONG 19, V2, P116; Suba EJ, 2001, CANCER-AM CANCER SOC, V91, P928, DOI 10.1002/1097-0142(20010301)91:5<928::AID-CNCR1082>3.0.CO;2-S; Tantivess Sripen, 2008, J Med Assoc Thai, V91 Suppl 2, pS88; Thatte U, 2009, VALUE HEALTH, V12, pS18, DOI 10.1111/j.1524-4733.2009.00622.x; Tran BX, 2012, DRUG ALCOHOL DEPEN, V125, P260, DOI 10.1016/j.drugalcdep.2012.02.021; Tsu VD, 2009, HEALTH POLICY PLANN, V24, P438, DOI 10.1093/heapol/czp020; Tyrrell A, 2011, TRANSFUSION MED, V21, P158, DOI 10.1111/j.1365-3148.2010.01058.x; Yn NT, 2006, Y HC PHONG 16, VXVI-1, P32; Young J., 2005, INT DEV, V17, P727, DOI [10.1002/jid.1235, DOI 10.1002/JID.1235]	38	25	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103825	10.1371/journal.pone.0103825	http://dx.doi.org/10.1371/journal.pone.0103825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO0QT	25122180	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000020
J	Vaisnav, M; Xing, C; Ku, HC; Hwang, D; Stojadinovic, S; Pertsemlidis, A; Abrams, JM				Vaisnav, Mahesh; Xing, Chao; Ku, Hung-Chih; Hwang, Daniel; Stojadinovic, Strahinja; Pertsemlidis, Alexander; Abrams, John M.			Genome-Wide Association Analysis of Radiation Resistance in Drosophila melanogaster	PLOS ONE			English	Article							DNA-REPAIR GENES; IONIZING-RADIATION; HERITABILITY; RADIOTHERAPY; EXPOSURE; CANCER; INSTABILITY; VARIANTS; RISKS	Background: Ionizing radiation is genotoxic to cells. Healthy tissue toxicity in patients and radiation resistance in tumors present common clinical challenges in delivering effective radiation therapies. Radiation response is a complex, polygenic trait with unknown genetic determinants. The Drosophila Genetic Reference Panel (DGRP) provides a model to investigate the genetics of natural variation for sensitivity to radiation. Methods and Findings: Radiation response was quantified in 154 inbred DGRP lines, among which 92 radiosensitive lines and 62 radioresistant lines were classified as controls and cases, respectively. A case-control genome-wide association screen for radioresistance was performed. There are 32 single nucleotide polymorphisms (SNPs) associated with radio resistance at a nominal p<10(-5); all had modest effect sizes and were common variants with the minor allele frequency. 5%. All the genes implicated by those SNP hits were novel, many without a known role in radiation resistance and some with unknown function. Variants in known DNA damage and repair genes associated with radiation response were below the significance threshold of p<10(-5) and were not present among the significant hits. No SNP met the genome-wide significance threshold (p = 1.49x10(-7)), indicating a necessity for a larger sample size. Conclusions: Several genes not previously associated with variation in radiation resistance were identified. These genes, especially the ones with human homologs, form the basis for exploring new pathways involved in radiation resistance in novel functional studies. An improved DGRP model with a sample size of at least 265 lines and ideally up to 793 lines is recommended for future studies of complex traits.	[Vaisnav, Mahesh; Hwang, Daniel; Abrams, John M.] UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75235 USA; [Xing, Chao; Ku, Hung-Chih] UT Southwestren Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX USA; [Stojadinovic, Strahinja] UT Southwestren Med Ctr, Dept Radiat Oncol, Dallas, TX USA; [Pertsemlidis, Alexander] UT Southwestren Med Ctr, Greehey Childrens Canc Res Inst, Dept Pediat & Cellular & Struct Biol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Abrams, JM (corresponding author), UT Southwestern Med Ctr, Dept Cell Biol, Dallas, TX 75235 USA.	John.Abrams@UTSouthwestern.edu	Stojadinovic, Strahinja/R-3818-2019; Pertsemlidis, Alexander/Q-7899-2017	Stojadinovic, Strahinja/0000-0002-6840-5747; Pertsemlidis, Alexander/0000-0003-1624-9372; Xing, Chao/0000-0002-1838-0502	NIH [C06 RR30414, R01GM072124]; Cancer Prevention Research Institute of Texas [RP110076]; Ellison Medical Foundation; Welch Foundation [I-1727]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR030414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; Ellison Medical Foundation(Lawrence Ellison Foundation); Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was performed in laboratories constructed with support from NIH grant C06 RR30414, and was funded by NIH R01GM072124, Cancer Prevention Research Institute of Texas RP110076, Ellison Medical Foundation and Welch Foundation (I-1727). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Boice JD, 2012, J RADIOL PROT, V32, pN33, DOI 10.1088/0952-4746/32/1/N33; Chow CY, 2013, P NATL ACAD SCI USA, V110, P9013, DOI 10.1073/pnas.1307125110; Curwen GB, 2010, INT J RADIAT BIOL, V86, P986, DOI 10.3109/09553002.2010.496027; Finnon P, 2008, HUM GENET, V123, P485, DOI 10.1007/s00439-008-0500-1; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gomez FH, 2013, INT J RADIAT BIOL, V89, P583, DOI 10.3109/09553002.2012.711503; Katsnelson A, 2013, NAT MED, V19, P249, DOI 10.1038/nm0313-249; Kerns SL, 2010, INT J RADIAT ONCOL, V78, P1292, DOI 10.1016/j.ijrobp.2010.07.036; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Little MP, 2003, BRIT MED BULL, V68, P259, DOI 10.1093/bmb/ldg031; MACKAY TF, 2008, PROPOSAL SEQUENCE DR; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Marian AJ, 2012, TRANSL RES, V159, P64, DOI 10.1016/j.trsl.2011.08.001; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Pawitan Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007969; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sankaranarayanan K, 2006, J RADIAT RES, V47, pB57, DOI 10.1269/jrr.47.B57; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Suzuki K, 2003, ONCOGENE, V22, P6988, DOI 10.1038/sj.onc.1206881; Turesson I, 1996, INT J RADIAT ONCOL, V36, P1065, DOI 10.1016/S0360-3016(96)00426-9; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745; West CML, 2012, SEMIN RADIAT ONCOL, V22, P91, DOI 10.1016/j.semradonc.2011.12.007; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Xing G, 2012, ANN HUM GENET, V76, P168, DOI 10.1111/j.1469-1809.2011.00700.x; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	32	21	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104858	10.1371/journal.pone.0104858	http://dx.doi.org/10.1371/journal.pone.0104858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121966	Green Submitted, gold, Green Published			2022-12-27	WOS:000341017000067
J	Klecka, J				Klecka, Jan			Modelling Size Structured Food Webs Using a Modified Niche Model with Two Predator Traits	PLOS ONE			English	Article							BODY-SIZE; ECOLOGICAL NETWORKS; STABILITY; PREY; ECOSYSTEMS; COMPLEXITY; PATTERNS; INTERVALITY; CONNECTANCE; EFFICIENCY	The structure of food webs is frequently described using phenomenological stochastic models. A prominent example, the niche model, was found to produce artificial food webs resembling real food webs according to a range of summary statistics. However, the size structure of food webs generated by the niche model and real food webs has not yet been rigorously compared. To fill this void, I use a body mass based version of the niche model and compare prey-predator body mass allometry and predator-prey body mass ratios predicted by the model to empirical data. The results show that the model predicts weaker size structure than observed in many real food webs. I introduce a modified version of the niche model which allows to control the strength of size-dependence of predator-prey links. In this model, optimal prey body mass depends allometrically on predator body mass and on a second trait, such as foraging mode. These empirically motivated extensions of the model allow to represent size structure of real food webs realistically and can be used to generate artificial food webs varying in several aspects of size structure in a controlled way. Hence, by explicitly including the role of species traits, this model provides new opportunities for simulating the consequences of size structure for food web dynamics and stability.	[Klecka, Jan] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Fish Ecol & Evolut, Kastanienbaum, Switzerland; [Klecka, Jan] Acad Sci Czech Republic, Ctr Biol, Inst Entomol, Lab Theoret Ecol, Ceske Budejovice, Czech Republic; [Klecka, Jan] Univ South Bohemia, Fac Sci, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic	Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice	Klecka, J (corresponding author), Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Fish Ecol & Evolut, Kastanienbaum, Switzerland.	jan.klecka@eawag.ch	Klecka, Jan/H-7874-2014	Klecka, Jan/0000-0003-0633-3896	ERASMUS scholarship; Grant Agency of the University of South Bohemia [GAJU 145/2010/P]	ERASMUS scholarship; Grant Agency of the University of South Bohemia	The study was supported by ERASMUS scholarship and the Grant Agency of the University of South Bohemia (grant no. GAJU 145/2010/P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Allesina S, 2011, J THEOR BIOL, V279, P161, DOI 10.1016/j.jtbi.2010.06.040; Beckerman AP, 2006, P NATL ACAD SCI USA, V103, P13745, DOI 10.1073/pnas.0603039103; Berec L, 2010, J THEOR BIOL, V266, P211, DOI 10.1016/j.jtbi.2010.06.034; Bersier LF, 1999, AM NAT, V153, P676, DOI 10.1086/303200; Bersier LF, 2008, ECOL COMPLEX, V5, P132, DOI 10.1016/j.ecocom.2007.06.013; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Elton C., 1927, ANIMAL ECOLOGY; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; HAMLEY JM, 1975, J FISH RES BOARD CAN, V32, P1943, DOI 10.1139/f75-233; Harley SJ, 2001, CAN J FISH AQUAT SCI, V58, P1569, DOI 10.1139/cjfas-58-8-1569; Heckmann L, 2012, ECOL LETT, V15, P243, DOI 10.1111/j.1461-0248.2011.01733.x; Jennings S, 2005, ICES J MAR SCI, V62, P397, DOI 10.1016/j.icesjms.2004.07.030; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Klecka J, 2013, J ANIM ECOL, V82, P1031, DOI 10.1111/1365-2656.12078; Klecka J, 2011, ECOL INDIC, V11, P500, DOI 10.1016/j.ecolind.2010.07.005; Kondoh M, 2003, SCIENCE, V299, P1388, DOI 10.1126/science.1079154; Lang A, 2000, ANZ SCHADL-J PEST SC, V73, P99; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Melian CJ, 2011, ADV ECOL RES, V45, P225, DOI 10.1016/B978-0-12-386475-8.00006-X; Mommertz S, 1996, ANN ZOOL FENN, V33, P117; Montoya JM, 2003, OIKOS, V102, P614, DOI 10.1034/j.1600-0706.2003.12031.x; Naisbit RE, 2012, P ROY SOC B-BIOL SCI, V279, P3291, DOI 10.1098/rspb.2012.0327; Naisbit RE, 2011, ECOLOGY, V92, P2183, DOI 10.1890/10-2234.1; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; Olesen JM, 2011, P ROY SOC B-BIOL SCI, V278, P725, DOI 10.1098/rspb.2010.1371; Petchey OL, 2008, P NATL ACAD SCI USA, V105, P4191, DOI 10.1073/pnas.0710672105; Petchey OL, 2011, J THEOR BIOL, V279, P169, DOI 10.1016/j.jtbi.2011.03.019; R Core Team, 2012, R LANG ENV STAT COMP; Riede JO, 2010, ADV ECOL RES, V42, P139, DOI 10.1016/S0065-2504(10)42003-6; Riede JO, 2011, ECOL LETT, V14, P169, DOI 10.1111/j.1461-0248.2010.01568.x; Rohr RP, 2010, AM NAT, V176, P170, DOI 10.1086/653667; Rossberg AG, 2006, J THEOR BIOL, V241, P552, DOI 10.1016/j.jtbi.2005.12.021; Rossberg AG, 2010, THEOR ECOL-NETH, V3, P13, DOI 10.1007/s12080-009-0049-1; Sanders D, 2011, ENTOMOL EXP APPL, V138, P234, DOI 10.1111/j.1570-7458.2010.01094.x; Schmid-Araya JM, 2002, J ANIM ECOL, V71, P1056, DOI 10.1046/j.1365-2656.2002.00668.x; Stouffer DB, 2006, P NATL ACAD SCI USA, V103, P19015, DOI 10.1073/pnas.0603844103; Stouffer DB, 2007, P ROY SOC B-BIOL SCI, V274, P1931, DOI 10.1098/rspb.2007.0571; Stouffer DB, 2011, J ANIM ECOL, V80, P632, DOI 10.1111/j.1365-2656.2011.01812.x; Stouffer DB, 2005, ECOLOGY, V86, P1301, DOI 10.1890/04-0957; Trautmann H., 2012, TRUNCNORM TRUNCATED; WARREN PH, 1987, OECOLOGIA, V74, P231, DOI 10.1007/BF00379364; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Williams RJ, 2008, J ANIM ECOL, V77, P512, DOI 10.1111/j.1365-2656.2008.01362.x; Williams RJ, 2011, ECOLOGY, V92, P1849, DOI 10.1890/11-0200.1; Williams RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012092; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Wirtz KW, 2012, MAR ECOL PROG SER, V445, P1, DOI 10.3354/meps09502; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Woodward G, 2010, ADV ECOL RES, V43, P211, DOI 10.1016/B978-0-12-385005-8.00006-X; Woodward Guy, 2007, P98, DOI 10.1017/CBO9780511611223.007; Zook AE, 2011, J THEOR BIOL, V271, P106, DOI 10.1016/j.jtbi.2010.11.045	57	1	1	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e99355	10.1371/journal.pone.0099355	http://dx.doi.org/10.1371/journal.pone.0099355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119999	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600002
J	Janjanam, J; Singh, S; Jena, MK; Varshney, N; Kola, S; Kumar, S; Kaushik, JK; Grover, S; Dang, AK; Mukesh, M; Prakash, BS; Mohanty, AK				Janjanam, Jagadeesh; Singh, Surender; Jena, Manoj K.; Varshney, Nishant; Kola, Srujana; Kumar, Sudarshan; Kaushik, Jai K.; Grover, Sunita; Dang, Ajay K.; Mukesh, Manishi; Prakash, B. S.; Mohanty, Ashok K.			Comparative 2D-DIGE Proteomic Analysis of Bovine Mammary Epithelial Cells during Lactation Reveals Protein Signatures for Lactation Persistency and Milk Yield	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; NF-KAPPA-B; GLAND DEVELOPMENT; KINASE PATHWAYS; GROWTH; GELSOLIN; CALCIUM; CYCLE; EXPRESSION; INTEGRITY	Mammary gland is made up of a branching network of ducts that end with alveoli which surrounds the lumen. These alveolar mammary epithelial cells (MEC) reflect the milk producing ability of farm animals. In this study, we have used 2D-DIGE and mass spectrometry to identify the protein changes in MEC during immediate early, peak and late stages of lactation and also compared differentially expressed proteins in MEC isolated from milk of high and low milk producing cows. We have identified 41 differentially expressed proteins during lactation stages and 22 proteins in high and low milk yielding cows. Bioinformatics analysis showed that a majority of the differentially expressed proteins are associated in metabolic process, catalytic and binding activity. The differentially expressed proteins were mapped to the available biological pathways and networks involved in lactation. The proteins up-regulated during late stage of lactation are associated with NF-kappa B stress induced signaling pathways and whereas Akt, PI3K and p38/MAPK signaling pathways are associated with high milk production mediated through insulin hormone signaling.	[Janjanam, Jagadeesh; Singh, Surender; Jena, Manoj K.; Varshney, Nishant; Kumar, Sudarshan; Kaushik, Jai K.; Grover, Sunita; Mohanty, Ashok K.] Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal, India; [Kola, Srujana] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India; [Dang, Ajay K.; Prakash, B. S.] Natl Dairy Res Inst, Dairy Cattle Physiol Div, Karnal, India; [Mukesh, Manishi] Natl Bur Anim Genet Resources, Karnal, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; All India Institute of Medical Sciences (AIIMS) New Delhi; Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources	Janjanam, J (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA.	jjanjana@uthsc.edu; ashokmohanty1@gmail.com	Jena, M/AGM-1989-2022; Dang, Ajay Kumar/AAB-4090-2019; Golla, Srujana/ACZ-0457-2022; BS, Prakash/D-2337-2010; Golla, Srujana/AAU-2822-2020; Jan, Jag/J-4812-2014	Dang, Ajay Kumar/0000-0002-7306-5302; Golla, Srujana/0000-0002-3763-1549; Jan, Jag/0000-0002-2197-1426; Kaushik, Jai/0000-0002-8872-0066; Jena, Manoj/0000-0003-3847-8539; Kumar, Sudarshan/0000-0002-9816-4307	National Agricultural Innovation Project (NAIP), Component-4; Indian Council of Agricultural Research (ICAR), Government of India	National Agricultural Innovation Project (NAIP), Component-4; Indian Council of Agricultural Research (ICAR), Government of India(Indian Council of Agricultural Research (ICAR))	This research was funded by National Agricultural Innovation Project (NAIP), Component-4. Indian Council of Agricultural Research (ICAR), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn J, 2002, J PHARMACOL EXP THER, V303, P487, DOI 10.1124/jpet.102.038315; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Bionaz M, 2011, BIOINFORM BIOL INSIG, V5, P83, DOI 10.4137/BBI.S7003; Boutinaud M, 2008, J DAIRY SCI, V91, P988, DOI 10.3168/jds.2007-0587; Brantley DM, 2000, MECH DEVELOP, V97, P149, DOI 10.1016/S0925-4773(00)00405-6; Bringans S, 2008, PROTEOMICS, V8, P1081, DOI 10.1002/pmic.200700948; BURGOYNE RD, 1989, CELL CALCIUM, V10, P1, DOI 10.1016/0143-4160(89)90038-9; BURGOYNE RD, 1988, NATURE, V331, P20, DOI 10.1038/331020a0; Chen P, 1996, J CELL BIOL, V134, P689, DOI 10.1083/jcb.134.3.689; Clarkson RWE, 1999, J MAMMARY GLAND BIOL, V4, P165, DOI 10.1023/A:1018725207969; Connelly L, 2010, J CELL PHYSIOL, V222, P73, DOI 10.1002/jcp.21922; Crowley MR, 2000, DEV BIOL, V225, P407, DOI 10.1006/dbio.2000.9844; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Frey BM, 1999, FASEB J, V13, P2235, DOI 10.1096/fasebj.13.15.2235; Friedman DB, 2007, MOL CELL PROTEOMICS, V6, P150, DOI 10.1074/mcp.D600001-MCP200; Gade D, 2003, J MOL MICROB BIOTECH, V5, P240, DOI 10.1159/000071076; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Grossman M, 2003, J DAIRY SCI, V86, P988, DOI 10.3168/jds.S0022-0302(03)73682-0; Hadsell D, 2007, J MAMMARY GLAND BIOL, V12, P59, DOI 10.1007/s10911-007-9038-4; Hadsell Darryl L, 2003, Breast Dis, V17, P3; Hadsell DL, 2006, EXP GERONTOL, V41, P271, DOI 10.1016/j.exger.2005.12.005; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hofer D, 1998, ANN NY ACAD SCI, V859, P75, DOI 10.1111/j.1749-6632.1998.tb11112.x; HONG K, 1981, J BIOL CHEM, V256, P3641; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Janjanam J, 2013, PROTEOMICS, V13, P3189, DOI 10.1002/pmic.201300031; Janjanam J, 2012, MOL BIOL REP, V39, P10031, DOI 10.1007/s11033-012-1872-9; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; KNIGHT CH, 1987, J DAIRY SCI, V70, P1991, DOI 10.3168/jds.S0022-0302(87)80241-2; Lemay DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067531; Lemay DG, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r43; Lemay DG, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-56; Lewallen LP, 2006, JOGNN-J OBST GYN NEO, V35, P166, DOI 10.1111/J.1552-6909.2006.00031.x; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; Liang P, 1997, J CELL SCI, V110, P1431; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; NEVILLE MC, 1991, AM J CLIN NUTR, V54, P81, DOI 10.1093/ajcn/54.1.81; NEVILLE MC, 1981, J PHYSIOL-LONDON, V313, P561, DOI 10.1113/jphysiol.1981.sp013682; O'Donnell R, 2004, INT DAIRY J, V14, P1013, DOI 10.1016/j.idairyj.2004.04.004; Oliver CH, 2013, JAK STAT, V2; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Reinhardt TA, 2012, J PROTEOMICS, V75, P1486, DOI 10.1016/j.jprot.2011.11.017; Roncada P, 2012, J PROTEOMICS, V75, P4259, DOI 10.1016/j.jprot.2012.05.028; Rosfjord EC, 1999, J MAMMARY GLAND BIOL, V4, P229, DOI 10.1023/A:1018789527533; SCHLAEPFER DD, 1990, J CELL BIOL, V111, P229, DOI 10.1083/jcb.111.1.229; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; STELWAGEN K, 1995, AM J PHYSIOL-REG I, V269, pR848, DOI 10.1152/ajpregu.1995.269.4.R848; STELWAGEN K, 1994, J DAIRY SCI, V77, P426, DOI 10.3168/jds.S0022-0302(94)76969-1; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Taylor MR, 1997, DNA CELL BIOL, V16, P861, DOI 10.1089/dna.1997.16.861; Tonge R, 2001, PROTEOMICS, V1, P377; TUCKER HA, 1969, J DAIRY SCI, V52, P720, DOI 10.3168/jds.S0022-0302(69)86637-3; Turk R, 2012, J PROTEOMICS, V75, P4412, DOI 10.1016/j.jprot.2012.05.021; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Vetharaniam I, 2003, J DAIRY SCI, V86, P1987, DOI 10.3168/jds.S0022-0302(03)73787-4; Von Eggeling F, 2001, INT J MOL MED, V8, P373; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39	67	28	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e102515	10.1371/journal.pone.0102515	http://dx.doi.org/10.1371/journal.pone.0102515			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111801	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100010
J	Kamaeva, AA; Vasilchenko, AS; Deryabin, DG				Kamaeva, Anara A.; Vasilchenko, Alexey S.; Deryabin, Dmitry G.			Atomic Force Microscopy Reveals a Morphological Differentiation of Chromobacterium violaceum Cells Associated with Biofilm Development and Directed by N-Hexanoyl-L-Homoserine Lactone	PLOS ONE			English	Article							TWITCHING MOTILITY; QUORUM; COMMUNICATION; MOLECULES; INFECTION; BACTERIA; GENES	Chromobacterium violaceum abounds in soil and water ecosystems in tropical and subtropical regions and occasionally causes severe and often fatal human and animal infections. The quorum sensing (QS) system and biofilm formation are essential for C. violaceum's adaptability and pathogenicity, however, their interrelation is still unknown. C. violaceum's cell and biofilm morphology were examined by atomic force microscopy (AFM) in comparison with growth rates, QS-dependent violacein biosynthesis and biofilm biomass quantification. To evaluate QS regulation of these processes, the wild-type strain C. violaceum ATCC 31532 and its mini-Tn5 mutant C. violaceum NCTC 13274, cultivated with and without the QS autoinducer N-hexanoyl-L-homoserine lactone (C-6-HSL), were used. We report for the first time the unusual morphological differentiation of C. violaceum cells, associated with biofilm development and directed by the QS autoinducer. AFM revealed numerous invaginations of the external cytoplasmic membrane of wild-type cells, which were repressed in the mutant strain and restored by exogenous C-6-HSL. With increasing bacterial growth, polymer matrix extrusions formed in place of invaginations, whereas mutant cells were covered with a diffusely distributed extracellular substance. Thus, quorum sensing in C. violaceum involves a morphological differentiation that organises biofilm formation and leads to a highly differentiated matrix structure.	[Kamaeva, Anara A.; Vasilchenko, Alexey S.; Deryabin, Dmitry G.] Orenburg State Univ, Dept Microbiol, Orenburg, Russia; [Vasilchenko, Alexey S.] RAS, Inst Cellular & Intracellular Symbiosis, Lab Disbiosis, Orenburg, Russia; [Kamaeva, Anara A.] RSE Republican Collect Microorganisms, Astana, Kazakhstan	Orenburg State University; Russian Academy of Sciences; Orenburg Federal Research Center of the Ural Branch of the Russian Academy of Sciences; Institute of Cellular & Intracellular Symbiosis	Deryabin, DG (corresponding author), Orenburg State Univ, Dept Microbiol, Orenburg, Russia.	dgderyabin@yandex.ru	Vasilchenko, Alexey/C-9873-2012; Deryabin, Dmitrij Gennad'evich/F-2030-2015	Vasilchenko, Alexey/0000-0001-9970-4881; Deryabin, Dmitrij Gennad'evich/0000-0002-2495-6694; Deryabin, Dmitry/0000-0002-9578-7947	Ministry of Education and Science of the Russian Federation at the Orenburg State University	Ministry of Education and Science of the Russian Federation at the Orenburg State University	This work was supported by The Ministry of Education and Science of the Russian Federation as the government assignment to perform research at the Orenburg State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes AA, 2006, REV BIOLOGIA 101 NCI, P48; Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Baumgarten T, 2012, APPL ENVIRON MICROB, V78, P6217, DOI 10.1128/AEM.01525-12; Becker S, 2009, GENET MOL BIOL, V32, P640, DOI 10.1590/S1415-47572009000300031; Brito Cristiana F Alves de, 2004, Genet Mol Res, V3, P148; Chernin LS, 1998, J BACTERIOL, V180, P4435, DOI 10.1128/JB.180.17.4435-4441.1998; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Duran N, 2001, CRIT REV MICROBIOL, V27, P201, DOI 10.1080/20014091096747; Dyer NW, 2000, J VET DIAGN INVEST, V12, P177, DOI 10.1177/104063870001200217; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gillis M, 2005, BERGEYS MANUALR SYST, P824; Heydorn A, 2002, APPL ENVIRON MICROB, V68, P2008, DOI 10.1128/AEM.68.4.2008-2017.2002; Hoiby Niels, 2007, Ugeskr Laeger, V169, P4163; Hooshangi S, 2008, CURR OPIN BIOTECH, V19, P550, DOI 10.1016/j.copbio.2008.10.007; Hoshino T, 2011, APPL MICROBIOL BIOT, V91, P1463, DOI 10.1007/s00253-011-3468-z; Hungria Mariangela, 2004, Genet Mol Res, V3, P102; Lee J, 1999, J CLIN MICROBIOL, V37, P2068, DOI 10.1128/JCM.37.6.2068-2070.1999; Nadell CD, 2008, PLOS BIOL, V6, P171, DOI 10.1371/journal.pbio.0060014; Nikiyan Hike, 2010, Int J Microbiol, V2010, P704170, DOI 10.1155/2010/704170; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Purevdorj B, 2002, APPL ENVIRON MICROB, V68, P4457, DOI 10.1128/AEM.68.9.4457-4464.2002; Rajalakshmi G., 2011, J ADV LAB RES BIOL, V1, P22; RICHARD C, 1993, B SOC PATHOL EXOT, V86, P169; RUCINSKY TE, 1974, J BACTERIOL, V118, P717, DOI 10.1128/JB.118.2.717-724.1974; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Silva Rosane, 2004, Genet Mol Res, V3, P64; Stauff DL, 2011, J BACTERIOL, V193, P3871, DOI 10.1128/JB.05125-11; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535; Wagner VE, 2007, ANAL BIOANAL CHEM, V387, P469, DOI 10.1007/s00216-006-0964-6; Wang Y, 2008, BIOSCI BIOTECH BIOCH, V72, P1958, DOI 10.1271/bbb.80090; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Yang CH, 2011, J CHIN MED ASSOC, V74, P435, DOI 10.1016/j.jcma.2011.08.013; Yonezawa H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-197; Zhang ML, 2010, J BACTERIOL, V193, P5510; Zhurina MV, 2013, MICROBIOLOGY+, V82, P517, DOI 10.1134/S0026261713040164	47	14	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e103741	10.1371/journal.pone.0103741	http://dx.doi.org/10.1371/journal.pone.0103741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111599	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100020
J	Al-Barwani, F; Young, SL; Baird, MA; Larsen, DS; Ward, VK				Al-Barwani, Farah; Young, Sarah L.; Baird, Margaret A.; Larsen, David S.; Ward, Vernon K.			Mannosylation of Virus-Like Particles Enhances Internalization by Antigen Presenting Cells	PLOS ONE			English	Article							MACROPHAGE MANNOSE RECEPTOR; HEMORRHAGIC-DISEASE VIRUS; DENDRITIC CELLS; CROSS-PRESENTATION; SELECTIVE RECOGNITION; DOWN-REGULATION; I-TASSER; PROTEIN; EXPRESSION; DELIVERY	Internalization of peptides by antigen presenting cells is crucial for the initiation of the adaptive immune response. Mannosylation has been demonstrated to enhance antigen uptake through mannose receptors, leading to improved immune responses. In this study we test the effect of surface mannosylation of protein-based virus-like particles (VLP) derived from Rabbit hemorrhagic disease virus (RHDV) on uptake by murine and human antigen presenting cells. A monomannoside and a novel dimannoside were synthesized and successfully conjugated to RHDV VLP capsid protein, providing approximately 270 mannose groups on the surface of each virus particle. VLP conjugated to the mannoside or dimannoside exhibited significantly enhanced binding and internalization by murine dendritic cells, macrophages and B cells as well as human dendritic cells and macrophages. This uptake was inhibited by the inclusion of mannan as a specific inhibitor of mannose specific uptake, demonstrating that mannosylation of VLP targets mannose receptor-based uptake. Consistent with mannose receptor-based uptake, partial retargeting of the intracellular processing of RHDV VLP was observed, confirming that mannosylation of VLP provides both enhanced uptake and modified processing of associated antigens.	[Al-Barwani, Farah; Ward, Vernon K.] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand; [Young, Sarah L.; Baird, Margaret A.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand; [Larsen, David S.] Univ Otago, Div Sci, Dept Chem, Dunedin, New Zealand	University of Otago; University of Otago; University of Otago	Ward, VK (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand.	vernon.ward@otago.ac.nz	Larsen, David S/A-6367-2014	Larsen, David S/0000-0002-3563-1086; Ward, Vernon/0000-0001-8692-5116; Young, Sarah/0000-0003-0374-2221	Health Research Council of New Zealand [10/135]; University of Otago, New Zealand	Health Research Council of New Zealand(Health Research Council of New Zealand); University of Otago, New Zealand	This work was supported by Health Research Council of New Zealand grant (10/135) and a Priming Partnership Project from the University of Otago, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida SR, 2001, INT IMMUNOL, V13, P1193, DOI 10.1093/intimm/13.9.1193; Apostolopoulos V, 2000, VACCINE, V18, P3174, DOI 10.1016/S0264-410X(00)00090-6; Apostolopoulos V, 2000, EUR J IMMUNOL, V30, P1714, DOI 10.1002/1521-4141(200006)30:6<1714::AID-IMMU1714>3.0.CO;2-C; Apostolopoulos V, 2003, MOL B INT U, P297; Autenrieth SE, 2009, IMMUNOLOGY, V127, P523, DOI 10.1111/j.1365-2567.2008.02960.x; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BOSONE E, 1983, SYNTHESIS-STUTTGART, P942; Brode S, 2004, IMMUNOLOGY, V112, P345, DOI 10.1111/j.1365-2567.2004.01920.x; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941; Espuelas S, 2008, BIOCONJUGATE CHEM, V19, P2385, DOI 10.1021/bc8002524; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Fernandez E, 2013, PLOS ONE IN PRESS, V8; Frison N, 2003, J BIOL CHEM, V278, P23922, DOI 10.1074/jbc.M302483200; Furneaux RH, 2002, CAN J CHEM, V80, P964, DOI 10.1139/V02-120; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Ghosh M, 2012, J IMMUNOL, V188, P5489, DOI 10.4049/jimmunol.1103490; HARRIS N, 1992, BLOOD, V80, P2363; Jemon K, 2013, PLOS ONE IN PRESS, V8; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; KERY V, 1992, ARCH BIOCHEM BIOPHYS, V298, P49, DOI 10.1016/0003-9861(92)90092-B; LAURENT S, 1994, J VIROL, V68, P6794, DOI 10.1128/JVI.68.10.6794-6798.1994; Li KY, 2013, J IMMUNOTHER, V36, P11, DOI 10.1097/CJI.0b013e3182787f5e; Mayer TG, 1999, EUR J ORG CHEM, V1999, P1153; McKee SJ, 2012, J CONTROL RELEASE, V159, P338, DOI 10.1016/j.jconrel.2012.02.015; Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7; Peacey M, 2008, VACCINE, V26, P5334, DOI 10.1016/j.vaccine.2008.07.074; Peacey M, 2007, BIOTECHNOL BIOENG, V98, P968, DOI 10.1002/bit.21518; Petrushina I, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-42; PODLASEK CA, 1995, J AM CHEM SOC, V117, P8635, DOI 10.1021/ja00138a020; Ramirez MC, 2002, J IMMUNOL, V169, P6733, DOI 10.4049/jimmunol.169.12.6733; Rodriguez-Limas WA, 2013, CURR OPIN B IN PRESS; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Roy P, 2008, HUM VACCINES, V4, P5, DOI 10.4161/hv.4.1.5559; Ryan EJ, 2002, J IMMUNOL, V169, P5638, DOI 10.4049/jimmunol.169.10.5638; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sandgren KJ, 2013, J IMMUNOL, V191, P60, DOI 10.4049/jimmunol.1202489; Sheng KC, 2008, EUR J IMMUNOL, V38, P424, DOI 10.1002/eji.200737578; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TROWBRIDGE IS, 1974, J BIOL CHEM, V249, P6004; VINUESA CG, 2003, MOL B INT U, P128; White KL, 2006, J PHARM PHARMACOL, V58, P729, DOI 10.1211/jpp.58.6.0003; Win SJ, 2011, IMMUNOL CELL BIOL, V89, P681, DOI 10.1038/icb.2010.161; WITMERPACK MD, 1995, CELL IMMUNOL, V163, P157, DOI 10.1006/cimm.1995.1110; Young SL, 2006, VACCINE, V24, P5406, DOI 10.1016/j.vaccine.2006.03.052; Zeltins A, 2013, MOL BIOTECHNOL, V53, P92, DOI 10.1007/s12033-012-9598-4; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	49	32	33	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104523	10.1371/journal.pone.0104523	http://dx.doi.org/10.1371/journal.pone.0104523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122183	Green Submitted, gold, Green Published			2022-12-27	WOS:000341017000041
J	Duarte, LD; Bergamin, RS; Marcilio-Silva, V; Seger, GDD; Marques, MCM				Duarte, Leandro Da Silva; Bergamin, Rodrigo Scarton; Marcilio-Silva, Vinicius; Dos Santos Seger, Guilherme Dubal; Mendes Marques, Marcia Cristina			Phylobetadiversity among Forest Types in the Brazilian Atlantic Forest Complex	PLOS ONE			English	Article							FLORISTIC DIFFERENTIATION; PHYLOGENETIC STRUCTURE; SOUTH; DIVERSITY; CONSERVATION; PLANT; PATTERNS; CLASSIFICATION; BIOGEOGRAPHY; TRANSITION	Phylobetadiversity is defined as the phylogenetic resemblance between communities or biomes. Analyzing phylobetadiversity patterns among different vegetation physiognomies within a single biome is crucial to understand the historical affinities between them. Based on the widely accepted idea that different forest physiognomies within the Southern Brazilian Atlantic Forest constitute different facies of a single biome, we hypothesize that more recent phylogenetic nodes should drive phylobetadiversity gradients between the different forest types within the Atlantic Forest, as the phylogenetic divergence among those forest types is biogeographically recent. We compiled information from 206 checklists describing the occurrence of shrub/tree species across three different forest physiognomies within the Southern Brazilian Atlantic Forest (Dense, Mixed and Seasonal forests). We analyzed intra-site phylogenetic structure (phylogenetic diversity, net relatedness index and nearest taxon index) and phylobetadiversity between plots located at different forest types, using five different methods differing in sensitivity to either basal or terminal nodes (phylogenetic fuzzy weighting, COMDIST, COMDISTNT, UniFrac and Rao's H). Mixed forests showed higher phylogenetic diversity and overdispersion than the other forest types. Furthermore, all forest types differed from each other in relation phylobetadiversity patterns, particularly when phylobetadiversity methods more sensitive to terminal nodes were employed. Mixed forests tended to show higher phylogenetic differentiation to Dense and Seasonal forests than these latter from each other. The higher phylogenetic diversity and phylobetadiversity levels found in Mixed forests when compared to the others likely result from the biogeographical origin of several taxa occurring in these forests. On one hand, Mixed forests shelter several temperate taxa, like the conifers Araucaria and Podocarpus. On the other hand, tropical groups, like Myrtaceae, are also very representative of this forest type. We point out to the need of more attention to Mixed forests as a conservation target within the Brazilian Atlantic Forest given their high phylogenetic uniqueness.	[Duarte, Leandro Da Silva; Bergamin, Rodrigo Scarton; Dos Santos Seger, Guilherme Dubal] Univ Fed Rio Grande do Sul, Dept Ecol, Porto Alegre, RS, Brazil; [Marcilio-Silva, Vinicius; Mendes Marques, Marcia Cristina] Univ Fed Parana, Dept Bot, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Parana	Duarte, LD (corresponding author), Univ Fed Rio Grande do Sul, Dept Ecol, Porto Alegre, RS, Brazil.	duarte.ldas@gmail.com	da Silva Duarte, Leandro/B-6552-2012; Marques, Marcia Cristina Mendes/F-8699-2012; Duarte, Leandro/GZK-6828-2022; Seger, Guilherme Dubal S./I-9239-2014	da Silva Duarte, Leandro/0000-0003-1771-0407; Marques, Marcia Cristina Mendes/0000-0002-1003-9596; Seger, Guilherme Dubal S./0000-0002-0710-3550	Brazilian National Research Foundation (CNPq)	Brazilian National Research Foundation (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was funded by the Brazilian National Research Foundation (CNPq, http://www.cnpq.br) via researcher fellowships granted to Leandro Duarte and Marcia Marques. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim Dalton De Souza, 1994, Revista Brasileira de Entomologia, V38, P517; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Behling H, 2002, PALAEOGEOGR PALAEOCL, V177, P19, DOI 10.1016/S0031-0182(01)00349-2; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Bergamin RS, 2012, COMMUNITY ECOL, V13, P162, DOI 10.1556/ComEc.13.2012.2.5; Bertoncello R, 2011, BIODIVERS CONSERV, V20, P3413, DOI 10.1007/s10531-011-0129-6; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Burleigh J. G., 2012, Journal of Botany, V2012, P292857; Burnham RJ, 2004, PHILOS T R SOC B, V359, P1595, DOI 10.1098/rstb.2004.1531; Carlucci MB, 2011, NAT CONSERVACAO, V9, P111, DOI 10.4322/natcon.2011.015; Carvalho, 2008, ESPECIES ARBOREAS BR; Carvalho P.E.R, 2006, ESPECIES ARBOREAS BR; Carvalho PER, 2010, ESPECIES ARBOREAS BR; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase MW, 2009, BOT J LINN SOC, V161, P122, DOI 10.1111/j.1095-8339.2009.01002.x; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; CRISCI JV, 1991, SYST ZOOL, V40, P152, DOI 10.2307/2992254; Debastiani VJ, 2012, BIOINFORMATICS, V28, P2067, DOI 10.1093/bioinformatics/bts325; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Duarte LDS, 2014, GLOBAL ECOL BIOGEOGR, V23, P213, DOI 10.1111/geb.12089; Duarte LDS, 2012, ECOGRAPHY, V35, P952, DOI 10.1111/j.1600-0587.2011.07193.x; Duarte LD, 2009, GLOBAL ECOL BIOGEOGR, V18, P314, DOI 10.1111/j.1466-8238.2009.00448.x; Duarte LD, 2011, OIKOS, V120, P208, DOI 10.1111/j.1600-0706.2010.18898.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fiaschi P, 2009, J SYST EVOL, V47, P477, DOI 10.1111/j.1759-6831.2009.00046.x; Giulietti AM, 2005, CONSERV BIOL, V19, P632, DOI 10.1111/j.1523-1739.2005.00704.x; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Giehl ELH, 2012, ECOGRAPHY, V35, P933, DOI 10.1111/j.1600-0587.2011.07430.x; Hueck K., 1972, FLORESTAS AM; *IBGE, 1992, SER MAN TECN GEOC, V1; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lopretto EC, 1998, ZOOL SCR, V27, P311, DOI 10.1111/j.1463-6409.1998.tb00463.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Marques MCM, 2011, BIODIVERS CONSERV, V20, P153, DOI 10.1007/s10531-010-9952-4; Martini AMZ, 2007, BIODIVERS CONSERV, V16, P3111, DOI 10.1007/s10531-007-9166-6; Mittermeier Russell A., 2004, P1; MORI SA, 1981, BRITTONIA, V33, P233, DOI 10.2307/2806330; Morley R.J., 2000, ORIGIN EVOLUTION TRO; Morrone JJ, 2006, ANNU REV ENTOMOL, V51, P467, DOI 10.1146/annurev.ento.50.071803.130447; Morrone Juan J., 2001, Biogeographica (Paris), V77, P65; Murray-Smith C, 2009, CONSERV BIOL, V23, P151, DOI 10.1111/j.1523-1739.2008.01075.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Oliveira-Filho A. T., 1995, Edinburgh Journal of Botany, V52, P141; Oliveira-Filho Ary T., 2005, Rodriguésia, V56, P185, DOI 10.1590/2175-78602005568715; Parmentier I, 2009, ECOGRAPHY, V32, P613, DOI 10.1111/j.1600-0587.2008.05697.x; Pennington RT, 2004, PHILOS T R SOC B, V359, P1611, DOI 10.1098/rstb.2004.1532; Pillar VD, 2010, ECOL LETT, V13, P587, DOI 10.1111/j.1461-0248.2010.01456.x; Pillar VD, 1996, J VEG SCI, V7, P585, DOI 10.2307/3236308; Rambo B., 1951, ANAIS BOT HERBARIO B, V3, P7; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Sanmartin I, 2004, SYST BIOL, V53, P216, DOI 10.1080/10635150490423430; Scheer MB, 2011, DYNAMICAL PROCESSES OF BIODIVERSITY - CASE STUDIES OF EVOLUTION AND SPATIAL DISTRIBUTION, P109; Scudeller VV, 2001, PLANT ECOL, V152, P185, DOI 10.1023/A:1011494228661; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Stehmann J. R., 2009, PLANTAS FLORESTA ATL; Swenson NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021264; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448	67	47	47	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105043	10.1371/journal.pone.0105043	http://dx.doi.org/10.1371/journal.pone.0105043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121495	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000092
J	Mousavi, S; Alisoltani, A; Shiran, B; Fallahi, H; Ebrahimie, E; Imani, A; Houshmand, S				Mousavi, Sadegh; Alisoltani, Arghavan; Shiran, Behrouz; Fallahi, Hossein; Ebrahimie, Esameil; Imani, Ali; Houshmand, Saadollah			De Novo Transcriptome Assembly and Comparative Analysis of Differentially Expressed Genes in Prunus dulcis Mill. in Response to Freezing Stress	PLOS ONE			English	Article							RNA-SEQ DATA; COLD-ACCLIMATION; HIGH-SALT; DROUGHT; PROTEIN; PEACH; PLANT; IDENTIFICATION; TOLERANCE; QUALITY	Almond (Prunus dulcis Mill.), one of the most important nut crops, requires chilling during winter to develop fruiting buds. However, early spring chilling and late spring frost may damage the reproductive tissues leading to reduction in the rate of productivity. Despite the importance of transcriptional changes and regulation, little is known about the almond's transcriptome under the cold stress conditions. In the current reserch, we used RNA-seq technique to study the response of the reporuductive tissues of almond (anther and ovary) to frost stress. RNA sequencing resulted in more than 20 million reads from anther and ovary tissues of almond, individually. About 40,000 contigs were assembled and annotated de novo in each tissue. Profile of gene expression in ovary showed significant alterations in 5,112 genes, whereas in anther 6,926 genes were affected by freezing stress. Around two thousands of these genes were common altered genes in both ovary and anther libraries. Gene ontology indicated the involvement of differentially expressed (DE) genes, responding to freezing stress, in metabolic and cellular processes. qRT-PCR analysis verified the expression pattern of eight genes randomley selected from the DE genes. In conclusion, the almond gene index assembled in this study and the reported DE genes can provide great insights on responses of almond and other Prunus species to abiotic stresses. The obtained results from current research would add to the limited available information on almond and Rosaceae. Besides, the findings would be very useful for comparative studies as the number of DE genes reported here is much higher than that of any previous reports in this plant.	[Mousavi, Sadegh; Alisoltani, Arghavan; Shiran, Behrouz; Houshmand, Saadollah] Shahrekord Univ, Fac Agr, Dept Plant Breeding & Biotechnol, Shahrekord, Iran; [Shiran, Behrouz] Shahrekord Univ, Inst Biotechnol, Shahrekord, Iran; [Fallahi, Hossein] Razi Univ, Sch Sci, Dept Biol, Bagh E Abrisham Kermansh, Iran; [Ebrahimie, Esameil] Shiraz Univ, Fac Agr, Dept Crop Prod & Plant Breeding, Shiraz, Iran; [Ebrahimie, Esameil] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Imani, Ali] SPII, Dept Hort, Karaj, Iran	Shahrekord University; Shahrekord University; Razi University; Shiraz University; University of Adelaide	Shiran, B (corresponding author), Shahrekord Univ, Fac Agr, Dept Plant Breeding & Biotechnol, Shahrekord, Iran.	shiran@agr.sku.ac.ir	Shiran, Behrouz/ABF-1831-2020; Imani, Ali Akbar/ABF-7484-2021; Ebrahimi, Mansour/AAO-9096-2021; Fallahi, Hossein/I-7541-2019; Ebrahimie, Esmaeil/AAN-2611-2020; Alisoltani, Arghavan/AAV-9681-2020	Shiran, Behrouz/0000-0001-9997-4718; Ebrahimi, Mansour/0000-0001-7011-2567; Fallahi, Hossein/0000-0002-8754-3491; Ebrahimie, Esmaeil/0000-0002-4431-2861; /0000-0002-1138-210X; Alisoltani, Arghavan/0000-0003-3638-2218	Shahrekord University	Shahrekord University	This study supported partly by Shahrekord University. Also, the authors contributed personally in supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GM, 2006, J PROTEOME RES, V5, P396, DOI 10.1021/pr050291g; Alkio M, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.11; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barros PM, 2012, J EXP BOT, V63, P4585, DOI 10.1093/jxb/ers144; Ben Mohamed H, 2010, SCI HORTIC-AMSTERDAM, V124, P440, DOI 10.1016/j.scienta.2010.01.029; Cao SF, 2011, FOOD CHEM, V127, P1777, DOI 10.1016/j.foodchem.2011.02.059; Chen YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090842; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Court NW, 2004, BIOCHEM BIOPH RES CO, V319, P130, DOI 10.1016/j.bbrc.2004.04.148; Cushman JC, 2000, CURR OPIN PLANT BIOL, V3, P117, DOI 10.1016/S1369-5266(99)00052-7; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; Diaz-Martin J, 2005, PLANT PHYSIOL, V139, P1483, DOI 10.1104/pp.105.069963; Ding Y, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-229; Dirlewanger E, 2002, THEOR APPL GENET, V105, P127, DOI 10.1007/s00122-002-0867-7; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Hong SW, 1997, PLANT PHYSIOL, V113, P1203, DOI 10.1104/pp.113.4.1203; HORMAZA J, 2007, APRICOT FRUITS NUTS, P171; Imani A., 2012, International Journal of Nuts and Related Sciences (IJNRS), V3, P29; Imani A., 2011, International Journal of Nuts and Related Sciences (IJNRS), V2, P31; Jiang Y, 2013, BIOCHEMISTRY-MOSCOW+, V78, P342, DOI 10.1134/S0006297913040032; Jung KH, 2012, J PLANT BIOL, V55, P458, DOI 10.1007/s12374-012-0271-z; Kakumanu A, 2012, PLANT PHYSIOL, V160, P846, DOI 10.1104/pp.112.200444; Kawamura Y, 2003, PLANT J, V36, P141, DOI 10.1046/j.1365-313X.2003.01864.x; KE X, 2014, FUNGAL GENETICS BIOL; KHANIZADEH S, 1989, CAN J PLANT SCI, V69, P1277, DOI 10.4141/cjps89-155; Kodad O, 2010, ITEA-INF TEC ECON AG, V106, P142; KOHL DH, 1991, J EXP BOT, V42, P831, DOI 10.1093/jxb/42.7.831; Lambert P, 2004, THEOR APPL GENET, V108, P1120, DOI 10.1007/s00122-003-1526-3; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li HW, 2011, PLANTA, V234, P1007, DOI 10.1007/s00425-011-1458-0; Li HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073380; Liu Q, 2000, CHINESE SCI BULL, V45, P1153, DOI 10.1007/BF02886068; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Ma RC, 2000, MOL GEN GENET, V263, P925, DOI 10.1007/s004380000258; Matteucci M, 2011, J EXP BOT, V62, P3403, DOI 10.1093/jxb/err013; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Mizuno H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-683; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; MOUSAVI S, 2014, J CROP PROD IN PRESS; Pang T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-488; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Proebsting E.L., 1978, J AM SOC HORTICULTUR; Rays DB, 2000, J EXP BOT, V51, P1851, DOI 10.1093/jexbot/51.352.1851; Rodrigo J, 2000, SCI HORTIC-AMSTERDAM, V85, P155, DOI 10.1016/S0304-4238(99)00150-8; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Sathe SK, 2002, J AGR FOOD CHEM, V50, P4333, DOI 10.1021/jf020007v; SCALABRIN S, 2011, CATALOG MOL DIVERSIT, P169; Schliesky S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00220; Shinozaki K, 2003, CURR OPIN PLANT BIOL, V6, P410, DOI 10.1016/S1369-5266(03)00092-X; Shiran B, 2007, SCI HORTIC-AMSTERDAM, V111, P280, DOI 10.1016/j.scienta.2006.10.024; Socquet-Juglard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054196; Staiger D, 2011, TRENDS PLANT SCI, V16, P517, DOI 10.1016/j.tplants.2011.06.002; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wang L, 2013, PLANT MOL BIOL, V83, P365, DOI 10.1007/s11103-013-0093-5; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Yang G, 2008, PREP BIOCHEM BIOTECH, V38, P257, DOI 10.1080/10826060802164991; Zhang JY, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r92; Zhao ZG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-222; Zhong WJ, 2013, PLANT MOL BIOL, V83, P247, DOI 10.1007/s11103-013-0086-4	63	38	40	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104541	10.1371/journal.pone.0104541	http://dx.doi.org/10.1371/journal.pone.0104541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122458	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000042
J	Tsai, YH; Yuan, R; Huang, YC; Weng, HH; Yeh, MY; Lin, CP; Biswal, BB				Tsai, Yuan-Hsiung; Yuan, Rui; Huang, Yen-Chu; Weng, Hsu-Huei; Yeh, Mei-Yu; Lin, Ching-Po; Biswal, Bharat B.			Altered Resting-State fMRI Signals in Acute Stroke Patients with Ischemic Penumbra	PLOS ONE			English	Article							LOW-FREQUENCY FLUCTUATION; FUNCTIONAL CONNECTIVITY; BRAIN; MRI; THROMBOLYSIS; ALTEPLASE; AMPLITUDE; INJURY; CORTEX	Background: Identifying the ischemic penumbra in acute stroke subjects is important for the clinical decision making process. The aim of this study was to use resting-state functional magnetic resonance singal (fMRI) to investigate the change in the amplitude of low-frequency fluctuations (ALFF) of these subjects in three different subsections of acute stroke regions: the infarct core tissue, the penumbra tissue, and the normal brain tissue. Another aim of this study was to test the feasilbility of consistently detecting the penumbra region of the brain through ALFF analysis. Methods: Sixteen subjects with first-ever acute ischemic stroke were scanned within 27 hours of the onset of stroke using magnetic resonance imaging. The core of infarct regions and penumbra regions were determined by diffusion and perfusion-weighted imaging respectively. The ALFF were measured from resting-state blood oxygen level dependent (BOLD) fMRI scans. The averaged relative ALFF value of each regions were correlated with the time after the onset of stroke. Results: Relative ALFF values were significantly different in the infarct core tissue, penumbra tissue and normal brain tissue. The locations of lesions in the ALFF maps did not match perfectly with diffusion and perfusion-weighted imagings; however, these maps provide a contrast that can be used to differentiate between penumbra brain tissue and normal brain tissue. Significant correlations between time after stroke onset and the relative ALFF values were present in the penumbra tissue but not in the infarct core and normal brain tissue. Conclusion: Preliminary results from this study suggest that the ALFF reflects the underlying neurovascular activity and has a great potential to estimate the brain tissue viability after ischemia. Results also show that the ALFF may contribute to acute stroke imaging for thrombolytic or neuroprotective therapies.	[Tsai, Yuan-Hsiung; Weng, Hsu-Huei; Yeh, Mei-Yu] Chang Gung Mem Hosp, Coll Med, Dept Diagnost Radiol, Chiayi, Taiwan; [Tsai, Yuan-Hsiung; Huang, Yen-Chu; Weng, Hsu-Huei; Yeh, Mei-Yu] Chang Gung Univ, Sch Med Technol, Chiayi, Taiwan; [Yuan, Rui; Biswal, Bharat B.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Huang, Yen-Chu] Chang Gung Mem Hosp, Coll Med, Dept Neurol, Chiayi, Taiwan; [Lin, Ching-Po] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; New Jersey Institute of Technology; Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, CP (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	ChingPoLin@gmail.com; bbiswal@gmail.com	Huang, Yenchu/AAO-1140-2020; Weng, Hsu-Huei/N-8329-2014	Weng, Hsu-Huei/0000-0002-2020-8912	US National Institutes of Health [5R01AG032088]; Chang Gung Medical Research Fund, Chang Gung Memorial Hospital, Taiwan [CMRPG690472, CMRPG690452]; NATIONAL INSTITUTE ON AGING [R01AG032088] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chang Gung Medical Research Fund, Chang Gung Memorial Hospital, Taiwan; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the US National Institutes of Health grant 5R01AG032088 and the Chang Gung Medical Research Fund, Chang Gung Memorial Hospital, Taiwan CMRPG690472 and CMRPG690452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Badaut J, 2010, J CEREB BLOOD FLOW M; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Di X, 2013, CEREB CORTEX, V23, P255, DOI 10.1093/cercor/bhs001; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; GINSBERG MD, 1994, ANN NEUROL, V36, P553, DOI 10.1002/ana.410360402; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Heiss WD, 2010, INT J STROKE, V5, P290, DOI 10.1111/j.1747-4949.2010.00444.x; Huang YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069085; Jensen-Kondering U, 2012, STROKE; Kannurpatti SS, 2010, MAGN RESON IMAGING, V28, P466, DOI 10.1016/j.mri.2009.12.007; Kidwell CS, 2003, STROKE, V34, P2729, DOI 10.1161/01.STR.0000097608.38779.CC; Lansberg MG, 2011, STROKE, V42, P1608, DOI 10.1161/STROKEAHA.110.609008; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liu YT, 2007, J MAGN RESON IMAGING, V26, P1112, DOI 10.1002/jmri.21131; Lo EH, 2005, STROKE, V36, P189, DOI 10.1161/01.STR.0000153069.96296.fd; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Martin A, 2012, J CEREB BLOOD FLOW M; Mishra NK, 2010, STROKE, V41, pE25, DOI 10.1161/STROKEAHA.109.566869; Sobesky J, 2005, STROKE, V36, P980, DOI 10.1161/01.STR.0000160751.79241.a3; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Yao QL, 2012, NEUROSCI LETT, V509, P22, DOI 10.1016/j.neulet.2011.12.036; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	33	10	13	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105117	10.1371/journal.pone.0105117	http://dx.doi.org/10.1371/journal.pone.0105117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121486	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000099
J	Fortel, L; Henry, M; Guilbaud, L; Guirao, AL; Kuhlmann, M; Mouret, H; Rollin, O; Vaissiere, BE				Fortel, Laura; Henry, Mickael; Guilbaud, Laurent; Guirao, Anne Laure; Kuhlmann, Michael; Mouret, Hugues; Rollin, Orianne; Vaissiere, Bernard E.			Decreasing Abundance, Increasing Diversity and Changing Structure of the Wild Bee Community (Hymenoptera: Anthophila) along an Urbanization Gradient	PLOS ONE			English	Article							BUMBLE BEES; SPECIES RICHNESS; FORAGING RANGES; PAN TRAPS; URBAN; LANDSCAPE; APIFORMES; ECOLOGY; DESERT; CONSERVATION	Background: Wild bees are important pollinators that have declined in diversity and abundance during the last decades. Habitat destruction and fragmentation associated with urbanization are reported as part of the main causes of this decline. Urbanization involves dramatic changes of the landscape, increasing the proportion of impervious surface while decreasing that of green areas. Few studies have investigated the effects of urbanization on bee communities. We assessed changes in the abundance, species richness, and composition of wild bee community along an urbanization gradient. Methodology/Principal Findings: Over two years and on a monthly basis, bees were sampled with colored pan traps and insect nets at 24 sites located along an urbanization gradient. Landscape structure within three different radii was measured at each study site. We captured 291 wild bee species. The abundance of wild bees was negatively correlated with the proportion of impervious surface, while species richness reached a maximum at an intermediate (50%) proportion of impervious surface. The structure of the community changed along the urbanization gradient with more parasitic species in sites with an intermediate proportion of impervious surface. There were also greater numbers of cavity-nesting species and long-tongued species in sites with intermediate or higher proportion of impervious surface. However, urbanization had no effect on the occurrence of species depending on their social behavior or body size. Conclusions/Significance: We found nearly a third of the wild bee fauna known from France in our study sites. Indeed, urban areas supported a diverse bee community, but sites with an intermediate level of urbanization were the most speciose ones, including greater proportion of parasitic species. The presence of a diverse array of bee species even in the most urbanized area makes these pollinators worthy of being a flagship group to raise the awareness of urban citizens about biodiversity.	[Fortel, Laura; Henry, Mickael; Guilbaud, Laurent; Guirao, Anne Laure; Vaissiere, Bernard E.] INRA, UR Abeilles & Environm 406, Avignon, France; [Henry, Mickael; Rollin, Orianne; Vaissiere, Bernard E.] UMT Protect Abeilles Environm, Avignon, France; [Kuhlmann, Michael] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Mouret, Hugues] Arthropologia, Ecoctr Lyonnais, La Tour De Salvagny, France; [Rollin, Orianne] ACTA, Avignon, France	INRAE; Natural History Museum London	Fortel, L (corresponding author), INRA, UR Abeilles & Environm 406, Avignon, France.	laura.fortel@gmail.com	Rollin, Orianne/R-9705-2019	Rollin, Orianne/0000-0002-1455-9302	LIFE financial instrument of the European Community [LIFE08 NAT/F/000478]; French Ministry of Ecology (MEDDAT - Bureau de la Faune et de la Flore Sauvages); region Rhone-Alpes; Communaute Urbaine du Grand Lyon; Botanic sas	LIFE financial instrument of the European Community; French Ministry of Ecology (MEDDAT - Bureau de la Faune et de la Flore Sauvages); region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Communaute Urbaine du Grand Lyon; Botanic sas	This research was funded with the contribution of the LIFE financial instrument of the European Community for the project "URBANBEES - URBAN BEE biodiversity action planS" (LIFE08 NAT/F/000478). Additional funding was provided by the French Ministry of Ecology (MEDDAT - Bureau de la Faune et de la Flore Sauvages), the region Rhone-Alpes, the Communaute Urbaine du Grand Lyon, and Botanic sas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005574; Amiet F, 1999, APIDAE 2 COLLETES DU; Amiet F., 2004, APIDAE 4 ANTHIDIUM C; Amiet F., 2010, APIDAE 6 ANDRENA MEL; Amiet F., 2007, APIDAE 5 AMMOBATES A; [Anonymous], 2012, FRAGSTATS SPATIAL PA; Araújo E. D., 2004, Braz. J. Biol., V64, P563, DOI 10.1590/S1519-69842004000400003; Banaszak-Cibicka W, 2012, J INSECT CONSERV, V16, P331, DOI 10.1007/s10841-011-9419-2; Bates AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023459; Baum KA, 2011, J KANSAS ENTOMOL SOC, V84, P155, DOI 10.2317/JKES100629.1; Begon M, 2006, ECOLOGY INDIVIDUALS, V4th; Blair RB, 2001, BIOTIC HOMOGENIZATION, P33; C. suisse de cartographie de la Faune, 2001, APIDAE 3 HALICTUS LA; Cane JH, 2006, ECOL APPL, V16, P632, DOI 10.1890/1051-0761(2006)016[0632:CRWADB]2.0.CO;2; CANE JH, 1987, J KANSAS ENTOMOL SOC, V60, P145; Cane JH, 2000, J KANSAS ENTOMOL SOC, V73, P225; Clergeau P, 2006, BIOL CONSERV, V127, P336, DOI 10.1016/j.biocon.2005.06.035; Clucas B, 2008, BIODIVERS CONSERV, V17, P1517, DOI 10.1007/s10531-008-9361-0; Collins JP, 2000, AM SCI, V88, P416; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Combes C, 1996, BIODIVERS CONSERV, V5, P953, DOI 10.1007/BF00054413; Danforth B, 2007, CURR BIOL, V17, pR156, DOI 10.1016/j.cub.2007.01.025; Dauber J, 2003, AGR ECOSYST ENVIRON, V98, P321, DOI 10.1016/S0167-8809(03)00092-6; Entwistle Abigail C., 2000, Conservation Biology Series (Cambridge), V3, P1; Fetridge ED, 2008, ANN ENTOMOL SOC AM, V101, P1067, DOI 10.1603/0013-8746-101.6.1067; Frankie GW, 2005, J KANSAS ENTOMOL SOC, V78, P227, DOI 10.2317/0407.08.1; Gaston KJ, 2005, BIODIVERS CONSERV, V14, P3327, DOI 10.1007/s10531-004-9513-9; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Henle K, 2004, BIODIVERS CONSERV, V13, P207, DOI 10.1023/B:BIOC.0000004319.91643.9e; Hernandez JL, 2009, CITIES ENV, V2, P1, DOI DOI 10.15365/cate.2132009; Home R, 2009, ENVIRON CONSERV, V36, P139, DOI 10.1017/S0376892909990051; Horwitz P, 2005, INT J PARASITOL, V35, P725, DOI 10.1016/j.ijpara.2005.03.002; Hudson PJ, 2006, TRENDS ECOL EVOL, V21, P381, DOI 10.1016/j.tree.2006.04.007; KEVAN PG, 1983, ANNU REV ENTOMOL, V28, P407, DOI 10.1146/annurev.en.28.010183.002203; Kindt R., 2005, WORLD; Kirk W. D., 2012, PLANTS BEES GUIDE PL; Klein AM, 2008, ECOLOGY, V89, P935, DOI 10.1890/07-0088.1; Kolasa J., 1991, ECOLOGICAL HETEROGEN, V86, P1, DOI DOI 10.1007/978-1-4612-3062-5_1; Kremen C, 2011, CONSERV BIOL, V25, P607, DOI 10.1111/j.1523-1739.2011.01657.x; Kuhlmann M, 2013, CHECKLIST W PALAEARC; Kuhn I, 2004, EVOL ECOL RES, V6, P749; Lelievre F., 2010, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P187; Leonhardt SD, 2013, BASIC APPL ECOL, V14, P461, DOI 10.1016/j.baae.2013.06.003; Marcogliese D. J., 2004, ECOHEALTH, V1, P151, DOI DOI 10.1007/S10393-004-0028-3; Matteson K.C., 2009, CITIES ENV, V2, P1, DOI [10.15365/cate.2152009, DOI 10.15365/CATE.2152009]; Matteson KC, 2008, ANN ENTOMOL SOC AM, V101, P140, DOI 10.1603/0013-8746(2008)101[140:BRAAIN]2.0.CO;2; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; MCDONNELL MJ, 1990, ECOLOGY, V71, P1232, DOI 10.2307/1938259; McFrederick QS, 2006, BIOL CONSERV, V129, P372, DOI 10.1016/j.biocon.2005.11.004; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McIntyre NE, 2001, BASIC APPL ECOL, V2, P209, DOI 10.1078/1439-1791-00051; McIntyre NE, 2001, LANDSCAPE URBAN PLAN, V52, P257, DOI 10.1016/S0169-2046(00)00122-5; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Michener C. D., 2000, The bees of the world; MICHENER CD, 1979, ANN MO BOT GARD, V66, P277, DOI 10.2307/2398833; Morand S, 1997, ECOL MODEL, V95, P61, DOI 10.1016/S0304-3800(96)00028-2; Morandin LA, 2005, ECOL APPL, V15, P871, DOI 10.1890/03-5271; Moretti M, 2009, J ANIM ECOL, V78, P98, DOI 10.1111/j.1365-2656.2008.01462.x; Neame LA, 2013, INSECT CONSERV DIVER, V6, P57, DOI 10.1111/j.1752-4598.2012.00187.x; Nielsen A, 2011, ECOL RES, V26, P969, DOI 10.1007/s11284-011-0852-1; Niemela J, 1999, BIODIVERS CONSERV, V8, P119, DOI 10.1023/A:1008817325994; Oertli S, 2005, EUR J ENTOMOL, V102, P53, DOI 10.14411/eje.2005.008; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; Osborne JL, 2001, AGR ECOSYST ENVIRON, V83, P129, DOI 10.1016/S0167-8809(00)00262-0; Pasquet RS, 2008, P NATL ACAD SCI USA, V105, P13456, DOI 10.1073/pnas.0806040105; Porter E. E., 2001, URBAN ECOSYST, V5, P131; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pouvreau A., 2004, INSECTES POLLINISATE; Ramalho CE, 2012, TRENDS ECOL EVOL, V27, P179, DOI 10.1016/j.tree.2011.10.008; REBELE F, 1994, GLOBAL ECOL BIOGEOGR, V4, P173, DOI 10.2307/2997649; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roulston TH, 2007, J KANSAS ENTOMOL SOC, V80, P179, DOI 10.2317/0022-8567(2007)80[179:ACOPTA]2.0.CO;2; Samways MJ, 1995, GLOBAL BIODIVERSITY, P475; Sattler T, 2010, ECOLOGY, V91, P3343, DOI 10.1890/09-1810.1; Saure Christoph, 1996, Linnean Society Symposium Series, V18, P47; Saville NM, 1997, AGR ECOSYST ENVIRON, V61, P145, DOI 10.1016/S0167-8809(96)01100-0; Sheffield CS, 2013, APIDOLOGIE, V44, P501, DOI 10.1007/s13592-013-0200-2; Sheffield CS, 2013, CAN ENTOMOL, V145, P94, DOI 10.4039/tce.2012.89; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Steffan-Dewenter I, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P387; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Toler TR, 2005, PAN-PAC ENTOMOL, V81, P103; Tommasi D, 2004, CAN ENTOMOL, V136, P851; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; United Nations, 2007, WORLD POP PROSP 2006; Walther BA, 1998, PARASITOLOGY, V116, P395, DOI 10.1017/S0031182097002230; Walther-Hellwig K, 2000, J INSECT BEHAV, V13, P239, DOI 10.1023/A:1007740315207; Westphal C, 2008, ECOL MONOGR, V78, P653, DOI 10.1890/07-1292.1; Westrich P., 1996, The conservation of bees., P1; Westrich P, 1989, WILDBIENEN BADEN WUR; Williams NM, 2007, ECOL APPL, V17, P910, DOI 10.1890/06-0269; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Williams NM, 2001, CONSERV ECOL, V5; Wilson JS, 2008, J KANSAS ENTOMOL SOC, V81, P288, DOI 10.2317/JKES-802.06.1; Winfree R, 2007, CONSERV BIOL, V21, P213, DOI 10.1111/j.1523-1739.2006.00574.x; WITTIG R, 1985, FLORA, V177, P265, DOI 10.1016/S0367-2530(17)30180-9; Wood CL, 2007, P NATL ACAD SCI USA, V104, P9335, DOI 10.1073/pnas.0700062104; Zanette LRS, 2005, LANDSCAPE URBAN PLAN, V71, P105, DOI 10.1016/j.landurbplan.2004.02.003; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	103	189	197	8	262	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104679	10.1371/journal.pone.0104679	http://dx.doi.org/10.1371/journal.pone.0104679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118722	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600077
J	Jiang, YY; Subbiah, V; Janku, F; Ludwig, JA; Naing, A; Benjamin, RS; Brown, RE; Anderson, P; Kurzrock, R				Jiang, Yunyun; Subbiah, Vivek; Janku, Filip; Ludwig, Joseph A.; Naing, Aung; Benjamin, Robert S.; Brown, Robert E.; Anderson, Pete; Kurzrock, Razelle			Novel Secondary Somatic Mutations in Ewing's Sarcoma and Desmoplastic Small Round Cell Tumors	PLOS ONE			English	Article							PRIMITIVE NEUROECTODERMAL TUMOR; GENE FUSION; CHROMOSOME-TRANSLOCATION; ACQUIRED-RESISTANCE; HUMAN CANCERS; SOLID TUMORS; LUNG-CANCER; PHASE-I; C-MET; GROWTH	Background: Ewing's sarcoma (ES) and desmoplastic small round cell tumors (DSRCT) are small round blue cell tumors driven by an N-terminal containing EWS translocation. Very few somatic mutations have been reported in ES, and none have been identified in DSRCT. The aim of this study is to explore potential actionable mutations in ES and DSRCT. Methodology: Twenty eight patients with ES or DSRCT had tumor tissue available that could be analyzed by one of the following methods: 1) Next-generation exome sequencing platform; 2) Multiplex PCR/Mass Spectroscopy; 3) Polymerase chain reaction (PCR)-based single- gene mutation screening; 4) Sanger sequencing; 5) Morphoproteomics. Principal Findings: Novel somatic mutations were identified in four out of 18 patients with advanced ES and two of 10 patients with advanced DSRCT (six out of 28 (21.4%));KRAS (n = 1), PTPRD (n = 1), GRB10 (n = 2), MET (n = 2) and PIK3CA (n = 1). One patient with both PTPRD and GRB10 mutations and one with a GRB10 mutation achieved a complete remission (CR) on an Insulin like growth factor 1 receptor (IGF1R) inhibitor based treatment. One patient, who achieved a partial remission (PR) with IGF1R inhibitor treatment, but later developed resistance, demonstrated a KRAS mutation in the post-treatment resistant tumor, but not in the pre-treatment tumor suggesting that the RAF/RAS/MEK pathway was activated with progression. Conclusions: We have reported several different mutations in advanced ES and DSRCT that have direct implications for molecularly-directed targeted therapy. Our technology agnostic approach provides an initial mutational roadmap used in the path towards individualized combination therapy.	[Jiang, Yunyun; Subbiah, Vivek; Janku, Filip; Naing, Aung; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA; [Subbiah, Vivek; Anderson, Pete] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Ludwig, Joseph A.; Benjamin, Robert S.] Univ Texas MD Anderson Canc Ctr, Dept Sarcoma Med Oncol, Houston, TX 77030 USA; [Brown, Robert E.] UT Hlth Dept Pathol & Lab Med, Dept Pathol, Houston, TX USA; [Anderson, Pete] Levine Childrens Hosp, Levine Canc Inst, Charlotte, NC USA; [Kurzrock, Razelle] Univ Calif San Diego, Moores Canc Ctr, Ctr Personalized Canc Therapy, La Jolla, CA 92093 USA; [Kurzrock, Razelle] Univ Calif San Diego, Moores Canc Ctr, Div Hematol & Oncol, La Jolla, CA 92093 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego; University of California System; University of California San Diego	Subbiah, V (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA.	vsubbiah@mdanderson.org	Kurzrock, Razelle/AAU-9782-2020; Janku, Filip/ABB-9136-2020; Jiang, Yunyun/E-8127-2016; Subbiah, Vivek/O-3347-2019	Jiang, Yunyun/0000-0003-4427-8103; Subbiah, Vivek/0000-0002-6064-6837; Naing, Aung/0000-0002-4803-8513	University of Texas MD Anderson Cancer Center [CA 016672]; Bob Howe Research Funds; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	University of Texas MD Anderson Cancer Center; Bob Howe Research Funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The University of Texas MD Anderson Cancer Center is supported by Cancer Center Support Grant no. CA 016672. Vivek Subbiah acknowledges the Bob Howe Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchahda M, 2010, CANCER CHEMOTH PHARM, V66, P605, DOI 10.1007/s00280-010-1298-9; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; GERALD WL, 1995, P NATL ACAD SCI USA, V92, P1028, DOI 10.1073/pnas.92.4.1028; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; Hayes-Jordan A, 2011, CURR OPIN ONCOL, V23, P385, DOI 10.1097/CCO.0b013e3283477aab; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Huang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026060; Jiang YY, 2013, ONCOTARGET, V4, P884, DOI 10.18632/oncotarget.1021; Krishnaswamy S, 2009, CLIN CANCER RES, V15, P5714, DOI 10.1158/1078-0432.CCR-09-0070; Kurzrock R, 2010, CLIN CANCER RES, V16, P2458, DOI 10.1158/1078-0432.CCR-09-3220; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; La Quaglia MP, 2000, SURG ONCOL, V9, P77; Ladanyi M, 1996, J PATHOL, V180, P462; Lai R, 2006, J PATHOL, V208, P624, DOI 10.1002/path.1941; Ma PC, 2003, CANCER RES, V63, P6272; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Miser JS, 2004, J CLIN ONCOL, V22, P2873, DOI 10.1200/JCO.2004.01.041; Naing A, 2012, CLIN CANCER RES; Naing A, 2011, CLIN CANCER RES, V17, P6052, DOI 10.1158/1078-0432.CCR-10-2979; Naing A, 2010, CLIN COLORECTAL CANC, V9, pE1, DOI 10.3816/CCC.2010.n.026; Philippe-Chomette P, 2012, PEDIATR BLOOD CANCER, V58, P891, DOI 10.1002/pbc.23403; Puri N, 2007, CLIN CANCER RES, V13, P2246, DOI 10.1158/1078-0432.CCR-06-0776; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; SAWYER JR, 1992, AM J SURG PATHOL, V16, P411, DOI 10.1097/00000478-199204000-00010; Shukla N, 2012, CLIN CANCER RES, V18, P748, DOI 10.1158/1078-0432.CCR-11-2056; Subbiah V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068985; Subbiah V, 2012, DISCOV MED, V13, P405; Subbiah V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018424; Subbiah V, 2009, CURR TREAT OPTION ON, V10, P126, DOI 10.1007/s11864-009-0104-6; To CTT, 1998, ONCOL REP, V5, P1013; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Vilar E, 2012, NATURE, V486, P482, DOI 10.1038/486482a; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang WZ, 2006, MOL CELL BIOL, V26, P413, DOI 10.1128/MCB.26.2.413-424.2006	39	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e93676	10.1371/journal.pone.0093676	http://dx.doi.org/10.1371/journal.pone.0093676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119929	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600001
J	Patil, SP; Xiao, S; Gkagkas, K; Markert, B; Grater, F				Patil, Sandeep P.; Xiao, Senbo; Gkagkas, Konstantinos; Markert, Bernd; Graeter, Frauke			Viscous Friction between Crystalline and Amorphous Phase of Dragline Silk	PLOS ONE			English	Article							FORCE-DISTRIBUTION ANALYSIS; MOLECULAR-DYNAMICS METHOD; SPIDER SILK; POTENTIAL FUNCTIONS; WATER; DEFORMATION; VISCOSITY; PEPTIDE; POLYMER; FIBER	The hierarchical structure of spider dragline silk is composed of two major constituents, the amorphous phase and crystalline units, and its mechanical response has been attributed to these prime constituents. Silk mechanics, however, might also be influenced by the resistance against sliding of these two phases relative to each other under load. We here used atomistic molecular dynamics (MD) simulations to obtain friction forces for the relative sliding of the amorphous phase and crystalline units of Araneus diadematus spider silk. We computed the coefficient of viscosity of this interface to be in the order of 10(2) Ns/m(2) by extrapolating our simulation data to the viscous limit. Interestingly, this value is two orders of magnitude smaller than the coefficient of viscosity within the amorphous phase. This suggests that sliding along a planar and homogeneous surface of straight polyalanine chains is much less hindered than within entangled disordered chains. Finally, in a simple finite element model, which is based on parameters determined from MD simulations including the newly deduced coefficient of viscosity, we assessed the frictional behavior between these two components for the experimental range of relative pulling velocities. We found that a perfectly relative horizontal motion has no significant resistance against sliding, however, slightly inclined loading causes measurable resistance. Our analysis paves the way towards a finite element model of silk fibers in which crystalline units can slide, move and rearrange themselves in the fiber during loading.	[Patil, Sandeep P.; Xiao, Senbo; Graeter, Frauke] Heidelberg Inst Theoret Studies, Heidelberg, Germany; [Gkagkas, Konstantinos] Toyota Motor Europe NV SA, Ctr Tech, Zaventem, Belgium; [Markert, Bernd] Rhein Westfal TH Aachen, Inst Gen Mech, Aachen, North Rhine Wes, Germany	Heidelberg Institute for Theoretical Studies; Toyota Motor Corporation; RWTH Aachen University	Grater, F (corresponding author), Heidelberg Inst Theoret Studies, Heidelberg, Germany.	frauke.graeter@h-its.org	Xiao, Senbo/E-8814-2019; Gräter, Frauke/D-3450-2009; Xiao, Senbo/AAE-7837-2021; Gkagkas, Konstantinos/A-5627-2010	Xiao, Senbo/0000-0001-7021-9591; Gräter, Frauke/0000-0003-2891-3381; Gkagkas, Konstantinos/0000-0001-6326-7317; Patil, Sandeep P/0000-0003-3980-6995; Markert, Bernd/0000-0001-7893-6229	Klaus Tschira Foundation; Deutsche Forschungsgemeinschaft [GR 3494/7-1]; Toyota Europe	Klaus Tschira Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Toyota Europe	This study was funded by the Klaus Tschira Foundation (http://www.klaus-tschira-stiftung.de), the Deutsche Forschungsgemeinschaft(http://www.dfg.de) via grant GR 3494/7-1 and the Toyota Europe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858; Brookes VL, 2008, J MATER SCI, V43, P3728, DOI 10.1007/s10853-008-2597-y; Cetinkaya M, 2011, BIOPHYS J, V100, P1298, DOI 10.1016/j.bpj.2010.12.3712; Danielsson J, 2002, MAGN RESON CHEM, V40, pS89, DOI 10.1002/mrc.1132; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; EICHER LD, 1971, J PHYS CHEM-US, V75, P2016, DOI 10.1021/j100682a019; Erbas A, 2013, BIOPHYS J, V104, P1285, DOI 10.1016/j.bpj.2013.02.008; Erbas A, 2012, J AM CHEM SOC, V134, P623, DOI 10.1021/ja209454a; Gosline JM, 1999, J EXP BIOL, V202, P3295; Grubb DT, 1997, MACROMOLECULES, V30, P2860, DOI 10.1021/ma961293c; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Heuberger M, 1999, J PHYS CHEM B, V103, P10127, DOI 10.1021/jp991098a; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Horinek D, 2008, P NATL ACAD SCI USA, V105, P2842, DOI 10.1073/pnas.0707879105; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; Lefevre T, 2007, BIOPHYS J, V92, P2885, DOI 10.1529/biophysj.106.100339; Livermore Software Technology Corporation, 2010, LS DYNA KEYW US MAN; Livermore Software Technology Corporation, 2011, LS PREP; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w; Oroudjev E, 2002, P NATL ACAD SCI USA, V99, P6460, DOI 10.1073/pnas.082526499; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patil SP, 2014, BIOPHYS J, V106, P2511, DOI 10.1016/j.bpj.2014.04.033; Patil SP, 2012, P 3 GAMM SEM CONT BI, V21, P75; Porter D, 2005, EUR PHYS J E, V16, P199, DOI 10.1140/epje/e2005-00021-2; Schorr PA, 2003, MACROMOLECULES, V36, P389, DOI 10.1021/ma011207v; SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060; SMITH PE, 1993, CHEM PHYS LETT, V215, P315, DOI 10.1016/0009-2614(93)85720-9; SWINDELLS JF, 1952, J RES NAT BUR STAND, V48, P1, DOI 10.6028/jres.048.001; TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wu X, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3216804; Xiao SB, 2009, BIOPHYS J, V96, P3997, DOI 10.1016/j.bpj.2009.02.052; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zhou HJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028104	41	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104832	10.1371/journal.pone.0104832	http://dx.doi.org/10.1371/journal.pone.0104832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119288	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600092
J	Peng, KT; Huang, KC; Huang, TW; Lee, YS; Hsu, WH; Hsu, RWW; Ueng, SWN; Lee, MS				Peng, Kou-Ti; Huang, Kuo-Chin; Huang, Tsan-Wen; Lee, Yun-Shien; Hsu, Wei-Hsiu; Hsu, Robert W. W.; Ueng, Steve W. N.; Lee, Mel S.			Single Nucleotide Polymorphisms Other than Factor V Leiden Are Associated with Coagulopathy and Osteonecrosis of the Femoral Head in Chinese Patients	PLOS ONE			English	Article							ACTIVATED PROTEIN-C; VENOUS THROMBOSIS; NONTRAUMATIC OSTEONECROSIS; R485K POLYMORPHISM; AVASCULAR NECROSIS; PROTHROMBIN GENE; COMPLEX DISEASE; MUTATION; THROMBOPHILIA; POPULATION	Single nucleotide polymorphisms (SNPs) of factor V Leiden have been associated with osteonecrosis of the femoral head (ONFH) in Caucasians but remains controversial in Asians. We used an SNP microarray to screen 55 loci of factor V gene in patients with ONFH of Chinese. Significantly different candidate SNPs at 14 loci were analyzed in 146 patients and 116 healthy controls using MALDI-TOF (matrix-assisted laser desorption/ionization time-of-flight) mass spectrometry and gene sequencing. The factor V Leiden (rs6025) was not found in all participants. Six SNP loci (rs9332595, rs6020, rs9332647, rs3766110, rs10919186, and rs12040141) were confirmed with significant differences in patients but not in controls. The rs6020 G-to-A polymorphism was found in 88.9% of the patients. In addition, a high percentage (87.6%) of the patients had an abnormal coagulation profile that included hyperfibrinogen, elevated fibrinogen degradation products, elevated D-dimer, abnormal protein S, abnormal protein C, or a decrease in anti-thrombin III. Patients with the rs6020 G-to-A polymorphism (mutation) had a higher risk (odds ratio: 4.62; 95% confidence interval: 1.44-14.8) of having coagulation abnormalities than did those without the mutation (wild-type) (chi(2) p = 0.006). Our findings suggested that the rs6020 polymorphism might be the genetic trait that accounts for the higher prevalence of ONFH in the Chinese population than in Westerners. Exposure to risk factors such as alcohol and steroids in patients with the rs6020 polymorphism causes coagulation abnormalities and, subsequently, thromboembolisms in the femoral head.	[Peng, Kou-Ti; Huang, Kuo-Chin; Huang, Tsan-Wen; Hsu, Wei-Hsiu; Hsu, Robert W. W.; Lee, Mel S.] Chang Gung Mem Hosp, Dept Orthopaed Surg, Chiayi, Taiwan; [Lee, Yun-Shien; Lee, Mel S.] Ming Chuan Univ, Dept Biotechnol, Taoyuan, Taiwan; [Lee, Yun-Shien] Chang Gung Mem Hosp, Genom Med Res Core Lab, Taoyuan, Taiwan; [Ueng, Steve W. N.] Chang Gung Mem Hosp, Dept Orthoped Surg, Linkou, Taiwan; [Lee, Mel S.] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Ming Chuan University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lee, MS (corresponding author), Chang Gung Mem Hosp, Dept Orthopaed Surg, Chiayi, Taiwan.	bone@doctor.com	Pinheiro, Maísa/E-7424-2012; HUANG, Kuo-Chin/S-7371-2019	HUANG, Kuo-Chin/0000-0002-3225-1504; Hsu, Wen-Wei Robert/0000-0001-7535-2498	Taiwan National Science Council [NSC-95-2314-B-182A-141-MY3, NSC-98-2314-B-182012-MY3]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This study was sponsored by grants NSC-95-2314-B-182A-141-MY3 and NSC-98-2314-B-182012-MY3 from the Taiwan National Science Council. The authors also thank the Genomic Medicine Research Core Laboratory at Chang Gung Memorial Hospital for technical and analytic support to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bjorkman A, 2004, CLIN ORTHOP RELAT R, P168, DOI 10.1097/01.blo.0000137238.02035.c2; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Chang JD, 2008, CLIN ORTHOP RELAT R, V466, P1041, DOI 10.1007/s11999-008-0147-1; Chen WM, 2004, AM J HUM GENET, V75, P310, DOI 10.1086/422702; Gardeniers JW, 1993, ARCO NEWS LETT, V5, P79; Glueck CJ, 1997, J LAB CLIN MED, V130, P540, DOI 10.1016/S0022-2143(97)90132-3; Glueck CJ, 2001, CLIN ORTHOP RELAT R, P19; Glueck CJ, 1997, CLIN ORTHOP RELAT R, P43; GREENGARD JS, 1994, LANCET, V343, P1361, DOI 10.1016/S0140-6736(94)92497-X; Gruppo R, 1998, J PEDIATR-US, V132, P885, DOI 10.1016/S0022-3476(98)70326-9; Hiyoshi M, 1998, THROMB HAEMOSTASIS, V80, P705; Jun ZJ, 2006, CLIN LAB HAEMATOL, V28, P111, DOI 10.1111/j.1365-2257.2006.00757.x; Kim TH, 2010, MOL CELLS, V29, P343, DOI 10.1007/s10059-010-0054-7; Kim YW, 1997, THROMB RES, V86, P181; Koo KH, 2006, J ORTHOP RES, V24, P1722, DOI 10.1002/jor.20164; Le W, 2000, CLIN GENET, V57, P296, DOI 10.1034/j.1399-0004.2000.570409.x; Lee Mel S, 2002, Chang Gung Med J, V25, P228; Lee Mel S, 2010, Chang Gung Med J, V33, P351; Margaglione M, 1998, THROMB HAEMOSTASIS, V79, P907; Mont MA, 2006, J BONE JOINT SURG AM, V88A, P1117, DOI 10.2106/JBJS.E.01041; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Segers K, 2007, THROMB HAEMOSTASIS, V98, P530, DOI 10.1160/TH07-02-0150; VANVELDHUIZEN PJ, 1993, AM J HEMATOL, V44, P243, DOI 10.1002/ajh.2830440405; Vos HL, 2007, J THROMB HAEMOST, V5, P185, DOI 10.1111/j.1538-7836.2006.02258.x; Watanabe H, 2001, THROMB HAEMOSTASIS, V86, P1594; Zalavras CG, 2004, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000127921.13253.e3	28	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104461	10.1371/journal.pone.0104461	http://dx.doi.org/10.1371/journal.pone.0104461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119470	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600058
J	Campbell, CD; Mohajeri, K; Malig, M; Hormozdiari, F; Nelson, B; Du, GX; Patterson, KM; Eng, C; Torgerson, DG; Hu, DL; Herman, C; Chong, JX; Ko, A; O'Roak, BJ; Krumm, N; Vives, L; Lee, CL; Roth, LA; Rodriguez-Cintron, W; Rodriguez-Santana, J; Brigino-Buenaventura, E; Davis, A; Meade, K; LeNoir, MA; Thyne, S; Jackson, DJ; Gern, JE; Lemanske, RF; Shendure, J; Abney, M; Burchard, EG; Ober, C; Eichler, EE				Campbell, Catarina D.; Mohajeri, Kiana; Malig, Maika; Hormozdiari, Fereydoun; Nelson, Benjamin; Du, Gaixin; Patterson, Kristen M.; Eng, Celeste; Torgerson, Dara G.; Hu, Donglei; Herman, Catherine; Chong, Jessica X.; Ko, Arthur; O'Roak, Brian J.; Krumm, Niklas; Vives, Laura; Lee, Choli; Roth, Lindsey A.; Rodriguez-Cintron, William; Rodriguez-Santana, Jose; Brigino-Buenaventura, Emerita; Davis, Adam; Meade, Kelley; LeNoir, Michael A.; Thyne, Shannon; Jackson, Daniel J.; Gern, James E.; Lemanske, Robert F., Jr.; Shendure, Jay; Abney, Mark; Burchard, Esteban G.; Ober, Carole; Eichler, Evan E.			Whole-Genome Sequencing of Individuals from a Founder Population Identifies Candidate Genes for Asthma	PLOS ONE			English	Article							COPY-NUMBER VARIATION; WIDE ASSOCIATION; STRUCTURAL VARIATION; PUERTO-RICAN; SEGMENTAL DUPLICATIONS; LINKAGE DISEQUILIBRIUM; VARIATION DISCOVERY; LATINO POPULATIONS; CHILDHOOD ASTHMA; LOCAL ANCESTRY	Asthma is a complex genetic disease caused by a combination of genetic and environmental risk factors. We sought to test classes of genetic variants largely missed by genome-wide association studies (GWAS), including copy number variants (CNVs) and low-frequency variants, by performing whole-genome sequencing (WGS) on 16 individuals from asthma-enriched and asthma-depleted families. The samples were obtained from an extended 13-generation Hutterite pedigree with reduced genetic heterogeneity due to a small founding gene pool and reduced environmental heterogeneity as a result of a communal lifestyle. We sequenced each individual to an average depth of 13-fold, generated a comprehensive catalog of genetic variants, and tested the most severe mutations for association with asthma. We identified and validated 1960 CNVs, 19 nonsense or splice-site single nucleotide variants (SNVs), and 18 insertions or deletions that were out of frame. As follow-up, we performed targeted sequencing of 16 genes in 837 cases and 540 controls of Puerto Rican ancestry and found that controls carry a significantly higher burden of mutations in IL27RA (2.0% of controls; 0.23% of cases; nominal p = 0.004; Bonferroni p = 0.21). We also genotyped 593 CNVs in 1199 Hutterite individuals. We identified a nominally significant association (p = 0.03; Odds ratio (OR) = 3.13) between a 6 kbp deletion in an intron of NEDD4L and increased risk of asthma. We genotyped this deletion in an additional 4787 non-Hutterite individuals (nominal p = 0.056; OR = 1.69). NEDD4L is expressed in bronchial epithelial cells, and conditional knockout of this gene in the lung in mice leads to severe inflammation and mucus accumulation. Our study represents one of the early instances of applying WGS to complex disease with a large environmental component and demonstrates how WGS can identify risk variants, including CNVs and low-frequency variants, largely untested in GWAS.	[Campbell, Catarina D.; Mohajeri, Kiana; Malig, Maika; Hormozdiari, Fereydoun; Nelson, Benjamin; Ko, Arthur; O'Roak, Brian J.; Krumm, Niklas; Vives, Laura; Lee, Choli; Shendure, Jay; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Du, Gaixin; Patterson, Kristen M.; Herman, Catherine; Chong, Jessica X.; Abney, Mark; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Eng, Celeste; Torgerson, Dara G.; Hu, Donglei; Roth, Lindsey A.; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Rodriguez-Cintron, William] Vet Caribbean Hlth Care Syst, San Juan, PR USA; [Rodriguez-Santana, Jose] Ctr Neumol Pediat, San Juan, PR USA; [Brigino-Buenaventura, Emerita] Kaiser Permanente Vallejo Med Ctr, Dept Allergy & Immunol, Vallejo, CA USA; [Davis, Adam; Meade, Kelley] Childrens Hosp & Res Ctr Oakland, Oakland, CA USA; [LeNoir, Michael A.] Bay Area Pediat, Oakland, CA USA; [Thyne, Shannon] San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Thyne, Shannon] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Jackson, Daniel J.; Gern, James E.; Lemanske, Robert F., Jr.] Univ Wisconsin, Dept Pediat, Madison, WI USA; [Lemanske, Robert F., Jr.] Univ Wisconsin, Dept Med, Madison, WI USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Chicago; University of California System; University of California San Francisco; Kaiser Permanente; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Francisco; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Du, Gaixin/M-9901-2014; Chong, Jessica/GZH-1625-2022; Shendure, Jay/AAU-3684-2021	Du, Gaixin/0000-0002-4616-7725; Shendure, Jay/0000-0002-1516-1865; Ober, Carole/0000-0003-4626-9809; Ko, Arthur/0000-0002-1523-7225; Hormozdiari, Fereydoun/0000-0003-2703-9274; O'Roak, Brian/0000-0002-4141-0095; Chong, Jessica/0000-0002-1616-2448	American Asthma Foundation; National Institutes of Health [R01 HL085197, R01 HD21244, P01 HL070831, U19 AI095230, RC2 HL101651, R01-ES015794, U19-AI077439, R01-HL088133, R01-HL078885, R01-HL004464, R01-HL104608, P01-HL070831, UL1TR000427]; National Institute on Minority Health and Health Disparities [P60MD006902]; Flight Attendant Medical Research Institute, RWJF Amos Medical Faculty Development Award; Sandler Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000428, UL1TR000430, UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101651, R01HL078885, R01HL088133, R01HL104608, P01HL070831, R01HL085197] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095230, U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	American Asthma Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Flight Attendant Medical Research Institute, RWJF Amos Medical Faculty Development Award; Sandler Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an American Asthma Foundation Senior Investigator Award to E.E.E.; National Institutes of Health R01 HL085197, R01 HD21244, P01 HL070831, U19 AI095230, and RC2 HL101651 to C.O.; National Institutes of Health R01-ES015794, U19-AI077439, R01-HL088133, R01-HL078885, R01-HL004464, and R01-HL104608 to E.G.B.; the National Institute on Minority Health and Health Disparities under Award Number P60MD006902 to E.G.B.; the Flight Attendant Medical Research Institute, RWJF Amos Medical Faculty Development Award, the Sandler Foundation, and the American Asthma Foundation to E.G.B; National Institutes of Health P01-HL070831 to J.E.G; and National Institutes of Health UL1TR000427 to D.J.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baran Y, 2012, BIOINFORMATICS, V28, P1359, DOI 10.1093/bioinformatics/bts144; Beane J, 2011, CANCER PREV RES, V4, P803, DOI 10.1158/1940-6207.CAPR-11-0212; Borrell LN, 2013, AM J RESP CRIT CARE, V187, P697, DOI 10.1164/rccm.201211-2116OC; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Burchard EG, 2004, AM J RESP CRIT CARE, V169, P386, DOI 10.1164/rccm.200309-1293OC; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Campbell CD, 2011, AM J HUM GENET, V88, P317, DOI 10.1016/j.ajhg.2011.02.004; CARTERPOKRAS OD, 1993, AM J PUBLIC HEALTH, V83, P580, DOI 10.2105/AJPH.83.4.580; Chong JX, 2011, EUR J HUM GENET, V19, P1045, DOI 10.1038/ejhg.2011.85; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Georgi B, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004229; Gilliland FD, 2002, AM J RESP CRIT CARE, V166, P710, DOI 10.1164/rccm.2112065; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hancock DB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000623; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Homa DM, 2000, AM J RESP CRIT CARE, V161, P504, DOI 10.1164/ajrccm.161.2.9906025; Hormozdiari F, 2011, GENOME RES, V21, P2203, DOI 10.1101/gr.120501.111; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Hunter CA, 2012, IMMUNITY, V37, P960, DOI 10.1016/j.immuni.2012.11.003; Imboden M, 2008, THORAX, V63, P322, DOI 10.1136/thx.2007.085555; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Ivaschenko TE, 2002, J MOL MED, V80, P39, DOI 10.1007/s001090100274; Kabesch M, 2004, THORAX, V59, P569, DOI 10.1136/thx.2003.016667; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Kimura T, 2011, P NATL ACAD SCI USA, V108, P3216, DOI 10.1073/pnas.1010334108; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Lee YL, 2005, CHEST, V128, P1156, DOI 10.1378/chest.128.3.1156; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Los H, 2001, Twin Res, V4, P81, DOI 10.1375/1369052012191; Mathias RA, 2010, J ALLERGY CLIN IMMUN, V125, P336, DOI 10.1016/j.jaci.2009.08.031; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moffatt MF, 2008, CURR OPIN ALLERGY CL, V8, P411, DOI 10.1097/ACI.0b013e32830f1dc1; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Sankararaman S, 2008, AM J HUM GENET, V82, P290, DOI 10.1016/j.ajhg.2007.09.022; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Thompson EE, 2010, GENET EPIDEMIOL, V34, P133, DOI 10.1002/gepi.20442; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Torgerson DG, 2012, J ALLERGY CLIN IMMUN, V130, P76, DOI 10.1016/j.jaci.2012.02.040; Torgerson DG, 2012, AM J HUM GENET, V90, P273, DOI 10.1016/j.ajhg.2012.01.008; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; Uricchio LH, 2012, GENET EPIDEMIOL, V36, P312, DOI 10.1002/gepi.21623; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wan YI, 2012, THORAX, V67, P762, DOI 10.1136/thoraxjnl-2011-201262; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Yao TC, 2013, J ALLERGY CLIN IMMUN; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253	83	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104396	10.1371/journal.pone.0104396	http://dx.doi.org/10.1371/journal.pone.0104396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116239	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400046
J	Liao, B; Jiang, Y; Yuan, GQ; Zhu, W; Cai, LJ; Cao, Z				Liao, Bo; Jiang, Yan; Yuan, Guanqun; Zhu, Wen; Cai, Lijun; Cao, Zhi			Learning a Weighted Meta-Sample Based Parameter Free Sparse Representation Classification for Microarray Data	PLOS ONE			English	Article							NONNEGATIVE MATRIX FACTORIZATION; GENE-EXPRESSION; CANCER; TUMOR; PREDICTION; DECOMPOSITION; DISCOVERY	Sparse representation classification (SRC) is one of the most promising classification methods for supervised learning. This method can effectively exploit discriminating information by introducing a l(1) regularization terms to the data. With the desirable property of sparisty, SRC is robust to both noise and outliers. In this study, we propose a weighted meta-sample based non-parametric sparse representation classification method for the accurate identification of tumor subtype. The proposed method includes three steps. First, we extract the weighted meta-samples for each sub class from raw data, and the rationality of the weighting strategy is proven mathematically. Second, sparse representation coefficients can be obtained by l(1) regularization of underdetermined linear equations. Thus, data dependent sparsity can be adaptively tuned. A simple characteristic function is eventually utilized to achieve classification. Asymptotic time complexity analysis is applied to our method. Compared with some state-of-the-art classifiers, the proposed method has lower time complexity and more flexibility. Experiments on eight samples of publicly available gene expression profile data show the effectiveness of the proposed method.	[Liao, Bo; Jiang, Yan; Yuan, Guanqun; Zhu, Wen; Cai, Lijun; Cao, Zhi] Hunan Univ, Coll Informat Sci & Engn, Key Lab Embedded & Network Comp Hunan Prov, Changsha 410082, Hunan, Peoples R China	Hunan University	Liao, B (corresponding author), Hunan Univ, Coll Informat Sci & Engn, Key Lab Embedded & Network Comp Hunan Prov, Changsha 410082, Hunan, Peoples R China.	dragonbw@163.com			Program for New Century Excellent Talents in University [NCET-10-0365]; National Nature Science Foundation of China [60973082, 11171369, 61272395, 61370171, 61300128]; National Nature Science Foundation of Hunan province [12JJ2041]; Planned Science and Technology Project of Hunan Province [2009FJ3195, 2012FJ2012]; Fundamental Research Funds for the Central Universities, Hunan university; Graduate research and innovation projects in Hunan Province [CX2012B144]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Nature Science Foundation of Hunan province; Planned Science and Technology Project of Hunan Province; Fundamental Research Funds for the Central Universities, Hunan university(Fundamental Research Funds for the Central Universities); Graduate research and innovation projects in Hunan Province	This work is supported by the Program for New Century Excellent Talents in University (Grant NCET-10-0365), National Nature Science Foundation of China (Grant 60973082, 11171369, 61272395, 61370171, 61300128), the National Nature Science Foundation of Hunan province (Grant 12JJ2041), the Planned Science and Technology Project of Hunan Province (Grant 2009FJ3195, 2012FJ2012) and supported by the Fundamental Research Funds for the Central Universities, Hunan university, Graduate research and innovation projects in Hunan Province (Grant CX2012B144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Cai D, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P714; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CHEN SB, 1994, CONF REC ASILOMAR C, P41, DOI 10.1109/ACSSC.1994.471413; Chen SSB, 2001, SIAM REV, V43, P129, DOI 10.1137/S1064827596304010; Cheng B, 2010, IEEE T IMAGE PROCESS, V19, P858, DOI 10.1109/TIP.2009.2038764; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grant M., 2014, CVX MATLAB SOFTWARE; Han XX, 2010, IEEE ACM T COMPUT BI, V7, P537, DOI 10.1109/TCBB.2009.36; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Lazar C, 2012, IEEE ACM T COMPUT BI, V9, P1106, DOI 10.1109/TCBB.2012.33; Lee DD, 2001, ADV NEUR IN, V13, P556; Liu B, 2013, PATTERN RECOGNITION; Nutt CL, 2003, CANCER RES, V63, P1602; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Sharon Y, 2007, IEEE T INFORM UNPUB, V5; Statnikov A, 2005, BIOINFORMATICS, V21, P631, DOI 10.1093/bioinformatics/bti033; Sugiyama M., 2006, P INT C MACH LEAR IC, P905, DOI DOI 10.1145/1143844.1143958; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wang SL, 2012, IEEE ACM T COMPUT BI, V9, P580, DOI 10.1109/TCBB.2011.135; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zheng CH, 2011, IEEE ACM T COMPUT BI, V8, P1592, DOI 10.1109/TCBB.2011.79; Zheng CH, 2011, IEEE T NANOBIOSCI, V10, P86, DOI 10.1109/TNB.2011.2144998; Zheng CH, 2011, IEEE ACM T COMPUT BI, V8, P1273, DOI 10.1109/TCBB.2011.20; Zheng CH, 2009, IEEE T INF TECHNOL B, V13, P599, DOI 10.1109/TITB.2009.2018115	34	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104314	10.1371/journal.pone.0104314	http://dx.doi.org/10.1371/journal.pone.0104314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115965	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400041
J	Norman, A; Riber, L; Luo, WT; Li, LL; Hansen, LH; Sorensen, SJ				Norman, Anders; Riber, Leise; Luo, Wenting; Li, Li Li; Hansen, Lars Hestbjerg; Sorensen, Soren Johannes			An Improved Method for Including Upper Size Range Plasmids in Metamobilomes	PLOS ONE			English	Article							HORIZONTAL TRANSFER; DNA-POLYMERASE; REPLICATION; IDENTIFICATION; MOBILITY; PKJK5	Two recently developed isolation methods have shown promise when recovering pure community plasmid DNA (metamobilomes/plasmidomes), which is useful in conducting culture-independent investigations into plasmid ecology. However, both methods employ multiple displacement amplification (MDA) to ensure suitable quantities of plasmid DNA for high-throughput sequencing. This study demonstrates that MDA greatly favors smaller circular DNA elements (<10 Kbp), which, in turn, leads to stark underrepresentation of upper size range plasmids (>10 Kbp). Throughout the study, we used two model plasmids, a 4.4 Kbp cloning vector (pBR322), and a 56 Kbp conjugative plasmid (pKJK10), to represent lower-and upper plasmid size ranges, respectively. Subjecting a mixture of these plasmids to the overall isolation protocol revealed a 34-fold over-amplification of pBR322 after MDA. To address this bias, we propose the addition of an electroelution step that separates different plasmid size ranges prior to MDA in order to reduce size-dependent competition during incubation. Subsequent analyses of metamobilome data from wastewater spiked with the model plasmids showed in silica recovery of pKJK10 to be very poor with the established method and a 1,300-fold overrepresentation of pBR322. Conversely, complete recovery of pKJK10 was enabled with the new modified protocol although considerable care must be taken during electroelution to minimize cross-contamination between samples. For further validation, non-spiked wastewater metamobilomes were mapped to more than 2,500 known plasmid genomes. This displayed an overall recovery of plasmids well into the upper size range (median size: 30 kilobases) with the modified protocol. Analysis of de novo assembled metamobilome data also suggested distinctly better recovery of larger plasmids, as gene functions associated with these plasmids, such as conjugation, was exclusively encoded in the data output generated through the modified protocol. Thus, with the suggested modification, access to a large uncharacterized pool of accessory elements that reside on medium-to-large plasmids has been improved.	[Norman, Anders; Riber, Leise; Luo, Wenting; Li, Li Li; Hansen, Lars Hestbjerg; Sorensen, Soren Johannes] Univ Copenhagen, Dept Biol, Microbiol Sect, Copenhagen, Denmark; [Norman, Anders] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Hansen, Lars Hestbjerg] Aarhus Univ, Dept Environm Sci, Roskilde, Denmark	University of Copenhagen; University of California System; University of California Berkeley; Aarhus University	Hansen, LH (corresponding author), Univ Copenhagen, Dept Biol, Microbiol Sect, Copenhagen, Denmark.	lhha@dmu.dk	Sørensen, Søren Johannes/N-2120-2019; Sørensen, Søren J/J-5015-2014; Luo, Wenting/M-5143-2014; Norman, Anders/E-2515-2011	Sørensen, Søren Johannes/0000-0001-6227-9906; Sørensen, Søren J/0000-0001-6227-9906; Luo, Wenting/0000-0002-6819-3860; Norman, Anders/0000-0002-1282-394X; Riber, Leise/0000-0003-4793-6095; Hestbjerg Hansen, Lars/0000-0003-0027-1524	Danish Council for Independent Research in Natural Sciences (FNU) [09-065940, 11-107935]; Lundbeck Foundation [44-A4384]; Seventh Framework Programme (FP7) [222625]; Center for Environmental and Agricultural Microbiology (CREAM) - Villum Foundation; Lundbeck Foundation [R44-2009-4384] Funding Source: researchfish	Danish Council for Independent Research in Natural Sciences (FNU)(Danish Natural Science Research Council); Lundbeck Foundation(Lundbeckfonden); Seventh Framework Programme (FP7)(European Commission); Center for Environmental and Agricultural Microbiology (CREAM) - Villum Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants 09-065940 and 11-107935 provided by The Danish Council for Independent Research in Natural Sciences (FNU), the Lundbeck Foundation (www. lundbeckfoundation. com) project DK nr R44-A4384, the METAEXPLORE grant (no: 222625) provided by The Seventh Framework Programme (FP7), and the Center for Environmental and Agricultural Microbiology (CREAM), funded by The Villum Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040438; Bahl MI, 2007, PLASMID, V58, P31, DOI 10.1016/j.plasmid.2006.11.007; Bahl MI, 2007, FEMS MICROBIOL LETT, V266, P250, DOI 10.1111/j.1574-6968.2006.00536.x; Bahl ML, 2004, FEMS MICROBIOL LETT, V232, P45, DOI 10.1016/S0378-1097(04)00015-1; BLANCO L, 1989, J BIOL CHEM, V264, P8935; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; FIGURSKI DH, 1979, J MOL BIOL, V133, P295, DOI 10.1016/0022-2836(79)90395-4; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jones BV, 2007, NAT METHODS, V4, P55, DOI 10.1038/NMETH964; Jorgensen TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087924; Kampmann ML, 2011, J VIROL METHODS, V178, P243, DOI 10.1016/j.jviromet.2011.09.001; Kav AB, 2013, J MICROBIOL METH, V95, P272, DOI 10.1016/j.mimet.2013.09.008; Kav AB, 2012, P NATL ACAD SCI USA, V109, P5452, DOI 10.1073/pnas.1116410109; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LL, 2012, CLIN MICROBIOL INFEC, V18, P8, DOI 10.1111/j.1469-0691.2012.03862.x; LINCHAO S, 1986, MOL GEN GENET, V203, P143, DOI 10.1007/BF00330395; Meyer R, 2009, PLASMID, V62, P57, DOI 10.1016/j.plasmid.2009.05.001; MOTALLEBIVESHAREH M, 1990, MOL MICROBIOL, V4, P1455, DOI 10.1111/j.1365-2958.1990.tb02056.x; MUKAI T, 1973, P NATL ACAD SCI USA, V70, P2884, DOI 10.1073/pnas.70.10.2884; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; Pan XH, 2008, P NATL ACAD SCI USA, V105, P15499, DOI 10.1073/pnas.0808028105; Peng Y, 2011, BIOINFORMATICS, V27, pI94, DOI 10.1093/bioinformatics/btr216; Garcillan-Barcia MP, 2011, FEMS MICROBIOL REV, V35, P936, DOI 10.1111/j.1574-6976.2011.00291.x; Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065; Rosario K, 2011, CURR OPIN VIROL, V1, P289, DOI 10.1016/j.coviro.2011.06.004; Santos CL, 2009, FEMS MICROBIOL REV, V33, P411, DOI 10.1111/j.1574-6976.2008.00154.x; Schluter A, 2007, FEMS MICROBIOL REV, V31, P449, DOI 10.1111/j.1574-6976.2007.00074.x; Sengelov G, 2001, CURR MICROBIOL, V42, P160, DOI 10.1007/s002840010197; Sentchilo V, 2013, ISME J, V7, P1173, DOI 10.1038/ismej.2013.13; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Szczepanowski R, 2008, J BIOTECHNOL, V136, P54, DOI 10.1016/j.jbiotec.2008.03.020; THOMAS CM, 1980, J BACTERIOL, V141, P213, DOI 10.1128/JB.141.1.213-222.1980; TOP E, 1994, APPL ENVIRON MICROB, V60, P831, DOI 10.1128/AEM.60.3.831-839.1994; Walker A, 2012, NAT REV MICROBIOL, V10, P379, DOI 10.1038/nrmicro2804; Warburton PJ, 2011, FEMS MICROBIOL ECOL, V78, P349, DOI 10.1111/j.1574-6941.2011.01166.x; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026041	43	23	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104405	10.1371/journal.pone.0104405	http://dx.doi.org/10.1371/journal.pone.0104405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116381	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400048
J	O'Sullivan, D; Green, L; Stone, S; Zareie, P; Kharkrang, M; Fong, DN; Connor, B; La Flamme, AC				O'Sullivan, David; Green, Laura; Stone, Sarrabeth; Zareie, Pirooz; Kharkrang, Marie; Fong, Dahna; Connor, Bronwen; La Flamme, Anne Camille			Treatment with the Antipsychotic Agent, Risperidone, Reduces Disease Severity in Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; INDUCED MICROGLIAL ACTIVATION; MULTIPLE-SCLEROSIS; T-CELLS; ATYPICAL ANTIPSYCHOTICS; INTERFERON-GAMMA; DENDRITIC CELLS; IN-VITRO; SCHIZOPHRENIA; DOPAMINE	Recent studies have demonstrated that atypical antipsychotic agents, which are known to antagonize dopamine D2 and serotonin 5-HT2a receptors, have immunomodulatory properties. Given the potential of these drugs to modulate the immune system both peripherally and within the central nervous system, we investigated the ability of the atypical antipsychotic agent, risperidone, to modify disease in the animal model of multiple sclerosis (MS)(4), experimental autoimune encephalomyelitis (EAE). We found that chronic oral administration of risperidone dose-dependently reduced the severity of disease and decreased both the size and number of spinal cord lesions. Furthermore, risperidone treatment substantially reduced antigen-specific interleukin (IL)-17a, IL-2, and IL-4 but not interferon (IFN)-gamma production by splenocytes at peak disease and using an in vitro model, we show that treatment of macrophages with risperidone alters their ability to bias naive T cells. Another atypical antipsychotic agent, clozapine, showed a similar ability to modify macrophages in vitro and to reduce disease in the EAE model but this effect was not due to antagonism of the type 1 or type 2 dopamine receptors alone. Finally, we found that while risperidone treatment had little effect on the in vivo activation of splenic macrophages during EAE, it significantly reduced the activation of microglia and macrophages in the central nervous system. Together these studies indicate that atypical antipsychotic agents like risperidone are effective immunomodulatory agents with the potential to treat immune-mediated diseases such as MS.	[O'Sullivan, David; Green, Laura; Stone, Sarrabeth; Zareie, Pirooz; Kharkrang, Marie; Fong, Dahna; La Flamme, Anne Camille] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Connor, Bronwen] Univ Auckland, Fac Med & Hlth Sci, Ctr Brain Res, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand; [La Flamme, Anne Camille] Malaghan Inst Med Res, Wellington, New Zealand	Victoria University Wellington; University of Auckland; Malaghan Institute; Victoria University Wellington	La Flamme, AC (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	anne.laflamme@vuw.ac.nz		Stone, Sarrabeth/0000-0001-7866-8228; Zareie, Pirooz/0000-0001-6000-2305; Connor, Bronwen/0000-0001-6828-4175	Neurological Foundation of New Zealand [0932-SPG, 1130-PG]; Victoria University of Wellington (University Research Fund); Great New Zealand Trek	Neurological Foundation of New Zealand; Victoria University of Wellington (University Research Fund); Great New Zealand Trek	This work was supported by the Neurological Foundation of New Zealand (0932-SPG and 1130-PG), Victoria University of Wellington (University Research Fund), and generous donations from the Great New Zealand Trek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers MM, 2004, NEUROCHEM INT, V45, P409, DOI 10.1016/j.neuint.2003.08.018; Basta-Kaim A, 2006, J PHYSIOL PHARMACOL, V57, P247; Berghmans N, 2011, J INTERF CYTOK RES, V31, P575, DOI 10.1089/jir.2010.0137; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bian Q, 2008, PROG NEURO-PSYCHOPH, V32, P42, DOI 10.1016/j.pnpbp.2007.06.031; Brown SW, 2003, J NEUROIMMUNOL, V135, P47, DOI 10.1016/S0165-5728(02)00435-6; Calabrese M, 2010, J NEUROL NEUROSUR PS, V81, P401, DOI 10.1136/jnnp.2009.177733; Chemel BR, 2006, PSYCHOPHARMACOLOGY, V188, P244, DOI 10.1007/s00213-006-0490-4; Confavreux C, 2006, CLIN NEUROL NEUROSUR, V108, P327, DOI 10.1016/j.clineuro.2005.11.018; Cope MB, 2005, INT J OBESITY, V29, P607, DOI 10.1038/sj.ijo.0802928; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Crume KP, 2007, EXP BIOL MED, V232, P607; DeAngelis T, 2008, CURR OPIN NEUROL, V21, P261, DOI 10.1097/WCO.0b013e328300c70d; DIJKSTRA CD, 1994, PSYCHONEUROENDOCRINO, V19, P135, DOI 10.1016/0306-4530(94)90003-5; Drzyzga L, 2006, BRAIN BEHAV IMMUN, V20, P532, DOI 10.1016/j.bbi.2006.02.002; Ferber IA, 1996, J IMMUNOL, V156, P5; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Franco R, 2007, TRENDS IMMUNOL, V28, P400, DOI 10.1016/j.it.2007.07.005; Freire-Garabal M, 2003, NEUROSCI LETT, V342, P33, DOI 10.1016/S0304-3940(03)00215-5; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Guillin O, 2007, INT REV NEUROBIOL, V78, P377, DOI 10.1016/S0074-7742(06)78012-6; Hasko G, 2002, J NEUROIMMUNOL, V122, P34, DOI 10.1016/S0165-5728(01)00459-3; Horacek J, 2006, CNS DRUGS, V20, P389, DOI 10.2165/00023210-200620050-00004; Kapur S, 2003, J PHARMACOL EXP THER, V305, P625, DOI 10.1124/jpet.102.046987; Kapur S, 2001, ANNU REV MED, V52, P503, DOI 10.1146/annurev.med.52.1.503; Karl T, 2006, BEHAV BRAIN RES, V171, P286, DOI 10.1016/j.bbr.2006.04.004; Kato T, 2008, J NEUROCHEM, V106, P815, DOI 10.1111/j.1471-4159.2008.05435.x; Kato T, 2007, SCHIZOPHR RES, V92, P108, DOI 10.1016/j.schres.2007.01.019; La Flamme AC, 2003, INFECT IMMUN, V71, P4996, DOI 10.1128/IAI.71.9.4996-5004.2003; Leary SM, 2005, CNS DRUGS, V19, P369, DOI 10.2165/00023210-200519050-00001; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lutton JD, 2004, EXP BIOL MED, V229, P12, DOI 10.1177/153537020422900102; Macdowell K. S., 2011, INT J NEUROPSYCHOPH, P1; Maes M, 2002, SCHIZOPHR RES, V54, P281, DOI 10.1016/S0920-9964(00)00094-3; Martiney JA, 1998, J IMMUNOL, V160, P5588; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; Meltzer HY, 2011, AM J PSYCHIAT, V168, P957, DOI 10.1176/appi.ajp.2011.10060907; Meyer U, 2011, PHARMACOL THERAPEUT, V132, P96, DOI 10.1016/j.pharmthera.2011.06.003; MULLER N, 1993, ACTA PSYCHIAT SCAND, V87, P66, DOI 10.1111/j.1600-0447.1993.tb03331.x; Murphy AC, 2010, BRAIN BEHAV IMMUN, V24, P641, DOI 10.1016/j.bbi.2010.01.014; Naiker DV, 2006, EUR J PHARMACOL, V540, P87, DOI 10.1016/j.ejphar.2006.04.048; Nakano K, 2008, BIOCHEM BIOPH RES CO, V373, P286, DOI 10.1016/j.bbrc.2008.06.012; Nakano K, 2011, J IMMUNOL, V186, P3745, DOI 10.4049/jimmunol.1002475; Nakano K, 2009, INT IMMUNOL, V21, P645, DOI 10.1093/intimm/dxp033; Pacheco R, 2009, J NEUROIMMUNOL, V216, P8, DOI 10.1016/j.jneuroim.2009.07.018; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Rinner I, 1998, J NEUROIMMUNOL, V81, P31, DOI 10.1016/S0165-5728(97)00155-0; Roth BL, 2003, CLIN NEUROSCI RES, V3, P108, DOI 10.1016/S1566-2772(03)00021-5; Schenk S, 2011, BRIT J PHARMACOL, V162, P1770, DOI 10.1111/j.1476-5381.2010.01193.x; Sorensen PS, 2007, MULT SCLER J, V13, P616, DOI 10.1177/1352458506072344; Strous RD, 2006, J AUTOIMMUN, V27, P71, DOI 10.1016/j.jaut.2006.07.006; Sugino H, 2009, PROG NEURO-PSYCHOPH, V33, P303, DOI 10.1016/j.pnpbp.2008.12.006; Tierney JB, 2009, IMMUNOL CELL BIOL, V87, P235, DOI 10.1038/icb.2008.99; Toker A, 2011, SCAND J IMMUNOL, V74, P235, DOI 10.1111/j.1365-3083.2011.02575.x; Tran EH, 1998, J IMMUNOL, V161, P3767; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Zheng LT, 2008, J NEUROCHEM, V107, P1225, DOI 10.1111/j.1471-4159.2008.05675.x	59	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104430	10.1371/journal.pone.0104430	http://dx.doi.org/10.1371/journal.pone.0104430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116424	Green Published, Green Submitted			2022-12-27	WOS:000341230400049
J	de Vega, WC; Vernon, SD; McGowan, PO				de Vega, Wilfred C.; Vernon, Suzanne D.; McGowan, Patrick O.			DNA Methylation Modifications Associated with Chronic Fatigue Syndrome	PLOS ONE			English	Article							GENE-EXPRESSION; IMMUNOLOGICAL ABNORMALITIES; CPG SITES; BLOOD; DISCOVERY; CELLS; IDENTIFICATION; EPIGENETICS; CULTURES; ETIOLOGY	Chronic Fatigue Syndrome (CFS), also known as myalgic encephalomyelitis, is a complex multifactorial disease that is characterized by the persistent presence of fatigue and other particular symptoms for a minimum of 6 months. Symptoms fail to dissipate after sufficient rest and have major effects on the daily functioning of CFS sufferers. CFS is a multi-system disease with a heterogeneous patient population showing a wide variety of functional disabilities and its biological basis remains poorly understood. Stable alterations in gene function in the immune system have been reported in several studies of CFS. Epigenetic modifications have been implicated in long-term effects on gene function, however, to our knowledge, genome-wide epigenetic modifications associated with CFS have not been explored. We examined the DNA methylome in peripheral blood mononuclear cells isolated from CFS patients and healthy controls using the Illumina HumanMethylation450 BeadChip array, controlling for invariant probes and probes overlapping polymorphic sequences. Gene ontology (GO) and network analysis of differentially methylated genes was performed to determine potential biological pathways showing changes in DNA methylation in CFS. We found an increased abundance of differentially methylated genes related to the immune response, cellular metabolism, and kinase activity. Genes associated with immune cell regulation, the largest coordinated enrichment of differentially methylated pathways, showed hypomethylation within promoters and other gene regulatory elements in CFS. These data are consistent with evidence of multisystem dysregulation in CFS and implicate the involvement of DNA modifications in CFS pathology.	[de Vega, Wilfred C.; McGowan, Patrick O.] Univ Toronto, Ctr Environm Epigenet & Dev, Scarborough, ON M1C 1A4, Canada; [de Vega, Wilfred C.; McGowan, Patrick O.] Univ Toronto, Dept Biol Sci, Scarborough, ON M1C 1A4, Canada; [de Vega, Wilfred C.; McGowan, Patrick O.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada; [Vernon, Suzanne D.] CFIDS Assoc Amer, Charlotte, NC USA	University of Toronto; University Toronto Scarborough; University of Toronto; University Toronto Scarborough; University of Toronto	McGowan, PO (corresponding author), Univ Toronto, Ctr Environm Epigenet & Dev, Scarborough, ON M1C 1A4, Canada.	patrick.mcgowan@utoronto.ca			CFIDS Association of America	CFIDS Association of America	This work was supported by the CFIDS Association of America. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbi B, 2013, QJM-INT J MED, V106, P3, DOI 10.1093/qjmed/hcs156; AOKI T, 1993, CLIN IMMUNOL IMMUNOP, V69, P253, DOI 10.1006/clin.1993.1178; Aspler AL, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-44; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Brint EK, 2002, J BIOL CHEM, V277, P49205, DOI 10.1074/jbc.M209685200; Broderick G, 2010, BRAIN BEHAV IMMUN, V24, P1209, DOI 10.1016/j.bbi.2010.04.012; CALIGIURI M, 1987, J IMMUNOL, V139, P3306; Carmel L, 2006, PHARMACOGENOMICS, V7, P375, DOI 10.2217/14622416.7.3.375; Carruthers BM, 2007, J CLIN PATHOL, V60, P117, DOI 10.1136/jcp.2006.042754; CHAO CC, 1991, CYTOKINE, V3, P292, DOI 10.1016/1043-4666(91)90497-2; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Cleare AJ, 2003, ENDOCR REV, V24, P236, DOI 10.1210/er.2002-0014; de la Rica L, 2013, J AUTOIMMUN, V41, P6, DOI 10.1016/j.jaut.2012.12.005; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; Essex MJ, 2013, CHILD DEV, V84, P58, DOI 10.1111/j.1467-8624.2011.01641.x; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gameiro CM, 2010, MATURITAS, V67, P316, DOI 10.1016/j.maturitas.2010.08.003; Garden GA, 2013, NEUROTHERAPEUTICS, V10, P782, DOI 10.1007/s13311-013-0207-4; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Heyn H, 2013, CARCINOGENESIS, V34, P102, DOI 10.1093/carcin/bgs321; Hickie I, 2006, BRIT MED J, V333, P575, DOI 10.1136/bmj.38933.585764.AE; Horvath S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-r97; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jason LA, 2005, NEUROPSYCHOL REV, V15, P29, DOI 10.1007/s11065-005-3588-2; JASON LA, 2014, J HLTH PSYCHOL; Jones MJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-58; Kashipaz MRA, 2003, CLIN EXP IMMUNOL, V132, P360, DOI 10.1046/j.1365-2249.2003.02149.x; Kaushik N, 2005, J CLIN PATHOL, V58, P826, DOI 10.1136/jcp.2005.025718; Kerr JR, 2008, J INFECT DIS, V197, P1171, DOI 10.1086/533453; Klimas Nancy G, 2007, Curr Rheumatol Rep, V9, P482, DOI 10.1007/s11926-007-0078-y; Klimas NG, 2012, BRAIN BEHAV IMMUN, V26, P1202, DOI 10.1016/j.bbi.2012.06.006; KLIMAS NG, 1990, J CLIN MICROBIOL, V28, P1403, DOI 10.1128/JCM.28.6.1403-1410.1990; Lam LL, 2012, P NATL ACAD SCI USA, V109, P17253, DOI 10.1073/pnas.1121249109; Light AR, 2012, J INTERN MED, V271, P64, DOI 10.1111/j.1365-2796.2011.02405.x; Lim PS, 2013, IMMUNOLOGY, V139, P285, DOI 10.1111/imm.12100; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Lorusso L, 2009, AUTOIMMUN REV, V8, P287, DOI 10.1016/j.autrev.2008.08.003; Maes M, 2009, CURR OPIN PSYCHIATR, V22, P75, DOI 10.1097/YCO.0b013e32831a4728; Maher KJ, 2005, CLIN EXP IMMUNOL, V142, P505, DOI 10.1111/j.1365-2249.2005.02935.x; Martino D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r42; Mehta D, 2013, P NATL ACAD SCI USA, V110, P8302, DOI 10.1073/pnas.1217750110; Menzies V, 2013, NURS RES PRACT, V2013, DOI 10.1155/2013/795784; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; MITTERER M, 1995, BRIT J HAEMATOL, V90, P526, DOI 10.1111/j.1365-2141.1995.tb05579.x; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Powell R, 2003, CLIN EXP ALLERGY, V33, P1450, DOI 10.1046/j.1365-2222.2003.01745.x; Presson AP, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-95; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Reynolds Kenneth J, 2004, Cost Eff Resour Alloc, V2, P4, DOI 10.1186/1478-7547-2-4; Robertson MJ, 2005, CLIN EXP IMMUNOL, V141, P326, DOI 10.1111/j.1365-2249.2005.02833.x; Rodriguez-Hernandez H, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/678159; Sanders P, 2008, WORLD J BIOL PSYCHIA, V9, P165, DOI 10.1080/15622970701310971; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Simonatto M, 2013, BRIEF FUNCT GENOMICS, V12, P483, DOI 10.1093/bfgp/elt023; Skowera A, 2004, CLIN EXP IMMUNOL, V135, P294, DOI 10.1111/j.1365-2249.2004.02354.x; Smith AK, 2011, NEUROPSYCHOBIOLOGY, V64, P183, DOI 10.1159/000326692; Suarez-Alvarez B, 2013, EPIGENETICS-US, V8, P694, DOI 10.4161/epi.25201; Suarez-Alvarez B, 2012, TRENDS GENET, V28, P506, DOI 10.1016/j.tig.2012.06.005; Taylor KH, 2013, SEMIN HEMATOL, V50, P38, DOI 10.1053/j.seminhematol.2013.01.003; ter Wolbeek M, 2007, BRAIN BEHAV IMMUN, V21, P1063, DOI 10.1016/j.bbi.2007.04.007; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; TIRELLI U, 1994, SCAND J IMMUNOL, V40, P601, DOI 10.1111/j.1365-3083.1994.tb03511.x; Trajkovic V, 2004, CYTOKINE GROWTH F R, V15, P87, DOI 10.1016/j.cytogfr.2004.02.004; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Vernon SD, 2006, PHARMACOGENOMICS, V7, P345, DOI 10.2217/14622416.7.3.345; Vernon SD, 2002, DIS MARKERS, V18, P193, DOI 10.1155/2002/892374; Visser J, 2001, J NEUROIMMUNOL, V119, P343, DOI 10.1016/S0165-5728(01)00400-3; Vojdani A, 1997, J INTERN MED, V242, P465, DOI 10.1111/j.1365-2796.1997.tb00019.x; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Wessely S, 1999, LANCET, V354, P936, DOI 10.1016/S0140-6736(98)08320-2; Whistler T, 2006, PHARMACOGENOMICS, V7, P395, DOI 10.2217/14622416.7.3.395; Wrangle J, 2013, ONCOTARGET, V4, P2067, DOI 10.18632/oncotarget.1542; Yoshiuchi K, 2007, PHYSIOL BEHAV, V92, P963, DOI 10.1016/j.physbeh.2007.07.001; Zhi D, 2013, EPIGENETICS-US, V8, P802, DOI 10.4161/epi.25501; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	80	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104757	10.1371/journal.pone.0104757	http://dx.doi.org/10.1371/journal.pone.0104757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111603	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100098
J	Jin, JO; Zhang, W; Wong, KW; Kwak, M; van Driel, IR; Yu, Q				Jin, Jun-O; Zhang, Wei; Wong, Ka-Wing; Kwak, Minseok; van Driel, Ian R.; Yu, Qing			Inhibition of Breast Cancer Resistance Protein (ABCG2) in Human Myeloid Dendritic Cells Induces Potent Tolerogenic Functions during LPS Stimulation	PLOS ONE			English	Article							REGULATORY T-CELLS; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; SEMI-MATURE; PHASE-I; DIFFERENTIATION; COMBINATION; EXPRESSION; MATURATION; INDUCTION	Breast cancer resistance protein (ABCG2), a member of the ATP-binding cassette transporters has been identified as a major determinant of multidrug resistance (MDR) in cancer cells, but ABC transporter inhibition has limited therapeutic value in vivo. In this research, we demonstrated that inhibition of efflux transporters ABCG2 induced the generation of tolerogenic DCs from human peripheral blood myeloid DCs (mDCs). ABCG2 expression was present in mDCs and was further increased by LPS stimulation. Treatment of CD1c(+) mDCs with an ABCG2 inhibitor, Ko143, during LPS stimulation caused increased production of IL-10 and decreased production of pro-inflammatory cytokines and decreased expression of CD83 and CD86. Moreover, inhibition of ABCG2 in monocyte-derived DCs (MDDCs) abrogated the up-regulation of co-stimulatory molecules and production of pro-inflammatory cytokines in these cells in response to LPS. Furthermore, CD1c(+) mDCs stimulated with LPS plus Ko143 inhibited the proliferation of allogeneic and superantigen-specific syngenic CD4(+) T cells and promoted expansion of CD25(+) FOXP3(+) regulatory T (Treg) cells in an IL-10-dependent fashion. These tolerogenic effects of ABCG2 inhibition could be abolished by ERK inhibition. Thus, we demonstrated that inhibition of ABCG2 in LPS-stimulated mDCs can potently induce tolerogenic potentials in these cells, providing crucial new information that could lead to development of better strategies to combat MDR cancer.	[Jin, Jun-O; Zhang, Wei; Wong, Ka-Wing] Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Kwak, Minseok] Pukyong Natl Univ, Dept Chem, Pusan, South Korea; [van Driel, Ian R.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Yu, Qing] Forsyth Inst, Dept Immunol & Infect Dis, Cambridge, MA USA	Fudan University; Pukyong National University; University of Melbourne; Harvard University; Forsyth Institute	Jin, JO (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	Junojin1@gmail.com	yu, qing/HGC-4611-2022; Jin, Jun-O/G-2998-2014	van Driel, Ian/0000-0001-5371-120X; Kwak, Minseok/0000-0002-0480-1804; Jin, Jun-O/0000-0003-4216-8111	Shanghai Public Health Clinical Center in Fudan University [RCJJP17]; National Institutes of Health [DE023838]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023838] Funding Source: NIH RePORTER	Shanghai Public Health Clinical Center in Fudan University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by grant RCJJP17 from the Shanghai Public Health Clinical Center in Fudan University. Qing Yu was supported by grant DE023838 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambudkar SV, 2003, ONCOGENE, V22, P7468, DOI 10.1038/sj.onc.1206948; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Bates S, 2001, CANCER-AM CANCER SOC, V92, P1577, DOI 10.1002/1097-0142(20010915)92:6<1577::AID-CNCR1484>3.0.CO;2-H; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Boks MA, 2012, CLIN IMMUNOL, V142, P332, DOI 10.1016/j.clim.2011.11.011; Castiello L, 2011, CANCER IMMUNOL IMMUN, V60, P457, DOI 10.1007/s00262-010-0954-6; Chen WS, 2007, EXP EYE RES, V84, P626, DOI 10.1016/j.exer.2006.11.006; Cripe LD, 2010, BLOOD, V116, P4077, DOI 10.1182/blood-2010-04-277269; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Gafter-Gvili A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004386.pub3; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grohmann U, 1998, IMMUNITY, V9, P315, DOI 10.1016/S1074-7613(00)80614-7; Kudo-Saito C, 2009, CANCER CELL, V15, P195, DOI 10.1016/j.ccr.2009.01.023; Kuppens IELM, 2007, CLIN CANCER RES, V13, P3276, DOI 10.1158/1078-0432.CCR-06-2414; Kusmartsev S, 2006, CANCER METAST REV, V25, P323, DOI 10.1007/s10555-006-9002-6; Larmonier N, 2007, CANCER IMMUNOL IMMUN, V56, P48, DOI 10.1007/s00262-006-0160-8; Laupeze B, 2001, HUM IMMUNOL, V62, P1073, DOI 10.1016/S0198-8859(01)00307-X; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lozza L, 2013, EUROPEAN J IMMUNOLOG; Lutz MB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00123; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Ma MT, 2013, CANCER LETT, V339, P107, DOI 10.1016/j.canlet.2013.07.016; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Puget N, 1999, CANCER RES, V59, P455; Qian C, 2006, BLOOD, V108, P2307, DOI 10.1182/blood-2006-03-005595; Randolph GJ, 1998, P NATL ACAD SCI USA, V95, P6924, DOI 10.1073/pnas.95.12.6924; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403; Saito M, 2011, J EXP MED, V208, P235, DOI 10.1084/jem.20100799; Schroeijers AB, 2002, J IMMUNOL, V168, P1572, DOI 10.4049/jimmunol.168.4.1572; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Szatmari I, 2006, J BIOL CHEM, V281, P23812, DOI 10.1074/jbc.M604890200; Toi M, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.08.1646; Torres-Aguilar H, 2010, AUTOIMMUN REV, V10, P8, DOI 10.1016/j.autrev.2010.07.015; van Dalen EC, 2012, COCHRANE DB SYST REV, V9, DOI [10.1002/14651858.CD006247.pub2, DOI 10.1002/14651858]; van de Ven R, 2008, BLOOD, V112, P2353, DOI 10.1182/blood-2008-03-147850; van de Ven R, 2006, J IMMUNOL, V176, P5191, DOI 10.4049/jimmunol.176.9.5191; van de Ven R, 2012, IMMUNOL CELL BIOL, V90, P206, DOI 10.1038/icb.2011.25; van de Ven R, 2009, TRENDS IMMUNOL, V30, P421, DOI 10.1016/j.it.2009.06.004; Wang HY, 2007, CURR OPIN IMMUNOL, V19, P217, DOI 10.1016/j.coi.2007.02.004; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104753	10.1371/journal.pone.0104753	http://dx.doi.org/10.1371/journal.pone.0104753			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111504	Green Published, gold			2022-12-27	WOS:000341105100097
J	Yao, YX; Du, J; Cao, XQ; Wang, Y; Huang, YH; Hu, SS; Zheng, Z				Yao, Youxiu; Du, Juan; Cao, Xiaoqing; Wang, Yang; Huang, Yaohua; Hu, Shengshou; Zheng, Zhe			Plasma Levels of MicroRNA-499 Provide an Early Indication of Perioperative Myocardial Infarction in Coronary Artery Bypass Graft Patients	PLOS ONE			English	Article							CIRCULATING MICRORNAS; CARDIOVASCULAR-DISEASE; SENSITIVE BIOMARKERS; UNIVERSAL DEFINITION; SERUM; DIAGNOSIS	Background: Recent studies indicated that microRNAs (miRNAs, miRs) were important for many biological and pathological processes, and they might be potential biomarkers for cardiovascular diseases. The present study aims to determine the release patterns of miRNAs in cardiac surgery and to analyze the ability of miRs to provide early prediction of perioperative myocardial infarction (PMI) in patients undergoing coronary artery bypass graft (CABG) surgery. Methodology/Principal Findings: Thirty on-pump CABG patients were recruited in this study; and miR-499, miR-133a and miR-133b, cardiac troponin I (cTnI) were selected for measurement. Serial plasma samples were collected at seven perioperative time points (preoperatively, and 1, 3, 6, 12, 24, and 48 hours after declamping) and were tested for cTnI and miRs levels. Importantly, miR levels peaked as early as 1-3 hours, whereas cTnI levels peaked at 6 hours after declamping. Peak plasma concentrations of miRs correlated significantly with cTnI (miR-499, r = 0.583, P = 0.001; miR-133a, r = 0.514, P = 0.006; miR-133b, r = 0.437, P = 0.05), indicating the degree of myocardial damage. In addition, 30 off-pump CABG patients were recruited; miR-499 and miR-133a levels were tested, which were significantly lower in off-pump group than in on-pump group. A prospective cohort of CABG patients (n = 120) was recruited to study the predictive power of miRs for PMI. The diagnosis of PMI strictly adhered to the principles of universal definition of myocardial infarction. The data analysis revealed that miR-499 had higher sensitivity and specificity than cTnI, and indicated that miR-499 could be an independent risk factor for PMI. Conclusion: Our results demonstrate that circulating miR-499 is a novel, early biomarker for identifying perioperative myocardial infarction in cardiac surgery.	[Yao, Youxiu; Du, Juan; Wang, Yang; Huang, Yaohua; Hu, Shengshou; Zheng, Zhe] Chinese Acad Med Sci, Beijing, Peoples R China; [Yao, Youxiu; Du, Juan; Wang, Yang; Huang, Yaohua; Hu, Shengshou; Zheng, Zhe] Peking Union Med Coll, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Yao, Youxiu; Du, Juan; Wang, Yang; Huang, Yaohua; Hu, Shengshou; Zheng, Zhe] Fuwai Hosp, Dept Cardiac Surg, Beijing, Peoples R China; [Yao, Youxiu; Du, Juan; Wang, Yang; Huang, Yaohua; Hu, Shengshou; Zheng, Zhe] Cardiovasc Inst, Beijing, Peoples R China; [Yao, Youxiu; Du, Juan; Hu, Shengshou; Zheng, Zhe] Natl Ctr Cardiovasc Dis, Minist Hlth, Key Lab Cardiac Regenerat Med, Beijing, Peoples R China; [Cao, Xiaoqing] Capital Med Univ, Beijing Chest Hosp, Beijing TB & Thorac Tumor Res Inst, Dept Thorac Surg, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Capital Medical University	Hu, SS (corresponding author), Chinese Acad Med Sci, Beijing, Peoples R China.	shengshouhu@yahoo.com; zhengzhe@fuwai.com			Key Project in the National Science and Technology Pillar Program [2011BAI11B21]; Program for New Century Excellent Talents in University; PUMC; Fundamental Research Funds for the Central Universities [3332013011]	Key Project in the National Science and Technology Pillar Program; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); PUMC; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported in part by a grant from the Key Project in the National Science and Technology Pillar Program during the 12th 5-Year Plan Period (Grant No. 2011BAI11B21) and Program for New Century Excellent Talents in University and by the PUMC Youth Fund and the Fundamental Research Funds for the Central Universities (No. 3332013011, to Y. Yao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2010, CLIN CHEM, V56, P1183, DOI 10.1373/clinchem.2010.144121; Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Barringhaus KG, 2009, CIRCULATION, V119, P2217, DOI 10.1161/CIRCULATIONAHA.107.715839; Benoit MO, 2001, CRIT CARE MED, V29, P1880, DOI 10.1097/00003246-200110000-00005; Cao XQ, 2013, FEBS LETT, V587, P1548, DOI 10.1016/j.febslet.2013.01.075; Chen JC, 2007, CRIT CARE MED, V35, P1296, DOI 10.1097/01.CCM.0000262403.08546.A2; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; D'Alessandra Y, 2012, CURR OPIN CARDIOL, V27, P228, DOI 10.1097/HCO.0b013e3283522052; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; De Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572; Du J, 2013, PLOS ONE, V8; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Gerszten RE, 2011, CIRC RES, V109, P463, DOI 10.1161/CIRCRESAHA.110.225003; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Kuwabara Y, 2011, CIRC-CARDIOVASC GENE, V4, P446, DOI 10.1161/CIRCGENETICS.110.958975; Landesberg G, 2009, CIRCULATION, V119, P2936, DOI 10.1161/CIRCULATIONAHA.108.828228; Li CW, 2012, CLIN BIOCHEM, V45, P727, DOI 10.1016/j.clinbiochem.2012.04.013; Long GW, 2012, INT J BIOL SCI, V8, P811, DOI 10.7150/ijbs.4439; Mackey WC, 2006, J VASC SURG, V43, P533, DOI 10.1016/j.jvs.2005.11.013; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Priebe HJ, 2005, BRIT J ANAESTH, V95, P3, DOI 10.1093/bja/aei063; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Xiao JJ, 2014, INT J CLIN EXP MED, V7, P136; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735	31	33	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104618	10.1371/journal.pone.0104618	http://dx.doi.org/10.1371/journal.pone.0104618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111390	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100083
J	Szuplewska, M; Ludwiczak, M; Lyzwa, K; Czarnecki, J; Bartosik, D				Szuplewska, Magdalena; Ludwiczak, Marta; Lyzwa, Katarzyna; Czarnecki, Jakub; Bartosik, Dariusz			Mobility and Generation of Mosaic Non-Autonomous Transposons by Tn3-Derived Inverted-Repeat Miniature Elements (TIMEs)	PLOS ONE			English	Article							REPABC-TYPE REPLICON; NUCLEOTIDE-SEQUENCE; INSERTION SEQUENCES; SHUTTLE VECTOR; PLASMID PRA2; IDENTIFICATION; ORGANIZATION; OPERON; KUPFERSCHIEFER; CONSTRUCTION	Functional transposable elements (TEs) of several Pseudomonas spp. strains isolated from black shale ore of Lubin mine and from post-flotation tailings of Zelazny Most in Poland, were identified using a positive selection trap plasmid strategy. This approach led to the capture and characterization of (i) 13 insertion sequences from 5 IS families (IS3, IS5, ISL3, IS30 and IS1380), (ii) isoforms of two Tn3-family transposons - Tn5563a and Tn4662a (the latter contains a toxin-antitoxin system), as well as (iii) non-autonomous TEs of diverse structure, ranging in size from 262 to 3892 bp. The non-autonomous elements transposed into AT-rich DNA regions and generated 5- or 6-bp sequence duplications at the target site of transposition. Although these TEs lack a transposase gene, they contain homologous 38-bp-long terminal inverted repeat sequences (IRs), highly conserved in Tn5563a and many other Tn3-family transposons. The simplest elements of this type, designated TIMEs (Tn3 family-derived Inverted-repeat Miniature Elements) (262 bp), were identified within two natural plasmids (pZM1P1 and pLM8P2) of Pseudomonas spp. It was demonstrated that TIMEs are able to mobilize segments of plasmid DNA for transposition, which results in the generation of more complex non-autonomous elements, resembling IS-driven composite transposons in structure. Such transposon-like elements may contain different functional genetic modules in their core regions, including plasmid replication systems. Another non-autonomous element "captured'' with a trap plasmid was a TIME derivative containing a predicted resolvase gene and a res site typical for many Tn3-family transposons. The identification of a portable site-specific recombination system is another intriguing example confirming the important role of non-autonomous TEs of the TIME family in shuffling genetic information in bacterial genomes. Transposition of such mosaic elements may have a significant impact on diversity and evolution, not only of transposons and plasmids, but also of other types of mobile genetic elements.	[Szuplewska, Magdalena; Ludwiczak, Marta; Lyzwa, Katarzyna; Czarnecki, Jakub; Bartosik, Dariusz] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland	University of Warsaw	Bartosik, D (corresponding author), Univ Warsaw, Fac Biol, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland.	bartosik@biol.uw.edu.pl		Czarnecki, Jakub/0000-0003-4372-5143; Bartosik, Dariusz/0000-0002-3589-8864; Szuplewska, Magdalena/0000-0003-1900-4995; Ludwiczak, Marta/0000-0002-5905-4498	National Science Centre, Poland [N N303 579238]	National Science Centre, Poland(National Science Centre, Poland)	This work was supported by the National Science Centre, Poland (grant N N303 579238). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AVILA P, 1988, J BACTERIOL, V170, P1350, DOI 10.1128/jb.170.3.1350-1353.1988; Aziz RK, 2010, NUCLEIC ACIDS RES, V38, P4207, DOI 10.1093/nar/gkq140; Bardaji L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025773; Bartosik D, 2001, J BACTERIOL, V183, P6234, DOI 10.1128/JB.183.21.6234-6243.2001; Bartosik D, 1998, MICROBIOL-UK, V144, P3149, DOI 10.1099/00221287-144-11-3149; Bartosik D, 2008, J BACTERIOL, V190, P3306, DOI 10.1128/JB.01878-07; Bechtel A, 2000, INT J EARTH SCI, V89, P72, DOI 10.1007/s005310050318; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Chandler M, 2008, MICROBE, V3, P445; Chandler M, 2002, MOBILE DNA, V2, P305; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Chen Y, 2008, GENETICS, V179, P2291, DOI 10.1534/genetics.108.089995; Christie-Oleza JA, 2010, J BACTERIOL, V192, P1423, DOI 10.1128/JB.01336-09; CORREIA FF, 1986, J BACTERIOL, V167, P1009, DOI 10.1128/jb.167.3.1009-1015.1986; CORREIA FF, 1988, J BIOL CHEM, V263, P12194; d'Hugues P, 2008, MINER ENG, V21, P111, DOI 10.1016/j.mineng.2007.10.004; De Gregorio E, 2005, J BACTERIOL, V187, P7945, DOI 10.1128/JB.187.23.7945-7954.2005; De Gregorio E, 2006, J BACTERIOL, V188, P7876, DOI 10.1128/JB.00942-06; De Palmenaer D, 2004, MOL MICROBIOL, V53, P457, DOI 10.1111/j.1365-2958.2004.04146.x; Delihas N, 2008, MOL MICROBIOL, V67, P475, DOI 10.1111/j.1365-2958.2007.06068.x; Delihas N, 2011, GENOME BIOL EVOL, V3, P959, DOI 10.1093/gbe/evr077; Dziewit L, 2007, J BACTERIOL, V189, P1983, DOI 10.1128/JB.01610-06; Dziewit L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032277; FISCHHOFF DA, 1980, J MOL BIOL, V144, P247, DOI 10.1016/0022-2836(80)90089-3; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; Grindley NDF, 2002, MOBILE DNA, P272; Haines AS, 2006, MICROBIOL-SGM, V152, P2689, DOI 10.1099/mic.0.28941-0; Haines AS, 2005, J BACTERIOL, V187, P4728, DOI 10.1128/JB.187.14.4728-4738.2005; ISHIZAKI K, 1985, MOL GEN GENET, V199, P388, DOI 10.1007/BF00330747; Kholodii GY, 1997, MICROBIOL-SGM, V143, P2549, DOI 10.1099/00221287-143-8-2549; Kushner SR, 1978, GENET ENG N Y, P17; Kwong SM, 1998, FEMS MICROBIOL LETT, V158, P159, DOI 10.1111/j.1574-6968.1998.tb12815.x; Lauf U, 1998, MOL GEN GENET, V259, P674, DOI 10.1007/s004380050862; Marx CJ, 2001, MICROBIOL-SGM, V147, P2065, DOI 10.1099/00221287-147-8-2065; Matlakowska R, 2009, J APPL MICROBIOL, V107, P858, DOI 10.1111/j.1365-2672.2009.04261.x; Mikosa M, 2006, MICROBIOL-SGM, V152, P1063, DOI 10.1099/mic.0.28603-0; Nagy Z, 2004, RES MICROBIOL, V155, P387, DOI 10.1016/j.resmic.2004.01.008; NAKATSU C, 1991, P NATL ACAD SCI USA, V88, P8312, DOI 10.1073/pnas.88.19.8312; Oszczepalski S, 1999, MINER DEPOSITA, V34, P599, DOI 10.1007/s001260050222; Peters M, 1997, APPL ENVIRON MICROB, V63, P4899, DOI 10.1128/AEM.63.12.4899-4906.1997; Qin XT, 2001, CURR MICROBIOL, V43, P158, DOI 10.1007/s002840010280; Rodriguez-Herva JJ, 2007, ENVIRON MICROBIOL, V9, P1550, DOI 10.1111/j.1462-2920.2007.01276.x; Sambrook J., 2001, MOL CLONING LAB MANU; Segura A, 2003, EXTREMOPHILES, V7, P371, DOI 10.1007/s00792-003-0331-x; SHERRATT D, 1989, MOBILE DNA, P163; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Sklodowska A, 2005, GEOMICROBIOL J, V22, P65, DOI 10.1080/01490450590922596; Stavrinides J, 2004, J BACTERIOL, V186, P5101, DOI [10.1128/JB.186.15.5101-5115.2004, 10.1128/jb.186.15.5101-5115.2004]; Szuplewska M, 2009, FEMS MICROBIOL LETT, V292, P216, DOI 10.1111/j.1574-6968.2009.01495.x; Thibodeau SA, 2004, BIOTECHNIQUES, V36, P410, DOI 10.2144/04363BM07; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Woo PCY, 2007, BIOTECHNOL LETT, V29, P1575, DOI 10.1007/s10529-007-9447-x; Yano H, 2010, J BACTERIOL, V192, P4337, DOI 10.1128/JB.00359-10; Yeo CC, 1998, FEMS MICROBIOL LETT, V165, P253, DOI 10.1016/S0378-1097(98)00286-9; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105010	10.1371/journal.pone.0105010	http://dx.doi.org/10.1371/journal.pone.0105010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121765	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000087
J	Zhang, K; Jin, CC; Wu, LZ; Hou, MY; Dou, SJ; Pan, YY				Zhang, Ke; Jin, Congcong; Wu, Lizhu; Hou, Mingyu; Dou, Shijuan; Pan, Yanyun			Expression Analysis of a Stress-Related Phosphoinositide-Specific Phospholipase C Gene in Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							PROLINE ACCUMULATION; SIGNAL-TRANSDUCTION; DROUGHT TOLERANCE; PLASMA-MEMBRANES; ABSCISIC-ACID; PI-PLC; CALCIUM; SALT; INVOLVEMENT; ACTIVATION	Plant phosphoinositide-specific phospholipases C ( PI-PLCs) function in several essential plant processes associated with either development or environmental stress. In this report, we examined the expression patterns of TaPLC1 under drought and high salinity stress at the transcriptional and post-transcriptional levels. TaPLC1 mRNA was expressed in all wheat organs examined. U73122 and edelfosine, the PLC inhibitor, impaired seedling growth and enhanced seedling sensitivity to drought and high salinity stress. Though TaPLC1 expression in wheat was lowest at the seedling stage, it was strongly induced under conditions of stress. When 6-day-old wheat seedlings were treated with 200 mM NaCl or 20% (w/v) PEG 6000 for 6 or 12 h, respectively, the TaPLC1 transcript level increased by 16-fold compared to the control. Western blotting showed that the TaPLC protein concentration was also maintained at a high level from 24 to 48 h during stress treatment. Together, our results indicate the possible biological functions of TaPLC1 in regulating seedling growth and the response to drought and salinity stress.	[Zhang, Ke; Jin, Congcong; Wu, Lizhu; Hou, Mingyu; Dou, Shijuan; Pan, Yanyun] Agr Univ Hebei, Coll Life Sci, Baoding, Peoples R China	Hebei Agricultural University	Pan, YY (corresponding author), Agr Univ Hebei, Coll Life Sci, Baoding, Peoples R China.	pyycell@163.com			National Natural Science Foundation of China [30570993]; Hebei Natural Science Foundation Program, Hebei Province, China [C2008000292]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hebei Natural Science Foundation Program, Hebei Province, China	This research was financially co-supported by the National Natural Science Foundation of China (Grant No. 30570993) and Hebei Natural Science Foundation Program, Hebei Province, China (No. C2008000292). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apone F, 2003, PLANT PHYSIOL, V133, P571, DOI 10.1104/pp.103.026005; Apostolakos P, 2008, CELL MOTIL CYTOSKEL, V65, P863, DOI 10.1002/cm.20308; Arisz SA, 2009, BBA-MOL CELL BIOL L, V1791, P869, DOI 10.1016/j.bbalip.2009.04.006; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Capriotti AL, 2013, ANAL BIOANAL CHEM, V405, P635, DOI 10.1007/s00216-011-5691-y; Dhindsa R.S., 1980, J EXP BOT, V32, P127; Djafi N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00307; Dowd PE, 2006, PLANT CELL, V18, P1438, DOI 10.1105/tpc.106.041582; Fleury D, 2010, J EXP BOT, V61, P3211, DOI 10.1093/jxb/erq152; Ghars MA, 2012, PLANT CELL PHYSIOL, V53, P183, DOI 10.1093/pcp/pcr164; Hegedus A, 2001, PLANT SCI, V160, P1085, DOI 10.1016/S0168-9452(01)00330-2; HIRAYAMA T, 1995, P NATL ACAD SCI USA, V92, P3903, DOI 10.1073/pnas.92.9.3903; Hou ChunYan, 2002, Acta Phytopathologica Sinica, V32, P147; Huang CH, 2009, PLANTA, V230, P925, DOI 10.1007/s00425-009-0990-7; HUANG CN, 1995, PLANT CELL REP, V14, P730, DOI 10.1007/BF00232657; Ischebeck T, 2010, PROTOPLASMA, V240, P13, DOI 10.1007/s00709-009-0093-0; JONES DL, 1995, PLANT CELL, V7, P1913, DOI 10.1105/tpc.7.11.1913; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Khalil HB, 2011, PLANT MOL BIOL, V77, P145, DOI 10.1007/s11103-011-9801-1; Kim YJ, 2004, FEBS LETT, V556, P127, DOI 10.1016/S0014-5793(03)01388-7; Kopka J, 1998, PLANT PHYSIOL, V116, P239, DOI 10.1104/pp.116.1.239; Li HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073380; Lin WH, 2004, CELL RES, V14, P34, DOI 10.1038/sj.cr.7290200; Liu HT, 2006, CELL RES, V16, P394, DOI 10.1038/sj.cr.7310051; Liu P, 2013, J EXP BOT, V64, P2915, DOI 10.1093/jxb/ert133; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; MELIN PM, 1992, BIOCHIM BIOPHYS ACTA, V1123, P163, DOI 10.1016/0005-2760(92)90107-7; Morran S, 2011, PLANT BIOTECHNOL J, V9, P230, DOI 10.1111/j.1467-7652.2010.00547.x; Munnik T, 2010, PLANT CELL ENVIRON, V33, P655, DOI 10.1111/j.1365-3040.2009.02097.x; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; Nakamura K, 2009, PLANT SIGNAL BEHAV, V4, P26, DOI 10.4161/psb.4.1.7222; Nevo E, 2010, PLANT CELL ENVIRON, V33, P670, DOI 10.1111/j.1365-3040.2009.02107.x; Pan YY, 2005, PLANT CELL PHYSIOL, V46, P1657, DOI 10.1093/pcp/pci181; Parre E, 2007, PLANT PHYSIOL, V144, P503, DOI 10.1104/pp.106.095281; PICAL C, 1992, PLANT PHYSIOL, V100, P1296, DOI 10.1104/pp.100.3.1296; PICAL C, 1997, PLANT PHYSIOL, V114, P747; Pokotylo I, 2014, BIOCHIMIE, V96, P144, DOI 10.1016/j.biochi.2013.07.004; Pokotylo I, 2013, PROG LIPID RES, V52, P62, DOI 10.1016/j.plipres.2012.09.001; Reggiani R, 2000, PLANT CELL PHYSIOL, V41, P1392, DOI 10.1093/pcp/pcd073; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SHI JR, 1995, PLANT J, V8, P381, DOI 10.1046/j.1365-313X.1995.08030381.x; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Takahashi S, 2001, PLANT CELL PHYSIOL, V42, P214, DOI 10.1093/pcp/pce028; Tasma IM, 2008, PLANT PHYSIOL BIOCH, V46, P627, DOI 10.1016/j.plaphy.2008.04.015; Tuteja N, 2007, METHOD ENZYMOL, V428, P419, DOI 10.1016/S0076-6879(07)28024-3; Vergnolle C, 2005, PLANT PHYSIOL, V139, P1217, DOI 10.1104/pp.105.068171; Vermeer JEM, 2009, PLANT J, V57, P356, DOI 10.1111/j.1365-313X.2008.03679.x; Vossen JH, 2010, PLANT J, V62, P224, DOI 10.1111/j.1365-313X.2010.04136.x; Wang CR, 2008, PLANTA, V227, P1127, DOI 10.1007/s00425-007-0686-9; Wong R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-15; YAMAMOTO YT, 1995, PLANT PHYSIOL, V107, P1029, DOI 10.1104/pp.107.3.1029; Zhang ZA, 2004, PLANT PHYSL EXPT GUI, P54	52	13	20	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105061	10.1371/journal.pone.0105061	http://dx.doi.org/10.1371/journal.pone.0105061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121594	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000093
J	Liu, X; Yuan, H; Peres, L; Chen, SJ; Chen, Z; de The, HG; Zhou, J; Zhu, J				Liu, Xi; Yuan, Hao; Peres, Laurent; Chen, Saijuan; Chen, Zhu; de The, Hugues; Zhou, Jun; Zhu, Jun			The DNA Binding Property of PML/RARA but Not the Integrity of PML Nuclear Bodies Is Indispensable for Leukemic Transformation	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; RETINOIC ACID RECEPTOR; ALPHA FUSION PROTEIN; RAR-ALPHA; HISTONE DEACETYLASE; DIFFERENTIATION; ELEMENT; RXR; DIMERIZATION; HOMODIMERS	PML/RARA is the oncoprotein driving acute promyelocytic leukemia (APL). It suppresses genes expression by recruitment of a number of transcriptional repressors, resulting in differentiation block and malignant transformation of hematopoietic cells. Here, we found that mice primary hematopoietic progenitor cells (HPCs), transduced by DNA-binding-defective PML/RARA mutants, were deficient in colony formation. Further experiments showed that DNA-binding-defective PML/RARA mutants could not repress the transcription of retinoic acid regulated genes. Intriguingly, there were no significant differences of the micro-speckled intracellular distribution between the mutants and wild-type PML/RARA. Some retinoic acid target genes regulated by PML/RARA are involved in not only differentiation block but also hematopoietic cell self-renewal. Altogether, our data demonstrate that direct DNA-binding is essential for PML/RARA to immortalize hematopoietic cells, while disruption of PML-nuclear body does not seem to be a prerequisite for hematopoietic cell transformation.	[Liu, Xi; Yuan, Hao; Chen, Saijuan; Chen, Zhu; de The, Hugues; Zhou, Jun; Zhu, Jun] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp,CNRS LIA 124, State Key Lab Med Genom,Sino French Res Ctr Life, Shanghai 200030, Peoples R China; [Peres, Laurent; de The, Hugues; Zhu, Jun] Univ Paris 07, Hop St Louis, INSERM, Equipe Labellisee Ligue Natl Contre Canc 11,CNRS, Paris, France	Chinese Academy of Sciences; Shanghai Jiao Tong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Zhou, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp,CNRS LIA 124, State Key Lab Med Genom,Sino French Res Ctr Life, Shanghai 200030, Peoples R China.	junjun_j@yahoo.com; zhuj1966@yahoo.com			National Basic Research Program of China (973 Program) [2012CB910300]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by The National Basic Research Program of China (973 Program) (2012CB910300), JZ. The National Natural Science Foundation of China (81070434), JZ. The Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedetti L, 1996, BLOOD, V87, P1939; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Du CC, 1999, BLOOD, V94, P793, DOI 10.1182/blood.V94.2.793.414k43_793_802; DURAND B, 1994, EMBO J, V13, P5370, DOI 10.1002/j.1460-2075.1994.tb06872.x; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Grignani F, 1996, EMBO J, V15, P4949, DOI 10.1002/j.1460-2075.1996.tb00875.x; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; JANSEN JH, 1995, P NATL ACAD SCI USA, V92, P7401, DOI 10.1073/pnas.92.16.7401; Kamashev D, 2004, J EXP MED, V199, P1163, DOI 10.1084/jem.20032226; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Lin RJ, 2001, ONCOGENE, V20, P7204, DOI 10.1038/sj.onc.1204853; Lin RJ, 2000, MOL CELL, V5, P821, DOI 10.1016/S1097-2765(00)80322-6; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; PEREZ A, 1993, EMBO J, V12, P3171, DOI 10.1002/j.1460-2075.1993.tb05986.x; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; van Wageningen S, 2008, BLOOD, V111, P1634, DOI 10.1182/blood-2007-04-081125; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Wang KK, 2010, CANCER CELL, V17, P186, DOI 10.1016/j.ccr.2009.12.045; Wang ZG, 1998, SCIENCE, V279, P1547; WARRELL RP, 1993, BLOOD, V82, P1949, DOI 10.1182/blood.V82.7.1949.bloodjournal8271949; Yan JS, 2010, P NATL ACAD SCI USA, V107, P3716, DOI 10.1073/pnas.0915006107; Zhong S, 2000, J EXP MED, V191, P631, DOI 10.1084/jem.191.4.631; Zhou J, 2006, P NATL ACAD SCI USA, V103, P9238, DOI 10.1073/pnas.0603324103; Zhu J, 2005, CANCER CELL, V7, P143, DOI 10.1016/j.ccr.2005.01.005; Zhu J, 1999, P NATL ACAD SCI USA, V96, P14807, DOI 10.1073/pnas.96.26.14807; Zhu J, 2007, CANCER CELL, V12, P23, DOI 10.1016/j.ccr.2007.06.004	31	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104906	10.1371/journal.pone.0104906	http://dx.doi.org/10.1371/journal.pone.0104906			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119106	gold, Green Submitted, Green Published			2022-12-27	WOS:000340900600103
J	Mukherjee, AK; Kalita, B; Thakur, R				Mukherjee, Ashis K.; Kalita, Bhargab; Thakur, Rupamoni			Two Acidic, Anticoagulant PLA(2) Isoenzymes Purified from the Venom of Monocled Cobra Naja kaouthia Exhibit Different Potency to Inhibit Thrombin and Factor Xa via Phospholipids Independent, Non-Enzymatic Mechanism	PLOS ONE			English	Article							DABOIA-RUSSELII-RUSSELII; SNAKE-VENOM; MEMBRANE PHOSPHOLIPIDS; BOTHROPS-ASPER; A(2); BINDING; PROTHROMBINASE; HYDROLYSIS; PROTEINS	Background: The monocled cobra (Naja kaouthia) is responsible for snakebite fatality in Indian subcontinent and in south-western China. Phospholipase A(2) (PLA(2); EC 3.1.1.4) is one of the toxic components of snake venom. The present study explores the mechanism and rationale(s) for the differences in anticoagulant potency of two acidic PLA(2) isoenzymes, Nk-PLA(2)alpha (13463.91 Da) and Nk-PLA(2)beta (13282.38 Da) purified from the venom of N. kaouthia. Principal Findings: By LC-MS/MS analysis, these PLA(2)s showed highest similarity (23.5% sequence coverage) with PLA(2) III isolated from monocled cobra venom. The catalytic activity of Nk-PLA(2)beta exceeds that of Nk-PLA(2)alpha. Heparin differentially regulated the catalytic and anticoagulant activities of these Nk-PLA(2) isoenzymes. The anticoagulant potency of Nk-PLA(2)alpha was comparable to commercial anticoagulants warfarin, and heparin/antithrombin-III albeit Nk-PLA(2)beta demonstrated highest anticoagulant activity. The anticoagulant action of these PLA(2)s was partially contributed by a small but specific hydrolysis of plasma phospholipids. The strong anticoagulant effect of Nk-PLA(2)alpha and Nk-PLA(2)beta was achieved via preferential, non-enzymatic inhibition of FXa (Ki = 43 nM) and thrombin (Ki = 8.3 nM), respectively. Kinetics study suggests that the Nk-PLA(2) isoenzymes inhibit their "pharmacological target(s)" by uncompetitive mechanism without the requirement of phospholipids/Ca2+. The anticoagulant potency of Nk-PLA(2)beta which is higher than that of Nk-PLA(2)alpha is corroborated by its superior catalytic activity, its higher capacity for binding to phosphatidylcholine, and its greater strength of thrombin inhibition. These PLA(2) isoenzymes thus have evolved to affect haemostasis by different mechanisms. The Nk-PLA(2)beta partially inhibited the thrombin-induced aggregation of mammalian platelets suggesting its therapeutic application in the prevention of unwanted clot formation. Conclusion/Significance: In order to develop peptide-based superior anticoagulant therapeutics, future application of Nk-PLA(2)alpha and Nk-PLA(2)beta for the treatment and/or prevention of cardiovascular disorders are proposed.	[Mukherjee, Ashis K.; Kalita, Bhargab; Thakur, Rupamoni] Tezpur Univ, Sch Sci, Dept Mol Biol & Biotechnol, Microbial Biotechnol & Prot Res Lab, Tezpur, Assam, India	Tezpur University	Mukherjee, AK (corresponding author), Tezpur Univ, Sch Sci, Dept Mol Biol & Biotechnol, Microbial Biotechnol & Prot Res Lab, Tezpur, Assam, India.	akm@tezu.ernet.in	Kalita, Bhargab/AAX-4351-2021	Kalita, Bhargab/0000-0002-1878-219X				BJORK I, 1982, MOL CELL BIOCHEM, V48, P161, DOI 10.1007/BF00421226; CONDREA E, 1981, THROMB HAEMOSTASIS, V45, P82; DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6; Doley R, 2004, ARCH BIOCHEM BIOPHYS, V425, P1, DOI 10.1016/j.abb.2004.02.007; Doley R, 2003, TOXICON, V41, P81, DOI 10.1016/S0041-0101(02)00213-1; DUA R, 1994, EUR J BIOCHEM, V221, P481, DOI 10.1111/j.1432-1033.1994.tb18761.x; Faure G, 2011, ACTA CHIM SLOV, V58, P671; FENTON JW, 1993, HEMATOL ONCOL CLIN N, V7, P1107, DOI 10.1016/S0889-8588(18)30201-6; Hylek EM, 2004, CARDIOVASC INTERVEN, V1, P62; Jacomella V, 2013, CURR OPIN PHARMACOL, V13, P1; Kini RM, 2006, BIOCHEM J, V397, P377, DOI 10.1042/BJ20060302; Koh CY, 2012, TOXICON, V59, P497, DOI 10.1016/j.toxicon.2011.03.017; LOMONTE B, 1994, BIOCHEM PHARMACOL, V47, P1509, DOI 10.1016/0006-2952(94)90525-8; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mounier CM, 1998, J BIOL CHEM, V273, P23764, DOI 10.1074/jbc.273.37.23764; Mukherjee AK, 2002, COMP BIOCHEM PHYS B, V131, P125, DOI 10.1016/S1096-4959(01)00473-0; Mukherjee AK, 2007, BBA-GEN SUBJECTS, V1770, P187, DOI 10.1016/j.bbagen.2006.09.021; Mukherjee AK, 2014, INT J BIOL MACROMOL, V67, P154, DOI 10.1016/j.ijbiomac.2014.02.058; Mukherjee AK, 2014, BIOCHIMIE, V99, P153, DOI 10.1016/j.biochi.2013.11.026; Mukherjee AK, 2013, BBA-GEN SUBJECTS, V1830, P3476, DOI 10.1016/j.bbagen.2013.02.007; Osipov AV, 2010, TOXICON, V55, P186, DOI 10.1016/j.toxicon.2009.07.011; Pulcinelli FM, 2004, J AM COLL CARDIOL, V43, P979, DOI 10.1016/j.jacc.2003.08.062; Pungercar J, 2007, TOXICON, V50, P871, DOI 10.1016/j.toxicon.2007.07.025; Saikia D, 2013, TOXICON, V76, P291, DOI 10.1016/j.toxicon.2013.10.001; Saikia D, 2012, BBA-BIOMEMBRANES, V1818, P3149, DOI 10.1016/j.bbamem.2012.08.005; Saikia D, 2011, TOXICON, V57, P841, DOI 10.1016/j.toxicon.2011.02.018; Saul FA, 2010, J STRUCT BIOL, V169, P360, DOI 10.1016/j.jsb.2009.10.010; STEFANSSON S, 1990, BIOCHEMISTRY-US, V29, P7742, DOI 10.1021/bi00485a024; VERHEIJ HM, 1980, EUR J BIOCHEM, V112, P25, DOI 10.1111/j.1432-1033.1980.tb04982.x; Zingali RB, 2007, TOXIN REV, V26, P25, DOI 10.1080/15569540600567412	30	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e101334	10.1371/journal.pone.0101334	http://dx.doi.org/10.1371/journal.pone.0101334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118676	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600004
J	Takeshima, Y; Gyoba, J				Takeshima, Yasuhiro; Gyoba, Jiro			Hemispheric Asymmetry in the Auditory Facilitation Effect in Dual-Stream Rapid Serial Visual Presentation Tasks	PLOS ONE			English	Article							ATTENTIONAL BLINK; MULTISENSORY INTEGRATION; CROSSMODAL FACILITATION; REPETITION BLINDNESS; SUPERIOR COLLICULUS; HUMAN V1; PERCEPTION; SOUND; CORTEX; STIMULI	Even though auditory stimuli do not directly convey information related to visual stimuli, they often improve visual detection and identification performance. Auditory stimuli often alter visual perception depending on the reliability of the sensory input, with visual and auditory information reciprocally compensating for ambiguity in the other sensory domain. Perceptual processing is characterized by hemispheric asymmetry. While the left hemisphere is more involved in linguistic processing, the right hemisphere dominates spatial processing. In this context, we hypothesized that an auditory facilitation effect in the right visual field for the target identification task, and a similar effect would be observed in the left visual field for the target localization task. In the present study, we conducted target identification and localization tasks using a dual-stream rapid serial visual presentation. When two targets are embedded in a rapid serial visual presentation stream, the target detection or discrimination performance for the second target is generally lower than for the first target; this deficit is well known as attentional blink. Our results indicate that auditory stimuli improved target identification performance for the second target within the stream when visual stimuli were presented in the right, but not the left visual field. In contrast, auditory stimuli improved second target localization performance when visual stimuli were presented in the left visual field. An auditory facilitation effect was observed in perceptual processing, depending on the hemispheric specialization. Our results demonstrate a dissociation between the lateral visual hemifield in which a stimulus is projected and the kind of visual judgment that may benefit from the presentation of an auditory cue.	[Takeshima, Yasuhiro; Gyoba, Jiro] Tohoku Univ, Grad Sch Arts & Letters, Dept Psychol, Sendai, Miyagi 980, Japan	Tohoku University	Takeshima, Y (corresponding author), Tohoku Univ, Grad Sch Arts & Letters, Dept Psychol, Sendai, Miyagi 980, Japan.	yasuhiro.takeshima@gmail.com		Takeshima, Yasuhiro/0000-0002-7777-2952; Gyoba, Jiro/0000-0003-4198-6323	JSPS [26330306];  [24-4354]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This study was supported by a Grant-in-Aid for JSPS (Japan Society for the Promotion of Science) Fellows to YT (24-4354) and partially by a JSPS Grant-in-Aid for Scientific Research (C) (26330306) to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; Asanowicz D, 2012, BRAIN COGNITION, V79, P117, DOI 10.1016/j.bandc.2012.02.014; Bolognini N, 2005, EXP BRAIN RES, V160, P273, DOI 10.1007/s00221-004-2005-z; Busse L, 2005, P NATL ACAD SCI USA, V102, P18751, DOI 10.1073/pnas.0507704102; Chen YC, 2008, PSYCHON B REV, V15, P404, DOI 10.3758/PBR.15.2.404; Chen YC, 2011, J EXP PSYCHOL HUMAN, V37, P1784, DOI 10.1037/a0025638; Chen YC, 2009, EXP BRAIN RES, V198, P209, DOI 10.1007/s00221-009-1831-4; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Clavagnier S, 2004, COGN AFFECT BEHAV NE, V4, P117, DOI 10.3758/CABN.4.2.117; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dell'Acqua R, 2006, PSYCHOPHYSIOLOGY, V43, P394, DOI 10.1111/j.1469-8986.2006.00411.x; Du F, 2010, BRAIN COGNITION, V72, P310, DOI 10.1016/j.bandc.2009.10.006; Falchier A, 2002, J NEUROSCI, V22, P5749; Fink GR, 1997, P ROY SOC B-BIOL SCI, V264, P487, DOI 10.1098/rspb.1997.0070; Frassinetti F, 2002, EXP BRAIN RES, V147, P332, DOI 10.1007/s00221-002-1262-y; GEFFEN G, 1972, J EXP PSYCHOL, V95, P25, DOI 10.1037/h0033265; Han SH, 2002, NEUROIMAGE, V17, P1290, DOI 10.1006/nimg.2002.1255; Heilman KM, 2012, INT J CLIN NEUROPSYC, P296; HELLIGE JB, 1980, J EXP PSYCHOL HUMAN, V6, P639; Hollander A, 2005, J INT NEUROPSYCH SOC, V11, P263, DOI 10.1017/S1355617705050319; Hollander A, 2005, NEUROPSYCHOLOGIA, V43, P35, DOI 10.1016/j.neuropsychologia.2004.06.006; KANWISHER NG, 1987, COGNITION, V27, P117, DOI 10.1016/0010-0277(87)90016-3; KIMURA D, 1969, CAN J PSYCHOLOGY, V23, P445, DOI 10.1037/h0082830; KIMURA D, 1966, NEUROPSYCHOLOGIA, V4, P275, DOI 10.1016/0028-3932(66)90033-9; MEREDITH MA, 1992, EXP BRAIN RES, V88, P181, DOI 10.1007/BF02259139; Mishra J, 2007, J NEUROSCI, V27, P4120, DOI 10.1523/JNEUROSCI.4912-06.2007; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Ngo MK, 2010, ATTEN PERCEPT PSYCHO, V72, P1938, DOI 10.3758/APP.72.7.1938; Nicholls M E, 1996, Laterality, V1, P97; O'Boyle M W, 1982, Brain Cogn, V1, P224, DOI 10.1016/0278-2626(82)90019-7; Okubo M, 2008, BRAIN COGNITION, V66, P168, DOI 10.1016/j.bandc.2007.07.002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olivers CNL, 2008, BRAIN RES, V1242, P191, DOI 10.1016/j.brainres.2008.01.070; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; ROBERTSON LC, 1991, COGNITIVE PSYCHOL, V23, P299, DOI 10.1016/0010-0285(91)90012-D; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Sanabria D, 2007, COGNITION, V102, P299, DOI 10.1016/j.cognition.2006.01.003; Serences JT, 2007, CEREB CORTEX, V17, P284, DOI 10.1093/cercor/bhj146; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; SHIPLEY T, 1964, SCIENCE, V145, P1328, DOI 10.1126/science.145.3638.1328; Spence C, 2007, ACOUST SCI TECHNOL, V28, P61, DOI 10.1250/ast.28.61; STEIN BE, 1988, BRAIN RES, V448, P355, DOI 10.1016/0006-8993(88)91276-0; SWISHER L, 1972, NEUROPSYCHOLOGIA, V10, P137, DOI 10.1016/0028-3932(72)90053-X; Takeshima Y, 2013, JPN J PSYCHONOMIC SC, V32, P139; Takeshima Y, 2013, MULTISENS RES, V26, P317, DOI 10.1163/22134808-00002422; Takeshima Y, 2013, ATTEN PERCEPT PSYCHO, V75, P501, DOI 10.3758/s13414-012-0403-z; UMILTA C, 1974, NEUROPSYCHOLOGIA, V12, P165, DOI 10.1016/0028-3932(74)90001-3; Van der Burg E, 2011, NEUROIMAGE, V55, P1208, DOI 10.1016/j.neuroimage.2010.12.068; Verleger R, 2010, EXP BRAIN RES, V203, P355, DOI 10.1007/s00221-010-2237-z; Verleger R, 2009, J COGNITIVE NEUROSCI, V21, pD; Visser TAW, 2007, J EXP PSYCHOL HUMAN, V33, P285, DOI 10.1037/0096-1523.33.2.285; Vogel EK, 1998, J EXP PSYCHOL HUMAN, V24, P1656, DOI 10.1037/0096-1523.24.6.1656; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Wada Y, 2003, INT J PSYCHOPHYSIOL, V50, P117, DOI 10.1016/S0167-8760(03)00128-4; Wallace MT, 1998, J NEUROPHYSIOL, V80, P1006, DOI 10.1152/jn.1998.80.2.1006; Watkins S, 2007, NEUROIMAGE, V37, P572, DOI 10.1016/j.neuroimage.2007.05.027; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	60	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104131	10.1371/journal.pone.0104131	http://dx.doi.org/10.1371/journal.pone.0104131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9BM	25119997	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600038
J	Garcia, PA; Davalos, RV; Miklavcic, D				Garcia, Paulo A.; Davalos, Rafael V.; Miklavcic, Damijan			A Numerical Investigation of the Electric and Thermal Cell Kill Distributions in Electroporation-Based Therapies in Tissue	PLOS ONE			English	Article							PERCUTANEOUS IRREVERSIBLE ELECTROPORATION; IN-VIVO; FIELD DISTRIBUTION; TUMOR ABLATION; ELECTROCHEMOTHERAPY; SAFETY; MODEL; MECHANISMS; METASTASES; PRINCIPLES	Electroporation-based therapies are powerful biotechnological tools for enhancing the delivery of exogeneous agents or killing tissue with pulsed electric fields (PEFs). Electrochemotherapy (ECT) and gene therapy based on gene electrotransfer (EGT) both use reversible electroporation to deliver chemotherapeutics or plasmid DNA into cells, respectively. In both ECT and EGT, the goal is to permeabilize the cell membrane while maintaining high cell viability in order to facilitate drug or gene transport into the cell cytoplasm and induce a therapeutic response. Irreversible electroporation (IRE) results in cell kill due to exposure to PEFs without drugs and is under clinical evaluation for treating otherwise unresectable tumors. These PEF therapies rely mainly on the electric field distributions and do not require changes in tissue temperature for their effectiveness. However, in immediate vicinity of the electrodes the treatment may results in cell kill due to thermal damage because of the inhomogeneous electric field distribution and high current density during the electroporation-based therapies. Therefore, the main objective of this numerical study is to evaluate the influence of pulse number and electrical conductivity in the predicted cell kill zone due to irreversible electroporation and thermal damage. Specifically, we simulated a typical IRE protocol that employs ninety 100-mu s PEFs. Our results confirm that it is possible to achieve predominant cell kill due to electroporation if the PEF parameters are chosen carefully. However, if either the pulse number and/or the tissue conductivity are too high, there is also potential to achieve cell kill due to thermal damage in the immediate vicinity of the electrodes. Therefore, it is critical for physicians to be mindful of placement of electrodes with respect to critical tissue structures and treatment parameters in order to maintain the non-thermal benefits of electroporation and prevent unnecessary damage to surrounding healthy tissue, critical vascular structures, and/or adjacent organs.	[Garcia, Paulo A.; Davalos, Rafael V.] Wake Forest Univ, Virginia Tech, Bioelectromech Syst Lab, Blacksburg, VA USA; [Miklavcic, Damijan] Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia	Virginia Polytechnic Institute & State University; Wake Forest University; University of Ljubljana	Miklavcic, D (corresponding author), Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia.	damijan.miklavcic@fe.uni-lj.si	Miklavčič, Damijan/A-9497-2008	Miklavčič, Damijan/0000-0003-3506-9449	Slovenian Research agency; NSF CAREER [1055913]	Slovenian Research agency(Slovenian Research Agency - Slovenia); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was in part supported by Slovenian Research agency. It has been performed within the scope of LEA EBAM. The study was made possible due to networking efforts of the COST TD1104 action (www.electroporation.net). The authors would also like to acknowledge the NSF CAREER 1055913 for partial support (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2011, RADIOLOGY, V258, P351, DOI 10.1148/radiol.10081634; Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Appelbaum L, 2012, RADIOLOGY, V262, P117, DOI 10.1148/radiol.11110475; Arena CB, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025334; Ben-David E, 2012, AM J ROENTGENOL, V198, pW62, DOI 10.2214/AJR.11.6940; Canatella PJ, 2001, BIOPHYS J, V80, P755, DOI 10.1016/S0006-3495(01)76055-9; Cannon R, 2013, J SURG ONCOL, V107, P544, DOI 10.1002/jso.23280; Chang IA, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-27; Cheung W, 2013, TECHNOL CANCER RES T, V12, P233, DOI 10.7785/tcrt.2012.500317; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; Corovic S, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-16; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; Davalos RV, 2008, INT J HEAT MASS TRAN, V51, P5617, DOI 10.1016/j.ijheatmasstransfer.2008.04.046; Davalos RV, 2003, BIOELECTROCHEMISTRY, V61, P99, DOI 10.1016/j.bioelechem.2003.07.001; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Deipolyi AR, 2014, DIAGN INTERV RADIOL, V20, P147, DOI 10.5152/dir.2013.13304; Deodhar A, 2011, CARDIOVASC INTER RAD, V34, P1278, DOI 10.1007/s00270-011-0143-9; Deodhar A, 2011, AM J ROENTGENOL, V196, pW330, DOI 10.2214/AJR.10.4490; Deodhar A, 2011, UROLOGY, V77, P754, DOI 10.1016/j.urology.2010.08.036; Duck F.A., 1990, MED PHYS, V18; Edd JF, 2007, TECHNOL CANCER RES T, V6, P275, DOI 10.1177/153303460700600403; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Edhemovic I, 2011, TECHNOL CANCER RES T, V10, P475, DOI 10.7785/tcrt.2012.500224; Edhemovic I, 2014, J SURG ONCOL, V110, P320, DOI 10.1002/jso.23625; Ellis TL, 2011, J NEUROSURG, V114, P681, DOI 10.3171/2010.5.JNS091448; Faroja M, 2013, RADIOLOGY, V266, P462, DOI 10.1148/radiol.12120609; Garcia PA, 2011, TECHNOL CANCER RES T, V10, P73, DOI 10.7785/tcrt.2012.500181; Garcia PA, 2012, IEEE ENG MED BIO, P2575, DOI 10.1109/EMBC.2012.6346490; Garcia PA, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-34; Garcia PA, 2010, J MEMBRANE BIOL, V236, P127, DOI 10.1007/s00232-010-9284-z; GLASER RW, 1988, BIOCHIM BIOPHYS ACTA, V940, P275, DOI 10.1016/0005-2736(88)90202-7; Golberg A, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-13; Ivorra A, 2011, ANN BIOMED ENG, V39, P2080, DOI 10.1007/s10439-011-0295-4; Jarm T, 2010, EXPERT REV ANTICANC, V10, P729, DOI 10.1586/ERA.10.43; Jourabchi N, 2014, GASTROINTESTINAL INT, V3, P8, DOI [DOI 10.1016/J.GII.2014.02.002, 10.1016/j.gii.2014.02.002]; Jourabchi N, 2014, GASTROINTESTINAL INT; Kim BM, 1996, IEEE J SEL TOP QUANT, V2, P922, DOI 10.1109/2944.577317; KINOSITA K, 1977, NATURE, V268, P438, DOI 10.1038/268438a0; Kos B, 2010, J MEMBRANE BIOL, V236, P147, DOI 10.1007/s00232-010-9274-1; Kotnik T, 2012, IEEE ELECTR INSUL M, V28, P14, DOI 10.1109/MEI.2012.6268438; Kurata K, 2014, INT J HEAT MASS TRAN, V72, P66, DOI 10.1016/j.ijheatmasstransfer.2013.12.065; Lackovic I, 2009, IEEE T DIELECT EL IN, V16, P1338, DOI 10.1109/TDEI.2009.5293947; Lee EW, 2007, TECHNOL CANCER RES T, V6, P287, DOI 10.1177/153303460700600404; Lee RC, 2005, ANN NY ACAD SCI, V1066, P85, DOI 10.1196/annals.1363.007; Lee Raphael C., 1993, Journal of Burn Care and Rehabilitation, V14, P528, DOI 10.1097/00004630-199309000-00007; Lee RC, 2000, ANNU REV BIOMED ENG, V2, P477, DOI 10.1146/annurev.bioeng.2.1.477; Maglietti F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080167; Mali B, 2013, EJSO-EUR J SURG ONC, V39, P4, DOI 10.1016/j.ejso.2012.08.016; Martin RCG, 2012, J AM COLL SURGEONS, V215, P361, DOI 10.1016/j.jamcollsurg.2012.05.021; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Miklavcic D, 2000, BBA-GEN SUBJECTS, V1523, P73, DOI 10.1016/S0304-4165(00)00101-X; Miklavcic D, 2005, BIOELECTROCHEMISTRY, V65, P121, DOI 10.1016/j.bioelechem.2004.07.004; Miklavcic D, 1998, BIOPHYS J, V74, P2152, DOI 10.1016/S0006-3495(98)77924-X; Miklavcic D, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-10; MIR LM, 1991, CR ACAD SCI III-VIE, V313, P613; Narayanan G, 2012, J VASC INTERV RADIOL, V23, P1613, DOI 10.1016/j.jvir.2012.09.012; Neal RE, 2014, PROSTATE, V74, P458, DOI 10.1002/pros.22760; Neal RE, 2012, IEEE T BIO-MED ENG, V59, P1076, DOI 10.1109/TBME.2012.2182994; Neal RE, 2011, J CLIN ONCOL, V29, pE372, DOI 10.1200/JCO.2010.33.0902; Olweny EO, 2013, UROLOGY, V81, P679, DOI 10.1016/j.urology.2012.11.026; Onik G, 2007, TECHNOL CANCER RES T, V6, P295, DOI 10.1177/153303460700600405; Pakhomova ON, 2013, J CELL MOL MED, V17, P154, DOI 10.1111/j.1582-4934.2012.01658.x; Pearce JA, 2009, SPIE ENERGY BASED TR, V7181; Pliquett U, 2003, MED BIOL ENG COMPUT, V41, P215, DOI 10.1007/BF02344892; Pucihar G, 2002, BIOELECTROCHEMISTRY, V57, P167, DOI 10.1016/S1567-5394(02)00116-0; Pucihar G, 2011, IEEE T BIO-MED ENG, V58, P3279, DOI 10.1109/TBME.2011.2167232; Qin ZP, 2013, ANN BIOMED ENG, V41, P619, DOI 10.1007/s10439-012-0686-1; Rebersek M, 2014, IEEE ELECTR INSUL M, V30, P8, DOI 10.1109/MEI.2014.6804737; Rossmeisl JH, 2013, J VET SCI, V14, P433, DOI 10.4142/jvs.2013.14.4.433; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P255, DOI 10.1177/153303460700600401; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; Scheffer HJ, 2014, J VASC INTERV RADIOL, V25, P997, DOI 10.1016/j.jvir.2014.01.028; Sel D, 2005, IEEE T BIO-MED ENG, V52, P816, DOI 10.1109/TBME.2005.845212; Sersa G, 2008, EJSO-EUR J SURG ONC, V34, P232, DOI 10.1016/j.ejso.2007.05.016; Sersa G, 2008, BRIT J CANCER, V98, P388, DOI 10.1038/sj.bjc.6604168; Shafiee H, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3143027; Sherar MD, 2000, PHYS MED BIOL, V45, P3563, DOI 10.1088/0031-9155/45/12/304; Thomsen S, 2011, OPTICAL THERMAL RESPONSE OF LASER-IRRADIATED TISSUE, SECOND EDITION, P487, DOI 10.1007/978-90-481-8831-4_13; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; WEAVER JC, 1993, J CELL BIOCHEM, V51, P426, DOI 10.1002/jcb.2400510407; Yarmush ML, 2014, ANNU REV BIOMED ENG, V16, P295, DOI 10.1146/annurev-bioeng-071813-104622; Zupanic A, 2012, PHYS MED BIOL, V57, P5425, DOI 10.1088/0031-9155/57/17/5425	83	113	116	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103083	10.1371/journal.pone.0103083	http://dx.doi.org/10.1371/journal.pone.0103083			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115970	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400011
J	Grootjans-van Kampen, I; Engelfriet, PM; van Baal, PHM				Grootjans-van Kampen, Inge; Engelfriet, Peter M.; van Baal, Pieter H. M.			Disease Prevention: Saving Lives or Reducing Health Care Costs?	PLOS ONE			English	Article							EXPENDITURE; POPULATION	Background: Disease prevention has been claimed to reduce health care costs. However, preventing lethal diseases increases life expectancy and, thereby, indirectly increases the demand for health care. Previous studies have argued that on balance preventing diseases that reduce longevity increases health care costs while preventing non-fatal diseases could lead to health care savings. The objective of this research is to investigate if disease prevention could result in both increased longevity and lower lifetime health care costs. Methods: Mortality rates for Netherlands in 2009 were used to construct cause-deleted life tables. Data originating from the Dutch Costs of Illness study was incorporated in order to estimate lifetime health care costs in the absence of selected disease categories. We took into account that for most diseases health care expenditures are concentrated in the last year of life. Results: Elimination of diseases that reduce life expectancy considerably increase lifetime health care costs. Exemplary are neoplasms that, when eliminated would increase both life expectancy and lifetime health care spending with roughly 5% for men and women. Costs savings are incurred when prevention has only a small effect on longevity such as in the case of mental and behavioural disorders. Diseases of the circulatory system stand out as their elimination would increase life expectancy while reducing health care spending. Conclusion: The stronger the negative impact of a disease on longevity, the higher health care costs would be after elimination. Successful treatment of fatal diseases leaves less room for longevity gains due to effective prevention but more room for health care savings.	[Grootjans-van Kampen, Inge] Tech Univ, Delft, Netherlands; [Engelfriet, Peter M.] Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, Bilthoven, Netherlands; [van Baal, Pieter H. M.] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands	Erasmus University Rotterdam	van Baal, PHM (corresponding author), Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, Netherlands.	vanbaal@bmg.eur.nl		van Baal, Pieter/0000-0001-9913-2393	Network for Studies on Pensions, Aging and Retirement (NETSPAR)	Network for Studies on Pensions, Aging and Retirement (NETSPAR)	The contributions of author Pieter van Baal were supported by the Network for Studies on Pensions, Aging and Retirement (NETSPAR www.netspar.nl) as part of the project "Rising life expectancy: causes and consequences in the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barendregt JJ, 1997, NEW ENGL J MED, V337, P1052, DOI 10.1056/NEJM199710093371506; Bonneux L, 1998, BRIT MED J, V316, P26, DOI 10.1136/bmj.316.7124.26; Engelfriet PM, 2011, EUR J HEART FAIL, V13, P377, DOI 10.1093/eurjhf/hfq223; FRIES JF, 1993, NEW ENGL J MED, V329, P321, DOI 10.1056/NEJM199307293290506; Kanters TA, 2013, SOC SCI MED, V76, P150, DOI 10.1016/j.socscimed.2012.10.019; Kommer GJ, 2006, TRENDS VERKENNIGEN K; Lansdorp-Vogelaar I, 2012, JNCI, V101, P1412; Longman Philip, 1987, BORN PAY NEW POLITIC; Nauta ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026917; OECD, 2011, PROV PAY LONG TERM C; Poos MJ, 2008, COST ILNESS NETHERLA; Robine JM, 1999, B WORLD HEALTH ORGAN, V77, P181; Seshamani M, 2004, HEALTH ECON, V13, P303, DOI 10.1002/hec.826; Statistics Netherlands, 2011, CAUS DEATH MAIN PRIM; van Baal PHM, 2008, PLOS MED, V5, P242, DOI 10.1371/journal.pmed.0050029; van Baal PHM, 2011, PHARMACOECONOMICS, V29, P175, DOI 10.2165/11586130-000000000-00000; Van der Meulen A, 2004, STAT NETHERLANDS BEV, V1, P34; Van Duin C, 2011, BEVOLKINGSTRENDS, V2, P28; Werblow A, 2007, HEALTH ECON, V16, P1109, DOI 10.1002/hec.1213; Wong A, 2011, HEALTH ECON, V20, P379, DOI 10.1002/hec.1597; Zweifel P, 1999, HEALTH ECON, V8, P485, DOI 10.1002/(SICI)1099-1050(199909)8:6<485::AID-HEC461>3.0.CO;2-4	21	13	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104469	10.1371/journal.pone.0104469	http://dx.doi.org/10.1371/journal.pone.0104469			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LJ	25116681	Green Published, gold			2022-12-27	WOS:000341230400052
J	Meilleur, AAS; Berthiaume, C; Bertone, A; Mottron, L				Meilleur, Andree-Anne S.; Berthiaume, Claude; Bertone, Armando; Mottron, Laurent			Autism-Specific Covariation in Perceptual Performances: "g'' or "p'' Factor?	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; GABA CONCENTRATION; DISCRIMINATION; PITCH; SENSITIVITY; FREQUENCY; INTELLIGENCE; INDIVIDUALS; SELECTIVITY; MECHANISMS	Background: Autistic perception is characterized by atypical and sometimes exceptional performance in several low- (e.g., discrimination) and mid-level (e. g., pattern matching) tasks in both visual and auditory domains. A factor that specifically affects perceptive abilities in autistic individuals should manifest as an autism-specific association between perceptual tasks. The first purpose of this study was to explore how perceptual performances are associated within or across processing levels and/or modalities. The second purpose was to determine if general intelligence, the major factor that accounts for covariation in task performances in non-autistic individuals, equally controls perceptual abilities in autistic individuals. Methods: We asked 46 autistic individuals and 46 typically developing controls to perform four tasks measuring low-or mid-level visual or auditory processing. Intelligence was measured with the Wechsler's Intelligence Scale (FSIQ) and Raven Progressive Matrices (RPM). We conducted linear regression models to compare task performances between groups and patterns of covariation between tasks. The addition of either Wechsler's FSIQ or RPM in the regression models controlled for the effects of intelligence. Results: In typically developing individuals, most perceptual tasks were associated with intelligence measured either by RPM or Wechsler FSIQ. The residual covariation between unimodal tasks, i.e. covariation not explained by intelligence, could be explained by a modality-specific factor. In the autistic group, residual covariation revealed the presence of a plurimodal factor specific to autism. Conclusions: Autistic individuals show exceptional performance in some perceptual tasks. Here, we demonstrate the existence of specific, plurimodal covariation that does not dependent on general intelligence (or "g'' factor). Instead, this residual covariation is accounted for by a common perceptual process (or "p'' factor), which may drive perceptual abilities differently in autistic and non-autistic individuals.	[Meilleur, Andree-Anne S.; Berthiaume, Claude; Bertone, Armando; Mottron, Laurent] Univ Montreal, Hop Riviere Des Prairies, Ctr Excellence Pervas Dev Disorders CETEDUM, Montreal, PQ, Canada; [Bertone, Armando] McGill Univ, Sch Appl Child Psychol, Dept Educ & Counselling Psychol, Montreal, PQ, Canada	Universite de Montreal; McGill University	Mottron, L (corresponding author), Univ Montreal, Hop Riviere Des Prairies, Ctr Excellence Pervas Dev Disorders CETEDUM, Montreal, PQ, Canada.	laurent.mottron@gmail.com		Mottron, Laurent/0000-0001-5668-5422	CIHR [171795]; Autism Speaks Foundation [2706]; Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award (CGS-D)	CIHR(Canadian Institutes of Health Research (CIHR)); Autism Speaks Foundation; Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award (CGS-D)(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from CIHR (171795); Autism Speaks Foundation (2706) and the Frederick Banting and Charles Best Canada Graduate Scholarships Doctoral Award (CGS-D) (AASM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton GS, 2001, INTELLIGENCE, V29, P263, DOI 10.1016/S0160-2896(01)00066-6; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, P50, DOI [DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Barbeau EB, 2013, J ABNORM PSYCHOL, V122, P295, DOI 10.1037/a0029984; Ben-David E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002556; Bertone A, 2005, BRAIN, V128, P2430, DOI 10.1093/brain/awh561; Bertone A, 2010, J AUTISM DEV DISORD, V40, P1541, DOI 10.1007/s10803-010-1110-z; Bhatara A, 2013, J AUTISM DEV DISORD, V43, P2312, DOI 10.1007/s10803-013-1778-y; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; Bonnel A, 2010, NEUROPSYCHOLOGIA, V48, P2465, DOI 10.1016/j.neuropsychologia.2010.04.020; Bouvet L, 2014, COGNITION, V131, P367, DOI 10.1016/j.cognition.2014.02.006; Caron MJ, 2006, BRAIN, V129, P1789, DOI 10.1093/brain/awl072; Conrad R., 1979, DEAF SCHOOLCHILD LAN; Dawson M, 2007, PSYCHOL SCI, V18, P657, DOI 10.1111/j.1467-9280.2007.01954.x; Edden RAE, 2009, J NEUROSCI, V29, P15721, DOI 10.1523/JNEUROSCI.4426-09.2009; Falter CM, 2013, J AUTISM DEV DISORD, V43, P1857, DOI 10.1007/s10803-012-1735-1; Fatemi SH, 2009, CEREBELLUM, V8, P64, DOI 10.1007/s12311-008-0075-3; Fatemi SH, 2009, J AUTISM DEV DISORD, V39, P223, DOI 10.1007/s10803-008-0646-7; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Gomes Erissandra, 2008, Pró-Fono R. Atual. Cient., V20, P279, DOI 10.1590/S0104-56872008000400013; Grudnik JL, 2001, INTELLIGENCE, V29, P523, DOI 10.1016/S0160-2896(01)00078-2; Harvey LO, 1997, SPATIAL VISION, V11, P121, DOI 10.1163/156856897X00159; Hayashi M, 2008, BRAIN COGNITION, V66, P306, DOI 10.1016/j.bandc.2007.09.008; Heaton P, 2008, COGN NEUROPSYCHOL, V25, P771, DOI 10.1080/02643290802336277; Heaton P, 2008, AUTISM, V12, P203, DOI 10.1177/1362361307085270; Jarvinen-Pasley A, 2008, DEVELOPMENTAL SCI, V11, P109, DOI 10.1111/j.1467-7687.2007.00644.x; Jemel B, 2010, J VISION, V10, DOI 10.1167/10.6.13; Jones CRG, 2009, NEUROPSYCHOLOGIA, V47, P2850, DOI 10.1016/j.neuropsychologia.2009.06.015; Kaldy Z, 2011, DEVELOPMENTAL SCI, V14, P980, DOI 10.1111/j.1467-7687.2011.01053.x; Keita L, 2014, SCI REP-UK, V4, DOI 10.1038/srep05475; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 1999, AUTISM DIAGNOSTIC OB; Mackintosh Nicholas John, 2011, IQ HUMAN INTELLIGENC; McCleery JP, 2007, BIOL PSYCHIAT, V62, P1007, DOI 10.1016/j.biopsych.2007.02.009; McGrew K. S., 2005, CONT INTELLECTUAL AS, P136, DOI DOI 10.5860/CHOICE.34-5370; Melnick MD, 2013, CURR BIOL, V23, P1013, DOI 10.1016/j.cub.2013.04.053; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Mitchell P, 2010, AUTISM RES, V3, P113, DOI 10.1002/aur.130; Mottron L, 2000, J CHILD PSYCHOL PSYC, V41, P1057, DOI 10.1111/1469-7610.00693; Mottron L, 2004, J AUTISM DEV DISORD, V34, P19, DOI 10.1023/B:JADD.0000018070.88380.83; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Mottron L, 2013, NEUROSCI BIOBEHAV R, V37, P209, DOI 10.1016/j.neubiorev.2012.11.016; Pellicano E, 2011, AUTISM RES, V4, P271, DOI 10.1002/aur.201; PERETZ I, 1987, CORTEX, V23, P317, DOI 10.1016/S0010-9452(87)80042-4; Perreault A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019519; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Poulin-Lord MP, 2014, NEUROIMAGE-CLIN, V4, P444, DOI 10.1016/j.nicl.2014.02.008; Puts NAJ, 2011, J NEUROSCI, V31, P16556, DOI 10.1523/JNEUROSCI.4489-11.2011; Razak KA, 2010, J NEUROPHYSIOL, V104, P517, DOI 10.1152/jn.00294.2010; Razak KA, 2009, J NEUROPHYSIOL, V102, P1366, DOI 10.1152/jn.00334.2009; Remington AM, 2012, J ABNORM PSYCHOL, V121, P544, DOI 10.1037/a0027670; Samson F, 2012, HUM BRAIN MAPP, V33, P1553, DOI 10.1002/hbm.21307; Schwarzkopf DS, 2014, J NEUROSCI, V34, P2713, DOI 10.1523/JNEUROSCI.4416-13.2014; Sinclair J., 1999, WHY I DISLIKE PERSON; Soulieres I, 2009, HUM BRAIN MAPP, V30, P4082, DOI 10.1002/hbm.20831; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stevenson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059329; Tervaniemi M, 2009, EUR J NEUROSCI, V30, P1636, DOI 10.1111/j.1460-9568.2009.06955.x; Vattikuti S, 2010, BIOL PSYCHIAT, V67, P672, DOI 10.1016/j.biopsych.2009.09.008; Vlamings PHJM, 2010, BIOL PSYCHIAT, V68, P1107, DOI 10.1016/j.biopsych.2010.06.024; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Woodbury-Smith MR, 2005, J AUTISM DEV DISORD, V35, P331, DOI 10.1007/s10803-005-3300-7; Zwaigenbaum L, 2010, CURR OPIN NEUROL, V23, P97, DOI 10.1097/WCO.0b013e3283372430	63	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103781	10.1371/journal.pone.0103781	http://dx.doi.org/10.1371/journal.pone.0103781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117450	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400023
J	Saggese, A; Scamardella, V; Sirec, T; Cangiano, G; Isticato, R; Pane, F; Amoresano, A; Ricca, E; Baccigalupi, L				Saggese, Anella; Scamardella, Veronica; Sirec, Teja; Cangiano, Giuseppina; Isticato, Rachele; Pane, Francesca; Amoresano, Angela; Ricca, Ezio; Baccigalupi, Loredana			Antagonistic Role of CotG and CotH on Spore Germination and Coat Formation in Bacillus subtilis	PLOS ONE			English	Article							PROTEIN; SPORULATION; GENES; GERE; EXPRESSION; MUTANTS	Spore formers are bacteria able to survive harsh environmental conditions by differentiating a specialized, highly resistant spore. In Bacillus subtilis, the model system for spore formers, the recently discovered crust and the proteinaceous coat are the external layers that surround the spore and contribute to its survival. The coat is formed by about seventy different proteins assembled and organized into three layers by the action of a subset of regulatory proteins, referred to as morphogenetic factors. CotH is a morphogenetic factor needed for the development of spores able to germinate efficiently and involved in the assembly of nine outer coat proteins, including CotG. Here we report that CotG has negative effects on spore germination and on the assembly of at least three outer coat proteins. Such negative action is exerted only in mutants lacking CotH, thus suggesting an antagonistic effect of the two proteins, with CotH counteracting the negative role of CotG.	[Saggese, Anella; Scamardella, Veronica; Sirec, Teja; Cangiano, Giuseppina; Isticato, Rachele; Ricca, Ezio; Baccigalupi, Loredana] Univ Naples Federico II, Dept Biol, Naples, Italy; [Pane, Francesca; Amoresano, Angela] Univ Naples Federico II, Dept Chem, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Baccigalupi, L (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	lorbacci@unina.it	Saggese, Anella/AAL-1243-2021; Isticato, Rachele/J-3476-2012; Ricca, Ezio/AAG-2998-2020; ISTICATO, Rachele/AAX-9972-2021	Ricca, Ezio/0000-0002-7355-0332; ISTICATO, Rachele/0000-0001-9141-4038; Baccigalupi, Loredana/0000-0003-3070-161X; Saggese, Anella/0000-0002-0968-8644; AMORESANO, Angela/0000-0002-8386-655X	EU [613703, 614088]	EU(European Commission)	This work was supported by EU grants (contract number 613703 and 614088) to ER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoresana A, 2010, J PROTEOME RES, V9, P2042, DOI 10.1021/pr9011156; Baccigalupi L, 2004, MICROBIOL-SGM, V150, P3441, DOI 10.1099/mic.0.27356-0; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cutting S., 1990, MOL BIOL METHODS BAC; Dworkin J, 2010, NAT REV MICROBIOL, V8, P890, DOI 10.1038/nrmicro2453; Fritze D, 2004, BACTERIAL SPORE FORMERS: PROBIOTICS AND EMERGING APPLICATIONS, P17; Galperin MY, 2012, ENVIRON MICROBIOL, V14, P2870, DOI 10.1111/j.1462-2920.2012.02841.x; Giglio R, 2011, J BACTERIOL, V193, P6664, DOI 10.1128/JB.06121-11; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Isticato R, 2004, J BACTERIOL, V186, P1129, DOI 10.1128/JB.186.4.1129-1135.2004; Isticato R, 2008, J BACTERIOL, V190, P1267, DOI 10.1128/JB.01425-07; Isticato R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074949; Isticato R, 2010, J BACTERIOL, V192, P949, DOI 10.1128/JB.01408-09; ITAYA M, 1989, NUCLEIC ACIDS RES, V17, P4410, DOI 10.1093/nar/17.11.4410; Kim H, 2006, MOL MICROBIOL, V59, P487, DOI 10.1111/j.1365-2958.2005.04968.x; Little S, 2001, MOL MICROBIOL, V42, P1107, DOI 10.1046/j.1365-2958.2001.02708.x; Manzo N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062093; McKenney PT, 2013, NAT REV MICROBIOL, V11, P33, DOI 10.1038/nrmicro2921; McPherson SA, 2010, MOL MICROBIOL, V76, P1527, DOI 10.1111/j.1365-2958.2010.07182.x; Naclerio G, 1996, J BACTERIOL, V178, P4375, DOI 10.1128/jb.178.15.4375-4380.1996; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; RICCA E, 1992, J BACTERIOL, V174, P3177, DOI 10.1128/jb.174.10.3177-3184.1992; SACCO M, 1995, J BACTERIOL, V177, P372, DOI 10.1128/jb.177.2.372-377.1995; Sambrook J., 2002, MOL CLONING LAB MANU; Sirec T, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-100; Takamatsu H, 1998, J BACTERIOL, V180, P2968, DOI 10.1128/JB.180.11.2968-2974.1998; YOUNGMAN P, 1984, MOL GEN GENET, V195, P424, DOI 10.1007/BF00341443; ZHENG LB, 1988, GENE DEV, V2, P1047, DOI 10.1101/gad.2.8.1047; Zilhao R, 2004, J BACTERIOL, V186, P1110, DOI 10.1128/JB.186.4.1110-1119.2004; Zilhao R, 1999, J BACTERIOL, V181, P2631	33	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104900	10.1371/journal.pone.0104900	http://dx.doi.org/10.1371/journal.pone.0104900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115591	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230400103
J	Wang, HY; Zhao, YL; Yi, YT; Gao, Y; Liu, QO; Wang, DY; Li, Q; Lan, L; Li, N; Guan, J; Yin, ZF; Han, B; Zhao, FF; Zong, L; Xiong, WP; Yu, L; Song, LJ; Yi, X; Yang, L; Petit, C; Wang, QU				Wang, Hongyang; Zhao, Yali; Yi, Yuting; Gao, Yun; Liu, Qiong; Wang, Dayong; Li, Qian; Lan, Lan; Li, Na; Guan, Jing; Yin, Zifang; Han, Bing; Zhao, Feifan; Zong, Liang; Xiong, Wenping; Yu, Lan; Song, Lijie; Yi, Xin; Yang, Ling; Petit, Christine; Wang, Qiuju			Targeted High-Throughput Sequencing Identifies Pathogenic Mutations in KCNQ4 in Two Large Chinese Families with Autosomal Dominant Hearing Loss	PLOS ONE			English	Article							OUTER HAIR-CELLS; POTASSIUM CHANNEL; K+ CHANNELS; HOT-SPOT; DEAFNESS; GENE; IMPAIRMENT; MECHANISMS; EXPRESSION; DFNA2	Autosomal dominant non-syndromic hearing loss (ADNSHL) is highly heterogeneous, among them, KCNQ4 is one of the most frequent disease-causing genes. More than twenty KCNQ4 mutations have been reported, but none of them were detected in Chinese mainland families. In this study, we identified a novel KCNQ4 mutation in a five generation Chinese family with 84 members and a known KCNQ4 mutation in a six generation Chinese family with 66 members. Mutation screening of 30 genes for ADNSHL was performed in the probands from thirty large Chinese families with ADNSHL by targeted region capture and high-throughput sequencing. The candidate variants and the co-segregation of the phenotype were verified by polymerase chain reaction (PCR) amplification and Sanger sequencing in all ascertained family members. Then we identified a novel KCNQ4 mutation p.W275R in exon 5 and a known KCNQ4 mutation p.G285S in exon 6 in two large Chinese ADNSHL families segregating with post-lingual high frequency-involved and progressive sensorineural hearing loss. This is the first report of KCNQ4 mutation in Chinese mainland families. KCNQ4, a member of voltage-gated potassium channel family, is likely to be a common gene in Chinese patients with ADNSHL. The results also support that the combination of targeted enrichment and high-throughput sequencing is a valuable molecular diagnostic tool for autosomal dominant hereditary deafness.	[Wang, Hongyang; Zhao, Yali; Gao, Yun; Liu, Qiong; Wang, Dayong; Li, Qian; Lan, Lan; Li, Na; Guan, Jing; Yin, Zifang; Han, Bing; Zhao, Feifan; Zong, Liang; Xiong, Wenping; Yu, Lan; Wang, Qiuju] Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Inst Otolaryngol, Beijing, Peoples R China; [Yi, Yuting; Song, Lijie; Yi, Xin] BGI Tianjin, Tianjin, Peoples R China; [Petit, Christine] Inst Pasteur, Unite Genet & Physiol Audit, Paris, France; [Petit, Christine] INSERM, UMRS 1120, Paris, France; [Petit, Christine] Univ Paris 06, Paris, France; [Petit, Christine] Coll France, F-75231 Paris, France	Chinese People's Liberation Army General Hospital; Beijing Genomics Institute (BGI); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; College de France	Wang, QU (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Med Sch Chinese PLA, Inst Otolaryngol, Beijing, Peoples R China.	wqcr@263.net	song, lijie/GSI-4348-2022; Jing, Guan/GLV-0764-2022	Petit, Christine/0000-0002-9069-002X	National Key Basic Research Program of China [2014CB943001]; National Natural Science Foundation of China [81120108009]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants of the National Key Basic Research Program of China, No. 2014CB943001, the National Natural Science Foundation of China, Major Project, No. 81120108009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JI, 2011, BBA-MOL BASIS DIS, V1812, P536, DOI 10.1016/j.bbadis.2010.09.001; Coucke PJ, 1999, HUM MOL GENET, V8, P1321, DOI 10.1093/hmg/8.7.1321; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063026; Gao YH, 2013, J CELL MOL MED, V17, P889, DOI 10.1111/jcmm.12080; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Holt JR, 2007, J NEUROSCI, V27, P8940, DOI 10.1523/JNEUROSCI.2085-07.2007; Kamada F, 2006, J HUM GENET, V51, P455, DOI 10.1007/s10038-006-0384-7; Kharkovets T, 2006, EMBO J, V25, P642, DOI 10.1038/sj.emboj.7600951; Kim HJ, 2011, J BIOL CHEM, V286, P1517, DOI 10.1074/jbc.M110.179010; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; [李丽娜 Li Lina], 2007, [听力学及言语疾病杂志, Journal of Audiology and Speech Pathology], V15, P25; Mencia A, 2008, HUM GENET, V123, P41, DOI 10.1007/s00439-007-0447-7; Naito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063231; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Su CC, 2007, AUDIOL NEURO-OTOL, V12, P20, DOI 10.1159/000096154; Topsakal V, 2005, OTOL NEUROTOL, V26, P52, DOI 10.1097/00129492-200501000-00009; Trune DR, 2010, CURR OPIN OTOLARYNGO, V18, P413, DOI 10.1097/MOO.0b013e32833d9597; Van Camp G, 2002, HUM MUTAT, V20, P15, DOI 10.1002/humu.10096; Van Eyken E, 2006, HUM MUTAT, V27, P1007, DOI 10.1002/humu.20375; Wang Qiuju, 2002, Zhonghua Er Bi Yan Hou Ke Za Zhi, V37, P343; Wei XM, 2012, CLIN CHIM ACTA, V413, P1866, DOI 10.1016/j.cca.2012.07.022; Wei XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029500; Yan D, 2013, P NATL ACAD SCI USA, V110, P2228, DOI 10.1073/pnas.1222285110; Zhao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069549	25	22	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103133	10.1371/journal.pone.0103133	http://dx.doi.org/10.1371/journal.pone.0103133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116015	Green Submitted, gold, Green Published			2022-12-27	WOS:000341230400012
J	Zafrani, L; Lemiale, V; Lapidus, N; Lorillon, G; Schlemmer, B; Azoulay, E				Zafrani, Lara; Lemiale, Virginie; Lapidus, Nathanael; Lorillon, Gwenael; Schlemmer, Benoit; Azoulay, Elie			Acute Respiratory Failure in Critically Ill Patients with Interstitial Lung Disease	PLOS ONE			English	Article							DISTRESS-SYNDROME; BRONCHOALVEOLAR LAVAGE; PROTECTIVE-VENTILATION; PULMONARY-HYPERTENSION; CT FINDINGS; RECRUITMENT; PNEUMONIA; DIAGNOSIS	Background: Patients with chronic known or unknown interstitial lung disease (ILD) may present with severe respiratory flares that require intensive management. Outcome data in these patients are scarce. Patients and Methods: Clinical and radiological features were collected in 83 patients with ILD-associated acute respiratory failure (ARF). Determinants of hospital mortality and response to corticosteroid therapy were identified by logistic regression. Results: Hospital and 1-year mortality rates were 41% and 54% respectively. Pulmonary hypertension, computed tomography (CT) fibrosis and acute kidney injury were independently associated with mortality (odds ratio (OR) 4.55; 95% confidence interval (95% CI) (1.20-17.33); OR, 7.68; (1.78-33.22) and OR 10.60; (2.25-49.97) respectively). Response to steroids was higher in patients with shorter time from hospital admission to corticosteroid therapy. Patients with fibrosis on CT had lower response to steroids (OR, 0.03; (0.005-0.21)). In mechanically ventilated patients, overdistension induced by high PEEP settings was associated with CT fibrosis and hospital mortality. Conclusion: Mortality is high in ILD-associated ARF. CT and echocardiography are valuable prognostic tools. Prompt corticosteroid therapy may improve survival.	[Zafrani, Lara; Lemiale, Virginie; Schlemmer, Benoit; Azoulay, Elie] St Louis Univ Hosp, Med Intens Care Unit, Paris, France; [Lapidus, Nathanael] St Louis Univ Hosp, Dept Biostat, Paris, France; [Lorillon, Gwenael] St Louis Univ Hosp, Dept Pulmonol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Zafrani, L (corresponding author), St Louis Univ Hosp, Med Intens Care Unit, Paris, France.	larazafrani@hotmail.com	Lapidus, N./AAT-4479-2020	Lapidus, N./0000-0002-4837-1068				Akira M, 1997, AM J ROENTGENOL, V168, P79, DOI 10.2214/ajr.168.1.8976924; Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; BOOMARS KA, 1995, THORAX, V50, P1087, DOI 10.1136/thx.50.10.1087; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Bull TM, 2010, AM J RESP CRIT CARE, V182, P1123, DOI 10.1164/rccm.201002-0250OC; Chuang Ming-Lung, 2003, J Intensive Care Med, V18, P21, DOI 10.1177/0885066602239121; Fernandez-Perez ER, 2008, CHEST, V133, P1113, DOI 10.1378/chest.07-1481; Fireman E, 1998, EUR RESPIR J, V11, P706; Gattinoni L, 2006, NEW ENGL J MED, V354, P1775, DOI 10.1056/NEJMoa052052; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; Gungor G, 2013, RESP CARE, V58, P525, DOI 10.4187/respcare.01734; Hodnett PA, 2013, AM J RESP CRIT CARE, V188, P141, DOI 10.1164/rccm.201208-1544CI; Ichikado K, 2002, AM J RESP CRIT CARE, V165, P1551, DOI 10.1164/rccm.2106157; Ichikado K, 1997, AM J ROENTGENOL, V168, P333, DOI 10.2214/ajr.168.2.9016201; Judge EP, 2012, EUR RESPIR J, V40, P93, DOI 10.1183/09031936.00115511; LECESSIE S, 1991, BIOMETRICS, V47, P1267, DOI 10.2307/2532385; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; Meduri GU, 1998, JAMA-J AM MED ASSOC, V280, P159, DOI 10.1001/jama.280.2.159; Mercat A, 2008, JAMA-J AM MED ASSOC, V299, P646, DOI 10.1001/jama.299.6.646; Meyer KC, 2012, AM J RESP CRIT CARE, V185, P1004, DOI 10.1164/rccm.201202-0320ST; Moloney ED, 2003, EUR RESPIR J, V21, P720, DOI 10.1183/09031936.03.00120102; Nava S, 1999, THORAX, V54, P390, DOI 10.1136/thx.54.5.390; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Richard JC, 2001, AM J RESP CRIT CARE, V163, P1609, DOI 10.1164/ajrccm.163.7.2004215; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Strange C, 2008, AM J RESP CRIT CARE, V177, P91, DOI 10.1164/rccm.200705-655OC; Thille AW, 2013, AM J RESP CRIT CARE, V187, P761, DOI 10.1164/rccm.201211-1981OC; Vieillard-Baron A, 2001, CRIT CARE MED, V29, P1551, DOI 10.1097/00003246-200108000-00009; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	31	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104897	10.1371/journal.pone.0104897	http://dx.doi.org/10.1371/journal.pone.0104897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115557	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230400102
J	Chalmel, F; Com, E; Lavigne, R; Hernio, N; Teixeira-Gomes, AP; Dacheux, JL; Pineau, C				Chalmel, Frederic; Com, Emmanuelle; Lavigne, Regis; Hernio, Nolwen; Teixeira-Gomes, Ana-Paula; Dacheux, Jean-Louis; Pineau, Charles			An Integrative Omics Strategy to Assess the Germ Cell Secretome and to Decipher Sertoli-Germ Cell Crosstalk in the Mammalian Testis	PLOS ONE			English	Article							MOLECULAR INTERACTION DATABASE; ANDROGEN-BINDING-PROTEIN; PROXIMITY LIGATION ASSAY; IN-VITRO PRODUCTION; GENE-EXPRESSION; SEMINIFEROUS EPITHELIUM; SPERM PRODUCTION; FLUID SECRETION; SPERMATOGENESIS; RAT	Mammalian spermatogenesis, which takes place in complex testicular structures called seminiferous tubules, is a highly specialized process controlled by the integration of juxtacrine, paracrine and endocrine information. Within the seminiferous tubules, the germ cells and Sertoli cells are surrounded by testicular fluid (TF), which probably contains most of the secreted proteins involved in crosstalk between these cells. It has already been established that germ cells can modulate somatic Sertoli cell function through the secretion of diffusible factors. We studied the germ cell secretome, which was previously considered inaccessible, by analyzing the TF collected by microsurgery in an "integrative omics'' strategy combining proteomics, transcriptomics, genomics and interactomics data. This approach identified a set of proteins preferentially secreted by Sertoli cells or germ cells. An interaction network analysis revealed complex, interlaced cell-cell dialog between the secretome and membranome of seminiferous cells, mediated via the TF. We then focused on germ cell-secreted candidate proteins, and we identified several potential interacting partners located on the surface of Sertoli cells. Two interactions, APOH/CDC42 and APP/NGFR, were validated in situ, in a proximity ligation assay (PLA). Our results provide new insight into the crosstalk between germ cells and Sertoli cells occurring during spermatogenesis. Our findings also demonstrate that this "integrative omics'' strategy is powerful enough for data mining and highlighting meaningful cell-cell communication events between different types of cells in a complex tissue, via a biological fluid. This integrative strategy could be applied more widely, to gain access to secretomes that have proved difficult to study whilst avoiding the limitations of in vitro culture.	[Chalmel, Frederic] INSERM, IRSET, U1085, Rennes, France; [Com, Emmanuelle; Lavigne, Regis; Hernio, Nolwen; Pineau, Charles] INSERM, U1085, Prote Core Facil Biogenouest, IRSET, Rennes, France; [Teixeira-Gomes, Ana-Paula] INRA, UMR 1282, F-37380 Nouzilly, France; [Teixeira-Gomes, Ana-Paula] INRA, Plate Forme Anal Integrat Biomol PAIB2, F-37380 Nouzilly, France; [Dacheux, Jean-Louis] CNRS, UMR 85, INRA, Nouzilly, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; INRAE; Centre National de la Recherche Scientifique (CNRS); INRAE	Chalmel, F (corresponding author), INSERM, IRSET, U1085, Campus Beaulieu, Rennes, France.	frederic.chalmel@inserm.fr; charles.pineau@inserm.fr	Com, Emmanuelle/E-8656-2011; Pineau, Charles G/D-9185-2013; Chalmel, Frédéric/L-5360-2018; Chalmel, Frédéric/AAM-1079-2021; Chalmel, Frederic/M-1297-2016; Com, Emmanuelle/AAD-2312-2020; , Protim/C-4687-2012	Com, Emmanuelle/0000-0002-7401-817X; Pineau, Charles G/0000-0002-7461-5433; Chalmel, Frédéric/0000-0002-0535-3628; Chalmel, Frédéric/0000-0002-0535-3628; Com, Emmanuelle/0000-0002-7401-817X; 	Biogenouest and Infrastructures en Biologie Sante et Agronomie (IBiSA); European Regional Development Fund; Conseil Regional de Bretagne grants	Biogenouest and Infrastructures en Biologie Sante et Agronomie (IBiSA); European Regional Development Fund(European Commission); Conseil Regional de Bretagne grants(Region Bretagne)	This work was supported by Biogenouest and Infrastructures en Biologie Sante et Agronomie (IBiSA), European Regional Development Fund and Conseil Regional de Bretagne grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; [Anonymous], 1865, MORGAGNI; BEER J, 1995, NEURODEGENERATION, V4, P51, DOI 10.1006/neur.1995.0006; Bortoluzzi S, 2006, PROTEINS, V62, P776, DOI 10.1002/prot.20803; Brown KJ, 2013, BBA-PROTEINS PROTEOM, V1834, P2454, DOI 10.1016/j.bbapap.2013.04.007; Brown KJ, 2012, EXPERT REV PROTEOMIC, V9, P337, DOI [10.1586/epr.12.21, 10.1586/EPR.12.21]; Cahoreau C, 1979, J Reprod Fertil Suppl, P97; Calvel P, 2010, PHILOS T R SOC B, V365, P1481, DOI 10.1098/rstb.2009.0294; Chalmel F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-86; Chalmel F, 2007, ANN NY ACAD SCI, V1120, P1, DOI 10.1196/annals.1411.010; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Cheng S L, 1982, Prog Clin Biol Res, V87, P193; Chocu S, 2012, SYST BIOL REPROD MED, V58, P179, DOI 10.3109/19396368.2012.691943; CHONN A, 1995, J BIOL CHEM, V270, P25845, DOI 10.1074/jbc.270.43.25845; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Com E, 2003, MOL CELL PROTEOMICS, V2, P248, DOI 10.1074/mcp.M300010-MCP200; Com E, 2006, MOL REPROD DEV, V73, P866, DOI 10.1002/mrd.20453; Cote RG, 2012, MOL CELL PROTEOMICS, V11, P1682, DOI 10.1074/mcp.O112.021543; Courot M, 1979, J Reprod Fertil Suppl, P165; DACHEUX JL, 1981, J REPROD FERTIL, V61, P363, DOI 10.1530/jrf.0.0610363; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; de Rooij DG, 2003, CYTOGENET GENOME RES, V103, P267, DOI 10.1159/000076812; DEJONG FH, 1988, PHYSIOL REV, V68, P555, DOI 10.1152/physrev.1988.68.2.555; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Fardilha M, 2007, ANN NY ACAD SCI, V1096, P196, DOI 10.1196/annals.1397.086; Flenkenthaler F, 2014, J PROTEOME RES, V13, P1259, DOI 10.1021/pr400769z; Giuffrida V, 2006, INT J MOL MED, V17, P523; Griffiths GS, 2009, BIOL REPROD, V81, P562, DOI 10.1095/biolreprod.108.075739; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; Gullberg M, 2003, CURR OPIN BIOTECH, V14, P82, DOI 10.1016/S0958-1669(02)00011-3; Guyonnet B, 2011, J ANDROL, V32, P651, DOI 10.2164/jandrol.111.013086; Hasebe N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082321; Hathout Y, 2007, EXPERT REV PROTEOMIC, V4, P239, DOI 10.1586/14789450.4.2.239; Ishida T, 2002, BIOSCIENCE REP, V22, P197, DOI 10.1023/A:1020134521778; JEGOU B, 1978, MOL CELL ENDOCRINOL, V9, P335, DOI 10.1016/0303-7207(78)90075-8; JEGOU B, 1979, J REPROD FERTIL, V57, P311, DOI 10.1530/jrf.0.0570311; JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4; JEGOU B, 1999, MALE REPROD FUNCTION, P41; Jegou B., 1993, MOL BIOL MALE REPROD, P271; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Lavigne R, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012682; LAW GL, 1994, BIOL REPROD, V50, P669, DOI 10.1095/biolreprod50.3.669; LEMAGUERESSE B, 1988, J ENDOCRINOL, V118, pR13, DOI 10.1677/joe.0.118R013; Li CJ, 2013, REPRODUCTION, V145, pR89, DOI 10.1530/REP-12-0466; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Martin-DeLeon PA, 2011, INT J ANDROL, V34, pE306, DOI 10.1111/j.1365-2605.2010.01138.x; Martin-DeLeon PA, 2006, MOL CELL ENDOCRINOL, V250, P114, DOI 10.1016/j.mce.2005.12.033; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; ONODA M, 1993, MOL CELL ENDOCRINOL, V93, P53, DOI 10.1016/0303-7207(93)90139-B; Perrard MH, 2007, J CELL PHYSIOL, V210, P51, DOI 10.1002/jcp.20805; PINEAU C, 1993, J ANDROL, V14, P87; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rolland AD, 2013, HUM REPROD, V28, P199, DOI 10.1093/humrep/des360; Rolland AD, 2008, ADV EXP MED BIOL, V636, P16, DOI 10.1007/978-0-387-09597-4_2; Sato T, 2013, NAT PROTOC, V8, P2098, DOI 10.1038/nprot.2013.138; Sato T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1478; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; SETCHELL B. P., 1971, Journal of Reproduction and Fertility, P15; SETCHELL BP, 1967, J REPROD FERTIL, V14, P347; SETCHELL BP, 1969, J REPROD FERTIL, V19, P391; Sharpe R.M, 1994, REGULATION SPERMATOG; SHARPE RM, 1983, J REPROD FERTIL, V69, P125, DOI 10.1530/jrf.0.0690125; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; SHOJI M, 1990, AM J PATHOL, V137, P1027; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Trifilieff P, 2011, BIOTECHNIQUES, V51, P111, DOI 10.2144/000113719; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; Wang J, 2008, J PROTEOME RES, V7, P3879, DOI 10.1021/pr8001645; Wong EWP, 2010, P NATL ACAD SCI USA, V107, P11399, DOI 10.1073/pnas.1001077107; Wong EWP, 2009, INT REV CEL MOL BIO, V278, P309, DOI 10.1016/S1937-6448(09)78007-4; Wrobel G, 2005, REPRODUCTION, V129, P1, DOI 10.1530/rep.1.00408; Zwickl H, 2005, ELECTROPHORESIS, V26, P2779, DOI 10.1002/elps.200410387	81	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104418	10.1371/journal.pone.0104418	http://dx.doi.org/10.1371/journal.pone.0104418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111155	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100055
J	Fukai, J; Koizumi, F; Nakao, N				Fukai, Junya; Koizumi, Fumiaki; Nakao, Naoyuki			RETRACTED: Enhanced Anti-Tumor Effect of Zoledronic Acid Combined with Temozolomide against Human Malignant Glioma Cell Expressing O-6-Methylguanine DNA Methyltransferase (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							DELTA-T-CELLS; ADJUVANT TEMOZOLOMIDE; GLIOBLASTOMA; PROTEIN; ARREST; PROLIFERATION; RADIOTHERAPY; METHYLATION; CONCOMITANT; ACTIVATION	Temozolomide (TMZ), a DNA methylating agent, is widely used in the adjuvant treatment of malignant gliomas. O-6-methylguanine-DNA methyltranferase (MGMT), a DNA repair enzyme, is frequently discussed as the main factor that limits the efficacy of TMZ. Zoledronic acid (ZOL), which is clinically applied to treat cancer-induced bone diseases, appears to possess direct anti-tumor activity through apoptosis induction by inhibiting mevalonate pathway and prenylation of intracellular small G proteins. In this study, we evaluated whether ZOL can be effectively used as an adjuvant to TMZ in human malignant glioma cells that express MGMT. Malignant glioma cell lines, in which the expression of MGMT was detected, did not exhibit growth inhibition by TMZ even at a longer exposure. However, combination experiment of TMZ plus ZOL revealed that a supra-additive effect resulted in a significant decrease in cell growth. In combined TMZ/ZOL treatment, an increased apoptotic rate was apparent and significant activation of caspase-3 and cleavage of poly-(ADP-ribose) polymerase were observed compared with each single drug exposure. There were decreased amounts of Ras-GTP, MAPK and Akt phosphorylation and MGMT expression in the ZOL-treated cells. Subcutanous xenograft models showed significant decrease of tumor growth with combined TMZ/ZOL treatment. These results suggest that ZOL efficaciously inhibits activity of Ras in malignant glioma cells and potentiates TMZ-mediated cytotoxicity, inducing growth inhibition and apoptosis of malignant glioma cells that express MGMT and resistant to TMZ. Based on this work, combination of TMZ with ZOL might be a potential therapy in malignant gliomas that receive less therapeutic effects of TMZ due to cell resistance.	[Fukai, Junya; Nakao, Naoyuki] Wakayama Med Univ, Sch Med, Dept Neurol Surg, Wakayama, Japan; [Fukai, Junya; Koizumi, Fumiaki] Natl Canc Ctr, Shien Lab, Tokyo, Japan	Wakayama Medical University; National Cancer Center - Japan	Fukai, J (corresponding author), Wakayama Med Univ, Sch Med, Dept Neurol Surg, Wakayama, Japan.	jun-fukai461111@est.hi-ho.ne.jp			Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science [23700424]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding provided by Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology and Japan Society for the Promotion of Science (23700424) (http://www.e-rad.go.jp) (JF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Bryant NL, 2009, NEURO-ONCOLOGY, V11, P357, DOI 10.1215/15228517-2008-111; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Friedman HS, 1998, J CLIN ONCOL, V16, P3851, DOI 10.1200/JCO.1998.16.12.3851; Fukai J, 2008, CANCER SCI, V99, P2062, DOI 10.1111/j.1349-7006.2008.00945.x; Fukai J, 2008, MOL CANCER THER, V7, P2768, DOI 10.1158/1535-7163.MCT-07-2263; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Hirose Y, 2005, CANCER RES, V65, P4861, DOI 10.1158/0008-5472.CAN-04-2633; Hirose Y, 2001, CANCER RES, V61, P1957; Ito M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062351; Jeuken J, 2007, ACTA NEUROPATHOL, V114, P121, DOI 10.1007/s00401-007-0239-0; Kanzawa F, 1997, INT J CANCER, V71, P311, DOI 10.1002/(SICI)1097-0215(19970502)71:3<311::AID-IJC1>3.3.CO;2-4; Knizhnik AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055665; Kuroda J, 2004, CANCER SCI, V95, P186, DOI 10.1111/j.1349-7006.2004.tb03202.x; Matsumoto S, 2005, LUNG CANCER, V47, P31, DOI 10.1016/j.lungcan.2004.06.003; Momota H, 2005, CANCER RES, V65, P7429, DOI 10.1158/0008-5472.CAN-05-1042; Nakazawa T, 2014, J NEURO-ONCOL, V116, P31, DOI 10.1007/s11060-013-1258-4; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Patra SK, 2008, EXP CELL RES, V314, P1193, DOI 10.1016/j.yexcr.2008.01.012; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Senaratne SG, 2002, BRIT J CANCER, V86, P1479, DOI 10.1038/sj.bjc.6600297; Spiegl-Kreinecker S, 2010, NEURO-ONCOLOGY, V12, P28, DOI 10.1093/neuonc/nop003; Stresing V, 2007, CANCER LETT, V257, P16, DOI 10.1016/j.canlet.2007.07.007; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2007, J CLIN ONCOL, V25, P4127, DOI 10.1200/JCO.2007.11.8554; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Weiss HM, 2008, DRUG METAB DISPOS, V36, P2043, DOI 10.1124/dmd.108.021071	29	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104538	10.1371/journal.pone.0104538	http://dx.doi.org/10.1371/journal.pone.0104538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111384	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100071
J	Kupari, J; Airaksinen, MS				Kupari, Jussi; Airaksinen, Matti S.			Different Requirements for GFR alpha 2-Signaling in Three Populations of Cutaneous Sensory Neurons	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; DRG NEURONS; RECEPTOR COMPONENTS; NEURTURIN RECEPTOR; NERVE INJURY; RET; FAMILY; MOUSE; GDNF; MECHANORECEPTORS	Many primary sensory neurons in mouse dorsal root ganglia (DRG) express one or several GFR alpha's, the ligand-binding receptors of the GDNF family, and their common signaling receptor Ret. GFR alpha 2, the principal receptor for neurturin, is expressed in most of the small nonpeptidergic DRG neurons, but also in some large DRG neurons that start to express Ret earlier. Previously, GFR alpha 2 has been shown to be crucial for the soma size of small nonpeptidergic nociceptors and for their target innervation of glabrous epidermis. However, little is known about this receptor in other Ret-expressing DRG neuron populations. Here we have investigated two populations of Ret-positive low-threshold mechanoreceptors that innervate different types of hair follicles on mouse back skin: the small C-LTMRs and the large A beta-LTMRs. Using GFR alpha 2-KO mice and immunohistochemistry we found that, similar to the nonpeptidergic nociceptors, GFR alpha 2 controls the cell size but not the survival of both C-LTMRs and A beta-LTMRs. In contrast to the nonpeptidergic neurons, GFR alpha 2 is not required for the target innervation of C-LTMRs and A beta-LTMRs in the back skin. These results suggest that different factors drive target innervation in these three populations of neurons. In addition, the observation that the large Ret-positive DRG neurons lack GFR alpha 2 immunoreactivity in mature animals suggests that these neurons switch their GFR alpha signaling pathways during postnatal development.	[Kupari, Jussi; Airaksinen, Matti S.] Univ Helsinki, Inst Biomed, Helsinki, Finland	University of Helsinki	Airaksinen, MS (corresponding author), Univ Helsinki, Inst Biomed, Helsinki, Finland.	matti.airaksinen@helsinki.fi		Airaksinen, Matti/0000-0002-7199-4984	Academy of Finland	Academy of Finland(Academy of Finland)	This study was supported by a grant from the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Baumer BE, 2014, J NEUROSCI, V34, P1633, DOI 10.1523/JNEUROSCI.3094-13.2014; Bennett DLH, 1998, J NEUROSCI, V18, P3059; Bennett DLH, 2000, J NEUROSCI, V20, P427, DOI 10.1523/JNEUROSCI.20-01-00427.2000; Bourane S, 2009, NEURON, V64, P857, DOI 10.1016/j.neuron.2009.12.004; BujBello A, 1997, NATURE, V387, P721, DOI 10.1038/42729; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Franck MCM, 2011, EUR J NEUROSCI, V33, P1385, DOI 10.1111/j.1460-9568.2011.07634.x; Golden JP, 2010, J NEUROSCI, V30, P3983, DOI 10.1523/JNEUROSCI.5930-09.2010; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; HALATA Z, 1993, J INVEST DERMATOL, V101, P75; Honma Y, 2010, DEVELOPMENT, V137, P2319, DOI 10.1242/dev.046995; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Lauren J, 2003, MOL CELL NEUROSCI, V24, P581, DOI 10.1016/S1044-7431(03)00199-4; Li LS, 2014, ELIFE, V3, DOI 10.7554/eLife.01901; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Lindfors PH, 2006, J NEUROSCI, V26, P1953, DOI 10.1523/JNEUROSCI.4065-05.2006; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; Lou S, 2013, J NEUROSCI, V33, P870, DOI 10.1523/JNEUROSCI.3942-12.2013; Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; PLENDERLEITH MB, 1993, NEUROSCI LETT, V159, P17, DOI 10.1016/0304-3940(93)90787-L; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Stucky CL, 2002, J PHYSIOL-LONDON, V545, P43, DOI 10.1113/jphysiol.2002.027656; Wang T, 2013, J NEUROSCI, V33, P2060, DOI 10.1523/JNEUROSCI.4012-12.2013; Wang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028908; Wanigasekara Y, 2006, NEUROSCIENCE, V142, P369, DOI 10.1016/j.neuroscience.2006.06.031; Wende H, 2012, SCIENCE, V335, P1373, DOI 10.1126/science.1214314; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104764	10.1371/journal.pone.0104764	http://dx.doi.org/10.1371/journal.pone.0104764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111710	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100099
J	Ross, LE; Bauer, GR; MacLeod, MA; Robinson, M; MacKay, J; Dobinson, C				Ross, Lori E.; Bauer, Greta R.; MacLeod, Melissa A.; Robinson, Margaret; MacKay, Jenna; Dobinson, Cheryl			Mental Health and Substance Use among Bisexual Youth and Non-Youth in Ontario, Canada	PLOS ONE			English	Article							SEXUAL ORIENTATION; ANXIETY SEVERITY; SUICIDE ATTEMPTS; SOCIAL STRESS; REDUCED RISK; GAY MEN; POPULATION; DISORDERS; DISPARITIES; DEPRESSION	Research has shown that bisexuals have poorer health outcomes than heterosexuals, gays, or lesbians, particularly with regard to mental health and substance use. However, research on bisexuals is often hampered by issues in defining bisexuality, small sample sizes, and by the failure to address age differences between bisexuals and other groups or age gradients in mental health. The Risk & Resilience Survey of Bisexual Mental Health collected data on 405 bisexuals from Ontario, Canada, using respondent-driven sampling, a network-based sampling method for hidden populations. The weighted prevalence of severe depression (PHQ-9 >= 20) was 4.7%, possible anxiety disorder (OASIS >= 8) was 30.9%, possible post-traumatic stress disorder (PCL-C >= 50) was 10.8%, and past year suicide attempt was 1.9%. With respect to substance use, the weighted prevalence of problem drinking (AUDIT >= 5) was 31.2%, and the weighted prevalence of illicit polydrug use was 30.5%. Daily smoking was low in this sample, with a weighted prevalence of 7.9%. Youth (aged 16-24) reported significantly higher weighted mean scores on depression and post-traumatic stress disorder, and higher rates of past year suicidal ideation (29.7% vs. 15.2%) compared with those aged 25 and older. The burden of mental health and substance use among bisexuals in Ontario is high relative to population-based studies of other sexual orientation groups. Bisexual youth appear to be at risk for poor mental health. Additional research is needed to understand if and how minority stress explains this burden.	[Ross, Lori E.; Robinson, Margaret; MacKay, Jenna; Dobinson, Cheryl] Ctr Addict & Mental Hlth, Hlth Syst & Hlth Equ Res Grp, Toronto, ON, Canada; [Bauer, Greta R.; MacLeod, Melissa A.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Western University (University of Western Ontario)	Ross, LE (corresponding author), Ctr Addict & Mental Hlth, Hlth Syst & Hlth Equ Res Grp, Toronto, ON, Canada.	l.ross@utoronto.ca	Bauer, Greta/ABG-1472-2020; Robinson, Margaret/V-2541-2019	Robinson, Margaret/0000-0002-2677-0607; Bauer, Greta/0000-0003-0663-7160	Institute of Gender and Health of the Canadian Institutes for Health Research [MOP 106609]	Institute of Gender and Health of the Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by an operating grant from the Institute of Gender and Health of the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193. html), Funding Reference Number MOP 106609. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JP, 1997, ALCOHOLISM CLIN EXPT, V21, P513; [Anonymous], 2012, SAS SOFTW VERS 9 3 S; Balsam KF, 2005, J ABNORM PSYCHOL, V114, P471, DOI 10.1037/0021-843X.114.3.471; Bauer GR, 2013, J BISEXUALITY, V13, P148, DOI 10.1080/15299716.2013.782260; Bazargan M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-663; Berman AH, 2007, J SUBST ABUSE TREAT, V32, P357, DOI 10.1016/j.jsat.2006.10.001; Bostwick W, 2014, CULT HEALTH SEX, V16, P488, DOI 10.1080/13691058.2014.889754; Brennan DJ, 2010, CAN J PUBLIC HEALTH, V101, P255, DOI 10.1007/BF03404385; Brewster ME, 2013, J COUNS PSYCHOL, V60, P543, DOI 10.1037/a0033224; Brown T., 2002, J BISEXUALITY, V2, P67, DOI [https://doi.org/10.1300/J159v02n04_05, DOI 10.1300/J159V02N04_05]; Campbell-Sills L, 2009, J AFFECT DISORDERS, V112, P92, DOI 10.1016/j.jad.2008.03.014; Cardom R, 2013, J ADOLESCENT HEALTH, V53, P671, DOI 10.1016/j.jadohealth.2013.07.023; Case P, 2004, J WOMENS HEALTH, V13, P1033, DOI 10.1089/jwh.2004.13.1033; Cochran SD, 2007, AM J PUBLIC HEALTH, V97, P2048, DOI 10.2105/AJPH.2006.087254; Crosby Alex E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Eady A, 2011, COMMUNITY MENT HLT J, V47, P378, DOI 10.1007/s10597-010-9329-x; Entrup L, 2007, BECOMING VISIBLE COU, P89; Gruskin EP, 2007, AM J PUBLIC HEALTH, V97, P1496, DOI 10.2105/AJPH.2006.090258; GY Zou, 2013, COMMUNICATION; Hatzenbuehler ML, 2014, AM J PUBLIC HEALTH, V104, P279, DOI 10.2105/AJPH.2013.301508; Hatzenbuehler ML, 2013, J ADOLESCENT HEALTH, V53, pS21, DOI 10.1016/j.jadohealth.2012.08.010; Hatzenbuehler ML, 2011, PEDIATRICS, V127, P896, DOI 10.1542/peds.2010-3020; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Husky MM, 2012, PSYCHIAT SERV, V63, P989, DOI 10.1176/appi.ps.201200058; Institute of Medicine (US) Committee on Lesbian Gay Bisexual and Transgender Health Issues and Research Gaps and Opportunities, 2011, HLTH LESB GAY BIS TR; Jorm AF, 2002, BRIT J PSYCHIAT, V180, P423, DOI 10.1192/bjp.180.5.423; Kaestle CE, 2012, J BISEXUALITY, V12, P35, DOI 10.1080/15299716.2012.645701; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Koh AS, 2006, J HOMOSEXUAL, V51, P33, DOI 10.1300/J082v51n01_03; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Mao LM, 2009, AUST NZ J PUBL HEAL, V33, P83, DOI 10.1111/j.1753-6405.2009.00344.x; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; McNair R, 2005, AUST NZ J PUBL HEAL, V29, P265, DOI 10.1111/j.1467-842X.2005.tb00766.x; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Morrow DF, 2004, FAM SOC-J CONTEMP H, V85, P91, DOI 10.1606/1044-3894.246; Norman SB, 2006, DEPRESS ANXIETY, V23, P245, DOI 10.1002/da.20182; OECD, 2013, SMOK OECD FACTB 2013; Pakula B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-209; Patten SB, 2009, COMPR PSYCHIAT, V50, P26, DOI 10.1016/j.comppsych.2008.05.012; Pizacani BA, 2009, PREV MED, V48, P555, DOI 10.1016/j.ypmed.2009.03.013; Ross LE, 2010, AM J PUBLIC HEALTH, V100, P496, DOI 10.2105/AJPH.2008.156307; ROTHERAMBORUS MJ, 1995, SUICIDE LIFE-THREAT, V25, P26, DOI 10.1111/j.1943-278X.1995.tb00487.x; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Saewyc E. M., 2007, NOT YET EQUAL HLTH L; Saewyc EM, 2011, J RES ADOLESCENCE, V21, P256, DOI 10.1111/j.1532-7795.2010.00727.x; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Sandfort TGM, 2006, AM J PUBLIC HEALTH, V96, P1119, DOI 10.2105/AJPH.2004.058891; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schwartz S, 2010, SOC SCI MED, V70, P1111, DOI 10.1016/j.socscimed.2009.11.032; Sletteng R, 2011, PSYCHOL REP, V109, P663, DOI 10.2466/03.09.13.15.PR0.109.5.663-674; Statistics Canada, 2007, CAN COMM HLTH SURV C; Statistics Canada, 2011, HEAV DRINK 2011; Steele LS, 2009, WOMEN HEALTH, V49, P353, DOI 10.1080/03630240903238685; Tang H, 2004, CANCER CAUSE CONTROL, V15, P797, DOI 10.1023/B:CACO.0000043430.32410.69; Tjepkema M, 2004, HLTH REPORTS S; Tjepkema Michael, 2008, Health Rep, V19, P53; Volz EM, 2010, RESPONDENT DRIVEN SA; Weathers F.W., 1994, PTSD CHECKLIST CIVIL; Weiss J.T., 2003, J BISEXUALITY, V3, P25, DOI [10.1300/J159v03n03_02, DOI 10.1300/J159V03N03_02, https://doi.org/10.1300/J159v03n03_02]; Wejnert C, 2009, SOCIOL METHODOL, V39, P73, DOI 10.1111/j.1467-9531.2009.01216.x; Welzer-Lang D, 2008, J BISEXUALITY, V8, P81, DOI 10.1080/15299710802142259; Williams KA, 2011, HEALTH SOC WORK, V36, P197, DOI 10.1093/hsw/36.3.197; Zou GY, 2008, STAT MED, V27, P1693, DOI 10.1002/sim.3095	65	46	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e101604	10.1371/journal.pone.0101604	http://dx.doi.org/10.1371/journal.pone.0101604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WB	25111292	gold, Green Published			2022-12-27	WOS:000341105100004
J	Williams, D; Venardos, KM; Byrne, M; Joshi, M; Horlock, D; Lam, NT; Gregorevic, P; McGee, SL; Kaye, DM				Williams, David; Venardos, Kylie M.; Byrne, Melissa; Joshi, Mandar; Horlock, Duncan; Lam, Nicholas T.; Gregorevic, Paul; McGee, Sean L.; Kaye, David M.			Abnormal Mitochondrial L-Arginine Transport Contributes to the Pathogenesis of Heart Failure and Rexoygenation Injury	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION; MYOCARDIAL-ISCHEMIA; METABOLIC STATES; AMINO-ACIDS; COMPLEX-I; MODULATION; IDENTIFICATION; HYPERTENSION; RESPIRATION	Background: Impaired mitochondrial function is fundamental feature of heart failure (HF) and myocardial ischemia. In addition to the effects of heightened oxidative stress, altered nitric oxide (NO) metabolism, generated by a mitochondrial NO synthase, has also been proposed to impact upon mitochondrial function. However, the mechanism responsible for arginine transport into mitochondria and the effect of HF on such a process is unknown. We therefore aimed to characterize mitochondrial L-arginine transport and to investigate the hypothesis that impaired mitochondrial L-arginine transport plays a key role in the pathogenesis of heart failure and myocardial injury. Methods and Results: In mitochondria isolated from failing hearts (sheep rapid pacing model and mouse Mst1 transgenic model) we demonstrated a marked reduction in L-arginine uptake (p<0.05 and p<0.01 respectively) and expression of the principal L-arginine transporter, CAT-1 (p<0.001, p<0.01) compared to controls. This was accompanied by significantly lower NO production and higher 3-nitrotyrosine levels (both p<0.05). The role of mitochondrial L-arginine transport in modulating cardiac stress responses was examined in cardiomyocytes with mitochondrial specific overexpression of CAT-1 (mtCAT1) exposed to hypoxia-reoxygenation stress. mtCAT1 cardiomyocytes had significantly improved mitochondrial membrane potential, respiration and ATP turnover together with significantly decreased reactive oxygen species production and cell death following mitochondrial stress. Conclusion: These data provide new insights into the role of L-arginine transport in mitochondrial biology and cardiovascular disease. Augmentation of mitochondrial L-arginine availability may be a novel therapeutic strategy for myocardial disorders involving mitochondrial stress such as heart failure and reperfusion injury.	[Williams, David; Venardos, Kylie M.; Byrne, Melissa; Joshi, Mandar; Horlock, Duncan; Lam, Nicholas T.; Kaye, David M.] Baker IDI Heart & Diabet Inst, Heart Failure Res Grp, Melbourne, Vic, Australia; [Venardos, Kylie M.; Kaye, David M.] Monash Univ, Dept Med, Melbourne, Vic 3004, Australia; [Gregorevic, Paul] Baker IDI Heart & Diabet Inst, Muscle Res & Therapeut Lab, Melbourne, Vic, Australia; [McGee, Sean L.] Deakin Univ, Metab Res Unit, Geelong, Vic 3217, Australia	Baker Heart and Diabetes Institute; Monash University; Baker Heart and Diabetes Institute; Deakin University	Kaye, DM (corresponding author), Baker IDI Heart & Diabet Inst, Heart Failure Res Grp, Melbourne, Vic, Australia.	david.kaye@bakeridi.edu.au	Gregorevic, Paul/AAH-6040-2021; Venardos, kylie/AAH-3234-2019; Kaye, David/AAF-1202-2021	Gregorevic, Paul/0000-0002-7418-8945; Venardos, kylie/0000-0002-1714-5594; Lam, Nicholas/0000-0002-9446-7378; Kaye, David/0000-0003-4058-0372	NHMRC [1036352]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding provided by NHMRC Program Grant 1036352. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borutaite V, 2006, BBA-BIOENERGETICS, V1757, P562, DOI 10.1016/j.bbabio.2006.02.014; Boveris A, 2006, BBA-BIOENERGETICS, V1757, P535, DOI 10.1016/j.bbabio.2006.02.010; Brown GC, 2007, CARDIOVASC RES, V75, P283, DOI 10.1016/j.cardiores.2007.03.022; Byrne M, 2008, J CARD FAIL, V14, P320, DOI 10.1016/j.cardfail.2007.12.005; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Closs EI, 2004, J NUTR, V134, p2752S, DOI 10.1093/jn/134.10.2752S; Davidson SM, 2006, CARDIOVASC RES, V71, P10, DOI 10.1016/j.cardiores.2006.01.019; Dedkova EN, 2005, AM J PHYSIOL-CELL PH, V289, pC836, DOI 10.1152/ajpcell.00011.2005; Duranski MR, 2005, J CLIN INVEST, V115, P1232, DOI 10.1172/JCI200522493; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Ghafourifar P, 2005, TRENDS PHARMACOL SCI, V26, P190, DOI 10.1016/j.tips.2005.02.005; Han D, 2005, BIOCHEMISTRY-US, V44, P11986, DOI 10.1021/bi0509393; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; Kaye DM, 2000, CIRCULATION, V102, P2707, DOI 10.1161/01.CIR.102.22.2707; Kaye DM, 2002, CIRC RES, V91, P1198, DOI 10.1161/01.RES.0000047506.52381.90; Krotova KY, 2003, AM J PHYSIOL-LUNG C, V284, pL1037, DOI 10.1152/ajplung.00308.2002; Lacza Z, 2001, FREE RADICAL BIO MED, V31, P1609, DOI 10.1016/S0891-5849(01)00754-7; Lacza Z, 2009, FRONT BIOSCI, V14, P4436, DOI 10.2741/3539; Loke KE, 2000, J CARDIOVASC PHARM, V35, P84, DOI 10.1097/00005344-200001000-00011; Mootha VK, 1997, AM J PHYSIOL-HEART C, V272, pH769, DOI 10.1152/ajpheart.1997.272.2.H769; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Nisoli E, 2008, AM J CARDIOL, V101, p22E, DOI 10.1016/j.amjcard.2008.02.077; Persichini T, 2005, NEUROSCI LETT, V384, P254, DOI 10.1016/j.neulet.2005.04.085; Prime TA, 2009, P NATL ACAD SCI USA, V106, P10764, DOI 10.1073/pnas.0903250106; Razavi HM, 2005, PHARMACOL THERAPEUT, V106, P147, DOI 10.1016/j.pharmthera.2004.11.006; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Riess ML, 2008, ANESTH ANALG, V106, P1049, DOI 10.1213/ane.0b013e318167875e; Sawyer DB, 2000, CIRC RES, V86, P119, DOI 10.1161/01.RES.86.2.119; Schlaich MP, 2004, CIRCULATION, V110, P3680, DOI 10.1161/01.CIR.0000149748.79945.52; Schlaich MP, 2004, J HYPERTENS, V22, P1917, DOI 10.1097/00004872-200410000-00014; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Soetens O, 1998, EUR J BIOCHEM, V258, P702, DOI 10.1046/j.1432-1327.1998.2580702.x; Steppan J, 2006, P NATL ACAD SCI USA, V103, P4759, DOI 10.1073/pnas.0506589103; Sun JH, 2013, FREE RADICAL BIO MED, V54, P105, DOI 10.1016/j.freeradbiomed.2012.09.005; Valdez LB, 2006, BBA-BIOENERGETICS, V1757, P166, DOI 10.1016/j.bbabio.2006.02.013; Valerio A, 2011, AGING-US, V3, P464, DOI 10.18632/aging.100322; Venardos K, 2009, J MOL CELL CARDIOL, V46, P86, DOI 10.1016/j.yjmcc.2008.09.712; Venardos KM, 2009, J CELL BIOCHEM, V108, P156, DOI 10.1002/jcb.22235; Venardos KM, 2007, CURR MED CHEM, V14, P1539, DOI 10.2174/092986707780831078; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Yang ZY, 2007, CIRCULATION, V115, P1269, DOI 10.1161/CIRCULATIONAHA.106.665836; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zanella B, 2004, BASIC RES CARDIOL, V99, P159, DOI 10.1007/s00395-003-0454-3; Zaobornyj T, 2012, AM J PHYSIOL-HEART C, V303, pH1283, DOI 10.1152/ajpheart.00674.2011	46	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104643	10.1371/journal.pone.0104643	http://dx.doi.org/10.1371/journal.pone.0104643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111602	Green Published, gold			2022-12-27	WOS:000341105100085
J	Brown, S; Reid, D; Rogan, E				Brown, Susie; Reid, David; Rogan, Emer			Characteristics of Fishing Operations, Environment and Life History Contributing to Small Cetacean Bycatch in the Northeast Atlantic	PLOS ONE			English	Article							DOLPHINS DELPHINUS-DELPHIS; PORPOISE PHOCOENA-PHOCOENA; COMMON DOLPHIN; MARINE-MAMMALS; BY-CATCH; INCIDENTAL CATCHES; GILLNET FISHERIES; SEA-TURTLES; BEHAVIOR; IMPACTS	Fisheries bycatch is a key threat to cetacean species globally. Managing the impact requires an understanding of the conditions under which animals are caught and the sections of the population affected. We used observer data collected on an albacore tuna gillnet fishery in the northeast Atlantic, to assess operational and environmental factors contributing to bycatch of common and striped dolphins, using generalised linear models and model averaging. Life history demographics of the captured animals were also investigated. In both species, young males dominated the catch. The age ratio of common dolphins was significantly different from that estimated for the population in the region, based on life tables (G = 17.1, d.f. = 2, p = 0.002). Skewed age and sex ratios may reflect varying vulnerability to capture, through differences in behaviour or segregation in populations. Adult females constituted the second largest portion of the bycatch for both species, with potential consequences for population sustainability. Depth was the most important parameter influencing bycatch of both species and reflected what is known about common and striped dolphin habitat use in the region as the probability of catching common dolphins decreased, and striped dolphins increased, with increasing depth. Striped dolphin capture was similarly influenced by the extent to which operations were conducted in daylight, with the probability of capture increasing with increased operations in the pre-sunset and post-sunrise period, potentially driven by increased ability of observers to record animals during daylight operations, or by diurnal movements increasing contact with the fishery. Effort, based on net length and soak time, had little influence on the probability of capturing either species. Our results illustrate the importance of assessing the demographic of the animals captured during observer programmes and, perhaps more importantly, suggest that effort restrictions alone may not be sufficient to eradicate bycatch in areas where driftnets and small cetaceans co-occur.	[Brown, Susie; Rogan, Emer] Natl Univ Ireland Univ Coll Cork, Cork Enterprise Ctr, Sch Biol Earth & Environm Sci, Distillery Fields North Mall, Cork, Ireland; [Reid, David] Marine Inst Headquarters, Galway, Ireland	University College Cork; Marine Institute Ireland	Brown, S (corresponding author), Natl Univ Ireland Univ Coll Cork, Cork Enterprise Ctr, Sch Biol Earth & Environm Sci, Distillery Fields North Mall, Cork, Ireland.	s.brown@ucc.ie	Reid, David/ABC-5916-2021	Reid, Dave/0000-0002-8494-0918	Beaufort Ecosystem Approach, Irish Government's National Development Plan (NDP); Department of Communications, Energy and Natural Resources (DCENR); Department of Agriculture, Fisheries and Food (DAFF) under the Strategy for Science Technology and Innovation (SSTI); Sea Change StrategyEuropean Commission [FAIR-CT95-0523]	Beaufort Ecosystem Approach, Irish Government's National Development Plan (NDP); Department of Communications, Energy and Natural Resources (DCENR); Department of Agriculture, Fisheries and Food (DAFF) under the Strategy for Science Technology and Innovation (SSTI); Sea Change StrategyEuropean Commission	This analysis is funded under the Beaufort Ecosystem Approach to Fisheries Management award, as part of the Irish Government's National Development Plan (NDP), the Beaufort Marine Research Award is grant aided by the Department of Communications, Energy and Natural Resources (DCENR) and the Department of Agriculture, Fisheries and Food (DAFF) under the Strategy for Science Technology and Innovation (SSTI) and the Sea Change Strategy. This analysis was based on data collected under the European Commission funded EC-FAIR contract FAIR-CT95-0523: Assessment and Reduction of the By-catch of Small Cetaceans (BY-CARE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Atkins S, 2013, BIOL CONSERV, V159, P442, DOI 10.1016/j.biocon.2012.10.007; AU WWL, 1991, MAR MAMMAL SCI, V7, P258, DOI 10.1111/j.1748-7692.1991.tb00101.x; Barton K., 2013, MUMIN MULTIMODEL INF; BERKELEY SA, 1988, MAR FISH REV, V50, P9; Bjorge A, 2013, BIOL CONSERV, V161, P164, DOI 10.1016/j.biocon.2013.03.009; Booth GD, 1994, INT470 SU DEP AGR FO; Brostrom G., 2011, GLMMML GEN LINEAR MO; Brown SL, 2013, BIOL CONSERV, V168, P78, DOI 10.1016/j.biocon.2013.09.019; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Carbonell A, 2003, FISH RES, V61, P7, DOI 10.1016/S0165-7836(02)00242-4; Carretta JV, 2012, NMFSSWFSC488; Caurant F, 2009, USE ECOLOGICAL TRCER; Cox TM, 2004, BIOL CONSERV, V115, P203, DOI 10.1016/S0006-3207(03)00108-3; Cury PM, 2008, TRENDS ECOL EVOL, V23, P338, DOI 10.1016/j.tree.2008.02.005; de Boer MN., 2012, INT J BIODIVERS CONS, V4, P481, DOI DOI 10.5897/IJBC12.016; Di-Meglio Nathalie, 1996, Aquatic Mammals, V22, P11; Fernandez-Contreras MM, 2010, ICES J MAR SCI, V67, P1732, DOI 10.1093/icesjms/fsq077; FERRERO RC, 1995, FISH B-NOAA, V93, P483; Fiedler FN, 2012, BIODIVERS CONSERV, V21, P915, DOI 10.1007/s10531-012-0227-0; Filby NE, 2013, AUST J ZOOL, V61, P291, DOI 10.1071/ZO12033; Gannier Alexandre, 1999, Aquatic Mammals, V25, P123; Goldsworthy SD, 2006, MARINE MAMMALS FISHE, P62; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Hamer DJ, 2006, BIOL CONSERV, V130, P517, DOI 10.1016/j.biocon.2006.01.014; Hammond P.S., 2009, CETACEAN OFFSHORE DI; Hammond PS, 2013, BIOL CONSERV, V164, P107, DOI 10.1016/j.biocon.2013.04.010; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kastelein RA, 2006, MAR ENVIRON RES, V61, P363, DOI 10.1016/j.marenvres.2005.11.005; Kastelein RA, 2007, MAR ENVIRON RES, V64, P160, DOI 10.1016/j.marenvres.2006.12.012; Lahaye V, 2005, MAR ECOL PROG SER, V305, P275, DOI 10.3354/meps305275; Leung ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045389; Levin PS, 2010, FISH FISH, V11, P307, DOI 10.1111/j.1467-2979.2010.00355.x; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lopez A, 2003, BIOL CONSERV, V111, P25, DOI 10.1016/S0006-3207(02)00244-6; Macri S, 2002, ANIM BEHAV, V64, P541, DOI 10.1006/anbe.2002.4004; Mannocci L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032615; McAuley RB, 2007, ICES J MAR SCI, V64, P1702, DOI 10.1093/icesjms/fsm136; Mirimin L, 2009, MAR BIOL, V156, P821, DOI 10.1007/s00227-008-1120-y; Mooney TA, 2007, ICES J MAR SCI, V64, P1324, DOI 10.1093/icesjms/fsm135; Moore CH, 2009, ICES J MAR SCI, V66, P2068, DOI 10.1093/icesjms/fsp205; Morizur Y, 1999, FISH RES, V41, P297, DOI 10.1016/S0165-7836(99)00013-2; Murphy S, 2005, J MAMMAL, V86, P1247, DOI 10.1644/1545-1542(2005)86[1247:MSITMC]2.0.CO;2; Murphy S, 2006, ACTA ZOOL-STOCKHOLM, V87, P315, DOI 10.1111/j.1463-6395.2006.00245.x; Murphy S, 2009, MAR ECOL PROG SER, V388, P273, DOI 10.3354/meps08129; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Neumann Dirk R., 2001, Aquatic Mammals, V27, P121; Northridge S, 2006, PETRACET PELAGIC FIS; Northridge S, 2007, 2 ANN REPORT UK CETA; Northridge S.P., 1991, 320 FAO; O Cadhla O, 2002, CETACEANS SEABIRDS I, VII; Orphanides CD, 2009, J NW ATL FISH SCI, V42, P55, DOI DOI 10.2960/J.V42.M647; Owens IPF, 2002, SCIENCE, V297, P2008, DOI 10.1126/science.1076813; Palka D., 2009, NMFSNE212 NOAA; Perrin W.F., 1984, Reports of the International Whaling Commission Special Issue, P97; Perry RI, 2010, J MARINE SYST, V79, P427, DOI 10.1016/j.jmarsys.2008.12.017; Pusineri C, 2007, MAR MAMMAL SCI, V23, P30, DOI 10.1111/j.1748-7692.2006.00088.x; R Core Team, 2021, R LANGUAGE ENV STAT; Read AJ, 2006, CONSERV BIOL, V20, P163, DOI 10.1111/j.1523-1739.2006.00338.x; Rogan E, 2007, FISH RES, V86, P6, DOI 10.1016/j.fishres.2007.02.013; Rossman MC, 2010, J NW ATL FISH SCI, V42, P77, DOI DOI 10.2960/J.V42.M650; Silvani L, 1999, BIOL CONSERV, V90, P79, DOI 10.1016/S0006-3207(98)00079-2; Stockin KA, 2009, MAR MAMMAL SCI, V25, P283, DOI 10.1111/j.1748-7692.2008.00262.x; Svane I, 2009, ESTUAR COAST SHELF S, V82, P621, DOI 10.1016/j.ecss.2009.03.009; Thompson FN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064438; Travers M, 2010, J MARINE SYST, V79, P101, DOI 10.1016/j.jmarsys.2009.07.005; Tregenza N.J.C., 1997, Report of the International Whaling Commission, V47, P835; Tudela S, 2005, BIOL CONSERV, V121, P65, DOI 10.1016/j.biocon.2004.04.010; Van der Hoop JM, 2013, CONSERV BIOL, V27, P121, DOI 10.1111/j.1523-1739.2012.01934.x; Wade P.R., 2012, J MAR BIOL, V2012, P1, DOI [10.1155/2012/567276, DOI 10.1155/2012/567276]; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Yan J., 2002, R NEWS, V2, P12; Yates KL, 2013, MAR POLICY, V38, P140, DOI 10.1016/j.marpol.2012.05.030	78	9	9	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104468	10.1371/journal.pone.0104468	http://dx.doi.org/10.1371/journal.pone.0104468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121802	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000039
J	Carrillo-Sepulveda, MA; Keen, HL; Davis, DR; Grobe, JL; Sigmund, CD				Carrillo-Sepulveda, Maria Alicia; Keen, Henry L.; Davis, Deborah R.; Grobe, Justin L.; Sigmund, Curt D.			Role of Vascular Smooth Muscle PPAR gamma in Regulating AT(1) Receptor Signaling and Angiotensin II-Dependent Hypertension	PLOS ONE			English	Article							INSULIN-RESISTANCE; TYPE-1 RECEPTOR; DOWN-REGULATION; BLOOD-PRESSURE; INTERFERENCE; DYSFUNCTION; ACTIVATION; CELLS; ATHEROSCLEROSIS; ROSIGLITAZONE	Peroxisome proliferator activated receptor gamma (PPAR gamma) has been reported to play a protective role in the vasculature; however, the underlying mechanisms involved are not entirely known. We previously showed that vascular smooth muscle-specific overexpression of a dominant negative human PPAR gamma mutation in mice (S-P467L) leads to enhanced myogenic tone and increased angiotensin-II-dependent vasoconstriction. S-P467L mice also exhibit increased arterial blood pressure. Here we tested the hypotheses that a) mesenteric smooth muscle cells isolated from S-P467L mice exhibit enhanced angiotensinII AT(1) receptor signaling, and b) the increased arterial pressure of S-P467L mice is angiotensin-II AT(1) receptor dependent. Phosphorylation of mitogen-activated protein/extracellular signal-regulated kinase (ERK1/2) was robustly increased in mesenteric artery smooth muscle cell cultures from S-P467L in response to angiotensin-II. The increase in ERK1/2 activation by angiotensin-II was blocked by losartan, a blocker of AT(1) receptors. Angiotensin-II-induced ERK1/2 activation was also blocked by Tempol, a scavenger of reactive oxygen species, and correlated with increased Nox4 protein expression. To investigate whether endogenous renin-angiotensin system activity contributes to the elevated arterial pressure in S-P467L, non-transgenic and S-P467L mice were treated with the AT(1) receptor blocker, losartan (30 mg/kg per day), for 14-days and arterial pressure was assessed by radiotelemetry. At baseline S-P467L mice showed a significant increase of systolic arterial pressure (142.0 +/- 10.2 vs 129.1 +/- 3.0 mmHg, p<0.05). Treatment with losartan lowered systolic arterial pressure in S-P467L (132.2 +/- 6.9 mmHg) to a level similar to untreated non-transgenic mice. Losartan also lowered arterial pressure in non-transgenic (113.0 +/- 3.9 mmHg) mice, such that there was no difference in the losartan-induced depressor response between groups (-13.53 +/- 1.39 in S-P467L vs -16.16 +/- 3.14 mmHg in non-transgenic). Our results suggest that interference with PPAR gamma in smooth muscle: a) causes enhanced angiotensin-II AT(1) receptor-mediated ERK1/2 activation in resistance vessels, b) and may elevate arterial pressure through both angiotensin-II AT(1) receptor-dependent and -independent mechanisms.	[Carrillo-Sepulveda, Maria Alicia; Keen, Henry L.; Davis, Deborah R.; Grobe, Justin L.; Sigmund, Curt D.] Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA	University of Iowa	Sigmund, CD (corresponding author), Univ Iowa, Roy J & Lucille Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA.	curt-sigmund@uiowa.edu	Sigmund, Curt D./W-1611-2019	Sigmund, Curt D./0000-0002-1453-0921; Grobe, Justin/0000-0001-9737-0873	National Institutes of Health [HL048058, HL061446, HL062984, HL084207, HL098276]; Roy J. Carver Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048058, R37HL048058, R00HL098276, P01HL062984, R01HL061446, K99HL098276, P01HL084207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roy J. Carver Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported through research grants from the National Institutes of Health to CDS (HL048058, HL061446, HL062984), to CDS and JLG (HL084207), and to JLG (HL098276). The authors also gratefully acknowledge the generous research support of the Roy J. Carver Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Beyer AM, 2008, CIRC RES, V103, P654, DOI 10.1161/CIRCRESAHA.108.176339; Beyer AM, 2008, HYPERTENSION, V51, P867, DOI 10.1161/HYPERTENSIONAHA.107.103648; Blanquicett C, 2010, FREE RADICAL BIO MED, V48, P1618, DOI 10.1016/j.freeradbiomed.2010.03.007; Borges GR, 2014, HYPERTENSION; Caron-Debarle M, 2013, ARTERIOSCLER THROMB, V33, P829; Carrillo-Sepulveda MA, 2010, CARDIOVASC RES, V85, P560, DOI 10.1093/cvr/cvp304; Cat AND, 2013, ANTIOXID REDOX SIGN, V19, P1110, DOI 10.1089/ars.2012.4641; Diep QN, 2002, CIRCULATION, V105, P2296, DOI 10.1161/01.CIR.0000016049.86468.23; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gray SL, 2006, DIABETES, V55, P2669, DOI 10.2337/db06-0389; Green DE, 2012, AM J RESP CELL MOL, V47, P718, DOI 10.1165/rcmb.2011-0418OC; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Grobe JL, 2010, CELL METAB, V12, P431, DOI 10.1016/j.cmet.2010.09.011; Halabi CM, 2008, CELL METAB, V7, P215, DOI 10.1016/j.cmet.2007.12.008; Hilzendeger AM, 2013, HYPERTENSION, V61, P716, DOI 10.1161/HYPERTENSIONAHA.111.00356; Ji YY, 2009, LAB INVEST, V89, P887, DOI 10.1038/labinvest.2009.45; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Keen HL, 2010, ARTERIOSCL THROM VAS, V30, P518, DOI 10.1161/ATVBAHA.109.200733; Keen HL, 2004, PHYSIOL GENOMICS, V18, P33, DOI 10.1152/physiolgenomics.00027.2004; Ketsawatsomkron P, 2012, CIRC RES, V111, P1446, DOI 10.1161/CIRCRESAHA.112.271577; Kleinhenz JM, 2009, AM J PHYSIOL-HEART C, V297, pH1647, DOI 10.1152/ajpheart.00148.2009; Marchesi C, 2013, CARDIOVASC RES, V97, P562, DOI 10.1093/cvr/cvs362; Meredith D, 2009, ARTERIOSCL THROM VAS, V29, P465, DOI 10.1161/ATVBAHA.109.184234; Nicol CJ, 2005, AM J HYPERTENS, V18, P549, DOI 10.1016/j.amjhyper.2004.10.032; Nisbet RE, 2010, AM J RESP CELL MOL, V42, P482, DOI 10.1165/rcmb.2008-0132OC; Pelham CJ, 2013, AM J PHYSIOL-REG I, V304, pR690, DOI 10.1152/ajpregu.00607.2012; Pelham CJ, 2012, CELL METAB, V16, P462, DOI 10.1016/j.cmet.2012.08.011; Ryan MJ, 2004, HYPERTENSION, V43, P661, DOI 10.1161/01.HYP.0000116303.71408.c2; Sigmund CD, 2013, ARTERIOSCL THROM VAS, V33, P676, DOI 10.1161/ATVBAHA.112.301125; Sigmund CD, 2010, HYPERTENSION, V55, P437, DOI 10.1161/HYPERTENSIONAHA.109.144170; Subramanian V, 2010, CIRC RES, V107, P953, DOI 10.1161/CIRCRESAHA.110.219089; Takeda K, 2000, CIRCULATION, V102, P1834; Tham DM, 2002, PHYSIOL GENOMICS, V11, P21, DOI 10.1152/physiolgenomics.00062.2002; Tsai YS, 2004, J CLIN INVEST, V114, P240, DOI 10.1172/JCI200420964; Xiao J, 2009, CLIN IMMUNOL, V132, P266, DOI 10.1016/j.clim.2009.04.004; Yang HM, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.112; Zhang LL, 2010, J BIOL CHEM, V285, P13666, DOI 10.1074/jbc.M109.087718; Zhao SM, 2008, CHINESE J PHYSIOL, V51, P357	40	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103786	10.1371/journal.pone.0103786	http://dx.doi.org/10.1371/journal.pone.0103786			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122005	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000019
J	Du, XD; Li, L; Zhang, SD; Meng, F; Zhang, GF				Du, Xuedi; Li, Li; Zhang, Shoudu; Meng, Fei; Zhang, Guofan			SNP Identification by Transcriptome Sequencing and Candidate Gene-Based Association Analysis for Heat Tolerance in the Bay Scallop Argopecten irradians	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALLELE-SPECIFIC EXPRESSION; RNA-SEQ DATA; LAMARCK; POPULATION; DISCOVERY; SELECTION; TOOL; POLYMORPHISM; DEGRADATION	The northern bay scallop Argopecten irradians irradians (Lamarck) and the southern bay scallop Argopecten irradians concentricus (Say) were introduced into China in the 1980s and 1990s, and are now major aquaculture molluscs in China. Here, we report the transcriptome sequencing of the two subspecies and the subsequent association analysis on candidate gene on the trait of heat tolerance. In total, RNA from six tissues of 67 and 42 individuals of northern and southern bay scallops, respectively, were used and 55.5 and 34.9 million raw reads were generated, respectively. There were 82,267 unigenes produced in total, of which 32,595 were annotated. Altogether, 32,206 and 23,312 high-quality SNPs were identified for northern and southern bay scallops, respectively. For case-control analysis, two intercrossed populations were heat stress treated, and both heat-susceptible and heat-resistant individuals were collected. According to annotation and SNP allele frequency analysis, 476 unigenes were selected, and 399 pairs of primers were designed. Genotyping was conducted using the high-resolution melting method, and Fisher's exact test was performed for allele frequency comparison between the heat-susceptible and heat-resistant groups. SNP all-53308-760 T/C showed a significant difference in allele frequency between the heat-susceptible and heat-resistant groups. Notably, considerable difference in allele frequency at this locus was also observed between the sequenced natural populations. These results suggest that SNP all-53308- 760 T/C may be related to the heat tolerance of the bay scallop. Moreover, quantitative expression analysis revealed that the expression level of all-53308 was negatively correlated with heat tolerance of the bay scallop.	[Du, Xuedi; Li, Li; Zhang, Shoudu; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao, Shandong, Peoples R China; [Du, Xuedi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Meng, Fei] Biomarker Technol Corp, Dept Informat Anal, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao, Shandong, Peoples R China.	lili@qdio.ac.cn; gzhang@qdio.ac.cn	Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022; li, li/GPX-3938-2022; li, li/HII-4157-2022; Du, Xuedi/A-4008-2013	Du, Xuedi/0000-0002-6699-1658	National High Technology Research and Development Program (863 program) [2012AA10A410]; National Basic Research Program of China (973 Program) [2010CB126402]; earmarked fund for Modern Agro-industry Technology Research System [CARS-48]; Taishan Scholars Climbing Program of Shandong; Biomarker Technology Corporation	National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); earmarked fund for Modern Agro-industry Technology Research System; Taishan Scholars Climbing Program of Shandong; Biomarker Technology Corporation	This research was supported by National High Technology Research and Development Program (863 program, 2012AA10A410, LL), National Basic Research Program of China (973 Program, No.2010CB126402, LL), the earmarked fund for Modern Agro-industry Technology Research System (CARS-48, GZ), Taishan Scholars Climbing Program of Shandong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Fei Meng is employed by Biomarker Technology Corporation. Biomarker Technology Corporation provided support in the form of salary for author FM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Blake SG, 1997, J SHELLFISH RES, V16, P55; Brun NT, 2008, J EXP MAR BIOL ECOL, V358, P151, DOI 10.1016/j.jembe.2008.02.006; Brun NT, 2009, J EXP MAR BIOL ECOL, V371, P77, DOI 10.1016/j.jembe.2009.01.006; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Friant S, 2003, EMBO J, V22, P3783, DOI 10.1093/emboj/cdg375; Fu X, 2014, MOL ECOL RESOUR, V14, P184, DOI 10.1111/1755-0998.12169; Gao Q, 2008, FISH SHELLFISH IMMUN, V24, P379, DOI 10.1016/j.fsi.2007.08.008; Geraldes A, 2011, MOL ECOL RESOUR, V11, P81, DOI 10.1111/j.1755-0998.2010.02960.x; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knight JC, 2004, TRENDS GENET, V20, P113, DOI 10.1016/j.tig.2004.01.001; Li H, 2012, NAT GENET; Li RH, 2009, FISHERIES SCI, V75, P1389, DOI 10.1007/s12562-009-0167-0; Li YF, 2000, INTRO F1 REARING AM, P29; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Paschold A, 2012, GENOME RES, V22, P2445, DOI 10.1101/gr.138461.112; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qin YJ, 2007, AQUAC RES, V38, P174, DOI 10.1111/j.1365-2109.2006.01644.x; Roberts S, 2005, MOL ECOL NOTES, V5, P567, DOI 10.1111/j.1471-8286.2005.00996.x; Roberts SB, 2003, BIOL BULL-US, V205, P227, DOI 10.2307/1543266; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Salem M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036264; Schunter C, 2014, MOL ECOL RESOUR, V14, P157, DOI 10.1111/1755-0998.12155; Seeb JE, 2011, MOL ECOL RESOUR, V11, P335, DOI 10.1111/j.1755-0998.2010.02936.x; Seipp MT, 2007, J MOL DIAGN, V9, P284, DOI 10.2353/jmoldx.2007.060136; Shi YY, 2012, NAT GENET, V44, P1020, DOI 10.1038/ng.2384; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Song LS, 2006, MAR BIOTECHNOL, V8, P161, DOI 10.1007/s10126-005-0126-4; Springer NM, 2007, PLANT CELL, V19, P2391, DOI 10.1105/tpc.107.052258; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Torres JM, 2013, PEDIATR DIABETES, V14, P90, DOI 10.1111/pedi.12015; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Wang XQ, 2012, FISH SHELLFISH IMMUN, V33, P1016, DOI 10.1016/j.fsi.2012.08.026; Wen WW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4438; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Xiao H, 2005, AQUACULTURE, V250, P602, DOI 10.1016/j.aquaculture.2005.05.002; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yang CY, 2013, GENE, V526, P429, DOI 10.1016/j.gene.2013.05.033; Yang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028564; Yang HS, 1999, MAR SCI, V1; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zhang F., 2000, ENG SCI, V2, P30; Zhang Fusui, 1986, Oceanologia et Limnologia Sinica, V17, P367; Zhang Fusui, 1994, Oceanologia et Limnologia Sinica, V25, P372; Zhang G, 2007, AQUACULTURE, V272, pS320, DOI 10.1016/j.aquaculture.2007.07.206; Zhang G, 2007, J SHELLFISH RES, V26, P1355; Zhang HB, 2008, AQUAC RES, V39, P913, DOI 10.1111/j.1365-2109.2008.01948.x; Zhang H, 2009, FISH SHELLFISH IMMUN, V26, P56, DOI 10.1016/j.fsi.2008.07.019; Zhang X, 2009, GENETICS, V182, P943, DOI 10.1534/genetics.109.103499; Zheng HP, 2006, J SHELLFISH RES, V25, P807, DOI 10.2983/0730-8000(2006)25[807:HBTSOT]2.0.CO;2; Zheng HP, 2006, AQUACULTURE, V255, P579, DOI 10.1016/j.aquaculture.2005.11.037; Zheng H, 2011, AQUAC RES, V42, P602, DOI 10.1111/j.1365-2109.2010.02657.x	65	17	19	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104960	10.1371/journal.pone.0104960	http://dx.doi.org/10.1371/journal.pone.0104960			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121601	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000079
J	Greene, SL; Kisha, TJ; Yu, LX; Parra-Quijano, M				Greene, Stephanie L.; Kisha, Theodore J.; Yu, Long-Xi; Parra-Quijano, Mauricio			Conserving Plants in Gene Banks and Nature: Investigating Complementarity with Trifolium thompsonii Morton	PLOS ONE			English	Article							ESTIMATING POPULATION-STRUCTURE; MULTILOCUS GENOTYPE DATA; EX-SITU CONSERVATION; IN-SITU; DIVERSITY; DOMINANT; AFLP; WILD; L.; COLLECTION	A standard conservation strategy for plant genetic resources integrates in situ (on-farm or wild) and ex situ (gene or field bank) approaches. Gene bank managers collect ex situ accessions that represent a comprehensive snap shot of the genetic diversity of in situ populations at a given time and place. Although simple in theory, achieving complementary in situ and ex situ holdings is challenging. Using Trifolium thompsonii as a model insect-pollinated herbaceous perennial species, we used AFLP markers to compare genetic diversity and structure of ex situ accessions collected at two time periods (1995, 2004) from four locations, with their corresponding in situ populations sampled in 2009. Our goal was to assess the complementarity of the two approaches. We examined how gene flow, selection and genetic drift contributed to population change. Across locations, we found no difference in diversity between ex situ and in situ samples. One population showed a decline in genetic diversity over the 15 years studied. Population genetic differentiation among the four locations was significant, but weak. Association tests suggested infrequent, long distance gene flow. Selection and drift occurred, but differences due to spatial effects were three times as strong as differences attributed to temporal effects, and suggested recollection efforts could occur at intervals greater than fifteen years. An effective collecting strategy for insect pollinated herbaceous perennial species was to sample >150 plants, equalize maternal contribution, and sample along random transects with sufficient space between plants to minimize intrafamilial sampling. Quantifying genetic change between ex situ and in situ accessions allows genetic resource managers to validate ex situ collecting and maintenance protocols, develop appropriate recollection intervals, and provide an early detection mechanism for identifying problematic conditions that can be addressed to prevent further decline in vulnerable in situ populations.	[Greene, Stephanie L.] USDA ARS, Natl Ctr Genet Resource Preservat, Ft Collins, CO 80522 USA; [Kisha, Theodore J.; Yu, Long-Xi] USDA ARS, Western Reg Plant Intro Stn, Pullman, WA USA; [Parra-Quijano, Mauricio] Univ Politecn Madrid, Dept Biol Vegetal, Madrid, Spain	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Universidad Politecnica de Madrid	Greene, SL (corresponding author), USDA ARS, Natl Ctr Genet Resource Preservat, Ft Collins, CO 80522 USA.	stephanie.greene@ars.usda.gov		Greene, Stephanie/0000-0002-3624-5021	USDA Agricultural Research Service National Program [301, 215]; International Treaty on Plant Genetic Resources for Food and Agriculture - FAO	USDA Agricultural Research Service National Program; International Treaty on Plant Genetic Resources for Food and Agriculture - FAO	Sources of funding included USDA Agricultural Research Service National Program 301 and 215 and the International Treaty on Plant Genetic Resources for Food and Agriculture - FAO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; Baskauf CJ, 2009, J HERED, V100, P424, DOI 10.1093/jhered/esp033; Bomblies K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000890; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bothwell H, 2013, CONSERV GENET, V14, P467, DOI 10.1007/s10592-012-0411-5; Breese E. L., 1989, REGENERATION MULTIPL; Bretting PK, 1997, ADV AGRON, V61, P1, DOI 10.1016/S0065-2113(08)60661-6; Brown A. H. D., 1995, P75; Brown AHD, 1997, CROP SCI, V37, P7, DOI 10.2135/cropsci1997.0011183X003700010002x; Brutting C, 2013, PLANT BIOLOGY, V15, P505, DOI 10.1111/j.1438-8677.2012.00655.x; CANFIELD JE, 1977, THESIS U WASHINGTON; Che YH, 2011, CROP PASTURE SCI, V62, P639, DOI 10.1071/CP11065; Cobben MMP, 2011, ECOGRAPHY, V34, P920, DOI 10.1111/j.1600-0587.2011.06713.x; delRio AH, 1997, THEOR APPL GENET, V95, P199, DOI 10.1007/s001220050548; Duchesne P, 2002, MOL ECOL NOTES, V2, P380, DOI 10.1046/j.1471-8286.2002.00251.x; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; ELLSTRAND NC, 1992, OIKOS, V63, P77, DOI 10.2307/3545517; Etisham-Ul-Haq M, 2001, ANN BOT-LONDON, V87, P813, DOI 10.1006/anbo.2001.1420; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FELSENSTEIN J, 1993, PHYLOGENY INFERENCE; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2010, MOL ECOL, V19, P4638, DOI 10.1111/j.1365-294X.2010.04820.x; Garrido JL, 2012, ANN BOT-LONDON, V109, P953, DOI 10.1093/aob/mcs011; Gomaa NH, 2011, MOL ECOL, V20, P3540, DOI 10.1111/j.1365-294X.2011.05193.x; Gomez OJ, 2005, GENET RESOUR CROP EV, V52, P371, DOI 10.1007/s10722-005-2249-x; Greene SL, 2004, GENET RESOUR CROP EV, V51, P643, DOI 10.1023/B:GRES.0000024655.48989.ab; Hahn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041608; Hargreaves S, 2010, CONSERV GENET, V11, P1317, DOI 10.1007/s10592-009-9960-7; Harrod RJ, 2009, RESTOR ECOL, V17, P215, DOI 10.1111/j.1526-100X.2008.00371.x; Harrod RJ, 2005, NAT AREA J, V25, P156; Jabis MD, 2011, AM J BOT, V98, P1583, DOI 10.3732/ajb.1000515; Jarvis A, 2008, AGR ECOSYST ENVIRON, V126, P13, DOI 10.1016/j.agee.2008.01.013; Jensen HR, 2012, EVOL APPL, V5, P353, DOI 10.1111/j.1752-4571.2011.00227.x; Jorde PE, 1999, MOL ECOL, V8, P1171, DOI 10.1046/j.1365-294x.1999.00676.x; Khanlou KM, 2011, GENET MOL BIOL, V34, P252, DOI 10.1590/S1415-47572011000200015; Lauterbach D, 2012, BOT J LINN SOC, V168, P64, DOI 10.1111/j.1095-8339.2011.01185.x; Leberg P, 2005, J WILDLIFE MANAGE, V69, P1385, DOI 10.2193/0022-541X(2005)69[1385:GAFETE]2.0.CO;2; Li QM, 2005, BIOCHEM GENET, V43, P387, DOI 10.1007/s10528-005-6778-y; Li QM, 2002, BIOL CONSERV, V106, P151, DOI 10.1016/S0006-3207(01)00240-3; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Malice M, 2007, GENET RESOUR CROP EV, V54, P685, DOI 10.1007/s10722-006-9180-7; MANTEL N, 1967, CANCER RES, V27, P209; MARSHALL DR, 1975, CROP GENETIC RESOURC, V2, P53; Maxted N., 2008, P3, DOI 10.1079/9781845930998.0003; Maxted N, 2012, CROP SCI, V52, P774, DOI 10.2135/cropsci2011.08.0415; McInerny GJ, 2009, P ROY SOC B-BIOL SCI, V276, P1527, DOI 10.1098/rspb.2008.1567; Meirmans PG, 2011, MOL ECOL, V20, P3144, DOI 10.1111/j.1365-294X.2011.05164.x; Morris JB, 2001, CROP SCI, V41, P893, DOI 10.2135/cropsci2001.413893x; Mosjidis JA, 2004, CROP SCI, V44, P665, DOI 10.2135/cropsci2004.6650; NATURESERVE, 2011, NATURESERVE EXPL ONL; Negri V, 2010, GENETICA, V138, P985, DOI 10.1007/s10709-010-9485-5; Nei M., 1983, P 5 WORLD C GEN APPL, V21, P405; Osborn TJ, 2006, SCIENCE, V311, P841, DOI 10.1126/science.1120514; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peters MD, 2009, CONSERV GENET, V10, P1, DOI 10.1007/s10592-008-9509-1; Pritchard JK, 2000, GENETICS, V155, P945; Rice EB, 2006, CROP SCI, V46, P428, DOI 10.2135/cropsci2005.06-0116; Rivers MC, 2011, CONSERV GENET, V12, P1333, DOI 10.1007/s10592-011-0234-9; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sackville Hamilton N. R., 1997, HDB GENEBANKS, V5; Scherer G, 1996, NORTHWEST SCI, V70, P242; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; SOLERI D, 1995, ECON BOT, V49, P56, DOI 10.1007/BF02862278; Steffan-Dewenter I, 2008, J APPL ECOL, V45, P737, DOI 10.1111/j.1365-2664.2008.01483.x; Tin HQ, 2001, EUPHYTICA, V122, P491, DOI 10.1023/A:1017544406975; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Von Bothmer R., 1995, P93; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; WAITT J, 1983, LATE QUATERNARY ENV, V1; Wright S, 1931, GENETICS, V16, P0097; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	78	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105145	10.1371/journal.pone.0105145	http://dx.doi.org/10.1371/journal.pone.0105145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121602	gold, Green Submitted, Green Published			2022-12-27	WOS:000341017000100
J	Mazuc, E; Guglielmi, L; Bec, N; Parez, V; Hahn, CS; Mollevi, C; Parrinello, H; Desvignes, JP; Larroque, C; Jupp, R; Dariavach, P; Martineau, P				Mazuc, Elsa; Guglielmi, Laurence; Bec, Nicole; Parez, Vincent; Hahn, Chang S.; Mollevi, Caroline; Parrinello, Hugues; Desvignes, Jean-Pierre; Larroque, Christian; Jupp, Ray; Dariavach, Piona; Martineau, Pierre			In-Cell Intrabody Selection from a Diverse Human Library Identifies C12orf4 Protein as a New Player in Rodent Mast Cell Degranulation	PLOS ONE			English	Article							ANTIBODY FRAGMENT; INTRACELLULAR ANTIBODIES; SINGLE; IMMUNOGLOBULIN; TARGETS; KINASE; TRANSLOCATION; REPERTOIRE; PREVENTION; INHIBITION	The high specificity of antibodies for their antigen allows a fine discrimination of target conformations and post-translational modifications, making antibodies the first choice tool to interrogate the proteome. We describe here an approach based on a large-scale intracellular expression and selection of antibody fragments in eukaryotic cells, so-called intrabodies, and the subsequent identification of their natural target within living cell. Starting from a phenotypic trait, this integrated system allows the identification of new therapeutic targets together with their companion inhibitory intrabody. We applied this system in a model of allergy and inflammation. We first cloned a large and highly diverse intrabody library both in a plasmid and a retroviral eukaryotic expression vector. After transfection in the RBL-2H3 rat basophilic leukemia cell line, we performed seven rounds of selection to isolate cells displaying a defect in Fc epsilon RI-induced degranulation. We used high throughput sequencing to identify intrabody sequences enriched during the course of selection. Only one intrabody was common to both plasmid and retroviral selections, and was used to capture and identify its target from cell extracts. Mass spectrometry analysis identified protein RGD1311164 (C12orf4), with no previously described function. Our data demonstrate that RGD1311164 is a cytoplasmic protein implicated in the early signaling events following Fc epsilon RI-induced cell activation. This work illustrates the strength of the intrabody-based in-cell selection, which allowed the identification of a new player in mast cell activation together with its specific inhibitor intrabody.	[Mazuc, Elsa; Guglielmi, Laurence; Bec, Nicole; Parez, Vincent; Larroque, Christian; Dariavach, Piona; Martineau, Pierre] Inst Rech Cancerol Montpellier, IRCM, Montpellier, France; [Mazuc, Elsa; Guglielmi, Laurence; Bec, Nicole; Parez, Vincent; Larroque, Christian; Dariavach, Piona; Martineau, Pierre] INSERM, U896, Montpellier, France; [Mazuc, Elsa; Guglielmi, Laurence; Bec, Nicole; Parez, Vincent; Larroque, Christian; Dariavach, Piona; Martineau, Pierre] Univ Montpellier I, Montpellier, France; [Mazuc, Elsa; Guglielmi, Laurence; Bec, Nicole; Parez, Vincent; Larroque, Christian; Dariavach, Piona; Martineau, Pierre] Inst Reg Canc Montpellier, ICM, Montpellier, France; [Hahn, Chang S.; Jupp, Ray] Sanofi Aventis, Bridgewater, NJ USA; [Parrinello, Hugues; Desvignes, Jean-Pierre] MGX Montpellier GenomiX, Inst Genom Fonct, Montpellier, France; [Dariavach, Piona] Univ Montpellier 2, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Sanofi-Aventis; Universite de Montpellier; Universite de Montpellier	Dariavach, P (corresponding author), Inst Rech Cancerol Montpellier, IRCM, Montpellier, France.	piona.dariavach@inserm.fr; pierre.martineau@inserm.fr	Desvignes, Jean-Pierre/I-2858-2016; Mollevi, Caroline/AAA-6839-2019; Martineau, Pierre/N-4386-2017	Desvignes, Jean-Pierre/0000-0003-3142-1994; Mollevi, Caroline/0000-0003-4827-3684; Martineau, Pierre/0000-0002-7993-7183; bec, nicole/0000-0001-7608-2434; Guglielmi, Laurence/0000-0003-2517-4616	Sanofi-Aventis [L07053]; Labex MabImprove	Sanofi-Aventis(Sanofi-Aventis); Labex MabImprove	This work was supported by the Sanofi-Aventis collaboration agreement No L07053, and Labex MabImprove. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RD, 2000, CLIN CANCER RES, V6, P3081; Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Boldicke T, 2007, J CELL MOL MED, V11, P54, DOI 10.1111/j.1582-4934.2007.00002.x; Bounab Y, 2013, CURR OPIN IMMUNOL, V25, P313, DOI 10.1016/j.coi.2013.04.001; Butler DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029199; Cassimeris L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059812; Cattaneo A, 1999, TRENDS BIOTECHNOL, V17, P115, DOI 10.1016/S0167-7799(98)01268-2; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Cohen PA, 1998, ONCOGENE, V17, P2445, DOI 10.1038/sj.onc.1202190; D'Cruz OJ, 2012, J PHARM DRUG DELIV R, V1, DOI [10.4172/2325-9604.1000107, DOI 10.4172/2325-9604.1000107]; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; Dauvillier S, 2002, J IMMUNOL, V169, P2274, DOI 10.4049/jimmunol.169.5.2274; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Fisher AC, 2009, J MOL BIOL, V385, P299, DOI 10.1016/j.jmb.2008.10.051; Freund G, 2013, MABS-AUSTIN, V5, P518, DOI 10.4161/mabs.25084; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Gargano N, 1997, J GEN VIROL, V78, P2591, DOI 10.1099/0022-1317-78-10-2591; Gargano N, 1997, FEBS LETT, V414, P537, DOI 10.1016/S0014-5793(97)01065-X; Genini S, 2006, ANIM GENET, V37, P239, DOI 10.1111/j.1365-2052.2006.01447.x; Giudicelli V, 2006, NUCLEIC ACIDS RES, V34, pD781, DOI 10.1093/nar/gkj088; Griffin H, 2006, J MOL BIOL, V355, P360, DOI 10.1016/j.jmb.2005.10.077; Guglielmi L, 2011, PROTEIN ENG DES SEL, V24, P873, DOI 10.1093/protein/gzr049; Huang SD, 2012, CELL, V151, P937, DOI 10.1016/j.cell.2012.10.035; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kontermann RE, 2004, METHODS, V34, P163, DOI 10.1016/j.ymeth.2004.04.002; Li J, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/527610; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Marschall ALJ, 2011, MABS-AUSTIN, V3, P3, DOI 10.4161/mabs.3.1.14110; Martineau P, 1998, J MOL BIOL, V280, P117, DOI 10.1006/jmbi.1998.1840; Mazuc E, 2008, J ALLERGY CLIN IMMUN, V122, P188, DOI 10.1016/j.jaci.2008.04.026; Meltzer EO, 2005, J ALLERGY CLIN IMMUN, V115, P791, DOI 10.1016/j.jaci.2005.01.040; Miller TW, 2005, NEUROBIOL DIS, V19, P47, DOI 10.1016/j.nbd.2004.11.003; Norman P, 2009, EXPERT OPIN THER PAT, V19, P1469, DOI 10.1517/13543770903059281; Paz K, 2005, MOL CANCER THER, V4, P1801, DOI 10.1158/1535-7163.MCT-05-0174; Philibert P, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-81; Quintana FJ, 2012, J NEUROIMMUNOL, V248, P53, DOI 10.1016/j.jneuroim.2012.01.002; Rabu C, 2012, FUTURE ONCOL, V8, P943, DOI [10.2217/FON.12.88, 10.2217/fon.12.88]; Ravn U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq789; Riccaboni M, 2010, DRUG DISCOV TODAY, V15, P517, DOI 10.1016/j.drudis.2010.05.001; Schneider P, 2000, METHOD ENZYMOL, V322, P325; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sibler AP, 2003, EXP CELL RES, V286, P276, DOI 10.1016/S0014-4827(03)00093-4; Su C, 2002, MOL BIOL EVOL, V19, P205, DOI 10.1093/oxfordjournals.molbev.a004073; Swaminathan J, 2012, EXPERT OPIN DRUG DEL, V9, P1489, DOI 10.1517/17425247.2012.735658; Tanaka T, 2003, J MOL BIOL, V331, P1109, DOI 10.1016/S0022-2836(03)00836-2; Tanaka T, 2007, EMBO J, V26, P3250, DOI 10.1038/sj.emboj.7601744; Villoutreix BO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021117; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Xie J, 2014, CHEM BIOL, V21, P274, DOI 10.1016/j.chembiol.2013.12.006; Yea K, 2013, P NATL ACAD SCI USA, V110, P14966, DOI 10.1073/pnas.1313671110	52	11	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104998	10.1371/journal.pone.0104998	http://dx.doi.org/10.1371/journal.pone.0104998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122211	Green Submitted, Green Published, gold			2022-12-27	WOS:000341017000083
J	Fang, KY; Chen, F; Sen, AK; Davi, N; Huang, W; Li, JB; Seppa, H				Fang, Keyan; Chen, Fahu; Sen, Asok K.; Davi, Nicole; Huang, Wei; Li, Jinbao; Seppa, Heikki			Hydroclimate Variations in Central and Monsoonal Asia over the Past 700 Years	PLOS ONE			English	Article							PACIFIC DECADAL OSCILLATION; NORTHEASTERN TIBETAN PLATEAU; DROUGHT SEVERITY INDEX; TREE-RINGS; PRECIPITATION VARIATION; SURFACE-TEMPERATURE; CLIMATE VARIABILITY; MILLENNIUM; RECONSTRUCTION; RAINFALL	Hydroclimate variations since 1300 in central and monsoonal Asia and their interplay on interannual and interdecadal timescales are investigated using the tree-ring based Palmer Drought Severity Index (PDSI) reconstructions. Both the interannual and interdecadal variations in both regions are closely to the Pacific Decadal Oscillation (PDO). On interannual timescale, the most robust correlations are observed between PDO and hydroclimate in central Asia. Interannual hydroclimate variations in central Asia are more significant during the warm periods with high solar irradiance, which is likely due to the enhanced variability of the eastern tropical Pacific Ocean, the high-frequency component of PDO, during the warm periods. We observe that the periods with significant interdecadal hydroclimate changes in central Asia often correspond to periods without significant interdecadal variability in monsoonal Asia, particularly before the 19th century. The PDO-hydroclimate relationships appear to be bridged by the atmospheric circulation between central North Pacific Ocean and Tibetan Plateau, a key area of PDO. While, in some periods the atmospheric circulation between central North Pacific Ocean and monsoonal Asia may lead to significant interdecadal hydroclimate variations in monsoonal Asia.	[Fang, Keyan; Seppa, Heikki] Fujian Normal Univ, Coll Geog Sci, Minist Educ, Key Lab Humid Subtrop Eco Geog Proc, Fuzhou, Fujian, Peoples R China; [Fang, Keyan] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland; [Chen, Fahu; Huang, Wei] Lanzhou Univ, Key Lab Western Chinas Environm Syst MOE, Lanzhou, Gansu, Peoples R China; [Sen, Asok K.] Indiana Univ, Dept Math Sci, Richard G Lugar Ctr Renewable Energy, Indianapolis, IN 46204 USA; [Davi, Nicole] Columbia Univ, Lamont Doherty Geol Observ, Tree Ring Lab, Palisades, NY 10964 USA; [Li, Jinbao] Univ Hong Kong, Dept Geog, Hong Kong, Hong Kong, Peoples R China	Fujian Normal University; University of Helsinki; Lanzhou University; Indiana University System; Indiana University-Purdue University Indianapolis; Columbia University; University of Hong Kong	Fang, KY (corresponding author), Fujian Normal Univ, Coll Geog Sci, Minist Educ, Key Lab Humid Subtrop Eco Geog Proc, Fuzhou, Fujian, Peoples R China.	kujanfang@gmail.com; fhchen@lzu.edu.cn	Huang, Wei/W-5743-2018; Li, Jinbao/D-3561-2011; Fahu, Chen/B-2788-2011	Li, Jinbao/0000-0002-8919-4715; Davi, Nicole/0000-0002-4529-5418; Seppa, Heikki/0000-0003-2494-7955; Chen, Fahu/0000-0002-8874-1035; Fang, Keyan/0000-0002-0207-0112	National Basic Research Program of China [2012CB955301]; National Science Foundation of China [41210002]; Nordic top-level research initiative CRAICC (Cryosphere-atmosphere interactions in a changing Arctic climate); National Science Foundation (NSF) [AGS-PRF1137729]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nordic top-level research initiative CRAICC (Cryosphere-atmosphere interactions in a changing Arctic climate); National Science Foundation (NSF)(National Science Foundation (NSF))	This research is supported by National Basic Research Program of China (2012CB955301), National Science Foundation of China (41210002), the Nordic top-level research initiative CRAICC (Cryosphere-atmosphere interactions in a changing Arctic climate) and the National Science Foundation fellowship (NSF AGS-PRF1137729). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00619; BRETHERTON CS, 1992, J CLIMATE, V5, P541, DOI 10.1175/1520-0442(1992)005<0541:AIOMFF>2.0.CO;2; BROCCOLI AJ, 1992, J CLIMATE, V5, P1181, DOI 10.1175/1520-0442(1992)005<1181:TEOOOM>2.0.CO;2; Chen FH, 2010, QUATERNARY SCI REV, V29, P1055, DOI 10.1016/j.quascirev.2010.01.005; Chen FH, 2008, QUATERNARY SCI REV, V27, P351, DOI 10.1016/j.quascirev.2007.10.017; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Cook ER, 2004, SCIENCE, V306, P1015, DOI 10.1126/science.1102586; COOK ER, 1995, HOLOCENE, V5, P229, DOI 10.1177/095968369500500211; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; EDDY JA, 1976, SCIENCE, V192, P1189, DOI 10.1126/science.192.4245.1189; Fang K, 2012, QUATERNARY INT; Fang KY, 2011, CLIM RES, V49, P17, DOI 10.3354/cr01019; Fang KY, 2010, CLIM DYNAM, V35, P941, DOI 10.1007/s00382-009-0739-9; Fang KY, 2010, CLIM DYNAM, V35, P577, DOI 10.1007/s00382-009-0636-2; Feng S, 2013, ATMOS CHEM PHYS, V13, P10081, DOI 10.5194/acp-13-10081-2013; Gou XH, 2008, SCI CHINA SER D, V51, P41, DOI 10.1007/s11430-007-0154-1; Gou XH, 2010, CHINESE SCI BULL, V55, P4179, DOI 10.1007/s11434-010-4215-z; Huang J, 2012, ATMOS CHEM PHYS, V12, P5391, DOI 10.5194/acp-12-5391-2012; Li JB, 2011, NAT CLIM CHANGE, V1, P114, DOI [10.1038/nclimate1086, 10.1038/NCLIMATE1086]; Li JB, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL041162; Liu Y, 2006, SCI CHINA SER D, V49, P408, DOI 10.1007/s11430-006-0408-3; Liu Y, 2009, PALAEOGEOGR PALAEOCL, V282, P81, DOI 10.1016/j.palaeo.2009.08.012; Ma ZG, 2007, CHINESE SCI BULL, V52, P2130, DOI 10.1007/s11434-007-0284-z; MacDonald GM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022478; Mann ME, 1996, CLIMATIC CHANGE, V33, P409, DOI 10.1007/BF00142586; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Mariotti A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030078; Meehl GA, 2002, J CLIMATE, V15, P722, DOI 10.1175/1520-0442(2002)015<0722:TTBOAA>2.0.CO;2; Nan SL, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011559; Narisma GT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028628; Palmer W.C., 1965, WEATHER BUREAU RES P; Sato T, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022089; Shao XM, 2005, SCI CHINA SER D, V48, P939, DOI 10.1360/03yd0146; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Wells N, 2004, J CLIMATE, V17, P2335, DOI 10.1175/1520-0442(2004)017&lt;2335:ASPDSI&gt;2.0.CO;2; Yang LM, 2007, CHINESE J GEOPHYS-CH, V50, P412; Zhang QB, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017425; Zhao P, 2007, CLIM DYNAM, V29, P293, DOI 10.1007/s00382-007-0236-y	42	8	8	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e102751	10.1371/journal.pone.0102751	http://dx.doi.org/10.1371/journal.pone.0102751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119567	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600011
J	Jacobson, LDV; Hacon, SD; de Castro, HA; Ignotti, E; Artaxo, P; Saldiva, PHN; de Leon, ACMP				Viana Jacobson, Ludmilla da Silva; Hacon, Sandra de Souza; de Castro, Hermano Albuquerque; Ignotti, Eliane; Artaxo, Paulo; Nascimento Saldiva, Paulo Hilario; Monteiro Ponce de Leon, Antonio Carlos			Acute Effects of Particulate Matter and Black Carbon from Seasonal Fires on Peak Expiratory Flow of Schoolchildren in the Brazilian Amazon	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; RESPIRATORY SYMPTOMS; LUNG-FUNCTION; SUBEQUATORIAL AMAZON; DISTRIBUTED LAG; CHILDREN; HEALTH; PANEL	Background: Panel studies have shown adverse effects of air pollution from biomass burning on children's health. This study estimated the effect of current levels of outdoor air pollution in the Amazonian dry season on peak expiratory flow (PEF). Methods: A panel study with 234 schoolchildren from 6 to 15 years old living in the municipality of Tangara da Serra, Brazil was conducted. PEF was measured daily in the dry season in 2008. Mixed-effects models and unified modelling repeated for every child were applied. Time trends, temperature, humidity, and subject characteristics were regarded. Inhalable particulate matter (PM10), fine particulate matter (PM2.5), and black carbon (BC) effects were evaluated based on 24-hour exposure lagged by 1 to 5 days and the averages of 2 or 3 days. Polynomial distributed lag models (PDLM) were also applied. Results: The analyses revealed reductions in PEF for PM10 and PM2.5 increases of 10 mu g/m(3) and 1 mu g/m(3) for BC. For PM10, the reductions varied from 0.15 (confidence interval (CI) 95%: -0.29; -0.01) to 0.25 l/min (CI95%: -0.40; -0.10). For PM2.5, they ranged from 0.46 (CI95%: -0.86 to -0.06) to 0.54 l/min (CI95%: -0.95; -0.14). As for BC, the reduction was approximately 1.40 l/min. In relation to PDLM, adverse effects were noticed in models based on the exposure on the current day through the previous 3 days (PDLM 0-3) and on the current day through the previous 5 days (PDLM 0-5), specially for PM10. For all children, for PDLM 0-5 the global effect was important for PM10, with PEF reduction of 0.31 l/min (CI95%: -0.56; -0.05). Also, reductions in lags 3 and 4 were observed. These associations were stronger for children between 6 and 8 years old. Conclusion: Reductions in PEF were associated with air pollution, mainly for lagged exposures of 3 to 5 days and for younger children.	[Viana Jacobson, Ludmilla da Silva] Univ Fed Fluminense, Dept Stat, Niteroi, RJ, Brazil; [Hacon, Sandra de Souza; de Castro, Hermano Albuquerque] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, Brazil; [Ignotti, Eliane] Mato Grosso State Univ, Inst Nat & Technol Sci, Caceres, Brazil; [Artaxo, Paulo] Univ Sao Paulo, Inst Phys, Sao Paulo, Brazil; [Nascimento Saldiva, Paulo Hilario] Univ Sao Paulo, Dept Pathol, Sao Paulo, Brazil; [Monteiro Ponce de Leon, Antonio Carlos] Univ Estado Rio De Janeiro, Dept Epidemiol, Rio De Janeiro, Brazil	Universidade Federal Fluminense; Fundacao Oswaldo Cruz; Universidade do Estado de Mato Grosso; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade do Estado do Rio de Janeiro	Jacobson, LDV (corresponding author), Univ Fed Fluminense, Dept Stat, Niteroi, RJ, Brazil.	ludmillaviana@yahoo.com.br	DE HACON, SANDRA/AAL-8958-2020; Artaxo, Paulo/E-8874-2010; Ignotti, Eliane/ABD-2251-2020; de Leon, Antonio C M Ponce/G-5730-2012; Saldiva, Paulo HN/D-7385-2012; Hacon, Sandra/P-4815-2016	Artaxo, Paulo/0000-0001-7754-3036; de Leon, Antonio C M Ponce/0000-0002-0704-5215; Saldiva, Paulo HN/0000-0003-2005-8253; Hacon, Sandra/0000-0002-8222-0992	CNPq [555223/2006-0, 306620/2010-3, 573797/2008-0]; FAPESP [2008/57719-9]; FAPEMAT [10037682/2006, 010/2006]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPEMAT(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT))	This work was supported by CNPq (http://www.cnpq.br)- research grant no. 555223/2006-0 (Edital 18/CNPq), CNPq (http://www.cnpq.br) - research grant no. 306620/2010-3, CNPq (http://www.cnpq.br) - research grant no. 573797/2008-0, FAPESP (http://www.fapesp.br) - research grant no. 2008/57719-9, and FAPEMAT (http://www.fapemat.mt.gov.br) - research grant no. 10037682/2006 (Edital PPSUS-MT 2006/FAPEMAT - No. 010/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Oliveira BFA, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-64; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Castro Hermano Albuquerque de, 2009, Rev. Saúde Pública, V43, P26; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; do Carmo CN, 2010, REV PANAM SALUD PUBL, V27, P10, DOI 10.1590/S1020-49892010000100002; Epton MJ, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-16; Escamilla-Nunez MC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-74; Freitas Saulo R., 2005, Estud. av., V19, P167, DOI 10.1590/S0103-40142005000100011; Gold DR, 1999, EPIDEMIOLOGY, V10, P8, DOI 10.1097/00001648-199901000-00004; Gotschi T, 2008, EPIDEMIOLOGY, V19, P690, DOI 10.1097/EDE.0b013e318181650f; IBGE, 2010, CENS DEM; Ignotti E, 2010, CAD SAUDE PUBLICA, V26, P747, DOI 10.1590/S0102-311X2010000400017; Ignotti Eliane, 2007, Rev. bras. epidemiol., V10, P453; Jedrychowski WA, 2010, PAEDIATR PERINAT EP, V24, P492, DOI 10.1111/j.1365-3016.2010.01136.x; Li SS, 2012, J ASTHMA, V49, P895, DOI 10.3109/02770903.2012.724129; Lin WW, 2011, ENVIRON HEALTH PERSP, V119, P1507, DOI 10.1289/ehp.1103461; Malloy EJ, 2010, BIOSTATISTICS, V11, P432, DOI 10.1093/biostatistics/kxq003; Mascarenhas Márcio Dênis Medeiros, 2008, J. bras. pneumol., V34, P42, DOI 10.1590/S1806-37132008000100008; Murray, 2004, COMP QUANTIFICATION, V2; PAHO, 2005, ASS HLTH EFF AMB AIR; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; R Development Core Team, 2012, R LANG ENV STAT COMP; Riguera D, 2011, REV SAUDE PUBL, V45, P878, DOI 10.1590/S0034-89102011005000052; Roemer W, 1998, EUR RESPIR J, V12, P1354, DOI 10.1183/09031936.98.12061354; Schwartz J, 2000, EPIDEMIOLOGY, V11, P320, DOI 10.1097/00001648-200005000-00016; Silva Ageo Mário Cândido da, 2010, Rev. bras. epidemiol., V13, P337, DOI 10.1590/S1415-790X2010000200015; Sisenando HA, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-6; Snijders TAB, 1999, MULTILEVEL ANAL INTR, P261; Jacobson LDV, 2012, ENVIRON RES, V117, P27, DOI 10.1016/j.envres.2012.05.006; Ward DJ, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2003.007088; Weinmayr G, 2010, ENVIRON HEALTH PERSP, V118, P449, DOI 10.1289/ehp.0900844; World Health Organization, 2006, WHO AIR QUAL GUID PA; Xu ZW, 2012, ENVIRON RES, V117, P120, DOI 10.1016/j.envres.2012.07.002	34	39	41	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104177	10.1371/journal.pone.0104177	http://dx.doi.org/10.1371/journal.pone.0104177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118606	gold, Green Published			2022-12-27	WOS:000340900600039
J	Hu, SS; Zhang, HG; Zhang, QJ; Xiu, RJ				Hu, Shuai-Shuai; Zhang, Hong-Gang; Zhang, Qiu-Ju; Xiu, Rui-Juan			Small-Size Circulating Endothelial Microparticles in Coronary Artery Disease	PLOS ONE			English	Article							CELLS	Objectives: Several recent lines of evidence indicate that endothelial microparticles are a new biomarker that can be used to monitor endothelial dysfunction in coronary artery disease (CAD). However, data concerning the detection of small microparticles (diameter <0.5 mu m) are lacking. The aim of this study was to detect small-size endothelial microparticles (SEMPs) in CAD patients to monitor endothelial dysfunction. Methods: In total, 19 CAD patients and 14 healthy subjects were recruited. The absolute numbers and percentages of CD31(+)/CD42b(-) SEMPs and CD62E(+) SEMPs were determined by flow cytometry. Clinical parameters were also recorded. Results: The mean percentage of CD62E(+) SEMPs was higher in the CAD patient group than in the healthy subject group. The area under the receiver operating characteristic curve of the percentage of CD62E(+) SEMPs was 0.795, and the cut-off value was 1.35. There was no correlation between the percentage of CD62E(+) SEMPs and various clinical parameters. Conclusion: The percentage of CD62E(+) SEMPs is a potential biomarker for monitoring endothelial function in CAD.	[Zhang, Hong-Gang] Peking Union Med Coll, Inst Microcirculat, Beijing 100021, Peoples R China; Chinese Acad Med Sci, Key Lab Microcirculat, Natl Hlth & Family Planning Commiss, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Microcirculation - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Microcirculation - CAMS	Zhang, HG (corresponding author), Peking Union Med Coll, Inst Microcirculat, Beijing 100021, Peoples R China.	zhanghg1966126@imc.pumc.edu.cn	zhang, qiu/GXG-5600-2022	Xiu, Ruijuan/0000-0002-1446-2711	National Natural Science Foundation of China [3332013021]; Peking Union Medical College [3332013021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking Union Medical College	This study is project supported by the National Natural Science Foundation of China (Grant No. 3332013021) & Peking Union Medical College Innovation Funding (No. 3332013021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burger D, 2013, CLIN SCI, V124, P423, DOI 10.1042/CS20120309; Gutierrez E, 2013, EUR HEART J, V34, P3175, DOI 10.1093/eurheartj/eht351; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Montoro-Garcia S, 2013, ATHEROSCLEROSIS, V227, P313, DOI 10.1016/j.atherosclerosis.2013.01.028; Nozaki T, 2010, EUR J HEART FAIL, V12, P1223, DOI 10.1093/eurjhf/hfq145; Preston RA, 2003, HYPERTENSION, V41, P211, DOI 10.1161/01.HYP.0000049760.15764.2D; Robert S, 2012, ARTERIOSCL THROM VAS, V32, P1054, DOI 10.1161/ATVBAHA.111.244616; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; World Health Organization, 1999, WORLD HLTH REP, P13; Yuana Y, 2010, J THROMB HAEMOST, V8, P315, DOI 10.1111/j.1538-7836.2009.03654.x	11	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104528	10.1371/journal.pone.0104528	http://dx.doi.org/10.1371/journal.pone.0104528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116867	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400055
J	Paquette, AG; Lester, BM; Koestler, DC; Lesseur, C; Armstrong, DA; Marsit, CJ				Paquette, Alison G.; Lester, Barry M.; Koestler, Devin C.; Lesseur, Corina; Armstrong, David A.; Marsit, Carmen J.			Placental FKBP5 Genetic and Epigenetic Variation Is Associated with Infant Neurobehavioral Outcomes in the RICHS Cohort	PLOS ONE			English	Article							DNA METHYLATION; ADHD SYMPTOMS; STRESS; POLYMORPHISMS; PREGNANCY; RISK; ABNORMALITIES; EXPRESSION; EXPOSURE; SMOKING	Adverse maternal environments can lead to increased fetal exposure to maternal cortisol, which can cause infant neurobehavioral deficits. The placenta regulates fetal cortisol exposure and response, and placental DNA methylation can influence this function. FK506 binding protein (FKBP5) is a negative regulator of cortisol response, FKBP5 methylation has been linked to brain morphology and mental disorder risk, and genetic variation of FKBP5 was associated with post-traumatic stress disorder in adults. We hypothesized that placental FKBP5 methylation and genetic variation contribute to gene expression control, and are associated with infant neurodevelopmental outcomes assessed using the Neonatal Intensive Care Unit (NICU) Network Neurobehavioral Scales (NNNS). In 509 infants enrolled in the Rhode Island Child Health Study, placental FKBP5 methylation was measured at intron 7 using quantitative bisulfite pyrosequencing. Placental FKBP5 mRNA was measured in a subset of 61 infants by quantitative PCR, and the SNP rs1360780 was genotyped using a quantitative allelic discrimination assay. Relationships between methylation, expression and NNNS scores were examined using linear models adjusted for confounding variables, then logistic models were created to determine the influence of methylation on membership in high risk groups of infants. FKBP5 methylation was negatively associated with expression (P = 0.08, r = -0.22); infants with the TT genotype had higher expression than individuals with CC and CT genotypes (P = 0.06), and those with CC genotype displayed a negative relationship between methylation and expression (P = 0.06, r = -0.43). Infants in the highest quartile of FKBP5 methylation had increased risk of NNNS high arousal compared to infants in the lowest quartile (OR 2.22, CI 1.07-4.61). TT genotype infants had increased odds of high NNNS stress abstinence (OR 1.98, CI 0.92-4.26). Placental FKBP5 methylation reduces expression in a genotype specific fashion, and genetic variation supersedes this effect. These genetic and epigenetic differences in expression may alter the placenta's ability to modulate cortisol response and exposure, leading to altered neurobehavioral outcomes.	[Paquette, Alison G.; Lesseur, Corina; Armstrong, David A.; Marsit, Carmen J.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [Lester, Barry M.] Brown Univ, Warren Alpert Med Sch, Women & Infants Hosp, Ctr Study Children Risk,Dept Pediat, Providence, RI 02912 USA; [Koestler, Devin C.] Univ Kansas, Med Ctr, Dept Biostat, Kansas City, KS USA; [Marsit, Carmen J.] Geisel Sch Med Dartmouth, Sect Biostat & Epidemiol, Dept Community & Family Med, Hanover, NH USA	Dartmouth College; Brown University; Women & Infants Hospital Rhode Island; University of Kansas; University of Kansas Medical Center; Dartmouth College	Marsit, CJ (corresponding author), Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA.	Carmen.J.Marsit@dartmouth.edu	Lesseur, Corina/W-1034-2019; Koestler, Devin/D-7902-2015	Lesseur, Corina/0000-0001-6744-6750; Koestler, Devin/0000-0002-0598-0146; Marsit, Carmen/0000-0003-4566-150X	National Institutes of Health-National Institute of Mental Health (NIH-NIMH) [R01MH094609]; National Institute of Environmental Health Sciences (NIH-NIEHS) [R01ES022223]; NIH-NIEHS [P01 ES022832/EPA RD83544201]; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES022832, R01ES022223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094609] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Mental Health (NIH-NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Environmental Health Sciences (NIH-NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH-NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by grants received by CJM: National Institutes of Health-National Institute of Mental Health (NIH-NIMH) R01MH094609 (http://grants.nih.gov/grants/guide/search_results.htm?year = active&scope = rfa); National Institute of Environmental Health Sciences (NIH-NIEHS) R01ES022223 (http://www.niehs.nih.gov/research/supported/dert/programs/srp/funding/funding2/); and NIH-NIEHS P01 ES022832/EPA RD83544201 (http://www.niehs.nih.gov/funding/grants/mechanisms/p01/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074691; Armstrong DA, 2014, FASEB J, V28, P2088, DOI 10.1096/fj.13-238402; Baughman G, 1997, BIOCHEM BIOPH RES CO, V232, P437, DOI 10.1006/bbrc.1997.6307; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Blair LJ, 2013, J CLIN INVEST, V123, P4158, DOI 10.1172/JCI69003; Bromer C, 2012, DEV PSYCHOBIOL; Brown NC, 2009, J PEDIATR-US, V155, P32, DOI 10.1016/j.jpeds.2009.01.038; Coleman MB, 2013, EARLY HUM DEV, V89, P733, DOI 10.1016/j.earlhumdev.2013.05.006; Conradt E, 2013, EPIGENETICS-US, V8, P1321, DOI 10.4161/epi.26634; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ewald ER, 2014, PSYCHONEUROENDOCRINO, V44, P112, DOI 10.1016/j.psyneuen.2014.03.003; Fani N, 2013, JAMA PSYCHIAT, V70, P392, DOI 10.1001/2013.jamapsychiatry.210; Fink NS, 2012, J PEDIATR-US, V161, P1073, DOI 10.1016/j.jpeds.2012.05.036; Gabory A, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-5; Grissom NM, 2013, INT J DEV NEUROSCI, V31, P406, DOI 10.1016/j.ijdevneu.2012.11.006; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Houseman EA, 2014, BIOINFORMATICS; Ising M, 2008, EUR J NEUROSCI, V28, P389, DOI 10.1111/j.1460-9568.2008.06332.x; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Laplante DP, 2008, J AM ACAD CHILD PSY, V47, P1063, DOI 10.1097/CHI.0b013e31817eec80; Law KL, 2003, PEDIATRICS, V111, P1318, DOI 10.1542/peds.111.6.1318; LESSARD J, 2013, HLTH PSYCHOL; Lester BM, 2009, DEV NEUROSCI-BASEL, V31, P23, DOI 10.1159/000207491; Lester BM, 2004, PEDIATRICS, V113, P641; Lester BM, 2004, PEDIATRICS, V113, P634; Levy-Gigi E, 2013, BIOL PSYCHIAT, V74, P793, DOI 10.1016/j.biopsych.2013.05.017; Liu J, 2010, PEDIATRICS, V125, pE90, DOI 10.1542/peds.2009-0204; Luijk MPCM, 2010, PSYCHONEUROENDOCRINO, V35, P1454, DOI 10.1016/j.psyneuen.2010.04.012; Marsit CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033794; Mehta D, 2011, ARCH GEN PSYCHIAT, V68, P901, DOI 10.1001/archgenpsychiatry.2011.50; Meller M, 2005, PLACENTA, V26, P601, DOI 10.1016/j.placenta.2004.09.009; Menke A, 2013, GENES BRAIN BEHAV, V12, P289, DOI 10.1111/gbb.12026; Novakovic B, 2012, PLACENTA, V33, P959, DOI 10.1016/j.placenta.2012.10.003; Novakovic B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-529; O'Connor TG, 2013, DEV PSYCHOBIOL, V55, P145, DOI 10.1002/dev.21007; Paquette AG, 2013, EPIGENETICS-US, V8, P796, DOI 10.4161/epi.25358; R Core Team, 2013, R LANG ENV STAT COMP; Rodriguez A, 2005, J CHILD PSYCHOL PSYC, V46, P246, DOI 10.1111/j.1469-7610.2004.00359.x; Sandman Curt A, 2011, Int J Pept, V2011, P837596, DOI 10.1155/2011/837596; Seckl JR, 2007, PROG BRAIN RES, V167, P17, DOI 10.1016/S0079-6123(07)67002-2; Stephens BE, 2010, J PEDIATR-US, V156, P366, DOI 10.1016/j.jpeds.2009.09.042; Suter M, 2011, EPIGENETICS-US, V6, P1284, DOI 10.4161/epi.6.11.17819; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Tronick E, 2013, J CHILD ADOL PS NURS, V26, P193, DOI 10.1111/jcap.12042; URSACHE A, 2013, DEV PSYCHOBIOLOGY; Van den Bergh BRH, 2004, CHILD DEV, V75, P1085, DOI 10.1111/j.1467-8624.2004.00727.x; Xie P, 2010, NEUROPSYCHOPHARMACOL, V35, P1684, DOI 10.1038/npp.2010.37; YEN SSC, 1994, J REPROD MED, V39, P277; ZANNAS AS, 2013, GENES BRAIN BEHAV	51	48	48	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104913	10.1371/journal.pone.0104913	http://dx.doi.org/10.1371/journal.pone.0104913			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115650	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400105
J	Hofland, J; Steenbergen, J; Voorsluijs, JM; Verbiest, MMPJ; de Krijger, RR; Hofland, LJ; de Herder, WW; Uitterlinden, AG; Feelders, RA; de Jong, FH				Hofland, Johannes; Steenbergen, Jacobie; Voorsluijs, Jacoba M.; Verbiest, Michael M. P. J.; de Krijger, Ronald R.; Hofland, Leo J.; de Herder, Wouter W.; Uitterlinden, Andre G.; Feelders, Richard A.; de Jong, Frank H.			Inhibin Alpha-Subunit (INHA) Expression in Adrenocortical Cancer Is Linked to Genetic and Epigenetic INHA Promoter Variation	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; ADRENAL-CORTICAL CARCINOMA; PROGNOSTIC VALUE; DEFICIENT MICE; TUMORS; ACTIVIN; SECRETION; CORTEX; ACTIVATION; CHILDHOOD	Adrenocortical carcinoma (ACC) is a rare, but highly malignant tumor of unknown origin. Inhibin alpha-subunit (Inha) knockout mice develop ACCs following gonadectomy. In man, INHA expression varies widely within ACC tissues and its circulating peptide inhibin pro-alpha C has been described as a novel tumor marker for ACC. We investigated whether genetic and epigenetic changes of the INHA gene in human ACC cause loss or variation of INHA expression. To this end, analyses of INHA sequence, promoter methylation and mRNA expression were performed in human adrenocortical tissues. Serum inhibin pro-alpha C levels were also measured in ACC patients. INHA genetic analysis in 37 unique ACCs revealed 10 novel, heterozygous rare variants. Of the 3 coding bases affected, one variant was synonymous and two were missense variants: S72F and S184F. The minor allele of rs11893842 at -124 bp was observed at a low frequency (24%) in ACC samples and was associated with decreased INHA mRNA levels: 4.7 +/- 1.9 arbitrary units for AA, compared to 26 +/- 11 for AG/GG genotypes (P = 0.034). The methylation of four proximal INHA promoter CpGs was aberrantly increased in five ACCs (47.7 +/- 3.9%), compared to normal adrenals (18.4 +/- 0.6%, P = 0.0052), whereas the other 14 ACCs studied showed diminished promoter methylation (9.8 +/- 1.1%, P = 0.020). CpG methylation was inversely correlated to INHA mRNA levels in ACCs (r = -0.701, p = 0.0036), but not associated with serum inhibin pro-alpha C levels. In conclusion, aberrant methylation and common genetic variation in the INHA promoter occur in human ACCs and are associated with decreased INHA expression.	[Hofland, Johannes; Steenbergen, Jacobie; Voorsluijs, Jacoba M.; Verbiest, Michael M. P. J.; Hofland, Leo J.; de Herder, Wouter W.; Uitterlinden, Andre G.; Feelders, Richard A.; de Jong, Frank H.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [de Krijger, Ronald R.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Hofland, J (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	j.hofland@erasmusmc.nl	Hofland, Johannes/I-6379-2013; de Krijger, Ronald/J-2564-2019; De Jong, Frank H/A-9876-2011; de+Herder, Wouter/AAN-8429-2021	De Jong, Frank H/0000-0003-3578-1065; 				Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arola J, 2000, J ENDOCRINOL, V165, P223, DOI 10.1677/joe.0.1650223; Beuschlein F, 2003, MOL CELL BIOL, V23, P3951, DOI 10.1128/MCB.23.11.3951-3964.2003; Boulle N, 1998, J CLIN ENDOCR METAB, V83, P1713, DOI 10.1210/jc.83.5.1713; DEJONG FH, 1988, PHYSIOL REV, V68, P555, DOI 10.1152/physrev.1988.68.2.555; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fassnacht M, 2009, CANCER-AM CANCER SOC, V115, P243, DOI 10.1002/cncr.24030; Figueiredo BC, 1999, J CLIN ENDOCR METAB, V84, P1116, DOI 10.1210/jc.84.3.1116; Hisada M, 1998, JNCI-J NATL CANCER I, V90, P606, DOI 10.1093/jnci/90.8.606; Hofland J, 2006, CLIN ENDOCRINOL, V65, P792, DOI 10.1111/j.1365-2265.2006.02668.x; Hofland J, 2013, AM J PHYSIOL-ENDOC M, V305, pE736, DOI 10.1152/ajpendo.00034.2013; Hofland J, 2012, MOL CELL ENDOCRINOL, V359, P92, DOI 10.1016/j.mce.2011.06.005; Hofland J, 2012, EUR J ENDOCRINOL, V166, P281, DOI 10.1530/EJE-11-0693; Ito M, 2000, MOL ENDOCRINOL, V14, P66, DOI 10.1210/me.14.1.66; James LA, 1999, BRIT J CANCER, V81, P300, DOI 10.1038/sj.bjc.6990691; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Liu J, 2004, J MOL ENDOCRINOL, V33, P651, DOI 10.1677/jme.1.01560; Longui CA, 2004, J MED GENET, V41, P354, DOI 10.1136/jmg.2004.018978; Looyenga BD, 2006, MOL ENDOCRINOL, V20, P2848, DOI 10.1210/me.2006-0182; Looyenga BD, 2010, MOL ENDOCRINOL, V24, P608, DOI 10.1210/me.2008-0374; MATZUK MM, 1994, P NATL ACAD SCI USA, V91, P8817, DOI 10.1073/pnas.91.19.8817; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; McCluggage WG, 1998, J CLIN PATHOL, V51, P114, DOI 10.1136/jcp.51.2.114; Munro LMA, 1999, J ENDOCRINOL, V161, P341, DOI 10.1677/joe.0.1610341; NISHI Y, 1995, EUR J ENDOCRINOL, V132, P292, DOI 10.1530/eje.0.1320292; Nishi Yoshihiro, 2000, Fukuoka Acta Medica, V91, P8; Pelkey TJ, 1998, MODERN PATHOL, V11, P516; REINCKE M, 1994, J CLIN ENDOCR METAB, V78, P790, DOI 10.1210/jc.78.3.790; Renshaw AA, 1998, MODERN PATHOL, V11, P1160; Sidhu S, 2002, J CLIN ENDOCR METAB, V87, P3467, DOI 10.1210/jc.87.7.3467; SOREIDE JA, 1992, WORLD J SURG, V16, P663, DOI 10.1007/BF02067349; Tissier F, 2005, CANCER RES, V65, P7622, DOI 10.1158/0008-5472.CAN-05-0593; Tremblay JJ, 2001, ENDOCRINOLOGY, V142, P977, DOI 10.1210/en.142.3.977; Utriainen P, 2006, J ENDOCRINOL, V188, P305, DOI 10.1677/joe.1.06392; van't Sant HP, 2007, HISTOPATHOLOGY, V51, P239, DOI 10.1111/j.1365-2559.2007.02747.x; VOUTILAINEN R, 1995, EUR J ENDOCRINOL, V132, P290, DOI 10.1530/eje.0.1320290; WIEDEMANN HR, 1983, EUR J PEDIATR, V140, P5, DOI 10.1007/BF00661895; WOOTEN MD, 1993, CANCER, V72, P3145, DOI 10.1002/1097-0142(19931201)72:11<3145::AID-CNCR2820721105>3.0.CO;2-N	38	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104944	10.1371/journal.pone.0104944	http://dx.doi.org/10.1371/journal.pone.0104944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111790	Green Submitted, gold, Green Published			2022-12-27	WOS:000341105100113
J	Cai, RR; Yuan, Y; Zhou, Y; Xia, WQ; Wang, P; Sun, HX; Yang, Y; Huang, R; Wang, SH				Cai, Rongrong; Yuan, Yang; Zhou, Yi; Xia, Wenqing; Wang, Pin; Sun, Haixia; Yang, Yue; Huang, Rong; Wang, Shaohua			Lower Intensified Target LDL-c Level of Statin Therapy Results in a Higher Risk of Incident Diabetes: A Meta-Analysis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; 14 RANDOMIZED-TRIALS; PRIMARY PREVENTION; CHOLESTEROL; EFFICACY; ATORVASTATIN; PRAVASTATIN; EVENTS; ROSUVASTATIN; MEN	Background: A recent meta-analysis has reported that intensive-dose statin drug increases the risk of incident diabetes. However, doubling of the statin dose generates only a further 6% decrease in low-density lipoprotein cholesterol (LDL-c) on average. This study aimed to determine whether statin therapy with lower intensive-target LDL-c level contributes to higher risk of new-onset diabetes. Methods: Medline, Embase, and the Cochrane Central Register of Controlled Trials were searched for randomized controlled endpoint trials of statins conducted from 1966 to 2012. We included trials with more than 1000 participants who were followed up for at least 2 years. The included trials were stratified by the target LDL-c level. I-2 statistic was used to measure heterogeneity between trials. We further calculated risk estimates with random-effect meta-analysis. Meta-regression was used to identify the potential risk factors of statin-induced diabetes. Results: Fourteen trials with a total of 95 102 non-diabetic participants were included. The risks elevated by 33% [odds ratio (OR) = 1.33; 95% confidence interval (CI) 1.14-1.56; I-2 = 7.7%] and 16% (OR = 1.16; 95% CI 1.06-1.28; I-2 = 0.0%) when the intensified target LDL-c levels were <= 1.8 mmol/L and 1.8-2.59 mmol/L, respectively. The risk of incident diabetes did not increase when the target LDL-c level was >= 2.59 mmol/L. Apart from age, female, and baseline level of total cholesterol, meta-regression analysis showed that the target and baseline levels of LDL-c and relative LDL-c reduction were predictors of statin-induced diabetes. Conclusion: A lower intensified target LDL-c level of statin therapy resulted in a higher risk of incident diabetes.	[Cai, Rongrong; Yuan, Yang; Zhou, Yi; Xia, Wenqing; Wang, Pin; Sun, Haixia; Yang, Yue; Huang, Rong; Wang, Shaohua] Southeast Univ, Affiliated ZhongDa Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Wang, SH (corresponding author), Southeast Univ, Affiliated ZhongDa Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China.	gyjwsh@gmail.com		Wang, Shaohua/0000-0001-9567-6668	National Natural Science Foundation of China [81370921, 81070638, 81070916]; Social Development Project of JiangSu Province [SBE201170735]; National Nature Science Youth Foundation of China [81200635]; National Nature Science Foundation of Jiangsu Province [SBK201122155]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Social Development Project of JiangSu Province; National Nature Science Youth Foundation of China; National Nature Science Foundation of Jiangsu Province	This work was partially supported by the National Natural Science Foundation of China (No. 81370921, Wang SH; No. 81070638, Wang SH; and No. 81070916, Guo YJ), the Social Development Project of JiangSu Province (No. SBE201170735, Wang SH), the National Nature Science Youth Foundation of China (No. 81200635, Yang Y), and the National Nature Science Foundation of Jiangsu Province (No. SBK201122155, Yang Y). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarenco P, 2006, NEW ENGL J MED, V355, P549; [Anonymous], 2000, Ital Heart J, V1, P810; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Collins R, 2003, LANCET, V361, P2005; da Silva CR, 2005, REV SAUDE PUBL, V39, P865, DOI 10.1590/S0034-89102005000600001; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Germano G, 2012, EUR HEART J, V33, P137; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kjaergard LL, 2008, ANN INTERN MED, V149, P219, DOI 10.7326/0003-4819-149-3-200808050-00023; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; Koh KK, 2012, INT J CARDIOL, V154, P97, DOI 10.1016/j.ijcard.2011.09.002; Kruit JK, 2010, CURR OPIN LIPIDOL, V21, P178, DOI 10.1097/MOL.0b013e328339387b; Kumar V. H., 2011, ASIAN J PHARM CLIN R, V4, P74; Marder SR, 2004, AM J PSYCHIAT, V161, P1334, DOI 10.1176/appi.ajp.161.8.1334; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Nakata M, 1999, CELL STRUCT FUNCT, V24, P451, DOI 10.1247/csf.24.451; Navarese EP, 2013, AM J CARDIOL, V111, P1123, DOI 10.1016/j.amjcard.2012.12.037; Nicholls SJ, 2010, AM J CARDIOL, V105, P69, DOI 10.1016/j.amjcard.2009.08.651; PEDERSEN TR, 1994, LANCET, V344, P1383; Preiss D, 2011, CURR OPIN LIPIDOL, V22, P460, DOI 10.1097/MOL.0b013e32834b4994; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sattar N, 2012, ATHEROSCLEROSIS SUPP, V13, P1, DOI 10.1016/j.atherosclerosissup.2012.06.001; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Ting RZW, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-77; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Waters DD, 2011, J AM COLL CARDIOL, V57, P1535, DOI 10.1016/j.jacc.2010.10.047	40	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104922	10.1371/journal.pone.0104922	http://dx.doi.org/10.1371/journal.pone.0104922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122464	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000076
J	Matsumura, H; Umezawa, K; Takeda, K; Sugimoto, N; Ishida, T; Samejima, M; Ohno, H; Yoshida, M; Igarashi, K; Nakamura, N				Matsumura, Hirotoshi; Umezawa, Kiwamu; Takeda, Kouta; Sugimoto, Naohisa; Ishida, Takuya; Samejima, Masahiro; Ohno, Hiroyuki; Yoshida, Makoto; Igarashi, Kiyohiko; Nakamura, Nobuhumi			Discovery of a Eukaryotic Pyrroloquinoline Quinone-Dependent Oxidoreductase Belonging to a New Auxiliary Activity Family in the Database of Carbohydrate-Active Enzymes	PLOS ONE			English	Article							QUINOPROTEIN GLUCOSE-DEHYDROGENASE; PHANEROCHAETE-CHRYSOSPORIUM; CELLOBIOSE DEHYDROGENASE; ALCOHOL DEHYDROGENASES; SUBSTRATE-SPECIFICITY; PQQ; COFACTOR; OXIDASE; MAFFT	Pyrroloquinoline quinone (PQQ) is a redox cofactor utilized by a number of prokaryotic dehydrogenases. Not all prokaryotic organisms are capable of synthesizing PQQ, even though it plays important roles in the growth and development of many organisms, including humans. The existence of PQQ-dependent enzymes in eukaryotes has been suggested based on homology studies or the presence of PQQ-binding motifs, but there has been no evidence that such enzymes utilize PQQ as a redox cofactor. However, during our studies of hemoproteins, we fortuitously discovered a novel PQQ-dependent sugar oxidoreductase in a mushroom, the basidiomycete Coprinopsis cinerea. The enzyme protein has a signal peptide for extracellular secretion and a domain for adsorption on cellulose, in addition to the PQQ-dependent sugar dehydrogenase and cytochrome domains. Although this enzyme shows low amino acid sequence homology with known PQQ-dependent enzymes, it strongly binds PQQ and shows PQQ-dependent activity. BLAST search uncovered the existence of many genes encoding homologous proteins in bacteria, archaea, amoebozoa, and fungi, and phylogenetic analysis suggested that these quinoproteins may be members of a new family that is widely distributed not only in prokaryotes, but also in eukaryotes.	[Matsumura, Hirotoshi; Sugimoto, Naohisa; Ishida, Takuya; Samejima, Masahiro; Igarashi, Kiyohiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo, Japan; [Umezawa, Kiwamu; Yoshida, Makoto] Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Tokyo, Japan; [Takeda, Kouta; Ohno, Hiroyuki; Nakamura, Nobuhumi] Tokyo Univ Agr & Technol, Dept Biotechnol & Life Sci, Tokyo, Japan; [Ishida, Takuya; Igarashi, Kiyohiko; Nakamura, Nobuhumi] Japan Sci & Technol Agcy JST, Adv Low Carbon Technol Res & Dev Program ALCA, Tokyo, Japan	University of Tokyo; Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology; Japan Science & Technology Agency (JST)	Yoshida, M (corresponding author), Tokyo Univ Agr & Technol, Dept Environm & Nat Resource Sci, Tokyo, Japan.	ymakoto@cc.tuat.ac.jp; aquarius@mail.ecc.u-tokyo.ac.jp; nobu1@cc.tuat.ac.jp	Nakamura, Nobuhumi/C-1972-2013; Ohno, Hiroyuki/F-6459-2012; Yoshida, Makoto/E-8017-2013; Igarashi, Kiyohiko/E-6799-2016; Takeda, Kouta/G-6554-2016	Nakamura, Nobuhumi/0000-0002-5373-2972; Ohno, Hiroyuki/0000-0001-9716-3495; Igarashi, Kiyohiko/0000-0001-5152-7177; Takeda, Kouta/0000-0001-5227-4132; Umezawa, Kiwamu/0000-0003-1277-0558	JSPS [21605004]; Japanese Ministry of Education, Culture, Sports, and Technology (MEXT) [24114001, 24114008]; Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [208304]; Grants-in-Aid for Scientific Research [14J08641, 14J08518] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Culture, Sports, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported financially by grants from JSPS (No. 21605004 to N. N.), by a Grant-in-Aid for Innovative Areas (No. 24114001 and 24114008 to K. I.) from the Japanese Ministry of Education, Culture, Sports, and Technology (MEXT), and by a grant from the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST) to K. I. and N. N. H. M. was supported by a research fellowship from the Japan Society for the Promotion of Science (JSPS) for Young Scientists (Grant No. 208304) during his postdoc period at the University of Tokyo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anthony C, 1998, PROG BIOPHYS MOL BIO, V69, P1, DOI 10.1016/S0079-6107(97)00020-5; Anthony C, 2001, ANTIOXID REDOX SIGN, V3, P757, DOI 10.1089/15230860152664966; AYERS AR, 1978, EUR J BIOCHEM, V90, P171, DOI 10.1111/j.1432-1033.1978.tb12588.x; Bishop B, 2009, NAT STRUCT MOL BIOL, V16, P698, DOI 10.1038/nsmb.1607; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hallberg BM, 2000, STRUCT FOLD DES, V8, P79, DOI 10.1016/S0969-2126(00)00082-4; Harris CB, 2013, J NUTR BIOCHEM, V24, P2076, DOI 10.1016/j.jnutbio.2013.07.008; HAUGE JG, 1964, J BIOL CHEM, V239, P3630; Igarashi K, 1999, J BIOL CHEM, V274, P3338, DOI 10.1074/jbc.274.6.3338; Igarashi S, 2004, BIOMOL ENG, V21, P81, DOI 10.1016/j.bioeng.2003.12.001; Jongejan JA, 1989, CHEM PQQ; Kasahara T, 2003, NATURE, V422, P832, DOI 10.1038/422832a; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; KREMER SM, 1992, EUR J BIOCHEM, V205, P133, DOI 10.1111/j.1432-1033.1992.tb16760.x; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Matsushita K, 2002, APPL MICROBIOL BIOT, V58, P13, DOI 10.1007/s00253-001-0851-1; Misra HS, 2012, J BIOSCIENCES, V37, P313, DOI 10.1007/s12038-012-9195-5; Oubrie A, 1999, EMBO J, V18, P5187, DOI 10.1093/emboj/18.19.5187; Oubrie A, 1999, P NATL ACAD SCI USA, V96, P11787, DOI 10.1073/pnas.96.21.11787; Oubrie A, 1999, J MOL BIOL, V289, P319, DOI 10.1006/jmbi.1999.2766; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Sakuraba H, 2010, ARCH BIOCHEM BIOPHYS, V502, P81, DOI 10.1016/j.abb.2010.08.002; SALISBURY SA, 1979, NATURE, V280, P843, DOI 10.1038/280843a0; SAMEJIMA M, 1992, EUR J BIOCHEM, V207, P103, DOI 10.1111/j.1432-1033.1992.tb17026.x; Southall SM, 2006, J BIOL CHEM, V281, P30650, DOI 10.1074/jbc.M601783200; Stites TE, 2000, J NUTR, V130, P719, DOI 10.1093/jn/130.4.719; Toyama H, 2004, ARCH BIOCHEM BIOPHYS, V428, P10, DOI 10.1016/j.abb.2004.03.037; YANAGI SO, 1988, AGR BIOL CHEM TOKYO, V52, P281; Yoshida M, 2005, APPL ENVIRON MICROB, V71, P4548, DOI 10.1128/AEM.71.8.4548-4555.2005; Yoshida M, 2001, BIOSCI BIOTECH BIOCH, V65, P2050, DOI 10.1271/bbb.65.2050	36	48	48	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104851	10.1371/journal.pone.0104851	http://dx.doi.org/10.1371/journal.pone.0104851			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121592	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000065
J	Andre, A; Quillevere, F; Morard, R; Ujiie, Y; Escarguel, G; de Vargas, C; de Garidel-Thoron, T; Douady, CJ				Andre, Aurore; Quillevere, Frederic; Morard, Raphael; Ujiie, Yurika; Escarguel, Gilles; de Vargas, Colomban; de Garidel-Thoron, Thibault; Douady, Christophe J.			SSU rDNA Divergence in Planktonic Foraminifera: Molecular Taxonomy and Biogeographic Implications	PLOS ONE			English	Article							RIBOSOMAL DNA; SPECIES DELIMITATION; CRYPTIC SPECIATION; GENETIC TYPES; SEQUENCES; DIVERSITY; EVOLUTION; PHYLOGENY; DIFFERENTIATION; OCEAN	The use of planktonic foraminifera in paleoceanography requires taxonomic consistency and precise assessment of the species biogeography. Yet, ribosomal small subunit (SSUr) DNA analyses have revealed that most of the modern morphospecies of planktonic foraminifera are composed of a complex of several distinct genetic types that may correspond to cryptic or pseudo-cryptic species. These genetic types are usually delimitated using partial sequences located at the 3'end of the SSUrDNA, but typically based on empirical delimitation. Here, we first use patristic genetic distances calculated within and among genetic types of the most common morpho-species to show that intra-type and inter-type genetic distances within morpho-species may significantly overlap, suggesting that genetic types have been sometimes inconsistently defined. We further apply two quantitative and independent methods, ABGD (Automatic Barcode Gap Detection) and GMYC (General Mixed Yule Coalescent) to a dataset of published and newly obtained partial SSU rDNA for a more objective assessment of the species status of these genetic types. Results of these complementary approaches are highly congruent and lead to a molecular taxonomy that ranks 49 genetic types of planktonic foraminifera as genuine (pseudo) cryptic species. Our results advocate for a standardized sequencing procedure allowing homogenous delimitations of (pseudo) cryptic species. On the ground of this revised taxonomic framework, we finally provide an integrative taxonomy synthesizing geographic, ecological and morphological differentiations that can occur among the genuine (pseudo) cryptic species. Due to molecular, environmental or morphological data scarcities, many aspects of our proposed integrative taxonomy are not yet fully resolved. On the other hand, our study opens up the potential for a correct interpretation of environmental sequence datasets.	[Andre, Aurore; Quillevere, Frederic; Escarguel, Gilles] Univ Lyon 1, CNRS, Geol Lab, UMR 5276, F-69622 Villeurbanne, France; [Andre, Aurore] Univ Angers, CNRS, Lab Planetol & Geodynam Bioindicators Actuels & F, UMR 6112, Angers, France; [Morard, Raphael] Univ Bremen, Zentrum Marine Umweltwissensch MARUM, D-28359 Bremen, Germany; [Ujiie, Yurika] Shinshu Univ, Dept Biol, Matsumoto, Nagano 390, Japan; [de Vargas, Colomban] Univ Pierre & Marie Curie Stn Biolog Roscoff, CNRS, UMR 7144, Roscoff, France; [de Garidel-Thoron, Thibault] Univ Aix Marseille 1, CNRS, Ctr Rech & DEnseignement Geosci IEnvironnem, F-13331 Marseille 3, France; [Douady, Christophe J.] Univ Lyon 1, CNRS, UMR 5023, F-69622 Villeurbanne, France; [Douady, Christophe J.] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite d'Angers; University of Bremen; Shinshu University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut Universitaire de France	Andre, A (corresponding author), Univ Lyon 1, CNRS, Geol Lab, UMR 5276, F-69622 Villeurbanne, France.	aurore.andre1@orange.fr	Escarguel, Gilles/C-3297-2011; Douady, Christophe J/N-1357-2014; Douady, Christophe/N-3069-2019; de Garidel-Thoron, Thibault/B-1204-2008	Douady, Christophe J/0000-0002-4503-8040; Douady, Christophe/0000-0002-4503-8040; de Garidel-Thoron, Thibault/0000-0001-8983-9571; Ujiie, Yurika/0000-0001-7627-7979; Escarguel, Gilles/0000-0003-0985-6369; de Vargas, Colomban/0000-0002-6476-6019; Quillevere, Frederic/0000-0002-6248-0447	FR41 of Universite Lyon 1; INSU INTERRVIE program; PALEO-CTD [ANR-06-JCJC-0142]; ANR Blanc FORCLIM; OCEANOMICS [ANR-11-BTBR-0008]	FR41 of Universite Lyon 1; INSU INTERRVIE program; PALEO-CTD; ANR Blanc FORCLIM(French National Research Agency (ANR)); OCEANOMICS	The authors declare funding from the following programs (see details for the role of each funders): Grants from the FR41 of Universite Lyon 1 (molecular analyses); INSU INTERRVIE program (sampling and molecular analyses); ANR-06-JCJC-0142 PALEO-CTD (sampling); ANR Blanc FORCLIM (sampling); ANR-11-BTBR-0008 OCEANOMICS (molecular analyses). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Andersson JO, 2005, CELL MOL LIFE SCI, V62, P1182, DOI 10.1007/s00018-005-4539-z; Andre A, 2013, PALEOBIOLOGY, V39, P21, DOI 10.1666/0094-8373-39.1.21; Aurahs R, 2011, MAR MICROPALEONTOL, V79, P1, DOI 10.1016/j.marmicro.2010.12.001; Aurahs R, 2009, BIOINFORM BIOL INSIG, V3, P155; Aurahs R, 2009, MOL ECOL, V18, P1692, DOI 10.1111/j.1365-294X.2009.04136.x; Bijma J, 1998, MAR MICROPALEONTOL, V35, P141, DOI 10.1016/S0377-8398(98)00017-6; Boenigk J, 2012, EUR J PROTISTOL, V48, P96, DOI 10.1016/j.ejop.2011.11.004; Bolli H.M., 1985, P155; Brady HB, 1879, Q J MICROSCOPICAL SC, V19, P61; Cavalier-Smith T, 2003, PROTIST, V154, P341, DOI 10.1078/143446103322454112; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2003, TRENDS GENET, V19, P370, DOI 10.1016/S0168-9525(03)00118-5; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Darling KF, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001189; Darling KF, 2007, P NATL ACAD SCI USA, V104, P5002, DOI 10.1073/pnas.0700520104; Darling KF, 2004, P NATL ACAD SCI USA, V101, P7657, DOI 10.1073/pnas.0402401101; Darling KF, 1999, PALEOCEANOGRAPHY, V14, P3, DOI 10.1029/1998PA900002; Darling KF, 1996, J FORAMIN RES, V26, P324, DOI 10.2113/gsjfr.26.4.324; Darling KF, 1997, MAR MICROPALEONTOL, V30, P251, DOI 10.1016/S0377-8398(96)00057-6; Darling KF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000723; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; de Vargas C, 2001, PALEOBIOLOGY, V27, P104, DOI 10.1666/0094-8373(2001)027<0104:PARIGT>2.0.CO;2; de Vargas C, 1998, MOL PHYLOGENET EVOL, V9, P463, DOI 10.1006/mpev.1998.0491; de Vargas C, 2002, MAR MICROPALEONTOL, V45, P101, DOI 10.1016/S0377-8398(02)00037-3; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; deVargas C, 1997, J MOL EVOL, V45, P285, DOI 10.1007/PL00006232; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; ELWOOD HJ, 1985, MOL BIOL EVOL, V2, P399; Ezard T, 2009, PACKAGE SPLITS SPECI; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Goker M, 2010, EVOL BIOINFORM, V6, P97; Grimm GW, 2007, MAR MICROPALEONTOL, V62, P75, DOI 10.1016/j.marmicro.2006.07.005; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; Hoef-Emden K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043652; Huber BT, 1997, PALEOBIOLOGY, V23, P33, DOI 10.1017/S0094837300016638; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Katz ME, 2010, J FORAMIN RES, V40, P165, DOI 10.2113/gsjfr.40.2.165; Kennett J.P., 1983, NEOGENE PLANKTONIC F; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kucera M, 2005, QUATERNARY SCI REV, V24, P813, DOI 10.1016/j.quascirev.2004.07.017; Kucera M, 2007, DEV MARINE GEOL, V1, P213, DOI 10.1016/S1572-5480(07)01011-1; Kuroyanagi A, 2008, MAR MICROPALEONTOL, V68, P236, DOI 10.1016/j.marmicro.2008.04.004; Laetsch DR, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-60; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lee J.J., 1991, BIOL FORAMINIFERA; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Li BH, 2007, PROG NAT SCI-MATER, V17, P798; Logares R, 2007, MICROB ECOL, V53, P549, DOI 10.1007/s00248-006-9088-y; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Mayol M, 2001, MOL PHYLOGENET EVOL, V19, P167, DOI 10.1006/mpev.2001.0934; Miralles M, 2013, PLOS ONE, V8; Morard R, 2013, PALAEOGEOGR PALAEOCL, V391, P13, DOI 10.1016/j.palaeo.2013.05.011; Morard R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026665; Morard R, 2009, MAR MICROPALEONTOL, V71, P148, DOI 10.1016/j.marmicro.2009.03.001; Morvan C, 2013, SYST BIOL, V62, P512, DOI 10.1093/sysbio/syt015; Odorico DM, 1997, MOL BIOL EVOL, V14, P465, DOI 10.1093/oxfordjournals.molbev.a025783; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pawlowski J, 2000, MICROPALEONTOLOGY, V46, P1; Pawlowski J, 1996, MOL BIOL EVOL, V13, P445, DOI 10.1093/oxfordjournals.molbev.a025605; Pawlowski J, 1997, MOL BIOL EVOL, V14, P498, DOI 10.1093/oxfordjournals.molbev.a025786; Pawlowski J, 2010, J EUKARYOT MICROBIOL, V57, P197, DOI 10.1111/j.1550-7408.2009.00468.x; Pillet L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032373; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Quillevere F, PALAEOGEOGRAPHY PALA, V391, P2; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Seears HA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-54; Stewart IA, 2001, MAR MICROPALEONTOL, V43, P143, DOI 10.1016/S0377-8398(01)00024-X; Ujiie Y, 2012, ECOL EVOL, V2, P1725, DOI 10.1002/ece3.286; Ujiie Y, 2009, J FORAMIN RES, V39, P145, DOI 10.2113/gsjfr.39.3.145; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411; Weber AAT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056739; Weiner A, 2012, MOL ECOL, V21, P4063, DOI 10.1111/j.1365-294X.2012.05686.x	81	42	44	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104641	10.1371/journal.pone.0104641	http://dx.doi.org/10.1371/journal.pone.0104641			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119900	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600073
J	Fialho, VS; Chamorro-Rengifo, J; Lopes-Andrade, C; Yotoko, KSC				Fialho, Veronica Saraiva; Chamorro-Rengifo, Juliana; Lopes-Andrade, Cristiano; Clemente Yotoko, Karla Suemy			Systematics of Spiny Predatory Katydids (Tettigoniidae: Listroscelidinae) from the Brazilian Atlantic Forest Based on Morphology and Molecular Data	PLOS ONE			English	Article							ORTHOPTERA ARTHROPODA; PHYLOGENY; DNA; EVOLUTION; BIODIVERSITY; LIKELIHOOD; INFERENCE; MRBAYES	Listroscelidinae (Orthoptera: Tettigoniidae) are insectivorous Pantropical katydids whose taxonomy presents a long history of controversy, with several genera incertae sedis. This work focused on species occurring in the Brazilian Atlantic Forest, one of the world's most threatened biomes. We examined material deposited in scientific collections and visited 15 conservation units from Rio de Janeiro to southern Bahia between November 2011 and January 2012, catching 104 specimens from 10 conservation units. Based on morphological and molecular data we redefined Listroscelidini, adding a new tribe, new genus and eight new species to the subfamily. Using morphological analysis, we redescribed and added new geographic records for six species, synonymized two species and built a provisional identification key for the Atlantic Forest Listroscelidinae. Molecular results suggest two new species and a new genus to be described, possibly by the fission of the genus Hamayulus. We also proposed a 500 bp region in the final portion of the COI to be used as a molecular barcode. Our data suggest that the Atlantic Forest Listroscelidinae are seriously endangered, because they occur in highly preserved forest remnants, show high rates of endemism and have a narrow geographic distribution. Based on our results, we suggest future collection efforts must take into account the molecular barcode data to accelerate species recognition.	[Fialho, Veronica Saraiva; Chamorro-Rengifo, Juliana] Univ Fed Vicosa, Dept Entomol, Programa Posgrad Entomol, Vicosa, MG, Brazil; [Chamorro-Rengifo, Juliana; Lopes-Andrade, Cristiano] Univ Fed Vicosa, Dept Biol Anim, Lab Sistemat Biol Coleoptera, Vicosa, MG, Brazil; [Fialho, Veronica Saraiva; Clemente Yotoko, Karla Suemy] Univ Fed Vicosa, Dept Biol Geral, Lab Bioinformat Evolucao, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Yotoko, KSC (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Lab Bioinformat Evolucao, Vicosa, MG, Brazil.	karla@ufv.br	Yotoko, Karla/G-5151-2010; Lopes-Andrade, Cristiano/A-5525-2013; Fialho, Verônica Saraiva/ABB-5517-2021	Yotoko, Karla/0000-0003-2051-4204; Lopes-Andrade, Cristiano/0000-0001-9652-1369; Fialho, Verônica Saraiva/0000-0003-4721-6899	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302480/2012-9, 562229/2010-8]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); SISBIOTA (MCT/CNPq/MMA/MEC/CAPES/FNDCT - Acao Transversal/FAPs [47/2010]; Secretaria de Estado de Ciencia, Tecnologia e Ensino Superior de Minas Gerais (SECTES-MG); Floresta-Escola Project; Orthopterists' Society; FAPEMIG; Pro-Reitoria de Pesquisa e Pos-Graduacao da Universidade Federal de Vicosa	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); SISBIOTA (MCT/CNPq/MMA/MEC/CAPES/FNDCT - Acao Transversal/FAPs; Secretaria de Estado de Ciencia, Tecnologia e Ensino Superior de Minas Gerais (SECTES-MG); Floresta-Escola Project; Orthopterists' Society; FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Pro-Reitoria de Pesquisa e Pos-Graduacao da Universidade Federal de Vicosa	This study was partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; research grant to CLA no 302480/2012-9; with TWAS - The World Academy of Sciences for the doctoral fellowship of JCR; PROTAX - Programa de Formacao em Taxonomia no 562229/2010-8), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), SISBIOTA (MCT/CNPq/MMA/MEC/CAPES/FNDCT - Acao Transversal/FAPs no 47/2010), Secretaria de Estado de Ciencia, Tecnologia e Ensino Superior de Minas Gerais (SECTES-MG) and Floresta-Escola Project. JCR thanks to Orthopterists' Society for a research grant gained in 2011. Publication costs were supported by FAPEMIG and Pro-Reitoria de Pesquisa e Pos-Graduacao da Universidade Federal de Vicosa. The funders had no role in study design, collection and analysis of data, decision to publish, or preparation of the manuscript.	Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Berthier K, 2011, SYST ENTOMOL, V36, P285, DOI 10.1111/j.1365-3113.2010.00561.x; Bruner L, 1915, ANN CARNEGIE MUS, V9, P284; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Chamorro-Rengifo Juliana, 2010, Zootaxa, V2635, P41; Chenuil A, 2006, GENETICA, V127, P101, DOI 10.1007/s10709-005-2485-1; Cohn T, 1957, MISC PUBL MUS ZOOL, V588, P1; Cohn T. J., 1965, Miscellaneous Publications Museum of Zoology University of Michigan, Vno. 126, P1; Cristiano MP, 2012, APIDOLOGIE, V43, P527, DOI 10.1007/s13592-012-0122-4; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Eades DC, 2014, ORTHOPTERA SPECIES F; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flook PK, 1999, SYST BIOL, V48, P233, DOI 10.1080/106351599260274; Flook PK, 1997, MOL PHYLOGENET EVOL, V8, P177, DOI 10.1006/mpev.1997.0425; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gorochov A. V., 2012, ZOOSYSTEMATICA ROSSICA, V22, P59; Gorochov AV, 1995, ZOOSYST ROSSICA, V3, P202; GOROKHOV A V, 1990, Entomologicheskoe Obozrenie, V69, P820; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingrisch Sigfrid, 1998, Courier Forschungsinstitut Senckenberg, V206, P1; Jost MC, 2006, MOL PHYLOGENET EVOL, V38, P510, DOI 10.1016/j.ympev.2005.10.004; Karny H., 1911, Verhandlungen der Zoologisch-Botanischen Gesellschaft in Wien, V61; Karny H., 1907, Abhandlungen der Zoologisch-Botanischen Gesellschaft in Wien Jena, V4; Karny H, 1924, TREUBIA, V5, P105; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirby WF, 1906, SYNONYMIC CATALOGUE, V2; Mayer R, 2000, WATER AIR SOIL POLL, V121, P59, DOI 10.1023/A:1005249615589; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Mugleston JD, 2013, MOL PHYLOGENET EVOL, V69, P1120, DOI 10.1016/j.ympev.2013.07.014; Naskrecki P, 2000, THESIS U CONNECTICUT; Nylander JAA, 2008, MRMODELTEST V2 3; Piza Jr SdT, 1982, REV AGR PIRACICABA, V57, P213; Piza Jr SdT, 1958, REV BRAS BIOL, V18, P237; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Redtenbacher J., 1891, Verhandlungen der Zoologisch botanischen Wien, Vxli, P315; Rentz D.C.F., 1995, Journal of Orthoptera Research, V4, P199; RENTZ DCF, 1979, AUST J ZOOL, V27, P991, DOI 10.1071/ZO9790991; Rentz DCF, 2001, ENTOMOL OBOZR, V3, P536; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; RIEK E F, 1976, Journal of the Australian Entomological Society, V15, P161; ROBINSON MH, 1969, T ROY ENT SOC LONDON, V121, P281; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowell C.H.F., 1998, Journal of Orthoptera Research, V7, P147; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDOW JD, 1978, ANIM BEHAV, V26, P1004, DOI 10.1016/0003-3472(78)90089-1; Saussure deH, 1898, BIOL CENTRALI AM, V1, P345; SNODGRASS R. E., 1937, SMITHSONIAN MISC COLL, V96, P1; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Szinwelski N, 2012, ZOOKEYS, P11, DOI 10.3897/zookeys.196.3130; Tabarelli M, 2010, BIOL CONSERV, V143, P2328, DOI 10.1016/j.biocon.2010.02.005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Zeuner FE, 1940, J SOC BRIT ENTOMOLOG, V2, P77; ZEUNER FRIEDRICH E., 1936, PROC ROY ENT SOC LONDON, V11, P11; ZEUNER FRIEDRICH E., 1936, PROC ROY ENT SOC LONDON B TAX, V5, P103; Zhou ZJ, 2010, J GENET GENOMICS, V37, P315, DOI 10.1016/S1673-8527(09)60049-7	61	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103758	10.1371/journal.pone.0103758	http://dx.doi.org/10.1371/journal.pone.0103758			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118712	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600029
J	Liu, Y; Xie, LP; Gong, GH; Zhang, W; Zhu, BQ; Hu, YJ				Liu, Yan; Xie, Liping; Gong, Guihua; Zhang, Wei; Zhu, Baoquan; Hu, Youjia			De novo Comparative Transcriptome Analysis of Acremonium chrysogenum: High-Yield and Wild-Type Strains of Cephalosporin C Producer	PLOS ONE			English	Article							OXIDATIVE STRESS; CEFG GENE; RNA-SEQ; BIOSYNTHESIS; EXPRESSION; PROTEIN; CLONING; SYNTHETASE; CULTURES; ENCODES	beta-lactam antibiotics are widely used in clinic. Filamentous fungus Acremonium chrysogenum is an important industrial fungus for the production of CPC, one of the major precursors of beta-lactam antibiotics. Although its fermentation yield has been bred significantly over the past decades, little is known regarding molecular changes between the industrial strain and the wild type strain. This limits the possibility to improve CPC production further by molecular breeding. Comparative transcriptome is a powerful tool to understand the molecular mechanisms of CPC industrial high yield producer compared to wild type. A total of 57 million clean sequencing reads with an average length of 100 bp were generated from Illumina sequencing platform. 22,878 sequences were assembled. Among the assembled unigenes, 9502 were annotated and 1989 annotated sequences were assigned to 121 pathways by searching against the Kyoto Encyclopedia of Genes and Genomes pathway (KEGG) database. Furthermore, we compared the transcriptome differences between a high-yield and a wild-type strain during fermentation. A total of 4329 unigenes with significantly different transcription level were identified, among which 1737 were up-regulated and 2592 were down-regulated. 24 pathways were subsequently determined which involve glycerolipid metabolism, galactose metabolism, and pyrimidine metabolism. We also examined the transcription levels of 18 identified genes, including 11 up-regulated genes and 7 down-regulated genes using reverse transcription quantitative - PCR (RT-qPCR). The results of RT-qPCR were consistent with the Illumina sequencing. In this study, the Illumina sequencing provides the most comprehensive sequences for gene expression profile of Acremonium chrysogenum and allows de novo transcriptome assembly while lacking genome information. Comparative analysis of RNA-seq data reveals the complexity of the transcriptome in the fermentation of different yield strains. This is an important public information platform which could be used to accelerate the research to improve CPC production in Acremonium chrysogenum.	[Liu, Yan; Xie, Liping; Gong, Guihua; Zhang, Wei; Zhu, Baoquan; Hu, Youjia] Zhangjiang Inst, China State Inst Pharmaceut Ind, Shanghai, Peoples R China; [Liu, Yan; Xie, Liping; Gong, Guihua; Zhang, Wei; Hu, Youjia] Shanghai Inst Pharmaceut Ind, Shanghai, Peoples R China		Zhu, BQ (corresponding author), Zhangjiang Inst, China State Inst Pharmaceut Ind, Shanghai, Peoples R China.	baoquanzhu@sipi.com.cn; bebydou@hotmail.com	Xie, li/HGE-6052-2022		China National Center for Biotechnology Development [2011ZX09203-001-06]; Science and Technology Commission of Shanghai Municipality [13431900204, 11ZR1435200]	China National Center for Biotechnology Development; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work is supported by China National Center for Biotechnology Development, Grant #2011ZX09203-001-06, and by Science and Technology Commission of Shanghai Municipality, Grant #13431900204& 11ZR1435200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM EP, 1955, NATURE, V176, P551, DOI 10.1038/176551a0; ALFEEL W, 1992, P NATL ACAD SCI USA, V89, P4534, DOI 10.1073/pnas.89.10.4534; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Carrier G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086889; Choudhary V, 2012, P NATL ACAD SCI USA, V109, P16882, DOI 10.1073/pnas.1209086109; de la Torre F, 2009, PLANT PHYSIOL, V149, P1648, DOI 10.1104/pp.108.134510; DEMODENA JA, 1993, BIO-TECHNOL, V11, P926, DOI 10.1038/nbt0893-926; DOTZLAF JE, 1987, J BACTERIOL, V169, P1611, DOI 10.1128/jb.169.4.1611-1618.1987; Dreyer J, 2007, APPL ENVIRON MICROB, V73, P3412, DOI 10.1128/AEM.00129-07; Elander RP, 2003, APPL MICROBIOL BIOT, V61, P385, DOI 10.1007/s00253-003-1274-y; Eldarov MA, 2014, MITOCHONDRIAL DNA; Fremont N, 2013, PLANT PHYSIOL, V161, P1127, DOI 10.1104/pp.112.210583; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gutierrez S, 1997, APPL MICROBIOL BIOT, V48, P606, DOI 10.1007/s002530051103; Henriksen CM, 1996, J BIOTECHNOL, V45, P149, DOI 10.1016/0168-1656(95)00164-6; Hoff B, 2010, APPL MICROBIOL BIOT, V85, P1081, DOI 10.1007/s00253-009-2168-4; HWANG CS, 1995, PLANT CELL, V7, P183, DOI 10.1105/tpc.7.2.183; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kataoka M, 1999, APPL MICROBIOL BIOT, V51, P486, DOI 10.1007/s002530051421; Kennedy J, 1999, SCIENCE, V284, P1368, DOI 10.1126/science.284.5418.1368; Kerscher SJ, 2000, BBA-BIOENERGETICS, V1459, P274, DOI 10.1016/S0005-2728(00)00162-6; Kosalkova K, 2001, J IND MICROBIOL BIOT, V27, P252, DOI 10.1038/sj.jim.7000192; Kubo A, 1997, ARCH BIOCHEM BIOPHYS, V345, P271, DOI 10.1006/abbi.1997.0242; Leadsham JE, 2013, CELL METAB, V18, P279, DOI 10.1016/j.cmet.2013.07.005; Li Q, 2009, CRIT REV BIOTECHNOL, V29, P199, DOI 10.1080/07388550903004795; Liu L, 2013, APPL MICROBIOL BIOT, V97, P2551, DOI 10.1007/s00253-012-4368-6; Liu Y, 2010, MOL BIOTECHNOL, V44, P101, DOI 10.1007/s12033-009-9214-4; Lu Y, 2013, PLANT CELL REP, V32, P1427, DOI 10.1007/s00299-013-1455-9; Mandrich L, 2002, J BIOL CHEM, V277, P48241, DOI 10.1074/jbc.M207398200; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Martin JF, 2010, MICROB BIOTECHNOL, V3, P285, DOI 10.1111/j.1751-7915.2009.00123.x; Mayer K, 1999, NATURE, V402, P769, DOI 10.1038/47134; NASH CH, 1971, APPL MICROBIOL, V22, P6, DOI 10.1128/AEM.22.1.6-10.1971; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Poggeler S, 2008, APPL ENVIRON MICROB, V74, P6006, DOI 10.1128/AEM.01188-08; Ponts N, 2006, FEMS MICROBIOL LETT, V258, P102, DOI 10.1111/j.1574-6968.2006.00200.x; Pusztahelyi T, 2011, FUNGAL GENET BIOL, V48, P92, DOI 10.1016/j.fgb.2010.08.006; Reverberi M, 2012, APPL MICROBIOL BIOT, V95, P1293, DOI 10.1007/s00253-012-3985-4; Schmitt EK, 2004, ADV BIOCHEM ENG BIOT, V88, P1, DOI 10.1007/b99256; Schuster A, 2010, APPL MICROBIOL BIOT, V87, P787, DOI 10.1007/s00253-010-2632-1; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; SKATRUD PL, 1989, GENE, V78, P331, DOI 10.1016/0378-1119(89)90235-7; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; Uhlmann S, 2013, ACS CHEM BIOL, V8, P2586, DOI 10.1021/cb400555e; Ullan RV, 2002, MOL GENET GENOMICS, V267, P673, DOI 10.1007/s00438-002-0702-5; van Gulik WM, 2000, BIOTECHNOL BIOENG, V68, P602, DOI 10.1002/(SICI)1097-0290(20000620)68:6<602::AID-BIT3>3.0.CO;2-2; Velasco J, 1999, BIOCHEM J, V337, P379, DOI 10.1042/0264-6021:3370379; Vercesi AE, 2001, BIOSCIENCE REP, V21, P195, DOI 10.1023/A:1013652409337; Wang MH, 1996, ARCH BIOCHEM BIOPHYS, V336, P240, DOI 10.1006/abbi.1996.0554; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; ZHOU W, 1992, ENZYME MICROB TECH, V14, P848, DOI 10.1016/0141-0229(92)90103-U	53	1	5	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104542	10.1371/journal.pone.0104542	http://dx.doi.org/10.1371/journal.pone.0104542			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118715	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600065
J	Ostenfeld, EB; Erichsen, R; Pedersen, L; Farkas, DK; Weiss, NS; Sorensen, HT				Ostenfeld, Eva B.; Erichsen, Rune; Pedersen, Lars; Farkas, Dora K.; Weiss, Noel S.; Sorensen, Henrik T.			Atrial Fibrillation as a Marker of Occult Cancer	PLOS ONE			English	Article							RISK; EPIDEMIOLOGY; INFLAMMATION; PREVALENCE; REGISTRY; FLUTTER; INDEX	Background: Recent studies suggest that cancer increases risk of atrial fibrillation. Whether atrial fibrillation is a marker for underlying occult cancer is unknown. Methods: We conducted a cohort study (1980-2011) of all Danish patients with new-onset atrial fibrillation. To examine cancer risk, we computed absolute risk at 3 months and standardized incidence ratios (SIRs) by comparing observed cancer incidence among patients newly diagnosed with atrial fibrillation with that expected based on national cancer incidence during the period. Results: Median follow-up time was 3.4 years among 269 742 atrial fibrillation patients. Within 3 months of follow-up, 6656 cancers occurred (absolute risk, 2.5%; 95% confidence intervals [CI], 2.4%-2.5%) versus 1302 expected, yielding a SIR of 5.11; 95% CI, 4.99-5.24. Associations were particularly strong for cancers of the lung, kidney, colon, ovary, and for non-Hodgkin's lymphoma. The SIR within 3 months of follow-up was 7.02; 95% CI, 6.76-7.28 for metastatic and 3.53; 95% CI, 3.38-3.68 for localized cancer. Beyond 3 months of follow-up, overall cancer risk was modestly increased (SIR, 1.13; 95% CI, 1.12-1.15). Conclusion: Patients with new-onset atrial fibrillation had a markedly increased relative risk of a cancer diagnosis within the next three months, however, corresponding absolute risk was small.	[Ostenfeld, Eva B.; Erichsen, Rune; Pedersen, Lars; Farkas, Dora K.; Weiss, Noel S.; Sorensen, Henrik T.] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Ostenfeld, Eva B.] Univ Aalborg Hosp, Dept Gastrointestinal Surg, Aalborg, Denmark; [Weiss, Noel S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Aarhus University; Aalborg University; Aalborg University Hospital; University of Washington; University of Washington Seattle	Ostenfeld, EB (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark.	eos@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Ostenfeld, Eva Bjerre/0000-0003-4125-4317; Erichsen, Rune/0000-0001-9398-9185	Clinical Epidemiological Research Foundation, Aarhus University Hospital, Denmark	Clinical Epidemiological Research Foundation, Aarhus University Hospital, Denmark	This work was supported by the Clinical Epidemiological Research Foundation, Aarhus University Hospital, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TF, 1999, DAN MED BULL, V46, P263; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Breslow N E, 1987, IARC Sci Publ, P1; Chamberlain AM, 2011, HEART RHYTHM, V8, P1160, DOI 10.1016/j.hrthm.2011.03.038; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cogliano VJ, 2011, JNCI-J NATL CANCER I, V103, P1827, DOI 10.1093/jnci/djr483; Erichsen R, 2011, INTERN EMERG MED; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Frost L, 2004, ARCH INTERN MED, V164, P1993, DOI 10.1001/archinte.164.18.1993; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Grossman E, 2002, AM J MED, V112, P479, DOI 10.1016/S0002-9343(02)01049-5; Gupta K, 2002, AM J MED SCI, V323, P140, DOI 10.1097/00000441-200203000-00004; Guzzetti S, 2002, AM J MED, V112, P587, DOI 10.1016/S0002-9343(02)01029-X; Guzzetti S, 2008, INTERN EMERG MED, V3, P227, DOI 10.1007/s11739-008-0124-4; Guzzetti Stefano, 2003, Recenti Progressi in Medicina, V94, P260; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kannel WB, 2008, MED CLIN N AM, V92, P17, DOI 10.1016/j.mcna.2007.09.002; Li J, 2010, HEART RHYTHM, V7, P438, DOI 10.1016/j.hrthm.2009.12.009; Noble S, 2010, BRIT J CANCER, V102, pS2, DOI 10.1038/sj.bjc.6605599; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rix TA, 2012, SCAND CARDIOVASC J, V46, P149, DOI 10.3109/14017431.2012.673728; Smith RA, 2012, CA CANC J CLIN; Sorensen HT, 2012, EUR J CANCER, V48, P586, DOI 10.1016/j.ejca.2011.10.032; Storm HH, 1997, DAN MED BULL, V44, P535; The Danish Health and Medicines Authority, CANC 2010; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83	29	67	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e102861	10.1371/journal.pone.0102861	http://dx.doi.org/10.1371/journal.pone.0102861			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119880	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600013
J	Porro, F; Bockor, L; De Caneva, A; Bortolussi, G; Muro, AF				Porro, Fabiola; Bockor, Luka; De Caneva, Alessia; Bortolussi, Giulia; Muro, Andres F.			Generation of Ugt1-Deficient Murine Liver Cell Lines Using TALEN Technology	PLOS ONE			English	Article							MOUSE-CHROMOSOME 1; UDP-GLUCURONOSYLTRANSFERASE; CRIGLER-NAJJAR; GUNN RAT; BILIRUBIN GLUCURONIDATION; TARGETED MUTAGENESIS; GENE-FUNCTION; EXPRESSION; KNOCKOUT; METABOLISM	The Crigler-Najjar Syndrome Type I (CNSI) is a rare genetic disorder caused by mutations in the Ugt1a1 gene. It is characterized by unconjugated hyperbilirubinemia that may result in severe neurologic damage and death if untreated. To date, liver transplantation is the only curative treatment. With the aim of generating mutant cell lines of the Ugt1 gene, we utilized the TALEN technology to introduce site-specific mutations in Ugt1 exon 4. We report a fast and efficient method to perform gene knockout in tissue culture cells, based on the use of TALEN pairs targeting restriction enzyme (RE) sites in the region of interest. This strategy overcame the presence of allele-specific single nucleotide polymorphisms (SNPs) and pseudogenes, conditions that limit INDELs' detection by Surveyor. We obtained liver-derived murine N-Muli cell clones having INDELs with efficiency close to 40%, depending on the TALEN pair and RE target site. Sequencing of the target locus and WB analysis of the isolated cell clones showed a high proportion of biallelic mutations in cells treated with the most efficient TALEN pair. Ugt glucuronidation activity was reduced basal levels in the biallelic mutant clones. These mutant liver-derived cell lines could be a very useful tool to study biochemical aspects of Ugt1 enzyme activity in a more natural context, such as substrate specificity, requirement of specific co-factors, the study of inhibitors and other pharmacological aspects, and to correlate enzyme activity to the presence of specific mutations in the gene, by adding back to the mutant cell clones specific variants of the Ugt1 gene. In addition, since genome editing has recently emerged as a potential therapeutic approach to cure genetic diseases, the definition of the most efficient TALEN pair could be an important step towards setting up a platform to perform genome editing in CNSI.	[Porro, Fabiola; Bockor, Luka; De Caneva, Alessia; Bortolussi, Giulia; Muro, Andres F.] ICGEB, Trieste, TS, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB)	Muro, AF (corresponding author), ICGEB, Trieste, TS, Italy.	muro@icgeb.org	Muro, Andrés F/K-3156-2016	Muro, Andrés F/0000-0002-9628-0494; Bockor, Luka/0000-0002-2096-0944; Bortolussi, Giulia/0000-0001-9470-0902	Telethon [GGP10051]; Friuli-Venezia Giulia Regional Grant [LR 26/2005]; AXA Research Fund; Beneficentia Stiftung	Telethon(Fondazione Telethon); Friuli-Venezia Giulia Regional Grant(Regione Friuli Venezia Giulia); AXA Research Fund(AXA Research Fund); Beneficentia Stiftung	Telethon (GGP10051) to AFM; Friuli-Venezia Giulia Regional Grant LR 26/2005 to AFM; Beneficentia Stiftung to AFM; AXA Research Fund to GB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Bortolussi G, 2012, FASEB J, V26, P1052, DOI 10.1096/fj.11-195461; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cheng ZQ, 1999, DRUG METAB DISPOS, V27, P1165; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Emi Y, 2002, ARCH BIOCHEM BIOPHYS, V405, P163, DOI 10.1016/S0003-9861(02)00351-X; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; IYANAGI T, 1989, J BIOL CHEM, V264, P21302; Iyanagi T, 1998, BBA-MOL BASIS DIS, V1407, P173, DOI 10.1016/S0925-4439(98)00044-1; Iyer L, 1999, CLIN PHARMACOL THER, V65, P576, DOI 10.1016/S0009-9236(99)70078-0; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kadakol A, 2000, HUM MUTAT, V16, P297, DOI 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z; KRAWCZAK M, 1992, HUM GENET, V90, P41; Latham KE, 1998, DEVELOPMENT, V125, P929; Liang Z, 2014, J GENET GENOMICS, V41, P63, DOI 10.1016/j.jgg.2013.12.001; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; MILES JS, 1991, GENOMICS, V11, P309, DOI 10.1016/0888-7543(91)90137-4; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Ota S, 2013, GENES CELLS, V18, P450, DOI 10.1111/gtc.12050; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Ramirez J, 2007, DRUG METAB DISPOS, V35, P2149, DOI 10.1124/dmd.107.015446; RITTER JK, 1991, J BIOL CHEM, V266, P1043; Seldin MF, 1997, MAMM GENOME, V7, pS3, DOI 10.1007/s003359900313; Seldin MF, 1998, MAMM GENOME, V8, pS1, DOI 10.1007/s003359900646; SEPPEN J, 1994, J CLIN INVEST, V94, P2385, DOI 10.1172/JCI117604; Seppen J, 1996, BIOCHEM J, V314, P477, DOI 10.1042/bj3140477; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842	34	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104816	10.1371/journal.pone.0104816	http://dx.doi.org/10.1371/journal.pone.0104816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118822	gold, Green Submitted, Green Published			2022-12-27	WOS:000340900600089
J	Vandeperre, F; Aires-da-Silva, A; Fontes, J; Santos, M; Santos, RS; Afonso, P				Vandeperre, Frederic; Aires-da-Silva, Alexandre; Fontes, Jorge; Santos, Marco; Santos, Ricardo Serrao; Afonso, Pedro			Movements of Blue Sharks (Prionace glauca) across Their Life History	PLOS ONE			English	Article							NORTH-ATLANTIC; PELAGIC SHARKS; SEXUAL SEGREGATION; HABITAT USE; DIVING BEHAVIOR; SITE FIDELITY; CONSERVATION; PATTERNS; OCEAN; FISH	Spatial structuring and segregation by sex and size is considered to be an intrinsic attribute of shark populations. These spatial patterns remain poorly understood, particularly for oceanic species such as blue shark (Prionace glauca), despite its importance for the management and conservation of this highly migratory species. This study presents the results of a long-term electronic tagging experiment to investigate the migratory patterns of blue shark, to elucidate how these patterns change across its life history and to assess the existence of a nursery area in the central North Atlantic. Blue sharks belonging to different life stages (n = 34) were tracked for periods up to 952 days during which they moved extensively (up to an estimated 28.139 km), occupying large parts of the oceanic basin. Notwithstanding a large individual variability, there were pronounced differences in movements and space use across the species' life history. The study provides strong evidence for the existence of a discrete central North Atlantic nursery, where juveniles can reside for up to at least 2 years. In contrast with previously described nurseries of coastal and semi-pelagic sharks, this oceanic nursery is comparatively vast and open suggesting that shelter from predators is not its main function. Subsequently, male and female blue sharks spatially segregate. Females engage in seasonal latitudinal migrations until approaching maturity, when they undergo an ontogenic habitat shift towards tropical latitudes. In contrast, juvenile males generally expanded their range southward and apparently displayed a higher degree of behavioural polymorphism. These results provide important insights into the spatial ecology of pelagic sharks, with implications for the sustainable management of this heavily exploited shark, especially in the central North Atlantic where the presence of a nursery and the seasonal overlap and alternation of different life stages coincides with a high fishing mortality.	[Vandeperre, Frederic; Fontes, Jorge; Santos, Marco; Santos, Ricardo Serrao; Afonso, Pedro] Univ Azores, Ctr IMAR, Dept Oceanog & Fisheries, Horta, Portugal; [Vandeperre, Frederic; Fontes, Jorge; Santos, Marco; Santos, Ricardo Serrao; Afonso, Pedro] LARSyS Associated Lab, Lisbon, Portugal; [Aires-da-Silva, Alexandre] Interamer Trop Tuna Commiss, La Jolla, CA USA	Universidade dos Acores	Vandeperre, F (corresponding author), Univ Azores, Ctr IMAR, Dept Oceanog & Fisheries, Horta, Portugal.	vandeperre@uac.pt	Santos, Ricardo/B-3960-2008; Afonso, Pedro/B-7815-2013; Santos, Marco/HGF-1439-2022	Santos, Ricardo/0000-0002-2536-1369; Afonso, Pedro/0000-0002-4618-2589; Fontes, Jorge/0000-0002-8451-5532; Vandeperre, Frederic/0000-0002-3947-6917	Azores Fund for Science and Technology (FRCT); OE; COMPETE; QREN; ProConvergencia; FCT [Pest/OE/EEI/LA0009/2014]; EU FP7 project MADE, Mitigating adverse ecological impacts of open ocean fisheries [FP7 KBBE/2007/1/210496]; FCT/MCTES-MEC [SFRH/BD/46891/2008, SFRH/BPD/66532/2009, Ciencia 2008/POPH/QREN]; Portuguese Foundation for Science and Technology (FCT) [FCT - Pest/OE/EEI/LA0009/2011-2014]	Azores Fund for Science and Technology (FRCT); OE; COMPETE; QREN; ProConvergencia; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); EU FP7 project MADE, Mitigating adverse ecological impacts of open ocean fisheries; FCT/MCTES-MEC; Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work was conducted in the framework of the EU FP7 project MADE, Mitigating adverse ecological impacts of open ocean fisheries (FP7 KBBE/2007/1/210496). FCT/MCTES-MEC provided individual funding to FV, JF and PA (SFRH/BD/46891/2008, SFRH/BPD/66532/2009, and Ciencia 2008/POPH/QREN). IMARDOP/UAz is Research and Development Unit no. 531 and LARSyS-Associated Laboratory no. 9 funded by the Portuguese Foundation for Science and Technology (FCT) through FCT - Pest/OE/EEI/LA0009/2011-2014 and by the Azores Fund for Science and Technology (FRCT), funded by OE, COMPETE, QREN and ProConvergencia. The Open Access of this paper is funded by FCT - Pest/OE/EEI/LA0009/2014 (OE, COMPETE and QREN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso P, 2009, MAR ECOL PROG SER, V381, P273, DOI 10.3354/meps07946; Aires-da-Silva AM, 2008, FISH RES, V92, P41, DOI 10.1016/j.fishres.2007.12.019; Aires-da-Silva AM, 2007, MAR FRESHWATER RES, V58, P570, DOI 10.1071/MF06156; Aires-da-Silva AM, 2009, MAR FRESHWATER RES, V60, P1029, DOI 10.1071/MF08235; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Bass A.J., 1978, P545; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bolten A.B., 2003, LOGGERHEAD SEA TURTL, P63; Bolten AB, 2003, CRC MAR BIOL SER, P243; Bonfil Ramon, 2008, Fish and Aquatic Resources Series, V13, P128; BRANSTETTER S, 1990, NOAA Technical Report NMFS, P17; Buencuerpo V, 1998, FISH B-NOAA, V96, P667; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Campana SE, 2006, CAN J FISH AQUAT SCI, V63, P670, DOI 10.1139/f05-251; Campana SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016854; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; Castro J, 2000, COLLECT VOL SCI PAP, V51, P1882; Castro JA, 1995, MAR FRESHWATER RES, V46, P967, DOI 10.1071/MF9950967; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Duncan KM, 2006, MAR ECOL PROG SER, V312, P211, DOI 10.3354/meps312211; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fitzmaurice P., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P1171; Foote AD, 2010, EVOL ECOL, V24, P803, DOI 10.1007/s10682-009-9337-x; Frisk MG, 2001, CAN J FISH AQUAT SCI, V58, P969, DOI 10.1139/cjfas-58-5-969; Goldman K.J., 2008, SHARKS OPEN OCEAN BI, P95; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; HAZIN FHV, 1994, FISHERIES SCI, V60, P487, DOI 10.2331/fishsci.60.487; Henderson AC, 2001, J FISH BIOL, V58, P1347, DOI 10.1111/j.1095-8649.2001.tb02291.x; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Hueter R. E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P239; Hurley PCF, 1998, FISH RES, V39, P107, DOI 10.1016/S0165-7836(98)00177-5; ICCAT, 2009, ICCAT COLL VOL SCI P, V64, P1343; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Klimley AP, 2002, ENVIRON BIOL FISH, V63, P117; KLIMLEY AP, 1987, ENVIRON BIOL FISH, V18, P27, DOI 10.1007/BF00002325; Kohler Nancy E., 2002, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V54, P1231; Kohler Nancy E., 2008, Fish and Aquatic Resources Series, V13, P339; Litvinov F.F, 2006, J ICHTHYOL, V46, P613, DOI DOI 10.1134/S0032945206080091; Litvinov FF, 2007, SEAMOUNTS ECOLOGY FI, P202; Mailly T, 1997, ANN GEOPHYS-ATM HYDR, V15, P1354, DOI 10.1007/s00585-997-1354-x; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; Matsunaga H, 2013, FISHERIES SCI, V79, P737, DOI 10.1007/s12562-013-0660-3; Mejuto J, 2009, COLLECTIVE VOLUME SC, V64, P2455; Mejuto J, 1985, INT COUNC EXPL SEA C; Mejuto Jaime, 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P974; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; Musick John A., 1997, P137; Nakano H, 1996, FISHERIES SCI, V62, P860, DOI 10.2331/fishsci.62.860; Nakano H., 2008, SHARKS OPEN OCEAN BI, P140, DOI DOI 10.1002/9781444302516; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; PRATT HL, 1979, FISH B-NOAA, V77, P445; Queiroz N, 2005, J MAR BIOL ASSOC UK, V85, P1107, DOI 10.1017/S0025315405012154; Queiroz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032374; Queiroz N, 2010, MAR ECOL PROG SER, V406, P265, DOI 10.3354/meps08500; R Core Team, 2021, R LANGUAGE ENV STAT; Robbins RL, 2007, J FISH BIOL, V70, P1350, DOI 10.1111/j.1095-8649.2007.01414.x; Santos Marco A., 2007, Fish and Aquatic Resources Series, V12, P239; Silva MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076507; Simpfendorfer CA, 2002, FISH RES, V55, P175; Sims David W., 2005, P127; Skomal GB, 2003, FISH B-NOAA, V101, P627; Snelson Franklin F. Jr, 2008, Fish and Aquatic Resources Series, V13, P24; Springer S, 1967, SHARKS SKATES RAYS, P149, DOI DOI 10.1111/J.1095-8649.2012.03244.X; STEVENS JD, 1974, J MAR BIOL ASSOC UK, V54, P373, DOI 10.1017/S0025315400058604; STEVENS JD, 1976, J MAR BIOL ASSOC UK, V56, P929, DOI 10.1017/S002531540002097X; STEVENS JD, 1990, J MAR BIOL ASSOC UK, V70, P707, DOI 10.1017/S0025315400058999; Stevens JD, 2010, MAR BIOL, V157, P575, DOI 10.1007/s00227-009-1343-6; Tavares R, 2012, FISH RES, V129, P137, DOI 10.1016/j.fishres.2012.06.018; Tremblay Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004711; Vandeperre F, 2014, FISH RES, V153, P89, DOI 10.1016/j.fishres.2014.01.006; Walli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006151; Ward P, 2005, ECOLOGY, V86, P835, DOI 10.1890/03-0746; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; [No title captured]	79	77	78	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103538	10.1371/journal.pone.0103538	http://dx.doi.org/10.1371/journal.pone.0103538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119716	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600023
J	Zhang, JL; Bera, TK; Liu, WH; Du, X; Alewine, C; Hassan, R; Pastan, I				Zhang, Jingli; Bera, Tapan K.; Liu, Wenhai; Du, Xing; Alewine, Christine; Hassan, Raffit; Pastan, Ira			Megakaryocytic Potentiating Factor and Mature Mesothelin Stimulate the Growth of a Lung Cancer Cell Line in the Peritoneal Cavity of Mice	PLOS ONE			English	Article							MOLECULAR-CLONING; EXPRESSION; BINDING; MARKER; TARGET	The mesothelin (MSLN) gene encodes a 71 kilodalton (kDa) precursor protein that is processed into megakaryocytic potentiating factor (MPF), a 31 kDa protein that is secreted from the cell, and mature mesothelin (mMSLN), a 40 kDa cell surface protein. The mMSLN binds to CA125, an interaction that has been implicated in the intra-cavitary spread of mesothelioma and ovarian cancer. To better define the role of MPF and mMSLN, growth of the lung cancer cell line A549 was evaluated in immuno-deficient mice with inactivation of the Msln gene. We observed that Msln-/- mice xenografted with intraperitoneal A549 tumors survive significantly long than tumor-bearing Msln+/+ mice. When tumor-bearing Msln-/- mice are supplemented with recombinant MPF (and to a lesser extent mMSLN), most of this survival advantage is lost. These studies demonstrate that MPF and mMSLN have an important role in the growth of lung cancer cells in vivo and raise the possibility that inactivation of MPF may be a useful treatment for lung and other MSLN expressing cancers.	[Zhang, Jingli; Bera, Tapan K.; Liu, Wenhai; Du, Xing; Alewine, Christine; Hassan, Raffit; Pastan, Ira] NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hassan, R (corresponding author), NCI, Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	hassanr@mail.nih.gov; pastani@mail.nih.gov	pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270; Alewine, Christine/0000-0003-1661-0957	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010816] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2001, CLIN CANCER RES, V7, P3862; Bera TK, 2000, MOL CELL BIOL, V20, P2902, DOI 10.1128/MCB.20.8.2902-2906.2000; Bharadwaj U, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-106; Bharadwaj U, 2011, CARCINOGENESIS, V32, P1013, DOI 10.1093/carcin/bgr075; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; Hassan R, 2005, AM J CLIN PATHOL, V124, P838, DOI 10.1309/F1B64CL7H8VJKEAF; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Kachala SS, 2014, CLIN CANC R IN PRESS; Kaneko O, 2009, J BIOL CHEM, V284, P3739, DOI 10.1074/jbc.M806776200; KOJIMA T, 1995, J BIOL CHEM, V270, P21984, DOI 10.1074/jbc.270.37.21984; Onda M, 2006, CLIN CANCER RES, V12, P4225, DOI 10.1158/1078-0432.CCR-06-0472; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Tchou J, 2012, BREAST CANCER RES TR, V133, P799, DOI 10.1007/s10549-012-2018-4; Uehara N, 2008, MOL CANCER RES, V6, P186, DOI 10.1158/1541-7786.MCR-07-0254; Yamashita Y, 2000, BIOCHEM BIOPH RES CO, V275, P134, DOI 10.1006/bbrc.2000.3280; Zhang D, CANC SCI, V102, P720; Zhang YJ, 2011, CANCER RES, V71, P5915, DOI 10.1158/0008-5472.CAN-11-0466; Zheng CN, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-84	20	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104388	10.1371/journal.pone.0104388	http://dx.doi.org/10.1371/journal.pone.0104388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118887	Green Submitted, gold, Green Published			2022-12-27	WOS:000340900600054
J	Caso, F; Agosta, F; Peric, S; Rakocevic-Stojanovic, V; Copetti, M; Kostic, VS; Filippi, M				Caso, Francesca; Agosta, Federica; Peric, Stojan; Rakocevic-Stojanovic, Vidosava; Copetti, Massimiliano; Kostic, Vladimir S.; Filippi, Massimo			Cognitive Impairment in Myotonic Dystrophy Type 1 Is Associated with White Matter Damage	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RATING-SCALE; INTELLECTUAL IMPAIRMENT; CEREBRAL INVOLVEMENT; WORKSHOP REPORT; BRAIN; MRI; ABNORMALITIES; HYPERSOMNIA; LESIONS	Objective: To investigate grey (GM) and white matter (WM) abnormalities and their effects on cognitive and behavioral deficits in a large, phenotypically and genotypically well-characterized cohort of classic adult (aDM1, age at onset >= 20 years) or juvenile (jDM1, age at onset <20 years) patients with myotonic dystrophy type 1 (DM1). Methods: A case-control study including 51 DM1 patients (17 jDM1 and 34 aDM1) and 34 controls was conducted at an academic medical center. Clinical, cognitive and structural MRI evaluations were obtained. Quantitative assessments of regional GM volumes, WM hyperintensities (WMHs), and microstructural WM tract damage were performed. The association between structural brain damage and clinical and cognitive findings was assessed. Results: DM1 patients showed a high prevalence of WMHs, severe regional GM atrophy including the key nodes of the sensorimotor and main cognitive brain networks, and WM microstructural damage of the interhemispheric, corticospinal, limbic and associative pathways. WM tract damage extends well beyond the focal WMHs. While aDM1 patients had severe patterns of GM atrophy and WM tract damage, in jDM1 patients WM abnormalities exceeded GM involvement. In DM1, WMHs and microstructural damage, but not GM atrophy, correlated with cognitive deficits. Conclusions: WM damage, through a disconnection between GM structures, is likely to be the major contributor to cognitive impairment in DM1. Our MRI findings in aDM1 and jDM1 patients support the hypothesis of a degenerative (premature aging) origin of the GM abnormalities and of developmental changes as the principal substrates of microstructural WM alterations in DM1.	[Caso, Francesca; Agosta, Federica; Filippi, Massimo] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Inst Expt Neurol, Div Neurosci,Neuroimaging Res Unit, Milan, Italy; [Peric, Stojan; Rakocevic-Stojanovic, Vidosava; Kostic, Vladimir S.] Univ Belgrade, Sch Med, Neurol Clin, Belgrade, Serbia; [Copetti, Massimiliano] IRCCS Osped Casa Sollievo Sofferenza, Biostat Unit, Foggia, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Belgrade; IRCCS Casa Sollievo Della Sofferenza	Filippi, M (corresponding author), Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Inst Expt Neurol, Div Neurosci,Neuroimaging Res Unit, Milan, Italy.	filippi.massimo@hsr.it	Kostić, Vladimir S/Q-6998-2018; Caso, Francesca/AAB-8235-2019; Filippi, Massimo/K-1755-2018; Copetti, Massimiliano/K-3186-2016; COPETTI, MASSIMILIANO/AAG-1473-2021; Agosta, Federica/J-9908-2016	Caso, Francesca/0000-0002-3072-1218; Filippi, Massimo/0000-0002-5485-0479; Copetti, Massimiliano/0000-0002-7960-5947; COPETTI, MASSIMILIANO/0000-0002-7960-5947; Agosta, Federica/0000-0003-3121-4979	Ministry of Education, Science and Technological Development of Serbia [11111, 175083]; Neuroimaging Research Unit, Institute of Experimental Neurology, San Raffaele Scientific Institute, Milan, Italy	Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia); Neuroimaging Research Unit, Institute of Experimental Neurology, San Raffaele Scientific Institute, Milan, Italy	This study was supported by Ministry of Education, Science and Technological Development of Serbia (Grants #11111 and 175083) and Neuroimaging Research Unit, Institute of Experimental Neurology, San Raffaele Scientific Institute, Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1994, J NEUROL SCI, V127, P179, DOI 10.1016/0022-510X(94)90071-X; Antonini G, 2004, J NEUROL NEUROSUR PS, V75, P1611, DOI 10.1136/jnnp.2003.032417; Ashizawa T, 1998, ARCH NEUROL-CHICAGO, V55, P291, DOI 10.1001/archneur.55.3.291; Axford MM, 2013, NEUROMUSCULAR DISORD, V23, P370, DOI 10.1016/j.nmd.2013.01.003; Bachmann G, 1996, NEURORADIOLOGY, V38, P629, DOI 10.1007/s002340050322; Bugiardini E, 2014, NEUROMUSCULAR DISORD, V24, P445, DOI 10.1016/j.nmd.2014.01.013; BURKE HR, 1985, J CLIN PSYCHOL, V41, P231, DOI 10.1002/1097-4679(198503)41:2<231::AID-JCLP2270410216>3.0.CO;2-Z; Caramia F, 2010, MAGN RESON IMAGING, V28, P226, DOI 10.1016/j.mri.2009.07.006; CIRIGNOTTA F, 1987, J NEUROL, V235, P80, DOI 10.1007/BF00718014; Di Costanzo A, 2002, J NEUROL, V249, P1175, DOI 10.1007/s00415-002-0796-z; Di Costanzo A, 2001, NEURORADIOLOGY, V43, P198, DOI 10.1007/s002340000459; Di Costanzo A, 2008, NEUROMUSCULAR DISORD, V18, P299, DOI 10.1016/j.nmd.2008.01.008; Douniol M, 2012, DEV MED CHILD NEUROL, V54, P905, DOI 10.1111/j.1469-8749.2012.04379.x; Franc DT, 2012, NEUROMUSCULAR DISORD, V22, P483, DOI 10.1016/j.nmd.2012.01.003; Fukuda H, 2005, ACTA RADIOL, V46, P104, DOI 10.1080/02841850510015974; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; GLANTZ RH, 1988, ARCH NEUROL-CHICAGO, V45, P36, DOI 10.1001/archneur.1988.00520250042017; Gonzalez I, 2000, NEUROLOGY, V54, P1218; Goodglass H., 1983, ASSESSMENT APHASIA R, V2nd; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hooper H.E., 1958, HOOPER VISUAL ORG TE; HUBER SJ, 1989, ARCH NEUROL-CHICAGO, V46, P536, DOI 10.1001/archneur.1989.00520410070026; Itoh K, 2010, ACTA HISTOCHEM CYTOC, V43, P149, DOI 10.1267/ahc.10019; Johnson NE, 2012, SEMIN NEUROL, V32, P246, DOI 10.1055/s-0032-1329202; Kornblum C, 2004, J NEUROL, V251, P710, DOI 10.1007/s00415-004-0408-1; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kuo HC, 2008, ACTA NEUROL SCAND, V117, P101, DOI 10.1111/j.1600-0404.2007.00911.x; Laberge L, 2009, J NEUROL NEUROSUR PS, V80, P642, DOI 10.1136/jnnp.2008.165035; Mathieu J, 2001, NEUROLOGY, V56, P336, DOI 10.1212/WNL.56.3.336; Meola G, 1999, NEUROLOGY, V53, P1042, DOI 10.1212/WNL.53.5.1042; Meola G, 2003, NEUROMUSCULAR DISORD, V13, P813, DOI 10.1016/S0960-8966(03)00137-8; Meola G, 2007, MUSCLE NERVE, V36, P294, DOI 10.1002/mus.20800; Minnerop M, 2011, BRAIN, V134, P3527, DOI 10.1093/brain/awr299; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Naka H, 2002, J NEUROL SCI, V193, P111, DOI 10.1016/S0022-510X(01)00652-9; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ogata A, 1998, NEURORADIOLOGY, V40, P411, DOI 10.1007/s002340050613; Ono S, 1998, NEUROLOGY, V50, P535, DOI 10.1212/WNL.50.2.535; ONO S, 1995, J NEUROL SCI, V128, P225, DOI 10.1016/0022-510X(94)00244-I; Ota M, 2006, NEUROSCI LETT, V407, P234, DOI 10.1016/j.neulet.2006.08.077; PAVLOVIC D., 2003, DIJAGNOSTICKI TESTOV; Peric S, 2014, ACTA NEUROL SCAND, V129, P219, DOI 10.1111/ane.12173; Peric S, 2014, EUR J NEUROL, V21, P231, DOI 10.1111/ene.12237; Romeo V, 2010, J NEUROL, V257, P1246, DOI 10.1007/s00415-010-5498-3; Romigi A, 2011, EUR J NEUROL, V18, P1139, DOI 10.1111/j.1468-1331.2011.03352.x; Rubinsztein JS, 1998, J NEUROL NEUROSUR PS, V64, P510, DOI 10.1136/jnnp.64.4.510; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Spreen O, 1991, COMPENDIUM NEUROPHYS; Turner C, 2010, J NEUROL NEUROSUR PS, V81, P358, DOI 10.1136/jnnp.2008.158261; Vermersch P, 1996, NEUROLOGY, V47, P711, DOI 10.1212/WNL.47.3.711; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Weber YG, 2010, NEUROLOGY, V74, P1108, DOI 10.1212/WNL.0b013e3181d8c35f; Wozniak JR, 2013, J NEUROL, V260, P1122, DOI 10.1007/s00415-012-6771-4; Wozniak JR, 2011, NEUROMUSCULAR DISORD, V21, P89, DOI 10.1016/j.nmd.2010.11.013	56	59	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104697	10.1371/journal.pone.0104697	http://dx.doi.org/10.1371/journal.pone.0104697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115999	gold, Green Submitted, Green Published			2022-12-27	WOS:000341230400070
J	Chen, PP; Wu, RR; Zhu, W; Jiang, Z; Xu, YC; Chen, H; Zhang, ZC; Chen, HQ; Zhang, L; Yu, H; Wang, JA; Hu, XY				Chen, Panpan; Wu, Rongrong; Zhu, Wei; Jiang, Zhi; Xu, Yinchuan; Chen, Han; Zhang, Zhaocai; Chen, Huiqiang; Zhang, Ling; Yu, Hong; Wang, Jian'an; Hu, Xinyang			Hypoxia Preconditioned Mesenchymal Stem Cells Prevent Cardiac Fibroblast Activation and Collagen Production via Leptin	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MYOFIBROBLAST DIFFERENTIATION; MYOCARDIAL-INFARCTION; TGF-BETA; ADVENTITIAL FIBROBLASTS; IN-VITRO; FIBROSIS; TRANSPLANTATION; THERAPY; PROLIFERATION	Aims: Activation of cardiac fibroblasts into myofibroblasts constitutes a key step in cardiac remodeling after myocardial infarction (MI), due to interstitial fibrosis. Mesenchymal stem cells (MSCs) have been shown to improve post-MI remodeling an effect that is enhanced by hypoxia preconditioning (HPC). Leptin has been shown to promote cardiac fibrosis. The expression of leptin is significantly increased in MSCs after HPC but it is unknown whether leptin contributes to MSC therapy or the fibrosis process. The objective of this study was to determine whether leptin secreted from MSCs modulates cardiac fibrosis. Methods: Cardiac fibroblast (CF) activation was induced by hypoxia (0.5% O-2). The effects of MSCs on fibroblast activation were analyzed by co-culturing MSCs with CFs, and detecting the expression of alpha-SMA, SM22 alpha, and collagen I alpha I in CFs by western blot, immunofluorescence and Sirius red staining. In vivo MSCs antifibrotic effects on left ventricular remodeling were investigated using an acute MI model involving permanent ligation of the left anterior descending coronary artery. Results: Co-cultured MSCs decreased fibroblast activation and HPC enhanced the effects. Leptin deficit MSCs from Ob/Ob mice did not decrease fibroblast activation. Consistent with this, H-MSCs significantly inhibited cardiac fibrosis after MI and mediated decreased expression of TGF-beta/Smad2 and MRTF-A in CFs. These effects were again absent in leptin-deficient MSCs. Conclusion: Our data demonstrate that activation of cardiac fibroblast was inhibited by MSCs in a manner that was leptin-dependent. The mechanism may involve blocking TGF-beta/Smad2 and MRTF-A signal pathways.	[Chen, Panpan; Wu, Rongrong; Zhu, Wei; Jiang, Zhi; Xu, Yinchuan; Chen, Han; Zhang, Zhaocai; Chen, Huiqiang; Zhang, Ling; Yu, Hong; Wang, Jian'an; Hu, Xinyang] Zhejiang Univ, Affiliated Hosp 2, Coll Med, Div Cardiol, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Panpan; Wu, Rongrong; Zhu, Wei; Jiang, Zhi; Xu, Yinchuan; Chen, Han; Zhang, Zhaocai; Chen, Huiqiang; Zhang, Ling; Yu, Hong; Wang, Jian'an; Hu, Xinyang] Prov Key Lab Cardiovasc Res, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Wang, JA (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Coll Med, Div Cardiol, Hangzhou 310003, Zhejiang, Peoples R China.	Jian_an_wang@yahoo.com; hxy0507@hotmail.com	Chen, Han/AAA-8050-2021; Zhang, Zhaocai/AAS-3160-2020	Chen, Han/0000-0002-6412-0808; Chen, Panpan/0000-0002-6992-7248	National Natural Science Foundation of China [31371498, 31171418, 81170308, 81370247, 81202948, 31101052, 31271585]; Minister of Science and Technology of China [2012CBA1305]; program for Zhejiang Leading Team of Science and Technology Innovation [2010R50047]; Science and Technology Department of Zhejiang province [20130289]; Zhejiang Provincial Natural Science Foundation [2013C34G2010050]; Joint Research Fund for Overseas Natural Science of China [81128003]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2011ZX09302-002]; National High-tech RD 863 Program [2011AA020102]; Science and Technology Major Project of Zhejiang Province [2012C13013-3]; Science and Technology Department of Zhejiang province public welfare projects [2013C37054]; Zhejiang Provincial Natural Science Foundation of China [2013C37054, Y2110254, 2013C24009, Y2110158]; Health Bureau of Zhejiang province [N20110634]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Minister of Science and Technology of China; program for Zhejiang Leading Team of Science and Technology Innovation; Science and Technology Department of Zhejiang province; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Joint Research Fund for Overseas Natural Science of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project of the Ministry of Science and Technology of China; National High-tech RD 863 Program(National High Technology Research and Development Program of China); Science and Technology Major Project of Zhejiang Province; Science and Technology Department of Zhejiang province public welfare projects; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Health Bureau of Zhejiang province	This work was supported by grants of the National Natural Science Foundation of China (Nos. 31371498, 31171418, 81170308, 81370247, 81202948, 31101052, 31271585), Minister of Science and Technology of China (2012CBA1305) program for Zhejiang Leading Team of Science and Technology Innovation (No. 2010R50047), grant from Science and Technology Department of Zhejiang province (No. 20130289), Zhejiang Provincial Natural Science Foundation (2013C34G2010050), the Joint Research Fund for Overseas Natural Science of China (No. 81128003), National Science and Technology Major Project of the Ministry of Science and Technology of China (No. 2011ZX09302-002), National High-tech R&D 863 Program (No. 2011AA020102), and Science and Technology Major Project of Zhejiang Province (No. 2012C13013-3), grant from Science and Technology Department of Zhejiang province public welfare projects (No. 2013C37054), grant from Zhejiang Provincial Natural Science Foundation of China (Y2110254), grant from Health Bureau of Zhejiang province (N20110634). Zhejiang Provincial Natural Science Foundation (2013C24009, Y2110158). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Crider BJ, 2011, J INVEST DERMATOL, V131, P2378, DOI 10.1038/jid.2011.219; Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937; Davis J, 2013, J MOL CELL CARDIOL; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; Elnakish MT, 2013, J PATHOL, V229, P347, DOI 10.1002/path.4111; Hoh BL, 2011, CIRCULATION, V124, P2243, DOI 10.1161/CIRCULATIONAHA.111.036061; Hu X, 2014, BMC GENOMIC IN PRESS; Hu XY, 2011, J ZHEJIANG UNIV-SC B, V12, P644, DOI 10.1631/jzus.B1101005; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; Li LH, 2009, AM J PHYSIOL-HEART C, V297, pH1504, DOI 10.1152/ajpheart.00194.2009; Li P, 2008, CIRC RES, V102, P185, DOI 10.1161/CIRCRESAHA.107.157677; Martinez-Martinez E, 2014, INT J OBES LOND; Martinez-Martinez E, 2014, J HYPERTENS; Moon YM, 2012, INT ARCH ALLERGY IMM, V159, P399, DOI 10.1159/000337658; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Oberringer M, 2008, J MOL HISTOL, V39, P37, DOI 10.1007/s10735-007-9124-3; Ohnishi S, 2007, FEBS LETT, V581, P3961, DOI 10.1016/j.febslet.2007.07.028; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Shinde AV, 2013, J MOL CELL CARDIOL; Short M, 2004, AM J PHYSIOL-CELL PH, V286, pC416, DOI 10.1152/ajpcell.00169.2003; Small EM, 2012, J CARDIOVASC TRANSL, V5, P794, DOI 10.1007/s12265-012-9397-0; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Stenmark KR, 2002, CHEST, V122, p326S, DOI 10.1378/chest.122.6_suppl.326S; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Velasquez LS, 2013, P NATL ACAD SCI USA, V110, P16850, DOI 10.1073/pnas.1316764110; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zhang ZC, 2013, INT J CARDIOL, V168, P1711, DOI 10.1016/j.ijcard.2013.03.126	31	32	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103587	10.1371/journal.pone.0103587	http://dx.doi.org/10.1371/journal.pone.0103587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116394	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400018
J	Yan, X; Dong, XC; Zhang, W; Yin, HX; Xiao, HL; Chen, P; Ma, XF				Yan, Xia; Dong, Xicun; Zhang, Wen; Yin, Hengxia; Xiao, Honglang; Chen, Peng; Ma, Xiao-Fei			Reference Gene Selection for Quantitative Real-Time PCR Normalization in Reaumuria soongorica	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; RT-PCR; INTERNAL CONTROL; HOUSEKEEPING GENES; EXPRESSION; STRESS; VALIDATION; IDENTIFICATION	Despite its superiority for evaluating gene expression, real-time quantitative polymerase chain reaction (qPCR) results can be significantly biased by the use of inappropriate reference genes under different experimental conditions. Reaumuria soongorica is a dominant species of desert ecosystems in arid central Asia. Given the increasing interest in ecological engineering and potential genetic resources for arid agronomy, it is important to analyze gene function. However, systematic evaluation of stable reference genes should be performed prior to such analyses. In this study, the stabilities of 10 candidate reference genes were analyzed under 4 kinds of abiotic stresses (drought, salt, dark, and heat) within 4 accessions (HG010, HG020, XGG030, and XGG040) from 2 different habitats using 3 algorithms (geNorm, NormFinder, and BestKeeper). After validation of the ribulose-1,5-bisphosphate carboxylase/oxygenase large unite (rbcL) expression pattern, our data suggested that histone H2A (H2A) and eukaryotic initiation factor 4A-2 (EIF4A2) were the most stable reference genes, cyclophilin (CYCL) was moderate, and elongation factor 1 alpha (EF1 alpha) was the worst choice. This first systematic analysis for stably expressed genes will facilitate future functional analyses and deep mining of genetic resources in R. soongorica and other species of the Reaumuria genus.	[Yan, Xia; Xiao, Honglang] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Inland River Ecohydrol, Lanzhou, Peoples R China; [Yan, Xia; Zhang, Wen; Yin, Hengxia; Ma, Xiao-Fei] Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Stress Physiol & Ecol Cold & Arid Reg Gan, Lanzhou, Peoples R China; [Dong, Xicun] Chinese Acad Sci, Inst Modern Phys, Dept Radiobiol, Lanzhou, Peoples R China; [Chen, Peng] Huazhong Agr Univ, Fac Plant Sci & Technol, Wuhan, Peoples R China	Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; Chinese Academy of Sciences; Institute of Modern Physics, CAS; Huazhong Agricultural University	Ma, XF (corresponding author), Chinese Acad Sci, Cold & Arid Reg Environm & Engn Res Inst, Key Lab Stress Physiol & Ecol Cold & Arid Reg Gan, Lanzhou, Peoples R China.	maxiaofei@lzb.ac.cn	Ma, Xiaofei/ABB-5302-2022	Ma, Xiaofei/0000-0001-9456-0065	Chinese Academy of Sciences [29Y127E71]; National Natural Science Foundation of China [91125025]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the "One Hundred Talents'' Project of the Chinese Academy of Sciences (Grant No. 29Y127E71) and National Natural Science Foundation of China (No. 91125025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai J, 2009, J PLANT BIOL, V52, P417, DOI 10.1007/s12374-009-9053-7; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Carmo-Silva AE, 2010, J EXP BOT, V61, P2355, DOI 10.1093/jxb/erq071; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; Dhingra A, 2004, P NATL ACAD SCI USA, V101, P6315, DOI 10.1073/pnas.0400981101; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Dubrovina AS, 2013, J PLANT PHYSIOL, V170, P1491, DOI 10.1016/j.jplph.2013.06.014; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Fink L, 1998, NAT MED, V4, P1329, DOI 10.1038/3327; Gantasala Nagavara Prasad, 2013, BMC Res Notes, V6, P312, DOI 10.1186/1756-0500-6-312; GIMENEZ C, 1992, PLANT PHYSIOL, V98, P516, DOI 10.1104/pp.98.2.516; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Janska A, 2013, MOL GENET GENOMICS, V288, P639, DOI 10.1007/s00438-013-0774-4; Javad MA, 2012, JUNDISHAPUR SCI MED, V11, P85; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Klie Maik, 2011, BMC Res Notes, V4, P518, DOI 10.1186/1756-0500-4-518; Liu JQ, 1982, ACTA BOT SIN, V24, P485; Liu YB, 2007, J ARID ENVIRON, V70, P183, DOI 10.1016/j.jaridenv.2006.12.020; Liu YB, 2007, SCI CHINA SER C, V50, P15, DOI 10.1007/s11427-007-0002-8; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Luo HL, 2010, ANAL BIOCHEM, V404, P100, DOI 10.1016/j.ab.2010.05.002; Ma J, 2007, FRONTIERS EARTH SCI, V1, P150, DOI DOI 10.1007/S11707-007-0019-0; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Qian ZQ, 2008, BIOCHEM SYST ECOL, V36, P593, DOI 10.1016/j.bse.2008.01.008; Rai V, 2012, GENE, V497, P243, DOI 10.1016/j.gene.2012.01.018; Rai V, 2011, GENE, V478, P19, DOI 10.1016/j.gene.2011.01.004; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Saito T, 2008, J JPN SOC HORTIC SCI, V77, P61, DOI 10.2503/jjshs1.77.61; SALVUCCI ME, 1986, PLANT PHYSIOL, V80, P655, DOI 10.1104/pp.80.3.655; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VU JCV, 1987, PLANT PHYSIOL, V83, P573, DOI 10.1104/pp.83.3.573; Wang XH, 2011, PLANT CELL REP, V30, P955, DOI 10.1007/s00299-011-1020-3; Xu H, 2010, BIOTECHNOL LETT, V32, P1961, DOI 10.1007/s10529-010-0362-1; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Zhong HY, 2011, PLANT CELL REP, V30, P641, DOI 10.1007/s00299-010-0992-8; Zhu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056318	50	18	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104124	10.1371/journal.pone.0104124	http://dx.doi.org/10.1371/journal.pone.0104124			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117551	Green Published, gold			2022-12-27	WOS:000341230400033
J	Elfwing, M; Fallahshahroudi, A; Lindgren, I; Jensen, P; Altimiras, J				Elfwing, Magnus; Fallahshahroudi, Amir; Lindgren, Isa; Jensen, Per; Altimiras, Jordi			The Strong Selective Sweep Candidate Gene ADRA2C Does Not Explain Domestication Related Changes in the Stress Response of Chickens	PLOS ONE			English	Article							RED JUNGLEFOWL; RECEPTOR SUBTYPES; PRODUCTION TRAITS; RESOURCE-ALLOCATION; EXPRESSION; BEHAVIOR; LOCI; ANIMALS; POULTRY; BRAIN	Analysis of selective sweeps to pinpoint causative genomic regions involved in chicken domestication has revealed a strong selective sweep on chromosome 4 in layer chickens. The autoregulatory alpha-adrenergic receptor 2C (ADRA2C) gene is the closest to the selective sweep and was proposed as an important gene in the domestication of layer chickens. The ADRA2C promoter region was also hypermethylated in comparison to the non-selected ancestor of all domesticated chicken breeds, the Red Junglefowl, further supporting its relevance. In mice the receptor is involved in the fight-or-flight response as it modulates epinephrine release from the adrenals. To investigate the involvement of ADRA2C in chicken domestication, we measured gene expression in the adrenals and radiolabeled receptor ligand in three brain regions comparing the domestic White Leghorn strain with the wild ancestor Red Junglefowl. In adrenals ADRA2C was twofold greater expressed than the related receptor gene ADRA2A, indicating that ADRA2C is the predominant modulator of epinephrine release but no strain differences were measured. In hypothalamus and amygdala, regions associated with the stress response, and in striatum, receptor binding pIC50 values ranged between 8.1-8.4, and the level was not influenced by the genotyped allele. Because chicken strains differ in morphology, physiology and behavior, differences attributed to a single gene may be lost in the noise caused by the heterogeneous genetic background. Therefore an F-10 advanced intercross strain between White Leghorn and Red Junglefowl was used to investigate effects of ADRA2C alleles on fear related behaviors and fecundity. We did not find compelling genotype effects in open field, tonic immobility, aerial predator, associative learning or fecundity. Therefore we conclude that ADRA2C is probably not involved in the domestication of the stress response in chicken, and the strong selective sweep is probably caused by selection of some unknown genetic element in the vicinity of the gene.	[Elfwing, Magnus; Fallahshahroudi, Amir; Lindgren, Isa; Jensen, Per; Altimiras, Jordi] Linkoping Univ, IFM Biol, Div Biol, AVIAN Behav Genom & Physiol Grp, Linkoping, Sweden	Linkoping University	Altimiras, J (corresponding author), Linkoping Univ, IFM Biol, Div Biol, AVIAN Behav Genom & Physiol Grp, Linkoping, Sweden.	jordi.altimiras@liu.se	Fallahshahroudi, Amir/Y-3555-2019	Fallahshahroudi, Amir/0000-0001-8820-0098	Swedish Research Council [2008-14496-59340-36]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS [221-2007-838]; European Research Council (ERC grant) [322206]; Linkoping University strategic initiative LiU-Neuro; Swedish Center of Excellence in Animal Welfare Science	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS(Swedish Research Council Formas); European Research Council (ERC grant)(European Research Council (ERC)); Linkoping University strategic initiative LiU-Neuro; Swedish Center of Excellence in Animal Welfare Science	Grant support came from The Swedish Research Council (2008-14496-59340-36), www.vr.se; The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS (221-2007-838), http://www.formas.se/en/; the European Research Council (ERC grant 322206 GENEWELL), http://erc.europa.eu/; the Linkoping University strategic initiative LiU-Neuro and the Swedish Center of Excellence in Animal Welfare Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnvall B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035162; Andersson L, 2012, J INTERN MED, V271, P1, DOI 10.1111/j.1365-2796.2011.02450.x; Brede M, 2003, MOL ENDOCRINOL, V17, P1640, DOI 10.1210/me.2003-0035; Campler M, 2009, BEHAV PROCESS, V81, P39, DOI 10.1016/j.beproc.2008.12.018; De Koning DJ, 2004, GENET RES, V83, P211, DOI 10.1017/S0016672304006846; Drummond GB, 2012, MICROCIRCULATION, V19, P188, DOI 10.1111/j.1549-8719.2012.00162.x; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Hakansson J, 2008, APPL ANIM BEHAV SCI, V114, P409, DOI 10.1016/j.applanim.2008.04.003; Hein L, 1999, NATURE, V402, P181, DOI 10.1038/46040; Holmberg M, 1999, NEUROSCIENCE, V93, P1323, DOI 10.1016/S0306-4522(99)00260-2; Jensen P, 2006, APPL ANIM BEHAV SCI, V97, P3, DOI 10.1016/j.applanim.2005.11.015; Johnsson M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002914; Li Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030687; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MOUDGAL RP, 1981, NATURE, V293, P738, DOI 10.1038/293738a0; Natt D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-59; NICHOLAS AP, 1993, J COMP NEUROL, V328, P575, DOI 10.1002/cne.903280409; Philipp M, 2004, PHARMACOL THERAPEUT, V101, P65, DOI 10.1016/j.pharmthera.2003.10.004; Price EO, 2002, AN DOM BEH EL RES; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rosin DL, 1996, J COMP NEUROL, V372, P135; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sallinen J, 1998, J NEUROSCI, V18, P3035; Schreiweis MA, 2006, ANIM GENET, V37, P106, DOI 10.1111/j.1365-2052.2005.01394.x; Schutz K, 2002, BEHAV GENET, V32, P423, DOI 10.1023/A:1020880211144; Schutz KE, 2001, ETHOLOGY, V107, P753, DOI 10.1046/j.1439-0310.2001.00703.x; Wang R, 1996, NEUROSCIENCE, V74, P199, DOI 10.1016/0306-4522(96)00116-9; Wright D, 2006, ANIM GENET, V37, P529, DOI 10.1111/j.1365-2052.2006.01515.x; Wright D, 2010, MOL ECOL, V19, P5140, DOI 10.1111/j.1365-294X.2010.04882.x	30	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e103218	10.1371/journal.pone.0103218	http://dx.doi.org/10.1371/journal.pone.0103218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111139	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100015
J	Takano, A; Toyomane, K; Konnai, S; Ohashi, K; Nakao, M; Ito, T; Andoh, M; Maeda, K; Watarai, M; Sato, K; Kawabata, H				Takano, Ai; Toyomane, Kochi; Konnai, Satoru; Ohashi, Kazuhiko; Nakao, Minoru; Ito, Takuya; Andoh, Masako; Maeda, Ken; Watarai, Masahisa; Sato, Kozue; Kawabata, Hiroki			Tick Surveillance for Relapsing Fever Spirochete Borrelia miyamotoi in Hokkaido, Japan	PLOS ONE			English	Article							LYME-DISEASE; IXODES-PERSULCATUS; VECTOR TICK; SENSU-LATO; MENINGOENCEPHALITIS; BURGDORFERI; RODENTS; HUMANS; HOST	During 2012-2013, a total of 4325 host-seeking adult ticks belonging to the genus Ixodes were collected from various localities of Hokkaido, the northernmost island of Japan. Tick lysates were subjected to real-time PCR assay to detect borrelial infection. The assay was designed for specific detection of the Relapsing fever spirochete Borrelia miyamotoi and for unspecific detection of Lyme disease-related spirochetes. Overall prevalence of B. miyamotoi was 2% (71/3532) in Ixodes persulcatus, 4.3% (5/117) in Ixodes pavlovskyi and 0.1% (1/676) in Ixodes ovatus. The prevalence in I. persulcatus and I. pavlovskyi ticks were significantly higher than in I. ovatus. Co-infections with Lyme disease-related spirochetes were found in all of the tick species. During this investigation, we obtained 6 isolates of B. miyamotoi from I. persulcatus and I. pavlovskyi by culture in BSK-M medium. Phylogenetic trees of B. miyamotoi inferred from each of 3 housekeeping genes (glpQ, 16S rDNA, and flaB) demonstrated that the Hokkaido isolates were clustered with Russian B. miyamotoi, but were distinguishable from North American and European B. miyamotoi. A multilocus sequence analysis using 8 genes (clpA, clpX, nifS, pepX, pyrG, recG, rplB, and uvrA) suggested that all Japanese B. miyamotoi isolates, including past isolates, were genetically clonal, although these were isolated from different tick and vertebrate sources. From these results, B. miyamotoi-infected ticks are widely distributed throughout Hokkaido. Female I. persulcatus are responsible for most human tick-bites, thereby I. persulcatus is likely the most important vector of indigenous relapsing fever from tick bites in Hokkaido.	[Takano, Ai; Maeda, Ken; Watarai, Masahisa] Yamaguchi Univ, Dept Vet Med, Joint Fac Vet Med, Yamaguchi, Japan; [Takano, Ai; Maeda, Ken; Watarai, Masahisa] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Japan; [Toyomane, Kochi; Konnai, Satoru; Ohashi, Kazuhiko] Hokkaido Univ, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Nakao, Minoru] Asahikawa Med Coll, Dept Parasitol, Asahikawa, Hokkaido 078, Japan; [Ito, Takuya] Hokkaido Inst Publ Health, Dept Infect Dis, Sapporo, Hokkaido, Japan; [Andoh, Masako] Kagoshima Univ, Lab Vet Publ Hlth, Joint Fac Vet Med, Kagoshima 890, Japan; [Sato, Kozue; Kawabata, Hiroki] Natl Inst Infect Dis, Dept Bacteriol 1, Shinjuku Ku, Tokyo, Japan; [Kawabata, Hiroki] Gifu Univ, United Grad Sch Agr Sci & Vet Sci, Gifu, Japan	Yamaguchi University; Yamaguchi University; Hokkaido University; Asahikawa Medical College; Kagoshima University; National Institute of Infectious Diseases (NIID); Gifu University	Takano, A (corresponding author), Yamaguchi Univ, Dept Vet Med, Joint Fac Vet Med, Yamaguchi, Japan.	a-takano@yamaguchi-u.ac.jp		Satoru, Konnai/0000-0002-3230-7109; TAKANO, Ai/0000-0002-5919-3738	Japanese Ministry of Health, Labor, and Welfare [H24-Shinko-Ippan-008]; MEXT, Japan	Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant for research on emerging and reemerging infectious diseases from the Japanese Ministry of Health, Labor, and Welfare (H24-Shinko-Ippan-008) (http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo-h25/gaiyo/19.html), and Program to Disseminate Tenure Tracking System, MEXT, Japan (http://www.jst.go.jp/tenure/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour AG, 2005, TICK-BORNE DISEASES OF HUMANS, P268; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; Chowdri HR, 2013, ANN INTERN MED, V159, P21, DOI 10.7326/0003-4819-159-1-201307020-00005; Fraenkel CJ, 2002, J CLIN MICROBIOL, V40, P3308, DOI 10.1128/JCM.40.9.3308-3312.2002; Fukunaga M, 2000, J PARASITOL, V86, P38, DOI 10.1645/0022-3395(2000)086[0038:MPAOIT]2.0.CO;2; FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; Geller J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051914; Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039; Hashimoto Y., 2002, JPN J DERMATOL, V112, P1467; Hovius JWR, 2013, LANCET, V382, P658, DOI 10.1016/S0140-6736(13)61644-X; Hue F, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00713-13; Korenberg EI, 2010, VECTOR-BORNE ZOONOT, V10, P453, DOI 10.1089/vbz.2009.0033; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Masuzawa T, 2004, JPN J INFECT DIS, V57, P229; MIYAMOTO K, 1992, J MED ENTOMOL, V29, P216, DOI 10.1093/jmedent/29.2.216; Mun J, 2006, J MED ENTOMOL, V43, P120, DOI 10.1603/0022-2585(2006)043[0120:DOABMS]2.0.CO;2; Nakao Minoru, 1992, Japanese Journal of Sanitary Zoology, V43, P229; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Richter D, 2003, EMERG INFECT DIS, V9, P697; Salkeld DJ, 2014, EMERG INFECT DIS, V20, P493, DOI 10.3201/eid2003.130668; Schwan TG, 2002, EMERG INFECT DIS, V8, P115, DOI 10.3201/eid0802.010198; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Takano A., 2014, Medical Entomology and Zoology, V65, P13; Takano A, 2011, ENV MICROBIOL REP, V3, P632, DOI 10.1111/j.1758-2229.2011.00280.x; Takano A, 2012, TICKS TICK-BORNE DIS, V3, P259, DOI 10.1016/j.ttbdis.2012.06.003; Takano A, 2011, J CLIN MICROBIOL, V49, P2035, DOI 10.1128/JCM.02544-10; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor KR, 2013, VECTOR-BORNE ZOONOT, V13, P92, DOI 10.1089/vbz.2012.1027; Yamazaki-Matsune W, 2007, J MED MICROBIOL, V56, P1467, DOI 10.1099/jmm.0.47363-0	30	67	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104532	10.1371/journal.pone.0104532	http://dx.doi.org/10.1371/journal.pone.0104532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111141	Green Submitted, Green Published, gold			2022-12-27	WOS:000341105100068
J	Cao, HS; Butler, K; Hossain, M; Lewis, JD				Cao, Huansheng; Butler, Kevin; Hossain, Mithi; Lewis, James D.			Variation in the Fitness Effects of Mutations with Population Density and Size in Escherichia coli	PLOS ONE			English	Article							TERM EXPERIMENTAL EVOLUTION; NATURAL-SELECTION; BENEFICIAL MUTATIONS; TRADE-OFFS; PROBABILITY; FIXATION; ADAPTATION; ARCHITECTURE; BACTERIA; GROWTH	The fitness effects of mutations are context specific and depend on both external (e. g., environment) and internal (e. g., cellular stress, genetic background) factors. The influence of population size and density on fitness effects are unknown, despite the central role population size plays in the supply and fixation of mutations. We addressed this issue by comparing the fitness of 92 Keio strains (Escherichia coli K12 single gene knockouts) at comparatively high (1.2x10(7) CFUs/mL) and low (2.5x10(2) CFUs/mL) densities, which also differed in population size (high: 1.2x10(8); low: 1.25x10(3)). Twenty-eight gene deletions (30%) exhibited a fitness difference, ranging from 5 to 174% (median: 35%), between the high and low densities. Our analyses suggest this variation among gene deletions in fitness responses reflected in part both gene orientation and function, of the gene properties we examined (genomic position, length, orientation, and function). Although we could not determine the relative effects of population density and size, our results suggest fitness effects of mutations vary with these two factors, and this variation is gene-specific. Besides being a mechanism for density-dependent selection (r-K selection), the dependence of fitness effects on population density and size has implications for any population that varies in size over time, including populations undergoing evolutionary rescue, species invasions into novel habitats, and cancer progression and metastasis. Further, combined with recent advances in understanding the roles of other context-specific factors in the fitness effects of mutations, our results will help address theoretical and applied biological questions more realistically.	[Lewis, James D.] Fordham Univ, Louis Calder Ctr, Biol Field Stn, Armonk, NY 10504 USA; Fordham Univ, Dept Biol Sci, Armonk, NY USA	Fordham University; Fordham University	Lewis, JD (corresponding author), Fordham Univ, Louis Calder Ctr, Biol Field Stn, Armonk, NY 10504 USA.	jdlewis@fordham.edu	Cao, Huansheng/C-2182-2015	Cao, Huansheng/0000-0002-2538-1589	Calder Graduate Research Grant; Fordham University	Calder Graduate Research Grant; Fordham University	This work was supported by a Calder Graduate Research Grant (HC) and Fordham University (JDL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1877, DIFFERENT FORMS FLOW; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bershtein S, 2013, MOL CELL, V49, P133, DOI 10.1016/j.molcel.2012.11.004; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Darch SE, 2012, P NATL ACAD SCI USA, V109, P8259, DOI 10.1073/pnas.1118131109; Dorman CJ, 2013, NAT REV MICROBIOL, V11, P349, DOI 10.1038/nrmicro3007; Elena SF, 1998, GENETICA, V102-3, P349, DOI 10.1023/A:1017031008316; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Fry JD, 2002, GENETICS, V161, P1155; GOMULKIEWICZ R, 1995, EVOLUTION, V49, P201, DOI 10.1111/j.1558-5646.1995.tb05971.x; Gossmann TI, 2012, GENOME BIOL EVOL, V4, P658, DOI 10.1093/gbe/evs027; Heithoff DM, 1997, P NATL ACAD SCI USA, V94, P934, DOI 10.1073/pnas.94.3.934; Hendrickson H, 2006, J MOL EVOL, V62, P615, DOI 10.1007/s00239-005-0192-2; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; KIMURA M, 1962, GENETICS, V47, P713; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Lind PA, 2010, SCIENCE, V330, P825, DOI 10.1126/science.1194617; Maharjan R, 2013, HEREDITY, V110, P10, DOI 10.1038/hdy.2012.46; Mao XZ, 2012, NUCLEIC ACIDS RES, V40, P8210, DOI 10.1093/nar/gks605; Marx CJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-109; Mates AK, 2007, J BACTERIOL, V189, P2759, DOI 10.1128/JB.01490-06; MUELLER LD, 1991, SCIENCE, V253, P433, DOI 10.1126/science.1907401; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Ochman H, 1987, ESCHERICHIA COLI SAL, P1649; Casanueva MO, 2012, SCIENCE, V335, P82, DOI 10.1126/science.1213491; Otto SP, 1997, GENETICS, V146, P723; Patwa Z, 2008, J R SOC INTERFACE, V5, P1279, DOI 10.1098/rsif.2008.0248; Perfeito L, 2007, SCIENCE, V317, P813, DOI 10.1126/science.1142284; Plague GR, 2011, GENETICA, V139, P895, DOI 10.1007/s10709-011-9593-x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rozen DE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001715; Tan CM, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.49; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; VASI F, 1994, AM NAT, V144, P432, DOI 10.1086/285685; Wahl LM, 2001, EVOLUTION, V55, P2606; Waxman D, 2011, GENETICS, V188, P907, DOI 10.1534/genetics.111.129288	38	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105369	10.1371/journal.pone.0105369	http://dx.doi.org/10.1371/journal.pone.0105369			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121498	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000120
J	Joubert, C; Linard, C; Le Moullac, G; Soyez, C; Saulnier, D; Teaniniuraitemoana, V; Ky, CL; Gueguen, Y				Joubert, Caroline; Linard, Ciementine; Le Moullac, Gilles; Soyez, Claude; Saulnier, Denis; Teaniniuraitemoana, Vaihiti; Ky, Chin Long; Gueguen, Yannick			Temperature and Food Influence Shell Growth and Mantle Gene Expression of Shell Matrix Proteins in the Pearl Oyster Pinctada margaritifera	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; NACREOUS LAYER; FAMILY; BIVALVIA; CULTURE; QUALITY; BIOMINERALIZATION; MOLLUSCA; TISSUES; RATION	In this study, we analyzed the combined effect of microalgal concentration and temperature on the shell growth of the bivalve Pinctada margaritifera and the molecular mechanisms underlying this biomineralization process. Shell growth was measured after two months of rearing in experimental conditions, using calcein staining of the calcified structures. Molecular mechanisms were studied though the expression of 11 genes encoding proteins implicated in the biomineralization process, which was assessed in the mantle. We showed that shell growth is influenced by both microalgal concentration and temperature, and that these environmental factors also regulate the expression of most of the genes studied. Gene expression measurement of shell matrix protein thereby appears to be an appropriate indicator for the evaluation of the biomineralization activity in the pearl oyster P. margaritifera under varying environmental conditions. This study provides valuable information on the molecular mechanisms of mollusk shell growth and its environmental control.	[Joubert, Caroline; Linard, Ciementine; Le Moullac, Gilles; Soyez, Claude; Saulnier, Denis; Teaniniuraitemoana, Vaihiti; Ky, Chin Long; Gueguen, Yannick] IFREMER, Ctr Pacifique, UMR Ecosyst Insulaires Oceaniens 241, Labex Corail, F-98719 Tahiti, Fr Polynesia, France; [Linard, Ciementine; Teaniniuraitemoana, Vaihiti] Univ French Polynesia, UMR Ecosyst Insulaires Oceaniens 241, Tahiti, France	Ifremer; Ifremer	Le Moullac, G (corresponding author), IFREMER, Ctr Pacifique, UMR Ecosyst Insulaires Oceaniens 241, Labex Corail, F-98719 Tahiti, Fr Polynesia, France.	Gilles.Le.Moullac@ifremer.fr	Gueguen, Yannick/O-3248-2014; saulnier, denis/A-6690-2011	Gueguen, Yannick/0000-0002-8749-9582; saulnier, denis/0000-0003-1422-0242; Le Moullac, Gilles/0000-0003-3749-8239	ANR (POLYPERL project) [ANR-11-AGRO-006]; French Polynesia government through the collaborative project GDR ADEQUA; Ifremer; University of French Polynesia	ANR (POLYPERL project)(French National Research Agency (ANR)); French Polynesia government through the collaborative project GDR ADEQUA; Ifremer; University of French Polynesia	The work was financially supported by ANR funding (POLYPERL project, reference ANR-11-AGRO-006) and by the French Polynesia government through the collaborative project GDR ADEQUA. It was also supported by Ifremer and the University of French Polynesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal D, 2002, J NATL CANCER I, V94, P513; Blay C, 2014, AQUACULT INT, V22, P937, DOI 10.1007/s10499-013-9719-5; BROOM MJ, 1978, MAR BIOL, V47, P277, DOI 10.1007/BF00541005; Chavez-Villalba J, 2013, AQUAT LIVING RESOUR, V26, P263, DOI 10.1051/alr/2013059; Cheung SG, 2008, MAR POLLUT BULL, V57, P280, DOI 10.1016/j.marpolbul.2008.03.039; DELRIOPORTILLA MA, 1992, MAR ECOL PROG SER, V89, P221, DOI 10.3354/meps089221; Doroudi MS, 1999, AQUAC RES, V30, P271, DOI 10.1046/j.1365-2109.1999.00324.x; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; GOKHALE S. V., 1954, JOUR BOMBAY NAT HIST SOC, V52, P124; Hawkins LE, 2005, AQUACULTURE, V250, P841, DOI 10.1016/j.aquaculture.2005.05.037; Huang XD, 2013, MAR BIOTECHNOL, V15, P253, DOI 10.1007/s10126-012-9484-x; Inoue N, 2011, ZOOL SCI, V28, P32, DOI 10.2108/zsj.28.32; Ivanina AV, 2013, COMP BIOCHEM PHYS A, V166, P101, DOI 10.1016/j.cbpa.2013.05.016; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613; Kanazawa T, 2008, J MOLLUS STUD, V74, P89, DOI 10.1093/mollus/eym049; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Kleinman S, 1996, AQUACULTURE, V142, P75, DOI 10.1016/0044-8486(95)01165-X; Kvingedal R, 2008, AQUACULTURE, V279, P23, DOI 10.1016/j.aquaculture.2008.04.022; Ky CL, 2013, AQUAT LIVING RESOUR, V26, P133, DOI 10.1051/alr/2013055; Laing I, 2000, AQUACULTURE, V183, P325, DOI 10.1016/S0044-8486(99)00262-8; Larsen JB, 2005, MAR BIOL, V146, P1119, DOI 10.1007/s00227-004-1524-2; Linard C, 2011, AQUACULTURE, V313, P149, DOI 10.1016/j.aquaculture.2011.01.008; Liu WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033679; Mann S, 2001, BIOMINERALIZATION PR, P205; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Montagnani C, 2011, CHEMBIOCHEM, V12, P2033, DOI 10.1002/cbic.201100216; Nishida K, 2012, PALAEOGEOGR PALAEOCL, V363, P99, DOI 10.1016/j.palaeo.2012.08.017; PANDYA J A, 1976, Indian Journal of Marine Sciences, V5, P249; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pouvreau S, 2001, AQUAT LIVING RESOUR, V14, P155, DOI 10.1016/S0990-7440(01)01120-2; Pouvreau S, 2000, AQUACULTURE, V186, P117, DOI 10.1016/S0044-8486(99)00373-7; Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3; SCHEIRER CJ, 1976, BIOMETRICS, V32, P429, DOI 10.2307/2529511; Schone BR, 2003, MAR BIOL, V142, P473, DOI 10.1007/s00227-002-0970-y; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793; Tayale A, 2012, AQUAT LIVING RESOUR, V25, P269, DOI 10.1051/alr/2012034; Thebault J, 2008, AQUAT LIVING RESOUR, V21, P45, DOI 10.1051/alr:2008021; Tomaru Y, 2002, AQUAC RES, V33, P109, DOI 10.1046/j.1365-2109.2002.00653.x; WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cbpb.2006.03.004	45	65	67	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103944	10.1371/journal.pone.0103944	http://dx.doi.org/10.1371/journal.pone.0103944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121605	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000023
J	Shiota, S; Suzuki, R; Matsuo, Y; Miftahussurur, M; Tran, TTH; Binh, TT; Yamaoka, Y				Shiota, Seiji; Suzuki, Rumiko; Matsuo, Yuichi; Miftahussurur, Muhammad; Trang Thu Huyen Tran; Tran Thanh Binh; Yamaoka, Yoshio			Helicobacter pylori from Gastric Cancer and Duodenal Ulcer Show Same Phylogeographic Origin in the Andean Region in Colombia	PLOS ONE			English	Article							VIRULENCE FACTORS; INCREASED RISK; CYTOTOXIN PRODUCTION; PEPTIC-ULCER; ASSOCIATION; POLYMORPHISMS; GENE; EPIDEMIOLOGY; INFECTION; PACIFIC	Background: A recent report has shown that the phylogenetic origin of Helicobacter pylori based on multi-locus sequence typing (MLST) was significantly associated with the severity of gastritis in Colombia. However, the potential relationship between phylogenetic origin and clinical outcomes was not examined in that study. If the phylogenetic origin rather than virulence factors were truly associated with clinical outcomes, identifying a population at high risk for gastric cancer in Colombia would be relatively straightforward. In this study, we examined the phylogenetic origins of strains from gastric cancer and duodenal ulcer patients living in Bogota, Colombia. Methods: We included 35 gastric cancer patients and 31 duodenal ulcer patients, which are considered the variant outcomes. The genotypes of cagA and vacA were determined by polymerase chain reaction. The genealogy of these Colombian strains was analyzed by MLST. Bacterial population structure was analyzed using STRUCTURE software. Results: H. pylori strains from gastric cancer and duodenal ulcer patients were scattered in the phylogenetic tree; thus, we did not detect any difference in phylogenetic distribution between gastric cancer and duodenal ulcer strains in the hpEurope group in Colombia. Sixty-six strains, with one exception, were classified as hpEurope irrespective of the cagA and vacA genotypes, and type of disease. STRUCTURE analysis revealed that Colombian hpEurope strains have a phylogenetic connection to Spanish strains. Conclusions: Our study showed that a phylogeographic origin determined by MLST was insufficient for distinguishing between gastric cancer and duodenal ulcer risk among hpEurope strains in the Andean region in Colombia. Our analysis also suggests that hpEurope strains in Colombia were primarily introduced by Spanish immigrants.	[Shiota, Seiji; Suzuki, Rumiko; Matsuo, Yuichi; Miftahussurur, Muhammad; Trang Thu Huyen Tran; Tran Thanh Binh; Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan; [Yamaoka, Yoshio] Michael E DeBakey VA Med Ctr, Dept Medicine Gastroenterol, Houston, TX USA; [Yamaoka, Yoshio] Baylor Coll Med, Houston, TX 77030 USA	Oita University; Baylor College of Medicine; Baylor College of Medicine	Yamaoka, Y (corresponding author), Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan.	yyamaoka@oita-u.ac.jp	Matsuo, Yuichi/AAG-4137-2019; Miftahussurur, Muhammad/AAB-6151-2021	Shiota, Seiji/0000-0001-9811-218X; Matsuo, Yuichi/0000-0001-6942-3202; Miftahussurur, Muhammad/0000-0003-1415-6033; Yamaoka, Yoshio/0000-0002-1222-5819	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22390085, 22659087, 24406015, 24659200, 23790798]; Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [25860544] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062813, P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This report is based on work supported in part by grants from the National Institutes of Health (DK62813) (YY), and grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (22390085, 22659087, 24406015 and 24659200) (YY), (23790798) (SS) and Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, MOL MICROBIOL, V32, P459, DOI 10.1046/j.1365-2958.1999.01382.x; Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; CORREA P, 1976, JNCI-J NATL CANCER I, V57, P1027, DOI 10.1093/jnci/57.5.1027; CUELLO C, 1976, JNCI-J NATL CANCER I, V57, P1015, DOI 10.1093/jnci/57.5.1015; de Sablet T, 2011, GUT, V60, P1189, DOI 10.1136/gut.2010.234468; Dominguez-Bello MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003307; El-Omar EM, 2003, GASTROENTEROLOGY, V124, P1193, DOI 10.1016/S0016-5085(03)00157-4; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Goh KL, 2011, HELICOBACTER, V16, P1, DOI 10.1111/j.1523-5378.2011.00874.x; Kersulyte D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015076; Kodaman N, 2014, P NATL ACAD SCI USA, V111, P1455, DOI 10.1073/pnas.1318093111; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; LI WH, 1991, GENETICS, V129, P513; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lu H, 2005, GASTROENTEROLOGY, V128, P833, DOI 10.1053/j.gastro.2005.01.009; Machado JC, 2001, GASTROENTEROLOGY, V121, P823, DOI 10.1053/gast.2001.28000; Machado JC, 2003, GASTROENTEROLOGY, V125, P364, DOI 10.1016/S0016-5085(03)00899-0; Matsunari O, 2012, J CLIN MICROBIOL, V50, P876, DOI 10.1128/JCM.05562-11; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Olbermann P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001069; Rugge M, 2000, AM J SURG PATHOL, V24, P167, DOI 10.1097/00000478-200002000-00001; Salas A, 2008, AM J HUM BIOL, V20, P584, DOI 10.1002/ajhb.20783; Shiota S, 2013, J DIGEST DIS, V14, P341, DOI 10.1111/1751-2980.12054; Shiota S, 2012, GUT, V61, P469, DOI 10.1136/gutjnl-2011-300317; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suerbaum S, 2007, NAT REV MICROBIOL, V5, P441, DOI 10.1038/nrmicro1658; Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P1443, DOI 10.1111/j.1440-1746.2006.04613.x; Sugimoto M, 2007, J GASTROEN HEPATOL, V22, P51, DOI 10.1111/j.1440-1746.2006.04442.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ubukata H, 2011, GASTRIC CANCER, V14, P4, DOI 10.1007/s10120-011-0005-9; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Watada M, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-141; Yamaoka Y, 2000, EPIDEMIOL INFECT, V124, P91, DOI 10.1017/S0950268899003209; Yamaoka Y, 1999, GASTROENTEROLOGY, V117, P342, DOI 10.1053/gast.1999.0029900342; Yamaoka Y, 1998, HELICOBACTER, V3, P241, DOI 10.1046/j.1523-5378.1998.08056.x; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0; Yamaoka Y, 2002, GASTROENTEROLOGY, V123, P414, DOI 10.1053/gast.2002.34781; Yamaoka Y, 2009, CLIN MICROBIOL INFEC, V15, P829, DOI 10.1111/j.1469-0691.2009.02967.x; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154; Yamaoka Y, 2008, INTERNAL MED, V47, P1077, DOI 10.2169/internalmedicine.47.0975	44	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105392	10.1371/journal.pone.0105392	http://dx.doi.org/10.1371/journal.pone.0105392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121764	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000341017000122
J	Xu, JY; Zhou, JW; Li, MS; Ng, CF; Ng, YK; Lai, PBS; Tsui, SKW				Xu, Jiaying; Zhou, Junwei; Li, Man-Shan; Ng, Chor-Fung; Ng, Yuen-Keng; Lai, Paul Bo-San; Tsui, Stephen Kwok-Wing			Transcriptional Regulation of the Tumor Suppressor FHL2 by p53 in Human Kidney and Liver Cells	PLOS ONE			English	Article							ONLY PROTEIN FHL2; COACTIVATOR FHL2; CANCER CELLS; LIM; EXPRESSION; GENE; INTERACTS; GROWTH; 4-AND-A-HALF-LIM; CARCINOGENESIS	(F) under bar our and a (H) under bar alf (L) under bar IM protein 2 (FHL2) is a LIM domain only protein that is able to form various protein complexes and regulate gene transcription. Recent findings showed that FHL2 is a potential tumor suppressor gene that was down-regulated in hepatocellular carcinoma (HCC). Moreover, FHL2 can bind to and activate the TP53 promoter in hepatic cells. In this study, the activity of the two promoters of FHL2, 1a and 1b, were determined in the human embryonic kidney cell line HEK293 and the activation of these two promoters by p53 was investigated. Our results showed that the 1b promoter has a higher activity than the 1a promoter in HEK 293 cells but the 1a promoter is more responsive to the activation by p53 when compared with the 1b promoter. The regulation of FHL2 by p53 was further confirmed in liver cells by the overexpression of p53 in Hep3B cells and the knockdown of p53 in HepG2 cells. Combining promoter activity results of truncated mutants and predictions by bioinformatics tools, a putative p53 binding site was found in the exon 1a of FHL2 from +213 to +232. The binding between the p53 protein and the putative p53 binding site was then validated by the ChIP assay. Furthermore, the expression of FHL2 and TP53 were down-regulated in majority of HCC tumour samples (n = 41) and significantly correlated (P = 0.026). Finally, we found that the somatic mutation 747 (G -> T), a hot spot mutation of the TP53 gene, is potentially associated with a higher expression of FHL2 in HCC tumour samples. Taken together, this is the first in-depth study about the transcriptional regulation of FHL2 by p53.	[Xu, Jiaying; Zhou, Junwei; Li, Man-Shan; Ng, Chor-Fung; Tsui, Stephen Kwok-Wing] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Ng, Yuen-Keng; Lai, Paul Bo-San] Chinese Univ Hong Kong, Dept Surg, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong	Tsui, SKW (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	kwtsui@cuhk.edu.hk	Ng, Yuen-Keng/ABC-3906-2020; Lai, Paul BS/K-8556-2015; Tsui, Stephen Kwok-Wing/E-4385-2015; xu, jia/GSD-6347-2022	Ng, Yuen-Keng/0000-0003-4491-5221; Lai, Paul BS/0000-0002-9469-6728; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; 	"Establishment of the Centre for Microbial Genomics and Proteomics'' of the Focused Investment Scheme of the Chinese University of Hong Kong	"Establishment of the Centre for Microbial Genomics and Proteomics'' of the Focused Investment Scheme of the Chinese University of Hong Kong	This project is supported by the Scheme B funding on the project "Establishment of the Centre for Microbial Genomics and Proteomics'' of the Focused Investment Scheme of the Chinese University of Hong Kong. All the authors declare that they have no conflicts of interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR F, 1993, P NATL ACAD SCI USA, V90, P8586, DOI 10.1073/pnas.90.18.8586; Amaar YG, 2002, J BIOL CHEM, V277, P12053, DOI 10.1074/jbc.M110872200; Brun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055034; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chan KK, 1998, GENE, V210, P345, DOI 10.1016/S0378-1119(97)00644-6; Dahan J, 2013, MOL CELL BIOL, V33, P3299, DOI 10.1128/MCB.00105-13; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Gabriel B, 2004, ANTICANCER RES, V24, P921; Jiang WD, 2010, INT J CANCER, V127, P1011, DOI 10.1002/ijc.25118; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kang CM, 2003, RADIAT RES, V159, P312, DOI 10.1667/0033-7587(2003)159[0312:PBFIRE]2.0.CO;2; Kleiber K, 2007, ANTICANCER RES, V27, P55; Kong YF, 2001, CIRCULATION, V103, P2731; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; Lee SW, 2006, BIOCHEM BIOPH RES CO, V339, P1056, DOI 10.1016/j.bbrc.2005.11.116; Li M, 2008, GLIA, V56, P1328, DOI 10.1002/glia.20701; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; McGrath MJ, 2013, CANCER RES, V73, P5066, DOI 10.1158/0008-5472.CAN-12-4520; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Ng CF, 2011, GENE, V481, P41, DOI 10.1016/j.gene.2011.04.005; Ng CF, 2011, CANCER LETT, V304, P97, DOI 10.1016/j.canlet.2011.02.001; Nogueira JA, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-204; Nouet Y, 2012, J HEPATOL, V57, P1029, DOI 10.1016/j.jhep.2012.06.035; Paul C, 2006, ONCOGENE, V25, P5475, DOI 10.1038/sj.onc.1209567; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Scholl FA, 2000, J CELL BIOL, V151, P495, DOI 10.1083/jcb.151.3.495; Verset L, 2013, BRIT J CANCER, V109, P114, DOI 10.1038/bjc.2013.290; Wang JD, 2007, GASTROENTEROLOGY, V132, P1066, DOI 10.1053/j.gastro.2006.12.004; Wong CH, 2012, CYTOKINE, V59, P286, DOI 10.1016/j.cyto.2012.04.044; Xia T, 2013, J BIOL CHEM, V288, P1785, DOI 10.1074/jbc.M112.439760; Xiong ZH, 2010, IUBMB LIFE, V62, P669, DOI 10.1002/iub.367; Yan JH, 2003, FEBS LETT, V553, P183, DOI 10.1016/S0014-5793(03)00978-5; Zhang WJ, 2010, CARCINOGENESIS, V31, P1220, DOI 10.1093/carcin/bgq094	36	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e99359	10.1371/journal.pone.0099359	http://dx.doi.org/10.1371/journal.pone.0099359			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121502	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000001
J	Boecker, R; Holz, NE; Buchmann, AF; Blomeyer, D; Plichta, MM; Wolf, I; Baumeister, S; Meyer-Lindenberg, A; Banaschewski, T; Brandeis, D; Laucht, M				Boecker, Regina; Holz, Nathalie E.; Buchmann, Arlette F.; Blomeyer, Dorothea; Plichta, Michael M.; Wolf, Isabella; Baumeister, Sarah; Meyer-Lindenberg, Andreas; Banaschewski, Tobias; Brandeis, Daniel; Laucht, Manfred			Impact of Early Life Adversity on Reward Processing in Young Adults: EEG-fMRI Results from a Prospective Study over 25 Years	PLOS ONE			English	Article							MONETARY REWARD; ACUTE STRESS; VENTRAL STRIATUM; DOPAMINE; ANTICIPATION; BRAIN; RISK; GENE; ENVIRONMENT; ASSOCIATION	Several lines of evidence have implicated the mesolimbic dopamine reward pathway in altered brain function resulting from exposure to early adversity. The present study examined the impact of early life adversity on different stages of neuronal reward processing later in life and their association with a related behavioral phenotype, i.e. attention deficit/hyperactivity disorder (ADHD). 162 healthy young adults (mean age = 24.4 years; 58% female) from an epidemiological cohort study followed since birth participated in a simultaneous EEG-fMRI study using a monetary incentive delay task. Early life adversity according to an early family adversity index (EFA) and lifetime ADHD symptoms were assessed using standardized parent interviews conducted at the offspring's age of 3 months and between 2 and 15 years, respectively. fMRI region-of-interest analysis revealed a significant effect of EFA during reward anticipation in reward-related areas (i.e. ventral striatum, putamen, thalamus), indicating decreased activation when EFA increased. EEG analysis demonstrated a similar effect for the contingent negative variation (CNV), with the CNV decreasing with the level of EFA. In contrast, during reward delivery, activation of the bilateral insula, right pallidum and bilateral putamen increased with EFA. There was a significant association of lifetime ADHD symptoms with lower activation in the left ventral striatum during reward anticipation and higher activation in the right insula during reward delivery. The present findings indicate a differential long-term impact of early life adversity on reward processing, implicating hyporesponsiveness during reward anticipation and hyperresponsiveness when receiving a reward. Moreover, a similar activation pattern related to lifetime ADHD suggests that the impact of early life stress on ADHD may possibly be mediated by a dysfunctional reward pathway.	[Boecker, Regina; Holz, Nathalie E.; Buchmann, Arlette F.; Blomeyer, Dorothea; Wolf, Isabella; Baumeister, Sarah; Banaschewski, Tobias; Brandeis, Daniel; Laucht, Manfred] Heidelberg Univ, CIMH Med Fac Mannheim, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany; [Plichta, Michael M.; Meyer-Lindenberg, Andreas] Heidelberg Univ, CIMH Med Fac Mannheim, Dept Psychiat & Psychotherapy, Mannheim, Germany; [Wolf, Isabella] Heidelberg Univ, CIMH Med Fac Mannheim, Dept Neuroimaging, Mannheim, Germany; [Brandeis, Daniel] Univ Zurich, Dept Child & Adolescent Psychiat, Zurich, Switzerland; [Brandeis, Daniel] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Brandeis, Daniel] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Brandeis, Daniel] ETH, Zurich, Switzerland; [Laucht, Manfred] Univ Potsdam, Dept Psychol, Potsdam, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Potsdam	Laucht, M (corresponding author), Heidelberg Univ, CIMH Med Fac Mannheim, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany.	manfred.laucht@zi-mannheim.de	Baumeister, Sarah/CAE-8790-2022; Banaschewski, Tobias/ABE-5985-2020; Meyer-Lindenberg, Andreas/H-1076-2011	Banaschewski, Tobias/0000-0003-4595-1144; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	German Research Foundation (DFG) [LA 733/1-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation (DFG LA 733/1-2) to ML, DB, TB, and AML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 1997, MANUAL YOUNG ADULT S, DOI DOI 10.1126/science.aap8757; Albrecht B, 2013, PSYCHOL MED, V43, P1997, DOI 10.1017/S003329171200270X; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Baker CN, 2012, PERS INDIV DIFFER, V52, P800, DOI 10.1016/j.paid.2011.12.034; Banaschewski T, 2003, J CHILD PSYCHOL PSYC, V44, P356, DOI 10.1111/1469-7610.00127; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bates J, 1991, DEV TREATMENT CHILDH; Berghorst LH, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00133; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Blum Kenneth, 2000, Journal of Psychoactive Drugs, V32, pi; Bogdan R, 2006, BIOL PSYCHIAT, V60, P1147, DOI 10.1016/j.biopsych.2006.03.037; Broyd SJ, 2012, J NEUROSCI METH, V209, P40, DOI 10.1016/j.jneumeth.2012.05.015; Brunia CHM, 2011, CLIN NEUROPHYSIOL, V122, P858, DOI 10.1016/j.clinph.2010.12.039; Burchinal M, 2008, PARENT-SCI PRACT, V8, P41, DOI 10.1080/15295190701830672; Cabib S, 1996, PSYCHOPHARMACOLOGY, V128, P331, DOI 10.1007/s002130050142; Camara E, 2010, CEREB CORTEX, V20, P1985, DOI 10.1093/cercor/bhp263; Capa RL, 2013, CORTEX, V49, P1943, DOI 10.1016/j.cortex.2012.05.018; Cho YST, 2013, NEUROIMAGE, V66, P508, DOI 10.1016/j.neuroimage.2012.10.013; Debener S, 2008, INT J PSYCHOPHYSIOL, V67, P189, DOI 10.1016/j.ijpsycho.2007.05.015; Delmo C., 2000, KIDDIE SADS PRESENT, V3rd ed.; Delmonte S, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-7; Diekhof EK, 2012, NEUROPSYCHOLOGIA, V50, P1252, DOI 10.1016/j.neuropsychologia.2012.02.007; Dillon DG, 2009, BIOL PSYCHIAT, V66, P206, DOI 10.1016/j.biopsych.2009.02.019; Doehnert M, 2013, J CHILD PSYCHOL PSYC, V54, P260, DOI 10.1111/j.1469-7610.2012.02572.x; Dreher JC, 2009, P NATL ACAD SCI USA, V106, P617, DOI 10.1073/pnas.0805517106; Esser G., 1989, MANNHEIM PARENT INTE; Evans GW, 2013, PSYCHOL BULL, V139, P1342, DOI 10.1037/a0031808; Frank MJ, 2006, PSYCHOL REV, V113, P300, DOI 10.1037/0033-295X.113.2.300; Friedman DP, 2002, J COMP NEUROL, V450, P345, DOI 10.1002/cne.10336; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; Furukawa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089129; Glascoe FP, 2010, PEDIATRICS, V125, P313, DOI 10.1542/peds.2008-3129; Goldstein RZ, 2006, INT J PSYCHOPHYSIOL, V62, P272, DOI 10.1016/j.ijpsycho.2006.05.006; Guyer AE, 2006, J AM ACAD CHILD PSY, V45, P1059, DOI 10.1097/01.chi.0000227882.50404.11; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hahn T, 2011, HUM BRAIN MAPP, V32, P1557, DOI 10.1002/hbm.21127; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Heim C, 2012, EXP NEUROL, V233, P102, DOI 10.1016/j.expneurol.2011.10.032; Holz NE, 2014, JAMA PSYCHIAT; IRWIN DA, 1966, ELECTROEN CLIN NEURO, V21, P538, DOI 10.1016/0013-4694(66)90172-6; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kaufman J., 1996, KIDDIE SADS PRESENT, DOI 10.1097/00004583-199707000-00021; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2008, BIOL PSYCHIAT, V63, P686, DOI 10.1016/j.biopsych.2007.07.023; Kotani Y, 2001, PSYCHOPHYSIOLOGY, V38, P873, DOI 10.1111/1469-8986.3860873; Kumar P, 2014, NEUROSCIENCE, V266, P1, DOI 10.1016/j.neuroscience.2014.01.058; Laucht M, 2007, J NEURAL TRANSM, V114, P1097, DOI 10.1007/s00702-007-0703-y; Laucht M, 2000, J AM ACAD CHILD PSY, V39, P1229, DOI 10.1097/00004583-200010000-00009; Laucht M, 2001, DEV MED CHILD NEUROL, V43, P292, DOI 10.1017/S0012162201000561; Laucht M, 1997, J CHILD PSYCHOL PSYC, V38, P843, DOI 10.1111/j.1469-7610.1997.tb01602.x; Laucht M, 2007, ARCH GEN PSYCHIAT, V64, P585, DOI 10.1001/archpsyc.64.5.585; Laucht M, 2009, INT J NEUROPSYCHOPH, V12, P737, DOI 10.1017/S1461145708009875; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Makeig S, 1996, ADV NEUR IN, V8, P145; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McLaughlin KA, 2012, ARCH GEN PSYCHIAT, V69, P1151, DOI 10.1001/archgenpsychiatry.2011.2277; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Mehta MA, 2010, J COGNITIVE NEUROSCI, V22, P2316, DOI 10.1162/jocn.2009.21394; MULLER R, 1991, CHANGING TRENDS CONS; Murty VP, 2013, CEREB CORTEX; Paloyelis Y, 2012, J AM ACAD CHILD PSY, V51, P722, DOI 10.1016/j.jaac.2012.05.006; Pheula GF, 2011, EUR CHILD ADOLES PSY, V20, P137, DOI 10.1007/s00787-011-0158-4; PIERSON A, 1987, INT J PSYCHOPHYSIOL, V5, P107, DOI 10.1016/0167-8760(87)90015-8; Plichta MM, 2013, J NEUROSCI, V33, P14526, DOI 10.1523/JNEUROSCI.0631-13.2013; Plichta MM, 2009, BIOL PSYCHIAT, V65, P7, DOI 10.1016/j.biopsych.2008.07.008; Poppenk J, 2013, TRENDS COGN SCI, V17, P230, DOI 10.1016/j.tics.2013.03.005; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Pressman LJ, 2006, J AM ACAD CHILD PSY, V45, P346, DOI 10.1097/01.chi.0000192248.61271.c8; Rademacher L, 2010, NEUROIMAGE, V49, P3276, DOI 10.1016/j.neuroimage.2009.10.089; Roth TL, 2011, HORM BEHAV, V59, P315, DOI 10.1016/j.yhbeh.2010.05.005; Rutter M, 1977, ECOLOGICAL FACTORS H, P173; Scheres A, 2008, J NEURAL TRANSM, V115, P221, DOI 10.1007/s00702-007-0813-6; Schmid B, 2011, J PSYCHIATR RES, V45, P1387, DOI 10.1016/j.jpsychires.2011.05.010; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Stark R, 2011, NEUROPSYCHOLOGIA, V49, P426, DOI 10.1016/j.neuropsychologia.2010.12.012; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; Treadway MT, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00180; Tripp G, 2008, J CHILD PSYCHOL PSYC, V49, P691, DOI 10.1111/j.1469-7610.2007.01851.x; Tripp G, 2009, NEUROPHARMACOLOGY, V57, P579, DOI 10.1016/j.neuropharm.2009.07.026; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; van Leeuwen TH, 1998, BEHAV BRAIN RES, V94, P97, DOI 10.1016/S0166-4328(97)00173-3; Walter B., 2003, 9 INT C FUNCT MAPP H; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wittchen H-U., 1997, STRUCTURED CLIN INTE; Yacubian J, 2007, P NATL ACAD SCI USA, V104, P8125, DOI 10.1073/pnas.0702029104	89	88	88	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104185	10.1371/journal.pone.0104185	http://dx.doi.org/10.1371/journal.pone.0104185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118701	Green Published, gold, Green Accepted			2022-12-27	WOS:000340900600040
J	Choy, JS; Zhang, ZD; Pitsillides, K; Sosa, M; Kassab, GS				Choy, Jenny S.; Zhang, Zhen-Du; Pitsillides, Koullis; Sosa, Margo; Kassab, Ghassan S.			Longitudinal Hemodynamic Measurements in Swine Heart Failure Using a Fully Implantable Telemetry System	PLOS ONE			English	Article							BLOOD-PRESSURE; DIASTOLIC SUCTION; FLOW; RADIOTELEMETRY; DOG; ECG	Chronic monitoring of heart rate, blood pressure, and flow in conscious free-roaming large animals can offer considerable opportunity to understand the progression of cardiovascular diseases and can test new diagnostics and therapeutics. The objective of this study was to demonstrate the feasibility of chronic, simultaneous measurement of several hemodynamic parameters (left ventricular pressure, systemic pressure, blood flow velocity, and heart rate) using a totally implantable multichannel telemetry system in swine heart failure models. Two solid-state blood pressure sensors were inserted in the left ventricle and the descending aorta for pressure measurements. Two Doppler probes were placed around the left anterior descending (LAD) and the brachiocephalic arteries for blood flow velocity measurements. Electrocardiographic (ECG) electrodes were attached to the surface of the left ventricle to monitor heart rate. The telemeter body was implanted in the right side of the abdomen under the skin for approximately 4 to 6 weeks. The animals were subjected to various heart failure models, including volume overload (A-V fistula, n = 3), pressure overload (aortic banding, n = 2) and dilated cardiomyopathy (pacing-induced tachycardia, n = 3). Longitudinal changes in hemodynamics were monitored during the progression of the disease. In the pacing-induced tachycardia animals, the systemic blood pressure progressively decreased within the first 2 weeks and returned to baseline levels thereafter. In the aortic banding animals, the pressure progressively increased during the development of the disease. The pressure in the A-V fistula animals only showed a small increase during the first week and remained stable thereafter. The results demonstrated the ability of this telemetry system of long-term, simultaneous monitoring of blood flow, pressure and heart rate in heart failure models, which may offer significant utility for understanding cardiovascular disease progression and treatment.	[Choy, Jenny S.; Zhang, Zhen-Du; Kassab, Ghassan S.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Pitsillides, Koullis] Transon EndoGear Inc, Davis, CA USA; [Sosa, Margo] Transon Syst Inc, Ithaca, NY USA; [Kassab, Ghassan S.] Indiana Univ, Dept Surg, Indianapolis, IN USA; [Kassab, Ghassan S.] Indiana Univ, Dept Cellular & Integrat Physiol, Indianapolis, IN 46204 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Kassab, GS (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	gkassab@iupui.edu						Akasaka T, 1994, J Am Soc Echocardiogr, V7, P9; Anderson NH, 1999, HYPERTENSION, V33, P248, DOI 10.1161/01.HYP.33.1.248; Axelsson M, 2007, J APPL PHYSIOL, V102, P1220, DOI 10.1152/japplphysiol.00887.2006; Bell SP, 2000, CIRC RES, V87, P235, DOI 10.1161/01.RES.87.3.235; BRECHER GA, 1958, CIRC RES, V6, P554, DOI 10.1161/01.RES.6.5.554; Cardon AD, 2012, J AM ASSOC LAB ANIM, V51, P301; CLAUDE JP, 1979, BIOTELEM PAT MON, V6, P160; Dang CQ, 2008, ANN BIOMED ENG, V36, P933, DOI 10.1007/s10439-008-9488-x; DEPASQUALE MJ, 1994, CLIN EXP HYPERTENS, V16, P245, DOI 10.3109/10641969409067952; Franklin D L, 1970, UCLA Forum Med Sci, V10, P377; FRANKLIN DL, 1964, NATURE, V203, P528, DOI 10.1038/203528a0; FRYER TB, 1975, J APPL PHYSIOL, V39, P318, DOI 10.1152/jappl.1975.39.2.318; GILSON N, 1990, AM J PHYSIOL, V258, pH634, DOI 10.1152/ajpheart.1990.258.3.H634; HOLLANDER W, 1968, J CLIN INVEST, V47, P1221, DOI 10.1172/JCI105811; Huetteman DA, 2009, METHODS MOL BIOL, V573, P57, DOI 10.1007/978-1-60761-247-6_4; Kawai H, 2000, AM J PHYSIOL-HEART C, V278, pH1708, DOI 10.1152/ajpheart.2000.278.5.H1708; KVETNANSKY R, 1978, ENDOCRINOLOGY, V103, P1868, DOI 10.1210/endo-103-5-1868; Lionetti V, 2007, AM J PHYSIOL-HEART C, V293, pH2747, DOI 10.1152/ajpheart.00592.2007; NAKATANI S, 1994, AM HEART J, V127, P143, DOI 10.1016/0002-8703(94)90519-3; National Research Council, 2011, GUIDE CARE USE LAB A; Nemeth S, 1997, ENDOKRINOLOGIE, V69, P87; RADER RD, 1973, IEEE T BIO-MED ENG, VBM20, P37, DOI 10.1109/TBME.1973.324249; Smith TL, 1980, AM J PHYSIOL, V238, P539; Stehlin E, 1985, J APPL PHYSIOL, V115, P1672; Taylor Gemma L., 2007, Journal of Pharmacological and Toxicological Methods, V56, P212, DOI 10.1016/j.vascn.2007.04.003; VANDENBUUSE M, 1994, PHYSIOL BEHAV, V55, P783, DOI 10.1016/0031-9384(94)90060-4; WILSON JR, 1987, CIRCULATION, V75, P857, DOI 10.1161/01.CIR.75.4.857; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968	28	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103331	10.1371/journal.pone.0103331	http://dx.doi.org/10.1371/journal.pone.0103331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119289	gold, Green Submitted, Green Published			2022-12-27	WOS:000340900600020
J	Wojdak, JM; Edman, RM; Wyderko, JA; Zemmer, SA; Belden, LK				Wojdak, Jeremy M.; Edman, Robert M.; Wyderko, Jennie A.; Zemmer, Sally A.; Belden, Lisa K.			Host Density and Competency Determine the Effects of Host Diversity on Trematode Parasite Infection	PLOS ONE			English	Article							SPECIES-DIVERSITY; DISEASE RISK; LIFE-HISTORY; ANTIPARASITE BEHAVIOR; SCHISTOSOMA-MANSONI; IMMUNE DEFENSE; LYME-DISEASE; CERCARIAE; TRANSMISSION; COMPETITION	Variation in host species composition can dramatically alter parasite transmission in natural communities. Whether diverse host communities dilute or amplify parasite transmission is thought to depend critically on species traits, particularly on how hosts affect each other's densities, and their relative competency as hosts. Here we studied a community of potential hosts and/or decoys (i.e. non-competent hosts) for two trematode parasite species, Echinostoma trivolvis and Ribeiroia ondatrae, which commonly infect wildlife across North America. We manipulated the density of a focal host (green frog tadpoles, Rana clamitans), in concert with manipulating the diversity of alternative species, to simulate communities where alternative species either (1) replace the focal host species so that the total number of individuals remains constant (substitution) or (2) add to total host density (addition). For E. trivolvis, we found that total parasite transmission remained roughly equal (or perhaps decreased slightly) when alternative species replaced focal host individuals, but parasite transmission was higher when alternative species were added to a community without replacing focal host individuals. Given the alternative species were roughly equal in competency, these results are consistent with current theory. Remarkably, both total tadpole and per-capita tadpole infection intensity by E. trivolvis increased with increasing intraspecific host density. For R. ondatrae, alternative species did not function as effective decoys or hosts for parasite infective stages, and the diversity and density treatments did not produce clear changes in parasite transmission, although high tank to tank variation in R. ondatrae infection could have obscured patterns.	[Wojdak, Jeremy M.] Radford Univ, Dept Biol, Radford, VA 24142 USA; [Edman, Robert M.; Wyderko, Jennie A.; Zemmer, Sally A.; Belden, Lisa K.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA	Radford University; Virginia Polytechnic Institute & State University	Wojdak, JM (corresponding author), Radford Univ, Dept Biol, Radford, VA 24142 USA.	jmwojdak@radford.edu		Belden, Lisa/0000-0002-3514-3920	US National Science Foundation [DEB-0918960, DEB-0918656]; Direct For Biological Sciences [0918960] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support was provided by the US National Science Foundation, through grants DEB-0918960 (Belden) and DEB-0918656 (Wojdak). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2009, OECOLOGIA, V158, P699, DOI 10.1007/s00442-008-1169-9; Bavarri M, 2004, STAT SCI, V19, P58; BEAVER PAUL CHESTER, 1937, ILLINOIS BIOL MONOGR, V15, P1; Belden LK, 2011, OECOLOGIA, V166, P1077, DOI 10.1007/s00442-011-1946-8; BRONMARK C, 1991, OECOLOGIA, V87, P8, DOI 10.1007/BF00323774; Brunner JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066798; Civitello DJ, 2013, ECOL LETT, V16, P626, DOI 10.1111/ele.12089; Cooper N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042190; CROFTON HD, 1971, PARASITOLOGY, V62, P179, DOI 10.1017/S0031182000071420; Cronin JP, 2010, ECOL LETT, V13, P1221, DOI 10.1111/j.1461-0248.2010.01513.x; Daly EW, 2011, OECOLOGIA, V165, P1043, DOI 10.1007/s00442-010-1778-y; Dare OK, 2006, J PARASITOL, V92, P543, DOI 10.1645/GE-674R1.1; Detwiler JT, 2010, MOL PHYLOGENET EVOL, V55, P611, DOI 10.1016/j.ympev.2010.01.004; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Fried B, 1997, PARASITOL RES, V83, P666, DOI 10.1007/s004360050316; Fried B, 2009, BIOL ECHINOSTOMES MO, P333; Gelman A., 1996, MARKOV CHAIN MONTE C, P131, DOI DOI 10.1007/978-1-4899-4485-6_8; Gosner K. L., 1960, Herpetologica, V16, P183; Hall SR, 2009, ECOLOGY, V90, P791, DOI 10.1890/08-0838.1; Holland MP, 2007, J ZOOL, V271, P455, DOI 10.1111/j.1469-7998.2006.00229.x; Holland MP, 2010, J PARASITOL, V96, P851, DOI 10.1645/GE-2351.1; Holomuzki JR, 1996, AM MIDL NAT, V136, P315, DOI 10.2307/2426735; Huang ZYX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054341; Johnson PTJ, 2008, ECOL LETT, V11, P1017, DOI 10.1111/j.1461-0248.2008.01212.x; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Johnson PTJ, 2012, ECOLOGY, V93, P56, DOI 10.1890/11-0636.1; Johnson PTJ, 2011, ECOLOGY, V92, P535, DOI 10.1890/10-0570.1; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Johnson PTJ, 2003, TRENDS PARASITOL, V19, P332, DOI 10.1016/S1471-4922(03)00148-X; Joseph MB, 2013, ECOL LETT, V16, P1405, DOI 10.1111/ele.12180; Karvonen A, 2003, PARASITOLOGY, V127, P217, DOI 10.1017/S0031182003003561; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kery M., 2010, INTRO WINBUGS ECOLOG, VFirst, DOI [10.1016/B978-0-12-378605-0.00054-5, DOI 10.1016/B978-0-12-378605-0.00054-5]; Kiesecker JM, 2000, ECOLOGY, V81, P2939, DOI 10.1890/0012-9658(2000)081[2939:COOSBG]2.0.CO;2; Koprivnikar J, 2006, CAN J ZOOL, V84, P1623, DOI 10.1139/Z06-158; Lacroix C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0947; LAMBERT D, 1992, TECHNOMETRICS, V34, P1, DOI 10.2307/1269547; LICHTENFELS JR, 1971, J PARASITOL, V57, P348, DOI 10.2307/3278041; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Magnanou E, 2006, PARASITOL RES, V99, P97, DOI 10.1007/s00436-005-0063-1; Martin LB, 2007, ECOLOGY, V88, P2516, DOI 10.1890/07-0060.1; Miller E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080279; Mitchell CE, 2002, ECOLOGY, V83, P1713, DOI 10.1890/0012-9658(2002)083[1713:EOGPSD]2.0.CO;2; MONE H, 1986, J PARASITOL, V72, P410, DOI 10.2307/3281681; Mouritsen KN, 2002, J HELMINTHOL, V76, P341, DOI 10.1079/JOH2002136; Nunn CL, 2002, EVOLUTION, V56, P177; OSENBERG CW, 1989, OECOLOGIA, V79, P512, DOI 10.1007/BF00378669; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; Palacios MG, 2011, J ANIM ECOL, V80, P431, DOI 10.1111/j.1365-2656.2010.01785.x; Paller VGV, 2007, J PARASITOL, V93, P436, DOI 10.1645/GE-997R.1; Poulin R, 2010, PARASITOLOGY, V137, P889, DOI 10.1017/S0031182009991624; Previtali MA, 2012, OIKOS, V121, P1483, DOI 10.1111/j.1600-0706.2012.020215.x; Raffel TR, 2010, ECOLOGY, V91, P1900, DOI 10.1890/09-1697.1; Rohr JR, 2008, NATURE, V455, P1235, DOI 10.1038/nature07281; Rondelaud D, 2001, PARASITOL RES, V87, P475, DOI 10.1007/s004360100385; Rudolf VHW, 2005, AM NAT, V166, P112, DOI 10.1086/430674; Schotthoefer AM, 2003, J PARASITOL, V89, P475, DOI 10.1645/0022-3395(2003)089[0475:ROTSTL]2.0.CO;2; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Spiegelhalter DJ, 1996, BUGS BAYESIAN INFERE; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Szuroczki D, 2009, OECOLOGIA, V161, P371, DOI 10.1007/s00442-009-1388-8; Thieltges DW, 2008, PARASITOLOGY, V135, P407, DOI 10.1017/S0031182007000248; Thiemann GW, 2000, BIOL J LINN SOC, V71, P513, DOI [10.1111/j.1095-8312.2000.tb01272.x, 10.1006/bijl.2000.0459]; Toledo R, 2005, TRENDS PARASITOL, V21, P251, DOI 10.1016/j.pt.2005.04.006; VANBUSKIRK J, 1995, ECOL APPL, V5, P1133, DOI 10.2307/2269360; Venables WN., 2002, MODERN APPL STAT S, V4; WARREN KS, 1968, NATURE, V217, P647, DOI 10.1038/217647a0; WEDDERBURN RWM, 1974, BIOMETRIKA, V61, P439, DOI 10.2307/2334725; Wojdak JM, 2013, PARASITOL RES, V112, P799, DOI 10.1007/s00436-012-3203-4; Young H, 2013, ECOL LETT, V16, P656, DOI 10.1111/ele.12094; Zuur A.F, 2012, ZERO INFLATED MODELS	72	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105059	10.1371/journal.pone.0105059	http://dx.doi.org/10.1371/journal.pone.0105059			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119568	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600119
J	Wulfhorst, H; Franken, LE; Wessinghage, T; Boekema, EJ; Nowaczyk, MM				Wulfhorst, Hannes; Franken, Linda E.; Wessinghage, Thomas; Boekema, Egbert J.; Nowaczyk, Marc M.			The 5 kDa Protein NdhP Is Essential for Stable NDH-1L Assembly in Thermosynechococcus elongatus	PLOS ONE			English	Article							DEHYDROGENASE-LIKE COMPLEX; CYCLIC ELECTRON-TRANSPORT; PHOTOSYSTEM-II; STRUCTURAL-CHARACTERIZATION; NAD(P)H DEHYDROGENASE; FLUORESCENT PROTEIN; SUBUNIT; OXIDOREDUCTASE; DOMAIN; TAGS	The cyanobacterial NADPH: plastoquinone oxidoreductase complex (NDH-1), that is related to Complex I of eubacteria and mitochondria, plays a pivotal role in respiration as well as in cyclic electron transfer (CET) around PSI and is involved in a unique carbon concentration mechanism (CCM). Despite many achievements in the past, the complex protein composition and the specific function of many subunits of the different NDH-1 species remain elusive. We have recently discovered in a NDH-1 preparation from Thermosynechococcus elongatus two novel single transmembrane peptides (NdhP, NdhQ) with molecular weights below 5 kDa. Here we show that NdhP is a unique component of the similar to 450 kDa NDH-1L complex, that is involved in respiration and CET at high CO2 concentration, and not detectable in the NDH-1MS and NDH-1MS' complexes that play a role in carbon concentration. C-terminal fusion of NdhP with his-tagged superfolder GFP and the subsequent analysis of the purified complex by electron microscopy and single particle averaging revealed its localization in the NDH-1L specific distal unit of the NDH-1 complex, that is formed by the subunits NdhD1 and NdhF1. Moreover, NdhP is essential for NDH-1L formation, as this type of NDH-1 was not detectable in a Delta ndhP::Km mutant.	[Wulfhorst, Hannes; Wessinghage, Thomas; Nowaczyk, Marc M.] Ruhr Univ Bochum, Dept Plant Biochem, Bochum, Germany; [Franken, Linda E.; Boekema, Egbert J.] Univ Groningen, Electron Microscopy Dept, Groningen, Netherlands	Ruhr University Bochum; University of Groningen	Nowaczyk, MM (corresponding author), Ruhr Univ Bochum, Dept Plant Biochem, Univ Str 150, Bochum, Germany.	marc.m.nowaczyk@rub.de	Nowaczyk, Marc/D-4214-2014	Nowaczyk, Marc/0000-0002-9269-0672; Franken, Linda/0000-0002-3040-8192	RUB Research School; Deutsche Forschungsgemeinschaft; BioSolar Cells project	RUB Research School; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BioSolar Cells project	This work was supported by the RUB Research School (HW) and by grants of the Deutsche Forschungsgemeinschaft (HW and MMN) and the BioSolar Cells project (LEF and EJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteni AA, 2006, BBA-BIOENERGETICS, V1757, P1469, DOI 10.1016/j.bbabio.2006.05.042; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Battchikova N, 2011, J BIOL CHEM, V286, P36992, DOI 10.1074/jbc.M111.263780; Bernat G, 2011, J BACTERIOL, V193, P292, DOI 10.1128/JB.00984-10; Birungi M, 2010, BBA-BIOENERGETICS, V1797, P1681, DOI 10.1016/j.bbabio.2010.06.004; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boekema EJ, 1999, EUR J BIOCHEM, V266, P444, DOI 10.1046/j.1432-1327.1999.00876.x; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Cava F, 2008, ENVIRON MICROBIOL, V10, P605, DOI 10.1111/j.1462-2920.2007.01482.x; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hirst J, 2010, BIOCHEM J, V425, P327, DOI 10.1042/BJ20091382; Hu P, 2013, FEBS LETT, V587, P2340, DOI 10.1016/j.febslet.2013.05.040; Ifuku K, 2011, PLANT CELL PHYSIOL, V52, P1560, DOI 10.1093/pcp/pcr098; Ishikawa N, 2008, PLANT CELL PHYSIOL, V49, P1066, DOI 10.1093/pcp/pcn083; Iwai M, 2004, PLANT CELL PHYSIOL, V45, P171, DOI 10.1093/pcp/pch015; Kouril R, 2014, PLANT J, V77, P568, DOI 10.1111/tpj.12402; Kuhl H, 2000, J BIOL CHEM, V275, P20652, DOI 10.1074/jbc.M001321200; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Nowaczyk MM, 2012, BBA-BIOENERGETICS, V1817, P1339, DOI 10.1016/j.bbabio.2012.02.017; Nowaczyk MM, 2011, BIOCHEMISTRY-US, V50, P1121, DOI 10.1021/bi102044b; Ogawa T, 2007, PHOTOSYNTH RES, V93, P69, DOI 10.1007/s11120-006-9128-y; Oostergetel GT, 1998, ULTRAMICROSCOPY, V74, P47, DOI 10.1016/S0304-3991(98)00022-9; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schwarz D, 2013, PLANT PHYSIOL, V163, P1191, DOI 10.1104/pp.113.224287; Shikanai T, 2014, CURR OPIN BIOTECH, V26, P25, DOI 10.1016/j.copbio.2013.08.012; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291; Zhang JS, 2014, J BIOL CHEM, V289, P18770, DOI 10.1074/jbc.M114.553404; Zhang PP, 2005, BIOCHEM J, V390, P513, DOI 10.1042/BJ20050390; Zickermann V, 2010, FEBS LETT, V584, P2516, DOI 10.1016/j.febslet.2010.04.021	38	21	23	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103584	10.1371/journal.pone.0103584	http://dx.doi.org/10.1371/journal.pone.0103584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119998	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600026
J	Liu, YC; Liu, YN; Yang, FS; Wang, XQ				Liu, Yu-Cheng; Liu, Ya-Nan; Yang, Fu-Sheng; Wang, Xiao-Quan			Molecular Phylogeny of Asian Meconopsis Based on Nuclear Ribosomal and Chloroplast DNA Sequence Data	PLOS ONE			English	Article							PAPAVERACEAE; POPPY; PAPAVEROIDEAE; CALIFORNICUM; EVOLUTION	The taxonomy and phylogeny of Asian Meconopsis (Himalayan blue poppy) remain largely unresolved. We used the internal transcribed spacer (ITS) region of nuclear ribosomal DNA (nrDNA) and the chloroplast DNA (cpDNA) trnL-F region for phylogenetic reconstruction of Meconopsis and its close relatives Papaver, Roemeria, and Stylomecon. We identified five main clades, which were well-supported in the gene trees reconstructed with the nrDNA ITS and cpDNA trnL-F sequences. We found that 41 species of Asian Meconopsis did not constitute a monophyletic clade, but formed two solid clades (I and V) separated in the phylogenetic tree by three clades (II, III and IV) of Papaver and its allies. Clade V includes only four Asian Meconopsis species, with the remaining 90 percent of Asian species included in clade I. In this core Asian Meconopsis clade, five subclades (Ia-Ie) were recognized in the nrDNA ITS tree. Three species (Meconopsis discigera, M. pinnatifolia, and M. torquata) of subgenus Discogyne were imbedded in subclade Ia, indicating that the present definition of subgenera in Meconopsis should be rejected. These subclades are inconsistent with any series or sections of the present classifications, suggesting that classifications of the genus should be completely revised. Finally, proposals for further revision of the genus Meconopsis were put forward based on molecular, morphological, and biogeographical evidences.	[Liu, Yu-Cheng; Liu, Ya-Nan; Yang, Fu-Sheng; Wang, Xiao-Quan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Liu, Yu-Cheng; Liu, Ya-Nan; Wang, Xiao-Quan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, FS (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	yang_fsh@ibcas.ac.cn			National Natural Science Foundation of China [31270263, 31330008, 31110103911]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant Nos. 31270263, 31330008, and 31110103911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernath J, 1998, POOPY GENUS PAPAVER; Carolan JC, 2006, ANN BOT-LONDON, V98, P141, DOI 10.1093/aob/mcl079; Egan PA, 2012, FLORA NEPAL; Egan PA, 2011, PHYTOTAXA, V20, P47, DOI 10.11646/phytotaxa.20.1.4; Ernst WR, 1962, THESIS STANFORD U ST; Fedde F, 1909, PFLANZENREICH, V4, P245; Grey-Wilson C, 2012, TAXON, V61, P473, DOI 10.1002/tax.612026; Jork KB, 1995, PLANT SYST EVOL, P171; KADEREIT J W, 1986, Notes from the Royal Botanic Garden Edinburgh, V44, P25; Kadereit J. W., 1996, Edinburgh Journal of Botany, V53, P285; KADEREIT J W, 1988, Notes from the Royal Botanic Garden Edinburgh, V45, P225; Kadereit Joachim W., 1993, Edinburgh Journal of Botany, V50, P125; Kadereit Joachim W., 2011, Madrono, V58, P92, DOI 10.3120/0024-9637-58.2.92; Kadereit JW, 2012, TAXON, V61, P3, DOI 10.1002/tax.611001; Kadereit Joachim W., 2011, New Journal of Botany, V1, P80, DOI 10.1179/204234811X13194453002742; Kadereit JW, 2011, AM J BOT, V98, P1243, DOI 10.3732/ajb.1100066; KADEREIT JW, 1988, RHODORA, V90, P7; KADEREIT JW, 1990, BOT J LINN SOC, V103, P221, DOI 10.1111/j.1095-8339.1990.tb00185.x; Kadereit JW, 1997, PLANT SYST EVOL, V204, P75, DOI 10.1007/BF00982533; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Prain D, 1915, B MISC INFORM KEW, V1915, P129; Prain D, 1895, J ASIATIC SOC BENGAL, V64, P303; Prain D, 1906, ANN BOT, V20, P23; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; TAYLOR G, 1934, ACCOUNT GENUS MECONO; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ward FK, 1926, ANN BOT-LONDON, V40, P535, DOI 10.1093/oxfordjournals.aob.a090036; WU C-Y, 1980, Acta Botanica Yunnanica, V2, P371; Yang FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037196; Yoshida K, 2006, PHYTOCHEMISTRY, V67, P992, DOI 10.1016/j.phytochem.2006.03.013; Yoshida T., 2012, Plantsman, V11, P96; Yoshida Toshio, 2012, Plant Diversity and Resources, V34, P145, DOI 10.3724/SP.J.1143.2012.11188; Yoshida Toshio, 2012, Curtis's Botanical Magazine, V29, P194, DOI 10.1111/j.1467-8748.2012.01785.x; Zhang ML, 2008, FLORA CHINA, V7, P262	36	3	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104823	10.1371/journal.pone.0104823	http://dx.doi.org/10.1371/journal.pone.0104823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25118100	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400091
J	Rogowski, I; Creveaux, T; Cheze, L; Mace, P; Dumas, R				Rogowski, Isabelle; Creveaux, Thomas; Cheze, Laurence; Mace, Pierre; Dumas, Raphael			Effects of the Racket Polar Moment of Inertia on Dominant Upper Limb Joint Moments during Tennis Serve	PLOS ONE			English	Article							ELECTROMYOGRAPHIC ANALYSIS; COORDINATE SYSTEMS; ISB RECOMMENDATION; MOTION; ELBOW; SHOULDER; BIOMECHANICS; KINETICS; FLAT; KICK	This study examined the effect of the polar moment of inertia of a tennis racket on upper limb loading in the serve. Eight amateur competition tennis players performed two sets of 10 serves using two rackets identical in mass, position of center of mass and moments of inertia other than the polar moment of inertia (0.00152 vs 0.00197 kg.m(2)). An eight-camera motion analysis system collected the 3D trajectories of 16 markers, located on the thorax, upper limbs and racket, from which shoulder, elbow and wrist net joint moments and powers were computed using inverse dynamics. During the cocking phase, increased racket polar moment of inertia was associated with significant increases in the peak shoulder extension and abduction moments, as well the peak elbow extension, valgus and supination moments. During the forward swing phase, peak wrist extension and radial deviation moments significantly increased with polar moment of inertia. During the follow-through phase, the peak shoulder adduction, elbow pronation and wrist external rotation moments displayed a significant inverse relationship with polar moment of inertia. During the forward swing, the magnitudes of negative joint power at the elbow and wrist were significantly larger when players served using the racket with a higher polar moment of inertia. Although a larger polar of inertia allows players to better tolerate off-center impacts, it also appears to place additional loads on the upper extremity when serving and may therefore increase injury risk in tennis players.	[Rogowski, Isabelle; Creveaux, Thomas] Univ Lyon 1, Univ Lyon, Ctr Rech & Innovat Sport, UFRSTAPS,EA 647, F-69622 Villeurbanne, France; [Cheze, Laurence; Dumas, Raphael] Univ Lyon 1, Univ Lyon, IFSTTAR, LBMC,UMR T9406, F-69622 Villeurbanne, France; [Mace, Pierre] Babolat VS, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Gustave-Eiffel	Rogowski, I (corresponding author), Univ Lyon 1, Univ Lyon, Ctr Rech & Innovat Sport, UFRSTAPS,EA 647, F-69622 Villeurbanne, France.	isabelle.rogowski@univ-lyon1.fr	Dumas, Raphael/H-2281-2018; CHEZE, Laurence/H-2885-2018	Dumas, Raphael/0000-0002-0368-8248; CHEZE, Laurence/0000-0003-2265-9781	Agence Nationale pour la Recherche; "pole de Competitivite Sporaltec" [ANR ACE] [2010-BLANC-901]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); "pole de Competitivite Sporaltec" [ANR ACE](French National Research Agency (ANR))	This study was supported by the "Agence Nationale pour la Recherche" and the "pole de Competitivite Sporaltec" [ANR ACE no2010-BLANC-901] (www.agence-nationale-recherche.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GD, 2011, SPORT BIOMECH, V10, P378, DOI 10.1080/14763141.2011.629302; Aguinaldo AL, 2009, AM J SPORT MED, V37, P2043, DOI 10.1177/0363546509336721; Bahamonde R, 2005, INT SPORTMED J, V6, P42; Bahamonde RE, 2000, J SPORT SCI, V18, P579, DOI 10.1080/02640410050082297; Baker R, 2003, J BIOMECH, V36, P300, DOI 10.1016/S0021-9290(02)00336-6; Bonnefoy-Mazure A, 2010, J BIOMECH, V43, P2022, DOI 10.1016/j.jbiomech.2010.03.028; Cohen J.E., 1988, STAT POWER ANAL BEHA; Creveaux T, 2013, COMPUT METHOD BIOMEC, V16, P99, DOI 10.1080/10255842.2013.815922; Creveaux T, 2013, J SPORT SCI MED, V12, P259; Cross R, 2001, SPORTS ENG, V4, P1, DOI DOI 10.1046/J.1460-2687.2001.00069.X; Desroches G, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002537; Desroches G, 2010, CLIN BIOMECH, V25, P299, DOI 10.1016/j.clinbiomech.2009.12.011; Dumas R., 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P159, DOI 10.1080/10255840410001727805; Dumas R, 2007, J BIOMECH, V40, P543, DOI 10.1016/j.jbiomech.2006.02.013; Durovic N, 2008, ACTA KINESIOL, V2, P45; Elliott B, 2003, J SCI MED SPORT, V6, P76, DOI 10.1016/S1440-2440(03)80011-7; ELLIOTT BC, 1988, SPORTS MED, V6, P285, DOI 10.2165/00007256-198806050-00004; Kettaneh N, 2005, COMPUT STAT DATA AN, V48, P69, DOI 10.1016/j.csda.2003.11.027; Kotze J, 2000, SPORTS ENG, V3, P67, DOI DOI 10.1046/j.1460-2687.2000.00050.x; Marshall RN, 2000, J SPORT SCI, V18, P247; Martin C, 2014, SCAND J MED SCI SPOR, V24, P700, DOI 10.1111/sms.12043; Miller S, 2006, BRIT J SPORT MED, V40, P401, DOI 10.1136/bjsm.2005.023283; MORRIS M, 1989, AM J SPORT MED, V17, P241, DOI 10.1177/036354658901700215; Morrow MMB, 2009, J REHABIL RES DEV, V46, P939, DOI 10.1682/JRRD.2008.12.0165; Reid M, 2007, BRIT J SPORT MED, V41, P884, DOI 10.1136/bjsm.2007.036657; RYU RKN, 1988, AM J SPORT MED, V16, P481, DOI 10.1177/036354658801600509; Seeley MK, 2008, SPORT BIOMECH, V7, P248, DOI 10.1080/14763140701841746; Sheets AL, 2011, ANN BIOMED ENG, V39, P3011, DOI 10.1007/s10439-011-0418-y; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042	29	11	11	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104785	10.1371/journal.pone.0104785	http://dx.doi.org/10.1371/journal.pone.0104785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117871	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230400085
J	Yan, WS; Jung, YS; Zhang, YH; Chen, XB				Yan, Wensheng; Jung, Yong-Sam; Zhang, Yanhong; Chen, Xinbin			Arsenic Trioxide Reactivates Proteasome-Dependent Degradation of Mutant p53 Protein in Cancer Cells in Part via Enhanced Expression of Pirh2 E3 Ligase	PLOS ONE			English	Article							GAIN-OF-FUNCTION; LI-FRAUMENI-SYNDROME; UBIQUITIN LIGASE; GENE-EXPRESSION; FUNCTION MUTATIONS; MDM2; P63; P73; IMPACT; RNF4	The p53 gene is mutated in more than 50% of human tumors. Mutant p53 exerts an oncogenic function and is often highly expressed in cancer cells due to evasion of proteasome-dependent degradation. Thus, reactivating proteasome-dependent degradation of mutant p53 protein is an attractive strategy for cancer management. Previously, we found that arsenic trioxide (ATO), a drug for acute promyelocytic leukemia, degrades mutant p53 protein through a proteasome pathway. However, it remains unclear what is the E3 ligase that targets mutant p53 for degradation. In current study, we sought to identify an E3 ligase necessary for ATO-mediated degradation of mutant p53. We found that ATO induces expression of Pirh2 E3 ligase at the transcriptional level. We also found that knockdown of Pirh2 inhibits, whereas ectopic expression of Pirh2 enhances, ATO-induced degradation of mutant p53 protein. Furthermore, we found that Pirh2 E3 ligase physically interacts with and targets mutant p53 for polyubiquitination and subsequently proteasomal degradation. Interestingly, we found that ATO cooperates with HSP90 or HDAC inhibitor to promote mutant p53 degradation and growth suppression in tumor cells. Together, these data suggest that ATO promotes mutant p53 degradation in part via induction of the Pirh2-dependent proteasome pathway.	[Yan, Wensheng; Jung, Yong-Sam; Zhang, Yanhong; Chen, Xinbin] Univ Calif Davis, Sch Med & Vet Med, Comparat Oncol Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Chen, XB (corresponding author), Univ Calif Davis, Sch Med & Vet Med, Comparat Oncol Lab, Davis, CA 95616 USA.	xbchen@ucdavis.edu			National Institutes of Health [CA 121137, CA 076069]; NATIONAL CANCER INSTITUTE [R01CA121137, R29CA076069, R01CA076069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA 121137 and CA 076069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blandino G, 1999, ONCOGENE, V18, P477, DOI 10.1038/sj.onc.1202314; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Choudhury S, 2013, CELL CYCLE, V12, P1022, DOI 10.4161/cc.24128; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; DITTMER D, 1993, NAT GENET, V4, P42, DOI 10.1038/ng0593-42; Emadi A, 2010, BLOOD REV, V24, P191, DOI 10.1016/j.blre.2010.04.001; Frazier MW, 1998, MOL CELL BIOL, V18, P3735, DOI 10.1128/MCB.18.7.3735; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Geoffroy MC, 2010, MOL BIOL CELL, V21, P4227, DOI 10.1091/mbc.E10-05-0449; Hanel W, 2012, J CELL BIOCHEM, V113, P433, DOI 10.1002/jcb.23400; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Jung YS, 2013, J INVEST DERMATOL, V133, P1178, DOI 10.1038/jid.2012.466; Jung YS, 2010, MOL CELL BIOL, V30, P1041, DOI 10.1128/MCB.01198-09; Karsy M, 2014, TUMOR BIOL, V35, P4567, DOI 10.1007/s13277-013-1601-6; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee JT, 2010, CELL DEATH DIFFER, V17, P86, DOI 10.1038/cdd.2009.77; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Li D, 2011, CELL DEATH DIFFER, V18, P1904, DOI 10.1038/cdd.2011.71; Li D, 2011, MOL CANCER RES, V9, P577, DOI 10.1158/1541-7786.MCR-10-0534; Li RZ, 1998, ONCOGENE, V16, P3269, DOI 10.1038/sj.onc.1201867; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Rangel LP, 2014, PRION IN PRESS, V8; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Shen SC, 2012, EXP DERMATOL, V21, P370, DOI 10.1111/j.1600-0625.2012.01479.x; Shloush J, 2011, J BIOL CHEM, V286, P4796, DOI 10.1074/jbc.M110.157669; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Strano S, 2000, J BIOL CHEM, V275, P29503, DOI 10.1074/jbc.M003360200; Suh YA, 2011, CANCER RES, V71, P7168, DOI 10.1158/0008-5472.CAN-11-0459; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Vakifahmetoglu-Norberg H, 2013, GENE DEV, V27, P1718, DOI 10.1101/gad.220897.113; Whitesell L, 1998, MOL CELL BIOL, V18, P1517, DOI 10.1128/MCB.18.3.1517; Wiech M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051426; Yan W, 2013, ONCOGENE, V32, P599, DOI 10.1038/onc.2012.81; Yan WS, 2008, CANCER RES, V68, P6789, DOI 10.1158/0008-5472.CAN-08-0810; Yan WS, 2013, J BIOL CHEM, V288, P2907, DOI 10.1074/jbc.M112.428607; Yan WS, 2011, J BIOL CHEM, V286, P17478, DOI 10.1074/jbc.M111.231639; Yan WS, 2009, J BIOL CHEM, V284, P12178, DOI 10.1074/jbc.M900994200; Yeudall WA, 2012, CARCINOGENESIS, V33, P442, DOI 10.1093/carcin/bgr270; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724; Zheng G, 2007, BIOCHEM BIOPH RES CO, V364, P344, DOI 10.1016/j.bbrc.2007.10.003; Zheng TS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3996; Zhu HB, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-22	51	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103497	10.1371/journal.pone.0103497	http://dx.doi.org/10.1371/journal.pone.0103497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116336	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400017
J	Yi, WX; Li, Q; Shen, J; Ren, LJ; Liu, XH; Wang, Q; He, SD; Wu, QY; Hu, H; Mao, XL; Zhu, L				Yi, Wenxiu; Li, Qiang; Shen, Jian; Ren, Lijie; Liu, Xiaohui; Wang, Qi; He, Sudan; Wu, Qingyu; Hu, Hu; Mao, Xinliang; Zhu, Li			Modulation of Platelet Activation and Thrombus Formation Using a Pan-PI3K Inhibitor S14161	PLOS ONE			English	Article							RECEPTOR GAMMA-CHAIN; PROTEIN-KINASE-B; PHOSPHOINOSITIDE 3-KINASE; ARTERIAL THROMBOSIS; CLINICAL-TRIALS; IN-VITRO; COLLAGEN; AGGREGATION; MICE; ATHEROTHROMBOSIS	The phosphatidylinositol 3-kinase (PI3K) signaling pathway is critical in modulating platelet functions. In the present study, we evaluated the effect of S14161, a recently identified pan-class I PI3K inhibitor, on platelet activation and thrombus formation. Results showed that S14161 inhibited human platelet aggregation induced by collagen, thrombin, U46619, and ADP in a dose-dependent manner. Flow cytometric studies showed that S14161 inhibited convulxin-or thrombin-induced P-selectin expression and fibrinogen binding of single platelet. S14161 also inhibited platelet spreading on fibrinogen and clot retraction, processes mediated by outside-in signaling. Using a microfluidic chamber we demonstrated that S14161 decreased platelet adhesion on collagen-coated surface by about 80%. Western blot showed that S14161 inhibited phosphorylation of Akt at both Ser473 and Thr308 sites, and GSK3 beta at Ser9 in response to collagen, thrombin, or U46619. Comparable studies showed that S14161 has a higher potential bioavailability than LY294002, a prototypical inhibitor of pan-class I PI3K. Finally, the effects of S14161 on thrombus formation in vivo were measured using a ferric chloride-induced carotid artery injury model in mice. The intraperitoneal injection of S14161 (2 mg/kg) to male C57BL/6 mice significantly extended the first occlusion time (5.05 +/- 0.99 min, n = 9) compared to the vehicle controls (3.72 +/- 0.95 min, n = 8) (P<0.05), but did not prolong the bleeding time (P>0.05). Taken together, our data showed that S14161 inhibits platelet activation and thrombus formation without significant bleeding tendency and toxicity, and considering its potential higher bioavailability, it may be developed as a novel therapeutic agent for the prevention of thrombotic disorders.	[Yi, Wenxiu; Li, Qiang; Shen, Jian; Ren, Lijie; Liu, Xiaohui; Wang, Qi; He, Sudan; Wu, Qingyu; Mao, Xinliang; Zhu, Li] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol,MOH Key Lab Thrombosis & Hem, Cyrus Tang Hematol Ctr,Collaborat Innovat Ctr Hem, Suzhou, Peoples R China; [Hu, Hu] Zhejiang Univ, Dept Pathol & Pathophysiol, Hangzhou 310003, Zhejiang, Peoples R China	Soochow University - China; Zhejiang University	Mao, XL (corresponding author), Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol,MOH Key Lab Thrombosis & Hem, Cyrus Tang Hematol Ctr,Collaborat Innovat Ctr Hem, Suzhou, Peoples R China.	xinliangmao@suda.edu.cn; zhul@suda.edu.cn		Wu, Qingyu/0000-0003-0561-9315	National Science Foundation of China [81071410, 81170132]; Jiangsu Province's Key Discipline of Medicine [XK201118]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Key Discipline of Medicine; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	This work was supported in part by grants from the National Science Foundation of China (81071410, 81170132), Jiangsu Province's Key Discipline of Medicine (XK201118), the Priority Academic Program Development of Jiangsu Higher Education Institutions of China (L.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfic H, 1998, J BIOL CHEM, V273, P13, DOI 10.1074/jbc.273.1.13; Barrett NE, 2008, BRIT J PHARMACOL, V154, P918, DOI 10.1038/bjp.2008.151; Brass LF, 2013, PLATELETS, P367, DOI DOI 10.3109/09537104.2013.821602; Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428; Chen X, 2013, BLOOD, V121, P3718, DOI 10.1182/blood-2012-10-461897; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Gibbins JM, 1998, J BIOL CHEM, V273, P34437, DOI 10.1074/jbc.273.51.34437; Gilio K, 2009, J BIOL CHEM, V284, P33750, DOI 10.1074/jbc.M109.048439; Hirsch E, 2001, FASEB J, V15, P2019, DOI 10.1096/fj.00-0810fje; Hong SS, 2008, J NAT PROD, V71, P1055, DOI 10.1021/np0705965; Huang ZS, 2010, J THROMB HAEMOST, V8, P1383, DOI 10.1111/j.1538-7836.2010.03859.x; Kaplan ZS, 2011, HEMATOL-AM SOC HEMAT, P51, DOI 10.1182/asheducation-2011.1.51; Lei X, 2014, THROMB HAEMOSTASIS, V111, P279, DOI 10.1160/TH13-06-0490; Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085120; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Li ZY, 2003, J BIOL CHEM, V278, P30725, DOI 10.1074/jbc.M301838200; Lova P, 2003, J BIOL CHEM, V278, P131, DOI 10.1074/jbc.M204821200; Mao XL, 2011, BLOOD, V117, P1986, DOI 10.1182/blood-2010-05-284810; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Moore SF, 2011, J BIOL CHEM, V286, P24553, DOI 10.1074/jbc.M110.202341; Mou PP, 2013, BLOOD, V121, P4221, DOI 10.1182/blood-2012-11-470609; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Prevost N, 2002, P NATL ACAD SCI USA, V99, P9219, DOI 10.1073/pnas.142053899; Reheman A, 2009, BLOOD, V113, P1809, DOI 10.1182/blood-2008-04-148361; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Selheim F, 2000, PLATELETS, V11, P69; Su XY, 2008, BLOOD, V112, P592, DOI 10.1182/blood-2007-09-110437; Sun HD, 2006, NAT PROD REP, V23, P673, DOI 10.1039/b604174d; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Watanabe N, 2003, BLOOD, V102, P541, DOI 10.1182/blood-2002-11-3327; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Yang H, 2006, J THROMB HAEMOST, V4, P2230, DOI 10.1111/j.1538-7836.2006.02116.x; Yang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037323; Yin SQ, 2013, BIOORG MED CHEM LETT, V23, P3314, DOI 10.1016/j.bmcl.2013.03.097; Zhang WL, 2011, INT J MOL SCI, V12, P2125, DOI 10.3390/ijms12042125; Zhu L, 2007, P NATL ACAD SCI USA, V104, P1621, DOI 10.1073/pnas.0606344104	39	21	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e102394	10.1371/journal.pone.0102394	http://dx.doi.org/10.1371/journal.pone.0102394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115838	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400004
J	Chamberlain, P; Delker, S; Pagarigan, B; Mahmoudi, A; Jackson, P; Abbasian, M; Muir, J; Raheja, N; Cathers, B				Chamberlain, Philip; Delker, Silvia; Pagarigan, Barbra; Mahmoudi, Afshin; Jackson, Pilgrim; Abbasian, Mahan; Muir, Jeff; Raheja, Neil; Cathers, Brian			Crystal Structures of PRK1 in Complex with the Clinical Compounds Lestaurtinib and Tofacitinib Reveal Ligand Induced Conformational Changes	PLOS ONE			English	Article							PROTEIN-KINASE N; CATALYTIC DOMAIN; JAK2 INHIBITOR; DOCKING SITE; TURN MOTIF; PHOSPHORYLATION; ACTIVATION; RHO; PKN; LEUKEMIA	Protein kinase C related kinase 1 (PRK1) is a component of Rho-GTPase, androgen receptor, histone demethylase and histone deacetylase signaling pathways implicated in prostate and ovarian cancer. Herein we describe the crystal structure of PRK1 in apo form, and also in complex with a panel of literature inhibitors including the clinical candidates lestaurtinib and tofacitinib, as well as the staurosporine analog Ro-31-8220. PRK1 is a member of the AGC-kinase class, and as such exhibits the characteristic regulatory sequence at the C-terminus of the catalytic domain - the 'C-tail'. The C-tail fully encircles the catalytic domain placing a phenylalanine in the ATP-binding site. Our inhibitor structures include examples of molecules which both interact with, and displace the C-tail from the active site. This information may assist in the design of inhibitors targeting both PRK and other members of the AGC kinase family.	[Chamberlain, Philip; Delker, Silvia; Pagarigan, Barbra; Mahmoudi, Afshin; Jackson, Pilgrim; Abbasian, Mahan; Muir, Jeff; Raheja, Neil; Cathers, Brian] Celgene Corp, San Diego, CA 92121 USA; [Chamberlain, Philip] Celgene Corp, Dept Biochem & Struct Biol, San Diego, CA USA	Bristol-Myers Squibb; Celgene Corporation; Bristol-Myers Squibb; Celgene Corporation	Chamberlain, P (corresponding author), Celgene Corp, San Diego, CA 92121 USA.	pchamberlain@celgene.com		JACKSON, PILGRIM/0000-0002-2796-5297; Cathers, Brian/0000-0003-2793-7533	Celgene	Celgene(Bristol-Myers SquibbCelgene Corporation)	This work was funded by Celgene. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Biondi RM, 2002, EMBO J, V21, P4219, DOI 10.1093/emboj/cdf437; Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flanagan ME, 2010, J MED CHEM, V53, P8468, DOI 10.1021/jm1004286; Galgano MT, 2009, HUM PATHOL, V40, P1434, DOI 10.1016/j.humpath.2009.02.008; Harrison BC, 2010, FEBS LETT, V584, P1103, DOI 10.1016/j.febslet.2010.02.057; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Hexner EO, 2008, BLOOD, V111, P5663, DOI 10.1182/blood-2007-04-083402; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Kohler J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034973; Levis M, 2002, BLOOD, V99, P3885, DOI 10.1182/blood.V99.11.3885; Lohse B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067653; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messerschmidt A, 2005, J MOL BIOL, V352, P918, DOI 10.1016/j.jmb.2005.07.060; Metzger E, 2003, EMBO J, V22, P270, DOI 10.1093/emboj/cdg023; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Mukai H, 1996, P NATL ACAD SCI USA, V93, P10195, DOI 10.1073/pnas.93.19.10195; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALMER RH, 1995, J BIOL CHEM, V270, P22412, DOI 10.1074/jbc.270.38.22412; Santos FPS, 2010, BLOOD, V115, P1131, DOI 10.1182/blood-2009-10-246363; Slynko I, 2014, J CHEM INF MODEL, V54, P138, DOI 10.1021/ci400628q; Standaert M, 1998, J BIOL CHEM, V273, P7470, DOI 10.1074/jbc.273.13.7470; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Vulpetti Anna, 2004, Farmaco (Lausanne), V59, P759; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200; Yasui T, 2012, P NATL ACAD SCI USA, V109, P21022, DOI 10.1073/pnas.1218925110	34	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e103638	10.1371/journal.pone.0103638	http://dx.doi.org/10.1371/journal.pone.0103638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111382	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100018
J	Huang, HL; Huang, YC; Lee, WY; Yeh, CN; Lin, KJ; Yu, CS				Huang, Ho-Lien; Huang, Ying-Cheng; Lee, Wei-Yuan; Yeh, Chun-Nan; Lin, Kun-Ju; Yu, Chung-Shan			F-18-Glutathione Conjugate as a PET Tracer for Imaging Tumors that Overexpress L-PGDS Enzyme	PLOS ONE			English	Article							PROSTAGLANDIN D SYNTHASE; POSITRON-EMISSION-TOMOGRAPHY; OXIDATIVE STRESS; BRAIN-TUMORS; PROLIFERATION; D-2; FLUORINATION; BEVACIZUMAB; INHIBITORS; RECEPTORS	Lipocalin-type prostaglandin D synthase (L-PGDS) has been correlated with the progression of neurological disorders. The present study aimed at evaluating the imaging potency of a glutathione conjugate of fluorine-18-labeled fluorobutyl ethacrynic amide ([F-18]FBuEA-GS) for brain tumors. Preparation of [F-18]FBuEA-GS has been modified from the -4-tosylate derivative via radiofluorination in 5% radiochemical yield. The mixture of nonradioactive FBuEA-GS derived from a parallel preparation has be resolved to two isomers in a ratio of 9:1 using analytic chiral reversed phase high performance liquid chromatography (RP-HPLC). The two fluorine-18-labeled isomers purified through nonchiral semipreparative RP-HPLC as a mixture were studied by assessing the binding affinity toward L-PGDS through a gel filtration HPLC, by analyzing radiotracer accumulation in C6 glioma cells, and by evaluating the imaging of radiotracer in a C6 glioma rat with positron emission tomography. The inhibition percentage of the production of PGD(2) from PGH(2) at the presence of 200 mu M of FBuEA-GS and 4-Dibenzo[a,d]cyclohepten-5-ylidene-1-[4-(2H-tetrazol-5-yl)butyl]piperidine (AT-56) were 74.1 +/- 4.8% and 97.6 +/- 16.0%, respectively. [F-18]FBuEA-GS bound L-PGDS (16.3-21.7%) but not the isoform, microsomal prostaglandin E synthase 1. No binding to GST-alpha and GST-pi was observed. The binding strength between [F-18]FBuEA-GS and L-PGDS has been evaluated using analytic gel filtration HPLC at the presence of various concentrations of the cold competitor FBuEA-GS. The contrasted images indicated that the radiotracer accumulation in tumor lesions is probably related to the overexpression of L-PGDS.	[Huang, Ho-Lien; Lee, Wei-Yuan; Yu, Chung-Shan] Natl Tsinghua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Huang, Ying-Cheng] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Dept Neurosurg, Taoyuan, Taiwan; [Yeh, Chun-Nan] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Dept Surg, Taoyuan, Taiwan; [Lin, Kun-Ju] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Dept Nucl Med, Taoyuan, Taiwan; [Yu, Chung-Shan] Natl Tsinghua Univ, Inst Nucl Engn & Sci, Hsinchu, Taiwan	National Tsing Hua University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Tsing Hua University	Yu, CS (corresponding author), Natl Tsinghua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	csyu@mx.nthu.edu.tw	Lin, Kun-Ju/H-3120-2015; huang, holien/S-4008-2017	Lin, Kun-Ju/0000-0003-1933-4564; 	National Science Council of Taiwan; CGMH_NTHU Joint Research; Chang-Gung Medical Research Project; Chang-Gung Medical Research Project [NSC-100-2113-M-007-003, NSC-97-2314-B-182A-020-MY3, CGTH96N2342E1, CMRPG390931, CMRPG3A0512, CMRPG3B0361, CMRPG3C0331]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); CGMH_NTHU Joint Research; Chang-Gung Medical Research Project; Chang-Gung Medical Research Project	Chung-Shan Yu was supported by National Science Council of Taiwan and CGMH_NTHU Joint Research. Ying-Cheng Huang was supported by National Science Council of Taiwan, CGMH_NTHU Joint Research, and Chang-Gung Medical Research Project. The authors are grateful to the National Science Council of Taiwan, CGMH_NTHU Joint Research, and Chang-Gung Medical Research Project for providing financial support via the following grants: NSC-100-2113-M-007-003, NSC-97-2314-B-182A-020-MY3, NSC-97-2314-B-182A-020-MY3, CGTH96N2342E1, CMRPG390931, CMRPG3A0512, CMRPG3B0361, and CMRPG3C0331. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ametamey SM, 2008, CHEM REV, V108, P1501, DOI 10.1021/cr0782426; Bejot R, 2009, ANGEW CHEM INT EDIT, V48, P586, DOI 10.1002/anie.200803897; Brader P, 2012, ADV DRUG DELIVER REV, V64, P749, DOI 10.1016/j.addr.2011.04.007; Chen W, 2007, J CLIN ONCOL, V25, P4714, DOI 10.1200/JCO.2006.10.5825; Christ AN, 2010, J MED CHEM, V53, P5536, DOI 10.1021/jm100194a; Corroyer-Dulmont A, 2013, NEURO-ONCOLOGY, V15, P41, DOI 10.1093/neuonc/nos260; de Jong LAA, 2005, J CHROMATOGR B, V829, P1, DOI 10.1016/j.jchromb.2005.10.002; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; Eskola O, 2012, EUR J NUCL MED MOL I, V39, P800, DOI 10.1007/s00259-011-2032-5; FANI M, 2012, EUR J NUCL MED MO S1, V39, P11, DOI DOI 10.1007/s00259-011-2001-z; Federici L, 2009, CANCER RES, V69, P8025, DOI 10.1158/0008-5472.CAN-09-1314; Fletcher JI, 2012, CANCER RES, V72, P845, DOI 10.1158/0008-5472.CAN-11-1885; Frisch K, 2011, NUCL MED BIOL, V38, P477, DOI 10.1016/j.nucmedbio.2010.11.006; Fujimori K, 2012, J NEUROCHEM, V120, P279, DOI 10.1111/j.1471-4159.2011.07570.x; Fukuhara A, 2012, BIOCHEM J, V443, P75, DOI 10.1042/BJ20111889; Funke U, 2013, J LABELLED COMPD RAD, V56, P120, DOI 10.1002/jlcr.3038; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Herholz K, 2012, SEMIN NUCL MED, V42, P356, DOI 10.1053/j.semnuclmed.2012.06.001; Huang HL, 2013, BIOMATERIALS, V34, P3355, DOI 10.1016/j.biomaterials.2013.01.050; Huang HL, 2012, BIOORG MED CHEM LETT, V22, P3998, DOI 10.1016/j.bmcl.2012.04.091; Irikura D, 2009, J BIOL CHEM, V284, P7623, DOI 10.1074/jbc.M808593200; Jacobs AH, 2005, J NUCL MED, V46, P1948; Jacobson O, 2011, BIOCONJUGATE CHEM, V22, P422, DOI 10.1021/bc100437q; Josephs D, 2009, TARGET ONCOL, V4, P151, DOI 10.1007/s11523-009-0117-x; Kirjavainen A, 2013, MOL IMAGING BIOL, V15, P131, DOI 10.1007/s11307-012-0584-9; Koslowsky I, 2010, ORG BIOMOL CHEM, V8, P4730, DOI 10.1039/c0ob00255k; Krohn KA, 2003, NUCL MED BIOL, V30, P819, DOI 10.1016/S0969-8051(03)00132-X; Lee E, 2011, SCIENCE, V334, P639, DOI 10.1126/science.1212625; Lee S, 2010, CHEM REV, V110, P3087, DOI 10.1021/cr900361p; Lee S, 2012, J BIOL CHEM, V287, P9414, DOI 10.1074/jbc.M111.330662; McCarthy Bridget J, 2013, J Registry Manag, V40, P32; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; Morgenstern R, 2011, DRUG METAB REV, V43, P300, DOI 10.3109/03602532.2011.558511; Nakamura M, 2011, CHEM REV, V111, P6231, DOI 10.1021/cr100392s; Nasrallah I, 2013, SEMIN NUCL MED, V43, P449, DOI 10.1053/j.semnuclmed.2013.06.003; Rae CD, 2014, NEUROCHEM RES, V39, P1, DOI 10.1007/s11064-013-1199-5; Rendic S, 1997, DRUG METAB REV, V29, P413, DOI 10.3109/03602539709037591; Rice SL, 2011, SEMIN NUCL MED, V41, P265, DOI 10.1053/j.semnuclmed.2011.02.002; Richter S, 2012, NUCL MED BIOL, V39, P1202, DOI 10.1016/j.nucmedbio.2012.06.003; Ritchie KJ, 2007, CANCER RES, V67, P9248, DOI 10.1158/0008-5472.CAN-07-1764; Shetty D, 2012, BIOORGAN MED CHEM, V20, P5941, DOI 10.1016/j.bmc.2012.07.050; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Way J, 2013, NUCL MED BIOL, V40, P430, DOI 10.1016/j.nucmedbio.2012.11.010; Wuest F, 2009, AMINO ACIDS, V36, P283, DOI 10.1007/s00726-008-0065-2; Yang XM, 2010, J MED CHEM, V53, P1015, DOI 10.1021/jm9011565; Yu R, 2011, J PHARMACOL EXP THER, V339, P716, DOI 10.1124/jpet.111.185405; Zhao HY, 2011, ORG LETT, V13, P1444, DOI 10.1021/ol200129q	48	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104118	10.1371/journal.pone.0104118	http://dx.doi.org/10.1371/journal.pone.0104118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111383	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100032
J	Li, C; Wang, Y; Qiu, Q; Shi, TJ; Wu, Y; Han, J; Chai, XY; Wang, W				Li, Chun; Wang, Yong; Qiu, Qi; Shi, Tianjiao; Wu, Yan; Han, Jing; Chai, Xingyun; Wang, Wei			Qishenyiqi Protects Ligation-Induced Left Ventricular Remodeling by Attenuating Inflammation and Fibrosis via STAT3 and NF-kappa B Signaling Pathway	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; INHIBITION; BIOMARKERS; CYTOKINES	Aim: Qi-shen-yi-qi (QSYQ), a formula used for the routine treatment of heart failure (HF) in China, has been demonstrated to improve cardiac function through down-regulating the activation of the Renin-Angiotensin-Aldosterone System (RAAS). However, the mechanisms governing its therapeutic effects are largely unknown. The present study aims to demonstrate that QSYQ treatment can prevent left ventricular remodeling in heart failure by attenuating oxidative stress and inhabiting inflammation. Methods: Sprague-Dawley (SD) rats were randomly divided into 6 groups: sham group, model group (LAD coronary artery ligation), QSYQ group with high dosage, middle dosage and low dosage (LAD ligation and treated with QSYQ), and captopril group (LAD ligation and treated with captopril as the positive drug). Indicators of fibrosis (Masson, MMPs, and collagens) and inflammation factors were detected 28 days after surgery. Results: Results of hemodynamic alterations (dp/dt value) in the model group as well as other ventricular remodeling (VR) markers, such as MMP-2, MMP-9, collagen I and III elevated compared with sham group. VR was accompanied by activation of RAAS (angiotensin II and NADPHoxidase). Levels of pro-inflammatory cytokines (TNF-alpha, IL-6) in myocardial tissue were also up-regulated. Treatment of QSYQ improved cardiac remodeling through counter-acting the aforementioned events. The improvement of QSYQ was accompanied with a restoration of angiotensin II-NADPHoxidase-ROS-MMPs pathways. In addition, "therapeutic'' QSYQ administration can reduce both TNF-alpha-NF-B and IL-6-STAT3 pathways, respectively, which further proves the beneficial effects of QSYQ. Conclusions: Our study demonstrated that QSYQ protected LAD ligation-induced left VR via attenuating AngII -NADPH oxidase pathway and inhabiting inflammation. These findings provide evidence as to the cardiac protective efficacy of QSYQ to HF and explain the beneficial effects of QSYQ in the clinical application for HF.	[Li, Chun; Chai, Xingyun] Beijing Univ Chinese Med, Modern Res Ctr Tradit Chinese Med, Beijing, Peoples R China; [Wang, Yong; Shi, Tianjiao; Wu, Yan; Han, Jing; Wang, Wei] Beijing Univ Chinese Med, Basic Med Coll, Beijing, Peoples R China; [Qiu, Qi] Capital Med Univ, Anzhen Hosp, Beijing, Peoples R China	Beijing University of Chinese Medicine; Beijing University of Chinese Medicine; Capital Medical University	Wang, W (corresponding author), Beijing Univ Chinese Med, Basic Med Coll, Beijing, Peoples R China.	wangwei26960@126.com			National Natural Science Foundation of China [81202788, 81302908]; National Science & Technology Pillar Program [2012BAI29B07]; Beijing Natural Science Foundation [7142099]; Creation for Significant New Drugs Project of China [2012ZX09103-201-011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Pillar Program; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Creation for Significant New Drugs Project of China	This study was financially supported, in part, by the Grants from the National Natural Science Foundation of China (No. 81202788 and 81302908), the National Science & Technology Pillar Program (No. 2012BAI29B07), Beijing Natural Science Foundation (7142099), and Creation for Significant New Drugs Project of China (No. 2012ZX09103-201-011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; Ahmad T, 2012, NAT REV CARDIOL, V9, P347, DOI 10.1038/nrcardio.2012.37; Armstrong PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020062; Bartunek J, 2012, BIOMARK MED, V6, P1, DOI [10.2217/BMM.12.3, 10.2217/bmm.12.3]; Dai Guo-hua, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P653; Ferreira AS, 2011, CHIN J INTEGR MED, V17, P818, DOI 10.1007/s11655-011-0892-y; Fertin M, 2012, AM J CARDIOL, V110, P277, DOI 10.1016/j.amjcard.2012.02.069; Gullestad L, 2012, CARDIOLOGY, V122, P23, DOI 10.1159/000338166; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; Hohensinner PJ, 2011, CURR OPIN INFECT DIS, V24, P259, DOI 10.1097/QCO.0b013e328344f50f; Hong Chengtao, 2009, Zhongguo Zhong Yao Za Zhi, V34, P1018; Houser SR, 2012, CIRC RES, V111, P131, DOI 10.1161/RES.0b013e3182582523; Kairouz V, 2012, ANN NY ACAD SCI, V1254, P42, DOI 10.1111/j.1749-6632.2012.06520.x; Khatib R, 2012, INT J CARDIOLOGY; Kirkpatrick James N, 2012, Curr Heart Fail Rep, V9, P328, DOI 10.1007/s11897-012-0116-6; Kurdi Mazen, 2010, Congest Heart Fail, V16, P234, DOI 10.1111/j.1751-7133.2010.00175.x; Lecour S, 2011, EUR HEART J, V32, P680, DOI 10.1093/eurheartj/ehq484; Li YW, 2006, CARDIOVASC RES, V71, P684, DOI 10.1016/j.cardiores.2006.06.003; Lin Yang, 2012, China Journal of Traditional Chinese Medicine and Pharmacy, V27, P1280; Mir SA, 2012, J BIOL CHEM, V287, P2666, DOI 10.1074/jbc.M111.246173; Mukhopadhyay P, 2007, J AM COLL CARDIOL, V50, P528, DOI 10.1016/j.jacc.2007.03.057; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Rajesh M, 2010, J AM COLL CARDIOL, V56, P2115, DOI 10.1016/j.jacc.2010.07.033; Schroder K, 2012, CIRC RES, V110, P1217, DOI 10.1161/CIRCRESAHA.112.267054; Wang MJ, 2007, AM J PHYSIOL-HEART C, V293, pH2101, DOI 10.1152/ajpheart.00125.2007; Wang Y., 2012, EVIDENCE BASED COMPL; Wang Y, 2013, EVIDENCE BASED COMPL, V2013; Wysong A, 2011, AM J PATHOL, V178, P1059, DOI 10.1016/j.ajpath.2010.12.009; Zhang M, 2013, ANTIOXID REDOX SIGN, V18, P1024, DOI 10.1089/ars.2012.4550	29	52	58	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104255	10.1371/journal.pone.0104255	http://dx.doi.org/10.1371/journal.pone.0104255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122164	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000033
J	Long, ZJ; Hu, YA; Li, XD; He, Y; Xiao, RZ; Fang, ZG; Wang, DN; Liu, JJ; Yan, JS; Huang, RW; Lin, DJ; Liu, QT				Long, Zi-Jie; Hu, Yuan; Li, Xu-Dong; He, Yi; Xiao, Ruo-Zhi; Fang, Zhi-Gang; Wang, Dong-Ning; Liu, Jia-Jun; Yan, Jin-Song; Huang, Ren-Wei; Lin, Dong-Jun; Liu, Quentin			ATO/ATRA/Anthracycline-Chemotherapy Sequential Consolidation Achieves Long-Term Efficacy in Primary Acute Promyelocytic Leukemia	PLOS ONE			English	Article							TRANS-RETINOIC ACID; ARSENIC TRIOXIDE AS2O3; REMISSION INDUCTION; INITIAL THERAPY; COMBINATION; SURVIVAL; DIFFERENTIATION; ANTHRACYCLINE; INTERGROUP; SAFETY	The combination of all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3, ATO) has been effective in obtaining high clinical complete remission (CR) rates in acute promyelocytic leukemia (APL), but the long-term efficacy and safety among newly diagnosed APL patients are unclear. In this retrospective study, total 45 newly diagnosed APL patients received ATRA/chemotherapy combination regimen to induce remission. Among them, 43 patients (95.6%) achieved complete remission (CR) after induction therapy, followed by ATO/ATRA/anthracycline-based chemotherapy sequential consolidation treatment with a median follow-up of 55 months. In these patients, the estimated overall survival (OS) and the relapse-free survival (RFS) were 94.4%+/- 3.9% and 94.6 +/- 3.7%, respectively. The toxicity profile was mild and reversible. No secondary carcinoma was observed. These results demonstrated the high efficacy and minimal toxicity of ATO/ATRA/anthracycline-based chemotherapy sequential consolidation treatment for newly diagnosed APL in long-term follow-up, suggesting a potential frontline therapy for APL.	[Long, Zi-Jie; Hu, Yuan; Li, Xu-Dong; He, Yi; Xiao, Ruo-Zhi; Fang, Zhi-Gang; Wang, Dong-Ning; Liu, Jia-Jun; Huang, Ren-Wei; Lin, Dong-Jun; Liu, Quentin] Sun Yat Sen Univ, Sun Yat Sen Inst Hematol, Affiliated Hosp 3, Dept Hematol, Guangzhou, Guangdong, Peoples R China; [Liu, Quentin] Dalian Med Univ, Inst Canc Stem Cell, Dalian, Peoples R China; [Yan, Jin-Song] Dalian Med Univ, Affiliated Hosp 2, Dept Hematol, Dalian, Peoples R China	Sun Yat Sen University; Dalian Medical University; Dalian Medical University	Huang, RW (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Inst Hematol, Affiliated Hosp 3, Dept Hematol, Guangzhou, Guangdong, Peoples R China.	huangrw56@163.com; lindj@mail.sysu.edu.cn; liuq9@mail.sysu.edu.cn	liu, xiaoyun/GXV-0330-2022; Yan, Jinsong/ABC-6784-2020	liu, xiaoyun/0000-0002-5425-7456; Yan, Jinsong/0000-0003-4109-2602				Aribi A, 2007, CANCER, V109, P1355, DOI 10.1002/cncr.22524; Asou N, 2007, BLOOD, V110, P59, DOI 10.1182/blood-2006-08-043992; Au WY, 2002, BRIT J HAEMATOL, V117, P130, DOI 10.1046/j.1365-2141.2002.03409.x; Avvisati G, 2011, BLOOD, V117, P4716, DOI 10.1182/blood-2010-08-302950; Chen GQ, 1997, BLOOD, V89, P3345; Coutre SE, 2014, BRIT J HAEMATOL, V165, P497, DOI 10.1111/bjh.12775; CUNNINGHAM I, 1989, BLOOD, V73, P1116; Dai CW, 2009, ACTA HAEMATOL-BASEL, V121, P1, DOI 10.1159/000204472; dos Santos GA, 2013, J EXP MED, V210, P2793, DOI 10.1084/jem.20131121; Estey E, 2006, BLOOD, V107, P3469, DOI 10.1182/blood-2005-10-4006; Galimberti S, 1999, BONE MARROW TRANSPL, V24, P345, DOI 10.1038/sj.bmt.1701875; Ghavamzadeh A, 2006, ANN ONCOL, V17, P131, DOI 10.1093/annonc/mdj019; Gianni M, 1998, BLOOD, V91, P4300, DOI 10.1182/blood.V91.11.4300.411k41_4300_4310; Gore SD, 2010, J CLIN ONCOL, V28, P1047, DOI 10.1200/JCO.2009.25.5158; Grigg A, 2003, LEUKEMIA, V17, P1916, DOI 10.1038/sj.leu.2403050; Hu J, 2009, P NATL ACAD SCI USA, V106, P3342, DOI 10.1073/pnas.0813280106; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Iland HJ, 2012, BLOOD, V120, P1570, DOI 10.1182/blood-2012-02-410746; Jing YK, 2001, BLOOD, V97, P264, DOI 10.1182/blood.V97.1.264; Lallemand-Breitenbach V, 1999, J EXP MED, V189, P1043, DOI 10.1084/jem.189.7.1043; Lengfelder E, 2009, LEUKEMIA, V23, P2248, DOI 10.1038/leu.2009.183; Li X, 2007, LEUKEMIA RES, V31, P765, DOI 10.1016/j.leukres.2006.07.028; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Mathews V, 2006, BLOOD, V107, P2627, DOI 10.1182/blood-2005-08-3532; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Powell BL, 2010, BLOOD, V116, P3751, DOI 10.1182/blood-2010-02-269621; Quezada G, 2008, PEDIATR BLOOD CANCER, V51, P133, DOI 10.1002/pbc.21529; Raffoux E, 2003, J CLIN ONCOL, V21, P2326, DOI 10.1200/JCO.2003.01.149; Rock N, 2014, PEDIATR HEMAT ONCOL, V31, P143, DOI 10.3109/08880018.2013.876470; SANZ MA, 1988, CANCER, V61, P7, DOI 10.1002/1097-0142(19880101)61:1<7::AID-CNCR2820610103>3.0.CO;2-6; Sanz MA, 2010, BLOOD, V115, P5137, DOI 10.1182/blood-2010-01-266007; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Shigeno K, 2005, INT J HEMATOL, V82, P224, DOI 10.1532/IJH97.05044; Soignet SL, 2001, J CLIN ONCOL, V19, P3852, DOI 10.1200/JCO.2001.19.18.3852; Sun H. D., 1992, CHIN J INTEGRAT CHIN, V12, P170; Tallman MS, 2007, BEST PRACT RES CL HA, V20, P57, DOI 10.1016/j.beha.2006.11.002; Tallman MS, 2002, BLOOD, V100, P4298, DOI 10.1182/blood-2002-02-0632; Wang GJ, 2004, HEMATOL ONCOL, V22, P63, DOI 10.1002/hon.728; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; ZHANG P, 1996, CHIN J HEMATOL, V17, P58; Zhang YM, 2013, CANCER-AM CANCER SOC, V119, P115, DOI 10.1002/cncr.27650; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102	43	12	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104610	10.1371/journal.pone.0104610	http://dx.doi.org/10.1371/journal.pone.0104610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122165	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000047
J	Noguchi, F; Nakajima, T; Inui, S; Reddy, JK; Itami, S				Noguchi, Fumihito; Nakajima, Takeshi; Inui, Shigeki; Reddy, Janardan K.; Itami, Satoshi			Alteration of Skin Wound Healing in Keratinocyte-Specific Mediator Complex Subunit 1 Null Mice	PLOS ONE			English	Article							FOLLICLE STEM-CELLS; PROLIFERATOR-ACTIVATED RECEPTOR; VITAMIN-D-RECEPTOR; HAIR FOLLICLE; HUMAN FOLLISTATIN; EPIDERMAL ALTERATIONS; PORCINE FOLLISTATIN; ACTIVIN-BINDING; REPAIR; REGENERATION	MED1 (Mediator complex subunit 1) is a co-activator of various transcription factors that function in multiple transcriptional pathways. We have already established keratinocyte-specific MED1 null mice (Med1(epi-/-)) that develop epidermal hyperplasia. Herein, to investigate the function(s) of MED1 in skin wound healing, full-thickness skin wounds were generated in Med1(epi-/-) and age-matched wild-type mice and the healing process was analyzed. Macroscopic wound closure and the re-epithelialization rate were accelerated in 8-week-old Med1(epi-/-) mice compared with age-matched wildtype mice. Increased lengths of migrating epithelial tongues and numbers of Ki67-positive cells at the wounded epidermis were observed in 8-week-old Med1(epi-/-) mice, whereas wound contraction and the area of alpha-SMA-positive myofibroblasts in the granulation tissue were unaffected. Migration was enhanced in Med1(epi-/-) keratinocytes compared with wild-type keratinocytes in vitro. Immunoblotting revealed that the expression of follistatin was significantly decreased in Med1(epi-/-) keratinocytes. Moreover, the mitogen-activated protein kinase pathway was enhanced before and after treatment of Med1(epi-/-) keratinocytes with activin A in vitro. Cell-cycle analysis showed an increased ratio of S phase cells after activin A treatment of Med1(epi-/-) keratinocytes compared with wild-type keratinocytes. These findings indicate that the activinfollistatin system is involved in this acceleration of skin wound healing in 8-week-old Med1(epi-/-) mice. On the other hand, skin wound healing in 6-month-old Med1(epi-/-) mice was significantly delayed with decreased numbers of Ki67-positive cells at the wounded epidermis as well as BrdU-positive label retaining cells in hair follicles compared with age-matched wildtype mice. These results agree with our previous observation that hair follicle bulge stem cells are reduced in older Med1(epi-/-) mice, indicating a decreased contribution of hair follicle stem cells to epidermal regeneration after wounding in 6-month-old Med1(epi-/-) mice. This study sheds light on the novel function of MED1 in keratinocytes and suggests a possible new therapeutic approach for skin wound healing and aging.	[Noguchi, Fumihito; Inui, Shigeki; Itami, Satoshi] Osaka Univ, Grad Sch Med, Dept Regenerat Dermatol, Osaka, Japan; [Nakajima, Takeshi] Osaka Gen Med Ctr, Dept Dermatol, Osaka, Japan; [Reddy, Janardan K.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA	Osaka University; Northwestern University; Feinberg School of Medicine	Noguchi, F (corresponding author), Osaka Univ, Grad Sch Med, Dept Regenerat Dermatol, Osaka, Japan.	noguchi@r-derma.med.osaka-u.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [19790784, 21791075, 23591644]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097249] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports and Culture of Japan (19790784, 21791075 and 23591644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antsiferova M, 2009, LAB INVEST, V89, P131, DOI 10.1038/labinvest.2008.120; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Bikle DD, 2006, J CELL PHYSIOL, V207, P340, DOI 10.1002/jcp.20578; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2010, NATURE, V464, P686, DOI 10.1038/464686a; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Castilho RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010503; Chen YG, 2006, EXP BIOL MED, V231, P534; Cianferotti L, 2007, P NATL ACAD SCI USA, V104, P9428, DOI 10.1073/pnas.0702884104; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; deWinter JP, 1996, MOL CELL ENDOCRINOL, V116, P105, DOI 10.1016/0303-7207(95)03705-5; Frye M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000763; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Gazel A, 2006, J BIOL CHEM, V281, P20530, DOI 10.1074/jbc.M602712200; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hubner G, 1996, DEV BIOL, V173, P490, DOI 10.1006/dbio.1996.0042; INOUYE S, 1991, ENDOCRINOLOGY, V129, P815, DOI 10.1210/endo-129-2-815; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2002, J INVEST DERMATOL, V119, P1310, DOI 10.1046/j.1523-1747.2002.19644.x; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Lau K, 2009, EXP DERMATOL, V18, P921, DOI 10.1111/j.1600-0625.2009.00942.x; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Li M, 2001, DEVELOPMENT, V128, P675; Mardaryev AN, 2011, DEVELOPMENT, V138, P4843, DOI 10.1242/dev.070284; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Matsumoto K, 2007, J BIOL CHEM, V282, P17053, DOI 10.1074/jbc.M701956200; McDowall A, 2008, CYTOKINE GROWTH F R, V19, P415, DOI [10.1016/j.cytogfr.2009.08.005, 10.1016/j.cytogfr.2008.08.005]; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Munz B, 1999, EMBO J, V18, P5205, DOI 10.1093/emboj/18.19.5205; Munz B, 2001, MOL CELL ENDOCRINOL, V180, P169, DOI 10.1016/S0303-7207(01)00514-7; Nakajima T, 2012, J INVEST DE IN PRESS; Necela BM, 2008, J BIOL CHEM, V283, P29784, DOI 10.1074/jbc.M804481200; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oda Y, 2012, J INVEST DERMATOL, V132, P1075, DOI 10.1038/jid.2011.430; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; SHIMASAKI S, 1988, BIOCHEM BIOPH RES CO, V152, P717, DOI 10.1016/S0006-291X(88)80097-4; SHIMASAKI S, 1988, P NATL ACAD SCI USA, V85, P4218, DOI 10.1073/pnas.85.12.4218; SHIMONAKA M, 1991, ENDOCRINOLOGY, V128, P3313, DOI 10.1210/endo-128-6-3313; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Uchugonova A, 2011, J CELL BIOCHEM, V112, P2046, DOI 10.1002/jcb.23122; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang QF, 2000, ENDOCRINOLOGY, V141, P3183, DOI 10.1210/en.141.9.3183; Wankell M, 2003, ANN NY ACAD SCI, V995, P48, DOI 10.1111/j.1749-6632.2003.tb03209.x; Wankell M, 2001, EMBO J, V20, P5361, DOI 10.1093/emboj/20.19.5361; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440; Zhang L, 2005, MOL CELL BIOL, V25, P60, DOI 10.1128/MCB.25.1.60-65.2005; Zhang M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025143; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	59	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e102271	10.1371/journal.pone.0102271	http://dx.doi.org/10.1371/journal.pone.0102271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122137	Green Submitted, Green Published, gold			2022-12-27	WOS:000341017000005
J	Novotny, SA; Mader, TL; Greising, AG; Lin, AS; Guldberg, RE; Warren, GL; Lowe, DA				Novotny, Susan A.; Mader, Tara L.; Greising, Angela G.; Lin, Angela S.; Guldberg, Robert E.; Warren, Gordon L.; Lowe, Dawn A.			Low Intensity, High Frequency Vibration Training to Improve Musculoskeletal Function in a Mouse Model of Duchenne Muscular Dystrophy	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; BONE-MINERAL DENSITY; LEVEL MECHANICAL VIBRATIONS; SKELETAL-MUSCLE; MDX MICE; ECCENTRIC CONTRACTION; SOLEUS MUSCLE; OLDER-ADULTS; EDL MUSCLES; SHORT-TERM	The objective of the study was to determine if low intensity, high frequency vibration training impacted the musculoskeletal system in a mouse model of Duchenne muscular dystrophy, relative to healthy mice. Three-week old wildtype (n = 26) and mdx mice (n = 22) were randomized to non-vibrated or vibrated (45 Hz and 0.6 g, 15 min/d, 5 d/wk) groups. In vivo and ex vivo contractile function of the anterior crural and extensor digitorum longus muscles, respectively, were assessed following 8 wks of vibration. Mdx mice were injected 5 and 1 days prior to sacrifice with Calcein and Xylenol, respectively. Muscles were prepared for histological and triglyceride analyses and subcutaneous and visceral fat pads were excised and weighed. Tibial bones were dissected and analyzed by micro-computed tomography for trabecular morphometry at the metaphysis, and cortical geometry and density at the mid-diaphysis. Three-point bending tests were used to assess cortical bone mechanical properties and a subset of tibiae was processed for dynamic histomorphometry. Vibration training for 8 wks did not alter trabecular morphometry, dynamic histomorphometry, cortical geometry, or mechanical properties (P >= 0.34). Vibration did not alter any measure of muscle contractile function (P >= 0.12); however the preservation of muscle function and morphology in mdx mice indicates vibration is not deleterious to muscle lacking dystrophin. Vibrated mice had smaller subcutaneous fat pads (P = 0.03) and higher intramuscular triglyceride concentrations (P = 0.03). These data suggest that vibration training at 45 Hz and 0.6 g did not significantly impact the tibial bone and the surrounding musculature, but may influence fat distribution in mice.	[Novotny, Susan A.; Mader, Tara L.; Greising, Angela G.; Lowe, Dawn A.] Univ Minnesota, Program Phys Therapy & Rehabil Sci, Minneapolis, MN 55455 USA; [Lin, Angela S.; Guldberg, Robert E.] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Warren, Gordon L.] Georgia State Univ, Dept Phys Therapy, Atlanta, GA 30303 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia State University	Novotny, SA (corresponding author), Univ Minnesota, Program Phys Therapy & Rehabil Sci, Minneapolis, MN 55455 USA.	golne003@umn.edu	Warren, Gordon/A-9794-2008	Warren, Gordon/0000-0002-7073-8524; Novotny, Susan/0000-0003-1165-132X; Lowe, Dawn/0000-0002-5784-9289	Muscular Dystrophy Association (DAL) [114071]; National Institute of Health [T32-AR07612]; University of Minnesota Muscular Dystrophy Center [P30-AR0507220]; DAL [K02-AG036827]; Patrick and Kathy Lewis Fund (SAN); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG036827] Funding Source: NIH RePORTER	Muscular Dystrophy Association (DAL); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Muscular Dystrophy Center; DAL; Patrick and Kathy Lewis Fund (SAN); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research has been supported by grants from the Muscular Dystrophy Association grant 114071 (DAL, http://mda.org/), National Institute of Health (http://nih.gov/) grants T32-AR07612 (SAN), P30-AR0507220 (University of Minnesota Muscular Dystrophy Center), and K02-AG036827 (DAL), and the Patrick and Kathy Lewis Fund (SAN, http://www.cehd.umn.edu/gradsehd/grants/default.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JE, 1993, BONE, V14, P625, DOI 10.1016/8756-3282(93)90084-N; Baltgalvis KA, 2009, MUSCLE NERVE, V40, P443, DOI 10.1002/mus.21327; Bianchi ML, 2003, OSTEOPOROSIS INT, V14, P761, DOI 10.1007/s00198-003-1443-y; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; Blottner D, 2006, EUR J APPL PHYSIOL, V97, P261, DOI 10.1007/s00421-006-0160-6; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Brouwers JEM, 2010, J ORTHOP RES, V28, P62, DOI 10.1002/jor.20951; Call JA, 2011, J APPL PHYSIOL, V111, P1768, DOI 10.1152/japplphysiol.00942.2011; Christiansen BA, 2006, ANN BIOMED ENG, V34, P1149, DOI 10.1007/s10439-006-9133-5; Cozzi F, 2001, ACTA NEUROPATHOL, V101, P469; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gainer TG, 2008, SKELETAL MUSCLE DAMA, P113; Garlich MW, 2010, AM J PHYS MED REHAB, V89, P976, DOI 10.1097/PHM.0b013e3181fc7c9e; Garman R, 2007, J ORTHOP RES, V25, P732, DOI 10.1002/jor.20354; Gilsanz V, 2006, J BONE MINER RES, V21, P1464, DOI 10.1359/JBMR.060612; Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008; Ingalls CP, 1996, J APPL PHYSIOL, V80, P332, DOI 10.1152/jappl.1996.80.1.332; Iwaniec UT, 2007, J BONE MINER RES, V22, P394, DOI 10.1359/JBMR.061118; Judex S, 2002, FASEB J, V16, P1280, DOI 10.1096/fj.01-0913fje; Judex S, 2007, J BIOMECH, V40, P1333, DOI 10.1016/j.jbiomech.2006.05.014; Kiiski J, 2008, J BONE MINER RES, V23, P1318, DOI [10.1359/jbmr.080315, 10.1359/JBMR.080315]; King W, 2009, VOLUMETRIC RADIAL TI, P72; Koves TR, 2013, J LIPID RES, V54, P522, DOI 10.1194/jlr.P028910; Landisch RM, 2008, MUSCLE NERVE, V38, P1290, DOI 10.1002/mus.21141; Landoll J, 2008, FOREARM PQCT MEASURM, P23; Larson CM, 2000, J PEDIATR ORTHOPED, V20, P71, DOI 10.1097/00004694-200001000-00016; Lau RWK, 2011, CLIN REHABIL, V25, P975, DOI 10.1177/0269215511405078; Lee BJ, 2007, NORTHEAST BIOENGIN C, P35, DOI 10.1109/NEBC.2007.4413267; Lotinun S, 2005, J BONE MINER RES, V20, P644, DOI 10.1359/JBMR.041209; Luu YK, 2009, J BONE MINER RES, V24, P50, DOI [10.1359/jbmr.080817, 10.1359/JBMR.080817]; Maddalozzo GF, 2008, INT J OBESITY, V32, P1348, DOI 10.1038/ijo.2008.111; Manske SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036486; McDonald DGM, 2002, DEV MED CHILD NEUROL, V44, P695; Mckeehen JN, 2013, MED SCI SPORT EXER, V45, P1051, DOI 10.1249/MSS.0b013e3182811947; Mikhael M, 2010, MATURITAS, V66, P150, DOI 10.1016/j.maturitas.2010.01.013; MOENS P, 1993, J MUSCLE RES CELL M, V14, P446, DOI 10.1007/BF00121296; Montgomery E, 2005, ANAT REC PART A, V286A, P814, DOI 10.1002/ar.a.20224; Moran AL, 2005, EXP GERONTOL, V40, P966, DOI 10.1016/j.exger.2005.09.005; Muir J, 2011, GAIT POSTURE, V33, P429, DOI 10.1016/j.gaitpost.2010.12.019; Murfee WL, 2005, J APPL PHYSIOL, V98, P2376, DOI 10.1152/japplphysiol.01135.2004; Nakagaki WR, 2011, BONE, V48, P372, DOI 10.1016/j.bone.2010.09.011; Necking LE, 1996, SCAND J PLAST RECONS, V30, P99, DOI 10.3109/02844319609056390; Novotny SA, 2013, J MUSCULOSKEL NEURON, V13, P418; Novotny SA, 2013, J MUSCULOSKEL NEURON, V13, P412; Novotny SA, 2012, J MUSCULOSKEL NEURON, V12, P16; Novotny SA, 2011, NEUROMUSCULAR DISORD, V21, P183, DOI 10.1016/j.nmd.2010.12.002; Oxlund BS, 2003, BONE, V32, P69, DOI 10.1016/S8756-3282(02)00916-X; Ozcivici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011178; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Prisby RD, 2008, AGEING RES REV, V7, P319, DOI 10.1016/j.arr.2008.07.004; Qin YX, 1998, J ORTHOPAED RES, V16, P482, DOI 10.1002/jor.1100160414; Reyes ML, 2011, J BONE MINER RES, V26, P1759, DOI 10.1002/jbmr.402; Rittweger J, 2010, EUR J APPL PHYSIOL, V108, P877, DOI 10.1007/s00421-009-1303-3; Ritzmann R, 2012, EUR J APPL PHYSL; Rubin C, 2001, FASEB J, V15, P2225, DOI 10.1096/fj.01-0166com; Rubin C, 2001, NATURE, V412, P603, DOI 10.1038/35088122; Rubin C, 2002, BONE, V30, P445, DOI 10.1016/S8756-3282(01)00689-5; Rubin C, 2003, SPINE, V28, P2621, DOI 10.1097/01.BRS.0000102682.61791.C9; Rufo A, 2011, J BONE MINER RES, V26, P1891, DOI 10.1002/jbmr.410; Slatkovska L, 2010, OSTEOPOROSIS INT, V21, P1969, DOI 10.1007/s00198-010-1228-z; Soderpalm AC, 2013, J MUSCULOSKEL NEURON, V13, P13; Soderpalm AC, 2007, NEUROMUSCULAR DISORD, V17, P919, DOI 10.1016/j.nmd.2007.05.008; Straathof CSM, 2009, J NEUROL, V256, P768, DOI 10.1007/s00415-009-5012-y; Torvinen S, 2003, J BONE MINER RES, V18, P876, DOI 10.1359/jbmr.2003.18.5.876; Ward K, 2004, J BONE MINER RES, V19, P360, DOI 10.1359/JBMR.040129; WARREN GL, 1994, J APPL PHYSIOL, V77, P1421, DOI 10.1152/jappl.1994.77.3.1421; Warren GL, 1996, J APPL PHYSIOL, V80, P1660, DOI 10.1152/jappl.1996.80.5.1660; Warren GL, 2007, AM J PHYSIOL-REG I, V293, pR2015, DOI 10.1152/ajpregu.00569.2007; Xie LQ, 2008, J APPL PHYSIOL, V104, P1056, DOI 10.1152/japplphysiol.00764.2007; Xie LQ, 2006, BONE, V39, P1059, DOI 10.1016/j.bone.2006.05.012	72	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104339	10.1371/journal.pone.0104339	http://dx.doi.org/10.1371/journal.pone.0104339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121503	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000036
J	Andreassen, CS; Griffiths, MD; Hetland, J; Kravina, L; Jensen, F; Pallesen, S				Andreassen, Cecilie Schou; Griffiths, Mark D.; Hetland, Jorn; Kravina, Luca; Jensen, Fredrik; Pallesen, Stale			The Prevalence of Workaholism: A Survey Study in a Nationally Representative Sample of Norwegian Employees	PLOS ONE			English	Article							WORK ENGAGEMENT; SATISFACTION; PERSONALITY; ADDICTION; NETHERLANDS; DEFINITION; VALIDATION; TENDENCIES; NARCISSISM; SPILLOVER	Workaholism has become an increasingly popular area for empirical study. However, most studies examining the prevalence of workaholism have used non-representative samples and measures with poorly defined cut-off scores. To overcome these methodological limitations, a nationally representative survey among employees in Norway (N = 1,124) was conducted. Questions relating to gender, age, marital status, caretaker responsibility for children, percentage of full-time equivalent, and educational level were asked. Workaholism was assessed by the use of a psychometrically validated instrument (i.e., Bergen Work Addiction Scale). Personality was assessed using the Mini-International Personality Item Pool. Results showed that the prevalence of workaholism was 8.3% (95% Cl = 6.7-9.9%). An adjusted logistic regression analysis showed that workaholism was negatively related to age and positively related to the personality dimensions agreeableness, neuroticism, and intellect/imagination. Implications for these findings are discussed.	[Andreassen, Cecilie Schou; Hetland, Jorn; Jensen, Fredrik; Pallesen, Stale] Univ Bergen, Dept Psychosocial Sci, Bergen, Norway; [Andreassen, Cecilie Schou] Bergen Clin Fdn, Competence Ctr, Bergen, Norway; [Griffiths, Mark D.] Nottingham Trent Univ, Psychol Div, Nottingham, England; [Kravina, Luca] Univ Padua, Dept FISPPA, Sect Appl Psychol, Padua, Italy	University of Bergen; Nottingham Trent University; University of Padua	Andreassen, CS (corresponding author), Univ Bergen, Dept Psychosocial Sci, Bergen, Norway.	cecilie.andreassen@psych.uib.no	Griffiths, Mark D./AAY-3546-2021	Griffiths, Mark D./0000-0001-8880-6524; Andreassen, Cecilie S./0000-0002-3511-2155				American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Andreassen CS, 2014, J BEHAV ADDICT, V3, P1, DOI 10.1556/JBA.2.2013.017; Andreassen CS, 2013, J BEHAV ADDICT, V2, P90, DOI 10.1556/JBA.2.2013.003; Andreassen CS, 2014, J MANAGE PSYCHOL, V29, P7, DOI 10.1108/JMP-05-2013-0143; Andreassen CS, 2013, EUR J WORK ORGAN PSY, V22, P78, DOI 10.1080/1359432X.2011.626201; Andreassen CS, 2012, SOC BEHAV PERSONAL, V40, P881, DOI 10.2224/sbp.2012.40.6.881; Andreassen CS, 2012, SCAND J PSYCHOL, V53, P265, DOI 10.1111/j.1467-9450.2012.00947.x; Andreassen CS, 2011, STRESS HEALTH, V27, pE209, DOI 10.1002/smi.1366; Andreassen CS, 2010, EUR J PERSONALITY, V24, P3, DOI 10.1002/per.737; Aziz S, 2006, J OCCUP HEALTH PSYCH, V11, P52, DOI 10.1037/1076-8998.11.1.52; Aziz S, 2011, PSYCHOL REC, V61, P269, DOI 10.1007/BF03395760; Bakker AB, 2009, J OCCUP HEALTH PSYCH, V14, P23, DOI 10.1037/a0013290; Bardakci S, 2012, EGIT BILIM, V37, P45; Binnewies C., 2008, LONG WORK HOURS CULT, P275; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Bonebright CA, 2000, J COUNS PSYCHOL, V47, P469, DOI 10.1037/0022-0167.47.4.469; Brown R.I.F., 1993, GAMBLING BEHAV PROBL; Burke RJ, 2006, PERS INDIV DIFFER, V40, P1223, DOI 10.1016/j.paid.2005.10.017; Burke RJ, 2002, PSYCHOL REP, V91, P1098, DOI 10.2466/pr0.2002.91.3f.1098; Burke RJ, 2001, J APPL SOC PSYCHOL, V31, P2339, DOI 10.1111/j.1559-1816.2001.tb00179.x; Burke RJ, 1999, SEX ROLES, V41, P333, DOI 10.1023/A:1018818731922; Burnwell R., 2008, LONG WORK HOURS CULT, P295; Chen CP, 2006, NEW HORIZ MANAG, P310; Clark MA, 2010, PERS INDIV DIFFER, V48, P786, DOI 10.1016/j.paid.2010.01.013; Cohen J, 1988, STAT POWER ANAL FORF; Cook D.R., 1987, PSYCHOL ADDICT BEHAV, V1, P55, DOI [DOI 10.1037/H0080429, 10.1037/h0080429]; DOERFLER MC, 1986, SEX ROLES, V14, P551, DOI 10.1007/BF00287455; Dolle K, 2012, PSYCHIAT RES, V200, P843, DOI 10.1016/j.psychres.2012.05.011; Donnellan MB, 2006, PSYCHOL ASSESSMENT, V18, P192, DOI 10.1037/1040-3590.18.2.192; Falco A, 2013, J OCCUP ENVIRON MED, V55, P1255, DOI 10.1097/JOM.0000000000000007; Fry LW, 2006, NEW HORIZ MANAG, P330; Graziano W. G., 2009, HDB INDIVIDUAL DIFFE, P46, DOI DOI 10.1037/0022-3514.50.1.212; Griffiths M.D., 2005, J SUBST USE, V10, P191, DOI [DOI 10.1080/14659890500114359, 10.1080/14659890500114359]; Griffiths M, 2011, PSYCHOLOGIST, V24, P740; Harpaz I, 2003, HUM RELAT, V56, P291, DOI 10.1177/0018726703056003613; Johnson LC, 2000, INT J STRESS MANAGE, V7, P247, DOI 10.1023/A:1009589812697; Kanai A, 1996, JPN PSYCHOL RES, V38, P192, DOI 10.1111/j.1468-5884.1996.tb00024.x; Krueger RF, 2006, CURR DIR PSYCHOL SCI, V15, P113, DOI 10.1111/j.0963-7214.2006.00418.x; Kubota K, 2010, IND HEALTH, V48, P864, DOI 10.2486/indhealth.MS1139; Lemmens JS, 2009, MEDIA PSYCHOL, V12, P77, DOI 10.1080/15213260802669458; Machlowitz M., 1980, WORKAHOLICS LIVING T; MacLaren VV, 2010, ADDICT BEHAV, V35, P252, DOI 10.1016/j.addbeh.2009.09.023; McMillan LHW, 2002, J OCCUP ORGAN PSYCH, V75, P357, DOI 10.1348/096317902320369758; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Molde H., 2010, INT GAMBL STUD, V10, P189, DOI DOI 10.1080/14459795.2010.502182; Molino M, 2013, WORKAHOLISM DEFINITI; Mudrack PE, 2006, NEW HORIZ MANAG, P108; Muller KW, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/546342; O'Brien CP, 2006, AM J PSYCHIAT, V163, P764, DOI 10.1176/appi.ajp.163.5.764; Oates W., 1971, CONFESSIONS WORKAHOL; Osorio FD, 2011, INT J PSYCHIAT CLIN, V15, P255, DOI 10.3109/13651501.2011.605955; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Porter G, 2001, INT J STRESS MANAGE, V8, P147, DOI 10.1023/A:1009581330960; Reiss M., 2002, NEW INT, V343, P16; Robinson B.E., 2013, CHAINED DESK GUIDEBO, V3rd; Robinson BE, 2001, AM J FAM THER, V29, P397, DOI 10.1080/01926180127624; Robinson BE, 2001, CONTEMP FAM THER, V23, P123, DOI 10.1023/A:1007880301342; Robinson BE, 2001, INT J STRESS MANAGE, V8, P165, DOI 10.1023/A:1009533415030; Robinson BE, 2007, CHAINED DESK GUIDEBO; Russo J. A., 2006, CAREER DEV INT, V11, P418, DOI DOI 10.1108/13620430610683052; Schaufeli WB, 2008, APPL PSYCHOL-INT REV, V57, P173, DOI 10.1111/j.1464-0597.2007.00285.x; Schaufeli WB, 2009, CROSS-CULT RES, V43, P320, DOI 10.1177/1069397109337239; Scott KS, 1997, HUM RELAT, V50, P287, DOI 10.1177/001872679705000304; Shonin E, 2014, EXPLORE-NY, V10, P193, DOI 10.1016/j.explore.2014.02.004; Snir R., 2006, CAREER DEV INT, V11, P374, DOI [10.1108/13620430610683034, DOI 10.1108/13620430610683034]; Snir R, 2012, HUM RESOUR MANAGE R, V22, P232, DOI 10.1016/j.hrmr.2011.11.011; SPENCE JT, 1992, J PERS ASSESS, V58, P160, DOI 10.1207/s15327752jpa5801_15; Sussman S, 2011, EVAL HEALTH PROF, V34, P3, DOI 10.1177/0163278710380124; Taris TW, 2012, PSYCHOL REP, V110, P547, DOI 10.2466/03.09.17.PR0.110.2.547-554; Taris TW, 2010, WORK ENGAGEMENT: A HANDBOOK OF ESSENTIAL THEORY AND RESEARCH, P39; Taris TW, 2005, APPL PSYCHOL-INT REV, V54, P37, DOI 10.1111/j.1464-0597.2005.00195.x; Van den Broeck A, 2011, APPL PSYCHOL-INT REV, V60, P600, DOI 10.1111/j.1464-0597.2011.00449.x; van Wijhe CI, 2010, PSYCHOL BEHAV ASPECT, P107; Wiggins J.S., 1996, 5 FACTOR MODEL PERSO; Wojdylo K, 2013, BASIC APPL SOC PSYCH, V35, P547, DOI 10.1080/01973533.2013.840631; World Health Organization, 1992, ICD 10 CLASSIFICATIO, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P	76	68	69	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e102446	10.1371/journal.pone.0102446	http://dx.doi.org/10.1371/journal.pone.0102446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9BM	25118877	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600006
J	Gagne, CR; MacEvoy, SP				Gagne, Christopher R.; MacEvoy, Sean P.			Do Simultaneously Viewed Objects Influence Scene Recognition Individually or as Groups? Two Perceptual Studies	PLOS ONE			English	Article							REPRESENTATION; INFORMATION; IDENTIFICATION; CONSISTENCY; FEATURES; CONTEXT; CORTEX; PAIRS	The ability to quickly categorize visual scenes is critical to daily life, allowing us to identify our whereabouts and to navigate from one place to another. Rapid scene categorization relies heavily on the kinds of objects scenes contain; for instance, studies have shown that recognition is less accurate for scenes to which incongruent objects have been added, an effect usually interpreted as evidence of objects' general capacity to activate semantic networks for scene categories they are statistically associated with. Essentially all real-world scenes contain multiple objects, however, and it is unclear whether scene recognition draws on the scene associations of individual objects or of object groups. To test the hypothesis that scene recognition is steered, at least in part, by associations between object groups and scene categories, we asked observers to categorize briefly-viewed scenes appearing with object pairs that were semantically consistent or inconsistent with the scenes. In line with previous results, scenes were less accurately recognized when viewed with inconsistent versus consistent pairs. To understand whether this reflected individual or group-level object associations, we compared the impact of pairs composed of mutually related versus unrelated objects; i.e., pairs, which, as groups, had clear associations to particular scene categories versus those that did not. Although related and unrelated object pairs equally reduced scene recognition accuracy, unrelated pairs were consistently less capable of drawing erroneous scene judgments towards scene categories associated with their individual objects. This suggests that scene judgments were influenced by the scene associations of object groups, beyond the influence of individual objects. More generally, the fact that unrelated objects were as capable of degrading categorization accuracy as related objects, while less capable of generating specific alternative judgments, indicates that the process by which objects interfere with scene recognition is separate from the one through which they inform it.	[Gagne, Christopher R.; MacEvoy, Sean P.] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA	Boston College	MacEvoy, SP (corresponding author), Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA.	sean.macevoy.1@bc.edu			Boston College	Boston College	This work was funded by Boston College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTES JR, 1981, PSYCHOL RES-PSYCH FO, V43, P277, DOI 10.1007/BF00308452; Baeck A, 2013, NEUROIMAGE, V70, P37, DOI 10.1016/j.neuroimage.2012.12.023; Bar M, 1996, PERCEPTION, V25, P343, DOI 10.1068/p250343; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; BIEDERMA.I, 1972, SCIENCE, V177, P77, DOI 10.1126/science.177.4043.77; BIEDERMAN I, 1981, PERCEPTION, V10, P573, DOI 10.1068/p100573; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; BOYCE SJ, 1992, J EXP PSYCHOL LEARN, V18, P531, DOI 10.1037/0278-7393.18.3.531; BOYCE SJ, 1989, J EXP PSYCHOL HUMAN, V15, P556, DOI 10.1037/0096-1523.15.3.556; Davenport JL, 2004, PSYCHOL SCI, V15, P559, DOI 10.1111/j.0956-7976.2004.00719.x; Davenport JL, 2007, MEM COGNITION, V35, P393, DOI 10.3758/BF03193280; Green C, 2006, J EXP PSYCHOL HUMAN, V32, P1107, DOI 10.1037/0096-1523.32.5.1107; Greene MR, 2009, PSYCHOL SCI, V20, P464, DOI 10.1111/j.1467-9280.2009.02316.x; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; Gronau N, 2008, J COGNITIVE NEUROSCI, V20, P371, DOI 10.1162/jocn.2008.20.3.371; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Kim JG, 2011, CEREB CORTEX, V21, P1738, DOI 10.1093/cercor/bhq240; Kravitz DJ, 2011, J NEUROSCI, V31, P7322, DOI 10.1523/JNEUROSCI.4588-10.2011; Linsley D, 2015, CEREB CORTEX, V25, P2267, DOI 10.1093/cercor/bhu034; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; MacEvoy SP, 2011, NAT NEUROSCI, V14, P1323, DOI 10.1038/nn.2903; MacEvoy SP, 2009, CURR BIOL, V19, P943, DOI 10.1016/j.cub.2009.04.020; Mack ML, 2010, J VISION, V10, DOI 10.1167/10.3.11; McCotter M, 2005, VIS COGN, V12, P938, DOI 10.1080/13506280444000599; Mudrik L, 2010, NEUROPSYCHOLOGIA, V48, P507, DOI 10.1016/j.neuropsychologia.2009.10.011; Nagy K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024450; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oliva A, 2000, COGNITIVE PSYCHOL, V41, P176, DOI 10.1006/cogp.1999.0728; Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2; PALMER SE, 1975, MEM COGNITION, V3, P519, DOI 10.3758/BF03197524; POTTER MC, 1975, SCIENCE, V187, P965, DOI 10.1126/science.1145183; Reddy L, 2009, P NATL ACAD SCI USA, V106, P21447, DOI 10.1073/pnas.0907330106; Remy F, 2014, BRAIN COGNITION, V84, P34, DOI 10.1016/j.bandc.2013.10.008; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Stansbury DE, 2013, NEURON, V79, P1025, DOI 10.1016/j.neuron.2013.06.034	36	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e102819	10.1371/journal.pone.0102819	http://dx.doi.org/10.1371/journal.pone.0102819			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9BM	25119715	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600012
J	Mao, LJ; Liu, QY; Zhou, SW				Mao Liangjie; Liu Qingyou; Zhou Shouwei			Experimental Study of the Vortex-Induced Vibration of Drilling Risers under the Shear Flow with the Same Shear Parameter at the Different Reynolds Numbers	PLOS ONE			English	Article							CIRCULAR-CYLINDER; LOCK-IN; UNIFORM; FREQUENCY; SPHERE; MODEL; LONG	A considerable number of studies for VIV under the uniform flow have been performed. However, research on VIV under shear flow is scarce. An experiment for VIV under the shear flow with the same shear parameter at the two different Reynolds numbers was conducted in a deep-water offshore basin. Various measurements were obtained by the fiber bragg grating strain sensors. Experimental data were analyzed by modal analysis method. Results show several valuable features. First, the corresponding maximum order mode of the natural frequency for shedding frequency is the maximum dominant vibration mode and multi-modal phenomenon is appeared in VIV under the shear flow, and multi-modal phenomenon is more apparent at the same shear parameter with an increasing Reynolds number under the shear flow effect. Secondly, the riser vibrates at the natural frequency and the dominant vibration frequency increases for the effect of the real-time tension amplitude under the shear flow and the IL vibration frequency is the similar with the CF vibration frequency at the Reynolds number of 1105 in our experimental condition and the IL dominant frequency is twice the CF dominant frequency with an increasing Reynolds number. In addition, the displacement trajectories at the different locations of the riser appear the same shape and the shape is changed at the same shear parameter with an increasing Reynolds number under the shear flow. The diagonal displacement trajectories are observed at the low Reynolds number and the crescent-shaped displacement trajectories appear with an increasing Reynolds number under shear flow in the experiment.	[Mao Liangjie; Liu Qingyou] Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Sichuan, Peoples R China; [Zhou Shouwei] China Natl Offshore Oil Corp, Beijing, Peoples R China	Southwest Petroleum University; China National Offshore Oil Corporation (CNOOC)	Liu, QY (corresponding author), Southwest Petr Univ, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Sichuan, Peoples R China.	liuqy66@aliyun.com			National Natural Science Foundation of China [51274171]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Project supported by National Natural Science Foundation of China (Grant No 51274171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 1996, J FLUID STRUCT, V10, P197, DOI 10.1006/jfls.1996.0013; Chaplin JR, 2005, J FLUID STRUCT, V21, P25, DOI 10.1016/j.jfluidstructs.2005.05.016; Franzini GR, 2009, J FLUID STRUCT, V25, P742, DOI 10.1016/j.jfluidstructs.2009.01.003; Govardhan R, 2000, J FLUID MECH, V420, P85, DOI 10.1017/S0022112000001233; Govardhan R, 1997, J WIND ENG IND AEROD, V71, P375, DOI 10.1016/s0167-6105(97)00170-0; Huang K, 2012, INT J OFFSHORE POLAR, V22, P142; Jauvtis N, 2003, J FLUID STRUCT, V17, P1035, DOI 10.1016/S0889-9746(03)00051-3; JORDAN SK, 1972, PHYS FLUIDS, V15, P972, DOI 10.1063/1.1694058; Kang S, 2006, J FLUID STRUCT, V22, P541, DOI 10.1016/j.jfluidstructs.2006.02.003; Kiya M, 1980, J FLUID MECH, V141, P721; Kurose R, 1999, J FLUID MECH, V384, P183, DOI 10.1017/S0022112099004164; KWON TS, 1992, J FLUID ENG-T ASME, V114, P457, DOI 10.1115/1.2910053; Lei C, 2000, OCEAN ENG, V27, P271, DOI 10.1016/S0029-8018(98)00050-X; [李子丰 Li Zifeng], 2013, [振动、测试与诊断, Journal of Vibration, Measurement and Diagnosis], V33, P1003; Lie H, 2006, J FLUID STRUCT, V22, P557, DOI 10.1016/j.jfluidstructs.2006.01.002; [林琳 Lin Lin], 2013, [船舶力学, Journal of Ship Mechanics], V17, P901; Liu QY, 2014, J VIBROENG, V16, P1842; Marcollo H, 2006, J FLUID STRUCT, V22, P197, DOI 10.1016/j.jfluidstructs.2005.10.001; Raghavan K, 2011, OCEAN ENG, V38, P719, DOI 10.1016/j.oceaneng.2010.09.003; Sumner D, 2003, J FLUID STRUCT, V18, P441, DOI 10.1016/j.jfluidstructs.2003.08.004; Trim AD, 2005, J FLUID STRUCT, V21, P335, DOI 10.1016/j.jfluidstructs.2005.07.014; VANDIVER JK, 1993, J FLUID STRUCT, V7, P423, DOI 10.1006/jfls.1993.1028; Vandiver JK, 1996, J FLUID STRUCT, V10, P555, DOI 10.1006/jfls.1996.0037; Vikestad K, 2000, J FLUID STRUCT, V14, P1071, DOI 10.1006/jfls.2000.0308; Williamson CHK, 2008, J WIND ENG IND AEROD, V96, P713, DOI 10.1016/j.jweia.2007.06.019; Williamson C.H.K., 1988, J FLUIDS STRUCT, V2, P355, DOI [10.1016/S0889-9746(88)90058-8, DOI 10.1016/S0889-9746(88)90058-8, 10.1016/s0889-9746(88)90058-8]	27	2	3	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104806	10.1371/journal.pone.0104806	http://dx.doi.org/10.1371/journal.pone.0104806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118607	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600087
J	Tripathi, R; Benz, N; Culleton, B; Trouve, P; Ferec, C				Tripathi, Rashmi; Benz, Nathalie; Culleton, Bridget; Trouve, Pascal; Ferec, Claude			Biophysical Characterisation of Calumenin as a Charged F508del-CFTR Folding Modulator	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; CFTR; PROTEINS; AGGREGATION; CHANNEL; DESICCATION; MEMBRANE; DISORDER; ATP	The cystic fibrosis transmembrane regulator (CFTR) is a cyclic-AMP dependent chloride channel expressed at the apical surface of epithelial cells lining various organs such as the respiratory tract. Defective processing and functioning of this protein caused by mutations in the CFTR gene results in loss of ionic balance, defective mucus clearance, increased proliferation of biofilms and inflammation of human airways observed in cystic fibrosis (CF) patients. The process by which CFTR folds and matures under the influence of various chaperones in the secretory pathway remains incompletely understood. Recently, calumenin, a secretory protein, belonging to the CREC family of low affinity calcium binding proteins has been identified as a putative CFTR chaperone whose biophysical properties and functions remain uncharacterized. We compared hydropathy, instability, charge, unfoldability, disorder and aggregation propensity of calumenin and other CREC family members with CFTR associated chaperones and calcium binding proteins, wild-type and mutant CFTR proteins and intrinsically disordered proteins (IDPs). We observed that calumenin, along with other CREC proteins, was significantly more charged and less folded compared to CFTR associated chaperones. Moreover like IDPs, calumenin and other CREC proteins were found to be less hydrophobic and aggregation prone. Phylogenetic analysis revealed a close link between calumenin and other CREC proteins indicating how evolution might have shaped their similar biophysical properties. Experimentally, calumenin was observed to significantly reduce F508del-CFTR aggregation in a manner similar to AavLEA1, a well-characterized IDP. Fluorescence microscopy based imaging analysis also revealed altered trafficking of calumenin in bronchial cells expressing F508del-CFTR, indicating its direct role in the pathophysiology of CF. In conclusion, calumenin is characterized as a charged protein exhibiting close similarity with IDPs and is hypothesized to regulate F508del-CFTR folding by electrostatic effects. This work provides useful insights for designing optimized synthetic structural correctors of CFTR mutant proteins in the future.	[Tripathi, Rashmi; Benz, Nathalie; Trouve, Pascal; Ferec, Claude] INSERM, UMR1078, Brest, France; [Tripathi, Rashmi; Ferec, Claude] Univ Bretagne Occidentale, Fac Med & Sci Sante, Brest, France; [Benz, Nathalie] Assoc Gaetan Saleun, Brest, France; Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland; [Culleton, Bridget; Ferec, Claude] Hop Morvan, Lab Genet Mol & Histocompa, Brest, France; [Ferec, Claude] Etab Francais Sang Bretagne, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Maynooth University; CHU Brest; Universite de Bretagne Occidentale	Tripathi, R (corresponding author), INSERM, UMR1078, Brest, France.	rashmi_tripathi81@hotmail.com	Ferec, Claude/ABG-9699-2020	Ferec, Claude/0000-0002-2325-0710	Association Gaetan Saleun; French foundation Vaincre la Mucoviscidose, Conseil General de Bretagne; Inserm; Irish Research Council EMBARK	Association Gaetan Saleun; French foundation Vaincre la Mucoviscidose, Conseil General de Bretagne; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Irish Research Council EMBARK(Irish Research Council for Science, Engineering and Technology)	The authors thank the Association Gaetan Saleun, the French foundation Vaincre la Mucoviscidose, Conseil General de Bretagne (http://www.conseil-general.com/conseil-regional/conseil-regional-bretagne.htm) and Inserm (http://www.inserm.fr) for their financial support. BC was funded by an Irish Research Council EMBARK post-graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardwell JCA, 2012, TRENDS BIOCHEM SCI, V37, P517, DOI 10.1016/j.tibs.2012.08.006; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Boschetti C, 2011, J EXP BIOL, V214, P59, DOI 10.1242/jeb.050328; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Bruscia E, 2002, GENE THER, V9, P683, DOI 10.1038/sj.gt.3301741; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chakrabortee S, 2012, MOL BIOSYST, V8, P210, DOI 10.1039/c1mb05263b; Chakrabortee S, 2010, P NATL ACAD SCI USA, V107, P16084, DOI 10.1073/pnas.1006276107; Choi MY, 2005, J BIOL CHEM, V280, P4968, DOI 10.1074/jbc.M410069200; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Du K, 2009, MOL BIOL CELL, V20, P1903, DOI 10.1091/mbc.E08-09-0950; Egan ME, 2002, NAT MED, V8, P485, DOI 10.1038/nm0502-485; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; Feng H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.403; Fu LW, 2009, EUR J CELL BIOL, V88, P215, DOI 10.1016/j.ejcb.2008.11.003; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Grana-Montes R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00438; Hattori K, 2007, MOL GENET METAB, V91, P285, DOI 10.1016/j.ymgme.2007.02.003; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Hwang TC, 2009, J PHYSIOL-LONDON, V587, P2151, DOI 10.1113/jphysiol.2009.171595; Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799; Kovacs D, 2012, BIOCHEM SOC T, V40, P963, DOI 10.1042/BST20120108; Kumar V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S22; Lao O, 2003, EUR J HUM GENET, V11, P385, DOI 10.1038/sj.ejhg.5200970; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Maillard N, 2009, NAT PROTOC, V4, P132, DOI 10.1038/nprot.2008.241; Martins JR, 2011, BBA-MOL BASIS DIS, V1812, P1385, DOI 10.1016/j.bbadis.2011.08.008; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mehta A, 2005, PEDIATR PULM, V39, P292, DOI 10.1002/ppul.20147; Mekahli D, 2011, COLD SPRING HARB PER, V3; Neira JL, 2010, PROTEIN ENG DES SEL, V23, P507, DOI 10.1093/protein/gzq020; O'Ryan L, 2012, JOVE-J VIS EXP, P1; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Papp S, 2003, J CELL BIOL, V160, P475, DOI 10.1083/jcb.200207136; Pouchkina-Stantcheva NN, 2007, SCIENCE, V318, P268, DOI 10.1126/science.1144363; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; PRINCE LS, 1994, P NATL ACAD SCI USA, V91, P5192, DOI 10.1073/pnas.91.11.5192; Qadri YJ, 2012, J BIOL CHEM, V287, P16781, DOI 10.1074/jbc.M111.332031; Rathinakumar R, 2008, J AM CHEM SOC, V130, P9849, DOI 10.1021/ja8017863; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; REISIN IL, 1994, J BIOL CHEM, V269, P20584; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Strickland E, 1997, J BIOL CHEM, V272, P25421, DOI 10.1074/jbc.272.41.25421; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Sun F, 2008, FASEB J, V22, P3255, DOI 10.1096/fj.07-105338; Suzuki N, 2014, J BIOCHEM, V155, P281, DOI 10.1093/jb/mvu003; Teng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040173; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035344; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; YOO SH, 1994, J BIOL CHEM, V269, P12001; Yoo SH, 1996, J BIOL CHEM, V271, P1558; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	67	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104970	10.1371/journal.pone.0104970	http://dx.doi.org/10.1371/journal.pone.0104970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25120007	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600110
J	Vangoitsenhoven, R; Rondas, D; Crevecoeur, I; D'Hertog, W; Baatsen, P; Masini, M; Andjelkovic, M; Van Loco, J; Matthys, C; Mathieu, C; Overbergh, L; Van der Schueren, B				Vangoitsenhoven, Roman; Rondas, Dieter; Crevecoeur, Inne; D'Hertog, Wannes; Baatsen, Pieter; Masini, Matilde; Andjelkovic, Mirjana; Van Loco, Joris; Matthys, Christophe; Mathieu, Chantal; Overbergh, Lut; Van der Schueren, Bart			Foodborne Cereulide Causes Beta-Cell Dysfunction and Apoptosis	PLOS ONE			English	Article							BACILLUS-CEREUS; EMETIC TOXIN; ESTABLISHMENT; PREVALENCE; LANGERHANS; RESISTANCE; TOXICITY; RICE	Aims/Hypothesis: To study the effects of cereulide, a food toxin often found at low concentrations in take-away meals, on beta-cell survival and function. Methods: Cell death was quantified by Hoechst/Propidium Iodide in mouse (MIN6) and rat (INS-1E) beta-cell lines, whole mouse islets and control cell lines (HepG2 and COS-1). Beta-cell function was studied by glucose-stimulated insulin secretion (GSIS). Mechanisms of toxicity were evaluated in MIN6 cells by mRNA profiling, electron microscopy and mitochondrial function tests. Results: 24 h exposure to 5 ng/ml cereulide rendered almost all MIN6, INS-1E and pancreatic islets apoptotic, whereas cell death did not increase in the control cell lines. In MIN6 cells and murine islets, GSIS capacity was lost following 24 h exposure to 0.5 ng/ml cereulide (P < 0.05). Cereulide exposure induced markers of mitochondrial stress including Puma (p53 up-regulated modulator of apoptosis, P < 0.05) and general pro-apoptotic signals as Chop (CCAAT/-enhancer-binding protein homologous protein). Mitochondria appeared swollen upon transmission electron microscopy, basal respiration rate was reduced by 52% (P < 0.05) and reactive oxygen species increased by more than twofold (P < 0.05) following 24 h exposure to 0.25 and 0.50 ng/ml cereulide, respectively. Conclusions/Interpretation: Cereulide causes apoptotic beta-cell death at low concentrations and impairs beta-cell function at even lower concentrations, with mitochondrial dysfunction underlying these defects. Thus, exposure to cereulide even at concentrations too low to cause systemic effects appears deleterious to the beta-cell.	[Vangoitsenhoven, Roman; Rondas, Dieter; Crevecoeur, Inne; D'Hertog, Wannes; Matthys, Christophe; Mathieu, Chantal; Overbergh, Lut; Van der Schueren, Bart] Katholieke Univ Leuven, Lab Clin & Expt Med & Endocrinol, Leuven, Belgium; [Baatsen, Pieter] Katholieke Univ Leuven, VIB Bio Imaging Core, EM Facil, Leuven, Belgium; [Baatsen, Pieter] Katholieke Univ Leuven, VIB Dept Biol Dis, Leuven, Belgium; [Masini, Matilde] Univ Pisa, Dept Translat Res & New Surg & Med Technol, Pisa, Italy; [Andjelkovic, Mirjana; Van Loco, Joris] Sci Inst Publ Hlth, Brussels, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Pisa	Van der Schueren, B (corresponding author), Katholieke Univ Leuven, Lab Clin & Expt Med & Endocrinol, Leuven, Belgium.	bart.vanderschueren@uzleuven.be	mathieu, chantal/ABD-5505-2021; Overbergh, Lut/AAC-3515-2020; Matthys, Christophe/I-4203-2016; Vangoitsenhoven, Roman/B-3196-2018	mathieu, chantal/0000-0002-4055-5233; Matthys, Christophe/0000-0003-1770-6862; Vangoitsenhoven, Roman/0000-0003-3523-669X; Van der Schueren, Bart/0000-0003-4754-784X; Andjelkovic, Mirjana/0000-0002-3504-7066; Van Loco, Joris/0000-0001-8439-3371	Flemish Research Foundation [G.0857.13]; University of Leuven [GOA 13/006, IOF KP/12012]; Flemish Research Foundation (FWO); Agency for Innovation of Science and Technology (IWT) [121086]	Flemish Research Foundation(FWO); University of Leuven(KU Leuven); Flemish Research Foundation (FWO)(FWO); Agency for Innovation of Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This research was supported by grants from the Flemish Research Foundation (G.0857.13, www.fwo.be) and the University of Leuven (GOA 13/006 and IOF KP/12012, www.kuleuven.be/research/funding). C. Mathieu has a clinical research fellowship and W. D'Hertog a postdoctoral fellowship from the Flemish Research Foundation (FWO). I. Crevecoeur has a grant from the Agency for Innovation of Science and Technology (IWT, 121086, www.IWT.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata N, 2002, INT J FOOD MICROBIOL, V73, P23, DOI 10.1016/S0168-1605(01)00692-4; AGATA N, 1994, FEMS MICROBIOL LETT, V121, P31, DOI 10.1016/0378-1097(94)90141-4; Andersson MA, 2007, TOXICON, V49, P351, DOI 10.1016/j.toxicon.2006.10.006; Andreoletti O, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2662; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Boonen K, 2007, GEN COMP ENDOCR, V152, P231, DOI 10.1016/j.ygcen.2007.05.002; Carpenter David O., 2008, Reviews on Environmental Health, V23, P59; Delbrassinne L, 2012, FOODBORNE PATHOG DIS, V9, P809, DOI 10.1089/fpd.2012.1168; Delbrassinne L, 2011, FOOD MICROBIOL, V28, P1105, DOI 10.1016/j.fm.2011.02.014; Eelen G, 2005, MOL PHARMACOL, V67, P1566, DOI 10.1124/mol.104.008730; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Hectors TLM, 2011, DIABETOLOGIA, V54, P1273, DOI 10.1007/s00125-011-2109-5; Hoornstra D, 2013, APPL ENVIRON MICROB, V79, P3534, DOI 10.1128/AEM.00201-13; Hu EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1454; Imagawa A, 2000, NEW ENGL J MED, V342, P301, DOI 10.1056/NEJM200002033420501; Jaaskelainen EL, 2003, TOXICOL IN VITRO, V17, P737, DOI 10.1016/S0887-2333(03)00096-1; Kawamura-Sato K, 2005, MICROBIOL IMMUNOL, V49, P25, DOI 10.1111/j.1348-0421.2005.tb03636.x; Mahler H, 1997, NEW ENGL J MED, V336, P1142, DOI 10.1056/NEJM199704173361604; Messelhausser U, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/465603; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Naranjo M, 2011, J CLIN MICROBIOL, V49, P4379, DOI 10.1128/JCM.05129-11; Paananen A, 2002, CLIN EXP IMMUNOL, V129, P420, DOI 10.1046/j.1365-2249.2002.01898.x; Rajkovic A, 2008, LETT APPL MICROBIOL, V46, P536, DOI 10.1111/j.1472-765X.2008.02350.x; Ramachandran A, 2012, WORLD J DIABETES, V3, P110, DOI 10.4239/wjd.v3.i6.110; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Schuit F, 2012, DIABETES, V61, P969, DOI 10.2337/db11-1564; Shaheen R, 2006, INT J FOOD MICROBIOL, V107, P287, DOI 10.1016/j.ijfoodmicro.2005.10.007; SHINAGAWA K, 1995, FEMS MICROBIOL LETT, V130, P87, DOI 10.1016/0378-1097(95)00188-B; Shiota M, 2010, PEDIATRICS, V125, pE951, DOI 10.1542/peds.2009-2319; van Malensteina H, 2012, CANCER LETT, V315, P178, DOI 10.1016/j.canlet.2011.09.039; Virtanen SM, 2008, TOXICON, V51, P1029, DOI 10.1016/j.toxicon.2008.01.019; Yokoyama K, 1999, FEMS IMMUNOL MED MIC, V24, P115, DOI 10.1016/S0928-8244(99)00017-6; Zuniga YLM, 2014, BRIT J NUTR, V111, P1118, DOI 10.1017/S0007114513003486	34	28	31	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104866	10.1371/journal.pone.0104866	http://dx.doi.org/10.1371/journal.pone.0104866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119564	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600094
J	Zhang, YF; Wei, LF; Wu, CT; Miron, RJ				Zhang, Yufeng; Wei, Lingfei; Wu, Chengtie; Miron, Richard J.			Periodontal Regeneration Using Strontium-Loaded Mesoporous Bioactive Glass Scaffolds in Osteoporotic Rats	PLOS ONE			English	Article							MARROW STROMAL CELLS; POSTMENOPAUSAL WOMEN; RANELATE; DIFFERENTIATION; RISK; INVOLVEMENT; DELIVERY; REPAIR; OSTEOCLASTOGENESIS; OSSEOINTEGRATION	Recent studies demonstrate that the rate of periodontal breakdown significantly increased in patients compromised from both periodontal disease and osteoporosis. One pharmacological agent used for their treatment is strontium renalate due to its simultaneous ability to increase bone formation and halt bone resorption. The aim of the present study was to achieve periodontal regeneration of strontium-incorporated mesoporous bioactive glass (Sr-MBG) scaffolds in an osteoporotic animal model carried out by bilateral ovariectomy (OVX). 15 female Wistar rats were randomly assigned to three groups: control unfilled periodontal defects, 2) MBG alone and 3) Sr-MBG scaffolds. 10 weeks after OVX, bilateral fenestration defects were created at the buccal aspect of the first mandibular molar and assessed by micro-CT and histomorphometric analysis after 28 days. Periodontal fenestration defects treated with Sr-MBG scaffolds showed greater new bone formation (46.67%) when compared to MBG scaffolds (39.33%) and control unfilled samples (17.50%). The number of TRAP-positive osteoclasts was also significantly reduced in defects receiving Sr-MBG scaffolds. The results from the present study suggest that Sr-MBG scaffolds may provide greater periondontal regeneration. Clinical studies are required to fully characterize the possible beneficial effect of Sr-releasing scaffolds for patients suffering from a combination of both periodontal disease and osteoporosis.	[Zhang, Yufeng; Wei, Lingfei; Miron, Richard J.] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China; [Zhang, Yufeng; Wei, Lingfei; Miron, Richard J.] Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Wuhan 430072, Peoples R China; [Wu, Chengtie] Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai, Peoples R China; [Miron, Richard J.] Univ Laval, Fac Med Dentaire, Quebec City, PQ, Canada	Wuhan University; Wuhan University; Chinese Academy of Sciences; Shanghai Institute of Ceramics, CAS; Laval University	Wu, CT (corresponding author), Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai, Peoples R China.	chengtiewu@mail.sic.ac.cn; richard.miron@zmk.unibe.ch	Wei, Lingfei/AAM-4323-2020; Zhang, Yufeng/GZL-1973-2022		Program for New Century Excellent Talents in University [NCET-11-0414]; Excellent Youth Foundation of Hubei; Shanghai Pujiang Talent Program [12PJ1409500]; Natural Science Foundation of China [31370963]; National Natural Science Foundation of China [81271108]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Excellent Youth Foundation of Hubei; Shanghai Pujiang Talent Program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by Program for New Century Excellent Talents in University (NCET-11-0414), Excellent Youth Foundation of Hubei and the funds of the National Natural Science Foundation of China (81271108). Shanghai Pujiang Talent Program (12PJ1409500) and Natural Science Foundation of China (Grant 31370963). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann P, 2007, J BONE MINER RES, V22, P1419, DOI 10.1359/jbmr.070607; Andersen OZ, 2013, BIOMATERIALS, V34, P5883, DOI 10.1016/j.biomaterials.2013.04.031; Baier M, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-16; Berglund IS, 2012, J BIOMED MATER RES B, V100B, P1524, DOI 10.1002/jbm.b.32721; Blake GM, 2009, J BONE MINER RES, V24, P1354, DOI [10.1359/JBMR.090601, 10.1359/jbmr.090601]; Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043; Boonen S, 2012, J BONE MINER RES, V27, P963, DOI 10.1002/jbmr.1570; Brauer DS, 2012, J R SOC INTERFACE; Caudrillier A, 2010, MOL PHARMACOL, V78, P569, DOI 10.1124/mol.109.063347; Chattopadhyay N, 2007, BIOCHEM PHARMACOL, V74, P438, DOI 10.1016/j.bcp.2007.04.020; Cheng N, 2013, J MATER SCI-MATER M, V24, P1963, DOI 10.1007/s10856-013-4945-y; Choudhary S, 2007, J BONE MINER RES, V22, P1002, DOI 10.1359/JBMR.070321; Chung CJ, 2011, ACTA BIOMATER, V7, P4081, DOI 10.1016/j.actbio.2011.07.004; Fu DL, 2012, J ZHEJIANG UNIV-SC B, V13, P364, DOI 10.1631/jzus.B1100381; Gallacher SJ, 2010, CALCIFIED TISSUE INT, V87, P469, DOI 10.1007/s00223-010-9420-x; Genant HK, 1999, OSTEOPOROSIS INT, V10, P259, DOI 10.1007/s001980050224; Han L, 2011, DENT MAT J; Hao J, 2015, CLIN ORAL IMPLAN RES, V26, P1, DOI 10.1111/clr.12289; Li X, 2008, J BIOMED MATER RES A, V84A, P84, DOI 10.1002/jbm.a.31371; Lopa S, 2013, J BIOMED MAT RES A; Marie PJ, 2010, MOL INTERV, V10, P305, DOI 10.1124/mi.10.5.7; Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055; Mentaverri Romuald, 2012, Curr Mol Pharmacol, V5, P189; Meunier PJ, 2002, J CLIN ENDOCR METAB, V87, P2060, DOI 10.1210/jc.87.5.2060; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Miron RJ, 2014, J PERIODONTOL, P1; Mohan BG, 2013, J BIOMED MATER RES A, V101, P261, DOI 10.1002/jbm.a.34324; Passos JD, 2010, J PERIODONTOL, V81, P1773, DOI 10.1902/jop.2010.100143; Pei LM, 2004, J CLIN INVEST, V113, P805, DOI 10.1172/JCI200421311; Peng SL, 2011, BONE, V49, P1290, DOI 10.1016/j.bone.2011.08.031; Peng SL, 2011, J BONE MINER RES, V26, P1272, DOI 10.1002/jbmr.325; Qiu K, 2006, BIOMATERIALS, V27, P1277, DOI 10.1016/j.biomaterials.2005.08.006; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Rizzoli Rene, 2011, Expert Rev Clin Pharmacol, V4, P593; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Roy M, 2012, J BIOMED MATER RES A, V100A, P2450, DOI 10.1002/jbm.a.34181; Sakai A, 2012, DENT MATER J, V31, P197, DOI 10.4012/dmj.2011-177; Seeman E, 2008, J BONE MINER RES, V23, P433, DOI 10.1359/JBMR.071105; Silva BC, 2011, ANNU REV MED, V62, P307, DOI 10.1146/annurev-med-061709-145401; Sultan N, 2011, MED ORAL PATOL ORAL, V16, pE440, DOI 10.4317/medoral.16.e440; Verberckmoes SC, 2003, KIDNEY INT, V64, P534, DOI 10.1046/j.1523-1755.2003.00123.x; VONWOWERN N, 1994, J PERIODONTOL, V65, P1134, DOI 10.1902/jop.1994.65.12.1134; Wei L, 2014, OSTEOPOROS INT; Wu CT, 2012, ACTA BIOMATER, V8, P3805, DOI 10.1016/j.actbio.2012.06.023; Wu CT, 2011, ACTA BIOMATER, V7, P2229, DOI 10.1016/j.actbio.2010.12.019; Wu C, 2009, BIOMATERIALS, V30, P2199, DOI 10.1016/j.biomaterials.2009.01.029; Yamaguchi M, 2012, MOL CELL BIOCHEM, V359, P399, DOI 10.1007/s11010-011-1034-8; Yan XX, 2006, BIOMATERIALS, V27, P3396, DOI 10.1016/j.biomaterials.2006.01.043; Yang GL, 2012, INT J ORAL MAX IMPL, V27, P1332; Zhang YF, 2013, J MATER CHEM B, V1, P5711, DOI 10.1039/c3tb21047b; Zhang YF, 2012, BIOMATERIALS, V33, P6698, DOI 10.1016/j.biomaterials.2012.06.021; Zhao M, 2004, J PERIODONTOL, V75, P154, DOI 10.1902/jop.2004.75.1.154	52	30	30	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104527	10.1371/journal.pone.0104527	http://dx.doi.org/10.1371/journal.pone.0104527			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116811	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400054
J	Derer, A; Groetsch, B; Harre, U; Bohm, C; Towne, J; Schett, G; Frey, S; Hueber, AJ				Derer, Anja; Groetsch, Bettina; Harre, Ulrike; Boehm, Christina; Towne, Jennifer; Schett, Georg; Frey, Silke; Hueber, Axel J.			Blockade of IL-36 Receptor Signaling Does Not Prevent from TNF-Induced Arthritis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; BONE LOSS; OSTEOCLAST FORMATION; IN-VITRO; INFLAMMATION; PSORIASIS; INTERLEUKIN-1; INHIBITION; LIGANDS; MEMBERS	Introduction: Interleukin (IL)-36 alpha is a newly described member of the IL-1 cytokine family with a known inflammatory and pathogenic function in psoriasis. Recently, we could demonstrate that the receptor (IL-36R), its ligand IL-36 alpha and its antagonist IL-36Ra are expressed in synovial tissue of arthritis patients. Furthermore, IL-36 alpha induces MAP-kinase and NF kappa B signaling in human synovial fibroblasts with subsequent expression and secretion of pro-inflammatory cytokines. Methods: To understand the pathomechanism of IL-36 dependent inflammation, we investigated the biological impact of IL-36 alpha signaling in the hTNFtg mouse. Also the impact on osteoclastogenesis by IL-36 alpha was tested in murine and human osteoclast assays. Results: Diseased mice showed an increased expression of IL-36R and IL-36 alpha in inflamed knee joints compared to wildtype controls. However, preventively treating mice with an IL-36R blocking antibody led to no changes in clinical onset and pattern of disease. Furthermore, blockade of IL-36 signaling did not change histological signs of TNF-induced arthritis. Additionally, no alteration on bone homeostasis was observed in ex vivo murine and human osteoclast differentiation assays. Conclusion: Thus we conclude that IL-36 alpha does not affect the development of inflammatory arthritis.	[Derer, Anja; Groetsch, Bettina; Harre, Ulrike; Boehm, Christina; Schett, Georg; Frey, Silke; Hueber, Axel J.] Univ Hosp Erlangen, Dept Internal Med 3, Erlangen, Germany; [Derer, Anja; Groetsch, Bettina; Harre, Ulrike; Boehm, Christina; Schett, Georg; Frey, Silke; Hueber, Axel J.] Univ Hosp Erlangen, Inst Clin Immunol, Erlangen, Germany; [Derer, Anja] Univ Hosp Erlangen, Dept Radiat Oncol, Erlangen, Germany; [Towne, Jennifer] Amgen Inc, Dept Inflammat Res, Longmont, CO USA	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Amgen	Hueber, AJ (corresponding author), Univ Hosp Erlangen, Dept Internal Med 3, Erlangen, Germany.	axel.hueber@uk-erlangen.de		Frey, Silke/0000-0001-9411-8357; Steffen, Ulrike/0000-0003-2934-3202; Hueber, Axel/0000-0001-6454-1234	German Science Foundation [SFB463, SPP1468, GK1660]; EU project Masterswitch; IMI funded project BTCure; Marie Curie project OSTEOIMMUNE; EU project TEAM	German Science Foundation(German Research Foundation (DFG)); EU project Masterswitch; IMI funded project BTCure; Marie Curie project OSTEOIMMUNE; EU project TEAM	The study was supported by the German Science Foundation (projects SFB463, SPP1468, and GK1660), the EU projects Masterswitch and TEAM, the IMI funded project BTCure, and the Marie Curie project OSTEOIMMUNE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axmann R, 2008, ANN RHEUM DIS, V67, P1603, DOI 10.1136/ard.2007.080713; Axmann R, 2009, ARTHRITIS RHEUM-US, V60, P2747, DOI 10.1002/art.24781; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Frey S, 2013, ANN RHEUM DIS; Gortz B, 2004, J BONE MINER RES, V19, P990, DOI 10.1359/JBMR.040205; Herrak P, 2004, ARTHRITIS RHEUM-US, V50, P2327, DOI 10.1002/art.20384; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Lamacchia C, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4192; Magne D, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1946; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Ochi S, 2007, P NATL ACAD SCI USA, V104, P11394, DOI 10.1073/pnas.0701971104; Redlich K, 2004, ARTHRITIS RHEUM, V50, P1001, DOI 10.1002/art.20194; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Towne JE, 2012, CURR OPIN PHARM; Vigne S, 2011, BLOOD, V118, P5813, DOI 10.1182/blood-2011-05-356873; Zwerina J, 2004, ARTHRITIS RHEUM, V50, P277, DOI 10.1002/art.11487; Zwerina K, 2012, EUR J IMMUNOL, V42, P413, DOI 10.1002/eji.201141871	19	38	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e101954	10.1371/journal.pone.0101954	http://dx.doi.org/10.1371/journal.pone.0101954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111378	Green Submitted, Green Published, gold			2022-12-27	WOS:000341105100005
J	Fernandez, ER; Olivera, GC; Palacio, LPQ; Gonzalez, MN; Hernandez-Vasquez, Y; Sirena, NM; Moran, ML; Patino, OSL; Postan, M				Fernandez, Esteban R.; Olivera, Gabriela C.; Quebrada Palacio, Luz P.; Gonzalez, Mariela N.; Hernandez-Vasquez, Yolanda; Maria Sirena, Natalia; Moran, Maria L.; Ledesma Patino, Oscar S.; Postan, Miriam			Altered Distribution of Peripheral Blood Memory B Cells in Humans Chronically Infected with Trypanosoma cruzi	PLOS ONE			English	Article							SOLUBLE CD27; CHAGASIC PATIENTS; ACTIVATED T; RESPONSES; DIFFERENTIATION; LYMPHOCYTES; EXPRESSION; RELEASE; DISEASE; IDENTIFICATION	Numerous abnormalities of the peripheral blood T cell compartment have been reported in human chronic Trypanosoma cruzi infection and related to prolonged antigenic stimulation by persisting parasites. Herein, we measured circulating lymphocytes of various phenotypes based on the differential expression of CD19, CD4, CD27, CD10, IgD, IgM, IgG and CD138 in a total of 48 T. cruzi-infected individuals and 24 healthy controls. Infected individuals had decreased frequencies of CD19+CD27+ cells, which positively correlated with the frequencies of CD4+CD27+ cells. The contraction of CD19+CD27+ cells was comprised of IgG+IgD-, IgM+IgD- and isotype switched IgM-IgD- memory B cells, CD19+CD10+CD27+ B cell precursors and terminally differentiated CD19+CD27+CD138+ plasma cells. Conversely, infected individuals had increased proportions of CD19+IgG+CD27-IgD- memory and CD19+IgM+CD27-IgD+ transitional/naive B cells. These observations prompted us to assess soluble CD27, a molecule generated by the cleavage of membrane-bound CD27 and used to monitor systemic immune activation. Elevated levels of serum soluble CD27 were observed in infected individuals with Chagas cardiomyopathy, indicating its potentiality as an immunological marker for disease progression in endemic areas. In conclusion, our results demonstrate that chronic T. cruzi infection alters the distribution of various peripheral blood B cell subsets, probably related to the CD4+ T cell deregulation process provoked by the parasite in humans.	[Fernandez, Esteban R.; Olivera, Gabriela C.; Quebrada Palacio, Luz P.; Gonzalez, Mariela N.; Hernandez-Vasquez, Yolanda; Postan, Miriam] Inst Nacl Parasitol Dr Mario Fatala Chaben, Dept Invest, Buenos Aires, DF, Argentina; [Fernandez, Esteban R.; Olivera, Gabriela C.; Gonzalez, Mariela N.; Postan, Miriam] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Maria Sirena, Natalia; Moran, Maria L.; Ledesma Patino, Oscar S.] Hosp Independencia, Ctr Enfermedad Chagas & Patol Reg, Santiago Del Estero, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Postan, M (corresponding author), Inst Nacl Parasitol Dr Mario Fatala Chaben, Dept Invest, Buenos Aires, DF, Argentina.	miriampostan@yahoo.com		Olivera, Gabriela Carina/0000-0002-0179-4880; GONZALEZ, MARIELA NATACHA/0000-0002-7274-4282	Ministerio de Ciencia, Tecnologia e Innovacion Productiva/Fondo para la Investigacion Cientifica y Tecnologica (FONCyT), Argentina [PICT-2007-01732, PICT-2010-02148]; Consejo Nacional de Investigaciones Cientificas y Tecnicas	Ministerio de Ciencia, Tecnologia e Innovacion Productiva/Fondo para la Investigacion Cientifica y Tecnologica (FONCyT), Argentina; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Ministerio de Ciencia, Tecnologia e Innovacion Productiva/Fondo para la Investigacion Cientifica y Tecnologica (FONCyT), Argentina [PICT-2007-01732 and PICT-2010-02148 to MP]. Consejo Nacional de Investigaciones Cientificas y Tecnicas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2006, J IMMUNOL METHODS, V317, P175, DOI 10.1016/j.jim.2006.09.005; Arguello RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035966; Atlas A, 2004, J MED VIROL, V72, P345, DOI 10.1002/jmv.20006; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; Bohnhorst JO, 2002, CLIN IMMUNOL, V103, P79, DOI 10.1006/clim.2002.5199; Caraux A, 2010, HAEMATOL-HEMATOL J, V95, P1016, DOI 10.3324/haematol.2009.018689; Cardillo F, 2007, IMMUNOLOGY, V122, P584, DOI 10.1111/j.1365-2567.2007.02677.x; Albareda MC, 2009, J IMMUNOL, V183, P4103, DOI 10.4049/jimmunol.0900852; Cobo ED, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/232646; Cordeiro FD, 2001, CLIN DIAGN LAB IMMUN, V8, P112, DOI 10.1128/CDLI.8.1.112-118.2001; Croft M, 2012, TRENDS IMMUNOL, V33, P144, DOI 10.1016/j.it.2011.10.004; Cunha-Neto E, 2011, ADV PARASIT, V76, P129, DOI 10.1016/B978-0-12-385895-5.00006-2; Dekkers PEP, 2000, INFECT IMMUN, V68, P3036, DOI 10.1128/IAI.68.5.3036-3039.2000; Denoeud J, 2011, J LEUKOCYTE BIOL, V89, P195, DOI 10.1189/jlb.0610351; dos Santos DM, 2009, EXP PARASITOL, V121, P8, DOI 10.1016/j.exppara.2008.09.012; Dutra WO, 1996, SCAND J IMMUNOL, V43, P88, DOI 10.1046/j.1365-3083.1996.d01-9.x; Dutra WO, 2000, SCAND J IMMUNOL, V51, P91; DUTRA WO, 1994, INT IMMUNOL, V6, P499, DOI 10.1093/intimm/6.4.499; Fares RCG, 2013, PARASITE IMMUNOL, V35, P214, DOI 10.1111/pim.12038; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Giraldo NA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002038; GRAUERT MR, 1993, CLIN EXP IMMUNOL, V93, P85, DOI 10.1111/j.1365-2249.1993.tb06501.x; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; HINTZEN RQ, 1991, J IMMUNOL, V147, P29; Huang JP, 2013, J IMMUNOL, V190, P6250, DOI 10.4049/jimmunol.1300022; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Kato K, 2007, EXP HEMATOL, V35, P434, DOI 10.1016/j.exphem.2006.10.018; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Klinker MW, 2012, MOL MED, V18, P123, DOI 10.2119/molmed.2011.00333; Krettli AU, 2009, MEM I OSWALDO CRUZ, V104, P142, DOI 10.1590/S0074-02762009000900020; Kumar S, 1998, PARASITE IMMUNOL, V20, P207, DOI 10.1046/j.1365-3024.1998.00154.x; KUSCHNIR E, 1985, Arquivos Brasileiros de Cardiologia, V45, P249; Laucella SA, 2009, CLIN INFECT DIS, V49, P1675, DOI 10.1086/648072; LOENEN WAM, 1992, EUR J IMMUNOL, V22, P447, DOI 10.1002/eji.1830220224; Machado FS, 2012, SEMIN IMMUNOPATHOL, V34, P753, DOI 10.1007/s00281-012-0351-7; MINOPRIO P, 1988, SCAND J IMMUNOL, V28, P553, DOI 10.1111/j.1365-3083.1988.tb01487.x; Olivera GC, 2010, MICROBES INFECT, V12, P359, DOI 10.1016/j.micinf.2010.01.011; Piedras J, 1997, CYTOMETRY, V30, P28, DOI 10.1002/(SICI)1097-0320(19970215)30:1<28::AID-CYTO4>3.0.CO;2-B; POSTAN M, 1987, AM J TROP MED HYG, V37, P541, DOI 10.4269/ajtmh.1987.37.541; Ramirez G, 2011, TRENDS PARASITOL, V27, P115, DOI 10.1016/j.pt.2010.12.007; REIS DD, 1993, AM J TROP MED HYG, V48, P637, DOI 10.4269/ajtmh.1993.48.637; Rodrigues V, 2008, MICROBES INFECT, V10, P29, DOI 10.1016/j.micinf.2007.09.015; Seifert M, 2009, J EXP MED, V206, P2659, DOI 10.1084/jem.20091087; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Tangye SG, 2013, BLOOD, V121, P5109, DOI 10.1182/blood-2013-05-500074; Taylor JJ, 2012, TRENDS IMMUNOL, V33, P590, DOI 10.1016/j.it.2012.07.005; VANOERS MHJ, 1993, BLOOD, V82, P3430; Vaskova M, 2008, TISSUE ANTIGENS, V71, P57, DOI 10.1111/j.1399-0039.2007.00968.x; Vicco MH, 2013, REV ESP CARDIOL, V66, P791, DOI [10.1016/j.rec.2013.05.028, 10.1016/j.recesp.2013.05.028]; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Weller S, 2008, J EXP MED, V205, P1331, DOI 10.1084/jem.20071555; Weller S, 2012, BLOOD, V120, P4992, DOI 10.1182/blood-2012-07-440776; Wu YCB, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00081; Yuseff MI, 2013, NAT REV IMMUNOL, V13, P475, DOI 10.1038/nri3469; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009; Zuniga E, 2005, EUR J IMMUNOL, V35, P1849, DOI 10.1002/eji.200526005; Zuniga E, 2002, J IMMUNOL, V168, P3965, DOI 10.4049/jimmunol.168.8.3965	59	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104951	10.1371/journal.pone.0104951	http://dx.doi.org/10.1371/journal.pone.0104951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111833	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100115
J	Johansson, MA; Powers, AM; Pesik, N; Cohen, NJ; Staples, JE				Johansson, Michael A.; Powers, Ann M.; Pesik, Nicki; Cohen, Nicole J.; Staples, J. Erin			Nowcasting the Spread of Chikungunya Virus in the Americas	PLOS ONE			English	Article							AEDES-AEGYPTI; INDIAN-OCEAN; SEROPREVALENCE; INFECTION; FEVER; ALBOPICTUS; OUTBREAK; ISLAND; RISK; SUSCEPTIBILITY	Background: In December 2013, the first locally-acquired chikungunya virus (CHIKV) infections in the Americas were reported in the Caribbean. As of May 16, 55,992 cases had been reported and the outbreak was still spreading. Identification of newly affected locations is paramount to intervention activities, but challenging due to limitations of current data on the outbreak and on CHIKV transmission. We developed models to make probabilistic predictions of spread based on current data considering these limitations. Methods and Findings: Branching process models capturing travel patterns, local infection prevalence, climate dependent transmission factors, and associated uncertainty estimates were developed to predict probable locations for the arrival of CHIKV-infected travelers and for the initiation of local transmission. Many international cities and areas close to where transmission has already occurred were likely to have received infected travelers. Of the ten locations predicted to be the most likely locations for introduced CHIKV transmission in the first four months of the outbreak, eight had reported local cases by the end of April. Eight additional locations were likely to have had introduction leading to local transmission in April, but with substantial uncertainty. Conclusions: Branching process models can characterize the risk of CHIKV introduction and spread during the ongoing outbreak. Local transmission of CHIKV is currently likely in several Caribbean locations and possible, though uncertain, for other locations in the continental United States, Central America, and South America. This modeling framework may also be useful for other outbreaks where the risk of pathogen spread over heterogeneous transportation networks must be rapidly assessed on the basis of limited information.	[Johansson, Michael A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR 00937 USA; [Powers, Ann M.; Staples, J. Erin] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA; [Pesik, Nicki; Cohen, Nicole J.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Johansson, MA (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR 00937 USA.	mjohansson@cdc.gov		Johansson, Michael/0000-0002-5090-7722				ANDERSON R M, 1991; Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x; Boelle PY, 2008, VECTOR-BORNE ZOONOT, V8, P207, DOI 10.1089/vbz.2006.0620; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; Centers for Disease Control and Prevention, 2014, CHIK AM; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Chursi S, 2014, AM J TROP MED HYG, V90, P410, DOI 10.4269/ajtmh.12-0681; Cire Antilles Guyane, 2014, CHIK ANT GUYAN; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99; Government of the Virgin Islands, 2014, 3 CAS CHICK CONF VIR; Guyane Cire Antilles, 2014, CHIKUNGUNYA ANTILLES; Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; Laurent P, 2007, CLIN CHEM, V53, P1408, DOI 10.1373/clinchem.2007.086595; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08; Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x; Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322; Pan American Health Organization, 2014, NUMB REP CAS CHIK FE; Pan American Health Organization, 2014, CUM NUMB REP CAS CHI, V1; Pesko K, 2009, J MED ENTOMOL, V46, P395, DOI 10.1603/033.046.0228; Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189; SINGH KRP, 1967, ACTA VIROL, V11, P517; Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066; Staples E, 2011, PREPAREDNESS RESPONS; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108; TURELL MJ, 1992, J MED ENTOMOL, V29, P49, DOI 10.1093/jmedent/29.1.49; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448	35	86	86	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104915	10.1371/journal.pone.0104915	http://dx.doi.org/10.1371/journal.pone.0104915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111394	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100109
J	Liang, SQ; Chen, XL; Deng, JM; Wei, X; Gong, C; Chen, ZR; Wang, ZB				Liang, Si-Qiao; Chen, Xiao-Li; Deng, Jing-Min; Wei, Xuan; Gong, Chen; Chen, Zhang-Rong; Wang, Zhi-Bo			Beta-2 Adrenergic Receptor (ADRB2) Gene Polymorphisms and the Risk of Asthma: A Meta-Analysis of Case-Control Studies	PLOS ONE			English	Article							BETA(2)-ADRENERGIC RECEPTOR; CANDIDATE GENES; LEADER CISTRON; ASSOCIATION; GENOTYPES; CHILDREN; BETA(2)-AGONISTS; DISEQUILIBRIUM; SUSCEPTIBILITY; FREQUENCIES	Background and Objective: A number of studies have assessed the relationship between beta-2 adrenergic receptor (ADRB2) gene polymorphisms and asthma risk. However, the results are inconsistent. A meta-analysis that focused on the association between asthma and all ADRB2 polymorphisms with at least three case-control studies was thus performed. Methods: A literature search of the PubMed, Embase, Web of Science, CNKI, and Wangfang databases was conducted. Odds ratios with 95% confidence intervals were used to assess the strength of associations. Results: Arg16Gly, Gln27Glu, Thr164Ile, and Arg19Cys single nucleotide polymorphisms (SNPs) were identified in 46 case-control studies. The results showed that not all of the SNPs were associated with asthma in the overall population. Significant associations were found for the Arg16Gly polymorphism in the South American population via dominant model comparison (OR = 1.754, 95% CI = 1.179-2.609, I-2 = 16.9%, studies = 2, case = 314, control = 237) in an analysis stratified by ethnicity. For the Gln27Glu polymorphism, a protective association was found in children via recessive model comparison (OR = 0.566, 95% CI = 0.417-0.769, I-2 = 0.0%, studies = 11, case = 1693, control = 502) and homozygote genotype comparison (OR = 0.610, 95% CI = 0.434-0.856, I-2 = 0.0%, studies = 11, case = 1693, control = 1502), and in adults via dominant model comparison (OR = 0.864, 95% CI = 0.768-0.971, I-2 = 46.9%, n = 18, case = 3160, control = 3433). Conclusions: None of the ADRB2 gene polymorphisms were reproducibly associated with a risk of asthma across ethnic groups in the general population.	[Liang, Si-Qiao; Chen, Xiao-Li; Deng, Jing-Min; Wei, Xuan; Gong, Chen; Chen, Zhang-Rong; Wang, Zhi-Bo] Guangxi Med Univ, Dept Resp Med, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Deng, JM (corresponding author), Guangxi Med Univ, Dept Resp Med, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.	ldyyy666@163.com	Wang, Zhibo/GSD-3371-2022					Abula, 2004, J CARDIOVASCULAR PUL, V23, P147; Bhatnagar P, 2005, PHARMACOGENOMICS, V6, P713, DOI 10.2217/14622416.6.7.713; Binaei S, 2003, CHEST, V123, p375S, DOI 10.1016/S0012-3692(15)35221-1; Birbian N, 2012, LUNG, V190, P497, DOI 10.1007/s00408-012-9407-7; Brodde OE, 2005, PHARMACOGENET GENOM, V15, P267, DOI 10.1097/01213011-200505000-00001; Chai, 2008, J APPL CLIN PEDIAT, V23, P272; Chan IHS, 2008, ALLERGY, V63, P1031, DOI 10.1111/j.1398-9995.2008.01639.x; Chiang CH, 2012, J CHIN MED ASSOC, V75, P635, DOI 10.1016/j.jcma.2012.08.012; Chung LP, 2010, RESPIROLOGY, V15, pA42; Cichy Malgorzata, 2005, Folia Med Cracov, V46, P33; Contopoulos-Ioannidis DG, 2005, J ALLERGY CLIN IMMUN, V115, P963, DOI 10.1016/j.jaci.2004.12.1119; Dai XH, 2008, SHANDONG MED J, V48, P119; Dewar JC, 1998, CLIN EXP ALLERGY, V28, P442; Fan D. S., 2007, CHINESE J CLIN MED, V14, P477; Finkelstein Y, 2009, J ASTHMA, V46, P900, DOI 10.3109/02770900903199961; Fu Jin, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P41; Fu WP, 2011, RESPIROLOGY, V16, P1221, DOI 10.1111/j.1440-1843.2011.02028.x; Gao Guangkai, 2000, Zhonghua Jiehe He Huxi Zazhi, V23, P93; Gao Jin-Ming, 2004, Chinese Medical Sciences Journal, V19, P164; GREEN SA, 1995, AM J RESP CELL MOL, V13, P25, DOI 10.1165/ajrcmb.13.1.7598936; Guo XR, 2005, CHINESE J PRIMARY ME, V12, P2; Hakonarson H, 2001, AM J RESP CRIT CARE, V164, P2036, DOI 10.1164/ajrccm.164.11.2101086; Hawkins GA, 2006, AM J RESP CRIT CARE, V174, P1101, DOI 10.1164/rccm.200509-1405OC; He, 2008, J CLIN PEDIAT, V26, P399; [何选秋 He Xuanqiu], 2012, [免疫学杂志, Immunological Journal], V28, P687; Holloway JW, 2000, CLIN EXP ALLERGY, V30, P1097; Huo J, 2011, STUDY VERIFICATION P; HY Sy, 2010, PAEDIATR RESPIR REV, V11, pS2; Isaza C, 2012, PEDIATR PULM, V47, P848, DOI 10.1002/ppul.22521; Kocabas NA, 2007, TOXICOL LETT, V172, pS164, DOI 10.1016/j.toxlet.2007.05.422; Kohyama K, 2011, INT ARCH ALLERGY IMM, V156, P405, DOI 10.1159/000324463; Kotani Y, 1999, J ASTHMA, V36, P583, DOI 10.3109/02770909909087295; Kukreti R, 2005, PHARMACOGENOMICS, V6, P399, DOI 10.1517/14622416.6.4.399; Larocca N, 2012, BIOMED PAP, V157, P374; Leung T, 2009, ALLERGY, V64, P186; Leung TF, 2002, PEDIATR PULM, V34, P419, DOI 10.1002/ppul.10210; Liggett SB, 1997, AM J RESP CRIT CARE, V156, pS156, DOI 10.1164/ajrccm.156.4.12tac-15; Lin YC, 2003, J ASTHMA, V40, P265, DOI 10.1081/JAS-120018323; Litonjua AA, 2010, PHARMACOGENET GENOM, V20, P64, DOI 10.1097/FPC.0b013e328333dae6; Liu, 2002, CHINESE J TUBERCULOS, V25, P554; Liu L, 2009, MED RECAPITULATE, V15, P4; Llanes E, 2009, INT ARCH ALLERGY IMM, V148, P228, DOI 10.1159/000161583; Luo R. R., 2004, J MODERN CLIN MED BI, V10, P5; Lv J, 2009, J ASTHMA, V46, P582, DOI 10.1080/02770900902915847; Migita O, 2004, INT ARCH ALLERGY IMM, V134, P150, DOI 10.1159/000078648; Munakata Mitsuru, 2006, Allergol Int, V55, P191, DOI 10.2332/allergolint.55.191; Ni SQ, 2012, PHARM TODAY, V22, P159; PAROLA AL, 1994, J BIOL CHEM, V269, P4497; Pignatti PF, 2004, PHARMACOL RES, V49, P343, DOI 10.1016/j.phrs.2003.04.002; Pinto LA, 2008, J PEDIAT, V84, pS68, DOI [10.1590/S0021-75572008000500010, 10.2223/JPED.1781]; Qiu YY, 2010, ALLERGY ASTHMA PROC, V31, pE91, DOI 10.2500/aap.2010.31.3371; REIHSAUS E, 1993, AM J RESP CELL MOL, V8, P334, DOI 10.1165/ajrcmb/8.3.334; Ren L, 2011, ASS ADAM33 LTS PATHW; Santillan AA, 2003, J ALLERGY CLIN IMMUN, V112, P1095, DOI 10.1016/j.jaci.2003.09.029; Shachor J, 2003, ISRAEL MED ASSOC J, V5, P821; Su MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030694; Szczepankiewicz A, 2009, J APPL GENET, V50, P275, DOI 10.1007/BF03195683; Tatarskyy P. F., 2011, Biopolymers and Cell, V27, P66; Telleria JJ, 2006, RESP MED, V100, P1072, DOI 10.1016/j.rmed.2005.09.028; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Tsai HJ, 2006, HUM GENET, V119, P547, DOI 10.1007/s00439-006-0169-2; Tuerxun KLBN, 2007, J XINJIANG MED U, V30, P945; Wang JY, 2009, J CLIN IMMUNOL, V29, P205, DOI 10.1007/s10875-008-9256-6; Wang ZX, 2001, AM J RESP CRIT CARE, V163, P1404, DOI 10.1164/ajrccm.163.6.2001101; Weir TD, 1998, AM J RESP CRIT CARE, V158, P787, DOI 10.1164/ajrccm.158.3.9801035; Xi, 2001, J 3 MILITARY MED U, V23, P968; Xing J, 2001, CHINESE J INTERNAL M, V40, P340; [杨珍 Yang Zhen], 2012, [临床儿科杂志, Journal of Chinical Pediatrics], V30, P739; Ye WX, 2011, J MED RES, V40, P83; Zheng Bo-Qiang, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P811	71	28	30	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104488	10.1371/journal.pone.0104488	http://dx.doi.org/10.1371/journal.pone.0104488			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111792	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100062
J	Pfeffer, LM; Li, K; Fleckenstein, JF; Marion, TN; Diament, J; Yang, CH; Pfeffer, SR; Fan, MY; Handorf, E; Handorf, CR				Pfeffer, Lawrence M.; Li, Kui; Fleckenstein, Jaquelyn F.; Marion, Tony N.; Diament, Joel; Yang, Chuan He; Pfeffer, Susan R.; Fan, Meiyun; Handorf, Elizabeth; Handorf, Charles R.			An Interferon Response Gene Signature Is Associated with the Therapeutic Response of Hepatitis C Patients	PLOS ONE			English	Article							STIMULATED GENES; ADAPTER PROTEIN; INNATE IMMUNITY; ISG EXPRESSION; KAPPA-B; VIRUS; IL28B; LIVER; ACTIVATION; EVASION	Infection with the hepatitis C virus (HCV) is a major cause of chronic liver diseases and hepatocellular carcinoma worldwide, and thus represents a significant public health problem. The type I interferon (IFN), IFN alpha, has been successful in treating HCV-infected patients, but current IFN-based treatment regimens for HCV have suboptimal efficacy, and relatively little is known about why IFN therapy eliminates the virus in some patients but not in others. Therefore, it is critical to understand the basic mechanisms that underlie the therapeutic resistance to IFN action in HCV-infected individuals, and there is an urgent need to identify those patients most likely to respond to IFN therapy for HCV. To characterize the response of HCV-infected patients to treatment with IFN alpha, the expression of an IFN-response gene signature comprised of IFN-stimulated genes and genes that play an important role in the innate immune response was examined in liver biopsies from HCV-infected patients enrolled in a clinical trial. In the present study we found that the expression of a subset of IFN-response genes was dysregulated in liver biopsy samples from nonresponsive hepatitis C patients as compared with virologic responders. Based on these findings, a statistical model was developed to help predict the response of patients to IFN therapy, and compared to results obtained to the IL28 mutation model, which is highly predictive of the response to IFN-based therapy in HCV-infected patients. We found that a model incorporating gene expression data can improve predictions of IFN responsiveness compared to IL28 mutation status alone.	[Pfeffer, Lawrence M.; Diament, Joel; Yang, Chuan He; Pfeffer, Susan R.; Fan, Meiyun; Handorf, Charles R.] Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA; [Pfeffer, Lawrence M.; Diament, Joel; Yang, Chuan He; Pfeffer, Susan R.; Fan, Meiyun; Handorf, Charles R.] Univ Tennessee, Ctr Hlth Sci, Ctr Canc Res, Memphis, TN 38163 USA; [Li, Kui; Marion, Tony N.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Fleckenstein, Jaquelyn F.] Washington Univ, Sch Med, Dept Med, Div Gastroenterol, St Louis, MO 63110 USA; [Handorf, Elizabeth] Fox Chase Canc Ctr, Biostat & Bioinformat Facil, Philadelphia, PA 19111 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Washington University (WUSTL); Fox Chase Cancer Center	Pfeffer, LM (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Pathol & Lab Med, Memphis, TN 38163 USA.	LPFEFFER@UTHSC.EDU		Pfeffer, Lawrence/0000-0003-2809-1234	National Institute of Health [U19 AI066316, R01-AI069285]; General Clinical Research Center [M01-RR00211]; University of Tennessee Research Foundation; Muirhead Chair Endowment; Gerwin Endowment at the University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE [R01CA140346] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066316, R01AI069285] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Tennessee Research Foundation; Muirhead Chair Endowment; Gerwin Endowment at the University of Tennessee Health Science Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	1. National Institute of Health grants U19 AI066316, R01-AI069285, General Clinical Research Center Grant M01-RR00211, a maturation grant from the University of Tennessee Research Foundation, and by funds from the Muirhead Chair Endowment and the Gerwin Endowment at the University of Tennessee Health Science Center. 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002289; Asselah T, 2009, GUT, V58, P846, DOI 10.1136/gut.2008.166348; Berres ML, 2010, J CLIN INVEST, V120, P4129, DOI 10.1172/JCI41732; Bigger CB, 2001, J VIROL, V75, P7059, DOI 10.1128/JVI.75.15.7059-7066.2001; Castellino S, 2004, BLOOD, V103, P2460, DOI 10.1182/blood-2003-07-2565; Chen J, 1999, AIDS RES HUM RETROV, V15, P81, DOI 10.1089/088922299311754; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Fleckenstein Jaquelyn, 2004, Curr Gastroenterol Rep, V6, P66, DOI 10.1007/s11894-004-0028-z; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Han JQ, 2002, RNA, V8, P512, DOI 10.1017/S1355838202020617; Hastie T., 2009, UNSUPERVISED LEARNIN; Heim MH, 2013, J HEPATOL, V58, P564, DOI 10.1016/j.jhep.2012.10.005; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Katsounas A, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-9; Lanford RE, 2007, HEPATOLOGY, V46, P999, DOI 10.1002/hep.21776; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; Lemon SM, 2010, J BIOL CHEM, V285, P22739, DOI 10.1074/jbc.R109.099556; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; LEVY D, 1990, New Biologist, V2, P923; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li K, 2013, SEMIN IMMUNOPATHOL, V35, P53, DOI 10.1007/s00281-012-0332-x; Li K, 2012, HEPATOLOGY, V55, P666, DOI 10.1002/hep.24763; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Park H, 2012, HEPATOLOGY, V56, P2060, DOI 10.1002/hep.25897; Pfeffer LM, 2009, J INTERF CYTOK RES, V29, P299, DOI 10.1089/jir.2008.0092; Pfeffer LM, 2004, J BIOL CHEM, V279, P31304, DOI 10.1074/jbc.M308975200; Pfeffer LM, 1998, CANCER RES, V58, P2489; PINE R, 1994, EMBO J, V13, P158, DOI 10.1002/j.1460-2075.1994.tb06245.x; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Schulze-Krebs A, 2005, GASTROENTEROLOGY, V129, P246, DOI 10.1053/j.gastro.2005.03.089; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Wei L, 2008, J INTERF CYTOK RES, V28, P541, DOI 10.1089/jir.2007.0136; Zhou Z, 2011, VIROLOGY, V409, P175, DOI 10.1016/j.virol.2010.10.008	53	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104202	10.1371/journal.pone.0104202	http://dx.doi.org/10.1371/journal.pone.0104202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111807	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100037
J	Venugopalan, G; Camarillo, DB; Webster, KD; Reber, CD; Sethian, JA; Weaver, VM; Fletcher, DA; El-Samad, H; Rycroft, CH				Venugopalan, Gautham; Camarillo, David B.; Webster, Kevin D.; Reber, Clay D.; Sethian, James A.; Weaver, Valerie M.; Fletcher, Daniel A.; El-Samad, Hana; Rycroft, Chris H.			Multicellular Architecture of Malignant Breast Epithelia Influences Mechanics	PLOS ONE			English	Article							COLLAGEN MICROSPHERE ASSAY; NAVIER-STOKES EQUATIONS; CELL TRACTION FORCE; CARCINOMA IN-SITU; E-CADHERIN; MODEL; PHENOTYPE; CANCER; MORPHOGENESIS; INTERFACE	Cell-matrix and cell-cell mechanosensing are important in many cellular processes, particularly for epithelial cells. A crucial question, which remains unexplored, is how the mechanical microenvironment is altered as a result of changes to multicellular tissue structure during cancer progression. In this study, we investigated the influence of the multicellular tissue architecture on mechanical properties of the epithelial component of the mammary acinus. Using creep compression tests on multicellular breast epithelial structures, we found that pre-malignant acini with no lumen (MCF10AT) were significantly stiffer than normal hollow acini (MCF10A) by 60%. This difference depended on structural changes in the premalignant acini, as neither single cells nor normal multicellular acini tested before lumen formation exhibited these differences. To understand these differences, we simulated the deformation of the acini with different multicellular architectures and calculated their mechanical properties; our results suggest that lumen filling alone can explain the experimentally observed stiffness increase. We also simulated a single contracting cell in different multicellular architectures and found that lumen filling led to a 20% increase in the "perceived stiffness'' of a single contracting cell independent of any changes to matrix mechanics. Our results suggest that lumen filling in carcinogenesis alters the mechanical microenvironment in multicellular epithelial structures, a phenotype that may cause downstream disruptions to mechanosensing.	[Venugopalan, Gautham; Webster, Kevin D.; Reber, Clay D.; Fletcher, Daniel A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Venugopalan, Gautham; Webster, Kevin D.; Reber, Clay D.; Fletcher, Daniel A.] Univ Calif Berkeley, Biophys Program, Berkeley, CA 94720 USA; [Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Camarillo, David B.; El-Samad, Hana] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Sethian, James A.] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Sethian, James A.; Rycroft, Chris H.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Math, Berkeley, CA 94720 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Therapeut Sci, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Ctr Bioengn & Tissue Regenerat, San Francisco, CA 94143 USA; [Fletcher, Daniel A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Rycroft, Chris H.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University; University of California System; University of California San Francisco; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Harvard University	El-Samad, H (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	hana.el-samad@ucsf.edu; chr@seas.harvard.edu		Rycroft, Chris/0000-0003-4677-6990; Camarillo, David/0000-0003-4965-2977; Weaver, Valerie marie/0000-0003-4786-6752	National Cancer Institute [U54CA143836]; Ruth L. Kirschstein National Research Service Award (NRSA) of the National Institutes of Health [T32CA108462]; NATIONAL CANCER INSTITUTE [U54CA143836, T32CA108462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074751] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ruth L. Kirschstein National Research Service Award (NRSA) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Cancer Institute under Contract Number U54CA143836. D. B. C. was supported by the postdoctoral Ruth L. Kirschstein National Research Service Award (NRSA) of the National Institutes of Health under grant number T32CA108462. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz J, 2008, EMBO J, V27, P2829, DOI 10.1038/emboj.2008.206; Almgren AS, 1996, SIAM J SCI COMPUT, V17, P358, DOI 10.1137/S1064827593244213; BAROCAS VH, 1995, J BIOMECH ENG-T ASME, V117, P161, DOI 10.1115/1.2795998; BASOLO F, 1991, MOL CARCINOGEN, V4, P25, DOI 10.1002/mc.2940040106; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Bryan BB, 2006, MODERN PATHOL, V19, P617, DOI 10.1038/modpathol.3800570; CHORIN AJ, 1968, MATH COMPUT, V22, P745, DOI 10.2307/2004575; Crow A, 2012, BIOPHYS J, V102, P443, DOI 10.1016/j.bpj.2011.11.4020; Dawson PJ, 1996, AM J PATHOL, V148, P313; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DEMBO M, 1986, BIOPHYS J, V50, P109, DOI 10.1016/S0006-3495(86)83444-0; Fournier MV, 2009, CANCER RES, V69, P4545, DOI 10.1158/0008-5472.CAN-08-1694; Guevorkian K, 2011, P NATL ACAD SCI USA, V108, P13387, DOI 10.1073/pnas.1105741108; Herant M, 2003, BIOPHYS J, V84, P3389, DOI 10.1016/S0006-3495(03)70062-9; Herant M, 2010, BIOPHYS J, V98, P1408, DOI 10.1016/j.bpj.2009.12.4303; Huveneers S, 2013, J CELL SCI, V126, P403, DOI 10.1242/jcs.109447; Kim JH, 2011, J CELL SCI, V124, P1280, DOI 10.1242/jcs.078394; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; MILLER FR, 1993, J NATL CANCER I, V85, P1725, DOI 10.1093/jnci/85.21.1725; MOON AG, 1993, AICHE J, V39, P163, DOI 10.1002/aic.690390116; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PLOPPER G, 1993, BIOCHEM BIOPH RES CO, V193, P571, DOI 10.1006/bbrc.1993.1662; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Schneider D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080068; Sethian JA, 1996, LEVEL SET METHODS FA; Sinkus R, 2000, PHYS MED BIOL, V45, P1649, DOI 10.1088/0031-9155/45/6/317; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; SOULE HD, 1990, CANCER RES, V50, P6075; Tanner K, 2012, P NATL ACAD SCI USA, V109, P1973, DOI 10.1073/pnas.1119578109; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482; von Dassow M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015359; WATABE M, 1994, J CELL BIOL, V127, P247, DOI 10.1083/jcb.127.1.247	39	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e101955	10.1371/journal.pone.0101955	http://dx.doi.org/10.1371/journal.pone.0101955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111489	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100006
J	Xuan, ICY; Hampson, DR				Xuan, Ingrid C. Y.; Hampson, David R.			Gender-Dependent Effects of Maternal Immune Activation on the Behavior of Mouse Offspring	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; SEX-DIFFERENCES; INFECTION; CHILDREN; BRAIN; AGE; SCHIZOPHRENIA; INVOLVEMENT; CHALLENGE; PREGNANCY	Autism spectrum disorders are neurodevelopmental disorders characterized by two core symptoms; impaired social interactions and communication, and ritualistic or repetitive behaviors. Both epidemiological and biochemical evidence suggests that a subpopulation of autistics may be linked to immune perturbations that occurred during fetal development. These findings have given rise to an animal model, called the "maternal immune activation'' model, whereby the offspring from female rodents who were subjected to an immune stimulus during early or mid-pregnancy are studied. Here, C57BL/6 mouse dams were treated mid-gestation with saline, lipopolysaccharide (LPS) to mimic a bacterial infection, or polyinosinic: polycytidylic acid (Poly IC) to mimic a viral infection. Autism-associated behaviors were examined in the adult offspring of the treated dams. Behavioral tests were conducted to assess motor activity, exploration in a novel environment, sociability, and repetitive behaviors, and data analyses were carried independently on male and female mice. We observed a main treatment effect whereby male offspring from Poly IC-treated dams showed reduced motor activity. In the marble burying test of repetitive behavior, male offspring but not female offspring from both LPS and Poly IC-treated mothers showed increased marble burying. Our findings indicate that offspring from mothers subjected to immune stimulation during gestation show a gender-specific increase in stereotyped repetitive behavior.	[Xuan, Ingrid C. Y.; Hampson, David R.] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada; [Hampson, David R.] Univ Toronto, Dept Pharmacol & Toxicol, Fac Med, Toronto, ON, Canada	University of Toronto; University of Toronto	Hampson, DR (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, Toronto, ON, Canada.	d.hampson@utoronto.ca			Canadian Institutes for Health Research (CIHR); CIHR Strategic Training Program in Biological Therapeutics	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Strategic Training Program in Biological Therapeutics(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes for Health Research (CIHR) and the CIHR Strategic Training Program in Biological Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Andersson GW, 2013, RES DEV DISABIL, V34, P413, DOI 10.1016/j.ridd.2012.08.025; Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748; Ashwood P, 2011, J NEUROIMMUNOL, V232, P196, DOI 10.1016/j.jneuroim.2010.10.025; Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Atladottir HO, 2012, PEDIATRICS, V130, pE1447, DOI 10.1542/peds.2012-1107; Bakos J, 2004, ANN NY ACAD SCI, V1018, P281, DOI 10.1196/annals.1296.033; Brown AS, 2013, MOL PSYCHIA IN PRESS; Careaga M, 2010, NEUROTHERAPEUTICS, V7, P283, DOI 10.1016/j.nurt.2010.05.003; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Charman T, 2011, PSYCHOL MED, V41, P619, DOI 10.1017/S0033291710000991; Ehninger D, 2012, MOL PSYCHIATR, V17, P469, DOI 10.1038/mp.2011.39; Garay PA, 2013, BRAIN BEHAV IMMUN, V31, P54, DOI 10.1016/j.bbi.2012.07.008; Gillberg C, 2006, J AUTISM DEV DISORD, V36, P429, DOI 10.1007/s10803-006-0081-6; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Harvey L, 2012, DEV NEUROBIOL, V72, P1335, DOI 10.1002/dneu.22043; Hattier MA, 2011, RES DEV DISABIL, V32, P2346, DOI 10.1016/j.ridd.2011.07.028; Hsiao EY, 2012, P NATL ACAD SCI USA, V109, P12776, DOI 10.1073/pnas.1202556109; Jones KA, 2013, MOL CELL NEUROSCI, V53, P52, DOI 10.1016/j.mcn.2012.10.002; Kalueff AV, 2005, J NEUROSCI METH, V143, P169, DOI 10.1016/j.jneumeth.2004.10.001; Kim KC, 2013, J NEUROCHEM, V124, P832, DOI 10.1111/jnc.12147; Kim YS, 2011, AM J PSYCHIAT, V168, P904, DOI 10.1176/appi.ajp.2011.10101532; Kirsten TB, 2012, J NEUROSCI RES, V90, P1903, DOI 10.1002/jnr.23089; Kirsten TB, 2010, BEHAV BRAIN RES, V211, P77, DOI 10.1016/j.bbr.2010.03.009; Lipina TV, 2013, J NEUROSCI, V33, P7654, DOI 10.1523/JNEUROSCI.0091-13.2013; Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011; Mandy W, 2012, J AUTISM DEV DISORD, V42, P1304, DOI 10.1007/s10803-011-1356-0; Maski KP, 2011, CURR OPIN PEDIATR, V23, P609, DOI 10.1097/MOP.0b013e32834c9282; Matson JL, 2007, RES DEV DISABIL, V28, P341, DOI 10.1016/j.ridd.2005.12.004; Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Pacey LKK, 2011, MOL CELL NEUROSCI, V46, P563, DOI 10.1016/j.mcn.2010.12.005; Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001; Patterson PH, 2009, BEHAV BRAIN RES, V204, P313, DOI 10.1016/j.bbr.2008.12.016; Piontkewitz Y, 2009, BIOL PSYCHIAT, V66, P1038, DOI 10.1016/j.biopsych.2009.07.005; Ramsey AJ, 2011, P NATL ACAD SCI USA, V108, P5795, DOI 10.1073/pnas.1012621108; Rana SA, 2012, HORM BEHAV, V62, P228, DOI 10.1016/j.yhbeh.2012.03.015; Schwartzer JJ, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.16; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Sipes M, 2011, RES AUTISM SPECT DIS, V5, P1465, DOI 10.1016/j.rasd.2011.02.007; Suzuki S, 2013, J NEUROSCI RES, V91, P462, DOI 10.1002/jnr.23160; Szatmari P, 2012, AM J MED GENET B, V159B, P5, DOI 10.1002/ajmg.b.31238; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Werling DM, 2013, CURR OPIN NEUROL, V26, P146, DOI 10.1097/WCO.0b013e32835ee548; Worley JA, 2011, RES AUTISM SPECT DIS, V5, P1086, DOI 10.1016/j.rasd.2010.12.002; Zager A, 2012, BEHAV BRAIN RES, V232, P30, DOI 10.1016/j.bbr.2012.03.036; Zahn-Waxler C, 2008, ANNU REV CLIN PSYCHO, V4, P275, DOI 10.1146/annurev.clinpsy.3.022806.091358; Zwaigenbaum L, 2012, J AUTISM DEV DISORD, V42, P2585, DOI 10.1007/s10803-012-1515-y	52	76	76	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104433	10.1371/journal.pone.0104433	http://dx.doi.org/10.1371/journal.pone.0104433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111339	gold, Green Submitted, Green Published			2022-12-27	WOS:000341105100057
J	Lopez-Caamal, F; Marquez-Lago, TT				Lopez-Caamal, Fernando; Marquez-Lago, Tatiana T.			Order Reduction of the Chemical Master Equation via Balanced Realisation	PLOS ONE			English	Article							MODEL-REDUCTION; TRUNCATION	We consider a Markov process in continuous time with a finite number of discrete states. The time-dependent probabilities of being in any state of the Markov chain are governed by a set of ordinary differential equations, whose dimension might be large even for trivial systems. Here, we derive a reduced ODE set that accurately approximates the probabilities of subspaces of interest with a known error bound. Our methodology is based on model reduction by balanced truncation and can be considerably more computationally efficient than solving the chemical master equation directly. We show the applicability of our method by analysing stochastic chemical reactions. First, we obtain a reduced order model for the infinitesimal generator of a Markov chain that models a reversible, monomolecular reaction. Later, we obtain a reduced order model for a catalytic conversion of substrate to a product (a so-called Michaelis-Menten mechanism), and compare its dynamics with a rapid equilibrium approximation method. For this example, we highlight the savings on the computational load obtained by means of the reduced-order model. Furthermore, we revisit the substrate catalytic conversion by obtaining a lower-order model that approximates the probability of having predefined ranges of product molecules. In such an example, we obtain an approximation of the output of a model with 5151 states by a reduced model with 16 states. Finally, we obtain a reduced-order model of the Brusselator.	[Lopez-Caamal, Fernando; Marquez-Lago, Tatiana T.] Okinawa Inst Sci & Technol, Integrat Syst Biol Unit, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Marquez-Lago, TT (corresponding author), Okinawa Inst Sci & Technol, Integrat Syst Biol Unit, Okinawa, Japan.	tatiana.marquez@oist.jp		Lopez-Caamal, Fernando/0000-0003-2861-7013	OIST	OIST(Okinawa Institute of Science & Technology Graduate University)	This work was done with OIST internal funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L.J.S., 2010, INTRO STOCHASTIC PRO; [Anonymous], [No title captured]; [Anonymous], 1996, ROBUST OPTIMAL CONTR; Badia JM, 2006, LECT NOTES COMPUT SC, V3732, P267; Barrio M, 2010, HDB RES COMPUTATIONA, P169; Barrio M, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4793982; Bremaud P., 1999, TEXT APPL M, V31; BURRAGE K., 2006, P AA MARK 150 ANN M, P21; Chen C.-T., 1998, LINEAR SYSTEM THEORY; Farina L., 2011, POSITIVE LINEAR SYST, V50; Feller W., 1968, INTRO PROBABILITY TH, V1; Feng JE, 2010, INT J CONTROL, V83, P575, DOI 10.1080/00207170903312116; Gillespie DT, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3072704; GILLESPIE DT, 1992, PHYSICA A, V188, P404, DOI 10.1016/0378-4371(92)90283-V; Grussler C, 2012, IEEE DECIS CONTR P, P4308, DOI 10.1109/CDC.2012.6426442; Gugercin S, 2004, INT J CONTROL, V77, P748, DOI 10.1080/00207170410001713448; Haseltine EL, 2002, J CHEM PHYS, V117, P6959, DOI 10.1063/1.1505860; Jahnke T, 2011, MULTISCALE MODEL SIM, V9, P1646, DOI 10.1137/110821500; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; Lee CH, 2012, J MATH CHEM, V50, P1550, DOI 10.1007/s10910-012-9988-7; Leier A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0108; Li P, 2011, AUTOMATICA, V47, P1504, DOI 10.1016/j.automatica.2011.02.032; Lopez-Caamal F, 2014, B MATH BIOL, V76, P2334, DOI 10.1007/s11538-014-9985-z; Marquez-Lago TT, 2010, BIOPHYS J, V98, P1742, DOI 10.1016/j.bpj.2010.01.018; Menz S, 2012, MULTISCALE MODEL SIM, V10, P1232, DOI 10.1137/110825716; MOORE BC, 1981, IEEE T AUTOMAT CONTR, V26, P17, DOI 10.1109/TAC.1981.1102568; Munsky B, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2145882; PERNEBO L, 1982, IEEE T AUTOMAT CONTR, V27, P382, DOI 10.1109/TAC.1982.1102945; PRIGOGIN.I, 1968, J CHEM PHYS, V48, P1695, DOI 10.1063/1.1668896; SAAD Y, 1992, SIAM J NUMER ANAL, V29, P209, DOI 10.1137/0729014; Sanft KR, 2011, IET SYST BIOL, V5, P58, DOI 10.1049/iet-syb.2009.0057; SEGEL LA, 1989, SIAM REV, V31, P446, DOI 10.1137/1031091; Skogestad S., 2007, MULTIVARIABLE FEEDBA, V2; Sunkara V, 2013, THESIS AUSTR NATL U; THERAPOS CP, 1989, IEEE T AUTOMAT CONTR, V34, P455, DOI 10.1109/9.28023; Thomas P, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3661156; Ullah M, 2011, STOCHASTIC APPROACHES FOR SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4614-0478-1; Van Kampen NG, 2007, NORTH-HOLL PERS LIBR, V1	38	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103521	10.1371/journal.pone.0103521	http://dx.doi.org/10.1371/journal.pone.0103521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121581	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000016
J	Sarangi, M; Ganguly, P; Zenia; Arvind, C; Lakshman, A; Vidya, TNC				Sarangi, Manaswini; Ganguly, Payel; Zenia; Arvind, Chiti; Lakshman, Abhilash; Vidya, T. N. C.			Common Myna Roosts Are Not Recruitment Centres	PLOS ONE			English	Article							INFORMATION-CENTER HYPOTHESIS; COMMUNAL ROOSTS; ACRIDOTHERES-TRISTIS; GROUP-SIZE; FOOD; BEHAVIOR; STRATEGIES; VIGILANCE; COLONIES; BIRDS	We studied communal roosting in the Common Myna (Acridotheres tristis) in the light of the recruitment centre hypothesis and predation at the roost. The number and sizes of flocks departing from and arriving at focal roosts were recorded over a two year period. We also recorded the sizes and behaviour of foraging flocks. We found that flock sizes of birds departing from roosts at sunrise were larger than those at the feeding site, suggesting that there was no recruitment from the roosts. Flocks entering the roosts during sunset were larger on average than those leaving the following sunrise, suggesting no consolidation of flocks in the morning. Flocks entering the roosts at sunset were also larger on average than those that had left that sunrise, although there was no recruitment at the feeding site. There was no effect of group size on the proportion of time spent feeding. Contrary to expectation, single birds showed lower apparent vigilance than birds that foraged in pairs or groups, possibly due to scrounging tactics being used in the presence of feeding companions. Thus, the recruitment centre hypothesis did not hold in our study population of mynas. Predation at dawn and dusk were also not important to communal roosting: predators near the roosts did not result in larger flocks, and resulted in larger durations of arrival/departure contrary to expectation. Since flock sizes were smallest at the feeding site and larger in the evening than in the morning, but did not coincide with predator activity, information transfer unrelated to food (such as breeding opportunities) may possibly give rise to the evening aggregations.	[Sarangi, Manaswini; Ganguly, Payel; Zenia; Arvind, Chiti; Lakshman, Abhilash; Vidya, T. N. C.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Bangalore 560012, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Vidya, TNC (corresponding author), Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Bangalore 560012, Karnataka, India.	tncvidya@jncasr.ac.in	Arvind, Chiti/ACN-1394-2022	Arvind, Chiti/0000-0003-0727-9465; T.N.C., Vidya/0000-0002-7143-9008; Abhilash, Lakshman/0000-0002-9933-8989	Department of Science and Technology's (Government of India) Ramanujan Fellowship; JNCASR's Project Oriented Biological Education (POBE) programme	Department of Science and Technology's (Government of India) Ramanujan Fellowship; JNCASR's Project Oriented Biological Education (POBE) programme	This project was carried out through the Department of Science and Technology's (Government of India) Ramanujan Fellowship to TNCV. Zenia and Chiti Arvind were supported by JNCASR's Project Oriented Biological Education (POBE) programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S., 1996, BOOK INDIAN BIRDS; BAYER RD, 1982, AUK, V99, P31, DOI 10.2307/4086019; Beauchamp G, 1999, BEHAV ECOL, V10, P675, DOI 10.1093/beheco/10.6.675; Beauchamp G, 2001, BEHAV ECOL SOCIOBIOL, V51, P47, DOI 10.1007/s002650100413; Bijleveld AI, 2010, OIKOS, V119, P277, DOI 10.1111/j.1600-0706.2009.17892.x; BROWN CR, 1986, SCIENCE, V234, P83, DOI 10.1126/science.234.4772.83; Buckley NJ, 1996, AUK, V113, P473, DOI 10.2307/4088913; Caccamise DF, 1997, AUK, V114, P628, DOI 10.2307/4089282; CACCAMISE DF, 1986, AM NAT, V128, P191, DOI 10.1086/284553; CARACO T, 1980, NATURE, V285, P400, DOI 10.1038/285400a0; COUNSILMAN J J, 1974, Emu, V74, P135; DUPLESSIS MA, 1994, CONDOR, V96, P631, DOI 10.2307/1369466; EISERER LA, 1984, BIRD BEHAV, V5, P61; EVANS RM, 1982, AUK, V99, P24, DOI 10.2307/4086018; Fernandez-Juricic E, 2004, BEHAV ECOL, V15, P371, DOI 10.1093/beheco/arh017; GADGIL M, 1975, Journal of the Bombay Natural History Society, V72, P716; GADGIL M, 1972, IBIS, V114, P531, DOI 10.1111/j.1474-919X.1972.tb00853.x; Hansen H, 2000, CAN J ZOOL, V78, P1813, DOI 10.1139/cjz-78-10-1813; HEINRICH B, 1988, BEHAV ECOL SOCIOBIOL, V23, P141, DOI 10.1007/BF00300349; HEINRICH B, 1991, BEHAV ECOL SOCIOBIOL, V28, P13; Joern A., 1990, P415; KREBS JR, 1974, BEHAVIOUR, V51, P99, DOI 10.1163/156853974X00165; Kulkarni S, 2007, BEHAV PROCESS, V74, P88, DOI 10.1016/j.beproc.2006.10.005; Lack D., 1968, pvii; MAHABAL A, 1989, P INDIAN AS-ANIM SCI, V98, P199, DOI 10.1007/BF03179646; Mahabal Anil, 1993, Biovigyanam, V19, P55; Mahabal Anil, 1991, Pavo, V29, P23; Marzluff JM, 1996, ANIM BEHAV, V51, P89, DOI 10.1006/anbe.1996.0008; McGiffin A, 2013, EMU, V113, P154, DOI 10.1071/MU12107; MOCK DW, 1988, ORNIS SCAND, V19, P231, DOI 10.2307/3676564; MOORE J, 1988, AM NAT, V131, P22, DOI 10.1086/284771; Moore JE, 1998, CAN J ZOOL, V76, P508, DOI 10.1139/cjz-76-3-508; Newey P, 2007, EMU, V107, P315, DOI 10.1071/MU06054; Ni SX, 2003, AGR ECOSYST ENVIRON, V95, P61, DOI 10.1016/S0167-8809(02)00165-2; RABENOLD PP, 1987, ANIM BEHAV, V35, P1775, DOI 10.1016/S0003-3472(87)80070-2; Richner H, 1996, BEHAV ECOL, V7, P115, DOI 10.1093/beheco/7.1.115; RICHNER H, 1995, ADV STUD BEHAV, V24, P1, DOI 10.1016/S0065-3454(08)60391-5; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; SENGUPTA S, 1976, Proceedings of the Indian National Science Academy Part B Biological Sciences, V42, P338; Sonerud GA, 2002, BEHAV ECOL SOCIOBIOL, V51, P309, DOI 10.1007/s00265-001-0440-4; Sonerud GA, 2001, P ROY SOC B-BIOL SCI, V268, P827, DOI 10.1098/rspb.2001.1586; StatSoft, 2007, STATISTICA 8; WAGNER RH, 1993, J THEOR BIOL, V163, P333, DOI 10.1006/jtbi.1993.1123; WALTZ EC, 1987, ANIM BEHAV, V35, P48, DOI 10.1016/S0003-3472(87)80209-9; WARD P., 1965, IBIS, V107, P173, DOI 10.1111/j.1474-919X.1965.tb07296.x; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; WEATHERHEAD PJ, 1983, AM NAT, V121, P237, DOI 10.1086/284053; WEATHERHEAD PJ, 1987, ANIM BEHAV, V35, P614, DOI 10.1016/S0003-3472(87)80295-6; Wright J, 2003, J ANIM ECOL, V72, P1003, DOI 10.1046/j.1365-2656.2003.00771.x; YOMTOV Y, 1979, IBIS, V121, P331, DOI 10.1111/j.1474-919X.1979.tb06852.x; ZAHAVI A, 1971, IBIS, V113, P106, DOI 10.1111/j.1474-919X.1971.tb05131.x; Zahavi A, 1996, BEHAV ECOL, V7, P118, DOI 10.1093/beheco/7.1.118	53	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103406	10.1371/journal.pone.0103406	http://dx.doi.org/10.1371/journal.pone.0103406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122467	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000014
J	Traini, C; Faussone-Pellegrini, MS; Evangelista, S; Mazzaferro, K; Cipriani, G; Santicioli, P; Vannucchi, MG				Traini, Chiara; Faussone-Pellegrini, Maria Simonetta; Evangelista, Stefano; Mazzaferro, Katia; Cipriani, Gianluca; Santicioli, Paolo; Vannucchi, Maria Giuliana			Inner and Outer Portions of Colonic Circular Muscle: Ultrastructural and Immunohistochemical Changes in Rat Chronically Treated with Otilonium Bromide	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; IRRITABLE-BOWEL-SYNDROME; SMOOTH-MUSCLE; INTERSTITIAL-CELLS; CALCIUM-CHANNELS; EXPRESSION; CAJAL	Rat colonic circular muscle, main target of otilonium bromide (OB) spasmolytic activity, is subdivided in an inner and outer portion. Since the inner one is particularly rich in organelles involved in calcium availability (caveolae, smooth endoplasmic reticulum, mitochondria), the expression of specific markers (Caveolin-1, eNOS, calreticulin, calsequestrin) in comparison with the outer portion was investigated. The possible changes of these organelles and related markers, and of muscarinic receptors (Mr2) were then studied after OB chronic exposition. Rats were treated with 2-20 mg/kg/OB for 10 or 30 days. Proximal colon was processed by electron microscopy, immunohistochemistry, and western blot. In colon strips the stimulated contractility response to muscarinic agonist was investigated. The inner portion showed a higher expression of Caveolin-1 and Mr2, but not of eNOS, calreticulin and calsequestrin, compared to the outer portion. Chronic OB treatment caused similar ultrastructural and immunohistochemical changes in both portions. Organelles and some related markers were increased at 10 days; Mr2 expression and muscle contractility induced by methacholine was increased at 30 days. The present findings: 1) provide new information on the immunohistochemical properties of the inner portion of the circular layer that are in favour of a role it might play in colonic motility distinct from that of the outer portion; 2) demonstrate that chronically administered OB interferes with cell structures and molecules responsible for calcium handling and storage, and modifies cholinergic transmission. In conclusion, chronic OB administration in the colonic circular muscle layer directly interacts with the organelles and molecules calcium-related and with the Mr2.	[Traini, Chiara; Faussone-Pellegrini, Maria Simonetta; Mazzaferro, Katia; Santicioli, Paolo; Vannucchi, Maria Giuliana] Dept Expt & Clin Med, Histol & Embryol Res Unit, Florence, Italy; [Evangelista, Stefano] Menarini Ric SpA, Preclin Dev, Florence, Italy; [Cipriani, Gianluca] Mayo Clin, Dept Physiol & Biomed Engn, Div Gastroenterol, Enter Neurosci Program, Rochester, MN USA	Menarini Group; Mayo Clinic	Vannucchi, MG (corresponding author), Dept Expt & Clin Med, Histol & Embryol Res Unit, Florence, Italy.	mariagiuliana.vannucchi@unifi.it		Evangelista, Stefano/0000-0001-6025-2400	Menarini IFR grant	Menarini IFR grant(Menarini Group)	There were no financial, professional, or personal disclosures from any of the authors. This work was supported by a Menarini IFR grant. The funder was involved in the decision to publish the manuscript.	Boeckxstaens G, 2013, INT J COLORECTAL DIS, V28, P295, DOI 10.1007/s00384-012-1598-0; Cho WJ, 2005, AM J PHYSIOL-GASTR L, V288, pG571, DOI 10.1152/ajpgi.00222.2004; Cipriani G, 2011, J CELL MOL MED, V15, P2411, DOI 10.1111/j.1582-4934.2011.01333.x; Cipriani G, 2013, GASTROENTEROLOGY, V144, pS369; Clave P, 2011, ALIMENT PHARM THER, V34, P432, DOI 10.1111/j.1365-2036.2011.04730.x; Colasanti M, 2000, TRENDS PHARMACOL SCI, V21, P249, DOI 10.1016/S0165-6147(00)01499-1; Copray JCVM, 1996, J CHEM NEUROANAT, V11, P57, DOI 10.1016/0891-0618(96)00125-1; Evangelista S, 2004, CURR PHARM DESIGN, V10, P3561, DOI 10.2174/1381612043382972; Evangelista S, 2000, DRUG METAB DISPOS, V28, P643; Evangelista S, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/936960; Faussone Pellegrini M S, 1984, Acta Anat (Basel), V120, P185; Faussone-Pellegrini MS, 1985, ARCH IT J ANAT EMBRI, V88, P25; FAUSSONEPELLEGRINI MS, 1990, CAN J PHYSIOL PHARM, V68, P1437, DOI 10.1139/y90-218; Gallego D, 2010, NEUROGASTROENT MOTIL, V22, pe180, DOI 10.1111/j.1365-2982.2010.01495.x; Huber A, 1998, AM J PHYSIOL-GASTR L, V275, pG1146, DOI 10.1152/ajpgi.1998.275.5.G1146; Martin MT, 2004, NEUROGASTROENT MOTIL, V16, P175, DOI 10.1111/j.1365-2982.2004.00518.x; Martinez-Cutillas M, 2013, NEUROGASTROENT MOTIL, V25, pE803, DOI 10.1111/nmo.12206; NARDUCCI F, 1986, DIGEST DIS SCI, V31, P241, DOI 10.1007/BF01318114; Santicioli P, 1999, N-S ARCH PHARMACOL, V359, P420, DOI 10.1007/PL00005370; Strege PR, 2004, NEUROGASTROENT MOTIL, V16, P167, DOI 10.1111/j.1365-2982.2004.00517.x; Sutton JA, 1997, EUR J CLIN PHARMACOL, V52, P365, DOI 10.1007/s002280050302; Teng BQ, 1998, AM J PHYSIOL-GASTR L, V275, pG342, DOI 10.1152/ajpgi.1998.275.2.G342; Traini C, 2013, NEUROGASTROENT MOTIL, V25, pE728, DOI 10.1111/nmo.12197; Triantafillidis JK, 2014, CLIN EXP GASTROENTER, V7, P75, DOI 10.2147/CEG.S46291; Vannucchi MG, 2002, NEUROSCI LETT, V326, P191, DOI 10.1016/S0304-3940(02)00338-5	25	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103237	10.1371/journal.pone.0103237	http://dx.doi.org/10.1371/journal.pone.0103237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122192	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000013
J	Wang, CL; Zhuang, Y; Guo, WW; Cao, LL; Zhang, H; Xu, LZ; Fan, YM; Zhang, DP; Wang, YP				Wang, Chunli; Zhuang, Yi; Guo, Wenwen; Cao, Lili; Zhang, Huan; Xu, Lizhi; Fan, Yimei; Zhang, Deping; Wang, Yaping			Mucin 5B Promoter Polymorphism Is Associated with Susceptibility to Interstitial Lung Diseases in Chinese Males	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; SYSTEMIC-SCLEROSIS; REVISED CRITERIA; EXPRESSION; MUC5B; GENE; CLASSIFICATION; PNEUMONIA; DERMATOMYOSITIS; POLYMYOSITIS	The variation of G>T in the MUC5B promoter (rs35705950) has been associated with idiopathic pulmonary fibrosis (IPF) and familial interstitial pneumonia (FIP) in Caucasians, but no information is available regarding this variant in the Chinese population. We recruited 405 patients with interstitial lung diseases (ILD), including 165 IPF patients and 2043 healthy controls, for genotyping the MUC5B gene in the Chinese population. One hundred three patients with pneumonia and 360 patients with autoimmune diseases (ADs) were recruited as disease controls. Our results indicated that the prevalence of the minor allele (T) of the polymorphism rs35705950 in healthy Chinese subjects was approximately 0.66%, which was lower than that described in the Caucasian population. The frequencies of the T allele were 3.33% and 2.22% in IPF and ILD patients, respectively, and these values were significantly higher than those of healthy controls (P = 0.001, OR = 4.332 for IPF, and P = 0.002, OR = 2.855 for ILD). A stratified analysis showed that this variant in MUC5B associated with the risk for ILD mainly in older male Chinese subjects. No difference was observed between patients with pneumonia, AD patients, and healthy controls.	[Wang, Chunli; Zhuang, Yi; Guo, Wenwen; Cao, Lili; Zhang, Huan; Xu, Lizhi; Fan, Yimei; Wang, Yaping] Nanjing Univ, Sch Med, Dept Med Genet, Nanjing 210008, Jiangsu, Peoples R China; [Zhuang, Yi; Zhang, Deping] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China; [Zhuang, Yi; Zhang, Deping] Nanjing Univ, Affiliated Drum Tower Hosp, Sch Med, Dept Respirol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University	Wang, YP (corresponding author), Nanjing Univ, Sch Med, Dept Med Genet, Nanjing 210008, Jiangsu, Peoples R China.	wangyap@nju.edu.cn		Guo, Wenwen/0000-0001-8563-0359	National Natural Science Foundation of China [81270152, 81070273]; Open Foundation of the State Key Laboratory of Pharmaceutical Biotechnology [KF-GN-201201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Foundation of the State Key Laboratory of Pharmaceutical Biotechnology	This work was partly supported by the National Natural Science Foundation of China (grant number: 81270152,81070273) and the Open Foundation of the State Key Laboratory of Pharmaceutical Biotechnology (grant number: KF-GN-201201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society, 2002, AM J RESP CRIT CARE, V165, P277, DOI DOI 10.1164/ajrccm.165.2.ats01; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Borie R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070621; Chinese Society of Respiratory Diseases, 2004, 6 NAT RESP DIS AC M, V27, P857; Choi WI, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-172; Cui Y, 2014, MOL MED, V20, P120, DOI 10.2119/molmed.2013.00123; Devine MS, 2012, CLIN CHEST MED, V33, P95, DOI 10.1016/j.ccm.2011.11.001; Ding M, 2013, CELL BIOCHEM BIOPHYS, V67, P905, DOI 10.1007/s12013-013-9580-1; Ekstrom M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004018; Ferri C, 2002, MEDICINE, V81, P139, DOI 10.1097/00005792-200203000-00004; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Gorini G, 2013, CANCER CAUSE CONTROL, V24, P1385, DOI 10.1007/s10552-013-0218-9; Gutsche M, 2012, CURR PULMONOL REP, V1, P224, DOI 10.1007/s13665-012-0028-7; Hermalin AI, 2012, POPUL RES POLICY REV, V31, P545, DOI 10.1007/s11113-012-9239-4; Hubbard R, 1998, AM J RESP CRIT CARE, V157, P743, DOI 10.1164/ajrccm.157.3.9701093; Hubbard R, 1996, LANCET, V347, P284, DOI 10.1016/S0140-6736(96)90465-1; Hutyrova B, 2002, AM J RESP CRIT CARE, V165, P148, DOI 10.1164/ajrccm.165.2.2106004; Kamio K, 2005, AM J RESP CRIT CARE, V171, P949, DOI 10.1164/rccm.200409-1168OC; Kim EA, 2002, RADIOGRAPHICS, V22, pS151, DOI 10.1148/radiographics.22.suppl_1.g02oc04s151; Kirkham S, 2008, AM J RESP CRIT CARE, V178, P1033, DOI 10.1164/rccm.200803-391OC; Lai CC, 2012, RESP MED, V106, P1566, DOI 10.1016/j.rmed.2012.07.012; Leikauf GD, 2002, CHEST, V121, p166S, DOI 10.1378/chest.121.5_suppl.166S; Ley Brett, 2013, Clin Epidemiol, V5, P483, DOI 10.2147/CLEP.S54815; Macneal Ken, 2012, Proc Am Thorac Soc, V9, P120, DOI 10.1513/pats.201112-055AW; Marie I, 2002, ARTHRIT RHEUM-ARTHR, V47, P614, DOI 10.1002/art.10794; Noth I, 2013, LANCET RESP MED, V1, P309, DOI 10.1016/S2213-2600(13)70045-6; O'Donnell RA, 2004, THORAX, V59, P1032, DOI 10.1136/thx.2004.028043; Park JH, 2007, AM J RESP CRIT CARE, V175, P705, DOI 10.1164/rccm.200607-912OC; Peljto AL, 2012, CHEST, V142, P1584, DOI 10.1378/chest.12-0110; Plantier L, 2011, THORAX, V66, P651, DOI 10.1136/thx.2010.151555; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Schwartz David A, 2008, Proc Am Thorac Soc, V5, P343, DOI 10.1513/pats.200710-158DR; Seibold MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058658; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Sepper R, 2012, J LEUKOCYTE BIOL, V92, P319, DOI 10.1189/jlb.0111047; Solomon JJ, 2013, EUR RESPIR REV, V22, P6, DOI 10.1183/09059180.00005512; Son JY, 2013, LUNG, V191, P199, DOI 10.1007/s00408-012-9447-z; Stock CJ, 2013, THORAX, V68, P436, DOI 10.1136/thoraxjnl-2012-201786; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; THORNTON DJ, 1994, AM J RESP CRIT CARE, V150, P823, DOI 10.1164/ajrccm.150.3.8087358; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vitali C, 1996, ANN RHEUM DIS, V55, P116, DOI 10.1136/ard.55.2.116; World Health Organization (WHO), 2012, TOB CONTR PRACT; Zhang J, 2012, RESP MED, V106, P1456, DOI 10.1016/j.rmed.2012.06.015; Zhang X, 2012, CHINESE MED J-PEKING, V125, P1945, DOI 10.3760/cma.j.issn.0366-6999.2012.11.020; Zhang YZ, 2011, NEW ENGL J MED, V364, P1576, DOI 10.1056/NEJMc1013504	48	37	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104919	10.1371/journal.pone.0104919	http://dx.doi.org/10.1371/journal.pone.0104919			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121989	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000074
J	Hoedt, E; Chaoui, K; Huvent, I; Mariller, C; Monsarrat, B; Burlet-Schiltz, O; Pierce, A				Hoedt, Esthelle; Chaoui, Karima; Huvent, Isabelle; Mariller, Christophe; Monsarrat, Bernard; Burlet-Schiltz, Odile; Pierce, Annick			SILAC-Based Proteomic Profiling of the Human MDA-MB-231 Metastatic Breast Cancer Cell Line in Response to the Two Antitumoral Lactoferrin Isoforms: The Secreted Lactoferrin and the Intracellular Delta-Lactoferrin	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; NF-KAPPA-B; MESSENGER-RNA; GROWTH ARREST; RECOMBINANT ADENOVIRUS; TRANSCRIPTION FACTOR; MILK LACTOFERRIN; SELENOPROTEIN-H; GENE; EXPRESSION	Background: Lactoferrins exhibit antitumoral activities either as a secretory lactoferrin or an intracellular delta-lactoferrin isoform. These activities involve processes such as regulation of the cell cycle and apoptosis. While lactoferrin has been shown to exert its function by activating different transduction pathways, delta-lactoferrin has been proven to act as a transcription factor. Like many tumor suppressors, these two proteins are under-expressed in several types of cancer, particularly in breast cancer. Methodology/Principal Findings: In order to compare the differential effects of the re-introduction of lactoferrin isoforms in breast cancer cells we chose the cancerous mammary gland MDA-MB-231 cell line as a model. We produced a cell line stably expressing delta-lactoferrin. We also treated these cells with fresh purified human breast lactoferrin. We performed two quantitative proteomic studies in parallel using SILAC coupled to mass spectrometry in order to compare the effects of different doses of the two lactoferrin isoforms. The proteome of untreated, delta-lactoferrin expressing and human lactoferrin treated MDA-MB-231 cells were compared. Overall, around 5300 proteins were identified and quantified using the in-house developed MFPaQ software. Among these, expression was increased by 1.5-fold or more for around 300 proteins in delta-lactoferrin expressing cells and 190 proteins in lactoferrin treated cells. At the same time, about 200 and 40 proteins were found to be downregulated (0-0.7-fold) in response to delta-lactoferrin and lactoferrin, respectively. Conclusions/Significance: Re-introduction of delta-lactoferrin and lactoferrin expression in MDA-MB-231 mainly leads to modifications of protein profiles involved in processes such as proliferation, apoptosis, oxidative stress, the ubiquitin pathway, translation and mRNA quality control. Moreover, this study identified new target genes of delta-lactoferrin transcriptional activity such as SelH, GTF2F2 and UBE2E1.	[Hoedt, Esthelle; Huvent, Isabelle; Mariller, Christophe; Pierce, Annick] CNRS, UGSF, USTL IFR 147, UMR 8576, Villeneuve Dascq, France; [Chaoui, Karima; Monsarrat, Bernard; Burlet-Schiltz, Odile] CNRS, IPBS, Toulouse, France; [Chaoui, Karima; Monsarrat, Bernard; Burlet-Schiltz, Odile] Univ Toulouse, IPBS, UPS, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Pierce, A (corresponding author), CNRS, UGSF, USTL IFR 147, UMR 8576, Villeneuve Dascq, France.	annick.pierce@univ-lille1.fr		Schiltz, Odile/0000-0002-3606-2356; Huvent, Isabelle/0000-0002-7241-0290	CNRS UMR 8576 (Unite de Glycobiologie Structurale et Fonctionnelle); Institut Federatif de Recherche [147]; Universite des Sciences et Technologies de Lille I; Comite du Nord de la Ligue Nationale contre le Cancer; Region Midi-Pyrenees, European funds (FEDER, Fonds Europeens de Developpement Regional)	CNRS UMR 8576 (Unite de Glycobiologie Structurale et Fonctionnelle); Institut Federatif de Recherche; Universite des Sciences et Technologies de Lille I; Comite du Nord de la Ligue Nationale contre le Cancer; Region Midi-Pyrenees, European funds (FEDER, Fonds Europeens de Developpement Regional)(Region Occitanie)	This investigation was supported in part by the CNRS UMR 8576 (Unite de Glycobiologie Structurale et Fonctionnelle), the Institut Federatif de Recherche no 147, the Universite des Sciences et Technologies de Lille I, the Comite du Nord de la Ligue Nationale contre le Cancer, the Region Midi-Pyrenees, European funds (FEDER, Fonds Europeens de Developpement Regional). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1023, DOI 10.1271/bbb.121011; Baker HM, 2012, BIOCHEM CELL BIOL, V90, P320, DOI [10.1139/O11-071, 10.1139/o11-071]; Benaissa M, 2005, INT J CANCER, V114, P299, DOI 10.1002/ijc.20728; BEZAULT J, 1994, CANCER RES, V54, P2310; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Bouyssie D, 2007, MOL CELL PROTEOMICS, V6, P1621, DOI 10.1074/mcp.T600069-MCP200; Breton M, 2004, BIOMETALS, V17, P325, DOI 10.1023/B:BIOM.0000027712.81056.13; Damiens E, 1999, J CELL BIOCHEM, V74, P486, DOI 10.1002/(SICI)1097-4644(19990901)74:3<486::AID-JCB16>3.3.CO;2-Y; Danish HH, 2013, BREAST J, V19, P231, DOI 10.1111/tbj.12097; Deng M, 2013, ONCOGENE, V32, P4273, DOI 10.1038/onc.2012.434; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elass E, 2002, INFECT IMMUN, V70, P1860, DOI 10.1128/IAI.70.4.1860-1866.2002; Fensterl V, 2011, J INTERF CYTOK RES, V31, P71, DOI 10.1089/jir.2010.0101; Fujita K, 2004, CARCINOGENESIS, V25, P1961, DOI 10.1093/carcin/bgh205; Goldberg Gary S, 2005, Med Chem, V1, P57, DOI 10.2174/1573406053402532; Ha NH, 2011, CANCER RES, V71, P7259, DOI 10.1158/0008-5472.CAN-11-1143; Habib HM, 2013, FOOD CHEM, V141, P148, DOI 10.1016/j.foodchem.2013.03.039; Hardiville S, 2014, BIOMETALS, V27, P875, DOI 10.1007/s10534-014-9744-5; Hardiville S, 2010, J BIOL CHEM, V285, P19205, DOI 10.1074/jbc.M109.080572; Haversen L, 2002, CELL IMMUNOL, V220, P83, DOI 10.1016/S0008-8749(03)00006-6; HE JL, 1995, NATURE, V373, P721, DOI 10.1038/373721a0; Hoedt E, 2010, BIOMETALS, V23, P441, DOI 10.1007/s10534-010-9305-5; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanwar RK, 2013, PROTEIN PEPTIDE LETT, V20, P450; Kim B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055338; Kim CW, 2012, FEBS LETT, V586, P229, DOI 10.1016/j.febslet.2011.12.011; Kim SY, 2003, NEUROCHEM RES, V28, P925, DOI 10.1023/A:1023283628454; Komiya M, 2013, JPN J CLIN ONCOL, V43, P685, DOI 10.1093/jjco/hyt053; Krishnan N, 2008, FREE RADICAL BIO MED, V44, P671, DOI 10.1016/j.freeradbiomed.2007.10.054; Lai KC, 2013, ONCOGENE, V32, P3686, DOI 10.1038/onc.2012.384; Lai KC, 2008, MOL CANCER RES, V6, P1; Lee SH, 2010, BIOMETALS, V23, P507, DOI 10.1007/s10534-010-9341-1; Lee SH, 2009, BIOCHIMIE, V91, P102, DOI 10.1016/j.biochi.2008.05.004; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Legrand D, 2008, ADV EXP MED BIOL, V606, P163, DOI 10.1007/978-0-387-74087-4_6; Legrand D, 2012, BIOCHEM CELL BIOL, V90, P252, DOI [10.1139/O11-056, 10.1139/o11-056]; Li WY, 2011, CANCER BIOTHER RADIO, V26, P477, DOI 10.1089/cbr.2010.0937; Lin TY, 2005, BIOCHEM BIOPH RES CO, V337, P330, DOI 10.1016/j.bbrc.2005.09.056; Liu DX, 2003, BIOCHEM BIOPH RES CO, V301, P472, DOI 10.1016/S0006-291X(02)03077-2; Mariller C, 2007, FEBS J, V274, P2038, DOI 10.1111/j.1742-4658.2007.05747.x; Mariller C, 2012, BIOCHEM CELL BIOL, V90, P307, DOI [10.1139/O11-070, 10.1139/o11-070]; Mariller C, 2009, BIOCHIMIE, V91, P109, DOI 10.1016/j.biochi.2008.07.009; MASSON PL, 1969, J EXP MED, V130, P643, DOI 10.1084/jem.130.3.643; Mendelev N, 2009, EXP NEUROL, V220, P328, DOI 10.1016/j.expneurol.2009.09.008; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; MISAWA Y, 2006, PROTOCOL EXCHANGE, DOI DOI 10.1038/NPROT.2006.219; Novoselov SV, 2007, J BIOL CHEM, V282, P11960, DOI 10.1074/jbc.M701605200; Oh SM, 2004, ONCOGENE, V23, P8282, DOI 10.1038/sj.onc.1208021; Oh SM, 2001, J BIOL CHEM, V276, P42575, DOI 10.1074/jbc.M107724200; Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; PANELLA TJ, 1991, CANCER RES, V51, P3037; Penco S, 2001, BIOTECHNOL APPL BIOC, V34, P151, DOI 10.1042/BA20010038; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reich NC, 2013, J INTERF CYTOK RES, V33, P199, DOI 10.1089/jir.2012.0159; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Shubbar E, 2013, BMC CANCER, V13, P13; Siebert PD, 1997, P NATL ACAD SCI USA, V94, P2198, DOI 10.1073/pnas.94.6.2198; Son HJ, 2006, BIOCHEM CELL BIOL, V84, P345, DOI 10.1139/O06-048; Son KN, 2002, BIOCHEM BIOPH RES CO, V290, P236, DOI 10.1006/bbrc.2001.6181; Sousa JF, 2012, AM J PATHOL, V181, P1560, DOI 10.1016/j.ajpath.2012.07.027; SPIK G, 1988, BIOCHIMIE, V70, P1459, DOI 10.1016/0300-9084(88)90283-0; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Suzuki YA, 2005, CELL MOL LIFE SCI, V62, P2560, DOI 10.1007/s00018-005-5371-1; TAN SY, 1994, J BIOL CHEM, V269, P25684; Teng C, 2004, BIOMETALS, V17, P317, DOI 10.1023/B:BIOM.0000027711.13818.8a; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Tsuda H, 2010, BIOMETALS, V23, P399, DOI 10.1007/s10534-010-9331-3; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vogel HJ, 2012, BIOCHEM CELL BIOL, V90, P233, DOI [10.1139/O2012-016, 10.1139/o2012-016]; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024967; Wang JJ, 2011, ARCH PHARM RES, V34, P987, DOI 10.1007/s12272-011-0616-z; Xiao S, 2006, P NATL ACAD SCI USA, V103, P16448, DOI 10.1073/pnas.0607830103; Xiao Y, 2004, CLIN CANCER RES, V10, P8683, DOI 10.1158/1078-0432.CCR-04-0988; Yin CM, 2013, CURR PROTEIN PEPT SC, V14, P492, DOI 10.2174/13892037113149990066; Zemann N, 2010, BIOCHIMIE, V92, P880, DOI 10.1016/j.biochi.2010.03.013; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	78	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104563	10.1371/journal.pone.0104563	http://dx.doi.org/10.1371/journal.pone.0104563			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116916	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400056
J	Ollivier, V; Syvannarath, V; Gros, A; Butt, A; Loyau, S; Jandrot-Perrus, M; Ho-Tin-Noe, B				Ollivier, Veronique; Syvannarath, Varouna; Gros, Angele; Butt, Amena; Loyau, Stephane; Jandrot-Perrus, Martine; Ho-Tin-Noe, Benoit			Collagen Can Selectively Trigger a Platelet Secretory Phenotype via Glycoprotein VI	PLOS ONE			English	Article							KISS-AND-RUN; ALPHA-GRANULES; AGGREGATION; ACTIVATION; PROTEINS; RELEASE; ANGIOGENESIS; ADHESION; IDENTIFICATION; INFLAMMATION	Platelets are not only central actors of hemostasis and thrombosis but also of other processes including inflammation, angiogenesis, and tissue regeneration. Accumulating evidence indicates that these "non classical'' functions of platelets do not necessarily rely on their well-known ability to form thrombi upon activation. This suggests the existence of non-thrombotic alternative states of platelets activation. We investigated this possibility through dose-response analysis of thrombin-and collagen-induced changes in platelet phenotype, with regards to morphological and functional markers of platelet activation including shape change, aggregation, P-selectin and phosphatidylserine surface expression, integrin activation, and release of soluble factors. We show that collagen at low dose (0.25 mu g/mL) selectively triggers a platelet secretory phenotype characterized by the release of dense-and alpha granule-derived soluble factors without causing any of the other major platelet changes that usually accompany thrombus formation. Using a blocking antibody to glycoprotein VI (GPVI), we further show that this response is mediated by GPVI. Taken together, our results show that platelet activation goes beyond the mechanisms leading to platelet aggregation and also includes alternative platelet phenotypes that might contribute to their thrombus-independent functions.	[Ollivier, Veronique; Syvannarath, Varouna; Gros, Angele; Butt, Amena; Loyau, Stephane; Jandrot-Perrus, Martine; Ho-Tin-Noe, Benoit] INSERM, Lab Vasc Translat Sci, Unit 1148, Paris, France; [Ollivier, Veronique; Syvannarath, Varouna; Gros, Angele; Loyau, Stephane; Jandrot-Perrus, Martine; Ho-Tin-Noe, Benoit] Paris Diderot Univ, Paris, France; [Butt, Amena] Univ Paris 13, F-93430 Villetaneuse, France; [Jandrot-Perrus, Martine] Hop Bichat Claude Bernard, AP HP, F-75877 Paris 18, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Ho-Tin-Noe, B (corresponding author), INSERM, Lab Vasc Translat Sci, Unit 1148, Paris, France.	benoit.ho-tin-noe@inserm.fr	Ollivier, Véronique/AAA-2241-2022; Jandrot-Perrus, Martine/GZM-1526-2022; Ho-Tin-Noé, Benoit/U-8059-2018	Ho-Tin-Noé, Benoit/0000-0002-7428-1760; Ollivier, Veronique/0000-0003-1318-1712; Loyau, stephane/0000-0001-8748-501X; JANDROT-PERRUS, Martine/0000-0002-8450-9247	Institut National de la Sante et de la Recherche Medicale; DHU FIRE; CORDDIM Region Ile de France; la Fondation de France	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); DHU FIRE; CORDDIM Region Ile de France(Region Ile-de-France); la Fondation de France(Fondation de France)	This work was supported by the Institut National de la Sante et de la Recherche Medicale and by grants from DHU FIRE, la Fondation de France, and CORDDIM Region Ile de France to Benoit Ho-Tin-Noe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSOIAN RK, 1983, J BIOL CHEM, V258, P7155; Bambace NM, 2010, PLATELETS, V21, P85, DOI 10.3109/09537100903470298; Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Bergmeier W, 2009, J THROMB HAEMOST, V7, P187, DOI 10.1111/j.1538-7836.2009.03379.x; BEVERS EM, 1982, EUR J BIOCHEM, V122, P81, DOI 10.1111/j.1432-1033.1982.tb05850.x; BEZEAUD A, 1985, EUR J BIOCHEM, V153, P491, DOI 10.1111/j.1432-1033.1985.tb09328.x; BOULAFTALI Y, 2013, J CLIN INVEST; Brill A, 2004, CARDIOVASC RES, V63, P226, DOI 10.1016/j.cardiores.2004.04.012; Broos K, 2012, THROMB RES, V129, P245, DOI 10.1016/j.thromres.2011.11.002; Broos K, 2011, BLOOD REV, V25, P155, DOI 10.1016/j.blre.2011.03.002; Chatterjee M, 2011, BLOOD, V117, P3907, DOI 10.1182/blood-2010-12-327007; Cognasse F, 2008, BRIT J HAEMATOL, V141, P84, DOI 10.1111/j.1365-2141.2008.06999.x; DACHARYPRIGENT J, 1993, BLOOD, V81, P2554; Elhamdani A, 2006, J NEUROSCI, V26, P3030, DOI 10.1523/JNEUROSCI.5275-05.2006; Fitch-Tewfik Jennifer L, 2013, Front Endocrinol (Lausanne), V4, P77, DOI 10.3389/fendo.2013.00077; Flaumenhaft R, 2003, ARTERIOSCL THROM VAS, V23, P1152, DOI 10.1161/01.ATV.0000075965.88456.48; FURIE B, 1991, CURR STUD HEMATOL BL, V58, P32; Ge SC, 2011, BIOPHYS J, V101, P2351, DOI 10.1016/j.bpj.2011.10.001; Goerge T, 2008, BLOOD, V111, P4958, DOI 10.1182/blood-2007-11-123620; HAMBURGER SA, 1990, BLOOD, V75, P550; He LM, 2007, TRENDS NEUROSCI, V30, P447, DOI 10.1016/j.tins.2007.06.012; Heemskerk JWM, 1997, BLOOD, V90, P2615, DOI 10.1182/blood.V90.7.2615.2615_2615_2625; Hirahashi J, 2009, CIRCULATION, V120, P1255, DOI 10.1161/CIRCULATIONAHA.109.873695; Ho-Tin-Noe B, 2008, CANCER RES, V68, P6851, DOI 10.1158/0008-5472.CAN-08-0718; Ho-Tin-Noe B, 2009, AM J PATHOL, V175, P1699, DOI 10.2353/ajpath.2009.090460; Ho-Tin-Noe B, 2009, CANCER RES, V69, P5623, DOI 10.1158/0008-5472.CAN-09-1370; Italiano JE, 2009, J THROMB HAEMOST, V7, P173, DOI 10.1111/j.1538-7836.2009.03387.x; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; JandrotPerrus M, 1997, J BIOL CHEM, V272, P27035, DOI 10.1074/jbc.272.43.27035; Jonnalagadda D, 2012, BLOOD, V120, P5209, DOI 10.1182/blood-2012-07-445080; Kamykowski J, 2011, BLOOD, V118, P1370, DOI 10.1182/blood-2011-01-330910; Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Leytin V, 2000, BIOCHEM BIOPH RES CO, V273, P565, DOI 10.1006/bbrc.2000.2977; Li JJ, 2001, THROMB HAEMOSTASIS, V85, P204, DOI 10.1055/s-0037-1615677; Li Y., 2012, ADV HEMATOL, V2012; Maxwell MJ, 2007, BLOOD, V109, P566, DOI 10.1182/blood-2006-07-028282; MCEVER RP, 1990, BLOOD CELLS, V16, P73; McNicol A, 1999, THROMB RES, V95, P1, DOI 10.1016/S0049-3848(99)00015-8; Meyer A, 2012, BLOOD, V119, P1064, DOI 10.1182/blood-2011-09-377648; Missy K, 2001, THROMB HAEMOSTASIS, V85, P514, DOI 10.1055/s-0037-1615614; Nurden AT, 2011, THROMB HAEMOSTASIS, V105, pS13, DOI 10.1160/THS10-11-0720; Ohlmann P, 2000, BLOOD, V96, P2134, DOI 10.1182/blood.V96.6.2134.h8002134_2134_2139; Sachais BS, 2004, SEMIN THROMB HEMOST, V30, P351, DOI 10.1055/s-2004-831048; Sehgal S, 2007, J THROMB HAEMOST, V5, P2009, DOI 10.1111/j.1538-7836.2007.02698.x; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739; Stefanini L, 2009, BLOOD, V114, P2506, DOI 10.1182/blood-2009-04-218768; Trumel C, 1999, BLOOD, V94, P4156, DOI 10.1182/blood.V94.12.4156.424k29_4156_4165; Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011	51	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104712	10.1371/journal.pone.0104712	http://dx.doi.org/10.1371/journal.pone.0104712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116206	Green Published, gold			2022-12-27	WOS:000341230400074
J	van Lent, M; Overbeke, J; Out, HJ				van Lent, Marlies; Overbeke, John; Out, Henk Jan			Role of Editorial and Peer Review Processes in Publication Bias: Analysis of Drug Trials Submitted to Eight Medical Journals	PLOS ONE			English	Article							SURGERY AMERICAN VOLUME; PHARMACEUTICAL-INDUSTRY; ASSOCIATION; ACCEPTANCE; POLICIES; QUALITY	Background: Publication bias is generally ascribed to authors and sponsors failing to submit studies with negative results, but may also occur after submission. We evaluated whether submitted manuscripts on randomized controlled trials (RCTs) with drugs are more likely to be accepted if they report positive results. Methods: Manuscripts submitted from January 2010 through April 2012 to one general medical journal (BMJ) and seven specialty journals (Annals of the Rheumatic Diseases, British Journal of Ophthalmology, Gut, Heart, Thorax, Diabetologia, and Journal of Hepatology) were included, if at least one study arm assessed the efficacy or safety of a drug and a statistical test was used to evaluate treatment effects. Publication status was retrospectively retrieved from submission systems or provided by journals. Sponsorship and trial results were extracted from manuscripts and classified according to predefined criteria. Main outcome measure was acceptance for publication. Results: Of 15,972 manuscripts submitted, 472 (3.0%) were drug RCTs, of which 98 (20.8%) were published. Among submitted drug RCTs, 287 (60.8%) had positive and 185 (39.2%) negative results. Of these, 60 (20.9%) and 38 (20.5%), respectively, were published. Manuscripts on non-industry trials (n = 213) reported positive results in 138 (64.8%) manuscripts, compared to 71 (47.7%) on industry-supported trials (n = 149), and 78 (70.9%) on industry-sponsored trials (n = 110). Twenty-seven (12.7%) non-industry trials were published, compared to 27 (18.1%) industry-supported and 44 (40.0%) industry-sponsored trials. After adjustment for other trial characteristics, manuscripts reporting positive results were not more likely to be published (OR, 1.00; 95% CI, 0.61 to 1.66). Submission to specialty journals, sample size, multicentre status, journal impact factor, and corresponding authors from Europe or US were significantly associated with publication. Conclusions: For the selected journals, there was no tendency to preferably publish manuscripts on drug RCTs that reported positive results, suggesting that publication bias may occur mainly prior to submission.	[van Lent, Marlies; Out, Henk Jan] Radboud Univ Nijmegen, Med Ctr, Clin Res Ctr Nijmegen, Dept Pharmacol Toxicol, NL-6525 ED Nijmegen, Netherlands; [Overbeke, John] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Out, Henk Jan] Teva Pharmaceut, Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	van Lent, M (corresponding author), Radboud Univ Nijmegen, Med Ctr, Clin Res Ctr Nijmegen, Dept Pharmacol Toxicol, NL-6525 ED Nijmegen, Netherlands.	Marlies.vanLent@radboudumc.nl	van Lent, Marlies/P-6033-2015		MSD, The Netherlands	MSD, The Netherlands	This research was supported by an unrestricted educational grant from MSD, The Netherlands. MSD (Merck, Sharp & Dohme) is a Dutch subsidiary of Merck & Co., Inc. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot NC, 1998, PERFUSION, V11, P182; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Conen D, 2008, CIRCULATION, V118, P1321, DOI 10.1161/CIRCULATIONAHA.108.794016; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; Emerson GB, 2010, ARCH INTERN MED, V170, P1934, DOI 10.1001/archinternmed.2010.406; Glymour MM, 2005, BRIT MED J, V331, P638, DOI 10.1136/bmj.331.7517.638-a; Handel AE, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4212; Hopewell S, 2003, INT J TECHNOL ASSESS, V19, P711, DOI 10.1017/S0266462303000680; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Kravitz RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010072; Kulkarni AV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000403; Lee KP, 2006, MED J AUSTRALIA, V184, P621, DOI 10.5694/j.1326-5377.2006.tb00418.x; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Lundh A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000354; Lynch JR, 2007, J BONE JOINT SURG AM, V89A, P1010, DOI 10.2106/JBJS.F.01152; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Okike K, 2008, J BONE JOINT SURG AM, V90A, P2432, DOI 10.2106/JBJS.G.01687; Okike K, 2008, J BONE JOINT SURG AM, V90A, P595, DOI 10.2106/JBJS.G.00279; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Sage Journals, 2022, SAGE J; Senn S, 2012, F1000RESEARCH, V1; Smulders YM, 2013, J CLIN EPIDEMIOL, V66, P946, DOI 10.1016/j.jclinepi.2013.03.023; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Song FJ, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-79; Sridharan L, 2009, ARCH INTERN MED, V169, P1022, DOI 10.1001/archinternmed.2009.100; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; van Lent M, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-120; Wager E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5248	33	44	45	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104846	10.1371/journal.pone.0104846	http://dx.doi.org/10.1371/journal.pone.0104846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25118182	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400096
J	Yu, JB; Shi, J; Gong, LR; Dong, SA; Xu, Y; Zhang, Y; Cao, XS; Wu, LL				Yu, Jian-bo; Shi, Jia; Gong, Li-rong; Dong, Shu-an; Xu, Yan; Zhang, Yuan; Cao, Xin-shun; Wu, Li-li			Role of Nrf2/ARE Pathway in Protective Effect of Electroacupuncture against Endotoxic Shock-Induced Acute Lung Injury in Rabbits	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; ISCHEMIA-REPERFUSION; HEME OXYGENASE-1; MONOXIDE SYSTEM; LIPOIC ACID; OLEIC-ACID; RATS; EXPRESSION; ACTIVATION	NF-E2 related factor 2 (Nrf2) is a major transcription factor and acts as a key regulator of antioxidant genes to exogenous stimulations. The aim of current study was to determine whether Nrf2/ARE pathway is involved in the protective effect of electroacupuncture on the injured lung in a rabbit model of endotoxic shock. A dose of lipopolysaccharide (LPS) 5 mg/kg was administered intravenously to replicate the model of acute lung injury induced by endotoxic shock. Electroacupuncture pretreatment was handled bilaterally at Zusanli and Feishu acupoints for five consecutive days while sham electroacupuncture punctured at non-acupoints. Fourty anesthetized New England male rabbits were randomized into normal control group (group C), LPS group (group L), electroacupuncture + LPS group (group EL) and sham electroacupuncture + LPS (group SEL). At 6 h after LPS administration, the animals were sacrificed and the blood samples were collected for biochemical measurements. The lungs were removed for calculation of wet-to-dry weight ratios (W/D), histopathologic examination, determination of heme oxygenase (HO)-1 protein and mRNA, Nrf2 total and nucleoprotein, as well as Nrf2 mRNA expression, and evaluation of the intracellular distribution of Nrf2 nucleoprotein. LPS caused extensive morphologic lung damage, which was lessened by electroacupuncture treatment. Besides, lung W/D ratios were significantly decreased, the level of malondialdehyde was inhibited, plasma levels of TNF-alpha and interleukin-6 were decreased, while the activities of superoxide dismutase, glutathione peroxidase and catalase were enhanced in the electroacupucnture treated animals. In addition, electroacupuncture stimulation distinctly increased the expressions of HO-1 and Nrf2 protein including Nrf2 total protein and nucleoprotein as well as mRNA in lung tissue, while these effects were blunted in the sham electroacupuncture group. We concluded that electroacupuncture treatment at ST36 and BL13 effectively attenuates lung injury in a rabbit model of endotoxic shock through activation of Nrf2/ARE pathway and following up-regulation of HO-1 expression.	[Yu, Jian-bo; Shi, Jia; Gong, Li-rong; Dong, Shu-an; Xu, Yan; Zhang, Yuan; Cao, Xin-shun; Wu, Li-li] Tianjin Med Univ, Tianjin Nankai Hosp, Dept Anesthesiol, Tianjin, Peoples R China	Tianjin Medical University	Yu, JB (corresponding author), Tianjin Med Univ, Tianjin Nankai Hosp, Dept Anesthesiol, Tianjin, Peoples R China.	yujianbo11@126.com			National Natural Science Foundation of China, Beijing, China [81372096]; Key Project of Tianjin Science and Technology Support, Tianjin, China [12ZCZDSY03300]	National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Key Project of Tianjin Science and Technology Support, Tianjin, China	This research was supported by grants No. 81372096 from the National Natural Science Foundation of China, Beijing, China, and grant 12ZCZDSY03300 from the Key Project of Tianjin Science and Technology Support, Tianjin, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Bauer M, 2008, INTENS CARE MED, V34, P640, DOI 10.1007/s00134-008-1010-2; Chen HI, 2008, CRIT CARE MED, V36, P1214, DOI 10.1097/CCM.0b013e31816a0607; Chen HH, 2012, FREE RADICAL BIO MED, V52, P1054, DOI 10.1016/j.freeradbiomed.2011.12.012; Chen XJ, 2013, RESP PHYSIOL NEUROBI, V188, P214, DOI 10.1016/j.resp.2013.04.014; Chernyak GV, 2005, ANESTHESIOLOGY, V102, P1031, DOI 10.1097/00000542-200505000-00024; Di Filippo A, 2006, ANN CLIN LAB SCI, V36, P345; Fer ND, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-91; Ferreira Arthurde de Sa, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P969, DOI 10.3736/jcim20091011; Francis RC, 2011, ANESTHESIOLOGY, V115, P1012, DOI 10.1097/ALN.0b013e31823306cf; GHOSH S, 1993, CRIT CARE MED, V21, pS19, DOI 10.1097/00003246-199302001-00005; Goraca A, 2007, J PHYSIOL PHARMACOL, V58, P541; Goraca A, 2009, J PHYSIOL PHARMACOL, V60, P61; Jian-Bo Y, 2008, CHINESE MED J-PEKING, V121, P49, DOI 10.1097/00029330-200801010-00010; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Kilic U, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-7; Kim JH, 2012, FREE RADICAL BIO MED, V53, P629, DOI 10.1016/j.freeradbiomed.2012.04.019; LOEWENBERG J. R., 1967, ANAL BIOCHEM, V19, P95, DOI 10.1016/0003-2697(67)90138-8; Mikawa K, 2003, ANESTH ANALG, V97, P1751, DOI 10.1213/01.ANE.0000086896.90343.13; MIKAWA K, 1994, ANESTHESIOLOGY, V81, P689, DOI 10.1097/00000542-199409000-00023; Mikawa K, 1998, CRIT CARE MED, V26, P905, DOI 10.1097/00003246-199805000-00026; MISRA HP, 1971, J BIOL CHEM, V246, P6886; NISHINA K, 1995, ANESTHESIOLOGY, V83, P169, DOI 10.1097/00000542-199507000-00020; Nishina K, 1997, ANESTH ANALG, V84, P1097, DOI 10.1097/00000539-199705000-00026; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pan P, 2010, EXP BIOL MED, V235, P642, DOI 10.1258/ebm.2010.009353; Sarkar S, 2013, CELL MOL BIOENG, V6, P130, DOI 10.1007/s12195-013-0272-0; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Song JG, 2012, ANESTHESIOLOGY, V116, P406, DOI 10.1097/ALN.0b013e3182426ebd; Takaki S, 2010, INTENS CARE MED, V36, P42, DOI 10.1007/s00134-009-1575-4; Takao Y, 2005, ANESTH ANALG, V100, P810, DOI 10.1213/01.ANE.0000144775.19385.8C; Tsai PS, 2006, ANESTHESIOLOGY, V105, P1201, DOI 10.1097/00000542-200612000-00020; Voigtsberger S, 2009, ANESTHESIOLOGY, V111, P1238, DOI 10.1097/ALN.0b013e3181bdf857; Wang C, 2011, CHINESE MED J-PEKING, V124, P3476, DOI 10.3760/cma.j.issn.0366-6999.2011.21.007; Wang K, 2009, ANESTH ANALG, V109, P1666, DOI 10.1213/ANE.0b013e3181b5a234; Xia JG, 2014, ANESTHESIOLOGY, V120, P1441, DOI 10.1097/ALN.0000000000000259; Yu JB, 2009, IRISH J MED SCI, V178, P491, DOI 10.1007/s11845-008-0260-x; Yu JB, 2009, TRANSL RES, V153, P283, DOI 10.1016/j.trsl.2009.01.002; Yu JB, 2013, EXP BIOL MED, V238, P705, DOI 10.1177/1535370213489487; Yu JB, 2013, ANESTH ANALG, V116, P239, DOI 10.1213/ANE.0b013e31826f0a4a; Yu M, 2013, REGUL TOXICOL PHARM, V66, P279, DOI 10.1016/j.yrtph.2013.04.005; Zhang HX, 2009, CAN J CARDIOL, V25, P359, DOI 10.1016/S0828-282X(09)70095-9; Zhang ZD, 2012, ANESTH ANALG, V114, P879, DOI 10.1213/ANE.0b013e318246536d; Zhao HD, 2010, WORLD J GASTROENTERO, V16, P3002, DOI 10.3748/wjg.v16.i24.3002	44	42	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104924	10.1371/journal.pone.0104924	http://dx.doi.org/10.1371/journal.pone.0104924			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115759	Green Submitted, gold, Green Published			2022-12-27	WOS:000341230400107
J	Lin, J; Yuan, YB; Zhou, JL; Gao, J				Lin, Jing; Yuan, Yongbo; Zhou, Jilai; Gao, Jie			Methodology to Improve Design of Accelerated Life Tests in Civil Engineering Projects	PLOS ONE			English	Article								For reliability testing an Energy Expansion Tree (EET) and a companion Energy Function Model (EFM) are proposed and described in this paper. Different from conventional approaches, the EET provides a more comprehensive and objective way to systematically identify external energy factors affecting reliability. The EFM introduces energy loss into a traditional Function Model to identify internal energy sources affecting reliability. The combination creates a sound way to enumerate the energies to which a system may be exposed during its lifetime. We input these energies into planning an accelerated life test, a Multi Environment Over Stress Test. The test objective is to discover weak links and interactions among the system and the energies to which it is exposed, and design them out. As an example, the methods are applied to the pipe in subsea pipeline. However, they can be widely used in other civil engineering industries as well. The proposed method is compared with current methods.	[Lin, Jing; Yuan, Yongbo; Zhou, Jilai; Gao, Jie] Dalian Univ Technol, Dept Construct Management, Dalian, Peoples R China	Dalian University of Technology	Lin, J (corresponding author), Dalian Univ Technol, Dept Construct Management, Dalian, Peoples R China.	jing.lin@mail.dlut.edu.cn			National Basic Research Program of China (973 Program) [2011CB013702]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This paper is funded by the 2nd subproject of the National Basic Research Program of China (973 Program), Lifetime Reliability Study of Subsea Structure under Extreme Environmental Conditions, Grant No: 2011CB013702 (URL: http://www.973.gov.cn/English/AreaList.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annappa CM, 2012, INT J APPL INNOVATIO, V1; Bhote K. R., 2004, WORLD CLASS RELIABIL; Bhote KR, 2004, WORLD CLASS RELIABIL, P28; Bhote KR, 2004, WORLD CLASS RELIABIL, P174; Brito R, 2013, OFFSH TECHN C HOUST; Chiles James R, 2002, INVITING DISASTER LE; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dugstad A, 1992, CORR 92; Hobbs G., 2000, ACCELERATED RELIABIL; Jin CS, 2002, ACTA GEOLOGICA SINIC, V76; Katz D.L., 1959, HDB NATURAL GAS ENG; Lin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093042; Liu BJ, 1989, MAT CORROSION CONTRO, P114; Liu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057473, 10.1371/journal.pone.0050719, 10.1371/journal.pone.0064143]; Marca D., 1987, SADT STRUCTURED ANAL; Martinez-Palou R, 2011, J PETROL SCI ENG, V75, P274, DOI 10.1016/j.petrol.2010.11.020; Neyman J, 1945, U CALIFORNIA BERKELE, V1; Pahl G., 1984, ENG DESIGN; Palmer AC, 2008, SUBSEA PIPELINE ENG; Palmer AC., 2008, SUBSEA PIPELINE ENG; Palmer AC, 2008, SUBSEA PIPELINE ENG; Palmer AC, 2008, SYSTEM RELIABILITY T; Palmer AC, 2008, SUBSEA PIPELINE ENG; Palmer AC, 2008, SCI ED; Pan DZ, 2007, DYNAMIC RESPONSE SEA; QY He, 2013, HYDRODYNAMIC TEST RE, P8; Rausand M, 2004, SYSTEM RELIABILITY T; Rausand M., 2004, SYSTEM RELIABILITY T; Stack MM, 2010, WEAR, V268, P533, DOI 10.1016/j.wear.2009.09.013; Sun BK, 2011, MAT PROTECTION, V44; Taleb NN, 2007, BLACK SWAN RANDOM HO; Tang X, 2004, SEM MEAS METH EL COR; Tang X, 2003, RES SOFT MEASUREMENT; Teng B, 2011, LIFETIME RELIABILITY, P15; Videm K, 1987, CORR 87; Wallis S, 2013, J QUANT LINGUIST, V20, P178, DOI 10.1080/09296174.2013.799918; Weibull W, 1951, STAT DISTRIBUTION FU; Xu PD, 2007, METHODOLOGY APPL RIS, P135	38	1	1	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e103937	10.1371/journal.pone.0103937	http://dx.doi.org/10.1371/journal.pone.0103937			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111800	Green Submitted, Green Published, gold			2022-12-27	WOS:000341105100023
J	Sabir, F; Leandro, MJ; Martins, AP; Loureiro-Dias, MC; Moura, TF; Soveral, G; Prista, C				Sabir, Farzana; Leandro, Maria Jose; Martins, Ana Paula; Loureiro-Dias, Maria C.; Moura, Teresa F.; Soveral, Graca; Prista, Catarina			Exploring Three PIPs and Three TIPs of Grapevine for Transport of Water and Atypical Substrates through Heterologous Expression in aqy-null Yeast	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEINS; PLASMA-MEMBRANE; REACTIVE OXYGEN; FUNCTIONAL-CHARACTERIZATION; HYDROGEN-PEROXIDE; GENE FAMILY; BORIC-ACID; AQUAPORINS; STRESS; BORON	Aquaporins are membrane channels that facilitate the transport of water and other small molecules across the cellular membranes. We examined the role of six aquaporins of Vitis vinifera (cv. Touriga nacional) in the transport of water and atypical substrates (other than water) in an aqy-null strain of Saccharomyces cerevisiae. Their functional characterization for water transport was performed by stopped-flow fluorescence spectroscopy. The evaluation of permeability coefficients (P-f) and activation energies (Ea) revealed that three aquaporins (VvTnPIP2;1, VvTnTIP1;1 and VvTnTIP2;2) are functional for water transport, while the other three (VvTnPIP1;4, VvTnPIP2;3 and VvTnTIP4;1) are non-functional. TIPs (VvTnTIP1;1 and VvTnTIP2; 2) exhibited higher water permeability than VvTnPIP2;1. All functional aquaporins were found to be sensitive to HgCl2, since their water conductivity was reduced (24-38%) by the addition of 0.5 mM HgCl2. Expression of Vitis aquaporins caused different sensitive phenotypes to yeast strains when grown under hyperosmotic stress generated by KCl or sorbitol. Our results also indicate that Vitis aquaporins are putative transporters of other small molecules of physiological importance. Their sequence analyses revealed the presence of signature sequences for transport of ammonia, boron, CO2, H2O2 and urea. The phenotypic growth variations of yeast cells showed that heterologous expression of Vitis aquaporins increased susceptibility to externally applied boron and H2O2, suggesting the contribution of Vitis aquaporins in the transport of these species.	[Sabir, Farzana; Leandro, Maria Jose; Martins, Ana Paula; Loureiro-Dias, Maria C.; Prista, Catarina] Univ Lisbon, Inst Super Agron, CBAA, P-1699 Lisbon, Portugal; [Sabir, Farzana; Martins, Ana Paula; Moura, Teresa F.; Soveral, Graca] Univ Lisbon, Fac Farm, Inst Invest Medicamento iMed ULisboa, P-1699 Lisbon, Portugal; [Soveral, Graca] Univ Lisbon, Fac Farm, Dept Bioquim & Biol Humana, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Prista, C (corresponding author), Univ Lisbon, Inst Super Agron, CBAA, P-1699 Lisbon, Portugal.	cprista@isa.ulisboa.pt	Moura, Teresa F/E-2485-2014; Martins, Ana Paula/A-5657-2013; Soveral, Graça/L-1550-2013; iMed.ULisboa, MetGen/B-5293-2014; Sabir, Farzana/A-7319-2014; Prista, C./H-9049-2019; Prista, Catarina/N-7079-2013; Leandro, Maria/K-5461-2015	Martins, Ana Paula/0000-0002-5064-6171; Soveral, Graça/0000-0001-8487-110X; Sabir, Farzana/0000-0002-0181-989X; Prista, C./0000-0001-9307-1905; Prista, Catarina/0000-0001-9307-1905; Leandro, Maria/0000-0002-2254-4610; Fonseca de Moura, Teresa Maria/0000-0003-3069-0770	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [SFRH/BPD/89427/2012, SFRH/BPD/41812/2007, Ciencia 2007, PTDC/AGR/AAM/099154/2008]	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	This work is supported by Fundacao para a Ciencia e Tecnologia (FCT), Portugal (Post-Doctral grants-SFRH/BPD/89427/2012 to F. S. and SFRH/BPD/41812/2007 to M. J. L., Ciencia 2007 to C. P. and project grant PTDC/AGR/AAM/099154/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes F, 2001, BIOCHEM J, V356, P549, DOI 10.1042/0264-6021:3560549; Azad AK, 2008, J EXP BOT, V59, P2085, DOI 10.1093/jxb/ern066; Azad AK, 2012, BBA-BIOMEMBRANES, V1818, P1, DOI 10.1016/j.bbamem.2011.09.014; Baiges I, 2001, J EXP BOT, V52, P1949, DOI 10.1093/jexbot/52.362.1949; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Bienert GP, 2014, BBA-BIOMEMBRANES, V1838, P216, DOI 10.1016/j.bbamem.2013.08.011; Boursiac Y, 2008, PLANT J, V56, P207, DOI 10.1111/j.1365-313X.2008.03594.x; Canetta E, 2009, J MICROBIOL BIOTECHN, V19, P547, DOI 10.4014/jmb.0809.515; Chaumont F, 2005, BIOL CELL, V97, P749, DOI 10.1042/BC20040133; DANIELS MJ, 1994, PLANT PHYSIOL, V106, P1325, DOI 10.1104/pp.106.4.1325; Daniels MJ, 1996, PLANT CELL, V8, P587, DOI 10.1105/tpc.8.4.587; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; Dordas C, 2000, PLANT PHYSIOL, V124, P1349, DOI 10.1104/pp.124.3.1349; Dynowski M, 2008, BIOCHEM J, V414, P53, DOI 10.1042/BJ20080287; Fitzpatrick KL, 2009, PLANT CELL ENVIRON, V32, P1357, DOI 10.1111/j.1365-3040.2009.02003.x; Flexas J, 2010, AUST J GRAPE WINE R, V16, P106, DOI 10.1111/j.1755-0238.2009.00057.x; Forrest KL, 2007, FUNCT INTEGR GENOMIC, V7, P263, DOI 10.1007/s10142-007-0049-4; Fouquet R, 2008, PLANT CELL REP, V27, P1541, DOI 10.1007/s00299-008-0566-1; Foyer CH, 2003, PHYSIOL PLANTARUM, V119, P355, DOI 10.1034/j.1399-3054.2003.00223.x; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Galmes J, 2007, PLANTA, V226, P671, DOI 10.1007/s00425-007-0515-1; Gambetta GA, 2012, J EXP BOT, V63, P6445, DOI 10.1093/jxb/ers312; Guldener U, 1998, TECHNICAL REPORT; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Hayes MA, 2007, J EXP BOT, V58, P1985, DOI 10.1093/jxb/erm061; Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hove RM, 2011, PLANT MOL BIOL, V75, P413, DOI 10.1007/s11103-011-9737-5; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358; Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Kjellbom P, 1999, TRENDS PLANT SCI, V4, P308, DOI 10.1016/S1360-1385(99)01438-7; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuthan M, 2003, MOL MICROBIOL, V47, P745, DOI 10.1046/j.1365-2958.2003.03332.x; Leitao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033219; MAUREL C, 1993, EMBO J, V12, P2241, DOI 10.1002/j.1460-2075.1993.tb05877.x; Maurel C, 2001, PLANT PHYSIOL, V125, P135, DOI 10.1104/pp.125.1.135; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Mitani N, 2008, PFLUG ARCH EUR J PHY, V456, P679, DOI 10.1007/s00424-007-0408-y; Mori IC, 2004, PLANT PHYSIOL, V135, P702, DOI 10.1104/pp.104.042069; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Noronha H, 2014, J EXP BOT, V65, P981, DOI 10.1093/jxb/ert448; Nozawa A, 2006, FEMS MICROBIOL LETT, V262, P216, DOI 10.1111/j.1574-6968.2006.00395.x; Nyblom M, 2009, J MOL BIOL, V387, P653, DOI 10.1016/j.jmb.2009.01.065; Pettersson N, 2006, CURR GENET, V50, P247, DOI 10.1007/s00294-006-0092-z; Pou A, 2013, PLANT CELL ENVIRON, V36, P828, DOI 10.1111/pce.12019; Prak S, 2008, MOL CELL PROTEOMICS, V7, P1019, DOI 10.1074/mcp.M700566-MCP200; Pronk JT, 2002, APPL ENVIRON MICROB, V68, P2095, DOI 10.1128/AEM.68.5.2095-2100.2002; Santoni V, 2006, BIOCHEM J, V400, P189, DOI 10.1042/BJ20060569; Schnurbusch T, 2010, PLANT PHYSIOL, V153, P1706, DOI 10.1104/pp.110.158832; Shelden MC, 2009, FUNCT PLANT BIOL, V36, P1065, DOI 10.1071/FP09117; Soveral G, 2007, APPL ENVIRON MICROB, V73, P2341, DOI 10.1128/AEM.02519-06; Soveral G, 2008, BBA-BIOMEMBRANES, V1778, P2573, DOI 10.1016/j.bbamem.2008.07.018; Suga S, 2004, PLANT CELL PHYSIOL, V45, P823, DOI 10.1093/pcp/pch120; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka M, 2008, PLANT CELL, V20, P2860, DOI 10.1105/tpc.108.058628; Tanaka M, 2008, PFLUG ARCH EUR J PHY, V456, P671, DOI 10.1007/s00424-007-0370-8; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Van Wilder V, 2008, PLANT CELL PHYSIOL, V49, P1364, DOI 10.1093/pcp/pcn112; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; Wudick MM, 2009, NEW PHYTOL, V184, P289, DOI 10.1111/j.1469-8137.2009.02985.x; Zelazny E, 2009, PLANT J, V57, P346, DOI 10.1111/j.1365-313X.2008.03691.x	67	18	18	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e102087	10.1371/journal.pone.0102087	http://dx.doi.org/10.1371/journal.pone.0102087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111598	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100007
J	Ye, H; Wong, KP; Wardak, M; Dahlbom, M; Kepe, V; Barrio, JR; Nelson, LD; Small, GW; Huang, SC				Ye, Hu; Wong, Koon-Pong; Wardak, Mirwais; Dahlbom, Magnus; Kepe, Vladimir; Barrio, Jorge R.; Nelson, Linda D.; Small, Gary W.; Huang, Sung-Cheng			Automated Movement Correction for Dynamic PET/CT Images: Evaluation with Phantom and Patient Data	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HUMAN BRAIN; MOTION CORRECTION; ATTENUATION CORRECTION; GRAPHICAL ANALYSIS; INPUT FUNCTION; 3D PET/CT; NEURORECEPTOR; QUANTIFICATION; REGISTRATION	Head movement during a dynamic brain PET/CT imaging results in mismatch between CT and dynamic PET images. It can cause artifacts in CT-based attenuation corrected PET images, thus affecting both the qualitative and quantitative aspects of the dynamic PET images and the derived parametric images. In this study, we developed an automated retrospective image-based movement correction (MC) procedure. The MC method first registered the CT image to each dynamic PET frames, then re-reconstructed the PET frames with CT-based attenuation correction, and finally re-aligned all the PET frames to the same position. We evaluated the MC method's performance on the Hoffman phantom and dynamic FDDNP and FDG PET/CT images of patients with neurodegenerative disease or with poor compliance. Dynamic FDDNP PET/CT images (65 min) were obtained from 12 patients and dynamic FDG PET/CT images (60 min) were obtained from 6 patients. Logan analysis with cerebellum as the reference region was used to generate regional distribution volume ratio (DVR) for FDDNP scan before and after MC. For FDG studies, the image derived input function was used to generate parametric image of FDG uptake constant (K-i) before and after MC. Phantom study showed high accuracy of registration between PET and CT and improved PET images after MC. In patient study, head movement was observed in all subjects, especially in late PET frames with an average displacement of 6.92 mm. The z-direction translation (average maximum = 5.32 mm) and x-axis rotation (average maximum = 5.19 degrees) occurred most frequently. Image artifacts were significantly diminished after MC. There were significant differences (P<0.05) in the FDDNP DVR and FDG Ki values in the parietal and temporal regions after MC. In conclusion, MC applied to dynamic brain FDDNP and FDG PET/CT scans could improve the qualitative and quantitative aspects of images of both tracers.	[Ye, Hu; Wong, Koon-Pong; Wardak, Mirwais; Dahlbom, Magnus; Kepe, Vladimir; Barrio, Jorge R.; Nelson, Linda D.; Small, Gary W.; Huang, Sung-Cheng] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Huang, SC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	hhuang@mednet.ucla.edu	Wong, Koon-Pong/AAI-3780-2020	Wong, Koon-Pong/0000-0002-6095-4645	Chinese Scholarship Council; Department of Molecular and Medical Pharmacology at UCLA; NIH [R01-EB001943, P50-CA086306, P01-AG025831, P01-AG033015]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033015, P01AG025831] Funding Source: NIH RePORTER	Chinese Scholarship Council(China Scholarship Council); Department of Molecular and Medical Pharmacology at UCLA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Hu Ye was supported by the Chinese Scholarship Council and the Department of Molecular and Medical Pharmacology at UCLA. This work was also partially supported by NIH grants R01-EB001943, P50-CA086306, P01-AG025831 and P01-AG033015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton-Rodriguez JM, 2010, IEEE NUCL SCI CONF R, P2935, DOI 10.1109/NSSMIC.2010.5874334; Bloomfield PM, 2003, PHYS MED BIOL, V48, P959, DOI 10.1088/0031-9155/48/8/301; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chen K, 1998, J CEREBR BLOOD F MET, V18, P716, DOI 10.1097/00004647-199807000-00002; Cizek J, 2004, NEUROIMAGE, V22, P434, DOI 10.1016/j.neuroimage.2004.01.016; Cizek J., 2004, FORSCHUNG WISSENSCHA, P115; Costes N, 2009, NEUROIMAGE, V47, P1496, DOI 10.1016/j.neuroimage.2009.05.052; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Herzog H, 2005, J NUCL MED, V46, P1059; HOFFMAN EJ, 1990, IEEE T NUCL SCI, V37, P616, DOI 10.1109/23.106686; HUANG SC, 1979, J COMPUT ASSIST TOMO, V3, P804; Keller SH, 2012, J NUCL MED, V53, P495, DOI 10.2967/jnumed.111.095240; Kinahan PE, 1998, MED PHYS, V25, P2046, DOI 10.1118/1.598392; Liu J, 2007, MOL IMAGING BIOL, V9, P6, DOI 10.1007/s11307-006-0061-4; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Maes F, 1999, Med Image Anal, V3, P373, DOI 10.1016/S1361-8415(99)80030-9; Mourik JEM, 2009, EUR J NUCL MED MOL I, V36, P2002, DOI 10.1007/s00259-009-1193-y; Nelson LD, 2011, ARCH NEUROL-CHICAGO, V68, P768, DOI 10.1001/archneurol.2011.104; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Shin J, 2011, J ALZHEIMERS DIS, V26, P135, DOI 10.3233/JAD-2011-0008; Silverman DHS, 2004, J NUCL MED, V45, P594; Slifstein M, 2000, J NUCL MED, V41, P2083; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Wardak M, 2010, J NUCL MED, V51, P210, DOI 10.2967/jnumed.109.063701; Watson CC, 2004, IEEE NUCL SCI CONF R, P3008; Wong KP, 2010, EUR J NUCL MED MOL I, V37, P575, DOI 10.1007/s00259-009-1293-8; Zanotti-Fregonara P, 2009, J CEREBR BLOOD F MET, V29, P1825, DOI 10.1038/jcbfm.2009.93; Zhou Y, 2009, NEUROIMAGE, V44, P661, DOI 10.1016/j.neuroimage.2008.09.021	29	17	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e103745	10.1371/journal.pone.0103745	http://dx.doi.org/10.1371/journal.pone.0103745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111700	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100021
J	Ruhl, H; Schroder, L; Muller, J; Sukhitashvili, S; Welz, J; Kuhn, WC; Oldenburg, J; Rudlowski, C; Potzsch, B				Ruehl, Heiko; Schroeder, Lars; Mueller, Jens; Sukhitashvili, Shorena; Welz, Julia; Kuhn, Walther C.; Oldenburg, Johannes; Rudlowski, Christian; Poetzsch, Bernd			Impact of Hormone-Associated Resistance to Activated Protein C on the Thrombotic Potential of Oral Contraceptives: A Prospective Observational Study	PLOS ONE			English	Article							RANDOMIZED CROSS-OVER; APC-RESISTANCE; FRAGMENT 1+2; COAGULATION; GENERATION; MUTATION; FIBRINOLYSIS; SENSITIVITY; PLASMA; BLOOD	Introduction: The increased thrombotic risk of oral contraceptives (OC) has been attributed to various alterations of the hemostatic system, including acquired resistance to activated protein C (APC). To evaluate to what extent OC-associated APC resistance induces a prothrombotic state we monitored plasma levels of thrombin and molecular markers specific for thrombin formation in women starting OC use. Elevated plasma levels of thrombin have been reported to characterize situations of high thrombotic risk such as trauma-induced hypercoagulability, but have not yet been studied during OC use. Patients and Methods: Blood samples were collected prospectively from healthy women (n = 21) before and during three menstruation cycles after start of OC. APC resistance was evaluated using a thrombin generation-based assay. Plasma levels of thrombin and APC were directly measured using highly sensitive oligonucleotide-based enzyme capture assay (OECA) technology. Thrombin generation markers and other hemostasis parameters were measured additionally. Results: All women developed APC resistance as indicated by an increased APC sensitivity ratio compared with baseline after start of OC (p = 0.0003). Simultaneously, plasma levels of thrombin, prothrombin fragment 1+2, and of thrombin-antithrombin complexes did not change, ruling out increased thrombin formation. APC plasma levels were also not influenced by OC use, giving further evidence that increased thrombin formation did not occur. Conclusions: In the majority of OC users no enhanced thrombin formation occurs despite the development of APC resistance. It cannot be ruled out, however, that thrombin formation might occur to a greater extent in the presence of additional risk factors. If this were the case, endogenous thrombin levels might be a potential biomarker candidate to identify women at high thrombotic risk during OC treatment. Large-scale studies are required to assess the value of plasma levels of thrombin as predictors of OC-associated thrombotic risk.	[Ruehl, Heiko; Mueller, Jens; Sukhitashvili, Shorena; Welz, Julia; Oldenburg, Johannes; Poetzsch, Bernd] Univ Hosp, Inst Expt Hematol & Transfus Med, Bonn, Germany; [Schroeder, Lars; Welz, Julia; Kuhn, Walther C.; Rudlowski, Christian] Univ Hosp, Ctr Integrated Oncol CIO Koln Bonn, Dept Gynecol & Obstet, Bonn, Germany	University of Bonn; University of Bonn; University of Cologne	Ruhl, H (corresponding author), Univ Hosp, Inst Expt Hematol & Transfus Med, Bonn, Germany.	heiko.ruehl@ukb.uni-bonn.de	Oldenburg, Johannes/ABB-7817-2020; Müller, Jens/A-8264-2012; Rühl, Heiko/E-3226-2017; Rühl, Heiko/AAI-3377-2021	Müller, Jens/0000-0001-7713-9631; Rühl, Heiko/0000-0003-0672-2453; Oldenburg, Johannes/0000-0002-1585-4100				Bremme K, 2012, THROMB RES, V130, P636, DOI 10.1016/j.thromres.2011.11.006; Castoldi E, 2010, J THROMB HAEMOST, V8, P445, DOI 10.1111/j.1538-7836.2009.03711.x; Castoldi E, 2011, THROMB RES, V127, pS21, DOI 10.1016/S0049-3848(11)70007-X; Crawley JTB, 2007, J THROMB HAEMOST, V5, P95, DOI 10.1111/j.1538-7836.2007.02500.x; Dahlback B, 2005, FEBS LETT, V579, P3310, DOI 10.1016/j.febslet.2005.03.001; de Bastos M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010813.pub2; De Visser MCH, 2005, J THROMB HAEMOST, V3, P1488; Gouin-Thibault I, 2002, THROMB RES, V107, P7, DOI 10.1016/S0049-3848(02)00189-5; Happich D, 1999, THROMB HAEMOSTASIS, V82, P1294; Happich D, 2000, THROMB HAEMOSTASIS, V84, P144, DOI 10.1055/s-0037-1613987; Hemker HC, 2006, THROMB HAEMOSTASIS, V96, P553, DOI 10.1160/TH06-07-0408; Jespersen J, 2003, CONTRACEPTION, V67, P173, DOI 10.1016/S0010-7824(02)00476-6; Manzoli L, 2012, DRUG SAFETY, V35, P191, DOI 10.2165/11598050-000000000-00000; Meijers JCM, 2000, THROMB HAEMOSTASIS, V84, P9; Middeldorp S, 2000, THROMB HAEMOSTASIS, V84, P4; Muller J, 2012, J THROMB HAEMOST, V10, P390, DOI 10.1111/j.1538-7836.2012.04623.x; Muller J, 2011, ANGEW CHEM INT EDIT, V50, P6075, DOI 10.1002/anie.201007032; Muller J, 2009, CHEM BIOL, V16, P442, DOI 10.1016/j.chembiol.2009.03.007; QUEHENBERGER P, 1993, ANN HEMATOL, V67, P33, DOI 10.1007/BF01709663; Rosing J, 1997, BRIT J HAEMATOL, V97, P233, DOI 10.1046/j.1365-2141.1997.192707.x; Rosing J, 1999, LANCET, V354, P2036, DOI 10.1016/S0140-6736(99)06092-4; Simioni P, 1996, BRIT J HAEMATOL, V92, P435, DOI 10.1046/j.1365-2141.1996.d01-1500.x; Tans G, 2000, THROMB HAEMOSTASIS, V84, P15, DOI 10.1055/s-0037-1613960; Tchaikovski SN, 2007, THROMB HAEMOSTASIS, V98, P1350, DOI 10.1160/TH07-07-0439; Van Vliet HAAM, 2004, J THROMB HAEMOST, V2, P2060, DOI 10.1111/j.1538-7836.2004.00983.x; van Vliet HAAM, 2008, THROMB RES, V121, P757, DOI 10.1016/j.thromres.2007.08.010; ZOLLER B, 1994, J CLIN INVEST, V94, P2521, DOI 10.1172/JCI117623; Zoller B, 1996, THROMB HAEMOSTASIS, V75, P270	28	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105007	10.1371/journal.pone.0105007	http://dx.doi.org/10.1371/journal.pone.0105007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121606	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000086
J	Belleville, S; Mellah, S; de Boysson, C; Demonet, JF; Bier, B				Belleville, Sylvie; Mellah, Samira; de Boysson, Chloe; Demonet, Jean-Francois; Bier, Bianca			The Pattern and Loci of Training-Induced Brain Changes in Healthy Older Adults Are Predicted by the Nature of the Intervention	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; EXECUTIVE FUNCTIONS; HEMISPHERIC-ASYMMETRY; PROSPECTIVE MEMORY; PREFRONTAL CORTEX; DISEASE SEVERITY; FRONTAL LOBES; PLASTICITY; TASK; FMRI	There is enormous interest in designing training methods for reducing cognitive decline in healthy older adults. Because it is impaired with aging, multitasking has often been targeted and has been shown to be malleable with appropriate training. Investigating the effects of cognitive training on functional brain activation might provide critical indication regarding the mechanisms that underlie those positive effects, as well as provide models for selecting appropriate training methods. The few studies that have looked at brain correlates of cognitive training indicate a variable pattern and location of brain changes - a result that might relate to differences in training formats. The goal of this study was to measure the neural substrates as a function of whether divided attentional training programs induced the use of alternative processes or whether it relied on repeated practice. Forty-eight older adults were randomly allocated to one of three training programs. In the SINGLE REPEATED training, participants practiced an alphanumeric equation and a visual detection task, each under focused attention. In the DIVIDED FIXED training, participants practiced combining verification and detection by divided attention, with equal attention allocated to both tasks. In the DIVIDED VARIABLE training, participants completed the task by divided attention, but were taught to vary the attentional priority allocated to each task. Brain activation was measured with fMRI pre- and post-training while completing each task individually and the two tasks combined. The three training programs resulted in markedly different brain changes. Practice on individual tasks in the SINGLE REPEATED training resulted in reduced brain activation whereas DIVIDED VARIABLE training resulted in a larger recruitment of the right superior and middle frontal gyrus, a region that has been involved in multitasking. The type of training is a critical factor in determining the pattern of brain activation.	[Belleville, Sylvie; Mellah, Samira; de Boysson, Chloe; Bier, Bianca] CRIUGM, Montreal, PQ, Canada; [Belleville, Sylvie; Bier, Bianca] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Demonet, Jean-Francois] CHU Vaudois, Vaud Univ Hosp, Leenaards Memory Ctr, Lausanne, Switzerland	Universite de Montreal; Universite de Montreal; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Belleville, S (corresponding author), CRIUGM, Montreal, PQ, Canada.	sylvie.belleville@umontreal.ca		Demonet, Jean-Francois/0000-0003-0100-6175	Natural Sciences and Engineering Research Council of Canada (NSERC); Faculty of Graduate studies of Universite de Montreal; CIHR	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Faculty of Graduate studies of Universite de Montreal; CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant to SB from the Natural Sciences and Engineering Research Council of Canada (NSERC; http://www.nserc-rsng.gc.ca/NSERC-CRSNG/). CDB was supported by scholarships from the Faculty of Graduate studies of Universite de Montreal. BB was supported by a scholarship from the CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; BARON A, 1989, PSYCHOL AGING, V4, P66, DOI 10.1037/0882-7974.4.1.66; Belleville S, 2012, CURR GERIATR REP, V1, P104, DOI 10.1007/s13670-012-0014-5; Belleville S, 2011, BRAIN, V134, P1623, DOI 10.1093/brain/awr037; Bherer L, 2004, AGING NEUROPSYCHOL C, V11, P37, DOI 10.1076/anec.11.1.37.29365; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Brehmer Y, 2011, NEUROIMAGE, V58, P1110, DOI 10.1016/j.neuroimage.2011.06.079; Brett M., 2002, INT C FUNCT MAPP HUM, V16, DOI 10.1016/S1053-8119(02)90013-3; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cabeza R., 2012, PRINCIPLES FRONTAL L; Carlson MC, 2009, J GERONTOL A-BIOL, V64, P1275, DOI 10.1093/gerona/glp117; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; Clare L, 2009, NEUROCASE, V15, P318, DOI 10.1080/13554790902783116; Clement F, 2013, CORTEX, V49, P1268, DOI 10.1016/j.cortex.2012.06.004; Clement F, 2012, J ALZHEIMERS DIS, V29, P109, DOI 10.3233/JAD-2012-110426; Clement F, 2010, BIOL PSYCHIAT, V68, P894, DOI 10.1016/j.biopsych.2010.02.004; Craik FIM, 2012, NEUROSCI BIOBEHAV R, V36, P1729, DOI 10.1016/j.neubiorev.2011.11.007; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; DiGirolamo GJ, 2001, NEUROREPORT, V12, P2065, DOI 10.1097/00001756-200107030-00054; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Erickson KI, 2007, NEUROBIOL AGING, V28, P272, DOI 10.1016/j.neurobiolaging.2005.12.012; Gilbert SJ, 2005, EUR J NEUROSCI, V21, P1423, DOI 10.1111/j.1460-9568.2005.03981.x; Hampstead BM, 2012, HIPPOCAMPUS, V22, P1652, DOI 10.1002/hipo.22006; Hampstead BM, 2011, NEUROREHAB NEURAL RE, V25, P210, DOI 10.1177/1545968310382424; Johnston MV, 2004, BRAIN DEV-JPN, V26, P73, DOI 10.1016/S0387-7604(03)00102-5; Kelly C, 2006, ARCH PHYS MED REHAB, V87, pS20, DOI 10.1016/j.apmr.2006.08.333; KOLB B, 1989, AM PSYCHOL, V44, P1203, DOI 10.1037/0003-066X.44.9.1203; Li SC, 1999, COGNITIVE NEUROSCIENCE OF MEMORY, P103; Lovden M, 2010, PSYCHOL BULL, V136, P659, DOI 10.1037/a0020080; Lustig C, 2009, NEUROPSYCHOL REV, V19, P504, DOI 10.1007/s11065-009-9119-9; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nyberg L, 2003, P NATL ACAD SCI USA, V100, P13728, DOI 10.1073/pnas.1735487100; Price CJ, 2002, TRENDS COGN SCI, V6, P416, DOI 10.1016/S1364-6613(02)01976-9; Prvulovic D, 2005, PSYCHIAT RES-NEUROIM, V140, P97, DOI 10.1016/j.pscychresns.2005.06.006; Reuter-Lorenz PA, 2005, CURR OPIN NEUROBIOL, V15, P245, DOI 10.1016/j.conb.2005.03.016; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Reuter-Lorenz PA, 2006, LIFESPAN DEVELOPMENT AND THE BRAIN: THE PERSPECTIVE OF BIOCULTURAL CO-CONSTRUCTIVISM, P255, DOI 10.1017/CBO9780511499722.014; Rosen AC, 2011, J ALZHEIMERS DIS, V26, P349, DOI 10.3233/JAD-2011-0009; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Szameitat AJ, 2011, NEUROIMAGE, V54, P1765, DOI 10.1016/j.neuroimage.2010.07.069; Wechsler D., 1997, WECHSLER ADULT INTEL; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709	48	47	50	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e102710	10.1371/journal.pone.0102710	http://dx.doi.org/10.1371/journal.pone.0102710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9BM	25119464	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600010
J	Kozhimanni, KB; Jou, J; Attanasio, LB; Joarnt, LK; McGovern, P				Kozhimanni, Katy B.; Jou, Judy; Attanasio, Laura B.; Joarnt, Lauren K.; McGovern, Patricia			Medically Complex Pregnancies and Early Breastfeeding Behaviors: A Retrospective Analysis	PLOS ONE			English	Article							FRIENDLY HOSPITAL PRACTICES; TO-SKIN CONTACT; CHRONIC HYPERTENSION; CESAREAN DELIVERY; MATERNAL OBESITY; MOTHER; WOMEN	Background: Breastfeeding is beneficial for women and infants, and medical contraindications are rare. Prenatal and labor-related complications may hinder breastfeeding, but supportive hospital practices may encourage women who intend to breastfeed. We measured the relationship between having a complex pregnancy (entering pregnancy with hypertension, diabetes, or obesity) and early infant feeding, accounting for breastfeeding intentions and supportive hospital practices. Methods: We performed a retrospective analysis of data from a nationally-representative survey of women who gave birth in 2011-2012 in a US hospital (N = 2400). We used logistic regression to examine the relationship between pregnancy complexity and breastfeeding. Self-reported prepregnancy diabetes or hypertension, gestational diabetes, or obesity indicated a complex pregnancy. The outcome was feeding status 1 week postpartum; any breastfeeding was evaluated among women intending to breastfeed (N = 1990), and exclusive breastfeeding among women who intended to exclusively breastfeed (N = 1418). We also tested whether breastfeeding intentions or supportive hospital practices mediated the relationship between pregnancy complexity and infant feeding status. Results: More than 33% of women had a complex pregnancy; these women had 30% lower odds of intending to breastfeed (AOR = 0.71; 95% CI, 0.52-0.98). Rates of intention to exclusively breastfeed were similar for women with and without complex pregnancies. Women who intended to breastfeed had similar rates of any breastfeeding 1 week postpartum regardless of pregnancy complexity, but complexity was associated with 30% lower odds of exclusive breastfeeding 1 week among women who intended to exclusively breastfeed (AOR = 0.68; 95% CI, 0.47-0.98). Supportive hospital practices were strongly associated with higher odds of any or exclusive breastfeeding 1 week postpartum (AOR = 4.03; 95% CI, 1.81-8.94; and AOR = 2.68; 95% CI, 1.70-4.23, respectively). Conclusions: Improving clinical and hospital support for women with complex pregnancies may increase breastfeeding rates and the benefits of breastfeeding for women and infants.	[Kozhimanni, Katy B.; Jou, Judy; Attanasio, Laura B.] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN 55455 USA; [Joarnt, Lauren K.] Harvard Univ, Cambridge, MA 02138 USA; [McGovern, Patricia] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; University of Minnesota System; University of Minnesota Twin Cities	Kozhimanni, KB (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN 55455 USA.	kbk@umn.edu			Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD) [R03HD070868]; Building Interdisciplinary Research Careers in Women's Health from NICHD [K12HD055887]; Office of Research on Women's Health; National Institute on Aging, at the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055887, R03HD070868] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Building Interdisciplinary Research Careers in Women's Health from NICHD; Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); National Institute on Aging, at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by a grant from the Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD; grant number R03HD070868) and the Building Interdisciplinary Research Careers in Women's Health Grant (grant number K12HD055887) from NICHD, the Office of Research on Women's Health, and the National Institute on Aging, at the National Institutes of Health, administered by the University of Minnesota Deborah E. Powell Center for Women's Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir Lisa H, 2007, BMC Pregnancy Childbirth, V7, P9, DOI 10.1186/1471-2393-7-9; [Anonymous], 2012, GOLD STAND CAR; Association of Women's Health Obstetric and Neonatal Nurses (AWHONN), 2009, STAND PROF NURS PRAC; Attanasio L, 2013, J HUM LACT, V29, P620, DOI 10.1177/0890334413504149; Aviram A, 2011, INT J GYNECOL OBSTET, V115, pS6, DOI 10.1016/S0020-7292(11)60004-0; Baby-Friendly USA, FIND FAC; Barbero P, 2013, J HUM LACT, V29, P446, DOI 10.1177/0890334413501287; Centre for Disease Control and Prevention, 2013, BREASTF REP CARD US; Chung M, 2008, INTERVENTIONS PRIMAR; Colaizy TT, 2008, J PERINATOL, V28, P505, DOI 10.1038/jp.2008.32; Declercq E, 2009, AM J PUBLIC HEALTH, V99, P929, DOI 10.2105/AJPH.2008.135236; Demirci JR, 2013, OBSTET GYNECOL, V122, P1263, DOI 10.1097/01.AOG.0000435453.93732.a6; DiGirolamo AM, 2008, PEDIATRICS, V122, pS43, DOI 10.1542/peds.2008-1315e; Dumas L, 2013, CLIN NURS RES, V22, P310, DOI 10.1177/1054773812468316; Dyson L, 2008, COCHRANE DB SYST REV, V2; Ekstrom Anette, 2003, J Hum Lact, V19, P172, DOI 10.1177/0890334403252537; Feig DS, 2002, LANCET, V359, P1690, DOI 10.1016/S0140-6736(02)08599-9; Ferrer RL, 2000, OBSTET GYNECOL, V96, P849, DOI 10.1016/S0029-7844(00)00938-8; Flaherman VJ, 2013, PEDIATR CLIN N AM, V60, P227, DOI 10.1016/j.pcl.2012.10.003; Flaherman VJ, 2011, PEDIATRICS, V127, P1177, DOI 10.1542/peds.2011-0056; Gilstrap LC, 2001, OBSTET GYNECOL, V98, P144; Gray JE, 2010, PEDIATRICS, V125, pE1460, DOI 10.1542/peds.2009-2621; Herrlich A, 2013, LISTENING MOTHERS; Kirchner L, 2009, ACTA PAEDIATR, V98, P981, DOI 10.1111/j.1651-2227.2009.01248.x; Kjos SL, 1999, NEW ENGL J MED, V341, P1749, DOI 10.1056/NEJM199912023412307; Kozhimannil KB, 2012, WOMEN HEALTH ISS, V23, pe77; Li RW, 2003, AM J CLIN NUTR, V77, P931, DOI 10.1093/ajcn/77.4.931; Lumbiganon P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006425.pub3; Martin Joyce A, 2013, Natl Vital Stat Rep, V62, P1; Matias SL, 2014, AM J CLIN NUTR, V99, P115, DOI 10.3945/ajcn.113.073049; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Murray EK, 2007, BIRTH-ISS PERINAT C, V34, P202, DOI 10.1111/j.1523-536X.2007.00172.x; Nyqvist KH, 2013, J HUM LACT, V29, P300, DOI 10.1177/0890334413489775; Perrine CG, 2012, PEDIATRICS, V130, P54, DOI 10.1542/peds.2011-3633; Prior E, 2012, AM J CLIN NUTR, V95, P1113, DOI 10.3945/ajcn.111.030254; Riley LE, 2012, GUID PER CAR AAP ACO; Rowe-Murray HJ, 2002, BIRTH-ISS PERINAT C, V29, P124, DOI 10.1046/j.1523-536X.2002.00172.x; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Sibai BM, 2002, OBSTET GYNECOL, V100, P369, DOI 10.1016/S0029-7844(02)02128-2; Taylor JS, 2005, J AM COLL NUTR, V24, P320, DOI 10.1080/07315724.2005.10719480; U. S. Department of Health and Human Services, 2013, HLTH PEOPL 2020 TOP; US Department of Health and Human Services, 2000, HLTH PEOPL 2010 C ED, V1; US Department of Health and Human Services, 2000, HLTH PEOPL 2010 C ED, V2; Velandia M, 2012, ACTA PAEDIATR, V101, P360, DOI 10.1111/j.1651-2227.2011.02523.x; Wahabi Hayfaa A, 2012, BMC Res Notes, V5, P496, DOI 10.1186/1756-0500-5-496; Weimers L., 2006, International Breastfeeding Journal, V1; Wiklund I, 2009, MIDWIFERY, V25, pE31, DOI 10.1016/j.midw.2007.07.005; Yoder SR, 2009, AM J MED, V122, P890, DOI 10.1016/j.amjmed.2009.03.036; Yogev Y, 2009, OBSTET GYN CLIN N AM, V36, P285, DOI 10.1016/j.ogc.2009.03.003; Zanardo V, 2010, BIRTH-ISS PERINAT C, V37, P275, DOI 10.1111/j.1523-536X.2010.00421.x	50	26	28	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104820	10.1371/journal.pone.0104820	http://dx.doi.org/10.1371/journal.pone.0104820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118976	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600090
J	Lehnert, LS; Kramer-Schadt, S; Schonborn, S; Lindecke, O; Niermann, I; Voigt, CC				Lehnert, Linn S.; Kramer-Schadt, Stephanie; Schoenborn, Sophia; Lindecke, Oliver; Niermann, Ivo; Voigt, Christian C.			Wind Farm Facilities in Germany Kill Noctule Bats from Near and Far	PLOS ONE			English	Article							ENERGY DEVELOPMENT; STABLE HYDROGEN; ADULT SURVIVAL; MIGRATION; MORTALITY; LASIURUS; ISOTOPES	Over recent years, it became widely accepted that alternative, renewable energy may come at some risk for wildlife, for example, when wind turbines cause large numbers of bat fatalities. To better assess likely populations effects of wind turbine related wildlife fatalities, we studied the geographical origin of the most common bat species found dead below German wind turbines, the noctule bat (Nyctalus noctula). We measured stable isotope ratios of non-exchangeable hydrogen in fur keratin to separate migrants from local individuals, used a linear mixed-effects model to identify temporal, spatial and biological factors explaining the variance in measured stable isotope ratios and determined the geographical breeding provenance of killed migrants using isoscape origin models. We found that 72% of noctule bat casualties (n = 136) were of local origin, while 28% were long-distance migrants. These findings highlight that bat fatalities at German wind turbines may affect both local and distant populations. Our results indicated a sex and age-specific vulnerability of bats towards lethal accidents at turbines, i.e. a relatively high proportion of killed females were recorded among migratory individuals, whereas more juveniles than adults were recorded among killed bats of local origin. Migratory noctule bats were found to originate from distant populations in the Northeastern parts of Europe. The large catchment areas of German wind turbines and high vulnerability of female and juvenile noctule bats call for immediate action to reduce the negative cross-boundary effects of bat fatalities at wind turbines on local and distant populations. Further, our study highlights the importance of implementing effective mitigation measures and developing species and scale-specific conservation approaches on both national and international levels to protect source populations of bats. The efficacy of local compensatory measures appears doubtful, at least for migrant noctule bats, considering the large geographical catchment areas of German wind turbines for this species.	[Lehnert, Linn S.; Kramer-Schadt, Stephanie; Schoenborn, Sophia; Lindecke, Oliver; Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Berlin, Germany; [Lindecke, Oliver] Univ Halle Wittenberg, Cent Repository Nat Sci Collect, D-06108 Halle, Saale, Germany; [Niermann, Ivo] Leibniz Univ Hannover, Inst Environm Planning, D-30167 Hannover, Germany	Leibniz Institut fur Zoo und Wildtierforschung; Martin Luther University Halle Wittenberg; Leibniz University Hannover	Lehnert, LS (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Berlin, Germany.	lehnert@izw-berlin.de	Lindecke, Oliver/Z-4304-2019; Lehnert, Linn/E-2941-2016; Kramer-Schadt, Stephanie/A-8778-2013	Lindecke, Oliver/0000-0002-2545-9999; Kramer-Schadt, Stephanie/0000-0002-9269-4446	Federal State of Berlin (Elsa-Neumann-Stipendium)	Federal State of Berlin (Elsa-Neumann-Stipendium)	We would like to thank Anja Luckner and Karin Sorgel from the IZW stable isotope laboratory for isotope analyses. We are indebted to Tobias Durr (Staatliche Vogelschutzwarte Buckow) for making fur samples available and thank Burkhard Lehmann and colleagues from MYOTIS - Buro fur Landschaftsokologie for support during fieldwork. Linn Sophia Lehnert was supported by the PhD student grant of the Federal State of Berlin (Elsa-Neumann-Stipendium).	Agostinelli C., 2011, R PACKAGE CIRCULAR C; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; BARCLAY RMR, 1991, J ANIM ECOL, V60, P165, DOI 10.2307/5452; Barrios L, 2004, J APPL ECOL, V41, P72, DOI 10.1111/j.1365-2664.2004.00876.x; Berkhout V, 2013, WIND ENERGY REPORT G; BfN, 2013, SHAPES NAT GLIED NAC; Blohm T, 2008, NATURSCH LANDSCHAFTS, V17, P153; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; BRD, 2010, NAT AKT ERN EN GEM R; Brinkmann R., 2011, ENTWICKLUNG METHODEN, P457; Cryan PM, 2004, J MAMMAL, V85, P995, DOI 10.1644/BRG-202; Cryan PM, 2003, J EXP BIOL, V206, P3381, DOI 10.1242/jeb.00574; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; Dietz C, 2009, HDB BATS EUROPE NW A; Ellison LE, 2013, 20121110 US GEOL SUR, P1; Fraser EE, 2013, CAN J ZOOL, V91, P533, DOI 10.1139/cjz-2013-0072; Hayes MA, 2013, BIOSCIENCE, V63, P975, DOI 10.1525/bio.2013.63.12.10; Heise G., 1989, NYCTALUS, V3, P17; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Hijmans RJ, 2012, GEOSPHERE SPHERICAL; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hutterer R, 2005, NATURSCHULT BIOL VIE, V28; ILYIN V. Y., 1990, P 5 ALL UN BAT C PEN, P86; Jones KE, 2003, AM NAT, V161, P601, DOI 10.1086/368289; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Kuvlesky WP, 2007, J WILDLIFE MANAGE, V71, P2487, DOI 10.2193/2007-248; O'Shea TJ, 2011, J MAMMAL, V92, P433, DOI 10.1644/10-MAMM-A-162.1; Ossa G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045729; Petersons G, 2004, MYOTIS, V41, P29; Petit E, 2000, MOL ECOL, V9, P683, DOI 10.1046/j.1365-294x.2000.00896.x; Pinheiro J., 2019, NLME LINEAR NONLINEA; Popa-Lisseanu AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030388; R Core Development Team, 2013, R LANG ENV STAT COMP; Rydell J, 2010, ACTA CHIROPTEROL, V12, P261, DOI 10.3161/150811010X537846; Schorcht W, 2009, J ANIM ECOL, V78, P1182, DOI 10.1111/j.1365-2656.2009.01577.x; Steffens R, 2004, 40 ANNIVERSARY BAT M, P132; Venables WN., 2002, MODERN APPL STAT S 4; Voigt CC, 2014, BIODIVERS CONSERV, DOI [10.1007/s10531-914-0620-y., DOI 10.1007/S10531-914-0620-Y]; Voigt CC, 2012, BIOL CONSERV, V153, P80, DOI 10.1016/j.biocon.2012.04.027; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	42	66	69	0	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103106	10.1371/journal.pone.0103106	http://dx.doi.org/10.1371/journal.pone.0103106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118805	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600017
J	Manzig, PC; Kellner, AWA; Weinschutz, LC; Fragoso, CE; Vega, CS; Guimaraes, GB; Godoy, LC; Liccardo, A; Ricetti, JHZ; de Moura, CC				Manzig, Paulo C.; Kellner, Alexander W. A.; Weinschutz, Luiz C.; Fragoso, Carlos E.; Vega, Cristina S.; Guimaraes, Gilson B.; Godoy, Luiz C.; Liccardo, Antonio; Ricetti, Joao H. Z.; de Moura, Camila C.			Discovery of a Rare Pterosaur Bone Bed in a Cretaceous Desert with Insights on Ontogeny and Behavior of Flying Reptiles	PLOS ONE			English	Article							PTERODACTYLOIDEA; CHINA; CTENOCHASMA; TAPEJARIDAE; LIMESTONE; GERMANY	A pterosaur bone bed with at least 47 individuals (wing spans: 0.65-2.35 m) of a new species is reported from southern Brazil from an interdunal lake deposit of a Cretaceous desert, shedding new light on several biological aspects of those flying reptiles. The material represents a new pterosaur, Caiuajara dobruskii gen. et sp. nov., that is the southermost occurrence of the edentulous clade Tapejaridae (Tapejarinae, Pterodactyloidea) recovered so far. Caiuajara dobruskii differs from all other members of this clade in several cranial features, including the presence of a ventral sagittal bony expansion projected inside the nasoantorbital fenestra, which is formed by the premaxillae; and features of the lower jaw, like a marked rounded depression in the occlusal concavity of the dentary. Ontogenetic variation of Caiuajara dobruskii is mainly reflected in the size and inclination of the premaxillary crest, changing from small and inclined (similar to 115 degrees) in juveniles to large and steep (similar to 90 degrees) in adults. No particular ontogenetic features are observed in postcranial elements. The available information suggests that this species was gregarious, living in colonies, and most likely precocial, being able to fly at a very young age, which might have been a general trend for at least derived pterosaurs.	[Manzig, Paulo C.; Weinschutz, Luiz C.; Ricetti, Joao H. Z.; de Moura, Camila C.] Univ Contestado, Ctr Paleontol UnC CENPALEO, Mafra, Santa Catarina, Brazil; [Manzig, Paulo C.] Univ Estadual Campinas UNICAMP, Programa Pos Grad IEL Labjor, Campinas, SP, Brazil; [Kellner, Alexander W. A.] Univ Fed Rio de Janeiro, Museu Nacl, Dept Geol & Paleontol, Lab Syst & Taphon Fossil Vertebrates, Rio De Janeiro, Brazil; [Fragoso, Carlos E.] Univ Estadual Ponta Grossa, Ponta Grossa, Parana, Brazil; Univ Fed Parana, Dept Geol, BR-80060000 Curitiba, Parana, Brazil; [Guimaraes, Gilson B.; Godoy, Luiz C.; Liccardo, Antonio] Univ Estadual Ponta Grossa, Dept Geociencias, Ponta Grossa, Parana, Brazil	Universidade do Contestado; Universidade Estadual de Campinas; Universidade Federal do Rio de Janeiro; Universidade Estadual de Ponta Grossa; Universidade Federal do Parana; Universidade Estadual de Ponta Grossa	Kellner, AWA (corresponding author), Univ Fed Rio de Janeiro, Museu Nacl, Dept Geol & Paleontol, Lab Syst & Taphon Fossil Vertebrates, Rio De Janeiro, Brazil.	kellner@mn.ufrj.br	Vega, Cristina/AAG-1471-2020; Kellner, Alexander W/H-1023-2015; Kellner, Alexander/ABE-9591-2020; Fragoso, Carlos Eduardo/U-6488-2017	Kellner, Alexander W/0000-0001-7174-9447; Kellner, Alexander/0000-0001-7174-9447; Fragoso, Carlos Eduardo/0000-0001-8971-2896; Ricetti, Joao Henrique Zahdi/0000-0003-3142-3869; Weinschutz, Luiz Carlos/0000-0002-8978-6120	Fundacao Carlos Chagas Filho de Amparo a pesquisa do Rio de Janeiro (FAPERJ) [E-26/102.737/2012]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [307276/2009-9]	Fundacao Carlos Chagas Filho de Amparo a pesquisa do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	AWAK acknowledges funding from the Fundacao Carlos Chagas Filho de Amparo a pesquisa do Rio de Janeiro (FAPERJ # E-26/102.737/2012) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq # 307276/2009-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres B, 2008, PALAEONTOLOGY, V51, P453, DOI 10.1111/j.1475-4983.2008.00761.x; Averianov A.O., 2010, Trudy Zoologicheskogo Instituta, V314, P264; Barrett Paul M., 2008, Zitteliana Reihe B, V28, P61; BELL CM, 1995, GEOL MAG, V132, P31, DOI 10.1017/S0016756800011407; Bennett S. C., 2001, PALAEONTOGR ABT A, V260, P1; Bennett SC, 2007, NEUES JAHRB GEOL P-A, V245, P23, DOI 10.1127/0077-7749/2007/0245-0023; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; Bennett SC, 1996, J VERTEBR PALEONTOL, V16, P432, DOI 10.1080/02724634.1996.10011332; BENNETT SC, 1989, J PALEONTOL, V63, P669, DOI 10.1017/S0022336000041305; BENNETT SC, 1995, J PALEONTOL, V69, P569, DOI 10.1017/S0022336000034946; Chiappe L.M., 1998, NEW MEXICO MUSEUM NA, V14, P187; Chinsamy A, 2008, BIOL LETTERS, V4, P282, DOI 10.1098/rsbl.2008.0004; Codorniu L, 2004, CAN J EARTH SCI, V41, P9, DOI 10.1139/E03-080; Costa F., 2013, SHORT COMMUNICATIONS, P54; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Eck Kristina, 2011, Swiss Journal of Palaeontology, V130, P277, DOI 10.1007/s13358-011-0024-5; Fernandes L.A., 2009, STIOS GEOLOGICOS PAL, P479; Frey Eberhard, 2003, Geological Society Special Publication, V217, P65, DOI 10.1144/GSL.SP.2003.217.01.06; Jouve S, 2004, J VERTEBR PALEONTOL, V24, P542, DOI 10.1671/0272-4634(2004)024[0542:DOTSOA]2.0.CO;2; Kellner, 2006, PTEROSSAUROS SENHORE; Kellner Alexander W.A., 2003, Geological Society Special Publication, V217, P105, DOI 10.1144/GSL.SP.2003.217.01.10; Kellner AWA, 2013, AN ACAD BRAS CIENC, V85, P113, DOI 10.1590/S0001-37652013000100009; Kellner AWA, 2010, AN ACAD BRAS CIENC, V82, P1063, DOI 10.1590/S0001-37652010000400025; Kellner Alexander W.A., 2007, Boletim do Museu Nacional Nova Serie Geologia, V75, P1; Kellner AWA, 2004, AMEGHINIANA, V41, P521; Kellner AWA, 2002, SCIENCE, V297, P389, DOI 10.1126/science.1073186; Kellner AWA, 2013, EARTH ENV SCI T R SO, V103, P1, DOI DOI 10.1017/S1755691013000327; Kellner AWA., 1994, ACTA GEOLOGICA LEOPO, V39, P175; Kellner AWA, 2000, NATL SCI MUSEUM MONO, V17, P1, DOI 10.1159/000061634; Lu JC, 2006, ACTA GEOL SIN-ENGL, V80, P315; Lu JC, 2011, SCIENCE, V331, P321, DOI 10.1126/science.1197323; MANZIG PC, 2012, MUSEUS FOSSEIS REGIA; Mateer N.J., 1976, Acta Univ Upsaliensis, V6, P97; Milani E. J., 2007, B GEOCIENCIAS PETROB, V15, P265; Nessov LA, 1994, PALAEONTOL Z, V1, P47; Peters D, 2011, ICHNOS, V18, P114, DOI 10.1080/10420940.2011.573605; Pinheiro FL, 2011, ACTA PALAEONTOL POL, V56, P567, DOI 10.4202/app.2010.0057; ROGERS R R, 1990, Palaios, V5, P394, DOI 10.2307/3514834; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Unwin David M., 2008, Zitteliana Reihe B, V28, P199; Vullo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038900; Wang XL, 2005, NATURE, V437, P875, DOI 10.1038/nature03982; Wang XL, 2003, CHINESE SCI BULL, V48, P16, DOI 10.1360/03tb9003; Wellnhofer P., 1991, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V31, P89; Wellnhofer P., 1970, ABH BAYER AKAD WISS, V141, P1; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Wellnhofer Peter, 1999, Palaeontologische Zeitschrift, V73, P133; Witton MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002271	48	65	66	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e100005	10.1371/journal.pone.0100005	http://dx.doi.org/10.1371/journal.pone.0100005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118592	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600003
J	Gomez-Sanchez, D; Olalde, I; Pierini, F; Matas-Lalueza, L; Gigli, E; Lari, M; Civit, S; Lozano, M; Verges, JM; Caramelli, D; Ramirez, O; Lalueza-Fox, C				Gomez-Sanchez, Daniel; Olalde, Inigo; Pierini, Federica; Matas-Lalueza, Laura; Gigli, Elena; Lari, Martina; Civit, Sergi; Lozano, Marina; Maria Verges, Josep; Caramelli, David; Ramirez, Oscar; Lalueza-Fox, Carles			Mitochondrial DNA from El Mirador Cave (Atapuerca, Spain) Reveals the Heterogeneity of Chalcolithic Populations	PLOS ONE			English	Article							ANCIENT DNA; HUNTER-GATHERERS; 1ST FARMERS; EUROPE; NEANDERTHAL; SUPPORTS; ORIGINS; HISTORY; POOL	Previous mitochondrial DNA analyses on ancient European remains have suggested that the current distribution of haplogroup H was modeled by the expansion of the Bell Beaker culture (ca 4,500-4,050 years BP) out of Iberia during the Chalcolithic period. However, little is known on the genetic composition of contemporaneous Iberian populations that do not carry the archaeological tool kit defining this culture. Here we have retrieved mitochondrial DNA (mtDNA) sequences from 19 individuals from a Chalcolithic sample from El Mirador cave in Spain, dated to 4,760-4,200 years BP and we have analyzed the haplogroup composition in the context of modern and ancient populations. Regarding extant African, Asian and European populations, El Mirador shows affinities with Near Eastern groups. In different analyses with other ancient samples, El Mirador clusters with Middle and Late Neolithic populations from Germany, belonging to the Rossen, the Salzmunde and the Baalberge archaeological cultures but not with contemporaneous Bell Beakers. Our analyses support the existence of a common genetic signal between Western and Central Europe during the Middle and Late Neolithic and points to a heterogeneous genetic landscape among Chalcolithic groups.	[Gomez-Sanchez, Daniel; Olalde, Inigo; Pierini, Federica; Matas-Lalueza, Laura; Ramirez, Oscar; Lalueza-Fox, Carles] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona, Spain; [Gigli, Elena; Lari, Martina; Caramelli, David] Univ Florence, Dept Biol, Lab Anthropol, Florence, Italy; [Civit, Sergi] Univ Barcelona, Dept Stat, Fac Biol, Barcelona, Spain; [Lozano, Marina; Maria Verges, Josep] Inst Catala Paleoecol Humana & Evolucio Social, Tarragona, Spain; [Maria Verges, Josep] Univ Rovira & Virgili, Dept Hist & Hist Art, Area Prehist, Tarragona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; University of Florence; University of Barcelona; ICREA; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Universitat Rovira i Virgili	Lalueza-Fox, C (corresponding author), Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona, Spain.	carles.lalueza@upf.edu	Gómez-Sánchez, Daniel/H-9476-2017; civit-vives, sergi/N-4287-2015; Lari, Martina/A-4085-2009; Ramirez, Oscar/E-7293-2012; LALUEZA-FOX, CARLES/AAG-5341-2020; Olalde, Iñigo/N-6928-2018; Vergès Bosch, Josep Maria/G-4490-2015; Lozano, Marina/G-7293-2015	Gómez-Sánchez, Daniel/0000-0003-1167-7239; civit-vives, sergi/0000-0002-2511-4579; Ramirez, Oscar/0000-0001-5164-6790; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Olalde, Iñigo/0000-0002-2660-6807; Vergès Bosch, Josep Maria/0000-0003-1807-7463; Lozano, Marina/0000-0002-6304-7848; Pierini, Federica/0000-0002-8246-5316; Caramelli, David/0000-0001-6468-1675	FEDER; Spanish Government [BFU2012-34157]	FEDER(European Commission); Spanish Government(Spanish GovernmentEuropean Commission)	This work is supported by FEDER and Spanish Government Grant BFU2012-34157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman AJ, 1984, THE NEOLITHIC TRANSI; Bellwood P., 2002, EXAMINING THE FARMIN; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; Caceres I, 2007, AM J PHYS ANTHROPOL, V133, P899, DOI 10.1002/ajpa.20610; Cavalli-Sforza L, 1994, THE HISTORY AND GEOG; Chikhi L, 1998, P NATL ACAD SCI USA, V95, P9053, DOI 10.1073/pnas.95.15.9053; Cooper A, 2000, SCIENCE, V289, P1139; Czebreszuk J, 2003, ANCIENT EUROPE 8000, V2, P476; Czebreszuk J, 2003, ANCIENT EUROPE 8000, V8000, P476; Deguilloux MF, 2012, EVOL ANTHROPOL, V21, P24, DOI 10.1002/evan.20341; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; Gamba C, 2012, MOL ECOL, V21, P45, DOI 10.1111/j.1365-294X.2011.05361.x; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Hervella M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034417; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Lalueza-Fox C, 2011, P NATL ACAD SCI USA, V108, P250, DOI 10.1073/pnas.1011553108; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Olalde I, 2014, NATURE, V507, P225, DOI 10.1038/nature12960; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pinhasi R, 2012, TRENDS GENET, V28, P496, DOI 10.1016/j.tig.2012.06.006; Renfrew, 1991, ARCHAEOLOGY THEORIES; Renfrew C., 2000, ARCHAEOGENETICS DNA; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, ANNU REV ANTHROPOL, V32, P135, DOI 10.1146/annurev.anthro.32.061002.093207; Sampietro ML, 2007, P ROY SOC B-BIOL SCI, V274, P2161, DOI 10.1098/rspb.2007.0465; Sanchez-Ouinto F, 2012, CURR BIOL, V22, P1494, DOI 10.1016/j.cub.2012.06.005; Skoglund P, 2014, P NATL ACAD SCI USA, V111, P2229, DOI 10.1073/pnas.1318934111; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Verges J. M., 2002, TRAB PREHIST, V59, P107, DOI DOI 10.3989/TP.2002.V59.I1.213; Whittle A., 1996, EUROPE IN THE NEOLIT	38	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e105105	10.1371/journal.pone.0105105	http://dx.doi.org/10.1371/journal.pone.0105105			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116044	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230400118
J	Opriessnig, T; Xiao, CT; Gerber, PF; Zhang, JQ; Halbur, PG				Opriessnig, Tanja; Xiao, Chao-Ting; Gerber, Priscilla F.; Zhang, Jianqiang; Halbur, Patrick G.			Porcine Epidemic Diarrhea Virus RNA Present in Commercial Spray-Dried Porcine Plasma Is Not Infectious to Naive Pigs	PLOS ONE			English	Article							ESCHERICHIA-COLI; CIRCOVIRUS TYPE-2; FED DIETS; EGG; ANTIBODIES; EFFICACY	Porcine epidemic diarrhea virus emerged in North America in April 2013 and has since been identified in 30 U.S. States, Canada and Mexico. The rapid spread of PEDV has raised concerns about the role of feed and particularly pork-by-product components such as spray-dried porcine plasma (SDPP) in PEDV transmission. The aim of this study was to determine the infectivity of PEDV RNA present in commercial SDPP. Specifically, 40 3-week-old PEDV naive pigs were randomly assigned to one of five treatment groups. At day post inoculation (dpi) 0, NEG-CONTROL pigs were sham-inoculated, PEDV-CONTROL pigs received cell culture propagated PEDV, and SDPP-CONTROL pigs were switched to a diet with 5% SDPP containing 5.1 +/- 0.1 log(10) PEDV RNA copies/g. To evaluate a potential positive effect of anti-PEDV antibodies in SDPP on PEDV challenge, four days prior to PEDV challenge the pigs in the SDPP-PEDV group were switched to and remained on a 5% SDPP diet through dpi 28. Another group, EGG-PEDV, was orally administered a commercial egg-derived liquid PEDV globulin product from dpi -4 through 6. All PEDV-CONTROL pigs began shedding PEDV in feces by dpi 3 and seroconverted between dpi 7 and 14, whereas pigs in NEG-CONTROL and SDPP-CONTROL groups remained PEDV RNA negative and did not seroconvert to PEDV for the study duration. This indicates no evidence of infectivity of the PEDV RNA in the SDPP lot utilized. Furthermore, under the study conditions SDPP or egg-derived liquid PEDV globulin addition did not significantly alter PEDV-shedding or overall disease course after experimental challenge.	[Opriessnig, Tanja; Gerber, Priscilla F.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Opriessnig, Tanja; Gerber, Priscilla F.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Opriessnig, Tanja; Xiao, Chao-Ting; Zhang, Jianqiang; Halbur, Patrick G.] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Iowa State University	Opriessnig, T (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	Tanja.Opriessnig@roslin.ed.ac.uk	Gerber, Priscilla F/K-4771-2012; Opriessnig, Tanja/F-2984-2012; Gerber, Priscilla/U-9385-2019; Xiao, Chaoting/H-3997-2014	Gerber, Priscilla F/0000-0002-8343-8299; Opriessnig, Tanja/0000-0001-9642-0904; Gerber, Priscilla/0000-0002-8343-8299; Xiao, Chaoting/0000-0001-5299-5650	APC, Inc., Ankeny, Iowa, United States of America; EPFX/EGCO Protein, Provanco Feeds, Le Center, Minnesota, United States of America; BBSRC [BBS/E/D/20241866, BBS/E/D/20241864] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864, BBS/E/D/20241866] Funding Source: researchfish	APC, Inc., Ankeny, Iowa, United States of America; EPFX/EGCO Protein, Provanco Feeds, Le Center, Minnesota, United States of America; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for this study was provided in part by APC, Inc., Ankeny, Iowa, United States of America and EPFX/EGCO Protein, Provanco Feeds, Le Center, Minnesota, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, VET REC, V174, P291, DOI 10.1136/vr.g2187; Campbell J, 2012, J ANIM SCI, V90, P299, DOI 10.2527/jas.51544; Canadian Food Inspection Agency, 2014, PORC EP DIARRH PED S; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; Ferreira Aloizio S, 2009, Recent Pat Food Nutr Agric, V1, P231, DOI 10.2174/1876142910901030231; Gao YY, 2011, J ANIM SCI, V89, P150, DOI 10.2527/jas.2010-2967; Heo JM, 2012, J ANIM SCI, V90, P239, DOI 10.2527/jas.53983; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; Imberechts H, 1997, VET MICROBIOL, V54, P329, DOI 10.1016/S0378-1135(96)01293-X; Jung K, 2014, EMERG INFECT DIS, V20, P662, DOI 10.3201/eid2004.131685; Kim O, 1999, J VET DIAGN INVEST, V11, P458, DOI 10.1177/104063879901100512; King AMQ., 2012, VIRUS TAXONOMY, P806, DOI 10.1016/ B978-0-12-384684-6.00068-9; Kweon CH, 2000, J VET MED SCI, V62, P961, DOI 10.1292/jvms.62.961; Lundeen T, 2014, ONTARIO FEED COMPANY; Niewold TA, 2007, VET MICROBIOL, V124, P362, DOI 10.1016/j.vetmic.2007.04.034; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Owusu-Asiedu A, 2003, J ANIM SCI, V81, P1781; Patterson AR, 2010, J ANIM SCI, V88, P4078, DOI 10.2527/jas.2009-2696; Peace RM, 2011, J NUTR, V141, P1312, DOI 10.3945/jn.110.136796; Polo J, 2005, J ANIM SCI, V83, P1933; Polo J, 2013, J ANIM SCI, V91, P2192, DOI 10.2527/jas.2012-5705; Polo J, 2012, J ANIM SCI, V90, P308, DOI 10.2527/jas.53716; Pujols J, 2008, VET REC, V163, P536, DOI 10.1136/vr.163.18.536; Pujols Joan, 2011, Vet J, V190, pe16, DOI 10.1016/j.tvjl.2011.02.021; Shen HG, 2011, J ANIM SCI, V89, P1930, DOI 10.2527/jas.2010-3502; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Van Dijk AJ, 2002, VET MICROBIOL, V84, P207, DOI 10.1016/S0378-1135(01)00463-1; WIEDEMANN V, 1991, J VET MED B, V38, P283, DOI 10.1111/j.1439-0450.1991.tb00872.x; Xiao CT, 2012, J VIROL METHODS, V183, P40, DOI 10.1016/j.jviromet.2012.03.026; Xu YP, 2011, BIOTECHNOL ADV, V29, P860, DOI 10.1016/j.biotechadv.2011.07.003	30	53	55	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104766	10.1371/journal.pone.0104766	http://dx.doi.org/10.1371/journal.pone.0104766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116479	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400079
J	Lazar, A; Coll, A; Dobnik, D; Baebler, S; Bedina-Zavec, A; Zel, J; Gruden, K				Lazar, Ana; Coll, Anna; Dobnik, David; Baebler, Spela; Bedina-Zavec, Apolonija; Zel, Jana; Gruden, Kristina			Involvement of Potato (Solanum tuberosum L.) MKK6 in Response to Potato virus Y	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CELL-DEATH; MAPK CASCADES; HYPERSENSITIVE RESPONSE; TRANSCRIPTION FACTORS; MEDIATED RESISTANCE; DISEASE RESISTANCE; SIGNALING PATHWAY; SALICYLIC-ACID; PLANT MAPK	Mitogen-activated protein kinase (MAPK) cascades have crucial roles in the regulation of plant development and in plant responses to stress. Plant recognition of pathogen-associated molecular patterns or pathogen-derived effector proteins has been shown to trigger activation of several MAPKs. This then controls defence responses, including synthesis and/or signalling of defence hormones and activation of defence related genes. The MAPK cascade genes are highly complex and interconnected, and thus the precise signalling mechanisms in specific plant-pathogen interactions are still not known. Here we investigated the MAPK signalling network involved in immune responses of potato (Solanum tuberosum L.) to Potato virus Y, an important potato pathogen worldwide. Sequence analysis was performed to identify the complete MAPK kinase (MKK) family in potato, and to identify those regulated in the hypersensitive resistance response to Potato virus Y infection. Arabidopsis has 10 MKK family members, of which we identified five in potato and tomato (Solanum lycopersicum L.), and eight in Nicotiana benthamiana. Among these, StMKK6 is the most strongly regulated gene in response to Potato virus Y. The salicylic acid treatment revealed that StMKK6 is regulated by the hormone that is in agreement with the salicylic acid-regulated domains found in the StMKK6 promoter. The involvement of StMKK6 in potato defence response was confirmed by localisation studies, where StMKK6 accumulated strongly only in Potato-virus-Y-infected plants, and predominantly in the cell nucleus. Using a yeast two-hybrid method, we identified three StMKK6 targets downstream in the MAPK cascade: StMAPK4_2, StMAPK6 and StMAPK13. These data together provide further insight into the StMKK6 signalling module and its involvement in plant defence.	[Lazar, Ana; Coll, Anna; Dobnik, David; Baebler, Spela; Zel, Jana; Gruden, Kristina] Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia; [Bedina-Zavec, Apolonija] Natl Inst Chem, Lab Mol Biol & Nanobiotechnol, Ljubljana, Slovenia	National Institute of Biology - Slovenia; National Institute of Chemistry - Slovenia	Lazar, A (corresponding author), Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia.	ana.lazar@nib.si	Gruden, kristina/AAI-6439-2020; Baebler, Spela/D-1486-2010; DOBNIK, DAVID/N-2410-2019; Coll, Anna/ABD-4199-2021	Baebler, Spela/0000-0003-4776-7164; DOBNIK, DAVID/0000-0002-4698-6931; Coll, Anna/0000-0003-0672-1530; gruden, kristina/0000-0001-5906-8569	Slovenian Research Agency [P4-0165, J1-4268]; European Cooperation in Science and Technology, COST action [FA0806]; Slovenian-Polish bilateral project	Slovenian Research Agency(Slovenian Research Agency - Slovenia); European Cooperation in Science and Technology, COST action(European Cooperation in Science and Technology (COST)); Slovenian-Polish bilateral project	The work was supported by the Slovenian Research Agency (https://www.arrs.gov.si/en/dobrodoslica.asp, grant nos.: P4-0165, J1-4268), The European Cooperation in Science and Technology, COST action FA0806 (http://www.cost.eu/domains_actions/fa/Actions/FA0806) and the Slovenian-Polish bilateral project (2010-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andreasson E, 2010, TRENDS PLANT SCI, V15, P106, DOI 10.1016/j.tplants.2009.12.001; Asai S, 2008, PLANT CELL, V20, P1390, DOI 10.1105/tpc.107.055855; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Baebler S, 2014, J EXP BOT, V65, P1095, DOI 10.1093/jxb/ert447; Baebler S, 2009, MOL PLANT PATHOL, V10, P263, DOI 10.1111/j.1364-3703.2008.00530.x; Baebler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029009; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; Cho SK, 2008, P NATL ACAD SCI USA, V105, P15629, DOI 10.1073/pnas.0805539105; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Doczi R, 2007, PLANT CELL, V19, P3266, DOI 10.1105/tpc.106.050039; Doczi R, 2012, TRENDS PLANT SCI, V17, P518, DOI 10.1016/j.tplants.2012.05.009; Ekengren SK, 2003, PLANT J, V36, P905, DOI 10.1046/j.1365-313X.2003.01944.x; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Gimenez-Ibanez S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00072; Glazebrook J, 2003, PLANT J, V34, P217, DOI 10.1046/j.1365-313X.2003.01717.x; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Hardin SC, 2001, PLANTA, V213, P916, DOI 10.1007/s004250100564; Hardin SC, 1998, PLANTA, V206, P577, DOI 10.1007/s004250050435; Heinrich M, 2012, PLANT MOL BIOL REP, V30, P731, DOI 10.1007/s11105-011-0388-0; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hwa CM, 2008, ACTA PHYSIOL PLANT, V30, P277, DOI 10.1007/s11738-007-0117-3; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Jin HL, 2003, PLANT J, V33, P719, DOI 10.1046/j.1365-313X.2003.01664.x; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kogovsek P, 2013, PROG BOT, V74, P101, DOI 10.1007/978-3-642-30967-0_3; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lewsey M, 2009, ANNU PLANT REV, V34, P134, DOI 10.1111/b.9781405175326.2009.00006.x; Liang WW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-392; Lin WY, 2010, PLANT SCI, V178, P245, DOI 10.1016/j.plantsci.2010.01.006; Liu HX, 2008, CELL RES, V18, P422, DOI 10.1038/cr.2008.29; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; Liu YL, 2004, PLANT J, V38, P800, DOI 10.1111/j.1365-313X.2004.02085.x; Liu YK, 2012, MOL BIOL REP, V39, P2957, DOI 10.1007/s11033-011-1057-y; Massa AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026801; Melikant B, 2004, FEBS LETT, V576, P5, DOI 10.1016/j.febslet.2004.08.051; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Meng XZ, 2013, PLANT CELL, V25, P1126, DOI 10.1105/tpc.112.109074; Miljkovic D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051822; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Naseem M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003026; Naseem M, 2012, PLANT CELL, V24, P1793, DOI 10.1105/tpc.112.098335; Nicole MC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-223; Pedley KF, 2004, J BIOL CHEM, V279, P49229, DOI 10.1074/jbc.M410323200; Piston DW, IMAGING PARAMETERS F; Pitzschke A, 2009, PLANT PHYSIOL, V149, P606, DOI 10.1104/pp.108.131557; Pohleven J, 2009, BBA-GEN SUBJECTS, V1790, P173, DOI 10.1016/j.bbagen.2008.11.006; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Qiu JL, 2008, PLANT PHYSIOL, V148, P212, DOI 10.1104/pp.108.120006; Ramsak Z, 2014, NUCLEIC ACIDS RES, V42, pD1167, DOI 10.1093/nar/gkt1056; Rasmussen MW, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00169; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shang J, 2011, PLANTA, V233, P299, DOI 10.1007/s00425-010-1308-5; Singh DP, 2004, MOL PLANT PATHOL, V5, P57, DOI 10.1111/j.1364-3703.2004.00203.x; Singh R, 2013, PLANT CELL REP, V32, P923, DOI 10.1007/s00299-013-1437-y; Soyano T, 2003, GENE DEV, V17, P1055, DOI 10.1101/gad.1071103; Szajko K, 2008, THEOR APPL GENET, V116, P297, DOI 10.1007/s00122-007-0667-1; Takahashi F, 2007, PLANT CELL, V19, P805, DOI 10.1105/tpc.106.046581; Takahashi Y, 2007, PLANT J, V49, P1030, DOI 10.1111/j.1365-313X.2006.03022.x; Takahashi Y, 2010, PLANT CELL PHYSIOL, V51, P1766, DOI 10.1093/pcp/pcq135; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanz SK, 2013, NUCLEIC ACIDS RES, V41, pD1185, DOI 10.1093/nar/gks1151; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Theocharidis A, 2009, NAT PROTOC, V4, P1535, DOI 10.1038/nprot.2009.177; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Weller SA, 2000, APPL ENVIRON MICROB, V66, P2853, DOI 10.1128/AEM.66.7.2853-2858.2000; Wen JQ, 2002, PLANT PHYSIOL, V129, P1880, DOI 10.1104/pp.006072; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Xie GS, 2012, BIOCHEM J, V443, P95, DOI 10.1042/BJ20111792; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yoo SD, 2008, NATURE, V451, P789, DOI 10.1038/nature06543; Yoshihiro T, 2007, PLANT SIGNAL BEHAV, V2, P396, DOI 10.4161/psb.2.5.4267; Zeng QN, 2011, PLANT SIGNAL BEHAV, V6, P1436, DOI 10.4161/psb.6.10.17089; Zhang SZ, 2013, GENE, V531, P377, DOI 10.1016/j.gene.2013.07.107; Zhang X, 2007, PLANT J, V52, P1066, DOI 10.1111/j.1365-313X.2007.03294.x	80	12	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104553	10.1371/journal.pone.0104553	http://dx.doi.org/10.1371/journal.pone.0104553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111695	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100074
J	Zhou, FQ; Gong, HH; Liu, XJ; Wu, L; Luk, KDK; Hu, Y				Zhou, Fuqing; Gong, Honghan; Liu, Xiaojia; Wu, Lin; Luk, Keith Dip-Kei; Hu, Yong			Increased Low-Frequency Oscillation Amplitude of Sensorimotor Cortex Associated with the Severity of Structural Impairment in Cervical Myelopathy	PLOS ONE			English	Article							SPINAL-CORD-INJURY; MAGNETIC-RESONANCE SPECTROSCOPY; SPONDYLOTIC MYELOPATHY; CORTICAL REORGANIZATION; FUNCTIONAL REORGANIZATION; DIFFUSION ANISOTROPY; DISEASE SEVERITY; BRAIN ACTIVITY; MOTOR CORTEX; MRI	Decreases in metabolites and increased motor-related, but decreased sensory-related activation of the sensorimotor cortex (SMC) have been observed in patients with cervical myelopathy (CM) using advanced MRI techniques. However, the nature of intrinsic neuronal activity in the SMC, and the relationship between cerebral function and structural damage of the spinal cord in patients with CM are not fully understood. The purpose of this study was to assess intrinsic neuronal activity by calculating the regional amplitude of low frequency fluctuations (ALFF) using resting-state functional MRI (rs-fMRI), and correlations with clinical and imaging indices. Nineteen patients and 19 age-and sex-matched healthy subjects underwent rs-fMRI scans. ALFF measurements were performed in the SMC, a key brain network likely to impaired or reorganized patients with CM. Compared with healthy subjects, increased amplitude of cortical low-frequency oscillations (LFO) was observed in the right precentral gyrus, right postcentral gyrus, and left supplementary motor area. Furthermore, increased z-ALFF values in the right precentral gyrus and right postcentral gyrus correlated with decreased fractional anisotropy values at the C2 level, which indicated increased intrinsic neuronal activity in the SMC corresponding to the structural impairment in the spinal cord of patients with CM. These findings suggest a complex and diverging relationship of cortical functional reorganization and distal spinal anatomical compression in patients with CM and, thus, add important information in understanding how spinal cord integrity may be a factor in the intrinsic covariance of spontaneous low-frequency fluctuations of BOLD signals involved in cortical plasticity.	[Zhou, Fuqing; Gong, Honghan; Wu, Lin] NanChang Univ, Dept Radiol, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Zhou, Fuqing; Liu, Xiaojia; Luk, Keith Dip-Kei; Hu, Yong] Univ Hong Kong, Dept Orthopaed & Traumatol, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China	Nanchang University; University of Hong Kong	Hu, Y (corresponding author), Univ Hong Kong, Dept Orthopaed & Traumatol, Li Ka Shing Fac Med, Pokfulam, Hong Kong, Peoples R China.	yhud@hku.hk	Hu, Yong/C-4276-2009	Hu, Yong/0000-0003-0305-5616	National Science Foundation of China [81101041]; China Postdoctoral Science Foundation [2013M541877]; Hong Kong Scholars Program of China [XJ2012026]; Research Grants Council of the Hong Kong [HKU 774211M]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Hong Kong Scholars Program of China; Research Grants Council of the Hong Kong(Hong Kong Research Grants Council)	This study has received by the National Science Foundation of China (81101041), the China Postdoctoral Science Foundation funded project (2013M541877), the Hong Kong Scholars Program of China (XJ2012026), and the Research Grants Council of the Hong Kong (HKU 774211M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Baron EM, 2007, NEUROSURGERY, V60, P35, DOI 10.1227/01.NEU.0000215383.64386.82; Cui JL, 2011, NEUROIMAGE, V54, P2125, DOI 10.1016/j.neuroimage.2010.10.018; Di X, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00118; Dong Y, 2008, J NEUROSURG-SPINE, V9, P538, DOI 10.3171/SPI.2008.10.0831; Duggal N, 2010, NEUROLOGY, V74, P1048, DOI 10.1212/WNL.0b013e3181d6b0ea; Fallani FDV, 2007, HUM BRAIN MAPP, V28, P1334, DOI 10.1002/hbm.20353; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Furkiewicz MT, 2007, NEUROREHAB NEURAL RE, V21, P527, DOI 10.1177/1545968307301872; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Holly LT, 2007, J NEUROSURG-SPINE, V6, P544, DOI 10.3171/spi.2007.6.6.5; Holly LT, 2009, CURR OPIN NEUROL, V22, P575, DOI 10.1097/WCO.0b013e3283325ea7; Huo Y, 2010, SYNCHRONIZATION MOTO, P1; Jones JGA, 2013, AM J NEURORADIOL, V34, P471, DOI 10.3174/ajnr.A3199; Jurkiewicz MT, 2010, NEUROREHAB NEURAL RE, V24, P136, DOI 10.1177/1545968309347680; Konomi T, 2012, NEUROIMAGE, V63, P1841, DOI 10.1016/j.neuroimage.2012.08.040; Kowalczyk I, 2012, BRAIN, V135, P461, DOI 10.1093/brain/awr328; Li ZJ, 2012, J MAGN RESON IMAGING, V36, P344, DOI 10.1002/jmri.23670; Pelled G, 2007, J MAGN RESON IMAGING, V26, P863, DOI 10.1002/jmri.21051; Puri BK, 1998, J NEUROL NEUROSUR PS, V65, P748, DOI 10.1136/jnnp.65.5.748; Roelcke U, 1997, J NEUROL NEUROSUR PS, V62, P61, DOI 10.1136/jnnp.62.1.61; Seminowicz DA, 2012, J NEUROSCI, V32, P15843, DOI 10.1523/JNEUROSCI.2927-12.2012; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sydekum E, 2009, NEUROIMAGE, V44, P1345, DOI 10.1016/j.neuroimage.2008.10.015; Wang X, 2013, NEUROSCIENCE, V254, P404, DOI 10.1016/j.neuroscience.2013.09.009; Wen CY, 2014, RADIOLOGY, V270, P197, DOI 10.1148/radiol.13121885; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yonenobu K, 2001, SPINE, V26, P1890, DOI 10.1097/00007632-200109010-00014; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhou FQ, 2014, NEUROSCI LETT, V558, P192, DOI 10.1016/j.neulet.2013.11.022; Zou QH, 2013, HUM BRAIN MAPP, V34, P3204, DOI 10.1002/hbm.22136; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	33	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104442	10.1371/journal.pone.0104442	http://dx.doi.org/10.1371/journal.pone.0104442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111566	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100059
J	Godfrey, KB; Swindale, NV				Godfrey, Keith B.; Swindale, Nicholas V.			Modeling Development in Retinal Afferents: Retinotopy, Segregation, and EphrinA/EphA Mutants	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; NICOTINIC ACETYLCHOLINE-RECEPTOR; DENDRITIC SPINE MORPHOLOGY; OCULAR DOMINANCE COLUMNS; AXONS IN-VIVO; SUPERIOR COLLICULUS; INSTRUCTIVE ROLE; GANGLION-CELLS; SYNAPTIC CONNECTIVITY; PRENATAL DEVELOPMENT	During neural development, neurons extend axons to target areas of the brain. Through processes of growth, branching and retraction these axons establish stereotypic patterns of connectivity. In the visual system, these patterns include retinotopic organization and the segregation of individual axons onto different subsets of target neurons based on the eye of origin (ocular dominance) or receptive field type (ON or OFF). Characteristic disruptions to these patterns occur when neural activity or guidance molecule expression is perturbed. In this paper we present a model that explains how these developmental patterns might emerge as a result of the coordinated growth and retraction of individual axons and synapses responding to position-specific markers, trophic factors and spontaneous neural activity. This model derives from one presented earlier (Godfrey et al., 2009) but which is here extended to account for a wider range of phenomena than previously described. These include ocular dominance and ON-OFF segregation and the results of altered ephrinA and EphA guidance molecule expression. The model takes into account molecular guidance factors, realistic patterns of spontaneous retinal wave activity, trophic molecules, homeostatic mechanisms, axon branching and retraction rules and intra-axonal signaling mechanisms that contribute to the survival of nearby synapses on an axon. We show that, collectively, these mechanisms can account for a wider range of phenomena than previous models of retino-tectal development.	[Godfrey, Keith B.] NERF, Leuven, Belgium; [Godfrey, Keith B.] IMEC, Leuven, Belgium; [Godfrey, Keith B.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Lethbridge, AB T1K 3M4, Canada; [Godfrey, Keith B.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge, England; [Godfrey, Keith B.; Swindale, Nicholas V.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada	IMEC; University of Lethbridge; University of Cambridge; University of British Columbia	Godfrey, KB (corresponding author), NERF, Leuven, Belgium.	keith@aquilonis.net			CIHR [15360]; NSERC [178702-05]; Alberta Heritage Foundation for Medical Research Polaris Award; NERF; imec; VIB; KU Leuven	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Heritage Foundation for Medical Research Polaris Award; NERF; imec; VIB; KU Leuven(KU Leuven)	This work was funded by CIHR 15360; NSERC 178702-05; Alberta Heritage Foundation for Medical Research Polaris Award; NERF, a joint research initiative between imec, VIB and KU Leuven (nerf.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; Chandrasekaran AR, 2009, J PHYSIOL-LONDON, V587, P953, DOI 10.1113/jphysiol.2008.160952; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Chen Y, 2012, J NEUROSCI, V32, P8263, DOI 10.1523/JNEUROSCI.1264-12.2012; CLINE HT, 1989, NEURON, V3, P413, DOI 10.1016/0896-6273(89)90201-8; Cohen-Cory S, 2004, INT J DEV BIOL, V48, P947, DOI 10.1387/ijdb.041883sc; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Dhande OS, 2011, J NEUROSCI, V31, P3384, DOI 10.1523/JNEUROSCI.4899-10.2011; DUBIN MW, 1986, J NEUROSCI, V6, P1021; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Fitzgerald M, 2008, BIOCHEM BIOPH RES CO, V374, P625, DOI 10.1016/j.bbrc.2008.07.110; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; FROST DO, 1979, NEUROSCIENCE, V4, P1649, DOI 10.1016/0306-4522(79)90026-5; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; FUKUDA Y, 1978, JPN J PHYSIOL, V28, P385; Gjorgjieva J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000618; Godfrey KB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000600; Godfrey KB, 2007, PLOS COMPUT BIOL, V3, P2408, DOI 10.1371/journal.pcbi.0030245; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Hu B, 2005, DEVELOPMENT, V132, P4285, DOI 10.1242/dev.02017; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; Ibata K, 2008, NEURON, V57, P819, DOI 10.1016/j.neuron.2008.02.031; Juttner R, 2001, INT J DEV NEUROSCI, V19, P255, DOI 10.1016/S0736-5748(01)00009-0; Kerschensteiner D, 2008, NEURON, V58, P851, DOI 10.1016/j.neuron.2008.04.025; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; Marler KJM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-30; Marler KJM, 2008, J NEUROSCI, V28, P12700, DOI 10.1523/JNEUROSCI.1915-08.2008; Marshak S, 2007, J NEUROSCI, V27, P2444, DOI 10.1523/JNEUROSCI.4434-06.2007; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Murai KK, 2003, NAT NEUROSCI, V6, P153, DOI 10.1038/nn994; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Plas DT, 2008, J NEUROSCI, V28, P7057, DOI 10.1523/JNEUROSCI.3598-06.2008; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Snider WD, 1996, MOL CELL NEUROSCI, V7, P433, DOI 10.1006/mcne.1996.0031; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; SRETAVAN D, 1984, NATURE, V308, P845, DOI 10.1038/308845a0; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Staras K, 2007, TRENDS NEUROSCI, V30, P292, DOI 10.1016/j.tins.2007.04.005; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; STRYKER MP, 1983, J NEUROSCI, V3, P1943; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; THOMPSON I, 1989, J COMP NEUROL, V282, P371; Tomita K, 2012, CEREBRAL CORTEX; Willshaw D, 2006, DEVELOPMENT, V133, P2705, DOI 10.1242/dev.02430; WILLSHAW DJ, 1979, PHILOS T ROY SOC B, V287, P203, DOI 10.1098/rstb.1979.0056; Wu YJ, 2004, J NEUROSCI RES, V75, P825, DOI 10.1002/jnr.20048; Xu HP, 2011, NEURON, V70, P1115, DOI 10.1016/j.neuron.2011.04.028; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zhou L, 2007, J NEUROSCI, V27, P5127, DOI 10.1523/JNEUROSCI.1170-07.2007	70	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104670	10.1371/journal.pone.0104670	http://dx.doi.org/10.1371/journal.pone.0104670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122119	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000054
J	Nowinski, WL; Gupta, V; Qian, GY; Ambrosius, W; Kazmierski, R				Nowinski, Wieslaw L.; Gupta, Varsha; Qian, Guoyu; Ambrosius, Wojciech; Kazmierski, Radoslaw			Population-Based Stroke Atlas for Outcome Prediction: Method and Preliminary Results for Ischemic Stroke from CT	PLOS ONE			English	Article							SCALE; THROMBOLYSIS; VOLUME; LOCALIZATION; VALIDATION; INSTRUMENT; HEMORRHAGE; SCORES; IMAGES; INDEX	Background and Purpose: Knowledge of outcome prediction is important in stroke management. We propose a lesion size and location-driven method for stroke outcome prediction using a Population-based Stroke Atlas (PSA) linking neurological parameters with neuroimaging in population. The PSA aggregates data from previously treated patients and applies them to currently treated patients. The PSA parameter distribution in the infarct region of a treated patient enables prediction. We introduce a method for PSA calculation, quantify its performance, and use it to illustrate ischemic stroke outcome prediction of modified Rankin Scale (mRS) and Barthel Index (BI). Methods: The preliminary PSA was constructed from 128 ischemic stroke cases calculated for 8 variants (various data aggregation schemes) and 3 case selection variables (infarct volume, NIHSS at admission, and NIHSS at day 7), each in 4 ranges. Outcome prediction for 9 parameters (mRS at 7th, and mRS and BI at 30th, 90th, 180th, 360th day) was studied using a leave-one-out approach, requiring 589,824 PSA maps to be analyzed. Results: Outcomes predicted for different PSA variants are statistically equivalent, so the simplest and most efficient variant aiming at parameter averaging is employed. This variant allows the PSA to be pre-calculated before prediction. The PSA constrained by infarct volume and NIHSS reduces the average prediction error (absolute difference between the predicted and actual values) by a fraction of 0.796; the use of 3 patient-specific variables further lowers it by 0.538. The PSA-based prediction error for mild and severe outcomes (mRS = [2-5]) is (0.5-0.7). Prediction takes about 8 seconds. Conclusions: PSA-based prediction of individual and group mRS and BI scores over time is feasible, fast and simple, but its clinical usefulness requires further studies. The case selection operation improves PSA predictability. A multiplicity of PSAs can be computed independently for different datasets at various centers and easily merged, which enables building powerful PSAs over the community.	[Nowinski, Wieslaw L.; Gupta, Varsha; Qian, Guoyu; Ambrosius, Wojciech] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Biomed Imaging Lab, Singapore, Singapore; [Ambrosius, Wojciech] Poznan Univ Med Sci, Dept Neurol, Poznan, Poland; [Kazmierski, Radoslaw] Poznan Univ Med Sci, L Bierkowski Hosp, Dept Neurol & Cerebrovasc Disorders, Poznan, Poland	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); Poznan University of Medical Sciences; Poznan University of Medical Sciences	Nowinski, WL (corresponding author), Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Biomed Imaging Lab, Singapore, Singapore.	wieslaw@sbic.a-star.edu.sg	Ambrosius, Wojciech/AGL-7764-2022; Nowinski, Wieslaw/AFR-8393-2022	Nowinski, Wieslaw/0000-0003-2869-0608; Gupta, Varsha/0000-0002-6634-5111	Biomedical Research Council, Agency for Science, Technology and Research ASTAR, Singapore [62/N-Singapur/2007/0, 072-1340049]; Ministry of Science and Higher Education, Poland	Biomedical Research Council, Agency for Science, Technology and Research ASTAR, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	This research was funded by Biomedical Research Council, Agency for Science, Technology and Research ASTAR, Singapore. The data contribution to this study was a part of a joined Polish-Singaporean project funded by the Ministry of Science and Higher Education, Poland and ASTAR, Singapore (project No. 62/N-Singapur/2007/0 and 072-1340049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosius W, 2011, EXP CLIN ENDOCR DIAB, V119, P139, DOI 10.1055/s-0030-1267918; Asadi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088225; Balucani C, 2012, NEUROLOGY, V78, P755, DOI 10.1212/WNL.0b013e318248e558; Beswick A. D., 2008, SYSTEMATIC REV RISK; Bilello M, 2006, NEUROINFORMATICS, V4, P234, DOI 10.1385/NI:4:3:235; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; Counsell C, 2001, CEREBROVASC DIS, V12, P159, DOI 10.1159/000047699; Cucchiara Brett, 2008, J Stroke Cerebrovasc Dis, V17, P331, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.012; Fink JN, 2002, STROKE, V33, P954, DOI 10.1161/01.STR.0000013069.24300.1D; Hacke W, 2006, NEW ENGL J MED, V359, P1317; Kazmierski R, 2006, EXPERT REV NEUROTHER, V6, P1349, DOI 10.1586/14737175.6.9.1349; Kazmierski R, 2012, NEUROLOGY, V79, P1677, DOI 10.1212/WNL.0b013e31826e9a83; Kent DM, 2006, STROKE, V37, P2957, DOI 10.1161/01.STR.0000249054.96644.c6; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Koenig IR, 2008, STROKE, V39, P1821, DOI 10.1161/STROKEAHA.107.505867; Kwakkel G, 2013, INT J STROKE, V8, P25, DOI 10.1111/j.1747-4949.2012.00967.x; Lou M, 2008, NEUROLOGY, V71, P1417, DOI 10.1212/01.wnl.0000330297.58334.dd; Mazya M, 2012, STROKE, V43, P1524, DOI 10.1161/STROKEAHA.111.644815; Menezes NM, 2007, STROKE, V38, P194, DOI 10.1161/01.STR.0000251792.76080.45; Navi BB, 2011, STROKE, V42, P3392, DOI 10.1161/STROKEAHA.111.620336; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Nowinski WL, 2013, NEURORADIOL J, V26, P56, DOI 10.1177/197140091302600110; Nowinski WL, 2012, J NEUROSCI METH, V204, P44, DOI 10.1016/j.jneumeth.2011.10.021; Nowinski WL, 2006, ACAD RADIOL, V13, P1025, DOI 10.1016/j.acra.2006.05.009; Nowinski WL, 2013, INVEST RADIOL, V48, P661, DOI 10.1097/RLI.0b013e31828d8403; Nowinski WL, 2001, ACTA NEUROCHIR, V143, P1045, DOI 10.1007/s007010170011; Nowinski WL, 2012, STROK INT STROK C 20; Ntaios G, 2012, NEUROLOGY, V78, P1916, DOI 10.1212/WNL.0b013e318259e221; O'Donnell MJ, 2012, ARCH INTERN MED, V15, P1; Qiao Q, 2012, INT J STROKE, V7, P662, DOI 10.1111/j.1747-4949.2011.00692.x; Richards A, 2013, STROKE, V44, P564, DOI 10.1161/STROKEAHA.111.649798; Saposnik G, 2013, NEUROLOGY, V80, P21, DOI 10.1212/WNL.0b013e31827b1ace; Saposnik G, 2011, STROKE, V42, P3421, DOI 10.1161/STROKEAHA.111.623116; Saposnik G, 2011, CIRCULATION, V123, P739, DOI 10.1161/CIRCULATIONAHA.110.983353; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Schlegel D, 2003, STROKE, V34, P134, DOI 10.1161/01.STR.0000048217.44714.02; Stinear CM, 2013, INT J STROKE, V8, P33, DOI 10.1111/j.1747-4949.2012.00970.x; Strbian D, 2012, NEUROLOGY, V78, P427, DOI 10.1212/WNL.0b013e318245d2a9; Strbian D, 2012, ANN NEUROL, V71, P634, DOI 10.1002/ana.23546; Talairach I., 1988, COPLANAR STEREOTACTI; Uyttenboogaart M, 2005, STROKE, V36, P1984, DOI 10.1161/01.STR.0000177872.87960.61; Vogt G, 2012, STROKE, V43, P1266, DOI 10.1161/STROKEAHA.111.646570; Volkau I, 2012, NEURORADIOL J, V25, P98, DOI 10.1177/197140091202500114; Volkau I, 2006, MED IMAGE ANAL, V10, P863, DOI 10.1016/j.media.2006.07.005; Weimar C, 2002, J NEUROL, V249, P888, DOI 10.1007/s00415-002-0755-8	45	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e102048	10.1371/journal.pone.0102048	http://dx.doi.org/10.1371/journal.pone.0102048			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121979	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000004
J	Casalegno, JS; Ferraris, O; Escuret, V; Bouscambert, M; Bergeron, C; Lines, L; Excoffier, T; Valette, M; Frobert, E; Pillet, S; Pozzetto, B; Lina, B; Ottmann, M				Casalegno, Jean-Sebastien; Ferraris, Olivier; Escuret, Vanessa; Bouscambert, Maude; Bergeron, Corinne; Lines, Laetitia; Excoffier, Thierry; Valette, Martine; Frobert, Emilie; Pillet, Sylvie; Pozzetto, Bruno; Lina, Bruno; Ottmann, Michele			Functional Balance between the Hemagglutinin and Neuraminidase of Influenza A(H1N1)pdm09 HA D222 Variants	PLOS ONE			English	Article							RECEPTOR SPECIFICITY; A VIRUS; MICE; OSELTAMIVIR; SENSITIVITY; INHIBITORS; VIRULENCE; FERRETS; FRANCE; CIRCULATION	D222G/N substitutions in A(H1N1)pdm09 hemagglutinin may be associated with increased binding of viruses causing low respiratory tract infections and human pathogenesis. We assessed the impact of such substitutions on the balance between hemagglutinin binding and neuraminidase cleavage, viral growth and in vivo virulence. Seven viruses with differing polymorphisms at codon 222 (2 with D, 3 G, 1 N and 1 E) were isolated from patients and characterized with regards hemagglutinin binding affinity (Kd) to alpha-2,6 sialic acid (SA alpha-2,6) and SA alpha-2,3 and neuraminidase enzymatic properties (Km, Ki and Vmax). The hemagglutination assay was used to quantitatively assess the balance between hemagglutinin binding and neuraminidase cleavage. Viral growth properties were compared in vitro in MDCK-SIAT1 cells and in vivo in BALB/c mice. Compared with D222 variants, the binding affinity of G222 variants was greater for SA alpha-2,3 and lower for SA alpha-2,6, whereas that of both E222 and N222 variants was greater for both SA alpha-2,3 and SA alpha-2,6. Mean neuraminidase activity of D222 variants (16.0 nmol/h/10(6)) was higher than that of G222 (1.7 nmol/h/10(6) viruses) and E/N222 variants (4.4 nmol/h/10(6) viruses). The hemagglutination assay demonstrated a deviation from functional balance by E222 and N222 variants that displayed strong hemagglutinin binding but weak neuraminidase activity. This deviation impaired viral growth in MDCK-SIAT1 cells but not infectivity in mice. All strains but one exhibited low infectious dose in mice (MID50) and replicated to high titers in the lung; this D222 strain exhibited a ten-fold higher MID50 and replicated to low titers. Hemagglutinin-neuraminidase balance status had a greater impact on viral replication than hemagglutinin affinity strength, at least in vitro, thus emphasizing the importance of an optimal balance for influenza virus fitness. The mouse model is effective in assessing binding to SA alpha-2,3 but cannot differentiate SA alpha-2,3-from SA alpha-2,6-preference, nor estimate the hemagglutinin-neuraminidase balance in A(H1N1)pdm09 strains.	[Casalegno, Jean-Sebastien; Ferraris, Olivier; Escuret, Vanessa; Bouscambert, Maude; Bergeron, Corinne; Lines, Laetitia; Frobert, Emilie; Lina, Bruno; Ottmann, Michele] Univ Lyon 1, Fac Med Lyon Est, Lab Virol & Pathol Humaine, EA 4610, Lyon, France; [Casalegno, Jean-Sebastien; Escuret, Vanessa; Bouscambert, Maude; Valette, Martine; Frobert, Emilie; Lina, Bruno] Natl Influenza Ctr South France, Virol Lab, Hosp Civils Lyon, Bron, France; [Ferraris, Olivier] Equipe Rech Lyon, IRBA, Lyon, France; [Excoffier, Thierry] Univ Lyon 2, INSA Lyon, Ecole Cent Lyon, CNRS,LIRIS UMR 5205, Lyon, France; [Pillet, Sylvie; Pozzetto, Bruno] Hop Nord St Etienne, CHU St Etienne, Lab Bacteriol Virol Hyg, St Etienne, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Lyon 2; CHU de St Etienne	Casalegno, JS (corresponding author), Univ Lyon 1, Fac Med Lyon Est, Lab Virol & Pathol Humaine, EA 4610, Lyon, France.	jean-sebastien.casalegno@chu-lyon.fr	LINA, bruno/M-4572-2014; casalegno, jean-sebastien/AAD-4467-2021; ottmann, michele/M-6346-2014; Casalegno, jean-sebastien/M-4566-2014; ESCURET, Vanessa/M-5530-2014; lina, bruno/N-3663-2019	lina, bruno/0000-0002-8959-2123; Pillet, Sylvie/0000-0002-0882-3162; POZZETTO, Bruno/0000-0002-2603-8467; ottmann, michele/0000-0002-6911-0705; FROBERT, Emilie/0000-0002-5712-0164; casalegno, jean-sebastien/0000-0003-3271-9856; ESCURET, Vanessa/0000-0002-5298-1002	Institut de Microbiologie et Madalies Infectieuses; National Influenza Center	Institut de Microbiologie et Madalies Infectieuses; National Influenza Center	This work was supported by the Institut de Microbiologie et Madalies Infectieuses and the National Influenza Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2011, J INFECT DIS, V204, P1008, DOI 10.1093/infdis/jir483; Belser JA, 2010, J VIROL, V84, P4194, DOI 10.1128/JVI.02742-09; Casalegno JS, 2010, ANTIVIR RES, V87, P242, DOI 10.1016/j.antiviral.2010.05.010; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Ernst AM, 2013, FEBS LETT, V587, P1411, DOI 10.1016/j.febslet.2013.03.019; Ferraris O, 2005, ANTIVIR RES, V68, P43, DOI 10.1016/j.antiviral.2005.07.004; Ferraris O, 2008, J CLIN VIROL, V41, P13, DOI 10.1016/j.jcv.2007.10.020; Ferraris O, 2012, ANTIVIR RES, V93, P374, DOI 10.1016/j.antiviral.2012.01.008; Gen F, 2013, ARCH VIROL, V158, P1003, DOI 10.1007/s00705-012-1577-3; Houng HSH, 2012, J CLIN VIROL, V53, P12, DOI 10.1016/j.jcv.2011.09.004; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kendal AP, 1982, CONCEPTS PROCEDURES; Lakdawala SS, 2013, VIROLOGY, V446, P349, DOI 10.1016/j.virol.2013.08.011; Ledesma J, 2011, J CLIN VIROL, V51, P75, DOI 10.1016/j.jcv.2011.01.020; Lina B, 1996, J CLIN MICROBIOL, V34, P3007, DOI 10.1128/JCM.34.12.3007-3011.1996; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Piralla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028332; Rameix-Welti MA, 2006, ANTIMICROB AGENTS CH, V50, P3809, DOI 10.1128/AAC.00645-06; Richard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033880; Rykkvin R, 2013, EURO SURVEILL, V18; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wang B, 2011, J CLIN VIROL, V52, P304, DOI 10.1016/j.jcv.2011.08.023; Xu R, 2012, J VIROL, V86, P9221, DOI 10.1128/JVI.00697-12	27	35	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104009	10.1371/journal.pone.0104009	http://dx.doi.org/10.1371/journal.pone.0104009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119465	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600034
J	Chutiwitoonchai, N; Kakisaka, M; Yamada, K; Aida, Y				Chutiwitoonchai, Nopporn; Kakisaka, Michinori; Yamada, Kazunori; Aida, Yoko			Comparative Analysis of Seven Viral Nuclear Export Signals (NESs) Reveals the Crucial Role of Nuclear Export Mediated by the Third NES Consensus Sequence of Nucleoprotein (NP) in Influenza A Virus Replication	PLOS ONE			English	Article							MATRIX PROTEIN; NS1 PROTEIN; M1 PROTEIN; RIBONUCLEOPROTEINS; DOMAIN; IDENTIFICATION; LOCALIZATION; PATHWAY; TARGETS; RNAS	The assembly of influenza virus progeny virions requires machinery that exports viral genomic ribonucleoproteins from the cell nucleus. Currently, seven nuclear export signal (NES) consensus sequences have been identified in different viral proteins, including NS1, NS2, M1, and NP. The present study examined the roles of viral NES consensus sequences and their significance in terms of viral replication and nuclear export. Mutation of the NP-NES3 consensus sequence resulted in a failure to rescue viruses using a reverse genetics approach, whereas mutation of the NS2-NES1 and NS2-NES2 sequences led to a strong reduction in viral replication kinetics compared with the wild-type sequence. While the viral replication kinetics for other NES mutant viruses were also lower than those of the wild-type, the difference was not so marked. Immunofluorescence analysis after transient expression of NP-NES3, NS2-NES1, or NS2-NES2 proteins in host cells showed that they accumulated in the cell nucleus. These results suggest that the NP-NES3 consensus sequence is mostly required for viral replication. Therefore, each of the hydrophobic (Phi) residues within this NES consensus sequence (Phi 1, Phi 2, Phi 3, or Phi 4) was mutated, and its viral replication and nuclear export function were analyzed. No viruses harboring NP-NES3 Phi 2 or Phi 3 mutants could be rescued. Consistent with this, the NP-NES3 Phi 2 and Phi 3 mutants showed reduced binding affinity with CRM1 in a pull-down assay, and both accumulated in the cell nucleus. Indeed, a nuclear export assay revealed that these mutant proteins showed lower nuclear export activity than the wild-type protein. Moreover, the Phi 2 and Phi 3 residues (along with other Phi residues) within the NP-NES3 consensus were highly conserved among different influenza A viruses, including human, avian, and swine. Taken together, these results suggest that the Phi 2 and Phi 3 residues within the NP-NES3 protein are important for its nuclear export function during viral replication.	[Chutiwitoonchai, Nopporn; Kakisaka, Michinori; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan; [Yamada, Kazunori] Computat Biol Res Ctr, Natl Inst Adv Ind Sci & Technol, Tokyo, Japan	RIKEN; National Institute of Advanced Industrial Science & Technology (AIST)	Aida, Y (corresponding author), RIKEN, Viral Infect Dis Unit, Wako, Saitama, Japan.	aida@riken.jp			research project for improving food safety and animal health of the Ministry of Agriculture, Forestry and Fisheries of Japan; RIKEN Program for Drug Discovery and Medical Technology Platforms	research project for improving food safety and animal health of the Ministry of Agriculture, Forestry and Fisheries of Japan; RIKEN Program for Drug Discovery and Medical Technology Platforms	This study was supported by a research project for improving food safety and animal health of the Ministry of Agriculture, Forestry and Fisheries of Japan, and by a RIKEN Program for Drug Discovery and Medical Technology Platforms. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bui M, 2000, J VIROL, V74, P1781, DOI 10.1128/JVI.74.4.1781-1786.2000; Cao S, 2012, J VIROL, V86, P4883, DOI 10.1128/JVI.06586-11; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Daugherty MD, 2010, NAT STRUCT MOL BIOL, V17, P1337, DOI 10.1038/nsmb.1902; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Hagiwara K, 2010, BIOCHEM BIOPH RES CO, V394, P721, DOI 10.1016/j.bbrc.2010.03.058; Han H, 2010, J GEN VIROL, V91, P2907, DOI 10.1099/vir.0.024943-0; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Huang SP, 2013, J VIROL, V87, P767, DOI 10.1128/JVI.06519-11; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Li YZ, 1998, P NATL ACAD SCI USA, V95, P4864, DOI 10.1073/pnas.95.9.4864; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Nayak DP, 2004, VIRUS RES, V106, P147, DOI 10.1016/j.virusres.2004.08.012; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Ozawa M, 2007, J VIROL, V81, P30, DOI 10.1128/JVI.01434-06; Paterson D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003019; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Read EKC, 2010, J GEN VIROL, V91, P1290, DOI 10.1099/vir.0.018564-0; Sasaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055765; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Wang P, 1997, J VIROL, V71, P1850, DOI 10.1128/JVI.71.3.1850-1856.1997; Wang W, 2008, NUCLEIC ACIDS RES, V36, P4913, DOI 10.1093/nar/gkn475; Watanabe K, 2001, VIRUS RES, V77, P31, DOI 10.1016/S0168-1702(01)00263-5; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; World Health Organization, INFL UPD; Yamada K, 2012, MICROBES INFECT, V14, P740, DOI 10.1016/j.micinf.2012.02.012; YE ZP, 1995, J VIROL, V69, P1964, DOI 10.1128/JVI.69.3.1964-1970.1995; York A, 2013, RNA BIOL, V10, P1274, DOI 10.4161/rna.25356; Yu MR, 2012, J VIROL, V86, P4970, DOI 10.1128/JVI.06159-11; Zheng WJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003624	41	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105081	10.1371/journal.pone.0105081	http://dx.doi.org/10.1371/journal.pone.0105081			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119991	Green Submitted, gold, Green Published			2022-12-27	WOS:000340900600122
J	Gossner, MM; Pasalic, E; Lange, M; Lange, P; Boch, S; Hessenmoller, D; Muller, J; Socher, SA; Fischer, M; Schulze, ED; Weisser, WW				Gossner, Martin M.; Pasalic, Esther; Lange, Markus; Lange, Patricia; Boch, Steffen; Hessenmoeller, Dominik; Mueller, Joerg; Socher, Stephanie A.; Fischer, Markus; Schulze, Ernst-Detlef; Weisser, Wolfgang W.			Differential Responses of Herbivores and Herbivory to Management in Temperate European Beech	PLOS ONE			English	Article							SPECIES RICHNESS; INSECT HERBIVORES; STRUCTURAL CHARACTERISTICS; ARTHROPOD COMMUNITIES; SPATIAL-DISTRIBUTION; FOREST MANAGEMENT; LEAF QUALITY; DIVERSITY; PLANT; CANOPY	Forest management not only affects biodiversity but also might alter ecosystem processes mediated by the organisms, i.e. herbivory the removal of plant biomass by plant-eating insects and other arthropod groups. Aiming at revealing general relationships between forest management and herbivory we investigated aboveground arthropod herbivory in 105 plots dominated by European beech in three different regions in Germany in the sun-exposed canopy of mature beech trees and on beech saplings in the understorey. We separately assessed damage by different guilds of herbivores, i.e. chewing, sucking and scraping herbivores, gall-forming insects and mites, and leaf-mining insects. We asked whether herbivory differs among different forest management regimes (unmanaged, uneven-aged managed, even-aged managed) and among age-classes within even-aged forests. We further tested for consistency of relationships between regions, strata and herbivore guilds. On average, almost 80% of beech leaves showed herbivory damage, and about 6% of leaf area was consumed. Chewing damage was most common, whereas leaf sucking and scraping damage were very rare. Damage was generally greater in the canopy than in the understorey, in particular for chewing and scraping damage, and the occurrence of mines. There was little difference in herbivory among differently managed forests and the effects of management on damage differed among regions, strata and damage types. Covariates such as wood volume, tree density and plant diversity weakly influenced herbivory, and effects differed between herbivory types. We conclude that despite of the relatively low number of species attacking beech; arthropod herbivory on beech is generally high. We further conclude that responses of herbivory to forest management are multifaceted and environmental factors such as forest structure variables affecting in particular microclimatic conditions are more likely to explain the variability in herbivory among beech forest plots.	[Gossner, Martin M.; Pasalic, Esther; Lange, Markus; Lange, Patricia; Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Jena, Germany; [Gossner, Martin M.; Weisser, Wolfgang W.] Tech Univ Munich, Ctr Food & Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany; [Lange, Markus; Hessenmoeller, Dominik; Schulze, Ernst-Detlef] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Boch, Steffen; Socher, Stephanie A.; Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Mueller, Joerg] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany	Friedrich Schiller University of Jena; Technical University of Munich; Max Planck Society; University of Bern; University of Potsdam	Gossner, MM (corresponding author), Univ Jena, Inst Ecol, Jena, Germany.	martin.gossner@tum.de	Fischer, Markus/C-6411-2008; Boch, Steffen/L-5436-2016; Weisser, Wolfgang W/B-9718-2014; Gossner, Martin M./J-2730-2015; Schulze, Ernst-Detlef/K-9627-2014	Fischer, Markus/0000-0002-5589-5900; Weisser, Wolfgang W/0000-0002-2757-8959; Gossner, Martin M./0000-0003-1516-6364; Socher, Stephanie/0000-0002-0090-4005	DFG [1374, WE 3081/21-1]; German Research Foundation (DFG); Technische Universitat Munchen within the funding programme Open Access Publishing	DFG(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen within the funding programme Open Access Publishing	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories'' (WE 3081/21-1) (www.exploratories.de). In addition, it was supported by the German Research Foundation (DFG; www.dfg.de) and the Technische Universitat Munchen within the funding programme Open Access Publishing (http://www.ub.tum.de/open-access-publikationsfonds-der-tum). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamczyk S, 2011, BIODIVERS CONSERV, V20, P2981, DOI 10.1007/s10531-011-0105-1; ABRAMS MD, 1990, FOREST ECOL MANAG, V31, P245, DOI 10.1016/0378-1127(90)90072-J; Atlegrim O, 1996, FOREST ECOL MANAG, V87, P139, DOI 10.1016/S0378-1127(96)03830-3; Bailey JK, 2003, OIKOS, V101, P127, DOI 10.1034/j.1600-0706.2003.12185.x; Basset Y, 2001, OECOLOGIA, V129, P253, DOI 10.1007/s004420100724; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Boch S, 2013, BASIC APPL ECOL, V14, P496, DOI 10.1016/j.baae.2013.06.001; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Boege K, 2005, OECOLOGIA, V143, P117, DOI 10.1007/s00442-004-1779-9; Boncina A, 2011, INT FOREST REV, V13, P13, DOI 10.1505/ifor.13.1.13; Brandle M, 2001, J ANIM ECOL, V70, P491, DOI 10.1046/j.1365-2656.2001.00506.x; Brunet J., 2010, ECOL BULL, V53, P77, DOI DOI 10.1046/J.1365-294X.1996.00094.X; CAMPBELL RW, 1977, ENVIRON ENTOMOL, V6, P323, DOI 10.1093/ee/6.2.323; Chumak Vasyl, 2005, Forest Snow and Landscape Research, V79, P101; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; COMMARMOT B., 2013, INVENTORY LARGEST PR; Commarmot Brigitte, 2005, Forest Snow and Landscape Research, V79, P45; Cunningham SA, 2009, OECOLOGIA, V158, P633, DOI 10.1007/s00442-008-1170-3; De Cauwer B, 2006, AGRON SUSTAIN DEV, V26, P35, DOI 10.1051/agro:2005058; Donaldson JR, 2006, J CHEM ECOL, V32, P1415, DOI 10.1007/s10886-006-9059-2; Fabian Y, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00375.1; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Fonte SJ, 2005, OECOLOGIA, V146, P423, DOI 10.1007/s00442-005-0203-4; Franklin RT, 1970, ANAL TEMPERATE FORES, P86; Frost CJ, 2008, OIKOS, V117, P13, DOI 10.1111/j.2007.0030-1299.16165.x; Gossner M, 2008, BIODIVERS CONSERV, V17, P3165, DOI 10.1007/s10531-008-9418-0; Gossner MM, 2014, BASIC APPL ECOL, V15, P347, DOI 10.1016/j.baae.2014.03.003; Gossner MM, 2014, BIODIVERS CONSERV, V23, P945, DOI 10.1007/s10531-014-0644-3; Gossner MM, 2013, FOREST ECOL MANAG, V302, P404, DOI 10.1016/j.foreco.2013.03.039; Gossner MM, 2009, EUR J ENTOMOL, V106, P241, DOI 10.14411/eje.2009.032; Hessenmoller D., 2011, Forstarchiv, V82, P171; Hirao T, 2009, ECOL RES, V24, P263, DOI 10.1007/s11284-008-0502-4; Hiura T, 2013, BASIC APPL ECOL, V14, P480, DOI 10.1016/j.baae.2013.06.004; Hochwender CG, 2004, OECOLOGIA, V138, P547, DOI 10.1007/s00442-003-1472-4; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; James SA, 2000, TREE PHYSIOL, V20, P1007; Kahmen A, 2005, OECOLOGIA, V142, P606, DOI 10.1007/s00442-004-1749-2; Kampichler C, 2002, EUR J ENTOMOL, V99, P79, DOI 10.14411/eje.2002.014; Kowalski E, 2011, ENTOMOL EXP APPL, V140, P35, DOI 10.1111/j.1570-7458.2011.01134.x; Kula E, 2008, INT J ACAROL, V34, P155, DOI 10.1080/01647950808683719; Lange M, 2014, FOREST ECOL MANAG, V329, P166, DOI 10.1016/j.foreco.2014.06.012; Larrivee M, 2009, AGR FOREST ENTOMOL, V11, P225, DOI 10.1111/j.1461-9563.2008.00421.x; Le Corff J, 1999, ECOL ENTOMOL, V24, P46, DOI 10.1046/j.1365-2311.1999.00174.x; Leigh EG, 1999, TROPICAL FOREST ECOL; Lindenmayer DB, 2012, BIOL CONSERV, V151, P11, DOI 10.1016/j.biocon.2011.10.032; LOREAU M, 1995, AM NAT, V145, P22, DOI 10.1086/285726; Maleque MA, 2010, INSECT CONSERV DIVER, V3, P143, DOI 10.1111/j.1752-4598.2010.00087.x; Meyer P, 2011, FOREST ECOL MANAG, V261, P342, DOI 10.1016/j.foreco.2010.08.037; Meyer P, 2003, FORSTWISS CENTRALBL, V122, P47, DOI 10.1046/j.1439-0337.2003.02041.x; NIELSEN BO, 1977, ECOL ENTOMOL, V2, P293, DOI 10.1111/j.1365-2311.1977.tb00894.x; Nol E, 2006, CAN FIELD NAT, V120, P15, DOI 10.22621/cfn.v120i1.239; Ober HK, 2010, BIODIVERS CONSERV, V19, P761, DOI 10.1007/s10531-009-9732-1; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Progar RA, 2002, ECOGRAPHY, V25, P129, DOI 10.1034/j.1600-0587.2002.250201.x; Rinker HB., 2004, FOREST CANOPIES, P359, DOI DOI 10.1016/B978-012457553-0/50024-1; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Savilaakso S, 2009, BIODIVERS CONSERV, V18, P3931, DOI 10.1007/s10531-009-9689-0; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Schoonhoven L. M., 2005, Insect-plant biology; SCHOWALTER TD, 1995, FOREST ECOL MANAG, V78, P115, DOI 10.1016/0378-1127(95)03592-4; SCHOWALTER TD, 1986, ANNU REV ENTOMOL, V31, P177, DOI 10.1146/annurev.en.31.010186.001141; Schuldt A, 2010, J ECOL, V98, P917, DOI 10.1111/j.1365-2745.2010.01659.x; Sobek S, 2009, ECOL ENTOMOL, V34, P772, DOI 10.1111/j.1365-2311.2009.01132.x; Sobek S, 2009, DIVERS DISTRIB, V15, P660, DOI 10.1111/j.1472-4642.2009.00570.x; Sobek S, 2009, OECOLOGIA, V160, P279, DOI 10.1007/s00442-009-1304-2; Southwood T.R.E., 1978, Symposia of the Royal Entomological Society of London, P19; Stadler B, 2001, OECOLOGIA, V126, P104, DOI 10.1007/s004420000514; Stokland JN, 2012, ECOL BIODIVERS CONS, P58; Summerville KS, 2002, ECOL APPL, V12, P820, DOI 10.1890/1051-0761(2002)012[0820:EOTHOF]2.0.CO;2; Taki H, 2010, FOREST ECOL MANAG, V259, P607, DOI 10.1016/j.foreco.2009.11.019; THOMAS AT, 1991, J APPL ECOL, V28, P703, DOI 10.2307/2404577; Throop HL, 2004, ECOSYSTEMS, V7, P109, DOI 10.1007/s10021-003-0225-x; Trotsiuk V, 2012, FOREST ECOL MANAG, V265, P181, DOI 10.1016/j.foreco.2011.10.042; Ulyshen MD, 2011, FOREST ECOL MANAG, V261, P1479, DOI 10.1016/j.foreco.2011.01.033; Unsicker SB, 2010, ECOLOGY, V91, P1083, DOI 10.1890/09-0402.1; Vehvilainen H, 2007, OECOLOGIA, V152, P287, DOI 10.1007/s00442-007-0673-7; Weisser WW, 2004, ECOL STU AN, V173, P3; Withers, 2005, BIOL ECOLOGY EVOLUTI	80	16	17	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104876	10.1371/journal.pone.0104876	http://dx.doi.org/10.1371/journal.pone.0104876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119984	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600097
J	Ikpeazu, A; Momah-Haruna, A; Mari, BM; Thompson, LH; Ogungbemi, K; Daniel, U; Aboki, H; Isac, S; Gorgens, M; Mziray, E; Njie, N; Akala, FA; Emmanuel, F; Odek, WO; Blanchard, JF				Ikpeazu, Akudo; Momah-Haruna, Amaka; Mari, Baba Madu; Thompson, Laura H.; Ogungbemi, Kayode; Daniel, Uduak; Aboki, Hafsatu; Isac, Shajy; Gorgens, Marelize; Mziray, Elizabeth; Njie, Ndella; Akala, Francisca Ayodeji; Emmanuel, Faran; Odek, Willis Omondi; Blanchard, James F.			An Appraisal of Female Sex Work in Nigeria - Implications for Designing and Scaling Up HIV Prevention Programmes	PLOS ONE			English	Article							RISK; TRANSMISSION; POPULATIONS	Background: The HIV epidemic in Nigeria is complex with diverse factors driving the epidemic. Accordingly, Nigeria's National Agency for the Control of AIDS is coordinating a large-scale initiative to conduct HIV epidemic appraisals across all states. These appraisals will help to better characterize the drivers of the epidemic and ensure that the HIV prevention programmes match the local epidemic context, with resources allocated to interventions that have the greatest impact locally. Currently, the mapping and size estimation of Female Sex Workers (FSWs) - a major component of the appraisal has been completed in seven states. These states are using the data generated to plan, prioritize and scale-up sub-national HIV prevention programmes. Methodology: It involved a two-level process of identifying and validating locations where FSWs solicit and/or meet clients ("hotspots"). In the first level, secondary key informants were interviewed to collect information about the geographic location and description of the hotspots. For the second level, FSWs were interviewed at each hotspot and information on population size estimates, typologies and operational dynamics of the FSWs were collected. Results: Across the seven states, a total of 17,266 secondary key informants and 5,732 FSWs were interviewed. 10,233 hotspots were identified with an estimated 126,489 FSWs ranging from 5,920 in Anambra to 46,691 in Lagos. The most common hotspots were bars/nightclubs (30%), hotels/lodges (29.6%), streets (16.6%), and brothels (14.6%). Furthermore, the population density of FSWs (per thousand adult men) across the states ranged from 2 in Anambra to 17 in the Federal Capital Territory. Conclusion: FSW populations in Nigeria are large and diverse, with substantial differences between and within states. Improved understanding of the location, population size, density, organizational typologies and clients of sex work has informed and is central to Nigeria's planning process for scaling up focused HIV prevention programmes.	[Ikpeazu, Akudo; Ogungbemi, Kayode; Daniel, Uduak; Aboki, Hafsatu] Natl Agcy Control AIDS, Abuja, Nigeria; [Momah-Haruna, Amaka; Mari, Baba Madu; Thompson, Laura H.; Isac, Shajy; Emmanuel, Faran; Odek, Willis Omondi; Blanchard, James F.] Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB R3T 2N2, Canada; [Gorgens, Marelize; Mziray, Elizabeth; Njie, Ndella; Akala, Francisca Ayodeji] World Bank, Washington, DC 20433 USA	University of Manitoba; The World Bank	Blanchard, JF (corresponding author), Univ Manitoba, Dept Community Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB R3T 2N2, Canada.	james_blanchard@umanitoba.ca	Odek, W./ABB-2958-2021; Thompson, Laura Hilary/Y-1832-2019	Thompson, Laura Hilary/0000-0003-3792-9772; Blanchard, James/0000-0002-4701-590X	Government of Nigeria; World Bank	Government of Nigeria; World Bank(The World Bank India)	This surveillance and mapping effort was funded by the Government of Nigeria (bulk of the funding), with the World Bank providing technical support. The World Bank funded its own staff to support their involvement in technical support for the work and also contracted the University of Manitoba to provide technical support services to the Government to execute the epidemic appraisals, to support the States to analyse data and to write the reports. The Federal and State level governments in Nigeria financed the training, fieldwork, supervision and data analysis. The Government of Nigeria made the determination how to undertake the surveillance and mapping (with technical guidance from University of Manitoba), and the decision to undertake the surveillance and mapping effort. They invited the World Bank and University of Manitoba to be a co-author of the study results.	Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Cuadros DF, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-28; Day S, 1997, GENITOURIN MED, V73, P161; Eluwa GI, 2012, JAIDS-J ACQ IMM DEF, V61, P507, DOI 10.1097/QAI.0b013e31826dfb41; Emmanuel F, 2013, SEX TRANSM INFECT, DOI [10.1136/sextrans-051062, DOI 10.1136/SEXTRANS-051062]; Emmanuel F, 2013, SEX TRANSM INFECT, V89, P11, DOI 10.1136/sextrans-2013-051017; Federal Ministry of Health Nigeria, 2010, NAT HIV SER PREV SEN; Jha P, 2001, SCIENCE, V292, P224, DOI 10.1126/science.1058187; Mishra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032324; National Agency for the Control of AIDS Nigeria, 2012, GEOGR MAPP MAN MAPP; National Agency for the Control of AIDS Nigeria, 2012, FED REP NIG GLOB AID; National AIDS/STI Control Programme Federal Ministry of Health Nigeria, 2010, HIV STI INT BIOL BEH; Odek WO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089180; Onwuliri VA, 2007, REACHING VULNERABLE; Rojanapithayalkorn W, 2006, REPROD HEALTH MATTER, V14, P41, DOI 10.1016/S0968-8080(06)28270-3; Society for Family Health (SFH) Nigeria, 2005, EV QUAS COMM LEV HIV; Society for Family Health (SFH) Nigeria, 2005, ASS BEH CHANG HIV RI; Verma R, 2010, SEX TRANSM INFECT, V86, pI76, DOI 10.1136/sti.2009.039115; Weir SS, 2002, SEX TRANSM INFECT, V78, pI106, DOI 10.1136/sti.78.suppl_1.i106	19	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103619	10.1371/journal.pone.0103619	http://dx.doi.org/10.1371/journal.pone.0103619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118691	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600028
J	Kim, J; Hsia, EYC; Kim, J; Sever, N; Beachy, PA; Zheng, X				Kim, Jynho; Hsia, Elaine Y. C.; Kim, James; Sever, Navdar; Beachy, Philip A.; Zheng, Xiaoyan			Simultaneous Measurement of Smoothened Entry Into and Exit From the Primary Cilium	PLOS ONE			English	Article							SMALL-MOLECULE MODULATION; DIFFUSION BARRIER; CILIARY MEMBRANE; HEDGEHOG; TRAFFICKING; PROTEIN; CYCLOPAMINE; ACTIVATION; MECHANISMS	Ciliary accumulation of signaling proteins must result from a rate of ciliary entry that exceeds ciliary exit, but approaches for distinguishing ciliary entry vs. exit are lacking. Using a photoconvertible fluorescent protein tag, we establish an assay that allows a separate but simultaneous examination of ciliary entry and exit of the Hedgehog signaling protein Smoothened in individual cells. We show that KAAD-cyclopamine selectively blocks entry, whereas ciliobrevin interferes initially with exit and eventually with both entry and exit of ciliary Smoothened. Our study provides an approach to understanding regulation of ciliary entry vs. exit of Hedgehog signaling components as well as other ciliary proteins.	[Kim, Jynho; Kim, James; Sever, Navdar; Beachy, Philip A.; Zheng, Xiaoyan] Stanford Univ Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Dev Biol, Stanford, CA USA; [Kim, Jynho; Sever, Navdar; Beachy, Philip A.] Stanford Univ Sch Med, Howard Hughes Med Inst, Stanford, CA USA; [Kim, James] Univ Texas Southwestern, Hamon Ctr Therapeut Oncol Res, Div Hematol & Oncol, Dallas, TX USA; [Hsia, Elaine Y. C.; Zheng, Xiaoyan] George Washington Univ, Sch Med & Hlth Sci, Dept Anat & Regenerat Biol, Washington, DC 20052 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; George Washington University	Beachy, PA (corresponding author), Stanford Univ Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Biochem, Stanford, CA 94305 USA.	pbeachy@stanford.edu; xzheng@gwu.edu	Sever, Navdar/AAB-7906-2022; Zheng, Xiaoyan/AAG-1251-2020	Sever, Navdar/0000-0001-9462-7979; Zheng, Xiaoyan/0000-0003-4983-5503	National Institutes of Health [R00HD065873, R01GM102498]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD065873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by funding from the National Institutes of Health to X.Z. (R00HD065873) and to P.A.B. (R01GM102498). P.A.B. is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huang KY, 2009, J CELL BIOL, V186, P601, DOI 10.1083/jcb.200903066; Ingham PW, 2011, NAT REV GENET, V12, P393, DOI 10.1038/nrg2984; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Mas C, 2010, BIOCHEM PHARMACOL, V80, P712, DOI 10.1016/j.bcp.2010.04.016; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Ott Carolyn, 2012, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0426s57; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Seeger-Nukpezah T, 2012, CURR OPIN CELL BIOL, V24, P652, DOI 10.1016/j.ceb.2012.06.002; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Wigley WC, 1999, J CELL BIOL, V145, P481; Wilson CW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005182; Ye F, 2013, ELIFE, V2, DOI 10.7554/eLife.00654	28	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104070	10.1371/journal.pone.0104070	http://dx.doi.org/10.1371/journal.pone.0104070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119726	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600036
J	Kretchun, AM; Scheller, RM; Lucash, MS; Clark, KL; Hom, J; Van Tuyl, S				Kretchun, Alec M.; Scheller, Robert M.; Lucash, Melissa S.; Clark, Kenneth L.; Hom, John; Van Tuyl, Steve			Predicted Effects of Gypsy Moth Defoliation and Climate Change on Forest Carbon Dynamics in the New Jersey Pine Barrens	PLOS ONE			English	Article							SIMULATION; SCENARIOS; OUTBREAKS; INSECTS; LANDIS; BEETLE; STATES; SINK	Disturbance regimes within temperate forests can significantly impact carbon cycling. Additionally, projected climate change in combination with multiple, interacting disturbance effects may disrupt the capacity of forests to act as carbon sinks at large spatial and temporal scales. We used a spatially explicit forest succession and disturbance model, LANDIS-II, to model the effects of climate change, gypsy moth (Lymantria dispar L.) defoliation, and wildfire on the C dynamics of the forests of the New Jersey Pine Barrens over the next century. Climate scenarios were simulated using current climate conditions (baseline), as well as a high emissions scenario (HadCM3 A2 emissions scenario). Our results suggest that long-term changes in C cycling will be driven more by climate change than by fire or gypsy moths over the next century. We also found that simulated disturbances will affect species composition more than tree growth or C sequestration rates at the landscape level. Projected changes in tree species biomass indicate a potential increase in oaks with climate change and gypsy moth defoliation over the course of the 100-year simulation, exacerbating current successional trends towards increased oak abundance. Our research suggests that defoliation under climate change may play a critical role in increasing the variability of tree growth rates and in determining landscape species composition over the next 100 years.	[Kretchun, Alec M.; Scheller, Robert M.; Lucash, Melissa S.] Portland State Univ, Dept Environm Sci & Management, Portland, OR 97207 USA; [Clark, Kenneth L.] USDA, Forest Serv, Silas Little Expt Forest, New Lisbon, NJ USA; [Hom, John; Van Tuyl, Steve] USDA ARS, Newtown Sq, PA USA	Portland State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA)	Kretchun, AM (corresponding author), Portland State Univ, Dept Environm Sci & Management, Portland, OR 97207 USA.	AlecKretchun@Gmail.com	Scheller, Robert M/B-3135-2009; Van Tuyl, Steven/E-2814-2014	Scheller, Robert M/0000-0002-7507-4499; Van Tuyl, Steven/0000-0002-8752-272X	National Fire Plan, Forest Health Monitoring [NE-F-08-01]; Eastern Landfire Prototype	National Fire Plan, Forest Health Monitoring; Eastern Landfire Prototype	This work was supported by the National Fire Plan, Forest Health Monitoring (NE-F-08-01), and the Eastern Landfire Prototype. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Campbell J, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000451; CAMPBELL RW, 1982, J FOREST, V80, P89; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Clark KL, 2010, GLOBAL CHANGE BIOL, V16, P88, DOI 10.1111/j.1365-2486.2009.01983.x; Davidson CB, 1999, FOR SCI, V45; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dymond CC, 2010, ECOSYSTEMS, V13, P917, DOI 10.1007/s10021-010-9364-z; Fajvan MA, 1996, FOREST ECOL MANAG, V89, P79, DOI 10.1016/S0378-1127(96)03865-0; FORMAN RTT, 1981, B TORREY BOT CLUB, V108, P34, DOI 10.2307/2484334; Foster J, 2011, FORET INSECT DEFOLIA; Gan JB, 2004, FOREST ECOL MANAG, V191, P61, DOI 10.1016/j.foreco.2003.11.001; Gustafson EJ, 2010, ECOL APPL, V20, P700, DOI 10.1890/08-1693.1; He HS, 2008, FOREST ECOL MANAG, V254, P484, DOI 10.1016/j.foreco.2007.08.022; Hicke JA, 2012, GLOBAL CHANGE BIOL, V18, P7, DOI 10.1111/j.1365-2486.2011.02543.x; Iverson LR, 2002, FOREST ECOL MANAG, V155, P205, DOI 10.1016/S0378-1127(01)00559-X; Johnson DM, 2006, ECOGRAPHY, V29, P367, DOI 10.1111/j.2006.0906-7590.04448.x; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; La Puma IP, 2012, FIRE PLAINS LANDSCAP; Lathrop Jr RG, 2004, NEW JERSEY LAND USE; Liebhold A, 2000, POPUL ECOL, V42, P257, DOI 10.1007/PL00012004; Lovett GM, 2006, BIOSCIENCE, V56, P395, DOI 10.1641/0006-3568(2006)056[0395:FERTEP]2.0.CO;2; McCormick J., 1973, PINE BARRENS VEGETAT; McKinley DC, 2011, ECOL APPL, V21, P1902, DOI 10.1890/10-0697.1; Medvigy D, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045703; Mladenoff DJ, 2004, ECOL MODEL, V180, P7, DOI 10.1016/j.ecolmodel.2004.03.016; Muzika RM, 2001, USDA NE EXP, V277, P117; Muzika RM, 1999, CAN J FOREST RES, V29, P1365, DOI 10.1139/cjfr-29-9-1365; Naidoo R, 2001, FOREST SCI, V47, P338; Pan Y, 2006, ECOL APPL, V16, P125, DOI 10.1890/05-0247; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pan YD, 2009, FOREST ECOL MANAG, V259, P151, DOI 10.1016/j.foreco.2009.09.049; Parton W.J., 1983, SIMULATION SOIL ORGA, P533; PARTON WJ, 1994, SSSA SPEC PUBL, P147; Scheller RM, 2008, FOREST ECOL MANAG, V255, P1489, DOI 10.1016/j.foreco.2007.11.025; Scheller RM, 2007, ECOL MODEL, V201, P409, DOI 10.1016/j.ecolmodel.2006.10.009; Scheller RM, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00241.1; Scheller RM, 2011, ECOSYSTEMS, V14, P987, DOI 10.1007/s10021-011-9462-6; Scheller RM, 2011, ECOL MODEL, V222, P144, DOI 10.1016/j.ecolmodel.2010.09.009; Sturtevant BR, 2009, ECOL MODEL, V220, P3380, DOI 10.1016/j.ecolmodel.2009.07.030; Tedrow J., 1986, SOILS NEW JERSEY; Ungerer MJ, 1999, J BIOGEOGR, V26, P1133, DOI 10.1046/j.1365-2699.1999.00363.x; White A, 1999, GLOBAL ENVIRON CHANG, V9, pS21, DOI 10.1016/S0959-3780(99)00016-3; Williams DW, 1995, J BIOGEOGR, V22, P665, DOI 10.2307/2845968	44	13	13	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e102531	10.1371/journal.pone.0102531	http://dx.doi.org/10.1371/journal.pone.0102531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119162	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600008
J	Monjazeb, AM; Tietze, JK; Grossenbacher, SK; Hsiao, HH; Zamora, AE; Mirsoian, A; Koehn, B; Blazar, BR; Weiss, JM; Wiltrout, RH; Sckisel, GD; Murphy, WJ				Monjazeb, Arta M.; Tietze, Julia K.; Grossenbacher, Steven K.; Hsiao, Hui-Hua; Zamora, Anthony E.; Mirsoian, Annie; Koehn, Brent; Blazar, Bruce R.; Weiss, Jonathan M.; Wiltrout, Robert H.; Sckisel, Gail D.; Murphy, William J.			Bystander Activation and Anti-Tumor Effects of CD8+T Cells Following Interleukin-2 Based Immunotherapy Is Independent of CD4+T Cell Help	PLOS ONE			English	Article							CD8(+) T-CELLS; PROGRAMMED DEATH-1; PD-1 EXPRESSION; MEMORY; RESPONSES; INFECTION; IL-21; MICE; PROLIFERATION; PHENOTYPE	We have previously demonstrated that immunotherapy combining agonistic anti-CD40 and IL-2 (IT) results in synergistic anti-tumor effects. IT induces expansion of highly cytolytic, antigen-independent "bystander-activated'' (CD8(+)CD44(high)) T cells displaying a CD25(-) NKG2D(+) phenotype in a cytokine dependent manner, which were responsible for the anti-tumor effects. While much attention has focused on CD4+ T cell help for antigen-specific CD8+ T cell expansion, little is known regarding the role of CD4+ T cells in antigen-nonspecific bystander-memory CD8+ T cell expansion. Utilizing CD4 deficient mouse models, we observed a significant expansion of bystander-memory T cells following IT which was similar to the non-CD4 depleted mice. Expanded bystander-memory CD8+ T cells upregulated PD-1 in the absence of CD4+ T cells which has been published as a hallmark of exhaustion and dysfunction in helpless CD8+ T cells. Interestingly, compared to CD8+ T cells from CD4 replete hosts, these bystander expanded cells displayed comparable (or enhanced) cytokine production, lytic ability, and in vivo anti-tumor effects suggesting no functional impairment or exhaustion and were enriched in an effector phenotype. There was no acceleration of the post-IT contraction phase of the bystander memory CD8+ response in CD4-depleted mice. The response was independent of IL-21 signaling. These results suggest that, in contrast to antigen-specific CD8+ T cell expansion, CD4+ T cell help is not necessary for expansion and activation of antigen-nonspecific bystander-memory CD8+ T cells following IT, but may play a role in regulating conversion of these cells from a central memory to effector phenotype. Additionally, the expression of PD-1 in this model appears to be a marker of effector function and not exhaustion.	[Monjazeb, Arta M.] Univ Calif Davis, Sch Med, Dept Radiat Oncol, Sacramento, CA 95817 USA; [Tietze, Julia K.; Grossenbacher, Steven K.; Hsiao, Hui-Hua; Zamora, Anthony E.; Mirsoian, Annie; Sckisel, Gail D.; Murphy, William J.] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Koehn, Brent; Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MA USA; [Koehn, Brent; Blazar, Bruce R.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MA USA; [Weiss, Jonathan M.; Wiltrout, Robert H.] NCI, Canc & Inflammat Program, Frederick, MD 21701 USA; [Murphy, William J.] Univ Calif Davis, Sch Med, Dept Internal Med, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Minnesota System; University of Minnesota System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Davis	Murphy, WJ (corresponding author), Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA.	wmjmurphy@ucdavis.edu	Zamora, Anthony E./O-2836-2017	Zamora, Anthony E./0000-0001-5712-5339	NIH [R01 CA095572]; NATIONAL CANCER INSTITUTE [R01CA072669, P30CA093373, R01CA095572, ZIABC009262, P01CA142106] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056067] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the NIH R01 CA095572. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2005, BLOOD, V106, P338, DOI 10.1182/blood-2004-09-3775; Allie SR, 2011, J IMMUNOL; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Belz GT, 2001, J VIROL, V75, P4435, DOI 10.1128/JVI.75.9.4435-4438.2001; Berner V, 2007, NAT MED, V13, P354, DOI 10.1038/nm1554; Bos R, 2010, CANCER RES, V70, P8368, DOI 10.1158/0008-5472.CAN-10-1322; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Bucher C, 2009, BLOOD, V114, P5375, DOI 10.1182/blood-2009-05-221135; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Casey KA, 2007, J IMMUNOL, V178, P7640, DOI 10.4049/jimmunol.178.12.7640; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dhanji S, 2004, BLOOD, V104, P2116, DOI 10.1182/blood-2004-01-0150; Ehl S, 1997, J EXP MED, V185, P1241, DOI 10.1084/jem.185.7.1241; Fuse S, 2009, J IMMUNOL, V182, P4244, DOI 10.4049/jimmunol.0802041; Hokey DA, 2008, EUR J IMMUNOL, V38, P1435, DOI 10.1002/eji.200737857; Hu HM, 2000, J IMMUNOL, V165, P4246, DOI 10.4049/jimmunol.165.8.4246; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Janssen EM, 2005, NATURE, V434, P88, DOI 10.1038/nature03337; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kinter AL, 2008, J IMMUNOL, V181, P6738, DOI 10.4049/jimmunol.181.10.6738; Li YQ, 2005, J IMMUNOL, V175, P2261, DOI 10.4049/jimmunol.175.4.2261; Liu ZQ, 2008, J IMMUNOL, V181, P4363, DOI 10.4049/jimmunol.181.6.4363; Lodge A, 2006, CANCER IMMUNOL IMMUN, V55, P1542, DOI 10.1007/s00262-006-0147-5; Marzo AL, 2000, J IMMUNOL, V165, P6047, DOI 10.4049/jimmunol.165.11.6047; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murphy WJ, 2003, J IMMUNOL, V170, P2727, DOI 10.4049/jimmunol.170.5.2727; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; RAHEMTULLA A, 1991, NATURE, V353, P180, DOI 10.1038/353180a0; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Sckisel GD, 2014, CLIN EXP IMMUNOL, V175, P79, DOI 10.1111/cei.12186; Seung SK, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003649; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sotomayor EM, 1999, NAT MED, V5, P780, DOI 10.1038/10503; Spolski R, 2010, CRIT REV IMMUNOL, V30, P559, DOI 10.1615/CritRevImmunol.v30.i6.50; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tietze JK, 2012, BLOOD, V119, P3073, DOI 10.1182/blood-2011-07-369736; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; vonHerrath MG, 1996, J VIROL, V70, P1072, DOI 10.1128/JVI.70.2.1072-1079.1996; Yi JS, 2010, MICROBES INFECT, V12, P1111, DOI 10.1016/j.micinf.2010.08.008; Zelinskyy G, 2011, J IMMUNOL, V187, P3730, DOI 10.4049/jimmunol.1101612	43	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e102709	10.1371/journal.pone.0102709	http://dx.doi.org/10.1371/journal.pone.0102709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119341	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600009
J	Pontier-Bres, R; Munro, P; Boyer, L; Anty, R; Imbert, V; Terciolo, C; Andre, F; Rampal, P; Lemichez, E; Peyron, JF; Czerucka, D				Pontier-Bres, Rodolphe; Munro, Patrick; Boyer, Laurent; Anty, Rodolphe; Imbert, Veronique; Terciolo, Chloe; Andre, Federic; Rampal, Patrick; Lemichez, Emmanuel; Peyron, Jean-Francois; Czerucka, Dorota			Saccharomyces boulardii Modifies Salmonella Typhimurium Traffic and Host Immune Responses along the Intestinal Tract	PLOS ONE			English	Article							ESCHERICHIA-COLI; VIRULENCE FACTORS; GNOTOBIOTIC MICE; DENDRITIC CELLS; T84 CELLS; INFECTION; ENTERICA; PATHOGENS; INTERFERES; MECHANISMS	Salmonella enterica serovar Typhimurium (ST) is an enteropathogenic Gram-negative bacterium that causes infection following oral ingestion. ST spreads rapidly along the gastrointestinal tract (GIT) and invades the intestinal epithelium to ultimately reach internal body organs. The probiotic yeast Saccharomyces boulardii BIOCODEX (S.b-B) is prescribed for prophylaxis of diarrheal infectious diseases. We previously showed that S.b-B prevents weight loss in ST-infected mice and significantly decreases bacterial translocation to the spleen and liver. This study was designed to investigate the effect of S.b-B on ST migration along the GIT and the impact of the yeast on the host's early innate immune responses. Bioluminescent imaging (BLI) was used to evaluate the effect of S.b-B on the progression of luminescent Salmonella Typhimurium (ST-lux) in the GIT of mice pretreated with streptomycin. Photonic emission (PE) was measured in GIT extracts (stomach, small intestine, cecum and colon) at various time periods post-infection (PI). PE analysis revealed that, 45 min PI, ST-lux had migrated slightly faster in the mice treated with S.b-B than in the untreated infected animals. At 90 min PI, ST-lux had reached the cecum in both groups of mice. Adhesion of ST to S.b-B was visualized in the intestines of the mice and probably accounts for (1) the faster elimination of ST-lux in the feces, and (2) reduced translocation of ST to the spleen and liver. In the early phase of infection, S.b-B also modifies the host's immune responses by (1) increasing IFN-gamma gene expression and decreasing IL-10 gene expression in the small intestine, and ( 2) elevating both IFN-gamma, and IL-10 mRNA levels in the cecum. BLI revealed that S.b-B modifies ST migration and the host immune response along the GIT. Study findings shed new light on the protective mechanisms of S.b-B during the early phase of Salmonella pathogenesis.	[Pontier-Bres, Rodolphe; Imbert, Veronique; Peyron, Jean-Francois; Czerucka, Dorota] INSERM, U1065, Ctr Med Med Mol C3M, Team Inflammat Canc Canc Stem Cells 4, Nice, France; [Munro, Patrick; Boyer, Laurent; Lemichez, Emmanuel] INSERM, U1065, Ctr Med Med Mol C3M, Team Microbial Toxins Host Pathogen Interact 6, Nice, France; [Anty, Rodolphe] INSERM, U1065, Ctr Med Med Mol C3M, Team Hepat Complicat Obes 8, Nice, France; [Pontier-Bres, Rodolphe; Munro, Patrick; Boyer, Laurent; Anty, Rodolphe; Imbert, Veronique; Lemichez, Emmanuel; Peyron, Jean-Francois; Czerucka, Dorota] Univ Nice Sophia Antipolis, UFR Med, IFR50, Fac Med, F-06189 Nice, France; [Rampal, Patrick] Ctr Sci Monaco, Monaco, Monaco; [Terciolo, Chloe] Univ Aix Marseille, CRO2 INSERM U911, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Aix-Marseille Universite	Czerucka, D (corresponding author), INSERM, U1065, Ctr Med Med Mol C3M, Team Inflammat Canc Canc Stem Cells 4, Nice, France.	czerucka@unice.fr	Imbert, Véronique/I-6093-2016; BOYER, Laurent/AAH-4543-2021; Jean-Francois, Peyron/AAA-9496-2022; Boyer, laurent/F-8921-2015; Lemichez, Emmanuel/G-3559-2013; Peyron, Jean-Francois/M-5682-2016; Munro, Patrick/A-6579-2009	Imbert, Véronique/0000-0003-2103-6718; BOYER, Laurent/0000-0002-1375-1706; Jean-Francois, Peyron/0000-0001-6113-916X; Boyer, laurent/0000-0002-1375-1706; Lemichez, Emmanuel/0000-0001-9080-7761; Peyron, Jean-Francois/0000-0001-6113-916X; Munro, Patrick/0000-0003-4283-4671; terciolo, chloe/0000-0003-2185-485X; Anty, Rodolphe/0000-0001-8194-9805; Anty, Rodolphe/0000-0002-8053-1957; PONTIER-BRES, Rodolphe/0000-0002-4139-5913	Biocodex S.A. (Gentilly France); INSERM; Region Provence-Alpes Cote d'Azur; Conseil General des Alpes Maritimes	Biocodex S.A. (Gentilly France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Provence-Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur)	This study was supported by Biocodex S.A. (Gentilly France), INSERM, the Region Provence-Alpes Cote d'Azur and the Conseil General des Alpes Maritimes. The funders had no role in study design, data collectionand analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Andreu N, 2011, FEMS MICROBIOL REV, V35, P360, DOI 10.1111/j.1574-6976.2010.00252.x; Bao S, 2000, IMMUNOLOGY, V99, P464, DOI 10.1046/j.1365-2567.2000.00955.x; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Broz P, 2012, GUT MICROBES, V3, P62, DOI 10.4161/gmic.19141; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Dahan S, 2003, INFECT IMMUN, V71, P766, DOI 10.1128/IAI.71.2.766-773.2003; Dalmasso G, 2006, RES MICROBIOL, V157, P456, DOI 10.1016/j.resmic.2005.11.007; Fidan I, 2009, MYCOSES, V52, P29, DOI 10.1111/j.1439-0507.2008.01545.x; Gedek BR, 1999, MYCOSES, V42, P261, DOI 10.1046/j.1439-0507.1999.00449.x; Hallstrom K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00088; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; Kaiser P, 2011, CURR OPIN IMMUNOL, V23, P456, DOI 10.1016/j.coi.2011.06.004; Kollaritsch H, 1993, Fortschr Med, V111, P152; Martins FS, 2013, MICROBES INFECT, V15, P270, DOI 10.1016/j.micinf.2012.12.007; Martins FS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008925; McFarland LV, 2010, WORLD J GASTROENTERO, V16, P2202, DOI 10.3748/wjg.v16.i18.2202; Muller AJ, 2012, CELL HOST MICROBE, V11, P19, DOI 10.1016/j.chom.2011.11.013; Mumy KL, 2008, AM J PHYSIOL-GASTR L, V294, pG599, DOI 10.1152/ajpgi.00391.2007; MUOTIALA A, 1990, MICROB PATHOGENESIS, V8, P135, DOI 10.1016/0882-4010(90)90077-4; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Pontier-Bres R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033796; Qamar A, 2001, INFECT IMMUN, V69, P2762, DOI 10.1128/IAI.69.4.2762-2765.2001; Rodrigues ACP, 2000, J APPL MICROBIOL, V89, P404, DOI 10.1046/j.1365-2672.2000.01128.x; Rodrigues ACP, 1996, J APPL BACTERIOL, V81, P251, DOI 10.1111/j.1365-2672.1996.tb04325.x; Santos RL, 2004, INT J MED MICROBIOL, V294, P225, DOI 10.1016/j.ijmm.2004.06.029; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; Tam MA, 2008, IMMUNOL REV, V225, P140, DOI 10.1111/j.1600-065X.2008.00679.x; Thomas S, 2009, CLIN EXP IMMUNOL, V156, P78, DOI 10.1111/j.1365-2249.2009.03878.x; Wick MJ, 2011, J INNATE IMMUN, V3, P543, DOI 10.1159/000330771; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x; Wu X, 2008, AM J PHYSIOL-GASTR L, V294, pG295, DOI 10.1152/ajpgi.00173.2007	34	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103069	10.1371/journal.pone.0103069	http://dx.doi.org/10.1371/journal.pone.0103069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118595	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600015
J	Shen, WY; Chung, SH; Irhimeh, MR; Li, SY; Lee, SR; Gillies, MC				Shen, Weiyong; Chung, Sook H.; Irhimeh, Mohammad R.; Li, Shiying; Lee, So-Ra; Gillies, Mark C.			Systemic Administration of Erythropoietin Inhibits Retinopathy in RCS Rats	PLOS ONE			English	Article							PHOTORECEPTOR DEGENERATION; RETINAL DEGENERATION; DIABETIC-RETINOPATHY; DOSE ERYTHROPOIETIN; VASCULAR PATHOLOGY; GENE-TRANSFER; CELL; STEM; ACTIVATION; MICROGLIA	Objective: Royal College of Surgeons (RCS) rats develop vasculopathy as photoreceptors degenerate. The aim of this study was to examine the effect of erythropoietin (EPO) on retinopathy in RCS rats. Methods: Fluorescein angiography was used to monitor retinal vascular changes over time. Changes in retinal glia and vasculature were studied by immunostaining. To study the effects of EPO on retinal pathology, EPO (5000 IU/kg) was injected intraperitoneally in 14 week old normal and RCS rats twice a week for 4 weeks. Changes in the retinal vasculature, glia and microglia, photoreceptor apoptosis, differential expression of p75 neurotrophin receptor (p75(NTR)), pro-neurotrophin 3 (pro-NT3), tumour necrosis factor-alpha (TNF alpha), pigment epithelium derived factor (PEDF) and vascular endothelial growth factor-A (VEGF-A), the production of CD34(+) cells and mobilization of CD34(+)/VEGF-R2(+) cells as well as recruitment of CD34(+) cells into the retina were examined after EPO treatment. Results: RCS rats developed progressive capillary dropout and subretinal neovascularization which were accompanied by retinal gliosis. Systemic administration of EPO stabilized the retinal vasculature and inhibited the development of focal vascular lesions. Further studies showed that EPO modulated retinal gliosis, attenuated photoreceptor apoptosis and p75(NTR) and pro-NT3 upregulation, promoted the infiltration of ramified microglia and stimulated VEGF-A expression but had little effect on TNF alpha and PEDF expression. EPO stimulated the production of red and white blood cells and CD34(+) cells along with effective mobilization of CD34(+)/VEGF-R2(+) cells. Immunofluorescence study demonstrated that EPO enhanced the recruitment of CD34(+) cells into the retina. Conclusions: Our results suggest that EPO has therapeutic potentials in treatment of neuronal and vascular pathology in retinal disease. The protective effects of EPO on photoreceptors and the retinal vasculature may involve multiple mechanisms including regulation of retinal glia and microglia, inhibition of p75(NTR)-pro-NT3 signaling together with stimulation of production and mobilization of bone marrow derived cells.	[Shen, Weiyong; Chung, Sook H.; Irhimeh, Mohammad R.; Li, Shiying; Lee, So-Ra; Gillies, Mark C.] Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia; [Li, Shiying] Third Mil Med Univ, Southwest Eye Hosp, Southwest Hosp, Chongqing, Peoples R China	University of Sydney; Army Medical University	Shen, WY (corresponding author), Univ Sydney, Save Sight Inst, Sydney, NSW 2006, Australia.	weiyong.shen@sydney.edu.au			National Health and Medical Research Council [632839]; Ophthalmic Research Institute of Australia; National Health and Medical Research Council (Australia) Practitioner Fellowship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia; National Health and Medical Research Council (Australia) Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants from National Health and Medical Research Council (632839) and Ophthalmic Research Institute of Australia. Mark Gillies is a fellow of Sydney Medical School Foundation and supported by a National Health and Medical Research Council (Australia) Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asheuer M, 2004, P NATL ACAD SCI USA, V101, P3557, DOI 10.1073/pnas.0306431101; Athanasiou D, 2013, FEBS LETT, V587, P2008, DOI 10.1016/j.febslet.2013.05.020; Banin E, 2006, INVEST OPHTH VIS SCI, V47, P2125, DOI 10.1167/iovs.05-1096; Barber AJ, 2011, INVEST OPHTH VIS SCI, V52, P1156, DOI 10.1167/iovs.10-6293; Barthelmes D, 2013, BLOOD CELL MOL DIS, V51, P163, DOI 10.1016/j.bcmd.2013.05.002; Barthelmes D, 2013, ANN HEMATOL, V92, P1461, DOI 10.1007/s00277-013-1815-0; Besler Christian, 2008, Expert Rev Cardiovasc Ther, V6, P1071, DOI 10.1586/14779072.6.8.1071; Bharadwaj AS, 2013, PROG RETIN EYE RES, V32, P102, DOI 10.1016/j.preteyeres.2012.08.004; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Chang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055291; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; Chen J, 2008, J AAPOS, V12, P221, DOI 10.1016/j.jaapos.2008.02.001; Chen J, 2008, J CLIN INVEST, V118, P526, DOI [10.1172/JC133813, 10.1172/JCI33813]; Chen J, 2009, INVEST OPHTH VIS SCI, V50, P1329, DOI 10.1167/iovs.08-2521; Coorey NJ, 2012, CLIN EXP OPTOM, V95, P266, DOI 10.1111/j.1444-0938.2012.00741.x; Dorrell MI, 2010, GLIA, V58, P43, DOI 10.1002/glia.20900; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Fleck BW, 2013, ARCH DIS CHILD-FETAL, V98, pF454, DOI 10.1136/archdischild-2013-303933; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Harada T, 2000, NEURON, V26, P533, DOI 10.1016/S0896-6273(00)81185-X; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; Jonas RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030763; Kurihara T, 2012, J CLIN INVEST, V122, P4213, DOI 10.1172/JCI65157; Ladeby R, 2005, GLIA, V50, P121, DOI 10.1002/glia.20159; LaVail M M, 2001, Prog Brain Res, V131, P617; Li FQ, 2004, NEUROSIGNALS, V13, P265, DOI 10.1159/000081963; Lifshitz L, 2009, MOL IMMUNOL, V46, P713, DOI 10.1016/j.molimm.2008.10.004; Lipsic E, 2008, EUR J HEART FAIL, V10, P22, DOI 10.1016/j.ejheart.2007.10.008; Marzo F, 2008, J THROMB THROMBOLYS, V26, P183, DOI 10.1007/s11239-008-0212-3; McVicar CM, 2011, DIABETES, V60, P2995, DOI 10.2337/db11-0026; Merchionne F, 2009, BRIT J HAEMATOL, V146, P127, DOI 10.1111/j.1365-2141.2009.07702.x; Mitsuhashi J, 2013, EXP EYE RES, V106, P64, DOI 10.1016/j.exer.2012.11.001; Mobius-Winkler S, 2009, CYTOM PART A, V75A, P25, DOI 10.1002/cyto.a.20669; Mowat FM, 2012, AM J PATHOL, V180, P1726, DOI 10.1016/j.ajpath.2011.12.033; Murakami T, 2012, INVEST OPHTH VIS SCI, V53, P1506, DOI 10.1167/iovs.11-9231; Otani A, 2004, J CLIN INVEST, V114, P765, DOI 10.1172/JCI200421686; Otani A, 2002, NAT MED, V8, P1004, DOI 10.1038/nm744; Pennesi ME, 2008, EXP EYE RES, V87, P561, DOI 10.1016/j.exer.2008.09.004; Peterson TE, 2007, BRIT J PHARMACOL, V150, P823, DOI 10.1038/sj.bjp.0707162; Prokosch V, 2011, EXP EYE RES, V92, P128, DOI 10.1016/j.exer.2010.12.002; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Rex TS, 2009, EXP EYE RES, V89, P735, DOI 10.1016/j.exer.2009.06.017; Ritter MR, 2006, J CLIN INVEST, V116, P3266, DOI 10.1172/JCI29683; Sanchis-Gomar F, 2014, INT J CARDIOL, V171, P116, DOI 10.1016/j.ijcard.2013.12.011; Shen JF, 2010, INVEST OPHTH VIS SCI, V51, P35, DOI 10.1167/iovs.09-3544; Shen WY, 2006, DIABETOLOGIA, V49, P1690, DOI 10.1007/s00125-006-0274-8; Shen WY, 2014, GLIA, V62, P1110, DOI 10.1002/glia.22666; Shen WY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-137; Shen WY, 2012, J NEUROSCI, V32, P15715, DOI 10.1523/JNEUROSCI.2841-12.2012; Shen WY, 2010, J NEUROSCI RES, V88, P1485, DOI 10.1002/jnr.22317; Shen WY, 2003, J GENE MED, V5, P576, DOI 10.1002/jgm.375; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Slusarski JD, 2009, PEDIATR RES, V66, P625, DOI 10.1203/PDR.0b013e3181bc33e6; Stahl A, 2010, RETINA-J RET VIT DIS, V30, P1524, DOI 10.1097/IAE.0b013e3181d37539; Sullivan T, 2011, NEUROCHEM RES, V36, P613, DOI 10.1007/s11064-010-0272-6; Urao N, 2006, CIRC RES, V98, P1405, DOI 10.1161/01.RES.0000224117.59417.f3; Urnemura T, 2008, J PHARMACOL SCI, V108, P1, DOI 10.1254/jphs.08R01CP; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; Wang MH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-173; Wang Q, 2011, CELL PHYSIOL BIOCHEM, V27, P769, DOI 10.1159/000330085; Yohannan J, 2013, OPHTHALMOLOGY, V120, P1254, DOI 10.1016/j.ophtha.2012.12.003; Yu DY, 2000, INVEST OPHTH VIS SCI, V41, P3999; Yu DY, 2005, EXP EYE RES, V80, P745, DOI 10.1016/j.exer.2005.01.018; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6; Zambarakji HJ, 2006, EXP EYE RES, V82, P164, DOI 10.1016/j.exer.2005.06.006	71	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104759	10.1371/journal.pone.0104759	http://dx.doi.org/10.1371/journal.pone.0104759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119659	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600083
J	Wang, ZS; Wu, X; Peng, JH; Hu, YD; Fang, BS; Huang, SY				Wang, Zhaoshou; Wu, Xin; Peng, Jianghai; Hu, Yidan; Fang, Baishan; Huang, Shiyang			Artificially Constructed Quorum-Sensing Circuits Are Used for Subtle Control of Bacterial Population Density	PLOS ONE			English	Article							SYNTHETIC BIOLOGY; PHOTOBACTERIUM-FISCHERI; DESIGN; AUTOINDUCER; GYRASE; MODEL	Vibrio fischeri is a typical quorum-sensing bacterium for which lux box, luxR, and luxI have been identified as the key elements involved in quorum sensing. To decode the quorum-sensing mechanism, an artificially constructed cell-cell communication system has been built. In brief, the system expresses several programmed cell-death BioBricks and quorum-sensing genes driven by the promoters lux pR and PlacO-1 in Escherichia coli cells. Their transformation and expression was confirmed by gel electrophoresis and sequencing. To evaluate its performance, viable cell numbers at various time periods were investigated. Our results showed that bacteria expressing killer proteins corresponding to ribosome binding site efficiency of 0.07, 0.3, 0.6, or 1.0 successfully sensed each other in a population-dependent manner and communicated with other to subtly control their population density. This was also validated using a proposed simple mathematical model.	[Wang, Zhaoshou; Wu, Xin; Peng, Jianghai; Hu, Yidan; Fang, Baishan; Huang, Shiyang] Xiamen Univ, Inst Biochem Engn, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen, Peoples R China; [Fang, Baishan] Xiamen Univ, Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China; [Wang, Zhaoshou; Wu, Xin; Hu, Yidan; Fang, Baishan; Huang, Shiyang] Xiamen Univ, Key Lab Synthet Biotechnol Xiamen City, Xiamen, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Fang, BS (corresponding author), Xiamen Univ, Inst Biochem Engn, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen, Peoples R China.	fbs@xmu.edu.cn		Hu, Yidan/0000-0002-6440-5678	National Natural Science Foundation of China [30770059, 21336009]; Fundamental Research Funds for the Central Universities in China [2010121050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China	Financial support for this work was provided by the National Natural Science Foundation of China (No. 30770059, No. 21336009) and the Fundamental Research Funds for the Central Universities in China (No. 2010121050). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapakis CM, 2009, MOL BIOSYST, V5, P704, DOI 10.1039/b901484e; Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Becker J, 2011, CURR OPIN BIOTECH, V23, P1; Ceroni F, 2010, BIOCOMPUT-PAC SYM, P409; Chandran D, 2008, Drug Discov Today Dis Models, V5, P299; Checa SK, 2012, CURR OPIN BIOTECH, V23, P766, DOI 10.1016/j.copbio.2012.05.003; Cheng AA, 2012, ANNU REV BIOMED ENG, V14, P155, DOI [10.1146/annurev-bioeng-071811-150118, 10.1146/annurev.bioeng-071811-150118]; Collin M, 2009, BACTERIAL SENSING SI, P1; Connor MR, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/541698; de Lorenzo V, 2008, CURR OPIN BIOTECH, V19, P579, DOI 10.1016/j.copbio.2008.10.004; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; Endler L, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0035.focus; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Galhardo RS, 2009, GENETICS, V182, P55, DOI 10.1534/genetics.109.100735; Gendrault Y, 2011, BIOTECHNOL J, V6, P796, DOI 10.1002/biot.201100083; Haseloff J, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0176.focus; Kambam PKR, 2008, IET SYST BIOL, V2, P33, DOI 10.1049/iet-syb:20070011; Kampranis SC, 1999, J MOL BIOL, V293, P733, DOI 10.1006/jmbi.1999.3182; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; KEMPNER ES, 1968, J BACTERIOL, V95, P975, DOI 10.1128/JB.95.3.975-979.1968; Kirby JR, 2010, NAT CHEM BIOL, V6, P398, DOI 10.1038/nchembio.378; Knight T., 2003, STRUCTURE, V1, P11, DOI 10.21236/ADA457791; Lee HC, 2010, INT J SYST SYNTH BIO, V1, P71; Leonard E, 2008, TRENDS BIOTECHNOL, V26, P674, DOI 10.1016/j.tibtech.2008.08.003; Lucks JB, 2008, CURR OPIN MICROBIOL, V11, P567, DOI 10.1016/j.mib.2008.10.002; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Neumann H, 2010, APPL MICROBIOL BIOT, V87, P75, DOI 10.1007/s00253-010-2578-3; Nicolaou SA, 2010, METAB ENG, V12, P307, DOI 10.1016/j.ymben.2010.03.004; Norville Julie E, 2010, J Biol Eng, V4, P17, DOI 10.1186/1754-1611-4-17; Redford KH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001530; Ruby EG, 1999, TRENDS MICROBIOL, V7, P414, DOI 10.1016/S0966-842X(99)01588-7; RUBY EG, 1976, BIOL BULL, V151, P574, DOI 10.2307/1540507; Serrano L, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100202; Slusarczyk AL, 2012, NAT REV GENET, V13, P406, DOI 10.1038/nrg3227; Speer MA, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-17; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Wang YH, 2013, ANNU REV CHEM BIOMOL, V4, P69, DOI 10.1146/annurev-chembioeng-061312-103351; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Zheng YT, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/541609	42	10	11	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104578	10.1371/journal.pone.0104578	http://dx.doi.org/10.1371/journal.pone.0104578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119347	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600069
J	Chang, KH; Chang, MY; Muo, CH; Wu, TN; Chen, CY; Kao, CH				Chang, Kuang-Hsi; Chang, Mei-Yin; Muo, Chih-Hsin; Wu, Trong-Neng; Chen, Chiu-Ying; Kao, Chia-Hung			Increased Risk of Dementia in Patients Exposed to Nitrogen Dioxide and Carbon Monoxide: A Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; COGNITIVE DECLINE; ALCOHOL-CONSUMPTION; CIGARETTE-SMOKING; ISCHEMIC-STROKE; HEALTH; ASSOCIATION; DISEASE; URBANIZATION; DRINKING	Background: The air pollution caused by vehicular emissions is associated with cognitive decline. However, the associations between the levels of nitrogen dioxide (NO2) and carbon monoxide (CO) exposure and dementia remain poorly defined and have been addressed in only a few previous studies. Materials and Methods: In this study, we obtained data on 29547 people from the National Health Insurance Research Database (NHIRD) of Taiwan, including data on 1720 patients diagnosed with dementia between 2000 and 2010, and we evaluated the risk of dementia among four levels of air pollutant. Detailed data on daily air pollution were available from January 1, 1998 to December 31, 2010. Yearly average concentrations of pollutants were calculated from the baseline to the date of dementia occurrence, withdrawal of patients, or the end of the study, and these data were categorized into quartiles, with Q1 being the lowest level and Q4 being the highest. Results: In the case of NO2, the adjusted hazard ratios (HRs) of dementia for all participants in Q2, Q3, and Q4 compared to Q1 were 1.10 (95% confidence interval (CI), 0.96-1.26), 1.01 (95% CI, 0.87-1.17), and 1.54 (95% CI, 1.34-1.77), and in the case of CO, the adjusted HRs were 1.07 (95% CI, 0.92-1.25), 1.37 (95% CI, 1.19-1.58), and 1.61 (95% CI, 1.39-1.85). Conclusion: The results of this large retrospective, population-based study indicate that exposure to NO2 and CO is associated with an increased risk of dementia in the Taiwanese population.	[Chang, Kuang-Hsi; Wu, Trong-Neng; Chen, Chiu-Ying] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Chang, Kuang-Hsi] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chang, Mei-Yin] Fooyin Univ, Sch Med & Hlth Sci, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Muo, Chih-Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taipei, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; Taichung Veterans General Hospital; Fooyin University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taipei, Taiwan.	d10040@mail.cmuh.org.tw			China Medical University [CMU102-BC-2]; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; Taiwan Ministry of Health and Welfare Cancer Research Center for Excellence [MOHW103-TD-B-111-03]; International Research-Intensive Centers of Excellence in Taiwan (I-RiCE) [NSC101-2911-I-002-303]	China Medical University(China Medical University); Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Taiwan Ministry of Health and Welfare Cancer Research Center for Excellence; International Research-Intensive Centers of Excellence in Taiwan (I-RiCE)	The study was supported in part by China Medical University (CMU102-BC-2), Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002), Taiwan Ministry of Health and Welfare Cancer Research Center for Excellence (MOHW103-TD-B-111-03), and International Research-Intensive Centers of Excellence in Taiwan (I-RiCE) (NSC101-2911-I-002-303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ZJ, 2012, STROKE, V43, P320, DOI 10.1161/STROKEAHA.111.629246; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Blanco F, 2009, J PHYS CHEM A, V113, P3237, DOI 10.1021/jp810462h; Cataldo JK, 2010, J ALZHEIMERS DIS, V19, P465, DOI 10.3233/JAD-2010-1240; Chang KH, 2014, AGE, V36, P967, DOI 10.1007/s11357-013-9608-x; Chen HL, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-129; Chen JC, 2009, NEUROTOXICOLOGY, V30, P231, DOI 10.1016/j.neuro.2008.12.011; Chiang PH, 2013, RES DEV DISABIL, V34, P2485, DOI 10.1016/j.ridd.2013.05.026; Chuang YC, 2008, SOC SCI MED, V67, P1321, DOI 10.1016/j.socscimed.2008.06.033; Clark C, 2012, AM J EPIDEMIOL, V176, P327, DOI 10.1093/aje/kws012; Deng J, 2006, CLIN NEUROL NEUROSUR, V108, P378, DOI 10.1016/j.clineuro.2005.06.005; Deng JA, 2010, EUR J PHARMACOL, V637, P83, DOI 10.1016/j.ejphar.2010.03.029; Dickey JH, 2000, DM-DIS MON, V46, P566, DOI 10.1016/S0011-5029(00)90024-5; Enoch MA, 2002, AM FAM PHYSICIAN, V65, P441; Freire C, 2010, J EPIDEMIOL COMMUN H, V64, P223, DOI 10.1136/jech.2008.084574; GARIBALDI RA, 1985, AM J MED, V78, P32, DOI 10.1016/0002-9343(85)90361-4; Gatto NM, 2014, NEUROTOXICOLOGY, V40, P1, DOI 10.1016/j.neuro.2013.09.004; Hopkins RO, 2007, AM J RESP CRIT CARE, V176, P1001, DOI 10.1164/rccm.200702-290OC; Juan D, 2004, EUR J NEUROL, V11, P277, DOI 10.1046/j.1468-1331.2003.00779.x; Jung CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075510; Knopman DS, 2007, BRIT J RADIOL, V80, pS121, DOI 10.1259/bjr/75681080; Kokmen E, 1996, NEUROLOGY, V46, P154, DOI 10.1212/WNL.46.1.154; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Kuo SS, 2010, THESIS NATL TAIWAN U; Lewtas J, 2007, MUTAT RES-REV MUTAT, V636, P95, DOI 10.1016/j.mrrev.2007.08.003; Li HY, 2013, CHEMOSPHERE, V92, P52, DOI 10.1016/j.chemosphere.2013.02.061; Liang CY, 2004, TAIWAN J ORAL MED HL, V20, P91; Lin HC, 2007, PALLIATIVE MED, V21, P705, DOI 10.1177/0269216307083033; Lin YJ, 2011, HEALTH POLICY, V103, P236, DOI 10.1016/j.healthpol.2011.08.007; Lisabeth LD, 2008, ANN NEUROL, V64, P53, DOI 10.1002/ana.21403; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Migliore L, 2009, MUTAT RES-GEN TOX EN, V674, P73, DOI 10.1016/j.mrgentox.2008.09.013; Ministry of the Interior ROC (Taiwan), MONTHL B INT STAT; Morales E, 2009, AM J EPIDEMIOL, V169, P1327, DOI 10.1093/aje/kwp067; O'Brien JT, 2006, AM J GERIAT PSYCHIAT, V14, P724, DOI 10.1097/01.JGP.0000231780.44684.7e; Oddo S, 2005, P NATL ACAD SCI USA, V102, P3046, DOI 10.1073/pnas.0408500102; Patel BD, 2006, THORAX, V61, P568, DOI 10.1136/thx.2005.053827; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Peters R, 2008, AGE AGEING, V37, P505, DOI 10.1093/ageing/afn095; Power MC, 2011, ENVIRON HEALTH PERSP, V119, P682, DOI 10.1289/ehp.1002767; Ranft U, 2009, ENVIRON RES, V109, P1004, DOI 10.1016/j.envres.2009.08.003; Roberts GP, 2004, MICROBIOL MOL BIOL R, V68, P453, DOI 10.1128/MMBR.68.3.453-473.2004; Suglia SF, 2008, AM J EPIDEMIOL, V167, P280, DOI 10.1093/aje/kwm308; Turin TC, 2012, CEREBROVASC DIS, V34, P130, DOI 10.1159/000339680; Weuve J, 2012, ARCH INTERN MED, V172, P219, DOI 10.1001/archinternmed.2011.683; Zhu N, 2012, TOXICOL LETT, V214, P120, DOI 10.1016/j.toxlet.2012.08.021	47	92	94	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103078	10.1371/journal.pone.0103078	http://dx.doi.org/10.1371/journal.pone.0103078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LJ	25115939	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400010
J	Gey, U; Czupalla, C; Hoflack, B; Krause, U; Rodel, G				Gey, Uta; Czupalla, Cornelia; Hoflack, Bernard; Krause, Udo; Roedel, Gerhard			Proteomic Analysis Reveals a Novel Function of the Kinase Sat4p in Saccharomyces cerevisiae Mitochondria	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; GLYCINE CLEAVAGE SYSTEM; HAL5 PROTEIN-KINASES; DIHYDROLIPOAMIDE ACETYLTRANSFERASE; RESPIRATORY GROWTH; YEAST MITOCHONDRIA; GENE; PHOSPHORYLATION; METABOLISM; MECHANISMS	The Saccharomyces cerevisiae kinase Sat4p has been originally identified as a protein involved in salt tolerance and stabilization of plasma membrane transporters, implicating a cytoplasmic localization. Our study revealed an additional mitochondrial (mt) localization, suggesting a dual function for Sat4p. While no mt related phenotype was observed in the absence of Sat4p, its overexpression resulted in significant changes of a specific mitochondrial subproteome. As shown by a comparative two dimensional difference gel electrophoresis (2D-DIGE) approach combined with mass spectrometry, particularly two groups of proteins were affected: the iron-sulfur containing aconitase-type proteins (Aco1p, Lys4p) and the lipoamide-containing subproteome (Lat1p, Kgd2p and Gcv3p). The lipoylation sites of all three proteins could be assigned by nanoLC-MS/MS to Lys75 (Lat1p), Lys114 (Kgd2p) and Lys102 (Gcv3p), respectively. Sat4p overexpression resulted in accumulation of the delipoylated protein variants and in reduced levels of aconitase-type proteins, accompanied by a decrease in the activities of the respective enzyme complexes. We propose a regulatory role of Sat4p in the late steps of the maturation of a specific subset of mitochondrial iron-sulfur cluster proteins, including Aco1p and lipoate synthase Lip5p. Impairment of the latter enzyme may account for the observed lipoylation defects.	[Gey, Uta; Krause, Udo; Roedel, Gerhard] Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany; [Czupalla, Cornelia; Hoflack, Bernard] Tech Univ Dresden, Ctr Biotechnol, D-01062 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Gey, U (corresponding author), Tech Univ Dresden, Inst Genet, D-01062 Dresden, Germany.	Uta.Gey@tu-dresden.de	HOFLACK, Bernard/AAZ-6668-2020; Roedel, Gerhard/AFQ-8997-2022; Roedel, Gerhard/AAH-3762-2022; Krause, Udo/N-8167-2014	Krause, Udo/0000-0001-9493-4522	German Research Foundation	German Research Foundation(German Research Foundation (DFG))	The publication fee for this article was covered by the Open Access Publication Funds of the TU Dresden financed by the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Blank LM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r49; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Christie KR, 2004, NUCLEIC ACIDS RES, V32, pD311, DOI 10.1093/nar/gkh033; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Czupalla C, 2006, MOL CELL PROTEOMICS, V5, P134, DOI 10.1074/mcp.M500291-MCP200; Dimmer KS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-209; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; Ferre F, 2006, NUCLEIC ACIDS RES, V34, pW182, DOI 10.1093/nar/gkl189; FUJIWARA K, 1991, FEBS LETT, V293, P115, DOI 10.1016/0014-5793(91)81164-4; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hirasaki M, 2011, J BIOSCI BIOENG, V111, P249, DOI 10.1016/j.jbiosc.2010.11.013; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Krause-Buchholz U, 2006, FEBS LETT, V580, P2553, DOI 10.1016/j.febslet.2006.04.002; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWSON JE, 1991, BIOCHEMISTRY-US, V30, P11249, DOI 10.1021/bi00111a009; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, BBA-MOL CELL RES, V1763, P652, DOI 10.1016/j.bbamcr.2006.05.011; Luttik MAH, 2000, J BACTERIOL, V182, P7007, DOI 10.1128/JB.182.24.7007-7013.2000; Meisinger C, 2000, ANAL BIOCHEM, V287, P339, DOI 10.1006/abio.2000.4868; Mok J, 2011, EXPERT REV PROTEOMIC, V8, P775, DOI [10.1586/EPR.11.64, 10.1586/epr.11.64]; Muhlenhoff U, 2007, EUKARYOT CELL, V6, P495, DOI 10.1128/EC.00191-06; Mulet JM, 1999, MOL CELL BIOL, V19, P3328; Nagarajan L, 1997, J BIOL CHEM, V272, P4444, DOI 10.1074/jbc.272.7.4444; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; NIU XD, 1988, P NATL ACAD SCI USA, V85, P7546, DOI 10.1073/pnas.85.20.7546; Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200; Ohlmeier S, 2010, ELECTROPHORESIS, V31, P2869, DOI 10.1002/elps.200900759; Onder O, 2006, MOL CELL PROTEOMICS, V5, P1426, DOI 10.1074/mcp.M600099-MCP200; Oswald C, 2009, J MOL BIOL, V389, P470, DOI 10.1016/j.jmb.2009.04.034; Perez-Valle J, 2007, MOL CELL BIOL, V27, P5725, DOI 10.1128/MCB.01375-06; Perez-Valle J, 2010, EUKARYOT CELL, V9, P1881, DOI 10.1128/EC.00184-10; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Przybyla-Zawislak B, 1999, GENETICS, V152, P153; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; REPETTO B, 1990, MOL CELL BIOL, V10, P4221, DOI 10.1128/MCB.10.8.4221; Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; SKALA J, 1991, YEAST, V7, P651, DOI 10.1002/yea.320070614; Tomaska L, 2000, GENE, V255, P59, DOI 10.1016/S0378-1119(00)00315-2; Treco D A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1301s23; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Zabriskie TM, 2000, NAT PROD REP, V17, P85, DOI 10.1039/a801345d; Zhang XP, 2004, J BIOL CHEM, V279, P22030, DOI 10.1074/jbc.M400299200	51	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103956	10.1371/journal.pone.0103956	http://dx.doi.org/10.1371/journal.pone.0103956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117470	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400026
J	Liang, GL; Wu, J; Shi, JT; Liu, J; He, FY; Xu, W				Liang, Guan-Lu; Wu, Jing; Shi, Jun-Ting; Liu, Jian; He, Feng-Ying; Xu, Wen			Implantable Collamer Lens Versus Iris-Fixed Phakic Intraocular Lens Implantation to Correct Myopia: A Meta-Analysis	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; PHOTOREFRACTIVE KERATECTOMY; EXCIMER-LASER; ARTISAN; ASTIGMATISM; OPACITIES; OUTCOMES; LASIK; ICL; CATARACTS	This study is a meta-analysis comparing the efficacy, predictability, and safety of correcting myopia via implantation of two types of phakic intraocular lens (PIOLs): the implantable collamer lens (ICL) and iris-fixed PIOL. The Cochrane library, Pubmed, and EMBASE were searched. Study selection, data exclusion, and quality assessment were performed by two independent observers. The pooled relative risk (RR), pooled standardized mean difference (SMD), and their 95% confidence intervals (CIs) were used to compare lenses. Seven studies, involving 511 eyes, were included. The pooled SMD in postoperative uncorrected distance visual acuity (UDVA) comparing ICLs to iris-fixed PIOLs was -0.22 (95% CI, -0.58 to 0.13; P = .22). The pooled RR values of UDVA of 20/20 or better and of 20/40 or better comparing ICLs to iris-fixed PIOLs were 1.15 (95% CI, 0.89 to 1.47; P = .29) and 1.01 (95% CI, 0.95 to 1.08; P = .75), respectively. The pooled RR of loss of best spectacle-corrected visual acuity (BSCVA) and gain in BSCVA comparing ICLs to iris-fixed PIOLs were 1.20 (95% CI, 0.24 to 6.00; P = .82) and 1.14 (95% CI, 0.89 to 1.48; P = .31), respectively. The pooled RR comparing ICLs to iris-fixed PIOLs was 0.78 (95% CI, 0.29 to 2.12; P = .63) for all reported complications and 2.80 (95% CI, 1.04 to 7.52; P = .04) for severe complications. The pooled RR of achieving a result within +/- 0.5 D (diopter) of the intended target comparing ICLs to iris-fixed PIOLs was 1.35 (95% CI, 1.04 to 1.77; P = .03). Overall, there is no significant difference in efficacy between the two types of PIOLs or in safety, except that the ICL is associated with a greater incidence of severe complications, especially anterior subcapsular cataract, primarily in the Version 2 and Version 3 groups. However, ICL has better predictability.	[Liang, Guan-Lu; Wu, Jing; Liu, Jian; He, Feng-Ying; Xu, Wen] Zhejiang Univ, Affiliated Hosp 2, Coll Med, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China; [Shi, Jun-Ting] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Ophthalmol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Xu, W (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Coll Med, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China.	xuwenhz2002@hotmail.com; xuwenhz2002@hotmail.com			Chinese Natural Science Foundation Youth Program [11104246/A040414]; Key Lab Fund of Zhejiang Province, China [2011E10006]	Chinese Natural Science Foundation Youth Program; Key Lab Fund of Zhejiang Province, China	This study was supported by Chinese Natural Science Foundation Youth Program (11104246/A040414) and Key Lab Fund of Zhejiang Province (No. 2011E10006), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio JL, 2009, BRIT J OPHTHALMOL, V93, P1313, DOI 10.1136/bjo.2007.131748; Awadein A, 2013, J REFRACT SURG, V29, P445, DOI 10.3928/1081597X-20130617-02; Barsam A, 2012, DATABASE COCHRANE DA; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Benedetti S, 2005, J REFRACT SURG, V21, P116; Budo C, 2000, J CATARACT REFR SURG, V26, P1163, DOI 10.1016/S0886-3350(00)00545-9; Chen LJ, 2008, J CATARACT REFR SURG, V34, P1181, DOI 10.1016/j.jcrs.2008.03.029; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Dupps WJ, 2011, J CATARACT REFR SURG, V37, P1, DOI 10.1016/j.jcrs.2010.11.010; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El Danasoury MA, 2002, OPHTHALMOLOGY, V109, P955, DOI 10.1016/S0161-6420(02)00964-8; Ghoreishi Mohammad, 2011, Oman J Ophthalmol, V4, P116, DOI 10.4103/0974-620X.91266; Guell JL, 2010, J CATARACT REFR SURG, V36, P1976, DOI 10.1016/j.jcrs.2010.08.014; Hassaballa MA, 2011, EYE, V25, P1365, DOI 10.1038/eye.2011.187; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang D, 2009, OPHTHALMOLOGY, V116, P2244, DOI 10.1016/j.ophtha.2009.08.018; Kamiya K, 2009, J REFRACT SURG, V25, P259, DOI 10.3928/1081597X-20090301-04; Lackner B, 2004, J CATARACT REFR SURG, V30, P2269, DOI 10.1016/j.jcrs.2004.07.018; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee SY, 2011, EYE, V25, P1409, DOI 10.1038/eye.2011.176; Lifshitz Tova, 2004, Int Ophthalmol, V25, P233, DOI 10.1007/s10792-005-5016-2; Maloney RK, 2002, OPHTHALMOLOGY, V109, P1631, DOI 10.1016/S0161-6420(02)01170-3; MANTEL N, 1959, J NATL CANCER I, V22, P719; Medical Advisory Secretariat, 2009, Ont Health Technol Assess Ser, V9, P1; Menezo JL, 2004, J CATARACT REFR SURG, V30, P33, DOI 10.1016/j.jcrs.2003.11.023; Pesando PM, 1999, J REFRACT SURG, V15, P415; Rapuano CJ, 1999, OPHTHALMOLOGY, V106, P422; Reinstein DZ, 2009, J REFRACT SURG, V25, P975, DOI 10.3928/1081597X-20091016-01; Rosen E, 1998, J CATARACT REFR SURG, V24, P596, DOI 10.1016/S0886-3350(98)80253-8; Samoocha David, 2010, J Med Internet Res, V12, pe23, DOI 10.2196/jmir.1286; Sanchez-Galeana CA, 2003, OPHTHALMOLOGY, V110, P781, DOI 10.1016/S0161-6420(02)01973-5; Sanders DR, 2008, J REFRACT SURG, V24, P566, DOI 10.3928/1081597X-20080601-04; Sanders DR, 2007, J REFRACT SURG, V23, P537; Sanders DR, 2004, OPHTHALMOLOGY, V111, P1683, DOI 10.1016/j.ophtha.2004.03.026; Sanders DR, 2002, J REFRACT SURG, V18, P673; Sarikkola AU, 2005, J CATARACT REFR SURG, V31, P511, DOI 10.1016/j.jcrs.2004.06.084; Schallhorn S, 2007, J REFRACT SURG, V23, P853, DOI 10.3928/1081-597X-20071101-01; Schallhorn SC, 2008, OPHTHALMOLOGY, V115, P1249, DOI 10.1016/j.ophtha.2008.04.010; SEILER T, 1991, OPHTHALMOLOGY, V98, P1156; Sharpe D, 1997, CLIN PSYCHOL REV, V17, P881, DOI 10.1016/S0272-7358(97)00056-1; Smallman DS, 2004, J CATARACT REFR SURG, V30, P905, DOI 10.1016/j.jcrs.2003.09.019; Sugar A, 2002, OPHTHALMOLOGY, V109, P175, DOI 10.1016/S0161-6420(01)00966-6; Varley GA, 2004, OPHTHALMOLOGY, V111, P1604, DOI 10.1016/j.ophtha.2004.05.016; Wachler BSB, 2009, J REFRACT SURG, V25, P765, DOI 10.3928/1081597X-20090813-02; Waring GO, 2000, J REFRACT SURG, V16, P459; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Zhang Zhi-hua, 2011, Zhonghua Yan Ke Za Zhi, V47, P531; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	49	22	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104649	10.1371/journal.pone.0104649	http://dx.doi.org/10.1371/journal.pone.0104649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115906	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400066
J	He, JZ; Wang, RW; Li, YT				He, Jun-Zhou; Wang, Rui-Wu; Li, Yao-Tang			Evolutionary Stability in the Asymmetric Volunteer's Dilemma	PLOS ONE			English	Article							STABLE STRATEGIES; SPOTTED HYENA; COOPERATION; GAME; MAINTENANCE; MUTUALISM; DYNAMICS; RELATEDNESS; INHERITANCE; MECHANISMS	It is often assumed that in public goods games, contributors are either strong or weak players and each individual has an equal probability of exhibiting cooperation. It is difficult to explain why the public good is produced by strong individuals in some cooperation systems, and by weak individuals in others. Viewing the asymmetric volunteer's dilemma game as an evolutionary game, we find that whether the strong or the weak players produce the public good depends on the initial condition (i.e., phenotype or initial strategy of individuals). These different evolutionarily stable strategies (ESS) associated with different initial conditions, can be interpreted as the production modes of public goods of different cooperation systems. A further analysis revealed that the strong player adopts a pure strategy but mixed strategies for the weak players to produce the public good, and that the probability of volunteering by weak players decreases with increasing group size or decreasing cost-benefit ratio. Our model shows that the defection probability of a "strong'' player is greater than the "weak'' players in the model of Diekmann (1993). This contradicts Selten's (1980) model that public goods can only be produced by a strong player, is not an evolutionarily stable strategy, and will therefore disappear over evolutionary time. Our public good model with ESS has thus extended previous interpretations that the public good can only be produced by strong players in an asymmetric game.	[He, Jun-Zhou] Yunnan Univ Finance & Econ, Stat & Math Coll, Kunming, Yunnan, Peoples R China; [He, Jun-Zhou; Wang, Rui-Wu] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Li, Yao-Tang] Yunnan Univ, Sch Math & Stat, Kunming, Yunnan, Peoples R China	Yunnan University of Finance & Economics; Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University	Wang, RW (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China.	wangrw@mail.kiz.ac.cn; liyaotang@ynu.edu.cn	Li, Yao/AAE-3550-2019		National Natural Science Foundation of China [31270433, 31170408, 71161020]; Yunnan Natural Science Foundation [2013FD030]; National Science Fund for Distinguished Young Scholars [31325005]; NSFC-Yunnan United fund [U1302267]; Program for Innovative Research Team (in Science and Technology) in University of Yunnan Province; West Light Foundation of the Chinese Academy of Sciences; Special Fund for the Excellent Youth of the Chinese Academy of Sciences [KSCX2-EW-Q-9]; Scientific Research Foundation for Introduction of Talent of Yunnan University of Finance and Economics [YC2013D05]; Special Fund for Chair Professor Lei Shi; Special Fund for Provincial Key Disciplines-Statistics	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); NSFC-Yunnan United fund; Program for Innovative Research Team (in Science and Technology) in University of Yunnan Province; West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); Special Fund for the Excellent Youth of the Chinese Academy of Sciences; Scientific Research Foundation for Introduction of Talent of Yunnan University of Finance and Economics; Special Fund for Chair Professor Lei Shi; Special Fund for Provincial Key Disciplines-Statistics	This research was supported by the National Natural Science Foundation of China (31270433, 31170408, 71161020), the Yunnan Natural Science Foundation (2013FD030), National Science Fund for Distinguished Young Scholars (31325005), NSFC-Yunnan United fund (U1302267), the Program for Innovative Research Team (in Science and Technology) in University of Yunnan Province, the West Light Foundation of the Chinese Academy of Sciences, Special Fund for the Excellent Youth of the Chinese Academy of Sciences (KSCX2-EW-Q-9), Scientific Research Foundation for Introduction of Talent of Yunnan University of Finance and Economics (YC2013D05), Special Fund for Chair Professor Lei Shi, Special Fund for Provincial Key Disciplines-Statistics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archetti M, 2009, J EVOLUTION BIOL, V22, P2192, DOI 10.1111/j.1420-9101.2009.01835.x; Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Archetti M, 2011, EVOLUTION, V65, P885, DOI 10.1111/j.1558-5646.2010.01176.x; Archetti M, 2009, J THEOR BIOL, V261, P475, DOI 10.1016/j.jtbi.2009.08.018; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Binmore K, 2001, J THEOR BIOL, V210, P1, DOI 10.1006/jtbi.2000.2083; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; Crowley PH, 2010, J THEOR BIOL, V265, P238, DOI 10.1016/j.jtbi.2010.05.005; DIEKMANN A, 1993, INT J GAME THEORY, V22, P75, DOI 10.1007/BF01245571; DIEKMANN A, 1985, J CONFLICT RESOLUT, V29, P605, DOI 10.1177/0022002785029004003; Doebeli M, 2004, SCIENCE, V306, P859, DOI 10.1126/science.1101456; Engh AL, 2000, ANIM BEHAV, V60, P323, DOI 10.1006/anbe.2000.1502; Frank, 1998, FDN SOCIAL EVOLUTION; Frankino WA, 2001, EVOL ECOL RES, V3, P939; GAUNERSDORFER A, 1991, THEOR POPUL BIOL, V39, P345, DOI 10.1016/0040-5809(91)90028-E; GRAFEN A, 1987, ANIM BEHAV, V35, P462, DOI 10.1016/S0003-3472(87)80271-3; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Harsanyi J. C., 1988, GEN THEORY EQUILIBRI; Hauert C., 2003, Complexity, V8, P31, DOI 10.1002/cplx.10092; Hauert C, 2002, J THEOR BIOL, V218, P187, DOI 10.1006/jtbi.2002.3067; Hauert C, 2006, P R SOC B, V273, P2565, DOI 10.1098/rspb.2006.3600; He JZ, 2013, CHINESE SCI BULL, V58, P2248, DOI 10.1007/s11434-013-5810-6; He JZ, 2012, CHINESE SCI BULL, V57, P1972, DOI 10.1007/s11434-012-5178-z; Hirsch M. W., 2004, DIFF EQUAT+; Hofbauer J, 2003, B AM MATH SOC, V40, P479, DOI 10.1090/S0273-0979-03-00988-1; Hofbauer J, 1998, EVOLUTIONARY GAMES P; HOLEKAMP KE, 1991, AM ZOOL, V31, P306; Kruuk H., 1972, SPOTTED HYENA STUDY; Maynard Smith J., 1982, pi; Menck PJ, 2013, NAT PHYS, V9, P89, DOI 10.1038/nphys2516; Nikiforakis N, 2010, SOUTH ECON J, V76, P638, DOI 10.4284/sej.2010.76.3.638; Otsubo H, 2008, J CONFLICT RESOLUT, V52, P961, DOI 10.1177/0022002708321401; PELLMYR O, 1994, NATURE, V372, P257, DOI 10.1038/372257a0; Pellmyr O, 2000, AM NAT, V156, pS62, DOI 10.1086/303416; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Ratnieks FLW, 2008, TRENDS ECOL EVOL, V23, P45, DOI 10.1016/j.tree.2007.09.013; REEVE HK, 1992, NATURE, V358, P147, DOI 10.1038/358147a0; SAMUELSON L, 1992, J ECON THEORY, V57, P363, DOI 10.1016/0022-0531(92)90041-F; Schelling T.C., 1960, STRATEGY CONFLICT; SELTEN R, 1980, J THEOR BIOL, V84, P93, DOI 10.1016/S0022-5193(80)81038-1; Singh M, 2006, J BIOSCIENCES, V31, P369, DOI 10.1007/BF02704110; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Szolnoki A, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041021; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056104; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Van Horn RC, 2004, MOL ECOL, V13, P449, DOI 10.1046/j.1365-294X.2003.02071.x; Wang RW, 2014, ECOLOGY, V95, P1384, DOI 10.1890/13-0749.1; Wang RW, 2011, J R SOC INTERFACE, V8, P1487, DOI 10.1098/rsif.2011.0063; Wang RW, 2010, ECOLOGY, V91, P1308, DOI 10.1890/09-1446.1; Wang RW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007802; Wang RW, 2010, SCI CHINA LIFE SCI, V53, P1041, DOI 10.1007/s11427-010-4016-2; Wang Z, 2013, SCI REP-UK, V3, DOI 10.1038/srep01183; Weesie J, 1998, J CONFLICT RESOLUT, V42, P600, DOI 10.1177/0022002798042005004; Weibull Jorgen W., EVOLUTIONARY GAME TH; Wenseleers T, 2006, AM NAT, V168, pE163, DOI 10.1086/508619; Wittman D., 1985, EUROPEAN J POLITICAL, V1, P77, DOI 10.1016/0176-2680(85)90008-4; Xu ZJ, 2010, J THEOR BIOL, V264, P19, DOI 10.1016/j.jtbi.2010.01.025	58	38	38	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e103931	10.1371/journal.pone.0103931	http://dx.doi.org/10.1371/journal.pone.0103931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111781	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100022
J	Ji, LN; Zhi, XY; Lu, JM; Guo, XH; Yang, WY; Jia, WP; Zou, DJ; Zhou, ZG; Ji, QH; Zhu, DL; Shi, LX; Weng, JP				Ji, Linong; Zhi, Xinyue; Lu, Juming; Guo, Xiaohui; Yang, Wenying; Jia, Weiping; Zou, Dajin; Zhou, Zhiguang; Ji, Qiuhe; Zhu, Dalong; Shi, Lixin; Weng, Jianping			Hyperglycemia and Blood Pressure Treatment Goal: A Cross Sectional Survey of 18350 Patients with Type 2 Diabetes in 77 Tertiary Hospitals in China	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; LOW-DENSITY-LIPOPROTEIN; GLUCOSE CONTROL; RISK-FACTORS; DISEASE; HYPERTENSION; ASSOCIATION; PREVALENCE; MELLITUS; CANCER	Objective: To investigate the association of hyperglycemia with blood pressure control goal in the patients with type 2 diabetes (T2D) cared by tertiary hospitals in China. Study Design and Methods: A cross sectional survey of 29442 patients was conducted in 77 tertiary hospitals in 4 major cities in China in 2011 and 18350 of them without known hypertension were used in the analysis. Univariable and multivariable logistic regression analysis stratified on cities and hospitals was performed to obtain odds ratio of factors of interest for achievement of the blood pressure treatment goal, i.e., 140/80 mmHg as recommended by American Diabetes Association (ADA). Sensitivity analysis was performed after re-inclusion of 11902 patients with diagnosed hypertension. Findings from were further replicated in patients with T2D recruited using the same protocol from tertiary hospitals located in other central cities in China. Results: The mean age was 58.2 (SD: 11.3) years and 53.3% were male, with a median of 4 years of disease duration. A total of 12129 patients (58.2%) did not achieve the ADA recommended goal for BP control. After adjusting for covariables, hyperglycemia was associated with failure to achieve the BP goal (OR of HbA1c at 6.5%-6.9% vs. <6.0%: 1.22, 95%CI: 1.08 to 1.39; OR of 7.0%-7.0% vs. <6.0%: 1.37, 1.21 to 1.54 and OR of >= 8.0% vs. <6.0%: 1.22, 95%CI: 1.08 to 1.38). The sensitivity analysis and the replication analysis showed similar results. Conclusions: Hyperglycemia defined as HbA1c >= 6.5% increased the risk of failure to achieve the BP goal in T2D patients.	[Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol, Beijing, Peoples R China; [Zhi, Xinyue] Tianjin Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Tianjin, Peoples R China; [Lu, Juming] Beijing Mil Command, Gen Hosp, Dept Endocrinol, Beijing, Peoples R China; [Guo, Xiaohui] Peking Univ, Hosp 1, Dept Endocrinol, Beijing 100871, Peoples R China; [Yang, Wenying] Sino Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China; [Jia, Weiping] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Endocrinol, Shanghai, Peoples R China; [Zou, Dajin] Changhai Hosp Shanghai, Dept Endocrinol, Shanghai, Peoples R China; [Zhou, Zhiguang] Cent S Univ, Xiangya Hosp 2, Dept Endocrinol, Changsha, Hunan, Peoples R China; [Ji, Qiuhe] 4th Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian, Peoples R China; [Zhu, Dalong] Nanjing Drum Tower Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Shi, Lixin] Hosp Guiyang Med Univ, Dept Endocrinol, Guiyang, Peoples R China; [Weng, Jianping] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Peking University; Tianjin Medical University; Seventh Medical Center of Chinese PLA General Hospital; Peking University; Shanghai Jiao Tong University; Naval Medical University; Central South University; Air Force Military Medical University; Nanjing University; Sun Yat Sen University	Ji, LN (corresponding author), Peking Univ, Peoples Hosp, Dept Endocrinol, Beijing, Peoples R China.	jiln@bjmu.edu.cn; wjianp@mail.sysu.edu.cn	Linong, Ji/AAB-6543-2020; Jia, Weiping/B-7483-2012	Weng, Jianping/0000-0002-7889-1697; Zhou, Zhiguang/0000-0002-0374-1838	Novo Nordisk, China	Novo Nordisk, China(Novo Nordisk)	The authors except for X.Z. were investigators of this project, which was supported by a grant from Novo Nordisk, China. The funders coordinated data collection but did not have a role in study design, and analysis, decision to publish, or preparation of the manuscript.	Bittencourt C, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-46; Chen JW, 2006, CURR HYPERTENS REP, V8, P139, DOI 10.1007/s11906-006-0010-2; Colagiuri S, 2011, DIABETES CARE, V34, P145, DOI 10.2337/dc10-1206; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Giacchetti G, 2005, TRENDS ENDOCRIN MET, V16, P120, DOI 10.1016/j.tem.2005.02.003; Haas L, 2013, DIABETES CARE, V36, pS100, DOI [10.2337/dc13-S100, 10.2337/dc13-S004]; Heller SR, 2009, DIABETES CARE, V32, pS357, DOI 10.2337/dc09-S339; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Liguori A, 2001, EUR HEART J, V22, P2075, DOI 10.1053/euhj.2001.2655; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nathan DM, 2013, DIABETES; Nichols GA, 2010, DIABETES RES CLIN PR, V90, P115, DOI 10.1016/j.diabres.2010.06.011; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Peti-Peterdi J, 2010, KIDNEY INT, V78, P1214, DOI 10.1038/ki.2010.333; Putnam K, 2012, AM J PHYSIOL-HEART C, V302, pH1219, DOI 10.1152/ajpheart.00796.2011; Sarkozy M, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-16; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Singh BM, 2003, ARCH INTERN MED, V163, P1296, DOI 10.1001/archinte.163.11.1296; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wakabayashi I, 2012, GENDER MED, V9, P267, DOI 10.1016/j.genm.2012.05.004; Wang Geng, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P307; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yang XL, 2008, CAN MED ASSOC J, V179, P427, DOI 10.1503/cmaj.071474; Yang XL, 2012, DIABETES-METAB RES, V28, P379, DOI 10.1002/dmrr.2287	31	1	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103507	10.1371/journal.pone.0103507	http://dx.doi.org/10.1371/journal.pone.0103507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121493	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000015
J	Alster, O; Bielak-Zmijewska, A; Mosieniak, G; Moreno-Villanueva, M; Dudka-Ruszkowska, W; Wojtala, A; Kusio-Kobialka, M; Korwek, Z; Burkle, A; Piwocka, K; Siwicki, JK; Sikora, E				Alster, Olga; Bielak-Zmijewska, Anna; Mosieniak, Grazyna; Moreno-Villanueva, Maria; Dudka-Ruszkowska, Wioleta; Wojtala, Aleksandra; Kusio-Kobialka, Monika; Korwek, Zbigniew; Burkle, Alexander; Piwocka, Katarzyna; Siwicki, Jan K.; Sikora, Ewa			The Role of Nibrin in Doxorubicin-Induced Apoptosis and Cell Senescence in Nijmegen Breakage Syndrome Patients Lymphocytes	PLOS ONE			English	Article							INDUCED PREMATURE SENESCENCE; DNA-DAMAGE RESPONSE; STRAND BREAKS; UP-REGULATION; NBS1; CHECKPOINT; PROTEIN; INSTABILITY; RESISTANT; BYPASS	Nibrin plays an important role in the DNA damage response (DDR) and DNA repair. DDR is a crucial signaling pathway in apoptosis and senescence. To verify whether truncated nibrin (p70), causing Nijmegen Breakage Syndrome (NBS), is involved in DDR and cell fate upon DNA damage, we used two (S4 and S3R) spontaneously immortalized T cell lines from NBS patients, with the founding mutation and a control cell line (L5). S4 and S3R cells have the same level of p70 nibrin, however p70 from S4 cells was able to form more complexes with ATM and BRCA1. Doxorubicin-induced DDR followed by cell senescence could only be observed in L5 and S4 cells, but not in the S3R ones. Furthermore the S3R cells only underwent cell death, but not senescence after doxorubicin treatment. In contrary to doxorubicin treatment, cells from all three cell lines were able to activate the DDR pathway after being exposed to gamma-radiation. Downregulation of nibrin in normal human vascular smooth muscle cells (VSMCs) did not prevent the activation of DDR and induction of senescence. Our results indicate that a substantially reduced level of nibrin or its truncated p70 form is sufficient to induce DNA-damage dependent senescence in VSMCs and S4 cells, respectively. In doxorubicin-treated S3R cells DDR activation was severely impaired, thus preventing the induction of senescence.	[Alster, Olga; Bielak-Zmijewska, Anna; Mosieniak, Grazyna; Wojtala, Aleksandra; Korwek, Zbigniew; Sikora, Ewa] Polish Acad Sci, Nencki Inst Expt Biol, Lab Mol Bases Aging, Warsaw, Poland; [Moreno-Villanueva, Maria; Burkle, Alexander] Univ Konstanz, Dept Biol, Mol Toxicol Grp, Constance, Germany; [Dudka-Ruszkowska, Wioleta; Kusio-Kobialka, Monika; Piwocka, Katarzyna] Polish Acad Sci, Nencki Inst Expt Biol, Lab Cytometry, Warsaw, Poland; [Siwicki, Jan K.] Maria Sklodowska Curie Mem Canc Ctr, Inst Oncol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Konstanz; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Maria Sklodowska-Curie National Research Institute of Oncology	Sikora, E (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, Lab Mol Bases Aging, Warsaw, Poland.	e.sikora@nencki.gov.pl	Piwocka, Katarzyna/P-2451-2016; Korwek, Zbigniew/U-4160-2017	Korwek, Zbigniew/0000-0001-8179-2924; Kusio-Kobialka, Monika/0000-0003-1995-2506; Dudka, Wioleta/0000-0002-7637-6480; Sikora, Ewa/0000-0002-1111-1748; Siwicki, Jan Konrad/0000-0002-5083-3022; Bielak-Zmijewska, Anna/0000-0002-6330-4867; Piwocka, Katarzyna/0000-0001-6676-5282; Mosieniak, Grazyna/0000-0001-7957-1241	National Center of Science in Poland [2011/01/M/NZ1/01597, UMO-2011/01/B/NZ3/02137, 0728/B/P01/2011/40]	National Center of Science in Poland	This work was supported by National Center of Science in Poland (grants: 2011/01/M/NZ1/01597, UMO-2011/01/B/NZ3/02137 and 0728/B/P01/2011/40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielak-Zmijewska A, 2014, BIOGERONTOLOGY, V15, P47, DOI 10.1007/s10522-013-9477-9; Cerosaletti K, 2006, MOL CELL BIOL, V26, P1691, DOI 10.1128/MCB.26.5.1691-1699.2006; Chebel A, 2009, AGING CELL, V8, P52, DOI 10.1111/j.1474-9726.2008.00448.x; Chrzanowska KH, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-13; Degerman S, 2010, AGING CELL, V9, P220, DOI 10.1111/j.1474-9726.2010.00550.x; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Falck J, 2002, NAT GENET, V30, P290, DOI 10.1038/ng845; Freedman DA, 2005, FRONT BIOSCI, V10, P940, DOI 10.2741/1588; Hiel JA, 2000, ARCH DIS CHILD, V82, P400; Hill R, 2010, CELL CYCLE, V9, P3460, DOI 10.4161/cc.9.17.13043; Hou YY, 2012, CELL BIOCHEM FUNCT, V30, P233, DOI 10.1002/cbf.1840; Keeshan K, 2001, LEUKEMIA, V15, P1823, DOI 10.1038/sj.leu.2402309; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Kruger L, 2007, CARCINOGENESIS, V28, P107, DOI 10.1093/carcin/bgl126; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mao Zhiyong, 2012, Aging (Albany NY), V4, P431; Maser RS, 2007, MOL CELL BIOL, V27, P2253, DOI 10.1128/MCB.01354-06; Moreno-Villanueva M, 2011, ALTEX-ALTERN ANIM EX, V28, P295, DOI 10.14573/altex.2011.4.295; Moreno-Villanueva M, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-39; Park J, 2013, BIOCHEM BIOPH RES CO, V430, P429, DOI 10.1016/j.bbrc.2012.11.040; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Sherman MY, 2011, AGING CELL, V10, P949, DOI 10.1111/j.1474-9726.2011.00736.x; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Siwicki JK, 2004, GENE CHROMOSOME CANC, V41, P133, DOI 10.1002/gcc.20059; Siwicki JK, 2003, EXP CELL RES, V287, P178, DOI 10.1016/S0014-4827(03)00140-X; Siwicki JK, 2000, EXP GERONTOL, V35, P375, DOI 10.1016/S0531-5565(00)00088-7; Sliwinska MA, 2009, MECH AGEING DEV, V130, P24, DOI 10.1016/j.mad.2008.04.011; Thierfelder N, 2008, EUR J CELL BIOL, V87, P111, DOI 10.1016/j.ejcb.2007.09.002; Zhang Y, 2006, CELL RES, V16, P45, DOI 10.1038/sj.cr.7310007; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	34	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104964	10.1371/journal.pone.0104964	http://dx.doi.org/10.1371/journal.pone.0104964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119968	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600109
J	de la Pena-Domene, M; Martinez-Garza, C; Palmas-Perez, S; Rivas-Alonso, E; Howe, HF				de la Pena-Domene, Marines; Martinez-Garza, Cristina; Palmas-Perez, Sebastian; Rivas-Alonso, Edith; Howe, Henry F.			Roles of Birds and Bats in Early Tropical-Forest Restoration	PLOS ONE			English	Article							SEED DISPERSAL; RAIN-FOREST; LOS-TUXTLAS; ECOLOGICAL RESTORATION; AGRICULTURAL LANDSCAPE; SPECIES RICHNESS; DEGRADED LANDS; COSTA-RICA; TREE; MEXICO	Restoration of tropical forest depended in large part on seed dispersal by fruit-eating animals that transported seeds into planted forest patches. We tested effectiveness of dispersal agents as revealed by established recruits of tree and shrub species that bore seeds dispersed by birds, bats, or both. We documented restoration of dispersal processes over the first 76 months of experimental restoration in southern Mexico. Mixed-model repeated-measures randomized-block ANOVAs of seedlings recruited into experimental controls and mixed-species plantings from late-secondary and mature forest indicated that bats and birds played different roles in the first years of a restoration process. Bats dispersed pioneer tree and shrub species to slowly regenerating grassy areas, while birds mediated recruitment of later-successional species into planted stands of trees and to a lesser extent into controls. Of species of pioneer trees and shrubs established in plots, seven were primarily dispersed by birds, three by bats and four by both birds and bats. Of later-successional species recruited past the seedling stage, 13 were of species primarily dispersed by birds, and six were of species dispersed by both birds and bats. No later-successional species primarily dispersed by bats established in control or planted plots. Establishment of recruited seedlings was ten-fold higher under cover of planted trees than in grassy controls. Even pre-reproductive trees drew fruit-eating birds and the seeds that they carried from nearby forest, and provided conditions for establishment of shade-tolerant tree species. Overall, after 76 months of cattle exclusion, 94% of the recruited shrubs and trees in experimental plots were of species that we did not plant.	[de la Pena-Domene, Marines; Howe, Henry F.] Univ Illinois, Chicago, IL 60607 USA; [Martinez-Garza, Cristina; Rivas-Alonso, Edith] Univ Autonoma Estado Morelos, Ctr Invest & Biodiversidad & Conservacion, Cuernavaca, Morelos, Mexico; [Palmas-Perez, Sebastian] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universidad Autonoma del Estado de Morelos; State University System of Florida; University of Florida	Howe, HF (corresponding author), Univ Illinois, Chicago, IL 60607 USA.	hfhowe@uic.edu	de la Peña-Domene, Marinés/W-3811-2017; Martínez-Garza, Cristina/K-4519-2019; Palmas, Sebastian/L-5456-2018; Martínez-Garza, Cristina/H-8956-2019	de la Peña-Domene, Marinés/0000-0003-4794-5450; Martínez-Garza, Cristina/0000-0002-9310-564X; Palmas, Sebastian/0000-0001-9474-5406; 	National Science Foundation of the United States (DEB) [0516259]; ERM Group Foundation; University of Illinois ROAAP Fund	National Science Foundation of the United States (DEB); ERM Group Foundation; University of Illinois ROAAP Fund	The experiment was established and supported for five years with a grant from the National Science Foundation of the United States (DEB 0516259) to HFH and CMG. The University of Illinois provided support for experiment maintenance to MPD and HFH, Universidad Autonoma del Estado de Morelos provided support for data collection and CMG and ERA, Universidad Nacional Autonoma de Mexico provided logistical support to MPD, CMG, ERA and HFH. A grant to MPD from the ERM Group Foundation supported data collection and maintenance. The University of Illinois ROAAP Fund defrayed publication costs. The National Geographic Society provided support for experiment maintenance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Benayas JMR, 2008, FRONT ECOL ENVIRON, V6, P329, DOI 10.1890/070057; BONGERS F, 1988, VEGETATIO, V74, P55, DOI 10.1007/BF00045614; Butler R, 2008, FOREST ECOL MANAG, V255, P2251, DOI 10.1016/j.foreco.2007.12.050; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Chazdon RL, 2008, SCIENCE, V320, P1458, DOI 10.1126/science.1155365; Clark CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063330; Cole RJ, 2010, ECOL APPL, V20, P1255, DOI 10.1890/09-0714.1; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Garcia-Aguirre MC, 2010, GEOMORPHOLOGY, V121, P245, DOI 10.1016/j.geomorph.2010.04.019; Corbin JD, 2012, FOREST ECOL MANAG, V265, P37, DOI 10.1016/j.foreco.2011.10.013; Cordeiro NJ, 2009, ECOLOGY, V90, P1030, DOI 10.1890/07-1208.1; Corlett RT, 2011, TRENDS ECOL EVOL, V26, P606, DOI 10.1016/j.tree.2011.06.015; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; Dalling JW, 2011, J ECOL, V99, P89, DOI 10.1111/j.1365-2745.2010.01739.x; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; de la Pena-Domene M, 2013, ECOL APPL, V23, P1124, DOI 10.1890/12-1728.1; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; ESTRADA A, 1993, VEGETATIO, V108, P245; ESTRADA A, 1984, BIOTROPICA, V16, P315, DOI 10.2307/2387942; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Galindo-Gonzalez J, 2000, CONSERV BIOL, V14, P1693, DOI [10.1046/j.1523-1739.2000.99072.x, 10.1111/j.1523-1739.2000.99072.x]; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Graham CH, 2001, CONSERV BIOL, V15, P1789, DOI 10.1046/j.1523-1739.2001.00070.x; GUEVARA S, 1993, VEGETATIO, V108, P319; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Harvey CA, 1998, AGROFOREST SYST, V44, P37, DOI 10.1023/A:1006122211692; Holl KD, 1998, RESTOR ECOL, V6, P253, DOI 10.1046/j.1526-100X.1998.00638.x; Howe H.F., 1986, P123; Howe HF, 2010, OECOLOGIA, V164, P731, DOI 10.1007/s00442-010-1669-2; Hubbell SP, 2008, P NATL ACAD SCI USA, V105, P11498, DOI 10.1073/pnas.0801915105; Hughes JB, 2002, ECOL LETT, V5, P121, DOI 10.1046/j.1461-0248.2002.00294.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kalko EKV, 1996, J BIOGEOGR, V23, P565, DOI 10.1111/j.1365-2699.1996.tb00018.x; Kramer AT, 2008, CONSERV BIOL, V22, P878, DOI 10.1111/j.1523-1739.2008.00944.x; Laborde J, 2008, ECOSCIENCE, V15, P6, DOI 10.2980/1195-6860(2008)15[6:TASSDI]2.0.CO;2; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Martinez-Garza C, 2013, LAND DEGRAD DEV, V24, P287, DOI 10.1002/ldr.1127; Martinez-Garza C, 2003, J APPL ECOL, V40, P423, DOI 10.1046/j.1365-2664.2003.00819.x; Martinez-Garza C, 2013, FOREST ECOL MANAG, V303, P35, DOI 10.1016/j.foreco.2013.03.046; Martinez-Garza C, 2009, J TROP ECOL, V25, P541, DOI 10.1017/S0266467409990113; Martinez-Ramos M., 1985, Investigations on the regeneration of high forests in Veracruz, Mexico. Volume 2, P191; McConkey KR, 2012, BIOL CONSERV, V146, P1, DOI 10.1016/j.biocon.2011.09.018; Medellin RA, 1999, BIOTROPICA, V31, P478, DOI 10.1111/j.1744-7429.1999.tb00390.x; Melo FPL, 2009, BIOTROPICA, V41, P737, DOI 10.1111/j.1744-7429.2009.00528.x; Metz MR, 2012, J ECOL, V100, P969, DOI 10.1111/j.1365-2745.2012.01972.x; Muller-Landau Helene C., 2005, P267, DOI 10.1017/CBO9780511541971.012; Muscarella R, 2007, BIOL REV, V82, P573, DOI 10.1111/j.1469-185X.2007.00026.x; Norden N, 2009, FUNCT ECOL, V23, P203, DOI 10.1111/j.1365-2435.2008.01477.x; Reid JL, 2013, RESTOR ECOL, V21, P153, DOI 10.1111/j.1526-100X.2012.00922.x; Reis A, 2010, SCI AGR, V67, P244, DOI 10.1590/S0103-90162010000200018; Mello MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017395; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; SCHUPP EW, 1989, ECOLOGY, V70, P562, DOI 10.2307/1940206; Seltzer CE, 2013, BIOTROPICA, V45, P450, DOI 10.1111/btp.12029; Slocum MG, 2001, ECOLOGY, V82, P2547, DOI 10.1890/0012-9658(2001)082[2547:HTSDAR]2.0.CO;2; Tobon W, 2011, J TROP FOR SCI, V23, P338; Turner IM, 1996, TRENDS ECOL EVOL, V11, P330, DOI 10.1016/0169-5347(96)10046-X; Vogt RC., 1997, HIST NATURAL TUXTLAS; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Wills C, 2006, SCIENCE, V314, P1877; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]; Wunderle JM, 1997, FOREST ECOL MANAG, V99, P223, DOI 10.1016/S0378-1127(97)00208-9	65	70	74	1	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104656	10.1371/journal.pone.0104656	http://dx.doi.org/10.1371/journal.pone.0104656			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118608	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600075
J	O'Shea, A; Aly, O; Parnaby, CN; Loudon, MA; Samuel, LM; Murray, GI				O'Shea, Aisling; Aly, Omar; Parnaby, Craig N.; Loudon, Malcolm A.; Samuel, Leslie M.; Murray, Graeme I.			Increased Lymph Node Yield in Colorectal Cancer Is Not Necessarily Associated with a Greater Number of Lymph Node Positive Cancers	PLOS ONE			English	Article							COLON-CANCER; RECTAL-CANCER; ADJUVANT TREATMENT; RATIO; SURVIVAL; RETRIEVAL; RESECTION; PATIENT; HARVEST; IDENTIFICATION	The presence of lymph node metastasis is a key prognostic factor in colorectal cancer and lymph node yield is an important parameter in assessing the quality of histopathology reporting of colorectal cancer excision specimens. This study assesses the trend in lymph node evaluation over time in a single institution and the relationship with the identification of lymph node positive tumours. It compares the lymph node yield of a contemporary dataset compiled from the histopathology reports of 2178 patients who underwent surgery for primary colorectal cancer between 2005 and 2012 with that of a historic dataset compiled from the histopathology reports of 1038 patients who underwent surgery for colorectal cancer at 5 yearly intervals from 1975 to 2000. The mean lymph node yield was 14.91 in 2005 rising to 21.38 in 2012. In 2012 92.9% of all cases had at least 12 lymph nodes examined. Comparison of the mean lymph node yield and proportion of Dukes C cases shows a significant increase (Pearson correlation = 0.927, p = 0.001) in lymph node yield while there is no corresponding significant trend in the proportion of Dukes C cases (Pearson correlation = -0.138, p = 0.745). This study shows that there is increasing yield of lymph nodes from colorectal cancer excision specimens. However, this is not necessarily associated with an increase number of lymph node positive cancers. Further risk stratifying of colorectal cancer requires consideration of other pathological parameters especially the presence of extramural venous invasion and relevant biomarkers.	[O'Shea, Aisling] Aberdeen Royal Infirm, NHS Grampian, Dept Pathol, Aberdeen, Scotland; [Aly, Omar; Murray, Graeme I.] Univ Aberdeen, Sch Med & Dent, Div Appl Med, Dept Pathol, Aberdeen, Scotland; [Parnaby, Craig N.; Loudon, Malcolm A.] Aberdeen Royal Infirm, NHS Grampian, Dept Colorectal Surg, Aberdeen, Scotland; [Samuel, Leslie M.] Aberdeen Royal Infirm, NHS Grampian, Dept Clin Oncol, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen	Murray, GI (corresponding author), Univ Aberdeen, Sch Med & Dent, Div Appl Med, Dept Pathol, Aberdeen, Scotland.	g.i.murray@abdn.ac.uk		Aly, Omar/0000-0002-7356-4785; Samuel, Leslie/0000-0002-8402-8670				Amajoyi R, 2013, AM J SURG, V205, P289, DOI 10.1016/j.amjsurg.2012.10.020; American College of Pathologists, 2013, PROT EX SPEC PAT PRI; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Bamboat ZM, 2011, INT J COLORECTAL DIS, V26, P1163, DOI 10.1007/s00384-011-1240-6; Baxter NN, 2005, J NATL CANCER I, V97, P219, DOI 10.1093/jnci/dji020; Bernhoff R, 2012, COLORECTAL DIS, V14, P691, DOI 10.1111/j.1463-1318.2012.03020.x; Bui L, 2006, J SURG ONCOL, V93, P439, DOI 10.1002/jso.20499; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Coghlin C, 2013, PROTEOMICS, V13, P2227, DOI 10.1002/pmic.201300245; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Gao P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035021; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Information Services Division, 2013, SCOTT BOW SCREEN PRO; La Torre M, 2013, COLORECTAL DIS, V15, pE382, DOI 10.1111/codi.12242; Lu YJ, 2013, WORLD J SURG, V37, P1927, DOI 10.1007/s00268-013-2051-4; Medani M, 2013, INT J COLORECTAL DIS, V28, P1377, DOI 10.1007/s00384-013-1707-8; Mekenkamp LJM, 2009, AM J SURG PATHOL, V33, P1547, DOI 10.1097/PAS.0b013e3181b2e01f; Minhas JS, 2011, INT J SURG PATHOL, V19, P462, DOI 10.1177/1066896911399280; Morris EJA, 2007, J CLIN ONCOL, V25, P2573, DOI 10.1200/JCO.2007.11.0445; Norwood MGA, 2010, COLORECTAL DIS, V12, P304, DOI 10.1111/j.1463-1318.2009.01788.x; O'Dwyer D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027718; Parsons HM, 2011, JAMA-J AM MED ASSOC, V306, P1089, DOI 10.1001/jama.2011.1285; Petrelli F, 2011, EJSO-EUR J SURG ONC, V37, P836, DOI 10.1016/j.ejso.2011.07.008; Ralton LD, 2010, CURR PROTEOMICS, V7, P212; Ralton LD, 2011, J CLIN PATHOL, V64, P297, DOI 10.1136/jcp.2010.086835; Scottish Cancer Taskforce, 2013, COL CANC CLIN QUAL P; Sjo OH, 2012, DIS COLON RECTUM, V55, P307, DOI 10.1097/DCR.0b013e3182423f62; Song YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028937; Storli K, 2011, WORLD J SURG, V35, P2796, DOI 10.1007/s00268-011-1248-7; Storli K, 2011, APMIS, V119, P127, DOI 10.1111/j.1600-0463.2010.02702.x; Williams GT, 2007, DATASET COLORECTAL C, P1; Wong SL, 2007, JAMA-J AM MED ASSOC, V298, P2149, DOI 10.1001/jama.298.18.2149	33	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104991	10.1371/journal.pone.0104991	http://dx.doi.org/10.1371/journal.pone.0104991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118594	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600111
J	Ota, E; Ganchimeg, T; Morisaki, N; Vogel, JP; Pileggi, C; Ortiz-Panozo, E; Souza, JP; Mori, R				Ota, Erika; Ganchimeg, Togoobaatar; Morisaki, Naho; Vogel, Joshua P.; Pileggi, Cynthia; Ortiz-Panozo, Eduardo; Souza, Joao P.; Mori, Rintaro		WHO Multicountry Survey Maternal	Risk Factors and Adverse Perinatal Outcomes among Term and Preterm Infants Born Small-for-Gestational-Age: Secondary Analyses of the WHO Multi-Country Survey on Maternal and Newborn Health	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; MIDDLE-INCOME COUNTRIES; BIRTH-WEIGHT; POPULATION; MORTALITY; PREECLAMPSIA; MATURATION; PREGNANCY; CANADA; COHORT	Background: Small for gestational age (SGA) is not only a major indicator of perinatal mortality and morbidity, but also the morbidity risks in later in life. We aim to estimate the association between the birth of SGA infants and the risk factors and adverse perinatal outcomes among twenty-nine countries in Africa, Latin America, the Middle East and Asia in 359 health facilities in 2010-11. Methods: We analysed facility-based, cross-sectional data from the WHO Multi-country Survey on Maternal and Newborn Health. We constructed multilevel logistic regression models with random effects for facilities and countries to estimate the risk factors for SGA infants using country-specific birthweight reference standards in preterm and term delivery, and SGA's association with adverse perinatal outcomes. We compared the risks and adverse perinatal outcomes with appropriate for gestational age (AGA) infants categorized by preterm and term delivery. Results: A total of 295,829 singleton infants delivered were analysed. The overall prevalence of SGA was highest in Cambodia (18.8%), Nepal (17.9%), the Occupied Palestinian Territory (16.1%), and Japan (16.0%), while the lowest was observed in Afghanistan (4.8%), Uganda (6.6%) and Thailand (9.7%). The risk of preterm SGA infants was significantly higher among nulliparous mothers and mothers with chronic hypertension and preeclampsia/eclampsia (aOR: 2.89; 95% CI: 2.55-3.28) compared with AGA infants. Higher risks of term SGA were observed among sociodemographic factors and women with preeclampsia/eclampsia, anaemia and other medical conditions. Multiparity (> = 3) (AOR: 0.88; 95% CI: 0.83-0.92) was a protective factor for term SGA. The risk of perinatal mortality was significantly higher in preterm SGA deliveries in low to high HDI countries. Conclusion: Preterm SGA is associated with medical conditions related to preeclampsia, but not with sociodemographic status. Term SGA is associated with sociodemographic status and various medical conditions.	[Ota, Erika; Ganchimeg, Togoobaatar; Morisaki, Naho; Mori, Rintaro] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Morisaki, Naho] Univ Tokyo, Grad Sch Med, Dept Paediat, Tokyo, Japan; [Vogel, Joshua P.; Pileggi, Cynthia] UNDP UNFPA UNICEF WHO, Dept Reprod Hlth & Res, World Bank Special Programme Res Dev & Res Traini, Geneva, Switzerland; [Vogel, Joshua P.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Ortiz-Panozo, Eduardo; Souza, Joao P.] Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca, Morelos, Mexico	National Center for Child Health & Development - Japan; University of Tokyo; The World Bank; United Nations Population Fund; University of Western Australia; Instituto Nacional de Salud Publica	Ota, E (corresponding author), Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan.	ota-e@ncchd.go.jp	Ortiz-Panozo, Eduardo/AAY-7743-2020; Cecatti, Jose Guilherme/M-5945-2013; Souza, João Paulo/G-1982-2010; Vogel, Joshua/K-7649-2019	Cecatti, Jose Guilherme/0000-0003-1285-8445; Souza, João Paulo/0000-0002-2288-4244; Vogel, Joshua/0000-0002-3214-7096; Mori, Rintaro/0000-0001-7656-6156; Ota, Erika/0000-0002-3945-7441; Yunis, Khalid/0000-0002-6384-2745; Ortiz-Panozo, Eduardo/0000-0002-3141-210X; Morisaki, Naho/0000-0001-6151-4513	UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); World Health Organization (WHO); United States Agency for International Development (USAID); Ministry of Health, Labour and Welfare of Japan; Gynuity Health Projects	UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP)(World Health Organization); World Health Organization (WHO)(World Health Organization); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Gynuity Health Projects	This study is financially supported by the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); the World Health Organization (WHO); the United States Agency for International Development (USAID); the Ministry of Health, Labour and Welfare of Japan, and Gynuity Health Projects. The sponsors had no role in the data collection, analysis, or interpretation of the data, the writing of the report, or the decision to submit for publication. All authors had access to the analysis plan, the outputs of that analysis and could see the data if they wished to do so. All authors participated in the final discussion and approved the submission.	Anderson NH, 2013, AUST NZ J OBSTET GYN, V53, P136, DOI 10.1111/ajo.12016; CARE, 2008, BMJ-BRIT MED J, V337, pa2332; Catov JM, 2008, OBSTET GYNECOL, V112, P290, DOI 10.1097/AOG.0b013e31817f589b; Clausson B, 1998, BRIT J OBSTET GYNAEC, V105, P1011, DOI 10.1111/j.1471-0528.1998.tb10266.x; Erickson AC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-102; Fairley L, 2006, J EPIDEMIOL COMMUN H, V60, P31, DOI 10.1136/jech.2005.038380; Ferdynus C, 2013, BJOG; FRIEDMAN SA, 1995, AM J OBSTET GYNECOL, V172, P1785, DOI 10.1016/0002-9378(95)91412-9; Gardosi J, 2005, BMJ-BRIT MED J, V331, P1113, DOI 10.1136/bmj.38629.587639.7C; Gissler M, 2003, J EPIDEMIOL COMMUN H, V57, P433, DOI 10.1136/jech.57.6.433; HEINONEN K, 1985, J PERINAT MED, V13, P171, DOI 10.1515/jpme.1985.13.4.171; Joshua PV, 2013, BJOG IN PRESS; Katz J, 2013, LANCET; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Koyanagi A, 2013, LANCET, V381, P476, DOI 10.1016/S0140-6736(12)61605-5; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; LAATIKAINEN TJ, 1988, AM J OBSTET GYNECOL, V159, P891, DOI 10.1016/S0002-9378(88)80163-7; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; Lubchenco L, 1976, HIGH RISK INFANT INT; Malik K., 2013, HUMAN DEV REPORT 201; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Paarlberg KM, 1999, BRIT J OBSTET GYNAEC, V106, P834, DOI 10.1111/j.1471-0528.1999.tb08406.x; Pileggi C, 2013, BJOG IN PRESS; Piper JM, 1996, OBSTET GYNECOL, V87, P169, DOI 10.1016/0029-7844(95)00400-9; PROCIANOY RS, 1980, ARCH DIS CHILD, V55, P502, DOI 10.1136/adc.55.7.502; Qiu XM, 2012, AM J PERINAT, V29, P87, DOI 10.1055/s-0031-1295647; Raisanen S, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-28; Raum E, 2001, INT J EPIDEMIOL, V30, P81, DOI 10.1093/ije/30.1.81; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; SCHIFF E, 1993, AM J OBSTET GYNECOL, V169, P1096, DOI 10.1016/0002-9378(93)90262-H; Sheppard BL, 1999, SEMIN THROMB HEMOST, V25, P443, DOI 10.1055/s-2007-994947; Simchen MJ, 2000, AM J PERINAT, V17, P187, DOI 10.1055/s-2000-9423; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Stotts AL, 2003, DRUG ALCOHOL DEPEN, V69, P1, DOI 10.1016/S0376-8716(02)00227-2; Thompson JMD, 2001, J PAEDIATR CHILD H, V37, P369, DOI 10.1046/j.1440-1754.2001.00684.x; TYSON JE, 1995, PEDIATRICS, V95, P534; Zeitlin JA, 2001, AM J OBSTET GYNECOL, V185, P208, DOI 10.1067/mob.2001.114869	39	68	73	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105155	10.1371/journal.pone.0105155	http://dx.doi.org/10.1371/journal.pone.0105155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119107	Green Published, gold			2022-12-27	WOS:000340900600127
J	Wang, TX; Shi, JC; Jing, YY; Zhao, TJ; Ji, D; Xiong, CA				Wang, Tianxing; Shi, Jiancheng; Jing, Yingying; Zhao, Tianjie; Ji, Dabin; Xiong, Chuan			Combining XCO2 Measurements Derived from SCIAMACHY and GOSAT for Potentially Generating Global CO2 Maps with High Spatiotemporal Resolution	PLOS ONE			English	Article							RETRIEVAL ALGORITHM; ATMOSPHERIC CO2; CARBON-DIOXIDE; SATELLITE DATA; PART 1; SPACE; VALIDATION; METHANE; CH4; OBJECTIVES	Global warming induced by atmospheric CO2 has attracted increasing attention of researchers all over the world. Although space-based technology provides the ability to map atmospheric CO2 globally, the number of valid CO2 measurements is generally limited for certain instruments owing to the presence of clouds, which in turn constrain the studies of global CO2 sources and sinks. Thus, it is a potentially promising work to combine the currently available CO2 measurements. In this study, a strategy for fusing SCIAMACHY and GOSAT CO2 measurements is proposed by fully considering the CO2 global bias, averaging kernel, and spatiotemporal variations as well as the CO2 retrieval errors. Based on this method, a global CO2 map with certain UTC time can also be generated by employing the pattern of the CO2 daily cycle reflected by Carbon Tracker (CT) data. The results reveal that relative to GOSAT, the global spatial coverage of the combined CO2 map increased by 41.3% and 47.7% on a daily and monthly scale, respectively, and even higher when compared with that relative to SCIAMACHY. The findings in this paper prove the effectiveness of the combination method in supporting the generation of global full-coverage XCO2 maps with higher temporal and spatial sampling by jointly using these two space-based XCO2 datasets.	[Wang, Tianxing; Shi, Jiancheng; Jing, Yingying; Zhao, Tianjie; Ji, Dabin; Xiong, Chuan] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Wang, TX (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.	wangtx@radi.ac.cn	Ji, Dabin/ADL-7793-2022; wang, Tianxing/R-8347-2016	Ji, Dabin/0000-0001-6388-2555; wang, Tianxing/0000-0002-8997-7197	project of "Climate Change: Carbon Budget and Related Issues" from Chinese Academy of Sciences (CAS) [XDA05040402]; CAS/SAFEA International Partnership Program for Creative Research Teams [KZZD-EW-TZ-09]; National Natural Science foundation of China [41301177]	project of "Climate Change: Carbon Budget and Related Issues" from Chinese Academy of Sciences (CAS); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	The work described in this paper has been jointly supported by project of "Climate Change: Carbon Budget and Related Issues" (Grant nr. XDA05040402) from Chinese Academy of Sciences (CAS), the CAS/SAFEA International Partnership Program for Creative Research Teams (Grant nr. KZZD-EW-TZ-09) and National Natural Science foundation of China (Grant nr. 41301177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumann HH, 2003, IEEE T GEOSCI REMOTE, V41, P253, DOI 10.1109/TGRS.2002.808356; Baker DF, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002439; Barkley MP, 2006, ATMOS CHEM PHYS, V6, P3517, DOI 10.5194/acp-6-3517-2006; Bosch H, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007080; Boesch H, 2011, REMOTE SENS-BASEL, V3, P270, DOI 10.3390/rs3020270; Bovensmann H, 1999, J ATMOS SCI, V56, P127, DOI 10.1175/1520-0469(1999)056<0127:SMOAMM>2.0.CO;2; Buchwitz M, 2000, J GEOPHYS RES-ATMOS, V105, P15231, DOI 10.1029/2000JD900191; Buchwitz M, 2005, ATMOS CHEM PHYS, V5, P941, DOI 10.5194/acp-5-941-2005; Butz A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047888; Butz A, 2009, APPL OPTICS, V48, P3322, DOI 10.1364/AO.48.003322; Chahine M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024165; Crisp D, 2004, ADV SPACE RES-SERIES, V34, P700, DOI 10.1016/j.asr.2003.08.062; Crisp D, 2012, ATMOS MEAS TECH, V5, P687, DOI 10.5194/amt-5-687-2012; Hammerling DM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051203; Hammerling DM, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017015; Houweling S, 2005, ATMOS CHEM PHYS, V5, P3003, DOI 10.5194/acp-5-3003-2005; Houweling S, 2004, ATMOS CHEM PHYS, V4, P523, DOI 10.5194/acp-4-523-2004; Kuze A, 2009, APPL OPTICS, V48, P6716, DOI 10.1364/AO.48.006716; Miller CE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007659; Morino I, 2011, ATMOS MEAS TECH, V4, P1061, DOI 10.5194/amt-4-1061-2011; O'Dell CW, 2012, ATMOS MEAS TECH, V5, P99, DOI 10.5194/amt-5-99-2012; Olsen SC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003968; Parker R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047871; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; Phulpin T, 2002, P 12 INT TOVS STUD C; Rayner PJ, 2001, GEOPHYS RES LETT, V28, P175, DOI 10.1029/2000GL011912; Reuter M, 2013, ATMOS CHEM PHYS, V13, P1771, DOI 10.5194/acp-13-1771-2013; Reuter M, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015047; Reuter M, 2010, ATMOS MEAS TECH, V3, P209, DOI 10.5194/amt-3-209-2010; Rodgers C. D, 2000, INVERSE METHODS ATMO; Schneising O, 2008, ATMOS CHEM PHYS, V8, P3827, DOI 10.5194/acp-8-3827-2008; Turquety S, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004821; Wang TX, 2013, CHINESE SCI BULL, V58, P4161, DOI 10.1007/s11434-013-5996-7; Wunch D, 2011, ATMOS CHEM PHYS, V11, P12317, DOI 10.5194/acp-11-12317-2011; Wunch D, 2011, PHILOS T R SOC A, V369, P2087, DOI 10.1098/rsta.2010.0240; Yang Z, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029742; Yokota T, 2009, SOLA, V5, P160, DOI 10.2151/sola.2009-041; Yoshida Y, 2011, ATMOS MEAS TECH, V4, P717, DOI 10.5194/amt-4-717-2011; Zeng ZC, 2014, IEEE T GEOSCI REMOTE, V52, P3594, DOI 10.1109/TGRS.2013.2273807	39	9	11	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105050	10.1371/journal.pone.0105050	http://dx.doi.org/10.1371/journal.pone.0105050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119468	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600118
J	Greetham, D; Wimalasena, TT; Leung, K; Marvin, ME; Chandelia, Y; Hart, AJ; Phister, TG; Tucker, GA; Louis, EJ; Smart, KA				Greetham, Darren; Wimalasena, Tithira T.; Leung, Kay; Marvin, Marcus E.; Chandelia, Yogeshwar; Hart, Andrew J.; Phister, Trevor G.; Tucker, Gregory A.; Louis, Edward J.; Smart, Katherine A.			The Genetic Basis of Variation in Clean Lineages of Saccharomyces cerevisiae in Response to Stresses Encountered during Bioethanol Fermentations	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; ETHANOL-PRODUCTION; OXIDATIVE STRESS; CYTOCHROME-C; ACETIC-ACID; YEAST; TOLERANCE; TRAIT; GLUCOSE; XYLOSE	Saccharomyces cerevisiae is the micro-organism of choice for the conversion of monomeric sugars into bioethanol. Industrial bioethanol fermentations are intrinsically stressful environments for yeast and the adaptive protective response varies between strain backgrounds. With the aim of identifying quantitative trait loci (QTL's) that regulate phenotypic variation, linkage analysis on six F1 crosses from four highly divergent clean lineages of S. cerevisiae was performed. Segregants from each cross were assessed for tolerance to a range of stresses encountered during industrial bioethanol fermentations. Tolerance levels within populations of F1 segregants to stress conditions differed and displayed transgressive variation. Linkage analysis resulted in the identification of QTL's for tolerance to weak acid and osmotic stress. We tested candidate genes within loci identified by QTL using reciprocal hemizygosity analysis to ascertain their contribution to the observed phenotypic variation; this approach validated a gene (COX20) for weak acid stress and a gene (RCK2) for osmotic stress. Hemizygous transformants with a sensitive phenotype carried a COX20 allele from a weak acid sensitive parent with an alteration in its protein coding compared with other S. cerevisiae strains. RCK2 alleles reveal peptide differences between parental strains and the importance of these changes is currently being ascertained.	[Greetham, Darren; Wimalasena, Tithira T.; Chandelia, Yogeshwar; Hart, Andrew J.; Phister, Trevor G.; Tucker, Gregory A.; Smart, Katherine A.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England; [Leung, Kay; Marvin, Marcus E.; Louis, Edward J.] Univ Leicester, Dept Genet, Ctr Genet Architecture Complex Traits, Leicester LE1 7RH, Leics, England	University of Nottingham; University of Leicester	Smart, KA (corresponding author), SABMiller Plc, SABMiller House, Surrey, England.	Katherine.smart@sabmiller.com	Louis, Edward/B-7920-2008	Louis, Edward/0000-0003-1157-3608; Tucker, Gregory/0000-0002-3377-9132	Biotechnology and Biological Sciences Research Council (BBSRC) Sustainable Bioenergy Centre (BSBEC), under the programme for 'Lignocellulosic Conversion to Ethanol' (LACE) [BB/G01616X/1]; European Regional Development Fund project [EMX05568]; BBSRC [BB/F015216/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1068247, BB/F015216/1, BB/G01616X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) Sustainable Bioenergy Centre (BSBEC), under the programme for 'Lignocellulosic Conversion to Ethanol' (LACE); European Regional Development Fund project; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research reported here was supported (in full or in part) by the Biotechnology and Biological Sciences Research Council (BBSRC) Sustainable Bioenergy Centre (BSBEC), under the programme for 'Lignocellulosic Conversion to Ethanol' (LACE) [Grant Ref: BB/G01616X/1]. This is a large interdisciplinary programme and the views expressed in this paper are those of the authors alone, and do not necessarily reflect the views of the collaborators or the policies of the funding bodies. This project is part financed by the European Regional Development Fund project EMX05568. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroset C, 2011, G3-GENES GENOM GENET, V1, P263, DOI 10.1534/g3.111.000422; Amorim HV, 2011, APPL MICROBIOL BIOT, V91, P1267, DOI 10.1007/s00253-011-3437-6; [Anonymous], PROJECTION CUMULATIV; Antoni D, 2007, APPL MICROBIOL BIOT, V77, P23, DOI 10.1007/s00253-007-1163-x; Aslankoohi E, 2013, APPL ENVIRON MICROB, V79, P7325, DOI 10.1128/AEM.02649-13; Beltran G, 2002, SYST APPL MICROBIOL, V25, P287, DOI 10.1078/072320202320386479; Benjaphokee S, 2012, NEW BIOTECHNOL, V29, P379, DOI 10.1016/j.nbt.2011.07.002; Bilsland E, 2004, MOL MICROBIOL, V53, P1743, DOI 10.1111/j.1365-2958.2004.04238.x; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cakar ZP, 2012, FEMS YEAST RES, V12, P171, DOI 10.1111/j.1567-1364.2011.00775.x; CASEY GP, 1986, CRC CR REV MICROBIOL, V13, P219, DOI 10.3109/10408418609108739; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Cubillos FA, 2009, FEMS YEAST RES, V9, P1217, DOI 10.1111/j.1567-1364.2009.00583.x; DAHLKVIST A, 1995, MOL GEN GENET, V246, P316, DOI 10.1007/BF00288604; Ehrenreich IM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002570; Fernandez-Sandoval MT, 2012, APPL MICROBIOL BIOT, V96, P1291, DOI 10.1007/s00253-012-4177-y; Giannattasio S, 2008, FEBS LETT, V582, P1519, DOI 10.1016/j.febslet.2008.03.048; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Guaragnella N, 2010, FEBS LETT, V584, P224, DOI 10.1016/j.febslet.2009.11.072; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Lin Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI 10.1007/s00253-005-0229-x; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Marullo P, 2007, FEMS YEAST RES, V7, P941, DOI 10.1111/j.1567-1364.2007.00252.x; Miles C., 2008, NAT ED, V1, P208; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Parts L, 2011, GENOME RES, V21, P1131, DOI 10.1101/gr.116731.110; R Development Core Team, 2008, LANG ENV STAT COMP; Sasano Y, 2012, INT J FOOD MICROBIOL, V152, P40, DOI 10.1016/j.ijfoodmicro.2011.10.004; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; Teige M, 2001, P NATL ACAD SCI USA, V98, P5625, DOI 10.1073/pnas.091610798; Tomas-Pejo E, 2010, J IND MICROBIOL BIOT, V37, P1211, DOI 10.1007/s10295-010-0768-8; Tomas-Pejo E, 2008, BIOTECHNOL BIOENG, V100, P1122, DOI 10.1002/bit.21849; Vallejo AJ, 2010, ANN BOT-LONDON, V106, P833, DOI 10.1093/aob/mcq179; Wimalasena TT, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-47; Wisselink HW, 2009, APPL ENVIRON MICROB, V75, P907, DOI 10.1128/AEM.02268-08; Zhang H, 2013, J GENET, V92, P213, DOI [10.1007/s12041-013-0253-z, 10.1]; Zorgo E, 2012, MOL BIOL EVOL, V29, P1781, DOI 10.1093/molbev/mss019	40	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103233	10.1371/journal.pone.0103233	http://dx.doi.org/10.1371/journal.pone.0103233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116161	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400014
J	Morfeld, P; Groneberg, DA; Spallek, MF				Morfeld, Peter; Groneberg, David A.; Spallek, Michael F.			Effectiveness of Low Emission Zones: Large Scale Analysis of Changes in Environmental NO2, NO and NOx Concentrations in 17 German Cities	PLOS ONE			English	Article							AIR-POLLUTION; NITROGEN-DIOXIDE; LUNG-CANCER; DIFFUSIVE SAMPLERS; STATISTICS NOTES; PM10; REGRESSION; EXPOSURE; IMPACT; REDUCTION	Background: Low Emission Zones (LEZs) are areas where the most polluting vehicles are restricted from entering. The effectiveness of LEZs to lower ambient exposures is under debate. This study focused on LEZs that restricted cars of Euro 1 standard without appropriate retrofitting systems from entering and estimated LEZ effects on NO2, NO, and NOx (= NO2 + NO). Methods: Continuous half-hour and diffuse sampler 4-week average NO2, NO, and NOx concentrations measured inside and outside LEZs in 17 German cities of 6 federal states (2005-2009) were analysed as matched quadruplets (two pairs of simultaneously measured index values inside LEZ and reference values outside LEZ, one pair measured before and one after introducing LEZs with time differences that equal multiples of 364 days) by multiple linear and log-linear fixed-effects regression modelling (covariables: e.g., wind velocity, amount of precipitation, height of inversion base, school holidays, truck-free periods). Additionally, the continuous half-hour data was collapsed into 4-week averages and pooled with the diffuse sampler data to perform joint analysis. Results: More than 3,000,000 quadruplets of continuous measurements (half-hour averages) were identified at 38 index and 45 reference stations. Pooling with diffuse sampler data from 15 index and 10 reference stations lead to more than 4,000 quadruplets for joint analyses of 4-week averages. Mean LEZ effects on NO2, NO, and NOx concentrations (reductions) were estimated to be at most -2 mu g/m(3) (or -4%). The 4-week averages of NO2 concentrations at index stations after LEZ introduction were 55 mu g/m(3) (median and mean values) or 82 mu g/m(3) (95th percentile). Conclusions: This is the first study investigating comprehensively the effectiveness of LEZs to reduce NO2, NO, and NOx concentrations controlling for most relevant potential confounders. Our analyses indicate that there is a statistically significant, but rather small reduction of NO2, NO, and NOx concentrations associated with LEZs.	[Morfeld, Peter] Evonik Ind, Inst Occupat Epidemiol & Risk Assessment IERA Evo, Essen, Germany; [Morfeld, Peter] Univ Cologne, Inst & Policlin Occupat Med Environm Med & Preven, D-50931 Cologne, Germany; [Groneberg, David A.; Spallek, Michael F.] Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, D-60054 Frankfurt, Germany; [Spallek, Michael F.] European Res Grp, Environm & Hlth Transport Sect EUGT, Berlin, Germany	Evonik Industries; University of Cologne; Goethe University Frankfurt	Morfeld, P (corresponding author), Evonik Ind, Inst Occupat Epidemiol & Risk Assessment IERA Evo, Essen, Germany.	Peter.Morfeld@evonik.com	Groneberg, David/A-5132-2018	Groneberg, David/0000-0001-8551-6556	European Research Group on Environment and Health in the Transport Sector	European Research Group on Environment and Health in the Transport Sector	The study was funded by the European Research Group on Environment and Health in the Transport Sector; www.eugt.org. The funder supported data collection and preparation of the manuscript.	Allison PD, 2009, FIXED EFFECT REGRESS; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; [Anonymous], 2004, 135283 DIN EN; [Anonymous], 2009, STAT REL 11 STAT SOF; Atkinson RW, 2009, ATMOS ENVIRON, V43, P5493, DOI 10.1016/j.atmosenv.2009.07.023; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Beevers SD, 2012, ATMOS ENVIRON, V54, P107, DOI 10.1016/j.atmosenv.2012.02.028; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAND JM, 1994, BRIT MED J, V309, P780, DOI 10.1136/bmj.309.6957.780; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boogaard H, 2012, SCI TOTAL ENVIRON, V435, P132, DOI 10.1016/j.scitotenv.2012.06.089; Briggs DJ, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-61; Bruckmann P, 2011, NEUE ENTWICKLUNGEN M, P3; Bruckmann P, 2011, ERFAHRUNGEN UMWELTZO, P27; Bruckmann P, 2010, TECHN K 24 25 MARZ F, P299; Builtjes P, 2012, STRATEGIEN VERMINDER, P1; Carslaw DC, 2011, ATMOS ENVIRON, V45, P7053, DOI 10.1016/j.atmosenv.2011.09.063; Cesaroni G, 2012, OCCUP ENVIRON MED, V69, P133, DOI 10.1136/oem.2010.063750; Colvile RN, 2001, ATMOS ENVIRON, V35, P1537, DOI 10.1016/S1352-2310(00)00551-3; Dons E, 2011, ATMOS ENVIRON, V45, P3594, DOI 10.1016/j.atmosenv.2011.03.064; Downs SH, 2007, NEW ENGL J MED, V357, P2338, DOI 10.1056/NEJMoa073625; Duyzer J, 2013, 2013R11055 TNO; Eikmann T, 2009, UMWELTMEDIZIN FORSCH, V14, P125; EU, 2013, LOW EM ZON EUR; European Environment Agency, 2014, IND EXC 492 AIR QUAL; European Environment Agency, 2014, AIRBASE EUR AIR QUAL; Fischer PH, 2000, ATMOS ENVIRON, V34, P3713, DOI 10.1016/S1352-2310(00)00067-4; Friedrich B, 2008, STRASSENVERKEHRSTECH, V11, P673; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Giannouli M, 2011, ATMOS ENVIRON, V45, P4753, DOI 10.1016/j.atmosenv.2010.03.016; GILL JS, 1985, LANCET, V1, P567; Graedel TE, 1994, CHEM ATMOSPHARE; Hoek G, 2002, ATMOS ENVIRON, V36, P4077, DOI 10.1016/S1352-2310(02)00297-2; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Hystad P, 2013, EPIDEMIOLOGY, V24, P762, DOI 10.1097/EDE.0b013e3182949ae7; INFRAS AG, 2010, HDB EM FACT ROAD TRA; Johansson C, 2009, ATMOS ENVIRON, V43, P4843, DOI 10.1016/j.atmosenv.2008.09.015; Kacsoh L, 2011, UMWELTZONEN EUROPA D, P5; Kelly F, 2011, HLTH EFFECTS I, V163, P1; Kerschbaumer A, 2003, ERSTELLUNG METEOROLO; Kerschbaumer A, 2010, 206432001 FKZ FREIEN; Klingner M, 2006, GEFAHRST REINHALT L, V66, P326; LANUV Landesamt fur Natur Umwelt und Verbraucherschutz NRW, 2008, VORG LANUV KORR KONT; Latza U, 2009, INT J HYG ENVIR HEAL, V212, P271, DOI 10.1016/j.ijheh.2008.06.003; Lenschow P, 2001, ATMOS ENVIRON, V35, pS23; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LUBW Landesanstalt fur Umwelt Messungen und Naturschutz Baden Wurttemberg, 2009, UNT MASS INH IR FEIN, P1; Lutz M., 2010, 14 ETH C COMB GEN PA; Lutz M, 2009, EIN JAHR UMWELTZONE, P1; Morfeld P, 2014, Pneumologie, V68, P173, DOI 10.1055/s-0033-1359180; Morfeld P, 2013, ARCH TOXICOL, V87, P2051, DOI 10.1007/s00204-013-1140-3; Morfeld P, 2013, ZENTRALBLATT ARB ARB, V63, P104, DOI 10.1007/BF03346194; Morfeld P, 2011, ZENTRALBLATT ARB ARB, V61, P148, DOI 10.1007/BF03344991; Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9; Neter J, 1985, APPL LINEAR REGRESSI; Pfeffer U, 2006, GEFAHRST REINHALT L, V66, P38; Pfeffer U, 2010, GEFAHRST REINHALT L, V70, P500; Pfeffer U, 2010, MESSTECHNIK STICKSTO, P113; Puls T, 2012, AUSWIRKUNGEN UMWELTZ, P1; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Rauterberg-Wulff A., 2011, UMID, V4, P11; REIMER E, 1992, AIR POLLUTION MODELI, V9, P565; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Royston P., 2008, MULTIVARIABLE MODEL; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Schuster C, 2009, DTSCH ARZTEBL, V106, pA228; Senn S., 1997, STAT METHODS MED RES, V6, P99; Stern R, 2004, WEITERE ENTWICKLUNG; Stern R, 2004, GROSSRAUMIGE PM10 AU, P33; Stern R., 2003, ENTWICKLUNG ANWENDUN; Sternberg R., 2013, TECHNOVATION, P1; Stigler S M, 1997, Stat Methods Med Res, V6, P103; Tonne C, 2008, OCCUP ENVIRON MED, V65, P620, DOI 10.1136/oem.2007.036533; Turner MC, 2011, AM J RESP CRIT CARE, V184, P1374, DOI 10.1164/rccm.201106-1011OC; Twisk JWR, 2004, APPL LONGITUDINAL DA; U.S. Environmental Protection Agency, 2008, EPA600R08071; Umweltbundesamt, 2014, STAT UMW; Umweltbundesamt, 2014, MED; Umweltbundesamt, 2012, LUFTQUALIT T 2011 FE; Umweltbundesamt, 2014, UMW DEUTSCHL; Umweltbundesamt, 2014, LUFT LUFTR; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Vogt R, 2010, 12 TECHN K 2010 24 2, P287; Zellner R, 2009, FEINSTAUBE UMWELTZON; ZUS LG, 2010, BEWERTUNG AUSWIRKUNG, V42, P15	86	29	29	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e102999	10.1371/journal.pone.0102999	http://dx.doi.org/10.1371/journal.pone.0102999			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115911	gold, Green Submitted, Green Published			2022-12-27	WOS:000341230400008
J	Wu, LF; Zhang, J; Zhao, M				Wu, Lingfei; Zhang, Jiang; Zhao, Min			The Metabolism and Growth of Web Forums	PLOS ONE			English	Article							COLLECTIVE DYNAMICS; CLICKSTREAM; MODEL; LIFE; LAWS	We view web forums as virtual living organisms feeding on user's clicks and investigate how they grow at the expense of clickstreams. We find that PVt (the number of page views in a given time period) and UVt (the number of unique visitors in the time period) of the studied forums satisfy the law of the allometric growth, i.e., PVt similar to UVt theta. We construct clickstream networks and explain the observed temporal dynamics of networks by the interactions between nodes. We describe the transportation of clickstreams using the function D-i similar to T-i(gamma), in which T-i is the total amount of clickstreams passing through node i and D-i is the amount of the clickstreams dissipated from i to the environment. It turns out that gamma, an indicator for the efficiency of network dissipation, not only negatively correlates with theta, but also sets the bounds for theta. In particular, 1/gamma > theta when 0 < gamma < 1 and 1/gamma < theta when gamma > 1. Our findings have practical consequences. For example, theta can be used as a measure of the "stickiness'' of forums, which quantifies the stable ability of forums to remain users "lock-in'' on the forum. Meanwhile, the correlation between gamma and theta provides a method to predict the long-term "stickiness'' of forums from the clickstream data in a short time period. Finally, we discuss a random walk model that replicates both of the allometric growth PVt similar to UVt theta and the dissipation function D-i similar to T-i(gamma).	[Wu, Lingfei; Zhao, Min] Baidu Inc, Beijing, Peoples R China; [Wu, Lingfei] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Wu, Lingfei] Arizona State Univ, Ctr Study Inst Divers, Tempe, AZ USA; [Zhang, Jiang] Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China	Baidu; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Beijing Normal University	Zhang, J (corresponding author), Beijing Normal Univ, Sch Syst Sci, Beijing 100875, Peoples R China.	zhangjiang@bnu.edu.cn		Wu, Lingfei/0000-0002-0102-3613	NNSFC [61004107]; Beijing Higher Education Young Elite Teacher Project [YETP0291]	NNSFC(National Natural Science Foundation of China (NSFC)); Beijing Higher Education Young Elite Teacher Project	This paper is supported by the NNSFC (http://www.nsfc.gov.cn/publish/portal1/) under Grant No. 61004107 and Beijing Higher Education Young Elite Teacher Project (http://www.bjedu.gov.cn) under the Grant No.YETP0291. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2005, IEEE INTELL SYST, V20, P67, DOI 10.1109/MIS.2005.81; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bejan A, 2011, PHYS LIFE REV, V8, P209, DOI 10.1016/j.plrev.2011.05.010; Benevenuto F, 2009, IMC'09: PROCEEDINGS OF THE 2009 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P49; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bodendorf F, 2009, P 2 ACM WORKSH SOC W, P65, DOI DOI 10.1145/1651437.1651448; Bollen J, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006022, 10.1371/journal.pone.0004803]; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bucklin RE, 2003, J MARKETING RES, V40, P249, DOI 10.1509/jmkr.40.3.249.19241; Bucklin RE, 2002, MARKET LETT, V13, P245, DOI 10.1023/A:1020231107662; Cammaerts B, 2005, POLIT COMMUN, V22, P179, DOI 10.1080/10584600590933188; Cattuto C, 2007, P NATL ACAD SCI USA, V104, P1461, DOI 10.1073/pnas.0610487104; Cattuto C, 2009, P NATL ACAD SCI USA, V106, P10511, DOI 10.1073/pnas.0901136106; Chen-Guang He, 2010, Proceedings 2010 IEEE Youth Conference on Information, Computing and Telecommunications (YC-ICT 2010), P351, DOI 10.1109/YCICT.2010.5713117; Cooley R., 2000, THESIS U MINNESOTA; Fang Wu, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P409, DOI 10.1109/CSE.2009.430; Garlaschelli D, 2003, NATURE, V423, P165, DOI 10.1038/nature01604; Henderson T, 2001, P 9 ACM INT C MULT, P212; HIGASHI M, 1986, ECOL MODEL, V32, P137, DOI 10.1016/0304-3800(86)90022-0; Huberman B.A., 2009, SOCIAL ATTENTION AGE, P62; Huberman BA, 1998, SCIENCE, V280, P95, DOI 10.1126/science.280.5360.95; Huberman BA, 2009, J INF SCI, V35, P758, DOI 10.1177/0165551509346786; Huberman Bernardo A., 2003, LAWS WEB PATTERNS EC; Johnson EJ, 2003, J MARKETING, V67, P62, DOI 10.1509/jmkg.67.2.62.18615; Kim D-H., 2004, P 6 ANN ACM INT WORK, P88, DOI DOI 10.1145/1031453.1031470; Lerman K, 2010, ICWSM, V10, P90, DOI DOI 10.1146/ANNUREV.AN.03.100174.001431; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; O'Reilly T., 2007, COMMUNICATIONS STRAT, V65, P17, DOI DOI 10.1109/KIMAS.2003.1245106; STEPHENS MA, 1974, J AM STAT ASSOC, V69, P730, DOI 10.2307/2286009; Straskraba M, 1999, ECOL MODEL, V117, P3, DOI 10.1016/S0304-3800(98)00194-X; Tessone CJ, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/58005; Top A, 2012, 500 GLOBAL SITES; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104; Wu LF, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026113; Xiaobin Fu, 2000, IUI 2000. 2000 International Conference on Intelligent User Interfaces, P106; Yu JF, 2010, PHYSICA A, V389, P3267, DOI 10.1016/j.physa.2010.03.043; Zhang J, 2013, ARXIV13025803; Zhang J., 2007, P 16 INT C WORLD WID, P221, DOI DOI 10.1145/1242572.1242603; Zhang JA, 2010, J THEOR BIOL, V264, P760, DOI 10.1016/j.jtbi.2010.03.024	44	13	14	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e102646	10.1371/journal.pone.0102646	http://dx.doi.org/10.1371/journal.pone.0102646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115897	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400007
J	Cernat, L; Blaj, C; Jackstadt, R; Brandl, L; Engel, J; Hermeking, H; Jung, A; Kirchner, T; Horst, D				Cernat, Laura; Blaj, Cristina; Jackstadt, Rene; Brandl, Lydia; Engel, Jutta; Hermeking, Heiko; Jung, Andreas; Kirchner, Thomas; Horst, David			Colorectal Cancers Mimic Structural Organization of Normal Colonic Crypts	PLOS ONE			English	Article							STEM-CELLS; BETA-CATENIN; PROGNOSTIC-SIGNIFICANCE; TUMOR PROGRESSION; WNT ACTIVITY; E-CADHERIN; EXPRESSION; PROLIFERATION; MICROENVIRONMENT; TUMORIGENESIS	Colonic crypts are stereotypical structures with distinct stem cell, proliferating, and differentiating compartments. Colorectal cancers derive from colonic crypt epithelia but, in contrast, form morphologically disarrayed glands. In this study, we investigated to which extent colorectal cancers phenocopy colonic crypt architecture and thus preserve structural organization of the normal intestinal epithelium. A subset of colon cancers showed crypt-like compartments with high WNT activity and nuclear beta-Catenin at the leading tumor edge, adjacent proliferation, and enhanced Cytokeratin 20 expression in most differentiated tumor epithelia of the tumor center. This architecture strongly depended on growth conditions, and was fully reproducible in mouse xenografts of cultured and primary colon cancer cells. Full crypt-like organization was associated with low tumor grade and was an independent prognostic marker of better survival in a collection of 221 colorectal cancers. Our findings suggest that full activation of preserved intestinal morphogenetic programs in colon cancer requires in vivo growth environments. Furthermore, crypt-like architecture was linked with less aggressive tumor biology, and may be useful to improve current colon cancer grading schemes.	[Cernat, Laura; Blaj, Cristina; Jackstadt, Rene; Brandl, Lydia; Hermeking, Heiko; Jung, Andreas; Kirchner, Thomas; Horst, David] Univ Munich, Inst Pathol, D-80539 Munich, Germany; [Cernat, Laura] Victor Babes Univ Med & Pharm, Timisoara, Romania; [Engel, Jutta] Klinikum Univ, Tumorregister Munchen TRM, Munich, Germany; [Engel, Jutta] Univ Munich, Inst Med Informat Verarbeitung Biometrie & Epidem, Munich, Germany; [Hermeking, Heiko; Jung, Andreas; Kirchner, Thomas] DKTK, Heidelberg, Germany; [Hermeking, Heiko; Jung, Andreas; Kirchner, Thomas] Deutsch Krebsforschungszentrum DKFZ, Heidelberg, Germany	University of Munich; Victor Babes University of Medicine & Pharmacy, Timisoara; University of Munich; University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ)	Horst, D (corresponding author), Univ Munich, Inst Pathol, Thalkirchner Str 36, D-80539 Munich, Germany.	david.horst@med.uni-muenchen.de		Blaj, Cristina/0000-0003-0449-2690	Wilhelm Sander-Stiftung; European Social Fund [107/1.5/S/78702]	Wilhelm Sander-Stiftung; European Social Fund(European Social Fund (ESF))	Supported by a grant from the Wilhelm Sander-Stiftung (to DH) and European Social Fund-Project 107/1.5/S/78702 (to LC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayrak R, 2011, PATHOL RES PRACT, V207, P156, DOI 10.1016/j.prp.2010.12.005; Benahmed F, 2007, AM J PATHOL, V170, P733, DOI 10.2353/ajpath.2007.060696; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chan CWM, 2009, P NATL ACAD SCI USA, V106, P1936, DOI 10.1073/pnas.0812904106; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056380; Chung GG, 2001, CLIN CANCER RES, V7, P4013; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; DEANS GT, 1992, BRIT J SURG, V79, P608, DOI 10.1002/bjs.1800790706; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gazdar AF, 2010, LUNG CANCER, V68, P309, DOI 10.1016/j.lungcan.2009.12.005; Gunderson LL, 2010, J CLIN ONCOL, V28, P264, DOI 10.1200/JCO.2009.24.0952; Horst D, 2012, CANCER RES, V72, P1547, DOI 10.1158/0008-5472.CAN-11-3222; Horst D, 2009, CANCER INVEST, V27, P844, DOI 10.1080/07357900902744502; Horst D, 2009, CANCER, V115, P2063, DOI 10.1002/cncr.24254; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; Kimura T, 2000, INT J ONCOL, V16, P55; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Lugli A, 2007, HISTOPATHOLOGY, V50, P453, DOI 10.1111/j.1365-2559.2007.02620.x; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Palmqvist R, 1999, BRIT J CANCER, V79, P577, DOI 10.1038/sj.bjc.6690091; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Tunca B, 2013, J CANCER RES CLIN, V139, P691, DOI 10.1007/s00432-013-1372-x; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Zhang ZC, 2014, MOL CANCER THER, V13, P1942, DOI 10.1158/1535-7163.MCT-13-1000	28	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104284	10.1371/journal.pone.0104284	http://dx.doi.org/10.1371/journal.pone.0104284			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111606	Green Submitted, Green Published, gold			2022-12-27	WOS:000341105100046
J	Jameson, JB; Kantz, A; Schultz, L; Kalyanaraman, C; Jacobson, MP; Maloney, DJ; Jadhav, A; Simeonov, A; Holman, TR				Jameson, J. Brian, II; Kantz, Auric; Schultz, Lena; Kalyanaraman, Chakrapani; Jacobson, Matthew P.; Maloney, David J.; Jadhav, Ajit; Simeonov, Anton; Holman, Theodore R.			A High Throughput Screen Identifies Potent and Selective Inhibitors to Human Epithelial 15-Lipoxygenase-2	PLOS ONE			English	Article							HUMAN RETICULOCYTE; 12-HUMAN LIPOXYGENASE; SUBSTRATE-SPECIFICITY; DISCOVERY; 12-LIPOXYGENASE; EXPRESSION; 15-HUMAN; PURIFICATION; LIBRARIES; 15-LOX2	Lipoxygenase (LOX) enzymes catalyze the hydroperoxidation of arachidonic acid and other polyunsaturated fatty acids to hydroxyeicosatetraenoic acids with varying positional specificity to yield important biological signaling molecules. Human epithelial 15-lipoxygenase-2 (15-LOX-2) is a highly specific LOX isozyme that is expressed in epithelial tissue and whose activity has been correlated with suppression of tumor growth in prostate and other epithelial derived cancers. Despite the potential utility of an inhibitor to probe the specific role of 15-LOX-2 in tumor progression, no such potent/specific 15-LOX-2 inhibitors have been reported to date. This study employs high throughput screening to identify two novel, specific 15-LOX-2 inhibitors. MLS000545091 is a mixed-type inhibitor of 15-LOX-2 with a K-i of 0.9+/-20.4 mu M and has a 20-fold selectivity over 5-LOX, 12-LOX, 15-LOX-1, COX-1, and COX-2. MLS000536924 is a competitive inhibitor with a K-i of 2.5+/-20.5 mu M and also possesses 20-fold selectivity toward 15-LOX-2 over the other oxygenases, listed above. Finally, neither compound possesses reductive activity towards the active-site ferrous ion.	[Jameson, J. Brian, II; Kantz, Auric; Holman, Theodore R.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Schultz, Lena; Maloney, David J.; Jadhav, Ajit; Simeonov, Anton] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Kalyanaraman, Chakrapani; Jacobson, Matthew P.] Univ Calif San Francisco, Sch Pharm, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California Santa Cruz; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of California System; University of California San Francisco	Simeonov, A (corresponding author), NIH, Natl Ctr Adv Translat Sci, Bldg 10, Bethesda, MD 20892 USA.	asimeono@mail.nih.gov; tholman@chemistry.ucsc.edu	Jacobson, Matthew/Y-5161-2018	Jacobson, Matthew/0000-0001-6262-655X; Jadhav, Ajit/0000-0001-7955-1451	National Institutes of Health [GM56062, S10-RR20939]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR020939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056062, R01GM056062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM56062 (TRH) and S10-RR20939 (University of California Santa Cruz)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagata T, 2003, J NAT PROD, V66, P230, DOI 10.1021/np020462l; Bhatia B, 2003, J BIOL CHEM, V278, P25091, DOI 10.1074/jbc.M301920200; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; CHEN XS, 1993, EUR J BIOCHEM, V214, P845, DOI 10.1111/j.1432-1033.1993.tb17988.x; Cichewicz RH, 2004, J AM CHEM SOC, V126, P14910, DOI 10.1021/ja046082z; Deschamps JD, 2007, BIOORGAN MED CHEM, V15, P6900, DOI 10.1016/j.bmc.2007.08.015; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Hoobler EK, 2013, BIOORGAN MED CHEM, V21, P3894, DOI 10.1016/j.bmc.2013.04.016; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Jack GS, 2000, HUM PATHOL, V31, P1146, DOI 10.1053/hupa.2000.16670; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; Joshi N, 2013, BIOCHEMISTRY-US, V52, P8026, DOI 10.1021/bi4010649; Kalyanaraman C, 2005, BIOCHEMISTRY-US, V44, P2059, DOI 10.1021/bi0481186; Kenyon V, 2011, J MED CHEM, V54, P5485, DOI 10.1021/jm2005089; Klil-Drori AJ, 2013, PROSTAG OTH LIPID M, V106, P16, DOI 10.1016/j.prostaglandins.2013.07.006; Kobe MJ, 2014, J BIOL CHEM, V289, P8562, DOI 10.1074/jbc.M113.543777; Luci DK, 2014, J MED CHEM, V57, P495, DOI 10.1021/jm4016476; MCMILLAN RM, 1992, TRENDS PHARMACOL SCI, V13, P323, DOI 10.1016/0165-6147(92)90100-K; O'Flaherty JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045480; Rai G, 2014, J MED CHEM, V57, P4035, DOI 10.1021/jm401915r; Rai G, 2010, J MED CHEM, V53, P7392, DOI 10.1021/jm1008852; Robinson SJ, 2009, J NAT PROD, V72, P1857, DOI 10.1021/np900465e; ROUZER CA, 1985, P NATL ACAD SCI USA, V82, P6040, DOI 10.1073/pnas.82.18.6040; Segraves EN, 2004, J MED CHEM, V47, P4060, DOI 10.1021/jm049872s; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Suraneni MV, 2010, ONCOGENE, V29, P4261, DOI 10.1038/onc.2010.197; Vasquez-Martinez Y, 2007, BIOORGAN MED CHEM, V15, P7408, DOI 10.1016/j.bmc.2007.07.036; Wecksler AT, 2008, BIOCHEMISTRY-US, V47, P7364, DOI 10.1021/bi800550n; Wecksler AT, 2009, BIOCHEMISTRY-US, V48, P8721, DOI 10.1021/bi9009242; Whitman S, 2002, J MED CHEM, V45, P2659, DOI 10.1021/jm0201262; Zuo XS, 2012, J NATL CANCER I, V104, P709, DOI 10.1093/jnci/djs187	31	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104094	10.1371/journal.pone.0104094	http://dx.doi.org/10.1371/journal.pone.0104094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111178	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100030
J	Perez, S; Cid, A; Inarrea, A; Pato, M; Lamas, MJ; Couso, B; Gil, M; Alvarez, MJ; Rey, S; Lopez-Miragaya, I; Melon, S; de Ona, M				Perez, Sonia; Cid, Ana; Inarrea, Amparo; Pato, Monica; Jose Lamas, Maria; Couso, Barbara; Gil, Margarita; Jesus Alvarez, Maria; Rey, Sonia; Lopez-Miragaya, Isabel; Melon, Santiago; de Ona, Maria			Prevalence of HPV 16 and HPV 18 Lineages in Galicia, Spain	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; SQUAMOUS INTRAEPITHELIAL LESIONS; VARIANT LINEAGES; CERVICAL-CANCER; E6 VARIANTS; SEQUENCE; CLASSIFICATION; PERSISTENCE; PHYLOGENY; GENOME	Genetic variants of human papillomavirus types 16 and 18 (HPV16/18) could differ in their cancer risk. We studied the prevalence and association with high-grade cervical lesions of different HPV16/18 variant lineages in a case-control study including 217 cases (cervical intraepithelial neoplasia grade 2 or grade 3 or worse: CIN2 or CIN3+) and 116 controls (no CIN2 or CIN3+ in two-year follow-up). HPV lineages were determined by sequencing the long control region (LCR) and the E6 gene. Phylogenetic analysis of HPV16 confirmed that isolates clustered into previously described lineages: A (260, 87.5%), B (4, 1.3%), C (8, 2.7%), and D (25, 8.4%). Lineage D/lineage A strains were, respectively, detected in 4/82 control patients, 19/126 CIN3+ cases (OR = 3.1, 95% CI: 1.0-12.9, p = 0.04), 6/1 glandular high-grade lesions (OR = 123, 95% CI: 9.7-5713.6, p<0.0001), and 4/5 invasive lesions (OR = 16.4, 95% CI: 2.2-113.7, p = 0.002). HPV18 clustered in lineages A (32, 88.9%) and B (4, 11.1%). Lineage B/lineage A strains were respectively detected in 1/23 control patients and 2/5 CIN3+ cases (OR = 9.2, 95% CI: 0.4-565.4, p = 0.12). In conclusion, lineages A of HPV16/18 were predominant in Spain. Lineage D of HPV16 was associated with increased risk for CIN3+, glandular high-grade lesions, and invasive lesions compared with lineage A. Lineage B of HPV18 may be associated with increased risk for CIN3+ compared with lineage A, but the association was not significant. Large well-designed studies are needed before the application of HPV lineage detection in clinical settings.	[Perez, Sonia; Rey, Sonia; Lopez-Miragaya, Isabel] Univ Hosp Vigo, Dept Microbiol, Vigo, Spain; [Cid, Ana] Univ Hosp Ourense, Dept Microbiol, Orense, Spain; [Inarrea, Amparo; Jose Lamas, Maria; Gil, Margarita] Univ Hosp Vigo, Dept Obstet & Gynecol, Vigo, Spain; [Pato, Monica; Couso, Barbara] Univ Hosp Ourense, Dept Obstet & Gynecol, Orense, Spain; [Jesus Alvarez, Maria] Univ Hosp Vigo, Dept Pathol, Vigo, Spain; [Melon, Santiago; de Ona, Maria] Univ Hosp Asturias, Dept Virol, Oviedo, Spain	Complexo Hospitalario Universitario de Vigo; Complexo Hospitalario Universitario de Ourense, Verin e O Barco de Valdeorras; Complexo Hospitalario Universitario de Vigo; Complexo Hospitalario Universitario de Ourense, Verin e O Barco de Valdeorras; Complexo Hospitalario Universitario de Vigo; Central University Hospital Asturias	Perez, S (corresponding author), Univ Hosp Vigo, Dept Microbiol, Vigo, Spain.	sonia.perez.castro@sergas.es	Melón, Santiago/AAY-1466-2021; Melón García, Santiago/AHE-7360-2022	Melón, Santiago/0000-0001-5770-7902; Melón García, Santiago/0000-0001-5770-7902; PEREZ CASTRO, SONIA/0000-0003-1734-1904	Conselleria de Sanidade, Galicia, Spain	Conselleria de Sanidade, Galicia, Spain	This work was supported by Conselleria de Sanidade, Galicia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Pulido H, 2005, VIROLOGY, V338, P22, DOI 10.1016/j.virol.2005.04.022; Arroyo SL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-258; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Burk RD, 2003, CANCER RES, V63, P7215; Burk RD, 2013, VIROLOGY, V445, P232, DOI 10.1016/j.virol.2013.07.018; Chen Z, 2009, J VIROL, V83, P1443, DOI 10.1128/JVI.02068-08; COLE ST, 1987, J MOL BIOL, V193, P599, DOI 10.1016/0022-2836(87)90343-3; Cornet I, 2013, BRIT J CANCER, V108, P240, DOI 10.1038/bjc.2012.508; Cornet I, 2012, J VIROL, V86, P6855, DOI 10.1128/JVI.00483-12; De la Cruz-Hernandez E, 2005, J GEN VIROL, V86, P2459, DOI 10.1099/vir.0.80945-0; Geraets DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080382; Gheit T, 2011, CANCER EPIDEM BIOMAR, V20, P1315, DOI 10.1158/1055-9965.EPI-10-1187; Godinez JM, 2013, INFECT GENET EVOL, V13, P96, DOI 10.1016/j.meegid.2012.09.011; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Myers G, 1997, HUMAN PAPILLOMAVIRUS; Ortiz M, 2006, J CLIN MICROBIOL, V44, P1428, DOI 10.1128/JCM.44.4.1428-1434.2006; Perez S, 2011, J VIROL METHODS, V173, P357, DOI 10.1016/j.jviromet.2011.03.010; Perez-Gallego L, 2001, AM J CLIN PATHOL, V116, P143; Quint KD, 2010, GYNECOL ONCOL, V117, P297, DOI 10.1016/j.ygyno.2010.02.003; Rose BR, 1997, GYNECOL ONCOL, V66, P282, DOI 10.1006/gyno.1997.4740; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Smith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021375; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tornesello ML, 2011, GYNECOL ONCOL, V121, P32, DOI 10.1016/j.ygyno.2010.12.005; Tornesello ML, 2006, J MED VIROL, V78, P1663, DOI 10.1002/jmv.20752; Villa LL, 2000, J GEN VIROL, V81, P2959, DOI 10.1099/0022-1317-81-12-2959; Wheeler CM, 1997, J CLIN MICROBIOL, V35, P11, DOI 10.1128/JCM.35.1.11-19.1997; Xi LF, 2007, CANCER EPIDEM BIOMAR, V16, P4, DOI 10.1158/1055-9965.EPI-06-0670; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; Zuna RE, 2009, INT J CANCER, V125, P2609, DOI 10.1002/ijc.24706	35	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104678	10.1371/journal.pone.0104678	http://dx.doi.org/10.1371/journal.pone.0104678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111834	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100089
J	Olbryt, M; Habryka, A; Student, S; Jarzab, M; Tyszkiewicz, T; Lisowska, KM				Olbryt, Magdalena; Habryka, Anna; Student, Sebastian; Jarzab, Michal; Tyszkiewicz, Tomasz; Lisowska, Katarzyna Marta			Global Gene Expression Profiling in Three Tumor Cell Lines Subjected to Experimental Cycling and Chronic Hypoxia	PLOS ONE			English	Article							INTERMITTENT BLOOD-FLOW; MESENCHYMAL STEM-CELLS; BREAST-CANCER; TRANSCRIPTION FACTORS; TRANSIENT HYPOXIA; PROGNOSTIC IMPACT; UP-REGULATION; SOLID TUMORS; REOXYGENATION; METASTASIS	Hypoxia is one of the most important features of the tumor microenvironment, exerting an adverse effect on tumor aggressiveness and patient prognosis. Two types of hypoxia may occur within the tumor mass, chronic (prolonged) and cycling (transient, intermittent) hypoxia. Cycling hypoxia has been shown to induce aggressive tumor cell phenotype and radioresistance more significantly than chronic hypoxia, though little is known about the molecular mechanisms underlying this phenomenon. The aim of this study was to delineate the molecular response to both types of hypoxia induced experimentally in tumor cells, with a focus on cycling hypoxia. We analyzed in vitro gene expression profile in three human cancer cell lines (melanoma, ovarian cancer, and prostate cancer) exposed to experimental chronic or transient hypoxia conditions. As expected, the cell-type specific variability in response to hypoxia was significant. However, the expression of 240 probe sets was altered in all 3 cell lines. We found that gene expression profiles induced by both types of hypoxia were qualitatively similar and strongly depend on the cell type. Cycling hypoxia altered the expression of fewer genes than chronic hypoxia (6,132 vs. 8,635 probe sets, FDR adjusted p<0.05), and with lower fold changes. However, the expression of some of these genes was significantly more affected by cycling hypoxia than by prolonged hypoxia, such as IL8, PLAU, and epidermal growth factor (EGF) pathway-related genes (AREG, HBEGF, and EPHA2). These transcripts were, in most cases, validated by quantitative reverse transcription polymerase chain reaction (qRT-PCR). Our results indicate that experimental cycling hypoxia exerts similar, although less intense effects, on the examined cancer cell lines than its chronic counterpart. Nonetheless, we identified genes and molecular pathways that seem to be preferentially regulated by cyclic hypoxia.	[Olbryt, Magdalena; Habryka, Anna; Lisowska, Katarzyna Marta] Gliwice Branch, Maria Sklodowska Curie Mem Canc Ctr, Ctr Translat Res & Mol Biol Canc, Gliwice, Poland; [Olbryt, Magdalena; Habryka, Anna; Jarzab, Michal; Tyszkiewicz, Tomasz; Lisowska, Katarzyna Marta] Inst Oncol, Gliwice Branch, Gliwice, Poland; [Student, Sebastian] Silesian Tech Univ, Inst Automat Control, Gliwice, Poland; [Jarzab, Michal] Gliwice Branch, Maria Sklodowska Curie Mem Canc Ctr, Dept Radiat Therapy & Chemotherapy 3, Gliwice, Poland; [Tyszkiewicz, Tomasz] Maria Sklodowska Curie Mem Canc Ctr, Nucl Med & Endocrine Oncol Dept, Gliwice Branch, Gliwice, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Silesian University of Technology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Olbryt, M (corresponding author), Gliwice Branch, Maria Sklodowska Curie Mem Canc Ctr, Ctr Translat Res & Mol Biol Canc, Gliwice, Poland.	molbryt@io.gliwice.pl	Lisowska, Katarzyna M/G-8295-2011; Student, Sebastian/H-7895-2013; Jarząb, Michał/G-4319-2012	Lisowska, Katarzyna M/0000-0001-9786-3993; Student, Sebastian/0000-0003-1812-5496; Jarząb, Michał/0000-0002-2642-9724; Tyszkiewicz, Tomasz/0000-0003-4863-0143; Olbryt, Magdalena/0000-0001-9961-6427; Habryka, Anna/0000-0002-7673-8402	Polish Ministry of Science and Higher Education [PBZ-MNiI-2/1/2005]; National Science Center (NCN, Poland) [DEC-2012/05/B/ST6/03472]; GCONiI-Upper-Silesian Center for Scientific Computation' [POIG.02.03.01-24-099/13]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Center (NCN, Poland); GCONiI-Upper-Silesian Center for Scientific Computation'	This work was supported by the Polish Ministry of Science and Higher Education (grant number PBZ-MNiI-2/1/2005) (MO MJ TT KML) and partially by the National Science Center (NCN, Poland) grant number DEC-2012/05/B/ST6/03472 (SS). The data analysis was partially performed using the infrastructure supported by POIG.02.03.01-24-099/13 grant: "GCONiI-Upper-Silesian Center for Scientific Computation''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer C, 2012, STRAHLENTHER ONKOL, V188, P616, DOI 10.1007/s00066-012-0085-4; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; BROWN JM, 1979, BRIT J RADIOL, V52, P650, DOI 10.1259/0007-1285-52-620-650; Brurberg KG, 2005, RADIOTHER ONCOL, V77, P220, DOI 10.1016/j.radonc.2005.09.009; Busser B, 2011, BBA-REV CANCER, V1816, P119, DOI 10.1016/j.bbcan.2011.05.003; Cairns RA, 2004, CANCER RES, V64, P2054, DOI 10.1158/0008-5472.CAN-03-3196; Cairns RA, 2001, CANCER RES, V61, P8903; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; CHAPLIN DJ, 1987, CANCER RES, V47, P597; Chen Z, 2003, J BIOL CHEM, V278, P35172, DOI 10.1074/jbc.M304241200; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Chihab R, 1998, MOL BRAIN RES, V63, P105, DOI 10.1016/S0169-328X(98)00266-6; Denko NC, 2003, ONCOGENE, V22, P5907, DOI 10.1038/sj.onc.1206703; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dewhirst MW, 2007, CANCER RES, V67, P854, DOI 10.1158/0008-5472.CAN-06-4744; Dietz A, 2003, HEAD NECK-J SCI SPEC, V25, P50, DOI 10.1002/hed.10177; Durand RE, 2001, CANCER METAST REV, V20, P57, DOI 10.1023/A:1013181107707; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Hsieh CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023945; Hu XY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-303; Jacobs B, 2009, J CLIN ONCOL, V27, P5068, DOI 10.1200/JCO.2008.21.3744; Kim YJ, 2007, CANCER RES, V67, P546, DOI 10.1158/0008-5472.CAN-06-2401; Kimura H, 1996, CANCER RES, V56, P5522; Lal A, 2001, JNCI-J NATL CANCER I, V93, P1337, DOI 10.1093/jnci/93.17.1337; Lanzen J, 2006, CANCER RES, V66, P2219, DOI 10.1158/0008-5472.CAN-03-2958; Louie E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2773; Low AYS, 2010, EXP CELL RES, V316, P466, DOI 10.1016/j.yexcr.2009.09.018; Marczyk M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-101; Martin-Rendon E, 2007, STEM CELLS, V25, P1003, DOI 10.1634/stemcells.2006-0398; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Matsumoto S, 2010, CANCER RES, V70, P10019, DOI 10.1158/0008-5472.CAN-10-2821; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Patwari P, 2011, CELL METAB, V14, P671, DOI 10.1016/j.cmet.2011.08.011; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pigott KH, 1996, RADIOTHER ONCOL, V40, P45, DOI 10.1016/0167-8140(96)01730-6; Ramirez TA, 2012, HYPERTENS RES, V35, P811, DOI 10.1038/hr.2012.32; Reimer D, 2007, CLIN CANCER RES, V13, P144, DOI 10.1158/1078-0432.CCR-06-0780; Reynolds TY, 1996, CANCER RES, V56, P5754; Richards H, 2010, IMMUNOLOGY, V131, P583, DOI 10.1111/j.1365-2567.2010.03333.x; Rofstad EK, 2007, CLIN CANCER RES, V13, P1971, DOI 10.1158/1078-0432.CCR-06-1967; Rofstad EK, 2010, INT J CANCER, V127, P1535, DOI 10.1002/ijc.25176; RUPEC RA, 1995, EUR J BIOCHEM, V234, P632, DOI 10.1111/j.1432-1033.1995.632_b.x; Shirakawa M, 2012, ONCOL REP, V27, P940, DOI 10.3892/or.2011.1607; Starmans MHW, 2012, RADIOTHER ONCOL, V102, P436, DOI 10.1016/j.radonc.2012.02.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Toustrup K, 2012, RADIOTHER ONCOL, V102, P122, DOI 10.1016/j.radonc.2011.09.010; Tsukahara T, 2008, CANCER SCI, V99, P368, DOI 10.1111/j.1349-7006.2008.00695.x; Udayakumar D, 2011, ONCOGENE, V30, P4921, DOI 10.1038/onc.2011.210; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Vengellur A, 2004, TOXICOL SCI, V82, P638, DOI 10.1093/toxsci/kfh278; Weinmann M, 2004, FASEB J, V18, P1906, DOI 10.1096/fj.04-1918fje; Winter SC, 2007, CANCER RES, V67, P3441, DOI 10.1158/0008-5472.CAN-06-3322; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Yeung HY, 2005, ENDOCRINOLOGY, V146, P4951, DOI 10.1210/en.2005-0365; Yuan G, 2008, J CELL PHYSIOL, V217, P674, DOI 10.1002/jcp.21537	60	30	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105104	10.1371/journal.pone.0105104	http://dx.doi.org/10.1371/journal.pone.0105104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122487	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000098
J	Shorter, KR; Anderson, V; Cakora, P; Owen, A; Lo, K; Crossland, J; South, ACH; Felder, MR; Vrana, PB				Shorter, Kimberly R.; Anderson, Vanessa; Cakora, Patricia; Owen, Amy; Lo, Keswick; Crossland, Janet; South, April C. H.; Felder, Michael R.; Vrana, Paul B.			Pleiotropic Effects of a Methyl Donor Diet in a Novel Animal Model	PLOS ONE			English	Article							FOLIC-ACID SUPPLEMENTATION; GENE-EXPRESSION; DNA METHYLATION; DEER MICE; PEROMYSCUS; BEHAVIOR; MOUSE; SUSCEPTIBILITY; FORTIFICATION; ALLELE	Folate and other methyl-donor pathway components are widely supplemented due to their ability to prevent prenatal neural tube defects. Several lines of evidence suggest that these supplements act through epigenetic mechanisms (e. g. altering DNA methylation). Primary among these are the experiments on the mouse viable yellow allele of the agouti locus (A(vy)). In the A(vy) allele, an Intracisternal A-particle retroelement has inserted into the genome adjacent to the agouti gene and is preferentially methylated. To further test these effects, we tested the same diet used in the A(vy) studies on wild-derived Peromyscus maniculatus, a native North American rodent. We collected tissues from neonatal offspring whose parents were fed the high-methyl donor diet as well as controls. In addition, we assayed coat-color of a natural variant (wide-band agouti = A(Nb)) that overexpresses agouti as a phenotypic biomarker. Our data indicate that these dietary components affected agouti protein production, despite the lack of a retroelement at this locus. Surprisingly, the methyl-donor diet was associated with defects (e.g. ovarian cysts, cataracts) and increased mortality. We also assessed the effects of the diet on behavior: We scored animals in open field and social interaction tests. We observed significant increases in female repetitive behaviors. Thus these data add to a growing number of studies that suggest that these ubiquitously added nutrients may be a human health concern.	[Shorter, Kimberly R.; Crossland, Janet; Felder, Michael R.; Vrana, Paul B.] Univ S Carolina, Peromyscus Genet Stock Ctr, Columbia, SC 29208 USA; [Shorter, Kimberly R.; Anderson, Vanessa; Cakora, Patricia; Owen, Amy; Lo, Keswick; South, April C. H.; Felder, Michael R.; Vrana, Paul B.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Felder, MR (corresponding author), Univ S Carolina, Peromyscus Genet Stock Ctr, Columbia, SC 29208 USA.	felder@biol.sc.edu; pbvrana@gmail.com			NIH [P40 OD010961]; University of South Carolina VP for research office; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010961] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina VP for research office; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was made possible by NIH P40 OD010961 and the University of South Carolina VP for research office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barua S, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-3; Cooney CA, 2002, J NUTR, V132, p2393S; Dice L. R., 1938, Occasional Papers of the Museum of Zoology University of Michigan Ann Arbor, Vno. 375, P1; Girotto F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01465; Godwin KA, 2008, CAN J PUBLIC HEALTH, V99, P271, DOI 10.1007/BF03403753; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Junaid MA, 2011, BIOCHEM BIOPH RES CO, V412, P688, DOI 10.1016/j.bbrc.2011.08.027; Kenney-Hunt J, 2014, MAMM GENOME, V25, P160, DOI 10.1007/s00335-014-9500-8; Kim YI, 2007, NUTR REV, V65, P504, DOI 10.1301/nr.2007.nov.504-511; Korff S, 2008, PROG NEURO-PSYCHOPH, V32, P348, DOI 10.1016/j.pnpbp.2007.08.032; Lamers Y, 2011, ANN NUTR METAB, V59, P32, DOI 10.1159/000332073; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; Ly A, 2011, CANCER RES, V71, P988, DOI 10.1158/0008-5472.CAN-10-2379; Marean A, 2011, HUM MOL GENET, V20, P3678, DOI 10.1093/hmg/ddr289; McGowan PO, 2008, BRAIN RES, V1237, P12, DOI 10.1016/j.brainres.2008.07.074; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; Powell SB, 1999, PHYSIOL BEHAV, V66, P355, DOI 10.1016/S0031-9384(98)00303-5; Powell SB, 2000, DEV PSYCHOBIOL, V37, P100, DOI 10.1002/1098-2302(200009)37:2<100::AID-DEV5>3.3.CO;2-Y; ROBINSON R, 1981, J HERED, V72, P132, DOI 10.1093/oxfordjournals.jhered.a109446; Schaible TD, 2011, HUM MOL GENET, V20, P1687, DOI 10.1093/hmg/ddr044; Shorter KR, 2014, BEHAV GENET, V44, P126, DOI 10.1007/s10519-013-9640-8; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Tanimura Y, 2008, BEHAV BRAIN RES, V189, P250, DOI 10.1016/j.bbr.2008.01.001; Tanimura Y, 2010, DEV PSYCHOBIOL, V52, P813, DOI 10.1002/dev.20477; Vasquez K, 2013, ADV EXP MED BIOL, V775, P101, DOI 10.1007/978-1-4614-6130-2_8; Vrana PB, 2014, WIRES DEV BIOL, V3, P211, DOI 10.1002/wdev.132; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949	31	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104942	10.1371/journal.pone.0104942	http://dx.doi.org/10.1371/journal.pone.0104942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121505	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000078
J	Tseng, WN; Lo, MH; Guo, MMH; Hsieh, KS; Chang, WC; Kuo, HC				Tseng, Wan-Ning; Lo, Mao-Hung; Guo, Mindy Ming-Huey; Hsieh, Kai-Sheng; Chang, Wei-Chiao; Kuo, Ho-Chang			IL-31 Associated with Coronary Artery Lesion Formation in Kawasaki Disease	PLOS ONE			English	Article							ATOPIC-DERMATITIS; T-CELLS; EOSINOPHILIA; SUSCEPTIBILITY; POLYMORPHISMS; INFLAMMATION; DIAGNOSIS; ANEURYSMS; COUNTS	Background: Kawasaki disease (KD) is known to be associated with T help (Th) 2 reaction and subsequently allergic diseases. Interleukin-31 (IL-31) has also been reported to be involved in Th2 mediated diseases such as allergic diseases. However, the role of IL-31 in KD has not been previously reported. The aim of this study is to investigate whether IL-31 is associated with KD and its clinical outcome. Material: A total of 78 KD patients who met the criteria of KD were enrolled in this study as well as 20 age-matched controls. Plasma samples were conducted to measure IL-31 before intravenous immunoglobulin (IVIG) treatment (KD1), within 3 days after IVIG treatment (KD2) and at least 3 weeks after IVIG treatment (KD3) by utilizing enzyme-linked immunosorbent assay (ELISA). Result: Our findings showed that IL-31 expression was higher in KD patients after IVIG treatment significantly (KD2>KD1: 1265.0 +/- 199.3 vs. 840.2 +/- 152.5 pg/ml, p<0.0001). Further analysis revealed that IL-31 level was significantly higher in KD patients with coronary artery lesion (CAL) (656.6 +/- 139.5 vs. 1373.0 +/- 422.0 pg/ml, p = 0.04) before IVIG treatment (KD1). There were no significant differences between the IVIG resistance and IVIG responsiveness groups. Conclusion: IL-31 was increased after IVIG treatment in patients with KD and was significantly associated with CAL formation. The results from this study may help to identify a novel risk factor for predicting KD and CAL formation.	[Tseng, Wan-Ning; Lo, Mao-Hung; Guo, Mindy Ming-Huey; Hsieh, Kai-Sheng; Kuo, Ho-Chang] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Coll Med, Dept Pediat, Kaohsiung, Taiwan; [Tseng, Wan-Ning; Lo, Mao-Hung; Guo, Mindy Ming-Huey; Hsieh, Kai-Sheng; Kuo, Ho-Chang] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Taipei Medical University	Chang, WC (corresponding author), Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan.	wcc@tmu.edu.tw; dr.hckuo@gmail.com	Kuo, Ho-Chang/AAQ-6644-2020	Kuo, Ho-Chang/0000-0002-3295-2984; Hsieh, Kai-Sheng/0000-0002-0294-9872; Chang, Wei-Chiao/0000-0002-8573-5924	National Science Council, Taiwan [NSC 102-2314-B-182-053-MY3]; Chang Gung Memorial Hospital [CMRPG8C1081, CMRPG8B0211]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by a grant from the National Science Council, Taiwan (NSC 102-2314-B-182-053-MY3) and a grant from the Chang Gung Memorial Hospital (CMRPG8C1081 and CMRPG8B0211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI T, 1992, J PEDIATR-US, V121, P689, DOI 10.1016/S0022-3476(05)81894-3; Beiser AS, 1998, AM J CARDIOL, V81, P1116, DOI 10.1016/S0002-9149(98)00116-7; BROSIUS CL, 1988, PEDIATR INFECT DIS J, V7, P863; Cheung PFY, 2010, INT IMMUNOL, V22, P453, DOI 10.1093/intimm/dxq027; Chu MP, 2012, MOL MED REP, V5, P1237, DOI 10.3892/mmr.2012.799; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Hospers JJ, 1999, AM J EPIDEMIOL, V150, P482; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Kuo HC, 2007, PEDIAT ALLERG IMM-UK, V18, P354, DOI 10.1111/j.1399-3038.2007.00516.x; Kuo HC, 2012, PEDIATR NEONATOL, V53, P4, DOI 10.1016/j.pedneo.2011.11.003; Lee CP, 2013, PEDIATR RES, V74, P545, DOI 10.1038/pr.2013.134; Liew WK, 2011, PEDIAT ALLERG IMM-UK, V22, P488, DOI 10.1111/j.1399-3038.2011.01149.x; Lin IC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038635; Lin LY, 2012, PEDIAT CARDIOL; Matsuoka S, 1997, EUR J PEDIATR, V156, P30; Mori K, 2000, EUR J PEDIATR, V159, P509, DOI 10.1007/s004310051321; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Okano M, 2011, J ALLERGY CLIN IMMUN, V127, P277, DOI 10.1016/j.jaci.2010.09.029; Ouyang H, 2014, EUR ARCH OTORHINOLAR; PRENTICE RL, 1982, AM J EPIDEMIOL, V116, P496, DOI 10.1093/oxfordjournals.aje.a113434; Raap U, 2008, J ALLERGY CLIN IMMUN, V122, P421, DOI 10.1016/j.jaci.2008.05.047; SHULMAN ST, 1995, PEDIATR CLIN N AM, V42, P1205; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Stott B, 2013, J ALLERGY CLIN IMMUN, V132, P446, DOI 10.1016/j.jaci.2013.03.050; Terai M, 2002, PEDIATR INFECT DIS J, V21, P777, DOI 10.1097/00006454-200208000-00015; Ting EC, 1998, PEDIATR INFECT DIS J, V17, P431, DOI 10.1097/00006454-199805000-00020; Wang YJ, 2013, ARTHRITIS RHEUM-US, V65, P805, DOI 10.1002/art.37815; Webster RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028004; Yu JI, 2012, KOREAN J PATHOL, V46, P162, DOI 10.4132/KoreanJPathol.2012.46.2.162	30	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105195	10.1371/journal.pone.0105195	http://dx.doi.org/10.1371/journal.pone.0105195			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122210	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000104
J	Motoo, Y; Arai, I; Tsutani, K				Motoo, Yoshiharu; Arai, Ichiro; Tsutani, Kiichiro			Use of Kampo Diagnosis in Randomized Controlled Trials of Kampo Products in Japan: A Systematic Review	PLOS ONE			English	Review							MEDICINE; HYPERTENSION	Background: The Committee for Evidence-based Medicine (EBM) of the Japan Society for Oriental Medicine started compiling Evidence Reports of Kampo Treatment (EKAT) in 2007. EKAT is a compilation of structured abstracts of randomized controlled trials (RCTs), along with comments by a third party reviewer. As of 31 December, 2012, there were 378 RCTs of Kampo medicines in Japan. The primary research question of this study is "How frequently is Kampo diagnosis used in RCTs of Kampo medicines?'' The secondary research question is "When is Kampo diagnosis used in RCTs?'' Materials and Methods: The structured abstract (SA) of each RCT article was reviewed to examine how Kampo diagnosis was used in RCTs, especially how Kampo diagnosis was used in the randomization process. Results: Kampo diagnosis was used before randomization in 27 RCTs (7.1%), after randomization in 31 RCTs (8.2%), and not used in 320 RCTs (84.7%). Before randomization, Kampo diagnosis was used as a criterion for inclusion in 10 RCTs, criterion for exclusion in 9 RCTs, and criteria for both inclusion and exclusion in 2 RCTs. Kampo formulas were determined according to Kampo diagnosis in 7 RCTs. After randomization, subgroup analyses according to Kampo diagnosis were done in 27 RCTs, and grade of disease severity at Kampo diagnosis was used for analysis as an endpoint in 4 RCTs. Conclusions: Kampo diagnosis was used before randomization only in approximately 15% of RCTs, and the number of RCT articles using Kampo diagnosis after randomization was almost the same as that before randomization. Further studies to determine the good RCTs conforming to CONSORT requirements and good systematic reviews conforming to PRISMA requirements are needed to clarify the significance of Kampo diagnosis.	[Motoo, Yoshiharu] Kanazawa Med Univ, Dept Med Oncol, Ishikawa, Japan; [Arai, Ichiro] Nihon Pharmaceut Univ, Dept Kampo Med, Saitama, Japan; [Tsutani, Kiichiro] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Drug Policy & Management, Tokyo, Japan	Kanazawa Medical University; University of Tokyo	Motoo, Y (corresponding author), Kanazawa Med Univ, Dept Med Oncol, Ishikawa, Japan.	motoo@kanazawa-med.ac.jp	Motoo, Yoshiharu/E-8277-2011					Adams Denise, 2012, J Evid Based Med, V5, P89, DOI 10.1111/j.1756-5391.2012.01173.x; Arakawa K, 2006, PHYTOMEDICINE, V13, P1, DOI 10.1016/j.phymed.2004.02.012; Japan Kampo Medicines Manufacturers Association, ACT COND SURV PRESCR; Kobayashi H, 2010, EVID-BASED COMPL ALT, V7, P367, DOI 10.1093/ecam/nen003; Ma B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020185; Miyamoto T., 2001, J CLIN THERAPEUTICS, V17, P1189; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Motoo Y., 2008, Botanical medicine in clinical practice, P105, DOI 10.1079/9781845934132.0105; Motoo Y, 2011, CHIN J INTEGR MED, V17, P85, DOI 10.1007/s11655-011-0653-y; Motoo Y, 2009, COMPLEMENT THER MED, V17, P147, DOI 10.1016/j.ctim.2008.09.003; Nakajima O, 2003, KAGAKU RYOHO KENKYUS, V34, P40; Odaguchi H, 2006, CURR MED RES OPIN, V22, P1587, DOI 10.1185/030079906X112769; Ohno S, 2006, KAMPO TO SAISHIN CHI, V15, P134; Panic N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083138; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Shi NN, 2013, J ALTERN COMPLEM MED, V19, P1, DOI 10.1089/acm.2011.0776; Shimada Y, 2007, DEV PERSONALIZED MED, P22; Tang WT, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-333; Tsutani K, 1993, CLIN RES METHODOLOGY, P365; Ushiroyama T, 2006, AM J CHINESE MED, V34, P177, DOI 10.1142/S0192415X06003746; Wieland LS, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-51	21	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104422	10.1371/journal.pone.0104422	http://dx.doi.org/10.1371/journal.pone.0104422			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119187	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600056
J	Pokorna, MJ; Rovatsos, M; Kratochvil, L				Pokorna, Martina Johnson; Rovatsos, Michail; Kratochvil, Lukas			Sex Chromosomes and Karyotype of the (Nearly) Mythical Creature, the Gila Monster, Heloderma suspectum (Squamata: Helodermatidae)	PLOS ONE			English	Article							DETERMINING MECHANISMS; POGONA-VITTICEPS; LIZARD; POLYMORPHISM; EVOLUTION; SNAKES; AMPLIFICATION; PHYLOGENY; POSITION; DRAGON	A wide variety of sex determination systems exist among squamate reptiles. They can therefore serve as an important model for studies of evolutionary transitions among particular sex determination systems. However, we still have only a limited knowledge of sex determination in certain important lineages of squamates. In this respect, one of the most understudied groups is the family Helodermatidae (Anguimorpha) encompassing the only two venomous species of lizards which are potentially lethal to human beings. We uncovered homomorphic ZZ/ZW sex chromosomes in the Gila monster (Heloderma suspectum) with a highly heterochromatic W chromosome. The sex chromosomes are morphologically similar to the ZZ/ZW sex chromosomes of monitor lizards (Varanidae). If the sex chromosomes of helodermatids and varanids are homologous, female heterogamety may be ancestral for the whole Anguimorpha group. Moreover, we found that the karyotype of the Gila monster consists of 2n = 36 chromosomes (14 larger metacentric chromosomes and 22 acrocentric microchromosomes). 2n = 36 is the widely distributed chromosomal number among squamates. In his pioneering works representing the only previous cytogenetic examination of the family Helodermatidae, Matthey reported the karyotype as 2n = 38 and suggested a different chromosomal morphology for this species. We believe that this was probably erroneously. We also discovered a strong accumulation of telomeric sequences on several pairs of microchromosomes in the Gila monster, which is a trait documented relatively rarely in vertebrates. These new data fill an important gap in our understanding of the sex determination and karyotype evolution of squamates.	[Pokorna, Martina Johnson; Rovatsos, Michail; Kratochvil, Lukas] Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic; [Pokorna, Martina Johnson] Acad Sci Czech Republ, Inst Anim Physiol & Genet, Libechov, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences	Kratochvil, L (corresponding author), Charles Univ Prague, Fac Sci, Dept Ecol, Prague, Czech Republic.	lukas.kratochvil@natur.cuni.cz	Pokorna, Martina Johnson/C-8274-2013; Kratochvil, Lukas/M-2134-2019; Rovatsos, Michail/D-3559-2013; Kratochvíl, Lukáš/A-1997-2008	Pokorna, Martina Johnson/0000-0003-1499-2170; Rovatsos, Michail/0000-0002-8429-5680; Kratochvíl, Lukáš/0000-0002-3515-729X	Czech Science Foundation [506/10/0718]	Czech Science Foundation(Grant Agency of the Czech Republic)	The project was supported by Czech Science Foundation (506/10/0718). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Beaman Kent R., 2006, Smithsonian Herpetological Information Service, V136, P1; BECAK ML, 1972, CARYOLOGIA, V25, P313, DOI 10.1080/00087114.1972.10796485; Beck D.D., 2005, BIOL GILA MONSTERS B; Campbell J. A., 2004, VENOMOUS REPTILES W, V1; Cole CJ, 1987, AM MUS NOVIT, V2869, P1; Douglas ME, 2002, BIOL VIPERS, P580; Douglas ME, 2010, MOL PHYLOGENET EVOL, V55, P153, DOI 10.1016/j.ympev.2009.12.009; Ezaz T, 2005, CHROMOSOME RES, V13, P763, DOI 10.1007/s10577-005-1010-9; Ezaz T, 2009, CHROMOSOME RES, V17, P965, DOI 10.1007/s10577-009-9102-6; Ezaz T, 2009, CHROMOSOME RES, V17, P91, DOI 10.1007/s10577-008-9019-5; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gamble T, 2010, SEX DEV, V4, P88, DOI 10.1159/000289578; Gamble T, 2014, EVOLUTION, V68, P1027, DOI 10.1111/evo.12328; Gorman G., 1973, CYTOTAXONOMY VERTEBR; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; Janzen Fredric J., 2004, P121; Kawai A, 2007, CYTOGENET GENOME RES, V117, P92, DOI 10.1159/000103169; KING M, 1982, GENETICA, V58, P39, DOI 10.1007/BF00056001; Kumazawa Y, 2007, GENE, V388, P19, DOI 10.1016/j.gene.2006.09.026; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; MATTHEY R., 1931, REV SUISSE ZOOL, V38, P117; MATTHEY R., 1933, Revue Suisse de Zoologie, V40, P281; Nanda I, 2002, CHROMOSOMA, V111, P215, DOI 10.1007/s00412-002-0206-4; Ocalewicz K, 2013, CYTOGENET GENOME RES, V141, P114, DOI 10.1159/000354278; Oguiura N, 2009, CYTOGENET GENOME RES, V127, P128, DOI 10.1159/000295789; OLMO E, 1987, CHROMOSOMA, V96, P33, DOI 10.1007/BF00285880; Olmo E, 2014, CHROMOREP REPTILE CH; Pellegrino KCM, 1999, HEREDITAS, V131, P15, DOI 10.1111/j.1601-5223.1999.00015.x; Pokorna M, 2014, CYTOGENET GENOME RES, V142, P190, DOI 10.1159/000358847; Pokorna Martina, 2011, Chromosoma, V120, P455, DOI 10.1007/s00412-011-0322-0; Pokorna M, 2012, CHROMOSOMA, V121, P409, DOI 10.1007/s00412-012-0371-z; Pokorna M, 2010, CHROMOSOME RES, V18, P809, DOI 10.1007/s10577-010-9154-7; Pokorna M, 2009, ZOOL J LINN SOC-LOND, V156, P168, DOI 10.1111/j.1096-3642.2008.00481.x; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Rovatsos MT, 2011, CHROMOSOME RES, V19, P869, DOI 10.1007/s10577-011-9242-3; Rovatsos M, 2014, EVOLUTION, V68, P2079, DOI 10.1111/evo.12357; Rovatsos M, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1093; Sarre SD, 2004, BIOESSAYS, V26, P639, DOI 10.1002/bies.20050; Srikulnath K, 2009, CYTOGENET GENOME RES, V125, P213, DOI 10.1159/000230005; Srikulnath K, 2013, CHROMOSOME RES, V21, P805, DOI 10.1007/s10577-013-9398-0; Srikulnath K, 2009, CHROMOSOME RES, V17, P975, DOI 10.1007/s10577-009-9101-7; STAMM B, 1975, Smithsonian Contributions to Zoology, V176, P52; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjio J. H., 1956, HEREDITAS, V42, P1, DOI [10.1007/978-94-011-6621-8_13, DOI 10.1111/J.1601-5223.1956.TB03010.X]; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Valenzuela N, 2003, AM NAT, V161, P676, DOI 10.1086/368292; Vicoso B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001643; Volker M, 2010, GENOME RES, V20, P503, DOI 10.1101/gr.103663.109; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703; Young MJ, 2013, CHROMOSOME RES, V21, P361, DOI 10.1007/s10577-013-9362-z	55	26	26	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104716	10.1371/journal.pone.0104716	http://dx.doi.org/10.1371/journal.pone.0104716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119263	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600080
J	Dighe, N; Khoury, M; Mattar, C; Chong, M; Choolani, M; Chen, JZ; Antoniou, MN; Chan, JKY				Dighe, Niraja; Khoury, Maroun; Mattar, Citra; Chong, Mark; Choolani, Mahesh; Chen, Jianzhu; Antoniou, Michael N.; Chan, Jerry K. Y.			Long-Term Reproducible Expression in Human Fetal Liver Hematopoietic Stem Cells with a UCOE-Based Lentiviral Vector	PLOS ONE			English	Article							CHROMATIN OPENING ELEMENT; SEVERE COMBINED IMMUNODEFICIENCY; CORD BLOOD TRANSPLANTATION; GENE-THERAPY; TRANSGENE EXPRESSION; STABLE TRANSDUCTION; IN-VIVO; PROMOTER; REPOPULATION; EXPANSION	Hematopoietic Stem Cell (HSC) targeted gene transfer is an attractive treatment option for a number of hematopoietic disorders caused by single gene defects. However, extensive methylation of promoter sequences results in silencing of therapeutic gene expression. The choice of an appropriate promoter is therefore crucial for reproducible, stable and long-term transgene expression in clinical gene therapy. Recent studies suggest efficient and stable expression of transgenes from the ubiquitous chromatin opening element (UCOE) derived from the human HNRPA2B1-CBX3 locus can be achieved in murine HSC. Here, we compared the use of HNRPA2B1-CBX3 UCOE (A2UCOE)-mediated transgene regulation to two other frequently used promoters namely EF1 alpha and PGK in human fetal liver-derived HSC (hflHSC). Efficient transduction of hflHSC with a lentiviral vector containing an HNRPA2B1-CBX3 UCOE-eGFP (A2UCOE-eGFP) cassette was achieved at higher levels than that obtained with umbilical cord blood derived HSC (3.1x; p<0.001). While hflHSC were readily transduced with all three test vectors (A2UCOE-eGFP, PGK-eGFP and EF1 alpha-eGFP), only the A2-UCOE construct demonstrated sustained transgene expression in vitro over 24 days (p < 0.001). In contrast, within 10 days in culture a rapid decline in transgene expression in both PGK-eGFP and EF1a-eGFP transduced hflHSC was seen. Subsequently, injection of transduced cells into immunodeficient mice (NOD/SCID/Il2rg(-/-)) demonstrated sustained eGFP expression for the A2UCOE-eGFP group up to 10 months post transplantation whereas PGK-eGFP and EF1a-eGFP transduced hflHSC showed a 5.1 and 22.2 fold reduction respectively over the same time period. We conclude that the A2UCOE allows a more efficient and stable expression in hflHSC to be achieved than either the PGK or EF1 alpha promoters and at lower vector copy number per cell.	[Dighe, Niraja; Mattar, Citra; Chong, Mark; Choolani, Mahesh; Chan, Jerry K. Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynecol, Expt Fetal Med Grp, Singapore 117548, Singapore; [Khoury, Maroun; Chen, Jianzhu] Singapore Massachusetts Inst Technol, Interdisciplinary Res Grp Infect Dis, Alliance Res & Technol, Singapore, Singapore; [Chong, Mark] Nanyang Technol Univ, Sch Chem & Biomed Engn, Div Bioengn, Singapore 639798, Singapore; [Chen, Jianzhu] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Chen, Jianzhu] MIT, Dept Biol, Cambridge, MA USA; [Antoniou, Michael N.] Guys Hosp, Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Dept Reprod Med, Singapore, Singapore; [Chan, Jerry K. Y.] Duke NUS Grad Med Sch, Canc & Stem Cell Program, Singapore, Singapore	National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; KK Women's & Children's Hospital; National University of Singapore	Chan, JKY (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynecol, Expt Fetal Med Grp, Singapore 117548, Singapore.	jerrychan@nus.edu.sg	Chong, Mark/D-2678-2013	Chong, Mark/0000-0002-9586-6303; Khoury, Maroun/0000-0002-9965-6266; Mattar, Citra Nurfarah/0000-0003-0068-6957	National Medical Research Council, Singapore [NMRC/NIG/0052/2009]; Ministry of Health's National Medical Research Council [NMRC/CSA/009/2009, NMRC/CSA/043/2012]	National Medical Research Council, Singapore(National Medical Research Council, Singapore); Ministry of Health's National Medical Research Council(Ministry of Health-SingaporeNational Medical Research Council, Singapore)	This work was funded by National Medical Research Council, Singapore (NMRC/NIG/0052/2009). MC and JKYC received salary support from the Ministry of Health's National Medical Research Council (NMRC/CSA/009/2009 and NMRC/CSA/043/2012). The funding body has supported the authors research ideas, with no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2014, BIOMATERIALS, V35, P1531, DOI 10.1016/j.biomaterials.2013.11.024; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Aiuti A, 2009, IMMUNOL RES, V44, P150, DOI 10.1007/s12026-009-8107-8; Antoniou M, 2003, GENOMICS, V82, P269, DOI 10.1016/S0888-7543(03)00107-1; Antoniou MN, 2013, HUM GENE THER, V24, P363, DOI 10.1089/hum.2013.062; Astrakhan A, 2012, BLOOD, V119, P4395, DOI 10.1182/blood-2011-03-340711; Brendel C, 2012, GENE THER, V19, P1018, DOI 10.1038/gt.2011.167; Campagnoli C, 2000, BLOOD, V95, P1967, DOI 10.1182/blood.V95.6.1967; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Case SS, 1999, P NATL ACAD SCI USA, V96, P2988, DOI 10.1073/pnas.96.6.2988; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cavazzana-Calvo M, 2013, BRIT J HAEMATOL, V160, P146, DOI 10.1111/bjh.12119; Cavazzana-Calvo M, 2012, CURR OPIN IMMUNOL, V24, P580, DOI 10.1016/j.coi.2012.08.008; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chan J, 2005, STEM CELLS, V23, P93, DOI 10.1634/stemcells.2004-0138; Drake AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018382; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Frecha C, 2012, BLOOD, V119, P1139, DOI 10.1182/blood-2011-04-346619; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; Gluckman E, 2009, BRIT J HAEMATOL, V147, P192, DOI 10.1111/j.1365-2141.2009.07780.x; Golfier F, 1999, BONE MARROW TRANSPL, V24, P451, DOI 10.1038/sj.bmt.1701940; Holyoake TL, 1999, EXP HEMATOL, V27, P1418, DOI 10.1016/S0301-472X(99)00078-8; Jin CH, 2003, GENE THER, V10, P272, DOI 10.1038/sj.gt.3301877; Khoury M, 2011, STEM CELLS DEV, V20, P1371, DOI 10.1089/scd.2010.0456; Liu JW, 2006, STEM CELLS, V24, P199, DOI 10.1634/stemcells.2004-0364; Luther-Wyrsch A, 2001, HUM GENE THER, V12, P377, DOI 10.1089/10430340150504000; Martin MA, 2005, STEM CELLS DEV, V14, P493, DOI 10.1089/scd.2005.14.493; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; Murdoch B, 2001, FASEB J, V15, P1628, DOI 10.1096/fj.00-0654fje; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Nava S, 2005, DIFFERENTIATION, V73, P249, DOI 10.1111/j.1432-0436.2005.00019.x; Nielsen TT, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-13; Papapetrou EP, 2005, GENE THER, V12, pS118, DOI 10.1038/sj.gt.3302626; Pfaff N, 2013, STEM CELLS, V31, P488, DOI 10.1002/stem.1316; Piacibello W, 2002, BLOOD, V100, P4391, DOI 10.1182/blood.V100.13.4391; Rebel VI, 1996, BLOOD, V87, P3500, DOI 10.1182/blood.V87.8.3500.bloodjournal8783500; Rollini P, 2004, BLOOD, V103, P1166, DOI 10.1182/blood-2003-06-1815; Scaradavou A, 2013, BLOOD, V121, P752, DOI 10.1182/blood-2012-08-449108; Stein S, 2013, HUM GENE THER CL DEV, V24, P86, DOI 10.1089/humc.2013.019; Tolar J, 2012, HUM GENE THER, V23, P141, DOI 10.1089/hum.2011.237; Urbinati F, 2009, MOL THER, V17, P1527, DOI 10.1038/mt.2009.89; van Til NP, 2012, MOL THER, V20, P1968, DOI 10.1038/mt.2012.110; Williams S, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-17; Wu MH, 2001, STEM CELLS, V19, P492, DOI 10.1634/stemcells.19-6-492; Zhang F, 2007, BLOOD, V110, P1448, DOI 10.1182/blood-2006-12-060814; Zhang F, 2010, MOL THER, V18, P1640, DOI 10.1038/mt.2010.132; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	47	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104805	10.1371/journal.pone.0104805	http://dx.doi.org/10.1371/journal.pone.0104805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25118036	Green Published, gold			2022-12-27	WOS:000341230400089
J	Doremus, T; Cousserans, F; Gyapay, G; Jouan, V; Milano, P; Wajnberg, E; Darboux, I; Consoli, FL; Volkoff, AN				Doremus, Tristan; Cousserans, Francois; Gyapay, Gabor; Jouan, Veronique; Milano, Patricia; Wajnberg, Eric; Darboux, Isabelle; Consoli, Fernando Luis; Volkoff, Anne-Nathalie			Extensive Transcription Analysis of the Hyposoter didymator Ichnovirus Genome in Permissive and Non-Permissive Lepidopteran Host Species	PLOS ONE			English	Article							CAMPOLETIS-SONORENSIS ICHNOVIRUS; CELLULAR IMMUNE-RESPONSE; COTESIA-PLUTELLAE BRACOVIRUS; POLYDNAVIRUS GENE FAMILY; REPEAT ELEMENT GENES; SPODOPTERA-FRUGIPERDA; BANCHINE POLYDNAVIRUS; PARASITOID WASP; FAT-BODY; REPLICATION	Ichnoviruses are large dsDNA viruses that belong to the Polydnaviridae family. They are specifically associated with endoparasitic wasps of the family Ichneumonidae and essential for host parasitization by these wasps. We sequenced the Hyposoter didymator Ichnovirus (HdIV) encapsidated genome for further analysis of the transcription pattern of the entire set of HdIV genes following the parasitization of four different lepidopteran host species. The HdIV genome was found to consist of at least 50 circular dsDNA molecules, carrying 135 genes, 98 of which formed 18 gene families. The HdIV genome had general features typical of Ichnovirus (IV) genomes and closely resembled that of the IV carried by Hyposoter fugitivus. Subsequent transcriptomic analysis with Illumina technology during the course of Spodoptera frugiperda parasitization led to the identification of a small subset of less than 30 genes with high RPKM values in permissive hosts, consisting with these genes encoding crucial virulence proteins. Comparisons of HdIV expression profiles between host species revealed differences in transcript levels for given HdIV genes between two permissive hosts, S. frugiperda and Pseudoplusia includens. However, we found no evident intrafamily gene-specific transcription pattern consistent with the presence of multigenic families within IV genomes reflecting an ability of the wasps concerned to exploit different host species. Interestingly, in two non-permissive hosts, Mamestra brassiccae and Anticarsia gemmatalis (most of the parasitoid eggs were eliminated by the host cellular immune response), HdIV genes were generally less strongly transcribed than in permissive hosts. This suggests that successful parasitism is dependent on the expression of given HdIV genes exceeding a particular threshold value. These results raise questions about the mecanisms involved in regulating IV gene expression according to the nature of the lepidopteran host species encountered.	[Doremus, Tristan; Cousserans, Francois; Jouan, Veronique; Darboux, Isabelle; Volkoff, Anne-Nathalie] Univ Montpellier 2, INRA, Unite Divers Genomes & Interact Insectes Microorg, Montpellier, France; [Gyapay, Gabor] Inst Genom Genoscope, France Genom Commissariat Energie Atom, Evry 2, France; [Milano, Patricia; Consoli, Fernando Luis] Univ Sao Paulo, Escola Super Agr Luiz Queiroz, Dept Entomol & Acarol, Lab Interacoes Insetos, Piracicaba, SP, Brazil; [Wajnberg, Eric] Univ Nice Sophia Antipolis, CNRS, INRA, Inst Sophia Agrobiotech, Sophia Antipolis, France	INRAE; Universite de Montpellier; Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur	Volkoff, AN (corresponding author), Univ Montpellier 2, INRA, Unite Divers Genomes & Interact Insectes Microorg, Pl Eugene Bataillon,CC101, Montpellier, France.	volkoff@supagro.inra.fr	Consoli, Fernando Luis/D-5706-2012	Consoli, Fernando Luis/0000-0002-2287-0782; Volkoff, Anne-Nathalie/0000-0002-7211-1370; Darboux, Isabelle/0000-0003-4990-8856	French National Research Agency [ANR-09-BLAN-0243-01]	French National Research Agency(French National Research Agency (ANR))	Grant from French National Research Agency (Paratoxose project, #ANR-09-BLAN-0243-01) URL www.agence-nationale-recherche.fr/ and HdIV genome sequencing provided by France Genomique URL https://www.france-genomique.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achcar F, 2009, NUCLEIC ACIDS RES, V37, pW63, DOI 10.1093/nar/gkp430; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bahena F., 1998, Boletin de Sanidad Vegetal Plagas, V24, P465; Barat-Houari M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-160; BECKAGE NE, 1994, ARCH INSECT BIOCHEM, V26, P165, DOI 10.1002/arch.940260209; Bitra K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002722; Bitra K, 2011, J GEN VIROL, V92, P2060, DOI 10.1099/vir.0.032680-0; Chen YF, 2011, VIROLOGY, V414, P42, DOI 10.1016/j.virol.2011.03.009; Choi JY, 2009, ARCH VIROL, V154, P1313, DOI 10.1007/s00705-009-0441-6; Clavijo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027522; CLEM RJ, 1993, J VIROL, V67, P3730, DOI 10.1128/JVI.67.7.3730-3738.1993; Cui LW, 1997, J VIROL, V71, P8504, DOI 10.1128/JVI.71.11.8504-8513.1997; Cui LW, 2000, J INSECT PHYSIOL, V46, P1397, DOI 10.1016/S0022-1910(00)00059-7; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Desjardins CA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-61; Desjardins CA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r183; Djoumad A, 2013, J GEN VIROL, V94, P1888, DOI 10.1099/vir.0.052506-0; Doremus T, 2013, J INSECT PHYSIOL, V59, P500, DOI 10.1016/j.jinsphys.2013.02.010; Doremus T, 2013, INSECT BIOCHEM MOLEC, V43, P292, DOI 10.1016/j.ibmb.2012.12.010; Doucet D, 1996, ENTOMOL EXP APPL, V81, P21, DOI 10.1007/BF00187834; Dupuy C, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P47, DOI 10.1016/B978-0-12-384858-1.00004-7; EDSON KM, 1981, SCIENCE, V211, P582, DOI 10.1126/science.7455695; Espagne E, 2004, GENOME SEQUENCE POLY; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; Fath-Goodin A, 2009, INSECT MOL BIOL, V18, P497, DOI 10.1111/j.1365-2583.2009.00892.x; Feng GZ, 2007, J GEN VIROL, V88, P2185, DOI 10.1099/vir.0.82919-0; Galibert L, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-48; Galibert L, 2003, J INSECT PHYSIOL, V49, P441, DOI 10.1016/S0022-1910(03)00061-1; Gueguen G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003580; Huguet E, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P63, DOI 10.1016/B978-0-12-384858-1.00005-9; Kim Yonggyun, 2007, Journal of Asia-Pacific Entomology, V10, P357, DOI 10.1016/S1226-8615(08)60376-3; Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006; Kroemer JA, 2005, J VIROL, V79, P7617, DOI 10.1128/JVI.79.12.7617-7628.2005; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Kroemer JA, 2006, J VIROL, V80, P12219, DOI 10.1128/JVI.01187-06; Krombein KV, 1979, CATALOG HYMENOPTERA, V2, P1253; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lapointe R, 2007, J VIROL, V81, P6491, DOI 10.1128/JVI.02702-06; LI XS, 1994, J VIROL, V68, P7482, DOI 10.1128/JVI.68.11.7482-7489.1994; Marziano NK, 2011, J VIROL, V85, P10222, DOI 10.1128/JVI.00691-11; McCullagh P, 1989, GEN LINEAR MODELS; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Provost B, 2004, J VIROL, V78, P13090, DOI 10.1128/JVI.78.23.13090-13103.2004; Rasoolizadeh Asieh, 2009, Virologica Sinica, V24, P478, DOI 10.1007/s12250-009-3050-3; Rasoolizadeh A, 2009, J GEN VIROL, V90, P1505, DOI 10.1099/vir.0.008664-0; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schafellner C, 2007, J INSECT PHYSIOL, V53, P858, DOI 10.1016/j.jinsphys.2007.05.010; Schneider M, 2004, 22 INT C ENT 2004 BR; STOLTZ DB, 1979, CAN J MICROBIOL, V25, P207, DOI 10.1139/m79-032; Tanaka K, 2007, VIROLOGY, V363, P26, DOI 10.1016/j.virol.2006.11.034; Theilmann DA, 1988, IDENTIFICATION COMPA; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; VINSON SB, 1986, ANN ENTOMOL SOC AM, V79, P216, DOI 10.1093/aesa/79.1.216; Volkoff AN, 1999, VIROLOGY, V263, P349, DOI 10.1006/viro.1999.9929; Volkoff AN, 2002, VIROLOGY, V300, P316, DOI 10.1006/viro.2002.1535; Volkoff AN, 2001, J GEN VIROL, V82, P963, DOI 10.1099/0022-1317-82-4-963; VOLKOFF AN, 1995, BIOL CELL, V83, P1, DOI 10.1016/0248-4900(96)89926-6; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010	58	20	22	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104072	10.1371/journal.pone.0104072	http://dx.doi.org/10.1371/journal.pone.0104072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117496	Green Published, gold			2022-12-27	WOS:000341230400029
J	Gabas-Rivera, C; Barranquero, C; Martinez-Beamonte, R; Navarro, MA; Surra, JC; Osada, J				Gabas-Rivera, Clara; Barranquero, Cristina; Martinez-Beamonte, Roberto; Navarro, Maria A.; Surra, Joaquin C.; Osada, Jesus			Dietary Squalene Increases High Density Lipoprotein-Cholesterol and Paraoxonase 1 and Decreases Oxidative Stress in Mice	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; VIRGIN OLIVE OIL; HUMAN SERUM PARAOXONASE; APOLIPOPROTEIN-A-I; ATHEROSCLEROTIC LESIONS; CARDIOVASCULAR-DISEASE; POMEGRANATE JUICE; KNOCKOUT MICE; RAPESEED OIL; PALM OIL	Background and Purpose: Squalene, the main hydrocarbon in the unsaponifiable fraction of virgin olive oil, is involved in cholesterol synthesis and it has been reported to own antiatherosclerotic and antiesteatosic effects. However, the squalene's role on lipid plasma parameters and the influence of genotype on this effect need to be addressed. Experimental Approaches: Three male mouse models (wild-type, Apoa1- and Apoe- deficient) were fed chow semisynthetic diets enriched in squalene to provide a dose of 1 g/kg during 11 weeks. After this period, their plasma parameters and lipoprotein profiles were analyzed. Key Results: Squalene administration at a dose of 1 g/kg showed decreased reactive oxygen species in lipoprotein fractions independently of the animal background and caused an specific increase in high density lipoprotein (HDL)-cholesterol levels, accompanied by an increase in phosphatidylcholine and paraoxonase 1 and no changes in apolipoproteins A1 and A4 in wild-type mice. In these mice, the cholesterol increase was due to its esterified form and associated with an increased hepatic expression of Lcat. These effects were not observed in absence of apolipoprotein A1. The increases in HDL-paraoxonase 1 were translated into decreased plasma malondialdehyde levels depending on the presence of Apolipoprotein A1. Conclusions and Implications: Dietary squalene promotes changes in HDL-cholesterol and paraoxonase 1 and decreases reactive oxygen species in lipoproteins and plasma malondialdehyde levels, providing new benefits of its intake that might contribute to explain the properties of virgin olive oil, although the phenotype related to apolipoproteins A1 and E may be particularly relevant.	[Gabas-Rivera, Clara; Barranquero, Cristina; Martinez-Beamonte, Roberto; Navarro, Maria A.; Osada, Jesus] Univ Zaragoza, Fac Vet, Inst Invest Sanitaria Aragon IIS, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain; [Surra, Joaquin C.] Escuela Politecn Super Huesca, Dept Anim Prod, Huesca, Spain; [Gabas-Rivera, Clara; Barranquero, Cristina; Martinez-Beamonte, Roberto; Navarro, Maria A.; Surra, Joaquin C.; Osada, Jesus] Inst Salud Carlos III, CIBER Fis Obesidad Nutr, Madrid, Spain	University of Zaragoza; Instituto de Salud Carlos III	Osada, J (corresponding author), Univ Zaragoza, Fac Vet, Inst Invest Sanitaria Aragon IIS, Dept Bioquim & Biol Mol & Celular, Zaragoza, Spain.	josada@unizar.es	Navarro, Ángeles/AAG-6089-2019; Surra, Joaquín Carlos/G-1128-2014; Martinez Beamonte, Roberto/E-4981-2016	Surra, Joaquín Carlos/0000-0002-5841-0462; Martinez Beamonte, Roberto/0000-0002-8100-5596	Ministerio de Ciencia e Inovacion-Fondo Europeo de Desarrollo Regional [SAF 2010-14958]; CIBER Fisiopatologia de la Obesidad y Nutricion as an initiative of ISCII-Fondo Social Europeo; Gobierno de Aragon [PI025/08]; Gobierno de Aragon-Fondo Social Europeo [B-69]	Ministerio de Ciencia e Inovacion-Fondo Europeo de Desarrollo Regional; CIBER Fisiopatologia de la Obesidad y Nutricion as an initiative of ISCII-Fondo Social Europeo; Gobierno de Aragon(Gobierno de Aragon); Gobierno de Aragon-Fondo Social Europeo(Gobierno de Aragon)	Funding provided by the Ministerio de Ciencia e Inovacion- Fondo Europeo de Desarrollo Regional SAF 2010-14958 (www.micinn.es/.../Anexo_ayudas_concedidas_proyectos_2010.xls); CIBER Fisiopatologia de la Obesidad y Nutricion as an initiative of ISCII-Fondo Social Europeo; Gobierno de Aragon (PI025/08) and Gobierno de Aragon-Fondo Social Europeo (B-69). C.G. and M.A.N were recipients of a Gobierno de Aragon fellowship and a Miguel Servet contract, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acin S, 2005, ATHEROSCLEROSIS, V182, P17, DOI 10.1016/j.atherosclerosis.2005.01.050; Allouche Y, 2007, J AGR FOOD CHEM, V55, P9646, DOI 10.1021/jf070628u; Arbones-Mainar JM, 2006, J NUTR, V136, P353, DOI 10.1093/jn/136.2.353; Arbones-Mainar JM, 2007, ATHEROSCLEROSIS, V194, P372, DOI 10.1016/j.atherosclerosis.2006.11.010; Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2; Asztalos BF, 2010, J CLIN LIPIDOL, V4, P405, DOI 10.1016/j.jacl.2010.08.012; Aviram M, 1999, FREE RADICAL BIO MED, V26, P892, DOI 10.1016/S0891-5849(98)00272-X; Banfi C, 2009, PROTEOMICS, V9, P1344, DOI 10.1002/pmic.200800566; Calleja L, 1999, ARTERIOSCL THROM VAS, V19, P2368, DOI 10.1161/01.ATV.19.10.2368; Escola-Gil JC, 2009, ATHEROSCLEROSIS, V206, P321, DOI 10.1016/j.atherosclerosis.2008.12.044; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; Chan P, 1996, J CLIN PHARMACOL, V36, P422, DOI 10.1002/j.1552-4604.1996.tb05029.x; Cho S, 2009, CLIN EXP DERMATOL, V34, P500, DOI 10.1111/j.1365-2230.2008.03133.x; CONTI M, 1991, CLIN CHEM, V37, P1273; Costa LG, 2003, ANNU REV MED, V54, P371, DOI 10.1146/annurev.med.54.101601.152421; Demetrius L, 2005, EMBO REP, V6, pS39, DOI 10.1038/sj.embor.7400422; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; DUVERGER N, 1994, BBA-LIPID LIPID MET, V1211, P23, DOI 10.1016/0005-2760(94)90134-1; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Gajkowska B, 1999, EXP TOXICOL PATHOL, V51, P75, DOI 10.1016/S0940-2993(99)80072-4; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Guillen N, 2008, ATHEROSCLEROSIS, V197, P72, DOI 10.1016/j.atherosclerosis.2007.08.008; GYLLING H, 1994, ATHEROSCLEROSIS, V106, P169, DOI 10.1016/0021-9150(94)90122-8; HASSETT C, 1991, BIOCHEMISTRY-US, V30, P10141, DOI 10.1021/bi00106a010; KADOWAKI H, 1993, J LIPID RES, V34, P180; KEYS A, 1986, AM J EPIDEMIOL, V124, P903, DOI 10.1093/oxfordjournals.aje.a114480; KOHNO Y, 1995, BBA-LIPID LIPID MET, V1256, P52, DOI 10.1016/0005-2760(95)00005-W; KOIVISTO PVI, 1988, LIPIDS, V23, P993, DOI 10.1007/BF02536349; Kok FJ, 2004, EUR J NUTR, V43, P2, DOI 10.1007/s00394-004-1102-x; Kontush A, 2010, CURR OPIN LIPIDOL, V21, P312, DOI 10.1097/MOL.0b013e32833bcdc1; LI H, 1993, ARTERIOSCLER THROMB, V13, P1814, DOI 10.1161/01.ATV.13.12.1814; LIU GCK, 1976, J LIPID RES, V17, P38; Liu YX, 2009, INDIAN J MED RES, V129, P150; Lou-Bonafonte JM, 2012, MOL NUTR FOOD RES, V56, P1043, DOI 10.1002/mnfr.201100668; MACKNESS MI, 1991, FEBS LETT, V286, P152, DOI 10.1016/0014-5793(91)80962-3; Martinez-Beamonte R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055231; Martinez-Beamonte R, 2011, J BIOTECHNOL, V151, P325, DOI 10.1016/j.jbiotec.2010.12.017; MIETTINEN TA, 1994, ATHEROSCLEROSIS, V105, P217, DOI 10.1016/0021-9150(94)90052-3; MIETTINEN TA, 1994, AM J CLIN NUTR, V59, P356, DOI 10.1093/ajcn/59.2.356; Moreno JJ, 2003, FREE RADICAL BIO MED, V35, P1073, DOI 10.1016/S0891-5849(03)00465-9; Navab M, 2001, J LIPID RES, V42, P1308; Navarro MA, 2005, CYTOKINE, V31, P52, DOI 10.1016/j.cyto.2005.03.002; Newmark HL, 2000, AM J CLIN NUTR, V72, P502; Newmark HL, 1997, CANCER EPIDEM BIOMAR, V6, P1101; NISHINA PM, 1993, LIPIDS, V28, P599, DOI 10.1007/BF02536053; Nuno-Ayala M, 2010, ATHEROSCLEROSIS, V212, P268, DOI 10.1016/j.atherosclerosis.2010.04.028; O'Neil M. J., 2001, MERCK INDEX; Osada J, 2000, CURR OPIN LIPIDOL, V11, P25, DOI 10.1097/00041433-200002000-00004; Overturf ML, 1992, CURR OPIN LIPIDOL, V3, P179, DOI DOI 10.1097/00041433-199206000-00004; Owen R W, 2000, Lancet Oncol, V1, P107, DOI 10.1016/S1470-2045(00)00015-2; Parsaeyan N, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-11; Pedersen A, 2000, J LIPID RES, V41, P1901; Perona JS, 2006, J NUTR BIOCHEM, V17, P429, DOI 10.1016/j.jnutbio.2005.11.007; Precourt LP, 2011, ATHEROSCLEROSIS, V214, P20, DOI 10.1016/j.atherosclerosis.2010.08.076; Rajaratnam RA, 1999, ATHEROSCLEROSIS, V146, P61, DOI 10.1016/S0021-9150(99)00129-X; Ramirez-Torres A, 2012, J PROTEOMICS, V77, P27, DOI 10.1016/j.jprot.2012.07.001; Reddy LH, 2009, ADV DRUG DELIVER REV, V61, P1412, DOI 10.1016/j.addr.2009.09.005; Rock W, 2008, J AGR FOOD CHEM, V56, P8704, DOI 10.1021/jf801756x; SAINTLEGER D, 1986, BRIT J DERMATOL, V114, P535, DOI 10.1111/j.1365-2133.1986.tb04060.x; Scolastici C, 2004, NUTR CANCER, V50, P101, DOI 10.1207/s15327914nc5001_13; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; Sotiroudis TG, 2008, EUR J NUTR, V47, P69, DOI 10.1007/s00394-008-2008-9; STEWART ME, 1992, SEMIN DERMATOL, V11, P100; STRANDBERG TE, 1990, J LIPID RES, V31, P1637; Surra JC, 2013, BRIT J NUTR, V109, P202, DOI 10.1017/S000711451200092X; TILVIS RS, 1983, LIPIDS, V18, P233, DOI 10.1007/BF02534554; Tsujimoto M, 1916, J IND ENG CHEM, V8, P889, DOI 10.1021/i500010a005; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Zhang ZS, 2002, INT J FOOD SCI NUTR, V53, P411, DOI 10.1080/0963748021000044750	69	33	36	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104224	10.1371/journal.pone.0104224	http://dx.doi.org/10.1371/journal.pone.0104224			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117703	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400039
J	Qi, ZM; Huang, L; Zhu, RS; Xin, DW; Liu, CY; Han, X; Jiang, HW; Hong, WG; Hu, GH; Zheng, HK; Chen, QS				Qi, Zhaoming; Huang, Long; Zhu, Rongsheng; Xin, Dawei; Liu, Chunyan; Han, Xue; Jiang, Hongwei; Hong, Weiguo; Hu, Guohua; Zheng, Hongkun; Chen, Qingshan			A High-Density Genetic Map for Soybean Based on Specific Length Amplified Fragment Sequencing	PLOS ONE			English	Article							LINKAGE MAP	Soybean is an important oil seed crop, but very few high-density genetic maps have been published for this species. Specific length amplified fragment sequencing (SLAF-seq) is a recently developed high-resolution strategy for large scale de novo discovery and genotyping of single nucleotide polymorphisms. SLAF-seq was employed in this study to obtain sufficient markers to construct a high-density genetic map for soybean. In total, 33.10 Gb of data containing 171,001,333 paired-end reads were obtained after preprocessing. The average sequencing depth was 42.29 in the Dongnong594, 56.63 in the Charleston, and 3.92 in each progeny. In total, 164,197 high-quality SLAFs were detected, of which 12,577 SLAFs were polymorphic, and 5,308 of the polymorphic markers met the requirements for use in constructing a genetic map. The final map included 5,308 markers on 20 linkage groups and was 2,655.68 cM in length, with an average distance of 0.5 cM between adjacent markers. To our knowledge, this map has the shortest average distance of adjacent markers for soybean. We report here a high-density genetic map for soybean. The map was constructed using a recombinant inbred line population and the SLAF-seq approach, which allowed the efficient development of a large number of polymorphic markers in a short time. Results of this study will not only provide a platform for gene/quantitative trait loci fine mapping, but will also serve as a reference for molecular breeding of soybean.	[Qi, Zhaoming; Zhu, Rongsheng; Xin, Dawei; Chen, Qingshan] Northeast Agr Univ, Coll Agr, Harbin, Heilongjiang, Peoples R China; [Liu, Chunyan; Han, Xue; Jiang, Hongwei; Hu, Guohua] Crop Res & Breeding Ctr Land Reclamat Heilongjian, Harbin, Heilongjiang, Peoples R China; [Huang, Long; Hong, Weiguo; Zheng, Hongkun] Biomarker Technol Corp, Beijing, Peoples R China	Northeast Agricultural University - China	Zheng, HK (corresponding author), Biomarker Technol Corp, Beijing, Peoples R China.	zhenghk@biomarker.com.cn; qshchen@126.com	Hong, Weiguo/ABD-4294-2020		Research Fund for the Doctoral Program of Higher Education of China [20122325120015]; China Postdoctoral Science Foundation [2012M520030]; Natural Science Foundation of Heilongjiang Province of China [ZD201213]; New Century Excellent Talent Training Plan of Heilongjiang Province Ordinary Institutions of Higher Learning [1252-NCET-004]; 863 Program [2013AA102602]; National Natural Science Foundation of China [31271747]	Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); New Century Excellent Talent Training Plan of Heilongjiang Province Ordinary Institutions of Higher Learning; 863 Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is supported by Research Fund for the Doctoral Program of Higher Education of China (20122325120015), China Postdoctoral Science Foundation (2012M520030), Natural Science Foundation of Heilongjiang Province of China (ZD201213), the 'New Century Excellent Talent Training Plan of Heilongjiang Province Ordinary Institutions of Higher Learning' (1252-NCET-004), 863 Program (2013AA102602), The National Natural Science Foundation of China (Grant No. 31271747). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3585; Chen SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065122; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Cregan PB, 1999, CROP SCI, V39, P1464, DOI 10.2135/cropsci1999.3951464x; Doyle J. J., 1987, PHYTOCHEM B, P11; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hyten DL, 2010, CROP SCI, V50, P960, DOI 10.2135/cropsci2009.06.0360; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; KEIM P, 1990, GENETICS, V126, P735; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; LARK KG, 1993, THEOR APPL GENET, V86, P901, DOI 10.1007/BF00211039; Liu DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098855; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shoemaker Randy C., 1993, P131; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; van Os H, 2005, THEOR APPL GENET, V112, P187, DOI 10.1007/s00122-005-0124-y; West MAL, 2006, GENOME RES, V16, P787, DOI 10.1101/gr.5011206; Wilson Richard F., 2008, V2, P3; Wu YH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000212; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141	29	124	136	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104871	10.1371/journal.pone.0104871	http://dx.doi.org/10.1371/journal.pone.0104871			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25118194	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400099
J	Schwappach, DLB; Gehring, K				Schwappach, David L. B.; Gehring, Katrin			Silence That Can Be Dangerous: A Vignette Study to Assess Healthcare Professionals' Likelihood of Speaking up about Safety Concerns	PLOS ONE			English	Article							PATIENT SAFETY; VIOLATIONS	Purpose: To investigate the likelihood of speaking up about patient safety in oncology and to clarify the effect of clinical and situational context factors on the likelihood of voicing concerns. Patients and Methods: 1013 nurses and doctors in oncology rated four clinical vignettes describing coworkers' errors and rule violations in a self-administered factorial survey (65% response rate). Multiple regression analysis was used to model the likelihood of speaking up as outcome of vignette attributes, responder's evaluations of the situation and personal characteristics. Results: Respondents reported a high likelihood of speaking up about patient safety but the variation between and within types of errors and rule violations was substantial. Staff without managerial function provided significantly higher levels of decision difficulty and discomfort to speak up. Based on the information presented in the vignettes, 74%-96% would speak up towards a supervisor failing to check a prescription, 45%-81% would point a coworker to a missed hand disinfection, 82%-94% would speak up towards nurses who violate a safety rule in medication preparation, and 59%-92% would question a doctor violating a safety rule in lumbar puncture. Several vignette attributes predicted the likelihood of speaking up. Perceived potential harm, anticipated discomfort, and decision difficulty were significant predictors of the likelihood of speaking up. Conclusions: Clinicians' willingness to speak up about patient safety is considerably affected by contextual factors. Physicians and nurses without managerial function report substantial discomfort with speaking up. Oncology departments should provide staff with clear guidance and trainings on when and how to voice safety concerns.	[Schwappach, David L. B.; Gehring, Katrin] Swiss Patient Safety Fdn, Zurich, Switzerland; [Schwappach, David L. B.] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Bern	Schwappach, DLB (corresponding author), Swiss Patient Safety Fdn, Zurich, Switzerland.	schwappach@patientensicherheit.ch	Schwappach, David L.B./L-8378-2018	Schwappach, David L.B./0000-0001-8668-3065	Krebsforschung Schweiz [Cancer Research Switzerland] [KFS-2974-08-2012]	Krebsforschung Schweiz [Cancer Research Switzerland]	This work was supported by a research grant from Krebsforschung Schweiz [Cancer Research Switzerland, KFS-2974-08-2012], www.krebsforschung.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalberti R, 2006, QUAL SAF HEALTH CARE, V15, pI66, DOI 10.1136/qshc.2005.015982; Banja J, 2010, BUS HORIZONS, V53, P139, DOI 10.1016/j.bushor.2009.10.006; Catchpole K, 2013, BMJ QUAL SAF, V22, P705, DOI 10.1136/bmjqs-2012-001604; Detert JR, 2006, 06024 HARV BUS SCH D; Edmondson AC, 2003, J MANAGE STUD, V40, P1419, DOI 10.1111/1467-6486.00386; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Henriksen K, 2006, HEALTH SERV RES, V41, P1539, DOI 10.1111/j.1475-6773.2006.00564.x; KIRWAN JR, 1983, ANN RHEUM DIS, V42, P644, DOI 10.1136/ard.42.6.644; Kobayashi H, 2006, QUAL SAF HEALTH CARE, V15, P277, DOI 10.1136/qshc.2005.017368; LANGLEY GR, 1991, J CLIN EPIDEMIOL, V44, P391, DOI 10.1016/0895-4356(91)90077-M; Leonard M, 2004, QUAL SAF HEALTH CARE, V13, pI85, DOI 10.1136/qshc.2004.010033; Lyndon A, 2011, BMJ QUALITY SAFETY; Lyndon A, 2008, JOGNN-J OBST GYN NEO, V37, P13, DOI [10.1111/j.1552-6909.2007.00204.x, 10.1111/J.1552-6909.2007.00204.x]; Maxfield DG, 2013, AM J OBSTET GYNECOL, V209, P402, DOI 10.1016/j.ajog.2013.07.013; Morrison EW, 2011, ACAD MANAG ANN, V5, P373, DOI 10.1080/19416520.2011.574506; Okuyama A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-61; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Schwappach DLB, 2014, BMJ OPEN IN PRESS; Singer SJ, 2008, MED CARE, V46, P1149, DOI 10.1097/MLR.0b013e31817925c1; Veloski J, 2005, AM J MED QUAL, V20, P151, DOI 10.1177/1062860605274520; Wallander L, 2009, SOC SCI RES, V38, P505, DOI 10.1016/j.ssresearch.2009.03.004; Wilson TD, 2005, CURR DIR PSYCHOL SCI, V14, P131, DOI 10.1111/j.0963-7214.2005.00355.x	22	41	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104720	10.1371/journal.pone.0104720	http://dx.doi.org/10.1371/journal.pone.0104720			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LJ	25116338	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400076
J	Shen, Y; Yang, JB; Li, J; Shi, XJ; Ouyang, L; Tian, YY; Lu, JX				Shen, Yao; Yang, Jianbo; Li, Juan; Shi, Xiaojie; Ouyang, Li; Tian, Yueyang; Lu, Jianxin			Carnosine Inhibits the Proliferation of Human Gastric Cancer SGC-7901 Cells through Both of the Mitochondrial Respiration and Glycolysis Pathways	PLOS ONE			English	Article							BIOLOGICAL ROLE; COPY NUMBER; DNA; METABOLISM; DIPEPTIDES; GROWTH	Carnosine, a naturally occurring dipeptide, has been recently demonstrated to possess anti-tumor activity. However, its underlying mechanism is unclear. In this study, we investigated the effect and mechanism of carnosine on the cell viability and proliferation of the cultured human gastric cancer SGC-7901 cells. Carnosine treatment did not induce cell apoptosis or necrosis, but reduced the proliferative capacity of SGC-7901 cells. Seahorse analysis showed SGC-7901 cells cultured with pyruvate have active mitochondria, and depend on mitochondrial oxidative phosphorylation more than glycolysis pathway for generation of ATP. Carnosine markedly decreased the absolute value of mitochondrial ATP-linked respiration, and reduced the maximal oxygen consumption and spare respiratory capacity, which may reduce mitochondrial function correlated with proliferative potential. Simultaneously, carnosine also reduced the extracellular acidification rate and glycolysis of SGC-7901 cells. Our results suggested that carnosine is a potential regulator of energy metabolism of SGC-7901 cells both in the anaerobic and aerobic pathways, and provided a clue for preclinical and clinical evaluation of carnosine for gastric cancer therapy.	[Shen, Yao] Wenzhou Med Univ, Coll Lab Med & Life Sci, Attardi Inst Mitochondrial Biomed, Key Lab Lab Med,Minist Educ, Wenzhou, Peoples R China; Wenzhou Med Univ, Coll Lab Med & Life Sci, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Shen, Y (corresponding author), Wenzhou Med Univ, Coll Lab Med & Life Sci, Attardi Inst Mitochondrial Biomed, Key Lab Lab Med,Minist Educ, Wenzhou, Peoples R China.	yueshen-2002@163.com; jxlu313@163.com	yang, jian/HIK-0188-2022		National Natural Science Foundation of China [81102427]; Zhejiang Provincial Scientific Research Foundations [Y2110322]; Program for Zhejiang Leading Team of ST Innovation [2010R50048]; Wenzhou City Science and Technology Project [2010S0094]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Scientific Research Foundations; Program for Zhejiang Leading Team of ST Innovation; Wenzhou City Science and Technology Project	This project was supported by the National Natural Science Foundation of China (81102427), and partly supported by Zhejiang Provincial Scientific Research Foundations (Y2110322), the Program for Zhejiang Leading Team of S&T Innovation (2010R50048) and Wenzhou City Science and Technology Project (2010S0094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Boldyrev AA, 2012, BIOCHEMISTRY-MOSCOW+, V77, P313, DOI 10.1134/S0006297912040013; Boldyrev AA, 2000, BIOCHEMISTRY-MOSCOW+, V65, P751; Bonfanti L, 1999, PROG NEUROBIOL, V59, P333, DOI 10.1016/S0301-0082(99)00010-6; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; Budzen S, 2013, ADV CLIN EXP MED, V22, P739; Chen WQ, 2012, CHINESE J CANCER RES, V24, P171, DOI 10.1007/s11670-012-0171-2; De Marchis S, 2000, BIOCHEMISTRY-MOSCOW+, V65, P824; de Moura MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040690; Dickinson A, 2013, CELL DEATH DIFFER, V20, P1644, DOI 10.1038/cdd.2013.115; Diers AR, 2012, BIOCHEM J, V444, P561, DOI 10.1042/BJ20120294; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herst PM, 2007, BBA-BIOENERGETICS, V1767, P170, DOI 10.1016/j.bbabio.2006.11.018; Hipkiss AR, 2009, ADV FOOD NUTR RES, V57, P87, DOI 10.1016/S1043-4526(09)57003-9; Holliday R, 1996, BRIT J CANCER, V73, P966, DOI 10.1038/bjc.1996.189; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Mahmood A, 2007, GUT, V56, P168, DOI 10.1136/gut.2006.099929; Mambo E, 2005, INT J CANCER, V116, P920, DOI 10.1002/ijc.21110; Mizumachi T, 2008, PROSTATE, V68, P408, DOI 10.1002/pros.20697; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Renner C, 2008, INT J PEPT RES THER, V14, P127, DOI 10.1007/s10989-007-9121-0; Renner C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-2; Renner C, 2010, NEUROL RES, V32, P101, DOI 10.1179/016164109X12518779082237; Shen Y, 2007, BIOCHEM PHARMACOL, V73, P709, DOI 10.1016/j.bcp.2006.11.007; SPITZ DR, 1990, BIOCHEM J, V267, P453, DOI 10.1042/bj2670453; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wen SL, 2013, ONCOL LETT, V6, P1098, DOI 10.3892/ol.2013.1492; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yin XF, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-46; Zhang J, 2012, NAT PROTOC, V7, P1068, DOI 10.1038/nprot.2012.048	31	45	47	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104632	10.1371/journal.pone.0104632	http://dx.doi.org/10.1371/journal.pone.0104632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115854	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400063
J	Wellbrock, J; Sheikhzadeh, S; Oliveira-Ferrer, L; Stamm, H; Hillebrand, M; Keyser, B; Klokow, M; Vohwinkel, G; Bonk, V; Otto, B; Streichert, T; Balabanov, S; Hagel, C; Rybczynski, M; Bentzien, F; Bokemeyer, C; von Kodolitsch, Y; Fiedler, W				Wellbrock, Jasmin; Sheikhzadeh, Sara; Oliveira-Ferrer, Leticia; Stamm, Hauke; Hillebrand, Mathias; Keyser, Britta; Klokow, Marianne; Vohwinkel, Gabi; Bonk, Veronika; Otto, Benjamin; Streichert, Thomas; Balabanov, Stefan; Hagel, Christian; Rybczynski, Meike; Bentzien, Frank; Bokemeyer, Carsten; von Kodolitsch, Yskert; Fiedler, Walter			Overexpression of Gremlin-1 in Patients with Loeys-Dietz Syndrome: Implications on Pathophysiology and Early Disease Detection	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MUTATIONS; IDENTIFICATION; GROWTH; PROTEINS; FIBROSIS; TGFBR1; GENE; PROLIFERATION; PATHOGENESIS	Backgrounds: The Loeys-Dietz syndrome (LDS) is an inherited connective tissue disorder caused by mutations in the transforming growth factor beta (TGF-beta) receptors TGFBR1 or TGFBR2. Most patients with LDS develop severe aortic aneurysms resulting in early need of surgical intervention. In order to gain further insight into the pathophysiology of the disorder, we investigated circulating outgrowth endothelial cells (OEC) from the peripheral blood of LDS patients from a cohort of 23 patients including 6 patients with novel TGF-beta receptor mutations. Methods and Results: We performed gene expression profiling of OECs using microarray analysis followed by quantitative PCR for verification of gene expression. Compared to OECs of age- and sex-matched healthy controls, OECs isolated from three LDS patients displayed altered expression of several genes belonging to the TGF-beta pathway, especially those affecting bone morphogenic protein (BMP) signalling including BMP2, BMP4 and BMPR1A. Gene expression of BMP antagonist Gremlin-1 (GREM1) showed the most prominent up-regulation. This increase was confirmed at the protein level by immunoblotting of LDS-OECs. In immunohistochemistry, abundant Gremlin-1 protein expression could be verified in endothelial cells as well as smooth muscle cells within the arterial media. Furthermore, Gremlin-1 plasma levels of LDS patients were significantly elevated compared to healthy control subjects. Conclusions: These findings open new avenues in the understanding of the pathogenesis of Loeys-Dietz syndrome and the development of new diagnostic serological methods for early disease detection.	[Wellbrock, Jasmin; Oliveira-Ferrer, Leticia; Stamm, Hauke; Klokow, Marianne; Vohwinkel, Gabi; Bonk, Veronika; Balabanov, Stefan; Bokemeyer, Carsten; Fiedler, Walter] Univ Med Ctr Hamburg Eppendorf, Hubertus Wald Univ Canc Ctr, Dept Oncol Hematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany; [Sheikhzadeh, Sara; Hillebrand, Mathias; Rybczynski, Meike; von Kodolitsch, Yskert] Univ Med Ctr Hamburg Eppendorf, Ctr Cardiol & Cardiovasc Surg, Hamburg, Germany; [Keyser, Britta] Hannover Med Sch, Inst Human Genet, Hannover, Germany; [Otto, Benjamin; Streichert, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, Cent Labs, Hamburg, Germany; [Balabanov, Stefan] Univ Zurich Hosp, Div Hematol, CH-8091 Zurich, Switzerland; [Hagel, Christian] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Bentzien, Frank] Univ Med Ctr Hamburg Eppendorf, Dept Transfus Med, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich; University Zurich Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Wellbrock, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Hubertus Wald Univ Canc Ctr, Dept Oncol Hematol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany.	j.wellbrock@uke.de	Balabanov, Stefan/E-9765-2014	Fiedler, Walter/0000-0003-0275-8803	Deutsche Forschungsgemeinschaft [FI 389/6-1]; Medical Faculty of the University of Hamburg [FFM program]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty of the University of Hamburg [FFM program]	This work was in part supported by the Deutsche Forschungsgemeinschaft [FI 389/6-1] and the Medical Faculty of the University of Hamburg [FFM program]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biaggi P, 2009, J AM SOC ECHOCARDIOG, V22, P720, DOI 10.1016/j.echo.2009.03.012; Cahill E, 2012, CIRCULATION, V125, P920, DOI 10.1161/CIRCULATIONAHA.111.038125; Denton CP, 2003, J BIOL CHEM, V278, P25109, DOI 10.1074/jbc.M300636200; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Fernandez-L A, 2005, CARDIOVASC RES, V68, P235, DOI 10.1016/j.cardiores.2005.06.009; Graham JR, 2014, J CELL BIOCH; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Lindsay ME, 2012, NAT GENET, V44, P922, DOI 10.1038/ng.2349; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Ma B, 2014, BIOCHEM BIOPH RES CO, V447, P689, DOI 10.1016/j.bbrc.2014.04.068; Maciel TT, 2008, J MOL CELL CARDIOL, V44, P370, DOI 10.1016/j.yjmcc.2007.10.021; Maleszewski JJ, 2009, AM J SURG PATHOL, V33, P194, DOI 10.1097/PAS.0b013e31817f3661; Mandegar M, 2004, MICROVASC RES, V68, P75, DOI 10.1016/j.mvr.2004.06.001; Matyas G, 2006, HUM MUTAT, V27, P760, DOI 10.1002/humu.20353; McMahon R, 2000, J BIOL CHEM, V275, P9901, DOI 10.1074/jbc.275.14.9901; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; O'Reilly S, 2014, J BIOL CHEM, V289, P9952, DOI 10.1074/jbc.M113.545822; Otten J, 2010, J ONCOL, V2010, DOI 10.1155/2010/317068; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pugsley MK, 2000, J PHARMACOL TOX MET, V44, P333, DOI 10.1016/S1056-8719(00)00125-8; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Smadja DM, 2008, ARTERIOSCL THROM VAS, V28, P2137, DOI 10.1161/ATVBAHA.108.168815; Stabile H, 2007, BLOOD, V109, P1834, DOI 10.1182/blood-2006-06-032276; Stheneur C, 2008, HUM MUTAT, V29, pE284, DOI 10.1002/humu.20871; Topol LZ, 1997, MOL CELL BIOL, V17, P4801, DOI 10.1128/MCB.17.8.4801; van de Laar IMBH, 2011, NAT GENET, V43, P121, DOI 10.1038/ng.744; Van Laer L, 2014, ADV EXP MED BIOL, V802, P95, DOI 10.1007/978-94-007-7893-1_7; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; Zhang QX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011709; Zode GS, 2009, GLIA, V57, P755, DOI 10.1002/glia.20803	35	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104742	10.1371/journal.pone.0104742	http://dx.doi.org/10.1371/journal.pone.0104742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116393	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400077
J	Kascakova, S; Hofland, LJ; De Bruijn, HS; Ye, YP; Achilefu, S; van der Wansem, K; van der Ploeg-van den Heuvel, A; van Koetsveld, PM; Brugts, MP; van der Lelij, AJ; Sterenborg, HJCM; ten Hagen, TLM; Robinson, DJ; van Hagen, MP				Kascakova, Slavka; Hofland, Leo J.; De Bruijn, Henriette S.; Ye, Yunpeng; Achilefu, Samuel; van der Wansem, Katy; van der Ploeg-van den Heuvel, Angelique; van Koetsveld, Peter M.; Brugts, Michael P.; van der Lelij, Aart-Jan; Sterenborg, Henricus J. C. M.; ten Hagen, Timo L. M.; Robinson, Dominic J.; van Hagen, Martin P.			Somatostatin Analogues for Receptor Targeted Photodynamic Therapy	PLOS ONE			English	Article							TUMOR-CELLS; SINGLET OXYGEN; CHLORIN E(6); CANCER; PHOTOSENSITIZERS; GROWTH; PHOTOIMMUNOTHERAPY; PHOTODESTRUCTION; DERIVATIVES; SENSITIZERS	Photodynamic therapy (PDT) is an established treatment modality, used mainly for anticancer therapy that relies on the interaction of photosensitizer, light and oxygen. For the treatment of pathologies in certain anatomical sites, improved targeting of the photosensitizer is necessary to prevent damage to healthy tissue. We report on a novel dual approach of targeted PDT (vascular and cellular targeting) utilizing the expression of neuropeptide somatostatin receptor (sst(2)) on tumor and neovascular-endothelial cells. We synthesized two conjugates containing the somatostatin analogue [Tyr3]-octreotate and Chlorin e6 (Ce6): Ce6-K-3-[Tyr3]-octreotate (1) and Ce6-[Tyr3]-octreotate-K-3-[Tyr3]-octreotate (2). Investigation of the uptake and photodynamic activity of conjugates in-vitro in human erythroleukemic K562 cells showed that conjugation of [Tyr3]-octreotate with Ce6 in conjugate 1 enhances uptake (by a factor 2) in cells over-expressing sst(2) compared to wildtype cells. Co-treatment with excess free Octreotide abrogated the phototoxicity of conjugate 1 indicative of a specific sst(2)-mediated effect. In contrast conjugate 2 showed no receptor-mediated effect due to its high hydrophobicity. When compared with un-conjugated Ce6, the PDT activity of conjugate 1 was lower. However, it showed higher photostability which may compensate for its lower phototoxicity. Intra-vital fluorescence pharmacokinetic studies of conjugate 1 in rat skin-fold observation chambers transplanted with sst(2)(+) AR42J acinar pancreas tumors showed significantly different uptake profiles compared to free Ce6. Co-treatment with free Octreotide significantly reduced conjugate uptake in tumor tissue (by a factor 4) as well as in the chamber neo-vasculature. These results show that conjugate 1 might have potential as an in-vivo sst(2) targeting photosensitizer conjugate.	[Kascakova, Slavka; van der Ploeg-van den Heuvel, Angelique; Sterenborg, Henricus J. C. M.] Erasmus MC, Ctr Opt Diagnost & Therapy, Dept Radiat Oncol, Rotterdam, Netherlands; [Hofland, Leo J.; van der Wansem, Katy; van Koetsveld, Peter M.; van der Lelij, Aart-Jan; van Hagen, Martin P.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [De Bruijn, Henriette S.; Robinson, Dominic J.] Erasmus MC, Dept Otolaryngol & Head & Neck Surg, Rotterdam, Netherlands; [Ye, Yunpeng; Achilefu, Samuel] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Brugts, Michael P.; van Hagen, Martin P.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [ten Hagen, Timo L. M.] Erasmus MC, Dept Surg Oncol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Washington University (WUSTL); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	van Hagen, MP (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	p.m.vanhagen@erasmusmc.nl	Achilefu, Samuel/AAC-2401-2019; Sterenborg, Henricus J.C.M./H-9401-2013; Kascakova, Slavka/V-1844-2018; Sterenborg, HJCM/O-7195-2019	Sterenborg, Henricus J.C.M./0000-0002-6007-2992; Sterenborg, HJCM/0000-0002-6007-2992; Achilefu, Samuel/0000-0002-3133-6717	National Institutes of Health [R01 EB001430]; Erasmus MC; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Erasmus MC; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported in part by the National Institutes of Health grant (R01 EB001430) to SA and by an Erasmus MC Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHLYNINA TV, 1995, CANCER RES, V55, P1014; [Anonymous], 1985, SINGLET O2; Cavanaugh PG, 2002, BREAST CANCER RES TR, V72, P117, DOI 10.1023/A:1014811915564; Chen B, 2006, CRIT REV EUKAR GENE, V16, P279, DOI 10.1615/CritRevEukarGeneExpr.v16.i4.10; Cunderlikova B, 1999, J PHOTOCH PHOTOBIO B, V53, P81, DOI 10.1016/s1011-1344(99)00130-x; de la Torre NG, 2002, CLIN ENDOCRINOL, V57, P425, DOI 10.1046/j.1365-2265.2002.01619.x; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Del Governatore M, 2000, BRIT J CANCER, V82, P56; Del Governatore M, 2000, CANCER RES, V60, P4200; Delhanty PJD, 2007, AM J PHYSIOL-ENDOC M, V293, pE302, DOI 10.1152/ajpendo.00377.2006; Denzler B, 1999, CANCER, V85, P188, DOI 10.1002/(SICI)1097-0142(19990101)85:1<188::AID-CNCR26>3.0.CO;2-3; Dougherty TJ, 2002, J CLIN LASER MED SUR, V20, P3, DOI 10.1089/104454702753474931; Dutour A, 1998, INT J CANCER, V76, P620, DOI 10.1002/(SICI)1097-0215(19980529)76:5<620::AID-IJC2>3.3.CO;2-X; Ferone D, 1999, ENDOCRINOLOGY, V140, P373, DOI 10.1210/en.140.1.373; Gibril F, 1996, ANN INTERN MED, V125, P26, DOI 10.7326/0003-4819-125-1-199607010-00005; Hasan T., 2006, CANC MED, P537; HOFLAND LJ, 1990, EUR J CANCER, V26, P37, DOI 10.1016/0277-5379(90)90254-Q; Hongying Y, 1999, DYES PIGMENTS, V43, P109, DOI DOI 10.1016/S0143-7208(99)00049-2; Isakau HA, 2008, J PHOTOCH PHOTOBIO B, V92, P165, DOI 10.1016/j.jphotobiol.2008.06.004; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; Kelbauskas L, 2002, PHOTOCHEM PHOTOBIOL, V76, P686, DOI 10.1562/0031-8655(2002)076<0686:IOAPBT>2.0.CO;2; Kessel D, 2004, J PORPHYR PHTHALOCYA, V8, P1009, DOI 10.1142/S1088424604000374; KOSTENICH GA, 1994, J PHOTOCH PHOTOBIO B, V22, P211, DOI 10.1016/1011-1344(93)06974-8; Kruijt B, 2009, LASER SURG MED, V41, P653, DOI 10.1002/lsm.20845; Kwekkeboom DJ, 2010, ENDOCR-RELAT CANCER, V17, pR53, DOI 10.1677/ERC-09-0078; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Li L, 2010, J CONTROL RELEASE, V143, P274, DOI 10.1016/j.jconrel.2010.01.006; Lobel J, 2001, LASER SURG MED, V29, P397, DOI 10.1002/lsm.10001.abs; MICHAELI A, 1994, PHOTOCHEM PHOTOBIOL, V59, P284, DOI 10.1111/j.1751-1097.1994.tb05035.x; MOAN J, 1991, PHOTOCHEM PHOTOBIOL, V53, P549, DOI 10.1111/j.1751-1097.1991.tb03669.x; Molecular Probes, 2004, PROD INF; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; OSEROFF AR, 1986, P NATL ACAD SCI USA, V83, P8744, DOI 10.1073/pnas.83.22.8744; Parkhots M. V., 2003, Journal of Applied Spectroscopy, V70, P921, DOI 10.1023/B:JAPS.0000016312.04644.c7; Redmond RW, 1999, PHOTOCHEM PHOTOBIOL, V70, P391, DOI 10.1562/0031-8655(1999)070<0391:ACOSOY>2.3.CO;2; Reubi JC, 2003, ENDOCR REV, V24, P389, DOI 10.1210/er.2002-0007; Reubi Jean Claude, 2004, Neuroendocrinology, V80 Suppl 1, P51, DOI 10.1159/000080742; Rosenkranz AA, 2000, IMMUNOL CELL BIOL, V78, P452, DOI 10.1046/j.1440-1711.2000.00925.x; Rotomskis R, 1997, J PHOTOCH PHOTOBIO B, V39, P167, DOI 10.1016/S1011-1344(96)00015-2; SAHAI D, 1993, PHOTOCHEM PHOTOBIOL, V58, P803, DOI 10.1111/j.1751-1097.1993.tb04973.x; Sharman WM, 2004, ADV DRUG DELIVER REV, V56, P53, DOI 10.1016/j.addr.2003.08.015; Soukos NS, 2001, CANCER RES, V61, P4490; Starkey JR, 2008, CLIN CANCER RES, V14, P6564, DOI 10.1158/1078-0432.CCR-07-4162; ten Bokum AMC, 2000, EUR CYTOKINE NETW, V11, P161; van Veen RLP, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2338009; Waldherr C, 2001, ANN ONCOL, V12, P941, DOI 10.1023/A:1011160913619; Watson JC, 2001, BRIT J CANCER, V85, P266, DOI 10.1054/bjoc.2001.1881; WILKINSON F, 1993, J PHYS CHEM REF DATA, V22, P113, DOI 10.1063/1.555934; Zenkevich E, 1996, J PHOTOCH PHOTOBIO B, V33, P171, DOI 10.1016/1011-1344(95)07241-1; Zhu TC, 2005, J PHOTOCH PHOTOBIO B, V79, P231, DOI 10.1016/j.jphotobiol.2004.09.013	51	13	13	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104448	10.1371/journal.pone.0104448	http://dx.doi.org/10.1371/journal.pone.0104448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111655	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100060
J	Root, JJ; Shriner, SA; Bentler, KT; Gidlewski, T; Mooers, NL; Spraker, TR; VanDalen, KK; Sullivan, HJ; Franklin, AB				Root, J. Jeffrey; Shriner, Susan A.; Bentler, Kevin T.; Gidlewski, Thomas; Mooers, Nicole L.; Spraker, Terry R.; VanDalen, Kaci K.; Sullivan, Heather J.; Franklin, Alan B.			Shedding of a Low Pathogenic Avian Influenza Virus in a Common Synanthropic Mammal - The Cottontail Rabbit	PLOS ONE			English	Article							UNITED-STATES; INFECTION; ASSAY	Background: Cottontails (Sylvilagus spp.) are common mammals throughout much of the U. S. and are often found in peridomestic settings, potentially interacting with livestock and poultry operations. If these animals are susceptible to avian influenza virus (AIV) infections and shed the virus in sufficient quantities they may pose a risk for movement of avian influenza viruses between wildlife and domestic animals in certain situations. Methodology/Principal Findings: To assess the viral shedding potential of AIV in cottontails, we nasally inoculated fourteen cottontails with a low pathogenic AIV (H4N6). All inoculated cottontails shed relatively large quantities of viral RNA both nasally (<= 10(6.94) PCR EID50 equivalents/mL) and orally (<= 10(5.09) PCR EID50 equivalents/mL). However, oral shedding tended to decline more quickly than did nasal shedding. No animals showed any obvious signs of disease throughout the study. Evidence of a serological response was found in all infected rabbits at 22 days post infection in convalescent sera. Conclusions/Significance: To our knowledge, cottontails have not been previously assessed for AIV shedding. However, it was obvious that they shed AIV RNA extensively via the nasal and oral routes. This is significant, as cottontails are widely distributed throughout the U. S. and elsewhere. These mammals are often found in highly peridomestic situations, such as farms, parks, and suburban neighborhoods, often becoming habituated to human activities. Thus, if infected these mammals could easily transport AIVs short distances.	[Root, J. Jeffrey; Shriner, Susan A.; Bentler, Kevin T.; Gidlewski, Thomas; Mooers, Nicole L.; VanDalen, Kaci K.; Sullivan, Heather J.; Franklin, Alan B.] US Fish & Wildlife Serv, USDA, Natl Wildlife Res Ctr, Ft Collins, CO 80525 USA; [Spraker, Terry R.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	United States Department of Agriculture (USDA); United States Department of the Interior; US Fish & Wildlife Service; Colorado State University	Root, JJ (corresponding author), US Fish & Wildlife Serv, USDA, Natl Wildlife Res Ctr, Ft Collins, CO 80525 USA.	Jeff.root@aphis.usda.gov		Shriner, Susan/0000-0003-0349-7182; Franklin, Alan/0000-0001-9491-795X	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture. The manuscript was reviewed for general policy statements committing the USDA to action, but otherwise the findings were independently developed by the authors.	Achenbach JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017643; Adams LW, 1994, URBAN WILDLIFE HABIT; Armstrong DM, 2011, MAMMALS OF COLORADO, 2ND EDITION, P1; BEARD CW, 1970, B WORLD HEALTH ORGAN, V42, P779; Britton AP, 2010, EMERG INFECT DIS, V16, P1043, DOI 10.3201/eid1606.100352; Cardona CJ, 2009, COMP IMMUNOL MICROB, V32, P255, DOI 10.1016/j.cimid.2008.01.001; CHAPMAN J A, 1978, Mammalian Species, P1; Chapman J. A., 2003, WILD MAMMALS N AM BI, P101; Ciacci-Zanella JR, 2010, J VET DIAGN INVEST, V22, P3, DOI 10.1177/104063871002200102; CVB NVSL, 2003, AV INFL AG GEL IMM T; Hall JS, 2008, J WILDLIFE DIS, V44, P362, DOI 10.7589/0090-3558-44.2.362; Hall JS, 2008, EMERG INFECT DIS, V14, P1842, DOI 10.3201/eid1412.071371; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Kumar S, 2010, PEDIATR INFECT DIS J, V29, P591, DOI 10.1097/INF.0b013e3181d73e32; McQuiston JH, 2005, JAVMA-J AM VET MED A, V226, P767, DOI 10.2460/javma.2005.226.767; NVSL, 2008, AVPRO1510042008 NVSL; Pedersen K, 2010, AVIAN DIS, V54, P405, DOI 10.1637/8693-031309-Reg.1; Perkins LEL, 2003, AVIAN DIS, V47, P956, DOI 10.1637/0005-2086-47.s3.956; Reperant LA, 2009, REV SCI TECH OIE, V28, P137, DOI 10.20506/rst.28.1.1876; Root JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102964; Root JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0070639; Root JJ, 2013, J WILDLIFE DIS, V49, P1060, DOI 10.7589/2013-02-033; SCHMIDLY D. J., 2004, MAMMALS TEXAS; Shriner SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039206; Slota KE, 2011, VECTOR-BORNE ZOONOT, V11, P1115, DOI 10.1089/vbz.2010.0114; Slota KE, 2011, AVIAN DIS, V55, P180, DOI 10.1637/9509-082310-Reg.1; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Suarez D. L., 2008, AVIAN INFLUENZA, P3; Swayne DE, 2008, AVIAN INFLUENZA, P123; Szretter K.J., 2006, CURRENT PROTOCOLS MI, V3, DOI [10.1002/0471729256.mc15g01-3, DOI 10.1002/0471729256.MC15G01-3, 10.1002/0471729256.mc15g01s3, DOI 10.1002/0471729256.MC15G01S3]; Zhou JY, 2009, J VIROL, V83, P8957, DOI 10.1128/JVI.00793-09	32	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e102513	10.1371/journal.pone.0102513	http://dx.doi.org/10.1371/journal.pone.0102513			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111780	Green Published, gold			2022-12-27	WOS:000341105100009
J	Chen, CH; Hsieh, JT; Huang, KH; Pu, YS; Chang, HC				Chen, Chien-Hua; Hsieh, Ju-Ton; Huang, Kuo-How; Pu, Yeong-Shiau; Chang, Hong-Chiang			Predictive Clinical Indicators of Biochemical Progression in Advanced Prostate Cancer Patients Receiving Leuplin Depot as Androgen Deprivation Therapy	PLOS ONE			English	Article							LEUPRORELIN ACETATE DEPOT; ANTIGEN PSA NADIR; PROGNOSTIC-FACTORS; RADIATION-THERAPY; SURVIVAL; TRIAL; TIME; MEN; ORCHIECTOMY; SUPPRESSION	Therapeutic planning and counseling for advanced prostate cancer patients receiving androgen deprivation therapy (ADT) is complicated because the prognoses are highly variable. The purpose of this study is to identify predictive clinical indicators of biochemical progression (BCP). In this retrospective analysis, data from 107 newly diagnosed patients (from November 1995 to April 2008) with advanced prostate adenocarcinoma receiving Leuprorelin acetate depot were analyzed. Data was collected from the computerized registry of two collaborating medical centers in Taiwan. Cox regression and Kaplan-Meier analyses were used to evaluate the relationship between potential predictive parameters and BCP. Univariate analysis revealed that predictors of BCP included (1) initial serum prostate-specific antigen (PSA) (hazard ratio [HR], 1.00; 95% confidence interval [CI] 1.00-1.00); (2) log of initial PSA (HR, 1.35; 95% CI 1.17-1.56); (3) PSA density at diagnosis (HR, 1.00; 95% CI 1.00-1.01), and (4) pathological bone fracture (HR, 2.22; 95% CI 1.20-4.11). Age (HR, 0.94; 95% CI 0.91-0.98) and hemoglobin levels (HR, 0.86; 95% CI 0.76-0.97) were also associated with greater risk of BCP. After adjusting for age, pathologic fracture, and hemoglobin level, the initial PSA and PSA density were no longer significantly associated with BCP. However, age and hemoglobin levels continued to be associated with greater risk of BCP (P <= 0.007). Using Kaplan-Meier analysis, patients with higher initial PSA concentration, pathological bone fracture, and low hemoglobin had a greater probability of BCP. Thus, low hemoglobin and age are predictive indicators of BCP and therefore early indicators of BCP despite ADT therapy.	[Chen, Chien-Hua] En Chu Kong Hosp, Dept Urol, Taipei, Taiwan; [Hsieh, Ju-Ton; Huang, Kuo-How; Pu, Yeong-Shiau; Chang, Hong-Chiang] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Hsieh, Ju-Ton; Huang, Kuo-How; Pu, Yeong-Shiau; Chang, Hong-Chiang] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chang, HC (corresponding author), En Chu Kong Hosp, Dept Urol, Taipei, Taiwan.	changhong@ntu.edu.tw		CHANG, HONG-CHIANG/0000-0001-5411-6680; HSIEH, JU-TON/0000-0001-7545-8487; Huang, Kuo-How/0000-0002-0989-0578; PU, YEONG-SHIAU/0000-0002-2859-3966				Adib RS, 1997, BRIT J UROL, V79, P235; AKAZA H, 1990, J INT MED RES, V18, P90, DOI 10.1177/03000605900180S114; BERRY WR, 1979, CANCER, V44, P763, DOI 10.1002/1097-0142(197908)44:2<763::AID-CNCR2820440251>3.0.CO;2-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CH, 2008, UROLOGY, V72, P1287, DOI 10.1016/j.urology.2008.01.026; Cho D, 2003, UROL ONCOL-SEMIN ORI, V21, P282, DOI 10.1016/S1078-1439(03)00057-7; Choueiri TK, 2009, CANCER, V115, P981, DOI 10.1002/cncr.24064; de Crevoisier R, 2010, ANN ONCOL, V21, P808, DOI 10.1093/annonc/mdp365; Denis LJ, 1998, EUR UROL, V33, P144, DOI 10.1159/000019546; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; EMRICH LJ, 1985, CANCER RES, V45, P5173; Glass TR, 2003, J UROLOGY, V169, P164, DOI 10.1016/S0022-5347(05)64059-1; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Graff JN, 2007, J UROLOGY, V177, P1307, DOI 10.1016/j.juro.2006.11.054; Hori S, 2011, J CANCER RES CLIN, V137, P235, DOI 10.1007/s00432-010-0877-9; Howlader N, 2012, SEER CANC STAT REV; Huang SP, 2012, AGING MALE, V15, P34, DOI 10.3109/13685538.2011.580398; Huang SP, 2011, PROSTATE, V71, P1189, DOI 10.1002/pros.21334; JANKNEGT RA, 1993, J UROLOGY, V149, P77, DOI 10.1016/S0022-5347(17)36003-2; Jorgensen T, 1997, J UROLOGY, V158, P164, DOI 10.1097/00005392-199707000-00052; Kachroo N, 2013, J CANCER RES CLIN, V139, P1, DOI 10.1007/s00432-012-1351-7; Kattan MW, 2008, CANCER, V112, P69, DOI 10.1002/cncr.23106; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Keto CJ, 2012, EUR UROL; McGuire SE, 2013, INT J RADIAT ONCOL, V85, pE39, DOI 10.1016/j.ijrobp.2012.08.036; National Cancer Registry, 2009, NAT CANC REG ANN REP; Oefelein MG, 2002, UROLOGY, V60, P120, DOI 10.1016/S0090-4295(02)01633-3; Radwan MH, 2007, UROLOGY, V69, P1121, DOI 10.1016/j.urology.2007.01.087; RIZZO M, 1990, J INT MED RES, V18, P114, DOI 10.1177/03000605900180S116; Robson M, 1996, HEMATOL ONCOL CLIN N, V10, P727, DOI 10.1016/S0889-8588(05)70364-6; Ross RW, 2008, J CLIN ONCOL, V26, P842, DOI 10.1200/JCO.2007.13.6804; Ross RW, 2008, CANCER-AM CANCER SOC, V112, P1247, DOI 10.1002/cncr.23304; Sasaki T, 2011, PROSTATE CANCER P D, V14, P248, DOI 10.1038/pcan.2011.14; Seidenfeld J, 2000, ANN INTERN MED, V132, P566, DOI 10.7326/0003-4819-132-7-200004040-00009; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Stephenson AJ, 2006, J CLIN ONCOL, V24, P3973, DOI 10.1200/JCO.2005.04.0756; Takizawa I, 2010, PROSTATE, V70, P1395, DOI 10.1002/pros.21174; Thomas BM, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0719-0; 1997, INT J RAD ONCOL BIOL, V37, P1035	39	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105091	10.1371/journal.pone.0105091	http://dx.doi.org/10.1371/journal.pone.0105091			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121948	gold, Green Submitted, Green Published			2022-12-27	WOS:000341017000095
J	Enishi, T; Yukata, K; Takahashi, M; Sato, R; Sairyo, K; Yasui, N				Enishi, Tetsuya; Yukata, Kiminori; Takahashi, Mitsuhiko; Sato, Ryosuke; Sairyo, Koichi; Yasui, Natsuo			Hypertrophic Chondrocytes in the Rabbit Growth Plate Can Proliferate and Differentiate into Osteogenic Cells when Capillary Invasion Is Interposed by a Membrane Filter	PLOS ONE			English	Article							ENDOCHONDRAL BONE-FORMATION; APOPTOSIS; OSSIFICATION; CARTILAGE; CHICK; CULTURE; RAT; TRANSDIFFERENTIATION; PERICHONDRIUM; OSTEOBLASTS	The fate of hypertrophic chondrocytes during endochondral ossification remains controversial. It has long been thought that the calcified cartilage is invaded by blood vessels and that new bone is deposited on the surface of the eroded cartilage by newly arrived cells. The present study was designed to determine whether hypertrophic chondrocytes were destined to die or could survive to participate in new bone formation. In a rabbit experiment, a membrane filter with a pore size of 1 mu m was inserted in the middle of the hypertrophic zone of the distal growth plate of ulna. In 33 of 37 animals, vascular invasion was successfully interposed by the membrane filter. During 8 days, the cartilage growth plate was enlarged, making the thickness 3-fold greater than that of the nonoperated control side. Histological examination demonstrated that the hypertrophic zone was exclusively elongated. At the terminal end of the growth plate, hypertrophic chondrocytes extruded from their territorial matrix into the open cavity on the surface of the membrane filter. The progenies of hypertrophic chondrocytes (PHCs) were PCNA positive and caspase-3 negative. In situ hybridization studies demonstrated that PHCs did not express cartilage matrix proteins anymore but expressed bone matrix proteins. Immunohistochemical studies also demonstrated that the new matrix produced by PHCs contained type I collagen, osteonectin, and osteocalcin. Based on these results, we concluded that hypertrophic chondrocytes switched into bone-forming cells after vascular invasion was interposed in the normal growth plate.	[Enishi, Tetsuya; Yukata, Kiminori; Takahashi, Mitsuhiko; Sato, Ryosuke; Sairyo, Koichi; Yasui, Natsuo] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Orthoped, Tokushima, Japan	Tokushima University	Yasui, N (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Orthoped, Tokushima, Japan.	nyasui@tokushima-u.ac.jp	Yukata, Kiminori/AAF-9505-2020; Kiminori, Yukata/S-1331-2019	Yukata, Kiminori/0000-0002-0040-1352; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [21659354, 24791549]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was supported by a grant from Grant-in-Aid for challenging Exploratory Research and Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant #21659354 and #24791549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, CHONDROID BONE SECON; Bahney CS, 2013, J BONE MINERAL RES O; Bianco P, 1998, MATRIX BIOL, V17, P185, DOI 10.1016/S0945-053X(98)90057-9; BRIGHTON C T, 1973, Journal of Bone and Joint Surgery American Volume, V55, P771; BRUCKNER P, 1989, J CELL BIOL, V109, P2537, DOI 10.1083/jcb.109.5.2537; CANCEDDA FD, 1992, J CELL BIOL, V117, P427, DOI 10.1083/jcb.117.2.427; Eguchi G, 1993, CURR OPIN CELL BIOL, V5, P1023, DOI 10.1016/0955-0674(93)90087-7; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; GALOTTO M, 1994, J BONE MINER RES, V9, P1239; Gibson G, 1997, EXP CELL RES, V233, P372, DOI 10.1006/excr.1997.3576; Gibson G, 1998, MICROSC RES TECHNIQ, V43, P191, DOI 10.1002/(SICI)1097-0029(19981015)43:2<191::AID-JEMT10>3.0.CO;2-T; GIBSON GJ, 1995, DEV DYNAM, V203, P468, DOI 10.1002/aja.1002030409; Hayman AR, 1996, DEVELOPMENT, V122, P3151; Higashino K, 2007, SPINE, V32, P2839, DOI 10.1097/BRS.0b013e31815b981f; KAHN AJ, 1977, CLIN ORTHOP RELAT R, P299; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Kronenberg HM, 2007, ANN NY ACAD SCI, V1116, P59, DOI 10.1196/annals.1402.059; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Maye P, 2011, GENESIS, V49, P410, DOI 10.1002/dvg.20733; Musumeci G, 2013, INT J MOL SCI, V14, P15767, DOI 10.3390/ijms140815767; Nordahl J, 1998, CALCIFIED TISSUE INT, V63, P401, DOI 10.1007/s002239900548; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Roach HI, 1996, CONNECT TISSUE RES, V35, P85, DOI 10.3109/03008209609029178; ROACH HI, 1992, BONE MINER, V19, P1, DOI 10.1016/0169-6009(92)90840-A; ROACH HI, 1989, BONE MINER, V6, P289, DOI 10.1016/0169-6009(89)90035-4; Roach HI, 2000, J BONE JOINT SURG BR, V82B, P601, DOI 10.1302/0301-620X.82B4.9846; ROACH HI, 1995, J CELL BIOL, V131, P483, DOI 10.1083/jcb.131.2.483; Roach HI, 1997, J BONE MINER RES, V12, P795, DOI 10.1359/jbmr.1997.12.5.795; SALTER RB, 1963, J BONE JOINT SURG AM, V45, P587, DOI 10.2106/00004623-196345030-00019; Shapiro Irving M., 2005, Birth Defects Research, V75, P330, DOI 10.1002/bdrc.20057; SHIMOMURA Y, 1975, CALC TISS RES, V19, P179, DOI 10.1007/BF02564002; Tsumaki N, 2005, CYTOKINE GROWTH F R, V16, P279, DOI 10.1016/j.cytogfr.2005.04.001; Wattenbarger JM, 2002, J PEDIATR ORTHOPED, V22, P703, DOI 10.1097/00004694-200211000-00002; Wlodarski KH, 2006, FOLIA BIOL-KRAKOW, V54, P75; Yasui N, 1997, J BONE JOINT SURG BR, V79B, P824, DOI 10.1302/0301-620X.79B5.7423	36	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104638	10.1371/journal.pone.0104638	http://dx.doi.org/10.1371/journal.pone.0104638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121501	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000050
J	Abd-El-Maeboud, KHI; Kortam, MAMF; Ali, MS; Ibrahim, MI; Mohamed, RMMZ				Abd-El-Maeboud, Karim H. I.; Kortam, Mohamed A. M. F.; Ali, Mohamed S.; Ibrahim, Mostafa I.; Mohamed, Radwa M. M. Z.			A Preliminary Pilot Randomized Crossover Study of Uzara (Xysmalobium undulatum) versus Ibuprofen in the Treatment of Primary Dysmenorrhea	PLOS ONE			English	Article							PAIN; ISOXSUPRINE; TERBUTALINE	Objective: Preliminary evaluation of efficacy and safety of uzara use in treatment of moderate and severe primary dysmenorrhea in comparison to ibuprofen. Materials and Methods: This randomized, comparative two way cross-over study comprised 60 single female students at Faculty of Medicine, Ain Shams University, Egypt, aged 19-28 years with moderate (n = 46) or severe (n = 14) primary dysmenorrhea. Participants were randomized to take either uzara (80 mg/8 hours for two doses, then 40 mg/8 hours) then ibuprofen (400 mg/6 hours) in two subsequent cycles or vice versa. The pain intensity, using VAS, was recorded immediately before taking the medication (0 hour) and after 4, 12, 24, 48-60, 96-120 hours. Main outcome measures included effectiveness of pain relief defined as drop of VAS to 3 or less, patient's global evaluation of the drug, absence from school, the use of a rescue medication, and, in those who continued the treatment, the pain intensity difference (PID) at different points after start of medication and its sum (SPID). Results: Uzara was comparably effective to ibuprofen (78.3% vs. 86.7% of cycles; respectively), with comparable rates of effectiveness on global evaluation (being around 50% for either drug), and rates of school absences (11.7% vs. 13.3%; respectively). The need for rescue medication was different (18.3% and 10%; respectively), albeit with no statistical significance. The means of PID at different time points and SPID were comparable, with significantly lower average mean of VAS scores compared to that felt with no medication (1.6 vs. 6.8, p<0.001). Side effects were less with uzara than ibuprofen (0% vs. 8.3%, p<0.05). Conclusions: Uzara might be as effective as ibuprofen in management of primary dysmenorrhea but with less side effects. These findings need to be confirmed by a properly designed trial with a larger sample size.	[Abd-El-Maeboud, Karim H. I.; Kortam, Mohamed A. M. F.; Ali, Mohamed S.; Ibrahim, Mostafa I.; Mohamed, Radwa M. M. Z.] Ain Shams Univ, Fac Med, Dept Obstet & Gynecol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University	Abd-El-Maeboud, KHI (corresponding author), Ain Shams Univ, Fac Med, Dept Obstet & Gynecol, Cairo, Egypt.	Kabdelmaeboud@yahoo.com	Ibrahim, Moustafa/E-8112-2015	Ibrahim, Moustafa/0000-0003-4614-7182				AKERLUND M, 1976, BRIT J OBSTET GYNAEC, V83, P673, DOI 10.1111/j.1471-0528.1976.tb00911.x; Blumenthal M, 1998, COMPLETE GERMAN COMM, P226; Coco AS, 1999, AM FAM PHYSICIAN, V60, P489; Dawood MY, 2006, OBSTET GYNECOL, V108, P428, DOI 10.1097/01.AOG.0000230214.26638.0c; Fedorowicz Z, 2012, BETA2 ANDRENOCEPTOR; GALLEGOSTORRES J, 1975, J INT MED RES, V3, P194, DOI 10.1177/030006057500300309; Ganon L, 1986, WOMEN HLTH, V14, P105; HANSEN MK, 1975, AM J OBSTET GYNECOL, V121, P566, DOI 10.1016/0002-9378(75)90096-4; Harlow SD, 1996, BRIT J OBSTET GYNAEC, V103, P1134, DOI 10.1111/j.1471-0528.1996.tb09597.x; Kraft K, 2004, POCKET GUIDE HERBAL, P124; KULLANDER S, 1981, ACTA OBSTET GYN SCAN, V60, P425, DOI 10.3109/00016348109154139; Lara-Munoz C, 2004, ARCH MED RES, V35, P43, DOI 10.1016/j.arcmed.2003.07.007; Lee JS, 2003, ACAD EMERG MED, V10, P1128, DOI 10.1197/S1069-6563(03)00372-5; Marjoribanks J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001751.pub2; Nejad V. Modaress, 2006, Eastern Mediterranean Health Journal, V12, P423; NESHEIM BI, 1976, ACTA OBSTET GYN SCAN, V55, P315, DOI 10.3109/00016347609158504; Novak J, 1913, BR MED J        0307, P39; Proctor M, 2005, COCHRANE DB SYST REV; Proctor M, 2007, COCHRANE DB SYST REV; Proctor M, 2006, COCHRANE DB SYST REV; Proctor ML., 2002, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD002123; Proctor ML, 2001, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002124; Rahnama P, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-92; Schmelzer GH, 2011, PROTA 11 2 MED PLANT, V2; Schmiedl S, 2012, INT J CLIN PHARM TH, V50, P729, DOI 10.5414/CP201712; Schulz V, 2004, RATIONAL PHYTOTHERAP, P264; Schulzke JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018107; Smith CA, 2011, COCHRANE DB SYST REV; Thurmann PA, 2004, INT J CLIN PHARM TH, V42, P281; WILLIAMS LT, 1977, J CLIN INVEST, V60, P815, DOI 10.1172/JCI108835; Wong CL, 2009, COCHRANE DB SYST REV	31	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104473	10.1371/journal.pone.0104473	http://dx.doi.org/10.1371/journal.pone.0104473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119571	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600059
J	Burg, NA; Pradhan, A; Gonzalez, RM; Morban, EZ; Zhen, EW; Sakchoowong, W; Lohman, DJ				Burg, Noah A.; Pradhan, Ashman; Gonzalez, Rebecca M.; Morban, Emely Z.; Zhen, Erica W.; Sakchoowong, Watana; Lohman, David J.			Inferring the Provenance of an Alien Species with DNA Barcodes: The Neotropical Butterfly Dryas iulia in Thailand	PLOS ONE			English	Article							ANIMAL RELEASE; PRIMERS; PROGRAM	The Neotropical butterfly Dryas iulia has been collected from several locations in Thailand and Malaysia since 2007, and has been observed breeding in the wild, using introduced Passiflora foetida as a larval host plant. The butterfly is bred by a butterfly house in Phuket, Thailand, for release at weddings and Buddhist ceremonies, and we hypothesized that this butterfly house was the source of wild, Thai individuals. We compared wing patterns and COI barcodes from two, wild Thai populations with individuals obtained from this butterfly house. All Thai individuals resemble the subspecies D. iulia modesta, and barcodes from wild and captive Thai specimens were identical. This unique, Thai barcode was not found in any of the 30 specimens sampled from the wild in the species' native range, but is most similar to specimens from Costa Rica, where many exporting butterfly farms are located. These data implicate the butterfly house as the source of Thailand's wild D. iulia populations, which are currently so widespread that eradication efforts are unlikely to be successful.	[Burg, Noah A.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Burg, Noah A.] CUNY Hunter Coll, Dept Psychol, New York, NY 10021 USA; [Burg, Noah A.; Lohman, David J.] CUNY, Grad Ctr, Biol PhD Program, New York, NY 10031 USA; [Pradhan, Ashman; Lohman, David J.] CUNY, Dept Biol, New York, NY 10021 USA; [Gonzalez, Rebecca M.; Morban, Emely Z.; Zhen, Erica W.] High Sch Environm Studies, New York, NY USA; [Sakchoowong, Watana] Dept Natl Pk Wildlife & Plant Conservat, Bangkok, Thailand; [Lohman, David J.] Natl Museum Philippines, Entomol Sect, Manila, Philippines	American Museum of Natural History (AMNH); City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; National Museum of the Philippines	Lohman, DJ (corresponding author), CUNY, Grad Ctr, Biol PhD Program, New York, NY 10031 USA.	dlohman@ccny.cuny.edu		Lohman, David/0000-0002-0689-2906	National Science Foundation [1120380, 0742457]; Professional Staff Congress of the City University of New York Research Award [60051-40 41]; Direct For Biological Sciences [1120380] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Professional Staff Congress of the City University of New York Research Award; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation Grant 1120380 to DJL; http://www.nsf.gov/awardsearch/showAward?AWD_ID=1120380. National Science Foundation Grant 0742457 funded NAB; http://www.nsf.gov/awardsearch/showAward?AWD_ID=0742457. Professional Staff Congress of the City University of New York Research Award 60051-40 41 to DJL; https://www.rfcuny.org/rfwebsite/research/content.aspx?catID=1190. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, BUTTERFLIES RELEASED; [Anonymous], 2012, PHUKET BUTTERFLY REL; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Boppre M, 2012, CONSERV SOC, V10, P285, DOI 10.4103/0972-4923.101831; Braby MF, 2000, BUTTERFLIES AUSTR TH; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CLENCH H K, 1975, Journal of the Lepidopterists' Society, V29, P230; Corlett RT, 2010, BIODIVERS CONSERV, V19, P411, DOI 10.1007/s10531-009-9624-4; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Wilde WJJO, 1972, FLORA MALESIANA 1, V7, P405; DEVRIES P. J., 1987, BUTTERFLIES COSTA RI; Eastwood R, 2006, ANN ENTOMOL SOC AM, V99, P164, DOI 10.1603/0013-8746(2006)099[0164:TPOOWS]2.0.CO;2; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ek-Amnuay P, 2012, BUTTERFLIES THAILAND; Fenner T.L., 1974, Proceedings Papua New Guin scient Soc, V25, P63; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Glassberg J, 2014, THERES NO NEED RELEA; Goloboff P, 2008, CLADISTICS, V24, P91; Hansen AK, 2006, SYST BOT, V31, P138, DOI 10.1600/036364406775971769; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HERNANDEZ L. R, 2004, FIELD GUIDE CUBAN W; ISSG, 2014, GLOBAL INVASIVE SPEC; Khew SK, 2009, NEW TAXON MALAYSIA D; Kirkwood J, 1998, DO COMMERCIAL BUTTER; Kuppers PV, 2007, ATALANTA, V38, P325; Liu X, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00368.1; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Miller M.A., 2010, P GAT COMP ENV WORKS; Mooney Harold A., 2000, P425; New TR, 2007, J INSECT CONSERV, V12, P93; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Pyle RM, 2010, NEWS LEPID SOC, V52, P54; Regier JC, 2005, BIOTECHNIQUES, V38, P34, DOI 10.2144/05381BM02; Severinghaus LL, 1999, BIOL CONSERV, V89, P301, DOI 10.1016/S0006-3207(98)00155-4; Shiu H, 2008, CONTEMP BUDDHISM, V9, P181, DOI 10.1080/14639940802556529; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strong D., 1984, INSECTS PLANTS COMMU; Vane-Wright R.I., 1993, Natural History Museum of Los Angeles County Science Series, P179; Walter GH, 2003, INSECT PEST MANAGEME; WARREN A. D., 2013, ILLUSTRATED LISTS AM; Woodworth LM, 2002, CONSERV GENET, V3, P277, DOI 10.1023/A:1019954801089; Zalucki MP, 2004, BIOL J LINN SOC, V82, P111, DOI 10.1111/j.1095-8312.2004.00322.x	43	1	1	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104076	10.1371/journal.pone.0104076	http://dx.doi.org/10.1371/journal.pone.0104076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119899	Green Published, gold			2022-12-27	WOS:000340900600037
J	Cebrian, J; Monturus, E; Martinez-Robles, ML; Hernandez, P; Krimer, DB; Schvartzman, JB				Cebrian, Jorge; Monturus, Estefania; Martinez-Robles, Maria-Luisa; Hernandez, Pablo; Krimer, Dora B.; Schvartzman, Jorge B.			Topoisomerase 2 Is Dispensable for the Replication and Segregation of Small Yeast Artificial Chromosomes (YACs)	PLOS ONE			English	Article							AGAROSE-GEL ELECTROPHORESIS; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; FORK PROGRESSION; RIBOSOMAL DNA; TELOMERIC SEQUENCES; BUDDING YEAST; ORIGIN; HELICASE	DNA topoisomerases are thought to play a critical role in transcription, replication and recombination as well as in the condensation and segregation of sister duplexes during cell division. Here, we used high-resolution two-dimensional agarose gel electrophoresis to study the replication intermediates and final products of small circular and linear minichromosomes of Saccharomyces cerevisiae in the presence and absence of DNA topoisomerase 2. The results obtained confirmed that whereas for circular minichromosomes, catenated sister duplexes accumulated in the absence of topoisomerase 2, linear YACs were able to replicate and segregate regardless of this topoisomerase. The patterns of replication intermediates for circular and linear YACs displayed significant differences suggesting that DNA supercoiling might play a key role in the modulation of replication fork progression. Altogether, this data supports the notion that for linear chromosomes the torsional tension generated by transcription and replication dissipates freely throughout the telomeres.	[Cebrian, Jorge; Monturus, Estefania; Martinez-Robles, Maria-Luisa; Hernandez, Pablo; Krimer, Dora B.; Schvartzman, Jorge B.] Ctr Invest Biol CSIC, Dept Cell & Mol Biol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Schvartzman, JB (corresponding author), Ctr Invest Biol CSIC, Dept Cell & Mol Biol, Madrid, Spain.	schvartzman@cib.csic.es	Krimer, Dora/J-9176-2014; Cebrián, Jorge/B-5836-2018; Schvartzman, Jorge B/J-9171-2014	Krimer, Dora/0000-0001-9972-3994; Cebrián, Jorge/0000-0001-5070-0070; Pablo, Hernandez/0000-0002-8113-1277	Spanish Ministerio de Economia y Competitividad [BFU2011-22489]	Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was sustained by grant BFU2011-22489 to JBS from the Spanish Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenova AY, 2013, P NATL ACAD SCI USA, V110, P19866, DOI 10.1073/pnas.1319313110; Anand RP, 2012, NUCLEIC ACIDS RES, V40, P1091, DOI 10.1093/nar/gkr836; Baxter J, 2011, SCIENCE, V331, P1328, DOI 10.1126/science.1201538; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Benguria A, 2003, NUCLEIC ACIDS RES, V31, P893, DOI 10.1093/nar/gkg188; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1992, CELL, V71, P267, DOI 10.1016/0092-8674(92)90355-G; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; BREWER BJ, 1988, CANCER CELL, V6, P229; BRILL SJ, 1987, NATURE, V326, P414, DOI 10.1038/326414a0; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; Drosopoulos WC, 2012, J CELL BIOL, V197, P253, DOI 10.1083/jcb.201112083; ENOMOTO S, 1994, CHROMOSOMA, V103, P237, DOI 10.1007/s004120050030; Farcas AM, 2011, MOL CELL, V44, P97, DOI 10.1016/j.molcel.2011.07.034; FITZGERALDHAYES M, 1982, CELL, V29, P235, DOI 10.1016/0092-8674(82)90108-8; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Forterre P, 2009, NUCLEIC ACIDS RES, V37, P679, DOI 10.1093/nar/gkp032; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Gadelle D, 2003, BIOESSAYS, V25, P232, DOI 10.1002/bies.10245; GELLERT M, 1981, ANNU REV BIOCHEM, V50, P879, DOI 10.1146/annurev.bi.50.070181.004311; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; GREENFEDER SA, 1992, MOL CELL BIOL, V12, P4056, DOI 10.1128/MCB.12.9.4056; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Harmon FG, 2003, J BIOL CHEM, V278, P42668, DOI 10.1074/jbc.M302994200; HIASA H, 1994, J BIOL CHEM, V269, P2093; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Huang TW, 2013, NUCLEIC ACIDS RES, V41, P10403, DOI 10.1093/nar/gkt757; HUBERMAN JA, 1987, CELL, V51, P473, DOI 10.1016/0092-8674(87)90643-X; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; Ivessa AS, 2002, GENE DEV, V16, P1383, DOI 10.1101/gad.982902; Joshi RS, 2010, EMBO J, V29, P740, DOI 10.1038/emboj.2009.391; Kegel A, 2011, NATURE, V471, P392, DOI 10.1038/nature09791; KLOBUTCHER LA, 1981, P NATL ACAD SCI-BIOL, V78, P3015, DOI 10.1073/pnas.78.5.3015; Kobayashi T, 2003, MOL CELL BIOL, V23, P9178, DOI 10.1128/MCB.23.24.9178-9188.2003; Kobayashi T, 1996, GENES CELLS, V1, P465, DOI 10.1046/j.1365-2443.1996.d01-256.x; KOSHLAND D, 1987, CELL, V48, P801, DOI 10.1016/0092-8674(87)90077-8; Kurth I, 2010, NUCLEIC ACIDS RES, V38, P467, DOI 10.1093/nar/gkp929; Martinez-Robles ML, 2009, NUCLEIC ACIDS RES, V37, P5126, DOI 10.1093/nar/gkp530; MARCHUK D, 1988, NUCLEIC ACIDS RES, V16, P7743, DOI 10.1093/nar/16.15.7743; MARTINPARRAS L, 1991, J MOL BIOL, V220, P843, DOI 10.1016/0022-2836(91)90357-C; Mayan-Santos MD, 2008, MOL MICROBIOL, V69, P361, DOI 10.1111/j.1365-2958.2008.06278.x; MURRAY AW, 1983, NATURE, V305, P189, DOI 10.1038/305189a0; MURRAY AW, 1986, CELL, V45, P529, DOI 10.1016/0092-8674(86)90284-9; Neidle S, 2003, CURR OPIN STRUC BIOL, V13, P275, DOI 10.1016/S0959-440X(03)00072-1; Nurse P, 2003, J BIOL CHEM, V278, P8653, DOI 10.1074/jbc.M211211200; Olavarrieta L, 2002, MOL MICROBIOL, V46, P699, DOI 10.1046/j.1365-2958.2002.03217.x; Peter BJ, 1998, CELL, V94, P819, DOI 10.1016/S0092-8674(00)81740-7; Santamaria D, 2000, NUCLEIC ACIDS RES, V28, P2099, DOI 10.1093/nar/28.10.2099; Schvartzman JB, 2010, PLASMID, V63, P1, DOI 10.1016/j.plasmid.2009.11.001; Schvartzman JB, 2013, METHODS MOL BIOL, V1054, P121, DOI 10.1007/978-1-62703-565-1_7; Schvartzman JB, 2012, METHODS, V57, P170, DOI 10.1016/j.ymeth.2012.03.013; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; SHAMPAY J, 1989, NUCLEIC ACIDS RES, V17, P3247, DOI 10.1093/nar/17.8.3247; Szostak JW, 2010, ANGEW CHEM INT EDIT, V49, P7386, DOI 10.1002/anie.201000635; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Viguera E, 1998, GENE, V217, P41, DOI 10.1016/S0378-1119(98)00375-8; Ward TR, 2000, MOL CELL BIOL, V20, P4948, DOI 10.1128/MCB.20.13.4948-4957.2000; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; ZHU JG, 1992, MOL CELL BIOL, V12, P4733, DOI 10.1128/MCB.12.10.4733	63	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104995	10.1371/journal.pone.0104995	http://dx.doi.org/10.1371/journal.pone.0104995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115861	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400111
J	Keyel, PA; Romero, M; Wu, WB; Kwak, DH; Zhu, Q; Liu, XY; Salter, RD				Keyel, Peter A.; Romero, Matthew; Wu, Wenbo; Kwak, Daniel H.; Zhu, Qin; Liu, Xinyu; Salter, Russell D.			Methylthioadenosine Reprograms Macrophage Activation through Adenosine Receptor Stimulation	PLOS ONE			English	Article							A(2A) RECEPTORS; THP-1 CELLS; TNF-ALPHA; EXPRESSION; MICE; METHIONINE; METHYLATION; MECHANISMS; AGONISTS; REVEALS	Regulation of inflammation is necessary to balance sufficient pathogen clearance with excessive tissue damage. Central to regulating inflammation is the switch from a pro-inflammatory pathway to an anti-inflammatory pathway. Macrophages are well-positioned to initiate this switch, and as such are the target of multiple therapeutics. One such potential therapeutic is methylthioadenosine (MTA), which inhibits TNF alpha production following LPS stimulation. We found that MTA could block TNFa production by multiple TLR ligands. Further, it prevented surface expression of CD69 and CD86 and reduced NF-kappa B signaling. We then determined that the mechanism of this action by MTA is signaling through adenosine A2 receptors. A2 receptors and TLR receptors synergized to promote an anti-inflammatory phenotype, as MTA enhanced LPS tolerance. In contrast, IL-1 beta production and processing was not affected by MTA exposure. Taken together, these data demonstrate that MTA reprograms TLR activation pathways via adenosine receptors to promote resolution of inflammation.	[Keyel, Peter A.; Salter, Russell D.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260` USA; [Keyel, Peter A.; Romero, Matthew; Wu, Wenbo] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Kwak, Daniel H.; Zhu, Qin; Liu, Xinyu] Univ Pittsburgh, Dept Chem, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Texas Tech University System; Texas Tech University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Salter, RD (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260` USA.	rds@pitt.edu	zhu, qin/G-3520-2016	zhu, qin/0000-0003-4093-9517; Salter, Russell/0000-0003-4553-2986	NIH [AI072083, CA168392]; University of Pittsburgh; Texas Tech University; NATIONAL CANCER INSTITUTE [R01CA168392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh(University of Pittsburgh); Texas Tech University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI072083 and CA168392 (RDS), a Competitive Medical Research Fund from University of Pittsburgh (XL), and start-up funding from Texas Tech University (PAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara AI, 2008, HEPATOLOGY, V47, P1655, DOI 10.1002/hep.22231; Benight NM, 2012, AM J PHYSIOL-GASTR L, V303, pG71, DOI 10.1152/ajpgi.00549.2011; BORCHARDT RT, 1980, J MED CHEM, V23, P347, DOI 10.1021/jm00178a001; Bshesh K, 2002, J LEUKOCYTE BIOL, V72, P1027; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Fernandes-Alnemri T, 2013, J IMMUNOLOGY; Hasko G, 1996, J IMMUNOL, V157, P4634; Hasko G, 2000, FASEB J, V14, P2065, DOI 10.1096/fj.99-0508com; Hasko G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00085; Hasko G, 2012, ARTERIOSCL THROM VAS, V32, P865, DOI 10.1161/ATVBAHA.111.226852; Hevia H, 2004, HEPATOLOGY, V39, P1088, DOI 10.1002/hep.20154; Keyel PA, 2013, TOXINS, V5, P1105, DOI 10.3390/toxins5061105; Khoa ND, 2003, J IMMUNOL, V171, P3991, DOI 10.4049/jimmunol.171.8.3991; Khoa ND, 2001, J IMMUNOL, V167, P4026, DOI 10.4049/jimmunol.167.7.4026; Ko DC, 2012, P NATL ACAD SCI USA, V109, pE2343, DOI 10.1073/pnas.1206701109; Latasa MU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015690; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Lu MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003339; Macedo L, 2007, AM J PATHOL, V171, P1774, DOI 10.2353/ajpath.2007.061048; Marzio R, 1997, J LEUKOCYTE BIOL, V62, P349, DOI 10.1002/jlb.62.3.349; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Moreno B, 2006, ANN NEUROL, V60, P323, DOI 10.1002/ana.20895; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Nemeth ZH, 2003, J PHARMACOL EXP THER, V306, P1042, DOI 10.1124/jpet.103.052944; Ohta A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00190; Pawaria S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1524; Pinhal-Enfield G, 2003, AM J PATHOL, V163, P711, DOI 10.1016/S0002-9440(10)63698-X; SAVARESE TM, 1983, CANCER RES, V43, P4699; Scheibner KA, 2009, AM J RESP CELL MOL, V40, P251, DOI 10.1165/rcmb.2008-0168OC; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Shnyra A, 1998, J IMMUNOL, V160, P3729; Szabo C, 1998, BRIT J PHARMACOL, V125, P379, DOI 10.1038/sj.bjp.0702040	33	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104210	10.1371/journal.pone.0104210	http://dx.doi.org/10.1371/journal.pone.0104210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117662	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400038
J	Miller, DK; Menezes, MJ; Simons, C; Riley, LG; Cooper, ST; Grimmond, SM; Thorburn, DR; Christodoulou, J; Taft, RJ				Miller, David K.; Menezes, Minal J.; Simons, Cas; Riley, Lisa G.; Cooper, Sandra T.; Grimmond, Sean M.; Thorburn, David R.; Christodoulou, John; Taft, Ryan J.			Rapid Identification of a Novel Complex I MT-ND3 m.10134C>A Mutation in a Leigh Syndrome Patient	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATION; ND3 GENE; DEFICIENCY; DISEASE	Leigh syndrome (LS) is a rare progressive multi-system neurodegenerative disorder, the genetics of which is frequently difficult to resolve. Rapid determination of the genetic etiology of LS in a 5-year-old girl facilitated inclusion in Edison Pharmaceutical's phase 2B clinical trial of EPI-743. SNP-arrays and high-coverage whole exome sequencing were performed on the proband, both parents and three unaffected siblings. Subsequent multi-tissue targeted high-depth mitochondrial sequencing was performed using custom long-range PCR amplicons. Tissue-specific mutant load was also assessed by qPCR. Complex I was interrogated by spectrophotometric enzyme assays and Western Blot. No putatively causal mutations were identified in nuclear-encoded genes. Analysis of low-coverage off-target mitochondrial reads revealed a previously unreported mitochondrial mutation in the proband in MT-ND3 (m.10134C>A, p.Q26K), a Complex I mitochondrial gene previously associated with LS. Targeted investigations demonstrated that this mutation was 1% heteroplasmic in the mother's blood and homoplasmic in the proband's blood, fibroblasts, liver and muscle. Enzyme assays revealed decreased Complex I activity. The identification of this novel LS MT-ND3 variant, the genomics of which was accomplished in less than 3.5 weeks, indicates that rapid genomic approaches may prove useful in time-sensitive cases with an unresolved genetic diagnosis.	[Miller, David K.; Grimmond, Sean M.] Univ Queensland, Queensland Ctr Med Gen, Inst Mol Biosci, St Lucia, Qld, Australia; [Menezes, Minal J.; Riley, Lisa G.; Christodoulou, John] Childrens Hosp Westmead, Kids Res Inst, Genet Metab Disorders Res Unit, Sydney, NSW, Australia; [Menezes, Minal J.; Cooper, Sandra T.; Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Camperdown, NSW, Australia; [Simons, Cas; Taft, Ryan J.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Cooper, Sandra T.] Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Sydney, NSW, Australia; [Thorburn, David R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Thorburn, David R.] Royal Childrens Hosp, Victorian Clin Genet Serv, Melbourne, Vic, Australia; [Thorburn, David R.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Christodoulou, John] Univ Sydney, Sydney Med Sch, Discipline Genet Med, Camperdown, NSW, Australia; [Taft, Ryan J.] George Washington Univ, Sch Med, Dept Integrat Syst Biol, Washington, DC USA; [Taft, Ryan J.] George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20052 USA	University of Queensland; University of Sydney; University of Sydney; University of Queensland; University of Sydney; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; University of Sydney; George Washington University; George Washington University	Christodoulou, J (corresponding author), Childrens Hosp Westmead, Kids Res Inst, Genet Metab Disorders Res Unit, Sydney, NSW, Australia.	john.christodoulou@health.nsw.gov.au; r.taft@uq.edu.au	Christodoulou, John/E-5866-2015; Grimmond, Sean M/J-5304-2016; Christodoulou, John/M-3628-2019; Thorburn, David R/G-6266-2013; Grimmond, Sean/K-3246-2019; Simons, Cas/A-7905-2011	Grimmond, Sean M/0000-0002-8102-7998; Christodoulou, John/0000-0002-8431-0641; Grimmond, Sean/0000-0002-8102-7998; Simons, Cas/0000-0003-3147-8042; thorburn, david/0000-0002-7725-9470; Cooper, Sandra/0000-0002-7314-5097	Illumina Inc.; National Health and Medical Research Council of Australia (NHMRC) [1026891]; University of Queensland Foundation Research Excellence Award; Crane family; Perkins family	Illumina Inc.; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland Foundation Research Excellence Award(University of Queensland); Crane family; Perkins family	The authors thank Illumina Inc. for their support of this project, and the Queensland Center for Medical Genomics and the IMB Sequencing Core for their assistance. This research was supported by National Health and Medical Research Council of Australia (NHMRC) Project Grant 1026891, and a University of Queensland Foundation Research Excellence Award to RJT. MM is an Australian Mitochondrial Diseases Foundation (AMDF) Postgraduate Research Scholar. DRT is an NHMRC Principal Research Fellow. The authors thank Wendy Fagan for assistance with enzyme assays and are grateful to the Crane and Perkins families for their generous financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Baertling F, 2013, J NEUROL NEUROSUR PS, P1; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cooper ST, 2007, NEUROMUSCULAR DISORD, V17, P276, DOI 10.1016/j.nmd.2006.12.010; Crimi M, 2004, PEDIATR RES, V55, P842, DOI 10.1203/01.PDR.0000117844.73436.68; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; Finsterer J, 2008, PEDIATR NEUROL, V39, P223, DOI 10.1016/j.pediatrneurol.2008.07.013; Frazier AE, 2012, METHODS MOL BIOL, V837, P49, DOI 10.1007/978-1-61779-504-6_4; Goldstein AC, 2013, NEUROTHERAPEUTICS, V10, P212, DOI 10.1007/s13311-013-0185-6; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Martinelli D, 2012, MOL GENET METAB, V107, P383, DOI 10.1016/j.ymgme.2012.09.007; McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787; Nesbitt V, 2012, DEV MED CHILD NEUROL, V54, P500, DOI 10.1111/j.1469-8749.2012.04224.x; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; Sarzi E, 2007, AM J MED GENET A, V143A, P33, DOI 10.1002/ajmg.a.31565; Swalwell H, 2011, EUR J HUM GENET, V19, P769, DOI 10.1038/ejhg.2011.18; Tarnopoisky M, 2013, AM J MED GENET A, V161, P2020, DOI 10.1002/ajmg.a.36000; Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55; Thorburn DR, 2003, GENEREVIEWS, P1	20	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104879	10.1371/journal.pone.0104879	http://dx.doi.org/10.1371/journal.pone.0104879			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25118196	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400100
J	Rieder, F; Paul, G; Schnoy, E; Schleder, S; Wolf, A; Kamm, F; Dirmeier, A; Strauch, U; Obermeier, F; Lopez, R; Achkar, JP; Rogler, G; Klebl, F				Rieder, Florian; Paul, Gisela; Schnoy, Elisabeth; Schleder, Stephan; Wolf, Alexandra; Kamm, Florian; Dirmeier, Andrea; Strauch, Ulrike; Obermeier, Florian; Lopez, Rocio; Achkar, Jean-Paul; Rogler, Gerhard; Klebl, Frank			Hemoglobin and Hematocrit Levels in the Prediction of Complicated Crohn's Disease Behavior - A Cohort Study	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CELL DISTRIBUTION WIDTH; ANEMIA; ANTIBODIES; MARKERS; ASSOCIATION; PREVALENCE	Background: Markers that predict the occurrence of a complicated disease behavior in patients with Crohn's disease (CD) can permit a more aggressive therapeutic regimen for patients at risk. The aim of this cohort study was to test the blood levels of hemoglobin (Hgb) and hematocrit (Hct) for the prediction of complicated CD behavior and CD related surgery in an adult patient population. Methods: Blood samples of 62 CD patients of the German Inflammatory Bowel Disease-network "Kompetenznetz CED'' were tested for the levels of Hgb and Hct prior to the occurrence of complicated disease behavior or CD related surgery. The relation of these markers and clinical events was studied using Kaplan-Meier survival analysis and adjusted COX-proportional hazard regression models. Results: The median follow-up time was 55.8 months. Of the 62 CD patients without any previous complication or surgery 34% developed a complication and/or underwent CD related surgery. Low Hgb or Hct levels were independent predictors of a shorter time to occurrence of the first complication or CD related surgery. This was true for early as well as late occurring complications. Stable low Hgb or Hct during serial follow-up measurements had a higher frequency of complications compared to patients with a stable normal Hgb or Hct, respectively. Conclusions: Determination of Hgb or Hct in complication and surgery naive CD patients might serve as an additional tool for the prediction of complicated disease behavior.	[Rieder, Florian; Paul, Gisela; Schnoy, Elisabeth; Schleder, Stephan; Wolf, Alexandra; Kamm, Florian; Dirmeier, Andrea; Strauch, Ulrike; Obermeier, Florian; Klebl, Frank] Univ Regensburg, Dept Internal Med 1, D-93053 Regensburg, Germany; [Lopez, Rocio] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA; [Rogler, Gerhard] Univ Hosp, Div Gastroenterol & Hepatol, Zurich, Switzerland; [Rieder, Florian; Achkar, Jean-Paul] Cleveland Clin Fdn, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Rieder, Florian; Achkar, Jean-Paul] Cleveland Clin, Dept Gastroenterol Hepatol & Nutr, Cleveland, OH 44106 USA	University of Regensburg; Cleveland Clinic Foundation; University of Zurich; University Zurich Hospital; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Rieder, F (corresponding author), Univ Regensburg, Dept Internal Med 1, D-93053 Regensburg, Germany.	riederf@ccf.org	Schnoy, Elisabeth/AGS-8375-2022; Rogler, Gerhard/O-5308-2015	Rogler, Gerhard/0000-0002-1733-9188; Schleder, Stephan/0000-0002-7785-3015; Lopez, Ana Rocio/0000-0002-4319-420X	German Competency Network Inflammatory Bowel Diseases	German Competency Network Inflammatory Bowel Diseases	German Competency Network Inflammatory Bowel Diseases supported this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amre DK, 2006, AM J GASTROENTEROL, V101, P645, DOI 10.1111/j.1572-0241.2006.00468.x; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Cabrera-Abreu JC, 2004, ARCH DIS CHILD, V89, P69; Cakal B, 2009, DIGEST DIS SCI, V54, P842, DOI 10.1007/s10620-008-0436-2; CASH JM, 1989, AM J MED, V87, P638; Dotan I, 2006, GASTROENTEROLOGY, V131, P366, DOI 10.1053/j.gastro.2006.04.030; Dubinsky MC, 2008, CLIN GASTROENTEROL H, V6, P1105, DOI 10.1016/j.cgh.2008.04.032; Jess T, 2007, INFLAMM BOWEL DIS, V13, P481, DOI 10.1002/ibd.20036; Kulnigg S, 2006, ALIMENT PHARM THER, V24, P1507, DOI 10.1111/j.1365-2036.2006.03146.x; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Mandrekar JN, 2003, P 28 SAS US GROUP IN; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P1367, DOI 10.1002/ibd.21179; Rieder F, 2010, INFLAMM BOWEL DIS, V16, P263, DOI 10.1002/ibd.21046; Semrin G, 2006, INFLAMM BOWEL DIS, V12, P1101, DOI 10.1097/01.mib.0000235097.86360.04; Song CS, 2012, DIGEST DIS SCI, V57, P1033, DOI 10.1007/s10620-011-1978-2; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Vijverman A, 2006, ACTA GASTRO-ENT BELG, V69, P1; Wilson A, 2004, AM J MED, V116, P44, DOI 10.1016/j.amjmed.2003.12.011; Yesil A, 2011, GUT LIVER, V5, P460, DOI 10.5009/gnl.2011.5.4.460	21	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104706	10.1371/journal.pone.0104706	http://dx.doi.org/10.1371/journal.pone.0104706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116048	gold, Green Submitted, Green Published			2022-12-27	WOS:000341230400071
J	Pizzutto, SJ; Yerkovich, ST; Upham, JW; Hales, BJ; Thomas, WR; Chang, AB				Pizzutto, Susan J.; Yerkovich, Stephanie T.; Upham, John W.; Hales, Belinda J.; Thomas, Wayne R.; Chang, Anne B.			Children with Chronic Suppurative Lung Disease Have a Reduced Capacity to Synthesize Interferon-Gamma In Vitro in Response to Non-Typeable Haemophilus influenzae	PLOS ONE			English	Article							CYSTIC-FIBROSIS BRONCHIECTASIS; OBSTRUCTIVE PULMONARY-DISEASE; NEW-ZEALAND; ASTHMA; IMMUNITY; SENSITIZATION; MATURATION; CHILDHOOD; CYTOKINE; ANTIGEN	Chronic suppurative lung disease (CSLD) is characterized by the presence of a chronic wet or productive cough and recurrent lower respiratory infections. The aim of this study was to identify features of innate, cell-mediated and humoral immunity that may increase susceptibility to respiratory infections in children with CSLD. Because non-typeable Haemophilus influenzae (NTHi) is commonly isolated from the airways in CSLD, we examined immune responses to this organism in 80 age-stratified children with CSLD and compared their responses with 51 healthy control children. Cytokines involved in the generation and control of inflammation (IFN-gamma, IL-13, IL-5, IL-10 at 72 hours and TNF alpha, IL-6, IL-10 at 24 hours) were measured in peripheral blood mononuclear cells challenged in vitro with live NTHi. We also measured circulating IgG subclass antibodies (IgG(1) and IgG(4)) to two H. influenzae outer membrane proteins, P4 and P6. The most notable finding was that PBMC from children with CSLD produced significantly less IFN-gamma in response to NTHi than healthy control children whereas mitogen-induced IFN-gamma production was similar in both groups. Overall there were minor differences in innate and humoral immune responses between CSLD and control children. This study demonstrates that children with chronic suppurative lung disease have an altered systemic cell-mediated immune response to NTHi in vitro. This deficient IFN-gamma response may contribute to increased susceptibility to NTHi infections and the pathogenesis of CSLD in children.	[Pizzutto, Susan J.; Yerkovich, Stephanie T.; Chang, Anne B.] Charles Darwin Univ, Menzies Sch Hlth Res, Brinkin, NT, Australia; [Yerkovich, Stephanie T.] Prince Charles Hosp, Queensland Lung Transplant Serv, Chermside, Qld, Australia; [Yerkovich, Stephanie T.; Upham, John W.] Univ Queensland, Sch Med, St Lucia, Qld, Australia; [Upham, John W.] Princess Alexandra Hosp, Dept Resp Med, Woolloongabba, Qld, Australia; [Hales, Belinda J.; Thomas, Wayne R.] Univ Western Australia, Telethon Kids Inst, Crawley, WA, Australia; [Chang, Anne B.] Royal Childrens Hosp, Dept Resp Med, Herston, Qld, Australia; [Chang, Anne B.] Royal Childrens Hosp, Queensland Childrens Med Res Inst, Herston, Qld, Australia	Charles Darwin University; Menzies School of Health Research; Prince Charles Hospital; University of Queensland; Telethon Kids Institute; University of Western Australia; Royal Children's Hospital Brisbane; Royal Children's Hospital Brisbane	Pizzutto, SJ (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Brinkin, NT, Australia.	susan.pizzutto@menzies.edu.au	Chang, Anne/F-2066-2013; Upham, John/F-4420-2010; Yerkovich, Stephanie/A-9004-2011	Chang, Anne/0000-0002-1331-3706; Upham, John/0000-0002-0017-3433; Yerkovich, Stephanie/0000-0003-4163-4782	Australian National Health and Medical Research Council [1038415, 545216, 511019]; Channel 7 Children's Research Foundation [13688]; Australian National Health and Medical Research Council Center for Research Excellence for Lung Health of Aboriginal and Torres Strait Islander [1040830]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Channel 7 Children's Research Foundation; Australian National Health and Medical Research Council Center for Research Excellence for Lung Health of Aboriginal and Torres Strait Islander(National Health and Medical Research Council (NHMRC) of Australia)	SP is funded by an Australian National Health and Medical Research Council postgraduate scholarship (1038415); AC (grant 545216) and JU (grant 511019) funded by Australian National Health and Medical Research Council practitioner fellowships (https://www.nhmrc.gov.au). The study was funded by Channel 7 Children's Research Foundation (grant 13688; http://www.crf.org.au) and supported by Australian National Health and Medical Research Council Center for Research Excellence for Lung Health of Aboriginal and Torres Strait Islander (grant 1040830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CR, 2011, J CLIN IMMUNOL, V31, P137, DOI 10.1007/s10875-010-9499-x; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Chalmers JD, 2012, AM J RESP CRIT CARE, V186, P657, DOI 10.1164/rccm.201203-0487OC; Chang AB, 2010, MED J AUSTRALIA, V193, P356, DOI 10.5694/j.1326-5377.2010.tb03949.x; Dunne EM, 2013, VACCINE, V31, P2333, DOI 10.1016/j.vaccine.2013.03.024; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Hales BJ, 2008, THORAX, V63, P221, DOI 10.1136/thx.2006.069492; Hales BJ, 2012, THORAX, V67, P321, DOI 10.1136/thoraxjnl-2011-200650; Hare KM, 2010, J PEDIATR-US, V157, P1001, DOI 10.1016/j.jpeds.2010.06.002; Heaton T, 2005, LANCET, V365, P142, DOI 10.1016/S0140-6736(05)17704-6; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Holt PG, 2005, J ALLERGY CLIN IMMUN, V116, P16, DOI 10.1016/j.jaci.2005.04.017; Hotomi M, 2005, VACCINE, V23, P1294, DOI 10.1016/j.vaccine.2004.08.042; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kapur N, 2012, PEDIATR PULM, V47, P300, DOI 10.1002/ppul.21550; Karadag B, 2005, RESPIRATION, V72, P233, DOI 10.1159/000085362; Kelly Martin G., 2003, Eur J Intern Med, V14, P488, DOI 10.1016/j.ejim.2003.10.002; King PT, 2007, RESP MED, V101, P1633, DOI 10.1016/j.rmed.2007.03.009; King PT, 2013, J ALLERGY CLIN IMMUN, V131, P1314, DOI 10.1016/j.jaci.2012.09.030; King PT, 2003, AM J RESP CRIT CARE, V167, P587, DOI 10.1164/rccm.200207-728OC; Lisciandro JG, 2012, J ALLERGY CLIN IMMUN, V130, P1167, DOI 10.1016/j.jaci.2012.06.005; Lisciandro JG, 2012, PEDIAT ALLERG IMM-UK, V23, P173, DOI 10.1111/j.1399-3038.2011.01242.x; Message SD, 2008, P NATL ACAD SCI USA, V105, P13562, DOI 10.1073/pnas.0804181105; Pfefferle PI, 2010, J ALLERGY CLIN IMMUN, V125, P108, DOI 10.1016/j.jaci.2009.09.019; Pickering J, 2013, J CLIN MICRO; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Rowe J, 2004, J ALLERGY CLIN IMMUN, V113, P710, DOI 10.1016/j.jaci.2003.12.585; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Singleton R, 2000, PEDIATR PULM, V29, P182, DOI 10.1002/(SICI)1099-0496(200003)29:3<182::AID-PPUL5>3.0.CO;2-T; Tulic MK, 2012, J ALLERGY CLIN IMMUN, V129, P199, DOI 10.1016/j.jaci.2011.10.016; Twiss J, 2005, ARCH DIS CHILD, V90, P737, DOI 10.1136/adc.2004.066472; Upham JW, 2002, INFECT IMMUN, V70, P6583, DOI 10.1128/IAI.70.12.6583-6588.2002; Wiertsema SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049061; Yerkovich ST, 2007, PEDIATR RES, V62, P547, DOI 10.1203/PDR.0b013e3181568105; Zheng L, 2000, EUR RESPIR J, V16, P691, DOI 10.1034/j.1399-3003.2000.16d21.x; Zhu XH, 2009, J IMMUNOL, V182, P3270, DOI 10.4049/jimmunol.0802622	36	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104236	10.1371/journal.pone.0104236	http://dx.doi.org/10.1371/journal.pone.0104236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111142	Green Submitted, Green Published, gold			2022-12-27	WOS:000341105100041
J	Ronat, JB; Kakol, J; Khoury, MN; Berthelot, M; Yun, O; Brown, V; Murphy, RA				Ronat, Jean-Baptiste; Kakol, Jabar; Khoury, Marwan N.; Berthelot, Mathilde; Yun, Oliver; Brown, Vincent; Murphy, Richard A.			Highly Drug-Resistant Pathogens Implicated in Burn-Associated Bacteremia in an Iraqi Burn Care Unit	PLOS ONE			English	Article								Objective: In low-and middle-income countries, bloodstream infections are an important cause of mortality in patients with burns. Increasingly implicated in burn-associated infections are highly drug-resistant pathogens with limited treatment options. We describe the epidemiology of bloodstream infections in patients with burns in a humanitarian surgery project in Iraq. Methods: We performed a retrospective, descriptive study of blood culture isolates identified between July 2008 and September 2009 among patients with burns in a single hospital in Iraq who developed sepsis. Results: In 1169 inpatients admitted to the burn unit during the study period, 212 (18%) had suspected sepsis, and 65 (6%) had confirmed bacteremia. Sepsis was considered the primary cause of death in 198 patients (65%; 95% CI 65-70) of the 304 patients that died. The most commonly isolated organisms were Pseudomonas aeruginosa (22 isolates [34%]), Staphylococcus aureus (17 [26%]), Klebsiella pneumoniae (8 [12%]), Staphylococcus epidermidis (7 [11%]), Acinetobacter baumannii (6 [9%]), and Enterobacter cloacae (5 [8%]). A high proportion of Enterobacteriaceae strains produced extended-spectrum beta-lactamase and S. aureus isolates were uniformly methicillin-resistant. For gram-negative bacteria, the most reliably active antibiotics were imipenen and amikacin. Conclusions: Burn patients with sepsis in Iraq were commonly found to have bloodstream pathogens resistant to most antibiotics available locally. Effective empirical therapy of burn sepsis in this region of Iraq would consist of vancomycin or teicoplanin and a carbapenem-class antibiotic with antipseudomonal activity.	[Ronat, Jean-Baptiste; Berthelot, Mathilde; Yun, Oliver; Brown, Vincent; Murphy, Richard A.] Med Sans Frontieres Doctors Without Borders, Paris, France; [Kakol, Jabar] Dept Hlth, Sulaymaniyah, Iraq; [Khoury, Marwan N.] Ibn Al Haytham Hosp, Amman, Jordan; [Murphy, Richard A.] Albert Einstein Coll Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Ronat, JB (corresponding author), Med Sans Frontieres Doctors Without Borders, Paris, France.	jean-baptiste.ronat@paris.msf.org		Murphy, Richard/0000-0003-2249-7452	Medecins Sans Frontiers/Doctors Without Borders	Medecins Sans Frontiers/Doctors Without Borders	This work was supported by Medecins Sans Frontiers/Doctors Without Borders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainaud P, 2007, RECOMMANDATIONS RELA; [Anonymous], 2008, M100S18 CLIN LAB STA; Bekeris LG, 2005, ARCH PATHOL LAB MED, V129, P1222; Broadhead J M, 2001, Crit Care Nurs Q, V24, P20; *CLIN LAB STAND I, 2006, M2A9 CLIN LAB STAND, V26; Forbes BA., 2007, BAILEY SCOTTS DIAGNO, V12th ed., P216; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lari Abdolaziz Rastegar, 2002, Journal of Burn Care & Rehabilitation, V23, P39; Lari AR, 2013, BURNS, V39, P174, DOI 10.1016/j.burns.2012.02.025; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; MANSON WL, 1992, J HOSP INFECT, V22, P55, DOI 10.1016/0195-6701(92)90130-E; Martin M A, 1993, New Horiz, V1, P162; O'Brien TF, 2001, CLIN INFECT DIS, V33, pS118, DOI 10.1086/321836; Othman N, 2010, THESIS U NOTTINGHAM; Ressner RA, 2008, J AM COLL SURGEONS, V206, P439, DOI 10.1016/j.jamcollsurg.2007.09.017	15	42	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e101017	10.1371/journal.pone.0101017	http://dx.doi.org/10.1371/journal.pone.0101017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111170	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100003
J	Sesti, G; Sciacqua, A; Fiorentino, TV; Perticone, M; Succurro, E; Perticone, F				Sesti, Giorgio; Sciacqua, Angela; Fiorentino, Teresa Vanessa; Perticone, Maria; Succurro, Elena; Perticone, Francesco			Association between Noninvasive Fibrosis Markers and Cardio-Vascular Organ Damage among Adults with Hepatic Steatosis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; LEFT-VENTRICULAR MASS; PLASMA-GLUCOSE LEVELS; TERM-FOLLOW-UP; INSULIN-RESISTANCE; NATURAL-HISTORY; RISK-FACTOR; NAFLD; POPULATION; INDEX	Evidence suggests that advanced fibrosis, as determined by the noninvasive NAFLD fibrosis score (NFS), is a predictor of cardiovascular mortality in individuals with ultrasonography-diagnosed NAFLD. Whether the severity of histology (i.e., fibrosis stage) is associated with more pronounced cardiovascular organ damage is unsettled. In this study, we analyzed the clinical utility of NFS in assessing increased carotid intima-media thickness (cIMT), and left ventricular mass index (LVMI). In this cross-sectional study NFS, cIMT and LVMI were assessed in 400 individuals with ultrasonography-diagnosed steatosis. As compared with individuals at low probability of liver fibrosis, individuals both at high and at intermediate probability of fibrosis showed an unfavorable cardio-metabolic risk profile having significantly higher values of waist circumference, insulin resistance, high sensitivity C-reactive protein (hsCRP), fibrinogen, cIMT, and LVMI, and lower insulin-like growth factor-1 (IGF-1) levels. The differences in cIMT and LVMI remained significant after adjustment for smoking and metabolic syndrome. In a logistic regression model adjusted for age, gender, smoking, and diagnosis of metabolic syndrome, individuals at high probability of fibrosis had a 3.9-fold increased risk of vascular atherosclerosis, defined as cIMT>0.9 mm, (OR 3.95, 95% CI 1.12-13.87) as compared with individuals at low probability of fibrosis. Individuals at high probability of fibrosis had a 3.5-fold increased risk of left ventricular hypertrophy (LVH) (OR 3.55, 95% CI 1.22-10.34) as compared with individuals at low probability of fibrosis. In conclusion, advanced fibrosis, determined by noninvasive fibrosis markers, is associated with cardiovascular organ damage independent of other known factors.	[Sesti, Giorgio; Sciacqua, Angela; Fiorentino, Teresa Vanessa; Perticone, Maria; Succurro, Elena; Perticone, Francesco] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy	Magna Graecia University of Catanzaro	Sesti, G (corresponding author), Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.	sesti@unicz.it	Succurro, Elena/K-4138-2016; Sesti, Giorgio/B-1509-2012; Perticone, Maria/J-9965-2016; Fiorentino, Teresa Vanessa/AAP-1855-2020; Perticone, Francesco/I-4260-2017	Succurro, Elena/0000-0003-2578-692X; Perticone, Maria/0000-0002-2456-1123; Sesti, Giorgio/0000-0002-1618-7688	Italian Ministry of University [FIRB/MERIT RBNE08NKH7_002]	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	This work was supported by Italian Ministry of University grant FIRB/MERIT RBNE08NKH7_002 to GS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Arturi F, 2011, J CLIN ENDOCR METAB, V96, pE1640, DOI 10.1210/jc.2011-1227; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Demir M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058360; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Genuth S, 2003, DIABETES CARE, V26, P3160; Goland S, 2006, J CLIN GASTROENTEROL, V40, P949, DOI 10.1097/01.mcg.0000225668.53673.e6; Harrison SA, 2008, GUT, V57, P1441, DOI 10.1136/gut.2007.146019; Hribal ML, 2013, J CLIN ENDOCR METAB, V98, pE304, DOI 10.1210/jc.2012-3290; Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Myers RP, 2008, LIVER INT, V28, P705, DOI 10.1111/j.1478-3231.2008.01691.x; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Schillaci G, 2000, HYPERTENSION, V35, P580, DOI 10.1161/01.HYP.35.2.580; Sciacqua A, 2011, NUTR METAB CARDIOVAS, V21, P485, DOI 10.1016/j.numecd.2009.11.015; Sciacqua A, 2011, DIABETES CARE, V34, P1406, DOI 10.2337/dc11-0155; Sesti G, 2013, NUTR METAB CARDIOVAS, V23, P1182, DOI 10.1016/j.numecd.2013.01.006; Sesti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088569; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Stepanova M, 2012, CLIN GASTROENTEROL H, V10, P646, DOI 10.1016/j.cgh.2011.12.039; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Succurro E, 2011, NUTR METAB CARDIOVAS, V21, P713, DOI 10.1016/j.numecd.2011.02.002; Succurro E, 2009, ATHEROSCLEROSIS, V207, P245, DOI 10.1016/j.atherosclerosis.2009.04.006; Targher G, 2006, DIABETES CARE, V29, P1325, DOI 10.2337/dc06-0135; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Treeprasertsuk S, 2013, WORLD J GASTROENTERO, V19, P1219, DOI 10.3748/wjg.v19.i8.1219; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yki-Jarvinen H, 2010, DIGEST DIS, V28, P203, DOI 10.1159/000282087	41	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104941	10.1371/journal.pone.0104941	http://dx.doi.org/10.1371/journal.pone.0104941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111713	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100112
J	Green, C; Richards, DA; Hill, JJ; Gask, L; Lovell, K; Chew-Graham, C; Bower, P; Cape, J; Pilling, S; Araya, R; Kessler, D; Bland, JM; Gilbody, S; Lewis, G; Manning, C; Hughes-Morley, A; Barkham, M				Green, Colin; Richards, David A.; Hill, Jacqueline J.; Gask, Linda; Lovell, Karina; Chew-Graham, Carolyn; Bower, Peter; Cape, John; Pilling, Stephen; Araya, Ricardo; Kessler, David; Bland, J. Martin; Gilbody, Simon; Lewis, Glyn; Manning, Chris; Hughes-Morley, Adwoa; Barkham, Michael			Cost-Effectiveness of Collaborative Care for Depression in UK Primary Care: Economic Evaluation of a Randomised Controlled Trial (CADET)	PLOS ONE			English	Article							HEALTH; METAANALYSIS; MANAGEMENT; COMMUNITY; DISORDER; GUIDE	Background: Collaborative care is an effective treatment for the management of depression but evidence on its cost-effectiveness in the UK is lacking. Aims: To assess the cost-effectiveness of collaborative care in a UK primary care setting. Methods: An economic evaluation alongside a multi-centre cluster randomised controlled trial comparing collaborative care with usual primary care for adults with depression (n = 581). Costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICER) were calculated over a 12-month follow-up, from the perspective of the UK National Health Service and Personal Social Services (i.e. Third Party Payer). Sensitivity analyses are reported, and uncertainty is presented using the cost-effectiveness acceptability curve (CEAC) and the cost-effectiveness plane. Results: The collaborative care intervention had a mean cost of 272.50 pound per participant. Health and social care service use, excluding collaborative care, indicated a similar profile of resource use between collaborative care and usual care participants. Collaborative care offered a mean incremental gain of 0.02 (95% CI: -0.02, 0.06) quality-adjusted life-years over 12 months, at a mean incremental cost of 270.72 pound (95% CI: -202.98, 886.04), and resulted in an estimated mean cost per QALY of 14,248 pound. Where costs associated with informal care are considered in sensitivity analyses collaborative care is expected to be less costly and more effective, thereby dominating treatment as usual. Conclusion: Collaborative care offers health gains at a relatively low cost, and is cost-effective compared with usual care against a decision-maker willingness to pay threshold of 20,000 per QALY gained. Results here support the commissioning of collaborative care in a UK primary care setting.	[Green, Colin; Richards, David A.] Univ Exeter, Sch Med, Exeter, Devon, England; [Hill, Jacqueline J.] Univ Exeter, Mood Disorders Ctr, Exeter, Devon, England; [Gask, Linda; Bower, Peter; Hughes-Morley, Adwoa] Univ Manchester, Inst Populat Hlth, Ctr Primary Care, Manchester, Lancs, England; [Lovell, Karina] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Chew-Graham, Carolyn] Keele Univ, Keele ST5 5BG, Staffs, England; [Cape, John; Pilling, Stephen] UCL, Res Dept Clin Educ & Hlth Psychol, London, England; [Araya, Ricardo; Kessler, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Bland, J. Martin] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Gilbody, Simon] Univ York, Hull York Med Sch, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Lewis, Glyn] UCL, Mental Hlth Sci Unit, London, England; [Manning, Chris] Upstream Healthcare, Teddington, Middx, England; [Barkham, Michael] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England	University of Exeter; University of Exeter; University of Manchester; University of Manchester; Keele University; University of London; University College London; University of Bristol; University of York - UK; University of Hull; University of York - UK; University of London; University College London; University of Sheffield	Green, C (corresponding author), Univ Exeter, Sch Med, Exeter, Devon, England.	c.green@exeter.ac.uk	Araya, Ricardo/S-3144-2019; Bower, Peter/A-1508-2011; Kessler, david/ABB-6489-2021; John, Cape/B-9039-2009; Lewis, Glyn/E-9944-2012; Lovell, Karina S E/E-6410-2012; Gilbody, Simon/AAY-3720-2021; Richards, David/B-4807-2009	Araya, Ricardo/0000-0002-0420-5148; Bower, Peter/0000-0001-9558-3349; John, Cape/0000-0003-3108-7228; Lewis, Glyn/0000-0001-5205-8245; Lovell, Karina S E/0000-0001-8821-895X; Gilbody, Simon/0000-0002-8236-6983; Barkham, Michael/0000-0003-1687-6376; Richards, David/0000-0002-8821-5027; Parker, Adwoa/0000-0002-2880-3935	UK Medical Research Council (MRC) [G0701013]; NIHR Collaboration for Leadership in Applied Health Research and Care South West Peninsula at the Royal Devon and Exeter NHS Foundation Trust; MRC [G0401181, G0701013] Funding Source: UKRI; Medical Research Council [G0401181, G0701013] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10203] Funding Source: researchfish	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Collaboration for Leadership in Applied Health Research and Care South West Peninsula at the Royal Devon and Exeter NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This report is independent research funded by the UK Medical Research Council (MRC; reference G0701013, www.mrc.ac.uk), managed by the National Institute for Health Research (NIHR, www.nihr.ac.uk), on behalf of the MRC-NIHR partnership. Research was supported by NIHR Collaboration for Leadership in Applied Health Research and Care South West Peninsula at the Royal Devon and Exeter NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GUID METH TECHN APPR; Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 2007, MEASURING VALUING HL; Briggs A, 2006, DECISION MODELLING H; Byford S, 2007, HEALTH ECON, V16, P531, DOI 10.1002/hec.1175; Curtis L, 2015, UNIT COSTS HLTH SOCI; Department for Communities and Local Government, 2008, ENGL IND MULT DEPR 2; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Ekers D, 2008, PSYCHOL MED, V38, P611, DOI 10.1017/S0033291707001614; EuroQol Group, 1996, EQ 5D US GUID; Fenwick E, 2005, BRIT J PSYCHIAT, V187, P106, DOI 10.1192/bjp.187.2.106; Gask L, 2005, SOC SCI MED, V61, P1785, DOI 10.1016/j.socscimed.2005.03.038; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gilbody S, 2006, BRIT J PSYCHIAT, V189, P297, DOI 10.1192/bjp.bp.105.016006; Gunn J, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-88; Hollinghurst S, 2010, BRIT J PSYCHIAT, V197, P297, DOI 10.1192/bjp.bp.109.073080; Irvin JE, 1999, J CONSULT CLIN PSYCH, V67, P563, DOI 10.1037/0022-006X.67.4.563; Jacob V, 2012, AM J PREV MED, V42, P539, DOI 10.1016/j.amepre.2012.01.011; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lairson DR, 2009, EPILEPSY RES, V87, P59, DOI 10.1016/j.eplepsyres.2009.07.010; Lawton-Smith M, 2008, COST MENTAL HLTH CAR; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Mann R, 2009, SOC PSYCH PSYCH EPID, V44, P569, DOI 10.1007/s00127-008-0463-5; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Meltzer H, 1995, 2 HMSO; Mukuria C, 2013, BRIT J PSYCHIAT, V202, P220, DOI 10.1192/bjp.bp.111.107888; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; Petrou S, 2002, INT J TECHNOL ASSESS, V18, P705, DOI 10.1017/S026646230200051X; Priebe, 2006, DEPRESSION REPORT NE; Richards DA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4913; Richards DA, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-188; Romeo R, 2013, BRIT J PSYCHIAT, V202, P121, DOI 10.1192/bjp.bp.112.115212; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Ware J., 1993, SF 36 HLTH SURVEY MA; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wolinsky FD, 2007, MED CARE, V45, P300, DOI 10.1097/01.mlr.0000254576.26353.09	42	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104225	10.1371/journal.pone.0104225	http://dx.doi.org/10.1371/journal.pone.0104225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO0QT	25121991	Green Accepted, Green Published, gold			2022-12-27	WOS:000341017000032
J	Leal, MF; Belangero, PS; Cohen, C; Figueiredo, EA; Loyola, LC; Pochini, AC; Smith, MC; Andreoli, CV; Belangero, SI; Ejnisman, B; Cohen, M				Leal, Mariana Ferreira; Belangero, Paulo Santoro; Cohen, Carina; Figueiredo, Eduardo Antonio; Loyola, Leonor Casilla; Pochini, Alberto Castro; Smith, Marilia Cardoso; Andreoli, Carlos Vicente; Belangero, Sintia Iole; Ejnisman, Benno; Cohen, Moises			Identification of Suitable Reference Genes for Gene Expression Studies of Shoulder Instability	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; REAL-TIME PCR; HOUSEKEEPING GENES; MATRIX MOLECULES; ROTATOR CUFF; NORMALIZATION; DISLOCATION; MANAGEMENT; LIGAMENTS; COLLAGEN	Shoulder instability is a common shoulder injury, and patients present with plastic deformation of the glenohumeral capsule. Gene expression analysis may be a useful tool for increasing the general understanding of capsule deformation, and reverse-transcription quantitative polymerase chain reaction (RT-qPCR) has become an effective method for such studies. Although RT-qPCR is highly sensitive and specific, it requires the use of suitable reference genes for data normalization to guarantee meaningful and reproducible results. In the present study, we evaluated the suitability of a set of reference genes using samples from the glenohumeral capsules of individuals with and without shoulder instability. We analyzed the expression of six commonly used reference genes (ACTB, B2M, GAPDH, HPRT1, TBP and TFRC) in the antero-inferior, antero-superior and posterior portions of the glenohumeral capsules of cases and controls. The stability of the candidate reference gene expression was determined using four software packages: NormFinder, geNorm, BestKeeper and DataAssist. Overall, HPRT1 was the best single reference gene, and HPRT1 and B2M composed the best pair of reference genes from different analysis groups, including simultaneous analysis of all tissue samples. GenEx software was used to identify the optimal number of reference genes to be used for normalization and demonstrated that the accumulated standard deviation resulting from the use of 2 reference genes was similar to that resulting from the use of 3 or more reference genes. To identify the optimal combination of reference genes, we evaluated the expression of COL1A1. Although the use of different reference gene combinations yielded variable normalized quantities, the relative quantities within sample groups were similar and confirmed that no obvious differences were observed when using 2, 3 or 4 reference genes. Consequently, the use of 2 stable reference genes for normalization, especially HPRT1 and B2M, is a reliable method for evaluating gene expression by RT-qPCR.	[Leal, Mariana Ferreira; Belangero, Paulo Santoro; Cohen, Carina; Figueiredo, Eduardo Antonio; Loyola, Leonor Casilla; Pochini, Alberto Castro; Andreoli, Carlos Vicente; Ejnisman, Benno; Cohen, Moises] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Leal, Mariana Ferreira; Loyola, Leonor Casilla; Smith, Marilia Cardoso; Belangero, Sintia Iole] Univ Fed Sao Paulo, Dept Morfol & Genet, Disciplina Genet, Sao Paulo, Brazil; [Belangero, Sintia Iole] Univ Fed Sao Paulo, Dept Psiquiatria, Lab Interdisciplinar Neurociencia Clin, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Leal, MF (corresponding author), Univ Fed Sao Paulo, Sao Paulo, Brazil.	mariana.morf@epm.br	Andreoli, Carlos Vicente/AAW-1228-2021; de A. C. Smith, Marilia/C-4397-2012; Belangero, Paulo/AAD-8299-2021; Belangero, Sintia I/A-6818-2009; Leal, Mariana/C-4010-2012; Ejnisman, Benno/J-1556-2015	de A. C. Smith, Marilia/0000-0002-1441-1033; Belangero, Sintia I/0000-0002-2419-4351; Leal, Mariana/0000-0003-4375-2563; Ejnisman, Benno/0000-0002-3301-1457	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; MC and MACS) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; MFL, and MC) as grants and fellowship awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bramono DS, 2005, CONNECT TISSUE RES, V46, P53, DOI 10.1080/03008200590935556; Burkart AC, 2002, CLIN ORTHOP RELAT R, P32; Buss DD, 2004, AM J SPORT MED, V32, P1430, DOI 10.1177/0363546503262069; Bustin SA, 2005, CLIN SCI, V109, P365, DOI 10.1042/CS20050086; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Clements DN, 2008, OSTEOARTHR CARTILAGE, V16, P195, DOI 10.1016/j.joca.2007.06.013; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Eriksen HA, 2002, J ORTHOPAED RES, V20, P1352, DOI 10.1016/S0736-0266(02)00064-5; Fu J, 2010, ACTA BIOCH BIOPH SIN, V42, P568, DOI 10.1093/abbs/gmq062; Gohlke F, 1994, J Shoulder Elbow Surg, V3, P111, DOI 10.1016/S1058-2746(09)80090-6; Hayes K, 2002, J ORTHOP SPORT PHYS, V32, P497, DOI 10.2519/jospt.2002.32.10.497; HOVELIUS L, 1983, J BONE JOINT SURG AM, V65, P343, DOI 10.2106/00004623-198365030-00008; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; KALTSAS DS, 1983, CLIN ORTHOP RELAT R, P20; KAZAR, 1969, ACTA ORTHOP SCAND, V40, P216, DOI 10.3109/17453676908989501; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Larrain MV, 2001, ARTHROSCOPY, V17, P373, DOI 10.1053/jars.2001.23226; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Lo IKY, 2003, CLIN ORTHOP RELAT R, P249, DOI 10.1097/01.blo.0000037442.23683.35; Lo IKY, 2005, ARTHROSCOPY, V21, P645, DOI 10.1016/j.arthro.2005.03.008; Lo IKY, 1998, J ORTHOPAED RES, V16, P421, DOI 10.1002/jor.1100160405; Lyng MB, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-20; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pombo-Suarez M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-17; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Shirachi I, 2011, ARTHROSCOPY, V27, P1173, DOI 10.1016/j.arthro.2011.03.078; te Slaa RL, 2004, J BONE JOINT SURG BR, V86B, P58, DOI 10.1302/0301-620X.86B1.13695; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Q, 2012, INT J LEGAL MED, V126, P943, DOI 10.1007/s00414-012-0774-7; Wang VM, 2005, J SHOULDER ELB SURG, V14, p2S, DOI 10.1016/j.jse.2004.10.002; Wisnieski F, 2013, WORLD J GASTROENTERO, V19, P7121, DOI 10.3748/wjg.v19.i41.7121; Xu YH, 2008, CLIN ORTHOP RELAT R, V466, P1528, DOI 10.1007/s11999-008-0286-4; Yuzbasioglu A, 2010, EXP MOL PATHOL, V88, P326, DOI 10.1016/j.yexmp.2009.12.007; Zhou ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088892	37	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105002	10.1371/journal.pone.0105002	http://dx.doi.org/10.1371/journal.pone.0105002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122470	Green Submitted, Green Published, gold			2022-12-27	WOS:000341017000084
J	Shen, Y; Zhao, J; Yao, PJ; Miao, HM; Niu, LL; Wang, XY; Zhou, XT				Shen, Yang; Zhao, Jing; Yao, Peijun; Miao, Huamao; Niu, Lingling; Wang, Xiaoying; Zhou, Xingtao			Changes in Corneal Deformation Parameters after Lenticule Creation and Extraction during Small Incision Lenticule Extraction (SMILE) Procedure	PLOS ONE			English	Article							LASER-ASSISTED LASIK; HUMAN DONOR EYES; FEMTOSECOND LASER; INTRAOCULAR-PRESSURE; NONCONTACT TONOMETRY; MYOPIA	Purpose: To investigate the effects of lenticule creation and subsequent corneal lenticule extraction on corneal deformation parameters during small incision lenticule extraction (SMILE) procedure. Materials and Methods: In this prospective study, 18 eyes of 10 patients (27.90 +/- 7.11 years, -5.64 +/- 2.45 diopters) scheduled for SMILE procedure were enrolled. Changes in the corneal deformation parameters, including deformation amplitude (DA), applanation time(AT1 and AT2), applanation length(AL1 and AL2), corneal velocity(CV1 and CV2), peak distance(P.Dist.), radius and intraocular pressure values were measured preoperatively, immediately after lenticule creation and subsequent to corneal lenticule extraction in all eyes with the Corvis Scheimpflug Technology (Corvis ST, OCULUS, Wetzlar, Germany). Repeated measures analysis of variance (ANOVA) with bonferroni-adjusted post hoc comparisons was performed to investigate changes following each step of the procedure. Results: All surgical procedures were uneventful. A significant difference was detected among the three time points (preoperation, post-lenticule creation and post lenticule extraction) for AT1 (P<0.001), AT2 (P=0.001), DA(P<0.001), and IOP(P=0.002). Bonferroni-adjusted post hoc comparisons indicated that there was no significant change in AT1, AT2, DA, or IOP after lenticule creation (post hoc P>0.05), but there was a significant change in these parameters following subsequent corneal lenticule extraction (post hoc P<0.01), when compared to values obtained pre-operatively. The scheimpflug camera of the Corvis ST demonstrated the intralamellar small gas bubbles formed from the vaporisation of tissue after lenticule creation and a gray zone was observed between the cap and the residual stromal bed after lenticule extraction. Conclusions: There is a significant change in corneal deformation parameters following SMILE procedure. The changes may be caused predominantly by stromal lenticule extraction, while lenticule creation with femtosecond laser may not have an obvious effect on corneal deformation properties.	[Shen, Yang; Zhao, Jing; Yao, Peijun; Miao, Huamao; Niu, Lingling; Wang, Xiaoying; Zhou, Xingtao] Fudan Univ, EYE & ENT Hosp, Dept Ophthalmol, Key Lab Myopia,Minsit Hlth, Shanghai 200433, Peoples R China	Fudan University	Wang, XY (corresponding author), Fudan Univ, EYE & ENT Hosp, Dept Ophthalmol, Key Lab Myopia,Minsit Hlth, Shanghai 200433, Peoples R China.	xiaoyingbbb@163.com; doctzhouxingtao@163.com	zhou, xt/GWZ-9212-2022; Shen, Yang/R-3539-2016	Shen, Yang/0000-0002-5859-0790	Natural Science Foundation of China [11074052]; Key Project of Science and Technology of Shanghai [11JC1402000]; Excellent Academic Leader Project of Shanghai Committee of Science and Technology [12XD1401600]; Outstanding Academic Leaders Program of Shanghai [XBR2013098]; Guiding Project of Shanghai Committee of Science and Technology [09411962100]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology of Shanghai; Excellent Academic Leader Project of Shanghai Committee of Science and Technology; Outstanding Academic Leaders Program of Shanghai; Guiding Project of Shanghai Committee of Science and Technology	This study was supported by Natural Science Foundation of China (Grant No. 11074052); The Key Project of Science and Technology of Shanghai (Grant No. 11JC1402000); The Excellent Academic Leader Project of Shanghai Committee of Science and Technology (Grant No. 12XD1401600); The Outstanding Academic Leaders Program of Shanghai (Grant No. XBR2013098); The Guiding Project of Shanghai Committee of Science and Technology (Grant No. 09411962100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio R, 2010, J REFRACT SURG, V26, P906, DOI 10.3928/1081597X-20100428-02; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; Faria-Correia F, 2013, J REFRACT SURG, V29, P356, DOI 10.3928/1081597X-20130129-03; Hon Y, 2013, OPTOMETRY VISION SCI, V90, pE1, DOI 10.1097/OPX.0b013e318279eb87; Hong JX, 2013, INVEST OPHTH VIS SCI, V54, P659, DOI 10.1167/iovs.12-10984; Li MY, 2014, J REFRACT SURG, V30, P94, DOI 10.3928/1081597X-20140120-04; Luce DA, 2005, J CATARACT REFR SURG, V31, P156, DOI 10.1016/j.jcrs.2004.10.044; Nemeth G, 2013, J REFRACT SURG, V29, P558, DOI 10.3928/1081597X-20130719-06; Pepose JS, 2007, AM J OPHTHALMOL, V143, P39, DOI 10.1016/j.ajo.2006.09.036; Reznicek L, 2013, BRIT J OPHTHALMOL, V97, P1410, DOI 10.1136/bjophthalmol-2013-303400; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Shen Y, 2014, J REFRACT SURG, V30, P310, DOI 10.3928/1081597X-20140422-01; Shin J, 2013, J GLAUCOMA IN PRESS; Strohmaier C, 2013, INVEST OPHTH VIS SCI, V54, P522, DOI 10.1167/iovs.12-11155; Uzbek AK, 2011, CURR EYE RES, V36, P614, DOI 10.3109/02713683.2010.546952; Vetter JM, 2012, J CATARACT REFR SURG, V38, P2011, DOI 10.1016/j.jcrs.2012.05.042	16	33	36	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103893	10.1371/journal.pone.0103893	http://dx.doi.org/10.1371/journal.pone.0103893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121508	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000022
J	Boyack, KW; Chen, MC; Chacko, G				Boyack, Kevin W.; Chen, Mei-Ching; Chacko, George			Characterization of the Peer Review Network at the Center for Scientific Review, National Institutes of Health	PLOS ONE			English	Review							COCITATION ANALYSIS; SCIENCE; MAPS; FIELDS	The National Institutes of Health (NIH) is the largest source of funding for biomedical research in the world. This funding is largely effected through a competitive grants process. Each year the Center for Scientific Review (CSR) at NIH manages the evaluation, by peer review, of more than 55,000 grant applications. A relevant management question is how this scientific evaluation system, supported by finite resources, could be continuously evaluated and improved for maximal benefit to the scientific community and the taxpaying public. Towards this purpose, we have created the first system-level description of peer review at CSR by applying text analysis, bibliometric, and graph visualization techniques to administrative records. We identify otherwise latent relationships across scientific clusters, which in turn suggest opportunities for structural reorganization of the system based on expert evaluation. Such studies support the creation of monitoring tools and provide transparency and knowledge to stakeholders.	[Boyack, Kevin W.] SciTech Strategies Inc, Albuquerque, NM USA; [Chen, Mei-Ching; Chacko, George] NIH, Off Planning Anal & Evaluat, Ctr Sci Review, Bethesda, MD 20892 USA; [Chacko, George] Univ Illinois, Off Vice Chancellor Res, Champaign, IL USA; [Chacko, George] Univ Illinois, Grad Sch Lib & Informat Sci, Champaign, IL USA	National Institutes of Health (NIH) - USA; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Chacko, G (corresponding author), NIH, Off Planning Anal & Evaluat, Ctr Sci Review, Bldg 10, Bethesda, MD 20892 USA.	george.chacko@nih.gov	Chacko, George/I-4945-2014	Chacko, George/0000-0002-2127-1892; Boyack, Kevin/0000-0001-7814-8951; Chen, Mei-Ching/0000-0002-7220-9773	US government [HHSN268201200369P, HHSN268200800281U]; Office of Planning, Analysis, and Evaluation, Center for Scientific Review, National Institutes of Health, United States Department of Health and Human Services	US government; Office of Planning, Analysis, and Evaluation, Center for Scientific Review, National Institutes of Health, United States Department of Health and Human Services	The effort contributed by SciTech Strategies was partially supported by US government contracts HHSN268201200369P and HHSN268200800281U. The Office of Planning, Analysis, and Evaluation, Center for Scientific Review, National Institutes of Health, United States Department of Health and Human Services, provided all other support for this study.	Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Bollen J, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006022, 10.1371/journal.pone.0004803]; Borner K, 2003, ANNU REV INFORM SCI, V37, P179, DOI 10.1002/aris.1440370106; Boyack KW, 2008, J INFORMETR, V2, P173, DOI 10.1016/j.joi.2008.03.001; Boyack KW, 2014, J ASSOC INF SCI TECH, V65, P670, DOI 10.1002/asi.22990; Boyack KW, 2013, EUR J CLIN INVEST, V43, P1339, DOI 10.1111/eci.12171; Boyack KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018029; Boyack KW, 2010, J AM SOC INF SCI TEC, V61, P2389, DOI 10.1002/asi.21419; Boyack KW, 2005, SCIENTOMETRICS, V64, P351, DOI 10.1007/s11192-005-0255-6; CALLON M, 1983, SOC SCI INFORM, V22, P191, DOI 10.1177/053901883022002003; Kamada T, 1988, INFORM PROCESSING LE, V31, P7; Kay L, 2014, J ASSOC INF SCI TECH, V65, P2432, DOI 10.1002/asi.23146; Klavans R, 2006, J AM SOC INF SCI TEC, V57, P251, DOI 10.1002/asi.20274; Klavans R, 2006, SCIENTOMETRICS, V68, P475, DOI 10.1007/s11192-006-0125-x; Klavans R, 2011, J AM SOC INF SCI TEC, V62, P1, DOI 10.1002/asi.21444; Klavans R, 2009, J AM SOC INF SCI TEC, V60, P455, DOI 10.1002/asi.20991; Mandel Richard, 1996, HALF CENTURY PEER RE; Martin S, 2011, PROC SPIE, V7868, DOI 10.1117/12.871402; National Institutes of Health, 1988, NIH GUID, V17; Rafols I, 2010, J AM SOC INF SCI TEC, V61, P1871, DOI 10.1002/asi.21368; Rinia EJ, 2002, SCIENTOMETRICS, V54, P347, DOI 10.1023/A:1016078331752; Salton G., 1989, AUTOMATIC TEXT PROCE, VVolume 169; Smalheiser NR, 2009, ANNU REV INFORM SCI, V43, P287; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; Talley EM, 2011, NAT METHODS, V8, P443, DOI 10.1038/nmeth.1619; White HD, 1998, J AM SOC INFORM SCI, V49, P327, DOI 10.1002/(SICI)1097-4571(19980401)49:4<327::AID-ASI4>3.0.CO;2-W	26	3	3	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104244	10.1371/journal.pone.0104244	http://dx.doi.org/10.1371/journal.pone.0104244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9BM	25119140	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600043
J	Griebe, M; Amann, M; Hirsch, JG; Achtnichts, L; Hennerici, MG; Gass, A; Szabo, K				Griebe, Martin; Amann, Michael; Hirsch, Jochen G.; Achtnichts, Lutz; Hennerici, Michael G.; Gass, Achim; Szabo, Kristina			Reduced Functional Reserve in Patients with Age-Related White Matter Changes: A Preliminary fMRI Study of Working Memory	PLOS ONE			English	Article							LESIONS; RECRUITMENT; DISEASE	Subcortical age-related white matter changes (ARWMC) are a frequent finding in healthy elderly people suggested to cause secondary tissue changes and possibly affecting cognitive processes. We aimed to determine the influence of the extent of ARWMC load on attention and working memory processes in healthy elderly individuals. Fourteen healthy elderly subjects (MMSE >26; age 55-80 years) performed three fMRI tasks with increasing difficulty assessing alertness, attention (0-back), and working memory (2-back). We compared activation patterns in those with only minimal ARWMC (Fazekas 0-1) to those with moderate to severe ARWMC (Fazekas 2-3). During the fMRI experiments, the study population showed activation in brain areas typically involved in attention and working memory with a recruitment of cortical areas with increasing task difficulty. Subjects with higher lesion load showed a higher activation at all task levels with only sparse increase of signal with increasing complexity. In the lower lesion load group, rising task difficulty lead to a significant and widely distributed increase of activation. Although the number of patients included in the study is small, these findings suggest that even clinically silent ARWMC may affect cognitive processing and lead to compensatory activation during cognitive tasks. This can be interpreted as a reduction of functional reserve and may pose a risk for cognitive decline in these patients.	[Griebe, Martin; Hennerici, Michael G.; Gass, Achim; Szabo, Kristina] Heidelberg Univ, Univ Med Mannheim, MR Res Neurol, Dept Neurol, Mannheim, Germany; [Amann, Michael; Achtnichts, Lutz] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Amann, Michael] Dept Radiol, Div Diagnost & Intervent Neuroradiol, Basel, Switzerland; [Hirsch, Jochen G.] Fraunhofer MEVIS, Inst Med Image Comp, Bremen, Germany	Ruprecht Karls University Heidelberg; University of Basel	Griebe, M (corresponding author), Heidelberg Univ, Univ Med Mannheim, MR Res Neurol, Dept Neurol, Mannheim, Germany.	griebe@neuro.ma.uni-heidelberg.de	Szabo, Kristina/AAE-7978-2021		Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich (SFB) 636]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (DFG), Sonderforschungsbereich (SFB) 636. URL: http://www.sfb636.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2011, HUM BRAIN MAPP, V32, P1704, DOI 10.1002/hbm.21142; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; BRETELER MMB, 1994, NEUROLOGY, V44, P1246, DOI 10.1212/WNL.44.7.1246; Cader S, 2006, BRAIN, V129, P527, DOI 10.1093/brain/awh670; Charlton RA, 2008, NEUROBIOL AGING, V29, P1547, DOI 10.1016/j.neurobiolaging.2007.03.017; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Cook IA, 2002, ARCH NEUROL-CHICAGO, V59, P1612, DOI 10.1001/archneur.59.10.1612; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Eyler LT, 2011, BIOL PSYCHIAT, V70, P115, DOI 10.1016/j.biopsych.2010.12.032; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Griebe M, 2011, J NEUROL, V258, P1451, DOI 10.1007/s00415-011-5956-6; Guttmann CRG, 2000, NEUROLOGY, V54, P1277, DOI 10.1212/WNL.54.6.1277; Kalpouzos G, 2012, NEUROBIOL AGING, V33, pe621; Kalpouzos G, 2012, NEUROBIOL AGING, V33, pe613; Kalpouzos G, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.021; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Linortner P, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.06.005; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; McIntosh AR, 1999, CURR BIOL, V9, P1275, DOI 10.1016/S0960-9822(99)80512-0; Nordahl CW, 2006, J COGNITIVE NEUROSCI, V18, P418, DOI 10.1162/089892906775990552; O'Brien JT, 2002, ANN NY ACAD SCI, V977, P436, DOI 10.1111/j.1749-6632.2002.tb04849.x; Prakash RS, 2012, BEHAV BRAIN RES, V230, P192, DOI 10.1016/j.bbr.2012.01.058; Roski C, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00067; Schulze Evan T, 2011, J Aging Res, V2011, P606871, DOI 10.4061/2011/606871; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Spreng RN, 2010, NEUROSCI BIOBEHAV R, V34, P1178, DOI 10.1016/j.neubiorev.2010.01.009; Talairach J., 1988, COPLANAR STEREOTAXIC; Thirion B, 2007, NEUROIMAGE, V35, P105, DOI 10.1016/j.neuroimage.2006.11.054; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wei P, 2013, NEUROSCIENCE, V250, P372, DOI 10.1016/j.neuroscience.2013.07.025	33	12	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103359	10.1371/journal.pone.0103359	http://dx.doi.org/10.1371/journal.pone.0103359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119565	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600022
J	Jia, L; Zhang, DY; Qi, XW; Ma, B; Xiang, ZH; He, NJ				Jia, Ling; Zhang, Dayan; Qi, Xiwu; Ma, Bi; Xiang, Zhonghuia; He, Ningjia			Identification of the Conserved and Novel miRNAs in Mulberry by High-Throughput Sequencing	PLOS ONE			English	Article							AUXIN RESPONSE FACTORS; SHOOT APICAL MERISTEM; SMALL RNAS; ARABIDOPSIS-THALIANA; FLORAL DEVELOPMENT; MICRORNA; BIOGENESIS; EXPRESSION; GENES; EVOLUTION	miRNAs are a class of non-coding endogenous small RNAs. They play vital roles in plant growth, development, and response to biotic and abiotic stress by negatively regulating genes. Mulberry trees are economically important species with multiple uses. However, to date, little is known about mulberry miRNAs and their target genes. In the present study, three small mulberry RNA libraries were constructed and sequenced using high-throughput sequencing technology. Results showed 85 conserved miRNAs belonging to 31 miRNA families and 262 novel miRNAs at 371 loci. Quantitative real-time PCR (qRT-PCR) analysis confirmed the expression pattern of 9 conserved and 5 novel miRNAs in leaves, bark, and male flowers. A total of 332 potential target genes were predicted to be associated with these 113 novel miRNAs. These results provide a basis for further understanding of mulberry miRNAs and the biological processes in which they are involved.	[Jia, Ling; Zhang, Dayan; Qi, Xiwu; Ma, Bi; Xiang, Zhonghuia; He, Ningjia] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	He, NJ (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	hejia@swu.edu.cn	Ma, Bi/G-9227-2018	Ma, Bi/0000-0002-3596-8949	National Hi-Tech Research and Development Program of China [2013AA100605-3]; "111" Project [B12006]; Science Fund for Distinguished Young Scholars of Chongqing [cstc2011jjjq0010]; Chong Qing Science & Technology Commission [cstc2012jjys80001]	National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); "111" Project(Ministry of Education, China - 111 Project); Science Fund for Distinguished Young Scholars of Chongqing; Chong Qing Science & Technology Commission(Natural Science Foundation Project of CQ CSTC)	This project was funded by the research grants from the National Hi-Tech Research and Development Program of China (No. 2013AA100605-3), the "111" Project (B12006), the Science Fund for Distinguished Young Scholars of Chongqing (Grant No. cstc2011jjjq0010), and Chong Qing Science & Technology Commission (NO. cstc2012jjys80001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chi XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027530; Clement WL, 2009, SYST BOT, V34, P530, DOI 10.1600/036364409789271155; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Ge AJ, 2012, PHYSIOL PLANTARUM, V148, P387; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; He NJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3445; Jung J, 2007, PLANTA, V225, P575, DOI 10.1007/s00425-006-0373-2; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Ling Shuang, 2010, Zhongguo Zhong Yao Za Zhi, V35, P3024; Liu CJ, 2012, FOOD CHEM TOXICOL, V50, P3032, DOI 10.1016/j.fct.2012.06.016; Liu XD, 2010, PLANT J, V62, P416, DOI 10.1111/j.1365-313X.2010.04164.x; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Tan Yongxia, 2010, Zhongguo Zhong Yao Za Zhi, V35, P2700; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang FD, 2012, MOL GENET GENOMICS, V287, P555, DOI 10.1007/s00438-012-0699-3; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Wang Y, 2011, PLANT CELL, V23, P3185, DOI 10.1105/tpc.111.088013; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xu L, 2013, PLANT SCI, V201, P108, DOI 10.1016/j.plantsci.2012.11.010; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010	52	36	44	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104409	10.1371/journal.pone.0104409	http://dx.doi.org/10.1371/journal.pone.0104409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118991	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600055
J	Jones, J; Higham, TFG; Oldfield, R; O'Connor, TP; Buckley, SA				Jones, Jana; Higham, Thomas F. G.; Oldfield, Ron; O'Connor, Terry P.; Buckley, Stephen A.			Evidence for Prehistoric Origins of Egyptian Mummification in Late Neolithic Burials	PLOS ONE			English	Article							ISOPRENOID FATTY-ACIDS; DEAD-SEA ASPHALT; ORGANIC-CHEMISTRY; MARINE SPONGES; ANCIENT-EGYPT; MUMMIES; LIPIDS; STEREOCHEMISTRY; DISTRIBUTIONS; LIGNIN	Traditional theories on ancient Egyptian mummification postulate that in the prehistoric period (i.e. the Neolithic and Chalcolithic periods, 5th and 4th millennia B.C.) bodies were naturally desiccated through the action of the hot, dry desert sand. Although molding of the body with resin-impregnated linen is believed to be an early Pharaonic forerunner to more complex processes, scientific evidence for the early use of resins in artificial mummification has until now been limited to isolated occurrences during the late Old Kingdom (c. 2200 B.C.), their use becoming more apparent during the Middle Kingdom (c. 2000-1600 BC). We examined linen wrappings from bodies in securely provenanced tombs (pit graves) in the earliest recorded ancient Egyptian cemeteries at Mostagedda in the Badari region (Upper Egypt). Our investigations of these prehistoric funerary wrappings using a combination of gas chromatography-mass spectrometry (GC-MS) and thermal desorption/pyrolysis (TD/Py)-GC-MS have identified a pine resin, an aromatic plant extract, a plant gum/sugar, a natural petroleum source, and a plant oil/animal fat in directly AMS-dated funerary wrappings. Predating the earliest scientific evidence by more than a millennium, these embalming agents constitute complex, processed recipes of the same natural products, in similar proportions, as those utilized at the zenith of Pharaonic mummification some 3,000 years later. The antibacterial properties of some of these ingredients and the localized soft-tissue preservation that they would have afforded lead us to conclude that these represent the very beginnings of experimentation that would evolve into the famous mummification practice of the Pharaonic period.	[Jones, Jana] Macquarie Univ, Fac Arts, Dept Ancient Hist, Sydney, NSW 2109, Australia; [Higham, Thomas F. G.] Univ Oxford, Oxford Radiocarbon Accelerator Unit, Res Lab Archaeol & Hist Art, Oxford, England; [Oldfield, Ron] Macquarie Univ, Fac Sci, Dept Biol Sci, Sydney, NSW 2109, Australia; [O'Connor, Terry P.; Buckley, Stephen A.] Univ York, Dept Archaeol, York YO10 5DD, N Yorkshire, England; [Buckley, Stephen A.] Univ York, Dept Archaeol, BioArch, York YO10 5DD, N Yorkshire, England; [Buckley, Stephen A.] Univ York, Dept Biol & Chem, York YO10 5DD, N Yorkshire, England	Macquarie University; University of Oxford; Macquarie University; University of York - UK; University of York - UK; University of York - UK	Buckley, SA (corresponding author), Univ York, Dept Archaeol, York YO10 5DD, N Yorkshire, England.	sb55@york.ac.uk	Higham, Tom/Y-2707-2019	Higham, Tom/0000-0002-5949-598X	Wellcome Trust [WT074315]; National Endowment for Science Technology and the Arts (NESTA); Macquarie University	Wellcome Trust(Wellcome TrustEuropean Commission); National Endowment for Science Technology and the Arts (NESTA)(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Macquarie University	Support for this research has been provided by: Professor Joann Fletcher and Pharos Research (SAB); The Wellcome Trust (Grant Number WT074315) (http://www.wellcome.ac.uk) (SAB); The National Endowment for Science Technology and the Arts (NESTA) (http://www.nesta.org.uk) (SAB); and Macquarie University (JJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKMAN RG, 1968, COMP BIOCHEM PHYSIOL, V24, P549, DOI 10.1016/0010-406X(68)91008-6; Aiello A, 2003, STEROIDS, V68, P719, DOI 10.1016/S0039-128X(03)00098-9; Aufderheide AC, 2003, SCI STUDY MUMMIES, P253; BARNATHAN G, 1993, J NAT PROD, V56, P2104, DOI 10.1021/np50102a012; Beck CW., 1999, ANCIENT BIOMOLECULES, V2, P281; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; BONINI C, 1983, J ORG CHEM, V48, P2108, DOI 10.1021/jo00160a039; BRIGGS DEG, 1994, CHEM BRIT, V30, P907; Brunton G., 1937, MOSTAGEDDA TASIAN CU; Brunton G, 1928, BADARIAN CIVILISATIO, P19; Buckley SA, 1999, ANALYST, V124, P443, DOI 10.1039/a809022j; Buckley SA, 2004, NATURE, V431, P294, DOI 10.1038/nature02849; Buckley SA, 2001, NATURE, V413, P837, DOI 10.1038/35101588; CARBALLEIRA NM, 1987, LIPIDS, V22, P767, DOI 10.1007/BF02533980; CLIFFORD DJ, 1995, ORG GEOCHEM, V23, P169, DOI 10.1016/0146-6380(94)00109-E; CLIFTON CG, 1990, APPL GEOCHEM, V5, P169, DOI 10.1016/0883-2927(90)90047-9; Colombini MP, 2000, STUD CONSERV, V45, P19, DOI 10.2307/1506680; CONNAN J, 1992, GEOCHIM COSMOCHIM AC, V56, P2743, DOI 10.1016/0016-7037(92)90357-O; CONNAN J, 1991, RECHERCHE, V22, P1503; Craig OE, 2011, P NATL ACAD SCI USA, V108, P17910, DOI 10.1073/pnas.1107202108; David A. R., 2000, ANCIENT EGYPTIAN MAT, P373; Dee M, 2000, NUCL INSTRUM METH B, V172, P449, DOI 10.1016/S0168-583X(00)00337-2; Dee M, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2013.0395; del Rio JC, 2011, J AGR FOOD CHEM, V59, P11088, DOI 10.1021/jf201222r; Dodson A., 1998, MUMMY ANCIENT EGYPT, P108; DOPESO J, 1994, TETRAHEDRON, V50, P3813, DOI 10.1016/S0040-4020(01)90401-6; Elias VO, 2000, ESTUAR COAST SHELF S, V50, P231, DOI 10.1006/ecss.1999.0574; FAULKNER DJ, 1994, NAT PROD REP, V11, P355, DOI 10.1039/np9941100355; Friedman R, 2002, ARCHEO NIL, V12, P55; GRIMALT J, 1987, GEOCHIM COSMOCHIM AC, V51, P1379, DOI 10.1016/0016-7037(87)90322-X; HAN J, 1969, P NATL ACAD SCI USA, V64, P436, DOI 10.1073/pnas.64.2.436; Harrell JA, 2002, ARCHAEOMETRY, V44, P285, DOI 10.1111/1475-4754.t01-1-00060; Hassan FA, 2001, GEOARCHAEOLOGY, V16, P29; Hendrickx S, 2006, HDB ORIENTAL STUDIES, P55; Hendrickx S., 2002, EGYPT LEVANT INTERRE, P346; Herodotus, 1954, HISTORIES, P160; Hjulstrom B, 2006, J ARCHAEOL SCI, V33, P283, DOI 10.1016/j.jas.2005.06.017; Jones J, 2008, EGYPT ITS ORIGINS, P99; Jones J, 2007, P 9 INT C EG GREN 6, P982; Koller J, 2003, NATURE, V425, P784, DOI 10.1038/425784a; Koller J, 1998, NATURE, V391, P343, DOI 10.1038/34809; Larter SR, 1980, ADV ORG GEOCHEM, V12, P579, DOI DOI 10.1016/0079-1946(79)90139-3; Laurent D, 2004, CHEM BIODIVERS, V1, P539, DOI 10.1002/cbdv.200490048; MADAIO A, 1990, J NAT PROD, V53, P565, DOI 10.1021/np50069a005; MADAIO A, 1988, TETRAHEDRON LETT, V29, P5999, DOI 10.1016/S0040-4039(00)82250-9; Maurer J, 2002, J ARCHAEOL SCI, V29, P751, DOI 10.1006/jasc.2001.0773; Mejanelle P, 1997, J CHROMATOGR A, V767, P177, DOI 10.1016/S0021-9673(96)01067-9; Mills JS, 1994, ORGANIC CHEM MUSEUM, P56; Oldfield RJ, 1994, LIGHT MICROSCOPY ILL, P160; Pollard AM, 1996, ARCHAEOLOGICAL CHEM, P247; PROEFKE ML, 1992, ANAL CHEM, V64, pA105, DOI 10.1021/ac00026a002; Pulfer MK, 2004, J BIOL CHEM, V279, P26331, DOI 10.1074/jbc.M403581200; Punyu VR, 2013, J EARTH SYST SCI, V122, P467, DOI 10.1007/s12040-013-0268-0; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; ROBINSON N, 1987, ANALYST, V112, P637, DOI 10.1039/an9871200637; Robinson SA, 2006, QUATERNARY SCI REV, V25, P1517, DOI 10.1016/j.quascirev.2006.02.006; Rost FWD, 2000, PHOTOGRAPHY MICROSCO, P288; RULLKOTTER J, 1988, NATURWISSENSCHAFTEN, V75, P618, DOI 10.1007/BF00366476; Serpico M, 2000, ANCIENT EGYPTIAN MAT, P465; Sica D, 2004, STEROIDS, V69, P743, DOI 10.1016/j.steroids.2004.09.001; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Taylor JH, 2001, DEATH AFTERLIFE ANCI, P48; Tomono S, 2009, BIOCHEM BIOPH RES CO, V383, P222, DOI 10.1016/j.bbrc.2009.03.155; Tulloch A. P., 1974, Cosmetics and Perfumery, V89, P53; TULLOCH AP, 1973, J AM OIL CHEM SOC, V50, P367, DOI 10.1007/BF02640842; Van der Werf ID, 2000, STUD CONSERV, V45, P1, DOI 10.2307/1506679; Vandenbroucke M, 2003, OIL GAS SCI TECHNOL, V58, P243, DOI 10.2516/ogst:2003016; Wentworth AD, 2009, CHEM COMMUN, P3098, DOI 10.1039/b821584g; Younes MA, 2005, J PETROL GEOL, V28, P301, DOI 10.1111/j.1747-5457.2005.tb00085.x	69	31	31	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103608	10.1371/journal.pone.0103608	http://dx.doi.org/10.1371/journal.pone.0103608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AN9BM	25118605	gold, Green Accepted, Green Published			2022-12-27	WOS:000340900600027
J	Kanthou, C; Dachs, GU; Lefley, DV; Steele, AJ; Coralli-Foxon, C; Harris, S; Greco, O; Dos Santos, SA; Reyes-Aldasoro, CC; English, WR; Tozer, GM				Kanthou, Chryso; Dachs, Gabi U.; Lefley, Diane V.; Steele, Andrew J.; Coralli-Foxon, Claudia; Harris, Sheila; Greco, Olga; Dos Santos, Sofia A.; Reyes-Aldasoro, Constantino C.; English, William R.; Tozer, Gillian M.			Tumour Cells Expressing Single VEGF Isoforms Display Distinct Growth, Survival and Migration Characteristics	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; INTEGRIN-LINKED KINASE; FACTOR-A; EXTRACELLULAR-MATRIX; SIGNALING COOPERATE; CANCER-CELLS; CARCINOMA; AKT; METASTASIS; INVASION	Vascular endothelial growth factor-A (VEGF) is produced by most cancer cells as multiple isoforms, which display distinct biological activities. VEGF plays an undisputed role in tumour growth, vascularisation and metastasis; nevertheless the functions of individual isoforms in these processes remain poorly understood. We investigated the effects of three main murine isoforms (VEGF188, 164 and 120) on tumour cell behaviour, using a panel of fibrosarcoma cells we developed that express them individually under endogenous promoter control. Fibrosarcomas expressing only VEGF188 (fs188) or wild type controls (fswt) were typically mesenchymal, formed ruffles and displayed strong matrix-binding activity. VEGF164- and VEGF120-producing cells (fs164 and fs120 respectively) were less typically mesenchymal, lacked ruffles but formed abundant cell-cell contacts. On 3D collagen, fs188 cells remained mesenchymal while fs164 and fs120 cells adopted rounded/amoeboid and a mix of rounded and elongated morphologies respectively. Consistent with their mesenchymal characteristics, fs188 cells migrated significantly faster than fs164 or fs120 cells on 2D surfaces while contractility inhibitors accelerated fs164 and fs120 cell migration. VEGF164/VEGF120 expression correlated with faster proliferation rates and lower levels of spontaneous apoptosis than VEGF188 expression. Nevertheless, VEGF188 was associated with constitutively active/phosphorylated AKT, ERK1/2 and Stat3 proteins. Differences in proliferation rates and apoptosis could be explained by defective signalling downstream of pAKT to FOXO and GSK3 in fs188 and fswt cells, which also correlated with p27/p21 cyclin-dependent kinase inhibitor over-expression. All cells expressed tyrosine kinase VEGF receptors, but these were not active/activatable suggesting that inherent differences between the cell lines are governed by endogenous VEGF isoform expression through complex interactions that are independent of tyrosine kinase receptor activation. VEGF isoforms are emerging as potential biomarkers for anti-VEGF therapies. Our results reveal novel roles of individual isoforms associated with cancer growth and metastasis and highlight the importance of understanding their diverse actions.	[Kanthou, Chryso; Lefley, Diane V.; Coralli-Foxon, Claudia; Harris, Sheila; Dos Santos, Sofia A.; English, William R.; Tozer, Gillian M.] Univ Sheffield, CR UK YCR Sheffield Canc Res Ctr, Sch Med, Dept Oncol,Tumour Microcirculat Grp, Sheffield, S Yorkshire, England; [Dachs, Gabi U.] Univ Otago, Dept Pathol, Mackenzie Canc Res Grp, Christchurch, New Zealand; [Steele, Andrew J.] Univ Southampton, Fac Med, Canc Sci Unit, Southampton, England; [Greco, Olga; Reyes-Aldasoro, Constantino C.] Univ Sheffield, Sheffield, S Yorkshire, England	University of Sheffield; University of Otago; University of Southampton; University of Sheffield	Kanthou, C (corresponding author), Univ Sheffield, CR UK YCR Sheffield Canc Res Ctr, Sch Med, Dept Oncol,Tumour Microcirculat Grp, Sheffield, S Yorkshire, England.	C.Kanthou@sheffield.ac.uk	Reyes-Aldasoro, Constantino/S-5093-2019	Reyes-Aldasoro, Constantino/0000-0002-9466-2018; English, William/0000-0003-3024-2441	Cancer Research UK [C1276/A9993]	Cancer Research UK(Cancer Research UK)	The work was funded by a programme grant from Cancer Research UK (C1276/A9993). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell K, 2005, NAT CELL BIOL, V7, P392, DOI 10.1038/ncb1242; Akerman S, 2013, INT J CANCER, V133, P2563, DOI 10.1002/ijc.28281; Benbrook DM, 2011, CURR CANCER DRUG TAR, V11, P586; Cao Y, 2012, CANCER RES, V72, P3912, DOI 10.1158/0008-5472.CAN-11-4058; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Carragher NO, 2006, ONCOGENE, V25, P5726, DOI 10.1038/sj.onc.1209582; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; D'Abaco GM, 2000, METHOD ENZYMOL, V325, P415; De Luca A, 2012, EXPERT OPIN THER TAR, V16, pS17, DOI 10.1517/14728222.2011.639361; El-Chemaly S, 2014, AM J RESP CELL MOL B; Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590; Frank DA, 2007, CANCER LETT, V251, P199, DOI 10.1016/j.canlet.2006.10.017; Fuchs BC, 2008, CANCER RES, V68, P2391, DOI 10.1158/0008-5472.CAN-07-2460; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Grille SJ, 2003, CANCER RES, V63, P2172; Hernandez F, 2010, MOL CELL BIOCHEM, V344, P211, DOI 10.1007/s11010-010-0544-0; Huang HC, 2007, ONCOGENE, V26, P2781, DOI 10.1038/sj.onc.1210078; Jayson GC, 2011, EUR J CANCER, V47, pS96, DOI 10.1016/S0959-8049(11)70641-4; Jayson GC, 2012, NAT REV CLIN ONCOL, V9, P297, DOI 10.1038/nrclinonc.2012.8; Kanthou C, 2002, BLOOD, V99, P2060, DOI 10.1182/blood.V99.6.2060; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Laird AD, 2003, EXPERT OPIN INV DRUG, V12, P51, DOI 10.1517/eoid.12.1.51.21253; Lambrechts D, 2012, LANCET ONCOL, V13, P724, DOI 10.1016/S1470-2045(12)70231-0; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Lejbkowicz F, 2005, ACTA HISTOCHEM, V106, P405, DOI 10.1016/j.acthis.2004.11.003; Li XJ, 2012, CARCINOGENESIS, V33, P1302, DOI 10.1093/carcin/bgs181; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Maes C, 2004, J CLIN INVEST, V113, P188, DOI 10.1172/JCI200419383; Mariotti A, 2007, EXPERT OPIN INV DRUG, V16, P451, DOI 10.1517/13543784.16.4.451; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mezquita B, 2010, J CELL BIOCHEM, V110, P732, DOI 10.1002/jcb.22584; Nakamura M, 2002, PATHOL INT, V52, P331, DOI 10.1046/j.1440-1827.2002.01367.x; Nishi M, 2005, INT J ONCOL, V26, P1517; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Park JI, 2003, MOL CELL BIOL, V23, P543, DOI 10.1128/MCB.23.2.543-554.2003; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Reyes-Aldasoro CC, 2011, COMPUT METH PROG BIO, V103, P97, DOI 10.1016/j.cmpb.2010.07.007; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Shih W, 2012, CELL ADH MIGR, V6; Surjit M, 2007, CELL CYCLE, V6, P580, DOI 10.4161/cc.6.5.3899; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Tokunaga T, 1998, BRIT J CANCER, V77, P998, DOI 10.1038/bjc.1998.164; Tozer GM, 2008, CANCER RES, V68, P2301, DOI 10.1158/0008-5472.CAN-07-2011; Van Cutsem E, 2012, J CLIN ONCOL, V30, P2119, DOI 10.1200/JCO.2011.39.9824; Vial E, 2004, ANN NY ACAD SCI, V1030, P208, DOI 10.1196/annals.1329.027; Vintonenko N, 2011, CELL ADHES MIGR, V5, P332, DOI 10.4161/cam.5.4.17287; Vultur A, 2004, ONCOGENE, V23, P2600, DOI 10.1038/sj.onc.1207378; Widmaier M, 2012, J CELL SCI, V125, P1839, DOI 10.1242/jcs.093864; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Zhang HT, 2000, BRIT J CANCER, V83, P63; Zhang XB, 2011, BBA-MOL CELL RES, V1813, P1978, DOI 10.1016/j.bbamcr.2011.03.010	60	11	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104015	10.1371/journal.pone.0104015	http://dx.doi.org/10.1371/journal.pone.0104015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119572	Green Published, gold, Green Accepted			2022-12-27	WOS:000340900600035
J	Luo, X; Tai, WL; Sun, LT; Qiu, Q; Xia, ZY; Chung, SK; Cheung, CW				Luo, Xin; Tai, Wai Lydia; Sun, Liting; Qiu, Qiu; Xia, Zhengyuan; Chung, Sookja Kim; Cheung, Chi Wai			Central Administration of C-X-C Chemokine Receptor Type 4 Antagonist Alleviates the Development and Maintenance of Peripheral Neuropathic Pain in Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; ENDOTHELIAL-CELLS; PATHOLOGICAL PAIN; EXPRESSION; RAT; INJURY; MODEL; CXCR4; HYPERSENSITIVITY	Aim: To explore the roles of C-X-C chemokine receptor type 4 (CXCR4) in spinal processing of neuropathic pain at the central nervous system (CNS). Methods: Peripheral neuropathic pain (PNP) induced by partial sciatic nerve ligation (pSNL) model was assessed in mice. Effects of a single intrathecal (central) administration of AMD3100 (intrathecal AMD3100), a CXCR4 antagonist, on pain behavior and pain-related spinal pathways and molecules in the L3-L5 spinal cord segment was studied compare to saline treatment. Results: Rotarod test showed that intrathecal AMD3100 did not impair mice motor function. In pSNL-induced mice, intrathecal AMD3100 delayed the development of mechanical allodynia and reversed the established mechanical allodynia in a dose-dependent way. Moreover, intrathecal AMD3100 downregulated the activation of JNK1 and p38 pathways and the protein expression of p65 as assessed by western blotting. Real-time PCR test also demonstrated that substance P mRNA was decreased, while adrenomedullin and intercellular adhesion molecule mRNA was increased following AMD3100 treatment. Conclusion: Our results suggest that central (spinal) CXCR4 is involved in the development and maintenance of PNP and the regulation of multiple spinal molecular events under pain condition, implicating that CXCR4 would potentially be a therapeutic target for chronic neuropathic pain.	[Luo, Xin; Tai, Wai Lydia; Sun, Liting; Qiu, Qiu; Xia, Zhengyuan; Cheung, Chi Wai] Univ Hong Kong, Dept Anaesthesiol, Hong Kong, Hong Kong, Peoples R China; [Chung, Sookja Kim] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Xia, Zhengyuan; Chung, Sookja Kim; Cheung, Chi Wai] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Luo, Xin; Tai, Wai Lydia; Sun, Liting; Qiu, Qiu; Chung, Sookja Kim; Cheung, Chi Wai] Univ Hong Kong, Lab & Clin Res Inst Pain, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Cheung, CW (corresponding author), Univ Hong Kong, Dept Anaesthesiol, Hong Kong, Hong Kong, Peoples R China.	cheucw@hku.hk	Irwin, Michael Garnet/GLR-9714-2022; Irwin, Michael Garnet/C-4286-2009	Irwin, Michael Garnet/0000-0001-5801-274X; Irwin, Michael Garnet/0000-0001-5801-274X; Tai, Wai Lydia/0000-0003-2619-0941	departmental fund, Department of Anaesthesiology, The University of Hong Kong	departmental fund, Department of Anaesthesiology, The University of Hong Kong	Funding for this study was provided by the departmental fund, Department of Anaesthesiology, The University of Hong Kong; the department fund, Department of Anaesthesiology, The University of Hong Kong had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Bartanusz V, 2011, ANN NEUROL, V70, P194, DOI 10.1002/ana.22421; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bhangoo S, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-38; Bhangoo SK, 2007, BRAIN BEHAV IMMUN, V21, P581, DOI 10.1016/j.bbi.2006.12.003; Bhangoo SK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-48; Chaudhary P, 2006, J NEUROIMMUNOL, V175, P87, DOI 10.1016/j.jneuroim.2006.03.007; Chou CW, 2011, J PAIN, V12, P13, DOI 10.1016/j.jpain.2010.03.018; D'Mello R, 2008, BRIT J ANAESTH, V101, P8, DOI 10.1093/bja/aen088; Dominguez E, 2008, J NEUROCHEM, V107, P50, DOI 10.1111/j.1471-4159.2008.05566.x; Dubovy P, 2010, HISTOCHEM CELL BIOL, V133, P323, DOI 10.1007/s00418-010-0675-0; Fairbanks CA, 2003, ADV DRUG DELIVER REV, V55, P1007, DOI 10.1016/S0169-409X(03)00101-7; Fernandez AP, 2010, ENDOCRINOLOGY, V151, P4908, DOI 10.1210/en.2010-0121; Hung VKL, 2012, LIFE SCI, V91, P618, DOI 10.1016/j.lfs.2012.06.038; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Knerlich-Lukoschus F, 2011, J NEUROSURG-SPINE, V14, P583, DOI 10.3171/2010.12.SPINE10480; Lee HL, 2004, NEUROREPORT, V15, P2807; Lee SJ, 1999, J NEUROIMMUNOL, V98, P77, DOI 10.1016/S0165-5728(99)00084-3; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Malmberg AB, 1998, PAIN, V76, P215, DOI 10.1016/S0304-3959(98)00045-1; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Meunier A, 2007, MOL THER, V15, P687, DOI 10.1038/sj.mt.6300107; Milligan ED, 2004, EUR J NEUROSCI, V20, P2294, DOI 10.1111/j.1460-9568.2004.03709.x; Nakagawa T, 2010, J PHARMACOL SCI, V114, P347, DOI 10.1254/jphs.10R04CP; Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001; Reaux-Le Goazigo A, 2012, EUR J NEUROSCI, V36, P2619, DOI 10.1111/j.1460-9568.2012.08179.x; Rigaud M, 2008, PAIN, V136, P188, DOI 10.1016/j.pain.2008.01.016; Rostene W, 2011, J NEUROCHEM, V118, P680, DOI 10.1111/j.1471-4159.2011.07371.x; Serrano A, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-90; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Wilson NM, 2011, BRAIN BEHAV IMMUN, V25, P565, DOI 10.1016/j.bbi.2010.12.014; Xu JT, 2007, EXP NEUROL, V206, P269, DOI 10.1016/j.expneurol.2007.05.029	32	23	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104860	10.1371/journal.pone.0104860	http://dx.doi.org/10.1371/journal.pone.0104860			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119456	Green Published, gold			2022-12-27	WOS:000340900600093
J	Honnold, SP; Bakken, RR; Fisher, D; Lind, CM; Cohen, JW; Eccleston, LT; Spurgers, KB; Maheshwari, RK; Glass, PJ				Honnold, Shelley P.; Bakken, Russell R.; Fisher, Diana; Lind, Cathleen M.; Cohen, Jeffrey W.; Eccleston, Lori T.; Spurgers, Kevin B.; Maheshwari, Radha K.; Glass, Pamela J.			Second Generation Inactivated Eastern Equine Encephalitis Virus Vaccine Candidates Protect Mice against a Lethal Aerosol Challenge	PLOS ONE			English	Article							ALPHAVIRUS ENCEPHALITIS; STRUCTURAL INTEGRITY; IMMUNE INTERFERENCE; VENEZUELAN; GLYCOPROTEIN; PRESERVATION; INFECTION; IMMUNOGENICITY; RESPONSES; MEMBRANE	Currently, there are no FDA-licensed vaccines or therapeutics for eastern equine encephalitis virus (EEEV) for human use. We recently developed several methods to inactivate CVEV1219, a chimeric live-attenuated eastern equine encephalitis virus (EEEV). Dosage and schedule studies were conducted to evaluate the immunogenicity and protective efficacy of three potential second-generation inactivated EEEV (iEEEV) vaccine candidates in mice: formalin-inactivated CVEV1219 (fCVEV1219), INA-inactivated CVEV1219 (iCVEV1219) and gamma-irradiated CVEV1219 (gCVEV1219). Both fCVEV1219 and gCVEV1219 provided partial to complete protection against an aerosol challenge when administered by different routes and schedules at various doses, while iCVEV1219 was unable to provide substantial protection against an aerosol challenge by any route, dose, or schedule tested. When evaluating antibody responses, neutralizing antibody, not virus specific IgG or IgA, was the best correlate of protection. The results of these studies suggest that both fCVEV1219 and gCVEV1219 should be evaluated further and considered for advancement as potential second-generation inactivated vaccine candidates for EEEV.	[Honnold, Shelley P.; Bakken, Russell R.; Fisher, Diana; Lind, Cathleen M.; Cohen, Jeffrey W.; Eccleston, Lori T.; Spurgers, Kevin B.; Glass, Pamela J.] US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; [Honnold, Shelley P.; Maheshwari, Radha K.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Honnold, SP (corresponding author), US Army, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.	shelley.p.honnold.mil@mail.mil	Glass, Pamela/AAN-5555-2020		Defense Threat Reduction Agency (DTRA) [H.H.0003_07_RD_B]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This work was funded by the Defense Threat Reduction Agency (DTRA) Project Number H.H.0003_07_RD_B. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELL BA, 1993, J VIROL, V67, P5496, DOI 10.1128/JVI.67.9.5496-5501.1993; Alsharifi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005336; Appaiahgari MB, 2004, VACCINE, V22, P3669, DOI 10.1016/j.vaccine.2004.03.024; Arrigo NC, 2010, J VIROL, V84, P1014, DOI 10.1128/JVI.01586-09; Carrera JP, 2013, NEW ENGL J MED, V369, P732, DOI 10.1056/NEJMoa1212628; DAVIS NL, 1995, VIROLOGY, V212, P102, DOI 10.1006/viro.1995.1458; Fine DL, 2010, J VIROL METHODS, V163, P424, DOI 10.1016/j.jviromet.2009.11.006; Furuya Y, 2010, J GEN VIROL, V91, P1450, DOI 10.1099/vir.0.018168-0; Griffin DE, 2007, FIELDS VIROLOGY, P1024; Hart MK, 1997, VACCINE, V15, P363, DOI 10.1016/S0264-410X(96)00204-6; Hart MK, 2000, VACCINE, V18, P3067, DOI 10.1016/S0264-410X(00)00042-6; Hart MK, 2001, VACCINE, V20, P616, DOI 10.1016/S0264-410X(01)00337-1; Labrada L, 2002, J VIROL, V76, P11688, DOI 10.1128/JVI.76.22.11688-11703.2002; Lowy RJ, 2001, ANTIVIR RES, V52, P261, DOI 10.1016/S0166-3542(01)00169-3; Martin SS, 2010, VACCINE, V28, P3143, DOI 10.1016/j.vaccine.2010.02.056; Martin SS, 2010, VACCINE, V28, P1031, DOI 10.1016/j.vaccine.2009.10.126; Paessler S, 2003, J VIROL, V77, P9278, DOI 10.1128/JVI.77.17.9278-9286.2003; Pandya J, 2012, VACCINE, V30, P1276, DOI 10.1016/j.vaccine.2011.12.121; Parker MD, 2010, J VIROL, V84, P12683, DOI 10.1128/JVI.01345-10; Pittman PR, 2009, VACCINE, V27, P4879, DOI 10.1016/j.vaccine.2009.02.090; Raviv Y, 2005, J VIROL, V79, P12394, DOI 10.1128/JVI.79.19.12394-12400.2005; RAVIV Y, 1987, P NATL ACAD SCI USA, V84, P6103, DOI 10.1073/pnas.84.17.6103; Raviv Y, 2008, J VIROL, V82, P4612, DOI 10.1128/JVI.02233-07; Reisler RB, 2012, VACCINE, V30, P7271, DOI 10.1016/j.vaccine.2012.09.049; Roy CJ, 2013, VACCINE, V31, P1464, DOI 10.1016/j.vaccine.2013.01.014; Roy CJ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-170; SCHMALJOHN AL, 1982, NATURE, V297, P70, DOI 10.1038/297070a0; Sharma A, 2007, BIOCHEM BIOPH RES CO, V358, P392, DOI 10.1016/j.bbrc.2007.04.115; Sharma A, 2011, VACCINE, V29, P953, DOI 10.1016/j.vaccine.2010.11.033; Stull J. W., 2006, Morbidity and Mortality Weekly Report, V55, P697; Viard M, 2008, BIOCHEMISTRY-US, V47, P1977, DOI 10.1021/bi701920f; Wang E, 2007, VACCINE, V25, P7573, DOI 10.1016/j.vaccine.2007.07.061; Warfield KL, 2007, J INFECT DIS, V196, pS276, DOI 10.1086/520605	33	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104708	10.1371/journal.pone.0104708	http://dx.doi.org/10.1371/journal.pone.0104708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116127	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400072
J	Korberg, IB; Sundstrom, E; Meadows, JRS; Pielberg, GR; Gustafson, U; Hedhammar, A; Karlsson, EK; Seddon, J; Soderberg, A; Vila, C; Zhang, XL; Akesson, M; Lindblad-Toh, K; Andersson, G; Andersson, L				Korberg, Izabella Baranowska; Sundstrom, Elisabeth; Meadows, Jennifer R. S.; Pielberg, Gerli Rosengren; Gustafson, Ulla; Hedhammar, Ake; Karlsson, Elinor K.; Seddon, Jennifer; Soderberg, Arne; Vila, Carles; Zhang, Xiaolan; Akesson, Mikael; Lindblad-Toh, Kerstin; Andersson, Goran; Andersson, Leif			A Simple Repeat Polymorphism in the MITF-M Promoter Is a Key Regulator of White Spotting in Dogs	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE PROMOTER; MOUSE; PIGMENTATION; CONSEQUENCES; ASSOCIATION; MUTATIONS; ELEMENTS; ENHANCER; SCORES	The white spotting locus (S) in dogs is colocalized with the MITF (microphtalmia-associated transcription factor) gene. The phenotypic effects of the four S alleles range from solid colour (S) to extreme white spotting (s(w)). We have investigated four candidate mutations associated with the s(w) allele, a SINE insertion, a SNP at a conserved site and a simple repeat polymorphism all associated with the MITF-M promoter as well as a 12 base pair deletion in exon 1B. The variants associated with white spotting at all four loci were also found among wolves and we conclude that none of these could be a sole causal mutation, at least not for extreme white spotting. We propose that the three canine white spotting alleles are not caused by three independent mutations but represent haplotype effects due to different combinations of causal polymorphisms. The simple repeat polymorphism showed extensive diversity both in dogs and wolves, and allele-sharing was common between wolves and white spotted dogs but was non-existent between solid and spotted dogs as well as between wolves and solid dogs. This finding was unexpected as Solid is assumed to be the wild-type allele. The data indicate that the simple repeat polymorphism has been a target for selection during dog domestication and breed formation. We also evaluated the significance of the three MITF-M associated polymorphisms with a Luciferase assay, and found conclusive evidence that the simple repeat polymorphism affects promoter activity. Three alleles associated with white spotting gave consistently lower promoter activity compared with the allele associated with solid colour. We propose that the simple repeat polymorphism affects cooperativity between transcription factors binding on either flanking sides of the repeat. Thus, both genetic and functional evidence show that the simple repeat polymorphism is a key regulator of white spotting in dogs.	[Korberg, Izabella Baranowska; Gustafson, Ulla; Andersson, Goran; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Sundstrom, Elisabeth; Meadows, Jennifer R. S.; Pielberg, Gerli Rosengren; Seddon, Jennifer; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab Uppsala, Uppsala, Sweden; [Hedhammar, Ake; Andersson, Leif] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Karlsson, Elinor K.; Zhang, Xiaolan; Lindblad-Toh, Kerstin] Broad Inst Harvard, Cambridge, MA USA; [Karlsson, Elinor K.; Zhang, Xiaolan; Lindblad-Toh, Kerstin] MIT, Cambridge, MA 02139 USA; [Karlsson, Elinor K.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Seddon, Jennifer] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [Soderberg, Arne] Natl Vet Inst SVA, Dept Pathol & Wildlife Dis, S-75007 Uppsala, Sweden; [Vila, Carles] CSIC, EBD, Conservat & Evolut Genet Grp, E-41080 Seville, Spain; [Akesson, Mikael] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden; [Andersson, Leif] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX USA	Swedish University of Agricultural Sciences; Uppsala University; Swedish University of Agricultural Sciences; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; University of Queensland; National Veterinary Institute SVA; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Swedish University of Agricultural Sciences; Texas A&M University System; Texas A&M University College Station	Andersson, L (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.	leif.andersson@imbim.uu.se	Seddon, Jennifer/A-1402-2010; Åkesson, Mikael/K-5370-2014; Vila, Carles/H-4893-2013; Andersson, Goran/AAK-6564-2020; Seddon, Jennifer/AAM-3827-2021	Seddon, Jennifer/0000-0003-3789-6878; Vila, Carles/0000-0002-4206-5246; Andersson, Goran/0000-0001-5131-3144; Seddon, Jennifer/0000-0003-3789-6878; Karlsson, Elinor/0000-0002-4343-3776; Hedhammar, Ake/0000-0001-7048-3851; Meadows, Jennifer/0000-0002-0850-230X	Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; Swedish Research Council; Swedish Research Council, FORMAS	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council, FORMAS(Swedish Research CouncilSwedish Research Council Formas)	The study was supported by the Swedish Foundation for Strategic Research, the Knut and Alice Wallenberg Foundation, and the Swedish Research Council. JRSM was supported by the Swedish Research Council, FORMAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2013, CURR OPIN GENET DEV, V23, P295, DOI 10.1016/j.gde.2013.02.014; Andersson L, 2011, GENETICS OF THE PIG, 2ND EDITION, P38, DOI 10.1079/9781845937560.0038; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Bandelt HJ, 2000, MOL PHYLOGENET EVOL, V16, P8, DOI 10.1006/mpev.2000.0792; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Forster ES, 1968, L JUNIUS MODERATUS C, VII; Hauswirth R, 2012, PLOS GENET, V8, P404, DOI 10.1371/journal.pgen.1002653; Kaelin CB, 2013, ANNU REV ANIM BIOSCI, V1, P125, DOI 10.1146/annurev-animal-031412-103659; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kirk R. E., 1982, EXPT DESIGN, P79; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107; Leegwater PA, 2007, J HERED, V98, P549, DOI 10.1093/jhered/esm022; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Little C., 1957, INHERITANCE COAT COL; MARINCOLA FM, 1994, J IMMUNOL, V153, P1225; Montoliu L, 2011, COLOR GENES; Ponicsan SL, 2010, CURR OPIN GENET DEV, V20, P149, DOI 10.1016/j.gde.2010.01.004; Rothschild MF, 2006, ANIM GENET, V37, P606, DOI 10.1111/j.1365-2052.2006.01534.x; Saito H, 2002, J BIOL CHEM, V277, P28787, DOI 10.1074/jbc.M203719200; Schmutz SM, 2009, J HERED, V100, pS66, DOI 10.1093/jhered/esp029; Smith SD, 2000, J MED GENET, V37, P446, DOI 10.1136/jmg.37.6.446; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; Strain GM, 2004, VET J, V167, P23, DOI 10.1016/S1090-0233(03)00104-7; Su M, 2006, J BIOL CHEM, V281, P9882, DOI 10.1074/jbc.M508364200; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; Tsuchida S, 2009, VET J, V182, P283, DOI 10.1016/j.tvjl.2008.06.004; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Yu M, 1997, J BIOL CHEM, V272, P29060, DOI 10.1074/jbc.272.46.29060	32	34	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104363	10.1371/journal.pone.0104363	http://dx.doi.org/10.1371/journal.pone.0104363			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116146	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400044
J	Law, HT; Sriram, A; Fevang, C; Nix, EB; Nano, FE; Guttman, JA				Law, H. T.; Sriram, Aarati; Fevang, Charlotte; Nix, Eli B.; Nano, Francis E.; Guttman, Julian Andrew			IgIC and PdpA Are Important for Promoting Francisella Invasion and Intracellular Growth in Epithelial Cells	PLOS ONE			English	Article							TULARENSIS PATHOGENICITY ISLAND; LIVE VACCINE STRAIN; VI SECRETION; IN-VITRO; MURINE MACROPHAGES; PHAGOSOMAL ESCAPE; SCHU S4; INFECTION; NOVICIDA; PROTEIN	The highly infectious bacteria, Francisella tularensis, colonize a variety of organs and replicate within both phagocytic as well as non-phagocytic cells, to cause the disease tularemia. These microbes contain a conserved cluster of important virulence genes referred to as the Francisella Pathogenicity Island (FPI). Two of the most characterized FPI genes, iglC and pdpA, play a central role in bacterial survival and proliferation within phagocytes, but do not influence bacterial internalization. Yet, their involvement in non-phagocytic epithelial cell infections remains unexplored. To examine the functions of IglC and PdpA on bacterial invasion and replication during epithelial cell infections, we infected liver and lung epithelial cells with F. novicida and F. tularensis 'Type B' Live Vaccine Strain (LVS) deletion mutants (Delta iglC and Delta pdpA) as well as their respective gene complements. We found that deletion of either gene significantly reduced their ability to invade and replicate in epithelial cells. Gene complementation of iglC and pdpA partially rescued bacterial invasion and intracellular growth. Additionally, substantial LAMP1-association with both deletion mutants was observed up to 12 h suggesting that the absence of IglC and PdpA caused deficiencies in their ability to dissociate from LAMP1-positive Francisella Containing Vacuoles (FCVs). This work provides the first evidence that IglC and PdpA are important pathogenic factors for invasion and intracellular growth of Francisella in epithelial cells, and further highlights the discrete mechanisms involved in Francisella infections between phagocytic and non-phagocytic cells.	[Law, H. T.; Sriram, Aarati; Fevang, Charlotte; Guttman, Julian Andrew] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Nix, Eli B.; Nano, Francis E.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	Simon Fraser University; University of Victoria	Guttman, JA (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	jguttman@sfu.ca			Canadian Institute for Health Research; Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institute for Health Research (http://www.cihr-irsc.gc.ca/) and Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril C, 2008, VET MICROBIOL, V127, P203, DOI 10.1016/j.vetmic.2007.08.006; ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Barrigan LM, 2013, INFECT IMMUN, V81, P2028, DOI 10.1128/IAI.00207-13; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Bonquist L, 2008, INFECT IMMUN, V76, P3502, DOI 10.1128/IAI.00226-08; Bradburne CE, 2013, J BIOL CHEM; Broms JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050473; Broms JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034639; Broms JE, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00136; Buchan BW, 2009, INFECT IMMUN, V77, P2517, DOI 10.1128/IAI.00229-09; Busse HJ, 2010, INT J SYST EVOL MICR, V60, P1718, DOI 10.1099/00207713-60-8-1718; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Clemens DL, 2005, INFECT IMMUN, V73, P5892, DOI 10.1128/IAI.73.9.5892-5902.2005; Cong Y, 2009, VACCINE, V27, P5554, DOI 10.1016/j.vaccine.2009.07.034; CONLAN JW, 1992, INFECT IMMUN, V60, P5164, DOI 10.1128/IAI.60.12.5164-5171.1992; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; De Tulleo L, 1998, EMBO J, V17, P4585, DOI 10.1093/emboj/17.16.4585; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; EIGELSBACH H, 1961, J IMMUNOL, V87, P415; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; EVANS ME, 1985, MEDICINE, V64, P251, DOI 10.1097/00005792-198507000-00006; FORTIER AH, 1991, INFECT IMMUN, V59, P2922, DOI 10.1128/IAI.59.9.2922-2928.1991; Geier H, 2011, INFECT IMMUN, V79, P2204, DOI 10.1128/IAI.01382-10; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Golovliov I, 1997, INFECT IMMUN, V65, P2183, DOI 10.1128/IAI.65.6.2183-2189.1997; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Gray CG, 2002, FEMS MICROBIOL LETT, V215, P53, DOI 10.1016/S0378-1097(02)00911-4; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; Horzempa J, 2010, INFECT IMMUN, V78, P2607, DOI 10.1128/IAI.00134-10; Huber B, 2010, INT J SYST EVOL MICR, V60, P1887, DOI 10.1099/ijs.0.015941-0; Johansson A, 2010, INT J SYST EVOL MICR, V60, P1717, DOI 10.1099/ijs.0.022830-0; Jones CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020609; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Kitamura S, 1956, PATHOLOGY INT, V6, P46; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; KuoLee R, 2007, INFECT IMMUN, V75, P1651, DOI 10.1128/IAI.01834-06; Lai XH, 2004, MICROB PATHOGENESIS, V37, P225, DOI 10.1016/j.micpath.2004.07.002; Larson CL, 1955, PUBLIC HEALTH REP, V70, P253, DOI 10.2307/4589039; Larsson P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000472; Law HT, 2011, SCI REP-UK, V1, DOI 10.1038/srep00192; Lertpiriyapong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042842; Lindemann SR, 2007, INFECT IMMUN, V75, P3178, DOI 10.1128/IAI.01811-06; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; Lo KYS, 2013, J MICROBIOL METH, V93, P153, DOI 10.1016/j.mimet.2013.03.004; LoVullo ED, 2009, MICROBIOL-SGM, V155, P1152, DOI 10.1099/mic.0.022491-0; Ludu JS, 2008, FEMS MICROBIOL LETT, V278, P86, DOI 10.1111/j.1574-6968.2007.00979.x; Mares CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014088; Martinez-Moya M, 1998, RES MICROBIOL, V149, P309, DOI 10.1016/S0923-2508(98)80436-1; McRae S, 2010, J BIOL CHEM, V285, P5171, DOI 10.1074/jbc.M109.039511; Miller MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031359; NANO FE, 1988, MICROB PATHOGENESIS, V5, P109, DOI 10.1016/0882-4010(88)90013-7; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Nano FE, 2007, ANN NY ACAD SCI, V1105, P122, DOI 10.1196/annals.1409.000; Park CH, 2009, J VET MED SCI, V71, P1629, DOI 10.1292/jvms.001629; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Robertson GT, 2013, INFECT IMMUN, V81, P4026, DOI 10.1128/IAI.00595-13; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Roth KM, 2008, FEMS IMMUNOL MED MIC, V53, P72, DOI 10.1111/j.1574-695X.2008.00395.x; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Sana TG, 2012, J BIOL CHEM, V287, P27095, DOI 10.1074/jbc.M112.376368; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2005, CELL MICROBIOL, V7, P957, DOI 10.1111/j.1462-5822.2005.00529.x; Santic M, 2006, TRENDS MICROBIOL, V14, P37, DOI 10.1016/j.tim.2005.11.008; Santic M, 2008, INFECT IMMUN, V76, P2671, DOI 10.1128/IAI.00185-08; Santic M, 2007, CELL MICROBIOL, V9, P2391, DOI 10.1111/j.1462-5822.2007.00968.x; Santic M, 2010, CELL MICROBIOL, V12, P129, DOI 10.1111/j.1462-5822.2009.01400.x; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1498, DOI 10.1099/mic.0.025445-0; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1489, DOI 10.1099/mic.0.025379-0; Sju┬stedt A.B., 2005, BERGEYS MANUAL SYSTE, P200; Stuart BM, 1945, AM J MED SCI, V210, P14; Tamilselvam B, 2008, J IMMUNOL, V180, P8262, DOI 10.4049/jimmunol.180.12.8262; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; VanNhieu GT, 1996, J BIOL CHEM, V271, P7665, DOI 10.1074/jbc.271.13.7665; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104	85	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104881	10.1371/journal.pone.0104881	http://dx.doi.org/10.1371/journal.pone.0104881			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115488	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400101
J	Nunes, JC; Braz, JRC; Oliveira, TS; de Carvalho, LR; Castiglia, YMM; Braz, LG				Nunes, Juscimar C.; Braz, Jose R. C.; Oliveira, Thais S.; de Carvalho, Lidia R.; Castiglia, Yara M. M.; Braz, Leandro G.			Intraoperative and Anesthesia-Related Cardiac Arrest and Its Mortality in Older Patients: A 15-Year Survey in a Tertiary Teaching Hospital	PLOS ONE			English	Article							THAI; DEATH	Background: Little information is known about factors that influence perioperative and anesthesia-related cardiac arrest (CA) in older patients. This study evaluated the incidence, causes and outcome of intraoperative and anesthesia-related CA in older patients in a Brazilian teaching hospital between 1996 and 2010. Methods: During the study, older patients received 18,367 anesthetics. Data collected included patient characteristics, surgical procedures, American Society of Anesthesiologists (ASA) physical status, anesthesia type, medical specialty team and outcome. All CAs were categorized by cause into one of four groups: patient's disease/condition-related, surgery-related, totally anesthesia-related or partially anesthesia-related. Results: All intraoperative CAs and deaths rates are shown per 10,000 anesthetics. There were 100 CAs (54.44; 95% confidence intervals [CI]: 44.68-64.20) and 68 deaths (37.02; 95% CI: 27.56-46.48). The majority of CAs were patient's disease-/condition-related (43.5; 95% CI: 13.44-73.68). There were six anesthesia-related CAs (3.26; 95% CI: 0.65-5.87) -1 totally and 5 partially anesthesia-related, and three deaths, all partially anesthesia-related (1.63; 95% CI: 0.0-3.47). ASA I-II physical status patients presented no anesthesia-related CA. Anesthesia-related CA, absent in the last five years of the study, was due to medication-/airway-related causes. ASA physical status was the most important predictor of CA (odds ratio: 14.52; 95% CI: 4.48-47.08; P<0.001) followed by emergency surgery (odds ratio: 8.07; 95% CI: 5.14-12.68; P<0.001). Conclusions: The study identified high incidence of intraoperative CAs with high mortality in older patients. The large majority of CAs were caused by factors not anesthesia-related. Anesthesia-related CA and mortality rates were 3.26 and 1.63 per 10,000 anesthetics, with no anesthesia-related CA in the last five years of the study. Major predictors of intraoperative CAs were poorer ASA physical status and emergency surgery. All anesthesia-related CAs were medication-related or airway-related, which is important for prevention strategies.	[Nunes, Juscimar C.; Braz, Jose R. C.; Oliveira, Thais S.; Castiglia, Yara M. M.; Braz, Leandro G.] Univ Estadual Paulista, Botucatu Med Sch, Dept Anesthesiol, Botucatu, SP, Brazil; [de Carvalho, Lidia R.] Univ Estadual Paulista, Inst Biosci, Dept Biostat, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Braz, LG (corresponding author), Univ Estadual Paulista, Botucatu Med Sch, Dept Anesthesiol, Botucatu, SP, Brazil.	lbraz@fmb.unesp.br	Braz, Leandro Gobbo/W-4445-2019; Carvalho, L.R./C-2973-2013; Braz, Leandro/AAK-8378-2021	Braz, Leandro Gobbo/0000-0002-1927-8729; Carvalho, L.R./0000-0003-0575-2263; 	CAPES/DINTER; PIBIC/CNPq	CAPES/DINTER; PIBIC/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	J.C. Nunes was granted a scholarship from CAPES/DINTER and T.S. Oliveira was granted a scholarship from PIBIC/CNPq. CAPES and CNPq are Brazilian governmental agencies dedicated to promoting scientific research.	AUBAS S, 1991, ANN FR ANESTH, V10, P436, DOI 10.1016/S0750-7658(05)80846-9; Bainbridge D, 2012, LANCET, V380, P1075, DOI 10.1016/S0140-6736(12)60990-8; Biboulet P, 2001, CAN J ANAESTH, V48, P326, DOI 10.1007/BF03014958; Bishop MJ, 2008, ANESTH ANALG, V107, P1924, DOI 10.1213/ane.0b013e31818af8f3; Braz LG, 2009, CLINICS, V64, P999, DOI 10.1590/S1807-59322009001000011; Braz LG, 2006, BRIT J ANAESTH, V96, P569, DOI 10.1093/bja/ael065; Deshpande JK, 2011, ANESTH ANALG, V112, P1259, DOI 10.1213/ANE.0b013e3182182199; Ellis SJ, 2014, ANESTHESIOLOGY, V120, P829, DOI 10.1097/ALN.0000000000000153; Goswami S, 2012, ANESTHESIOLOGY, V117, P1018, DOI 10.1097/ALN.0b013e31827005e9; Kawashima Yasuo, 2002, J Anesth, V16, P319; Kehlet H, 2008, ANN SURG, V248, P189, DOI 10.1097/SLA.0b013e31817f2c1a; KUBOTA Y, 1994, J CLIN ANESTH, V6, P227, DOI 10.1016/0952-8180(94)90064-7; MARX GF, 1973, ANESTHESIOLOGY, V39, P54, DOI 10.1097/00000542-197307000-00010; MOLLER IW, 1984, BRIT J ANAESTH, V56, P1191, DOI 10.1093/bja/56.11.1191; Morray JP, 2011, PEDIATR ANESTH, V21, P722, DOI 10.1111/j.1460-9592.2010.03440.x; OLSSON GL, 1988, ACTA ANAESTH SCAND, V32, P653, DOI 10.1111/j.1399-6576.1988.tb02804.x; Pearse RM, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5759; Rodanant Oraluxna, 2007, Journal of the Medical Association of Thailand, V90, P1375; Rooke GA, 2003, J CARDIOTHOR VASC AN, V17, P512, DOI 10.1016/S1053-0770(03)00161-7; Silva E, 2012, MINERVA ANESTESIOL, V78, P1215; Story DA, 2010, ANAESTHESIA, V65, P1022, DOI 10.1111/j.1365-2044.2010.06478.x; Tamdee Decha, 2009, Journal of the Medical Association of Thailand, V92, P198; Tuchinda Lawan, 2010, Journal of the Medical Association of Thailand, V93, P698; Ward SA, 2011, BEST PRACT RES-CLIN, V25, P305, DOI 10.1016/j.bpa.2011.05.002	24	37	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104041	10.1371/journal.pone.0104041	http://dx.doi.org/10.1371/journal.pone.0104041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117481	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230400028
J	van Beek, FE; Tiest, WMB; Kappers, AML				van Beek, Femke E.; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.			Haptic Discrimination of Distance	PLOS ONE			English	Article							HORIZONTAL-VERTICAL ILLUSION; FINGER-SPAN; KINESTHETIC PERCEPTION; LOCATION; LENGTH; MOVEMENT; INFORMATION; REPRODUCTION; ORIENTATION; JUDGMENT	While quite some research has focussed on the accuracy of haptic perception of distance, information on the precision of haptic perception of distance is still scarce, particularly regarding distances perceived by making arm movements. In this study, eight conditions were measured to answer four main questions, which are: what is the influence of reference distance, movement axis, perceptual mode (active or passive) and stimulus type on the precision of this kind of distance perception? A discrimination experiment was performed with twelve participants. The participants were presented with two distances, using either a haptic device or a real stimulus. Participants compared the distances by moving their hand from a start to an end position. They were then asked to judge which of the distances was the longer, from which the discrimination threshold was determined for each participant and condition. The precision was influenced by reference distance. No effect of movement axis was found. The precision was higher for active than for passive movements and it was a bit lower for real stimuli than for rendered stimuli, but it was not affected by adding cutaneous information. Overall, the Weber fraction for the active perception of a distance of 25 or 35 cm was about 11% for all cardinal axes. The recorded position data suggest that participants, in order to be able to judge which distance was the longer, tried to produce similar speed profiles in both movements. This knowledge could be useful in the design of haptic devices.	[van Beek, Femke E.; Tiest, Wouter M. Bergmann; Kappers, Astrid M. L.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	van Beek, FE (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	f.e.van.beek@vu.nl		van Beek, Femke/0000-0003-4741-6196	Dutch Technology Foundation STW; Ministry of Economic Affairs, Agriculture and Innovation; STW grant [12157]; Netherlands Organisation for Scientific Research (NWO)	Dutch Technology Foundation STW(Technologiestichting STW); Ministry of Economic Affairs, Agriculture and Innovation; STW grant; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research is supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organisation for Scientific Research (NWO) and partly funded by the Ministry of Economic Affairs, Agriculture and Innovation. STW grant 12157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAVANEL E, 1971, PERCEPT PSYCHOPHYS, V9, P327, DOI 10.3758/BF03208687; Armstrong L, 1999, PERCEPT PSYCHOPHYS, V61, P1211, DOI 10.3758/BF03207624; ASHBY A, 1980, PERCEPT MOTOR SKILL, V51, P403, DOI 10.2466/pms.1980.51.2.403; Coren S, 1992, LEFT HANDER SYNDROME; DAVIDON RS, 1964, Q J EXP PSYCHOL, V16, P277, DOI 10.1080/17470216408416380; DAY RH, 1970, J EXP PSYCHOL, V83, P172, DOI 10.1037/h0028514; DEREGOWSKI J, 1972, J EXP PSYCHOL, V95, P14, DOI 10.1037/h0033264; DURLACH NI, 1989, PERCEPT PSYCHOPHYS, V46, P29, DOI 10.3758/BF03208071; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Faineteau H, 2003, EXP BRAIN RES, V152, P166, DOI 10.1007/s00221-003-1526-1; Fasse ED, 2000, BIOL CYBERN, V82, P69, DOI 10.1007/PL00007962; GAYDOS HF, 1958, AM J PSYCHOL, V71, P557, DOI 10.2307/1420251; Gentaz E, 2004, PSYCHON B REV, V11, P31, DOI 10.3758/BF03206457; Gentaz E, 2008, HUMAN HAPTIC PERCEPT, P223; GUPTA RK, 1986, ACTA PSYCHOL, V62, P141, DOI 10.1016/0001-6918(86)90065-X; HERMELIN B, 1975, Q J EXP PSYCHOL, V27, P295, DOI 10.1080/14640747508400488; HOLLINS M, 1988, SOMATOSENS MOT RES, V5, P335, DOI 10.3109/07367228809144635; IMANAKA K, 1989, PERCEPT MOTOR SKILL, V68, P423, DOI 10.2466/pms.1989.68.2.423; Jastrow J, 1886, MIND, Vos-XI, P539, DOI [10.1093/mind/os-XI.44.539, DOI 10.1093/MIND/OS-XI.44.539]; JONES B, 1983, Q J EXP PSYCHOL-A, V35, P597, DOI 10.1080/14640748308402149; KELVIN RP, 1958, Q J EXP PSYCHOL, V10, P187, DOI 10.1080/17470215808416274; LANCA M, 1995, PERCEPT MOTOR SKILL, V80, P1291, DOI 10.2466/pms.1995.80.3c.1291; Leuba JH, 1909, AM J PSYCHOL, V20, P374, DOI 10.2307/1413368; MARTENIUK RG, 1972, ACTA PSYCHOL, V36, P471, DOI 10.1016/0001-6918(72)90027-3; McFarland J, 2007, EXP BRAIN RES, V178, P216, DOI 10.1007/s00221-006-0727-9; NOLL NC, 1985, B PSYCHONOMIC SOC, V23, P473; Norman JF, 1996, J EXP PSYCHOL HUMAN, V22, P173, DOI 10.1037/0096-1523.22.1.173; O'Malley MK, 2005, PRESENCE-TELEOP VIRT, V14, P366, DOI 10.1162/105474605323384690; Rincon-Gonzalez L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025214; Ross HE, 1997, BRIT J MATH STAT PSY, V50, P187; ROY EA, 1975, PERCEPT PSYCHOPHYS, V17, P559, DOI 10.3758/BF03203969; Soechting JF, 2011, IEEE T HAPTICS, V4, P263, DOI [10.1109/ToH.2011.18, 10.1109/TOH.2011.18]; STELMACH GE, 1975, MEM COGNITION, V3, P58, DOI 10.3758/BF03198211; STELMACH GE, 1970, J EXP PSYCHOL, V85, P425, DOI 10.1037/h0029725; STELMACH GE, 1976, MEM COGNITION, V4, P62, DOI 10.3758/BF03213256; STEVENS SS, 1959, J EXP PSYCHOL, V57, P91, DOI 10.1037/h0048829; Symmons M. A., 2004, TOUCH BLINDNESS NEUR, P179; Tan H Z, 1992, ADV ROBOTICS, P13; Teghtsoonian M., 1965, PSYCHON SCI, V3, P465, DOI 10.3758/BF03343234; TEGHTSOONIAN R, 1970, PERCEPT PSYCHOPHYS, V8, P389, DOI 10.3758/BF03207030; Terada K, 2006, J ROBOT MECHATRON, V18, P489, DOI 10.20965/jrm.2006.p0489; Tiest W. M. Bergmann, 2011, 2011 IEEE World Haptics Conference (WHC 2011), P593, DOI 10.1109/WHC.2011.5945552; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; Van Doorn George H., 2012, Haptics: Perception, Devices, Mobility, and Communication. Proceedings International Conference (EuroHaptics 2012), P25, DOI 10.1007/978-3-642-31404-9_5; VANDOREN CL, 1995, PERCEPT PSYCHOPHYS, V57, P555, DOI 10.3758/BF03213080; WAPNER S, 1967, AM J PSYCHOL, V80, P608, DOI 10.2307/1421193; Weber E. H., 1834, PULSU RESORPTIONE AU; WONG TS, 1977, J EXP PSYCHOL HUMAN, V3, P151, DOI 10.1037/0096-1523.3.1.151	48	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104769	10.1371/journal.pone.0104769	http://dx.doi.org/10.1371/journal.pone.0104769			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LJ	25116638	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400080
J	Linstadter, A; Schellberg, J; Bruser, K; Garcia, CAM; Oomen, RJ; du Preez, CC; Ruppert, JC; Ewert, F				Linstaedter, Anja; Schellberg, Juergen; Brueser, Katharina; Garcia, Cristian A. Moreno; Oomen, Roelof J.; du Preez, Chris C.; Ruppert, Jan C.; Ewert, Frank			Are There Consistent Grazing Indicators in Drylands? Testing Plant Functional Types of Various Complexity in South Africa's Grassland and Savanna Biomes	PLOS ONE			English	Article							LAND-USE; MANAGEMENT-SYSTEMS; SPECIES RICHNESS; TRAIT RESPONSES; LEAF ECONOMICS; CLIMATE-CHANGE; GRADIENTS; DEGRADATION; VEGETATION; IMPACTS	Despite our growing knowledge on plants' functional responses to grazing, there is no consensus if an optimum level of functional aggregation exists for detecting grazing effects in drylands. With a comparative approach we searched for plant functional types (PFTs) with a consistent response to grazing across two areas differing in climatic aridity, situated in South Africa's grassland and savanna biomes. We aggregated herbaceous species into PFTs, using hierarchical combinations of traits (from single-to three-trait PFTs). Traits relate to life history, growth form and leaf width. We first confirmed that soil and grazing gradients were largely independent from each other, and then searched in each biome for PFTs with a sensitive response to grazing, avoiding confounding with soil conditions. We found no response consistency, but biome-specific optimum aggregation levels. Three-trait PFTs (e.g. broad-leaved perennial grasses) and two-trait PFTs (e. g. perennial grasses) performed best as indicators of grazing effects in the semi-arid grassland and in the arid savanna biome, respectively. Some PFTs increased with grazing pressure in the grassland, but decreased in the savanna. We applied biome-specific grazing indicators to evaluate if differences in grazing management related to land tenure (communal versus freehold) had effects on vegetation. Tenure effects were small, which we mainly attributed to large variability in grazing pressure across farms. We conclude that the striking lack of generalizable PFT responses to grazing is due to a convergence of aridity and grazing effects, and unlikely to be overcome by more refined classification approaches. Hence, PFTs with an opposite response to grazing in the two biomes rather have a unimodal response along a gradient of additive forces of aridity and grazing. The study advocates for hierarchical trait combinations to identify localized indicator sets for grazing effects. Its methodological approach may also be useful for identifying ecological indicators in other ecosystems.	[Linstaedter, Anja; Ruppert, Jan C.] Univ Cologne, Inst Bot, Range Ecol & Range Management Grp, Cologne, Germany; [Linstaedter, Anja; Schellberg, Juergen; Brueser, Katharina; Garcia, Cristian A. Moreno; Oomen, Roelof J.; Ruppert, Jan C.; Ewert, Frank] Univ Bonn, Inst Crop Sci & Resource Conservat, Bonn, Germany; [du Preez, Chris C.] Univ Orange Free State, Dept Soil Crop & Climate Sci, Bloemfontein, South Africa	University of Cologne; University of Bonn; University of the Free State	Linstadter, A (corresponding author), Univ Cologne, Inst Bot, Range Ecol & Range Management Grp, Gyrhofstr 15, Cologne, Germany.	anja.linstaedter@uni-koeln.de	Linstädter, Anja/M-8629-2013; Ruppert, Jan C./O-7123-2014; Garcia, Cristian Moreno/C-3855-2019; Oomen, Roelof J/B-1116-2009	Linstädter, Anja/0000-0003-0038-9557; Ruppert, Jan C./0000-0001-7191-1918; Garcia, Cristian Moreno/0000-0002-8169-1119; Oomen, Roelof J/0000-0002-8395-9641; Ewert, Frank/0000-0002-4392-8154	German Science Foundation [FOR 1501]; German Federal Ministry of Education and Research [01LL1304-C, 01LL1304-D]	German Science Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was funded through the research project FOR 1501 by the German Science Foundation (http://www.dfg.de/en/). AL, JR and JS also acknowledge support by the German Federal Ministry of Education and Research (http://www.bmbf.de/en/) via the 'Limpopo Living Landscapes' project within the SPACES programme (grant numbers 01LL1304-C and -D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angassa A, 2012, J ARID ENVIRON, V81, P67, DOI 10.1016/j.jaridenv.2012.01.006; Austin MP, 2013, J VEG SCI, V24, P251, DOI 10.1111/j.1654-1103.2012.01467.x; Bredenkamp GJ, 1996, VEGETATION S AFRICA, P43; Bruser K, 2014, INT J REMOTE SENS, V35, P1653, DOI 10.1080/01431161.2014.882028; Burnham K. P., 1998, MODEL SELECTION INFE; Committee TN-ASAW, 1990, HDB STAND SOIL TEST; Cowling R. M., 1997, P99; Diaz S, 2001, J APPL ECOL, V38, P497, DOI 10.1046/j.1365-2664.2001.00635.x; Diaz S, 2007, GLOBAL CHANGE BIOL, V13, P313, DOI 10.1111/j.1365-2486.2006.01288.x; Edwards EJ, 2008, ECOL LETT, V11, P266, DOI 10.1111/j.1461-0248.2007.01144.x; Eldridge D. J., 2012, Ecology, V93, P2499, DOI 10.1890/12-0749.1; Frank ASK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068466; Fraser LH, 2013, FRONT ECOL ENVIRON, V11, P147, DOI 10.1890/110279; Fynn R, 2011, J VEG SCI, V22, P528, DOI 10.1111/j.1654-1103.2011.01268.x; Garcia CAM, 2014, APPL VEG SCI, V17, P470, DOI 10.1111/avsc.12092; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; HARGROVE WW, 1992, LANDSCAPE ECOL, V6, P251, DOI 10.1007/BF00129703; Harrison YA, 1999, LAND DEGRAD DEV, V10, P225, DOI 10.1002/(SICI)1099-145X(199905/06)10:3<225::AID-LDR337>3.3.CO;2-K; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Jackson JE, 2003, USERS GUIDE PRINCIPA; Jacobs N, 2003, ENV POWER INJUSTICE; Jauffret S, 2003, J VEG SCI, V14, P399, DOI 10.1111/j.1654-1103.2003.tb02165.x; Jeltsch F, 2008, PERSPECT PLANT ECOL, V9, P171, DOI 10.1016/j.ppees.2007.11.004; Kotze E, 2013, J ARID ENVIRON, V97, P220, DOI 10.1016/j.jaridenv.2013.07.004; Koyanagi T, 2013, APPL VEG SCI, V16, P95, DOI 10.1111/j.1654-109X.2012.01204.x; Kuhn A, 2010, IMPACTS OF GLOBAL CHANGE ON THE HYDROLOGICAL CYCLE IN WEST AND NORTHWEST AFRICA, P566; Laliberte E, 2012, J ECOL, V100, P662, DOI 10.1111/j.1365-2745.2011.01947.x; Lavorel SMS, 2007, J VEG SCI, V10, P661; Lienin P, 2011, AGR ECOSYST ENVIRON, V145, P67, DOI 10.1016/j.agee.2011.03.015; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Linstadter A, 2008, AFRICAN LANDSCAPES I, P79; Linstadter A, 2013, J ARID ENVIRON, V95, P30, DOI 10.1016/j.jaridenv.2013.03.008; Linstadter A, 2013, CATENA, V103, P3, DOI 10.1016/j.catena.2012.02.002; Luzuriaga AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041270; Manthey M, 2010, J ARID ENVIRON, V74, P1351, DOI 10.1016/j.jaridenv.2010.05.007; Martin R, 2014, GLOBAL ENVIRON CHANG, V24, P183, DOI 10.1016/j.gloenvcha.2013.09.009; McCune B., 2011, PC ORD MULTIVARIATE; McIntyre S, 1999, J VEG SCI, V10, P621, DOI 10.2307/3237077; Meyer KM, 2010, BASIC APPL ECOL, V11, P563, DOI 10.1016/j.baae.2010.08.001; Milchunas DG, 1998, OIKOS, V83, P65, DOI 10.2307/3546547; Mucina L., 2006, VEGETATION S AFRICA; Muller F, 2012, ECOSYST SERV, V1, P26, DOI 10.1016/j.ecoser.2012.06.001; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Murray C, 1997, AFR AFFAIRS, V96, P187, DOI 10.1093/oxfordjournals.afraf.a007825; O'Connor T. G., 1997, P215; O'Connor TG, 2003, S AFR J BOT, V69, P105, DOI 10.1016/S0254-6299(15)30365-3; O'Laughlin B, 2013, J AGRAR CHANGE, V13, P1, DOI 10.1111/joac.12010; Palmer AR, 2013, AFR J RANGE FOR SCI, V30, P57, DOI 10.2989/10220119.2013.779596; Palmer T., 2006, COUNTRY PASTURE FORA; Peters DPC, 2012, GLOBAL CHANGE BIOL, V18, P151, DOI 10.1111/j.1365-2486.2011.02498.x; Pyke DA, 2002, J RANGE MANAGE, V55, P584, DOI 10.2307/4004002; Quiroga RE, 2010, ECOL APPL, V20, P1876, DOI 10.1890/09-0641.1; RAUNKIAER C., 1934; Rooyen N. van, 1991, Koedoe, V34, P61; Rooyen van N, 2001, FLOWERING PLANTS KAL, P1; Rooyen van N, 1996, VEGETATION S AFRICA, P35; Ruppert JC, 2012, J VEG SCI, V23, P1035, DOI 10.1111/j.1654-1103.2012.01420.x; Rutherford MC, 2013, S AFR J BOT, V87, P146, DOI 10.1016/j.sajb.2013.03.020; Rutherford MC, 2011, PLANT ECOL, V212, P1407, DOI 10.1007/s11258-011-9916-0; Rutherford MC, 2012, APPL VEG SCI, V15, P14, DOI 10.1111/j.1654-109X.2011.01160.x; Saiz H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040551; Sander H, 1998, ERDE, V129, P301; Sasaki T, 2011, PLANT ECOL, V212, P327, DOI 10.1007/s11258-010-9825-7; Schellberg J, 2012, GRASS FORAGE SCI, V67, P305, DOI 10.1111/j.1365-2494.2012.00867.x; Schulte A, 2002, KOLNER GEOGRAPHISCHE, V77, P101; Shipley B, 2010, PLANT TRAITS VEGETAT; Smet M., 2005, African Journal of Range & Forage Science, V22, P59, DOI 10.2989/10220110509485862; Smet M, 2006, J ARID ENVIRON, V64, P251, DOI 10.1016/j.jaridenv.2005.04.014; Snyman HA, 2009, AGR ECOSYST ENVIRON, V130, P100, DOI 10.1016/j.agee.2008.12.003; ter Braak C.J.F., 2012, CANOCO REFERENCE MAN; van der Westhuizen H. C., 2005, African Journal of Range & Forage Science, V22, P47, DOI 10.2989/10220110509485861; van der Westhuizen H. C., 1999, African Journal of Range and Forage Science, V16, P49, DOI 10.2989/10220119909485719; Van Oudtshoorn FV., 1999, GUIDE GRASSES SO AFR; Vetter S., 2006, African Journal of Range & Forage Science, V23, P13, DOI 10.2989/10220110609485883; von Wehrden H, 2009, J VEG SCI, V20, P695, DOI 10.1111/j.1654-1103.2009.01063.x; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; Wesuls D, 2012, J VEG SCI, V23, P98, DOI 10.1111/j.1654-1103.2011.01342.x; Wiegand T, 2004, ECOSYSTEMS, V7, P243, DOI 10.1007/s10021-003-0235-8; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zimmermann J, 2008, J ECOL, V96, P1033, DOI 10.1111/j.1365-2745.2008.01409.x; Zimmermann J, 2010, PERSPECT PLANT ECOL, V12, P1, DOI 10.1016/j.ppees.2009.09.003	81	36	36	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104672	10.1371/journal.pone.0104672	http://dx.doi.org/10.1371/journal.pone.0104672			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111802	Green Submitted, Green Published, gold			2022-12-27	WOS:000341105100088
J	Jung, KM; Folkvord, A; Kjesbu, OS; Sundby, S				Jung, Kyung-Mi; Folkvord, Arild; Kjesbu, Olav Sigurd; Sundby, Svein			Experimental Parameterisation of Principal Physics in Buoyancy Variations of Marine Teleost Eggs	PLOS ONE			English	Article							COD GADUS-MORHUA; MACKEREL SCOMBER-SCOMBRUS; SPAWNING ATLANTIC COD; PELAGIC FISH EGGS; VERTICAL-DISTRIBUTION; BALTIC-SEA; LARVAE; DENSITY; AQUAPORINS; SURVIVAL	It is generally accepted that the high buoyancy of pelagic marine eggs is due to substantial influx of water across the cell membrane just before ovulation. Here we further develop the theoretical basis by applying laboratory observations of the various components of the fertilized egg in first-principle equations for egg specific gravity (rho(egg)) followed by statistical validation. We selected Atlantic cod as a model animal due to the affluent amount of literature on this species, but also undertook additional dedicated experimental works. We found that specific gravity of yolk plus embryo is central in influencing regg and thereby the buoyancy. However, our established framework documents the effect on regg of the initial deposition of the heavy chorion material in the gonad prior to spawning. Thereafter, we describe the temporal changes in regg during incubation: Generally, the eggs showed a slight rise in regg from fertilization to mid-gastrulation followed by a gradual decrease until full development of main embryonic organs just before hatching. Ontogenetic changes in rho(egg) were significantly associated with volume and mass changes of yolk plus embryo. The initial rho(egg) at fertilization appeared significantly influenced by the chorion volume fraction which is determined by the combination of the final chorion volume of the oocyte and of the degree of swelling (hydrolyzation) prior to spawning. The outlined principles and algorithms are universal in nature and should therefore be applicable to fish eggs in general.	[Jung, Kyung-Mi; Folkvord, Arild; Kjesbu, Olav Sigurd; Sundby, Svein] IMR, Bergen, Norway; [Jung, Kyung-Mi; Folkvord, Arild; Kjesbu, Olav Sigurd; Sundby, Svein] Hjort Ctr Marine Ecosyst Dynam, Bergen, Norway; [Jung, Kyung-Mi; Folkvord, Arild] Univ Bergen, Dept Biol, Bergen, Norway; [Kjesbu, Olav Sigurd] Univ Oslo, Dept Biol, CEES, Oslo, Norway	Institute of Marine Research - Norway; University of Bergen; University of Oslo	Jung, KM (corresponding author), IMR, Bergen, Norway.	kyungmi-toy@hanmail.net	Kjesbu, Olav Sigurd/M-3551-2015; Folkvord, Arild/A-5311-2012	Folkvord, Arild/0000-0002-4763-0590; Sundby, Svein/0000-0002-0815-9740	project "Population differentiation of Atlantic cod'' under the Programme on Biological mechanisms; Programme on Climate and Fish at the Institute of Marine Research in Norway	project "Population differentiation of Atlantic cod'' under the Programme on Biological mechanisms; Programme on Climate and Fish at the Institute of Marine Research in Norway	This study was funded by the project "Population differentiation of Atlantic cod'' under the Programme on Biological mechanisms and by the Programme on Climate and Fish at the Institute of Marine Research in Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adoff GR, 1986, FISH LARVAL PHYSL AN, P51; ANDERSON JT, 1994, ICES MAR SC, V198, P654; [Anonymous], 2010, R LANG ENV STAT COMP; Cerda J, 2009, J FISH BIOL, V75, P2175, DOI 10.1111/j.1095-8649.2009.02397.x; Cerda J, 2010, J EXP ZOOL PART A, V313A, P623, DOI 10.1002/jez.634; COOMBS SH, 1981, MAR BIOL, V63, P101, DOI 10.1007/BF00394667; Coombs SH, 2001, FISH RES, V50, P27, DOI 10.1016/S0165-7836(00)00240-X; CRAIK JCA, 1987, J MAR BIOL ASSOC UK, V67, P169, DOI 10.1017/S0025315400026436; DAVENPORT J, 1981, J FISH BIOL, V19, P317, DOI 10.1111/j.1095-8649.1981.tb05835.x; dlandsvik B, 2001, FISH RES, V50, P59; Finn RN, 1995, MAR BIOL, V124, P355, DOI 10.1007/BF00363909; FRIDGEIRSSON E, 1978, Rit Fiskideildar, V5, P1; FYHN HJ, 1987, MAR BIOL, V96, P335, DOI 10.1007/BF00412514; Govoni John J., 2008, P495; Jung KM, 2012, J SEA RES, V73, P63, DOI 10.1016/j.seares.2012.06.007; Jung KM, 2012, MAR BIOL, V159, P1969, DOI 10.1007/s00227-012-1984-8; Kjesbu OS, 1996, J FISH BIOL, V49, P1197, DOI 10.1111/j.1095-8649.1996.tb01789.x; KJESBU OS, 1992, J FISH BIOL, V41, P581, DOI 10.1111/j.1095-8649.1992.tb02685.x; KJORSVIK E, 1983, J FISH BIOL, V23, P1, DOI 10.1111/j.1095-8649.1983.tb02877.x; LONNING S, 1988, SARSIA, V73, P49, DOI 10.1080/00364827.1988.10420671; Mangor-Jensen A, 1986, FISH LARVAL PHYSL AN, P117; MANGORJENSEN A, 1987, FISH PHYSIOL BIOCHEM, V3, P17, DOI 10.1007/BF02183990; MANGORJENSEN A, 1991, J FISH BIOL, V39, P133, DOI 10.1111/j.1095-8649.1991.tb04349.x; Nissling A, 1996, J FISH BIOL, V48, P217; NISSLING A, 1994, MAR ECOL PROG SER, V110, P67, DOI 10.3354/meps110067; OPPENBERNTSEN DO, 1990, DEV BIOL, V137, P258, DOI 10.1016/0012-1606(90)90252-E; Ospina-Alvarez A, 2012, FISH RES, V117, P86, DOI 10.1016/j.fishres.2011.01.030; Riis-Vestergaard J, 2002, J FISH BIOL, V60, P1511, DOI 10.1006/jfbi.2002.2004; Riis-Vestergaard J, 1984, PROPAGATION COD, V1, P87; Skjaerven KH, 2003, BIG FISH BANG, P193; SOLEMDAL P, 1981, INT COUNC EXPLOR S G, V77, P1; StatSoft Inc, 2013, STATISTICA DAT AN SO; Sundby S, 1997, SCI MAR, V61, P159; SUNDBY S, 1983, DEEP-SEA RES, V30, P645, DOI 10.1016/0198-0149(83)90042-0; Sundby S, 2001, S AFR J MARINE SCI, V23, P317; SUNDBY S, 1991, ICES MAR SC, V192, P33; Thorsen A, 1996, J FISH BIOL, V48, P457, DOI 10.1111/j.1095-8649.1996.tb01440.x; WESTIN L, 1991, MAR BIOL, V108, P5, DOI 10.1007/BF01313465	38	14	14	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104089	10.1371/journal.pone.0104089	http://dx.doi.org/10.1371/journal.pone.0104089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122447	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000027
J	Nwabuo, CC; Dy, SM; Weeks, K; Young, JH				Nwabuo, Chike C.; Dy, Sydney Morss; Weeks, Kristina; Young, J. Hunter			Factors Associated with Appointment Non-Adherence among African-Americans with Severe, Poorly Controlled Hypertension	PLOS ONE			English	Article							BLOOD-PRESSURE; MEDICATION ADHERENCE; INSURANCE-COVERAGE; DIABETIC-PATIENTS; FOLLOW-UP; CARE; VISITS; DISPARITIES; ATTENDANCE; MORTALITY	Background: Missed appointments are associated with an increased risk of hospitalization and mortality. Despite its widespread prevalence, little data exists regarding factors related to appointment non-adherence among hypertensive African-Americans. Objective: To investigate factors associated with appointment non-adherence among African-Americans with severe, poorly controlled hypertension. Design and Participants: A cross-sectional survey of 185 African-Americans admitted to an urban medical center in Maryland, with severe, poorly controlled hypertension from 1999-2004. Categorical and continuous variables were compared using chi-square and t-tests. Adjusted multivariable logistic regression was used to assess correlates of appointment non-adherence. Main Outcome Measures: Appointment non-adherence was the primary outcome and was defined as patient-report of missing greater than 3 appointments out of 10 during their lifetime. Results: Twenty percent of participants (n = 37) reported missing more than 30% of their appointments. Patient characteristics independently associated with a higher odds of appointment non-adherence included not finishing high school (Odds ratio [OR] = 3.23 95% confidence interval [CI] (1.33-7.69), hypertension knowledge ([OR] = 1.20 95% CI: 1.01-1.42), lack of insurance ([OR] = 6.02 95% CI: 1.83-19.88), insurance with no medication coverage ([OR] = 5.08 95% CI: 1.05-24.63), cost of discharge medications ([OR] = 1.20 95% CI: 1.01-1.42), belief that anti-hypertensive medications do not work ([OR] = 3.67 95% CI: 1.16-11.7), experience of side effects ([OR] = 3.63 95% CI: 1.24-10.62), medication non-adherence ([OR] = 11.31 95% CI: 3.87-33.10). Substance abuse was not associated with appointment non-adherence ([OR] = 1.05 95% CI: 0.43-2.57). Conclusions: Appointment non-adherence among African-Americans with poorly controlled hypertension was associated with many markers of inadequate access to healthcare, knowledge, attitudes and beliefs.	[Nwabuo, Chike C.; Young, J. Hunter] Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Dy, Sydney Morss; Young, J. Hunter] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Dy, Sydney Morss] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Weeks, Kristina] Johns Hopkins Med Inst, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Nwabuo, CC (corresponding author), Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA.	cnwabuo1@jhu.edu	Nwabuo, Chike/H-5867-2019	Nwabuo, Chike/0000-0002-7888-9781	National Institutes of Health (NIH) through the National Center for Research Resources (NCRR) [K23RR16056]; American Heart Association (AHA) through a Scientist Development Grant [0130307N]; Johns Hopkins Medical Institution General Clinical Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016056] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through the National Center for Research Resources (NCRR); American Heart Association (AHA) through a Scientist Development Grant(American Heart Association); Johns Hopkins Medical Institution General Clinical Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health (NIH) through the National Center for Research Resources (NCRR) (K23RR16056) and by the American Heart Association (AHA) through a Scientist Development Grant (0130307N). Additional support was provided by the Johns Hopkins Medical Institution General Clinical Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averill RF, 2003, 3M APR DRG CLASSIFIC; Bailey JE, 2010, J GEN INTERN MED, V25, P495, DOI 10.1007/s11606-009-1240-1; BELL RL, 1985, CONTROL CLIN TRIALS, V6, P89, DOI 10.1016/0197-2456(85)90114-X; Berg MB, 2005, AIDS CARE, V17, P902, DOI 10.1080/09540120500101658; BIGBY J, 1983, JAMA-J AM MED ASSOC, V250, P1742, DOI 10.1001/jama.250.13.1742; Blavin F, 2012, STATE PROGR HLTH REF; Bosworth HB, 2008, J GEN INTERN MED, V23, P692, DOI 10.1007/s11606-008-0547-7; Capko Judy, 2007, J Med Pract Manage, V22, P368; DKS Ng, 2012, J GEN INTER IN PRESS; Gary TL, 2003, PREV MED, V37, P23, DOI 10.1016/S0091-7435(03)00040-9; GATES SJ, 1976, MED CARE, V14, P263, DOI 10.1097/00005650-197603000-00007; Gerver SM, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-29; Hill MN, 1999, AM J HYPERTENS, V12, P951, DOI 10.1016/S0895-7061(99)00121-1; Jones D, 2013, AIDS BEHAV, V17, P242, DOI 10.1007/s10461-012-0367-y; Karter AJ, 2004, MED CARE, V42, P110, DOI 10.1097/01.mlr.0000109023.64650.73; Kawasaki L, 2007, AM J MANAG CARE, V13, P257; Kim M T, 2000, Prog Cardiovasc Nurs, V15, P90, DOI 10.1111/j.1751-7117.2000.tb00211.x; Koh H, 2013, JAMA-J AM MED ASSOC, V309, P1893, DOI 10.1001/jama.2013.3469; Kramer H, 2004, AM J HYPERTENS, V17, P963, DOI 10.1016/j.amjhyper.2004.06.001; Lee JY, 1996, CONTROL CLIN TRIALS, V17, pS34, DOI 10.1016/S0197-2456(97)82680-3; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Little B, 1991, J Okla State Med Assoc, V84, P455; MACHARIA WM, 1992, JAMA-J AM MED ASSOC, V267, P1813, DOI 10.1001/jama.267.13.1813; Colubi MM, 2012, HIV CLIN TRIALS, V13, P289, DOI 10.1310/hct1305-289; McClure RJ, 1996, ARCH DIS CHILD, V74, P121, DOI 10.1136/adc.74.2.121; McDonough Beverley, 2013, Nurs Times, V109, P12; Miller NH, 1997, CIRCULATION, V95, P1085; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Morss S, 2008, J CLIN HYPERTENS, V10, P684, DOI 10.1111/j.1751-7176.2008.00004.x; Mugavero MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P100, DOI 10.1097/QAI.0b013e31818d5c37; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; Neuspiel DR, 2012, PEDIATR CLIN N AM, V59, P1341, DOI 10.1016/j.pcl.2012.08.006; Nuti LA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-304; Ogedegbe G, 2007, J GEN INTERN MED, V22, P1176, DOI 10.1007/s11606-007-0244-y; Park WB, 2007, J INTERN MED, V261, P268, DOI 10.1111/j.1365-2796.2006.01762.x; Parker MM, 2012, HEALTH SERV RES, V47, P572, DOI 10.1111/j.1475-6773.2011.01337.x; Pesata V, 1999, J Pediatr Health Care, V13, P178, DOI 10.1016/S0891-5245(99)90037-8; Romano PS, 2000, HEALTH SERV RES, V34, P1469; Schectman JM, 2008, J GEN INTERN MED, V23, P1685, DOI 10.1007/s11606-008-0747-1; SMITH EO, 1982, HYPERTENSION, V4, P710, DOI 10.1161/01.HYP.4.5.710; Sommers BD, 2012, JAMA-J AM MED ASSOC, V307, P913, DOI 10.1001/jama.307.9.913; Tilburt JC, 2008, J NATL MED ASSOC, V100, P91; Van der Meer G, 2008, East Afr J Public Health, V5, P154; WEBB PA, 1980, J FAM PRACTICE, V10, P1047	44	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103090	10.1371/journal.pone.0103090	http://dx.doi.org/10.1371/journal.pone.0103090			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO0QT	25121589	gold, Green Submitted, Green Published			2022-12-27	WOS:000341017000009
J	Al-Asmakh, M; Stukenborg, JB; Reda, A; Anuar, F; Strand, ML; Hedin, L; Pettersson, S; Soeder, O				Al-Asmakh, Maha; Stukenborg, Jan-Bernd; Reda, Ahmed; Anuar, Farhana; Strand, Mona-Lisa; Hedin, Lars; Pettersson, Sven; Soeder, Oiie			The Gut Microbiota and Developmental Programming of the Testis in Mice	PLOS ONE			English	Article							TIGHT JUNCTION STRANDS; SERTOLI-CELLS; POSTNATAL-DEVELOPMENT; SODIUM-BUTYRATE; GENE-EXPRESSION; GERM-CELLS; HELA-CELLS; BARRIER; BRAIN; PERMEABILITY	Nutrients and environmental chemicals, including endocrine disruptors, have been incriminated in the current increase in male reproductive dysfunction, but the underlying mechanisms remain unknown. The gastrointestinal tract represents the largest surface area exposed to our environment and thereby plays a key role in connection with exposure of internal organs to exogenous factors. In this context the gut microbiome (all bacteria and their metabolites) have been shown to be important contributors to body physiology including metabolism, cognitive functions and immunity. Pivotal to male reproduction is a proper development of the testis, including the formation of the blood-testis barrier (BTB) that encapsulates and protects germ cells from stress induced environmental cues, e.g. pathogenic organisms and xenobiotics. Here we used specific pathogen free (SPF) mice and germ-free (GF) mice to explore whether gut microbiota and/or their metabolites can influence testis development and regulation of BTB. Lumen formation in the seminiferous tubules, which coincides with the development of the BTB was delayed in the testes of GF mice at 16 days postpartum. In addition, perfusion experiments (Evans blue) demonstrated increased BTB permeability in these same mice. Reduced expressions of occludin, ZO-2 and E-cadherin in GF testis suggested that the microbiota modulated BTB permeability by regulation of cell-cell adhesion. Interestingly, exposure of GF mice to Clostridium Tyrobutyricum (CBUT), which secrete high levels of butyrate, restored the integrity of the BTB and normalized the levels of cell adhesion proteins. Moreover, the GF mice exhibited lower serum levels of gonadotropins (LH and FSH) than the SPF group. In addition, the intratesticular content of testosterone was lower in GF compared to SPF or CBUT animals. Thus, the gut microbiome can modulate the permeability of the BTB and might play a role in the regulation of endocrine functions of the testis.	[Al-Asmakh, Maha; Anuar, Farhana; Pettersson, Sven] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Al-Asmakh, Maha] Qatar Univ, Coll Arts & Sci, Dept Biomed Sci, Doha, Qatar; [Stukenborg, Jan-Bernd; Reda, Ahmed; Strand, Mona-Lisa; Soeder, Oiie] Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Paediat Endocrinol Unit, Stockholm, Sweden; [Pettersson, Sven] Nanyang Technol Univ, LKC Sch Med, Singapore 639798, Singapore; [Hedin, Lars] Sidra Med & Res Ctr, Div Clin Epidemiol, Doha, Qatar	Karolinska Institutet; Qatar University; Karolinska Institutet; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Sidra Medical & Research Center	Soeder, O (corresponding author), Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Paediat Endocrinol Unit, Stockholm, Sweden.	Oiie.Soder@ki.se	Pettersson, Sven/F-9511-2015	Reda, Ahmed/0000-0001-7053-7979; Stukenborg, Jan-bernd/0000-0002-2839-1870	Qatar University; Agency for Science, Technology and Research (A*STAR); Frimurare Barnhuset in Stockholm; Pediatric Research Foundation; Sallskapet Barnavard; Swedish research council Vetenskapsradet (VR); VR/FA and Barncancerfonden; EU	Qatar University(Qatar National Research Fund (QNRF)); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Frimurare Barnhuset in Stockholm; Pediatric Research Foundation; Sallskapet Barnavard; Swedish research council Vetenskapsradet (VR)(Swedish Research Council); VR/FA and Barncancerfonden; EU(European Commission)	The authors thank Qatar University for providing a scholarship to M.A.A. and the Agency for Science, Technology and Research (A*STAR) for postdoctoral funding for F.A. The authors and their research are supported by grants from the Frimurare Barnhuset in Stockholm, Pediatric Research Foundation, Sallskapet Barnavard, Swedish research council Vetenskapsradet (VR), VR/FA and Barncancerfonden and EU-project TORNADO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braniste V, 2014, SCI TRANSLATIONAL ME; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Cyr DG, 1999, ENDOCRINOLOGY, V140, P3815, DOI 10.1210/en.140.8.3815; Doi T, 2010, PEDIATR SURG INT, V26, P91, DOI 10.1007/s00383-009-2505-9; Dorgan JF, 1996, AM J CLIN NUTR, V64, P850, DOI 10.1093/ajcn/64.6.850; Gerard P, 2010, GASTROINTESTINAL TRA, P4789; GHOSH NK, 1977, NATURE, V267, P435, DOI 10.1038/267435a0; Giwercman A, 2011, BEST PRACT RES CL EN, V25, P391, DOI 10.1016/j.beem.2010.09.011; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hasegawa K, 2012, DEVELOPMENT, V139, P4347, DOI 10.1242/dev.080119; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Hudcovic T, 2012, CLIN EXP IMMUNOL, V167, P356, DOI 10.1111/j.1365-2249.2011.04498.x; JUTTE NHPM, 1982, J REPROD FERTIL, V65, P431, DOI 10.1530/jrf.0.0650431; Kalayci R, 2006, LIFE SCI, V79, P16, DOI 10.1016/j.lfs.2005.12.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazaud-Guittot S, 2010, BIOL REPROD, V82, P202, DOI 10.1095/biolreprod.109.078907; McCole DF, 2007, CURR OPIN GASTROEN, V23, P647, DOI 10.1097/MOG.0b013e3282f0153b; Meng J, 2005, P NATL ACAD SCI USA, V102, P16696, DOI 10.1073/pnas.0506084102; Meng Jing, 2011, Hormones & Cancer, V2, P145, DOI 10.1007/s12672-010-0063-1; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Nomura T ON, 1973, TESTICULAR FUNCTIONS; ORTH JM, 1982, ANAT REC, V203, P485, DOI 10.1002/ar.1092030408; Paul C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084354; Petersen C, 2006, HORM RES, V66, P153, DOI 10.1159/000094142; Poutahidis T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084877; RUDDON RW, 1979, CANCER RES, V39, P3885; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016; Sharpe RM, 2000, BRIT MED BULL, V56, P630, DOI 10.1258/0007142001903436; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969; Stevenson BR, 1998, ANNU REV CELL DEV BI, V14, P89, DOI 10.1146/annurev.cellbio.14.1.89; VERGOUWEN RPFA, 1993, J REPROD FERTIL, V99, P479, DOI 10.1530/jrf.0.0990479; Volek JS, 1997, J APPL PHYSIOL, V82, P49, DOI 10.1063/1.365847; Walczak-Jedrzejowska Renata, 2007, Folia Histochem Cytobiol, V45 Suppl 1, pS59; Wang RS, 2006, ENDOCRINOLOGY, V147, P5624, DOI 10.1210/en.2006-0138; Wang Y., 2003, CURR PROTOC TOXICOL, V16, P6, DOI [10.1002/0471140856.tx1606s14, 10.14421/biomedich.2015.41.1-3, DOI 10.1002/0471140856.TX1606S14]; Wong CH, 2004, J CELL SCI, V117, P783, DOI 10.1242/jcs.00900; Xu JL, 2009, MOL BIOL CELL, V20, P4268, DOI 10.1091/mbc.E08-12-1236	44	65	66	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103809	10.1371/journal.pone.0103809	http://dx.doi.org/10.1371/journal.pone.0103809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118984	Green Published, gold			2022-12-27	WOS:000340900600031
J	Ren, YF; Hansen, SF; Ebert, B; Lau, J; Scheller, HV				Ren, Yanfang; Hansen, Sara Fasmer; Ebert, Berit; Lau, Jane; Scheller, Henrik Vibe			Site-Directed Mutagenesis of IRX9, IRX9L and IRX14 Proteins Involved in Xylan Biosynthesis: Glycosyltransferase Activity Is Not Required for IRX9 Function in Arabidopsis	PLOS ONE			English	Article							GLUCURONOXYLAN BIOSYNTHESIS; REVEALS; COMPLEX; MEMBERS; GENES; GT43; ELONGATION	Xylans constitute the main non-cellulosic polysaccharide in the secondary cell walls of plants. Several genes predicted to encode glycosyltransferases are required for the synthesis of the xylan backbone even though it is a homopolymer consisting entirely of beta-1,4-linked xylose residues. The putative glycosyltransferases IRX9, IRX14, and IRX10 (or the paralogs IRX9L, IRX14L, and IRX10L) are required for xylan backbone synthesis in Arabidopsis. To investigate the function of IRX9, IRX9L, and IRX14, we identified amino acid residues known to be essential for catalytic function in homologous mammalian proteins and generated modified cDNA clones encoding proteins where these residues would be mutated. The mutated gene constructs were used to transform wild-type Arabidopsis plants and the irx9 and irx14 mutants, which are deficient in xylan synthesis. The ability of the mutated proteins to complement the mutants was investigated by measuring growth, determining cell wall composition, and microscopic analysis of stem cross-sections of the transgenic plants. The six different mutated versions of IRX9 and IRX9-L were all able to complement the irx9 mutant phenotype, indicating that residues known to be essential for glycosyltransferases function in homologous proteins are not essential for the biological function of IRX9/IRX9L. Two out of three mutated IRX14 complemented the irx14 mutant, including a mutant in the predicted catalytic amino acid. A IRX14 protein mutated in the substrate-binding DxD motif did not complement the irx14 mutant. Thus, substrate binding is important for IRX14 function but catalytic activity may not be essential for the function of the protein. The data indicate that IRX9/IRX9L have an essential structural function, most likely by interacting with the IRX10/IRX10L proteins, but do not have an essential catalytic function. Most likely IRX14 also has primarily a structural role, but it cannot be excluded that the protein has an important enzymatic activity.	[Ren, Yanfang; Hansen, Sara Fasmer; Ebert, Berit; Lau, Jane; Scheller, Henrik Vibe] Lawrence Berkeley Natl Lab, Joint Bioenergy Inst, Berkeley, CA 94720 USA; [Ren, Yanfang] Guizhou Univ, Coll Agr, Guiyang, Peoples R China; [Ebert, Berit] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Scheller, Henrik Vibe] Univ Calif, Dept Plant & Microbial Biol, Berkeley, CA USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory; Guizhou University; University of Copenhagen; University of California System; University of California Berkeley	Scheller, HV (corresponding author), Lawrence Berkeley Natl Lab, Joint Bioenergy Inst, Berkeley, CA 94720 USA.	hscheller@lbl.gov	Scheller, Henrik V/A-8106-2008; Scheller, Henrik/AAH-4770-2020; Ebert, Berit/C-1748-2019; Ebert, Berit/F-1856-2016	Scheller, Henrik V/0000-0002-6702-3560; Scheller, Henrik/0000-0002-6702-3560; Ebert, Berit/0000-0002-6914-5473; Ebert, Berit/0000-0002-6914-5473	U.S. Department of Energy, Office of Science (science.energy.gov), Office of Biological and Environmental Research [DE-AC02-05CH11231]; Lawrence Berkeley National Laboratory; China Scholarship Council [2010852564]; Carlsberg Foundation [2010_01_0509]	U.S. Department of Energy, Office of Science (science.energy.gov), Office of Biological and Environmental Research(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); China Scholarship Council(China Scholarship Council); Carlsberg Foundation(Carlsberg Foundation)	This work was funded by the U.S. Department of Energy, Office of Science (science.energy.gov), Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 with Lawrence Berkeley National Laboratory. YR was supported by China Scholarship Council (www.csc.edu.cn) grant 2010852564. SFH was supported by a fellowship from The Carlsberg Foundation (www.carlsbergfondet.dk) contract 2010_01_0509. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders N, 2010, ANN PLANT REV PLANT, V41, P251; Anders N, 2012, P NATL ACAD SCI USA, V109, P989, DOI 10.1073/pnas.1115858109; Atmodjo MA, 2011, P NATL ACAD SCI USA, V108, P20225, DOI 10.1073/pnas.1112816108; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; Chiniquy D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00083; Chiniquy D, 2012, P NATL ACAD SCI USA, V109, P17117, DOI 10.1073/pnas.1202079109; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fondeur-Gelinotte M, 2007, GLYCOBIOLOGY, V17, P857, DOI 10.1093/glycob/cwm055; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Jensen JK, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00183; Jensen JK, 2011, PLANT J, V66, P387, DOI 10.1111/j.1365-313X.2010.04475.x; Lee C, 2012, PLANT CELL PHYSIOL, V53, P135, DOI 10.1093/pcp/pcr158; Lee CH, 2011, MOL PLANT, V4, P730, DOI 10.1093/mp/ssr035; Lee C, 2010, PLANT PHYSIOL, V153, P526, DOI 10.1104/pp.110.155309; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; Mortimer JC, 2010, P NATL ACAD SCI USA, V107, P17409, DOI 10.1073/pnas.1005456107; Obro J, 2004, PHYTOCHEMISTRY, V65, P1429, DOI 10.1016/j.phytochem.2004.05.002; Ouzzine M, 2000, J BIOL CHEM, V275, P28254; Pedersen LC, 2002, J BIOL CHEM, V277, P21869, DOI 10.1074/jbc.M112343200; Rennie EA, 2014, CURR OPIN BIOTECH, V26, P100, DOI 10.1016/j.copbio.2013.11.013; Rennie EA, 2012, PLANT PHYSIOL, V159, P1408, DOI 10.1104/pp.112.200964; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x; Xiong GY, 2013, MOL PLANT, V6, P1373, DOI 10.1093/mp/sst014; York WS, 2008, CURR OPIN PLANT BIOL, V11, P258, DOI 10.1016/j.pbi.2008.02.007; Yuan YX, 2013, PLANT CELL PHYSIOL, V54, P1186, DOI 10.1093/pcp/pct070; Zeng W, 2010, PLANT PHYSIOL, V154, P78, DOI 10.1104/pp.110.159749	31	37	38	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105014	10.1371/journal.pone.0105014	http://dx.doi.org/10.1371/journal.pone.0105014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118690	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600112
J	Verspagen, JMH; Van de Waal, DB; Finke, JF; Visser, PM; Van Donk, E; Huisman, J				Verspagen, Jolanda M. H.; Van de Waal, Dedmer B.; Finke, Jan F.; Visser, Petra M.; Van Donk, Ellen; Huisman, Jef			Rising CO2 Levels Will Intensify Phytoplankton Blooms in Eutrophic and Hypertrophic Lakes	PLOS ONE			English	Article							CARBON-DIOXIDE SUPERSATURATION; GAS TRANSFER VELOCITIES; HARMFUL ALGAL BLOOMS; INORGANIC CARBON; NUTRIENT LIMITATION; SPATIAL-DISTRIBUTION; POPULATION-DYNAMICS; OCEAN ACIDIFICATION; SPECIES COMPOSITION; MIXING DEPTHS	Harmful algal blooms threaten the water quality of many eutrophic and hypertrophic lakes and cause severe ecological and economic damage worldwide. Dense blooms often deplete the dissolved CO2 concentration and raise pH. Yet, quantitative prediction of the feedbacks between phytoplankton growth, CO2 drawdown and the inorganic carbon chemistry of aquatic ecosystems has received surprisingly little attention. Here, we develop a mathematical model to predict dynamic changes in dissolved inorganic carbon (DIC), pH and alkalinity during phytoplankton bloom development. We tested the model in chemostat experiments with the freshwater cyanobacterium Microcystis aeruginosa at different CO2 levels. The experiments showed that dense blooms sequestered large amounts of atmospheric CO2, not only by their own biomass production but also by inducing a high pH and alkalinity that enhanced the capacity for DIC storage in the system. We used the model to explore how phytoplankton blooms of eutrophic waters will respond to rising CO2 levels. The model predicts that (1) dense phytoplankton blooms in low-and moderately alkaline waters can deplete the dissolved CO2 concentration to limiting levels and raise the pH over a relatively wide range of atmospheric CO2 conditions, (2) rising atmospheric CO2 levels will enhance phytoplankton blooms in low-and moderately alkaline waters with high nutrient loads, and (3) above some threshold, rising atmospheric CO2 will alleviate phytoplankton blooms from carbon limitation, resulting in less intense CO2 depletion and a lesser increase in pH. Sensitivity analysis indicated that the model predictions were qualitatively robust. Quantitatively, the predictions were sensitive to variation in lake depth, DIC input and CO2 gas transfer across the air-water interface, but relatively robust to variation in the carbon uptake mechanisms of phytoplankton. In total, these findings warn that rising CO2 levels may result in a marked intensification of phytoplankton blooms in eutrophic and hypertrophic waters.	[Verspagen, Jolanda M. H.; Van de Waal, Dedmer B.; Finke, Jan F.; Visser, Petra M.; Huisman, Jef] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Aquat Microbiol, Amsterdam, Netherlands; [Van de Waal, Dedmer B.; Van Donk, Ellen] Netherlands Inst Ecol, Dept Aquat Ecol, Wageningen, Netherlands; [Van Donk, Ellen] Univ Utrecht, Inst Environm Biol, Utrecht, Netherlands	University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Utrecht University	Huisman, J (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Aquat Microbiol, Amsterdam, Netherlands.	j.huisman@uva.nl	van Donk, Ellen/B-7272-2008; Huisman, Jef/A-1089-2013; Van de Waal, Dedmer B/B-8002-2012; KNAW, NIOO-KNAW/A-4320-2012	van Donk, Ellen/0000-0003-3279-4936; Huisman, Jef/0000-0001-9598-3211; Van de Waal, Dedmer B/0000-0001-8803-1247; Visser, Petra/0000-0003-3294-1908; KNAW, NIOO-KNAW/0000-0002-3835-159X; Verspagen, Jolanda/0000-0001-9295-4183	Earth and Life Sciences Foundation (ALW) [854.10.006]; Netherlands Organization for Scientific Research (NWO)	Earth and Life Sciences Foundation (ALW); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research was supported by grant 854.10.006 of the Earth and Life Sciences Foundation (ALW), which is subsidized by the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Balmer MB, 2011, INLAND WATERS, V1, P125, DOI 10.5268/IW-1.2.366; Beaulieu M, 2013, LIMNOL OCEANOGR, V58, P1736, DOI 10.4319/lo.2013.58.5.1736; Beninca E, 2008, NATURE, V451, P822, DOI 10.1038/nature06512; BERMANFRANK I, 1994, LIMNOL OCEANOGR, V39, P1822, DOI 10.4319/lo.1994.39.8.1822; Caraco NF, 1998, CAN J FISH AQUAT SCI, V55, P54, DOI 10.1139/cjfas-55-1-54; Chaffin JD, 2011, J GREAT LAKES RES, V37, P92, DOI 10.1016/j.jglr.2010.11.016; Chorus I., 1999, Toxic cyanobacteria in water: a guide to their public health consequences, monitoring and management; Cole JJ, 1998, LIMNOL OCEANOGR, V43, P647, DOI 10.4319/lo.1998.43.4.0647; COLE JJ, 1994, SCIENCE, V265, P1568, DOI 10.1126/science.265.5178.1568; Crusius J, 2003, LIMNOL OCEANOGR, V48, P1010, DOI 10.4319/lo.2003.48.3.1010; DELGIORGIO PA, 1994, LIMNOL OCEANOGR, V39, P772, DOI 10.4319/lo.1994.39.4.0772; Diehl S, 2002, ECOLOGY, V83, P386, DOI 10.1890/0012-9658(2002)083[0386:PLANIA]2.0.CO;2; Diehl S, 2002, ECOLOGY, V83, P399, DOI 10.1890/0012-9658(2002)083[0399:PLANIA]2.0.CO;2; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; DROOP MR, 1973, J PHYCOL, V9, P264; Dzialowski AR, 2005, J PLANKTON RES, V27, P587, DOI 10.1093/plankt/fbi034; Edenhofer O., 2014, CONTRIBUTION WORKING; EMERSON S, 1975, LIMNOL OCEANOGR, V20, P743, DOI 10.4319/lo.1975.20.5.0743; Frey HC, 2002, RISK ANAL, V22, P553; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Giordano M, 2005, ANNU REV PLANT BIOL, V56, P99, DOI 10.1146/annurev.arplant.56.032604.144052; GOLDMAN JC, 1980, LIMNOL OCEANOGR, V25, P352, DOI 10.4319/lo.1980.25.2.0352; GROVER JP, 1991, AM NAT, V138, P811, DOI 10.1086/285254; Gu BH, 2006, LIMNOL OCEANOGR, V51, P2837, DOI 10.4319/lo.2006.51.6.2837; Gu BH, 2011, AQUAT SCI, V73, P317, DOI 10.1007/s00027-010-0179-y; Guerin F, 2007, J MARINE SYST, V66, P161, DOI 10.1016/j.jmarsys.2006.03.019; Guildford SJ, 2000, LIMNOL OCEANOGR, V45, P1213, DOI 10.4319/lo.2000.45.6.1213; Gulati RD, 2002, HYDROBIOLOGIA, V478, P73, DOI 10.1023/A:1021092427559; Guo L, 2007, SCIENCE, V317, P1166, DOI 10.1126/science.317.5842.1166; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hein M, 1997, FRESHWATER BIOL, V37, P545, DOI 10.1046/j.1365-2427.1997.00180.x; Huisman J, 1999, ECOLOGY, V80, P211, DOI 10.1890/0012-9658(1999)080[0211:CFLBPS]2.0.CO;2; HUISMAN J, 1994, ECOLOGY, V75, P507, DOI 10.2307/1939554; Huisman J, 2004, ECOLOGY, V85, P2960, DOI 10.1890/03-0763; Huisman J, 1999, ECOLOGY, V80, P202, DOI 10.2307/176990; Huisman J., 2005, HARMFUL CYANOBACTERI; Ibelings BW, 1998, LIMNOL OCEANOGR, V43, P408, DOI 10.4319/lo.1998.43.3.0408; Jansson M, 2012, ECOL LETT, V15, P527, DOI 10.1111/j.1461-0248.2012.01762.x; Johnk KD, 2008, GLOBAL CHANGE BIOL, V14, P495, DOI 10.1111/j.1365-2486.2007.01510.x; Kangur K, 2008, HYDROBIOLOGIA, V599, P31, DOI 10.1007/s10750-007-9204-0; Kanoshina I, 2003, HARMFUL ALGAE, V2, P29, DOI 10.1016/S1568-9883(02)00085-9; Klausmeier CA, 2004, LIMNOL OCEANOGR, V49, P1463, DOI 10.4319/lo.2004.49.4_part_2.1463; Lazzarino JK, 2009, HYDROBIOLOGIA, V627, P169, DOI 10.1007/s10750-009-9723-y; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Lopez-Archilla AI, 2004, EXTREMOPHILES, V8, P109, DOI 10.1007/s00792-003-0369-9; Maberly SC, 1996, FRESHWATER BIOL, V35, P579, DOI 10.1111/j.1365-2427.1996.tb01770.x; Michalak AM, 2013, P NATL ACAD SCI USA, V110, P6448, DOI 10.1073/pnas.1216006110; MILLER AG, 1984, PLANT PHYSIOL, V75, P1064, DOI 10.1104/pp.75.4.1064; Millero FJ, 2006, MAR CHEM, V100, P80, DOI 10.1016/j.marchem.2005.12.001; MOREL FMM, 1987, J PHYCOL, V23, P137; Murphy J, 1962, WATER SCI TECHNOL, V32, P25; Noges T, 2010, AQUAT ECOSYST HEALTH, V13, P143, DOI 10.1080/14634981003788987; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; OCHUMBA PBO, 1989, AFR J ECOL, V27, P23, DOI 10.1111/j.1365-2028.1989.tb00925.x; Oduor SO, 2007, J PLANKTON RES, V29, P1041, DOI 10.1093/plankt/fbm078; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Ozawa K, 2005, ENVIRON TOXICOL, V20, P270, DOI 10.1002/tox.20117; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Passarge J, 2006, ECOL MONOGR, V76, P57, DOI 10.1890/04-1824; PORTIELJE R, 1995, LIMNOL OCEANOGR, V40, P690, DOI 10.4319/lo.1995.40.4.0690; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Qiu BS, 2002, J PHYCOL, V38, P721, DOI 10.1046/j.1529-8817.2002.01180.x; Sabart M, 2010, APPL ENVIRON MICROB, V76, P4750, DOI 10.1128/AEM.02531-09; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Sandrini G, 2014, ISME J, V8, P589, DOI 10.1038/ismej.2013.179; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; SCHINDLER DW, 1972, SCIENCE, V177, P1192, DOI 10.1126/science.177.4055.1192; SCHINDLER DW, 1985, BIOGEOCHEMISTRY, V1, P117, DOI 10.1007/BF02185037; Schippers P, 2004, ECOL LETT, V7, P446, DOI 10.1111/j.1461-0248.2004.00597.x; Shapiro J, 1997, FRESHWATER BIOL, V37, P307, DOI 10.1046/j.1365-2427.1997.00164.x; SIEGENTHALER U, 1993, NATURE, V365, P119, DOI 10.1038/365119a0; Sobek S, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002264; Soetaert K, 2007, MAR CHEM, V105, P30, DOI 10.1016/j.marchem.2006.12.012; Stumm W., 1996, AQUATIC CHEM CHEM EQ, V3rd ed., DOI [10.5860/choice.33-6312, DOI 10.5860/CHOICE.33-6312]; Suikkanen S, 2007, ESTUAR COAST SHELF S, V71, P580, DOI 10.1016/j.ecss.2006.09.004; TALLING J F, 1973, Freshwater Biology, V3, P53, DOI 10.1111/j.1365-2427.1973.tb00062.x; TALLING JF, 1976, J ECOL, V64, P79, DOI 10.2307/2258685; Van de Waal DB, 2009, ECOL LETT, V12, P1326, DOI 10.1111/j.1461-0248.2009.01383.x; van der Zee DJ, 2011, INT J PROD RES, V49, P7059, DOI 10.1038/ismej.2011.28; van Hannen EJ, 1999, APPL ENVIRON MICROB, V65, P795; Verschoor AM, 2013, FRESHWATER BIOL, V58, P597, DOI 10.1111/j.1365-2427.2012.02833.x; Verschuren D, 2002, P ROY SOC B-BIOL SCI, V269, P289, DOI 10.1098/rspb.2001.1850; Verspagen JMH, 2006, ECOL APPL, V16, P313, DOI 10.1890/04-1953; Verspagen JMH, 2005, FRESHWATER BIOL, V50, P854, DOI 10.1111/j.1365-2427.2005.01368.x; Verspagen JMH, 2014, ECOL LETT, V17, P951, DOI 10.1111/ele.12298; Visser PM, 1997, HYDROBIOLOGIA, V349, P99, DOI 10.1023/A:1003001713560; Weiss R.F., 1974, MAR CHEM, V2, P203, DOI DOI 10.1016/0304-4203(74)90015-2; Wetzel R.G., 2000, LIMNOLOGICAL ANAL; Wolf-Gladrow DA, 2007, MAR CHEM, V106, P287, DOI 10.1016/j.marchem.2007.01.006; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420	91	118	122	16	202	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104325	10.1371/journal.pone.0104325	http://dx.doi.org/10.1371/journal.pone.0104325			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119996	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600050
J	Vidal, D; Ortega, F; Sanz, JL				Vidal, Daniel; Ortega, Francisco; Luis Sanz, Jose			Titanosaur Osteoderms from the Upper Cretaceous of Lo Hueco (Spain) and Their Implications on the Armor of Laurasian Titanosaurs	PLOS ONE			English	Article							DINOSAURIA SAUROPODA OSTEODERM; PATAGONIA; SPECIMEN; BASIN	Titanosaurs are the only sauropod dinosaurs known to bear a dermal armor. Their osteoderms are relatively rare finds, with few more than a hundred specimens recovered worldwide. Also, little is known about their intra-individual, intra-specific or inter-specific variability. The macrovertebrate site of Lo Hueco (Upper Cretaceous; Cuenca, Spain) has yielded several complete specimens of osteoderms, some associated with fairly articulated specimens. They are all variations of the morphotype known as bulb and root. The presence of only this morphotype in Europe, which is considered as the primitive condition among titanosaurs, seems to indicate that the known Upper Cretaceous Laurasian titanosaurs only bore these referred bulb and root osteoderms. An eliptic Fourier analysis on the outline of complete specimens from this morphotype reveals: i) that they truly are part of a morphological cline; and ii) the existence of a consistent correlation between the outline and the morphology of the bulb. Such variation along a cline is more consistent with intra-individual rather than inter-specific variation. The osteoderms associated with a single titanosaur individual from Lo Hueco reinforce this hypothesis.	[Vidal, Daniel; Luis Sanz, Jose] Univ Autonoma Madrid, Unidad Paleontol, Madrid, Spain; [Ortega, Francisco] Univ Nacl Educ Distancia, Grp Biol Evolutiva, Madrid, Spain	Autonomous University of Madrid; Universidad Nacional de Educacion a Distancia (UNED)	Vidal, D (corresponding author), Univ Autonoma Madrid, Unidad Paleontol, Cantoblanco, Madrid, Spain.	rickraptor@me.com	Sanz, Jose Luis/O-1421-2019; Vidal, Daniel/T-1730-2019; Vidal, Daniel C/G-6174-2016; Ortega, Francisco/B-5760-2009; Ortega, Francisco/K-3255-2015	Vidal, Daniel/0000-0002-6054-1357; Vidal, Daniel C/0000-0002-6054-1357; Ortega, Francisco/0000-0002-7431-354X; Ortega, Francisco/0000-0002-7431-354X; Sanz, Jose Luis/0000-0002-5214-5725	Spanish Ministerio de Economia y Competitividad [CGL2012-35199]; Postgraduate Grant "Beca de posgrado'' from the Universidad Autonoma de Madrid	Spanish Ministerio de Economia y Competitividad(Spanish Government); Postgraduate Grant "Beca de posgrado'' from the Universidad Autonoma de Madrid	Daniel Vidal is recipient of a Postgraduate Grant "Beca de posgrado'' from the Universidad Autonoma de Madrid. Research funding was provided by project CGL2012-35199 of the Spanish Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour VM, 2014, J MORPHOL, V275, P39, DOI 10.1002/jmor.20194; Barroso-Barcenilla F, 2009, CRETACEOUS RES, V30, P1268, DOI 10.1016/j.cretres.2009.07.010; Bonaparte JF., 1980, MEMOIRES SOC GEOLOGI, V139, P19; Calvo Jorge O., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P485; Cerda IA, 2010, ACTA PALAEONTOL POL, V55, P389, DOI 10.4202/app.2009.1101; Chiappe LM, 1998, NATURE, V396, P258, DOI 10.1038/24370; Coria RA, 2007, J PALEONTOL, V81, P1528, DOI 10.1666/05-150.1; Csiki Zoltan, 1999, Oryctos, V2, P93; CZERKAS SA, 1992, GEOLOGY, V20, P1068, DOI 10.1130/0091-7613(1992)020<1068:DODSRA>2.3.CO;2; D'Emic MD, 2009, J VERTEBR PALEONTOL, V29, P165, DOI 10.1671/039.029.0131; Deperet C., 1896, Bulletin de la Societe Geologique de France, V(3), P176; Diez Diaz V, 2013, PALAEONTOLOGIA ELECT, V16, p18p; Diez Diaz V, CRETACEOUS IN PRESS; Diaz VD, 2013, ANN PALEONTOL, V99, P119, DOI 10.1016/j.annpal.2012.12.002; Gomani EM, 2005, PALAEONTOL ELECTRON, V8; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Knoll F., 2013, 73 ANN M SOC VERT PA, P122; Knoll F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054991; Le Loeuff Jean, 1994, Gaia, V10, P155; Lindoso RM, 2013, CRETACEOUS RES, V45, P43, DOI 10.1016/j.cretres.2013.07.005; Malkani MS, 2010, J EARTH SCI-CHINA, V21, P198; Marinho TS., 2011, PALEONTOLOGIA CEN RI, P367; Molnar RE, 2011, ALCHERINGA, V35, P329, DOI 10.1080/03115518.2011.533978; Ortega F, 2012, FUNDAMENTAL, V20, P173; PIVETEAU J., 1926, BULL SOC GIOL FRANCE, V26, P33; Powell JE., 2003, RECORDS QUEEN VICTOR, V111, P1; Riga BJG, 2003, AMEGHINIANA, V40, P155; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Rogers KC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1578; Salgado L, 2005, J VERTEBR PALEONTOL, V25, P623, DOI 10.1671/0272-4634(2005)025[0623:ANSONA]2.0.CO;2; Salgado L, 2003, AMEGHINIANA, V40, P441; Salgado Leonardo, 1993, Ameghiniana, V30, P119; Sanz J.L., 1987, 4 S MES TERR ECOS SH, P197; Sanz Jose Luis, 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P235; SEIDEL MR, 1979, HERPETOLOGICA, V35, P375	36	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e102488	10.1371/journal.pone.0102488	http://dx.doi.org/10.1371/journal.pone.0102488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118985	Green Published, gold			2022-12-27	WOS:000340900600007
J	Yao, B; Scott, GG; McAleer, P; O'Donnell, PJ; Sereno, SC				Yao, Bo; Scott, Graham G.; McAleer, Phil; O'Donnell, Patrick J.; Sereno, Sara C.			Familiarity with Interest Breeds Gossip: Contributions of Emotion, Expectation, and Reputation	PLOS ONE			English	Article							PERSPECTIVE	Although gossip serves several important social functions, it has relatively infrequently been the topic of systematic investigation. In two experiments, we advance a cognitive-informational approach to gossip. Specifically, we sought to determine which informational components engender gossip. In Experiment 1, participants read brief passages about other people and indicated their likelihood to share this information. We manipulated target familiarity (celebrity, non-celebrity) and story interest (interesting, boring). While participants were more likely to gossip about celebrity than non-celebrity targets and interesting than boring stories, they were even more likely to gossip about celebrity targets embedded within interesting stories. In Experiment 2, we additionally probed participants' reactions to the stories concerning emotion, expectation, and reputation information conveyed. Analyses showed that while such information partially mediated target familiarity and story interest effects, only expectation and reputation accounted for the interactive pattern of gossip behavior. Our findings provide novel insights into the essential components and processing mechanisms of gossip.	[Yao, Bo] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Scott, Graham G.] Univ West Scotland, Sch Social Sci, Paisley, Renfrew, Scotland; [McAleer, Phil; Sereno, Sara C.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [O'Donnell, Patrick J.; Sereno, Sara C.] Univ Glasgow, Sch Psychol, Glasgow, Lanark, Scotland	University of Manchester; University of West Scotland; University of Glasgow; University of Glasgow	Yao, B (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	Bo.Yao@manchester.ac.uk; Sara.Sereno@glasgow.ac.uk	Yao, Bo/F-9846-2010; McAleer, Phil/A-8178-2011	Yao, Bo/0000-0003-1852-2774; Sereno, Sara/0000-0001-7957-9542; McAleer, Phil/0000-0002-4523-2097	Institute of Neuroscience and Psychology, University of Glasgow	Institute of Neuroscience and Psychology, University of Glasgow	The study was supported by the Institute of Neuroscience and Psychology, University of Glasgow. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister RF, 2004, REV GEN PSYCHOL, V8, P111, DOI 10.1037/1089-2680.8.2.111; Curci A, 2004, COGNITION EMOTION, V18, P881, DOI 10.1080/02699930341000347; De Backer CJS, 2007, HUM NATURE-INT BIOS, V18, P334, DOI 10.1007/s12110-007-9023-z; Dunbar RIM, 2004, REV GEN PSYCHOL, V8, P100, DOI 10.1037/1089-2680.8.2.100; Ellwardt L, 2012, SOC NETWORKS, V34, P193, DOI 10.1016/j.socnet.2011.11.003; Feinberg M, 2014, PSYCHOL SCI, V25, P656, DOI 10.1177/0956797613510184; Feinberg M, 2012, J PERS SOC PSYCHOL, V102, P1015, DOI 10.1037/a0026650; Foster EK, 2004, REV GEN PSYCHOL, V8, P78, DOI 10.1037/1089-2680.8.2.78; Hayes A. F., 2012, PROCESS VERSATILE CO; McAndrew FT, 2007, J APPL SOC PSYCHOL, V37, P1562, DOI 10.1111/j.1559-1816.2007.00227.x; Osgood C.E., 1957, MEASUREMENT MEANING; Peters K, 2009, EUR J SOC PSYCHOL, V39, P207, DOI 10.1002/ejsp.523; Rime B, 2009, EMOT REV, V1, P60, DOI 10.1177/1754073908097189; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sommerfeld RD, 2008, P ROY SOC B-BIOL SCI, V275, P2529, DOI 10.1098/rspb.2008.0762; Tennie C, 2010, TRENDS COGN SCI, V14, P482, DOI 10.1016/j.tics.2010.07.003; Van Krieken Robert, 2012, CELEBRITY SOC; Wert SR, 2004, REV GEN PSYCHOL, V8, P122, DOI 10.1037/1089-2680.8.2.122	18	4	4	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104916	10.1371/journal.pone.0104916	http://dx.doi.org/10.1371/journal.pone.0104916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9BM	25119267	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000340900600104
J	Amable, PR; Teixeira, MVT; Carias, RBV; Granjeiro, JM; Borojevic, R				Amable, Paola Romina; Telles Teixeira, Marcus Vinicius; Vieira Carias, Rosana Bizon; Granjeiro, Jose Mauro; Borojevic, Radovan			Mesenchymal Stromal Cell Proliferation, Gene Expression and Protein Production in Human Platelet-Rich Plasma-Supplemented Media	PLOS ONE			English	Article							BONE-MARROW; STEM-CELLS; PROGENITOR CELLS; ADIPOSE-TISSUE; OPTIMIZATION; EXPANSION; DIFFERENTIATION; OCT-4	Background: Platelet-rich plasma (PRP) is increasingly used as a cell culture supplement, in order to reduce the contact of human cells with animal-derived products during in vitro expansion. The effect of supplementation changes on cell growth and protein production is not fully characterized. Methods: Human mesenchymal stromal cells from bone marrow, adipose tissue and Wharton's Jelly were isolated and cultured in PRP-supplemented media. Proliferation, in vitro differentiation, expression of cell surface markers, mRNA expression of key genes and protein secretion were quantified. Results: 10% PRP sustained five to tenfold increased cell proliferation as compared to 10% fetal bovine serum. Regarding cell differentiation, PRP reduced adipogenic differentiation and increased calcium deposits in bone marrow and adipose tissue-mesenchymal stromal cells. Wharton's Jelly derived mesenchymal stromal cells secreted higher concentrations of chemokines and growth factors than other mesenchymal stromal cells when cultured in PRP-supplemented media. Bone marrow derived mesenchymal stromal cells secreted higher concentrations of pro-inflammatory and pro-angiogenic proteins. Mesenchymal stromal cells isolated from adipose tissue secreted higher amounts of extracellular matrix components. Conclusions: Mesenchymal stromal cells purified from different tissues have distinct properties regarding differentiation, angiogenic, inflammatory and matrix remodeling potential when cultured in PRP supplemented media. These abilities should be further characterized in order to choose the best protocols for their therapeutic use.	[Amable, Paola Romina; Telles Teixeira, Marcus Vinicius; Vieira Carias, Rosana Bizon; Borojevic, Radovan] Excell Biomed Serv SA, Petropolis, RJ, Brazil; [Telles Teixeira, Marcus Vinicius; Vieira Carias, Rosana Bizon; Granjeiro, Jose Mauro; Borojevic, Radovan] Natl Inst Metrol Qual & Technol, Xerem, RJ, Brazil	Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO)	Amable, PR (corresponding author), Excell Biomed Serv SA, Petropolis, RJ, Brazil.	pramable@gmail.com	Borojevic, Radovan/V-8500-2019; Granjeiro, Jose/D-8289-2012	Borojevic, Radovan/0000-0002-2393-7280; Granjeiro, Jose/0000-0002-8027-8293	Excellion Servicos Biomedicos S.A.	Excellion Servicos Biomedicos S.A.	This work was funded by Excellion Servicos Biomedicos S.A. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amable PR, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt442; Amable PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073792; Amable PR, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt218; Ben Azouna N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt97; Bernardo ME, 2007, J CELL PHYSIOL, V211, P121, DOI 10.1002/jcp.20911; Bianchi G, 2003, EXP CELL RES, V287, P98, DOI 10.1016/S0014-4827(03)00138-1; Browning SR, 2012, J BONE JOINT SURG AM, V94, P1; Carvalho PP, 2011, CYTOTHERAPY, V13, P594, DOI 10.3109/14653249.2010.544721; Cho HS, 2011, KOREAN J LAB MED, V31, P212, DOI 10.3343/kjlm.2011.31.3.212; FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Haleem AM, 2010, CARTILAGE, V1, P253, DOI 10.1177/1947603510366027; Hasebe Y, 2011, J DERMATOL SCI, V62, P98, DOI 10.1016/j.jdermsci.2011.01.012; Hatlapatka T, 2011, TISSUE ENG PART C-ME, V17, P485, DOI [10.1089/ten.TEC.2010.0406, 10.1089/ten.tec.2010.0406]; Heng BC, 2009, BIOL PROCED ONLINE, V11, P161, DOI 10.1007/s12575-009-9001-4; Ikebe C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/951512; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085; Noel D, 2008, EXP CELL RES, V314, P1575, DOI 10.1016/j.yexcr.2007.12.022; Pochampally RR, 2004, BLOOD, V103, P1647, DOI 10.1182/blood-2003-06-1967; Rajala K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010246; Roche S, 2007, J CELL BIOCHEM, V101, P271, DOI 10.1002/jcb.21185; Russell KC, 2010, STEM CELLS, V28, P788, DOI 10.1002/stem.312; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Spreafico A, 2009, J CELL BIOCHEM, V108, P1153, DOI 10.1002/jcb.22344; Trouillas M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt149; Verrier S, 2010, EUR CELLS MATER, V20, P403; Wang SH, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-19; Xie XT, 2012, BIOMATERIALS, V33, P7008, DOI 10.1016/j.biomaterials.2012.06.058; Zimmermann S, 2003, LEUKEMIA, V17, P1146, DOI 10.1038/sj.leu.2402962	29	60	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104662	10.1371/journal.pone.0104662	http://dx.doi.org/10.1371/journal.pone.0104662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115920	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400067
J	Bevins, SN; Pedersen, K; Lutman, MW; Baroch, JA; Schmit, BS; Kohler, D; Gidlewski, T; Nolte, DL; Swafford, SR; DeLiberto, TJ				Bevins, Sarah N.; Pedersen, Kerri; Lutman, Mark W.; Baroch, John A.; Schmit, Brandon S.; Kohler, Dennis; Gidlewski, Thomas; Nolte, Dale L.; Swafford, Seth R.; DeLiberto, Thomas J.			Large-Scale Avian Influenza Surveillance in Wild Birds throughout the United States	PLOS ONE			English	Article							SOUTH-AMERICA; H5N1 VIRUS; A VIRUSES; NORTH; MIGRATION; PATTERNS; ECOLOGY; CANADA	Avian influenza is a viral disease that primarily infects wild and domestic birds, but it also can be transmitted to a variety of mammals. In 2006, the United States of America Departments of Agriculture and Interior designed a large-scale, interagency surveillance effort that sought to determine if highly pathogenic avian influenza viruses were present in wild bird populations within the United States of America. This program, combined with the Canadian and Mexican surveillance programs, represented the largest, coordinated wildlife disease surveillance program ever implemented. Here we analyze data from 197,885 samples that were collected from over 200 wild bird species. While the initial motivation for surveillance focused on highly pathogenic avian influenza, the scale of the data provided unprecedented information on the ecology of avian influenza viruses in the United States, avian influenza virus host associations, and avian influenza prevalence in wild birds over time. Ultimately, significant advances in our knowledge of avian influenza will depend on both large-scale surveillance efforts and on focused research studies.	[Bevins, Sarah N.; Pedersen, Kerri; Lutman, Mark W.; Baroch, John A.; Schmit, Brandon S.; Kohler, Dennis; Gidlewski, Thomas; Nolte, Dale L.; Swafford, Seth R.; DeLiberto, Thomas J.] APHIS, Wildlife Serv, USDA, Natl Wildlife Dis Program, Ft Collins, CO 80526 USA; [Bevins, Sarah N.; Baroch, John A.; Schmit, Brandon S.; Kohler, Dennis; Gidlewski, Thomas; DeLiberto, Thomas J.] Natl Wildlife Res Ctr, APHIS, Wildlife Serv, USDA, Ft Collins, CO USA; [Pedersen, Kerri; Lutman, Mark W.; Nolte, Dale L.] APHIS, Wildlife Serv, USDA, Natl Feral Swine Damage Management Program, Ft Collins, CO USA; [Swafford, Seth R.] United States Fish & Wildlife Serv, USDOI, Yazoo City, MS USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of the Interior; US Fish & Wildlife Service	Bevins, SN (corresponding author), APHIS, Wildlife Serv, USDA, Natl Wildlife Dis Program, Ft Collins, CO 80526 USA.	Sarah.N.Bevins@aphis.usda.gov	Baroch, John A./G-7317-2017	Baroch, John A./0000-0001-6265-4622	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture. The manuscript was reviewed for general policy statements committing the USDA to action, but otherwise the findings were independently developed by the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Brown JD, 2014, METHODS MOL BIOL, V1161, P69, DOI 10.1007/978-1-4939-0758-8_7; Brown VL, 2012, BIOL LETTERS, V8, P1036, DOI 10.1098/rsbl.2012.0635; Causey D, 2008, J INFECT DIS, V197, pS29, DOI 10.1086/524991; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; DEIBEL R, 1985, AVIAN DIS, V29, P970, DOI 10.2307/1590450; DeLiberto TJ, 2009, INTEGR ZOOL, V4, P426, DOI 10.1111/j.1749-4877.2009.00180.x; DeLiberto TJ, 2012, OIE GLOB C WIDL PAR; Deliberto TJ, 2011, PANDEMIC INFLUENZA V, P156; Farnsworth ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032729; Fuller TL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-187; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Latorre-Margalef N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0098; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Newman SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005729; OIE, 2012, MANUAL DIAGNOSTIC TE; OIE, 2009, AN DIS DIAGN SURV NO, V9; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Parmley EJ, 2008, EMERG INFECT DIS, V14, P84, DOI 10.3201/eid1401.061562; Parmley J, 2009, INTEGR ZOOL, V4, P409, DOI 10.1111/j.1749-4877.2009.00177.x; Pasick J, 2009, REV SCI TECH OIE, V28, P349, DOI 10.20506/rst.28.1.1875; Pedersen K, 2010, AVIAN DIS, V54, P405, DOI 10.1637/8693-031309-Reg.1; Sauer J. R., 2014, N AM BREEDING BIRD S, P3; Senne DA, 2007, AVIAN DIS, V51, P167, DOI 10.1637/7621-042606R1.1; Senne DA, 2010, AVIAN DIS, V54, P179, DOI 10.1637/8921-050809-Review.1; SLEMONS RD, 1991, AVIAN DIS, V35, P210, DOI 10.2307/1591316; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2008, J VET DIAGN INVEST, V20, P612, DOI 10.1177/104063870802000512; Stailknecht DE, 2007, J WILDLIFE DIS, V43, pS15; SWAYNE D., 1998, LAB MANUAL ISOLATION, P150; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; USDA, 2006, EARL DET SYST HIGHL; VanDalen KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012851; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yong W, 1997, SOUTHWEST NAT, V42, P137	42	42	43	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104360	10.1371/journal.pone.0104360	http://dx.doi.org/10.1371/journal.pone.0104360			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116079	Green Published, gold			2022-12-27	WOS:000341230400043
J	Einav, S				Einav, Shiri			Does the Majority Always Know Best? Young Children's Flexible Trust in Majority Opinion	PLOS ONE			English	Article							INFORMANTS; TRANSMISSION; ACCURACY; OTHERS	Copying the majority is generally an adaptive social learning strategy but the majority does not always know best. Previous work has demonstrated young children's selective uptake of information from a consensus over a lone dissenter. The current study examined children's flexibility in following the majority: do they overextend their reliance on this heuristic to situations where the dissenting individual has privileged knowledge and should be trusted instead? Four- to six-year-olds (N = 103) heard conflicting claims about the identity of hidden drawings from a majority and a dissenter in two between-subject conditions: in one, the dissenter had privileged knowledge over the majority (he drew the pictures); in the other he did not (they were drawn by an absent third party). Overall, children were less likely to trust the majority in the Privileged Dissenter condition. Moreover, 5- and 6- year-olds made majority-based inferences when the dissenter had no privileged knowledge but systematically endorsed the dissenter when he drew the pictures. The current findings suggest that by 5 years, children are able to make an epistemic-based judgment to decide whether or not to follow the majority rather than automatically following the most common view.	Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England	University of Nottingham	Einav, S (corresponding author), Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England.	shiri.einav@nottingham.ac.uk		Einav, Shiri/0000-0003-4632-605X	Oxford Brookes University; British Academy [SG-52013]	Oxford Brookes University; British Academy	This research was supported by a grant (SG-52013) from the British Academy (http://www.britac.ac.uk) and a School Research Strategy grant from Oxford Brookes University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch SAJ, 2008, COGNITION, V107, P1018, DOI 10.1016/j.cognition.2007.12.008; Boyd R., 1985, CULTURE EVOLUTIONARY; Chen EE, 2013, CHILD DEV, V84, P269, DOI 10.1111/j.1467-8624.2012.01850.x; Claidiere N, 2012, PSYCHOL BULL, V138, P126, DOI 10.1037/a0025868; Corriveau K, 2009, DEVELOPMENTAL SCI, V12, P426, DOI 10.1111/j.1467-7687.2008.00792.x; Corriveau KH, 2013, DEV PSYCHOL, V49, P470, DOI 10.1037/a0030604; Corriveau KH, 2009, PSYCHOL SCI, V20, P372, DOI 10.1111/j.1467-9280.2009.02291.x; Einav S, 2011, PSYCHOL SCI, V22, P1250, DOI 10.1177/0956797611416998; Haun DBM, 2012, CURR BIOL, V22, P727, DOI 10.1016/j.cub.2012.03.006; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Jaswal VK, 2006, PSYCHOL SCI, V17, P757, DOI 10.1111/j.1467-9280.2006.01778.x; Jaswal VK, 2006, COGNITION, V99, pB83, DOI 10.1016/j.cognition.2005.07.006; KELLEY HH, 1973, AM PSYCHOL, V28, P107, DOI 10.1037/h0034225; Koenig MA, 2005, CHILD DEV, V76, P1261, DOI 10.1111/j.1467-8624.2005.00849.x; Laland KN, 2004, LEARN BEHAV, V32, P4; Mills CM, 2013, DEV PSYCHOL, V49, P404, DOI 10.1037/a0029500; Nurmsoo E, 2009, CHILD DEV, V80, P23, DOI 10.1111/j.1467-8624.2008.01243.x; Preissler MA, 2008, COGNITION, V106, P512, DOI 10.1016/j.cognition.2007.02.002; Sabbagh MA, 2007, NEW DIR CHILD ADOLES, V115, P25, DOI 10.1002/cad.180; Schillaci RS, 2014, J COGN DEV, V15, P569, DOI 10.1080/15248372.2013.784973; VanderBorght M, 2009, INFANT CHILD DEV, V18, P61, DOI 10.1002/icd.591; Wood LA, 2013, DEV REV, V33, P341, DOI 10.1016/j.dr.2013.08.002	22	25	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104585	10.1371/journal.pone.0104585	http://dx.doi.org/10.1371/journal.pone.0104585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LJ	25116936	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400057
J	Orlowski, P; Tomaszewska, E; Gniadek, M; Baska, P; Nowakowska, J; Sokolowska, J; Nowak, Z; Donten, M; Celichowski, G; Grobelny, J; Krzyzowska, M				Orlowski, Piotr; Tomaszewska, Emilia; Gniadek, Marianna; Baska, Piotr; Nowakowska, Julita; Sokolowska, Justyna; Nowak, Zuzanna; Donten, Mikolaj; Celichowski, Grzegorz; Grobelny, Jaroslaw; Krzyzowska, Malgorzata			Tannic Acid Modified Silver Nanoparticles Show Antiviral Activity in Herpes Simplex Virus Type 2 Infection	PLOS ONE			English	Article							IN-VITRO; VIRAL ENTRY; INHIBITION; CELLS; IMMUNITY; HIV; CYTOTOXICITY; TRANSMISSION; MONOCYTES; RESPONSES	The interaction between silver nanoparticles and herpesviruses is attracting great interest due to their antiviral activity and possibility to use as microbicides for oral and anogenital herpes. In this work, we demonstrate that tannic acid modified silver nanoparticles sized 13 nm, 33 nm and 46 nm are capable of reducing HSV-2 infectivity both in vitro and in vivo. The antiviral activity of tannic acid modified silver nanoparticles was size-related, required direct interaction and blocked virus attachment, penetration and further spread. All tested tannic acid modified silver nanoparticles reduced both infection and inflammatory reaction in the mouse model of HSV-2 infection when used at infection or for a post-infection treatment. Smaller-sized nanoparticles induced production of cytokines and chemokines important for anti-viral response. The corresponding control buffers with tannic acid showed inferior antiviral effects in vitro and were ineffective in blocking in vivo infection. Our results show that tannic acid modified silver nanoparticles are good candidates for microbicides used in treatment of herpesvirus infections.	[Orlowski, Piotr; Krzyzowska, Malgorzata] Mil Inst Hyg & Epidemiol, Dept Regenerat Med, Warsaw, Poland; [Tomaszewska, Emilia; Celichowski, Grzegorz; Grobelny, Jaroslaw] Univ Lodz, Fac Chem, Dept Mat Technol & Chem, PL-90131 Lodz, Poland; [Gniadek, Marianna; Donten, Mikolaj] Univ Warsaw, Fac Chem, Warsaw, Poland; [Baska, Piotr] Warsaw Univ Life Sci, Fac Vet Med, Dept Preclin Sci, Warsaw, Poland; [Nowakowska, Julita] Univ Warsaw, Fac Biol, Lab Elect & Confocal Microscopy, Warsaw, Poland; [Sokolowska, Justyna] Warsaw Univ Life Sci, Fac Vet Med, Dept Morphol Sci, Warsaw, Poland; [Nowak, Zuzanna] Warsaw Univ Life Sci, Fac Anim Sci, Dept Genet & Anim Breeding, Warsaw, Poland	Military Institute of Hygiene & Epidemiology (MIHE); University of Lodz; University of Warsaw; Warsaw University of Life Sciences; University of Warsaw; Warsaw University of Life Sciences; Warsaw University of Life Sciences	Krzyzowska, M (corresponding author), Mil Inst Hyg & Epidemiol, Dept Regenerat Med, Warsaw, Poland.	krzyzowskam@yahoo.com	Nowak-Zyczynska, Zuzanna/GPC-5777-2022; Grzegorz Celichowski, Hab./N-2458-2018	Nowak-Zyczynska, Zuzanna/0000-0002-5907-9943; Grzegorz Celichowski, Hab./0000-0002-1624-3088; Baska, Piotr/0000-0001-8150-4187; sokolowska, justyna/0000-0003-0203-1604; Krzyzowska, Malgorzata/0000-0002-8409-3974; Nowakowska, Julita/0000-0001-7056-1688; Gniadek, Marianna/0000-0003-2206-5174; Grobelny, Jaroslaw/0000-0003-2648-2186	Polish National Science Centre [2011/03/B/NZ6/04878]; Centre for Preclinical Research and Technology (CePT) [POIG.02.02.00-14-024/08-0]	Polish National Science Centre; Centre for Preclinical Research and Technology (CePT)	This work was supported by the Polish National Science Centre grant No. 2011/03/B/NZ6/04878 (for MK) and Centre for Preclinical Research and Technology (CePT) Project No. POIG.02.02.00-14-024/08-0 (for MG and MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Akiyama H, 2001, J ANTIMICROB CHEMOTH, V48, P487, DOI 10.1093/jac/48.4.487; Aoki R, 2013, J INVEST DERMATOL, V133, P2170, DOI 10.1038/jid.2013.150; ATHAR M, 1989, CANCER RES, V49, P5784; Baram-Pinto D, 2009, BIOCONJUGATE CHEM, V20, P1497, DOI 10.1021/bc900215b; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; CHUNG KT, 1993, LETT APPL MICROBIOL, V17, P29, DOI 10.1111/j.1472-765X.1993.tb01428.x; Cumberbatch M, 1997, ADV EXP MED BIOL, V417, P125; de Lima R, 2012, J APPL TOXICOL, V32, P867, DOI 10.1002/jat.2780; DUFF R, 1971, NATURE-NEW BIOL, V233, P48, DOI 10.1038/newbio233048a0; Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6; Fayaz AM, 2012, INT J NANOMED, V7, P5007, DOI 10.2147/IJN.S34973; FUKUCHI K, 1989, ANTIVIR RES, V11, P285, DOI 10.1016/0166-3542(89)90038-7; Gaikwad S, 2013, INT J NANOMED, V8, P4303, DOI 10.2147/IJN.S50070; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Garner JA, 2003, ADV DRUG DELIVER REV, V55, P1497, DOI 10.1016/j.addr.2003.07.006; Grunewald K, 2003, SCIENCE, V302, P1396, DOI 10.1126/science.1090284; Gunalp A., 1965, P SOC EXP BIOL MED, V118, P185; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Halioua B, 1999, EUR J DERMATOL, V9, P177; Haslam E, 2007, PHYTOCHEMISTRY, V68, P2713, DOI 10.1016/j.phytochem.2007.09.009; HORIKAWA K, 1994, MUTAGENESIS, V9, P523, DOI 10.1093/mutage/9.6.523; Iijima N, 2011, P NATL ACAD SCI USA, V108, P284, DOI 10.1073/pnas.1005201108; Johnston HJ, 2010, CRIT REV TOXICOL, V40, P328, DOI 10.3109/10408440903453074; Khan NS, 2000, CHEM-BIOL INTERACT, V125, P177, DOI 10.1016/S0009-2797(00)00143-5; Khanbabaee K, 2001, NAT PROD REP, V18, P641, DOI 10.1039/b101061l; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim KJ, 2008, J MICROBIOL BIOTECHN, V18, P1482; Kleymann G, 2005, EXPERT OPIN INV DRUG, V14, P135, DOI 10.1517/13543784.14.2.135; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Krzyzowska M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.14; Krzyzowska M, 2014, IMMUNOBIOLOGY, V219, P64, DOI 10.1016/j.imbio.2013.08.002; KULESZMARTIN M, 1985, CARCINOGENESIS, V6, P1245, DOI 10.1093/carcin/6.9.1245; Lara Humberto H., 2010, Journal of Nanobiotechnology, V8, P15, DOI 10.1186/1477-3155-8-15; Lara Humberto H., 2010, Journal of Nanobiotechnology, V8, P1, DOI [10.1186/1477-3155-8-1, 10.1186/1477-3155-8-15]; Levin MJ, 2004, CLIN INFECT DIS, V39, pS248, DOI 10.1086/422364; Lin LT, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-187; Lin LT, 2011, J VIROL, V85, P4386, DOI 10.1128/JVI.01492-10; Liu HL, 2013, J HAZARD MATER, V248, P478, DOI 10.1016/j.jhazmat.2013.01.046; Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745; Lu L, 2008, ANTIVIR THER, V13, P253; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Mahad D, 2006, BRAIN, V129, P212, DOI 10.1093/brain/awh655; Milligan GN, 1999, J VIROL, V73, P6380, DOI 10.1128/JVI.73.8.6380-6386.1999; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Namvar L, 2005, J CLIN MICROBIOL, V43, P2058, DOI 10.1128/JCM.43.5.2058-2064.2005; Orlowski P, 2013, TOXICOL IN VITRO, V27, P1798, DOI 10.1016/j.tiv.2013.05.010; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Paludan SR, 2001, J VIROL, V75, P8008, DOI 10.1128/JVI.75.17.8008-8015.2001; PARR MB, 1994, LAB INVEST, V70, P369; Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10; Samberg ME, 2010, ENVIRON HEALTH PERSP, V118, P407, DOI 10.1289/ehp.0901398; SCALBERT A, 1991, PHYTOCHEMISTRY, V30, P3875, DOI 10.1016/0031-9422(91)83426-L; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Thapa M, 2008, Open Immunol J, V1, P33, DOI 10.2174/1874226200801010033; Tobian AAR, 2009, CURR OPIN HIV AIDS, V4, P294, DOI 10.1097/COH.0b013e32832c1881; Trefry JC, 2013, J BIOMED NANOTECHNOL, V9, P1624, DOI 10.1166/jbn.2013.1659; Varghese 1 M, 2012, INT J CELL BIOL, V2012; Wade James C, 2006, Hematology Am Soc Hematol Educ Program, P368; Wong KKY, 2009, CHEMMEDCHEM, V4, P1129, DOI 10.1002/cmdc.200900049; Xiang DX, 2013, INT J NANOMED, V8, P4103, DOI 10.2147/IJN.S53622; Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126; Yilma AN, 2013, INT J NANOMED, V8, P2421, DOI 10.2147/IJN.S44090	64	117	119	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104113	10.1371/journal.pone.0104113	http://dx.doi.org/10.1371/journal.pone.0104113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117537	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400032
J	Savinova, OV; Fillaus, K; Jing, L; Harris, WS; Shearer, GC				Savinova, Olga V.; Fillaus, Kristi; Jing, Linhong; Harris, William S.; Shearer, Gregory C.			Reduced Apolipoprotein Glycosylation in Patients with the Metabolic Syndrome	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; VERY-LOW-DENSITY; O-GLYCOSYLATION; MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; CORONARY EVENTS; ATTACHMENT SITE; A-II; PREVALENCE	Objective: The purpose of this study was to compare the apolipoprotein composition of the three major lipoprotein classes in patients with metabolic syndrome to healthy controls. Methods: Very low density (VLDL), intermediate/low density (IDL/LDL, hereafter LDL), and high density lipoproteins (HDL) fractions were isolated from plasma of 56 metabolic syndrome subjects and from 14 age-sex matched healthy volunteers. The apolipoprotein content of fractions was analyzed by one-dimensional (1D) gel electrophoresis with confirmation by a combination of mass spectrometry and biochemical assays. Results: Metabolic syndrome patients differed from healthy controls in the following ways: (1) total plasma - apoA1 was lower, whereas apoB, apoC2, apoC3, and apoE were higher; (2) VLDL - apoB, apoC3, and apoE were increased; (3) LDL - apoC3 was increased, (4) HDL -associated constitutive serum amyloid A protein (SAA4) was reduced (p<0.05 vs. controls for all). In patients with metabolic syndrome, the most extensively glycosylated (di-sialylated) isoform of apoC3 was reduced in VLDL, LDL, and HDL fractions by 17%, 30%, and 25%, respectively (p<0.01 vs. controls for all). Similarly, the glycosylated isoform of apoE was reduced in VLDL, LDL, and HDL fractions by 15%, 26%, and 37% (p<0.01 vs. controls for all). Finally, glycosylated isoform of SAA4 in HDL fraction was 42% lower in patients with metabolic syndrome compared with controls (p<0.001). Conclusions: Patients with metabolic syndrome displayed several changes in plasma apolipoprotein composition consistent with hypertriglyceridemia and low HDL cholesterol levels. Reduced glycosylation of apoC3, apoE and SAA4 are novel findings, the pathophysiological consequences of which remain to be determined.	[Savinova, Olga V.; Fillaus, Kristi; Shearer, Gregory C.] Sanford Res USD, Cardiovasc Hlth Res Ctr, Sioux Falls, SD 57104 USA; [Jing, Linhong] S Dakota State Univ, Dept Chem & Biochem, Brookings, SD 57007 USA; [Harris, William S.; Shearer, Gregory C.] Univ S Dakota, Sanford Sch Med, Dept Internal Med, Vermillion, SD 57069 USA	Sanford Health; South Dakota State University; University of South Dakota	Shearer, GC (corresponding author), Sanford Res USD, Cardiovasc Hlth Res Ctr, Sioux Falls, SD 57104 USA.	gcs13@psu.edu	Stefanadis, Christodoulos/ABH-2232-2020; Harris, William Stephen/T-1674-2019	Stefanadis, Christodoulos/0000-0001-5974-6454; Harris, William Stephen/0000-0003-3042-9353	National Institute of Health [5R01DK061486, 5P20RR017662-08]; GlaxoSmithKline; National Science Foundation (NSF)/EPSCoR [0091948]; State of South Dakota; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061486] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); National Science Foundation (NSF)/EPSCoR(National Science Foundation (NSF)); State of South Dakota; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health (5R01DK061486 and 5P20RR017662-08) and GlaxoSmithKline. The instrumentation in CCMSF at SDSU used in this study was obtained with support from the National Science Foundation (NSF)/EPSCoR Grant No. 0091948 and the State of South Dakota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Anber V, 1997, ARTERIOSCL THROM VAS, V17, P2507, DOI 10.1161/01.ATV.17.11.2507; ATGER V, 1989, ANN BIOL CLIN-PARIS, V47, P497; Atkinson KR, 2009, J LIPID RES, V50, P71, DOI 10.1194/jlr.M800296-JLR200; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Beltran-Sanchez H, 2013, J AM COLL CARDIOL, V62, P697, DOI 10.1016/j.jacc.2013.05.064; Borja MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071541; Brunzell JD, 2003, AM J MED, V115, P24, DOI 10.1016/j.amjmed.2003.08.011; Chan DC, 2012, ANN MED, V44, P313, DOI 10.3109/07853890.2011.573498; Corsetti JP, 2004, ATHEROSCLEROSIS, V177, P367, DOI 10.1016/j.atherosclerosis.2004.07.019; D'Avila F, 2013, J CELL BIOCHEM, V114, P204, DOI 10.1002/jcb.24355; Davidsson P, 2005, J LIPID RES, V46, P1999, DOI 10.1194/jlr.M500161-JLR200; DEBEER MC, 1995, J LIPID RES, V36, P526; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Halim A, 2013, J PROTEOME RES, V12, P573, DOI 10.1021/pr300963h; HARAKE B, 1991, CLIN BIOCHEM, V24, P255, DOI 10.1016/0009-9120(91)80016-V; Harvey SB, 2009, J PROTEOME RES, V8, P603, DOI 10.1021/pr800751x; Hiukka A, 2009, DIABETES, V58, P2018, DOI 10.2337/db09-0206; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; HUFF MW, 1987, J LIPID RES, V28, P1118; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kockx M, 2012, BIOCHEM J, V447, P51, DOI 10.1042/BJ20111891; Lee SJ, 2003, ARTERIOSCL THROM VAS, V23, P853, DOI 10.1161/01.ATV.0000066131.01313.EB; Lee Y, 2010, MOL CELL PROTEOMICS, V9, P1968, DOI 10.1074/mcp.M900430-MCP200; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; MAEDA H, 1987, J LIPID RES, V28, P1405; MAHLEY RW, 1986, COLD SPRING HARB SYM, V51, P821, DOI 10.1101/SQB.1986.051.01.095; MAHLEY RW, 1984, J LIPID RES, V25, P1277; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Millar JS, 1999, ATHEROSCLEROSIS, V145, P253, DOI 10.1016/S0021-9150(99)00071-4; Millar JS, 2001, ATHEROSCLEROSIS, V154, P1, DOI 10.1016/S0021-9150(00)00697-3; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Onat A, 2003, ATHEROSCLEROSIS, V168, P81, DOI 10.1016/S0021-9150(03)00025-X; Onat A, 2013, LIPIDS, V48, P51, DOI 10.1007/s11745-012-3724-8; OREKHOV AN, 1989, BIOCHEM BIOPH RES CO, V162, P206, DOI 10.1016/0006-291X(89)91982-7; Pitsavos C, 2008, ANGIOLOGY, V59, P335, DOI 10.1177/0003319707307273; Rabbani N, 2010, DIABETES, V59, P1038, DOI 10.2337/db09-1455; ROGHANI A, 1988, J BIOL CHEM, V263, P17925; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Shearer GC, 2005, J AM SOC NEPHROL, V16, P1309, DOI 10.1681/ASN.2004080644; Shearer GC, 2012, J LIPID RES; Sierra-Johnson J, 2006, AM J CARDIOL, V98, P1369, DOI 10.1016/j.amjcard.2006.06.029; Stahlman M, 2008, J LIPID RES, V49, P481, DOI 10.1194/jlr.D700025-JLR200; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Sun HY, 2010, CLIN CHIM ACTA, V411, P336, DOI 10.1016/j.cca.2009.11.023; Tailleux A, 2002, ATHEROSCLEROSIS, V164, P1, DOI 10.1016/S0021-9150(01)00751-1; TERTOV VV, 1993, J LIPID RES, V34, P365; TERTOV VV, 1990, BIOCHEM BIOPH RES CO, V167, P1122, DOI 10.1016/0006-291X(90)90639-5; Tertov VV, 2001, ATHEROSCLEROSIS, V159, P103, DOI 10.1016/S0021-9150(01)00498-1; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; WERNETTEHAMMOND ME, 1989, J BIOL CHEM, V264, P9094; WHITEHEAD AS, 1992, J BIOL CHEM, V267, P3862; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Williams K, 2003, CIRCULATION, V108, P2312, DOI 10.1161/01.CIR.0000097113.11419.9E; Yamada T, 1997, J CLIN LAB ANAL, V11, P363; Yamada T, 2001, CLIN CHEM LAB MED, V39, P7, DOI 10.1515/CCLM.2001.003; ZANNI EE, 1989, J BIOL CHEM, V264, P9137	66	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104833	10.1371/journal.pone.0104833	http://dx.doi.org/10.1371/journal.pone.0104833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25118169	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400094
J	Staelens, ASE; Van Cauwelaert, S; Tomsin, K; Mesens, T; Malbrain, MLN; Gyselaers, W				Staelens, Anneleen S. E.; Van Cauwelaert, Stefan; Tomsin, Kathleen; Mesens, Tinne; Malbrain, Manu L. N.; Gyselaers, Wilfried			Intra-Abdominal Pressure Measurements in Term Pregnancy and Postpartum: An Observational Study	PLOS ONE			English	Article							ABDOMINAL COMPARTMENT SYNDROME; INTERNATIONAL-CONFERENCE; BLADDER PRESSURE; VENOUS DISEASE; HYPERTENSION; EXPERTS; WOMEN	Objective: To determine intra-abdominal pressure (IAP) and to evaluate the reproducibility of IAP-measurements using the Foley Manometer Low Volume (FMLV) in term uncomplicated pregnancies before and after caesarean section (CS), relative to two different reference points and to non-pregnant values. Design: Observational cohort study. Setting: Secondary level referral center for feto-maternal medicine. Population: Term uncomplicated pregnant women as the case-group and non-pregnant patients undergoing a laparoscopic assisted vaginal hysterectomy (LAVH) as control group. Methods: IAP was measured in 23 term pregnant patients, before and after CS and in 27 women immediately after and 1 day after LAVH. The midaxillary line was used as zero-reference (IAP(MAL)) in all patients and in 13 CS and 13 LAVH patients, the symphysis pubis (IAP(SP)) was evaluated as additional zero-reference. Intraobserver correlation (ICC) was calculated for each zero-reference. Paired student's t-tests were performed to compare IAP values and Pearson's correlation was used to assess correlations between IAP and gestational variables. Main outcome measures: ICC before and after surgery, IAP before and after CS, IAP after CS and LAVH. Results: The ICC for IAP(MAL) before CS was lower than after (0.71 versus 0.87). Both mean IAP(MAL) and IAP(SP) were significantly higher before CS than after: 14.0 +/- 2.6 mmHg versus 9.8 +/- 3.0 mmHg (p<0.0001) and 8.2 +/- 2.5 mmHg versus 3.5 +/- 1.9 mmHg (p = 0.010), respectively. After CS, IAP was not different from values measured in the LAVH-group. Conclusion: IAP-measurements using FMLV is reproducible in pregnant women. Before CS, IAP is increased in the range of intra-abdominal hypertension for non-pregnant individuals. IAP significantly decreases to normal values after delivery.	[Staelens, Anneleen S. E.; Van Cauwelaert, Stefan; Tomsin, Kathleen; Gyselaers, Wilfried] Hasselt Univ, Dept Med & Life Sci, Hasselt, Belgium; [Staelens, Anneleen S. E.; Tomsin, Kathleen; Mesens, Tinne; Gyselaers, Wilfried] Ziekenhuis Oost Limburg, Dept Obstet & Gynaecol, Genk, Belgium; [Malbrain, Manu L. N.] ZNA Stuivenberg, Ziekenhuis Netwerk Antwerpen, Dept Intens Care, Antwerp, Belgium	Hasselt University; East Limburg Hospital; ZNA Stuivenberg	Staelens, ASE (corresponding author), Hasselt Univ, Dept Med & Life Sci, Hasselt, Belgium.	anneleen.staelens@zol.be	Malbrain, Manu LNG/B-3680-2017	Malbrain, Manu LNG/0000-0002-1816-5255	Limburg Clinical Research Program (LCRP) UHasselt-ZOL-Jessa; foundation Limburg Sterk Merk; Ziekenhuis Oost-Limburg; Jessa Hospital; Hasselt University	Limburg Clinical Research Program (LCRP) UHasselt-ZOL-Jessa; foundation Limburg Sterk Merk; Ziekenhuis Oost-Limburg; Jessa Hospital; Hasselt University	This work is part of a Ph.D. thesis, which is supported by the Limburg Clinical Research Program (LCRP) UHasselt-ZOL-Jessa, the foundation Limburg Sterk Merk, Hasselt University, Ziekenhuis Oost-Limburg, and Jessa Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Razeq SS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.055; Al-Khan A, 2011, J REPROD MED, V56, P53; Bloomfield GL, 2000, INT J OBESITY, V24, P819, DOI 10.1038/sj.ijo.0801234; Cheatham ML, 2007, INTENS CARE MED, V33, P951, DOI 10.1007/s00134-007-0592-4; Cheatham ML, 2011, AM SURGEON, V77, pS78; Chun R, 2012, INT J OBSTET ANESTH, V21, P135, DOI 10.1016/j.ijoa.2011.10.010; Chun R, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S5; Dart BW, 2004, J TRAUMA, V57, P171, DOI 10.1097/01.TA.0000135142.80368.65; De Keulenaer BL, 2009, INTENS CARE MED, V35, P969, DOI 10.1007/s00134-009-1445-0; De Potter TJR, 2005, INTENS CARE MED, V31, P747, DOI 10.1007/s00134-005-2597-1; De Waele JJ, 2006, CRIT CARE MED, V34, pA70, DOI 10.1097/00003246-200612002-00245; Fuchs F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077324; Gyselaers W, 2009, HYPERTENS PREGNANCY, V28, P23, DOI 10.1080/10641950802233056; Gyselaers W, 2009, ULTRASOUND MED BIOL, V35, P1278, DOI 10.1016/j.ultrasmedbio.2009.03.014; Katsios C, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2013.04.003; Kimball EJ, 2007, INTENS CARE MED, V33, P1195, DOI 10.1007/s00134-007-0641-z; Kirkpatrick AW, 2013, INTENS CARE MED, V39, P1190, DOI 10.1007/s00134-013-2906-z; KRON IL, 1984, ANN SURG, V199, P28, DOI 10.1097/00000658-198401000-00005; Lohr JM, 2013, J VASC SURG, V57, p37S, DOI 10.1016/j.jvs.2012.10.121; Malbrain MLNG, 2006, INTENS CARE MED, V32, P1722, DOI 10.1007/s00134-006-0349-5; Malbrain MLNG, 2004, INTENS CARE MED, V30, P822, DOI 10.1007/s00134-004-2169-9; Malbrain MLNG, 2005, CRIT CARE MED, V33, P315, DOI 10.1097/01.CCM.0000153408.09806.1B; Malbrain MLNG, 2004, INTENS CARE MED, V30, P357, DOI 10.1007/s00134-003-2107-2; McLennan CE, 1943, AM J OBSTET GYNECOL, V45, P568, DOI 10.1016/S0002-9378(43)90832-4; Olsfanger D, 1999, J CLIN ANESTH, V11, P328, DOI 10.1016/S0952-8180(99)00057-4; Paramore R H, 1913, Proc R Soc Med, V6, P291; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Richter CE, 2009, AM J PERINAT, V26, P751, DOI 10.1055/s-0029-1223289; ROOBOTTOM CA, 1995, J CLIN ULTRASOUND, V23, P477, DOI 10.1002/jcu.1870230804; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Sugerman H, 1998, INT J OBESITY, V22, P230, DOI 10.1038/sj.ijo.0800574; Sugerman HJ, 2011, MED HYPOTHESES, V77, P841, DOI 10.1016/j.mehy.2011.07.051; Tomsin K, 2013, CLIN EXP PHARMACOL P, V40, P438, DOI 10.1111/1440-1681.12105	33	26	29	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104782	10.1371/journal.pone.0104782	http://dx.doi.org/10.1371/journal.pone.0104782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117778	Green Published, gold			2022-12-27	WOS:000341230400083
J	Zhang, S; Skinner, D; Hicks, SB; Bevensee, MO; Sorscher, EJ; Lazrak, A; Matalon, S; McNicholas, CM; Woodworth, BA				Zhang, Shaoyan; Skinner, Daniel; Hicks, Stephen Bradley; Bevensee, Mark O.; Sorscher, Eric J.; Lazrak, Ahmed; Matalon, Sadis; McNicholas, Carmel M.; Woodworth, Bradford A.			Sinupret Activates CFTR and TMEM16A-Dependent Transepithelial Chloride Transport and Improves Indicators of Mucociliary Clearance	PLOS ONE			English	Article							CILIARY BEAT FREQUENCY; SINONASAL EPITHELIAL CULTURES; LIQUID INTERFACE CULTURES; HEALTH-CARE UTILIZATION; CYSTIC-FIBROSIS; CHRONIC RHINOSINUSITIS; IN-VITRO; DRUG-COMBINATION; ION-TRANSPORT; CONDUCTANCE	Introduction: We have previously demonstrated that Sinupret, an established treatment prescribed widely in Europe for respiratory ailments including rhinosinusitis, promotes transepithelial chloride (Cl-) secretion in vitro and in vivo. The present study was designed to evaluate other indicators of mucociliary clearance (MCC) including ciliary beat frequency (CBF) and airway surface liquid (ASL) depth, but also investigate the mechanisms that underlie activity of this bioflavonoid. Methods: Primary murine nasal septal epithelial (MNSE) [wild type (WT) and transgenic CFTR-/-], human sinonasal epithelial (HSNE), WT CFTR-expressing CFBE and TMEM16A-expressing HEK cultures were utilized for the present experiments. CBF and ASL depth measurements were performed. Mechanisms underlying transepithelial Cl- transport were determined using pharmacologic manipulation in Ussing chambers, Fura-2 intracellular calcium [Ca2+] imaging, cAMP signaling, regulatory domain (R-D) phosphorylation of CFTR, and excised inside out and whole cell patch clamp analysis. Results: Sinupret-mediated Cl- secretion [Delta l(SC)(mu A/cm(2))] was pronounced in WT MNSE (20.7+/-0.9 vs. 5.6+/-0.9(control), p<0.05), CFTR-/- MNSE (10.1+/-1.0 vs. 0.9+/-0.3(control), p<0.05) and HSNE (20.7+/-0.3 vs. 6.4+/-0.9(control), p<0.05). The formulation activated Ca2+ signaling and TMEM16A channels, but also increased CFTR channel open probability (Po) without stimulating PKA-dependent pathways responsible for phosphorylation of the CFTR R-domain and resultant Cl- secretion. Sinupret also enhanced CBF and ASL depth. Conclusion: Sinupret stimulates CBF, promotes transepithelial Cl- secretion, and increases ASL depth in a manner likely to enhance MCC. Our findings suggest that direct stimulation of CFTR, together with activation of Ca2+-dependent TMEM16A secretion account for the majority of anion transport attributable to Sinupret. These studies provide further rationale for using robust Cl(-)secretagogue based therapies as an emerging treatment modality for common respiratory diseases of MCC including acute and chronic bronchitis and CRS.	[Zhang, Shaoyan; Skinner, Daniel; Hicks, Stephen Bradley; Woodworth, Bradford A.] Univ Alabama Birmingham, Dept Surg, Div Otolaryngol, Birmingham, AL 35294 USA; [Zhang, Shaoyan; Skinner, Daniel; Bevensee, Mark O.; Sorscher, Eric J.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Bevensee, Mark O.; McNicholas, Carmel M.; Woodworth, Bradford A.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Sorscher, Eric J.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Lazrak, Ahmed; Matalon, Sadis] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Woodworth, BA (corresponding author), Univ Alabama Birmingham, Dept Surg, Div Otolaryngol, Birmingham, AL 35294 USA.	bwoodwo@hotmail.com		McNicholas-Bevensee, Carmel/0000-0002-7013-8764; Sorscher, Eric J./0000-0001-9341-3354; Lazrak, Ahmed/0000-0002-4127-1937	National Institutes of Health/National Heart, Lung, and Blood Institute [1K08HL107142-04]; Flight Attendant's Medical Research Institute Young Clinical Scientist Award [072218]; NIH/NIDDK [5P30DK072482-03, 2R01HL031197]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL107142, R01HL031197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Flight Attendant's Medical Research Institute Young Clinical Scientist Award; NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by the National Institutes of Health/National Heart, Lung, and Blood Institute (1K08HL107142-04) and Flight Attendant's Medical Research Institute Young Clinical Scientist Award (072218) to B.A.W.; NIH/NIDDK (5P30DK072482-03) to E.J.S and 2R01HL031197 to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander NS, 2012, LARYNGOSCOPE, V122, P1193, DOI 10.1002/lary.23278; Alexander NS, 2011, LARYNGOSCOPE, V121, P1313, DOI 10.1002/lary.21798; Antunes MB, 2007, BIOTECHNIQUES, V43, P195, DOI 10.2144/000112531; Azbell C, 2010, OTOLARYNG HEAD NECK, V143, P397, DOI 10.1016/j.otohns.2010.05.021; Bhargave G, 2008, AM J RHINOL, V22, P7, DOI 10.2500/ajr.2008.22.3125; Bhattacharyya N, 2011, ANN OTO RHINOL LARYN, V120, P423, DOI 10.1177/000348941112000701; Blount A, 2011, LARYNGOSCOPE, V121, P1929, DOI 10.1002/lary.21921; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CHIBANGUZA G, 1984, ARZNEIMITTEL-FORSCH, V34-1, P32; Cohen NA, 2009, LARYNGOSCOPE, V119, P2269, DOI 10.1002/lary.20223; Conger BT, 2013, JAMA OTOLARYNGOL, V139, P822, DOI 10.1001/jamaoto.2013.3917; GLIKLICH RE, 1995, OTOLARYNG HEAD NECK, V113, P104, DOI 10.1016/S0194-5998(95)70152-4; Guo R, 2006, OTOLARYNG HEAD NECK, V135, P496, DOI 10.1016/j.otohns.2006.06.1254; Gyomorey K, 2001, PFLUG ARCH EUR J PHY, V443, pS103, DOI 10.1007/s004240100654; Illek B, 1996, AM J PHYSIOL-CELL PH, V270, pC265, DOI 10.1152/ajpcell.1996.270.1.C265; ILLEK B, 1995, AM J PHYSIOL-CELL PH, V268, pC886, DOI 10.1152/ajpcell.1995.268.4.C886; Illek B, 1998, AM J PHYSIOL-LUNG C, V275, pL902, DOI 10.1152/ajplung.1998.275.5.L902; Lazrak A, 2013, AM J RESP CELL MOL B; Murphy MP, 2002, OTOLARYNG HEAD NECK, V127, P367, DOI 10.1067/mhn.2002.129815; Pyle LC, 2009, AM J RESP CELL MOL B; Richstein A, 1980, Ther Ggw, V119, P1055; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Schmolz M, 2001, INT IMMUNOPHARMACOL, V1, P1841, DOI 10.1016/S1567-5769(01)00108-4; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Solomon GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072398; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Virgin F, 2010, LARYNGOSCOPE, V120, P1051, DOI 10.1002/lary.20871; Virgin FW, 2010, LARYNGOSCOPE, V120, P1465, DOI 10.1002/lary.20930; Woodworth BA, 2008, AM J RHINOL, V22, P235, DOI 10.2500/ajr.2008.22.3178; Zhang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081589; Zhang SY, 2011, AM J RHINOL ALLERGY, V25, P307, DOI 10.2500/ajra.2011.25.3643; Zhang SY, 2009, AM J RHINOL ALLERGY, V23, P149, DOI 10.2500/ajra.2009.23.3285; Zsembery A, 2003, J BIOL CHEM, V278, P13398, DOI 10.1074/jbc.M212277200	34	37	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104090	10.1371/journal.pone.0104090	http://dx.doi.org/10.1371/journal.pone.0104090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117505	gold, Green Submitted, Green Published			2022-12-27	WOS:000341230400030
J	Lim, J; Bhoo-Pathy, N; Sothilingam, S; Malek, R; Sundram, M; Bahadzor, BH; Ong, TA; Ng, KL; Sivalingam, S; Razack, AHA				Lim, Jasmine; Bhoo-Pathy, Nirmala; Sothilingam, Selvalingam; Malek, Rohan; Sundram, Murali; Bahadzor, Badrul Hisham; Ong, Teng Aik; Ng, Keng Lim; Sivalingam, Sivaprakasam; Razack, Azad Hassan Abdul			Ethnicity Is an Independent Determinant of Age-Specific PSA Level: Findings from a Multiethnic Asian Setting	PLOS ONE			English	Article							PROSTATE-SPECIFIC-ANTIGEN; URINARY-TRACT SYMPTOMS; DIGITAL RECTAL EXAMINATION; COMMUNITY-BASED POPULATION; CANCER DETECTION; SERUM; MEN; VOLUME; RISK; CHINESE	Objectives: To study the baseline PSA profile and determine the factors influencing the PSA levels within a multiethnic Asian setting. Materials and Methods: We conducted a cross-sectional study of 1054 men with no clinical evidence of prostate cancer, prostate surgery or 5 alpha-reductase inhibitor treatment of known prostate conditions. The serum PSA concentration of each subject was assayed. Potential factors associated with PSA level including age, ethnicity, height, weight, family history of prostate cancer, lower urinary tract voiding symptoms (LUTS), prostate volume and digital rectal examination (DRE) were evaluated using univariable and multivariable analysis. Results: There were 38 men (3.6%) found to have a PSA level above 4 ng/ml and 1016 (96.4%) with a healthy PSA (<= 4 ng/ml). The median PSA level of Malay, Chinese and Indian men was 1.00 ng/ml, 1.16 ng/ml and 0.83 ng/ml, respectively. Indians had a relatively lower median PSA level and prostate volume than Malays and Chinese, who shared a comparable median PSA value across all 10-years age groups. The PSA density was fairly similar amongst all ethnicities. Further analysis showed that ethnicity, weight and prostate volume were independent factors associated with age specific PSA level in the multivariable analysis (p < 0.05). Conclusion: These findings support the concept that the baseline PSA level varies between different ethnicities across all age groups. In addition to age and prostate volume, ethnicity may also need to be taken into account when investigating serum PSA concentrations in the multiethnic Asian population.	[Lim, Jasmine; Ong, Teng Aik; Ng, Keng Lim; Sivalingam, Sivaprakasam; Razack, Azad Hassan Abdul] Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur, Malaysia; [Bhoo-Pathy, Nirmala] Univ Malaya, Fac Med, Julius Ctr Univ Malaya, Kuala Lumpur, Malaysia; [Sothilingam, Selvalingam] Tuanku Mizan Mil Hosp, Dept Urol, Kuala Lumpur, Malaysia; [Malek, Rohan] Selayang Hosp, Dept Urol, Selangor, Malaysia; [Sundram, Murali] Kuala Lumpur Hosp, Dept Urol, Kuala Lumpur, Malaysia; [Bahadzor, Badrul Hisham] Univ Kebangsaan Malaysia Med Ctr, Dept Surg, Kuala Lumpur, Malaysia; [Ng, Keng Lim] Univ Queensland, Sch Med, Ctr Kidney Dis Res, Translat Res Inst, Brisbane, Qld, Australia	Universiti Malaya; Universiti Malaya; Universiti Kebangsaan Malaysia; University of Queensland	Razack, AHA (corresponding author), Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur, Malaysia.	azadrazack@gmail.com	Pathy, Nirmala Bhoo/C-1228-2010; Razack, Azad HA/B-8152-2009; Ong, Teng Aik/B-5321-2010; JASMINE, LIM/F-7404-2015; Ong, Teng Aik/B-2284-2010	Pathy, Nirmala Bhoo/0000-0003-0568-8863; Razack, Azad HA/0000-0002-4237-6511; Ong, Teng Aik/0000-0002-0207-8966; JASMINE, LIM/0000-0002-7501-1834; 	University Malaya Research Grant [RG347/11HTM]; University Malaya High Impact Research Grant [HIR/MOHE/MED/35]	University Malaya Research Grant; University Malaya High Impact Research Grant	This work was funded by the University Malaya Research Grant (RG347/11HTM to S. S) and the University Malaya High Impact Research Grant (HIR/MOHE/MED/35 to AHAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Antenor JAV, 2004, J UROLOGY, V172, P90, DOI 10.1097/01.ju.0000132133.10470.bb; Banez LL, 2007, JAMA-J AM MED ASSOC, V298, P2275, DOI 10.1001/jama.298.19.2275; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Bunting PS, 1999, CAN MED ASSOC J, V160, P70; Bushman W, 2009, UROL CLIN N AM, V36, P403, DOI 10.1016/j.ucl.2009.07.003; Byun SS, 2005, UROLOGY, V66, P593, DOI 10.1016/j.urology.2005.04.017; Chia SE, 2007, ASIAN PAC J CANCER P, V8, P375; Chu DI, 2011, PROSTATE CANCER P D, V14, P346, DOI 10.1038/pcan.2011.31; Fang JY, 2001, UROLOGY, V58, P411, DOI 10.1016/S0090-4295(01)01304-8; Freedland SJ, 2006, J UROLOGY, V175, P500, DOI 10.1016/S0022-5347(05)00162-X; Grubb RL, 2009, CANCER EPIDEM BIOMAR, V18, P748, DOI 10.1158/1055-9965.EPI-08-0938; Gupta A, 2005, J UROLOGY, V173, P503, DOI 10.1097/01.ju.0000148907.92910.4d; He DL, 2004, UROLOGY, V63, P722, DOI 10.1016/j.urology.2003.10.066; Karakiewicz PI, 2005, J UROLOGY, V173, P1930, DOI 10.1097/01.ju.0000158039.94467.5d; Kehinde EO, 2005, BJU INT, V96, P308, DOI 10.1111/j.1464-410X.2005.05620.x; Khezri AA, 2009, IRAN J IMMUNOL, V6, P40, DOI IJIv6i1A6; Kort SAR, 2006, CLIN CHEM, V52, P1568, DOI 10.1373/clinchem.2006.069039; Lee SE, 2008, UROLOGY, V71, P395, DOI 10.1016/j.urology.2007.10.019; Lee SE, 2000, UROLOGY, V56, P1007, DOI 10.1016/S0090-4295(00)00837-2; Lepor H, 1996, UROLOGY, V47, P38, DOI 10.1016/S0090-4295(99)80379-3; Lilja H, 2007, J CLIN ONCOL, V25, P431, DOI 10.1200/JCO.2006.06.9351; Mao QQ, 2009, INT UROL NEPHROL, V41, P761, DOI 10.1007/s11255-009-9533-1; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; OESTERLING JE, 1995, BRIT J UROL, V75, P347, DOI 10.1111/j.1464-410X.1995.tb07347.x; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; Park DS, 2013, ASIAN J ANDROL, V15, P249, DOI 10.1038/aja.2012.132; Rohrmann S, 2007, UROLOGY, V69, P708, DOI 10.1016/j.urology.2007.01.011; Roobol MJ, 2006, PROSTATE, V66, P1266, DOI 10.1002/pros.20454; Rosenberg MT, 2007, INT J CLIN PRACT, V61, P1535, DOI 10.1111/j.1742-1241.2007.01491.x; Saraiya M, 2005, CANCER EPIDEM BIOMAR, V14, P2178, DOI 10.1158/1055-9965.EPI-05-0206; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; SMITH J, 1993, CLIN CHEM, V39, P2063; Stephan C, 2006, CLIN CHEM, V52, P59, DOI 10.1373/clinchem.2005.059170; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Trifiro MD, 2010, BJU INT, V105, P1554, DOI 10.1111/j.1464-410X.2009.09090.x; Tsukamoto T, 2009, INT J UROL, V16, P622, DOI 10.1111/j.1442-2042.2009.02323.x; VESSELLA RL, 1992, CLIN CHEM, V38, P2044; Xia SJ, 2012, ASIAN J ANDROL, V14, P458, DOI 10.1038/aja.2010.137	41	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104917	10.1371/journal.pone.0104917	http://dx.doi.org/10.1371/journal.pone.0104917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111507	gold, Green Published			2022-12-27	WOS:000341105100110
J	Bertolino, N; Ferraro, S; Nigri, A; Bruzzone, MG; Ghielmetti, F				Bertolino, Nicola; Ferraro, Stefania; Nigri, Anna; Bruzzone, Maria Grazia; Ghielmetti, Francesco		CRC Besta Inst	A Neural Network Approach to fMRI Binocular Visual Rivalry Task Analysis	PLOS ONE			English	Article							HUMAN BRAIN; FACE PERCEPTION; LIE DETECTION; CONSCIOUSNESS; PATTERN; VISION; CORTEX; AREA	The purpose of this study was to investigate whether artificial neural networks (ANN) are able to decode participants' conscious experience perception from brain activity alone, using complex and ecological stimuli. To reach the aim we conducted pattern recognition data analysis on fMRI data acquired during the execution of a binocular visual rivalry paradigm (BR). Twelve healthy participants were submitted to fMRI during the execution of a binocular non-rivalry (BNR) and a BR paradigm in which two classes of stimuli (faces and houses) were presented. During the binocular rivalry paradigm, behavioral responses related to the switching between consciously perceived stimuli were also collected. First, we used the BNR paradigm as a functional localizer to identify the brain areas involved the processing of the stimuli. Second, we trained the ANN on the BNR fMRI data restricted to these regions of interest. Third, we applied the trained ANN to the BR data as a 'brain reading' tool to discriminate the pattern of neural activity between the two stimuli. Fourth, we verified the consistency of the ANN outputs with the collected behavioral indicators of which stimulus was consciously perceived by the participants. Our main results showed that the trained ANN was able to generalize across the two different tasks (i.e. BNR and BR) and to identify with high accuracy the cognitive state of the participants (i.e. which stimulus was consciously perceived) during the BR condition. The behavioral response, employed as control parameter, was compared with the network output and a statistically significant percentage of correspondences (p-value<0.05) were obtained for all subjects. In conclusion the present study provides a method based on multivariate pattern analysis to investigate the neural basis of visual consciousness during the BR phenomenon when behavioral indicators lack or are inconsistent, like in disorders of consciousness or sedated patients.	[Bertolino, Nicola; Ghielmetti, Francesco] Ist Nazl Neurol Carlo Besta, Dept Hlth, Milan, Italy; [Ferraro, Stefania; Nigri, Anna; Bruzzone, Maria Grazia] Ist Nazl Neurol Carlo Besta, Neuroradiol Dept, Milan, Italy	IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta	Bertolino, N (corresponding author), Ist Nazl Neurol Carlo Besta, Dept Hlth, Milan, Italy.	nicola.bertolino@istituto-besta.it	Sattin, Davide/K-5963-2016; ghielmetti, francesco/AGP-2907-2022; Nigri, Anna/AAM-9827-2021; Panzica, Ferruccio/K-6711-2016; Bruzzone, Maria/AAM-4478-2021; Caldiroli, Dario/AAS-8405-2021; Parati, Eugenio Agostino/AAN-5893-2021; Rossi Sebastiano, Davide/G-8541-2016; Ferraro, Stefania/AAN-1066-2021; Sattin, Davide/AAX-4083-2020	Sattin, Davide/0000-0001-7736-4337; ghielmetti, francesco/0000-0003-2183-5077; Nigri, Anna/0000-0002-1197-5458; Panzica, Ferruccio/0000-0002-0105-943X; Bruzzone, Maria/0000-0002-2786-1471; Caldiroli, Dario/0000-0002-1106-3213; Parati, Eugenio Agostino/0000-0001-5020-6523; Rossi Sebastiano, Davide/0000-0003-3698-8615; Ferraro, Stefania/0000-0002-5939-0459; Sattin, Davide/0000-0001-7736-4337; Bertolino, Nicola/0000-0002-5924-0995; Rosazza, Cristina/0000-0002-7799-415X	Regione Lombardia [IX/000407 - 05/08/2010]	Regione Lombardia(Regione Lombardia)	The start-up Coma Research Centre (CRC) project was funded by a healthcare grant (No IX/000407 - 05/08/2010) awarded by Regione Lombardia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Bernstein M.A., 2004, HDB MRI PULSE SEQUEN, DOI 10.1016/B978-012092861-3/50021-2; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R, 2011, VISION RES, V51, P754, DOI 10.1016/j.visres.2010.10.009; Cant JS, 2011, J NEUROSCI, V31, P8248, DOI 10.1523/JNEUROSCI.6113-10.2011; Davatzikos C, 2005, NEUROIMAGE, V28, P663, DOI 10.1016/j.neuroimage.2005.08.009; Desjardins AE, 2001, NEUROIMAGE, V13, P751, DOI 10.1006/nimg.2000.0719; Gao JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064704; Goutte C, 1999, NEUROIMAGE, V9, P298, DOI 10.1006/nimg.1998.0391; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Hoshiyama M, 2006, NEUROSCI LETT, V402, P57, DOI 10.1016/j.neulet.2006.03.054; Hsieh PJ, 2012, NEUROPSYCHOLOGIA, V50, P522, DOI 10.1016/j.neuropsychologia.2011.09.019; Jiang YL, 2003, IEEE T MED IMAGING, V22, P913, DOI 10.1109/TMI.2003.815061; Langleben DD, 2013, PSYCHOL PUBLIC POL L, V19, P222, DOI 10.1037/a0028841; Laureys S, 2006, CURR OPIN NEUROL, V19, P520, DOI 10.1097/WCO.0b013e3280106ba9; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Minati L, 2012, MED ENG PHYS, V34, P650, DOI 10.1016/j.medengphy.2012.02.004; Monti MM, 2009, ANN NY ACAD SCI, V1157, P81, DOI 10.1111/j.1749-6632.2008.04121.x; Mourao-Miranda J, 2012, BIPOLAR DISORD, V14, P451, DOI 10.1111/j.1399-5618.2012.01019.x; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Picton P., 2000, NEURAL NETWORKS; Poldrack RA, 2007, SOC COGN AFFECT NEUR, V2, P67, DOI 10.1093/scan/nsm006; Roeber U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022612; Rossion B, 2012, BRAIN COGNITION, V79, P138, DOI 10.1016/j.bandc.2012.01.001; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Turner R, 1998, EXP BRAIN RES, V123, P5, DOI 10.1007/s002210050538; Weil RS, 2010, CURR OPIN NEUROL, V23, P649, DOI 10.1097/WCO.0b013e32834028c7; Wunderlich K, 2005, NAT NEUROSCI, V8, P1595, DOI 10.1038/nn1554; Yamamura H, 2009, NEUROREPORT, V20, P1630, DOI 10.1097/WNR.0b013e3283331322; Zhang P, 2012, PSYCHOL SCI, V23, P254, DOI 10.1177/0956797611424289	34	4	4	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105206	10.1371/journal.pone.0105206	http://dx.doi.org/10.1371/journal.pone.0105206			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121595	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000107
J	Chang, ML; Tsou, YK; Hu, TH; Lin, CH; Lin, WR; Sung, CM; Chen, TH; Cheng, ML; Chang, KC; Chiu, CT; Yeh, CT; Pang, JHS; Shiao, MS				Chang, Ming-Ling; Tsou, Yung-Kuan; Hu, Tsung-Hui; Lin, Cheng-Hui; Lin, Wey-Ran; Sung, Chang-Mu; Chen, Tsung-Hsing; Cheng, Mei-Ling; Chang, Kuo-Chin; Chiu, Cheng-Tang; Yeh, Chau-Ting; Pang, Jong-Hwei Su; Shiao, Ming-Shi			Distinct Patterns of the Lipid Alterations between Genotype 1 and 2 Chronic Hepatitis C Patients after Viral Clearance	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; INSULIN-RESISTANCE; METABOLIC SYNDROME; VIRUS-INFECTION; GLUCOSE ABNORMALITIES; INTERFERON THERAPY; RIBAVIRIN THERAPY; CHOLESTEROL; PEGINTERFERON; ASSOCIATIONS	Background: The hepatitis C virus (HCV) genotype-specific impacts on the host metabolic alterations remained inconclusive. Methods: A prospective study including 229 (118 genotype 1 (G1) and 111 G2) consecutive chronic HCV patients who had completed a course of anti-HCV treatment and underwent pre- and 24 weeks post-treatment surveys of metabolic profiles was conducted. Patients were stratified according to the therapeutic response, viral genotype and baseline insulin resistance (IR: homeostasis model assessments of IR (HOMA-IR) >= 2.5). Paired t-tests were used to compare the pre- and post-treatment variables. Results: Significant post-therapeutic increases in cholesterol, triglyceride, HDL, LDL, apolipoprotein A1 and apolipoprotein B were observed in patients with sustained virological response (SVR) but not in those without. Among those with SVR, post-therapeutic increases in HDL (p < 0.001) and apolipoprotein A1 (p = 0.012) were only found in G2, whereas increased triglyceride/HDL (p = 0.01) ratios were only found in G1 patients. When stratified by baseline IR among those with SVR, a significant increase in post-treatment HDL (p = 0.019) and apolipoprotein A1 (p = 0.012) but a decrease in HOMA-IR (p = 0.04), C-peptide (p = 0.019) and hemoglobin A1c (p = 0.047) were found in patients with baseline IR; a significant increase in HOMA-IR (p = 0.002) was found in patients without baseline IR. The latter change was observed only in G1 (p = 0.01) but not G2 patients. Although the pre-treatment metabolic profiles of G1 and G2 patients were indifferent, G1 had higher post-treatment triglyceride/HDL ratios (p = 0.041) and triglyceride (p = 0.044) levels than G2 patients. Conclusions: G2 benefit more than G1 patients from viral clearance in metabolic alterations, particularly in those without baseline IR.	[Chang, Ming-Ling; Tsou, Yung-Kuan; Lin, Cheng-Hui; Lin, Wey-Ran; Sung, Chang-Mu; Chen, Tsung-Hsing; Chiu, Cheng-Tang; Yeh, Chau-Ting] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Div Hepatol, Liver Res Ctr, Taoyuan, Taiwan; [Chang, Ming-Ling; Pang, Jong-Hwei Su] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Hu, Tsung-Hui; Chang, Kuo-Chin] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Hu, Tsung-Hui; Chang, Kuo-Chin] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Cheng, Mei-Ling; Shiao, Ming-Shi] Chang Gung Mem Hosp, Dept Lab Med, Linkou, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chang, ML (corresponding author), Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Div Hepatol, Liver Res Ctr, Taoyuan, Taiwan.	mlchang8210@gmail.com	Tsou, Yung-Kuan/AAE-8049-2022	PANG, JONG-HWEI/0000-0003-3432-0208	Chang Gung Medical Research Program [CMRPG380353, CMRPG3B1251, CMRPG3B1252, CMRPG 3B0401, CMRPG3B1741, XMRPG3A0521]; National Science Council, Taiwan [100-2314-B-182-069-, 101-2314-B-182-083-, 102-2628-B-182 -021 -MY3]; Investigator Initiated Studies Program of Merck Sharp Dohme Corp	Chang Gung Medical Research Program; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Investigator Initiated Studies Program of Merck Sharp Dohme Corp	This work was funded by grants from the Chang Gung Medical Research Program (CMRPG380353, CMRPG3B1251, CMRPG3B1252, CMRPG 3B0401, CMRPG3B1741 and XMRPG3A0521), the National Science Council, Taiwan (100-2314-B-182-069-, 101-2314-B-182-083- and 102-2628-B-182 -021 -MY3), and in part by a research grant from the Investigator Initiated Studies Program of Merck Sharp & Dohme Corp to M.L.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck Sharp & Dohme Corp.	Aghemo A, 2012, HEPATOLOGY, V56, P1681, DOI 10.1002/hep.25867; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Arase Y, 2009, HEPATOLOGY, V49, P739, DOI 10.1002/hep.22703; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Corey KE, 2009, HEPATOLOGY, V50, P1030, DOI 10.1002/hep.23219; Dai CY, 2008, J HEPATOL, V49, P9, DOI 10.1016/j.jhep.2008.03.016; Guiltinan AM, 2008, AM J EPIDEMIOL, V167, P743, DOI 10.1093/aje/kwm370; Hamamoto S, 2005, J GASTROEN HEPATOL, V20, P204, DOI 10.1111/j.1440-1746.2004.03526.x; Hamer OW, 2006, RADIOGRAPHICS, V26, P1637, DOI 10.1148/rg.266065004; Harrison SA, 2010, HEPATOLOGY, V52, P864, DOI 10.1002/hep.23787; Hsu CS, 2013, ALIMENT PHARM THER, V38, P415, DOI 10.1111/apt.12391; Hsu CS, 2009, AM J GASTROENTEROL, V104, P598, DOI 10.1038/ajg.2008.125; Hsu YC, 2014, HEPATOLOGY, V59, P1293, DOI 10.1002/hep.26892; Huang CF, 2012, ANTIVIR RES, V93, P239, DOI 10.1016/j.antiviral.2011.12.002; Huang JF, 2013, KAOHSIUNG J MED SCI, V29, P61, DOI 10.1016/j.kjms.2012.11.001; Huang JF, 2012, LIVER INT, V32, P962, DOI 10.1111/j.1478-3231.2012.02771.x; Jan CF, 2006, INT J OBESITY, V30, P794, DOI 10.1038/sj.ijo.0803204; Kang GH, 2011, J MAGN RESON IMAGING, V34, P928, DOI 10.1002/jmri.22701; Kawamoto R, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-79; Kocelak P, 2012, MINERVA ENDOCRINOL, V32, P247; Kono Y, 2003, J MED VIROL, V70, P42, DOI 10.1002/jmv.10372; Kuo YH, 2011, J FORMOS MED ASSOC, V110, P363, DOI 10.1016/S0929-6646(11)60054-5; Lee MH, 2011, GUT, V60, P688, DOI 10.1136/gut.2010.220889; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; Lin CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018322; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; Negro F, 2006, J HEPATOL, V45, P514, DOI 10.1016/j.jhep.2006.07.011; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Petta S, 2013, CLIN GASTROENTEROL H, V11, P311, DOI 10.1016/j.cgh.2012.11.022; Prasad H, 2012, POSTGRAD MED, V124, P21, DOI 10.3810/pgm.2012.01.2514; Prati D, 2006, J HEPATOL, V44, P679, DOI 10.1016/j.jhep.2006.01.004; Ramcharran D, 2010, HEPATOLOGY, V52, P854, DOI 10.1002/hep.23796; Rashid S, 2002, J DIABETES COMPLICAT, V16, P24, DOI 10.1016/S1056-8727(01)00191-X; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Su TH, 2013, P NATL ACAD SCI USA, V110, P7844, DOI 10.1073/pnas.1306138110; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Thompson AJ, 2012, GUT, V61, P128, DOI 10.1136/gut.2010.236158; Tillmann HL, 2011, J HEPATOL, V55, P1195, DOI 10.1016/j.jhep.2011.03.015; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yu ML, 2001, J MED VIROL, V65, P58, DOI 10.1002/jmv.2001	42	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104783	10.1371/journal.pone.0104783	http://dx.doi.org/10.1371/journal.pone.0104783			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122116	gold, Green Submitted, Green Published			2022-12-27	WOS:000341017000061
J	Kawagoshi, T; Uno, Y; Nishida, C; Matsuda, Y				Kawagoshi, Taiki; Uno, Yoshinobu; Nishida, Chizuko; Matsuda, Yoichi			The Staurotypus Turtles and Aves Share the Same Origin of Sex Chromosomes but Evolved Different Types of Heterogametic Sex Determination	PLOS ONE			English	Article							MICROCHROMOSOME SYSTEM; GENE DMRT1; EVOLUTION; BIRD; TESTUDINES; HOMOLOGY; INSIGHTS; OSTRICH	Reptiles have a wide diversity of sex-determining mechanisms and types of sex chromosomes. Turtles exhibit temperature-dependent sex determination and genotypic sex determination, with male heterogametic (XX/XY) and female heterogametic (ZZ/ZW) sex chromosomes. Identification of sex chromosomes in many turtle species and their comparative genomic analysis are of great significance to understand the evolutionary processes of sex determination and sex chromosome differentiation in Testudines. The Mexican giant musk turtle (Staurotypus triporcatus, Kinosternidae, Testudines) and the giant musk turtle (Staurotypus salvinii) have heteromorphic XY sex chromosomes with a low degree of morphological differentiation; however, their origin and linkage group are still unknown. Cross-species chromosome painting with chromosome-specific DNA from Chinese soft-shelled turtle (Pelodiscus sinensis) revealed that the X and Y chromosomes of S. triporcatus have homology with P. sinensis chromosome 6, which corresponds to the chicken Z chromosome. We cloned cDNA fragments of S. triporcatus homologs of 16 chicken Z-linked genes and mapped them to S. triporcatus and S. salvinii chromosomes using fluorescence in situ hybridization. Sixteen genes were localized to the X and Y long arms in the same order in both species. The orders were also almost the same as those of the ostrich (Struthio camelus) Z chromosome, which retains the primitive state of the avian ancestral Z chromosome. These results strongly suggest that the X and Y chromosomes of Staurotypus turtles are at a very early stage of sex chromosome differentiation, and that these chromosomes and the avian ZW chromosomes share the same origin. Nonetheless, the turtles and birds acquired different systems of heterogametic sex determination during their evolution.	[Kawagoshi, Taiki; Uno, Yoshinobu; Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Anim Genet, Nagoya, Aichi 4648601, Japan; [Nishida, Chizuko] Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 060, Japan; [Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi 4648601, Japan	Nagoya University; Hokkaido University; Nagoya University	Matsuda, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Lab Anim Genet, Nagoya, Aichi 4648601, Japan.	yoimatsu@agr.nagoya-u.ac.jp		Uno, Yoshinobu/0000-0001-9609-1186	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [23113004, 22370081]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by Grants-in-Aid for Scientific Research on Innovative Areas (No. 23113004) and Scientific Research (B) ( No. 22370081) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Badenhorst D, 2013, CHROMOSOME RES, V21, P137, DOI 10.1007/s10577-013-9343-2; BULL JJ, 1974, CYTOGENET CELL GENET, V13, P419, DOI 10.1159/000130295; Ezaz T, 2006, CHROMOSOME RES, V14, P139, DOI 10.1007/s10577-006-1029-6; Ezaz T, 2009, CYTOGENET GENOME RES, V127, P249, DOI 10.1159/000300507; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Ishijima J, 2014, CYTOGENET GENOME RES, V142, P255, DOI 10.1159/000362479; Iverson JB, 2013, MOL PHYLOGENET EVOL, V69, P929, DOI 10.1016/j.ympev.2013.06.011; Janzen FJ, 2006, J EVOLUTION BIOL, V19, P1775, DOI 10.1111/j.1420-9101.2006.01138.x; Kasai F, 2012, CYTOGENET GENOME RES, V136, P303, DOI 10.1159/000338111; Kawagoshi T, 2009, CYTOGENET GENOME RES, V125, P125, DOI 10.1159/000227837; Kawagoshi T, 2012, CHROMOSOME RES, V20, P95, DOI 10.1007/s10577-011-9267-7; Kawai A, 2007, CYTOGENET GENOME RES, V117, P92, DOI 10.1159/000103169; Kawai A, 2009, CHROMOSOMA, V118, P43, DOI 10.1007/s00412-008-0176-2; Kumazawa Y, 1999, MOL BIOL EVOL, V16, P784, DOI 10.1093/oxfordjournals.molbev.a026163; Martinez PA, 2008, CHROMOSOME RES, V16, P815, DOI 10.1007/s10577-008-1228-4; Matsubara K, 2003, CHROMOSOME RES, V11, P57, DOI 10.1023/A:1022010116287; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; MATSUDA Y, 1995, ELECTROPHORESIS, V16, P261, DOI 10.1002/elps.1150160142; Matsuda Y, 2005, CHROMOSOME RES, V13, P601, DOI 10.1007/s10577-005-0986-5; Nanda I, 2000, CYTOGENET CELL GENET, V89, P67, DOI 10.1159/000015567; Nishida-Umehara C, 2007, CHROMOSOME RES, V15, P721, DOI 10.1007/s10577-007-1157-7; O'Meally D, 2012, CHROMOSOME RES, V20, P7, DOI 10.1007/s10577-011-9266-8; Ogawa A, 1998, P NATL ACAD SCI USA, V95, P4415, DOI 10.1073/pnas.95.8.4415; Organ CL, 2008, INTEGR COMP BIOL, V48, P512, DOI 10.1093/icb/icn041; Pokorna M, 2009, ZOOL J LINN SOC-LOND, V156, P168, DOI 10.1111/j.1096-3642.2008.00481.x; Rest JS, 2003, MOL PHYLOGENET EVOL, V29, P289, DOI 10.1016/S1055-7903(03)00108-8; Shetty S, 2002, CYTOGENET GENOME RES, V99, P245, DOI 10.1159/000071600; SITES JW, 1979, SCIENCE, V206, P1410, DOI 10.1126/science.92052; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Tsuda Y, 2007, CHROMOSOMA, V116, P159, DOI 10.1007/s00412-006-0088-y; Uno Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053027; Valenzuela N., 2004, TEMPERATURE DEPENDEN; Valenzuela N, 2011, EVOLUTION, V65, P1808, DOI 10.1111/j.1558-5646.2011.01258.x; Vitt LJ, 2013, HERPETOLOGY INTRO BI; VOGT RC, 1992, HERPETOLOGICA, V48, P265; Wang Z, 2013, NAT GENET, V45, P701, DOI 10.1038/ng.2615; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105; Young MJ, 2013, CHROMOSOME RES, V21, P361, DOI 10.1007/s10577-013-9362-z	40	32	33	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105315	10.1371/journal.pone.0105315	http://dx.doi.org/10.1371/journal.pone.0105315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121779	Green Submitted, Green Published, gold			2022-12-27	WOS:000341017000115
J	McDowell, IC; Nikapitiya, C; Aguiar, D; Lane, CE; Istrail, S; Gomez-Chiarri, M				McDowell, Ian C.; Nikapitiya, Chamilani; Aguiar, Derek; Lane, Christopher E.; Istrail, Sorin; Gomez-Chiarri, Marta			Transcriptome of American Oysters, Crassostrea virginica, in Response to Bacterial Challenge: Insights into Potential Mechanisms of Disease Resistance	PLOS ONE			English	Article							RNA-SEQ DATA; EASTERN OYSTERS; ROSEOVARIUS-CRASSOSTREAE; DIFFERENTIAL EXPRESSION; STAPHYLOCOCCUS-AUREUS; BIOMPHALARIA-GLABRATA; IMMUNE-RESPONSE; INNATE IMMUNITY; VIBRIO-TAPETIS; SHELL MATRIX	The American oyster Crassostrea virginica, an ecologically and economically important estuarine organism, can suffer high mortalities in areas in the Northeast United States due to Roseovarius Oyster Disease ( ROD), caused by the gram-negative bacterial pathogen Roseovarius crassostreae. The goals of this research were to provide insights into: 1) the responses of American oysters to R. crassostreae, and 2) potential mechanisms of resistance or susceptibility to ROD. The responses of oysters to bacterial challenge were characterized by exposing oysters from ROD-resistant and susceptible families to R. crassostreae, followed by high-throughput sequencing of cDNA samples from various timepoints after disease challenge. Sequence data was assembled into a reference transcriptome and analyzed through differential gene expression and functional enrichment to uncover genes and processes potentially involved in responses to ROD in the American oyster. While susceptible oysters experienced constant levels of mortality when challenged with R. crassostreae, resistant oysters showed levels of mortality similar to non-challenged oysters. Oysters exposed to R. crassostreae showed differential expression of transcripts involved in immune recognition, signaling, protease inhibition, detoxification, and apoptosis. Transcripts involved in metabolism were enriched in susceptible oysters, suggesting that bacterial infection places a large metabolic demand on these oysters. Transcripts differentially expressed in resistant oysters in response to infection included the immune modulators IL-17 and arginase, as well as several genes involved in extracellular matrix remodeling. The identification of potential genes and processes responsible for defense against R. crassostreae in the American oyster provides insights into potential mechanisms of disease resistance.	[McDowell, Ian C.; Nikapitiya, Chamilani; Lane, Christopher E.; Gomez-Chiarri, Marta] Univ Rhode Isl, Coll Environm & Life Sci, Kingston, RI 02881 USA; [Aguiar, Derek; Istrail, Sorin] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Aguiar, Derek; Istrail, Sorin] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA	University of Rhode Island; Brown University; Brown University	Gomez-Chiarri, M (corresponding author), Univ Rhode Isl, Coll Environm & Life Sci, Kingston, RI 02881 USA.	gomezchi@mail.uri.edu	Aguiar, Derek/AAT-6242-2020	Aguiar, Derek/0000-0001-9166-8783; Nikapitiya, Chamilani/0000-0001-6273-9271; Gomez-Chiarri, Marta/0000-0002-2576-9612	USDA NIFA AFRI [2009-38925-19971]; Rhode Island Agricultural Experiment Station [Hatch13 901-INT]; RI-NSF EPSCoR [0554548]; NSF [1048831, 1321000]	USDA NIFA AFRI(United States Department of Agriculture (USDA)); Rhode Island Agricultural Experiment Station; RI-NSF EPSCoR; NSF(National Science Foundation (NSF))	This research has been funded by USDA NIFA AFRI award 2009-38925-19971 to MGC, CEL, and DP, Rhode Island Agricultural Experiment Station Hatch13 901-INT to MGC, CEL, and RR, and RI-NSF EPSCoR grant no. 0554548. Work by DA and SI was funded by NSF awards 1048831 and 1321000 to SI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema CM, 2010, MOL IMMUNOL, V47, P849, DOI 10.1016/j.molimm.2009.10.019; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Allam B, 2006, FISH SHELLFISH IMMUN, V20, P374, DOI 10.1016/j.fsi.2005.05.012; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barber BJ, 1998, J SHELLFISH RES, V17, P1171; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boardman CL, 2008, J INVERTEBR PATHOL, V97, P150, DOI 10.1016/j.jip.2007.08.007; Boettcher KJ, 2000, APPL ENVIRON MICROB, V66, P3924, DOI 10.1128/AEM.66.9.3924-3930.2000; Boettcher KJ, 2005, INT J SYST EVOL MICR, V55, P1531, DOI 10.1099/ijs.0.63620-0; Borrego JJ, 1996, AQUAT LIVING RESOUR, V9, P125, DOI 10.1051/alr:1996016; Bricelj V. Monica, 1992, Journal of Shellfish Research, V11, P331; Brulle F, 2012, DEV COMP IMMUNOL, V38, P368, DOI 10.1016/j.dci.2012.03.003; Cancela ML, 2010, INTRODUCTION TO MARINE GENOMICS, P213, DOI 10.1007/978-90-481-8639-6_7; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Carland TM, 2010, DEV COMP IMMUNOL, V34, P785, DOI 10.1016/j.dci.2010.02.014; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; David E, 2005, FEBS J, V272, P5635, DOI 10.1111/j.1742-4658.2005.04960.x; Davis CV, 1999, AQUACULTURE, V178, P253, DOI 10.1016/S0044-8486(99)00135-0; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; Dheilly NM, 2011, J INVERTEBR PATHOL, V106, P223, DOI 10.1016/j.jip.2010.09.008; Donaghy L, 2009, AQUACULTURE, V297, P10, DOI 10.1016/j.aquaculture.2009.09.003; Dower K, 2008, J IMMUNOL, V180, P3520, DOI 10.4049/jimmunol.180.5.3520; Dunn JR, 2006, BRIT J CANCER, V94, P1186, DOI 10.1038/sj.bjc.6603006; Egging D, 2007, ARCH DERMATOL RES, V298, P389, DOI 10.1007/s00403-006-0706-9; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fleury E, 2010, MAR BIOTECHNOL, V12, P326, DOI 10.1007/s10126-009-9227-9; Ford SE, 2001, J INVERTEBR PATHOL, V78, P141, DOI 10.1006/jipa.2001.5052; FORD SE, 1987, J PARASITOL, V73, P368, DOI 10.2307/3282092; Ford Susan E., 1996, P581; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Ghosh J, 2011, DEV COMP IMMUNOL, V35, P959, DOI 10.1016/j.dci.2010.12.009; Gomez-Leon J, 2008, DIS AQUAT ORGAN, V79, P95, DOI 10.3354/dao01902; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo Ximing, 2008, V2, P163, DOI 10.1007/978-3-540-73837-4_8; Gutierrez JL, 2003, OIKOS, V101, P79, DOI 10.1034/j.1600-0706.2003.12322.x; Haag ES, 1999, DEV BIOL, V211, P77, DOI 10.1006/dbio.1999.9283; Hanington PC, 2011, J INNATE IMMUN, V3, P17, DOI 10.1159/000321882; Hertel LA, 2005, DEV COMP IMMUNOL, V29, P295, DOI 10.1016/j.dci.2004.08.003; Huang GH, 2007, DEV COMP IMMUNOL, V31, P1013, DOI 10.1016/j.dci.2007.01.003; Hughes FM, 2010, FISH SHELLFISH IMMUN, V29, P247, DOI 10.1016/j.fsi.2010.03.003; Huvet A, 2004, GENE, V343, P211, DOI 10.1016/j.gene.2004.09.008; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Ivanina AV, 2008, J EXP BIOL, V211, P577, DOI 10.1242/jeb.011262; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Kong PF, 2010, DEV COMP IMMUNOL, V34, P837, DOI 10.1016/j.dci.2010.03.006; Kong Y, 2011, GENOMICS, V98, P152, DOI 10.1016/j.ygeno.2011.05.009; La Peyre JF, 2010, DEV COMP IMMUNOL, V34, P84, DOI 10.1016/j.dci.2009.08.007; Lacoste A, 2001, GEN COMP ENDOCR, V122, P252, DOI 10.1006/gcen.2001.7643; LANDE R, 1990, GENETICS, V124, P743; Lang RP, 2009, MAR BIOTECHNOL, V11, P650, DOI 10.1007/s10126-009-9181-6; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lettre G, 2006, NAT REV MOL CELL BIO, V7, P97, DOI 10.1038/nrm1836; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu L, 2011, DEV COMP IMMUNOL, V35, P227, DOI 10.1016/j.dci.2010.09.010; Loker ES, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00025; Lopez J, 2010, CURR OPIN CELL BIOL, V22, P872, DOI 10.1016/j.ceb.2010.08.025; Maloy AP, 2005, DIS AQUAT ORGAN, V67, P155, DOI 10.3354/dao067155; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6; Matussek A, 2005, SCAND J IMMUNOL, V61, P536, DOI 10.1111/j.1365-3083.2005.01597.x; Messier-Solek C, 2010, SEMIN IMMUNOL, V22, P39, DOI 10.1016/j.smim.2009.11.007; MOHANDAS A, 1985, J INVERTEBR PATHOL, V46, P189, DOI 10.1016/0022-2011(85)90148-X; Morga B, 2011, DEV COMP IMMUNOL, V35, P323, DOI 10.1016/j.dci.2010.10.005; Morita Y, 2007, FEBS LETT, V581, P1417, DOI 10.1016/j.febslet.2007.02.064; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mullner D, 2013, FASTCLUSTER FAST HIE; National Marine Fisheries Service (NMFS), 2012, ANN COMM LAND STAT F; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Nitta T, 2007, TRENDS IMMUNOL, V28, P58, DOI 10.1016/j.it.2006.12.002; Ordas MC, 2000, FISH SHELLFISH IMMUN, V10, P597, DOI 10.1006/fsim.2000.0274; Ottaviani E, 1996, PROG NEUROBIOL, V48, P421, DOI 10.1016/0301-0082(95)00049-6; Quintana FJ, 2011, TRENDS IMMUNOL, V32, P89, DOI 10.1016/j.it.2010.11.001; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts S, 2008, DEV COMP IMMUNOL, V32, P1099, DOI 10.1016/j.dci.2008.02.006; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Sarashina I, 2006, J MOL EVOL, V62, P307, DOI 10.1007/s00239-005-0095-2; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Smit A.F.A., 1996, REPEATMASTER OPEN 3 REPEATMASTER OPEN 3; Snyder MJ, 2000, AQUAT TOXICOL, V48, P529, DOI 10.1016/S0166-445X(00)00085-0; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Sunila I, 2003, DIS AQUAT ORGAN, V56, P163, DOI 10.3354/dao056163; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Villamil L, 2007, DEV COMP IMMUNOL, V31, P968, DOI 10.1016/j.dci.2007.01.006; Wang LL, 2012, FISH SHELLFISH IMMUN, V33, P427, DOI 10.1016/j.fsi.2012.05.032; Warnes GR, 2013, GPLOTS VARIOUS R PRO; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017089; Yu HY, 2011, FISH SHELLFISH IMMUN, V30, P757, DOI 10.1016/j.fsi.2010.12.015; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang H, 2009, FISH SHELLFISH IMMUN, V26, P56, DOI 10.1016/j.fsi.2008.07.019; Zhang LL, 2014, MAR BIOTECHNOL, V16, P17, DOI 10.1007/s10126-013-9526-z; Zhang LL, 2011, DEV COMP IMMUNOL, V35, P603, DOI 10.1016/j.dci.2011.01.005; Zhao ZG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045675, 10.1371/journal.pone.0046244]; Zhou Z, 2012, FISH SHELLFISH IMMUN, V33, P67, DOI 10.1016/j.fsi.2012.04.002; Zhou Z, 2011, FISH SHELLFISH IMMUN, V31, P1065, DOI 10.1016/j.fsi.2011.09.009	102	56	56	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105097	10.1371/journal.pone.0105097	http://dx.doi.org/10.1371/journal.pone.0105097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122115	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000096
J	An, PNT; Yamaguchi, M; Bamba, T; Fukusaki, E				Phan Nguyen Thuy An; Yamaguchi, Masamitsu; Bamba, Takeshi; Fukusaki, Eiichiro			Metabolome Analysis of Drosophila melanogaster during Embryogenesis	PLOS ONE			English	Article							MASS-SPECTROMETRY; SYSTEMATIC PREDICTION; ZEBRAFISH; CHROMATOGRAPHY; TREHALOSE; HYPOXIA; EMBRYO; GENOME	The Drosophila melanogaster embryo has been widely utilized as a model for genetics and developmental biology due to its small size, short generation time, and large brood size. Information on embryonic metabolism during developmental progression is important for further understanding the mechanisms of Drosophila embryogenesis. Therefore, the aim of this study is to assess the changes in embryos' metabolome that occur at different stages of the Drosophila embryonic development. Time course samples of Drosophila embryos were subjected to GC/MS-based metabolome analysis for profiling of low molecular weight hydrophilic metabolites, including sugars, amino acids, and organic acids. The results showed that the metabolic profiles of Drosophila embryo varied during the course of development and there was a strong correlation between the metabolome and different embryonic stages. Using the metabolome information, we were able to establish a prediction model for developmental stages of embryos starting from their high-resolution quantitative metabolite composition. Among the important metabolites revealed from our model, we suggest that different amino acids appear to play distinct roles in different developmental stages and an appropriate balance in trehalose-glucose ratio is crucial to supply the carbohydrate source for the development of Drosophila embryo.	[Phan Nguyen Thuy An; Bamba, Takeshi; Fukusaki, Eiichiro] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Yamaguchi, Masamitsu] Kyoto Inst Technol, Insect Biomed Res Ctr, Dept Appl Biol, Sakyo Ku, Kyoto 606, Japan	Osaka University; Kyoto Institute of Technology	Fukusaki, E (corresponding author), Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan.	fukusaki@bio.eng.osaka-u.ac.jp		THUY AN, PHAN NGUYEN/0000-0002-1438-416X; Yamaguchi, Masamitsu/0000-0002-6321-9750				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Al Bratty M, 2011, METABOLOMICS, V7, P542, DOI 10.1007/s11306-011-0275-6; [Anonymous], 1993, 3D QSAR DRUG DESIGN; Bakovic M, 2007, BIOCHEM CELL BIOL, V85, P283, DOI 10.1139/O07-006; Bender D.A, 2012, AMINO ACID METABIS, P1; Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S; Chambers MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050679; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; Colinet H, 2012, FUNCT ECOL, V26, P711, DOI 10.1111/j.1365-2435.2012.01985.x; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; Feala JD, 2008, PROG BIOPHYS MOL BIO, V96, P209, DOI 10.1016/j.pbiomolbio.2007.07.014; Fortini ME, 2000, J CELL BIOL, V150, pF23, DOI 10.1083/jcb.150.2.F23; Gilbert S, 2000, EARLY DROSOPHILA DEV; Hammad LA, 2011, RAPID COMMUN MASS SP, V25, P2959, DOI 10.1002/rcm.5187; Hayashi S, 2011, Z NATURFORSCH C, V66, P191, DOI 10.5560/ZNC.2011.66c0191; Hayashi S, 2009, BIOCHEM BIOPH RES CO, V386, P268, DOI 10.1016/j.bbrc.2009.06.041; Heinrichsen ET, MOL METABOLISM; Howe E, 2010, BIOMEDICAL INFORMATICS FOR CANCER RESEARCH, P267, DOI 10.1007/978-1-4419-5714-6_15; Huang SM, 2013, MOL BIOSYST, V9, P1372, DOI 10.1039/c3mb25450j; Kamleh MA, 2008, FEBS LETT, V582, P2916, DOI 10.1016/j.febslet.2008.07.029; Kamleh MA, 2009, FEBS J, V276, P6798, DOI 10.1111/j.1742-4658.2009.07397.x; Kanamori Y, 2010, INSECT BIOCHEM MOLEC, V40, P30, DOI 10.1016/j.ibmb.2009.12.006; Knee JM, 2013, J CHROMATOGR B, V936, P63, DOI 10.1016/j.jchromb.2013.07.027; Kostal V, 2012, P NATL ACAD SCI USA, V109, P3270, DOI 10.1073/pnas.1119986109; Kostal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025025; Leptin M, 1999, EMBO J, V18, P3187, DOI 10.1093/emboj/18.12.3187; Lommen A, 2007, ANAL CHIM ACTA, V584, P43, DOI 10.1016/j.aca.2006.11.018; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Malmendal A, 2006, AM J PHYSIOL-REG I, V291, pR205, DOI 10.1152/ajpregu.00867.2005; MERRILL PT, 1988, DEVELOPMENT, V104, P495; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Papan C, 2009, OMICS, V13, P397, DOI 10.1089/omi.2009.0023; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; Rockstein M., 2012, BIOCH INSECTS; Sarup P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047461; Soanes KH, 2011, J PROTEOME RES, V10, P5102, DOI 10.1021/pr2005549; Tennessen JM, 2014, COORDINATED METABOLI, pG3; Tram U., 2001, CLEAVAGE GASTRULATIO; Tsugawa H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-131; Turner A., 1986, BIOCH MOL BIOL ED, V14, P46; Vastag Livia, 2011, PLoS One, V6, pe16881, DOI 10.1371/journal.pone.0016881; YAMAGUCHI M, 1991, MOL CELL BIOL, V11, P4909, DOI 10.1128/MCB.11.10.4909; YAMAGUCHI M, 1991, J CELL SCI, V100, P729; Yang B, 2012, J PHARMACEUT BIOMED, V58, P113, DOI 10.1016/j.jpba.2011.09.033; Yoshida R, 2010, AGING CELL, V9, P616, DOI 10.1111/j.1474-9726.2010.00590.x	46	22	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e99519	10.1371/journal.pone.0099519	http://dx.doi.org/10.1371/journal.pone.0099519			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121768	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000003
J	Nguyen, TLM; Makhlouf, NT; Anthony, BA; Teague, RM; DiPaolo, RJ				Nguyen, Thanh-Long M.; Makhlouf, Nabil T.; Anthony, Bryan A.; Teague, Ryan M.; DiPaolo, Richard J.			In Vitro Induced Regulatory T Cells Are Unique from Endogenous Regulatory T Cells and Effective at Suppressing Late Stages of Ongoing Autoimmunity	PLOS ONE			English	Article							TGF-BETA; DENDRITIC CELLS; FOXP3 GENE; DIFFERENTIATION; ACTIVATION; INDUCTION; PREVENT; CD4(+); IL-2; AUTOANTIGEN	In Strategies to boost the numbers and functions of regulatory T cells (Tregs) are currently being tested as means to treat autoimmunity. While Tregs have been shown to be effective in this role, strategies to manipulate Tregs to effectively suppress later stages of ongoing diseases need to be established. In this study, we evaluated the ability of TGF-beta-induced Tregs (iTregs) specific for the major self-antigen in autoimmune gastritis to suppress established autoimmune gastritis in mice. When transferred into mice during later stages of disease, iTregs demethylated the Foxp3 promoter, maintained Foxp3 expression, and suppressed effector T cell proliferation. More importantly, these iTregs were effective at stopping disease progression. Untreated mice had high numbers of endogenous Tregs (enTregs) but these were unable to stop disease progression. In contrast, iTregs, were found in relatively low numbers in treated mice, yet were effective at stopping disease progression, suggesting qualitative differences in suppressor functions. We identified several inhibitory receptors (LAG-3, PD-1, GARP, and TNFR2), cytokines (TGF-beta 1 and IL12p35), and transcription factors (IRF4 and Tbet) expressed at higher levels by iTregs compared to enTregs isolated form mice with ongoing disease, which likely accounts for superior suppressor ability in this disease model. These data support efforts to use iTregs in therapies to treat establish autoimmunity, and show that iTregs are more effective than enTregs at suppressing inflammation in this disease model.	[Nguyen, Thanh-Long M.; Makhlouf, Nabil T.; Anthony, Bryan A.; Teague, Ryan M.; DiPaolo, Richard J.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA	Saint Louis University	DiPaolo, RJ (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63103 USA.	rdipaolo@slu.edu			RJD: American Cancer Society Research Scholar Grant [12-171-01-LIB]	RJD: American Cancer Society Research Scholar Grant	RJD: American Cancer Society Research Scholar Grant 12-171-01-LIB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Alderuccio F, 1995, AUTOIMMUNITY, V21, P215, DOI 10.3109/08916939509008018; Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Bennett CL, 2001, IMMUNOGENETICS, V53, P435, DOI 10.1007/s002510100358; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chattopadhyay G, 2013, J IMMUNOL, V191, P5875, DOI 10.4049/jimmunol.1301693; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen X, 2010, EUR J IMMUNOL, V40, P1099, DOI 10.1002/eji.200940022; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; CORREA P, 1988, CANCER RES, V48, P3554; Deknuydt F, 2009, CLIN IMMUNOL, V131, P298, DOI 10.1016/j.clim.2008.12.008; DiPaolo RJ, 2007, J IMMUNOL, V179, P4685, DOI 10.4049/jimmunol.179.7.4685; DiPaolo RJ, 2005, J IMMUNOL, V175, P7135, DOI 10.4049/jimmunol.175.11.7135; Fantini MC, 2006, GUT, V55, P671, DOI 10.1136/gut.2005.072801; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2003, NAT IMMUNOL; Fu WX, 2012, NAT IMMUNOL, V13, P972, DOI 10.1038/ni.2420; Godebu E, 2008, J IMMUNOL, V181, P1798, DOI 10.4049/jimmunol.181.3.1798; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Lan Q, 2012, J MOL CELL BIOL, V4, P22, DOI 10.1093/jmcb/mjr039; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liang BT, 2008, J IMMUNOL, V180, P5916, DOI 10.4049/jimmunol.180.9.5916; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; McHugh RS, 2001, EUR J IMMUNOL, V31, P2094, DOI 10.1002/1521-4141(200107)31:7<2094::AID-IMMU2094>3.0.CO;2-S; Nguyen TLM, 2011, J IMMUNOL, V187, P1745, DOI 10.4049/jimmunol.1004112; Nguyen TL, 2013, CANC RES; O'Connor RA, 2010, J IMMUNOL, V185, P7235, DOI 10.4049/jimmunol.1001551; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Rogers AB, 2005, CANCER RES, V65, P10709, DOI 10.1158/0008-5472.CAN-05-1846; Schmitt EG, 2012, J IMMUNOL, V189, P5638, DOI 10.4049/jimmunol.1200936; Sehrawat S, 2008, J VIROL, V82, P6838, DOI 10.1128/JVI.00697-08; Selvaraj RK, 2007, J IMMUNOL, V179, P1390, DOI 10.4049/jimmunol.179.2.1390-b; Selvaraj RK, 2008, J IMMUNOL, V180, P2830, DOI 10.4049/jimmunol.180.5.2830; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; van Driel IR, 2005, CURR OPIN IMMUNOL, V17, P570, DOI 10.1016/j.coi.2005.09.016; Wang CH, 2010, J NEUROSCI RES, V88, P7, DOI 10.1002/jnr.22181; Wang R, 2012, MOL BIOL CELL, V23, P1129, DOI 10.1091/mbc.E11-12-1018; Weber SE, 2006, J IMMUNOL, V176, P4730, DOI 10.4049/jimmunol.176.8.4730; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zhang H, 2010, J IMMUNOL, V184, P6629, DOI 10.4049/jimmunol.0904044; Zheng SG, 2004, J IMMUNOL, V172, P1531, DOI 10.4049/jimmunol.172.3.1531; Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	54	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104698	10.1371/journal.pone.0104698	http://dx.doi.org/10.1371/journal.pone.0104698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119105	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600079
J	Ruzagira, E; Abaasa, A; Karita, E; Mulenga, J; Kilembe, W; Allen, S; Bahemuka, U; Bwanika, AN; Levin, J; Price, MA; Kamali, A				Ruzagira, Eugene; Abaasa, Andrew; Karita, Etienne; Mulenga, Joseph; Kilembe, William; Allen, Susan; Bahemuka, Ubaldo; Bwanika, Agnes N.; Levin, Jonathan; Price, Matthew A.; Kamali, Anatoli			Effect of Seasonal Variation on Adult Clinical Laboratory Parameters in Rwanda, Zambia, and Uganda: Implications for HIV Biomedical Prevention Trials	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SERUM CREATINE-KINASE; REFERENCE INTERVALS; REFERENCE RANGES; LYMPHOCYTE SUBSETS; REFERENCE VALUES; BLOOD-DONORS; RAINY-SEASON; VITAMIN-D; COUNT	Objectives: To investigate the effect of seasonal variation on adult clinical laboratory parameters in Rwanda, Zambia, and Uganda and determine its implications for HIV prevention and other clinical trials. Methods: Volunteers in a cross-sectional study to establish laboratory reference intervals were asked to return for a seasonal visit after the local season had changed from dry to rainy or vice versa. Volunteers had to be clinically healthy, not pregnant and negative for HIV, Hepatitis B and C, and syphilis infection at both visits. At each visit, blood was taken for measurement of hemoglobin, haematocrit, mean corpuscular volume, red blood cells, platelets, total white blood cells (WBC), neutrophils, lymphocytes, monocytes, eosinophils, basophils, CD4/CD8 T cells, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, direct bilirubin, total bilirubin, total immunoglobulin gamma, total protein, creatinine, total amylase, creatine phosphokinase and lactate dehydrogenase (LDH). Consensus dry season reference intervals were applied to rainy season values (and vice versa) and the proportion of 'out-of-range' values determined. Percentage differences between dry and rainy season parameter mean values were estimated. Results: In this cohort of 903 volunteers, less than 10.0% of consensus parameter (except LDH) values in one season were "out-of-range" in the other. Twenty-two (22) percent of rainy season LDH values fell outside of the consensus dry season interval with the higher values observed in the rainy season. Variability between consensus seasonal means ranged from 0.0% (total WBC, neutrophils, monocytes, basophils, and direct bilirubin) to 40.0% (eosinophils). Within sites, the largest seasonal variations were observed for monocytes (Masaka, 11.5%), LDH (Lusaka, 21.7%), and basophils (Kigali, 22.2%). Conclusions: Seasonality had minimal impact on adult clinical laboratory parameter values in Rwanda, Zambia, and Uganda. Seasonal variation may not be an important factor in the evaluation of adult clinical laboratory parameters in HIV prevention and other clinical trials in these countries.	[Ruzagira, Eugene; Abaasa, Andrew; Bahemuka, Ubaldo; Bwanika, Agnes N.; Levin, Jonathan; Kamali, Anatoli] Uganda Virus Res Inst UVRI, Med Res Council MRC, Uganda Res Unit, Entebbe, Uganda; [Karita, Etienne] PSF, Kigali, Rwanda; [Mulenga, Joseph; Kilembe, William] Zambia Emory HIV Res Project ZEHRP, Lusaka, Zambia; [Mulenga, Joseph] Zambia Blood Transfus Serv, Lusaka, Zambia; [Allen, Susan] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Price, Matthew A.] Int AIDS Vaccine Initiat, New York, NY USA; [Price, Matthew A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Emory University; Rollins School Public Health; International AIDS Vaccine Initiative; University of California System; University of California San Francisco	Ruzagira, E (corresponding author), Uganda Virus Res Inst UVRI, Med Res Council MRC, Uganda Res Unit, Entebbe, Uganda.	eugene.ruzagira@mrcuganda.org	Price, Matt/AAK-6881-2021	Price, Matt/0000-0002-2918-1373; Bwanika Naggirinya, Agnes/0000-0001-6795-3138; Ruzagira, Eugene/0000-0002-7291-1693	International AIDS Vaccine Initiative (IAVI); Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of Denmark; Irish Aid; Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); American people through USAID	International AIDS Vaccine Initiative (IAVI); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of Denmark; Irish Aid(CGIAR); Ministry of Finance of Japan; Ministry of Foreign Affairs of the Netherlands; Norwegian Agency for Development Cooperation (NORAD)(CGIAR); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); American people through USAID(United States Agency for International Development (USAID))	This study was sponsored by the International AIDS Vaccine Initiative (IAVI). IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of Denmark; Irish Aid; the Ministry of Finance of Japan; the Ministry of Foreign Affairs of the Netherlands; the Norwegian Agency for Development Cooperation (NORAD); the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. This study is made possible by the generous support of the American people through USAID. The contents are the responsibility of IAVI and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam J, 2008, GOMAL J MED SCI, V6, P69; Bain BJ, 1996, J CLIN PATHOL, V49, P664, DOI 10.1136/jcp.49.8.664; Bolland MJ, 2007, AM J CLIN NUTR, V86, P959, DOI 10.1093/ajcn/86.4.959; Camberlin P, 2002, J CLIMATE, V15, P1002, DOI 10.1175/1520-0442(2002)015&lt;1002:TEAMMR&gt;2.0.CO;2; Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; Eller LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003919; Enns DL, 2010, SPORTS MED, V40, P41, DOI 10.2165/11319760-000000000-00000; EZEILO GC, 1972, LANCET, V2, P1003; Fares A, 2013, INT J PREVENTIVE MED, V4, P128; Gallerani M, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-31; Garba I. H., 2005, SMJ Singapore Medical Journal, V46, P632; Gomo E, 2004, Cent Afr J Med, V50, P10; Gomo E, 2003, EUR J OBSTET GYN R B, V107, P156, DOI 10.1016/S0301-2115(02)00346-9; Granger DA, 2007, ANN NY ACAD SCI, V1098, P122, DOI 10.1196/annals.1384.008; Hachigonta S, 2008, THEOR APPL CLIMATOL, V91, P229, DOI 10.1007/s00704-007-0306-4; Hagedorn F, 1997, PLANT SOIL, V195, P365, DOI 10.1023/A:1004266205502; Hammerich A, 2002, TROP MED INT HEALTH, V7, P573, DOI 10.1046/j.1365-3156.2002.00898.x; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Lawrie D, 2009, SAMJ S AFR MED J, V99, P243; Lisse IM, 1997, J PEDIATR-US, V130, P77, DOI 10.1016/S0022-3476(97)70313-5; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Maini MK, 1996, GENITOURIN MED, V72, P27; Malaria Control Programme, 2005, UG MAL CONTR STRAT P; Masaninga Freddie, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P89, DOI 10.1016/S2221-1691(13)60030-1; Mine M, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.5; Miyake K, 2009, ANN CLIN BIOCHEM, V46, P377, DOI 10.1258/acb.2009.008203; PAGLIERONI TG, 1994, TRANSFUSION, V34, P512, DOI 10.1046/j.1537-2995.1994.34694295067.x; Peng LM, 2004, THROMB HAEMOSTASIS, V91, P367, DOI 10.1160/TH03-05-0276; PERCY ME, 1982, MUSCLE NERVE, V5, P58, DOI 10.1002/mus.880050111; Phillips J, 2000, INT J CLIMATOL, V20, P171, DOI 10.1002/(SICI)1097-0088(200002)20:2&lt;171::AID-JOC471&gt;3.0.CO;2-O; SHAPER AG, 1971, LANCET, V2, P1021; SHUMATE JB, 1979, NEUROLOGY, V29, P902, DOI 10.1212/WNL.29.6.902; SMITH I, 1979, CLIN CHIM ACTA, V98, P207, DOI 10.1016/0009-8981(79)90147-5; Stevens W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002043; Troy SB, 2012, J TROP PEDIATRICS, V58, P59, DOI 10.1093/tropej/fmr031; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	38	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105089	10.1371/journal.pone.0105089	http://dx.doi.org/10.1371/journal.pone.0105089			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118593	gold, Green Submitted, Green Published			2022-12-27	WOS:000340900600123
J	Alele, PO; Sheil, D; Surget-Groba, Y; Shi, LL; Cannon, CH				Alele, Peter O.; Sheil, Douglas; Surget-Groba, Yann; Shi Lingling; Cannon, Charles H.			How Does Conversion of Natural Tropical Rainforest Ecosystems Affect Soil Bacterial and Fungal Communities in the Nile River Watershed of Uganda?	PLOS ONE			English	Article							SPECIES-DIVERSITY; BIOTIC HOMOGENIZATION; LAND-USE; MICROBIAL DIVERSITY; SCALE PATTERNS; SPATIAL SCALES; BIODIVERSITY; PLANT; CONSERVATION; BIOGEOGRAPHY	Uganda's forests are globally important for their conservation values but are under pressure from increasing human population and consumption. In this study, we examine how conversion of natural forest affects soil bacterial and fungal communities. Comparisons in paired natural forest and human-converted sites among four locations indicated that natural forest soils consistently had higher pH, organic carbon, nitrogen, and calcium, although variation among sites was large. Despite these differences, no effect on the diversity of dominant taxa for either bacterial or fungal communities was detected, using polymerase chain reaction-denaturing gradient gel electrophoresis (PCR-DGGE). Composition of fungal communities did generally appear different in converted sites, but surprisingly, we did not observe a consistent pattern among sites. The spatial distribution of some taxa and community composition was associated with soil pH, organic carbon, phosphorus and sodium, suggesting that changes in soil communities were nuanced and require more robust metagenomic methods to understand the various components of the community. Given the close geographic proximity of the paired sampling sites, the similarity between natural and converted sites might be due to continued dispersal between treatments. Fungal communities showed greater environmental differentiation than bacterial communities, particularly according to soil pH. We detected biotic homogenization in converted ecosystems and substantial contribution of beta-diversity to total diversity, indicating considerable geographic structure in soil biota in these forest communities. Overall, our results suggest that soil microbial communities are relatively resilient to forest conversion and despite a substantial and consistent change in the soil environment, the effects of conversion differed widely among sites. The substantial difference in soil chemistry, with generally lower nutrient quantity in converted sites, does bring into question, how long this resilience will last.	[Alele, Peter O.; Surget-Groba, Yann; Shi Lingling; Cannon, Charles H.] Chinese Acad Sci, XTBG, Key Lab Trop Forest Ecol, Kunming, Yunnan, Peoples R China; [Alele, Peter O.; Shi Lingling] Univ Chinese Acad Sci, Beijing, Peoples R China; [Alele, Peter O.] GNCC, Lira, Uganda; [Sheil, Douglas] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Sheil, Douglas] Ctr Int Forestry Res CIFOR, Bogor, Indonesia; [Sheil, Douglas] So Cross Univ, Sch Environm Sci & Engn, Dept Ecol & Nat Resource Management, Lismore, NSW 2480, Australia; [Alele, Peter O.; Sheil, Douglas] MUST, ITFC, Kabale, Uganda; [Cannon, Charles H.] Texas Tech Univ, Lubbock, TX 79409 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Norwegian University of Life Sciences; CGIAR; Center for International Forestry Research (CIFOR); Southern Cross University; Texas Tech University System; Texas Tech University	Alele, PO (corresponding author), Chinese Acad Sci, XTBG, Key Lab Trop Forest Ecol, Kunming, Yunnan, Peoples R China.	alelepeter@gmail.com	Sheil, Douglas/N-3291-2019; Cannon, Charles H/D-7186-2012; Cannon, Charles/AAE-7715-2019; Sheil, Douglas/A-3867-2015; Surget-Groba, Yann/K-4917-2012	Cannon, Charles H/0000-0003-1901-0420; Cannon, Charles/0000-0003-1901-0420; Sheil, Douglas/0000-0002-1166-6591; Surget-Groba, Yann/0000-0001-7612-4892	Xishuangbanna Tropical Botanical Garden (XTBG); Chinese Academy of Sciences	Xishuangbanna Tropical Botanical Garden (XTBG); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by Xishuangbanna Tropical Botanical Garden (XTBG) and the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Bissett A, 2011, APPL SOIL ECOL, V51, P66, DOI 10.1016/j.apsoil.2011.08.010; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chandy S, 2006, J APPL ECOL, V43, P792, DOI 10.1111/j.1365-2664.2006.01178.x; Cleary DFR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029380; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; de Vries FT, 2012, ECOL LETT, V15, P1230, DOI 10.1111/j.1461-0248.2012.01844.x; Demeny P, 2003, POPULATION POLICY CO; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Garbisu C, 2011, APPL SOIL ECOL, V49, P1, DOI 10.1016/j.apsoil.2011.04.018; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Gering JC, 2003, CONSERV BIOL, V17, P488, DOI 10.1046/j.1523-1739.2003.01465.x; Godfray HCJ, 2001, TRENDS ECOL EVOL, V16, P400, DOI 10.1016/S0169-5347(01)02150-4; Hartman WH, 2008, P NATL ACAD SCI USA, V105, P17842, DOI 10.1073/pnas.0808254105; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Kayanja FIB, 2001, CURR SCI INDIA, V81, P936; Kjeldahl J., 1883, Z ANAL CHEM, V22; Kuramae EE, 2012, FEMS MICROBIOL ECOL, V79, P12, DOI 10.1111/j.1574-6941.2011.01192.x; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; Legendre P., 2012, NUMERICAL ECOLOGY; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; MONKIEDJE A, 2006, J ENVIRON QUAL, V35, P2402, DOI DOI 10.2134/jeq2005.0447; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; NEMA, 2008, STAT ENV REP UG; Neris J, 2012, CATENA, V98, P55, DOI 10.1016/j.catena.2012.06.006; Nile Basin Initiative, 2012, STAT RIV NIL BAS; Obua J, 2010, AFR J ECOL, V48, P853, DOI 10.1111/j.1365-2028.2010.01217.x; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Olden JD, 2004, ECOLOGY, V85, P1867, DOI 10.1890/03-3131; Olden JD, 2003, AM NAT, V162, P442, DOI 10.1086/378212; Olden JD, 2006, J BIOGEOGR, V33, P2027, DOI 10.1111/j.1365-2699.2006.01572.x; Olson DM, 2002, CONSERV BIOL, V16, P1, DOI 10.1046/j.1523-1739.2002.01612.x; Reche I, 2005, ECOLOGY, V86, P1715, DOI 10.1890/04-1587; Ribeiro DB, 2008, DIVERS DISTRIB, V14, P961, DOI 10.1111/j.1472-4642.2008.00505.x; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rodrigues JLM, 2012, P NATL ACAD SCI US; Russo SE, 2012, SOIL BIOL BIOCHEM, V55, P48, DOI 10.1016/j.soilbio.2012.05.021; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Sasaki T, 2012, BIODIVERS CONSERV, V21, P1577, DOI 10.1007/s10531-012-0265-7; Scheckenbach F, 2010, P NATL ACAD SCI USA, V107, P115, DOI 10.1073/pnas.0908816106; Schulz S, 2012, ISME J, V6, P1763, DOI 10.1038/ismej.2012.17; Shange RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040338; Steenwerth KL, 2005, SOIL BIOL BIOCHEM, V37, P2249, DOI 10.1016/j.soilbio.2005.02.038; Summerville KS, 2003, CONSERV BIOL, V17, P1045, DOI 10.1046/j.1523-1739.2003.02059.x; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; United Nations, 2013, WORLD POP AG 2013; United Nations D of E and SAPD, 2007, WORLD POP PROSP 2006; Vainio EJ, 2000, MYCOL RES, V104, P927, DOI 10.1017/S0953756200002471; Veech JA, 2002, OIKOS, V99, P3, DOI 10.1034/j.1600-0706.2002.990101.x; Veech JA, 2009, PARTITION SOFTWARE H; Venail PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072561; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; WALKLEY A, 1947, SOIL SCI, V63, P251, DOI 10.1097/00010694-194704000-00001; Wang YP, 2011, MICROB ECOL, V62, P739, DOI 10.1007/s00248-011-9890-z; Weiher E, 2003, J VEG SCI, V14, P917, DOI 10.1111/j.1654-1103.2003.tb02226.x; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Winterbottom B, 2006, UGANDA BIODIVERSITY; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x; Wu F, 2010, DIVERS DISTRIB, V16, P1022, DOI 10.1111/j.1472-4642.2010.00710.x	73	16	16	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104818	10.1371/journal.pone.0104818	http://dx.doi.org/10.1371/journal.pone.0104818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25118069	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400090
J	Bashar, K; Healy, D; Browne, LD; Kheirelseid, EAH; Walsh, MT; Clarke-Moloney, M; Burke, PE; Kavanagh, EG; Walsh, SR				Bashar, Khalid; Healy, Donagh; Browne, Leonard D.; Kheirelseid, Elrasheid A. H.; Walsh, Michael T.; Clarke-Moloney, Mary; Burke, Paul E.; Kavanagh, Eamon G.; Walsh, Stewart Redmond			Role of Far Infra-Red Therapy in Dialysis Arterio-Venous Fistula Maturation and Survival: Systematic Review and Meta-Analysis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; VASCULAR ACCESS; THERMAL THERAPY; HEMODIALYSIS-PATIENTS; MANAGEMENT; OUTCOMES; PATENCY; IRRADIATION; EXPRESSION; INJURY	Introduction: A well-functioning arteriovenous fistula (AVF) is the best modality for vascular access in patients with end-stage renal disease (ESRD) requiring haemodialysis (HD). However, AVFs' main disadvantage is the high rate of maturation failure, with approximately one third (20%-50%) not maturing into useful access. This review examine the use of Far-Infra Red therapy in an attempt to enhance both primary (unassisted) and secondary (assisted) patency rates for AVF in dialysis and pre-dialysis patients. Method: We performed an online search for observational studies and randomised controlled trials (RCTs) that evaluated FIR in patients with AVF. Eligible studies compared FIR with control treatment and reported at least one outcome measure relating to access survival. Primary patency and secondary patency rates were the main outcomes of interest. Results: Four RCTs (666 patients) were included. Unassisted patency assessed in 610 patients, and was significantly better among those who received FIR (228/311) compared to (185/299) controls (pooled risk ratio of 1.23 [1.12-1.35], p = 0.00001). In addition, the two studies which reported secondary patency rates showed significant difference in favour of FIR therapy-160/168 patients - compared to 140/163 controls (pooled risk ratio of 1.11 [1.04-1.19], p = 0.003). Conclusion: FIR therapy may positively influence the complex process of AVF maturation improving both primary and secondary patency rates. However blinded RCTs performed by investigators with no commercial ties to FIR therapy technologies are needed.	[Bashar, Khalid; Healy, Donagh; Kheirelseid, Elrasheid A. H.; Clarke-Moloney, Mary; Burke, Paul E.; Kavanagh, Eamon G.] Univ Hosp Limerick, Dept Vasc Surg, Limerick, Ireland; [Browne, Leonard D.; Walsh, Michael T.] Univ Limerick, CABER, Mat & Surface Sci Inst, Dept Mech Aeronaut & Biomed Engn, Limerick, Ireland; [Walsh, Stewart Redmond] Natl Univ Ireland, Dept Surg, Galway, Ireland	University of Limerick; University of Limerick; Ollscoil na Gaillimhe-University of Galway	Bashar, K (corresponding author), Univ Hosp Limerick, Dept Vasc Surg, Limerick, Ireland.	khalidbashar@rcsi.ie	Walsh, Stewart R/AAC-1229-2021; Walsh, Michael T/C-1405-2010	Walsh, Michael T/0000-0002-1672-8106; Walsh, Stewart/0000-0002-1006-9541; Browne, Leonard/0000-0002-9203-1212				Akasaki Y, 2006, CIRC J, V70, P463, DOI 10.1253/circj.70.463; Allon M, 2002, KIDNEY INT, V62, P1109, DOI 10.1111/j.1523-1755.2002.kid551.x; Allon M, 2001, KIDNEY INT, V60, P2013, DOI 10.1046/j.1523-1755.2001.00031.x; Allon M, 2007, CLIN J AM SOC NEPHRO, V2, P786, DOI 10.2215/CJN.00860207; Brunori G, 2008, G Ital Nefrol, V25, P614; Capon A, 2003, AM J CLIN DERMATOL, V4, P1, DOI 10.2165/00128071-200304010-00001; COX JL, 1991, PROG CARDIOVASC DIS, V34, P45, DOI 10.1016/0033-0620(91)90019-I; DAVIES MG, 1994, BRIT J SURG, V81, P1254, DOI 10.1002/bjs.1800810904; DERSIMONIAN R, 1983, HARVARD EDUC REV, V53, P1; Dixon BS, 2006, KIDNEY INT, V70, P1413, DOI 10.1038/sj.ki.5001747; Dixon BS, 2002, AM J KIDNEY DIS, V39, P92, DOI 10.1053/ajkd.2002.29886; Frankel A, 2006, EUR J VASC ENDOVASC, V31, P417, DOI 10.1016/j.ejvs.2005.10.003; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoggard J, 2008, SEMIN DIALYSIS, V21, P186, DOI 10.1111/j.1525-139X.2008.00421.x; Huang CY, 2009, IEEE ENG MED BIO, P1589, DOI 10.1109/IEMBS.2009.5334124; Ikeda Y, 2001, JPN CIRC J, V65, P434, DOI 10.1253/jcj.65.434; Kawaura A, 2010, ACTA MED OKAYAMA, V64, P143; Kipshidze N, 2001, CIRCULATION, V104, P1850, DOI 10.1161/hc3901.096101; Lai CC, 2013, EUR J VASC ENDOVASC, V46, P726, DOI 10.1016/j.ejvs.2013.09.018; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin CC, 2013, AM J KIDNEY DIS; Lin CH, 2011, AM J CHINESE MED, V39, P839, DOI 10.1142/S0192415X1100924X; Lin CC, 2007, J AM SOC NEPHROL, V18, P985, DOI 10.1681/ASN.2006050534; Lin CC, 2013, NEPHROL DIAL TRANSPL, V28, P1284, DOI 10.1093/ndt/gfs608; Lok CE, 2005, KIDNEY INT, V67, P2462, DOI 10.1111/j.1523-1755.2005.00355.x; Ma A, 2013, PEDIATR NEPHROL, V28, P321, DOI 10.1007/s00467-012-2318-2; McCann M, 2010, J REN CARE, V36, P25, DOI 10.1111/j.1755-6686.2010.00138.x; McCann M, 2008, J REN CARE, V34, P77, DOI 10.1111/j.1755-6686.2008.00022.x; National Kidney Foundation. NKF- KDOQI, 2006, 2006 UPD CLIN PRACT; Newby AC, 2000, J PATHOL, V190, P300, DOI 10.1002/(SICI)1096-9896(200002)190:3<300::AID-PATH596>3.0.CO;2-I; Ocak G, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-79; Oliver MJ, 2001, KIDNEY INT, V60, P1532, DOI 10.1046/j.1523-1755.2001.00956.x; Polkinghorne KR, 2004, J AM SOC NEPHROL, V15, P477, DOI 10.1097/01.ASN.0000109668.05157.05; Polkinghorne KR, 2013, NEPHROLOGY CARLTON; Rayner HC, 2003, KIDNEY INT, V63, P323, DOI 10.1046/j.1523-1755.2003.00724.x; Shipley T, 2012, NEPHROL DIAL TRANSPL, V27, P261; Spergel LM, 2007, J NEPHROL, V20, P388; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Stolic R, 2013, MED PRIN PRACT, V22, P220, DOI 10.1159/000343669; Su LH, 2009, AM J CHINESE MED, V37, P215, DOI 10.1142/S0192415X09006783; The Nordic Cochrane Centre TCc, 2012, REV MAN REVMAN; Toyokawa H, 2003, EXP BIOL MED, V228, P724, DOI 10.1177/153537020322800612; Tu YP, 2013, LIFE SCI, V92, P35, DOI 10.1016/j.lfs.2012.10.019; W.-C LC-CY, 2012, NEPHR DIAL TRANSPL C	44	17	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104931	10.1371/journal.pone.0104931	http://dx.doi.org/10.1371/journal.pone.0104931			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115802	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230400108
J	Branas-Garza, P; Espin, AM; Neuman, S				Branas-Garza, Pablo; Espin, Antonio M.; Neuman, Shoshana			Religious Pro-Sociality? Experimental Evidence from a Sample of 766 Spaniards	PLOS ONE			English	Article							CULTURAL TRANSMISSION; FERTILITY; TRUST; GOD; PARTICIPATION; EVOLUTION; BELIEFS; REWARDS; REAL	This study explores the relationship between several personal religion-related variables and social behaviour, using three paradigmatic economic games: the dictator (DG), ultimatum (UG), and trust (TG) games. A large carefully designed sample of the urban adult population in Granada (Spain) is employed (N = 766). From participants' decisions in these games we obtain measures of altruism, bargaining behaviour and sense of fairness/equality, trust, and positive reciprocity. Three dimensions of religiosity are examined: (i) religious denomination; (ii) intensity of religiosity, measured by active participation at church services; and (iii) conversion out into a different denomination than the one raised in. The major results are: (i) individuals with "no religion'' made decisions closer to rational selfish behaviour in the DG and the UG compared to those who affiliate with a "standard'' religious denomination; (ii) among Catholics, intensity of religiosity is the key variable that affects social behaviour insofar as religiously-active individuals are generally more pro-social than non-active ones; and (iii) the religion raised in seems to have no effect on pro-sociality, beyond the effect of the current measures of religiosity. Importantly, behaviour in the TG is not predicted by any of the religion-related variables we analyse. While the results partially support the notion of religious pro-sociality, on the other hand, they also highlight the importance of closely examining the multidimensional nature of both religiosity and pro-social behaviour.	[Branas-Garza, Pablo] Middlesex Univ London, Sch Business, London, England; [Espin, Antonio M.] Univ Granada, Dept Teor Hist Econ, Granada, Spain; [Neuman, Shoshana] Bar Ilan Univ, Dept Econ, Ramat Gan, Israel; [Neuman, Shoshana] CEPR, London, England; [Neuman, Shoshana] IZA, Bonn, Germany	Middlesex University; University of Granada; Bar Ilan University; Centre for Economic Policy Research - UK; IZA Institute Labor Economics	Branas-Garza, P (corresponding author), Middlesex Univ London, Sch Business, Hendon Campus, London, England.	branasgarza@gmail.com	Brañas-Garza, Pablo/Q-1532-2018; Espin, Antonio M./AAB-1273-2020; Branas-Garza, Pablo/AAH-8894-2020	Brañas-Garza, Pablo/0000-0001-8456-6009; Branas-Garza, Pablo/0000-0001-8456-6009; Espin Martin, Antonio Manuel/0000-0002-1174-0771	Spanish Ministry of Science and Innovation [ECO2010-17049]; Government of Andalusia Project for Excellence in Research [P07.SEJ.02547]; Ramon Areces Foundation (R+D)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Government of Andalusia Project for Excellence in Research; Ramon Areces Foundation (R+D)	Funding was provided by the Spanish Ministry of Science and Innovation (ECO2010-17049), the Government of Andalusia Project for Excellence in Research (P07.SEJ.02547), and the Ramon Areces Foundation (R+D 2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2009, J SCI STUD RELIG, V48, P368, DOI 10.1111/j.1468-5906.2009.01452.x; Aleksynska M, 2013, REV ECON HOUSEHOLD, V11, P563, DOI 10.1007/s11150-013-9188-7; Andersen S, 2010, J ECON BEHAV ORGAN, V73, P209, DOI 10.1016/j.jebo.2009.09.006; Anderson L, 2010, KYKLOS, V63, P163, DOI 10.1111/j.1467-6435.2010.00456.x; Anderson LR, 2009, ECON LETT, V105, P58, DOI 10.1016/j.econlet.2009.05.016; Ashraf N, 2006, EXP ECON, V9, P193, DOI 10.1007/s10683-006-9122-4; Bar-El R, 2013, J POPUL ECON, V26, P1129, DOI 10.1007/s00148-011-0401-9; Barry JS, 1996, FLAT TAX WOULD AFFEC; Becker G.S., 1993, TREATISE FAMILY, DOI DOI 10.4159/9780674020665; Ben-Ner A, 2010, J ECON PSYCHOL, V31, P64, DOI 10.1016/j.joep.2009.10.001; Benjamin DJ, 2010, RELIG IDENTITY EC BE; Bisin A, 2000, Q J ECON, V115, P955, DOI 10.1162/003355300554953; Bisin A, 2001, J ECON THEORY, V97, P298, DOI 10.1006/jeth.2000.2678; Bisin A, 2004, J POLIT ECON, V112, P615, DOI 10.1086/383101; Branas-Garza P, 2007, REV ECON HOUSEHOLD, V5, P305, DOI DOI 10.1007/S11150-007-9011-4; Branas-Garza P, 2006, EXP ECON, V9, P253, DOI 10.1007/s10683-006-9126-0; Branas-Garza P, 2013, RELIGIONS, V4, P166, DOI 10.3390/rel4010166; Branas-Garza P, 2010, J BEHAV DECIS MAKING, V23, P288, DOI 10.1002/bdm.657; Branas-Garza P, 2009, J MONEY CREDIT BANK, V41, P555, DOI 10.1111/j.1538-4616.2009.00222.x; Brooks AC, 2003, POLICY REV, P121; Cohen-Zada D, 2006, J URBAN ECON, V60, P372, DOI 10.1016/j.jue.2006.04.007; Curry OS, 2008, PERS INDIV DIFFER, V44, P780, DOI 10.1016/j.paid.2007.09.023; Eckel CC, 2003, J PUBLIC ECON, V87, P681, DOI 10.1016/S0047-2727(01)00094-9; Ermisch J, 2009, J R STAT SOC A STAT, V172, P749, DOI 10.1111/j.1467-985X.2009.00591.x; Espin AM, 2013, ESI CHAPMAN WORKING; Espin AM, 2012, P ROY SOC B-BIOL SCI, V279, P4923, DOI 10.1098/rspb.2012.2043; Exadaktylos F, 2013, SCI REPORTS; Fan CS, 2008, J ECON BEHAV ORGAN, V65, P303, DOI 10.1016/j.jebo.2005.11.002; Fernandez R, 2006, J EUR ECON ASSOC, V4, P552, DOI 10.1162/jeea.2006.4.2-3.552; Fernandez R, 2009, AM ECON J-MACROECON, V1, P146, DOI 10.1257/mac.1.1.146; Flanagan J, 1991, SUCCESSFUL FUNDRAISI; Galen LW, 2012, PSYCHOL BULL, V138, P876, DOI 10.1037/a0028251; Garcia-Munoz T, 2013, IZA J MIGR, V2, DOI 10.1186/2193-9039-2-23; Guiso L, 2003, J MONETARY ECON, V50, P225, DOI 10.1016/S0304-3932(02)00202-7; Harrington D, 2005, JESUS VIRTUES ETHICS; Hoffmann R, 2013, J ECON SURV, V27, P813, DOI 10.1111/j.1467-6419.2011.00716.x; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Johnson DP, 2004, POLITICAL THEOLOGY, V5, P159, DOI DOI 10.1558/poth.2004.5.2.159; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; Keister LA, 2003, SOC FORCES, V82, P175, DOI 10.1353/sof.2003.0094; Lagorio CH, 2005, BEHAV PROCESS, V69, P173, DOI 10.1016/j.beproc.2005.02.003; Laurin K, 2012, P ROY SOC B-BIOL SCI, V279, P3272, DOI 10.1098/rspb.2012.0615; McKay R, 2011, P ROY SOC B-BIOL SCI, V278, P1858, DOI 10.1098/rspb.2010.2125; Migheli M, 2012, AM J ECON SOCIOL, V71, P298, DOI 10.1111/j.1536-7150.2012.00838.x; NEUMAN S, 1986, SOCIOL SOC RES, V70, P178; NEUMAN S, 1986, APPL ECON, V18, P1193, DOI 10.1080/00036848600000072; Neuman S, 2007, POP STUD-J DEMOG, V61, P219, DOI 10.1080/00324720701300354; Norenzayan A, 2008, SCIENCE, V322, P58, DOI 10.1126/science.1158757; Paciotti B, 2011, RES EC ANTHR, V31, P267, DOI DOI 10.1108/S0190-1281(2011)0000031014; Pew Research Center's Forum on Religion & Public Life, 2012, GLOB REL LANDSC; Rand DG, 2014, RELIG BRAIN BEHAV, V4, P31, DOI 10.1080/2153599X.2013.775664; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Staffiero G, 2013, ECON LETT, V121, P236, DOI 10.1016/j.econlet.2013.08.021; Tan JHW, 2006, ECON LETT, V90, P60, DOI 10.1016/j.econlet.2005.07.006; Wallis J, 2005, GODS POLITICS	55	16	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104685	10.1371/journal.pone.0104685	http://dx.doi.org/10.1371/journal.pone.0104685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LJ	25115938	gold, Green Published, Green Accepted			2022-12-27	WOS:000341230400068
J	Chee, SMQ; Wongsantichon, J; Tng, QS; Robinson, R; Joseph, TL; Verma, C; Lane, DP; Brown, CJ; Ghadessy, FJ				Chee, Sharon Min Qi; Wongsantichon, Jantana; Tng, Quah Soo; Robinson, Robert; Joseph, Thomas L.; Verma, Chandra; Lane, David P.; Brown, Christopher J.; Ghadessy, Farid J.			Structure of a Stapled Peptide Antagonist Bound to Nutlin-Resistant Mdm2	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PATHWAY; P53 PROTEIN; IN-VIVO; INHIBITION; ACTIVATION; COMPLEX; BINDING; CANCER	As key negative regulator of the p53 tumour suppressor, Mdm2 is an attractive therapeutic target. Small molecules such as Nutlin have been developed to antagonise Mdm2, resulting in p53-dependent death of tumour cells. We have recently described a mutation in Mdm2 (M62A), which precludes binding of Nutlin, but not p53. This Nutlin-resistant variant is not, however, refractory to binding and inhibition by stapled peptide antagonists targeting the same region of Mdm2. A detailed understanding of how stapled peptides are recalcitrant to Mdm2 mutations conferring Nutlin-resistance will aid in the further development of potent Mdm2 antagonists. Here, we report the 2.00 A crystal structure of a stapled peptide antagonist bound to Nutlin resistant Mdm2. The stapled peptide relies on an extended network of interactions along the hydrophobic binding cleft of Mdm2 for high affinity binding. Additionally, as seen in other stapled peptide structures, the hydrocarbon staple itself contributes to binding through favourable interactions with Mdm2. The structure highlights the intrinsic plasticity present in both Mdm2 and the hydrocarbon staple moiety, and can be used to guide future iterations of both small molecules and stapled peptides for improved antagonists of Mdm2.	[Chee, Sharon Min Qi; Tng, Quah Soo; Lane, David P.; Brown, Christopher J.; Ghadessy, Farid J.] ASTAR, P53Lab, Singapore, Singapore; [Wongsantichon, Jantana; Robinson, Robert] ASTAR, Inst Mol & Cellular Biol, Singapore, Singapore; [Joseph, Thomas L.; Verma, Chandra] ASTAR, Bioinformat Inst, Singapore, Singapore; [Verma, Chandra] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Verma, Chandra] Natl Univ Singapore, Sch Biol Sci, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Brown, CJ (corresponding author), ASTAR, P53Lab, Singapore, Singapore.	cjbrown@p53Lab.a-star.edu.sg; fghadessy@p53Lab.a-star.edu.sg	Robinson, Robert/G-9702-2011	Robinson, Robert/0000-0001-6367-6903; Wongsantichon, Jantana/0000-0002-4134-2248; Ghadessy, Farid/0000-0001-8559-903X; Lane, David/0000-0003-0551-3545	Agency for Science Technology and Research (A*STAR), Singapore	Agency for Science Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was funded by the Agency for Science Technology and Research (A*STAR), Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anil B, 2013, ACTA CRYSTALLOGR D, V69, P1358, DOI 10.1107/S0907444913004459; Baek S, 2012, J AM CHEM SOC, V134, P103, DOI 10.1021/ja2090367; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Beroud C, 1997, NUCLEIC ACIDS RES, V25, P138, DOI 10.1093/nar/25.1.138; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Brown CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024122; Brown CJ, 2012, ACS CHEM BIOL; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; Dastidar SG, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S15-S6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kallen J, 2009, J BIOL CHEM, V284, P8803, DOI 10.1074/jbc.M809096200; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; KASTAN MB, 1991, CANCER RES, V51, P6304; Kim YW, 2011, NAT PROTOC, V6, P761, DOI 10.1038/nprot.2011.324; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Lu X, 1996, ONCOGENE, V13, P413; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Phillips C, 2011, J AM CHEM SOC, V133, P9696, DOI 10.1021/ja202946k; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; See HY, 2010, J MOL BIOL, V404, P819, DOI 10.1016/j.jmb.2010.09.063; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081068; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062564; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	39	31	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104914	10.1371/journal.pone.0104914	http://dx.doi.org/10.1371/journal.pone.0104914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115702	Green Published, gold			2022-12-27	WOS:000341230400106
J	Chiavaroli, V; Marcovecchio, ML; de Giorgis, T; Diesse, L; Chiarelli, F; Mohn, A				Chiavaroli, Valentina; Marcovecchio, Maria Loredana; de Giorgis, Tommaso; Diesse, Laura; Chiarelli, Francesco; Mohn, Angelika			Progression of Cardio-Metabolic Risk Factors in Subjects Born Small and Large for Gestational Age	PLOS ONE			English	Article							INSULIN-RESISTANCE; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; PHYSICAL-ACTIVITY; OXIDATIVE STRESS; CHILDHOOD; CHILDREN; GROWTH; BIRTH; SIZE	Background: Subjects born small (SGA) and large (LGA) for gestational age have an increased risk of cardio-metabolic alterations already during prepuberty. Nevertheless, the progression of their cardio-metabolic profile from childhood to adolescence has not been fully explored. Our aim was to assess potential changes in the cardio-metabolic profile from childhood to adolescence in subjects born SGA and LGA compared to those born appropriate (AGA) for gestational age. Methods: This longitudinal study included 35 AGA, 24 SGA and 31 LGA subjects evaluated during childhood (mean age (+/- SD) 8.4 +/- 1.4 yr) and then re-assessed during adolescence (mean age 13.3 +/- 1.8 yr). BMI, blood pressure, insulin resistance (fasting insulin, HOMA-IR) and lipids were assessed. A cardio-metabolic risk z-score was applied and this consisted in calculating the sum of sex-specific z-scores for BMI, blood pressure, HOMA-IR, triglycerides and triglycerides: high-density lipoprotein cholesterol ratio. Results: Fasting insulin and HOMA-IR were higher in SGA and LGA than AGA subjects both during childhood (all P<0.01) and adolescence (all P<0.01). Similarly, the clustered cardio-metabolic risk score was higher in SGA and LGA than AGA children (both P<0.05), and these differences among groups increased during adolescence (both P<0.05). Of note, a progression of the clustered cardio-metabolic risk score was observed from childhood to adolescence within SGA and within LGA subjects (both P<0.05). Conclusions: SGA and LGA subjects showed an adverse cardio-metabolic profile during childhood when compared to AGA peers, with a worsening of this profile during adolescence. These findings indicate an overtime progression of insulin resistance and overall estimated cardiovascular risk from childhood to adolescence in SGA and LGA populations.	[Chiavaroli, Valentina; Marcovecchio, Maria Loredana; de Giorgis, Tommaso; Diesse, Laura; Chiarelli, Francesco; Mohn, Angelika] Univ G dAnnunzio, Dept Paediat, Chieti, Italy; [Chiavaroli, Valentina; Marcovecchio, Maria Loredana; de Giorgis, Tommaso; Chiarelli, Francesco; Mohn, Angelika] Univ G dAnnunzio, G DAnnunzio Univ Fdn, Ctr Excellence Aging, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Chiavaroli, V (corresponding author), Univ G dAnnunzio, Dept Paediat, Chieti, Italy.	valentinachiavaroli@hotmail.it	Chiavaroli, Valentina/ABB-1911-2020	Chiavaroli, Valentina/0000-0003-0555-2173; Maria Loredana, Marcovecchio/0000-0002-4415-316X				Andersen LB, 2008, INT J PEDIATR OBES, V3, P58, DOI 10.1080/17477160801896366; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Boukes FS, 1998, DIAGNOSTICS SHORT ST; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Brouwer SI, 2013, PEDIATR DIABETES, V14, P57, DOI 10.1111/j.1399-5448.2012.00893.x; Brufani C, 2009, J CLIN ENDOCR METAB, V94, P4448, DOI 10.1210/jc.2009-1079; Bueno AC, 2010, EUR J ENDOCRINOL, V162, P53, DOI 10.1530/EJE-09-0697; Bugge A, 2013, PEDIATR RES, V73, P245, DOI 10.1038/pr.2012.158; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Camhi SM, 2010, INT J PEDIATR OBES, V5, P122, DOI 10.3109/17477160903111763; Campbell MK, 2012, PAEDIATR PERINAT EP, V26, P525, DOI 10.1111/j.1365-3016.2012.01319.x; Chiavaroli V, 2009, PEDIATRICS, V124, P695, DOI 10.1542/peds.2008-3056; de Giorgis T, 2014, EUR J ENDOCRINOL, V170, P173, DOI 10.1530/EJE-13-0452; Deng HZ, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-107; Dyer JS, 2007, J CLIN ENDOCR METAB, V92, P3836, DOI 10.1210/jc.2007-0079; Efstathiou SP, 2012, CIRCULATION, V125, P902, DOI 10.1161/CIRCULATIONAHA.111.034546; Espineira AR, 2011, CLIN ENDOCRINOL, V75, P335, DOI 10.1111/j.1365-2265.2011.04054.x; Evagelidou EN, 2006, DIABETES CARE, V29, P1197, DOI 10.2337/dc05-2401; Evagelidou EN, 2010, DIABETES CARE, V33, P2468, DOI 10.2337/dc10-1190; Fabricius-Bjerre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020595; Frontini Maria G, 2004, BMC Pediatr, V4, P22, DOI 10.1186/1471-2431-4-22; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Heinze E, 2003, DIAGNOSTICS ENDOCRIN; Johnson RC, 2011, AM J PUBLIC HEALTH, V101, P2317, DOI 10.2105/AJPH.2011.300252; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Langer O, 2000, CLIN OBSTET GYNECOL, V43, P283, DOI 10.1097/00003081-200006000-00006; Liem ET, 2013, J PEDIATR-US, V162, P287, DOI 10.1016/j.jpeds.2012.07.053; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Mohn A, 2007, J CLIN ENDOCR METAB, V92, P1372, DOI 10.1210/jc.2006-1344; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Norris SA, 2012, DIABETES CARE, V35, P72, DOI 10.2337/dc11-0456; Setayeshgar S, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/276564; Taal HR, 2013, OBESITY, V21, P1261, DOI 10.1002/oby.20116; TANNER JM, 1970, ARCH DIS CHILD, V45, P755, DOI 10.1136/adc.45.244.755; Thorn LM, 2007, DIABETES CARE, V30, P1162, DOI 10.2337/dc06-2033	38	47	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104278	10.1371/journal.pone.0104278	http://dx.doi.org/10.1371/journal.pone.0104278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117750	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400040
J	Yang, SC; Yang, SG; Park, JS; Kirkwood, A; Bao, SW				Yang, Sungchil; Yang, Sunggu; Park, Jae-Sung; Kirkwood, Alfredo; Bao, Shaowen			Failed Stabilization for Long-Term Potentiation in the Auditory Cortex of Fmr1 Knockout Mice	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; CRITICAL PERIOD PLASTICITY; VISUAL-CORTEX; SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; MENTAL-RETARDATION; BARREL CORTEX; IN-VITRO; EXPERIENCE; INDIVIDUALS	Fragile X syndrome is a developmental disorder that affects sensory systems. A null mutation of the Fragile X Mental Retardation protein 1 (Fmr1) gene in mice has varied effects on developmental plasticity in different sensory systems, including normal barrel cortical plasticity, altered ocular dominance plasticity and grossly impaired auditory frequency map plasticity. The mutation also has different effects on long-term synaptic plasticity in somatosensory and visual cortical neurons, providing insights on how it may differentially affect the sensory systems. Here we present evidence that long-term potentiation (LTP) is impaired in the developing auditory cortex of the Fmr1 knockout (KO) mice. This impairment of synaptic plasticity is consistent with impaired frequency map plasticity in the Fmr1 KO mouse. Together, these results suggest a potential role of LTP in sensory map plasticity during early sensory development.	[Yang, Sungchil; Bao, Shaowen] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Yang, Sunggu; Park, Jae-Sung; Kirkwood, Alfredo] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of California System; University of California Berkeley; Johns Hopkins University	Bao, SW (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	sbao@berkeley.edu		Yang, Sunggu/0000-0002-7567-9949; YANG, Sungchil/0000-0003-3408-2019	National Institute of Health [DC009259]; NATIONAL EYE INSTITUTE [R01EY012124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009259] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by National Institute of Health (DC009259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranek Grace T, 2008, Phys Occup Ther Pediatr, V28, P79; Barkat TR, 2011, NAT NEUROSCI, V14, P1189, DOI 10.1038/nn.2882; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Choi SY, 2005, J NEUROSCI, V25, P11433, DOI 10.1523/JNEUROSCI.4084-05.2005; Chun SK, 2013, J NEUROSCI, V33, P7345, DOI 10.1523/JNEUROSCI.4500-12.2013; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Daw MI, 2007, MOL CELL NEUROSCI, V34, P493, DOI 10.1016/j.mcn.2007.01.001; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Finestack LH, 2009, TOP LANG DISORD, V29, P133, DOI 10.1097/TLD.0b013e3181a72016; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Han YK, 2007, NAT NEUROSCI, V10, P1191, DOI 10.1038/nn1941; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Insanally MN, 2009, J NEUROSCI, V29, P5456, DOI 10.1523/JNEUROSCI.5311-08.2009; Jiang B, 2007, J NEUROSCI, V27, P9648, DOI 10.1523/JNEUROSCI.2655-07.2007; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kim H, 2013, J NEUROSCI, V33, P15686, DOI 10.1523/JNEUROSCI.3246-12.2013; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; Kover H, 2013, J NEUROSCI, V33, P3699, DOI 10.1523/JNEUROSCI.3166-12.2013; Kotak VC, 2007, P NATL ACAD SCI USA, V104, P3550, DOI 10.1073/pnas.0607177104; Kudoh M, 1996, EXP BRAIN RES, V110, P21; KUDOH M, 1994, NEUROSCI LETT, V171, P21, DOI 10.1016/0304-3940(94)90594-0; MAFFEI L, 1992, J NEUROSCI, V12, P4651; Miller LJ, 1999, AM J MED GENET, V83, P268, DOI 10.1002/(SICI)1096-8628(19990402)83:4<268::AID-AJMG7>3.0.CO;2-K; Nielsen DM, 2002, BRAIN RES, V927, P8, DOI 10.1016/S0006-8993(01)03309-1; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Petrus E, 2014, NEURON, V81, P664, DOI 10.1016/j.neuron.2013.11.023; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Polley DB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3547; Popescu MV, 2010, NEURON, V65, P718, DOI 10.1016/j.neuron.2010.02.019; Strumbos JG, 2010, J NEUROSCI, V30, P10263, DOI 10.1523/JNEUROSCI.1125-10.2010; Tsiouris JA, 2004, CNS DRUGS, V18, P687, DOI 10.2165/00023210-200418110-00001; Wilson BM, 2007, P NATL ACAD SCI USA, V104, P2454, DOI 10.1073/pnas.0610875104; Yang S, 2013, CEREB CORTEX	40	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104691	10.1371/journal.pone.0104691	http://dx.doi.org/10.1371/journal.pone.0104691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115962	gold, Green Submitted, Green Published			2022-12-27	WOS:000341230400069
J	Fujiwara, Y; Toyoda, M; Chayahara, N; Kiyota, N; Shimada, T; Imamura, Y; Mukohara, T; Minami, H				Fujiwara, Yutaka; Toyoda, Masanori; Chayahara, Naoko; Kiyota, Naomi; Shimada, Takanobu; Imamura, Yoshinori; Mukohara, Toru; Minami, Hironobu			Effects of Aprepitant on the Pharmacokinetics of Controlled-Release Oral Oxycodone in Cancer Patients	PLOS ONE			English	Article							RECEPTOR ANTAGONIST APREPITANT; CYTOCHROME-P450 3A4; PHARMACODYNAMICS; METABOLISM; DEXAMETHASONE	Purpose: Oxycodone is a m-opioid receptor agonist widely used in the treatment of cancer pain. The predominant metabolic pathway of oxycodone is CYP3A4-mediated N-demethylation to noroxycodone, while a minor proportion undergoes 3-O-demethylation to oxymorphone by CYP2D6. The aim of this study was to investigate the effects of the mild CYP3A4 inhibitor aprepitant on the pharmacokinetics of orally administered controlled-release (CR) oxycodone. Method: This study design was an open-label, single-sequence with two phases in cancer patients with pain who continued to be administered orally with multiple doses of CR oxycodone every 8 or 12 hours. Plasma concentration of oxycodone and its metabolites were measured up to 8 hours after administration as follows: on day 1, CR oxycodone was administered alone; on day 2, CR oxycodone was administered with aprepitant (125 mg, at the same time of oxycodone dosing in the morning). The steady-state trough concentrations (Css) were measured from day 1 to day 3. Results: Aprepitant increased the area under the plasma concentration-time curve (AUC(0-8)) of oxycodone by 25% (p<0.001) and of oxymorphone by 34% (p, 0.001), as well as decreased the AUC(0-8) of noroxycodone by 14% (p<0.001). Moreover, aprepitant increased Css of oxycodone by 57% (p = 0.001) and of oxymorphone by 36% (p<0.001) and decreased Css of noroxycodone by 24% (p = 0.02) at day 3 compared to day 1. Conclusions: The clinical use of aprepitant in patients receiving multiple doses of CR oxycodone for cancer pain significantly altered plasma concentration levels, but would not appear to need modification of the CR oxycodone dose.	[Fujiwara, Yutaka; Toyoda, Masanori; Chayahara, Naoko; Kiyota, Naomi; Shimada, Takanobu; Imamura, Yoshinori; Mukohara, Toru; Minami, Hironobu] Kobe Univ, Grad Sch Med, Div Med Oncol Hematol, Kobe, Hyogo 657, Japan; [Mukohara, Toru; Minami, Hironobu] Kobe Univ, Grad Sch Med, Ctr Canc, Kobe, Hyogo 657, Japan; [Fujiwara, Yutaka] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Invest Canc Therapeut, Chiba, Japan	Kobe University; Kobe University; National Cancer Center - Japan	Fujiwara, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Med Oncol Hematol, Kobe, Hyogo 657, Japan.	yutakafu@ncc.go.jp	Kiyota, Naomi/K-3226-2016; Imamura, Yoshinori/ABD-4175-2021; Fujiwara, Yutaka/ABB-4863-2020	Kiyota, Naomi/0000-0001-8021-6116; Fujiwara, Yutaka/0000-0001-6981-0800; Minami, Hironobu/0000-0001-8630-9145; Imamura, Yoshinori/0000-0002-5202-531X	Research on Applying Health Technology from the Ministry of Health, Labour, and Welfare of Japan; Yokoyama-Rinsyo foundation	Research on Applying Health Technology from the Ministry of Health, Labour, and Welfare of Japan; Yokoyama-Rinsyo foundation	This study was supported by a grant for Research on Applying Health Technology from the Ministry of Health, Labour, and Welfare of Japan and Yokoyama-Rinsyo foundation. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Kalso E, 2005, J PAIN SYMPTOM MANAG, V29, pS47, DOI 10.1016/j.jpainsymman.2005.01.010; Kalso E, 2007, PAIN, V132, P227, DOI 10.1016/j.pain.2007.09.027; Lalovic B, 2004, DRUG METAB DISPOS, V32, P447, DOI 10.1124/dmd.32.4.447; Lalovic B, 2006, CLIN PHARMACOL THER, V79, P461, DOI 10.1016/j.clpt.2006.01.009; LEOW KP, 1992, CLIN PHARMACOL THER, V52, P487, DOI 10.1038/clpt.1992.176; LEOW KP, 1995, ANESTH ANALG, V80, P296, DOI 10.1097/00000539-199502000-00016; Loos WJ, 2007, CANCER CHEMOTH PHARM, V59, P407, DOI 10.1007/s00280-006-0359-6; Majumdar AK, 2003, CLIN PHARMACOL THER, V74, P150, DOI 10.1016/S0009-9236(03)00123-1; McCrea JB, 2003, CLIN PHARMACOL THER, V74, P17, DOI 10.1016/S0009-9236(03)00066-3; Merck, 2003, EMEND APR CAPS OR US; National Cancer Center, CANC STAT JAP 2010; Nygren P, 2005, CANCER CHEMOTH PHARM, V55, P609, DOI 10.1007/s00280-004-0946-3; POYHIA R, 1992, BRIT J CLIN PHARMACO, V33, P617, DOI 10.1111/j.1365-2125.1992.tb04090.x; Sanchez RI, 2004, DRUG METAB DISPOS, V32, P1287, DOI 10.1124/dmd.104.000216	14	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104215	10.1371/journal.pone.0104215	http://dx.doi.org/10.1371/journal.pone.0104215			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121773	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000031
J	Jha, V; Workman, CJ; McGaha, TL; Li, LP; Vas, J; Vignali, DAA; Monestier, M				Jha, Vibha; Workman, Creg J.; McGaha, Tracy L.; Li, Liping; Vas, Jaya; Vignali, Dario A. A.; Monestier, Marc			Lymphocyte Activation Gene-3 (LAG-3) Negatively Regulates Environmentally-Induced Autoimmunity	PLOS ONE			English	Article							MERCURY-INDUCED AUTOIMMUNITY; DENDRITIC CELLS; T-CELLS; ANTINUCLEOLAR ANTIBODIES; TRYPTOPHAN CATABOLISM; MOLECULAR ANALYSIS; EFFECTOR FUNCTION; PROTEIN; MICE; PROLIFERATION	Environmental factors including drugs, mineral oils and heavy metals such as lead, gold and mercury are triggers of autoimmune diseases in animal models or even in occupationally exposed humans. After exposure to subtoxic levels of mercury (Hg), genetically susceptible strains of mice develop an autoimmune disease characterized by the production of highly specific anti-nucleolar autoantibodies, hyperglobulinemia and nephritis. However, mice can be tolerized to the disease by a single low dose administration of Hg. Lymphocyte Activation Gene-3 (LAG-3) is a CD4-related, MHC-class II binding molecule expressed on activated T cells and NK cells which maintains lymphocyte homeostatic balance via various inhibitory mechanisms. In our model, administration of anti-LAG-3 monoclonal antibody broke tolerance to Hg resulting in autoantibody production and an increase in serum IgE level. In addition, LAG-3-deficient B6.SJL mice not only had increased susceptibility to Hg-induced autoimmunity but were also unresponsive to tolerance induction. Conversely, adoptive transfer of wild-type CD4(+) T cells was able to partially rescue LAG-3-deficient mice from the autoimmune disease. Further, in LAG-3-deficient mice, mercury elicited higher amounts of IL-6, IL-4 and IFN-gamma, cytokines known to play a critical role in mercury-induced autoimmunity. Therefore, we conclude that LAG-3 exerts an important regulatory effect on autoimmunity elicited by a common environmental pollutant.	[Jha, Vibha; Li, Liping; Vas, Jaya; Monestier, Marc] Temple Univ, Sch Med, Temple Autoimmun Ctr, Philadelphia, PA 19122 USA; [Jha, Vibha; Li, Liping; Vas, Jaya; Monestier, Marc] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19122 USA; [McGaha, Tracy L.] Temple Univ, Sch Med, Rheumatol Sect, Dept Med, Philadelphia, PA 19122 USA; [Workman, Creg J.; Vignali, Dario A. A.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; St Jude Children's Research Hospital	Monestier, M (corresponding author), Temple Univ, Sch Med, Temple Autoimmun Ctr, Philadelphia, PA 19122 USA.	marcm@temple.edu	li, liping/G-3163-2010	li, liping/0000-0001-6407-2589; McGaha, Tracy/0000-0003-4721-9301	National Institutes of Health [ES-12646]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES012646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Institutes of Health Grant ES-12646. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi-Valugerdi M, 2001, SCAND J IMMUNOL, V54, P190, DOI 10.1046/j.1365-3083.2001.00932.x; Arnett FC, 1996, ARTHRITIS RHEUM-US, V39, P1151, DOI 10.1002/art.1780390712; Bagenstose LM, 1998, CLIN EXP IMMUNOL, V114, P9; Bagenstose LM, 1998, J IMMUNOL, V160, P1612; BAIXERAS E, 1992, J EXP MED, V176, P327, DOI 10.1084/jem.176.2.327; Bertrand H, 1995, EUR J IMMUNOL, V25, P2718; Bilsborough J, 2003, IMMUNOLOGY, V108, P481, DOI 10.1046/j.1365-2567.2003.01606.x; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bruniquel D, 1997, IMMUNOGENETICS, V47, P96, DOI 10.1007/s002510050332; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2004, J IMMUNOL, V173, P3748, DOI 10.4049/jimmunol.173.6.3748; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Haggqvist B, 2003, CLIN EXP IMMUNOL, V134, P202, DOI 10.1046/j.1365-2249.2003.02303.x; Hanley GA, 1997, CLIN IMMUNOL IMMUNOP, V84, P328, DOI 10.1006/clin.1997.4405; Hanley GA, 1998, J IMMUNOL, V161, P1778; Havarinasab S, 2009, CLIN EXP IMMUNOL, V155, P567, DOI 10.1111/j.1365-2249.2008.03831.x; Houot R, 2006, J IMMUNOL, V176, P5293, DOI 10.4049/jimmunol.176.9.5293; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; HUARD B, 1994, IMMUNOGENETICS, V39, P213; HULTMAN P, 1992, CLIN IMMUNOL IMMUNOP, V65, P98, DOI 10.1016/0090-1229(92)90212-7; Johansson U, 1997, J AUTOIMMUN, V10, P347, DOI 10.1006/jaut.1997.0149; Kisielow M, 2005, EUR J IMMUNOL, V35, P2081, DOI 10.1002/eji.200526090; Kono DH, 1998, J IMMUNOL, V161, P234; LAUWERYS R, 1983, TOXICOL LETT, V17, P113, DOI 10.1016/0378-4274(83)90045-0; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Li NY, 2004, J IMMUNOL, V173, P6806, DOI 10.4049/jimmunol.173.11.6806; Liang BT, 2008, J IMMUNOL, V180, P5916, DOI 10.4049/jimmunol.180.9.5916; Martin P, 2002, BLOOD, V100, P383, DOI 10.1182/blood.V100.2.383; McGaha TL, 2008, J IMMUNOL, V180, P5670, DOI 10.4049/jimmunol.180.8.5670; Miyazaki T, 1996, SCIENCE, V272, P405, DOI 10.1126/science.272.5260.405; MONESTIER M, 1994, J IMMUNOL, V152, P667; Moszczynski P, 1995, Int J Occup Med Environ Health, V8, P49; OCHEL M, 1991, J IMMUNOL, V146, P3006; Pollard KM, 2005, AUTOIMMUN REV, V4, P282, DOI 10.1016/j.autrev.2004.12.005; Pollard KM, 2003, ANN NY ACAD SCI, V987, P236, DOI 10.1111/j.1749-6632.2003.tb06053.x; Pollard KM, 2001, INT IMMUNOPHARMACOL, V1, P581, DOI 10.1016/S1567-5769(00)00034-5; Pollard KM, 2001, ENVIRON HEALTH PERSP, V109, P27, DOI 10.2307/3434917; Richter K, 2010, INT IMMUNOL, V22, P13, DOI 10.1093/intimm/dxp107; Robinson CJG, 1997, CLIN IMMUNOL IMMUNOP, V83, P127, DOI 10.1006/clin.1997.4336; Schiraldi M, 2009, TRENDS IMMUNOL, V30, P502, DOI 10.1016/j.it.2009.07.005; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Silbergeld Ellen K, 2005, Toxicol Appl Pharmacol, V207, P282, DOI 10.1016/j.taap.2004.11.035; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Vas J, 2008, J IMMUNOL, V181, P6779, DOI 10.4049/jimmunol.181.10.6779; Vas J, 2008, ANN NY ACAD SCI, V1143, P240, DOI 10.1196/annals.1443.022; Via CS, 2003, ENVIRON HEALTH PERSP, V111, P1273, DOI 10.1289/ehp.6064; Workman CJ, 2005, J IMMUNOL, V174, P688, DOI 10.4049/jimmunol.174.2.688; Workman CJ, 2003, EUR J IMMUNOL, V33, P970, DOI 10.1002/eji.200323382; Workman CJ, 2002, EUR J IMMUNOL, V32, P2255, DOI 10.1002/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392; Workman CJ, 2009, J IMMUNOL, V182, P1885, DOI 10.4049/jimmunol.0800185; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhu XF, 2007, GRAEF ARCH CLIN EXP, V245, P1549, DOI 10.1007/s00417-007-0591-8; Ziemba SE, 2009, FASEB J, V23, P1663, DOI 10.1096/fj.08-117283	55	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104484	10.1371/journal.pone.0104484	http://dx.doi.org/10.1371/journal.pone.0104484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122007	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000040
J	Katz, C; Knops, A				Katz, Curren; Knops, Andre			Operational Momentum in Multiplication and Division?	PLOS ONE			English	Article							NUMBER; NUMEROSITY; MAGNITUDE; MOVEMENTS; JUDGMENTS; SHIFTS	Biases are commonly seen in numerical cognition. The operational momentum (OM) effect shows that responses to addition and subtraction problems are biased in the whole-number direction of the operation. It is not known if this bias exists for other arithmetic operations. To determine whether OM exists in scalar operations, we measured response bias in adults performing symbolic (Arabic digits) and non-symbolic (dots) multiplication and division problems. After seeing two operands, with either a multiplication (6) or division (4) sign, participants chose among five response choices. Both non-random performance profiles and the significant contribution of both operands in a multiple regression analysis predicting the chosen values, suggest that adults were able to use numerical information to approximate the outcomes in both notations, though they were more accurate on symbolic problems. Performance on non-symbolic problems was influenced by the size of the correct choice relative to alternatives. Reminiscent of the bias in addition and subtraction, we found a significant response bias for non-symbolic problems. Non-symbolic multiplication problems were overestimated and division problems were underestimated. These results indicate that operational momentum is present in non-symbolic multiplication and division. Given the influence of the size of the correct choice relative to alternatives, an interaction between heuristic bias and approximate calculation is possible.	[Katz, Curren; Knops, Andre] Humboldt Univ, Fac Life Sci, D-10099 Berlin, Germany	Humboldt University of Berlin	Katz, C (corresponding author), Humboldt Univ, Fac Life Sci, D-10099 Berlin, Germany.	curren@post.harvard.edu	Knops, André/D-5457-2013	Knops, André/0000-0001-6357-9951	Deutsche Forschungsgemeinschaft/German Research Council (DFG) [KN 959/2-1]	Deutsche Forschungsgemeinschaft/German Research Council (DFG)(German Research Foundation (DFG))	This work was supported by a grant (KN 959/2-1) from Deutsche Forschungsgemeinschaft/German Research Council (DFG (www.dfg.de) to Andre Knops in support of Curren Katz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCRAFT MH, 1981, MEM COGNITION, V9, P185, DOI 10.3758/BF03202334; Barth H, 2009, J EXP CHILD PSYCHOL, V103, P441, DOI 10.1016/j.jecp.2009.01.014; BERRY DA, 1987, BIOMETRICS, V43, P439, DOI 10.2307/2531826; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Chen Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031180; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 2003, TRENDS COGN SCI, V7, P145, DOI 10.1016/S1364-6613(03)00055-X; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Fischer MH, 2001, NEUROLOGY, V57, P822, DOI 10.1212/WNL.57.5.822; Friedman D, 2009, COGN AFFECT BEHAV NE, V9, P91, DOI 10.3758/CABN.9.1.91; Gebuis T, 2011, BEHAV RES METHODS, V43, P981, DOI 10.3758/s13428-011-0097-5; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; Gilmore CK, 2007, NATURE, V447, P589, DOI 10.1038/nature05850; Gilmore CK, 2010, COGNITION, V115, P394, DOI 10.1016/j.cognition.2010.02.002; Greer B, 1994, DEV MULTIPLICATIVE R, P61; Harvey BM, 2013, SCIENCE, V341, P1123, DOI 10.1126/science.1239052; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Inglis M, 2011, PSYCHON B REV, V18, P1222, DOI 10.3758/s13423-011-0154-1; Izard V, 2008, COGNITION, V106, P1221, DOI 10.1016/j.cognition.2007.06.004; Katz C, 2011, J CLIN PSYCHIAT, V72, P1628, DOI 10.4088/JCP.10m06186blu; Keppel G., 2004, DESIGN ANAL RES HDB; Klein E, 2014, Q J EXP PSYCHOL, V67, P1614, DOI 10.1080/17470218.2014.902976; Knops A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00325; Knops A, 2009, SCIENCE, V324, P1583, DOI 10.1126/science.1171599; Knops A, 2009, ATTEN PERCEPT PSYCHO, V71, P803, DOI 10.3758/APP.71.4.803; LeFevre JA, 1996, J EXP PSYCHOL GEN, V125, P284, DOI 10.1037/0096-3445.125.3.284; Lindemann O, 2011, Z PSYCHOL, V219, P50, DOI 10.1027/2151-2604/a000046; Livingstone MS, 2010, ANIM COGN, V13, P711, DOI 10.1007/s10071-010-0321-1; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; MCCLOSKEY M, 1992, COGNITION, V44, P107, DOI 10.1016/0010-0277(92)90052-J; McCrink K, 2007, PERCEPT PSYCHOPHYS, V69, P1324, DOI 10.3758/BF03192949; McCrink K, 2010, COGNITION, V116, P204, DOI 10.1016/j.cognition.2010.05.003; McCrink K, 2009, J EXP CHILD PSYCHOL, V103, P400, DOI 10.1016/j.jecp.2009.01.013; Ni YJ, 2005, EDUC PSYCHOL-US, V40, P27, DOI 10.1207/s15326985ep4001_3; Nicholls MER, 2008, PSYCHON B REV, V15, P413, DOI 10.3758/PBR.15.2.413; Otto A, 2011, DEV ESSENTIAL UNDERS, P3; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peters E, 2012, CURR DIR PSYCHOL SCI, V21, P31, DOI 10.1177/0963721411429960; Pinhas M, 2008, COGNITION, V109, P408, DOI 10.1016/j.cognition.2008.09.003; Vamvakoussi X, 2012, J MATH BEHAV, V31, P344, DOI 10.1016/j.jmathb.2012.02.001; Vamvakoussi X, 2013, EDUC STUD MATH, V82, P323, DOI 10.1007/s10649-012-9432-8; Xu F, 2005, DEVELOPMENTAL SCI, V8, P88, DOI 10.1111/j.1467-7687.2005.00395.x	45	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104777	10.1371/journal.pone.0104777	http://dx.doi.org/10.1371/journal.pone.0104777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO0QT	25121951	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000060
J	Kling, S; Bekesi, N; Dorronsoro, C; Pascual, D; Marcos, S				Kling, Sabine; Bekesi, Nandor; Dorronsoro, Carlos; Pascual, Daniel; Marcos, Susana			Corneal Viscoelastic Properties from Finite-Element Analysis of In Vivo Air-Puff Deformation	PLOS ONE			English	Article							BIOMECHANICAL PROPERTIES; ELASTOGRAPHY; ARCHITECTURE; ELASTICITY; SCLERA	Biomechanical properties are an excellent health marker of biological tissues, however they are challenging to be measured in-vivo. Non-invasive approaches to assess tissue biomechanics have been suggested, but there is a clear need for more accurate techniques for diagnosis, surgical guidance and treatment evaluation. Recently air-puff systems have been developed to study the dynamic tissue response, nevertheless the experimental geometrical observations lack from an analysis that addresses specifically the inherent dynamic properties. In this study a viscoelastic finite element model was built that predicts the experimental corneal deformation response to an air-puff for different conditions. A sensitivity analysis reveals significant contributions to corneal deformation of intraocular pressure and corneal thickness, besides corneal biomechanical properties. The results show the capability of dynamic imaging to reveal inherent biomechanical properties in vivo. Estimates of corneal biomechanical parameters will contribute to the basic understanding of corneal structure, shape and integrity and increase the predictability of corneal surgery.	[Kling, Sabine; Bekesi, Nandor; Dorronsoro, Carlos; Pascual, Daniel; Marcos, Susana] Inst Opt Daza de Valdes, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Optica (Daza de Valdes)	Marcos, S (corresponding author), Inst Opt Daza de Valdes, Madrid, Spain.	susana@io.cfmac.csic.es	Pascual, Daniel/ABH-2894-2020; Békési, Nándor/A-6812-2010; Dorronsoro, Carlos/A-2297-2011; Dorronsoro, Carlos/AAC-8003-2019	Békési, Nándor/0000-0001-7532-9589; Dorronsoro, Carlos/0000-0001-5968-1128; Dorronsoro, Carlos/0000-0001-5968-1128; Kling, Sabine/0000-0001-7202-7200	Spanish Government [FIS2011-25637]; European Research Council ERC [AdG-294099];  [FPI-BES-2009-024560]	Spanish Government(Spanish GovernmentEuropean Commission); European Research Council ERC(European Research Council (ERC)European Commission); 	Spanish Government FIS2011-25637, European Research Council ERC-2011 AdG-294099 to SM. FPI-BES-2009-024560 Pre-doctoral Fellowship to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastrue V, 2006, J BIOMECH ENG-T ASME, V128, P150, DOI 10.1115/1.2132368; Alexander RM, 2002, COMP BIOCHEM PHYS A, V133, P1001; ANDREASSEN TT, 1980, EXP EYE RES, V31, P435, DOI 10.1016/S0014-4835(80)80027-3; Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Boyce BL, 2007, J BIOMECH, V40, P2367, DOI 10.1016/j.jbiomech.2006.12.001; Boyer G, 2012, MED ENG PHYS, V34, P172, DOI 10.1016/j.medengphy.2011.07.007; Bron AJ, 2001, BRIT J OPHTHALMOL, V85, P379, DOI 10.1136/bjo.85.4.379; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chang EW, 2012, OPT LETT, V37, P3678, DOI 10.1364/OL.37.003678; Chao CYL, 2011, WOUND REPAIR REGEN, V19, P324, DOI 10.1111/j.1524-475X.2011.00694.x; Dorronsoro C, 2012, BIOMED OPT EXPRESS, V3, P473, DOI 10.1364/BOE.3.000473; Downs JC, 2005, INVEST OPHTH VIS SCI, V46, P540, DOI 10.1167/iovs.04-0114; Dupps WJ, 2006, EXP EYE RES, V83, P709, DOI 10.1016/j.exer.2006.03.015; Elsheikh A, 2007, CURR EYE RES, V32, P11, DOI 10.1080/02713680601077145; Fleury V, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021920; Ford M, 2006, J BIOMED OPT; Garcia-Ramos F. J., 2005, Spanish Journal of Agricultural Research, V3, P61; Grabner G, 2005, J CATARACT REFR SURG, V31, P163, DOI 10.1016/j.jcrs.2004.09.042; Hennighausen H, 1998, INVEST OPHTH VIS SCI, V39, P253; Hon Y, 2013, OPTOMETRY VISION SCI, V90, pE1, DOI 10.1097/OPX.0b013e318279eb87; Kampmeier J, 2000, CORNEA, V19, P355, DOI 10.1097/00003226-200005000-00020; Kerautret J, 2008, J CATARACT REFR SURG, V34, P510, DOI 10.1016/j.jcrs.2007.11.018; Kling S, 2013, INVEST OPHTH VIS SCI, V54, P5078, DOI 10.1167/iovs.13-12509; Kling S, 2013, J REFRACT SURG, V29, P490, DOI 10.3928/1081597X-20130617-08; Knudson D., 2007, FUNDAMENTALS BIOMECH; Lee YS, 2008, POULTRY SCI, V87, P1451, DOI 10.3382/ps.2007-00463; Litwiller DV, 2010, J MAGN RESON IMAGING, V32, P44, DOI 10.1002/jmri.22217; Metzler KM, 2013, INVEST OPHTH VIS SCI, V237, pE; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Nguyen TD, 2011, BIOMECH MODEL MECHAN, V10, P323, DOI 10.1007/s10237-010-0237-3; Olsen TW, 2002, INVEST OPHTH VIS SCI, V43, P2529; PINSKY PM, 1991, J BIOMECH, V24, P907, DOI 10.1016/0021-9290(91)90169-N; Roy AS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002934; Scarcelli G, 2008, NAT PHOTONICS, V2, P39, DOI 10.1038/nphoton.2007.250; Seiler T, 2006, CORNEA, V25, P1057, DOI 10.1097/01.ico.0000225720.38748.58; Shah S, 2007, INVEST OPHTH VIS SCI, V48, P3026, DOI 10.1167/iovs.04-0694; Sporl E, 1997, OPHTHALMOLOGE, V94, P902, DOI 10.1007/s003470050219; Swan L, 2012, FRESH INTERDISCIPLIN; Tanter M, 2009, IEEE T MED IMAGING, V28, P1881, DOI 10.1109/TMI.2009.2021471; Wang HC, 1996, J BIOMECH, V29, P1633, DOI 10.1016/S0021-9290(96)80017-0; Wang S, 2012, OPT LETT, V37, P5184, DOI 10.1364/OL.37.005184; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3	42	71	73	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104904	10.1371/journal.pone.0104904	http://dx.doi.org/10.1371/journal.pone.0104904			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121496	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000071
J	Li, Y; Ma, X; Zhao, ML; Qi, P; Zhong, JG				Li, Ying; Ma, Xiao; Zhao, Minglu; Qi, Pan; Zhong, Jingang			Quick and Label-Free Detection for Coumaphos by Using Surface Plasmon Resonance Biochip	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; ORGANOPHOSPHORUS INSECTICIDE FENTHION; LINKED-IMMUNOSORBENT-ASSAY; THIN-LAYER-CHROMATOGRAPHY; LIQUID-CHROMATOGRAPHY; PESTICIDE-RESIDUES; GAS-CHROMATOGRAPHY; APIS-MELLIFERA; HONEY SAMPLES; IMMUNOASSAY	Coumaphos is a common organophosphorus pesticide used in agricultural products. It is harmful to human health and has a strictly stipulated maximum residue limit (MRL) on fruits and vegetables. Currently existing methods for detection are complex in execution, require expensive tools and are time consuming and labor intensive. The surface plasmon resonance method has been widely used in biomedicine and many other fields. This study discusses a detection method based on surface plasmon resonance in organophosphorus pesticide residues. As an alternative solution, this study proposes a method to detect Coumaphos. The method, which is based on surface plasmon resonance (SPR) and immune reaction, belongs to the suppression method. A group of samples of Coumaphos was detected by this method. The concentrations of Coumaphos in the samples were 0 mu g/L, 50 mu g/L, 100 mu g/L, 300 mu g/L, 500 mu g/L, 1000 mu g/L, 3000 mu g/L and 5000 mu g/L, respectively. Through detecting a group of samples, the process of kinetic reactions was analyzed and the corresponding standard curve was obtained. The sensibility is less than 25 mu g/L, conforming to the standard of the MRL of Coumaphos stipulated by China. This method is label- free, using an unpurified single antibody only and can continuously test at least 80 groups of samples continuously. It has high sensitivity and specificity. The required equipments are simple, environmental friendly and easy to control. So this method is promised for a large number of samples quick detection on spot and for application prospects.	[Li, Ying; Zhong, Jingang] Jinan Univ, Guangdong Higher Educ Inst, Key Lab Optoelect Informat & Sensing Technol, Guangzhou, Guangdong, Peoples R China; [Li, Ying] Jinan Univ, Preuniv Dept, Guangzhou, Guangdong, Peoples R China; [Ma, Xiao; Zhao, Minglu; Zhong, Jingang] Jinan Univ, Dept Optoelect Engn, Guangzhou, Guangdong, Peoples R China; [Qi, Pan] Guangdong Commun Polytech, Dept Elect Engn, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University	Zhong, JG (corresponding author), Jinan Univ, Guangdong Higher Educ Inst, Key Lab Optoelect Informat & Sensing Technol, Guangzhou, Guangdong, Peoples R China.	tzjg@jnu.edu.cn			National Natural Science Foundation of China (NSFC) [41206081]; Key Laboratory of Integrated Marine Monitoring, Guangdong Natural Science Foundation [8451063201000076]; Applied Technologies for Harmful Algal Blooms [MATHAB20120208]; breakthroughs in key areas of Guangdong and Hong Kong [2005A20501001]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Laboratory of Integrated Marine Monitoring, Guangdong Natural Science Foundation; Applied Technologies for Harmful Algal Blooms; breakthroughs in key areas of Guangdong and Hong Kong	This work was supported by National Natural Science Foundation of China (NSFC) under the Grant No. 41206081, Key Laboratory of Integrated Marine Monitoring, Guangdong Natural Science Foundation under the Grant No. 8451063201000076, and Applied Technologies for Harmful Algal Blooms under the Grant No. MATHAB20120208, and breakthroughs in key areas of Guangdong and Hong Kong tender No. 2005A20501001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albero B, 2004, J AGR FOOD CHEM, V52, P5828, DOI 10.1021/jf049470t; Balayiannis G, 2008, ARCH ENVIRON CON TOX, V55, P462, DOI 10.1007/s00244-007-9126-x; Brun EM, 2004, J IMMUNOL METHODS, V295, P21, DOI 10.1016/j.jim.2004.08.014; BUTZ S, 1995, ANAL CHEM, V67, P620, DOI 10.1021/ac00099a021; Choudhary A, 2008, B ENVIRON CONTAM TOX, V80, P417, DOI 10.1007/s00128-008-9426-5; Dai Z, 2012, ANAL CHEM, V84, P8157, DOI 10.1021/ac301217s; Das YK, 2009, B ENVIRON CONTAM TOX, V83, P378, DOI 10.1007/s00128-009-9778-5; Eddleston M, 2002, QJM-INT J MED, V95, P275, DOI 10.1093/qjmed/95.5.275; EVERSOLE JW, 1965, J ECON ENTOMOL, V58, P709, DOI 10.1093/jee/58.4.709; Famiglini G, 2009, ANAL CHEM, V81, P7373, DOI 10.1021/ac9008995; Grimalt S, 2006, J AGR FOOD CHEM, V54, P1188, DOI 10.1021/jf052737j; HILL E F, 1982, Environmental Toxicology and Chemistry, V1, P27, DOI 10.1897/1552-8618(1982)1[27:APOBFM]2.0.CO;2; Huang Z, 2001, AM BEE J, V141, P730; Janotta M, 2003, ANAL CHIM ACTA, V496, P339, DOI 10.1016/S0003-2670(03)01011-0; Jimenez JJ, 1998, J CHROMATOGR A, V829, P269, DOI 10.1016/S0021-9673(98)00826-7; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Kim YJ, 2003, ANAL CHIM ACTA, V494, P29, DOI 10.1016/j.aca.2003.07.003; Kuo YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022382; LAWRENCE JF, 1976, J CHROMATOGR, V121, P343, DOI 10.1016/S0021-9673(00)85032-3; Li Y, 2014, EUR FOOD RES TECHNOL, V239, P195, DOI 10.1007/s00217-014-2201-4; MARRS TC, 1993, PHARMACOL THERAPEUT, V58, P51, DOI 10.1016/0163-7258(93)90066-M; Ministry of Health PR China Standardization Administration of the PR China, 2012, 27632012 GB MIN HLTH; Moeller N, 2007, EUR FOOD RES TECHNOL, V224, P285, DOI 10.1007/s00217-006-0392-z; Nogues C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012152; Pang GF, 2006, FOOD ADDIT CONTAM A, V23, P777, DOI 10.1080/02652030600657997; Pardio VT, 2007, J ENVIRON SCI HEAL B, V42, P359, DOI 10.1080/03601230701310500; POPENDORF WJ, 1982, RESIDUE REV, V82, P125; Rissato SR, 2007, FOOD CHEM, V101, P1719, DOI 10.1016/j.foodchem.2005.10.034; Sannino A, 2004, J CHROMATOGR A, V1036, P161, DOI 10.1016/j.chroma.2004.02.078; SAVAGE EP, 1988, ARCH ENVIRON HEALTH, V43, P38, DOI 10.1080/00039896.1988.9934372; Skerl MIS, 2009, B ENVIRON CONTAM TOX, V83, P374, DOI 10.1007/s00128-009-9762-0; Tanner PA, 1996, APPL SPECTROSC, V50, P565, DOI 10.1366/0003702963905781; Viveros L, 2006, SENSOR ACTUAT B-CHEM, V115, P150, DOI 10.1016/j.snb.2005.08.032; Weick J, 2002, J ECON ENTOMOL, V95, P227, DOI 10.1603/0022-0493-95.2.227; Xu ZL, 2011, ANAL CHIM ACTA, V708, P123, DOI 10.1016/j.aca.2011.09.040; Yavuz H, 2010, ENVIRON MONIT ASSESS, V168, P277, DOI 10.1007/s10661-009-1111-6; Yin GH, 2009, APPL MICROBIOL BIOT, V84, P323, DOI 10.1007/s00253-009-1967-y	37	2	3	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104689	10.1371/journal.pone.0104689	http://dx.doi.org/10.1371/journal.pone.0104689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122502	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000056
J	Lynch, AE; Triajianto, J; Routledge, E				Lynch, Adam E.; Triajianto, Junian; Routledge, Edwin			Low-Cost Motility Tracking System (LOCOMOTIS) for Time-Lapse Microscopy Applications and Cell Visualisation	PLOS ONE			English	Article							MIGRATION; ROBUST; VITRO; ASSAY	Direct visualisation of cells for the purpose of studying their motility has typically required expensive microscopy equipment. However, recent advances in digital sensors mean that it is now possible to image cells for a fraction of the price of a standard microscope. Along with low-cost imaging there has also been a large increase in the availability of high quality, open-source analysis programs. In this study we describe the development and performance of an expandable cell motility system employing inexpensive, commercially available digital USB microscopes to image various cell types using time-lapse and perform tracking assays in proof-of-concept experiments. With this system we were able to measure and record three separate assays simultaneously on one personal computer using identical microscopes, and obtained tracking results comparable in quality to those from other studies that used standard, more expensive, equipment. The microscopes used in our system were capable of a maximum magnification of 413.6x. Although resolution was lower than that of a standard inverted microscope we found this difference to be indistinguishable at the magnification chosen for cell tracking experiments (206.86x). In preliminary cell culture experiments using our system, velocities (mean mu m/min +/- SE) of 0.81 +/- 0.01 (Biomphalaria glabrata hemocytes on uncoated plates), 1.17 +/- 0.004 (MDA-MB-231 breast cancer cells), 1.24 +/- 0.006 (SC5 mouse Sertoli cells) and 2.21 +/- 0.01 (B. glabrata hemocytes on Poly-L-Lysine coated plates), were measured and are consistent with previous reports. We believe that this system, coupled with open-source analysis software, demonstrates that higher throughput time-lapse imaging of cells for the purpose of studying motility can be an affordable option for all researchers.	[Lynch, Adam E.; Routledge, Edwin] Brunel Univ, Inst Environm, London, England; [Triajianto, Junian] Karang Menjangan, Surabaya, Indonesia	Brunel University	Lynch, AE (corresponding author), Brunel Univ, Inst Environm, London, England.	adam.e.lynch@gmail.com	Routledge, Edwin John/V-2336-2019; Routledge, Edwin/AGI-0283-2022	Routledge, Edwin/0000-0001-7695-364X	National Environmental Research Council [R81081]; Natural Environment Research Council [990957] Funding Source: researchfish	National Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	AL received funding from a "National Environmental Research Council'' doctoral training grant. Code: R81081. http://www.nerc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishara W, 2011, SPIE NEWSROOM, DOI [10.1117/2.1201107.003812, DOI 10.1117/2.1201107.003812]; Boehmler AM, 1996, J PARASITOL, V82, P332, DOI 10.2307/3284173; Brown L., 2009, IMAGING PARTICLE ANA; Buggenthin F, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-297; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Cardona A, 2012, NAT METHODS, V9, P661, DOI 10.1038/nmeth.2082; CHERNIN E, 1963, J PARASITOL, V49, P353, DOI 10.2307/3275797; Coutu DL, 2013, J CELL SCI, V126, P3805, DOI 10.1242/jcs.118349; Dai LS, 2005, EXP CELL RES, V311, P272, DOI 10.1016/j.yexcr.2005.09.013; Frigault MM, 2009, J CELL SCI, V122, P753, DOI 10.1242/jcs.033837; Fryer Sarah E., 1995, Fish Immunology Technical Communications, V4, P123; Gough AH, 2007, METH MOL B, V356, P41; Ho CL, 2005, BIOTECHNIQUES, V38, P267, DOI 10.2144/05382RR03; HOFMANN MC, 1992, EXP CELL RES, V201, P417, DOI 10.1016/0014-4827(92)90291-F; Hulkower Keren I, 2011, Pharmaceutics, V3, P107, DOI 10.3390/pharmaceutics3010107; Huth J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-24; Irimia D, 2009, INTEGR BIOL, V1, P506, DOI 10.1039/b908595e; Kim SB, 2012, LAB CHIP, V12, P3976, DOI 10.1039/c2lc40345e; Li K., 2008, IMAGE STABILIZER PLU; Linder E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002547; Mak M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020825; Meijering E, 2009, SEMIN CELL DEV BIOL, V20, P894, DOI 10.1016/j.semcdb.2009.07.004; Muinonen-Martin AJ, 2013, METHODS MOL BIOL, V1046, P307, DOI 10.1007/978-1-62703-538-5_18; Onuki-Nagasaki R, 2008, LAB CHIP, V8, P1502, DOI 10.1039/b803879a; Patlak M, 2010, J NATL CANCER I, V102, P1221, DOI 10.1093/jnci/djq321; Pujic Z, 2009, COMB CHEM HIGH T SCR, V12, P580, DOI 10.2174/138620709788681952; Sellaro TL, 2013, J PATHOL INFORM, V4, P21, DOI DOI 10.4103/2153-3539.116866; Smith ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017150; Su TW, 2010, ANAL CHEM, V82, P8307, DOI 10.1021/ac101845q; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; Wang SJ, 2004, EXP CELL RES, V300, P180, DOI 10.1016/j.yexcr.2004.06.030; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005; Zheng GA, 2010, LAB CHIP, V10, P3125, DOI [10.1039/c01c00213e, 10.1039/c0lc00213e]; Zheng Q, 2013, J PHARM CLIN TOXICOL, V1, P1001; Zimic M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009577	36	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103547	10.1371/journal.pone.0103547	http://dx.doi.org/10.1371/journal.pone.0103547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121722	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000017
J	Mezei, T; Contac, A; Iacob, A; Egyed-Zsigmond, I				Mezei, Tibor; Contac, Anca; Iacob, Alina; Egyed-Zsigmond, Imre			Making Mock-FNA Smears from Fresh Surgical Pathology Specimens to Improve Smear Preparation Technique and to Create Cytohistological Correlation Series	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; SALIVARY-GLAND; CYTOLOGY; BIOPSY; EXPERIENCE; LESIONS	Background: Fine needle aspiration (FNA) cytology is a well-established diagnostic method based on the microscopic interpretation of often scant cytological material; therefore, experience, good technique and smear quality are equally important in obtaining satisfactory results. Aims of Study: We studied the use of fresh surgical pathology specimens for making so-called mock-FNA smears with the potential of cytohistological correlation. Additionally, we studied how this process aids the improvement of preparation technique and smear quality. Methods: Cytological aspirates from 32 fresh biopsy specimens from various sites: lung (20), lymph nodes (6), and breast (6) were obtained, all with a clinical diagnosis of tumor. Aspiration was performed from grossly palpable tumors. 25G needle and Cameco-type syringe holder was used with minimal or no suction. Results: Unfixed surgical specimens provided sufficient cytological material that resulted in good quality smears. After standard processing of specimens into microscopic sections from paraffin embedded tissues, cytohistological case-series were created. No significant alteration was reported in tissue architecture on hematoxylin-eosin stained sections after the aspiration procedure. A gradual, but steady improvement was observed in smear quality just after a few preparations. Discussions and Conclusions: Our study proved that surgical specimens may be used as a source of cytological material to create cytohistological correlation studies and also to improve FNA cytology skills. The use of very fine gauge needle (25G, 0,6 mm diameter) during the sampling process does not alter tissue architecture therefore the final histopathological diagnosis is not compromised. We conclude that by using fresh surgical specimens useful cytohistological collections can be created both as a teaching resource and as improving experience.	[Mezei, Tibor; Contac, Anca; Egyed-Zsigmond, Imre] Univ Med & Pharm Tirgu Mures, Dept Pathol, Targu Mures, Romania; [Iacob, Alina] Univ Med & Pharm Tirgu Mures, Dept Head & Neck Surg, Targu Mures, Romania	George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures; George Emil Palade University of Medicine, Pharmacy, Science, & Technology of Targu Mures	Mezei, T (corresponding author), Univ Med & Pharm Tirgu Mures, Dept Pathol, Targu Mures, Romania.	tmezei@pathologia.ro	Mezei, Tibor/A-7050-2012	Mezei, Tibor/0000-0001-5150-7993				Baruah BP, 2010, BRIT J SURG, V97, P680, DOI 10.1002/bjs.6964; Boccato P, 1998, ACTA CYTOL, V42, P888, DOI 10.1159/000331964; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Das DK, 2003, DIAGN CYTOPATHOL, V28, P345, DOI 10.1002/dc.10289; Diamantis A, 2009, FOLIA HISTOCHEM CYTO, V47, P191, DOI 10.2478/v10042-009-0027-x; El Hag IA, 2003, ACTA CYTOL, V47, P387, DOI 10.1159/000326538; Fritscher-Ravens Annette, 2013, Gastroenterol Hepatol (N Y), V9, P380; Greif J, 1999, ACTA CYTOL, V43, P756, DOI 10.1159/000331287; Kolonic SO, 2010, COLLEGIUM ANTROPOL, V34, P75; Kumar N, 2011, J CYTOL, V28, P49, DOI 10.4103/0970-9371.80727; Marthur S, 2007, INDIAN J PATHOL MICR, V50, P46; Seiberling KA, 2008, LARYNGOSCOPE, V118, P228, DOI 10.1097/MLG.0b013e318157465d; Sellami M, 2011, EUR ANN OTORHINOLARY, V128, P159, DOI 10.1016/j.anorl.2011.01.003; Shidham VB, 2009, J VIS EXP JOVE; Siddig E, 2014, BIOTECH HISTOCHEM, V89, P241, DOI 10.3109/10520295.2013.863971; STANLEY MW, 1993, FINE NEEDLE ASPIRATI; Stewart CJR, 2000, DIAGN CYTOPATHOL, V22, P139	17	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104983	10.1371/journal.pone.0104983	http://dx.doi.org/10.1371/journal.pone.0104983			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121972	gold, Green Submitted, Green Published			2022-12-27	WOS:000341017000081
J	Park, SA; Raghunathan, VK; Shah, NM; Teixeira, L; Motta, MJ; Covert, J; Dubielzig, R; Schurr, M; Isseroff, RR; Abbott, NL; McAnulty, J; Murphy, CJ				Park, Shin Ae; Raghunathan, Vijay Krishna; Shah, Nihar M.; Teixeira, Leandro; Motta, Monica J.; Covert, Jill; Dubielzig, Richard; Schurr, Michael; Isseroff, Roslyn Rivkah; Abbott, Nicholas L.; McAnulty, Jonathan; Murphy, Christopher J.			PDGF-BB Does Not Accelerate Healing in Diabetic Mice with Splinted Skin Wounds	PLOS ONE			English	Article							GROWTH FACTOR-BB; IN-VITRO; CELL-PROLIFERATION; KERATINOCYTES; BETA; FGF; DIFFERENTIATION; ANGIOGENESIS; EXPRESSION; MIGRATION	Topical application of platelet-derived growth factor-BB (PDGF-BB) is considered to accelerate tissue repair of impaired chronic wounds. However, the vast literature is plagued with conflicting reports of its efficacy in animal models and this is often influenced by a wide array of experimental variables making it difficult to compare the results across the studies. To mitigate the confounding variables that influence the efficacy of topically applied PDGF-BB, we used a controlled full thickness splinted excisional wound model in db/db mice (type 2 diabetic mouse model) for our investigations. A carefully-defined silicone-splinted wound model, with reduced wound contraction, controlled splint and bandage maintenance, allowing for healing primarily by reepithelialization was employed. Two splinted 8 mm dorsal full thickness wounds were made in db/db mice. Wounds were topically treated once daily with either 3 mu g PDGF-BB in 30 mu l of 5% PEG-PBS vehicle or an equal volume of vehicle for 10 days. Body weights, wound contraction, wound closure, reepithelialization, collagen content, and wound bed inflammation were evaluated clinically and histopathologically. The bioactivity of PDGF-BB was confirmed by in vitro proliferation assay. PDGF-BB, although bioactive in vitro, failed to accelerate wound healing in vivo in the db/db mice using the splinted wound model. Considering that the predominant mechanism of wound healing in humans is by re-epeithelialization, the most appropriate model for evaluating therapeutics is one that uses splints to prevent excessive wound contraction. Here, we report that PDGF-BB does not promote wound closure by reepithelialization in a murine splinted wound model. Our results highlight that the effects of cytoactive factors reported in vivo ought to be carefully interpreted with critical consideration of the wound model used.	[Park, Shin Ae; Raghunathan, Vijay Krishna; Shah, Nihar M.; Motta, Monica J.; Covert, Jill; Murphy, Christopher J.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Teixeira, Leandro; Dubielzig, Richard] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Schurr, Michael] Univ Colorado, Dept Surg, Denver, CO 80202 USA; [Isseroff, Roslyn Rivkah] Univ Calif Davis, Sch Med, Dept Dermatol, Davis, CA 95616 USA; [Isseroff, Roslyn Rivkah] VA Northern Calif Hlth Care Syst, Mather, CA USA; [Abbott, Nicholas L.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI USA; [McAnulty, Jonathan] Univ Wisconsin, Sch Vet Med, Dept Surg Sci, Madison, WI 53706 USA; [Murphy, Christopher J.] Univ Calif Davis, Sch Med, Davis, CA 95616 USA	University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Denver; University of California System; University of California Davis; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis	Murphy, CJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA.	murphyc@corl.vetmed.wisc.edu	Isseroff, Roslyn Rivkah/AAD-8478-2021; Raghunathan, Vijaykrishna/D-2911-2015; Teixeira, Leandro/AAU-6094-2021; Teixeira, Leandro B C/H-9272-2015	Isseroff, Roslyn Rivkah/0000-0001-7813-0858; Raghunathan, Vijaykrishna/0000-0003-1702-591X; Teixeira, Leandro/0000-0001-9960-678X; Teixeira, Leandro B C/0000-0001-9960-678X	National Institutes of Health [RC2AR058971]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC2AR058971] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The project described was supported by National Institutes of Health grant number RC2AR058971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSON S, 1993, SURGERY, V114, P368; Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Blom IE, 2001, NEPHROL DIAL TRANSPL, V16, P1139, DOI 10.1093/ndt/16.6.1139; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brown KRS, 2001, AM J PHYSIOL-LUNG C, V281, pL1001, DOI 10.1152/ajplung.2001.281.4.L1001; BROWN RL, 1994, J SURG RES, V56, P562, DOI 10.1006/jsre.1994.1090; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Cantero AV, 2007, FASEB J, V21, P3096, DOI 10.1096/fj.06-7536com; Chan RK, 2006, J BURN CARE RES, V27, P202, DOI 10.1097/01.BCR.0000202898.11277.58; Fan BS, 2011, GENE; Fang RC, 2008, J BIOMAT SCI-POLYM E, V19, P989, DOI 10.1163/156856208784909327; Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Greenhalgh David G., 1993, Wound Repair and Regeneration, V1, P69; Greenhalgh DG, 2003, METH MOLEC MED, V78, P181; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hardwicke J, 2011, BRIT J SURG, V98, pE11; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Judith R, 2010, LIFE SCI, V87, P1, DOI 10.1016/j.lfs.2010.05.003; Kim SJ, 2007, GROWTH FACTORS, V25, P77, DOI 10.1080/08977190701398977; Koria P, 2012, BIODRUGS, V26, P163, DOI 10.2165/11631850-000000000-00000; Lindblad WJ, 2008, J BIOMAT SCI-POLYM E, V19, P1087, DOI 10.1163/156856208784909390; Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8; Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muangman P, 2004, WOUND REPAIR REGEN, V12, P44, DOI 10.1111/j.1067-1927.2004.012110.x-1; Nass N, 2010, INT J BIOCHEM CELL B, V42, P749, DOI 10.1016/j.biocel.2010.01.012; Portero-Otin M, 2002, DIABETES, V51, P1535, DOI 10.2337/diabetes.51.5.1535; Raghunathan VK, 2013, BIOMATERIALS, V34, P3559, DOI 10.1016/j.biomaterials.2013.01.085; RANKIN S, 1994, J BIOL CHEM, V269, P704; Rende M, 2000, INT J DEV NEUROSCI, V18, P869, DOI 10.1016/S0736-5748(00)00041-1; Robson MC, 2005, WOUND HEALING, P491; Saaristo A, 2006, AM J PATHOL, V169, P1080, DOI 10.2353/ajpath.2006.051251; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Schoop VM, 1999, J INVEST DERMATOL, V112, P343, DOI 10.1046/j.1523-1747.1999.00524.x; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Senter Lucy H., 1995, Wound Repair and Regeneration, V3, P351, DOI 10.1046/j.1524-475X.1995.30316.x; Skobe M, 1998, P NATL ACAD SCI USA, V95, P1050, DOI 10.1073/pnas.95.3.1050; Smiell JM, 1999, WOUND REPAIR REGEN, V7, P335, DOI 10.1046/j.1524-475X.1999.00335.x; SPRUGEL KH, 1987, AM J PATHOL, V129, P601; Tkalcevic VI, 2009, TOXICOL PATHOL, V37, P183, DOI 10.1177/0192623308329280; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; TSUBOI R, 1995, J INVEST DERMATOL, V104, P199, DOI 10.1111/1523-1747.ep12612755; Uhl E, 2003, WOUND REPAIR REGEN, V11, P361, DOI 10.1046/j.1524-475X.2003.11508.x; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6; Yoshikawa Y, 2001, ACTA ORTHOP SCAND, V72, P287, DOI 10.1080/00016470152846646; Yu JH, 2001, BIOCHEM BIOPH RES CO, V282, P697, DOI 10.1006/bbrc.2001.4622	52	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104447	10.1371/journal.pone.0104447	http://dx.doi.org/10.1371/journal.pone.0104447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121729	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000038
J	Habis, M; Wroblewski, K; Bradaric, M; Ismail, N; Yamada, SD; Litchfield, L; Lengyel, E; Romero, IL				Habis, Mohammed; Wroblewski, Kristen; Bradaric, Michael; Ismail, Nadia; Yamada, S. Diane; Litchfield, Lacey; Lengyel, Ernst; Romero, Iris L.			Statin Therapy Is Associated with Improved Survival in Patients with Non-Serous-Papillary Epithelial Ovarian Cancer: A Retrospective Cohort Analysis	PLOS ONE			English	Article							CELL-LINES; PERITONEAL DISSEMINATION; COLORECTAL-CANCER; BREAST-CANCER; RISK; LOVASTATIN; INHIBITION; CARCINOMA; APOPTOSIS; GROWTH	Aim: To determine whether statin use is associated with improved epithelial ovarian cancer (OvCa) survival. Methods: This is a single-institution retrospective cohort review of patients treated for OvCa between 1992 and 2013. Inclusion criteria were International Federation of Gynecology and Obstetrics (FIGO) stage I-IV OvCa. The primary exposures analyzed were hyperlipidemia and statin use. The primary outcomes were progression-free survival (PFS) and disease-specific survival (DSS). Results: 442 patients met inclusion criteria. The cohort was divided into three groups: patients with hyperlipidemia who used statins (n = 68), patients with hyperlipidemia who did not use statins (n = 28), and patients without hyperlipidemia (n = 346). OvCa outcomes were evaluated. When we analyzed the entire cohort, we found no significant differences in PFS or DSS among the groups. The median PFS for hyperlipidemics using statins, hyperlipidemics not using statins, and non-hyperlipidemics was 21.7, 13.6, and 14.7 months, respectively (p = 0.69). Median DSS for hyperlipidemics using statins, hyperlipidemics not using statins, and non-hyperlipidemics was 44.2, 75.7, and 41.5 months, respectively (p = 0.43). These findings did not change after controlling for confounders. However, a secondary analysis revealed that, among patients with non-serous-papillary subtypes of OvCa, statin use was associated with a decrease in hazards of both disease recurrence (adjusted HR = 0.23, p = 0.02) and disease-specific death (adjusted HR = 0.23, p = 0.04). To augment the findings in the retrospective cohort, the histology-specific effects of statins were also evaluated in vitro using proliferation assays. Here, statin treatment of cell lines resulted in a variable level of cytotoxicity. Conclusion: Statin use among patients with non-serous-papillary OvCa was associated with improvement in both PFS and DSS.	[Habis, Mohammed; Ismail, Nadia; Yamada, S. Diane; Litchfield, Lacey; Lengyel, Ernst; Romero, Iris L.] Univ Chicago, Ctr Integrat Sci, Dept Obstet & Gynecol, Gynecol Oncol Sect, Chicago, IL 60637 USA; [Wroblewski, Kristen] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Bradaric, Michael] Chicago State Univ, Dept Pharmaceut Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Chicago State University	Romero, IL (corresponding author), Univ Chicago, Ctr Integrat Sci, Dept Obstet & Gynecol, Gynecol Oncol Sect, Chicago, IL 60637 USA.	iromero@uchicago.edu	Romero, Iris/N-8451-2018; Lengyel, Ernst/D-9220-2014	Romero, Iris/0000-0001-5849-5024; Lengyel, Ernst/0000-0001-8624-1507; Bradaric, Michael/0000-0003-4804-8911	University of Chicago Women's Board; Reproductive Scientist Development Program (NIH) [2K12HD000849-26]; American Board of Obstetrics and Gynecology; National Cancer Institute [5R01CA111882-07, 1R01CA169604-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA111882, P30CA014599, R01CA169604] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	University of Chicago Women's Board; Reproductive Scientist Development Program (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Board of Obstetrics and Gynecology; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the University of Chicago Women's Board, the Reproductive Scientist Development Program (NIH 2K12HD000849-26), and the American Board of Obstetrics and Gynecology (to I. L. R.). E. L. is supported by grants from the National Cancer Institute (5R01CA111882-07 and 1R01CA169604-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046691; Beck P, 2003, J CLIN EPIDEMIOL, V56, P280, DOI 10.1016/S0895-4356(02)00614-5; BROWN MS, 1980, J LIPID RES, V21, P505; Cauley JA, 2006, J NATL CANCER I, V98, P700, DOI 10.1093/jnci/djj188; Cruz PMR, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00119; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; Elmore RG, 2008, GYNECOL ONCOL, V111, P102, DOI 10.1016/j.ygyno.2008.06.007; GOLDSTEIN JL, 1979, J BIOL CHEM, V254, P5403; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; Ho AMH, 2013, ANAESTHESIA, V68, P126, DOI 10.1111/anae.12120; Horiuchi A, 2008, CANCER SCI, V99, P2532, DOI 10.1111/j.1349-7006.2008.00977.x; Karp I, 2008, AM J MED, V121, P302, DOI 10.1016/j.amjmed.2007.12.011; Kato S, 2010, J CELL MOL MED, V14, P1180, DOI 10.1111/j.1582-4934.2009.00771.x; KEYOMARSI K, 1991, CANCER RES, V51, P3602; Kumar S, 2013, CANCER-AM CANCER SOC, V119, P555, DOI 10.1002/cncr.27706; Lakha F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-487; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; LAU DHM, 1991, CANCER RES, V51, P5181; Lavie O, 2013, GYNECOL ONCOL, V130, P615, DOI 10.1016/j.ygyno.2013.05.025; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lengyel E, 2014, ONCOGENE, V33, P3619, DOI 10.1038/onc.2013.321; Levesque LE, 2010, BMJ-BRIT MED J, V340, P907; Li AJ, 2010, GYNECOL ONCOL, V116, P78, DOI 10.1016/j.ygyno.2009.09.027; Liao JK, 2002, J CLIN INVEST, V110, P285, DOI 10.1172/JCI200216421; Liu HL, 2009, CANCER CHEMOTH PHARM, V63, P997, DOI 10.1007/s00280-008-0830-7; Lloyd-Jones DM, 2014, LANCET, V383, P600, DOI 10.1016/S0140-6736(13)62348-X; LOUIE KG, 1986, BIOCHEM PHARMACOL, V35, P467, DOI 10.1016/0006-2952(86)90221-2; Marcuzzi A, 2012, INT J DEV NEUROSCI, V30, P451, DOI 10.1016/j.ijdevneu.2012.06.002; Martirosyan A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-103; Militello Rodrigo, 2013, Commun Integr Biol, V6, pe25460, DOI 10.4161/cib.25460; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Ozdemir BH, 2004, AM J CLIN PATHOL, V122, P696, DOI 10.1309/HW2MYB5TVF4AMOY4; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Robinson E, 2013, GYNECOL ONCOL, V129, P417, DOI 10.1016/j.ygyno.2013.02.003; Romero IL, 2012, OBSTET GYNECOL, V119, P61, DOI 10.1097/AOG.0b013e3182393ab3; Romero IL, 2012, GYNECOL ONCOL, V124, P134, DOI 10.1016/j.ygyno.2011.08.026; Rustin GJS, 2008, J NATL CANCER I, V96, P487; Sakayori M, 1990, Hum Cell, V3, P52; Sawada K, 2007, CANCER RES, V67, P1670, DOI 10.1158/0008-5472.CAN-06-1147; Siddiqui AA, 2009, DIGEST DIS SCI, V54, P1307, DOI 10.1007/s10620-009-0790-8; Skilling JS, 1996, GYNECOL ONCOL, V60, P72, DOI 10.1006/gyno.1996.0014; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taylor FC, 2013, JAMA-J AM MED ASSOC, V310, P2451, DOI 10.1001/jama.2013.281348; Terplan M, 2008, GYNECOL ONCOL, V111, P173, DOI 10.1016/j.ygyno.2008.08.013; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Yoshiya N, 1986, Nihon Sanka Fujinka Gakkai Zasshi, V38, P1747; Yu D, 1992, CANCER RES, V53, P891; Zhang Y, 2013, UROL INT, V90, P259, DOI 10.1159/000341977	50	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104521	10.1371/journal.pone.0104521	http://dx.doi.org/10.1371/journal.pone.0104521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118694	gold, Green Submitted, Green Published			2022-12-27	WOS:000340900600064
J	Wang, J; Sainju, UM				Wang, Jun; Sainju, Upendra M.			Soil Carbon and Nitrogen Fractions and Crop Yields Affected by Residue Placement and Crop Types	PLOS ONE			English	Article							LONG-TERM TILLAGE; ORGANIC-MATTER; MICROBIAL BIOMASS; DYNAMICS; SYSTEM; MINERALIZATION; SEQUESTRATION; FERTILIZER; INTENSITY; SEQUENCE	Soil labile C and N fractions can change rapidly in response to management practices compared to non-labile fractions. High variability in soil properties in the field, however, results in nonresponse to management practices on these parameters. We evaluated the effects of residue placement (surface application [or simulated no-tillage] and incorporation into the soil [or simulated conventional tillage]) and crop types (spring wheat [Triticum aestivum L.], pea [Pisum sativum L.], and fallow) on crop yields and soil C and N fractions at the 0-20 cm depth within a crop growing season in the greenhouse and the field. Soil C and N fractions were soil organic C (SOC), total N (STN), particulate organic C and N (POC and PON), microbial biomass C and N (MBC and MBN), potential C and N mineralization (PCM and PNM), NH4-N, and NO3-N concentrations. Yields of both wheat and pea varied with residue placement in the greenhouse as well as in the field. In the greenhouse, SOC, PCM, STN, MBN, and NH4-N concentrations were greater in surface placement than incorporation of residue and greater under wheat than pea or fallow. In the field, MBN and NH4-N concentrations were greater in no-tillage than conventional tillage, but the trend reversed for NO3-N. The PNM was greater under pea or fallow than wheat in the greenhouse and the field. Average SOC, POC, MBC, PON, PNM, MBN, and NO3-N concentrations across treatments were higher, but STN, PCM and NH4-N concentrations were lower in the greenhouse than the field. The coefficient of variation for soil parameters ranged from 2.6 to 15.9% in the greenhouse and 8.0 to 36.7% in the field. Although crop yields varied, most soil C and N fractions were greater in surface placement than incorporation of residue and greater under wheat than pea or fallow in the greenhouse than the field within a crop growing season. Short-term management effect on soil C and N fractions were readily obtained with reduced variability under controlled soil and environmental conditions in the greenhouse compared to the field. Changes occurred more in soil labile than non-labile C and N fractions in the greenhouse than the field.	[Wang, Jun] Northwest Univ, Coll Urban & Environm Sci, Xian, Shaanxi Provinc, Peoples R China; [Sainju, Upendra M.] USDA ARS, Northeren Plains Agr Res Lab, Sidney, MN USA	Northwest University Xi'an; United States Department of Agriculture (USDA)	Sainju, UM (corresponding author), USDA ARS, Northeren Plains Agr Res Lab, Sidney, MN USA.	upendra.sainju@ars.usda.gov			U.S. Department of Agriculture-Agricultural Research Service, Sidney, MT, USA; National Natural Science Foundation of China [31270484]; ARS [ARS-0425353] Funding Source: Federal RePORTER	U.S. Department of Agriculture-Agricultural Research Service, Sidney, MT, USA; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding came from the U.S. Department of Agriculture-Agricultural Research Service, Sidney, MT, USA and the National Natural Science Foundation of China (No. 31270484). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUER A, 1994, SOIL SCI SOC AM J, V58, P185, DOI 10.2136/sssaj1994.03615995005800010027x; Bezdicek D.F., 1996, METHODS ASSESS SOIL, V49, P1; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; CAMBARDELLA CA, 1992, SOIL SCI SOC AM J, V56, P777, DOI 10.2136/sssaj1992.03615995005600030017x; Coppens F, 2006, EUR J SOIL SCI, V57, P894, DOI 10.1111/j.1365-2389.2006.00783.x; FRANZLUEBBERS AJ, 1995, SOIL SCI SOC AM J, V59, P460, DOI 10.2136/sssaj1995.03615995005900020027x; Franzluebbers AJ, 1997, SOIL SCI SOC AM J, V61, P1090, DOI 10.2136/sssaj1997.03615995006100040015x; Franzluebbers AJ, 1996, SOIL SCI SOC AM J, V60, P1133, DOI 10.2136/sssaj1996.03615995006000040025x; GHIDEY F, 1993, T ASAE, V36, P1611; Giacomini SJ, 2007, PLANT SOIL, V301, P289, DOI 10.1007/s11104-007-9448-5; Halvorson AD, 2002, AGRON J, V94, P1429, DOI 10.2134/agronj2002.1429; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Haney RL, 2004, SOIL SCI SOC AM J, V68, P489, DOI 10.2136/sssaj2004.0489; Kuo S, 1997, SOIL SCI SOC AM J, V61, P1392, DOI 10.2136/sssaj1997.03615995006100050016x; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Lal R., 1995, Subsoil management techniques., P1; Lenssen AW, 2007, FIELD CROP RES, V100, P32, DOI 10.1016/j.fcr.2006.05.004; Liebig MA, 2004, SOIL TILL RES, V78, P131, DOI 10.1016/j.still.2004.02.002; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Lu YH, 2002, BIOL FERT SOILS, V36, P136, DOI 10.1007/s00374-002-0504-2; Lupwayi NZ, 2012, SOIL TILL RES, V118, P139, DOI 10.1016/j.still.2011.11.006; Malhi SS, 2007, SOIL TILL RES, V96, P269, DOI 10.1016/j.still.2007.06.011; Miller PR, 2002, AGRON J, V94, P261, DOI 10.2134/agronj2002.0261; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Paustian K., 1995, ADV SOIL SCI, P69; Peterson GA, 1998, SOIL TILL RES, V47, P207, DOI 10.1016/S0167-1987(98)00107-X; Pikul JL, 2003, SOIL SCI SOC AM J, V67, P859, DOI 10.2136/sssaj2003.0859; RASMUSSEN PE, 1980, SOIL SCI SOC AM J, V44, P596, DOI 10.2136/sssaj1980.03615995004400030033x; Sainju UM, 2006, SOIL SCI SOC AM J, V70, P668, DOI 10.2136/sssaj2005.0089; Sainju UM, 2007, SOIL SCI SOC AM J, V71, P1730, DOI 10.2136/sssaj2006.0433; Sainju UM, 2006, J ENVIRON QUAL, V35, P1341, DOI 10.2134/jeq2005.0131; Sainju UM, 2009, AGRON J, V101, P243, DOI 10.2134/agronj2008.0080x; Sherrod LA, 2003, SOIL SCI SOC AM J, V67, P1533, DOI 10.2136/sssaj2003.1533; Six J, 1999, SOIL SCI SOC AM J, V63, P1350, DOI 10.2136/sssaj1999.6351350x; VORONEY RP, 1984, SOIL BIOL BIOCHEM, V16, P9, DOI 10.1016/0038-0717(84)90117-2; Wright AL, 2008, APPL SOIL ECOL, V38, P168, DOI 10.1016/j.apsoil.2007.10.006	36	10	10	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105039	10.1371/journal.pone.0105039	http://dx.doi.org/10.1371/journal.pone.0105039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119381	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600117
J	Yin, XF; Xu, HM; Jiang, YX; Deng, WS; Wu, Z; Xiang, HW; Sun, P; Xie, JX				Yin, Xiaofeng; Xu, Huamin; Jiang, Yunxia; Deng, Wenshuai; Wu, Zeyu; Xiang, Hengwei; Sun, Peng; Xie, Junxia			The Effect of Lentivirus-Mediated PSPN Genetic Engineering Bone Marrow Mesenchymal Stem Cells on Parkinson's Disease Rat Model	PLOS ONE			English	Article							STROMAL CELLS; GDNF FAMILY; NEURAL CELLS; DIFFERENTIATION; EXPRESSION; PERSEPHIN; RECEPTOR; DOPAMINE; PROMOTE; NEURONS	Persephin (PSPN) is one of the neurotrophic factors of the glial cell line-derived neurotrophic factor (GDNF) family ligands (GFLs) which have been found to promote the survival of specific populations of neurons. The aim of this study was to assess the potential therapeutic function of gene-modified mesenchymal stem cells (MSCs)-Lv-PSPN-MSCs in 6-OHDA-induced Parkinson's disease (PD) rats models. Here, we worked on the isolation, purification, identification and amplification of MSCs in vitro. The expression analysis revealed that several of the neural marker proteins like nestin, GFAP and S100 were expressed by rat MSCs. MES23.5 cells co-cultured with Lv-PSPN-MSCs showed less 6-OHDA induced cell death than control cells in vitro. When Lv-PSPN-MSCs were injected into the striatum of PD rats, we observed the survival rate, migration, differentiation and the behavior change of PD rats. We found that Lv-PSPN-MSCs showed higher survival rate in rat brain compared with Lv-null-MSCs. Rotational behavior showed that rats receiving Lv-PSPN-MSCs showed the most significant improvement compared with those in other groups. HPLC results showed the content of DA in striatum of rats which received Lv-PSPN-MSCs was highest compared with those in other groups. In conclusion, our results suggest that transplantation of Lv-PSPN-MSCs can lead to remarkable therapeutic effects in PD rats.	[Yin, Xiaofeng; Deng, Wenshuai; Wu, Zeyu; Xiang, Hengwei; Sun, Peng] Qingdao Univ, Affiliated Hosp, Coll Med, Dept Neurosurg, Qingdao 266071, Peoples R China; [Xu, Huamin; Xie, Junxia] Qingdao Univ, Coll Med, Dept Physiol, Shandong Prov Key Lab Pathogenesis & Prevent Neur, Qingdao 266071, Peoples R China; [Jiang, Yunxia] Qingdao Univ, Coll Nursing, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University; Qingdao University	Sun, P (corresponding author), Qingdao Univ, Affiliated Hosp, Coll Med, Dept Neurosurg, Qingdao 266071, Peoples R China.	sunpengqd@163.com; jxiaxie@public.qd.sd.cn			National Foundation of Natural Science of China [81171208]; Natural Science Foundation of Shandong Province [Z2008C06]	National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	The National Foundation of Natural Science of China (81171208), the Natural Science Foundation of Shandong Province (Z2008C06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerud P, 2002, MOL CELL NEUROSCI, V21, P205, DOI 10.1006/mvne.2002.1171; Akerud T, 2002, J MOL BIOL, V322, P137, DOI 10.1016/S0022-2836(02)00714-3; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Choi MS, 2008, CELL TRANSPLANT, V17, P899, DOI 10.3727/096368908786576471; Deng WW, 2001, BIOCHEM BIOPH RES CO, V282, P148, DOI 10.1006/bbrc.2001.4570; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Dormady SP, 2001, J HEMATOTH STEM CELL, V10, P125, DOI 10.1089/152581601750098372; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; KROON JP, 1986, PHYSIOL BEHAV, V38, P593, DOI 10.1016/0031-9384(86)90430-0; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lennon DP, 2006, EXP HEMATOL, V34, P1606, DOI 10.1016/j.exphem.2006.07.015; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; MARSDEN CD, 1990, LANCET, V335, P948, DOI 10.1016/0140-6736(90)91006-V; Masure S, 2000, J BIOL CHEM, V275, P39427, DOI 10.1074/jbc.M003867200; Poteryaev D, 1999, FEBS LETT, V463, P63, DOI 10.1016/S0014-5793(99)01590-2; Roussa E, 2008, STEM CELLS, V26, P1683, DOI 10.1634/stemcells.2007-0805; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sarabi A, 2000, EXP NEUROL, V170, P283, DOI 10.1006/exnr.2001.7714; Shi DZ, 2011, NEUROL SCI, V32, P41, DOI 10.1007/s10072-010-0385-3; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Tang YP, 1998, J NEUROSCI RES, V53, P593; Trupp M, 1999, J BIOL CHEM, V274, P20885, DOI 10.1074/jbc.274.30.20885; Wang JY, 2012, J MOL NEUROSCI, V47, P113, DOI 10.1007/s12031-011-9693-1; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yoo Young Mi, 2003, Neurosurg Focus, V15, pECP1; Zhou JW, 2000, NEUROREPORT, V11, P3289, DOI 10.1097/00001756-200009280-00048; Zihlmann KB, 2005, BRAIN RES BULL, V68, P42, DOI 10.1016/j.brainresbull.2004.10.012	31	12	12	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105118	10.1371/journal.pone.0105118	http://dx.doi.org/10.1371/journal.pone.0105118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118697	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600124
J	He, XF; Wei, J; Liu, ZZ; Xie, JJ; Wang, W; Du, YP; Chen, Y; Si, HQ; Liu, Q; Wu, LX; Wei, W				He, Xiao-Feng; Wei, Jie; Liu, Zhi-Zhong; Xie, Jian-Jun; Wang, Wei; Du, Ya-Ping; Chen, Yu; Si, Hui-Qiang; Liu, Qing; Wu, Li-Xia; Wei, Wu			Association between CYP1A2 and CYP1B1 Polymorphisms and Colorectal Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							CARCINOGEN-METABOLIZING ENZYMES; GENETIC POLYMORPHISMS; RED MEAT; CIGARETTE-SMOKING; CYTOCHROMES P450; ACTIVATION; EXPRESSION; SUSCEPTIBILITY; CONSUMPTION; NUTRITION	Background: The previous published data on the association between CYP1A2*F (rs762551), CYP1B1 Leu432Val (rs1056836), Asn453Ser (rs180040), and Arg48Gly (rs10012) polymorphisms and colorectal cancer risk remained controversial. Methodology/Principal Findings: The purpose of this study is to evaluate the role of CYP1A2*F, CYP1B1 Leu432Val, Asn453Ser, and Arg48Gly genotypes in colorectal cancer susceptibility. We performed a meta-analysis on all the eligible studies that provided 5,817 cases and 6,544 controls for CYP1A2*F (from 13 studies), 9219 cases and 10406 controls for CYP1B1 Leu432Val (from 12 studies), 6840 cases and 7761 controls for CYP1B1 Asn453Ser (from 8 studies), and 4302 cases and 4791 controls for CYP1B1Arg48Gly (from 6 studies). Overall, no significant association was found between CYP1A2*F, CYP1B1 Leu432Val, Asn453Ser, and Arg48Gly and colorectal cancer risk when all the eligible studies were pooled into the meta-analysis. And in the subgroup by ethnicity and source of controls, no evidence of significant association was observed in any subgroup analysis. Conclusions/Significance: In summary, this meta-analysis indicates that CYP1A2*F, CYP1B1 Leu432Val, Asn453Ser, and Arg48Gly polymorphisms do not support an association with colorectal cancer, and further studies are needed to investigate the association. In addition, our work also points out the importance of new studies for CYP1A2*F polymorphism in Asians, because high heterogeneity was found (dominant model: I-2 = 81.3%; heterozygote model: I-2 = 79.0).	[He, Xiao-Feng; Wu, Li-Xia] Changzhi Med Coll, Peace Hosp, Dept Res, Changzhi, Shanxi Province, Peoples R China; [Wei, Jie] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Clin Lab, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Zhi-Zhong; Xie, Jian-Jun; Wang, Wei; Du, Ya-Ping; Chen, Yu; Si, Hui-Qiang; Liu, Qing] Second Peoples Hosp Zhuhai, Dept Gastroenterol, Zhuhai, Guangdong, Peoples R China; [Wei, Wu] Changzhi Med Coll, Peace Hosp, Dept Hematol, Changzhi, Shanxi Province, Peoples R China	Changzhi Medical College; Sun Yat Sen University; Changzhi Medical College	He, XF (corresponding author), Changzhi Med Coll, Peace Hosp, Dept Res, Changzhi, Shanxi Province, Peoples R China.	393120823@qq.com						Bae SY, 2006, CANCER SCI, V97, P774, DOI 10.1111/j.1349-7006.2006.00241.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bethke L, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-123; Buters JTM, 1999, P NATL ACAD SCI USA, V96, P1977, DOI 10.1073/pnas.96.5.1977; Cavalieri EL, 2002, CARCINOGENESIS, V23, P329, DOI 10.1093/carcin/23.2.329; Chen Kun, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P659; Cleary SP, 2010, AM J EPIDEMIOL, V172, P1000, DOI 10.1093/aje/kwq245; Colbert LH, 2001, CANCER EPIDEM BIOMAR, V10, P265; COPE GF, 1991, GUT, V32, P70, DOI 10.1136/gut.32.1.70; Cotterchio M, 2008, CANCER EPIDEM BIOMAR, V17, P3098, DOI 10.1158/1055-9965.EPI-08-0341; Davey SG, 1997, LANCET, V350, P1182, DOI DOI 10.1016/S0140-6736(05)63833-0; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DEVERDIER MG, 1990, INT J CANCER, V46, P832, DOI 10.1002/ijc.2910460514; EATON DL, 1995, PHARMACOGENETICS, V5, P259, DOI 10.1097/00008571-199510000-00001; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Hlavata I, 2010, ONCOL REP, V24, P1347, DOI 10.3892/or_0000992; Huber Ambros, 2005, J Soc Gynecol Investig, V12, pe51, DOI 10.1016/j.jsgi.2005.07.003; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ishibe N, 2002, PHARMACOGENETICS, V12, P145, DOI 10.1097/00008571-200203000-00008; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim JH, 1998, CARCINOGENESIS, V19, P1847, DOI 10.1093/carcin/19.10.1847; Kiss I, 2007, ANTICANCER RES, V27, P2931; Klug SJ, 2009, LANCET ONCOL, V10, P772, DOI 10.1016/S1470-2045(09)70187-1; Kobayashi M, 2009, SCAND J GASTROENTERO, V44, P952, DOI 10.1080/00365520902964721; Kury S, 2007, CANCER EPIDEM BIOMAR, V16, P1460, DOI 10.1158/1055-9965.EPI-07-0236; Kushi L, 2002, AM J MED, V113, P63, DOI 10.1016/S0002-9343(01)00994-9; Landi S, 2005, PHARMACOGENET GENOM, V15, P535, DOI 10.1097/01.fpc.0000165904.48994.3d; LEVIN B, 1992, CANCER-AM CANCER SOC, V70, P1723, DOI 10.1002/1097-0142(19920915)70:4+<1723::AID-CNCR2820701612>3.0.CO;2-3; MANTEL N, 1959, J NATL CANCER I, V22, P719; MCMANUS ME, 1990, CANCER RES, V50, P3367; Mei Q, 2012, METABOLISM, V61, P1321, DOI 10.1016/j.metabol.2012.02.010; Murray GI, 1997, CANCER RES, V57, P3026; Nakajima M, 1999, J BIOCHEM-TOKYO, V125, P803, DOI 10.1093/oxfordjournals.jbchem.a022352; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Nebert DW, 1996, DNA CELL BIOL, V15, P273, DOI 10.1089/dna.1996.15.273; Norat T, 2005, J NATL CANCER I, V97, P906, DOI 10.1093/jnci/dji164; Northwood EL, 2010, PHARMACOGENET GENOM, V20, P315, DOI 10.1097/FPC.0b013e3283395c6a; Potter JD, 1996, CANCER CAUSE CONTROL, V7, P127, DOI 10.1007/BF00115644; Rudolph A, 2011, ENDOCR-RELAT CANCER, V18, P371, DOI 10.1530/ERC-11-0057; Sachse C, 2002, CARCINOGENESIS, V23, P1839, DOI 10.1093/carcin/23.11.1839; Saebo M, 2008, ANTICANCER RES, V28, P2289; Sainz J, 2011, ENDOCR-RELAT CANCER, V18, P265, DOI 10.1530/ERC-10-0264; Shimada T, 1996, CANCER RES, V56, P2979; Stoilov I, 1998, AM J HUM GENET, V62, P573, DOI 10.1086/301764; Trubicka J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-420; Tsuchiya Y, 2005, CANCER LETT, V227, P115, DOI 10.1016/j.canlet.2004.10.007; Wang HS, 2011, CARCINOGENESIS, V32, P203, DOI 10.1093/carcin/bgq237; Wang J, 2012, INT J CANCER, V130, P1898, DOI 10.1002/ijc.26199; Williams JA, 2000, CARCINOGENESIS, V21, P1683, DOI 10.1093/carcin/21.9.1683; Xie Y, 2012, TUMOR BIOL, V33, P809, DOI 10.1007/s13277-011-0298-7; Yamazaki H, 1998, CHEM RES TOXICOL, V11, P659, DOI 10.1021/tx970217f; Yoshida K, 2007, ASIAN PAC J CANCER P, V8, P438; Zhao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071481	54	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e100487	10.1371/journal.pone.0100487	http://dx.doi.org/10.1371/journal.pone.0100487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115775	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400002
J	Galperin, I; Sorenson, O				Galperin, Inna; Sorenson, Olav			Valuation, Categories and Attributes	PLOS ONE			English	Article							SECURITIES ANALYSTS; CONJOINT-ANALYSIS; DYNAMICS; MARKETS	Existing research on categories has only examined indirectly the value associated with being a member of a category relative to the value of the set of attributes that determine membership in that category. This study uses survey data to analyze consumers' preferences for the "organic'' label versus for the attributes underlying that label. We found that consumers generally preferred products with the category label to those with the attributes required for the organic label but without the label. We also found that the value accorded to the organic label increased with the number of attributes that an individual associated with the category. Category membership nevertheless still had greater value than even that of the sum of the attributes associated with it.	[Sorenson, Olav] Yale Univ, Sch Management, New Haven, CT 06520 USA	Yale University	Sorenson, O (corresponding author), Yale Univ, Sch Management, New Haven, CT 06520 USA.	olav.sorenson@yale.edu	Sorenson, Olav/ABE-5373-2020	Sorenson, Olav/0000-0002-0599-6738	Michael Lee-Chin Family Institute for Corporate Citizenship at the Rotman School of Management; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER	Michael Lee-Chin Family Institute for Corporate Citizenship at the Rotman School of Management; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors thank the Michael Lee-Chin Family Institute for Corporate Citizenship at the Rotman School of Management for its generous funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bless H., 2000, FEELING THINKING ROL, DOI DOI 10.5860/CHOICE.37-5959; Carroll GR, 2000, AM J SOCIOL, V106, P715, DOI 10.1086/318962; Conford P, 2001, ORIGINS ORGANIC MOVE; Durkheim E., 1984, DIVISION LABOR SOC; Fiske S.T., 1986, HDB MOTIVATION COGNI, P464; GREEN PE, 1990, J MARKETING, V54, P3, DOI 10.2307/1251756; GREEN PE, 1978, J CONSUM RES, V5, P103, DOI 10.1086/208721; GREEN PE, 1974, J CONSUM RES, V1, P61, DOI 10.1086/208592; Hannan M.T., 2007, LOGICS ORG THEORY AU; HANNAN MT, 1984, AM SOCIOL REV, V49, P149, DOI 10.2307/2095567; Heckman J, 2006, RENEW AGR FOOD SYST, V21, P143, DOI 10.1079/RAF2005126; Hsu G, 2005, ORGAN SCI, V16, P474, DOI 10.1287/orsc.1050.0151; Hsu G, 2009, AM SOCIOL REV, V74, P150, DOI 10.1177/000312240907400108; Leung MD, 2014, AM SOCIOL REV, V79, P136, DOI 10.1177/0003122413518638; LOKEN B, 1990, J CONSUM RES, V17, P111, DOI 10.1086/208542; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; MEDIN DL, 1989, AM PSYCHOL, V44, P1469, DOI 10.1037/0003-066X.44.12.1469; MURPHY GL, 1985, PSYCHOL REV, V92, P289, DOI 10.1037/0033-295X.92.3.289; Navis C, 2010, ADMIN SCI QUART, V55, P439, DOI 10.2189/asqu.2010.55.3.439; Pontikes E, 2014, SOCIOLOGICA IN PRESS, V1; Pontikes E, 2012, WORKING PAPER; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Schwarz N., 1990, MOTIVATION COGNITION, V2, P527, DOI [10.2307/, DOI 10.2307/2072281]; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sorenson O, 1997, THESIS STANFORD U; Stinchcombe A. L., 1965, HDB ORG, V44, P142, DOI DOI 10.1016/S0742-3322(00)17019-6; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; Wansink B, 2002, J SENS STUD, V17, P483, DOI 10.1111/j.1745-459X.2002.tb00360.x; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; WHITE HC, 1981, AM J SOCIOL, V87, P517, DOI 10.1086/227495; Whorf B.L., 2012, LANGUAGE THOUGHT REA; Willer H., 2011, FIBL IFOAM REPORT; Willer H., 2008, WORLD ORGANIC AGR ST, V1st; Zerubavel E., 1991, FINE LINE MAKING DIS; Zuckerman EW, 1999, AM J SOCIOL, V104, P1398, DOI 10.1086/210178; Zuckerman EW, 2000, ADMIN SCI QUART, V45, P591, DOI 10.2307/2667110	36	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e103002	10.1371/journal.pone.0103002	http://dx.doi.org/10.1371/journal.pone.0103002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WB	25111831	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100011
J	Koshy, E; Bottle, A; Murray, J; Sharland, M; Saxena, S				Koshy, Elizabeth; Bottle, Alex; Murray, Joanna; Sharland, Mike; Saxena, Sonia			Changing Indications and Socio-Demographic Determinants of (Adeno) Tonsillectomy among Children in England - Are They Linked? A Retrospective Analysis of Hospital Data	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; SOCIOECONOMIC-STATUS; RISK-FACTORS; RATES; DEPRIVATION; SCOTLAND; DISADVANTAGE; PERSPECTIVE; POPULATION; ADMISSIONS	Objective: To assess whether increased awareness and diagnosis of obstructive sleep apnoea syndrome (OSAS) and national guidance on tonsillectomy for recurrent tonsillitis have influenced the socio-demographic profile of children who underwent tonsillectomy over the last decade. Method: Retrospective time-trends study of Hospital Episodes Statistics data. We examined the age, sex and deprivation level, alongside OSAS diagnoses, among children aged <16 years who underwent (adeno) tonsillectomy in England between 2001/2 and 2011/12. Results: Among children aged <16 years, there were 29,697 and 27,732 (adeno) tonsillectomies performed in 2001/2 and 2011/12, respectively. The median age at (adeno) tonsillectomy decreased from 7 (IQR: 5-11) to 5 (IQR: 4-9) years over the decade. (Adeno) tonsillectomy rates among children aged 4-15 years decreased by 14% from 350 (95% CI: 346-354) in 2001/2 to 300 (95% CI: 296-303) per 100,000 children in 2011/12. However, (adeno) tonsillectomy rates among children aged <4 years increased by 58% from 135 (95% CI: 131-140) to 213 (95% CI 208-219) per 100,000 children in 2001/2 and 2011/2, respectively. OSAS diagnoses among children aged <4 years who underwent surgery increased from 18% to 39% between these study years and the proportion of children aged <4 years with OSAS from the most deprived areas increased from 5% to 12%, respectively. Conclusions: (Adeno) tonsillectomy rates declined among children aged 4-15 years, which reflects national guidelines recommending the restriction of the operation to children with more severe recurrent throat infections. However, (adeno) tonsillectomy rates among pre-school children substantially increased over the past decade and one in five children undergoing the operation was aged <4 years in 2011/12. The increase in surgery rates in younger children is likely to have been driven by increased awareness and detection of OSAS, particularly among children from the most deprived areas.	[Koshy, Elizabeth; Murray, Joanna; Saxena, Sonia] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England; [Bottle, Alex] Univ London Imperial Coll Sci Technol & Med, Doctor Foster Unit, London, England; [Sharland, Mike] St Georges Hosp NHS Trust, Paediat Infect Dis Unit, London, England	Imperial College London; Imperial College London; St Georges University London	Koshy, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England.	e.koshy@imperial.ac.uk	Saxena, Sonia/ABD-7737-2021; Saxena, Sonia K/G-4821-2013	Saxena, Sonia/0000-0003-3787-2083; Saxena, Sonia K/0000-0003-3787-2083; sharland, mike/0000-0001-8626-8291	National Institute for Health Research (NIHR) Doctoral Research Fellowship; National Institute for Health Research (NIHR) under a Programme Grant for Applied Research; National Institute for Health Research Senior Researcher fellowship; Dr Foster Intelligence, an independent health care information company; National Institute for Health Research (NIHR); National Institute for Health Research [CDF-2011-04-048, DRF-2009-02-78] Funding Source: researchfish	National Institute for Health Research (NIHR) Doctoral Research Fellowship(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) under a Programme Grant for Applied Research; National Institute for Health Research Senior Researcher fellowship; Dr Foster Intelligence, an independent health care information company; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	EK is funded by a National Institute for Health Research (NIHR) Doctoral Research Fellowship. JM was funded through the National Institute for Health Research (NIHR) under a Programme Grant for Applied Research. SS is funded by a National Institute for Health Research Senior Researcher fellowship. The Dr Foster Unit at Imperial is principally funded via a research grant by Dr Foster Intelligence, an independent health care information company and joint venture with the Department of Health. This article presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, CHIEF MED OFF ANN RE; [Anonymous], 2009, ENTUK IND TONS POS P; Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; BISSET AF, 1994, BRIT MED J, V308, P1129, DOI 10.1136/bmj.308.6937.1129; Boss EF, 2012, J PEDIATR-US, V160, P814, DOI 10.1016/j.jpeds.2011.11.041; Brouillette RT, 2011, J PEDIATR-US, V158, P789, DOI 10.1016/j.jpeds.2010.10.036; Burns EM, 2011, J PUBLIC HLTH OXF; Burton MJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001802.pub2; CARSTAIRS V, 1989, BRIT MED J, V299, P886, DOI 10.1136/bmj.299.6704.886; Clement WA, 2013, J LARYNGOL OTOL, V127, P392, DOI 10.1017/S0022215113000108; Croxford R, 2004, ACTA PAEDIATR, V93, P1245, DOI 10.1080/08035250410033079; DONNELLY MJ, 1994, J LARYNGOL OTOL, V108, P131, DOI 10.1017/S0022215100126088; Ebell MH, 2000, JAMA-J AM MED ASSOC, V284, P2912, DOI 10.1001/jama.284.22.2912; Factor SH, 2005, EMERG INFECT DIS, V11, P1062, DOI 10.3201/eid1107.040900; HINTON AE, 1993, CLIN OTOLARYNGOL, V18, P178; Hugh C, 2007, TRENDS CHILDRENS SUR; JOKINEN C, 1993, AM J EPIDEMIOL, V137, P977, DOI 10.1093/oxfordjournals.aje.a116770; Jones Jason J, 2013, PLOS ONE; Koshy E, 2012, ARCH DIS CHILD, V97, P1064, DOI 10.1136/archdischild-2012-301755; Kuehni CE, 2008, EUR RESPIR J, V31, P326, DOI 10.1183/09031936.00088407; Kyle RG, 2011, ARCH DIS CHILD, V96, P221, DOI 10.1136/adc.2009.180125; Lescanne E, 2012, EUR ANN OTORHINOLARY, V129, P264, DOI 10.1016/j.anorl.2012.03.003; Lock C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14130; Manickavasagam J, 2012, J LARYNGOL OTOL, V126, P163, DOI 10.1017/S0022215111003070; Marcus CL, 2012, PEDIATRICS, V130, P576, DOI 10.1542/peds.2012-1671; Millett C, 2013, PEDIATRICS, V131, pE495, DOI 10.1542/peds.2012-2592; Parker NP, 2011, INT J PEDIATR OTORHI, V75, P282, DOI 10.1016/j.ijporl.2010.11.019; Royal College of Surgeons of England, 2005, NAT PROSP TONS AUD F; SIGN, 2010, MAN SOR THROAT IND T; Spencer DJ, 2012, ARCH OTOLARYNGOL, V138, P335, DOI 10.1001/archoto.2012.1; Spilsbury JC, 2006, J PEDIATR-US, V149, P342, DOI 10.1016/j.jpeds.2006.04.061; Suleman M, 2010, CLIN OTOLARYNGOL, V35, P111, DOI 10.1111/j.1749-4486.2010.02086.x; van den Akker EH, 2004, CLIN OTOLARYNGOL, V29, P161, DOI 10.1111/j.0307-7772.2004.00771.x; Victorino CC, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-53; Wang YF, 2012, INT REV PSYCHIATR, V24, P176, DOI 10.3109/09540261.2012.688195	35	13	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e103600	10.1371/journal.pone.0103600	http://dx.doi.org/10.1371/journal.pone.0103600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111171	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100016
J	Grdisa, M; Liber, Z; Radosavljevic, I; Carovic-Stanko, K; Kolak, I; Satovic, Z				Grdisa, Martina; Liber, Zlatko; Radosavljevic, Ivan; Carovic-Stanko, Klaudija; Kolak, Ivan; Satovic, Zlatko			Genetic Diversity and Structure of Dalmatian Pyrethrum (Tanacetum cinerariifolium Trevir./Sch./Bip., Asteraceae) within the Balkan Refugium	PLOS ONE			English	Article							POPULATION-STRUCTURE; REMNANT POPULATIONS; PHYLOGEOGRAPHY; RANGE; AFLP; DIFFERENTIATION; CONSERVATION; CONSEQUENCES; DIVERGENCE; DISTANCE	Dalmatian pyrethrum (Tanacetum cinerariifolium Trevir. /Sch./ Bip.) is an outcrossing, perennial insecticidal plant, restricted to the eastern Adriatic coast (Mediterranean). Amplified fragment-length polymorphisms (AFLP) were used to investigate the genetic diversity and structure within and among 20 natural plant populations. The highest level of gene diversity, the number of private alleles and the frequency down-weighted marker values (DW) were found in northern Adriatic populations and gradually decreased towards the southern boundary of the species range. Genetic impoverishment of these southern populations is most likely the result of human-related activities. An analysis of molecular variance (AMOVA) indicated that most of the genetic diversity was attributed to differences among individuals within populations (85.78%), which are expected due to the outcrossing nature of the species. A Bayesian analysis of the population structure identified two dominant genetic clusters. A spatial analysis of the genetic diversity indicated that 5.6% of the genetic differentiation resulted from isolation by distance (IBD), while 12.3% of the genetic differentiation among populations followed the pattern of isolation by environmental distance (IBED). Knowledge of the genetic diversity patterns of the natural populations and the mechanism behind these patterns is required for the exploitation and possible conservation management of this endemic and economically important species.	[Grdisa, Martina; Carovic-Stanko, Klaudija; Kolak, Ivan; Satovic, Zlatko] Univ Zagreb, Fac Agr, Dept Seed Sci & Technol, Zagreb 41000, Croatia; [Liber, Zlatko; Radosavljevic, Ivan] Univ Zagreb, Fac Sci, Div Biol, Dept Biol, Zagreb 41000, Croatia	University of Zagreb; University of Zagreb	Grdisa, M (corresponding author), Univ Zagreb, Fac Agr, Dept Seed Sci & Technol, Zagreb 41000, Croatia.	mgrdisa@agr.hr	Liber, Zlatko/D-3342-2016; Šatović, Zlatko/AAA-9626-2020	Šatović, Zlatko/0000-0002-9848-1601; Liber, Zlatko/0000-0002-2370-6650	Ministry of Science, Education and Sports of the Republic of Croatia [178-1191193-0212, 178-0000000-3595, 119-1191193-1232]	Ministry of Science, Education and Sports of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia)	This study was supported by the Ministry of Science, Education and Sports of the Republic of Croatia (public.mzos.hr), within the framework of Project No. 178-1191193-0212 (ZS), Project No. 178-0000000-3595 (IK) and Project No. 119-1191193-1232 (ZL). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	AEgisdottir HH, 2009, ANN BOT-LONDON, V104, P1313, DOI 10.1093/aob/mcp242; Bakaric P, 2005, GOSPOD LIST, V17, P41; Baldoni L, 2006, ANN BOT-LONDON, V98, P935, DOI 10.1093/aob/mcl178; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Bourguiba H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-49; Campillo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020986; Canestrelli D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041754; Canestrelli D, 2010, MOL ECOL, V19, P5432, DOI 10.1111/j.1365-294X.2010.04900.x; Carovic-Stanko K, 2011, PLANT SYST EVOL, V294, P253, DOI 10.1007/s00606-011-0471-x; Corander J, 2003, GENETICS, V163, P367; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Cruse-Sanders JM, 2004, AM J BOT, V91, P540, DOI 10.3732/ajb.91.4.540; Dahlgren JP, 2007, AM J BOT, V94, P1570, DOI 10.3732/ajb.94.9.1570; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Ehrich D, 2007, MOL ECOL, V16, P2542, DOI 10.1111/j.1365-294X.2007.03299.x; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; FELSENSTEIN J, 1993, PHYLOGENY INFERENCE; Ferrarese S, 2008, J MARINE SYST, V74, P659, DOI 10.1016/j.jmarsys.2008.07.003; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Head S.W., 1973, PYRETHRUM, P25; Herrmann D, 2010, GENOME, V53, P302, DOI [10.1139/G10-006, 10.1139/g10-006]; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Heywood V. H., 1976, FLORA EUROPAEA PLANT, VIV, P169; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Hou Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024497; HUA Y, 2010, BIOCH SYST ECOL, V38, P264; Huff DR, 1997, CROP SCI, V37, P557, DOI 10.2135/cropsci1997.0011183X003700020041x; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Krystufek B, 2007, MOL ECOL, V16, P1221, DOI 10.1111/j.1365-294X.2007.03235.x; Kucera J, 2008, PLANT SYST EVOL, V275, P193, DOI 10.1007/s00606-008-0061-8; Kukla GJ, 2002, QUATERNARY RES, V58, P2, DOI 10.1006/qres.2001.2316; Lakusic Dmitar, 2006, Willdenowia, V36, P177, DOI 10.3372/wi.36.36115; Lakusic D, 2013, TAXON, V62, P505, DOI 10.12705/623.1; Lambeck K, 2002, QUATERNARY SCI REV, V21, P343, DOI 10.1016/S0277-3791(01)00071-3; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li Q, 2005, BIOCHEM GENET, V43, P445, DOI 10.1007/s10528-005-6782-2; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; MacDonald William L., 1995, P55; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Muhs DR, 2001, QUATERNARY SCI REV, V20, P41, DOI 10.1016/S0277-3791(00)00132-3; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nikolic T, 2014, FLORA CROATICA DATAB; Oanic S, 1955, POLJOPRIVREDA DALMAC; Olden JD, 2004, TRENDS ECOL EVOL, V19, P18, DOI 10.1016/j.tree.2003.09.010; OZANIC S, 1930, BUHAC PYRETHRUM CINE; Parisod C, 2008, NEW PHYTOL, V178, P436, DOI 10.1111/j.1469-8137.2007.02361.x; Parlevliet J. E., 1975, Pyrethrum Post, V13, P47; Paun O, 2008, MOL ECOL, V17, P4263, DOI 10.1111/j.1365-294X.2008.03908.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pikelj K, 2009, GEOL CROAT, V62, P95, DOI 10.4154/gc.2009.08; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Podnar M, 2004, ORG DIVERS EVOL, V4, P307, DOI 10.1016/j.ode.2004.04.004; Pope LC, 2006, MOL ECOL, V15, P371, DOI 10.1111/j.1365-294X.2005.02815.x; Previsic A, 2009, MOL ECOL, V18, P634, DOI 10.1111/j.1365-294X.2008.04046.x; Pritchard JK, 2000, GENETICS, V155, P945; Rivera-Ocasio E, 2002, MOL ECOL, V11, P675, DOI 10.1046/j.1365-294X.2002.01476.x; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Rossignol-Strick M, 1999, QUATERNARY SCI REV, V18, P515, DOI 10.1016/S0277-3791(98)00093-6; Rousset F, 1997, GENETICS, V145, P1219; Savic I.R., 2008, ADV ARACHNOLOGY DEV, P57; Schmidt K, 2000, AM J BOT, V87, P678, DOI 10.2307/2656854; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schneider S., 2000, ARLEQUIN VERSION 20; Schonswetter P, 2005, TAXON, V54, P725, DOI 10.2307/25065429; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shim SI, 2000, THEOR APPL GENET, V101, P227, DOI 10.1007/s001220051473; Suric M, 2009, MAR GEOL, V262, P62, DOI 10.1016/j.margeo.2009.03.005; Surina B, 2011, J BIOGEOGR, V38, P1381, DOI 10.1111/j.1365-2699.2011.02493.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Temunovic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042764; Ursenbacher S, 2008, MOL PHYLOGENET EVOL, V46, P1116, DOI 10.1016/j.ympev.2007.11.002; Vega R, 2010, BIOL J LINN SOC, V100, P774, DOI 10.1111/j.1095-8312.2010.01454.x; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; Wang IJ, 2013, ECOL LETT, V16, P175, DOI 10.1111/ele.12025; Wang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041310; Warren RJ, 2011, GLOBAL CHANGE BIOL, V17, P2444, DOI 10.1111/j.1365-2486.2010.02386.x; Wielstra B, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-13; Wiersum KF, 2006, WAG UR FRON, V17, P43; Wright S, 1943, GENETICS, V28, P114; Yamagishi M, 2010, LANDSC ECOL ENG, V6, P75, DOI 10.1007/s11355-009-0084-5; Yang DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029678; Yao XH, 2012, CONSERV GENET, V13, P1499, DOI 10.1007/s10592-012-0393-3; Yuan QJ, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-29; Zaghloul MS, 2012, CONSERV GENET, V13, P9, DOI 10.1007/s10592-011-0260-7; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	102	24	25	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105265	10.1371/journal.pone.0105265	http://dx.doi.org/10.1371/journal.pone.0105265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121763	Green Published, gold			2022-12-27	WOS:000341017000108
J	Ji, D; Shao, Q; Han, P; Li, F; Li, B; Zang, H; Niu, XX; Li, ZB; Xin, SJ; Chen, GF				Ji, Dong; Shao, Qing; Han, Ping; Li, Fan; Li, Bing; Zang, Hong; Niu, Xiaoxia; Li, Zhongbin; Xin, Shaojie; Chen, Guofeng			The Frequency and Determinants of Liver Stiffness Measurement Failure: A Retrospective Study of "Real-Life'' 38,464 Examinations	PLOS ONE			English	Article							HEPATITIS-C VIRUS; TRANSIENT ELASTOGRAPHY; DIAGNOSTIC PERFORMANCE; NONINVASIVE MARKERS; XL PROBE; FIBROSIS; CIRRHOSIS; FIBROSCAN(R); FEASIBILITY; DISEASE	Objective: To investigate the frequency and determinants of liver stiffness measurement (LSM) failure by means of FibroScan in "real-life'' Chinese patients. Methods: A total of 38,464 "real-life'' Chinese patients in 302 military hospital of China through the whole year of 2013, including asymptomatic carrier, chronic hepatitis B, chronic hepatitis C, liver cirrhosis (LC), alcoholic liver disease, autoimmune liver disease, hepatocellular carcinoma (HCC) and other, were enrolled, their clinical and biological parameters were retrospectively investigated. Liver fibrosis was evaluated by FibroScan detection. S probe (for children with height less than 1.20 m) and M probe (for adults) were used. LSM failure defined as zero valid shots (unsuccessful LSM), or the ratio of the interquartile range to the median of 10 measurements (IQR/M) greater than 0.30 plus median LSM greater or equal to 7.1 kPa (unreliable LSM). Results: LSM failure occurred in 3.34% of all examinations (1286 patients out of 38,464), among them, there were 958 cases (2.49%) with unsuccessful LSM, and 328 patients (0.85%) with unreliable LSM. Statistical analyses showed that LSM failure was independently associated with body mass index (BMI) greater than 30 kg/m(2), female sex, age greater than 50 years, intercostal spaces (IS) less than 9 mm, decompensated liver cirrhosis and HCC patients. There were no significant differences among other diseases. By changing another skilled operator, success was achieved on 301 cases out of 1286, which reduced the failure rate to 2.56%, the decrease was significant (P<0.0001). Conclusions: The principal reasons of LSM failure are ascites, obesity and narrow of IS. The failure rates of HCC, decompensated LC, elder or female patients are higher. These results emphasize the need for adequate operator training, technological improvements and optimal criteria for specific patient subpopulations.	[Ji, Dong; Shao, Qing; Li, Fan; Li, Bing; Niu, Xiaoxia; Li, Zhongbin; Chen, Guofeng] 302 Mil Hosp China, Liver Fibrosis Diag & Treatment Ctr, Beijing, Peoples R China; [Han, Ping] 302 Mil Hosp China, Tumor Radiotherapy Ctr, Beijing, Peoples R China; [Zang, Hong; Xin, Shaojie] 302 Mil Hosp China, Liver Failure Diag & Treatment Ctr, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Xin, SJ (corresponding author), 302 Mil Hosp China, Liver Failure Diag & Treatment Ctr, Beijing, Peoples R China.	XinShaojie302@163.com; bjchen302@aliyun.com	ji, dong/AAF-6364-2019	ji, dong/0000-0001-8214-462X	Beijing Natural Science Foundation [7122177]; National Natural Science Foundation of China [81371799]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Beijing Natural Science Foundation (7122177, http://www.bjnsf.org/) and National Natural Science Foundation of China (81371799, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afdhal Nezam H, 2012, Gastroenterol Hepatol (N Y), V8, P605; Buster EHCJ, 2009, GASTROENTEROLOGY, V137, P2002, DOI 10.1053/j.gastro.2009.08.061; Calvaruso V, 2012, LIVER INT, V32, P2, DOI 10.1111/j.1478-3231.2011.02703.x; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Corpechot C, 2006, HEPATOLOGY, V43, P1118, DOI 10.1002/hep.21151; Crespo G, 2012, J HEPATOL, V57, P281, DOI 10.1016/j.jhep.2012.03.016; de Ledinghen V, 2010, LIVER INT, V30, P1043, DOI 10.1111/j.1478-3231.2010.02258.x; Duarte-Rojo A, 2012, ANN HEPATOL, V11, P426, DOI 10.1016/S1665-2681(19)31456-5; Ferraioli G, 2013, WORLD J GASTROENTERO, V19, P49, DOI 10.3748/wjg.v19.i1.49; Forestier J, 2010, EUR J GASTROEN HEPAT, V22, P532, DOI 10.1097/MEG.0b013e3283343f58; Fraquelli M, 2007, HEPATOLOGY, V46, P282, DOI 10.1002/hep.21653; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Friedrich-Rust M, 2010, EUR RADIOL, V20, P2390, DOI 10.1007/s00330-010-1820-9; Janssens F, 2010, ACTA GASTRO-ENT BELG, V73, P52; Kim BK, 2010, LIVER INT, V30, P1073, DOI 10.1111/j.1478-3231.2010.02269.x; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036676; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032233; Kim SU, 2010, J CLIN GASTROENTEROL, V44, P66, DOI 10.1097/MCG.0b013e3181a95c7f; Kim SU, 2009, J CLIN GASTROENTEROL, V43, P267, DOI 10.1097/MCG.0b013e31816f212e; Kirk GD, 2009, CLIN INFECT DIS, V48, P963, DOI 10.1086/597350; Kumar R, 2013, DIGEST DIS SCI, V58, P265, DOI 10.1007/s10620-012-2306-1; Lemoine M, 2008, ALIMENT PHARM THER, V28, P1102, DOI 10.1111/j.1365-2036.2008.03825.x; Liaw YF, 2012, HEPATOL INT, V6, P531, DOI 10.1007/s12072-012-9365-4; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577; Myers RP, 2012, HEPATOLOGY, V55, P199, DOI 10.1002/hep.24624; Nahon P, 2008, J HEPATOL, V49, P1062, DOI 10.1016/j.jhep.2008.08.011; Osaki A, 2010, WORLD J GASTROENTERO, V16, P2918, DOI 10.3748/wjg.v16.i23.2918; Povero D, 2010, HISTOL HISTOPATHOL, V25, P1075, DOI 10.14670/HH-25.1075; Saad Y, 2013, J CLIN DIAGN RES, V7, P2253, DOI 10.7860/JCDR/2013/6026.3484; Sanchez-Conde M, 2010, J VIRAL HEPATITIS, V17, P280, DOI 10.1111/j.1365-2893.2009.01180.x; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1573, DOI 10.1016/j.cgh.2013.07.034; Sporea I, 2011, HEPAT MON, V11, P182; Wong GLH, 2011, J GASTROEN HEPATOL, V26, P300, DOI 10.1111/j.1440-1746.2010.06510.x; Wong GLH, 2013, WORLD J HEPATOL, V5, P264, DOI 10.4254/wjh.v5.i5.264; Wong VWS, 2012, AM J GASTROENTEROL, V107, P1862, DOI 10.1038/ajg.2012.331	37	7	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105183	10.1371/journal.pone.0105183	http://dx.doi.org/10.1371/journal.pone.0105183			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122123	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000103
J	Lee, S; Park, H; Ha, SY; Paik, KY; Lee, SE; Kim, JM; Park, JB; Kwon, CHD; Joh, JW; Choi, YL; Kim, SJ				Lee, Sanghoon; Park, Hyojun; Ha, Sang Yun; Paik, Kwang Yeol; Lee, Seung Eun; Kim, Jong Man; Park, Jae Berm; Kwon, Choon Hyuck David; Joh, Jae-Won; Choi, Yoon-La; Kim, Sung Joo			CDK4 Amplification Predicts Recurrence of Well-Differentiated Liposarcoma of the Abdomen	PLOS ONE			English	Article							SOFT-TISSUE SARCOMA; MDM2; CHROMOSOMES; DIAGNOSIS; SUBTYPE	Background: The absence of CDK4 amplification in liposarcomas is associated with favorable prognosis. We aimed to identify the factors associated with tumor recurrence in patients with well-differentiated (WD) and dedifferentiated (DD) liposarcomas. Methods: From 2000 to 2010, surgical resections for 101 WD and DD liposarcomas were performed. Cases in which complete surgical resections with curative intent were carried out were selected. MDM2 and CDK4 gene amplification were analyzed by quantitative real-time polymerase chain reaction (Q-PCR). Results: There were 31 WD and 17 DD liposarcomas. Locoregional recurrence was observed in 11 WD and 3 DD liposarcomas. WD liposarcomas showed better patient survival compared to DD liposarcomas (P<0.05). Q-PCR analysis of the liposarcomas revealed the presence of CDK4 amplification in 44 cases (91.7%) and MDM2 amplification in 46 cases (95.8%). WD liposarcomas with recurrence after surgical resection had significantly higher levels of CDK4 amplification compared to those without recurrence (P = 0.041). High level of CDK4 amplification (cases with CDK4 amplification higher than the median 7.54) was associated with poor recurrence-free survival compared to low CDK4 amplification in both univariate (P = 0.012) and multivariate analyses (P = 0.020). Conclusions: Level of CDK4 amplification determined by Q-PCR was associated with the recurrence of WD liposarcomas after surgical resection.	[Lee, Sanghoon; Park, Hyojun; Kim, Jong Man; Park, Jae Berm; Kwon, Choon Hyuck David; Joh, Jae-Won; Kim, Sung Joo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Ha, Sang Yun; Lee, Seung Eun; Choi, Yoon-La] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Paik, Kwang Yeol] Catholic Univ Korea, Yeouido St Marys Hosp, Dept Surg, Seoul, South Korea; [Choi, Yoon-La; Kim, Sung Joo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, SHIST, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea; Sungkyunkwan University (SKKU); Samsung Medical Center	Choi, YL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea.	yla.choi@samsung.com; kmhyj.kim@samsung.com	Kwon, Choon Hyuck David/H-7263-2019; Kim, Jong Man/AAH-5295-2020; kim, jm/O-5935-2014	Kwon, Choon Hyuck David/0000-0002-1082-3321; Joh, Jae-Won/0000-0003-1732-6210				Aleixo PB, 2009, J CLIN PATHOL, V62, P1127, DOI 10.1136/jcp.2009.070201; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Binh MBN, 2006, AM J CLIN PATHOL, V125, P693, DOI 10.1309/VMBP67QUNN6Q3J0E; Dei Tos A P, 2000, Ann Diagn Pathol, V4, P252, DOI 10.1053/adpa.2000.8133; Dickson MA, 2012, J CLIN ONCOL, V30; EVANS HL, 1979, CANCER, V43, P574, DOI 10.1002/1097-0142(197902)43:2<574::AID-CNCR2820430226>3.0.CO;2-7; Fletcher CDM, 1996, AM J PATHOL, V148, P623; Hoffman A, 2011, DRUG RESIST UPDATE, V14, P52, DOI 10.1016/j.drup.2010.11.001; Italiano A, 2008, INT J CANCER, V122, P2233, DOI 10.1002/ijc.23380; Italiano A, 2009, CLIN CANCER RES, V15, P5696, DOI 10.1158/1078-0432.CCR-08-3185; Kim HS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-205; Lewis JJ, 1998, ANN SURG, V228, P355, DOI 10.1097/00000658-199809000-00008; Louis-Brennetot C, 2011, GENE CHROMOSOME CANC, V50, P896, DOI 10.1002/gcc.20909; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Meis-Kindblom JM, 2001, VIRCHOWS ARCH, V439, P141, DOI 10.1007/s004280100423; Neuhaus SJ, 2005, BRIT J SURG, V92, P246, DOI 10.1002/bjs.4802; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; PEDEUTOUR F, 1994, GENE CHROMOSOME CANC, V10, P85, DOI 10.1002/gcc.2870100203; Pilotti S, 2000, BRIT J CANCER, V82, P1271; Singer S, 2003, ANN SURG, V238, P358, DOI 10.1097/01.sla.0000086542.11899.38; Sirvent N, 2007, AM J SURG PATHOL, V31, P1476, DOI 10.1097/PAS.0b013e3180581fff	21	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e99452	10.1371/journal.pone.0099452	http://dx.doi.org/10.1371/journal.pone.0099452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121597	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000002
J	Lin, CH; Shih, CH; Tseng, CC; Yu, CC; Tsai, YJ; Bien, MY; Chen, BC				Lin, Chien-Huang; Shih, Chung-Huang; Tseng, Chih-Chieh; Yu, Chung-Chi; Tsai, Yuan-Jhih; Bien, Mauo-Ying; Chen, Bing-Chang			CXCL12 Induces Connective Tissue Growth Factor Expression in Human Lung Fibroblasts through the Rac1/ERK, JNK, and AP-1 Pathways	PLOS ONE			English	Article							NF-KAPPA-B; IDIOPATHIC PULMONARY-FIBROSIS; FACTOR-I; CIRCULATING FIBROCYTES; CANCER CELLS; REGULATED KINASE; EPITHELIAL-CELLS; FOCAL ADHESIONS; GENE-REGULATION; SIGNALING AXIS	CXCL12 (stromal cell-derived factor-1, SDF-1) is a potent chemokine for homing of CXCR4(+) fibrocytes to injury sites of lung tissue, which contributes to pulmonary fibrosis. Overexpression of connective tissue growth factor (CTGF) plays a critical role in pulmonary fibrosis. In this study, we investigated the roles of Rac1, extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and activator protein-1 (AP-1) in CXCL12-induced CTGF expression in human lung fibroblasts. CXCL12 caused concentration- and time-dependent increases in CTGF expression and CTGF-luciferase activity. CXCL12-induced CTGF expression was inhibited by a CXCR4 antagonist (AMD3100), small interfering RNA of CXCR4 (CXCR4 siRNA), a dominant negative mutant of Rac1 (RacN17), a mitogen-activated protein kinase (MAPK) kinase (MEK) inhibitor (PD98059), a JNK inhibitor (SP600125), a p21-activated kinase inhibitor (PAK18), c-Jun siRNA, and an AP-1 inhibitor (curcumin). Treatment of cells with CXCL12 caused activations of Rac1, Rho, ERK, and c-Jun. The CXCL12-induced increase in ERK phosphorylation was inhibited by RacN17. Treatment of cells with PD98059 and SP600125 both inhibited CXCL12-induced c-Jun phosphorylation. CXCL12 caused the recruitment of c-Jun and c-Fos binding to the CTGF promoter. Furthermore, CXCL12 induced an increase in alpha-smooth muscle actin (alpha-SMA) expression, a myofibroblastic phenotype, and actin stress fiber formation. CXCL12-induced actin stress fiber formation and alpha-SMA expression were respectively inhibited by AMD3100 and CTGF siRNA. Taken together, our results suggest that CXCL12, acting through CXCR4, activates the Rac/ERK and JNK signaling pathways, which in turn initiates c-Jun phosphorylation, and recruits c-Jun and c-Fos to the CTGF promoter and ultimately induces CTGF expression in human lung fibroblasts. Moreover, overexpression of CTGF mediates CXCL12-induced alpha-SMA expression.	[Lin, Chien-Huang; Tseng, Chih-Chieh; Yu, Chung-Chi; Tsai, Yuan-Jhih] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Shih, Chung-Huang; Bien, Mauo-Ying; Chen, Bing-Chang] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Shih, Chung-Huang; Bien, Mauo-Ying] Taipei Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Chen, BC (corresponding author), Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan.	bcchen@tmu.edu.tw		Lin, Chien-Huang/0000-0002-0916-8737	Taipei Medical University Hospital [101TMU-TMUH-06, 103-TMU-TMUH-04]; National Science Council of Taiwan [NSC100-2320-B-038-022MY2, NSC102-2320-B-038-049]	Taipei Medical University Hospital; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants (101TMU-TMUH-06 and 103-TMU-TMUH-04) from Taipei Medical University Hospital and (NSC100-2320-B-038-022MY2 and NSC102-2320-B-038-049) from the National Science Council of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksamitiene E, 2011, CELL SIGNAL, V23, P1794, DOI 10.1016/j.cellsig.2011.06.014; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Antoniou KM, 2013, EUR RESPIR REV, V22, P281, DOI 10.1183/09059180.00002113; Arai A, 2006, CELL SIGNAL, V18, P2162, DOI 10.1016/j.cellsig.2006.05.001; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Beei C, 2013, J TOXICOL SCI, V38, P793; Blom IE, 2001, J CLIN PATHOL-MOL PA, V54, P192, DOI 10.1136/mp.54.3.192; Blom IE, 2002, MATRIX BIOL, V21, P473, DOI 10.1016/S0945-053X(02)00055-0; Chen G, 2013, J CELL SCI, V126, P3697, DOI 10.1242/jcs.126714; Chen M, 2008, CELL PROLIFERAT, V41, P336, DOI 10.1111/j.1365-2184.2008.00519.x; Crean JKG, 2002, J BIOL CHEM, V277, P44187, DOI 10.1074/jbc.M203715200; Engers R, 2006, FEBS J, V273, P4754, DOI 10.1111/j.1742-4658.2006.05476.x; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Fuhler GM, 2008, BLOOD, V111, P359, DOI 10.1182/blood-2006-11-060632; Gassmann P, 2009, NEOPLASIA, V11, P651, DOI 10.1593/neo.09272; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Jin S, 2006, AM J PHYSIOL-GASTR L, V291, pG1137, DOI 10.1152/ajpgi.00031.2006; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kim K, 2007, J LEUKOCYTE BIOL, V82, P1332, DOI 10.1189/jlb.1106697; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Libura J, 2002, BLOOD, V100, P2597, DOI 10.1182/blood-2002-01-0031; Lin CH, 2006, J IMMUNOL, V177, P3427, DOI 10.4049/jimmunol.177.5.3427; Lin CH, 2013, CELL SIGNAL, V25, P1166, DOI 10.1016/j.cellsig.2013.01.018; Lin CH, 2011, J BIOL CHEM, V286, P10483, DOI 10.1074/jbc.M110.112433; Lin Q, 2010, EXP LUNG RES, V36, P120, DOI 10.3109/01902140903214659; Liu Y, 2013, J BIOL CHEM, V288, P30708, DOI 10.1074/jbc.M113.478685; Makino H, 2013, J MED INVESTIG, V60, P127, DOI 10.2152/jmi.60.127; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Murthy S, 2012, BIOCHEM J, V445, P229, DOI 10.1042/BJ20120053; Nakerakanti SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021911; Nasser MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023901; Oglesby IK, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-148; Oubrahim H, 2013, CELL SIGNAL, V25, P1136, DOI 10.1016/j.cellsig.2013.01.026; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Ping YF, 2011, J PATHOL, V224, P344, DOI 10.1002/path.2908; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Recchia AG, 2009, J MOL CELL CARDIOL, V46, P352, DOI 10.1016/j.yjmcc.2008.11.017; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; ROCHE WR, 1989, LANCET, V1, P520; Rosin NL, 2013, AM J PATHOL, V182, P714, DOI 10.1016/j.ajpath.2012.11.014; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Scupoli MT, 2008, HAEMATOLOGICA, V93, P524, DOI 10.3324/haematol.12098; Shi-wen X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007438; Singh AP, 2012, J BIOL CHEM, V287, P39115, DOI 10.1074/jbc.M112.409581; Tan CT, 2008, CARCINOGENESIS, V29, P1519, DOI 10.1093/carcin/bgn108; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Tung SY, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-91; Van Beek JP, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1890; Wang XH, 2011, RESPIROLOGY, V16, P500, DOI 10.1111/j.1440-1843.2011.01938.x; Wang Z, 2010, ONCOGENE, V29, P3362, DOI 10.1038/onc.2010.95; Weng CM, 2013, AM J RESP CRIT CARE, V188, P298, DOI 10.1164/rccm.201301-0132OC; Williams LA, 2008, MOL IMMUNOL, V45, P2446, DOI 10.1016/j.molimm.2007.12.011; Worrall JAR, 2011, FEBS J, V278, P663, DOI 10.1111/j.1742-4658.2010.07988.x; Xia W, 2007, ANN SURG, V246, P886, DOI 10.1097/SLA.0b013e318070d54f; Yu CC, 2009, J IMMUNOL, V182, P7916, DOI 10.4049/jimmunol.0801582; Zhang J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/492901	63	23	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104746	10.1371/journal.pone.0104746	http://dx.doi.org/10.1371/journal.pone.0104746			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121739	Green Submitted, Green Published, gold			2022-12-27	WOS:000341017000059
J	Zhang, YH; Meng, XZ; Chen, L; Li, D; Zhao, LF; Zhao, Y; Li, LX; Shi, HJ				Zhang, Yunhui; Meng, Xiangzhou; Chen, Li; Li, Dan; Zhao, Lifang; Zhao, Yan; Li, Luxi; Shi, Huijing			Age and Sex-Specific Relationships between Phthalate Exposures and Obesity in Chinese Children at Puberty	PLOS ONE			English	Article							WAIST CIRCUMFERENCE; BODY-MASS; ASSOCIATIONS; OVERWEIGHT; ACTIVATION; EXPRESSION; MONOESTERS; PATTERN; TISSUES; GIRLS	Objective: To examine the age and sex-specific associations of urine levels of six mono-phthalates with body size and fat distribution in Chinese children at puberty. Materials and Methods: Four hundred and ninety-three school-aged children (247 boys, 246 girls) were recruited. Obesity related anthropometric indices were measured and body fat proportion (BF%) was calculated. Spot urine samples were collected and phthalate monoesters were detected by an API 2000 electrospray triple quadrupole mass spectrometer (ESIMS/MS). Associations between phthalate exposure and overweight/obesity measures and their trends were examined by multiple linear regression and Logistic regression analyses, respectively. Results: Di-2-ethylhexyl phthalate (DEHP) metabolites and monobutyl phthalate (MBP) were found to be the most detectable chemicals. In 8-10 years (yrs) group, concentrations of MEHP and MBP were significantly higher in girls than those in boys. However, concentrations of all phthalate monoesters, except for MEP and MEHP, in 11-13 yrs boys were significantly higher than those in girls. After adjusting for confounders including puberty onset, urinary concentrations of MBP and sum of low molecular-weight phthalate metabolites (Sigma LMP) were positively associated with boys' obesity in a concentration-effect manner, while concentrations of MEHP, MEHHP and sum of DEHP metabolites (Sigma MEHP) were negatively associated with girls' obesity. Associations between phthalate exposure levels and BMI z-score changes were age-and sex-specific in school-age children. Conclusion: There are age and sex-specific concentration-effect associations between phthalate exposure and fat distribution in Chinese children. Urinary phthalate levels in 11-13 yrs boys were about 30 percent higher than those in girls, and Sigma MEHP levels in younger boys (<10 yrs) were significantly higher than those in elder boys (>10 yrs). Associations were positive for MBP and Sigma LMP with both BMI z-score and fat distribution in boys >10 years of age, and negative for Sigma MEHP with fat distribution in girls <10 years of age.	[Zhang, Yunhui; Chen, Li; Zhao, Yan; Li, Luxi] Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Key Lab Publ Hlth Safety,Chinese Minist Educ, Shanghai 200433, Peoples R China; [Meng, Xiangzhou; Zhao, Lifang] Tongji Univ, Coll Environm Sci & Engn, State Key Lab Pollut Control & Resources Reuse, Shanghai 200092, Peoples R China; [Li, Dan; Shi, Huijing] Fudan Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Key Lab Publ Hlth Safety,Chinese Minist Educ, Shanghai 200433, Peoples R China	Fudan University; Tongji University; Fudan University	Shi, HJ (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Key Lab Publ Hlth Safety,Chinese Minist Educ, Shanghai 200433, Peoples R China.	hjshi@fudan.edu.cn	Shi, Huijing/GRR-8564-2022		Natural Science Foundation of China [81072263, 81172684]; Shanghai Municipal Health Bureau [12GWZX0301]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau	This research was supported by grants from the Natural Science Foundation of China (Grant 81072263, to Y. Z.; Grant 81172684, to H. S.), and by an award from the Shanghai Municipal Health Bureau (Grant 12GWZX0301, to X. Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253; Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Feige JN, 2010, ENVIRON HEALTH PERSP, V118, P234, DOI 10.1289/ehp.0901217; Goran MI, 1999, AM J CLIN NUTR, V70, p149S; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3138, DOI 10.1021/es103879m; Hao CJ, 2012, BIOSCIENCE REP, V32, P619, DOI 10.1042/BSR20120042; Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27; Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212; HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145; Itsuki-Yoneda A, 2007, BIOSCI BIOTECH BIOCH, V71, P414, DOI 10.1271/bbb.60478; Jiang Y, 2007, SHANGHAI J PREVEN ME, V19, P544; Li De-Bing, 2013, Journal of Fisheries International, V8, P1; Lind PM, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-21; Ma HM, 2011, INT J ANDROL, V34, pE435, DOI 10.1111/j.1365-2605.2011.01173.x; Maffeis C, 2003, EUR J CLIN NUTR, V57, P566, DOI 10.1038/sj.ejcn.1601573; Marinelli R, 2010, OBESITY SILVER SPRIN, V18, P2170; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Organization WH, 2009, GLOB HLTH RISKS MORT; Prader A, 1966, Triangle, V7, P240; Silva MJ, 2004, ENV HLTH PERSPECT, V112, P685; Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882; Teitelbaum SL, 2012, ENVIRON RES, V112, P186, DOI 10.1016/j.envres.2011.12.006; Trasande L, 2013, ENVIRON HEALTH PERSP, V121, P501, DOI 10.1289/ehp.1205526; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074508; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Yao Xing-Jia, 1994, Zhonghua Yufang Yixue Zazhi, V28, P213	33	54	57	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104852	10.1371/journal.pone.0104852	http://dx.doi.org/10.1371/journal.pone.0104852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121758	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000066
J	Jiang, HC; Xing, ZJ; Lu, W; Qian, ZJ; Yu, HW; Li, JL				Jiang, Hucheng; Xing, Zhijun; Lu, Wei; Qian, Zhaojun; Yu, Hongwei; Li, Jiale			Transcriptome Analysis of Red Swamp Crawfish Procambarus clarkii Reveals Genes Involved in Gonadal Development	PLOS ONE			English	Article							VASA-LIKE GENE; MOLECULAR CHARACTERIZATION; OVARIAN DEVELOPMENT; VITELLOGENIN RECEPTOR; LITOPENAEUS-VANNAMEI; EXPRESSION ANALYSIS; MESSENGER-RNA; GERM-CELL; SHRIMP; PROTEIN	Background: The red swamp crawfish, Procambarus clarkii, has become one of the most economically important cultured species in China. Currently, little is known about the gonadal development of this species. Isolation and characterization of genes are an initial step towards understanding gonadal development of P. clarkii. Results: Using the 454 pyrosequencing technology, we obtained a total of 1,134,993 high quality sequence reads from the crawfish testis and ovary libraries. We aimed to identify different genes with a potential role in gonad development. The assembly formed into 22,652 isotigs, distributed by GO analysis across 55 categories in the three ontologies, 'molecular function', 'cellular component', and 'biological processes'. Comparative transcript analysis showed that 1,720 isotigs in the ovary were up-regulated and 2138 isotigs were down-regulated. Several gonad development related genes, such as vitellogenin, cyclin B, cyclin-dependent kinases 2, Dmc1 and ubiquitin were identified. Quantitative real-time PCR verified the expression profiles of 14 differentially expressed genes, and confirmed the reliability of the 454 pyrosequencing. Conclusions: Our findings provide an archive for future research on gonadal development at a molecular level in P. clarkii and other crustacean. This data will be helpful to develop new ideas for artificial regulation of the reproductive process in crawfish aquaculture.	[Jiang, Hucheng; Xing, Zhijun; Qian, Zhaojun; Li, Jiale] Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China; [Lu, Wei; Yu, Hongwei] Jiangsu Xuyi Riverred Crawfish Eco Pk CO LTD, Xuyi, Peoples R China; [Li, Jiale] Shanghai Ocean Univ, E Inst Shanghai Univ, Shanghai, Peoples R China	Shanghai Ocean University; Shanghai Ocean University	Li, JL (corresponding author), Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, Minist Educ, Shanghai, Peoples R China.	jlli2009@126.com	li, jia/GVT-7587-2022		Project of Shanghai Engineering and Technology Center for Promoting Ability [13DZ2280500]; Shanghai Universities Knowledge Service Platform [ZF1206]	Project of Shanghai Engineering and Technology Center for Promoting Ability; Shanghai Universities Knowledge Service Platform	This study was supported by the Project of Shanghai Engineering and Technology Center for Promoting Ability (13DZ2280500) and Shanghai Universities Knowledge Service Platform (ZF1206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflalo ED, 2007, MOL REPROD DEV, V74, P172, DOI 10.1002/mrd.20622; Alekseev OM, 2009, BIOL REPROD, V81, P739, DOI 10.1095/biolreprod.109.076497; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baarends WM, 1999, MOL CELL ENDOCRINOL, V151, P5, DOI 10.1016/S0303-7207(99)00060-X; Barrios F, 2010, J CELL SCI, V123, P871, DOI 10.1242/jcs.057968; Benjamini Y, 2001, ANN STAT, V29, P1165; Chen J., 2013, IEEE T IND INF, P1, DOI DOI 10.1145/2537052.2537057; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; FAO, 2009, FAO STAT DAT; Feng ZF, 2011, AQUACULTURE, V314, P202, DOI 10.1016/j.aquaculture.2011.02.017; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HADWIGER JA, 1989, MOL CELL BIOL, V9, P2034, DOI 10.1128/MCB.9.5.2034; Hall T.A., 1999, BIOEDIT SOFTWARE VER; Huner J.V., 1988, P239; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lalitha S., 2000, BIOTECH SOFTWARE INT, V1, P270, DOI [10.1089/152791600459894, DOI 10.1089/152791600459894]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leelatanawit R, 2009, COMP BIOCHEM PHYS A, V152, P66, DOI 10.1016/j.cbpa.2008.09.004; Li CF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034642, 10.1371/journal.pone.0030026, 10.1371/journal.pone.0047442]; Li J.L., 2007, INVASIVE AQUATIC SPE; Liang Chen, 2009, Nanfang Shuichan, V5, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Miura C, 2002, ZOOL SCI, V19, P87, DOI 10.2108/zsj.19.87; Miyamoto T, 2008, J ASSIST REPROD GEN, V25, P553, DOI 10.1007/s10815-008-9270-x; Mizuta H, 2013, COMP BIOCHEM PHYS B, V166, P81, DOI 10.1016/j.cbpb.2013.07.005; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Okutsu T, 2010, FISHERIES SCI, V76, P961, DOI 10.1007/s12562-010-0295-6; Olsen LC, 1997, MECH DEVELOP, V66, P95, DOI 10.1016/S0925-4773(97)00099-3; Phinyo M, 2013, GEN COMP ENDOCR, V193, P103, DOI 10.1016/j.ygcen.2013.07.012; Phiriyangkul P, 2006, MOL REPROD DEV, V73, P410, DOI 10.1002/mrd.20424; Prasertlux S, 2011, AQUACULTURE, V322, P134, DOI 10.1016/j.aquaculture.2011.09.037; Qiu GF, 2005, COMP BIOCHEM PHYS B, V140, P171, DOI 10.1016/j.cbpc.2004.09.027; Qiu LH, 2008, MOL BIOL REP, V35, P431, DOI 10.1007/s11033-007-9103-5; Raviv S, 2006, GEN COMP ENDOCR, V145, P39, DOI 10.1016/j.ygcen.2005.06.009; Roth Z, 2012, MOL REPROD DEV, V79, P478, DOI 10.1002/mrd.22055; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Sellars MJ, 2007, MAR BIOTECHNOL, V9, P377, DOI 10.1007/s10126-007-6118-9; Shui Y, 2012, AQUACULTURE, V370, P14, DOI 10.1016/j.aquaculture.2012.09.032; Song L, 2011, J CHANGSHU I TECHNOL, V25, P85; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiu SHK, 2008, BIOL REPROD, V79, P66, DOI 10.1095/biolreprod.107.066258; Turk B, 1997, BIOL CHEM, V378, P141; Vigodner M, 2006, AM J PHYSIOL-ENDOC M, V290, pE1022, DOI 10.1152/ajpendo.00527.2005; Vigodner M, 2005, DEV BIOL, V282, P480, DOI 10.1016/j.ydbio.2005.03.034; Visudtiphole V, 2009, COMP BIOCHEM PHYS A, V152, P535, DOI 10.1016/j.cbpa.2008.12.011; Wang W, 2005, FEMS MICROBIOL LETT, V249, P131, DOI 10.1016/j.femsle.2005.06.005; Wang YL, 2012, MOL BIOL REP, V39, P4327, DOI 10.1007/s11033-011-1220-5; Wu HY, 2010, FEBS LETT, V584, P2807, DOI 10.1016/j.febslet.2010.05.016; Wu MH, 2003, GENE EXPR PATTERNS, V3, P231, DOI 10.1016/S1567-133X(03)00036-X; Xia AJ, 2008, FRESHWATER FISHERIES, V38, P12; Xie S, 2009, MOL BIOL REP, V36, P389, DOI 10.1007/s11033-007-9192-1; Yang F, 2005, COMP BIOCHEM PHYS B, V142, P456, DOI 10.1016/j.cbpb.2005.09.011; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu QS, 2008, MOL CELL BIOCHEM, V315, P17, DOI 10.1007/s11010-008-9783-8; Yue GH, 2010, INT J BIOL SCI, V6, P107; Zhang EF, 2010, DEV GENES EVOL, V220, P151, DOI 10.1007/s00427-010-0336-2; Zhang ZP, 2010, DNA CELL BIOL, V29, P163, DOI 10.1089/dna.2009.0958; Zhao W, 2013, GENET MOL RES, V12, P5215, DOI 10.4238/2013.October.30.6; Zhao WH, 2011, MOL BIOL REP, V38, P1399, DOI 10.1007/s11033-010-0243-7; Zhu Xiao-ling, 2010, Marine Fisheries, V32, P132	66	46	49	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105122	10.1371/journal.pone.0105122	http://dx.doi.org/10.1371/journal.pone.0105122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118947	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600126
J	Pagnozzi, D; Biosa, G; Addis, MF; Mastrandrea, S; Masala, G; Uzzau, S				Pagnozzi, Daniela; Biosa, Grazia; Addis, Maria Filippa; Mastrandrea, Scilla; Masala, Giovanna; Uzzau, Sergio			An Easy and Efficient Method for Native and Immunoreactive Echinococcus granulosus Antigen 5 Enrichment from Hydatid Cyst Fluid	PLOS ONE			English	Article							SUBUNIT COMPOSITION; IMMUNODIAGNOSIS; DIAGNOSIS; PROTEINS; IDENTIFICATION; SERODIAGNOSIS; PURIFICATION; SPECIFICITY; LIPOPROTEIN; INFECTION	Background: Currently, the serodiagnosis of cystic echinococcosis relies mostly on crude Echinococcus granulosus hydatid cyst fluid as the antigen. Consequently, available immunodiagnostic tests lack standardization of the target antigen and, in turn, this is reflected on poor sensitivity and specificity of the serological diagnosis. Methodology/Principal Findings: Here, a chromatographic method enabling the generation of highly enriched Antigen 5 (Ag5) is described. The procedure is very easy, efficient and reproducible, since different hydatid cyst fluid (HCF) sources produced very similar chromatograms, notwithstanding the clearly evident and extreme heterogeneity of the starting material. In addition, the performance of the antigen preparation in immunological assays was preliminarily assessed by western immunoblotting and ELISA on a limited panel of cystic echinococcosis patients and healthy controls. Following western immunoblotting and ELISA experiments, a high reactivity of patient sera was seen, with unambiguous and highly specific results. Conclusions/Significance: The methods and results reported open interesting perspectives for the development of sensitive diagnostic tools to enable the timely and unambiguous detection of cystic echinococcosis antibodies in patient sera.	[Pagnozzi, Daniela; Biosa, Grazia; Addis, Maria Filippa; Uzzau, Sergio] Porto Conte Ric Srl, Sassari, Italy; [Mastrandrea, Scilla; Masala, Giovanna] Ctr Nazl Riferimento Echinococcosi, IZS G Pegreffi, Sassari, Italy; [Mastrandrea, Scilla] Azienda Osped Univ, Unita Operat Complessa Malattie Infett, Sassari, Italy	Porto Conte Ricerche; IZS Della Sardegna	Pagnozzi, D (corresponding author), Porto Conte Ric Srl, Sassari, Italy.	pagnozzi@portocontericerche.it	Uzzau, Sergio/F-3233-2015; Addis, Maria Filippa/I-5381-2019	Uzzau, Sergio/0000-0001-6246-2794; Addis, Maria Filippa/0000-0001-6934-7748; Pagnozzi, Daniela/0000-0001-7764-1867; , Giovanna Masala/0000-0001-5301-2580; Biosa, Grazia/0000-0002-0252-5439	Regione Autonoma della Sardegna	Regione Autonoma della Sardegna(Regione Sardegna)	This work was supported by Regione Autonoma della Sardegna (http://www.regione.sardegna.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis MF, 2011, INFECT IMMUN, V79, P3833, DOI 10.1128/IAI.00040-11; Addis MF, 2009, PROTEOMICS, V9, P4329, DOI 10.1002/pmic.200900010; Alberti A, 2008, VET MICROBIOL, V128, P81, DOI 10.1016/j.vetmic.2007.09.020; Auer H, 2009, WIEN KLIN WOCHENSCHR, V121, P37, DOI 10.1007/s00508-009-1233-4; Aziz A, 2011, J PROTEOMICS, V74, P1560, DOI 10.1016/j.jprot.2011.02.021; Ben Nouir N, 2009, T ROY SOC TROP MED H, V103, P355, DOI 10.1016/j.trstmh.2008.09.020; Benner C, 2010, B WORLD HEALTH ORGAN, V88, P49, DOI 10.2471/BLT.09.066795; Biava MF, 2001, WORLD J SURG, V25, P10, DOI 10.1007/s002680020002; Biosa G, 2011, J PROTEOMICS, V75, P93, DOI 10.1016/j.jprot.2011.06.025; Carmena D, 2006, ACTA TROP, V98, P74, DOI 10.1016/j.actatropica.2006.02.002; Carmena D, 2004, PARASITOLOGY, V129, P371, DOI 10.1017/S0031182004005670; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; CHORDI A, 1965, J PARASITOL, V51, P63, DOI 10.2307/3275647; DIFELICE G, 1986, MOL BIOCHEM PARASIT, V20, P133, DOI 10.1016/0166-6851(86)90025-3; Dionigi Gianlorenzo, 2007, J Med Case Rep, V1, P61, DOI 10.1186/1752-1947-1-61; Gadea I, 1999, CLIN DIAGN LAB IMMUN, V6, P504, DOI 10.1128/CDLI.6.4.504-508.1999; Garippa G., 2006, Parassitologia (Rome), V48, P57; Garippa G., 2004, Parassitologia (Rome), V46, P387; Grosso G, 2012, WORLD J GASTROENTERO, V18, P1425, DOI 10.3748/wjg.v18.i13.1425; Ishida MMI, 2003, ACTA TROP, V89, P73, DOI 10.1016/j.actatropica.2003.09.005; Jiang L, 2012, EXP PARASITOL, V131, P85, DOI 10.1016/j.exppara.2012.03.009; Kalantari E, 2010, PARASITOL RES, V106, P847, DOI 10.1007/s00436-010-1726-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAURIOLA L, 1978, ZBL BAKT-INT J MED M, V240, P251; LIGHTOWLERS MW, 1989, MOL BIOCHEM PARASIT, V37, P171, DOI 10.1016/0166-6851(89)90149-7; List C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000771; Lorenzo C, 2005, J CLIN MICROBIOL, V43, P2764, DOI 10.1128/JCM.43.6.2764-2770.2005; Lorenzo C, 2005, PARASITOLOGY, V131, P669, DOI 10.1017/S0031182005008309; Lorenzo C, 2003, BIOCHEM J, V369, P191, DOI 10.1042/BJ20021402; Margutti P, 2008, DIAGN MICR INFEC DIS, V60, P279, DOI 10.1016/j.diagmicrobio.2007.10.004; Mastrandrea S, 2012, ACTA TROP, V123, P184, DOI 10.1016/j.actatropica.2012.05.004; Monteiro KM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001551; Moro P, 2009, INT J INFECT DIS, V13, P125, DOI 10.1016/j.ijid.2008.03.037; Obal G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001642; ORIOL R, 1971, AM J TROP MED HYG, V20, P569, DOI 10.4269/ajtmh.1971.20.569; Ortona E, 2000, PARASITE IMMUNOL, V22, P553, DOI 10.1046/j.1365-3024.2000.00336.x; POZZUOLI R, 1975, J IMMUNOL, V115, P1459; POZZUOLI R, 1974, EXP PARASITOL, V35, P52, DOI 10.1016/0014-4894(74)90006-X; Siles-Lucas M, 1998, PARASITE IMMUNOL, V20, P473, DOI 10.1046/j.1365-3024.1998.00178.x; Siracusano A, 2009, INTERDISCIP PERSPECT, V2009; Siracusano A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/639362; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; van Doorn HR, 2007, DIAGN MICR INFEC DIS, V57, P409, DOI 10.1016/j.diagmicrobio.2006.10.002; Zhang LH, 1996, PARASITE IMMUNOL, V18, P597, DOI 10.1046/j.1365-3024.1996.d01-42.x; Zhang WB, 2003, CLIN MICROBIOL REV, V16, P18, DOI 10.1128/CMR.16.1.18-36.2003; Zhang Wenbao, 2012, Clin Dev Immunol, V2012, P101895, DOI 10.1155/2012/101895; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zheng HJ, 2013, NAT GENET, V45, P1168, DOI 10.1038/ng.2757	48	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104962	10.1371/journal.pone.0104962	http://dx.doi.org/10.1371/journal.pone.0104962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119821	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600108
J	Qin, H; Qiu, JG; Zhao, YY; Pan, G; Zeng, Y				Qin, Han; Qiu, Jianguo; Zhao, Yiyang; Pan, Gang; Zeng, Yong			Does Minimally-Invasive Pancreaticoduodenectomy Have Advantages over Its Open Method? A Meta-Analysis of Retrospective Studies	PLOS ONE			English	Article							ASSISTED LAPAROSCOPIC PANCREATICODUODENECTOMY; INTERNATIONAL STUDY-GROUP; DISTAL PANCREATECTOMY; GASTRIC-CANCER; COMPLICATIONS; RESECTION; GASTRECTOMY; OUTCOMES; SURGERY; FISTULA	Background: While more and more open procedures now routinely performed using laparoscopy, minimally invasive pancreaticoduodenectomy (MIPD) remains one of the most challenging abdominal procedures. Therefore, we carried out this meta-analysis to evaluate whether MIPD is safe, feasible and worthwhile. Methods: PubMed, EMBASE, and Cochrane Library were searched to identify studies published between January 1994 and November 2013 comparing MIPD with open pancreaticoduodenectomy (OPD). Intraoperative outcomes, oncologic safety, postoperative complications, and postoperative recovery were evaluated. Results: 11 retrospective studies representing 869 patients (327 MIPDs, 542 OPDs) were included. MIPD was associated with a reduction in estimated blood loss (MD -361.93 ml, 95% CI -519.22 to -204.63 ml, p<0.001, I-2 = 94%), wound infection (OR 0.41, 95% CI 0.22 to 0.78, p = 0.007, I-2 = 0%), and hospital stay (MD -2.64 d, 95% CI -4.23 to -1.05 d, p = 0.001, I-2 = 78%). However, it brings longer operative time (MD 105 min, 95% CI 49.73 to 160.26 min, p<0.001, I-2 = 93%). There were no significant differences between the two procedures in likelihood of overall complications (p = 0.05), pancreatic fistula (PF) (p = 0.86), delayed gastric empting (DGE) (p = 0.96), positive surgical margins (p = 0.07), retrieval of lymph nodes (p = 0.48), reoperation (p = 0.16) and mortality (p = 0.64). Conclusions: Our results suggest that MIPD is currently safe, feasible and worthwhile. But considering the selection bias, complexity of MIPD and lack of long-term oncologic outcomes, we suggest it be performed in a high-volume pancreatic surgery center in selected patients.	[Qin, Han; Pan, Gang; Zeng, Yong] Sichuan Univ, West China Hosp, Dept Hepat Surg, Chengdu 610064, Sichuan, Peoples R China; [Qiu, Jianguo] Chongqing Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Zhao, Yiyang] Sichuan Univ, West China Hosp, Dept Pediat Surg, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Chongqing Medical University; Sichuan University	Zeng, Y (corresponding author), Sichuan Univ, West China Hosp, Dept Hepat Surg, Chengdu 610064, Sichuan, Peoples R China.	zengyonghxyy@163.com						Asbun HJ, 2012, J AM COLL SURGEONS, V215, P810, DOI 10.1016/j.jamcollsurg.2012.08.006; Athanasiou T, 2004, ANN THORAC SURG, V77, P745, DOI 10.1016/j.athoracsur.2003.07.002; Bao PQ, 2013, J GASTROINTEST SURG; Barlehner E, 2002, DIGEST SURG, V19, P507, DOI 10.1159/000067606; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Buchs NC, 2011, WORLD J SURG, V35, P2739, DOI 10.1007/s00268-011-1276-3; Chalikonda S, 2012, SURG ENDOSC, V26, P2397, DOI 10.1007/s00464-012-2207-6; Cho A, 2009, AM J SURG, V198, P445, DOI 10.1016/j.amjsurg.2008.12.025; Clarke M, 2001, LANCET, V357, P1728, DOI 10.1016/S0140-6736(00)04934-5; Dulucq JL, 2006, SURG ENDOSC, V20, P1045, DOI 10.1007/s00464-005-0474-1; Dulucq JL, 2005, SURG ENDOSC, V19, P1028, DOI 10.1007/s00464-004-2182-7; Farid S, 2013, J AM COLL SURGEONS, V216, P1220, DOI 10.1016/j.jamcollsurg.2013.02.018; Gouma DJ, 2000, ANN SURG, V232, P786, DOI 10.1097/00000658-200012000-00007; Gumbs AA, 2008, J GASTROINTEST SURG, V12, P707, DOI 10.1007/s11605-007-0311-z; Gumbs AA, 2011, ANN SURG ONCOL, V18, P1335, DOI 10.1245/s10434-010-1503-4; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huscher CGS, 2005, ANN SURG, V241, P232, DOI 10.1097/01.sla.0000151892.35922.f2; Kendrick ML, 2010, ARCH SURG-CHICAGO, V145, P19, DOI 10.1001/archsurg.2009.243; Kuroki T, 2012, HEPATO-GASTROENTEROL, V59, P570, DOI 10.5754/hge11351; Lai ECH, 2013, ASIAN J ENDOSC SURG, V6, P158, DOI 10.1111/ases.12040; Lai ECH, 2012, INT J SURG, V10, P475, DOI 10.1016/j.ijsu.2012.06.003; Li Yong-bin, 2013, Zhonghua Wai Ke Za Zhi, V51, P304; Mesleh MG, 2013, SURG ENDOSC, V27, P4518, DOI 10.1007/s00464-013-3101-6; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Nakamura M, 2013, J HEPATO-BIL-PAN SCI, V20, P421, DOI 10.1007/s00534-012-0578-7; Palanivelu C, 2009, J HEPATO-BILIARY-PAN, V16, P731, DOI 10.1007/s00534-009-0157-8; Palanivelu C, 2007, J AM COLL SURGEONS, V205, P222, DOI 10.1016/j.jamcollsurg.2007.04.004; Pugliese R, 2008, SURG LAPARO ENDO PER, V18, P13, DOI 10.1097/SLE.0b013e3181581609; Qiu JG, 2011, WORLD J GASTROENTERO, V17, P3359, DOI 10.3748/wjg.v17.i28.3359; Qiu JG, 2013, SURG PRACT, V17, P49, DOI 10.1111/1744-1633.12009; Qiu JG, 2013, SURG LAPARO ENDO PER, V23, P1, DOI 10.1097/SLE.0b013e3182747af7; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suc B, 2003, ANN SURG, V237, P57, DOI 10.1097/00000658-200301000-00009; Tacconelli E, 2010, LANCET INFECT DIS, V10, P226, DOI DOI 10.1016/S1473-3099(10)70065-7; Tranchart H, 2012, ANN SURG, V256, P139, DOI 10.1097/SLA.0b013e318256c32c; Underwood R A, 1999, J Hepatobiliary Pancreat Surg, V6, P154, DOI 10.1007/s005340050099; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Zheng MH, 2006, MED SCI MONITOR, V12, pCS57; Zhou NX, 2011, INT J MED ROBOT COMP, V7, P131, DOI 10.1002/rcs.380; Zureikat AH, 2011, J GASTROINTEST SURG, V15, P1151, DOI 10.1007/s11605-011-1530-x	41	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104274	10.1371/journal.pone.0104274	http://dx.doi.org/10.1371/journal.pone.0104274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119463	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600045
J	Xue, RY; Hu, XL; Cao, GL; Huang, ML; Xue, GX; Qian, Y; Song, ZW; Gong, CL				Xue, Renyu; Hu, Xiaolong; Cao, Guangli; Huang, Moli; Xue, Gaoxu; Qian, Ying; Song, Zuowei; Gong, Chengliang			Bmovo-1 Regulates Ovary Size in the Silkworm, Bombyx mori	PLOS ONE			English	Article							DROSOPHILA-OVO GENE; EPIDERMIS DIFFERENTIATION; TREHALASE ACTIVITY; EXPRESSION; MELANOGASTER; GERMLINE; SEQUENCE; CODONS; GENOME; CREATE	The regulation of antagonistic OVO isoforms is critical for germline formation and differentiation in Drosophila. However, little is known about genes related to ovary development. In this study, we cloned the Bombyx mori ovo gene and investigated its four alternatively spliced isoforms. BmOVO-1, BmOVO-2 and BmOVO-3 all had four C2H2 type zinc fingers, but differed at the N-terminal ends, while BmOVO-4 had a single zinc finger. Bmovo-1, Bmovo-2 and Bmovo-4 showed the highest levels of mRNA in ovaries, while Bmovo-3 was primarily expressed in testes. The mRNA expression pattern suggested that Bmovo expression was related to ovary development. RNAi and transgenic techniques were used to analyze the biological function of Bmovo. The results showed that when the Bmovo gene was downregulated, oviposition number decreased. Upregulation of Bmovo-1 in the gonads of transgenic silkworms increased oviposition number and elevated the trehalose contents of hemolymph and ovaries. We concluded that Bmovo-1 was involved in protein synthesis, contributing to the development of ovaries and oviposition number in silkworms.	[Xue, Renyu; Hu, Xiaolong; Cao, Guangli; Huang, Moli; Xue, Gaoxu; Qian, Ying; Song, Zuowei; Gong, Chengliang] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou, Peoples R China; [Xue, Renyu; Hu, Xiaolong; Cao, Guangli; Gong, Chengliang] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou, Peoples R China	Soochow University - China; Soochow University - China	Gong, CL (corresponding author), Soochow Univ, Sch Biol & Basic Med Sci, Suzhou, Peoples R China.	gongcl@suda.edu.cn		Huang, Moli/0000-0001-5543-9334	National Basic Research Program of China (973 Program) [2012CB114600]; National Natural Science Foundation of China [31072085]; Specialized Research Fund for the Doctoral Program of Higher Education [20113201130002]; Priority Academic Program of Development of Jiangsu Higher Education Institutions	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program of Development of Jiangsu Higher Education Institutions	We gratefully acknowledge the financial support of the National Basic Research Program of China (973 Program, 2012CB114600), the National Natural Science Foundation of China (31072085), the Specialized Research Fund for the Doctoral Program of Higher Education (20113201130002), and a project funded by the Priority Academic Program of Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews J, 1998, DEV GENES EVOL, V207, P482, DOI 10.1007/s004270050139; Andrews J, 2000, DEVELOPMENT, V127, P881; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Cao GL, 2012, MOL BIOL REP, V39, P5967, DOI 10.1007/s11033-011-1409-7; Chidambaram A, 1997, MAMM GENOME, V8, P950, DOI 10.1007/s003359900620; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Dai X, 1998, GENE DEV, V12, P3452, DOI 10.1101/gad.12.21.3452; GARFINKEL MD, 1994, MOL CELL BIOL, V14, P6809, DOI 10.1128/MCB.14.10.6809; Ge LQ, 2011, PESTIC BIOCHEM PHYS, V100, P172, DOI 10.1016/j.pestbp.2011.03.007; Khila A, 2003, INSECT BIOCHEM MOLEC, V33, P691, DOI 10.1016/S0965-1748(03)00063-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JN, 1998, DEV GENES EVOL, V208, P213, DOI 10.1007/s004270050175; Masu Y, 1998, FEBS LETT, V421, P224, DOI 10.1016/S0014-5793(97)01567-6; MEVELNINIO M, 1991, EMBO J, V10, P2259, DOI 10.1002/j.1460-2075.1991.tb07762.x; MevelNinio M, 1996, DEVELOPMENT, V122, P4131; OLIVER B, 1987, GENE DEV, V1, P913, DOI 10.1101/gad.1.9.913; OLIVER B, 1994, DEVELOPMENT, V120, P3185; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Xue RY, 2009, J BIOTECHNOL, V144, P272, DOI 10.1016/j.jbiotec.2009.09.004; YAMASHITA O, 1972, GEN COMP ENDOCR, V18, P515, DOI 10.1016/0016-6480(72)90031-7; Zhang PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047861; Zhou WL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102822	26	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104928	10.1371/journal.pone.0104928	http://dx.doi.org/10.1371/journal.pone.0104928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119438	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600105
J	Chung, W; Kim, R				Chung, Woojin; Kim, Roeul			Does Marriage Really Matter to Health? Intra- and Inter-Country Evidence from China, Japan, Taiwan, and the Republic of Korea	PLOS ONE			English	Article							SELF-RATED HEALTH; MARITAL-STATUS; DEPRESSIVE SYMPTOMS; REPORTED HEALTH; SON PREFERENCE; MORTALITY; LIFE; SELECTION; AGE; QUALITY	Background: The health benefits of marriage have been demonstrated mainly by studies on Western populations. This study aims to test whether the benefits are also valid in East Asian populations. Methodology/Principal Findings: Individuals (n = 8,538) from China, Japan, Taiwan, and the Republic of Korea were sampled from the 2006 East Asian Social Survey. The association between self-rated health status and two marriage-related independent variables was analyzed using multivariate logistic regression models. In a two-level analysis for individuals from all countries, married individuals were more likely to report very good or good health compared to their never-married counterparts [odds ratio (OR) 1.56; 95% confidence interval (95% CI) 1.16-2.10]. However, the addition of marital satisfaction disintegrated the significant association of marriage with self-rated health. Married individuals in satisfying marriages were more likely to report very good or good health compared with never-married individuals (OR 1.85; 95% CI 1.37-2.50). In contrast, married individuals in dissatisfying marriages were as likely to report very good or good health as never-married individuals (OR 0.78; 95% CI 0.50-1.24). In a one-level analysis for each country, the importance of marital satisfaction varied greatly across countries. Unlike in other countries, in Japan, married individuals in dissatisfying marriages were about half as likely to report very good or good health as never-married individuals (OR 0.51, 95% CI 0.31-0.83), thereby showing no significant benefits from marriage with regard to self-rated health. Conclusion/Significance: The present study of East Asian countries suggests that marital satisfaction is of greater importance in determining self-rated health than marriage itself, and that the importance of marital satisfaction varies across countries. Further research is required to better understand the relationship between marital satisfaction and self-rated health in different socio-cultural settings, and to establish effective social policies aiming at improving public health.	[Chung, Woojin] Yonsei Univ, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Seoul 120749, South Korea; [Chung, Woojin; Kim, Roeul] Yonsei Univ, Inst Hlth Serv Res, Seoul 120749, South Korea; [Kim, Roeul] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University	Kim, R (corresponding author), Yonsei Univ, Inst Hlth Serv Res, Seoul 120749, South Korea.	claire00@yuhs.ac		chung, woojin/0000-0003-2090-4851; Kim, Roeul/0000-0003-4663-4490				Academy of East Asian Studies, 2006, E AS SOC SURV STUD D; Balog P, 2003, J PSYCHOSOM RES, V54, P113, DOI 10.1016/S0022-3999(02)00485-3; Benjamins MR, 2004, SOC SCI MED, V59, P1297, DOI 10.1016/j.socscimed.2003.01.001; Bookwala J, 2011, J GERONTOL B-PSYCHOL, V66, P605, DOI 10.1093/geronb/gbr091; CALLAHAN CM, 1994, J AM GERIATR SOC, V42, P833, DOI 10.1111/j.1532-5415.1994.tb06554.x; Carter H, 1976, MARRIAGE DIVORCE SOC; Cheung YB, 1998, PUBLIC HEALTH, V112, P113; D'Souza MS, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-24; Das Gupta M, 2003, J DEV STUD, V40, P153, DOI 10.1080/00220380412331293807; Das Gupta M, 2009, POPUL DEV REV, V35, P401; Dieperink KB, 2012, ACTA ONCOL, V51, P722, DOI 10.3109/0284186X.2012.682627; Dommaraju P, 2011, ASIAN J SOC SCI, V39, P725, DOI 10.1163/156853111X619201; EBRAHIM S, 1995, AM J EPIDEMIOL, V142, P834, DOI 10.1093/oxfordjournals.aje.a117723; Edlund L, 1999, J POLIT ECON, V107, P1275, DOI 10.1086/250097; Gardner J, 2004, J HEALTH ECON, V23, P1181, DOI 10.1016/j.jhealeco.2004.03.002; Ghimire DJ, 2006, AM J SOCIOL, V111, P1181, DOI 10.1086/498468; GOLDMAN N, 1993, DEMOGRAPHY, V30, P189, DOI 10.2307/2061837; Han B, 2002, J AM GERIATR SOC, V50, P1549, DOI 10.1046/j.1532-5415.2002.50411.x; Hanibuchi T, 2012, EUR J PUBLIC HEALTH, V22, P47, DOI 10.1093/eurpub/ckq174; Holt-Lunstad J, 2008, ANN BEHAV MED, V35, P239, DOI 10.1007/s12160-008-9018-y; Hosseinpoor AR, 2013, AM J PUBLIC HEALTH, V103, P1278, DOI 10.2105/AJPH.2012.301115; Idler E, 2004, J HEALTH SOC BEHAV, V45, P336, DOI 10.1177/002214650404500307; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; JENKINS CD, 1980, AM J PUBLIC HEALTH, V70, P82, DOI 10.2105/AJPH.70.1.82; Jones GW, 2005, J COMP FAM STUD, V36, P93, DOI 10.3138/jcfs.36.1.93; Joutsenniemi KE, 2006, EUR J PUBLIC HEALTH, V16, P476, DOI 10.1093/eurpub/cki221; Kimmel PL, 2000, J AM SOC NEPHROL, V11, P1518, DOI 10.1681/ASN.V1181518; Kivela SL, 1999, J AFFECT DISORDERS, V54, P177, DOI 10.1016/S0165-0327(98)00143-8; LILLARD LA, 1995, AM J SOCIOL, V100, P1131, DOI 10.1086/230634; Lindstrom M, 2009, HEALTH POLICY, V93, P172, DOI 10.1016/j.healthpol.2009.05.010; Liu H, 2012, SOC SCI MED, V74, P1107, DOI 10.1016/j.socscimed.2011.11.037; MADDOX GL, 1973, J HEALTH SOC BEHAV, V14, P87, DOI 10.2307/2136940; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; Murray JE, 2000, DEMOGRAPHY, V37, P511, DOI 10.1353/dem.2000.0010; Penninx BWJH, 1997, AM J EPIDEMIOL, V146, P510, DOI 10.1093/oxfordjournals.aje.a009305; Pimentel EF, 2000, J MARRIAGE FAM, V62, P32, DOI 10.1111/j.1741-3737.2000.00032.x; Prince MJ, 1999, BRIT J PSYCHIAT, V174, P339, DOI 10.1192/bjp.174.4.339; Proulx CM, 2013, J FAM PSYCHOL, V27, P194, DOI 10.1037/a0031877; Pruchno R, 2009, J GERONTOL B-PSYCHOL, V64, P212, DOI 10.1093/geronb/gbp006; Retherford R.D, 1975, CHANGING SEX DIFFERE; Rosand GMB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-66; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; St John PD, 2009, CAN J PSYCHIAT, V54, P487, DOI 10.1177/070674370905400710; Staehelin K, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.128397; Sudha S, 2006, J CROSS-CULT GERONTO, V21, P103, DOI 10.1007/s10823-006-9027-x; Sung Miai, 2013, INTERNATIONAL JOURNAL OF HUMAN ECOLOGY, V14, P103; Svedberg P, 2006, EUR J EPIDEMIOL, V21, P767, DOI 10.1007/s10654-006-9064-3; Troxel WM, 2005, ARCH INTERN MED, V165, P1022, DOI 10.1001/archinte.165.9.1022; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Urquia Marcelo L, 2013, Am J Public Health, V103, pe8, DOI 10.2105/AJPH.2012.301116; von dem Knesebeck O, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-272; Wade TJ, 2004, J HEALTH SOC BEHAV, V45, P155, DOI 10.1177/002214650404500203; Waldron I, 1996, SOC SCI MED, V43, P113, DOI 10.1016/0277-9536(95)00347-9; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Zuo JP, 2001, J MARRIAGE FAM, V63, P1122, DOI 10.1111/j.1741-3737.2001.01122.x	55	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104868	10.1371/journal.pone.0104868	http://dx.doi.org/10.1371/journal.pone.0104868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LJ	25118189	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400098
J	Heyman, T; Moors, P				Heyman, Tom; Moors, Pieter			Frequent Words Do Not Break Continuous Flash Suppression Differently from Infrequent or Nonexistent Words: Implications for Semantic Processing of Words in the Absence of Awareness	PLOS ONE			English	Article							DEFAULT BAYES FACTORS; INTEROCULAR SUPPRESSION; BINOCULAR-RIVALRY; VISUAL AWARENESS; OBJECT NAMES; NORMS; ACQUISITION; ENGLISH; SET; AGE	Continuous flash suppression (CFS) has been used as a paradigm to probe the extent to which word stimuli are processed in the absence of awareness. In the two experiments reported here, no evidence is obtained that word stimuli are processed up to the semantic level when suppressed through CFS. In Experiment 1, word stimuli did not break suppression faster than their pseudo-word variants nor was suppression time modulated by word frequency. Experiment 2 replicated these findings, but more critically showed that differential effects can be obtained with this paradigm using a simpler stimulus. In addition, pixel density of the stimuli did prove to be related to suppression time in both experiments, indicating that the paradigm is sensitive to differences in detectability. A third and final experiment replicated the well-known face inversion effect using the same set-up as Experiments 1 and 2, thereby demonstrating that the employed methodology can capture more high-level effects as well. These results are discussed in the context of previous evidence on unconscious semantic processing and two potential explanations are advanced. Specifically, it is argued that CFS might act at a level too low in the visual system for high-level effects to be observed or that the widely used breaking CFS paradigm is merely ill-suited to capture effects in the context of words.	[Heyman, Tom; Moors, Pieter] Univ Leuven, Expt Psychol Lab, Leuven, Belgium	KU Leuven	Moors, P (corresponding author), Univ Leuven, Expt Psychol Lab, Leuven, Belgium.	Pieter.Moors@ppw.kuleuven.be	Moors, Pieter/H-8638-2019; Heyman, Tom/I-6155-2019	Moors, Pieter/0000-0002-4667-1235; Heyman, Tom/0000-0003-0565-441X	Fonds Wetenschappelijk Onderzoek doctoral fellowships	Fonds Wetenschappelijk Onderzoek doctoral fellowships	This work was supported by Fonds Wetenschappelijk Onderzoek doctoral fellowships awarded to TH and PM (http://www.fwo.be/Default.aspx?L = en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, IME4 LINEAR MIXED EF; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Breitmeyer Bruno G, 2008, Adv Cogn Psychol, V3, P9, DOI 10.2478/v10053-008-0010-7; Brysbaert M, 2014, NORMS AGE ACQUISITIO; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Chalard M, 2003, EUR J COGN PSYCHOL, V15, P209, DOI 10.1080/09541440244000076; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Costello P, 2009, CONSCIOUS COGN, V18, P375, DOI 10.1016/j.concog.2009.02.003; Faivre N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00129; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Gobbini MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066620; Hesselmann G, 2011, CEREB CORTEX, V21, P2829, DOI 10.1093/cercor/bhr085; Heyman T, 2012, J NEUROSCI, V32, P1515, DOI 10.1523/JNEUROSCI.5726-11.2012; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jiang Y, 2007, PSYCHOL SCI, V18, P349, DOI 10.1111/j.1467-9280.2007.01902.x; Kang MS, 2011, J NEUROSCI, V31, P13535, DOI 10.1523/JNEUROSCI.1691-11.2011; Keuleers E, 2012, BEHAV RES METHODS, V44, P287, DOI 10.3758/s13428-011-0118-4; Keuleers E, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00174; Keuleers E, 2010, BEHAV RES METHODS, V42, P627, DOI 10.3758/BRM.42.3.627; Keuleers E, 2010, BEHAV RES METHODS, V42, P643, DOI 10.3758/BRM.42.3.643; Kim CY, 2005, TRENDS COGN SCI, V9, P381, DOI 10.1016/j.tics.2005.06.012; Kruschke JK, 2011, PERSPECT PSYCHOL SCI, V6, P299, DOI 10.1177/1745691611406925; Lamme VAF, 2000, FRONT BIOSCI, V5, pD232, DOI 10.2741/Lamme; Lamme VAF, 2000, VISION RES, V40, P1507, DOI 10.1016/S0042-6989(99)00243-6; Ludwig K, 2013, NEUROPSYCHOLOGIA, V51, P2930, DOI 10.1016/j.neuropsychologia.2013.09.035; Lupyan G, 2013, P NATL ACAD SCI USA, V110, P14196, DOI 10.1073/pnas.1303312110; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; MARCEL AJ, 1983, COGNITIVE PSYCHOL, V15, P238, DOI 10.1016/0010-0285(83)90010-5; Moors A, 2013, BEHAV RES METHODS, V45, P169, DOI 10.3758/s13428-012-0243-8; Morrison CM, 1997, Q J EXP PSYCHOL-A, V50, P528, DOI 10.1080/027249897392017; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Rouder JN, 2012, MULTIVAR BEHAV RES, V47, P877, DOI 10.1080/00273171.2012.734737; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; Sklar AY, 2012, P NATL ACAD SCI USA, V109, P19614, DOI 10.1073/pnas.1211645109; Stein T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00387; Stein T, 2014, PSYCHOL SCI, V25, P566, DOI 10.1177/0956797613512509; Stein T, 2012, COGNITION, V125, P64, DOI 10.1016/j.cognition.2012.06.005; Stein T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029361; Stein T, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00167; Stein T, 2011, COGNITION, V119, P307, DOI 10.1016/j.cognition.2011.01.008; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Tsuchiya N, 2006, J VISION, V6, P1068, DOI 10.1167/6.10.6; Van den Bussche E, 2009, PSYCHOL BULL, V135, P452, DOI 10.1037/a0015329; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wetzels R, 2011, PERSPECT PSYCHOL SCI, V6, P291, DOI 10.1177/1745691611406923; Yang E, 2007, EMOTION, V7, P882, DOI 10.1037/1528-3542.7.4.882; Yang E, 2010, INVEST OPHTH VIS SCI, V51, P588, DOI 10.1167/iovs.08-3076; Yang YH, 2014, EXP BRAIN RES, V232, P1109, DOI 10.1007/s00221-014-3820-5; Yang YH, 2011, CONSCIOUS COGN, V20, P223, DOI 10.1016/j.concog.2010.07.005; Zhou GM, 2010, CONSCIOUS COGN, V19, P408, DOI 10.1016/j.concog.2009.12.009	55	32	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104719	10.1371/journal.pone.0104719	http://dx.doi.org/10.1371/journal.pone.0104719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LJ	25116265	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400075
J	Patterson, HK; Boettcher, A; Carmichael, RH				Patterson, Heather K.; Boettcher, Anne; Carmichael, Ruth H.			Biomarkers of Dissolved Oxygen Stress in Oysters: A Tool for Restoration and Management Efforts	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; HEAT-SHOCK PROTEINS; CRASSOSTREA-VIRGINICA; EASTERN OYSTERS; MOBILE BAY; SUBLETHAL STRESS; PACIFIC OYSTER; IN-SITU; HYPOXIA; EXPRESSION	The frequency and intensity of anoxic and hypoxic events are increasing worldwide, creating stress on the organisms that inhabit affected waters. To understand the effects of low dissolved oxygen stress on oysters, hatchery-reared oysters were placed in cages and deployed along with continuously recording environmental data sondes at a reef site in Mobile Bay, AL that typically experiences low oxygen conditions. To detect and measure sublethal stress, we measured growth and survival of oysters as well as expression of three biomarkers, heat shock protein 70 (HSP70), hypoxia inducible factor (HIF) and phospho-p38 MAP kinase, in tissues from juvenile and adult oysters. Survival rates were high for both juvenile and adult oysters. Expression levels of each of the 3 isoforms of HSP 70 were negatively correlated to dissolved oxygen (DO) concentrations, suggesting that HSP 70 is useful to quantify sublethal effects of DO stress. Results for HIF and phospho-p38 MAP kinase were inconclusive. Test deployments of oysters to assess expression of HSP 70 relative to environmental conditions will be useful, in addition to measuring abiotic factors, to identify appropriate sites for restoration, particularly to capture negative effects of habitat quality on biota before lethal impacts are incurred.	[Patterson, Heather K.; Carmichael, Ruth H.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Patterson, Heather K.; Carmichael, Ruth H.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Boettcher, Anne] Univ S Alabama, Dept Biol, Mobile, AL 36688 USA	University of South Alabama; Dauphin Island Sea Lab; University of South Alabama	Patterson, HK (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.	hkpatt@uab.edu		Carmichael, Ruth/0000-0002-6033-3777	University of South Alabama Oyster Restoration Program; Northern Gulf Institute - BP Gulf Research Intiative (Phase 1)	University of South Alabama Oyster Restoration Program; Northern Gulf Institute - BP Gulf Research Intiative (Phase 1)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding provided by University of South Alabama Oyster Restoration Program, and the Northern Gulf Institute - BP Gulf Research Intiative (Phase 1) to MESC - to R. Carmichael.	[Anonymous], 2012, DOLLARS SENSE EC BEN; BAKER SM, 1994, MAR ECOL PROG SER, V104, P91, DOI 10.3354/meps104091; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Bierkens JGEA, 2000, TOXICOLOGY, V153, P61, DOI 10.1016/S0300-483X(00)00304-8; Bishop MJ, 2006, ESTUAR COAST SHELF S, V70, P415, DOI 10.1016/j.ecss.2006.06.031; Burnett LE, 2001, COASTAL HYPOXIA CONS; Canesi L, 2002, DEV COMP IMMUNOL, V26, P325, DOI 10.1016/S0145-305X(01)00078-7; Cerco CF, 2007, ESTUAR COAST, V30, P331, DOI 10.1007/BF02700175; Chatel A, 2010, AQUAT TOXICOL, V96, P247, DOI 10.1016/j.aquatox.2009.11.002; Clark MS, 2013, GLOBAL CHANGE BIOL, V19, P2251, DOI 10.1111/gcb.12197; Clegg JS, 1998, MOL MAR BIOL BIOTECH, V7, P21; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Coen LD, 2000, ECOL ENG, V15, P323, DOI 10.1016/S0925-8574(00)00084-7; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; Cooke SJ, 2007, FISHERIES MANAG ECOL, V14, P73, DOI 10.1111/j.1365-2400.2007.00527.x; Downs CA, 2012, ECOTOXICOLOGY, V21, P768, DOI 10.1007/s10646-011-0837-4; Eastern Oyster Biological Review Team, 2007, FSPO88 NOAA NMFS E O; Ermgassen PSEZ, 2013, ESTUAR COAST, V36, P36, DOI 10.1007/s12237-012-9559-y; Fabbri E., 2008, ISJ, V5, P135; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Gaitanaki C, 2004, MOL CELL BIOCHEM, V260, P119, DOI 10.1023/B:MCBI.0000026064.73671.91; Gorr TA, 2010, PHYSIOL BIOCHEM ZOOL, V83, P733, DOI 10.1086/648581; Grabowski JH, 2007, THEOR ECOL SER, P281; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; Gregalis KC, 2008, J SHELLFISH RES, V27, P1163, DOI 10.2983/0730-8000-27.5.1163; Helmuth BST, 2001, BIOL BULL-US, V201, P374, DOI 10.2307/1543615; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Husmann G, 2014, CELL STRESS CHAPERON, V19, P15, DOI 10.1007/s12192-013-0431-1; Ivanina AV, 2009, AQUAT TOXICOL, V91, P245, DOI 10.1016/j.aquatox.2008.11.016; Jackson SA, 2011, AQUACULTURE, V317, P168, DOI 10.1016/j.aquaculture.2011.04.004; Johnson MW, 2009, J SHELLFISH RES, V28, P185, DOI 10.2983/035.028.0202; Joyner-Matos J, 2009, J AQUAT ANIM HEALTH, V21, P104, DOI 10.1577/H08-066.1; Karouna-Renier NK, 1999, HYDROBIOLOGIA, V401, P255, DOI 10.1023/A:1003730225536; Kawabe S, 2012, MAR BIOTECHNOL, V14, P106, DOI 10.1007/s10126-011-9394-3; Kemp WM, 2009, BIOGEOSCIENCES, V6, P2985, DOI 10.5194/bg-6-2985-2009; Kennedy V.S., 1996, E OYSTER CRASSOSTREA; Korb A, 2006, ARTHRITIS RHEUM, V54, P2745, DOI 10.1002/art.22080; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; La Peyre MK, 2012, OCEAN COAST MANAGE, V67, P1, DOI 10.1016/j.ocecoaman.2012.06.001; Larade K, 2006, COMP BIOCHEM PHYS B, V143, P85, DOI 10.1016/j.cbpb.2005.10.008; Li TD, 2007, COMP BIOCHEM PHYS B, V147, P11, DOI 10.1016/j.cbpb.2006.12.018; Li Y, 2007, AM J PHYSIOL-REG I, V293, pR2353, DOI 10.1152/ajpregu.00463.2007; Ma E, 1997, MOL BRAIN RES, V46, P325, DOI 10.1016/S0169-328X(97)00074-0; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McCarthy J.F., 1990, BIOMARKERS ENV CONTA, DOI DOI 10.1201/9781351070263; Nascimento I.A., 1998, Aquatic Ecosystem Health & Management, V1, P101, DOI 10.1080/14634989808657009; NRC National Research Council., 2000, CLEAN COAST WAT UND; Park K, 2007, ESTUAR COAST, V30, P54, DOI 10.1007/BF02782967; PEAKALL DB, 1994, ECOTOXICOLOGY, V3, P157, DOI 10.1007/BF00117080; Piano A, 2004, CELL STRESS CHAPERON, V9, P134, DOI 10.1379/483.1; Piontkivska H, 2011, COMP BIOCHEM PHYS D, V6, P103, DOI 10.1016/j.cbd.2010.10.003; Pollack JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040839; Ringwood AH, 1999, BIOMARKERS, V4, P400, DOI 10.1080/135475099230570; Roberts RJ, 2010, J FISH DIS, V33, P789, DOI 10.1111/j.1365-2761.2010.01183.x; SANDERS BM, 1993, CRIT REV TOXICOL, V23, P49, DOI 10.3109/10408449309104074; Saoud IG, 2000, J SHELLFISH RES, V19, P809; Saoud IG, 2000, J WORLD AQUACULT SOC, V31, P640; Sonanez-Organis JG, 2009, COMP BIOCHEM PHYS C, V150, P395, DOI 10.1016/j.cbpc.2009.06.005; STICKLE WB, 1989, BIOL BULL, V177, P303, DOI 10.2307/1541945; Ueda N, 2009, J SHELLFISH RES, V28, P849, DOI 10.2983/035.028.0414; Wallace R, 2002, OPTIMUM SIZE PLANTIN; Wallace RK, 1999, OYSTER REEF HABITAT; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9	64	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104440	10.1371/journal.pone.0104440	http://dx.doi.org/10.1371/journal.pone.0104440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116465	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400050
J	Vasilev, N; Schmitz, C; Groemping, U; Fischer, R; Schillberg, S				Vasilev, Nikolay; Schmitz, Christian; Groemping, Ulrike; Fischer, Rainer; Schillberg, Stefan			Assessment of Cultivation Factors that Affect Biomass and Geraniol Production in Transgenic Tobacco Cell Suspension Cultures	PLOS ONE			English	Article							CATHARANTHUS-ROSEUS CELLS; CONDITIONED MEDIUM; HAIRY ROOTS; AZADIRACHTIN PRODUCTION; INOCULUM DENSITY; SYNTHASE; GROWTH; OPTIMIZATION; PLANTS; BIOREACTOR	A large-scale statistical experimental design was used to determine essential cultivation parameters that affect biomass accumulation and geraniol production in transgenic tobacco (Nicotiana tabacum cv. Samsun NN) cell suspension cultures. The carbohydrate source played a major role in determining the geraniol yield and factors such as filling volume, inoculum size and light were less important. Sucrose, filling volume and inoculum size had a positive effect on geraniol yield by boosting growth of plant cell cultures whereas illumination of the cultures stimulated the geraniol biosynthesis. We also found that the carbohydrates sucrose and mannitol showed polarizing effects on biomass and geraniol accumulation. Factors such as shaking frequency, the presence of conditioned medium and solubilizers had minor influence on both plant cell growth and geraniol content. When cells were cultivated under the screened conditions for all the investigated factors, the cultures produced similar to 5.2 mg/l geraniol after 12 days of cultivation in shaking flasks which is comparable to the yield obtained in microbial expression systems. Our data suggest that industrial experimental designs based on orthogonal arrays are suitable for the selection of initial cultivation parameters prior to the essential medium optimization steps. Such designs are particularly beneficial in the early optimization steps when many factors must be screened, increasing the statistical power of the experiments without increasing the demand on time and resources.	[Vasilev, Nikolay; Schmitz, Christian; Fischer, Rainer; Schillberg, Stefan] Fraunhofer Inst Mol Biol & Appl Ecol IME, Dept Plant Biotechnol, Aachen, Germany; [Groemping, Ulrike] Beuth Univ Appl Sci, Dept Math Phys & Chem 2, Berlin, Germany; [Fischer, Rainer] Rhein Westfal TH Aachen, Inst Mol Biotechnol, D-52062 Aachen, Germany; [Schillberg, Stefan] Univ Giessen, Inst Phytopathol & Appl Zool, D-35390 Giessen, Germany	Fraunhofer Gesellschaft; RWTH Aachen University; Justus Liebig University Giessen	Vasilev, N (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Dept Plant Biotechnol, Aachen, Germany.	nikolay.vasilev@ime.fraunhofer.de	Schillberg, Stefan/K-4211-2019; Schillberg, Stefan/I-5449-2013	Schillberg, Stefan/0000-0002-1896-4575	European Union [222716]	European Union(European Commission)	This research was funded by the European Union Seventh Framework Programme SmartCell (Rational design of plant systems for sustainable generation of value-added industrial products, grant agreement no. 222716). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2003, PLANT CELL, V15, P2866, DOI 10.1105/tpc.016253; Brewster ME, 2007, ADV DRUG DELIVER REV, V59, P645, DOI 10.1016/j.addr.2007.05.012; Cui XH, 2010, BIORESOURCE TECHNOL, V101, P4708, DOI 10.1016/j.biortech.2010.01.115; de Roode BM, 2001, BIOTECHNOL PROGR, V17, P881, DOI 10.1021/bp010081i; Dong LM, 2013, METAB ENG, V20, P198, DOI 10.1016/j.ymben.2013.09.002; Fischer MJC, 2013, J BIOTECHNOL, V163, P24, DOI 10.1016/j.jbiotec.2012.10.012; Fischer MJC, 2011, BIOTECHNOL BIOENG, V108, P1883, DOI 10.1002/bit.23129; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Gorret N, 2004, J BIOTECHNOL, V108, P253, DOI 10.1016/j.jbiotec.2003.12.009; Gromping U, 2014, AM STAT, V68, P108, DOI 10.1080/00031305.2014.896829; Gromping U., 2013, DOE BASE FULL FACTOR; Gutensohn M, 2013, PLANT J, V75, P351, DOI 10.1111/tpj.12212; Iijima Y, 2004, PLANT PHYSIOL, V134, P370, DOI 10.1104/pp.103.032946; Ito M, 2007, PHYTOCHEMISTRY, V68, P446, DOI 10.1016/j.phytochem.2006.11.006; Jeong GT, 2004, APPL BIOCHEM BIOTECH, V113, P1193, DOI 10.1385/ABAB:116:1-3:1193; Kanokwaree K, 1997, BIOTECHNOL BIOENG, V55, P520, DOI 10.1002/(SICI)1097-0290(19970805)55:3&lt;520::AID-BIT8&gt;3.0.CO;2-E; Klockner W, 2012, TRENDS BIOTECHNOL, V30, P307, DOI 10.1016/j.tibtech.2012.03.001; Lee CWT, 2000, BIOTECHNOL BIOENG, V67, P61, DOI 10.1002/(SICI)1097-0290(20000105)67:1&lt;61::AID-BIT7&gt;3.0.CO;2-J; Lipavska H, 1996, PLANT CELL TISS ORG, V45, P103, DOI 10.1007/BF00048751; Lu S, 2002, PLANT PHYSIOL, V130, P477, DOI 10.1104/pp.006544; Maier U, 2001, BIOCHEM ENG J, V7, P99, DOI 10.1016/S1369-703X(00)00107-8; MORENO PRH, 1993, APPL MICROBIOL BIOT, V39, P42, DOI 10.1007/BF00166846; Pearse A. G., 1980, HISTOCHEMISTRY THEOR; Prakash G, 2005, PROCESS BIOCHEM, V40, P3795, DOI 10.1016/j.procbio.2005.05.010; Prakash G, 2008, BIOCHEM ENG J, V40, P218, DOI 10.1016/j.bej.2007.12.017; Sathikge ND, 2008, THESIS N MENDELA MET; Schnurr JA, 2000, PLANT CELL REP, V19, P279, DOI 10.1007/s002990050012; Simkin AJ, 2013, PHYTOCHEMISTRY, V85, P36, DOI 10.1016/j.phytochem.2012.09.014; Smetanska I, 2008, ADV BIOCHEM ENG BIOT, V111, P187, DOI 10.1007/10_2008_103; Steinitz B, 1999, J PLANT PHYSIOL, V155, P1, DOI 10.1016/S0176-1617(99)80133-3; Takahashi Y, 2001, BIOCHEM ENG J, V8, P121, DOI 10.1016/S1369-703X(01)00094-8; Vaidya BK, 2009, J IND MICROBIOL BIOT, V36, P671, DOI 10.1007/s10295-009-0536-9; Vasilev N, 2013, PLANT BIOTECHNOL J, V11, P867, DOI 10.1111/pbi.12079; Wolf S, 1998, J PLANT PHYSIOL, V153, P574, DOI 10.1016/S0176-1617(98)80206-X; Woragidbumrung KO, 2001, PROCESS BIOCHEM, V37, P209, DOI 10.1016/S0032-9592(01)00197-2; Yang T, 2005, PHYTOCHEMISTRY, V66, P285, DOI 10.1016/j.phytochem.2004.12.004; Yuan M, 2007, TECHNOMETRICS, V49, P430, DOI 10.1198/004017007000000173; Zhang CH, 2002, APPL MICROBIOL BIOT, V60, P396, DOI 10.1007/s00253-002-1130-5	39	22	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104620	10.1371/journal.pone.0104620	http://dx.doi.org/10.1371/journal.pone.0104620			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117009	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400059
J	Galli, CL; Sensi, C; Fumagalli, A; Parravicini, C; Marinovich, M; Eberini, I				Galli, Corrado Lodovico; Sensi, Cristina; Fumagalli, Amos; Parravicini, Chiara; Marinovich, Marina; Eberini, Ivano			A Computational Approach to Evaluate the Androgenic Affinity of Iprodione, Procymidone, Vinclozolin and Their Metabolites	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; MOLECULAR DOCKING; RECEPTOR; TOXICITY; ENERGY; ANTIANDROGENS; 21ST-CENTURY; STRATEGY; AGONISTS; LIGANDS	Our research is aimed at devising and assessing a computational approach to evaluate the affinity of endocrine active substances (EASs) and their metabolites towards the ligand binding domain (LBD) of the androgen receptor (AR) in three distantly related species: human, rat, and zebrafish. We computed the affinity for all the selected molecules following a computational approach based on molecular modelling and docking. Three different classes of molecules with well-known endocrine activity (iprodione, procymidone, vinclozolin, and a selection of their metabolites) were evaluated. Our approach was demonstrated useful as the first step of chemical safety evaluation since ligand-target interaction is a necessary condition for exerting any biological effect. Moreover, a different sensitivity concerning AR LBD was computed for the tested species (rat being the least sensitive of the three). This evidence suggests that, in order not to over-/under-estimate the risks connected with the use of a chemical entity, further in vitro and/or in vivo tests should be carried out only after an accurate evaluation of the most suitable cellular system or animal species. The introduction of in silico approaches to evaluate hazard can accelerate discovery and innovation with a lower economic effort than with a fully wet strategy.	[Galli, Corrado Lodovico; Sensi, Cristina; Fumagalli, Amos; Parravicini, Chiara; Marinovich, Marina; Eberini, Ivano] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy	University of Milan	Galli, CL (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy.	corrado.galli@unimi.it						Bars R, 2012, REGUL TOXICOL PHARM, V64, P143, DOI 10.1016/j.yrtph.2012.06.013; Bauer ERS, 1998, ANALYST, V123, P2485, DOI 10.1039/a804606i; Blystone CR, 2007, TOXICOL LETT, V174, P74, DOI 10.1016/j.toxlet.2007.08.010; Bohl CE, 2007, J BIOL CHEM, V282, P13648, DOI 10.1074/jbc.M611711200; Borgert CJ, 2012, REGUL TOXICOL PHARM, V62, P313, DOI 10.1016/j.yrtph.2011.10.012; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Bursztyka J, 2008, J AGR FOOD CHEM, V56, P4832, DOI 10.1021/jf0728045; CHANG CS, 1988, P NATL ACAD SCI USA, V85, P7211, DOI 10.1073/pnas.85.19.7211; D'Ursi P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S10; De Jesus-Tran KP, 2006, PROTEIN SCI, V15, P987, DOI 10.1110/ps.051905906; de Waal PP, 2008, REPRODUCTION, V136, P225, DOI 10.1530/REP-08-0055; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Eberini I, 2008, J MOL GRAPH MODEL, V26, P1004, DOI 10.1016/j.jmgm.2007.08.006; Eberini I, 2011, J COMPUT AID MOL DES, V25, P743, DOI 10.1007/s10822-011-9455-8; Edelsbrunner H., 1995, P 28 HAW INT C SYST; Gibson JE, 2010, HUM EXP TOXICOL, V29, P33, DOI 10.1177/0960327109354659; Hosokawa S, 1992, J TOXICOLOGICAL SCI, V18; Hosokawa Shunji, 1993, Journal of Toxicological Sciences, V18, P83; Hur E, 2004, PLOS BIOL, V2, P1303, DOI 10.1371/journal.pbio.0020274; Kelce WR, 1997, J MOL MED, V75, P198, DOI 10.1007/s001090050104; Kortenkamp A, 2011, STATE ART ASSESSMENT; Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146; Mowszowic I, 1980, J CLIN ENDOCRINOLOGY; Muecheler EK, 1987, ENDOCRINE RES, V13; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Shikha P, 2013, J PHARM BIOALLIED SC, V5; Sierra-Santoyo A, 2011, ARCH TOXICOLOGY, V86; Soto AM, 2006, BEST PRACT RES CL EN, V20, P15, DOI 10.1016/j.beem.2005.09.001; Sotriffer CA, 2011, CURR TOP MED CHEM, V11, P179; Tarui H, 2009, J AGR FOOD CHEM, V57, P10883, DOI 10.1021/jf902006k; TEUTSCH G, 1994, J STEROID BIOCHEM, V48, P111, DOI 10.1016/0960-0760(94)90257-7; US EPA, 2011, ANDR REC BIND RAT VE; Uzumcu M, 2004, REPROD TOXICOL, V18, P765, DOI 10.1016/j.reprotox.2004.05.008; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Watanabe C, 2010, BBA-PROTEINS PROTEOM, V1804, P1832, DOI 10.1016/j.bbapap.2010.06.009; Wilson VS, 2002, TOXICOL SCI, V66, P69, DOI 10.1093/toxsci/66.1.69; Wojciechowski M, 2004, J PHYS CHEM; Wu B, 2010, CHEMOSPHERE, V80, P535, DOI 10.1016/j.chemosphere.2010.04.043; Yao ZF, 2013, CHEMOSPHERE, V92, P1169, DOI 10.1016/j.chemosphere.2013.01.081; Yu WJ, 2004, J VET MED SCI, V66, P847, DOI 10.1292/jvms.66.847	43	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104822	10.1371/journal.pone.0104822	http://dx.doi.org/10.1371/journal.pone.0104822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111804	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100101
J	Ioakeimidis, F; Ott, C; Kozjak-Pavlovic, V; Violitzi, F; Rinotas, V; Makrinou, E; Eliopoulos, E; Fasseas, C; Kollias, G; Douni, E				Ioakeimidis, Fotis; Ott, Christine; Kozjak-Pavlovic, Vera; Violitzi, Foteini; Rinotas, Vagelis; Makrinou, Eleni; Eliopoulos, Elias; Fasseas, Costas; Kollias, George; Douni, Eleni			A Splicing Mutation in the Novel Mitochondrial Protein DNAJC11 Causes Motor Neuron Pathology Associated with Cristae Disorganization, and Lymphoid Abnormalities in Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DOMINANT OPTIC ATROPHY; MEMBRANE ORGANIZATION; NERVOUS-SYSTEM; DATA-BANK; MITOFILIN; MODEL; BIOGENESIS; MORPHOLOGY; REVEALS	Mitochondrial structure and function is emerging as a major contributor to neuromuscular disease, highlighting the need for the complete elucidation of the underlying molecular and pathophysiological mechanisms. Following a forward genetics approach with N-ethyl-N-nitrosourea (ENU)-mediated random mutagenesis, we identified a novel mouse model of autosomal recessive neuromuscular disease caused by a splice-site hypomorphic mutation in a novel gene of unknown function, DnaJC11. Recent findings have demonstrated that DNAJC11 protein co-immunoprecipitates with proteins of the mitochondrial contact site (MICOS) complex involved in the formation of mitochondrial cristae and cristae junctions. Homozygous mutant mice developed locomotion defects, muscle weakness, spasticity, limb tremor, leucopenia, thymic and splenic hypoplasia, general wasting and early lethality. Neuropathological analysis showed severe vacuolation of the motor neurons in the spinal cord, originating from dilatations of the endoplasmic reticulum and notably from mitochondria that had lost their proper inner membrane organization. The causal role of the identified mutation in DnaJC11 was verified in rescue experiments by overexpressing the human ortholog. The full length 63 kDa isoform of human DNAJC11 was shown to localize in the periphery of the mitochondrial outer membrane whereas putative additional isoforms displayed differential submitochondrial localization. Moreover, we showed that DNAJC11 is assembled in a high molecular weight complex, similarly to mitofilin and that downregulation of mitofilin or SAM50 affected the levels of DNAJC11 in HeLa cells. Our findings provide the first mouse mutant for a putative MICOS protein and establish a link between DNAJC11 and neuromuscular diseases.	[Ioakeimidis, Fotis; Violitzi, Foteini; Rinotas, Vagelis; Eliopoulos, Elias; Douni, Eleni] Agr Univ Athens, Dept Biotechnol, GR-11855 Athens, Greece; [Ioakeimidis, Fotis; Violitzi, Foteini; Rinotas, Vagelis; Makrinou, Eleni; Kollias, George; Douni, Eleni] Biomed Sci Res Ctr Alexander Fleming, Div Immunol, Vari, Greece; [Ott, Christine; Kozjak-Pavlovic, Vera] Univ Wurzburg, Dept Microbiol, Bioctr, D-97070 Wurzburg, Germany; [Fasseas, Costas] Agr Univ Athens, Dept Crop Sci, GR-11855 Athens, Greece	Agricultural University of Athens; Alexander Fleming Biomedical Sciences Research Center; University of Wurzburg; Agricultural University of Athens	Douni, E (corresponding author), Agr Univ Athens, Dept Biotechnol, GR-11855 Athens, Greece.	douni@aua.gr	Kollias, George/A-7079-2012; Kozjak-Pavlovic, Vera/E-1494-2013	Kollias, George/0000-0003-1867-3150; Kozjak-Pavlovic, Vera/0000-0001-9658-7018; DOUNI, ELENI/0000-0003-0004-5121; Rinotas, Vagelis/0000-0002-2390-3136; Eliopoulos, Elias/0000-0002-0919-0571	European Commission [MUGEN LSHG-CT-2005-005203]; Research Funding Program HERACLEITUS II; Research Funding Program ARISTEIA II - European Union (European Social Fund-ESF) [4676]; National Strategic Reference Framework (NSRF); Deutsche Forschungsgemeinschaft [KO3882/1-1]	European Commission(European CommissionEuropean Commission Joint Research Centre); Research Funding Program HERACLEITUS II; Research Funding Program ARISTEIA II - European Union (European Social Fund-ESF); National Strategic Reference Framework (NSRF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the European Commission (grant number MUGEN LSHG-CT-2005-005203 to ED and GK); Research Funding Programs HERACLEITUS II (to FI) and ARISTEIA II (grant DnaJmito No 4676 to ED) co-financed by the European Union (European Social Fund-ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF); Deutsche Forschungsgemeinschaft (Grant KO3882/1-1 to VK-P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi MV, 2007, BRAIN, V130, P1029, DOI 10.1093/brain/awm005; Alkhaja AK, 2012, MOL BIOL CELL, V23, P247, DOI 10.1091/mbc.E11-09-0774; An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chung MJ, 2002, ULTRASTRUCT PATHOL, V26, P3, DOI 10.1080/01913120252934260; Cipolat S, 2006, CELL, V126, P163, DOI 10.1016/j.cell.2006.06.021; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Davey KM, 2006, J MED GENET, V43, P385, DOI 10.1136/jmg.2005.036657; Davies VJ, 2007, HUM MOL GENET, V16, P1307, DOI 10.1093/hmg/ddm079; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3; DiMauro S, 2008, ANNU REV NEUROSCI, V31, P91, DOI 10.1146/annurev.neuro.30.051606.094302; Douni Eleni, 2004, Methods Mol Med, V98, P137; Douni E, 2012, HUM MOL GENET, V21, P784, DOI 10.1093/hmg/ddr510; Dupuis L, 2004, NEURODEGENER DIS, V1, P245, DOI 10.1159/000085063; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Harms MB, 2012, ANN NEUROL, V71, P407, DOI 10.1002/ana.22683; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Hayashi M, 2006, NAT MED, V12, P128, DOI 10.1038/nm1327; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Jans DC, 2013, P NATL ACAD SCI USA, V110, P8936, DOI 10.1073/pnas.1301820110; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karbowski M, 2012, ACTA NEUROPATHOL, V123, P157, DOI 10.1007/s00401-011-0921-0; Katoh M, 2003, INT J ONCOL, V23, P1219; Kneissl J, 2009, PLANT CELL, V21, P3212, DOI 10.1105/tpc.109.066472; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Liu CM, 2011, BIOL PSYCHIAT, V70, P51, DOI 10.1016/j.biopsych.2011.02.033; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Nardin RA, 2001, MUSCLE NERVE, V24, P170, DOI 10.1002/1097-4598(200102)24:2<170::AID-MUS30>3.0.CO;2-0; Neu-Yilik G, 2008, ADV GENET, V62, P185, DOI 10.1016/S0065-2660(08)00604-4; Noskova L, 2011, AM J HUM GENET, V89, P241, DOI 10.1016/j.ajhg.2011.07.003; Ojala T, 2012, PEDIATR RES, V72, P432, DOI 10.1038/pr.2012.92; Ott C, 2012, MOL CELL BIOL, V32, P1173, DOI 10.1128/MCB.06388-11; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pellegrini L, 2007, CELL DEATH DIFFER, V14, P1275, DOI 10.1038/sj.cdd.4402145; Perkins GA, 2000, MICRON, V31, P97, DOI 10.1016/S0968-4328(99)00065-7; Rajan VBV, 2009, FUNCT INTEGR GENOMIC, V9, P433, DOI 10.1007/s10142-009-0132-0; Rinotas V, 2013, J BONE MINER RES; Rinotas V, 2014, J BONE MINER RES, V29, P1158, DOI 10.1002/jbmr.2112; Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303; van der Laan M, 2012, TRENDS CELL BIOL, V22, P185, DOI 10.1016/j.tcb.2012.01.004; Vazgiourakis VM, 2013, CLIN EXP RHEUMATOL, V31, P97; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Weber TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063683; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wu YK, 2005, J MOL BIOL, V346, P1005, DOI 10.1016/j.jmb.2004.12.040; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Zeviani M, 2004, BRAIN, V127, P2153, DOI 10.1093/brain/awh259; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	67	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104237	10.1371/journal.pone.0104237	http://dx.doi.org/10.1371/journal.pone.0104237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111180	Green Submitted, Green Published, gold			2022-12-27	WOS:000341105100042
J	La, GH; Choi, JY; Chang, KH; Jang, MH; Joo, GJ; Kim, HW				La, Geung-Hwan; Choi, Jong-Yun; Chang, Kwang-Hyeon; Jang, Min-Ho; Joo, Gea-Jae; Kim, Hyun-Woo			Mating Behavior of Daphnia: Impacts of Predation Risk, Food Quantity, and Reproductive Phase of Females	PLOS ONE			English	Article							SEXUAL REPRODUCTION; RESTING EGGS; CYCLICAL PARTHENOGEN; SWARMING BEHAVIOR; DIAPAUSING EGGS; LAKE-DAPHNIA; CRUSTACEA; PULEX; FISH; MAGNA	High predation risk and food depletion lead to sexual reproduction in cyclically parthenogenetic Daphnia. Mating, the core of sexual reproduction, also occurs under these conditions. Assessment of the environmental conditions and alteration of mating efforts may aid in determining the success of sexual reproduction. Here, we evaluated the impacts of predation risk, food quantity, and reproductive phase of females on the mating behavior of Daphnia obtusa males including contact frequency and duration using video analysis. Mating-related behavior involved male-female contact (mating) as well as male-male contact (fighting). Mating frequency increased while unnecessary fighting decreased in the presence of predation risk. In addition, low food concentration reduced fighting between males. Males attempted to attach to sexual females more than asexual females, and fighting occurred more frequently in the presence of sexual females. Duration of mating was relatively long; however, males separated shortly after contact in terms of fighting behavior. Thus, assessment of environmental factors and primary sexing of mates were performed before actual contact, possibly mechanically, and precise sex discrimination was conducted after contact. These results suggest that mating in Daphnia is not a random process but rather a balance between predation risk and energetic cost that results in changes in mating and fighting strategies.	[La, Geung-Hwan; Kim, Hyun-Woo] Sunchon Natl Univ, Dept Environm Educ, Sunchon, South Korea; [Choi, Jong-Yun; Joo, Gea-Jae] Pusan Natl Univ, Dept Life Sci, Pusan, South Korea; [Chang, Kwang-Hyeon] Kyung Hee Univ, Dept Environm Sci & Engn, Gyeonggi, South Korea; [Jang, Min-Ho] Kongju Natl Univ, Dept Biol Educ, Gongju, South Korea	Sunchon National University; Pusan National University; Kyung Hee University; Kongju National University	Kim, HW (corresponding author), Sunchon Natl Univ, Dept Environm Educ, Sunchon, South Korea.	hwkim@sunchon.ac.krmailto	CHOI, Jong-Yun/AAT-6338-2020	CHOI, Jong-Yun/0000-0003-3237-8334; chang, Kwang-Hyeon/0000-0002-7952-4047	Ministry of Environment of Korea; Sunchon National University	Ministry of Environment of Korea(Ministry of Environment (ME), Republic of Korea); Sunchon National University	The Korea National Long-Term Ecological Research Program (2011 similar to 2013) by the Ministry of Environment of Korea and postdoctoral program (2011) of the Sunchon National University supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernot RJ, 2006, AQUAT ECOL, V40, P361, DOI 10.1007/s10452-006-9035-5; Brewer MC, 1999, J PLANKTON RES, V21, P1317, DOI 10.1093/plankt/21.7.1317; Brewer MC, 1998, PHILOS T ROY SOC B, V353, P805, DOI 10.1098/rstb.1998.0244; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; CARVALHO GR, 1989, FRESHWATER BIOL, V22, P459, DOI 10.1111/j.1365-2427.1989.tb01118.x; CARVALHO GR, 1983, FRESHWATER BIOL, V13, P37, DOI 10.1111/j.1365-2427.1983.tb00655.x; CREASE TJ, 1983, FRESHWATER BIOL, V13, P491, DOI 10.1111/j.1365-2427.1983.tb00007.x; Deng HW, 1997, LIMNOL OCEANOGR, V42, P609, DOI 10.4319/lo.1997.42.3.0609; Dunn AM, 2008, ANIM BEHAV, V76, P1289, DOI 10.1016/j.anbehav.2008.06.013; ELENDT BP, 1990, PROTOPLASMA, V154, P25, DOI 10.1007/BF01349532; Fitzsimmons JM, 2006, HYDROBIOLOGIA, V568, P187, DOI 10.1007/s10750-006-0104-5; Forro L, 1997, HYDROBIOLOGIA, V360, P153, DOI 10.1023/A:1003105016758; Freund JA, 2002, J THEOR BIOL, V214, P71, DOI 10.1006/jtbi.2001.2445; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; Gries T, 1999, J PLANKTON RES, V21, P509, DOI 10.1093/plankt/21.3.509; HAIRSTON NG, 1995, ECOLOGY, V76, P1706, DOI 10.2307/1940704; Hairston NG, 2002, INTEGR COMP BIOL, V42, P481, DOI 10.1093/icb/42.3.481; HANN BJ, 1987, HYDROBIOLOGIA, V145, P219, DOI 10.1007/BF02530283; HEBERT PDN, 1987, HYDROBIOLOGIA, V145, P183, DOI 10.1007/BF02530279; Innes DJ, 1997, OECOLOGIA, V111, P53, DOI 10.1007/s004420050207; INNES DJ, 1986, HEREDITY, V57, P345, DOI 10.1038/hdy.1986.134; JAKOBSEN PJ, 1988, ANIM BEHAV, V36, P991, DOI 10.1016/S0003-3472(88)80058-7; Jarnagin ST, 2000, FRESHWATER BIOL, V43, P579, DOI 10.1046/j.1365-2427.2000.t01-1-00547.x; JOHNSEN GH, 1987, LIMNOL OCEANOGR, V32, P873, DOI 10.4319/lo.1987.32.4.0873; KATONA SK, 1973, LIMNOL OCEANOGR, V18, P574, DOI 10.4319/lo.1973.18.4.0574; KERFOOT WC, 1980, ECOLOGY, V61, P417, DOI 10.2307/1935198; Kerfoot WC, 1980, EVOLUTION ECOLOGY ZO, P609; KIRK KL, 1985, LIMNOL OCEANOGR, V30, P679, DOI 10.4319/lo.1985.30.3.0679; Koch U, 2009, OECOLOGIA, V159, P317, DOI 10.1007/s00442-008-1216-6; LANDRY MR, 1980, LIMNOL OCEANOGR, V25, P545, DOI 10.4319/lo.1980.25.3.0545; LARSSON P, 1991, HYDROBIOLOGIA, V225, P281, DOI 10.1007/BF00028406; Larsson P, 1997, HYDROBIOLOGIA, V360, P143, DOI 10.1023/A:1003128315850; Lass S, 2003, HYDROBIOLOGIA, V491, P221, DOI 10.1023/A:1024487804497; LIEDER U, 1956, NATURWISSENSCHAFTEN, V43, P207, DOI 10.1007/BF00632965; Lonsdale DJ, 1998, J MARINE SYST, V15, P1, DOI 10.1016/S0924-7963(97)00044-4; LUECKE C, 1990, LIMNOL OCEANOGR, V35, P1718, DOI 10.4319/lo.1990.35.8.1718; Maier G, 2000, J PLANKTON RES, V22, P1977, DOI 10.1093/plankt/22.10.1977; MALY EJ, 1970, LIMNOL OCEANOGR, V15, P566, DOI 10.4319/lo.1970.15.4.0566; MELLORS WK, 1975, ECOLOGY, V56, P974, DOI 10.2307/1936308; Penalva-Arana DC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-79; Pijanowska J, 1997, FRESHWATER BIOL, V37, P649, DOI 10.1046/j.1365-2427.1997.00192.x; Pijanowska J, 1996, J PLANKTON RES, V18, P1407, DOI 10.1093/plankt/18.8.1407; RATZLAFF W, 1974, LIMNOL OCEANOGR, V19, P993, DOI 10.4319/lo.1974.19.6.0993; RicoMartinez R, 1995, HYDROBIOLOGIA, V313, P105, DOI 10.1007/BF00025937; Schwind R, 1999, J EXP BIOL, V202, P3631; SLUSARCZYK M, 1995, ECOLOGY, V76, P1008, DOI 10.2307/1939364; Slusarczyk M, 2001, ECOLOGY, V82, P1089, DOI 10.2307/2679905; SNELL TW, 1994, HYDROBIOLOGIA, V293, P255, DOI 10.1007/BF00229949; Spaak P, 2004, J PLANKTON RES, V26, P625, DOI 10.1093/plankt/fbh064; Spaak P, 2001, HYDROBIOLOGIA, V442, P185, DOI 10.1023/A:1017578221814; STRATHMANN RR, 1967, LIMNOL OCEANOGR, V12, P411, DOI 10.4319/lo.1967.12.3.0411; Tagg N, 2005, OECOLOGIA, V143, P527, DOI 10.1007/s00442-005-0016-5; Van Damme K, 2006, FRESHWATER BIOL, V51, P2334, DOI 10.1111/j.1365-2427.2006.01654.x; Van Son TC, 2006, ANIM BEHAV, V71, P61, DOI 10.1016/j.anbehav.2005.03.018; Vandekerkhove J, 2005, FRESHWATER BIOL, V50, P96, DOI 10.1111/j.1365-2427.2004.01312.x; Winsor GL, 2002, FRESHWATER BIOL, V47, P441, DOI 10.1046/j.1365-2427.2002.00817.x; WOLF HG, 1989, FRESHWATER BIOL, V22, P471, DOI 10.1111/j.1365-2427.1989.tb01119.x; Wolinska J, 2007, FRESHWATER BIOL, V52, P1198, DOI 10.1111/j.1365-2427.2007.01757.x; YOUNG JPW, 1978, FRESHWATER BIOL, V8, P279, DOI 10.1111/j.1365-2427.1978.tb01448.x; YOUNG S, 1974, J EXP BIOL, V61, P261; YOUNG S, 1987, ANIM BEHAV, V35, P541, DOI 10.1016/S0003-3472(87)80279-8; ZARET TM, 1969, LIMNOL OCEANOGR, V14, P301, DOI 10.4319/lo.1969.14.2.0301	62	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104545	10.1371/journal.pone.0104545	http://dx.doi.org/10.1371/journal.pone.0104545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111600	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100073
J	Martin, J; Puig, P; Masque, P; Palanques, A; Sanchez-Gomez, A				Martin, Jacobo; Puig, Pere; Masque, Pere; Palanques, Albert; Sanchez-Gomez, Anabel			Impact of Bottom Trawling on Deep-Sea Sediment Properties along the Flanks of a Submarine Canyon	PLOS ONE			English	Article							PARTICULATE MATTER; ENVIRONMENTAL-IMPACT; ACCUMULATION RATES; CONTINENTAL-SHELF; THERMAIKOS GULF; RESUSPENSION; PB-210; FLUXES; CS-137; RADIONUCLIDES	The offshore displacement of commercial bottom trawling has raised concerns about the impact of this destructive fishing practice on the deep seafloor, which is in general characterized by lower resilience than shallow water regions. This study focuses on the flanks of La Fonera (or Palamos) submarine canyon in the Northwestern Mediterranean, where an intensive bottom trawl fishery has been active during several decades in the 400-800 m depth range. To explore the degree of alteration of surface sediments (0-50 cm depth) caused by this industrial activity, fishing grounds and control (untrawled) sites were sampled along the canyon flanks with an interface multicorer. Sediment cores were analyzed to obtain vertical profiles of sediment grain-size, dry bulk density, organic carbon content and concentration of the radionuclide Pb-210. At control sites, surface sediments presented sedimentological characteristics typical of slope depositional systems, including a topmost unit of unconsolidated and bioturbated material overlying sediments progressively compacted with depth, with consistently high Pb-210 inventories and exponential decaying profiles of Pb-210 concentrations. Sediment accumulation rates at these untrawled sites ranged from 0.3 to 1.0 cm y(-1). Sediment properties at most trawled sites departed from control sites and the sampled cores were characterized by denser sediments with lower Pb-210 surface concentrations and inventories that indicate widespread erosion of recent sediments caused by trawling gears. Other alterations of the physical sediment properties, including thorough mixing or grain-size sorting, as well as organic carbon impoverishment, were also visible at trawled sites. This work contributes to the growing realization of the capacity of bottom trawling to alter the physical properties of surface sediments and affect the seafloor integrity over large spatial scales of the deep-sea.	[Martin, Jacobo; Puig, Pere; Palanques, Albert; Sanchez-Gomez, Anabel] CSIC, ICM, Barcelona, Spain; [Masque, Pere] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals, Bellaterra, Spain; [Masque, Pere] Univ Autonoma Barcelona, Dept Fis, Bellaterra, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Autonomous University of Barcelona; Autonomous University of Barcelona	Martin, J (corresponding author), Consejo Nacl Invest Cient & Tecn CADIC CONICET, Ctr Austral Invest Cient, Ushuaia, Tierra Del Fueg, Argentina.	jmartin@icm.csic.es	Masque, Pere/B-7379-2008; Puig, Pere/E-5422-2013; Martin, Jacobo/F-1388-2011; Masque, Pere/AAC-9349-2022; Palanques, Albert/C-2661-2013	Masque, Pere/0000-0002-1789-320X; Puig, Pere/0000-0001-6189-5504; Martin, Jacobo/0000-0001-8933-7731; Palanques, Albert/0000-0003-2544-2342	HERMIONE project under the European Commission's Seventh Framework Programme [226354]; Spanish national Research Plan [CTM2010-11084-E]; JAEDOC contract within the Program "Junta para la Ampliacion de Estudios" - Consejo Superior de Investigaciones Cientificas; European Social Fund; ICREA Academia award	HERMIONE project under the European Commission's Seventh Framework Programme; Spanish national Research Plan(Spanish Government); JAEDOC contract within the Program "Junta para la Ampliacion de Estudios" - Consejo Superior de Investigaciones Cientificas; European Social Fund(European Social Fund (ESF)); ICREA Academia award(ICREA)	This work was funded by the HERMIONE project (http://www.eu-hermione.net) under the European Commission's Seventh Framework Programme (Grant agreement no: 226354) and by the Spanish national Research Plan (Ref. CTM2010-11084-E). J. Martin was funded through a JAEDOC contract within the Program "Junta para la Ampliacion de Estudios", granted by Consejo Superior de Investigaciones Cientificas (wwww.csic.es) and co-financed by the European Social Fund. P. Masque received financial support through the ICREA (www.icrea.cat) Academia award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benn AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012730; Bensch A, 2009, WORLDWIDE REV BOTTOM; CHURCHILL JH, 1989, CONT SHELF RES, V9, P841, DOI 10.1016/0278-4343(89)90016-2; Clark M, 1999, OCEANOL ACTA, V22, P593, DOI 10.1016/S0399-1784(00)88950-1; Cochran JK, 2003, REV MINERAL GEOCHEM, V52, P461, DOI 10.2113/0520461; de Juan S, 2007, MAR ECOL PROG SER, V334, P117; Demestre M, 1993, SCI MAR, V57, P175; Ferre B, 2008, CONT SHELF RES, V28, P2071, DOI 10.1016/j.csr.2008.02.002; He Q, 1996, J ENVIRON RADIOACTIV, V30, P117, DOI 10.1016/0265-931X(96)89275-7; Hinz H, 2009, ECOL APPL, V19, P761, DOI 10.1890/08-0351.1; JONES JB, 1992, NEW ZEAL J MAR FRESH, V26, P59, DOI 10.1080/00288330.1992.9516500; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Karageorgis AP, 2005, CONT SHELF RES, V25, P2456, DOI 10.1016/j.csr.2005.08.006; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; Lastras G, 2011, MAR GEOL, V280, P20, DOI 10.1016/j.margeo.2010.11.005; Alegret JL, 2008, AREAS, P26; Mabit L, 2008, J ENVIRON RADIOACTIV, V99, P1799, DOI 10.1016/j.jenvrad.2008.08.009; Martin J, 2008, MAR GEOL, V252, P150, DOI 10.1016/j.margeo.2008.03.012; Martin J, 2007, J MAR RES, V65, P193; Martin J, 2006, J MARINE SYST, V60, P75, DOI 10.1016/j.jmarsys.2005.09.010; Martin J, 2014, DEEP-SEA RES PT II, V104, P174, DOI 10.1016/j.dsr2.2013.05.036; NITTROUER CA, 1979, MAR GEOL, V31, P297, DOI 10.1016/0025-3227(79)90039-2; Ontiveros-Cuadras JF, 2012, J RADIOANAL NUCL CH, V292, P947, DOI 10.1007/s10967-012-1668-3; Palanques A, 2006, DEEP-SEA RES PT I, V53, P201, DOI 10.1016/j.dsr.2005.10.003; Palanques A, 2005, PROG OCEANOGR, V66, P89, DOI 10.1016/j.pocean.2004.07.016; Palanques A, 2001, LIMNOL OCEANOGR, V46, P1100, DOI 10.4319/lo.2001.46.5.1100; Palanques A, 2014, CONT SHELF RES, V72, P83, DOI 10.1016/j.csr.2013.10.008; Price SJ, 2011, PHILOS T R SOC A, V369, P1056, DOI 10.1098/rsta.2010.0296; Puig P, 2012, NATURE, V489, P286, DOI 10.1038/nature11410; Pusceddu A, 2005, CONT SHELF RES, V25, P2491, DOI 10.1016/j.csr.2005.08.013; Pusceddu A, 2014, P NATL ACAD SCI USA, V111, P8861, DOI 10.1073/pnas.1405454111; Radakovitch O, 2003, CONT SHELF RES, V23, P693, DOI 10.1016/S0278-4343(03)00021-9; Reed CW, 1999, MAR GEOL, V154, P143, DOI 10.1016/S0025-3227(98)00109-1; Ribo M, 2011, MAR GEOL, V284, P175, DOI 10.1016/j.margeo.2011.04.001; Roberts CM, 2002, TRENDS ECOL EVOL, V17, P242, DOI 10.1016/S0169-5347(02)02492-8; Sanchez-Cabeza JA, 1998, J RADIOANAL NUCL CH, V227, P19, DOI 10.1007/BF02386425; Sanchez-Cabeza JA, 1999, PROG OCEANOGR, V44, P313, DOI 10.1016/S0079-6611(99)00031-2; Sane E, 2013, BIOGEOSCIENCES, V10, P8093, DOI 10.5194/bg-10-8093-2013; Schoellhamer DH, 1996, ESTUAR COAST SHELF S, V43, P533, DOI 10.1006/ecss.1996.0086; THIEL H, 1990, AMBIO, V19, P245; Tobar R., 1987, INF T CN INV PESQ, V142, P3; WIBERG PL, 1994, CONT SHELF RES, V14, P1191, DOI 10.1016/0278-4343(94)90034-5	42	40	40	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104536	10.1371/journal.pone.0104536	http://dx.doi.org/10.1371/journal.pone.0104536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111298	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100070
J	Nishizuka, T; Kurahashi, T; Hara, T; Hirata, H; Kasuga, T				Nishizuka, Takanobu; Kurahashi, Toshikazu; Hara, Tatsuya; Hirata, Hitoshi; Kasuga, Toshihiro			Novel Intramedullary-Fixation Technique for Long Bone Fragility Fractures Using Bioresorbable Materials	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CEMENT; IN-VIVO; VERTEBROPLASTY; SCAFFOLD	Almost all of the currently available fracture fixation devices for metaphyseal fragility fractures are made of hard metals, which carry a high risk of implant-related complications such as implant cutout in severely osteoporotic patients. We developed a novel fracture fixation technique (intramedullary-fixation with biodegradable materials; IM-BM) for severely weakened long bones using three different non-metallic biomaterials, a poly(L-lactide) (PLLA) woven tube, a nonwoven polyhydroxyalkanoates (PHA) fiber mat, and an injectable calcium phosphate cement (CPC). The purpose of this work was to evaluate the feasibility of IM-BM with mechanical testing as well as with an animal experiment. To perform mechanical testing, we fixed two longitudinal acrylic pipes with four different methods, and used them for a three-point bending test (N = 5). The three-point bending test revealed that the average fracture energy for the IM-BM group (PLLA + CPC + PHA) was 3 times greater than that of PLLA + CPC group, and 60 to 200 times greater than that of CPC + PHA group and CPC group. Using an osteoporotic rabbit distal femur incomplete fracture model, sixteen rabbits were randomly allocated into four experimental groups (IM-BM group, PLLA + CPC group, CPC group, Kirschner wire (K-wire) group). No rabbit in the IM-BM group suffered fracture displacement even under full weight bearing. In contrast, two rabbits in the PLLA + CPC group, three rabbits in the CPC group, and three rabbits in the K-wire group suffered fracture displacement within the first postoperative week. The present work demonstrated that IM-BM was strong enough to reinforce and stabilize incomplete fractures with both mechanical testing and an animal experiment even in the distal thigh, where bone is exposed to the highest bending and torsional stresses in the body. IM-BM can be one treatment option for those with severe osteoporosis.	[Nishizuka, Takanobu; Kurahashi, Toshikazu; Hara, Tatsuya; Hirata, Hitoshi] Nagoya Univ, Grad Sch Med, Dept Hand Surg, Nagoya, Aichi 4648601, Japan; [Kasuga, Toshihiro] Nagoya Inst Technol, Dept Frontier Mat, Nagoya, Aichi, Japan	Nagoya University; Nagoya Institute of Technology	Nishizuka, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Hand Surg, Nagoya, Aichi 4648601, Japan.	nishizuka1@mail.goo.ne.jp	Nishizuka, Takanobu/Q-1515-2015		Japan Science and Technology Agency [AS2414028P]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by Japan Science and Technology Agency (AS2414028P, http://www.jst.go.jp/tt/EN/univ-ip/a-step.html#supportContent). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambard Alberto J, 2006, J Prosthodont, V15, P321, DOI 10.1111/j.1532-849X.2006.00129.x; Bhattarai SR, 2004, BIOMATERIALS, V25, P2595, DOI 10.1016/j.biomaterials.2003.09.043; Castaneda S, 2008, J BONE MINER METAB, V26, P53, DOI 10.1007/s00774-007-0797-1; GALIBERT P, 1987, NEUROCHIRURGIE, V33, P166; ISHIKAWA K, 1995, J BIOMED MATER RES, V29, P1537, DOI 10.1002/jbm.820291210; KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607; Kurashina K, 1997, BIOMATERIALS, V18, P147, DOI 10.1016/S0142-9612(96)00173-1; Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167; Mizutani Y, 2005, CHEM LETT, V34, P1110, DOI 10.1246/cl.2005.1110; Nakano M, 2002, J NEUROSURG, V97, P287, DOI 10.3171/spi.2002.97.3.0287; Owsley KC, 2008, J BONE JOINT SURG AM, V90A, P233, DOI 10.2106/JBJS.F.01351; PHILLIPS H, 1971, BMJ-BRIT MED J, V3, P460, DOI 10.1136/bmj.3.5772.460; Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011; STEINBUCHEL A, 1992, FEMS MICROBIOL LETT, V103, P217, DOI 10.1016/0378-1097(92)90313-D; Valappil SP, 2006, EXPERT REV MED DEVIC, V3, P853, DOI 10.1586/17434440.3.6.853; Wu Q, 2009, ARTIF CELL BLOOD SUB, V37, P1, DOI 10.1080/10731190802664429; Yamamuro T, 1998, BIOMATERIALS, V19, P1479, DOI 10.1016/S0142-9612(98)00062-3	17	6	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104603	10.1371/journal.pone.0104603	http://dx.doi.org/10.1371/journal.pone.0104603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111138	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100080
J	van der Mei, HC; Buijssen, KJDA; van der Laan, BFAM; Ovchinnikova, E; Geertsema-Doornbusch, GI; Atema-Smit, J; van de Belt-Gritter, B; Busscher, HJ				van der Mei, Henny C.; Buijssen, Kevin J. D. A.; van der Laan, Bernard F. A. M.; Ovchinnikova, Ekatarina; Geertsema-Doornbusch, Gesinda I.; Atema-Smit, Jelly; van de Belt-Gritter, Betsy; Busscher, Henk J.			Voice Prosthetic Biofilm Formation and Candida Morphogenic Conversions in Absence and Presence of Different Bacterial Strains and Species on Silicone-Rubber	PLOS ONE			English	Article							IN-VITRO; ALBICANS	Morphogenic conversion of Candida from a yeast to hyphal morphology plays a pivotal role in the pathogenicity of Candida species. Both Candida albicans and Candida tropicalis, in combination with a variety of different bacterial strains and species, appear in biofilms on silicone-rubber voice prostheses used in laryngectomized patients. Here we study biofilm formation on silicone-rubber by C. albicans or C. tropicalis in combination with different commensal bacterial strains and lactobacillus strains. In addition, hyphal formation in C. albicans and C. tropicalis, as stimulated by Rothia dentocariosa and lactobacilli was evaluated, as clinical studies outlined that these bacterial strains have opposite results on the clinical life-time of silicone-rubber voice prostheses. Biofilms were grown during eight days in a silicone-rubber tube, while passing the biofilms through episodes of nutritional feast and famine. Biofilms consisting of combinations of C. albicans and a bacterial strain comprised significantly less viable organisms than combinations comprising C. tropicalis. High percentages of Candida were found in biofilms grown in combination with lactobacilli. Interestingly, L. casei, with demonstrated favorable effects on the clinical life-time of voice prostheses, reduced the percentage hyphal formation in Candida biofilms as compared with Candida biofilms grown in absence of bacteria or grown in combination with R. dentocariosa, a bacterial strain whose presence is associated with short clinical life-times of voice prostheses.	[van der Mei, Henny C.; Buijssen, Kevin J. D. A.; van der Laan, Bernard F. A. M.; Ovchinnikova, Ekatarina; Geertsema-Doornbusch, Gesinda I.; Atema-Smit, Jelly; van de Belt-Gritter, Betsy; Busscher, Henk J.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands; [Buijssen, Kevin J. D. A.; van der Laan, Bernard F. A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol & Head & Neck Surg, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen	van der Mei, HC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.	h.c.van.der.mei@umcg.nl	Busscher, Henk/AAU-2113-2020; van der Laan, Bernard/H-2420-2011; van der Laan, Bernard/O-7723-2019	Busscher, Henk/0000-0002-3644-5533; van der Laan, Bernard/0000-0002-5016-2871; van der Laan, Bernard/0000-0002-5016-2871	University Medical Center Groningen, Groningen, The Netherlands	University Medical Center Groningen, Groningen, The Netherlands(Netherlands Government)	This study was entirely funded by the University Medical Center Groningen, Groningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie GS, 1999, J MED MICROBIOL, V48, P671, DOI 10.1099/00222615-48-7-671; Bertl K, 2013, J CLIN PERIODONTOL, V40, P833, DOI 10.1111/jcpe.12131; BRADSHAW DJ, 1994, MICROBIOL-UK, V140, P3407, DOI 10.1099/13500872-140-12-3407; Buijssen KJDA, 2007, OTOLARYNG HEAD NECK, V137, P505, DOI 10.1016/j.otohns.2007.05.051; Buijssen KJDA, 2012, THESIS GRONINGEN; BUSSCHER HJ, 1994, INT BIODETER BIODEGR, V33, P383, DOI 10.1016/0964-8305(94)90015-9; El-Azizi MA, 2004, J APPL MICROBIOL, V96, P1067, DOI 10.1111/j.1365-2672.2004.02213.x; Elving GJ, 2002, ANN OTO RHINOL LARYN, V111, P200, DOI 10.1177/000348940211100302; Everaert EPJM, 1997, EUR ARCH OTO-RHINO-L, V254, P261, DOI 10.1007/BF02905983; Gow NAR, 2002, CURR OPIN MICROBIOL, V5, P366, DOI 10.1016/S1369-5274(02)00338-7; MAHIEU HF, 1986, ARCH OTOLARYNGOL, V112, P321; NEU TR, 1993, BIOMATERIALS, V14, P459, DOI 10.1016/0142-9612(93)90149-V; Noverr MC, 2004, INFECT IMMUN, V72, P6206, DOI 10.1128/IAI.72.11.6206-6210.2004; ODDS FC, 1994, J AM ACAD DERMATOL, V31, pS2, DOI 10.1016/S0190-9622(08)81257-1; Parker AJ, 1995, P 6 INT C SURG PROST, P83; Schwandt LQ, 2005, HEAD NECK-J SCI SPEC, V27, P471, DOI 10.1002/hed.20180; ten Cate JM, 2009, J DENT RES, V88, P105, DOI 10.1177/0022034508329273	17	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104508	10.1371/journal.pone.0104508	http://dx.doi.org/10.1371/journal.pone.0104508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111806	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100063
J	Andersson, T; Ahlbom, A; Magnusson, C; Carlsson, S				Andersson, Tomas; Ahlbom, Anders; Magnusson, Cecilia; Carlsson, Sofia			Prevalence and Incidence of Diabetes in Stockholm County 1990-2010	PLOS ONE			English	Article							NORTHERN SWEDEN MONICA; FAVORABLE TRENDS; FOLLOW-UP; POPULATION; MORTALITY; METAANALYSIS; REGRESSION; REGISTER; RISK	Background: Diabetes is on the rise in the western world, but data from Scandinavia are inconsistent with indications of stable or even reverse trends. To shed new light on this issue, we investigated diabetes trends in Stockholm County 1990-2010, taking into account trends in risk factors and mortality. Methods: We used data from a large population-based quadrennial public health survey conducted between 1990 and 2010 in Stockholm County (similar to 2.1 million inhabitants), supplemented with data from national registers. The age-standardized prevalence and incidence rates of diabetes and related risk factors 1990-2010 were estimated in adult inhabitants. We also modelled the influence of potential risk factors on the diabetes trends and estimated the life time risk of diabetes. Results: The prevalence of diabetes was 4.6% (95% confidence interval (CI); 4.5-4.8%) in 2010 compared to 2.8% (95% CI; 2.3-3.5%) in 1990. Between 1990 and 2002 the prevalence rose annually by 3.8% (95% CI; 2.1-5.5). Incidence rates showed a similar pattern and rose by 3.0% (95% CI; 0.3-5.7%) annually 1990-2002. The rising incidence was mainly attributable to increasing prevalence of overweight/obesity, which rose by 46% during the observation period. In 2010, the lifetime risk of adult onset diabetes was 28% (95% CI; 26-31%) in men and 19% (95% CI; 17-21%) in women. Conclusions: Diabetes rates have been increasing in Stockholm over the last decades, both in terms of incidence and prevalence, and this development is most likely the result of increasing overweight and obesity in the population.	[Andersson, Tomas; Ahlbom, Anders; Carlsson, Sofia] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Andersson, Tomas; Ahlbom, Anders] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Magnusson, Cecilia] Stockholm Cty Council, Ctr Epidemiol & Community Med, Stockholm, Sweden; [Magnusson, Cecilia] Karolinska Inst, Dept Publ Hlth Sci, S-10401 Stockholm, Sweden	Karolinska Institutet; Stockholm County Council; Stockholm County Council; Karolinska Institutet	Carlsson, S (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	Sofia.carlsson@ki.se		Magnusson, Cecilia/0000-0002-8567-6725; carlsson, sofia/0000-0002-9497-2331				Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; Ainetdin T, 2001, 20017 STOCKH COUNT C; [Anonymous], 2011, REP STOCKH COUNT COU; [Anonymous], 2005, GUID ATC CLASS DDD A; Caman OK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-893; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Dahlquist GG, 2011, DIABETES CARE, V34, P1754, DOI 10.2337/dc11-0056; Davison AC, 1997, CAMBRIDGE SERIES STA; Eliasson M, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-32; Eriksson M, 2011, J INTERN MED, V269, P219, DOI 10.1111/j.1365-2796.2010.02312.x; Evans JMM, 2007, DIABETOLOGIA, V50, P729, DOI 10.1007/s00125-006-0585-9; Gudbjornsdottir S, 2011, NATL DIABETES REGIST; Hardoon SL, 2010, DIABETES CARE, V33, P1494, DOI 10.2337/dc09-2295; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Jansson SPO, 2007, DIABETOLOGIA, V50, P703, DOI 10.1007/s00125-007-0593-4; Jansson SPO, 2010, DIABETES CARE, V33, P551, DOI 10.2337/dc09-0680; Lilja M, 2013, DIABETIC MED, V30, P1054, DOI 10.1111/dme.12208; Lindahl B, 2010, GLOBAL HEALTH ACTION, V3, DOI 10.3402/gha.v3i0.5222; Gonzalez ELM, 2009, J EPIDEMIOL COMMUN H, V63, P332, DOI 10.1136/jech.2008.080382; MIDTHJELL K, 1992, J EPIDEMIOL COMMUN H, V46, P537, DOI 10.1136/jech.46.5.537; PRENTICE RL, 1978, BIOMETRICS, V34, P57, DOI 10.2307/2529588; Rautio A, 2005, J INTERN MED, V258, P369, DOI 10.1111/j.1365-2796.2005.01552.x; Rautio A, 2008, STROKE, V39, P3137, DOI 10.1161/STROKEAHA.107.504100; Ringborg A, 2008, DIABETIC MED, V25, P1178, DOI 10.1111/j.1464-5491.2008.02541.x; Svensson AC, 2013, INT J EPIDEMIOL, V42, P1263, DOI 10.1093/ije/dys126; Swedish National Board of Health and Welfare, OFF STAT SWED MYOC I; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654	29	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104033	10.1371/journal.pone.0104033	http://dx.doi.org/10.1371/journal.pone.0104033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121976	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000025
J	Bowden, JL; Lin, GG; McNulty, PA				Bowden, Jocelyn L.; Lin, Gaven G.; McNulty, Penelope A.			The Prevalence and Magnitude of Impaired Cutaneous Sensation across the Hand in the Chronic Period Post-Stroke	PLOS ONE			English	Article							SINGLE TACTILE AFFERENTS; FORCE CONTROL; SENSORY LOSS; STROKE; GRIP; AGE; DISCRIMINATION; DEXTERITY; RECOVERY; ARM	Sensation is commonly impaired immediately post-stroke but little is known about the long-term changes in cutaneous sensation that have the capacity to adversely impact independence and motor-function. We investigated cutaneous sensory thresholds across the hand in the chronic post-stroke period. Cutaneous sensation was assessed in 42 community-dwelling stroke patients and compared to 36 healthy subjects. Sensation was tested with calibrated monofilaments at 6 sites on the hand that covered the median, ulnar and radial innervation territories and included both glabrous (hairless) and hairy skin. The motor-function of stroke patients was assessed with the Wolf Motor Function Test and the upper-limb motor Fugl-Meyer Assessment. Impaired cutaneous sensation was defined as monofilament thresholds >3 SD above the mean of healthy subjects and good sensation was <= 3 SD. Cutaneous sensation was impaired for 33% of patients and was 40-84% worse on the more-affected side compared to healthy subjects depending on the site (p<0.05). When the stroke patient data were pooled cutaneous sensation fell within the healthy range, although similar to 1/3 of patients were classified with impaired sensation. Classification by motor-function revealed low levels of impaired sensation. The magnitude of sensory loss was only apparent when the sensory-function of stroke patients was classified as good or impaired. Sensation was most impaired on the dorsum of the hand where age-related changes in monofilament thresholds are minimal in healthy subjects. Although patients with both high and low motor-function had poor cutaneous sensation, overall patients with low motor-function had poorer cutaneous sensation than those with higher motor-function, and relationships were found between motor impairments and sensation at the fingertip and palm. These results emphasize the importance of identifying the presence and magnitude of cutaneous sensory impairments in the chronic period after stroke.	[Bowden, Jocelyn L.; Lin, Gaven G.; McNulty, Penelope A.] Neurosci Res Australia, Sydney, NSW, Australia; [Bowden, Jocelyn L.; McNulty, Penelope A.] Univ New S Wales, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	McNulty, PA (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	p.mcnulty@neura.edu.au	Bowden, Jocelyn/E-3964-2015	Bowden, Jocelyn/0000-0002-0340-0232	National Health and Medical Research Council, Australia; New South Wales Office of Science and Medical Research; Faculty of Medicine, University of New South Wales	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Office of Science and Medical Research; Faculty of Medicine, University of New South Wales	Funding provided by National Health and Medical Research Council, Australia; New South Wales Office of Science and Medical Research; and the Faculty of Medicine, University of New South Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031275; Australian Institute of Health and Welfare, 2010, AUSTR HLTH SER, V12; Aymard C, 2000, BRAIN, V123, P1688, DOI 10.1093/brain/123.8.1688; Bell-Krotoski J., 1995, REHABILITATION HAND; Berquin AD, 2010, MUSCLE NERVE, V42, P328, DOI 10.1002/mus.21689; Blennerhassett JM, 2007, NEUROREHAB NEURAL RE, V21, P263, DOI 10.1177/1545968306295560; Bleyenheuft Y, 2011, J REHABIL MED, V43, P251, DOI 10.2340/16501977-0651; Bowden JL, 2013, EXP GERONTOL, V48, P756, DOI 10.1016/j.exger.2013.03.011; Bowden JL, 2013, AGE, V35, P1077, DOI 10.1007/s11357-012-9429-3; Broeks JG, 1999, DISABIL REHABIL, V21, P357; Buma F, 2013, RESTOR NEUROL NEUROS, V31, P707, DOI 10.3233/RNN-130332; Carey L.M., 1995, CRIT REV PHYS REHABI, V7, P51, DOI [10.1615/CritRevPhysRehabilMed.v7.i1.40, DOI 10.1615/CRITREVPHYSREHABILMED.V7.I1.40]; Carey LM, 2011, J REHABIL MED, V43, P257, DOI 10.2340/16501977-0662; Carey LM, 1997, J NEUROL REHABIL, V11, P219, DOI 10.1177/154596839701100404; Connell LA, 2008, CLIN REHABIL, V22, P758, DOI 10.1177/0269215508090674; Connell LA, 2012, CLIN REHABIL, V26, P68, DOI 10.1177/0269215511412982; de Weerdt W, 1987, Int J Rehabil Res, V10, P110, DOI 10.1097/00004356-198700105-00022; DEUSCHL G, 1995, EXP BRAIN RES, V105, P138; Fallon JB, 2005, J NEUROPHYSIOL, V94, P3795, DOI 10.1152/jn.00359.2005; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FISHER CM, 1965, NEUROLOGY, V15, P76, DOI 10.1212/WNL.15.1.76; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Hermsdorfer J, 1999, EXP BRAIN RES, V128, P41, DOI 10.1007/s002210050815; Hermsdorfer J, 2003, CLIN NEUROPHYSIOL, V114, P915, DOI 10.1016/S1388-2457(03)00042-7; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V286, P283, DOI 10.1113/jphysiol.1979.sp012619; JOHANSSON RS, 1979, J PHYSIOL-LONDON, V297, P405, DOI 10.1113/jphysiol.1979.sp013048; Kalisch T, 2008, CLIN INTERV AGING, V3, P673, DOI 10.2147/CIA.S3174; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Kim JS, 2007, NEUROLOGY, V68, P174, DOI 10.1212/01.wnl.0000251298.12763.9b; Kim JS, 1996, STROKE, V27, P677, DOI 10.1161/01.STR.27.4.677; Lin JH, 2004, CLIN REHABIL, V18, P391, DOI 10.1191/0269215504cr737oa; McNulty PA, 2002, J PHYSIOL-LONDON, V538, P279, DOI 10.1113/jphysiol.2001.013200; McNulty PA, 2001, J PHYSIOL-LONDON, V537, P1021; McNulty PA, 1999, J PHYSIOL-LONDON, V518, P883, DOI 10.1111/j.1469-7793.1999.0883p.x; McNulty PA., 2013, SOC CARE NEURODISABI, V4, P114, DOI [10.1108/scn-04-2013-0018, DOI 10.1108/SCN-04-2013-0018]; Miller KJ, 2009, CLIN REHABIL, V23, P1104, DOI 10.1177/0269215509342331; Mirbagheri MM, 2009, J NEUROL NEUROSUR PS, V80, P1212, DOI 10.1136/jnnp.2008.155739; Monzee J, 2003, J NEUROPHYSIOL, V89, P672, DOI 10.1152/jn.00434.2001; NAKASHIMA K, 1989, BRAIN, V112, P681, DOI 10.1093/brain/112.3.681; Nowak DA, 2007, EUR J NEUROSCI, V25, P3173, DOI 10.1111/j.1460-9568.2007.05551.x; Reuter EM, 2012, EXP BRAIN RES, V216, P287, DOI 10.1007/s00221-011-2931-5; ROLAND PE, 1987, BRAIN RES REV, V12, P43, DOI 10.1016/0165-0173(87)90018-X; ROTHWELL JC, 1982, BRAIN, V105, P515, DOI 10.1093/brain/105.3.515; Seitz RJ, 1999, STROKE, V30, P1844, DOI 10.1161/01.STR.30.9.1844; Shiue I, 2011, CLIN NEUROL NEUROSUR, V113, P725, DOI 10.1016/j.clineuro.2011.07.015; Sullivan KJ, 2011, STROKE, V42, P427, DOI 10.1161/STROKEAHA.110.592766; Thompson-Butel AG, 2013, STIMULATION INHIBITI, P301; Tremblay F, 2005, EXP BRAIN RES, V164, P155, DOI 10.1007/s00221-005-2238-5; Tyson SF, 2008, NEUROREHAB NEURAL RE, V22, P166, DOI 10.1177/1545968307305523; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; van Nes SI, 2008, J NEUROL NEUROSUR PS, V79, P832, DOI 10.1136/jnnp.2007.139220; Welmer AK, 2008, J REHABIL MED, V40, P603, DOI 10.2340/16501977-0218; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; World Health Organization, 2002, COMMON LANGUAGE FUNC; Zackowski KM, 2004, BRAIN, V127, P1035, DOI 10.1093/brain/awh116	56	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104153	10.1371/journal.pone.0104153	http://dx.doi.org/10.1371/journal.pone.0104153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121607	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000030
J	Campos, MR; Rodrigues, ARS; Silva, WM; Silva, TBM; Silva, VRF; Guedes, RNC; Siqueira, HAA				Campos, Mateus R.; Rodrigues, Agna Rita S.; Silva, Wellington M.; Silva, Tadeu Barbosa M.; Silva, Vitoria Regina F.; Guedes, Raul Narciso C.; Siqueira, Herbert Alvaro A.			Spinosad and the Tomato Borer Tuta absoluta: A Bioinsecticide, an Invasive Pest Threat, and High Insecticide Resistance	PLOS ONE			English	Article							DIAMONDBACK MOTH LEPIDOPTERA; MEYRICK LEPIDOPTERA; BACILLUS-THURINGIENSIS; POPULATIONS; MANAGEMENT; IDENTIFICATION; INHERITANCE; STABILITY; ABAMECTIN; SYNERGISM	The introduction of an agricultural pest species into a new environment is a potential threat to agroecosystems of the invaded area. The phytosanitary concern is even greater if the introduced pest's phenotype expresses traits that will impair the management of that species. The invasive tomato borer, Tuta absoluta (Meyrick) (Lepidoptera: Gelechiidae), is one such species and the characterization of the insecticide resistance prevailing in the area of origin is important to guide management efforts in new areas of introduction. The spinosad is one the main insecticides currently used in Brazil for control of the tomato borer; Brazil is the likely source of the introduction of the tomato borer into Europe. For this reason, spinosad resistance in Brazilian populations of this species was characterized. Spinosad resistance has been reported in Brazilian field populations of this pest species, and one resistant population that was used in this study was subjected to an additional seven generations of selection for spinosad resistance reaching levels over 180,000-fold. Inheritance studies indicated that spinosad resistance is monogenic, incompletely recessive and autosomal with high heritability (h(2) = 0.71). Spinosad resistance was unstable without selection pressure with a negative rate of change in the resistance level (= -0.51) indicating an associated adaptive cost. Esterases and cytochrome P450-dependent monooxygenases titration decreased with spinosad selection, indicating that these detoxification enzymes are not the underlying resistance mechanism. Furthermore, the cross-resistance spectrum was restricted to the insecticide spinetoram, another spinosyn, suggesting that altered target site may be the mechanism involved. Therefore, the suspension of spinosyn use against the tomato borer would be a useful component in spinosad resistance management for this species. Spinosad use against this species in introduced areas should be carefully monitored to prevent rapid selection of high levels of resistance and the potential for its spread to new areas.	[Campos, Mateus R.; Rodrigues, Agna Rita S.; Silva, Wellington M.; Silva, Tadeu Barbosa M.; Silva, Vitoria Regina F.; Siqueira, Herbert Alvaro A.] Univ Fed Rural Pernambuco, Dept Agron Entomol, Recife, PE, Brazil; [Guedes, Raul Narciso C.] Univ Fed Vicosa, Dept Entomol, Vicosa, MG, Brazil	Universidade Federal Rural de Pernambuco (UFRPE); Universidade Federal de Vicosa	Siqueira, HAA (corresponding author), Univ Fed Rural Pernambuco, Dept Agron Entomol, Recife, PE, Brazil.	siqueira@depa.ufrpe.br	Guedes, Raul Narciso Carvalho/L-3924-2013; Campos, Mateus Ribeiro de/G-9828-2012; Siqueira, Herbert A. A./C-6062-2013	Guedes, Raul Narciso Carvalho/0000-0001-6229-7549; Campos, Mateus Ribeiro de/0000-0001-9317-3215; Siqueira, Herbert A. A./0000-0002-8802-8977	National Council of Scientific and Technological Development [CNPq-484240/2011-0]; CAPES Foundation; Insecticide Resistance Action Committee - Brazilian Section (IRAC-BR)	National Council of Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Insecticide Resistance Action Committee - Brazilian Section (IRAC-BR)	The financial support provided by the National Council of Scientific and Technological Development (CNPq-484240/2011-0) (HAAS), CAPES Foundation (MRC), and the Insecticide Resistance Action Committee - Brazilian Section (IRAC-BR) (HAAS) was greatly appreciated and acknowledged here. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, CROP PROTECTION PROD, DOI DOI 10.1021/BK-2007-0947.CH007; Biondi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076548; BRATTSTEN LB, 1986, SCIENCE, V231, P1255, DOI 10.1126/science.231.4743.1255; Campos MR, 2013, THESIS U FEDERAL RUR; Cifuentes D, 2011, PEST MANAG SCI, V67, P1155, DOI 10.1002/ps.2166; Coustau C, 2000, TRENDS ECOL EVOL, V15, P378, DOI 10.1016/S0169-5347(00)01929-7; Desneux N, 2011, J PEST SCI, V84, P403, DOI 10.1007/s10340-011-0398-6; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Falconer D. S., 1996, Introduction to quantitative genetics.; Ferguson JS, 2004, J ECON ENTOMOL, V97, P112, DOI 10.1603/0022-0493-97.1.112; Georghiou GP., 1972, ANNU REV ECOL EVOL S, V3, P133, DOI DOI 10.1146/ANNUREV.ES.03.110172.001025; Gontijo PC, 2013, ANN APPL BIOL, V162, P50, DOI 10.1111/aab.12000; Guedes R. N. C., 2012, CAB Reviews, V7, P1, DOI 10.1079/PAVSNNR20127055; Guedes R. N. C., 2012, Bulletin OEPP, V42, P211, DOI 10.1111/epp.2557; Guedes RNC, 2006, PHYSIOL ENTOMOL, V31, P30, DOI 10.1111/j.1365-3032.2005.00479.x; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; Haddi K, 2012, INSECT BIOCHEM MOLEC, V42, P506, DOI 10.1016/j.ibmb.2012.03.008; Hartl :D. L, 2000, PRIMER POPULATION GE; Heckel DG, 2012, SCIENCE, V337, P1613, DOI 10.1126/science.1226994; IRAC [Insecticide Resistance Action Committee], 2014, 022 IRAC; LANDE R, 1981, GENETICS, V99, P541; LeOra-Software, 2005, POLO PLUS POLO WIND; Lietti MMM, 2005, NEOTROP ENTOMOL, V34, P113, DOI 10.1590/S1519-566X2005000100016; MAPA, 2014, MAN GAR QUAL AN; NETTER KJ, 1964, J PHARMACOL EXP THER, V146, P61; Olson L. J., 2006, Agricultural and Resource Economics Review, V35, P178; Puinean AM, 2013, J NEUROCHEM, V124, P590, DOI 10.1111/jnc.12029; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Reyes M, 2012, PESTIC BIOCHEM PHYS, V102, P45, DOI 10.1016/j.pestbp.2011.10.008; Robertson J.L., 2007, BIOASSAYS ARTHROPODS, V2nd; Roditakis E, 2013, PEST MANAG SCI, V69, P834, DOI 10.1002/ps.3442; Roditakis E, 2013, PEST MANAG SCI, V69, P217, DOI 10.1002/ps.3404; Salazar E. R., 2001, Agricultura Tecnica, V61, P429; Salazar ER, 1997, SIMIENTE, V67, P8; Salgado VL, 2004, J INSECT PHYSIOL, V50, P867, DOI 10.1016/j.jinsphys.2004.07.007; Salgado VL., 2005, COMP MOLEC INSECT SC, V6, P137, DOI [10.1016/B0-44-451924-6/00078-8, DOI 10.1016/B0-44-451924-6/00078-8]; SAS Institute, 2008, SAS STAT US VERS; Sayyed AH, 2000, PEST MANAG SCI, V56, P743, DOI 10.1002/1526-4998(200009)56:9<743::AID-PS195>3.0.CO;2-8; Sayyed AH, 2008, J ECON ENTOMOL, V101, P1658, DOI 10.1603/0022-0493(2008)101[1658:GBAPCO]2.0.CO;2; Silva GA, 2011, PEST MANAG SCI, V67, P913, DOI 10.1002/ps.2131; Siqueira H. A. A., 2000, Agricultural and Forest Entomology, V2, P147, DOI 10.1046/j.1461-9563.2000.00062.x; Siqueira HAA, 2000, J APPL ENTOMOL, V124, P233, DOI 10.1046/j.1439-0418.2000.00470.x; Siqueira HAA, 2001, INT J PEST MANAGE, V47, P247, DOI 10.1080/09670870110044634; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sokal R. R., 2012, BIOMETRY; Sparks TC, 2012, PESTIC BIOCHEM PHYS, V102, P1, DOI 10.1016/j.pestbp.2011.11.004; STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325; Suinaga FA, 2004, PESQUI AGROPECU BRAS, V39, P645, DOI 10.1590/S0100-204X2004000700005; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; VANASPEREN K, 1962, J INSECT PHYSIOL, V8, P401, DOI 10.1016/0022-1910(62)90074-4; Wang D, 2010, PHYTOPARASITICA, V38, P103, DOI 10.1007/s12600-009-0077-9; Watson GB, 2010, INSECT BIOCHEM MOLEC, V40, P376, DOI 10.1016/j.ibmb.2009.11.004; Whalon ME, 2008, GLOBAL PESTICIDE RES, P208; Zhao JZ, 2002, J ECON ENTOMOL, V95, P430, DOI 10.1603/0022-0493-95.2.430	54	75	81	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103235	10.1371/journal.pone.0103235	http://dx.doi.org/10.1371/journal.pone.0103235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122089	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000012
J	Corrales-Guerrero, L; Flores, E; Herrero, A				Corrales-Guerrero, Laura; Flores, Enrique; Herrero, Antonia			Relationships between the ABC-Exporter HetC and Peptides that Regulate the Spatiotemporal Pattern of Heterocyst Distribution in Anabaena	PLOS ONE			English	Article							FORMING CYANOBACTERIUM; FILAMENT INTEGRITY; PCC 7120; DIFFERENTIATION; PROTEIN; EXPRESSION; GENES; PATS; LOCALIZATION; DIAZOTROPHY	In the model cyanobacterium Anabaena sp. PCC 7120, cells called heterocysts that are specialized in the fixation of atmospheric nitrogen differentiate from vegetative cells of the filament in the absence of combined nitrogen. Heterocysts follow a specific distribution pattern along the filament, and a number of regulators have been identified that influence the heterocyst pattern. PatS and HetN, expressed in the differentiating cells, inhibit the differentiation of neighboring cells. At least PatS appears to be processed and transferred from cell to cell. HetC is similar to ABC exporters and is required for differentiation. We present an epistasis analysis of these regulatory genes and of genes, hetP and asr2819, successively downstream from hetC, and we have studied the localization of HetC and HetP by use of GFP fusions. Inactivation of patS, but not of hetN, allowed differentiation to proceed in a hetC background, whereas inactivation of hetC in patS or patS hetN backgrounds decreased the frequency of contiguous proheterocysts. A HetC-GFP protein is localized to the heterocysts and especially near their cell poles, and a putative HetC peptidase domain was required for heterocyst differentiation but not for HetC-GFP localization. hetP is also required for heterocyst differentiation. A HetP-GFP protein localized mostly near the heterocyst poles. ORF asr2819, which we denote patC, encodes an 84-residue peptide and is induced upon nitrogen step-down. Inactivation of patC led to a late spreading of the heterocyst pattern. Whereas HetC and HetP appear to have linked functions that allow heterocyst differentiation to progress, PatC may have a role in selecting sites of differentiation, suggesting that these closely positioned genes may be functionally related.	[Herrero, Antonia] CSIC, Inst Bioquim Vegetal & Fotosintesis, E-41080 Seville, Spain; Univ Seville, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); University of Sevilla	Herrero, A (corresponding author), CSIC, Inst Bioquim Vegetal & Fotosintesis, E-41080 Seville, Spain.	herrero@ibvf.csic.es	Corrales-Guerrero, Laura/ABH-1786-2021; Corrales-Guerrero, Laura/D-7284-2015; Flores, Enrique/M-8407-2019; Flores, Enrique/L-2007-2014; Herrero, Antonia/B-7246-2015	Corrales-Guerrero, Laura/0000-0002-0878-5231; Corrales-Guerrero, Laura/0000-0002-0878-5231; Flores, Enrique/0000-0001-7605-7343; Flores, Enrique/0000-0001-7605-7343; Herrero, Antonia/0000-0003-1071-6590	Spanish Government [BFU2010-17980]; FEDER; CSIC	Spanish Government(Spanish GovernmentEuropean Commission); FEDER(European Commission); CSIC	Work was supported by grant BFU2010-17980 from the Spanish Government, co-financed by FEDER. L.C.-G. was the recipient of a JAE-predoc fellowship from CSIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer CC, 1997, FEMS MICROBIOL LETT, V151, P23, DOI 10.1111/j.1574-6968.1997.tb10390.x; BLACK TA, 1994, J BACTERIOL, V176, P2282, DOI 10.1128/JB.176.8.2282-2292.1994; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Borthakur PB, 2005, MOL MICROBIOL, V57, P111, DOI 10.1111/j.1365-2958.2005.04678.x; Callahan SM, 2001, MOL MICROBIOL, V40, P941, DOI 10.1046/j.1365-2958.2001.02437.x; Corbin BD, 2007, J BACTERIOL, V189, P3026, DOI 10.1128/JB.01581-06; Corrales-Guerrero L, 2013, MOL MICROBIOL, V88, P1093, DOI 10.1111/mmi.12244; ElhaI J, 1997, J BACTERIOL, V179, P1998, DOI 10.1128/jb.179.6.1998-2005.1997; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; FERNANDEZPINAS F, 1994, J BACTERIOL, V176, P5277; Flaherty BL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-332; Flores E, 2007, J BACTERIOL, V189, P3884, DOI 10.1128/JB.00085-07; Flores E, 2006, TRENDS MICROBIOL, V14, P439, DOI 10.1016/j.tim.2006.08.007; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; Herrero A, 2013, ADV BOT RES, V65, P281, DOI 10.1016/B978-0-12-394313-2.00008-1; Higa KC, 2012, MOL MICROBIOL, V83, P682, DOI 10.1111/j.1365-2958.2011.07949.x; Higa KC, 2010, MOL MICROBIOL, V77, P562, DOI 10.1111/j.1365-2958.2010.07257.x; Huang X, 2004, P NATL ACAD SCI USA, V101, P4848, DOI 10.1073/pnas.0400429101; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Khudyakov I, 1997, J BACTERIOL, V179, P6971, DOI 10.1128/jb.179.22.6971-6978.1997; Khudyakov IY, 2004, P NATL ACAD SCI USA, V101, P16040, DOI 10.1073/pnas.0405572101; Lopez-Igual R, 2012, ENVIRON MICROBIOL, V14, P1035, DOI 10.1111/j.1462-2920.2011.02683.x; Merino-Puerto V, 2013, J BACTERIOL, V195, P3957, DOI 10.1128/JB.00181-13; Merino-Puerto V, 2010, MOL MICROBIOL, V75, P1159, DOI 10.1111/j.1365-2958.2009.07031.x; Michiels J, 2001, TRENDS MICROBIOL, V9, P164, DOI 10.1016/S0966-842X(01)01979-5; Muro-Pastor AM, 2009, J BACTERIOL, V191, P5765, DOI 10.1128/JB.00616-09; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Risser DD, 2008, J BACTERIOL, V190, P7645, DOI 10.1128/JB.01110-08; Risser DD, 2012, P NATL ACAD SCI USA, V109, P15342, DOI 10.1073/pnas.1207530109; Risser DD, 2009, P NATL ACAD SCI USA, V106, P19884, DOI 10.1073/pnas.0909152106; Valladares A, 2011, J BACTERIOL, V193, P1172, DOI 10.1128/JB.01202-10; Wolk C.P., 1994, MOL BIOL CYANOBACTER, P769, DOI DOI 10.1007/978-94-011-0227-8_27; Wong FCY, 2001, J BACTERIOL, V183, P2654, DOI 10.1128/JB.183.8.2654-2661.2001; Xu XD, 2001, J BACTERIOL, V183, P393, DOI 10.1128/JB.183.1.393-396.2001; Yoon HS, 1998, SCIENCE, V282, P935, DOI 10.1126/science.282.5390.935; Yoon HS, 2001, J BACTERIOL, V183, P2605, DOI 10.1128/JB.183.8.2605-2613.2001; Zhang W, 2007, MOL MICROBIOL, V66, P1429, DOI 10.1111/j.1365-2958.2007.05997.x	39	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104571	10.1371/journal.pone.0104571	http://dx.doi.org/10.1371/journal.pone.0104571			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121608	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000044
J	Lago, BV; Mello, FC; Kramvis, A; Niel, C; Gomes, SA				Lago, Barbara V.; Mello, Francisco C.; Kramvis, Anna; Niel, Christian; Gomes, Selma A.			Hepatitis B Virus Subgenotype A1: Evolutionary Relationships between Brazilian, African and Asian Isolates	PLOS ONE			English	Article							LIVER-DISEASE PATIENTS; HBV GENOTYPE F; MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; GENETIC-VARIABILITY; NATURAL-HISTORY; HIGH PREVALENCE; SOUTH-AFRICA; MUTATIONS; SUBTYPE	Brazil is a country of low hepatitis B virus (HBV) endemicity in which the genotype A of HBV (HBV/A) is the most prevalent. The complete nucleotide sequences of 26 HBV/A isolates, originating from eight Brazilian states, were determined. All were adw2. Twenty-three belonged to subgenotype A1 and three to A2. By phylogenetic analysis, it was shown that all the 23 HBV/A1 isolates clustered together with isolates from Bangladesh, India, Japan, Nepal, the Philippines and United Arab Emirates, but not with those of Congo, Kenya, Malawi, Rwanda, South Africa, Tanzania, Uganda and Zimbabwe. Four amino acid residues in the polymerase (His138 in the terminal protein domain, Pro18 and His90 in the spacer, and Ser109 in the reverse transcriptase), and one (Phe17) in the precore region, predominated in Latin American and Asian HBV/A1 isolates, but were rarely encountered in African isolates, with the exception of those from Somalia. Specific variations of two adjacent amino acids in the C-terminal domain of the HBx protein, namely Ala146 and Pro147, were found in all the Brazilian, but rarely in the other HBV/A1 isolates. By Bayesian analysis, the existence of an 'Asian-American' clade within subgenotype A1 was supported by a posterior probability value of 0.996. The close relatedness of the Brazilian, Asian and Somalian isolates suggests that the HBV/A1 strains predominant in Brazil did not originate from the five million slaves who were imported from Central and Western Africa from 1551 to 1840, but rather from the 300-400,000 captives forcibly removed from southeast Africa at the middle of the 19th century.	[Lago, Barbara V.; Mello, Francisco C.; Niel, Christian; Gomes, Selma A.] Fiocruz MS, Inst Oswaldo Cruz, Mol Virol Lab, BR-21045900 Rio De Janeiro, Brazil; [Kramvis, Anna] Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Hepatitis Virus Div Res Programme,Dept Internal M, Johannesburg, South Africa	Fundacao Oswaldo Cruz; University of Witwatersrand	Gomes, SA (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Mol Virol Lab, BR-21045900 Rio De Janeiro, Brazil.	selma@ioc.fiocruz.br	gomes, selma A/D-2762-2015; Niel, Christian/G-3712-2013	Kramvis, Anna/0000-0001-6006-3765; Gomes, Selma/0000-0003-0233-3370	Oswaldo Cruz Institute, Rio de Janeiro, Brazil; University of the Witwatersrand, Johannesburg, South Africa	Oswaldo Cruz Institute, Rio de Janeiro, Brazil; University of the Witwatersrand, Johannesburg, South Africa	The authors thank Dr Gonzalo Bello for help in the phylogeographic analysis and Drs Natalia M. Araujo, Ana R. Motta-Castro and Caroline C. Soares for valuable comments. BVL received a doctoral fellowship in the context of cooperation between the Oswaldo Cruz Institute, Rio de Janeiro, Brazil, and the University of the Witwatersrand, Johannesburg, South Africa. The DNA Sequencing Platform PDTIS/FIOCRUZ is acknowledged for performing nucleotide sequencing.	Alvarado-Mora MV, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-415; Andernach IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081690; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618; Araujo NM, 2004, ARCH VIROL, V149, P1383, DOI 10.1007/s00705-003-0269-4; ARBOLEDA M, 1995, T ROY SOC TROP MED H, V89, P481, DOI 10.1016/0035-9203(95)90074-8; Beachey R., 1976, SLAVE TRADE E AFRICA; Bertolini DA, 2012, INFECT GENET EVOL, V12, P1295, DOI 10.1016/j.meegid.2012.04.009; Bottecchia M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-11; Bowyer SM, 1997, J GEN VIROL, V78, P1719, DOI 10.1099/0022-1317-78-7-1719; Brazilian Ministry of Health, 2010, EST PREV BAS POP INF; Brichler S, 2013, J GEN VIROL, V94, P2318, DOI 10.1099/vir.0.055459-0; Casey JL, 1996, J INFECT DIS, V174, P920, DOI 10.1093/infdis/174.5.920; Datta S, 2008, VIROLOGY, V382, P190, DOI 10.1016/j.virol.2008.09.007; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Souto FJD, 2007, REV SOC BRAS MED TRO, V40, P18, DOI 10.1590/S0037-86822007000100004; Eltis D., 2010, ATLAS TRANSATLANTIC; Crispim MAE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-94; Barros LMF, 2014, INFECT GENET EVOL, V24, P68, DOI 10.1016/j.meegid.2014.03.007; Freitas SZ, 2014, BRAZ J INFECT DIS, V18, P473, DOI 10.1016/j.bjid.2014.01.005; Goncalves VF, 2008, HUM HERED, V65, P23, DOI 10.1159/000106059; Gopalakrishnan D, 2013, WORLD J GASTROENTERO, V19, P9294, DOI 10.3748/wjg.v19.i48.9294; GUNTHER S, 1995, J VIROL, V69, P5437; Hadziyannis SJ, 2011, J HEPATOL, V55, P183, DOI 10.1016/j.jhep.2010.12.030; Hannoun C, 2005, J GEN VIROL, V86, P2163, DOI 10.1099/vir.0.80972-0; Hannoun C, 2000, J GEN VIROL, V81, P75, DOI 10.1099/0022-1317-81-1-75; Hubschen JM, 2011, CLIN MICROBIOL INFEC, V17, P88, DOI 10.1111/j.1469-0691.2010.03205.x; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Kay A, 2007, VIRUS RES, V127, P164, DOI 10.1016/j.virusres.2007.02.021; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kramvis A, 2002, J GEN VIROL, V83, P835, DOI 10.1099/0022-1317-83-4-835; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kramvis A, 2013, ANTIVIR THER, V18, P513, DOI 10.3851/IMP2657; Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0; Kwange SO, 2013, VIRUS GENES, V47, P448, DOI 10.1007/s11262-013-0976-1; Lago BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092223; Lazarevic I, 2014, WORLD J GASTROENTERO, V20, P7653, DOI 10.3748/wjg.v20.i24.7653; Makondo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046345; Marciano S, 2013, ANTIVIR THER, V18, P485, DOI 10.3851/IMP2604; Matos MAD, 2009, T ROY SOC TROP MED H, V103, P899, DOI 10.1016/j.trstmh.2009.01.013; Mello FCA, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-103; Motta-Castro A, 2008, ARCH VIROL, V153, P2197, DOI 10.1007/s00705-008-0237-0; Moura IF, 2013, INFECT GENET EVOL, V14, P195, DOI 10.1016/j.meegid.2012.11.022; Ochwoto M, 2013, INFECT GENET EVOL, V20, P103, DOI 10.1016/j.meegid.2013.08.013; OKAMOTO H, 1987, JPN J EXP MED, V57, P231; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; ORITO E, 1989, P NATL ACAD SCI USA, V86, P7059, DOI 10.1073/pnas.86.18.7059; Paraskevis D, 2013, HEPATOLOGY, V57, P908, DOI 10.1002/hep.26079; Pourkarim MR, 2011, CLIN MICROBIOL INFEC, V17, P947, DOI 10.1111/j.1469-0691.2010.03374.x; Pourkarim MR, 2010, J CLIN VIROL, V47, P356, DOI 10.1016/j.jcv.2010.01.015; Pourkarim MR, 2010, J CLIN VIROL, V47, P93, DOI 10.1016/j.jcv.2009.09.032; Santos AO, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-315; Tanaka Y, 2004, HEPATOLOGY, V40, P747, DOI 10.1002/hep.20365; Tanwar Sudeep, 2012, Curr Gastroenterol Rep, V14, P37, DOI 10.1007/s11894-011-0233-5; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Valente F, 2010, MEM I OSWALDO CRUZ, V105, P970, DOI 10.1590/S0074-02762010000800004; Viana S, 2005, AM J TROP MED HYG, V73, P808, DOI 10.4269/ajtmh.2005.73.808; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1	58	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105317	10.1371/journal.pone.0105317	http://dx.doi.org/10.1371/journal.pone.0105317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122004	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000116
J	Malikova, J; Camats, N; Fernandez-Cancio, M; Heath, K; Gonzalez, I; Caimari, M; del Campo, M; Albisu, M; Kolouskova, S; Audi, L; Fluck, CE				Malikova, Jana; Camats, Nuria; Fernandez-Cancio, Monica; Heath, Karen; Gonzalez, Isabel; Caimari, Maria; del Campo, Miguel; Albisu, Marian; Kolouskova, Stanislava; Audi, Laura; Flueck, Christa E.			Human NR5A1/SF-1 Mutations Show Decreased Activity on BDNF (Brain-Derived Neurotrophic Factor), an Important Regulator of Energy Balance: Testing Impact of Novel SF-1 Mutations Beyond Steroidogenesis	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; CHAIN-CLEAVAGE ENZYME; FACTOR-I SF-1; SEX DEVELOPMENT; GENE; EXPRESSION; DIFFERENTIATION; TRANSCRIPTION; DISORDERS; BEHAVIOR	Context: Human NR5A1/SF-1 mutations cause 46,XY disorder of sex development (DSD) with broad phenotypic variability, and rarely cause adrenal insufficiency although SF-1 is an important transcription factor for many genes involved in steroidogenesis. In addition, the Sf-1 knockout mouse develops obesity with age. Obesity might be mediated through Sf-1 regulating activity of brain-derived neurotrophic factor (BDNF), an important regulator of energy balance in the ventromedial hypothalamus. Objective: To characterize novel SF-1 gene variants in 4 families, clinical, genetic and functional studies were performed with respect to steroidogenesis and energy balance. Patients: 5 patients with 46,XY DSD were found to harbor NR5A1/SF-1 mutations including 2 novel variations. One patient harboring a novel mutation also suffered from adrenal insufficiency. Methods: SF-1 mutations were studied in cell systems (HEK293, JEG3) for impact on transcription of genes involved in steroidogenesis (CYP11A1, CYP17A1, HSD3B2) and in energy balance (BDNF). BDNF regulation by SF-1 was studied by promoter assays (JEG3). Results: Two novel NR5A1/SF-1 mutations (Glu7Stop, His408Profs*159) were confirmed. Glu7Stop is the 4th reported SF-1 mutation causing DSD and adrenal insufficiency. In vitro studies revealed that transcription of the BDNF gene is regulated by SF-1, and that mutant SF-1 decreased BDNF promoter activation (similar to steroid enzyme promoters). However, clinical data from 16 subjects carrying SF-1 mutations showed normal birth weight and BMI. Conclusions: Glu7Stop and His408Profs*159 are novel SF-1 mutations identified in patients with 46,XY DSD and adrenal insufficiency (Glu7Stop). In vitro, SF-1 mutations affect not only steroidogenesis but also transcription of BDNF which is involved in energy balance. However, in contrast to mice, consequences on weight were not found in humans with SF-1 mutations.	[Malikova, Jana; Kolouskova, Stanislava] Charles Univ Prague, Fac Med 2, Dept Pediat, Prague, Czech Republic; [Malikova, Jana; Kolouskova, Stanislava] Univ Hosp Motol, Prague, Czech Republic; [Malikova, Jana; Camats, Nuria; Flueck, Christa E.] Univ Childrens Hosp Bern, Dept Pediat, Bern, Switzerland; [Malikova, Jana; Camats, Nuria; Flueck, Christa E.] Univ Childrens Hosp Bern, Dept Clin Res, Bern, Switzerland; [Fernandez-Cancio, Monica; Albisu, Marian; Audi, Laura] Autonomous Univ Barcelona, CIBERER, Vall Hebron Res Inst VHIR, Barcelona, Spain; [Heath, Karen] Univ Autonoma Madrid, IdiPAZ, Inst Med & Mol Genet INGEMM, Hosp Univ La Paz, Madrid, Spain; [Gonzalez, Isabel] Univ Autonoma Madrid, IdiPAZ, Pediat Endocrinol Serv, Hosp Univ La Paz, Madrid, Spain; [Caimari, Maria] Son Espases Univ Hosp, Palma De Mallorca, Spain; [del Campo, Miguel] Hosp Valle De Hebron, Barcelona, Spain	Charles University Prague; Motol University Hospital; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; Hospital Universitari Son Espases; Hospital Universitari Vall d'Hebron	Fluck, CE (corresponding author), Charles Univ Prague, Fac Med 2, Dept Pediat, Prague, Czech Republic.	christa.flueck@dkf.unibe.ch	Camats, Nuria/K-8326-2017; Heath, Karen Elise/K-7760-2014; Heath, K. E./ABG-4658-2020	Camats, Nuria/0000-0002-4863-8201; Heath, Karen Elise/0000-0002-5816-7044; Heath, K. E./0000-0002-5816-7044; Flueck, Christa/0000-0002-4568-5504; Fernandez Cancio, Monica/0000-0003-1872-3488	Swiss National Science Foundation [320030-146127]; Instituto de Salud Carlos III, Madrid, Spain CIBERER [U-712]; AGAUR (University and Research Management and Evaluation Agency), Barcelona, Spain [2009SGR31]; ESPE (European Society of Pediatric Endocrinology); Novo Nordisk A/S	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Instituto de Salud Carlos III, Madrid, Spain CIBERER; AGAUR (University and Research Management and Evaluation Agency), Barcelona, Spain(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); ESPE (European Society of Pediatric Endocrinology); Novo Nordisk A/S(Novo Nordisk)	This work was supported by grants of the Swiss National Science Foundation (320030-146127) to CEF, the Instituto de Salud Carlos III, Madrid, Spain CIBERER U-712 to MFC and the AGAUR (University and Research Management and Evaluation Agency), Barcelona, Spain (2009SGR31) to LA, and by ESPE (European Society of Pediatric Endocrinology) Research Fellowship grants to JM and NC (sponsored by Novo Nordisk A/S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Achermann JC, 2002, J CLIN ENDOCR METAB, V87, P1829, DOI 10.1210/jc.87.4.1829; Adamovic T, 2012, SEX DEV, V6, P292, DOI 10.1159/000343782; Allali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024117; Bashamboo A, 2010, AM J HUM GENET, V87, P505, DOI 10.1016/j.ajhg.2010.09.009; Biason-Lauber A, 2000, AM J HUM GENET, V67, P1563, DOI 10.1086/316893; Camats N, 2012, J CLIN ENDOCR METAB, V97, pE1294, DOI 10.1210/jc.2011-3169; Ciaccio M, 2012, HORM RES PAEDIAT, V78, P119, DOI 10.1159/000338346; Ferraz-de-Souza B, 2011, MOL CELL ENDOCRINOL, V336, P198, DOI 10.1016/j.mce.2010.11.006; Fluck CE, 2004, MOL ENDOCRINOL, V18, P1144, DOI 10.1210/me.2003-0342; Gray J, 2006, DANCING TIMES, V96, P55; Halvorson LM, 1996, J BIOL CHEM, V271, P6645, DOI 10.1074/jbc.271.12.6645; Han JC, 2008, NEW ENGL J MED, V359, P918, DOI 10.1056/NEJMoa0801119; Hoivik EA, 2010, MOL CELL ENDOCRINOL, V315, P27, DOI 10.1016/j.mce.2009.07.003; Huang NW, 2000, J BIOL CHEM, V275, P2852, DOI 10.1074/jbc.275.4.2852; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; Jacobs SBR, 2003, MOL ENDOCRINOL, V17, P1470, DOI 10.1210/me.2002-0286; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Kim Kwang Young, 2011, Algae, V26, P1, DOI 10.4490/algae.2011.26.1.001; Kohler B, 2008, HUM MUTAT, V29, P59, DOI 10.1002/humu.20588; Kohjima M, 2010, ENDOCRINOLOGY, V151, P1532, DOI 10.1210/en.2009-1196; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; Morohashi K, 1999, BLOOD, V93, P1586; Patel MV, 2001, J INVEST DERMATOL, V117, P1559, DOI 10.1046/j.0022-202x.2001.01587.x; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Ramayya MS, 1997, J CLIN ENDOCR METAB, V82, P1799, DOI 10.1210/jc.82.6.1799; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Rios M, 2013, TRENDS NEUROSCI, V36, P83, DOI 10.1016/j.tins.2012.12.009; SADOVSKY Y, 1995, P NATL ACAD SCI USA, V92, P10939, DOI 10.1073/pnas.92.24.10939; Sarafoglou K, 2012, J CLIN ENDOCR METAB, V97, P2292, DOI 10.1210/jc.2012-2178; Schimmer BP, 2010, MOL ENDOCRINOL, V24, P1322, DOI 10.1210/me.2009-0519; Stranahan AM, 2011, NEUROENDOCRINOLOGY, V93, P58, DOI 10.1159/000322808; TAKETO M, 1995, GENOMICS, V25, P565, DOI 10.1016/0888-7543(95)80059-U; Tran PV, 2006, J COMP NEUROL, V498, P637, DOI 10.1002/cne.21070; Tran PV, 2003, MOL CELL NEUROSCI, V22, P441, DOI 10.1016/S1044-7431(03)00027-7; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Zhao LP, 2001, DEVELOPMENT, V128, P147	40	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104838	10.1371/journal.pone.0104838	http://dx.doi.org/10.1371/journal.pone.0104838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122490	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000063
J	Castelli, I; Massaro, D; Bicchieri, C; Chavez, A; Marchetti, A				Castelli, Ilaria; Massaro, Davide; Bicchieri, Cristina; Chavez, Alex; Marchetti, Antonella			Fairness Norms and Theory of Mind in an Ultimatum Game: Judgments, Offers, and Decisions in School-Aged Children	PLOS ONE			English	Article							BELIEFS; ABILITY	The sensitivity to fairness undergoes relevant changes across development. Whether such changes depend on primary inequity aversion or on sensitivity to a social norm of fairness is still debated. Using a modified version of the Ultimatum Game that creates informational asymmetries between Proposer and Responder, a previous study showed that both perceptions of fairness and fair behavior depend upon normative expectations, i.e., beliefs about what others expect one should do in a specific situation. Individuals tend to comply with the norm when risking sanctions, but disregard the norm when violations are undetectable. Using the same methodology with children aged 8-10 years, the present study shows that children's beliefs and behaviors differ from what is observed in adults. Playing as Proposers, children show a self-serving bias only when there is a clear informational asymmetry. Playing as Responders, they show a remarkable discrepancy between their normative judgment about fair procedures (a coin toss to determine the offer) and their behavior (rejection of an unfair offer derived from the coin toss), supporting the existence of an outcome bias effect. Finally, our results reveal no influence of theory of mind on children's decision-making behavior.	[Castelli, Ilaria; Massaro, Davide; Marchetti, Antonella] Univ Cattolica Sacro Cuore, Res Unit Theory Mind, Dept Psychol, I-20123 Milan, Italy; [Bicchieri, Cristina] Univ Penn, Dept Philosophy & Psychol, Behav Ethics Lab, Philadelphia, PA 19104 USA; [Chavez, Alex] Univ Michigan, Dept Psychol, Ann Arbor, MI USA	Catholic University of the Sacred Heart; University of Pennsylvania; University of Michigan System; University of Michigan	Castelli, I (corresponding author), Univ Cattolica Sacro Cuore, Res Unit Theory Mind, Dept Psychol, I-20123 Milan, Italy.	ilaria.castelli@unicatt.it	MARCHETTI, Antonella/AAL-6051-2020; Massaro, Davide/K-1233-2019; Castelli, Ilaria/S-5279-2019; Marchetti, Antonella/W-2226-2018	MARCHETTI, Antonella/0000-0001-9985-0539; Massaro, Davide/0000-0002-4511-6897; Marchetti, Antonella/0000-0001-9985-0539	Universita Cattolica del Sacro Cuore [D1-2011]	Universita Cattolica del Sacro Cuore	This research was made possible by a D1-2011 research grant from the Universita Cattolica del Sacro Cuore to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonietti A, 2006, SPR SER HUM EX, P1; Artinger F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092844; Astington J. W., 2003, INDIVIDUAL DIFFERENC; Astington JW, 2002, NEW IDEAS PSYCHOL, V20, P131, DOI 10.1016/S0732-118X(02)00005-3; Baglio F, 2012, J ALZHEIMERS DIS, V29, P25, DOI 10.3233/JAD-2011-111256; Bicchieri C., 2006, GRAMMAR SOC; Bicchieri C, 2013, ECON PHILOS, V29, P175, DOI 10.1017/S0266267113000187; Bicchieri C, 2010, J BEHAV DECIS MAKING, V23, P161, DOI 10.1002/bdm.648; Bloom P, 2000, COGNITION, V77, pB25, DOI 10.1016/S0010-0277(00)00096-2; Camerer C, 2003, BEHAV GAME THEORY; Castelli I., 2010, INT REV EC, V57, P269, DOI [10.1007/s12232-010-0101-x, DOI 10.1007/S12232-010-0101-X]; Castelli I, 2014, EUR J DEV PSYCHOL, V11, P49, DOI 10.1080/17405629.2013.806264; Castelli I, 2011, AGING MENT HEALTH, V15, P157, DOI 10.1080/13607863.2010.513038; Castelli I, 2010, NEUROPSYCHOLOGIA, V48, P2586, DOI 10.1016/j.neuropsychologia.2010.05.005; Cubitt RP, 2011, J PUBLIC ECON, V95, P253, DOI 10.1016/j.jpubeco.2010.10.011; Exadaktylos F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01213; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; German TP, 2006, COGNITION, V101, P129, DOI 10.1016/j.cognition.2005.05.007; Gino F., 2009, 08080 NOM HARV BUS S; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Harbaugh W.T., 2003, 20024 U OR EC; Harbaugh WT, 2007, J ECON PSYCHOL, V28, P127, DOI 10.1016/j.joep.2006.03.005; Marchetti A, 2011, J ECON PSYCHOL, V32, P446, DOI 10.1016/j.joep.2011.03.009; Murnighan JK, 1998, J ECON PSYCHOL, V19, P415, DOI 10.1016/S0167-4870(98)00017-8; PERNER J, 1985, J EXP CHILD PSYCHOL, V39, P437, DOI 10.1016/0022-0965(85)90051-7; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Sally D, 2006, J ECON PSYCHOL, V27, P73, DOI 10.1016/j.joep.2005.06.015; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Smith CE, 2013, PLOS ONE, V8, DOI [10.1371/annotation/4b9340db-455b-4e0d-86e5-b6783747111f, 10.1371/journal.pone.0059510]; Takagishi H, 2010, J EXP CHILD PSYCHOL, V105, P130, DOI 10.1016/j.jecp.2009.09.005; Weber RA, 2003, GAME ECON BEHAV, V44, P134, DOI 10.1016/S0899-8256(03)00002-2; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5	32	19	22	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105024	10.1371/journal.pone.0105024	http://dx.doi.org/10.1371/journal.pone.0105024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9BM	25118863	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600114
J	Mahony, H; Tsalatsanis, A; Kumar, A; Djulbegovic, B				Mahony, Helen; Tsalatsanis, Athanasios; Kumar, Ambuj; Djulbegovic, Benjamin			Evolution of Treatment Regimens in Multiple Myeloma: A Social Network Analysis	PLOS ONE			English	Article							TRANSPLANTATION; THALIDOMIDE; TRIAL	Background: Randomized controlled trials (RCTs) are considered the gold standard for assessing the efficacy of new treatments compared to standard treatments. However, the reasoning behind treatment selection in RCTs is often unclear. Here, we focus on a cohort of RCTs in multiple myeloma (MM) to understand the patterns of competing treatment selections. Methods: We used social network analysis (SNA) to study relationships between treatment regimens in MM RCTs and to examine the topology of RCT treatment networks. All trials considering induction or autologous stem cell transplant among patients with MM were eligible for our analysis. Medline and abstracts from the annual proceedings of the American Society of Hematology and American Society for Clinical Oncology, as well as all references from relevant publications were searched. We extracted data on treatment regimens, year of publication, funding type, and number of patients enrolled. The SNA metrics used are related to node and network level centrality and to node positioning characterization. Results: 135 RCTs enrolling a total of 36,869 patients were included. The density of the RCT network was low indicating little cohesion among treatments. Network Betweenness was also low signifying that the network does not facilitate exchange of information. The maximum geodesic distance was equal to 4, indicating that all connected treatments could reach each other in four "steps'' within the same pathway of development. The distance between many important treatment regimens was greater than 1, indicating that no RCTs have compared these regimens. Conclusion: Our findings show that research programs in myeloma, which is a relatively small field, are surprisingly decentralized with a lack of connectivity among various research pathways. As a result there is much crucial research left unexplored. Using SNA to visually and analytically examine treatment networks prior to designing a clinical trial can lead to better designed studies.	[Mahony, Helen; Tsalatsanis, Athanasios; Kumar, Ambuj; Djulbegovic, Benjamin] Univ S Florida, Div Evidence Based Med & Hlth Outcomes Res, Dept Internal Med, Tampa, FL 33612 USA; [Djulbegovic, Benjamin] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol & Hlth Outcomes & Behav, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute	Djulbegovic, B (corresponding author), Univ S Florida, Div Evidence Based Med & Hlth Outcomes Res, Dept Internal Med, Tampa, FL 33612 USA.	bdjulbeg@health.usf.edu	Kumar, Ambuj/I-4940-2012; Tsalatsanis, Athanasios/A-8742-2009; Djulbegovic, Benjamin/I-3661-2012; KUMAR, ASHOK/AAF-4055-2021; Kumar, Ambuj/U-5268-2019	Tsalatsanis, Athanasios/0000-0003-3818-8283; Djulbegovic, Benjamin/0000-0003-0671-1447; KUMAR, ASHOK/0000-0002-9244-0622; Mahony, Helen/0000-0002-6874-6824				Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Borgatti, 2003, KEYPLAYER; Borgatti S.P., 2002, NETDRAW NETWORK VISU; Breitkreutz I, 2007, LEUKEMIA, V21, P1294, DOI 10.1038/sj.leu.2404661; Djulbegovic B, 2008, LANCET, V371, P1642, DOI 10.1016/S0140-6736(08)60704-7; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FRIEDKIN NE, 1982, SOC NETWORKS, V3, P273, DOI 10.1016/0378-8733(82)90003-X; Georgiev H, 2011, SOCIAL NETWORK ANAL; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Haynes RB, 2005, BMJ-BRIT MED J, V330, P1179, DOI 10.1136/bmj.38446.498542.8F; HOLLAND JF, 1966, BLOOD-J HEMATOL, V27, P328, DOI 10.1182/blood.V27.3.328.328; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Kumar A, 2003, LANCET ONCOL, V4, P293, DOI 10.1016/S1470-2045(03)01077-5; Kumar A, 2011, AM J HEMATOL, V86, P18, DOI 10.1002/ajh.21904; Kumar A, 2009, J NATL CANCER I, V101, P100, DOI 10.1093/jnci/djn439; Mahony H, 2012, DATABASE RANDOMIZED; National Comprehensive Cancer Network, 2013, MULT MYEL VERS 1 201; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Skvoretz J, 2011, WORKSH BAS NETW METH, P1; Tsalatsanis A, 2010, SMALL WORLD NETWORKS, P6086; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	23	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104555	10.1371/journal.pone.0104555	http://dx.doi.org/10.1371/journal.pone.0104555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119186	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600068
J	Albinsson, ME; Negri, AP; Blackburn, SI; Bolch, CJS				Albinsson, Maria E.; Negri, Andrew P.; Blackburn, Susan I.; Bolch, Christopher J. S.			Bacterial Community Affects Toxin Production by Gymnodinium catenatum	PLOS ONE			English	Article							PARALYTIC SHELLFISH TOXINS; GENE-CLUSTER; SAXITOXIN BIOSYNTHESIS; LIQUID-CHROMATOGRAPHY; CELL-CYCLE; ALEXANDRIUM; GROWTH; DIVERSITY; PROFILES; TOXICITY	The paralytic shellfish toxin (PST)-producing dinoflagellate Gymnodinium catenatum grows in association with a complex marine bacterial community that is both essential for growth and can alter culture growth dynamics. Using a bacterial community replacement approach, we examined the intracellular PST content, production rate, and profile of G. catenatum cultures grown with bacterial communities of differing complexity and composition. Clonal offspring were established from surface-sterilized resting cysts (produced by sexual crosses of strain GCDE06 and strain GCLV01) and grown with: 1) complex bacterial communities derived from each of the two parent cultures; 2) simplified bacterial communities composed of the G. catenatum-associated bacteria Marinobacter sp. strain DG879 or Alcanivorax sp. strain DG881; 3) a complex bacterial community associated with an untreated, unsterilized sexual cross of the parents. Toxin content (STX-equivalent per cell) of clonal offspring (134-197 fmol STX cell(-1)) was similar to the parent cultures (169-206 fmol STX cell(-1)), however cultures grown with single bacterial types contained less toxin (134-146 fmol STX cell(-1)) than offspring or parent cultures grown with more complex mixed bacterial communities (152-176 fmol STX cell(-1)). Specific toxin production rate (fmol STX day(-1)) was strongly correlated with culture growth rate. Net toxin production rate (fmol STX cell(-1) day(-1)) did not differ among treatments, however, mean net toxin production rate of offspring was 8-fold lower than the parent cultures, suggesting that completion of the sexual lifecycle in laboratory cultures leads to reduced toxin production. The PST profiles of offspring cultures were most similar to parent GCDE06 with the exception of cultures grown with Marinobacter sp. DG879 which produced higher proportions of dcGTX2+3 and GC1+2, and lower proportions of C1+2 and C3+4. Our data demonstrate that the bacterial community can alter intracellular STX production of dinoflagellates. In G. catenatum the mechanism appears likely to be due to bacterial effects on dinoflagellate physiology rather than bacterial biotransformation of PST toxins.	[Albinsson, Maria E.; Bolch, Christopher J. S.] Univ Tasmania, Australian Maritime Coll, Natl Ctr Marine Conservat & Resource Sustainabil, Launceston, Tas 7250, Australia; [Albinsson, Maria E.; Blackburn, Susan I.] Commonwealth Sci & Ind Res Org, Hobart, Tas, Australia; [Negri, Andrew P.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian Institute of Marine Science	Albinsson, ME (corresponding author), Univ Tasmania, Australian Maritime Coll, Natl Ctr Marine Conservat & Resource Sustainabil, Launceston, Tas 7250, Australia.	Maria.Albinsson@csiro.au	Negri, Andrew P/G-9909-2017; Bolch, Christopher J/J-7619-2014	Negri, Andrew P/0000-0003-1388-7395; Bolch, Christopher J/0000-0001-9047-2391	Aquafin CRC Project [4.2(2)]; Australian Postgraduate Scholarship - The Thomas Crawford Memorial Scholarship	Aquafin CRC Project(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Postgraduate Scholarship - The Thomas Crawford Memorial Scholarship	This research was sponsored by the Aquafin CRC Project 4.2(2). A whole-of-ecosystem assessment of environmental issues for salmonid aquaculture. M. E. Albinsson was supported by an Australian Postgraduate Scholarship - The Thomas Crawford Memorial Scholarship while doing this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DM, 1990, MAR BIOL, V104, P511, DOI 10.1007/BF01314358; Anderson M.J., 2005, PERMANOVA PRIMER GUI; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Band-Schmidt C, 2006, J PHYCOL, V42, P757, DOI 10.1111/j.1529-8817.2006.00234.x; Blackburn SI, 2001, PHYCOLOGIA, V40, P78, DOI 10.2216/i0031-8884-40-1-78.1; Bok JW, 2006, MOL MICROBIOL, V61, P1636, DOI 10.1111/j.1365-2958.2006.05330.x; Bolch CJS, 2011, J PHYCOL, V47, P1009, DOI 10.1111/j.1529-8817.2011.01043.x; BRAVO I, 1998, HARMFUL ALGAE, P356; Carrasquero-Verde JR, 1999, AQUAT TOXICOL, V45, P19, DOI 10.1016/S0166-445X(98)00089-7; Cembella AD, 1988, NATO ASI SER, VG4, P381; Doucette G.J., 1998, NATO ASI Series Series G Ecological Sciences, V41, P619; ELLEGAARD M, 1993, J PHYCOL, V29, P418, DOI 10.1111/j.1529-8817.1993.tb00142.x; Flynn KJ, 1996, J PLANKTON RES, V18, P2093, DOI 10.1093/plankt/18.11.2093; Gallacher S, 1997, APPL ENVIRON MICROB, V63, P239, DOI 10.1128/AEM.63.1.239-245.1997; Gallacher S, 1996, HARMFUL TOXIC ALGAL, P355; Green DH, 2010, AQUAT MICROB ECOL, V61, P73, DOI 10.3354/ame01437; Green DH, 2004, FEMS MICROBIOL ECOL, V47, P345, DOI 10.1016/S0168-6496(03)00298-8; Hackett JD, 2013, MOL BIOL EVOL, V30, P70, DOI 10.1093/molbev/mss142; Hallegraeff GM, 2012, HARMFUL ALGAE, V14, P130, DOI 10.1016/j.hal.2011.10.018; Hold GL, 2001, FEMS MICROBIOL ECOL, V36, P223, DOI 10.1111/j.1574-6941.2001.tb00843.x; ISHIDA Y, 1993, DEV MAR BIO, V3, P881; Jasti S, 2005, APPL ENVIRON MICROB, V71, P3483, DOI 10.1128/AEM.71.7.3483-3494.2005; Kellmann R, 2008, APPL ENVIRON MICROB, V74, P4044, DOI 10.1128/AEM.00353-08; Kodama Masaaki, 2010, Aqua-Bioscience Monographs, V3, P1; KOTAKI Y, 1985, B JPN SOC SCI FISH, V51, P1009; Kotaki Y, 1985, TOXIC DINOFLAGELLATE, P287; LEVASSEUR M, 1993, J PHYCOL, V29, P587, DOI 10.1111/j.0022-3646.1993.00587.x; Maclean J.L., 1989, ICLARM Conference Proceedings, P1; Mihali Troco K, 2009, BMC Biochem, V10, P8, DOI 10.1186/1471-2091-10-8; Negri A, 2003, CHEM RES TOXICOL, V16, P1029, DOI 10.1021/tx034037j; Negri A.P., 2001, HARMFUL ALGAL BLOOMS, P210; Negri AP, 2007, HARMFUL ALGAE, V6, P774, DOI 10.1016/j.hal.2007.04.001; NEGRI AP, 1995, TOXICON, V33, P667, DOI 10.1016/0041-0101(94)00180-G; Orr RJS, 2013, MAR DRUGS, V11, P2814, DOI 10.3390/md11082814; Orr RJS, 2013, APPL ENVIRON MICROB, V79, P2128, DOI 10.1128/AEM.03279-12; OSHIMA Y, 1993, DEV MAR BIO, V3, P907; OSHIMA Y, 1987, TOXICON, V25, P1105, DOI 10.1016/0041-0101(87)90267-4; OSHIMA Y, 1992, TOXICON, V30, P1539, DOI 10.1016/0041-0101(92)90025-Z; OSHIMA Y, 1993, MAR BIOL, V116, P471, DOI 10.1007/BF00350064; Perez-Guzman L, 2008, MAR BIOTECHNOL, V10, P492, DOI 10.1007/s10126-008-9088-7; SAKO Y, 1992, BIOSCI BIOTECH BIOCH, V56, P692, DOI 10.1271/bbb.56.692; SHIMIZU Y, 1993, CHEM REV, V93, P1685, DOI 10.1021/cr00021a002; SINGH HT, 1982, B JPN SOC SCI FISH, V48, P1341; Smith CA, 2007, GENETICS, V176, P2077, DOI 10.1534/genetics.107.073460; Stuken A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020096; Taroncher-Oldenburg G, 2000, APPL ENVIRON MICROB, V66, P2105, DOI 10.1128/AEM.66.5.2105-2112.2000; TaroncherOldenburg G, 1997, LIMNOL OCEANOGR, V42, P1178, DOI 10.4319/lo.1997.42.5_part_2.1178; Tobe K, 2001, EUR J PHYCOL, V36, P243, DOI 10.1017/S0967026201003262; Uribe P, 2003, APPL ENVIRON MICROB, V69, P659, DOI 10.1128/AEM.69.1.659-662.2003; Vale P, 2008, J CHROMATOGR A, V1195, P85, DOI 10.1016/j.chroma.2008.04.073; Vale P, 2008, J CHROMATOGR A, V1190, P191, DOI 10.1016/j.chroma.2008.03.009; Yamamoto T, 2002, FISHERIES SCI, V68, P356, DOI 10.1046/j.1444-2906.2002.00433.x; Yang I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-248; Zhuang Y, 2012, J PHYCOL, V48, pS27; Zobell CE, 1941, J MAR RES, V4, P42	56	13	13	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104623	10.1371/journal.pone.0104623	http://dx.doi.org/10.1371/journal.pone.0104623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117053	Green Submitted, gold, Green Published			2022-12-27	WOS:000341230400060
J	Hassan, M; Dufor, O; Merlet, I; Berrou, C; Wendling, F				Hassan, Mahmoud; Dufor, Olivier; Merlet, Isabelle; Berrou, Claude; Wendling, Fabrice			EEG Source Connectivity Analysis: From Dense Array Recordings to Brain Networks	PLOS ONE			English	Article							HIGH-RESOLUTION EEG; CORTICAL FUNCTIONAL CONNECTIVITY; DIRECTED TRANSFER-FUNCTION; OBJECT RECOGNITION; ELECTROMAGNETIC TOMOGRAPHY; MULTIMODAL INTEGRATION; SOURCE LOCALIZATION; NAMING ACTIONS; MEG; ACTIVATION	The recent past years have seen a noticeable increase of interest for electroencephalography (EEG) to analyze functional connectivity through brain sources reconstructed from scalp signals. Although considerable advances have been done both on the recording and analysis of EEG signals, a number of methodological questions are still open regarding the optimal way to process the data in order to identify brain networks. In this paper, we analyze the impact of three factors that intervene in this processing: i) the number of scalp electrodes, ii) the combination between the algorithm used to solve the EEG inverse problem and the algorithm used to measure the functional connectivity and iii) the frequency bands retained to estimate the functional connectivity among neocortical sources. Using High-Resolution (hr) EEG recordings in healthy volunteers, we evaluated these factors on evoked responses during picture recognition and naming task. The main reason for selection this task is that a solid literature background is available about involved brain networks (ground truth). From this a priori information, we propose a performance criterion based on the number of connections identified in the regions of interest (ROI) that belong to potentially activated networks. Our results show that the three studied factors have a dramatic impact on the final result (the identified network in the source space) as strong discrepancies were evidenced depending on the methods used. They also suggest that the combination of weighted Minimum Norm Estimator (wMNE) and the Phase Synchronization (PS) methods applied on High-Resolution EEG in beta/gamma bands provides the best performance in term of topological distance between the identified network and the expected network in the above-mentioned cognitive task.	[Hassan, Mahmoud; Merlet, Isabelle; Wendling, Fabrice] INSERM, U642, Rennes, France; [Hassan, Mahmoud; Merlet, Isabelle; Wendling, Fabrice] Univ Rennes 1, LTSI, Rennes, France; [Dufor, Olivier; Berrou, Claude] UMR CNRS Lab STICC, Inst Mines Telecom, Telecom Bretagne, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); IMT - Institut Mines-Telecom; IMT Atlantique	Hassan, M (corresponding author), INSERM, U642, Rennes, France.	mahmoud.hassan@univ-rennes1.fr	Merlet, Isabelle/M-6572-2016; WENDLING, Fabrice/P-9574-2019; DUFOR, Olivier/ABB-7740-2021; Wendling, Fabrice/F-8924-2013; Hassan, Mahmoud/AAF-4519-2019; Merlet, Isabelle/O-3752-2019	Merlet, Isabelle/0000-0003-2590-6848; WENDLING, Fabrice/0000-0003-2428-9665; Hassan, Mahmoud/0000-0003-0307-5086; Merlet, Isabelle/0000-0003-2590-6848	French government; Rennes University Hospital; European Research Council [290901]	French government; Rennes University Hospital; European Research Council(European Research Council (ERC)European Commission)	This work has received a French government support granted to the CominLabs excellence laboratory and managed by the National Research Agency in the "Investing for the Future'' program under reference ANR-10-LABX-07-01. It was also supported by the Rennes University Hospital (COREC Project named conneXion, 2012-14). The authors also thank the European Research Council for the ERC-2011-ADG - Grant Agreement No290901 - Acronym "NEUCOD''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 2003, HUM BRAIN MAPP, V20, P29, DOI 10.1002/hbm.10126; Alario FX, 1999, BEHAV RES METH INS C, V31, P531, DOI 10.3758/BF03200732; Ansari-Asl K, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031916; Astolfi L, 2004, MAGN RESON IMAGING, V22, P1457, DOI 10.1016/j.mri.2004.10.006; Astolfi L, 2005, CLIN NEUROPHYSIOL, V116, P920, DOI 10.1016/j.clinph.2004.10.012; Astolfi L, 2007, HUM BRAIN MAPP, V28, P143, DOI 10.1002/hbm.20263; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Babiloni F, 2003, NEUROIMAGE, V19, P1, DOI 10.1016/S1053-8119(03)00052-1; Babiloni F, 2001, HUM BRAIN MAPP, V14, P197, DOI 10.1002/hbm.1052; Bai XX, 2007, NEUROIMAGE, V35, P598, DOI 10.1016/j.neuroimage.2006.12.026; Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; Bartolomei F, 2006, ANN NEUROL, V59, P128, DOI 10.1002/ana.20710; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Blinowska KJ, 2011, MED BIOL ENG COMPUT, V49, P521, DOI 10.1007/s11517-011-0739-x; BRAZIER MAB, 1968, ELECTROEN CLIN NEURO, V25, P309, DOI 10.1016/0013-4694(68)90171-5; BRAZIER MAB, 1952, ELECTROEN CLIN NEURO, V4, P201, DOI 10.1016/0013-4694(52)90010-2; Brookes MJ, 2012, NEUROIMAGE, V63, P910, DOI 10.1016/j.neuroimage.2012.03.048; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; David O, 2004, NEUROIMAGE, V21, P659, DOI 10.1016/j.neuroimage.2003.10.006; David O, 2003, NEUROIMAGE, V20, P186, DOI 10.1016/S1053-8119(03)00221-0; David O, 2002, IEEE T BIO-MED ENG, V49, P975, DOI 10.1109/TBME.2002.802013; de Lange FP, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.007.2008; DeLeon J, 2007, BRAIN, V130, P1408, DOI 10.1093/brain/awm011; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DiCarlo JJ, 2012, NEURON, V73, P415, DOI 10.1016/j.neuron.2012.01.010; Drakesmith M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081553; Duzel E, 2001, HUM BRAIN MAPP, V13, P104, DOI 10.1002/hbm.1028; Eddy M, 2006, PSYCHOPHYSIOLOGY, V43, P564, DOI 10.1111/j.1469-8986.2006.00455.x; Edwards E, 2010, NEUROIMAGE, V50, P291, DOI 10.1016/j.neuroimage.2009.12.035; Etard O, 2000, NEUROREPORT, V11, P617, DOI 10.1097/00001756-200002280-00036; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; Garn CL, 2009, CORTEX, V45, P610, DOI 10.1016/j.cortex.2008.02.004; Gerlach C, 2000, NEUROPSYCHOLOGIA, V38, P1693, DOI 10.1016/S0028-3932(00)00082-8; Ghuman AS, 2011, NEUROIMAGE, V56, P69, DOI 10.1016/j.neuroimage.2011.01.046; Grova C, 2006, NEUROIMAGE, V29, P734, DOI 10.1016/j.neuroimage.2005.08.053; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Hulten A, 2009, HUM BRAIN MAPP, V30, P976, DOI 10.1002/hbm.20561; Kawashima R, 2001, BRAIN RES BULL, V54, P313, DOI 10.1016/S0361-9230(00)00440-8; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Lachaux JP, 2000, INT J BIFURCAT CHAOS, V10, P2429, DOI 10.1142/S0218127400001560; Lantz G, 2003, CLIN NEUROPHYSIOL, V114, P63, DOI 10.1016/S1388-2457(02)00337-1; Leube DT, 2001, COGNITIVE BRAIN RES, V12, P425, DOI 10.1016/S0926-6410(01)00068-4; Levelt WJM, 1998, J COGNITIVE NEUROSCI, V10, P553, DOI 10.1162/089892998562960; Liljestrom M, 2008, NEUROIMAGE, V41, P1132, DOI 10.1016/j.neuroimage.2008.03.016; Liljestrom M, 2009, HUM BRAIN MAPP, V30, P1845, DOI 10.1002/hbm.20785; Lin FH, 2004, NEUROIMAGE, V23, P582, DOI 10.1016/j.neuroimage.2004.04.027; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Mandonnet E, 2009, CLIN NEUROL NEUROSUR, V111, P601, DOI 10.1016/j.clineuro.2009.03.007; MARS NJI, 1983, ELECTROEN CLIN NEURO, V56, P194, DOI 10.1016/0013-4694(83)90074-3; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; McDermott KB, 2003, NEUROPSYCHOLOGIA, V41, P293, DOI 10.1016/S0028-3932(02)00162-8; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Moore CJ, 1999, NEUROIMAGE, V10, P181, DOI 10.1006/nimg.1999.0450; Murtha S, 1999, J COGNITIVE NEUROSCI, V11, P399, DOI 10.1162/089892999563508; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Orban GA, 2004, TRENDS COGN SCI, V8, P315, DOI 10.1016/j.tics.2004.05.009; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pijn J, 1993, BASIC MECH EEG; Pikovsky A, 2003, SYNCHRONIZATION UNIV; Price CJ, 1996, P ROY SOC B-BIOL SCI, V263, P1501, DOI 10.1098/rspb.1996.0219; Price CJ, 2005, HUM BRAIN MAPP, V25, P70, DOI 10.1002/hbm.20132; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Rosenblum M., 2001, HDB BIOL PHYS, V4, P279; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; SALMELIN R, 1994, NATURE, V368, P463, DOI 10.1038/368463a0; Schneider W., 2002, E PRIME USERS GUIDE; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Smith CD, 2001, J NEUROIMAGING, V11, P165, DOI 10.1111/j.1552-6569.2001.tb00028.x; Soros P, 2003, NEUROIMAGE, V19, P1787, DOI 10.1016/S1053-8119(03)00217-9; Sporns Olaf, 2013, Dialogues Clin Neurosci, V15, P247; Stam CJ, 2003, HUM BRAIN MAPP, V19, P63, DOI 10.1002/hbm.10106; Stevens MC, 2009, BRAIN COGNITION, V70, P1, DOI 10.1016/j.bandc.2008.12.009; Supp GG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000684; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; Tyler LK, 2004, J COGNITIVE NEUROSCI, V16, P351, DOI 10.1162/089892904322926692; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; van Turennout M, 2003, CEREB CORTEX, V13, P381, DOI 10.1093/cercor/13.4.381; Vihla M, 2006, NEUROIMAGE, V33, P732, DOI 10.1016/j.neuroimage.2006.06.040; Vingerhoets G, 2003, NEUROIMAGE, V20, P2181, DOI 10.1016/j.neuroimage.2003.07.029; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Weaver W., 1949, MATH THEORY COMMUNIC, V19, P1; Wendling F, 2001, CLIN NEUROPHYSIOL, V112, P1201, DOI 10.1016/S1388-2457(01)00547-8; Wendling F, 2009, J NEUROSCI METH, V183, P9, DOI 10.1016/j.jneumeth.2009.04.021; Zhang JX, 2003, NEUROIMAGE, V20, P1531, DOI 10.1016/j.neuroimage.2003.07.016	94	142	144	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e105041	10.1371/journal.pone.0105041	http://dx.doi.org/10.1371/journal.pone.0105041			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115932	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400115
J	Kohshi, K; Tamaki, H; Lemaitre, F; Okudera, T; Ishitake, T; Denoble, PJ				Kohshi, Kiyotaka; Tamaki, Hideki; Lemaitre, Frederic; Okudera, Toshio; Ishitake, Tatsuya; Denoble, Petar J.			Brain Damage in Commercial Breath-Hold Divers	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; WHITE-MATTER LESIONS; MRI; AMA	Background: Acute decompression illness (DCI) involving the brain (Cerebral DCI) is one of the most serious forms of diving-related injuries which may leave residual brain damage. Cerebral DCI occurs in compressed air and in breath-hold divers, likewise. We conducted this study to investigate whether long-term breath-hold divers who may be exposed to repeated symptomatic and asymptomatic brain injuries, show brain damage on magnetic resonance imaging (MRI). Subjects and Methods: Our study subjects were 12 commercial breath-hold divers (Ama) with long histories of diving work in a district of Japan. We obtained information on their diving practices and the presence or absence of medical problems, especially DCI events. All participants were examined with MRI to determine the prevalence of brain lesions. Results: Out of 12 Ama divers (mean age: 54.+/- 65.1 years), four had histories of cerebral DCI events, and 11 divers demonstrated ischemic lesions of the brain on MRI studies. The lesions were situated in the cortical and/or subcortical area (9 cases), white matters (4 cases), the basal ganglia (4 cases), and the thalamus (1 case). Subdural fluid collections were seen in 2 cases. Conclusion: These results suggest that commercial breath-hold divers are at a risk of clinical or subclinical brain injury which may affect the long-term neuropsychological health of divers.	[Kohshi, Kiyotaka] Univ Hosp Ryukyus, Ctr Hyperbar Med & Environm Hlth, Nishihara, Okinawa, Japan; [Tamaki, Hideki] Tamaki Hosp, Hagi, Yamaguchi, Japan; [Lemaitre, Frederic] Univ Rouen, Fac Sport Sci, Mont St Aignan, France; [Okudera, Toshio] Shin Funagoya Hosp, Dept Neuroradiol & Psychiat, Miyama, Fukuoka, Japan; [Ishitake, Tatsuya] Kurume Univ, Sch Med, Dept Environm Med, Kurume, Fukuoka 830, Japan; [Denoble, Petar J.] Divers Alert Network, Durham, NC USA	University of the Ryukyus; Universite de Rouen Normandie; Kurume University	Kohshi, K (corresponding author), Univ Hosp Ryukyus, Ctr Hyperbar Med & Environm Hlth, Nishihara, Okinawa, Japan.	kohshi@med.u-ryukyu.ac.jp	Lemaitre, Frederic/AAZ-4457-2020; Denoble, Petar/AAU-5109-2021	Lemaitre, Frederic/0000-0003-4424-0981; Denoble, Petar/0000-0002-6770-8674				Batle JM, 2004, P 13 INT C HYP MED, P139; DUTKA AJ, 1985, UNDERSEA BIOMED RES, V12, P403; Erdem I, 2009, AVIAT SPACE ENVIR MD, V80, P2, DOI 10.3357/ASEM.2234.2009; GARDETTE B, 1979, UNDERSEA BIOMED RES, V6, P99; Gempp E, 2010, AVIAT SPACE ENVIR MD, V81, P1008, DOI 10.3357/ASEM.2786.2010; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; HONG SK, 1967, SCI AM, V216, P34, DOI 10.1038/scientificamerican0567-34; Hutzelmann A, 2000, ACTA RADIOL, V41, P18, DOI 10.1080/028418500127344894; Knauth M, 1997, BRIT MED J, V314, P701, DOI 10.1136/bmj.314.7082.701; Kohshi K, 2005, UNDERSEA HYPERBAR M, V32, P11; Kohshi K, 2001, J OCCUP HEALTH, V43, P56, DOI 10.1539/joh.43.56; Kohshi K, 1998, MT SINAI J MED, V65, P280; Kohshi K, 2000, J NEUROL SCI, V178, P66, DOI 10.1016/S0022-510X(00)00360-9; Kowalski JT, 2011, UNDERSEA HYPERBAR M, V38, P197; Lemaitre F, WILDERNESS IN PRESS; Liao DP, 1996, STROKE, V27, P2262, DOI 10.1161/01.STR.27.12.2262; LYNCH JJ, 1984, AM J CARDIOL, V53, P1478, DOI 10.1016/S0002-9149(84)91617-5; MANGO L, 1999, UNDERSEA HYPERB ME S, V26, P28; Matsuo R, 2012, CLIN NEUROL, V52, P757; Merl T, 1999, EUR J RADIOL, V30, P43, DOI 10.1016/S0720-048X(98)00134-X; Mull M, 1997, STROKE, V28, P118, DOI 10.1161/01.STR.28.1.118; Reuter M, 1997, ACTA RADIOL, V38, P940; RINCK PA, 1991, JMRI-J MAGN RESON IM, V1, P293, DOI 10.1002/jmri.1880010306; Tamaki H, 2010, UNDERSEA HYPERBAR M, V37, P209; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; WARREN LP, 1988, AM J ROENTGENOL, V151, P1003, DOI 10.2214/ajr.151.5.1003; Yanagawa Y, 1998, AVIAT SPACE ENVIR MD, V69, P892; YLIKOSKI A, 1995, STROKE, V26, P1171, DOI 10.1161/01.STR.26.7.1171	28	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e105006	10.1371/journal.pone.0105006	http://dx.doi.org/10.1371/journal.pone.0105006			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115903	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400113
J	Lee, SJ; Choi, EK; Seo, KW; Bae, JU; Park, SY; Kim, CD				Lee, Seung Jin; Choi, Eun Kyoung; Seo, Kyo Won; Bae, Jin Ung; Park, So Youn; Kim, Chi Dae			TLR4-Mediated Expression of Mac-1 in Monocytes Plays a Pivotal Role in Monocyte Adhesion to Vascular Endothelium	PLOS ONE			English	Article							ATHEROSCLEROSIS; INFLAMMATION; MACROPHAGES; CELLS; 5-LIPOXYGENASE; MOLECULES; LIPOPOLYSACCHARIDE; ATHEROGENESIS; LEUKOTRIENES; ACTIVATION	Toll-like receptor 4 (TLR4) is known to mediate monocyte adhesion to endothelial cells, however, its role on the expression of monocyte adhesion molecules is unclear. In the present study, we investigated the role of TLR4 on the expression of monocyte adhesion molecules, and determined the functional role of TLR4-induced adhesion molecules on monocyte adhesion to endothelial cells. When THP-1 monocytes were stimulated with Kdo2-Lipid A (KLA), a specific TLR4 agonist, Mac-1 expression was markedly increased in association with an increased adhesion of monocytes to endothelial cells. These were attenuated by anti-Mac-1 antibody, suggesting a functional role of TLR4-induced Mac-1 on monocyte adhesion to endothelial cells. In monocytes treated with MK886, a 5-lipoxygenase (LO) inhibitor, both Mac-1 expression and monocyte adhesion to endothelial cells induced by KLA were markedly attenuated. Moreover, KLA increased the expression of mRNA and protein of 5-LO, suggesting a pivotal role of 5-LO on these processes. In in vivo studies, KLA increased monocyte adhesion to aortic endothelium of wild-type (WT) mice, which was attenuated in WT mice treated with anti-Mac-1 antibody as well as in TLR4-deficient mice. Taken together, TLR4-mediated expression of Mac-1 in monocytes plays a pivotal role on monocyte adhesion to vascular endothelium, leading to increased foam cell formation in the development of atherosclerosis.	[Kim, Chi Dae] Pusan Natl Univ, Sch Med, Dept Pharmacol, Yangsan, South Korea; Pusan Natl Univ, MRC, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University	Kim, CD (corresponding author), Pusan Natl Univ, Sch Med, Dept Pharmacol, Yangsan, South Korea.	chidkim@pusan.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2013R1A2A2A01067921]; Basic Science Research Program through the National Research Foundation of Korea ( NRF) - Ministry of Education, Science and Technology [2010-0005969]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; Basic Science Research Program through the National Research Foundation of Korea ( NRF) - Ministry of Education, Science and Technology	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2013R1A2A2A01067921), and Basic Science Research Program through the National Research Foundation of Korea ( NRF) funded by the Ministry of Education, Science and Technology (2010-0005969). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cekic C, 2011, J IMMUNOL, V186, P3858, DOI 10.4049/jimmunol.1001034; Daub K, 2010, SEMIN THROMB HEMOST, V36, P146, DOI 10.1055/s-0030-1251498; De Caterina R, 2004, NEW ENGL J MED, V350, P4, DOI 10.1056/NEJMp038190; den Dekker WK, 2010, ATHEROSCLEROSIS, V209, P314, DOI 10.1016/j.atherosclerosis.2009.09.075; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Estruch M, 2013, ATHEROSCLEROSIS, V229, P356, DOI 10.1016/j.atherosclerosis.2013.05.011; Falck-Hansen M, 2013, INT J MOL SCI, V14, P14008, DOI 10.3390/ijms140714008; Fernandez-Pisonero I, 2012, J IMMUNOL, V189, P5402, DOI 10.4049/jimmunol.1201309; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Gower RM, 2011, ARTERIOSCL THROM VAS, V31, P160, DOI 10.1161/ATVBAHA.110.215434; Guo YL, 2009, ARTERIOSCL THROM VAS, V29, P75, DOI 10.1161/ATVBAHA.108.177717; Inoue M, 2010, MICROVASC RES, V80, P179, DOI 10.1016/j.mvr.2010.04.005; Jawien J, 2009, POL ARCH MED WEWN, V119, P90, DOI 10.20452/pamw.620; Kellersch Bettina, 2006, V43, P245, DOI 10.1007/024; Kim CE, 2010, TOXICOL APPL PHARM, V245, P76, DOI 10.1016/j.taap.2010.02.003; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lee SJ, 2010, CARDIOVASC RES, V88, P352, DOI 10.1093/cvr/cvq194; Lee SJ, 2013, CARDIOVASC RES, V99, P724, DOI 10.1093/cvr/cvt135; Lubos E, 2010, FASEB J, V24, P2525, DOI 10.1096/fj.09-147421; Menden H, 2013, AM J PHYSIOL-LUNG C, V304, pL445, DOI 10.1152/ajplung.00261.2012; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; Pamukcu B, 2010, ANN MED, V42, P394, DOI 10.3109/07853890.2010.497767; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Saha P, 2009, CURR OPIN PHARMACOL, V9, P109, DOI 10.1016/j.coph.2008.12.017; Sassi N, 2009, ADV EXP MED BIOL, V667, P69; Seo KW, 2010, ATHEROSCLEROSIS, V208, P56, DOI 10.1016/j.atherosclerosis.2009.06.012; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Srinivasan R, 2011, J THROMB HAEMOST, V9, P2087, DOI 10.1111/j.1538-7836.2011.04454.x; Zarbock A, 2007, BLOOD REV, V21, P99, DOI 10.1016/j.blre.2006.06.001; Zarbock A, 2006, J CLIN INVEST, V116, P3211, DOI 10.1172/JCI29499; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	33	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104588	10.1371/journal.pone.0104588	http://dx.doi.org/10.1371/journal.pone.0104588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116953	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400058
J	Ramunddal, T; Hoebers, L; Henriques, JPS; Dworeck, C; Angeras, O; Odenstedt, J; Ioanes, D; Olivecrona, G; Harnek, J; Jensen, U; Aasa, M; Jussila, R; James, S; Lagerqvist, B; Matejka, G; Albertsson, P; Omerovic, E				Ramunddal, Truls; Hoebers, Loes; Henriques, Jose P. S.; Dworeck, Christian; Angeras, Oskar; Odenstedt, Jacob; Ioanes, Dan; Olivecrona, Goran; Harnek, Jan; Jensen, Ulf; Aasa, Mikael; Jussila, Risto; James, Stefan; Lagerqvist, Bo; Matejka, Goran; Albertsson, Per; Omerovic, Elmir			Chronic Total Occlusions in Sweden - A Report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)	PLOS ONE			English	Article							INTERVENTION; REVASCULARIZATION; RECANALIZATION; OUTCOMES; IMPACT	Introduction: Evidence for the current guidelines for the treatment of patients with chronic total occlusions (CTO) in coronary arteries is limited. In this study we identified all CTO patients registered in the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) and studied the prevalence, patient characteristics and treatment decisions for CTO in Sweden. Methods and Results: Between January 2005 and January 2012, 276,931 procedures (coronary angiography or percutaneous coronary intervention) were performed in 215,836 patients registered in SCAAR. We identified all patients who had 100% luminal diameter stenosis known or assumed to be >= 3 months old. After exclusion of patients with previous coronary artery bypass graft (CABG) surgery or coronary occlusions due to acute coronary syndrome, we identified 16,818 CTO patients. A CTO was present in 10.9% of all coronary angiographies and in 16.0% of patients with coronary artery disease. The majority of CTO patients were treated conservatively and PCI of CTO accounted for only 5.8% of all PCI procedures. CTO patients with diabetes and multivessel disease were more likely to be referred to CABG. Conclusion: CTO is a common finding in Swedish patients undergoing coronary angiography but the number of CTO procedures in Sweden is low. Patients with CTO are a high-risk subgroup of patients with coronary artery disease. SCAAR has the largest register of CTO patients and therefore may be valuable for studies of clinical importance of CTO and optimal treatment for CTO patients.	[Ramunddal, Truls; Dworeck, Christian; Angeras, Oskar; Odenstedt, Jacob; Ioanes, Dan; Matejka, Goran; Albertsson, Per; Omerovic, Elmir] Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden; [Hoebers, Loes; Henriques, Jose P. S.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Olivecrona, Goran; Harnek, Jan] Skane Univ Hosp, Dept Coronary Heart Dis, Scania, Sweden; [Jensen, Ulf; Aasa, Mikael; Jussila, Risto] Stockholm South Gen Hosp, Dept Cardiol, Stockholm, Sweden; [James, Stefan; Lagerqvist, Bo] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Sahlgrenska University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Lund University; Skane University Hospital; Scania; Uppsala University	Ramunddal, T (corresponding author), Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden.	truls@wlab.gu.se	James, Stefan K/J-4554-2014; Dworeck, Christian/N-1123-2014	Henriques, Jose PS/0000-0002-8969-7929; Dworeck, Christian/0000-0002-2012-5818	Swedish Health Authorities	Swedish Health Authorities	The SCAAR registry is sponsored by the Swedish Health Authorities only and is independent of commercial funding. No current funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeras O, 2013, EUR HEART J, V34, P345, DOI 10.1093/eurheartj/ehs217; Christofferson RD, 2005, AM J CARDIOL, V95, P1088, DOI 10.1016/j.amjcard.2004.12.065; Fefer P, 2012, J AM COLL CARDIOL, V59, P991, DOI 10.1016/j.jacc.2011.12.007; Fox KAA, 2002, EUR HEART J, V23, P1177, DOI 10.1053/euhj.2001.3081; Galassi AR, 2011, EUROINTERVENTION, V7, P472, DOI 10.4244/EIJV7I4A77; Grantham JA, 2009, JACC-CARDIOVASC INTE, V2, P479, DOI 10.1016/j.jcin.2009.02.008; Joyal D, 2010, AM HEART J, V160, P179, DOI 10.1016/j.ahj.2010.04.015; KAHN JK, 1993, AM HEART J, V126, P561, DOI 10.1016/0002-8703(93)90404-W; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Mehran R, 2011, JACC-CARDIOVASC INTE, V4, P952, DOI 10.1016/j.jcin.2011.03.021; Prasad A, 2007, J AM COLL CARDIOL, V49, P1611, DOI 10.1016/j.jacc.2006.12.040; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Thompson CA, 2009, JACC-CARDIOVASC INTE, V2, P834, DOI 10.1016/j.jcin.2009.05.022; van der Schaaf RJ, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-89	14	83	86	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103850	10.1371/journal.pone.0103850	http://dx.doi.org/10.1371/journal.pone.0103850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117457	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230400025
J	Smith, KM; Maragnoli, ME; Phull, PM; Tran, KM; Choubey, L; Vaccarino, FM				Smith, Karen Mueller; Maragnoli, Maria Elisabetta; Phull, Pooja M.; Tran, Kathy May; Choubey, Lisha; Vaccarino, Flora M.			Fgfr1 Inactivation in the Mouse Telencephalon Results in Impaired Maturation of Interneurons Expressing Parvalbumin	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; DEVELOPING CORTICAL INTERNEURONS; DORSOLATERAL PREFRONTAL CORTEX; GLIAL-NEURONAL INTERACTIONS; ANTERIOR CINGULATE CORTEX; MESSENGER-RNA EXPRESSION; GABAERGIC INTERNEURONS; IN-VIVO; BIPOLAR DISORDER; PROGENITOR CELLS	Fibroblast growth factors (Fgfs) and their receptors (Fgfr) are expressed in the developing and adult CNS. Previous studies demonstrated a decrease in cortical interneurons and locomotor hyperactivity in mice with a conditional Fgfr1 deletion generated in radial glial cells during midneurogenesis (Fgfr1(f/f);hGfapCre+). Here, we report earlier and more extensive inactivation of Fgfr1 in neuroepithelial cells of the CNS (Fgfr1(f/f);NesCre+). Similar to findings in Fgfr1(f/f);hGfapCre+ mice, parvalbumin positive (PV+) cortical interneurons are also decreased in the neocortex of Fgfr1f/f; NesCre+ mice when compared to control littermates (Fgfr1f/f). Fgfr1f/f; NesCre+ embryos do not differ from controls in the initial specification of GABAergic cells in the ganglionic eminence (GE) as assessed by in situ hybridization for Dlx2, Mash1 and Nkx2. Equal numbers of GABAergic neuron precursors genetically labeled with green fluorescent protein (GFP) were observed at P0 in Fgfr1(f/f);hGfapCre+; Gad1-GFP mutant mice. However, fewer GFP+ and GFP+/PV+ interneurons were observed in these mutants at adulthood, indicating that a decrease in cortical interneuron markers is occurring postnatally. Fgfr1 is expressed in cortical astrocytes in the postnatal brain. To test whether the astrocytes of mice lacking Fgfr1 are less capable of supporting interneurons, we co-cultured wild type Gad1-GFP+ interneuron precursors isolated from the medial GE (MGE) with astrocytes from Fgfr1f/f control or Fgfr1(f/f);hGfapCre+ mice. Interneurons grown on Fgfr1 deficient astrocytes had small soma size and fewer neurites per cell, but no differences in cell survival. Decreased soma size of Gad67 immunopositive interneurons was also observed in the cortex of adult Fgfr1(f/f);NesCre+ mice. Our data indicate that astrocytes from Fgfr1 mutants are impaired in supporting the maturation of cortical GABAergic neurons in the postnatal period. This model may elucidate potential mechanisms of impaired PV interneuron maturation relevant to neuropsychiatric disorders that develop in childhood and adolescence.	[Smith, Karen Mueller; Maragnoli, Maria Elisabetta; Phull, Pooja M.; Tran, Kathy May; Vaccarino, Flora M.] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Choubey, Lisha] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Vaccarino, Flora M.] Yale Univ, Dept Neurobiol, New Haven, CT USA; [Vaccarino, Flora M.] Yale Univ, Kavli Inst Neurosci, New Haven, CT USA	Yale University; University of Louisiana Lafayette; Yale University; Yale University	Vaccarino, FM (corresponding author), Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA.	Flora.Vaccarino@yale.edu		Vaccarino, Flora/0000-0003-2167-981X; Smith, Karen/0000-0003-3932-4988	National Institutes of Health [NIH: R01 MH067715, NIH: K01MH087845]; Brain and Behavior Research Foundation Young Investigator Award; Brain and Behavior Research Foundation Distinguished Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067715, K01MH087845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain and Behavior Research Foundation Young Investigator Award; Brain and Behavior Research Foundation Distinguished Investigator Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support was provided by National Institutes of Health, NIH: R01 MH067715 and NIH: K01MH087845; Brain and Behavior Research Foundation Young Investigator Award; Brain and Behavior Research Foundation Distinguished Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBARIAN S, 1995, ARCH GEN PSYCHIAT, V52, P258, DOI 10.1001/archpsyc.1995.03950160008002; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Batista-Brito R, 2009, NEURON, V63, P466, DOI 10.1016/j.neuron.2009.08.005; BELLOT F, 1991, EMBO J, V10, P2849, DOI 10.1002/j.1460-2075.1991.tb07834.x; Blurton-Jones M, 2002, J COMP NEUROL, V452, P276, DOI 10.1002/cne.10393; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chadashvili T, 2006, J COMP NEUROL, V498, P1, DOI 10.1002/cne.21009; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Chow A, 1999, J NEUROSCI, V19, P9332; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cobos I, 2006, CEREB CORTEX, V16, pI82, DOI 10.1093/cercor/bhk003; Coyle JT, 2004, BIOCHEM PHARMACOL, V68, P1507, DOI 10.1016/j.bcp.2004.07.034; Cunningham MO, 2006, J NEUROSCI, V26, P2767, DOI 10.1523/JNEUROSCI.5054-05.2006; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Flames N, 2005, NEURON, V46, P377, DOI 10.1016/j.neuron.2005.04.020; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416; Goddard DR, 2002, J ANAT, V200, P57, DOI 10.1046/j.0021-8782.2001.00002.x; GONZALEZ AM, 1995, BRAIN RES, V701, P201, DOI 10.1016/0006-8993(95)01002-X; Gonzalez-Burgos G, 2005, J NEUROPHYSIOL, V93, P942, DOI 10.1152/jn.00787.2004; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Gutin G, 2006, DEVELOPMENT, V133, P2937, DOI 10.1242/dev.02465; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; Howard A, 2005, TRENDS NEUROSCI, V28, P310, DOI 10.1016/j.tins.2005.04.004; Huang HS, 2007, J NEUROSCI, V27, P11254, DOI 10.1523/JNEUROSCI.3272-07.2007; Kalanithi PSA, 2005, P NATL ACAD SCI USA, V102, P13307, DOI 10.1073/pnas.0502624102; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Komitova M, 2013, J NEUROSCI, V33, P13375, DOI 10.1523/JNEUROSCI.5286-12.2013; Kondziella D, 2007, NEUROCHEM INT, V50, P291, DOI 10.1016/j.neuint.2006.09.006; Kondziella D, 2006, NEUROPSYCHOPHARMACOL, V31, P1880, DOI 10.1038/sj.npp.1300993; Krystal JH, 2002, MOL PSYCHIATR, V7, pS71, DOI 10.1038/sj.mp.4001021; KUBOTA Y, 1994, JPN J PHYSIOL, V44, pS145; Kuwajima T, 2006, J NEUROSCI, V26, P5383, DOI 10.1523/JNEUROSCI.1262-06.2006; Levitt P, 2005, EPILEPSIA, V46, P22, DOI 10.1111/j.1528-1167.2005.00305.x; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Lu QR, 2001, P NATL ACAD SCI USA, V98, P10851, DOI 10.1073/pnas.181340798; Marin O, 2000, J NEUROSCI, V20, P6063; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Massengill JL, 1997, J NEUROSCI, V17, P3136; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Mohler H, 2006, CELL TISSUE RES, V326, P505, DOI 10.1007/s00441-006-0284-3; Morris HM, 2008, CEREB CORTEX, V18, P1575, DOI 10.1093/cercor/bhm186; Ohkubo Y, 2004, J NEUROSCI, V24, P6057, DOI 10.1523/JNEUROSCI.1140-04.2004; Patz S, 2004, CEREB CORTEX, V14, P342, DOI 10.1093/cercor/bhg132; Penschuck S, 2006, EUR J NEUROSCI, V23, P279, DOI 10.1111/j.1460-9568.2005.04536.x; Pillai-Nair N, 2005, J NEUROSCI, V25, P4659, DOI 10.1523/JNEUROSCI.0565-05.2005; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Rash BG, 2013, J NEUROSCI, V33, P10802, DOI 10.1523/JNEUROSCI.3621-12.2013; Rash BG, 2011, J NEUROSCI, V31, P15604, DOI 10.1523/JNEUROSCI.4439-11.2011; Reuss B, 2003, J NEUROSCI, V23, P6404; Reynolds GP, 2001, J CHEM NEUROANAT, V22, P95, DOI 10.1016/S0891-0618(01)00113-2; Rubenstein J L, 2000, Novartis Found Symp, V228, P67; Rujescu D, 2006, BIOL PSYCHIAT, V59, P721, DOI 10.1016/j.biopsych.2005.08.029; Sakai T, 2008, NEUROPATHOLOGY, V28, P143, DOI 10.1111/j.1440-1789.2007.00867.x; Sanacora G, 2004, ARCH GEN PSYCHIAT, V61, P705, DOI 10.1001/archpsyc.61.7.705; Sanacora G, 1999, ARCH GEN PSYCHIAT, V56, P1043, DOI 10.1001/archpsyc.56.11.1043; Smith KM, 2008, BIOL PSYCHIAT, V63, P953, DOI 10.1016/j.biopsych.2007.09.020; Smith KM, 2006, NAT NEUROSCI, V9, P787, DOI 10.1038/nn1705; SOMOGYI P, 1982, NEUROSCIENCE, V7, P2577, DOI 10.1016/0306-4522(82)90086-0; Southwell DG, 2012, NATURE, V491, P109, DOI 10.1038/nature11523; Stevens HE, 2012, BIOL PSYCHIAT, V71, P1090, DOI 10.1016/j.biopsych.2012.03.013; Stevens HE, 2010, J NEUROSCI, V30, P5590, DOI 10.1523/JNEUROSCI.5837-09.2010; Terauchi A, 2010, NATURE, V465, P783, DOI 10.1038/nature09041; Todtenkopf MS, 2005, SCHIZOPHR RES, V73, P79, DOI 10.1016/j.schres.2004.08.018; Tome CML, 2007, DEV PSYCHOBIOL, V49, P606, DOI 10.1002/dev.20246; Turner CP, 2010, EXP BRAIN RES, V201, P479, DOI 10.1007/s00221-009-2059-z; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Wang C. Z., 2007, NEUROPSYCHOPHARMACOL; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wonders CP, 2008, DEV BIOL, V314, P127, DOI 10.1016/j.ydbio.2007.11.018; Woo NH, 2006, NEUROSCIENTIST, V12, P43, DOI 10.1177/1073858405284360; Woo TUW, 2004, ARCH GEN PSYCHIAT, V61, P649, DOI 10.1001/archpsyc.61.7.649; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004	81	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103696	10.1371/journal.pone.0103696	http://dx.doi.org/10.1371/journal.pone.0103696			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116473	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400020
J	Herman, JS; McDevitt, AD; Kawalko, A; Jaarola, M; Wojcik, JM; Searle, JB				Herman, Jeremy S.; McDevitt, Allan D.; Kawalko, Agata; Jaarola, Maarit; Wojcik, Jan M.; Searle, Jeremy B.			Land-Bridge Calibration of Molecular Clocks and the Post-Glacial Colonization of Scandinavia by the Eurasian Field Vole Microtus agrestis	PLOS ONE			English	Article							RADIOCARBON AGE CALIBRATION; SUBSTITUTION RATES; TIME DEPENDENCY; ANCIENT DNA; HISTORY; PHYLOGEOGRAPHY; ORIGIN; SEA; OECONOMUS; CLIMATE	Phylogeography interprets molecular genetic variation in a spatial and temporal context. Molecular clocks are frequently used to calibrate phylogeographic analyses, however there is mounting evidence that molecular rates decay over the relevant timescales. It is therefore essential that an appropriate rate is determined, consistent with the temporal scale of the specific analysis. This can be achieved by using temporally spaced data such as ancient DNA or by relating the divergence of lineages directly to contemporaneous external events of known time. Here we calibrate a Eurasian field vole ( Microtus agrestis) mitochondrial genealogy from the well-established series of post-glacial geophysical changes that led to the formation of the Baltic Sea and the separation of the Scandinavian peninsula from the central European mainland. The field vole exhibits the common phylogeographic pattern of Scandinavian colonization from both the north and the south, however the southernmost of the two relevant lineages appears to have originated in situ on the Scandinavian peninsula, or possibly in the adjacent island of Zealand, around the close of the Younger Dryas. The mitochondrial substitution rate and the timescale for the genealogy are closely consistent with those obtained with a previous calibration, based on the separation of the British Isles from mainland Europe. However the result here is arguably more certain, given the level of confidence that can be placed in one of the central assumptions of the calibration, that field voles could not survive the last glaciation of the southern part of the Scandinavian peninsula. Furthermore, the similarity between the molecular clock rate estimated here and those obtained by sampling heterochronous (ancient) DNA ( including that of a congeneric species) suggest that there is little disparity between the measured genetic divergence and the population divergence that is implicit in our land-bridge calibration.	[Herman, Jeremy S.] Natl Museums Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland; [McDevitt, Allan D.; Kawalko, Agata; Wojcik, Jan M.] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Kawalko, Agata] Ctr Forestry & Preservat Nat, Stat Off, Bialystok, Poland; [Jaarola, Maarit] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Searle, Jeremy B.] Cornell Univ, Dept Ecol & Evolut, Ithaca, NY USA	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; Linkoping University; Cornell University	Herman, JS (corresponding author), Natl Museums Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland.	j.herman@nms.ac.uk	Wójcik, Jan/I-4568-2014; McDevitt, Allan/A-9316-2011	Wójcik, Jan/0000-0002-4921-6780; McDevitt, Allan/0000-0002-2677-7833; Searle, Jeremy/0000-0001-7710-5204	National Science Centre, Poland [N N304 058340]; European Union [245737]	National Science Centre, Poland(National Science Centre, Poland); European Union(European Commission)	Part of the work of AK and JMW was financed by the National Science Centre, Poland (grant no. N N304 058340). ADM was supported by postdoctoral fellowships under the project BIOCONSUS (Research Potential in Conservation and Sustainable Management of Biodiversity), funded by the European Union 7th Framework Programme (FP7 2010-2013; agreement no. 245737). The lead author (JSH) received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; BJORCK S, 1995, QUATERN INT, V27, P19, DOI 10.1016/1040-6182(94)00057-C; Bjorck S, 1995, ACTA ARCAEOLOGICA LU, V8, P123; Bjorck S, 1995, OXBOW MONOGRAPH, V53, P23; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Brunhoff C, 2003, MOL ECOL, V12, P957, DOI 10.1046/j.1365-294X.2003.01796.x; Brunhoff C, 2006, J BIOGEOGR, V33, P2136, DOI 10.1111/j.1365-2699.2006.01573.x; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Carden RF, 2012, QUATERNARY SCI REV, V42, P74, DOI 10.1016/j.quascirev.2012.02.012; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fredga K, 1997, HEREDITAS, V126, P25, DOI 10.1111/j.1601-5223.1997.00025.x; Gimenez MD, 2012, ACTA THERIOL, V57, P377, DOI 10.1007/s13364-012-0087-8; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Heled J, 2012, SYST BIOL, V61, P138, DOI 10.1093/sysbio/syr087; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Henn BM, 2009, MOL BIOL EVOL, V26, P217, DOI 10.1093/molbev/msn244; Herman JS, 2011, P ROY SOC B-BIOL SCI, V278, P3601, DOI 10.1098/rspb.2011.0321; Ho SYW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001615; Ho SYW, 2007, BIOL LETTERS, V3, P702, DOI 10.1098/rsbl.2007.0377; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2011, SYST BIOL, V60, P366, DOI 10.1093/sysbio/syq099; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Jaarola M, 1999, BIOL J LINN SOC, V68, P113, DOI 10.1111/j.1095-8312.1999.tb01161.x; Jaarola M, 2002, MOL ECOL, V11, P2613, DOI 10.1046/j.1365-294X.2002.01639.x; JAAROLA M, 1995, MOL ECOL, V4, P299, DOI 10.1111/j.1365-294X.1995.tb00223.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Knowles LL, 2012, MOL PHYLOGENET EVOL, V65, P501, DOI 10.1016/j.ympev.2012.07.004; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Lagerholm VK, 2014, MOL ECOL, V23, P2060, DOI 10.1111/mec.12698; LAMBECK K, 1995, J GEOL SOC LONDON, V152, P437, DOI 10.1144/gsjgs.152.3.0437; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liljegren R., 1996, ACTA ARCHAEOLOGICA L, V8, P135; Lokrantz H, 2006, TR0636 SVENSK KARNBR; Lundqvist AC, 2011, ACTA THERIOL, V56, P103, DOI 10.1007/s13364-010-0022-9; Martinkova N, 2006, MOL ECOL NOTES, V6, P1014, DOI 10.1111/j.1471-8286.2006.01482.x; Martinkova N, 2013, MOL ECOL, V22, P5205, DOI 10.1111/mec.12462; Mcdevitt AD, 2012, BIOL J LINN SOC, V106, P57, DOI 10.1111/j.1095-8312.2012.01840.x; Navascues M, 2009, MOL ECOL, V18, P4390, DOI 10.1111/j.1365-294X.2009.04333.x; Pauperio J, 2012, MOL ECOL, V21, P6015, DOI 10.1111/mec.12024; Peterson GI, 2009, MOL BIOL EVOL, V26, P2595, DOI 10.1093/molbev/msp175; Price C.R., 2003, BAR BRIT SERIES, V347; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Renssen H, 2003, QUATERNARY SCI REV, V22, P209, DOI 10.1016/S0277-3791(02)00190-7; Ruiz-Gonzalez A, 2013, BIOL J LINN SOC, V109, P1, DOI 10.1111/bij.12046; SEARLE JB, 1984, SYST ZOOL, V33, P184, DOI 10.2307/2413019; Searle JB, 2009, P ROY SOC B-BIOL SCI, V276, P4287, DOI 10.1098/rspb.2009.1422; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wojcik JM, 2010, J ZOOL, V281, P249, DOI 10.1111/j.1469-7998.2010.00699.x; Xia XH, 2011, MOL PHYLOGENET EVOL, V59, P342, DOI 10.1016/j.ympev.2011.01.017	58	34	35	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e103949	10.1371/journal.pone.0103949	http://dx.doi.org/10.1371/journal.pone.0103949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111840	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100024
J	Jamain, S; Cichon, S; Etain, B; Muhleisen, TW; Georgi, A; Zidane, N; Chevallier, L; Deshommes, J; Nicolas, A; Henrion, A; Degenhardt, F; Mattheisen, M; Priebe, L; Mathieu, F; Kahn, JP; Henry, C; Boland, A; Zelenika, D; Gut, I; Heath, S; Lathrop, M; Maier, W; Albus, M; Rietschel, M; Schulze, TG; McMahon, FJ; Kelsoe, JR; Hamshere, M; Craddock, N; Nothen, MM; Bellivier, F; Leboyer, M				Jamain, Stephane; Cichon, Sven; Etain, Bruno; Muehleisen, Thomas W.; Georgi, Alexander; Zidane, Nora; Chevallier, Lucie; Deshommes, Jasmine; Nicolas, Aude; Henrion, Annabelle; Degenhardt, Franziska; Mattheisen, Manuel; Priebe, Lutz; Mathieu, Flavie; Kahn, Jean-Pierre; Henry, Chantal; Boland, Anne; Zelenika, Diana; Gut, Ivo; Heath, Simon; Lathrop, Mark; Maier, Wolfgang; Albus, Margot; Rietschel, Marcella; Schulze, Thomas G.; McMahon, Francis J.; Kelsoe, John R.; Hamshere, Marian; Craddock, Nicholas; Noethen, Markus M.; Bellivier, Frank; Leboyer, Marion			Common and Rare Variant Analysis in Early-Onset Bipolar Disorder Vulnerability	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; I AFFECTIVE-DISORDER; COA TRANSFERASE SCOT; SUSCEPTIBILITY LOCI; LINKAGE SCAN; 3 SUBGROUPS; AGE; RISK; SCHIZOPHRENIA; FAMILIES	Bipolar disorder is one of the most common and devastating psychiatric disorders whose mechanisms remain largely unknown. Despite a strong genetic contribution demonstrated by twin and adoption studies, a polygenic background influences this multifactorial and heterogeneous psychiatric disorder. To identify susceptibility genes on a severe and more familial sub-form of the disease, we conducted a genome-wide association study focused on 211 patients of French origin with an early age at onset and 1,719 controls, and then replicated our data on a German sample of 159 patients with early-onset bipolar disorder and 998 controls. Replication study and subsequent meta-analysis revealed two genes encoding proteins involved in phosphoinositide signalling pathway (PLEKHA5 and PLCXD3). We performed additional replication studies in two datasets from the WTCCC (764 patients and 2,938 controls) and the GAIN-TGen cohorts (1,524 patients and 1,436 controls) and found nominal P-values both in the PLCXD3 and PLEKHA5 loci with the WTCCC sample. In addition, we identified in the French cohort one affected individual with a deletion at the PLCXD3 locus and another one carrying a missense variation in PLCXD3 (p.R93H), both supporting a role of the phosphatidylinositol pathway in early-onset bipolar disorder vulnerability. Although the current nominally significant findings should be interpreted with caution and need replication in independent cohorts, this study supports the strategy to combine genetic approaches to determine the molecular mechanisms underlying bipolar disorder.	[Jamain, Stephane; Etain, Bruno; Zidane, Nora; Chevallier, Lucie; Deshommes, Jasmine; Nicolas, Aude; Henrion, Annabelle; Mathieu, Flavie; Henry, Chantal; Bellivier, Frank; Leboyer, Marion] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France; [Jamain, Stephane; Etain, Bruno; Zidane, Nora; Chevallier, Lucie; Deshommes, Jasmine; Nicolas, Aude; Henrion, Annabelle; Mathieu, Flavie; Henry, Chantal; Leboyer, Marion] Univ Paris Est, Fac Med, Creteil, France; [Jamain, Stephane; Etain, Bruno; Zidane, Nora; Chevallier, Lucie; Deshommes, Jasmine; Nicolas, Aude; Henrion, Annabelle; Mathieu, Flavie; Kahn, Jean-Pierre; Henry, Chantal; Bellivier, Frank; Leboyer, Marion] Fdn FondaMental, Creteil, France; [Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM1, Julich, Germany; [Cichon, Sven; Muehleisen, Thomas W.; Degenhardt, Franziska; Mattheisen, Manuel; Priebe, Lutz; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Cichon, Sven; Muehleisen, Thomas W.; Degenhardt, Franziska; Mattheisen, Manuel; Priebe, Lutz; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Cichon, Sven] Univ Basel, Div Med Genet, Univ Hosp, Basel, Switzerland; [Cichon, Sven] Univ Basel, Dept Biomed, Basel, Switzerland; [Etain, Bruno; Deshommes, Jasmine; Henry, Chantal; Leboyer, Marion] Hop Henri Mondor Albert Chenevier, AP HP, Creteil, France; [Georgi, Alexander; Albus, Margot; Rietschel, Marcella; Schulze, Thomas G.] Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Georgi, Alexander; Maier, Wolfgang; Rietschel, Marcella] Univ Bonn, Dept Psychiat, Bonn, Germany; [Deshommes, Jasmine] Hop Henri Mondor Albert Chenevier, INSERM, Pole Rech Clin Sante Publ, Ctr Invest Clin 006, Creteil, France; [Mattheisen, Manuel] Aarhus Univ, Dept Biomed, iPSYCH, Aarhus, Denmark; [Mattheisen, Manuel] Aarhus Univ, Ctr Integrat Sequencing, iPSYCH, Aarhus, Denmark; [Kahn, Jean-Pierre] Hop Jeanne dArc, Ctr Hosp Univ Nancy, Dept Psychiat, Toul, France; [Kahn, Jean-Pierre] Hop Jeanne dArc, Ctr Hosp Univ Nancy, Psychol Clin, Toul, France; [Boland, Anne; Zelenika, Diana; Gut, Ivo; Heath, Simon; Lathrop, Mark] Commissariat Energie Atom, Inst Genom, Ctr Natl Genotypage, Evry, France; [Schulze, Thomas G.] Univ Gottingen, Dept Psychiat & Psychotherapy, Univ Med Ctr, D-37073 Gottingen, Germany; [McMahon, Francis J.] NIMH, Unit Genet Basis Mood & Anxiety Disorders, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Kelsoe, John R.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Hamshere, Marian; Craddock, Nicholas] Cardiff Univ, Sch Med, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales; [Bellivier, Frank] Grp Hosp Lariboisiere F Widal, AP HP, Pole Psychiat, Paris, France; [Bellivier, Frank] Univ Paris Diderot, Paris, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Helmholtz Association; Research Center Julich; University of Bonn; University of Bonn; University of Basel; University of Basel; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Central Institute of Mental Health; University of Bonn; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); CHU de Nancy; CHU de Nancy; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; University of Gottingen; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of California System; University of California San Diego; Cardiff University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Jamain, S (corresponding author), Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France.	stephane.jamain@inserm.fr	Degenhardt, Franziska/H-4169-2017; McMahon, Francis J/A-7290-2009; Mattheisen, Manuel/B-4949-2012; Etain, Bruno/L-6647-2017; Jamain, Stéphane/P-3710-2017; Mattheisen, Manuel/S-3725-2019; Heath, Simon C/J-4138-2012; BELLIVIER, FRANK/H-5197-2012; Gut, Ivo/ABF-3188-2020; Leboyer, Marion/AAW-3648-2021; Mathieu, Flavie/M-9855-2017; Jamain, Stéphane/L-1822-2019	McMahon, Francis J/0000-0002-9469-305X; Mattheisen, Manuel/0000-0002-8442-493X; Etain, Bruno/0000-0002-5377-1488; Jamain, Stéphane/0000-0002-4321-4100; Mattheisen, Manuel/0000-0002-8442-493X; Heath, Simon C/0000-0002-9550-0897; Gut, Ivo/0000-0001-7219-632X; Leboyer, Marion/0000-0001-5473-3697; Georgi, Alexander/0000-0002-1499-8524; Nothen, Markus/0000-0002-8770-2464; Mathieu, Flavie/0000-0002-3386-0299; BELLIVIER, FRANK/0000-0002-3660-6640; Chevallier, Lucie/0000-0001-8602-1993	INSERM (Poste d'Accueil INSERM); Assistance Publique des Hopitaux de Paris; Agence Nationale pour la Recherche (ANR NEURO - Project MANAGE_BPAD); Centre National de Genotypage (Centre d'Energie Atomique, Evry, France); Reseau Thematique de Recherche et de Soins en Sante Mentale (Fondation FondaMental); Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002843] Funding Source: NIH RePORTER	INSERM (Poste d'Accueil INSERM); Assistance Publique des Hopitaux de Paris; Agence Nationale pour la Recherche (ANR NEURO - Project MANAGE_BPAD)(French National Research Agency (ANR)); Centre National de Genotypage (Centre d'Energie Atomique, Evry, France); Reseau Thematique de Recherche et de Soins en Sante Mentale (Fondation FondaMental); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by INSERM (Poste d'Accueil INSERM to B. E.), Assistance Publique des Hopitaux de Paris, the Agence Nationale pour la Recherche (ANR NEURO2006 - Project MANAGE_BPAD), the Centre National de Genotypage (Centre d'Energie Atomique, Evry, France) and the Reseau Thematique de Recherche et de Soins en Sante Mentale (Fondation FondaMental). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Avramopoulos D, 2007, GENET MED, V9, P745, DOI 10.1097/GIM.0b013e318159a37c; Bellivier F, 2003, AM J PSYCHIAT, V160, P999, DOI 10.1176/appi.ajp.160.5.999; Bellivier F, 2001, ARCH GEN PSYCHIAT, V58, P510, DOI 10.1001/archpsyc.58.5.510; Bellivier F, 2014, WORLD J BIOL PSYCHIA, V15, P369, DOI 10.3109/15622975.2011.639801; Bouron A, 1999, NEUROSCIENCE, V90, P729, DOI 10.1016/S0306-4522(98)00480-1; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cheng R, 2006, MOL PSYCHIATR, V11, P252, DOI 10.1038/sj.mp.4001778; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Craddock N, 2013, LANCET, V381, P1654, DOI 10.1016/S0140-6736(13)60855-7; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Etain B, 2006, MOL PSYCHIATR, V11, P685, DOI 10.1038/sj.mp.4001815; Etain B, 2010, MOL PSYCHIATR, V15, P748, DOI 10.1038/mp.2008.148; Faraone SV, 2004, AM J PSYCHIAT, V161, P625, DOI 10.1176/appi.ajp.161.4.625; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fukao T, 2000, GENOMICS, V68, P144, DOI 10.1006/geno.2000.6282; FUKUDA H, 1994, NEUROCHEM INT, V25, P567, DOI 10.1016/0197-0186(94)90155-4; Geoffroy PA, 2013, J PHYSIOL-PARIS, V107, P278, DOI 10.1016/j.jphysparis.2013.03.006; Goodwin GM, 2008, EUR NEUROPSYCHOPHARM, V18, P535, DOI 10.1016/j.euroneuro.2008.03.003; Green EK, 2013, MOL PSYCHIATR, V18, P1302, DOI 10.1038/mp.2012.142; Green EK, 2010, MOL PSYCHIATR, V15, P1016, DOI 10.1038/mp.2009.49; Grigoroiu-Serbanescu M, 2001, AM J MED GENET, V105, P765, DOI 10.1002/ajmg.10047; Gurling HMD, 2001, AM J HUM GENET, V68, P661, DOI 10.1086/318788; Heath SC, 2008, EUR J HUM GENET, V16, P1413, DOI 10.1038/ejhg.2008.210; Heinrich A, 2013, BIPOLAR DISORD, V15, P440, DOI 10.1111/bdi.12068; KassovskaBratinova S, 1996, AM J HUM GENET, V59, P519; Kempton MJ, 2009, AM J PSYCHIAT, V166, P1413, DOI 10.1176/appi.ajp.2009.09050680; Kendler KS, 2000, AM J PSYCHIAT, V157, P402, DOI 10.1176/appi.ajp.157.3.402; Leboyer M, 2005, BIPOLAR DISORD, V7, P111, DOI 10.1111/j.1399-5618.2005.00181.x; Lin PI, 2006, AM J PSYCHIAT, V163, P240, DOI 10.1176/appi.ajp.163.2.240; Lorenzi C, 2010, NEUROPSYCHOBIOLOGY, V61, P10, DOI 10.1159/000258638; Manchia M, 2008, BIPOLAR DISORD, V10, P443, DOI 10.1111/j.1399-5618.2007.00572.x; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MITCHELL GA, 1995, CLIN INVEST MED, V18, P193; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; PULVER AE, 1995, AM J MED GENET, V60, P252, DOI 10.1002/ajmg.1320600316; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Roussos P, 2011, BIPOLAR DISORD, V13, P250, DOI 10.1111/j.1399-5618.2011.00924.x; Schloesser RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P110, DOI 10.1038/sj.npp.1301575; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; Torrey EF, 2003, AM J PSYCHIAT, V160, P2241, DOI 10.1176/appi.ajp.160.12.2241; Wessa M, 2010, MOL PSYCHIATR, V15, P1126, DOI 10.1038/mp.2009.103; Zubenko GS, 2004, AM J MED GENET B, V129B, P47, DOI 10.1002/ajmg.b.30092	51	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104326	10.1371/journal.pone.0104326	http://dx.doi.org/10.1371/journal.pone.0104326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111785	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000341105100048
J	Kramer, M; Halleran, D; Rahman, M; Iqbal, M; Anwar, MI; Sabet, S; Ackad, E; Yousef, M				Kramer, Mitchell; Halleran, Daniel; Rahman, Moazur; Iqbal, Mazhar; Anwar, Muhmad Ikram; Sabet, Salwa; Ackad, Edward; Yousef, Mohammad			Comparative Molecular Dynamics Simulation of Hepatitis C Virus NS3/4A Protease (Genotypes 1b, 3a and 4b) Predicts Conformational Instability of the Catalytic Triad in Drug Resistant Strains	PLOS ONE			English	Article							SWISS-MODEL; POLYMERASE INHIBITORS; CRYSTAL-STRUCTURES; HCV NS3; MECHANISM; BINDING; SUBSTRATE; COMPLEX; CHYMOTRYPSIN; ENVIRONMENT	The protease domain of the Hepatitis C Virus (HCV) nonstructural protein 3 (NS3) has been targeted for inhibition by several direct-acting antiviral drugs. This approach has had marked success to treat infections caused by HCV genotype 1 predominant in the USA, Europe, and Japan. However, genotypes 3 and 4, dominant in developing countries, are resistant to a number of these drugs and little progress has been made towards understanding the structural basis of their drug resistivity. We have previously developed a 4D computational methodology, based on 3D structure modeling and molecular dynamics simulation, to analyze the active sites of the NS3 proteases of HCV-1b and 4a in relation to their catalytic activity and drug susceptibility. Here, we improved the methodology, extended the analysis to include genotype 3a (predominant in South Asia including Pakistan), and compared the results of the three genotypes (1b, 3a and 4a). The 4D analyses of the interactions between the catalytic triad residues (His57, Asp81, and Ser139) indicate conformational instability of the catalytic site in HCV-3a and 4a compared to that of HCV-1b NS3 protease. The divergence is gradual and genotype-dependent, with HCV-1b being the most stable, HCV-4a being the most unstable and HCV-3a representing an intermediate state. These results suggest that the structural dynamics behavior, more than the rigid structure, could be related to the altered catalytic activity and drug susceptibility seen in NS3 proteases of HCV-3a and 4a.	[Kramer, Mitchell; Halleran, Daniel; Ackad, Edward; Yousef, Mohammad] So Illinois Univ, Dept Phys, Coll Arts & Sci, Edwardsville, IL 62026 USA; [Rahman, Moazur; Iqbal, Mazhar; Anwar, Muhmad Ikram] NIBGE, Drug Discovery & Struct Biol Grp, Hlth Biotechnol Div, Faisalabad, Pakistan; [Sabet, Salwa] Cairo Univ, Fac Sci, Dept Zool, Giza, Egypt; [Yousef, Mohammad] Cairo Univ, Dept Biophys, Fac Sci, Giza, Egypt	Southern Illinois University System; Southern Illinois University Edwardsville; Pakistan Institute of Engineering & Applied Science; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Yousef, M (corresponding author), So Illinois Univ, Dept Phys, Coll Arts & Sci, Edwardsville, IL 62026 USA.	myousef@siue.edu	Iqbal, Mazhar/C-5536-2019; Ackad, Edward/AAD-1947-2021; Iqbal, Mazhar/I-7242-2015; Anwar, Muhammad Ikram/AAJ-5276-2020; Rahman, Moazur/C-5515-2019	Iqbal, Mazhar/0000-0002-8675-1125; Rahman, Moazur/0000-0003-2892-1250; Sabet, Salwa/0000-0002-4097-7866; Yousef, Mohammad/0000-0003-0492-7658; Edward, Ackad/0000-0002-4896-180X	URCA program from SIUE	URCA program from SIUE	D.H. was supported by URCA program from SIUE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abian O, 2010, BIOPHYS J, V99, P3811, DOI 10.1016/j.bpj.2010.10.037; Ali A, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-334; Anjum S, 2013, J INFECT DIS, V208, P1888, DOI 10.1093/infdis/jit376; Anwar MI, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-351; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barbato G, 1999, J MOL BIOL, V289, P371, DOI 10.1006/jmbi.1999.2745; Cento V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039652; Chatel-Chaix L, 2010, VIRUSES-BASEL, V2, P1752, DOI 10.3390/v2081752; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Di Marco S, 2000, J BIOL CHEM, V275, P7152, DOI 10.1074/jbc.275.10.7152; Du GX, 2002, WORLD J GASTROENTERO, V8, P1088, DOI 10.3748/wjg.v8.i6.1088; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; FERSHT AR, 1973, J MOL BIOL, V74, P137, DOI 10.1016/0022-2836(73)90103-4; Franco S, 2008, VIRUS RES, V131, P260, DOI 10.1016/j.virusres.2007.10.003; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Gottwein JM, 2011, GASTROENTEROLOGY, V141, P1067, DOI 10.1053/j.gastro.2011.06.004; Guan Y, 2014, ANTIVIR RES, V103, P60, DOI 10.1016/j.antiviral.2014.01.010; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hagan LM, 2013, TRENDS MICROBIOL, V21, P625, DOI 10.1016/j.tim.2013.09.008; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Heintges T, 2001, J MED VIROL, V65, P671, DOI 10.1002/jmv.2089; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; HIROHARA H, 1974, P NATL ACAD SCI USA, V71, P1643, DOI 10.1073/pnas.71.5.1643; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imhof I, 2011, HEPATOLOGY, V53, P1090, DOI 10.1002/hep.24172; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khattab MA, 2011, J HEPATOL, V54, P1250, DOI 10.1016/j.jhep.2010.11.016; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kwo PY, 2011, GUT LIVER, V5, P406, DOI 10.5009/gnl.2011.5.4.406; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manos MM, 2012, J MED VIROL, V84, P1744, DOI 10.1002/jmv.23399; McCoy MA, 2001, J MOL BIOL, V305, P1099, DOI 10.1006/jmbi.2000.4365; Meeprasert A, 2014, J CHEM INF MODEL, V54, P1208, DOI 10.1021/ci400605a; Meller J, 2001, PROTEINS, V45, P241, DOI 10.1002/prot.1145; Miller FD, 2010, P NATL ACAD SCI USA, V107, P14757, DOI 10.1073/pnas.1008877107; Nguyen Mindie H, 2005, Clin Liver Dis, V9, P411, DOI 10.1016/j.cld.2005.05.010; Nishiya AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086413; Ozen A, 2013, J CHEM THEORY COMPUT, V9, P5693, DOI 10.1021/ct400603p; Pan DB, 2012, BBA-GEN SUBJECTS, V1820, P1526, DOI 10.1016/j.bbagen.2012.06.001; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Rimmert B, 2014, J BIOMOL STRUCT DYN, V32, P950, DOI 10.1080/07391102.2013.800001; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Rong X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052467; Saeed M, 2012, ANTIMICROB AGENTS CH, V56, P5365, DOI 10.1128/AAC.01256-12; Sardana VV, 1999, PROTEIN EXPRES PURIF, V16, P440, DOI 10.1006/prep.1999.1090; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shehzadi A, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-55; Tan S. L, 2006, HEPATITIS C VIRUSES, P163; Tong L, 2002, CHEM REV, V102, P4609, DOI 10.1021/cr010184f; Tong X, 2014, J INFECT DIS, V209, P668, DOI 10.1093/infdis/jit562; Van Gunsteren W. F., 1996, BIOMOLECULARS SIMULA; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xue WW, 2014, J CHEM INF MODEL, V54, P621, DOI 10.1021/ci400060j; Xue WW, 2012, ANTIVIR RES, V93, P126, DOI 10.1016/j.antiviral.2011.11.007; Yan YW, 1998, PROTEIN SCI, V7, P837	66	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104425	10.1371/journal.pone.0104425	http://dx.doi.org/10.1371/journal.pone.0104425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111232	gold, Green Submitted, Green Published			2022-12-27	WOS:000341105100056
J	Iacopino, F; Angelucci, C; Piacentini, R; Biamonte, F; Mangiola, A; Maira, G; Grassi, C; Sica, G				Iacopino, Fortunata; Angelucci, Cristiana; Piacentini, Roberto; Biamonte, Filippo; Mangiola, Annunziato; Maira, Giulio; Grassi, Claudio; Sica, Gigliola			Isolation of Cancer Stem Cells from Three Human Glioblastoma Cell Lines: Characterization of Two Selected Clones	PLOS ONE			English	Article							MARKER CD133; EXPRESSION; TUMORS; CHEMOSENSITIVITY; IDENTIFICATION; HETEROGENEITY; MULTIFORME; CHANNELS; MODELS; NESTIN	Cancer stem cells (CSC) were isolated via a non-adherent neurosphere assay from three glioma cell lines: LI, U87, and U373. Using a clonal assay, two clones (D2 and F11) were selected from spheres derived from LI cells and were characterized for the: expression of stem cell markers (CD133, Nestin, Musashi-1 and Sox2); proliferation; differentiation capability (determined by the expression of GalC, beta III-Tubulin and GFAP); Ca2+ signaling and tumorigenicity in nude mice. Both D2 and F11 clones expressed higher levels of all stem cell markers with respect to the parental cell line. Clones grew more slowly than LI cells with a two-fold increase in duplication time. Markers of differentiation (beta III-Tubulin and GFAP) were expressed at high levels in both LI cells and in neurospheres. The expression of Nestin, Sox2, and beta III-Tubulin was down-regulated in D2 and F11 when cultured in serum-containing medium, whereas Musashi-1 was increased. In this condition, duplication time of D2 and F11 increased without reaching that of LI cells. D2, F11 and parental cells did not express voltage-dependent Ca2+-channels but they exhibited increased intracellular Ca2+ levels in response to ATP. These Ca2+ signals were larger in LI cells and in spheres cultured in serum-containing medium, while they were smaller in serum-free medium. The ATP treatment did not affect cell proliferation. Both D2 and F11 induced the appearance of tumors when ortotopically injected in athymic nude mice at a density 50-fold lower than that of LI cells. All these data indicate that both clones have characteristics of CSC and share the same stemness properties. The findings regarding the expression of differentiation markers and Ca2+-channels show that both clones are unable to reach the terminal differentiation. Both D2 and F11 might represent a good model to improve the knowledge on CSC in glioblastoma and to identify new therapeutic approaches.	[Iacopino, Fortunata; Angelucci, Cristiana; Biamonte, Filippo; Sica, Gigliola] Univ Cattolica Sacro Cuore, Sch Med, Inst Histol & Embryol, I-00168 Rome, Italy; [Piacentini, Roberto; Grassi, Claudio] Univ Cattolica Sacro Cuore, Sch Med, Inst Human Physiol, I-00168 Rome, Italy; [Mangiola, Annunziato; Maira, Giulio] Univ Cattolica Sacro Cuore, Sch Med, Inst Neurosurg, I-00168 Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Iacopino, F (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Inst Histol & Embryol, I-00168 Rome, Italy.	iaco.forty@rm.unicatt.it	Biamonte, Filippo/AAU-7545-2021; Piacentini, Roberto/K-7526-2016; Grassi, Claudio/C-3188-2017	Biamonte, Filippo/0000-0003-1327-7642; Piacentini, Roberto/0000-0003-4215-1643; Grassi, Claudio/0000-0001-7253-1685	French government; Rennes University Hospital; European Research Council [290901]	French government; Rennes University Hospital; European Research Council(European Research Council (ERC)European Commission)	This work has received a French government support granted to the CominLabs excellence laboratory and managed by the National Research Agency in the "Investing for the Future'' program under reference ANR-10-LABX-07-01. It was also supported by the Rennes University Hospital (COREC Project named conneXion, 2012-14). We also thank the European Research Council for the ERC-2011-ADG - Grant Agreement No 290901 - Acronym "NEUCOD''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binda Elena, 2012, Front Biosci (Schol Ed), V4, P1235; Bleau AM, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E27; Brescia P, 2012, J ONCOL, V2012, DOI 10.1155/2012/376894; Butt AM, 2011, SEMIN CELL DEV BIOL, V22, P205, DOI 10.1016/j.semcdb.2011.02.023; Calloni R, 2013, STEM CELLS DEV, V22, P1455, DOI 10.1089/scd.2012.0637; Canazza A, 2011, CANCER BIOL THER, V12, P629, DOI 10.4161/cbt.12.7.16862; Chow EKH, 2013, JALA-J LAB AUTOM, V18, P6, DOI 10.1177/2211068212454739; Cruz M H, 2012, ISRN Oncol, V2012, P392647, DOI 10.5402/2012/392647; D'Ascenzo M, 2006, EUR J NEUROSCI, V23, P935, DOI 10.1111/j.1460-9568.2006.04628.x; Denysenko T, 2010, CELL BIOCHEM FUNCT, V28, P343, DOI 10.1002/cbf.1666; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Feng X, 2012, MOL MED REP, V6, P1117, DOI 10.3892/mmr.2012.1040; Fukaya R, 2010, CANCER LETT, V291, P150, DOI 10.1016/j.canlet.2009.10.010; Gedye Craig, 2013, Methods Mol Biol, V946, P181, DOI 10.1007/978-1-62703-128-8_12; Gilbert CA, 2009, J CELL BIOCHEM, V108, P1031, DOI 10.1002/jcb.22350; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; He H, 2012, J CLIN NEUROSCI, V19, P121, DOI 10.1016/j.jocn.2011.07.026; Hong X, 2012, INT J ONCOL, V41, P1693, DOI 10.3892/ijo.2012.1592; Huszthy PC, 2012, NEURO-ONCOLOGY, V14, P979, DOI 10.1093/neuonc/nos135; Iglesias-Rozas JR, 2005, HISTOL HISTOPATHOL, V20, P351, DOI 10.14670/HH-20.351; Irollo E, 2013, AM J TRANSL RES, V5, P563; Jin F, 2008, CANCER INVEST, V26, P338, DOI 10.1080/07357900701788064; Jin X, 2013, BIOCHEM BIOPH RES CO, V433, P496, DOI 10.1016/j.bbrc.2013.03.021; Johannessen TCA, 2009, NEUROPATH APPL NEURO, V35, P380, DOI [10.1111/j.1365-2990.2009.01008.x, 10.1111/j.1365-2990.2008.01008.x]; Katsetos CD, 2011, ANTI-CANCER AGENT ME, V11, P719; Keysar SB, 2010, MOL CANCER THER, V9, P2450, DOI 10.1158/1535-7163.MCT-10-0530; Kolenda J, 2011, J NEURO-ONCOL, V103, P43, DOI 10.1007/s11060-010-0357-8; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Kong BH, 2013, CHILD NERV SYST, V29, P217, DOI 10.1007/s00381-012-1964-9; Ledur PF, 2012, PURINERG SIGNAL, V8, P39, DOI 10.1007/s11302-011-9252-9; Li Z, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-17; Liu QH, 2009, J NEURO-ONCOL, V94, P1, DOI 10.1007/s11060-009-9919-z; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388; Mellodew K, 2004, DEV BRAIN RES, V151, P13, DOI 10.1016/j.devbrainres.2004.03.018; Molenaar R. J., 2011, ISRN NEUROL, V2011, DOI DOI 10.5402/2011/590249; Nickerson PEB, 2011, EXP EYE RES, V92, P344, DOI 10.1016/j.exer.2011.02.002; Pallini R, 2011, CANCER-AM CANCER SOC, V117, P162, DOI 10.1002/cncr.25581; Pavon LF, 2012, EINSTEIN-SAO PAULO, V10, P197, DOI 10.1590/S1679-45082012000200013; Peng CG, 2012, J NEUROSCI, V32, P13292, DOI 10.1523/JNEUROSCI.2124-12.2012; Pointer KB, 2014, NEUROCHEM INT, V71, P1, DOI 10.1016/j.neuint.2014.03.005; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Ramasamy S, 2013, ARCH BIOCHEM BIOPHYS, V534, P71, DOI 10.1016/j.abb.2013.02.004; Resende RR, 2007, NEUROSCIENCE, V146, P1169, DOI 10.1016/j.neuroscience.2007.02.041; Romaguera-Ros M, 2012, STEM CELL REV REP, V8, P288, DOI 10.1007/s12015-011-9283-1; Sakakibara S, 1997, J NEUROSCI, V17, P8300; Sampetrean O, 2013, BRAIN TUMOR PATHOL, V30, P209, DOI 10.1007/s10014-013-0141-5; SAVARESE A, 1992, EXP BRAIN RES, V89, P408; Shibata M, 2013, BIOESSAYS, V35, P253, DOI 10.1002/bies.201200101; Singh SK, 2003, CANCER RES, V63, P5821; Swayne LA, 2012, CHANNELS, V6, P69, DOI 10.4161/chan.19721; Tirino V, 2013, FASEB J, V27, P13, DOI 10.1096/fj.12-218222; van Staveren WCG, 2009, BBA-REV CANCER, V1795, P92, DOI 10.1016/j.bbcan.2008.12.004; Wakimoto H, 2012, NEURO-ONCOLOGY, V14, P132, DOI 10.1093/neuonc/nor195; Wan Y, 2012, CHIN J CANCER, V31, P207, DOI 10.5732/cjc.011.10336; Wolanczyk M, 2010, FOLIA NEUROPATHOL, V48, P27; Xu ZY, 2013, ULTRASONICS, V53, P232, DOI 10.1016/j.ultras.2012.06.005; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhou ZM, 2011, CANCER BIOTHER RADIO, V26, P77, DOI 10.1089/cbr.2010.0857; ZUPI G, 1988, J NEURO-ONCOL, V6, P169, DOI 10.1007/BF02327393	62	49	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105166	10.1371/journal.pone.0105166	http://dx.doi.org/10.1371/journal.pone.0105166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121761	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000101
J	Khankhet, J; Vanderwolf, KJ; McAlpine, DF; McBurney, S; Overy, DP; Slavic, D; Xu, JP				Khankhet, Jordan; Vanderwolf, Karen J.; McAlpine, Donald F.; McBurney, Scott; Overy, David P.; Slavic, Durda; Xu, Jianping			Clonal Expansion of the Pseudogymnoascus destructans Genotype in North America Is Accompanied by Significant Variation in Phenotypic Expression	PLOS ONE			English	Article							WHITE-NOSE SYNDROME; CRYPTOCOCCUS-NEOFORMANS; GEOMYCES-DESTRUCTANS; ASPERGILLUS-FUMIGATUS; SUSCEPTIBILITY; PENICILLIUM; MYCOTOXINS; VIRULENCE; DROPLETS; MELANIN	Pseudogymnoascus destructans is the causative agent of an emerging infectious disease that threatens populations of several North American bat species. The fungal disease was first observed in 2006 and has since caused the death of nearly six million bats. The disease, commonly known as white-nose syndrome, is characterized by a cutaneous infection with P. destructans causing erosions and ulcers in the skin of nose, ears and/or wings of bats. Previous studies based on sequences from eight loci have found that isolates of P. destructans from bats in the US all belong to one multilocus genotype. Using the same multilocus sequence typing method, we found that isolates from eastern and central Canada also had the same genotype as those from the US, consistent with the clonal expansion of P. destructans into Canada. However, our PCR fingerprinting revealed that among the 112 North American isolates we analyzed, three, all from Canada, showed minor genetic variation. Furthermore, we found significant variations among isolates in mycelial growth rate; the production of mycelial exudates; and pigment production and diffusion into agar media. These phenotypic differences were influenced by culture medium and incubation temperature, indicating significant variation in environmental condition - dependent phenotypic expression among isolates of the clonal P. destructans genotype in North America.	[Khankhet, Jordan; Xu, Jianping] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Vanderwolf, Karen J.; McAlpine, Donald F.] New Brunswick Museum, New Brunswick, NJ USA; [Vanderwolf, Karen J.] Canadian Wildlife Fed, Kanata, ON, Canada; [McBurney, Scott] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Pathol & Microbiol, Canadian Cooperat Wildlife Hlth Ctr, Charlottetown, PE C1A 4P3, Canada; [Overy, David P.] Univ Prince Edward Isl, Dept Chem, Charlottetown, PE C1A 4P3, Canada; [Overy, David P.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Pathol & Microbiol, Charlottetown, PE C1A 4P3, Canada; [Slavic, Durda] Univ Prince Edward Isl, Duffy Res Ctr, Nautilus Biosci Canada Inc, Charlottetown, PE C1A 4P3, Canada; [Slavic, Durda] Univ Guelph, Hlth Anim Lab, Lab Serv, Guelph, ON N1G 2W1, Canada	McMaster University; University of Prince Edward Island; University of Prince Edward Island; University of Prince Edward Island; University of Prince Edward Island; University of Guelph	Xu, JP (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	jpxu@mcmaster.ca	Vanderwolf, Karen/AAI-6010-2020	Vanderwolf, Karen/0000-0003-0963-3093; Overy, David/0000-0003-3107-4777	Ontario Graduate Scholarship; Natural Sciences and Engineering Research Coincil (NSERC) of Canada [5-31998-2010]; Canadian Cooperative Wildlife Health Centre, Atlantic Region	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Natural Sciences and Engineering Research Coincil (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Cooperative Wildlife Health Centre, Atlantic Region	This research was supported by the Ontario Graduate Scholarship and the Natural Sciences and Engineering Research Coincil (NSERC) of Canada (5-31998-2010). Funds in support of the field collection and initial culturing of P. destructans in New Brunswick were provided to DFM and KJV by the New Brunswick Environmental Trust Fund, New Brunswick Wildlife Trust Fund, New Brunswick Department of Natural Resources, National Speleological Society WNS Rapid Response Fund, and Parks Canada. The Canadian Cooperative Wildlife Health Centre, Atlantic Region provided funding for bat necropsies and fungal culture of Nova Scotia and Prince Edward Island samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Canadian Cooperative Wildlife Health Centre, 2013, BAT WHIT NOS SYNDR C; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; COLOTELO N, 1978, CAN J MICROBIOL, V24, P1173, DOI 10.1139/m78-191; Ehinger MO, 2012, NEW PHYTOL, V196, P853, DOI 10.1111/j.1469-8137.2012.04278.x; Foster J, 2012, 5 ANN WHIT NOS SYNDR; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Frisvad JC, 2004, STUD MYCOL, P201; Froschauer A, 2012, US FISH WILDL SERV, P1; Gareis M, 2007, MYCOPATHOLOGIA, V163, P207, DOI 10.1007/s11046-007-9003-1; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Grovel O, 2003, TOXICON, V42, P297, DOI 10.1016/S0041-0101(03)00146-6; Hutwimmer S, 2010, MYCOLOGIA, V102, P1, DOI 10.3852/09-079; Jahn B, 1997, INFECT IMMUN, V65, P5110, DOI 10.1128/IAI.65.12.5110-5117.1997; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; JENNINGS DH, 1991, MYCOL RES, V95, P883, DOI 10.1016/S0953-7562(09)80054-3; KWONCHUNG KJ, 1986, INFECT IMMUN, V51, P218, DOI 10.1128/IAI.51.1.218-223.1986; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; MCPHEE WJ, 1977, CAN J BOT, V55, P358, DOI 10.1139/b77-045; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Minnis AM, 2013, FUNGAL BIOL-UK, V117, P638, DOI 10.1016/j.funbio.2013.07.001; Pringle A, 2002, TRENDS MICROBIOL, V10, P474, DOI 10.1016/S0966-842X(02)02447-2; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Rajkumar SS, 2011, EMERG INFECT DIS, V17, P1273, DOI 10.3201/eid1707.102056; Raudabaugh DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078300; Ren P, 2012, EMERG INFECT DIS, V18, P883, DOI 10.3201/eid1805.111711; Rosas AL, 1997, FEMS MICROBIOL LETT, V153, P265, DOI 10.1016/S0378-1097(97)00239-5; Rosas AL, 2001, MYCOPATHOLOGIA, V151, P53, DOI 10.1023/A:1010977107089; Singh RS, 2012, RAPIDLY EVOLVING GENES AND GENETIC SYSTEMS, P1; Swofford DL, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turner Gregory G., 2011, Bat Research News, V52, P13; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; WANG YL, 1994, APPL ENVIRON MICROB, V60, P3864, DOI 10.1128/AEM.60.10.3864-3866.1994; WANG YL, 1995, INFECT IMMUN, V63, P3131, DOI 10.1128/IAI.63.8.3131-3136.1995; Warnecke L, 2012, P NATL ACAD SCI USA, P1; Wibbelt G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074105	39	23	23	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104684	10.1371/journal.pone.0104684	http://dx.doi.org/10.1371/journal.pone.0104684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122221	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000055
J	Ozawa, M; Kobayashi, W				Ozawa, Masayuki; Kobayashi, Wakako			Cadherin Cytoplasmic Domains Inhibit the Cell Surface Localization of Endogenous E-Cadherin, Blocking Desmosome and Tight Junction Formation and Inducing Cell Dissociation	PLOS ONE			English	Article							UVOMORULIN-CATENIN COMPLEX; BETA-CATENIN; ALPHA-CATENIN; EPITHELIAL-CELLS; ADHERENS JUNCTIONS; ADHESION MOLECULE; MAMMALIAN-CELLS; DILEUCINE MOTIF; N-CADHERIN; MDCK CELLS	The downregulation of E-cadherin function has fundamental consequences with respect to cancer progression, and occurs as part of the epithelial-mesenchymal transition (EMT). In this study, we show that the expression of the Discosoma sp. red fluorescent protein (DsRed)-tagged cadherin cytoplasmic domain in cells inhibited the cell surface localization of endogenous E-cadherin, leading to morphological changes, the inhibition of junctional assembly and cell dissociation. These changes were associated with increased cell migration, but were not accompanied by the down-regulation of epithelial markers and up-regulation of mesenchymal markers. Thus, these changes cannot be classified as EMT. The cadherin cytoplasmic domain interacted with beta-catenin or plakoglobin, reducing the levels of beta-catenin or plakoglobin associated with E-cadherin, and raising the possibility that beta-catenin and plakoglobin sequestration by these constructs induced E-cadherin intracellular localization. Accordingly, a cytoplasmic domain construct bearing mutations that weakened the interactions with beta-catenin or plakoglobin did not impair junction formation and adhesion, indicating that the interaction with beta-catenin or plakoglobin was essential to the potential of the constructs. E-cadherin-alpha-catenin chimeras that did not require beta-catenin or plakoglobin for their cell surface transport restored cell-cell adhesion and junction formation.	[Ozawa, Masayuki; Kobayashi, Wakako] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, Kagoshima 890, Japan	Kagoshima University	Ozawa, M (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, Kagoshima 890, Japan.	mozawa@m.kufm.kagoshima-u.ac.jp		Ozawa, Masayuki/0000-0002-7887-8441	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAGAI M, 1995, J INVEST DERMATOL, V104, P27, DOI 10.1111/1523-1747.ep12613462; Andersen H, 2005, MOL CELL BIOL, V25, P9138, DOI 10.1128/MCB.25.20.9138-9150.2005; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Capaldo CT, 2007, MOL BIOL CELL, V18, P189, DOI 10.1091/mbc.E06-05-0471; Carneiro P, 2012, FEBS LETT, V586, P2981, DOI 10.1016/j.febslet.2012.07.045; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Cong F, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-10; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; Flohr T, 1999, INT J CANCER, V80, P919, DOI 10.1002/(SICI)1097-0215(19990315)80:6<919::AID-IJC19>3.0.CO;2-U; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; Fukunaga Y, 2005, CELL STRUCT FUNCT, V30, P25, DOI 10.1247/csf.30.25; GINSBERG D, 1991, DEVELOPMENT, V111, P315; Godsel LM, 2005, J CELL BIOL, V171, P1045, DOI 10.1083/jcb.200510038; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Imamura Y, 1999, J CELL BIOL, V144, P1311, DOI 10.1083/jcb.144.6.1311; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; Kobayashi W, 2013, BIOCHEM BIOPH RES CO, V442, P133, DOI 10.1016/j.bbrc.2013.11.031; Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Maiers JL, 2013, J CELL SCI, V126, P3904, DOI 10.1242/jcs.126565; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Miyashita Y, 2007, J CELL SCI, V120, P4395, DOI 10.1242/jcs.03489; Miyashita Y, 2007, J BIOL CHEM, V282, P11540, DOI 10.1074/jbc.M608351200; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Nieman MT, 1999, J CELL SCI, V112, P1621; Nieset JE, 1997, J CELL SCI, V110, P1013; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; OJAKIAN GK, 1988, J CELL BIOL, V107, P2377, DOI 10.1083/jcb.107.6.2377; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Ozawa M, 1998, J BIOL CHEM, V273, P29524, DOI 10.1074/jbc.273.45.29524; Ozawa M, 2003, J BIOL CHEM, V278, P46014, DOI 10.1074/jbc.M307778200; OZAWA M, 1992, J CELL BIOL, V116, P989, DOI 10.1083/jcb.116.4.989; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pappas DJ, 2006, CELL COMMUN ADHES, V13, P151, DOI 10.1080/15419060600726142; Peng X, 2012, J BIOL CHEM, V287, P7728, DOI 10.1074/jbc.M111.297481; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Quinlan MP, 1999, CELL GROWTH DIFFER, V10, P839; Sadot E, 1998, P NATL ACAD SCI USA, V95, P15339, DOI 10.1073/pnas.95.26.15339; Simcha I, 2001, MOL BIOL CELL, V12, P1177, DOI 10.1091/mbc.12.4.1177; STAPPERT J, 1994, CELL ADHES COMMUN, V2, P319, DOI 10.3109/15419069409014207; STEVENSON BR, 1994, J CELL SCI, V107, P367; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Tinkle CL, 2004, P NATL ACAD SCI USA, V101, P552, DOI 10.1073/pnas.0307437100; Troxell ML, 2000, J CELL SCI, V113, P985; Troxell ML, 1999, AM J PHYSIOL-CELL PH, V276, pC404, DOI 10.1152/ajpcell.1999.276.2.C404; Tunggal JA, 2005, EMBO J, V24, P1146, DOI 10.1038/sj.emboj.7600605; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zhu AJ, 1996, J CELL SCI, V109, P3013	54	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105313	10.1371/journal.pone.0105313	http://dx.doi.org/10.1371/journal.pone.0105313			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121615	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000114
J	York, EM; Butler, CJ; Lord, WD				York, Emily M.; Butler, Christopher J.; Lord, Wayne D.			Global Decline in Suitable Habitat for Angiostrongylus (= Parastrongylus) cantonensis: The Role of Climate Change	PLOS ONE			English	Article							ECOLOGICAL NICHE MODELS; NEURAL ANGIOSTRONGYLOSIS; EOSINOPHILIC MENINGITIS; GEOGRAPHIC-DISTRIBUTION; CHANGE IMPACTS; DENGUE-FEVER; MALARIA; DISEASE; DISTRIBUTIONS; RISK	Climate change is implicated in the alteration of the ranges of species worldwide. Such shifts in species distributions may introduce parasites/pathogens, hosts, and vectors associated with disease to new areas. The parasite Angiostrongylus (= Parastrongylus) cantonensis is an invasive species that causes eosinophilic meningitis in humans and neurological abnormalities in domestic/wild animals. Although native to southeastern Asia, A. cantonensis has now been reported from more than 30 countries worldwide. Given the health risks, it is important to describe areas with potentially favorable climate for the establishment of A. cantonensis, as well as areas where this pathogen might become established in the future. We used the program Maxent to develop an ecological niche model for A. cantonensis based on 86 localities obtained from published literature. We then modeled areas of potential A. cantonensis distribution as well as areas projected to have suitable climatic conditions under four Representative Concentration Pathways (RCP) scenarios by the 2050s and the 2070s. The best model contained three bioclimatic variables: mean diurnal temperature range, minimum temperature of coldest month and precipitation of warmest quarter. Potentially suitable habitat for A. cantonensis was located worldwide in tropical and subtropical regions. Under all climate change RCP scenarios, the center of the projected distribution shifted away from the equator at a rate of 68-152 km per decade. However, the extent of areas with highly suitable habitat (>50%) declined by 10.66-15.66% by the 2050s and 13.11-16.11% by the 2070s. These results conflict with previous studies, which have generally found that the prevalence of tropical pathogens will increase during the 21st century. Moreover, it is likely that A. cantonensis will continue to expand its current range in the near future due to introductions and host expansion, whereas climate change will reduce the total geographic area of most suitable climatic conditions during the coming decades.	[York, Emily M.; Lord, Wayne D.] Univ Cent Oklahoma, W Roger Webb Forens Sci Inst, Edmond, OK 73034 USA; [York, Emily M.; Butler, Christopher J.; Lord, Wayne D.] Univ Cent Oklahoma, Dept Biol, Edmond, OK USA	University of Central Oklahoma; University of Central Oklahoma	York, EM (corresponding author), Univ Cent Oklahoma, W Roger Webb Forens Sci Inst, Edmond, OK 73034 USA.	eyork@ou.edu			University of Central Oklahoma Office of Research and Grants	University of Central Oklahoma Office of Research and Grants	Funding for this project was provided by the University of Central Oklahoma Office of Research and Grants. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouma MJ, 1997, TROP MED INT HEALTH, V2, P1122, DOI 10.1046/j.1365-3156.1997.d01-210.x; Bouma MJ, 1996, TROP MED INT HEALTH, V1, P86, DOI 10.1046/j.1365-3156.1996.d01-7.x; Butler CJ, 2003, IBIS, V145, P484, DOI 10.1046/j.1474-919X.2003.00193.x; Chen H. T., 1935, Annales de Parasitologie Paris, V13, P312; Chikweto A, 2009, VET PARASITOL, V162, P160, DOI 10.1016/j.vetpar.2009.02.020; Costa J, 2002, AM J TROP MED HYG, V67, P516, DOI 10.4269/ajtmh.2002.67.516; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Duffy MS, 2004, EMERG INFECT DIS, V10, P2207, DOI 10.3201/eid1012.040319; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Epstein PR, 2000, SCI AM, V283, P50, DOI 10.1038/scientificamerican0800-50; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Higgins DP, 1997, AUST VET J, V75, P564, DOI 10.1111/j.1751-0813.1997.tb14194.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Houghton J. T., 2001, CLIMATE CHANGE 2001; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Intergovernmental Panel on Climate Change, 2007, 4 INT PAN CLIM CHANG; Jones CC, 2010, ECOL APPL, V20, P311, DOI 10.1890/08-2261.1; Kim DY, 2002, J PARASITOL, V88, P1024, DOI 10.1645/0022-3395(2002)088[1024:PACNEI]2.0.CO;2; KLIKS MM, 1992, SOC SCI MED, V34, P199, DOI 10.1016/0277-9536(92)90097-A; Kutz SJ, 2005, P ROY SOC B-BIOL SCI, V272, P2571, DOI 10.1098/rspb.2005.3285; Kutz SJ, 2009, VET PARASITOL, V163, P217, DOI 10.1016/j.vetpar.2009.06.008; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lai CH, 2007, AM J TROP MED HYG, V76, P399, DOI 10.4269/ajtmh.2007.76.399; Lal A, 2013, TRENDS PARASITOL, V29, P83, DOI 10.1016/j.pt.2012.10.005; Levine RS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000176; Levine RS, 2004, AM J TROP MED HYG, V70, P105, DOI 10.4269/ajtmh.2004.70.105; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lv S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000368; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; MASON KV, 1987, AUST VET J, V64, P201, DOI 10.1111/j.1751-0813.1987.tb15181.x; McArthur R.H., 1972, GEOGRAPHICAL ECOLOGY; MCKENZIE RA, 1978, AUST VET J, V54, P86, DOI 10.1111/j.1751-0813.1978.tb00354.x; Monks DJ, 2005, J AVIAN MED SURG, V19, P289, DOI 10.1647/2004-024.1; Morgan UM, 2000, INT J PARASITOL, V30, P1407, DOI 10.1016/S0020-7519(00)00129-6; NEW D, 1995, NEW ENGL J MED, V332, P1105, DOI 10.1056/NEJM199504203321619; Panackel C, 2006, Indian J Med Microbiol, V24, P220; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Poulin R, 2006, PARASITOLOGY, V132, P143, DOI 10.1017/S0031182005008693; Qvarnstrom Y, 2007, APPL ENVIRON MICROB, V73, P1415, DOI 10.1128/AEM.01968-06; RADOMYOS P, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P167; Ramirez J, 2008, HIGH RESOLUTION STAT; Reed KD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002034; SMITH G, 1990, PARASITOLOGY, V101, P309, DOI 10.1017/S003118200006337X; So HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001230; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Townsend Peterson A., 2005, U S Forest Service General Technical Report PSW, V191, P1201; Wang QP, 2008, LANCET INFECT DIS, V8, P621, DOI 10.1016/S1473-3099(08)70229-9; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Woodruff RE, 2002, EPIDEMIOLOGY, V13, P384, DOI 10.1097/00001648-200207000-00005; WRIGHT JD, 1991, AUST VET J, V68, P58, DOI 10.1111/j.1751-0813.1991.tb03131.x	60	25	26	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103831	10.1371/journal.pone.0103831	http://dx.doi.org/10.1371/journal.pone.0103831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122457	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000021
J	Ayub, H; Micheal, S; Akhtar, F; Khan, MI; Bashir, S; Waheed, NK; Ali, M; Schoenmaker-Koller, FE; Shafique, S; Qamar, R; den Hollander, AI				Ayub, Humaira; Micheal, Shazia; Akhtar, Farah; Khan, Muhammad Imran; Bashir, Shaheena; Waheed, Nadia K.; Ali, Mahmood; Schoenmaker-Koller, Frederieke E.; Shafique, Sobia; Qamar, Raheel; den Hollander, Anneke I.			Association of a Polymorphism in the BIRC6 Gene with Pseudoexfoliative Glaucoma	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GENOME-WIDE ASSOCIATION; OXIDATIVE STRESS; DEATH; FIBRILLOPATHY; APOPTOSIS; PATHWAY; RISK; EYES	Recently an association was observed between alleles in genes of the unfolded protein response pathway and primary open angle glaucoma (POAG). The goal of the current study is to investigate the role of these two genes, protein disulphide isomerase A member 5 (PDIA5) and baculoviral IAP repeat containing 6 (BIRC6), in different forms of glaucoma. 278 patients with POAG, 132 patients with primary angle closure glaucoma (PACG) and 135 patients with pseudoexfoliative glaucoma (PEXG) were genotyped for single nucleotide polymorphisms (SNPs) rs11720822 in PDIA5 and 471 POAG, 184 PACG and 218 PEXG patients were genotyped for rs2754511 in BIRC6. Genotyping was done by allelic discrimination PCR, and genotype and allele frequencies were calculated. Logistic regression analyses were performed using R software to determine the association of these SNPs with glaucoma. The allele and genotype frequencies of rs11720822 in PDIA5 were not associated with POAG, PACG or PEXG. The TT genotype of rs2754511 in BIRC6 was found to be protective for PEXG (p = 0.05, OR 0.42 [0.22-0.81]) in the Pakistani population, but not for POAG or PACG. This study did not confirm a previously reported association of risk alleles in PDIA5 and BIRC6 with POAG, but did demonstrate a protective role of the T allele of rs2754511 in the BIRC6 gene in PEXG. This supports a role for the unfolded protein response pathway and regulation of apoptotic cell death in the pathogenesis of PEXG.	[Ayub, Humaira; Bashir, Shaheena; Qamar, Raheel] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Micheal, Shazia; Schoenmaker-Koller, Frederieke E.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands; [Akhtar, Farah; Ali, Mahmood] Al Shifa Trust Eye Hosp, Rawalpindi, Pakistan; [Khan, Muhammad Imran; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; [Waheed, Nadia K.] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Qamar, Raheel] Isra Univ, Al Nafees Med Coll & Hosp, Islamabad, Pakistan	COMSATS University Islamabad (CUI); Radboud University Nijmegen; Radboud University Nijmegen; Tufts University	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen, Netherlands.	anneke.denhollander@radboudumc.nl	Ali, Mahmood/AAD-9407-2022; Hollander, Anneke den/N-4911-2014	Ali, Mahmood/0000-0003-0963-9014; Khan, Muhammad Imran/0000-0003-0276-5480	Pakistan Science Foundation [PSF/RES/C-COMSATS/MED(280)]; COMSATS Institute of Information Technology	Pakistan Science Foundation; COMSATS Institute of Information Technology	This work was supported by grant no. PSF/RES/C-COMSATS/MED(280) awarded to R.Q. by the Pakistan Science Foundation and a core grant from the COMSATS Institute of Information Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayub H, 2010, MOL VIS, V16, P18; Borras T, 2003, GENETICS, V163, P637; Carbone MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020649; Carbone MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004216; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; Desai Manishi A, 2008, Int Ophthalmol Clin, V48, P95, DOI 10.1097/IIO.0b013e318187e902; Gibson J, 2012, MOL VIS, V18, P1083; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; Hao Y, 2001, NAT CELL BIOL, V6, P849; Ishiwata K, 2011, INT J ORAL MED SCI, V10, P67; Izzotti A, 2011, PLOS ONE, V20, P14567, DOI DOI 10.1371/J0URNAL.P0NE.0014567; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Konstas AGP, 1997, ARCH OPHTHALMOL-CHIC, V115, P182, DOI 10.1001/archopht.1997.01100150184006; Lamers F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-285; Lee RK, 2004, CURR OPIN OPTHOLMOL, V19, P95; Liu Cui-Hua, 2007, Chang Gung Med J, V30, P469; Micheal S, 2012, MOL VIS, V18, P1040; Nakano M, 2009, P NATL ACAD SCI USA, V106, P12838, DOI 10.1073/pnas.0906397106; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Ovodenko B, 2007, INVEST OPHTH VIS SCI, V48, P1447, DOI 10.1167/iovs.06-0411; Patel HY, 2012, CLIN EXP OPHTHALMOL, V40, pE208, DOI 10.1111/j.1442-9071.2011.02714.x; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Sacca SC, 2007, EXP EYE RES, V84, P389, DOI 10.1016/j.exer.2006.10.008; STREETEN BW, 1990, AM J OPHTHALMOL, V110, P490, DOI 10.1016/S0002-9394(14)77871-7; STREETEN BW, 1992, ARCH OPHTHALMOL-CHIC, V110, P1757, DOI 10.1001/archopht.1992.01080240097039; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yousaf S, 2011, MOL VIS, V17, P1153; Zenkel M, 2005, INVEST OPHTH VIS SCI, V46, P3742, DOI 10.1167/iovs.05-0249; Zenkel M, 2006, INVEST OPHTH VIS SCI, V47, P1982, DOI 10.1167/iovs.05-1580; Zenkel M, 2010, AM J PATHOL, V176, P2868, DOI 10.2353/ajpath.2010.090914	34	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105023	10.1371/journal.pone.0105023	http://dx.doi.org/10.1371/journal.pone.0105023			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118708	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600113
J	Hameed, W; Azmat, SK; Ali, M; Sheikh, MI; Abbas, G; Temmerman, M; Avan, BI				Hameed, Waqas; Azmat, Syed Khurram; Ali, Moazzam; Sheikh, Muhammad Ishaque; Abbas, Ghazunfer; Temmerman, Marleen; Avan, Bilal Iqbal			Women's Empowerment and Contraceptive Use: The Role of Independent versus Couples' Decision-Making, from a Lower Middle Income Country Perspective	PLOS ONE			English	Article							INSTITUTIONAL DELIVERY; AUTONOMY; CREDIT; HEALTH	Introduction: There is little available evidence of associations between the various dimensions of women's empowerment and contraceptive use having been examined - and of how these associations are mediated by women's socio-economic and demographic statuses. We assessed these phenomena in Pakistan using a structured-framework approach. Methods: We analyzed data on 2,133 women who were either using any form of contraceptive or living with unmet need for contraception. The survey was conducted during May - June 2012, with married women of reproductive age (15-49 years) in three districts of Punjab. The dimensions of empowerment were categorized broadly into: economic decision-making, household decision-making, and women's mobility. Two measures were created for each dimension, and for the overall empowerment: women's independent decisions, and those taken jointly by couples. Contraceptive use was categorized as either female-only or couple methods on the basis of whether a method requires the awareness of, or some support and cooperation from, the husband. Multinomial regression was used, by means of Odds Ratios (OR), to assess associations between empowerment dimensions and female-only and couple contraceptive methods. Results: Overall, women tend to get higher decision-making power with increased age, higher literacy, a greater number of children, or being in a household that has superior socio-economic status. The measures for couples' decision-making for overall empowerment and for each dimension of it showed positive associations with couple methods as well as with female-only methods. The only exception was the measure of economic empowerment, which was associated only with the couple method. Conclusion: Couples' joint decision-making is a stronger determinant of the use of contraceptive methods than women-only decision-making. This is the case over and above the contribution of women's socio-demographic and economic statuses. Effort needs to be made to educate women and their husbands equally, with particular focus on highly effective contraceptive methods.	[Hameed, Waqas; Azmat, Syed Khurram; Sheikh, Muhammad Ishaque; Abbas, Ghazunfer] Marie Stopes Soc, Res Monitoring & Evaluat Dept, Karachi, sindh, Pakistan; [Azmat, Syed Khurram; Temmerman, Marleen] Univ Ghent, Dept Urogynecol, B-9000 Ghent, E Flanders, Belgium; [Ali, Moazzam; Temmerman, Marleen] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Avan, Bilal Iqbal] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England	Ghent University; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Avan, BI (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.	bilal.avan@lshtm.ac.uk	Azmat, Syed Khurram/C-7244-2019	Azmat, Syed Khurram/0000-0003-0158-8734; Iqbal Avan, Bilal/0000-0003-4531-4508; Ali, Moazzam/0000-0001-6949-8976	David and Lucile Packard Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	Funded by The David and Lucile Packard Foundation, this study is implemented by Marie Stopes Society (MSS) Pakistan. The present paper includes the collective views of an international group of experts, and does not necessarily represent the decisions or the stated policy of the World Health Organization, Marie Stopes Society Pakistan, London School of Hygiene and Tropical Medicine or The David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya DR, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-15; Adhi M, 2007, PAK J PHYSL, V3, P41; Adhikari R, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-7; Agha S, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-31; Agha S, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-10; Ahmed S, 2012, LANCET, V380, P111, DOI 10.1016/S0140-6736(12)60478-4; Ali W., 2010, EUROPEAN J SOCIAL SC, V18, P147; Alsop R., 2006, EMPOWERMENT PRACTICE; [Anonymous], 2001, EP INF 6 04D VERS 6; [Anonymous], [No title captured]; [Anonymous], 2013, NAT I STAT ICF INT; Azmat SK, 2012, PAK J PUBLIC HLTH, V2, P2; Azmat SK, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-39; Bawah AA, 1999, STUD FAMILY PLANN, V30, P54, DOI 10.1111/j.1728-4465.1999.00054.x; Bhutta ZA, 2013, LANCET; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; Bongaarts J, 2009, INT PERSPECT SEX R H, V35, P39, DOI 10.1363/ifpp.35.039.09; Crissman HP, 2012, STUD FAMILY PLANN, V43, P201, DOI 10.1111/j.1728-4465.2012.00318.x; Dali S M, 1992, World Health Forum, V13, P353; Do M, 2012, INT PERSPECT SEX R H, V38, P23, DOI 10.1363/3802312; Fantahun M, 2007, ACTA PAEDIATR, V96, P582, DOI 10.1111/j.1651-2227.2007.00147.x; Fikree FF, 2001, INT FAM PLAN PERSPEC, V27, P130, DOI 10.2307/2673834; Govindasamy P, 1996, STUD FAMILY PLANN, V27, P328, DOI 10.2307/2138028; Haque M., 2011, BANGLADESH E J SOCIO, V8, P17; Hennink M, 2001, DEMAND FAMILY PLANNI; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Hou X, 2012, HLTH POLICY PLAN; Kabeer N, 2001, WORLD DEV, V29, P63, DOI 10.1016/S0305-750X(00)00081-4; Kassebaum N.J, 2014, LANCET; Krishna A, 2003, SOCIAL CAPITAL COMMU; Malhotra A., 2002, WORLD BANK WORKSH PO; Mason K. O., 2003, WOMENS EMPOWERMENT S; National Institute of Population Studies Pakistan, 2002, PAK POP DAT EST POP; National Institute of Population Studies Pakistan Macro International Inc., 2014, PAK DEM HLTH SURV 20; Safilios-Rothschild C., FEMALE POWER AUTONOM; Saleem Shabana, 2005, Reprod Health, V2, P8, DOI 10.1186/1742-4755-2-8; Santow G, 1995, P UN EXP GROUP M POP; Sathar Z. A., 2000, Pakistan Development Review, V39, P89; Sathar ZA, 1998, ONSET FERTILITY TRAN; SCHULER SR, 1994, STUD FAMILY PLANN, V25, P65, DOI 10.2307/2138085; Sida, 2006, MICR WOM EMP EV SELF; Ubaidur Rob A K, 1990, Biol Soc, V7, P31; United Nations, 1995, REP INT C POP DEV; United Nations Department of Economic and Social Affairs/Population Division, 2008, WORLD POP PROSP 2008; Upadhyay UD, 2005, SOC SCI MED, V60, P2641, DOI 10.1016/j.socscimed.2004.11.032; Waterhouse R, 2005, EVALUATION DFID DEV; Zahidi S., 2012, INSIGHT REPORT GLOBA	47	72	72	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104633	10.1371/journal.pone.0104633	http://dx.doi.org/10.1371/journal.pone.0104633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9BM	25119727	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600072
J	Jousse, C; Muranishi, Y; Parry, L; Montaurier, C; Even, P; Launay, JM; Carraro, V; Maurin, AC; Averous, J; Chaveroux, C; Bruhat, A; Mallet, J; Morio, B; Fafournoux, P				Jousse, Celine; Muranishi, Yuki; Parry, Laurent; Montaurier, Christophe; Even, Patrick; Launay, Jean-Marie; Carraro, Valerie; Maurin, Anne-Catherine; Averous, Julien; Chaveroux, Cedric; Bruhat, Alain; Mallet, Jacques; Morio, Beatrice; Fafournoux, Pierre			Perinatal Protein Malnutrition Affects Mitochondrial Function in Adult and Results in a Resistance to High Fat Diet-Induced Obesity	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; IMPAIRED OXIDATIVE-PHOSPHORYLATION; LOCAL-ANESTHETIC BUPIVACAINE; GROWTH-RETARDED RATS; UNCOUPLING PROTEIN-2; ENERGY-METABOLISM; ADIPOSE-TISSUE; MUSCLE MITOCHONDRIAL; INSULIN-RESISTANCE; LIPID-METABOLISM	Epidemiological findings indicate that transient environmental influences during perinatal life, especially nutrition, may have deleterious heritable health effects lasting for the entire life. Indeed, the fetal organism develops specific adaptations that permanently change its physiology/metabolism and that persist even in the absence of the stimulus that initiated them. This process is termed "nutritional programming". We previously demonstrated that mothers fed a Low-Protein-Diet (LPD) during gestation and lactation give birth to F1-LPD animals presenting metabolic consequences that are different from those observed when the nutritional stress is applied during gestation only. Compared to control mice, adult F1-LPD animals have a lower body weight and exhibit a higher food intake suggesting that maternal protein under-nutrition during gestation and lactation affects the energy metabolism of F1-LPD offspring. In this study, we investigated the origin of this apparent energy wasting process in F1-LPD and demonstrated that minimal energy expenditure is increased, due to both an increased mitochondrial function in skeletal muscle and an increased mitochondrial density in White Adipose Tissue. Importantly, F1-LPD mice are protected against high-fat-diet-induced obesity. Clearly, different paradigms of exposure to malnutrition may be associated with differences in energy expenditure, food intake, weight and different susceptibilities to various symptoms associated with metabolic syndrome. Taken together these results demonstrate that intra-uterine environment is a major contributor to the future of individuals and disturbance at a critical period of development may compromise their health. Consequently, understanding the molecular mechanisms may give access to useful knowledge regarding the onset of metabolic diseases.	[Jousse, Celine; Muranishi, Yuki; Parry, Laurent; Montaurier, Christophe; Carraro, Valerie; Maurin, Anne-Catherine; Averous, Julien; Chaveroux, Cedric; Bruhat, Alain; Morio, Beatrice; Fafournoux, Pierre] Univ Clermont 1, INRA, Nutr Humaine UMR1019, St Genes Champanelle, France; [Even, Patrick] AgroParisTech, INRA, Nutr Physiol & Ingest Behav UMR914, Paris, France; [Launay, Jean-Marie] Univ Paris 05, Hop Lariboisiere, AP HP,Fac Pharm, Serv Biochim & Biol Mol,Equipe Associee EA 3621, Paris, France; [Mallet, Jacques] Univ Paris 06, CNRS, Hop La Pitie Salpetriere, Lab Genet Mol Neurotransmiss & Proc,UMR7091, Paris, France	INRAE; Universite Clermont Auvergne (UCA); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Jousse, C (corresponding author), Univ Clermont 1, INRA, Nutr Humaine UMR1019, St Genes Champanelle, France.	celine.jousse@clermont.inra.fr; pierre.fafournoux@clermont.inra.fr	Carmen, Team2/Y-7383-2019; Morio, Béatrice/G-3571-2018; Carmen, Team1/Y-7382-2019; MONTAURIER, Christophe/AAB-9460-2022	Carmen, Team2/0000-0001-9867-5724; Morio, Béatrice/0000-0002-2418-1438; Carmen, Team1/0000-0003-4234-1746; Montaurier, Christophe/0000-0001-5487-8757; Chaveroux, Cedric/0000-0002-4116-3354; Lab, Carmen/0000-0002-5935-3236; Even, Patrick/0000-0001-5733-3023	ANR (French Agency for Research, Epidiabesity)	ANR (French Agency for Research, Epidiabesity)(French National Research Agency (ANR))	The study was funded by a grant from ANR (French Agency for Research, Epidiabesity). The Centre National pour la Recherche Scientifique (CNRS) provided salaries for CJ and PF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anedda A, 2008, J ENDOCRINOL, V199, P33, DOI 10.1677/JOE-08-0278; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; CAPALDI RA, 1982, BIOCHIM BIOPHYS ACTA, V694, P291, DOI 10.1016/0304-4157(82)90009-0; Chanseaume E, 2009, INT J MOL SCI, V10, P306, DOI 10.3390/ijms10010306; Desai M, 1997, AM J PHYSIOL-GASTR L, V273, pG899, DOI 10.1152/ajpgi.1997.273.4.G899; Desquiret V, 2008, INT J BIOCHEM CELL B, V40, P1629, DOI 10.1016/j.biocel.2007.12.010; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Gharid A, 2011, NEURODEGENERATION TH, P63; Guan HY, 2005, AM J PHYSIOL-ENDOC M, V288, pE663, DOI 10.1152/ajpendo.00461.2004; Holness MJ, 2000, BIOCHEM J, V349, P657, DOI 10.1042/bj3490657; Horvath TL, 2003, INT J OBESITY, V27, P433, DOI 10.1038/sj.ijo.0802257; Jousse C, 2011, FASEB J, V25, P3271, DOI 10.1096/fj.11-181792; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834; Morrison JL, 2010, PEDIATR NEPHROL, V25, P669, DOI 10.1007/s00467-009-1407-3; MRAD JA, 1992, AM J PHYSIOL, V262, pR684, DOI 10.1152/ajpregu.1992.262.4.R684; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Oh KS, 2006, BIOCHEM BIOPH RES CO, V345, P1232, DOI 10.1016/j.bbrc.2006.04.182; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V270, pE559, DOI 10.1152/ajpendo.1996.270.4.E559; Park HK, 2004, ANN NY ACAD SCI, V1011, P205, DOI 10.1196/annals.1293.021; Park KS, 2003, J NUTR, V133, P3085, DOI 10.1093/jn/133.10.3085; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002; Piccoli C, 2006, BIOCHEM J, V396, P573, DOI 10.1042/BJ20060077; Selak MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE130, DOI 10.1152/ajpendo.00322.2002; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; Stanner S A, 2001, Twin Res, V4, P287, DOI 10.1375/1369052012498; Sztark F, 1997, BIOCHEM MOL BIOL INT, V43, P997; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; Theys N, 2009, AM J PHYSIOL-REG I, V297, pR1516, DOI 10.1152/ajpregu.00280.2009; van den Broek NMA, 2010, FASEB J, V24, P1354, DOI 10.1096/fj.09-143842; VANDAM K, 1990, FEBS LETT, V277, P131, DOI 10.1016/0014-5793(90)80826-5; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Watson Elizabeth, 2009, BMC Physiology, V9, P19, DOI 10.1186/1472-6793-9-19; WEIR JBD, 1990, NUTRITION, V6, P213; Wong KE, 2009, AM J PHYSIOL-ENDOC M, V296, pE820, DOI 10.1152/ajpendo.90763.2008	38	24	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104896	10.1371/journal.pone.0104896	http://dx.doi.org/10.1371/journal.pone.0104896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118945	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600102
J	Santman-Berends, I; Luttikholt, S; Van den Brom, R; Van Schaik, G; Gonggrijp, M; Hage, H; Vellema, P				Santman-Berends, Inge; Luttikholt, Saskia; Van den Brom, Rene; Van Schaik, Gerdien; Gonggrijp, Maaike; Hage, Han; Vellema, Piet			Estimation of the Use of Antibiotics in the Small Ruminant Industry in the Netherlands in 2011 and 2012	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL USE; DRUG-USE; SHEEP; PREVALENCE; ONTARIO; HEALTH; USAGE; HERDS	The aim of this study was to estimate the quantity of antibiotics and classes of antibiotics used in the small ruminant industry in the Netherlands in 2011 and 2012. Twelve large veterinary practices, located throughout the Netherlands were selected for this study. All small ruminant farms associated with these practices that had complete records on the quantity of antibiotics prescribed were included. The veterinary practices provided data on all antibiotics prescribed, and the estimated animal used daily dose of antibiotics per year (AUDD/Y) was calculated for each farm. The median AUDD/Y in small ruminant farms was zero in both years (mean 0.60 in 2011, and 0.62 in 2012). The largest quantity of antibiotic use was observed in the professional goat industry (herds of >= 32 goats) with a median AUDD/Y of 1.22 in 2011 and 0.73 in 2012. In the professional sheep industry (flocks of >= 32 sheep), the median AUDD/Y was 0 in 2011 and 0.10 in 2012. In the small scale industry (flocks or herds of <32 sheep or goats), the median AUDD/Y never exceeded 0. The most frequently prescribed antibiotics in the small scale industry and professional sheep farms belonged to the penicillin class. In professional goat farms, antibiotics of the aminoglycoside class were most frequently prescribed. This study provides the first assessment on the quantity of antibiotic use in the small ruminant industry. Given a comparable attitude towards antibiotic use, these results might be valid for small ruminant populations in other north-western European countries as well. The antibiotic use in the small ruminant industry appeared to be low, and is expected to play a minor role in the development of antibiotic resistance. Nevertheless, several major zoonotic bacterial pathogens are associated with the small ruminant industry, and it remains important that antibiotics are used in a prudent way.	[Santman-Berends, Inge; Van Schaik, Gerdien; Gonggrijp, Maaike] GD Anim Hlth, Dept Epidemiol, Deventer, Netherlands; [Luttikholt, Saskia; Van den Brom, Rene; Vellema, Piet] GD Anim Hlth, Dept Small Ruminant Hlth, Deventer, Netherlands; [Hage, Han] GD Anim Hlth, Dept Cattle Hlth, Deventer, Netherlands		Santman-Berends, I (corresponding author), GD Anim Hlth, Dept Epidemiol, Deventer, Netherlands.	i.santman@gddiergezondheid.nl	van Schaik, Gerdien/AAD-7771-2020	van Schaik, Gerdien/0000-0002-0460-2629	Dutch Ministry of Economic affairs	Dutch Ministry of Economic affairs(Ministry of Economic Affairs, Netherlands)	This study was funded by the Dutch Ministry of Economic affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery BP, 2008, CAN J VET RES, V72, P137; Callens B, 2012, PREV VET MED, V106, P53, DOI 10.1016/j.prevetmed.2012.03.001; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Hendriksen RS, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-28; Krol DJ, 2007, INVENTARISATION SMAL; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LNV, 2008, CONV RED ANT RES LIV; MARAN, 2013, MON ANT RES ANT US A; Moon CS, 2010, CAN VET J, V51, P1373; Pardon B, 2012, J ANTIMICROB CHEMOTH, V67, P1027, DOI 10.1093/jac/dkr570; Persoons D, 2012, PREV VET MED, V105, P320, DOI 10.1016/j.prevetmed.2012.02.020; Santman-Berends I.M.G.A., 2013, DATA ANAL SMALL RUMI; Sawant AA, 2005, J DAIRY SCI, V88, P2991, DOI 10.3168/jds.S0022-0302(05)72979-9; Scott L, 2012, CAN J VET RES, V76, P109; Scott LC, 2011, VET CLIN N AM-FOOD A, V27, P23, DOI 10.1016/j.cvfa.2010.10.015; SDA, 2013, US ANT LIV SPEC 2012; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Stata Corporation, 2013, STAT SOFTW VERS 13; Tacconelli E, 2009, CURR OPIN INFECT DIS, V22, P352, DOI 10.1097/QCO.0b013e32832d52e0; Ungemach FR, 2006, INT J MED MICROBIOL, V296, P33, DOI 10.1016/j.ijmm.2006.01.059; Van den Brom R, 2013, PREV VET MED, V109, P76, DOI 10.1016/j.prevetmed.2012.09.002; Vieira AR, 2011, EPIDEMIOL INFECT, V139, P1601, DOI 10.1017/S0950268810002724	23	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e105052	10.1371/journal.pone.0105052	http://dx.doi.org/10.1371/journal.pone.0105052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115998	gold, Green Submitted, Green Published			2022-12-27	WOS:000341230400117
J	Segatto, M; Trapani, L; Di Tunno, I; Sticozzi, C; Valacchi, G; Hayek, J; Pallottini, V				Segatto, Marco; Trapani, Laura; Di Tunno, Ilenia; Sticozzi, Claudia; Valacchi, Giuseppe; Hayek, Joussef; Pallottini, Valentina			Cholesterol Metabolism Is Altered in Rett Syndrome: A Study on Plasma and Primary Cultured Fibroblasts Derived from Patients	PLOS ONE			English	Article							BIOSYNTHETIC-PATHWAY; HMGCOA REDUCTASE; MECP2; TRANSCRIPTION; MUTATIONS; LIVER	Rett (RTT) syndrome is a severe neurological disorder that affects almost exclusively females. Several detectable mutations in the X-linked methyl-CpG-binding protein 2 gene (MECP2) are responsible for the onset of the disease. MeCP2 is a key transcription regulator involved in gene silencing via methylation-dependent remodeling of chromatin. Recent data highlight that lipid metabolism is perturbed in brains and livers of MECP2-null male mice. In addition, altered plasma lipid profile in RTT patients has been observed. Thus, the aim of the work is to investigate the protein network involved in cholesterol homeostasis maintenance on freshly isolated fibroblasts and plasma from both RTT and healthy donors. To this end, protein expression of 3-hydroxy-3methyl glutaryl Coenzyme A reductase (HMGR), sterol regulatory element binding proteins (SREBPs), low density lipoprotein receptor (LDLr) and scavenger receptor B-1 (SRB-1) was assessed in cultured skin fibroblasts from unaffected individuals and RTT patients. In addition, lipid profile and the abundance of proprotein convertase subtilisin/kexin type 9 (PCSK9) were analyzed on plasma samples. The obtained results demonstrate that the main proteins belonging to cholesterol regulatory network are altered in RTT female patients, providing the proof of principle that cholesterol metabolism may be taken into account as a new target for the treatment of specific features of RTT pathology.	[Segatto, Marco; Trapani, Laura; Di Tunno, Ilenia; Pallottini, Valentina] Univ Roma Tre, Dept Sci, Sect Biomed Sci & Technol, Rome, Italy; [Sticozzi, Claudia; Valacchi, Giuseppe] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Hayek, Joussef] AOUS, Univ Hosp, Child Neuropsychiat Unit, Siena, Italy	Italfarmaco; Roma Tre University; University of Ferrara; University of Siena; University Hospital of Siena	Pallottini, V (corresponding author), Univ Roma Tre, Dept Sci, Sect Biomed Sci & Technol, Rome, Italy.	valentina.pallottini@uniroma3.it	Segatto, Marco/AHD-3607-2022; Pallottini, Valentina/AAA-3218-2021	Pallottini, Valentina/0000-0003-2511-6168; hayek, joussef/0000-0002-0440-2491; Segatto, Marco/0000-0003-0465-9470				Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ben-Shachar S, 2009, CLIN GENET, V75, P394, DOI 10.1111/j.1399-0004.2008.01114.x; Bourdon V, 2001, J MED GENET, V38, P867, DOI 10.1136/jmg.38.12.867; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1980, J LIPID RES, V21, P505; Buchovecky C, 2013, NATURE GENETICS; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; da Rocha JT, 2013, CURR MED CHEM; De Felice C, 2012, ANN NY ACAD SCI, V1259, P121, DOI 10.1111/j.1749-6632.2012.06611.x; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Gaussin V, 1997, FEBS LETT, V413, P115, DOI 10.1016/S0014-5793(97)00890-9; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Horton JD, 2002, BIOCHEM SOC T, V30, P1091, DOI 10.1042/bst0301091; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MacDonald JL, 2010, MOL CELL NEUROSCI, V44, P55, DOI 10.1016/j.mcn.2010.02.003; Nagy G, 2013, NAT GENET, V45, P965, DOI 10.1038/ng.2738; Pallottini V, 2006, J HEPATOL, V44, P368, DOI 10.1016/j.jhep.2005.06.011; Patankar JV, 2014, CLIN GENET, V85, P229, DOI 10.1111/cge.12284; Percy AK, 2013, SCIENCE, V342, P318, DOI 10.1126/science.1245657; Pfrieger FW, 2003, BBA-BIOMEMBRANES, V1610, P271, DOI 10.1016/S0005-2736(03)00024-5; Pfrieger FW, 2002, CURR OPIN NEUROBIOL, V12, P486, DOI 10.1016/S0959-4388(02)00358-6; Poirier S, 2013, DRUG DES DEV THER, V7, P1135, DOI 10.2147/DDDT.S36984; Rett A, 1966, Wien Med Wochenschr, V116, P723; SAVOLDI R, 1976, Quaderni Sclavo de Diagnostica Clinica e di Laboratorio, V12, P238; Segatto M, 2012, ACTA PHYSIOL, V206, P62, DOI 10.1111/j.1748-1716.2012.02450.x; Segatto M, 2014, NEUROPSYCHOPHARMACOL, V39, P841, DOI 10.1038/npp.2013.284; Segatto M, 2013, J CELL PHYSIOL, V228, P1561, DOI 10.1002/jcp.24315; Sticozzi C, 2013, FEBS LETT, V587, P2199, DOI 10.1016/j.febslet.2013.05.042; Trapani L, 2013, WORLD J HEPATOL, V5, P676, DOI 10.4254/wjh.v5.i12.676; Trapani L, 2011, IUBMB LIFE, V63, P964, DOI 10.1002/iub.522; TRINDER P, 1984, ANN CLIN BIOCHEM, V21, P430, DOI 10.1177/000456328402100516	33	46	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104834	10.1371/journal.pone.0104834	http://dx.doi.org/10.1371/journal.pone.0104834			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25118178	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400095
J	Deng, X; Zhou, J; Li, FF; Yan, P; Zhao, EY; Hao, L; Yu, KJ; Liu, SL				Deng, Xia; Zhou, Jing; Li, Fei-Feng; Yan, Peng; Zhao, Er-Ying; Hao, Ling; Yu, Kai-Jiang; Liu, Shu-Lin			Characterization of Nodal/TGF-Lefty Signaling Pathway Gene Variants for Possible Roles in Congenital Heart Diseases	PLOS ONE			English	Article							CELLS; MICROENVIRONMENT; DEFECTS	Background: Nodal/TGF-Lefty signaling pathway has important effects at early stages of differentiation of human embryonic stem cells in directing them to differentiate into different embryonic lineages. LEFTY, one of transforming growth factors in the Nodal/TGF-Lefty signaling pathway, plays an important role in the development of heart. The aim of this work was to find evidence on whether Lefty variations are associated with congenital heart diseases (CHD). Methods: We sequenced the Lefty gene for 230 Chinese Han CHD patients and evaluated SNPs rs2295418, rs360057 and g.G169A, which are located within the translated regions of the genes. The statistical analyses were conducted using Chi-Square Tests as implemented in SPSS (version 13.0). The Hardy-Weinberg equilibrium test of the population was carried out using online software OEGE, and multiple-sequence alignments of LEFTY proteins were carried out using the Vector NTI software. Results: Two heterozygous variants in Lefty1 gene, g.G169A and g.A1035C, and one heterozygous variant in Lefty2 gene, g.C925A, were identified. Statistical analyses showed that the rs2295418 (g.C925A) variant in Lefty2 gene was obviously associated with the risk of CHD (P value = 0.016<0.05). The genotype frequency of rs360057 (g.A1035C) variant in Lefty1 gene was associated with the risk of CHD (P value = 0.007<0.05), but the allele frequency was not (P value = 0.317>0.05). Conclusions: The SNP rs2295418 in the Lefty2 gene is associated with CHD in Chinese Han populations.	[Deng, Xia; Li, Fei-Feng; Zhao, Er-Ying; Liu, Shu-Lin] Harbin Med Univ, Genom Res Ctr, State Prov Key Lab Biopharmaceut Engn 1, Harbin, Peoples R China; [Zhou, Jing; Yu, Kai-Jiang] Harbin Med Univ, Intens Care Unit, Affiliated Hosp 2, Harbin, Peoples R China; [Yan, Peng] Harbin Med Univ, Dept Colorectal Surg, Affiliated Hosp 2, Harbin, Peoples R China; [Hao, Ling] Harbin Med Univ, Dept Oncol, Affiliated Hosp 4, Harbin, Peoples R China; [Liu, Shu-Lin] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; University of Calgary	Li, FF (corresponding author), Harbin Med Univ, Genom Res Ctr, State Prov Key Lab Biopharmaceut Engn 1, Harbin, Peoples R China.	lff-1981@163.com; drkaijiang@163.com; slliu@ucalgary.ca			Heilongjiang Innovation Research Foundation for Graduate Studies [YJSCX2012-199HLJ]; Heilongjiang Province [ZD200917]; Pharmacy College of Harbin Medical University; National Natural Science Foundation of China [NSFC81271786, 81110378, 30970119, 81030029]	Heilongjiang Innovation Research Foundation for Graduate Studies; Heilongjiang Province; Pharmacy College of Harbin Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from Heilongjiang Innovation Research Foundation for Graduate Studies (YJSCX2012-199HLJ) to XD; a grant from Heilongjiang Province (ZD200917) to KJY; a grant from Pharmacy College of Harbin Medical University to FFL for training undergraduate students; and grants of National Natural Science Foundation of China (NSFC81271786, 81110378, 30970119, 81030029) to SLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barroso-delJesus A, 2011, FASEB J, V25, P1497, DOI 10.1096/fj.10-172221; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Butler TL, 2010, GENET TEST MOL BIOMA; Costa FF, 2009, EPIGENOMICS-UK, V1, P387, DOI 10.2217/EPI.09.25; Dvash T, 2007, STEM CELLS, V25, P465, DOI 10.1634/stemcells.2006-0179; Gong W, 2001, J Med Genet, V38, pE45, DOI 10.1136/jmg.38.12.e45; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hoffman JIE, 2004, AM HEART J, V147, P425, DOI 10.1016/j.ahj.2003.05.003; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Malchenko S, 2010, J CELL PHYSIOL, V225, P390, DOI 10.1002/jcp.22280; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Richards AA, 2010, CURR CARDIOL REV, V6, P91, DOI 10.2174/157340310791162703; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schuldiner M, 2003, METHOD ENZYMOL, V365, P446; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; van Weerd JH, 2011, CARDIOVASC RES, V91, P203, DOI 10.1093/cvr/cvr138; Verheugt CL, 2010, EUR HEART J, V31, P1220, DOI 10.1093/eurheartj/ehq032; Wang B, 2009, INT J CARDIOL; Wang HH, 2012, MOL CELL BIOCHEM, V370, P53, DOI 10.1007/s11010-012-1397-5	25	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104535	10.1371/journal.pone.0104535	http://dx.doi.org/10.1371/journal.pone.0104535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111179	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100069
J	Kraus, P; Sivakamasundari, V; Yu, HB; Xing, X; Lim, SL; Adler, T; Pimentel, JAA; Becker, L; Bohla, A; Garrett, L; Hans, W; Holter, SM; Janas, E; Moreth, K; Prehn, C; Puk, O; Rathkolb, B; Rozman, J; Adamski, J; Bekeredjian, R; Busch, DH; Graw, J; Klingenspor, M; Klopstock, T; Neff, F; Ollert, M; Stoeger, T; Yildrim, AO; Eickelberg, O; Wolf, E; Wurst, W; Fuchs, H; Gailus-Durner, V; de Angelis, MH; Lufkin, T; Stanton, LW				Kraus, Petra; Sivakamasundari, V; Yu, Hong Bing; Xing, Xing; Lim, Siew Lan; Adler, Thure; Pimentel, Juan Antonio Aguilar; Becker, Lore; Bohla, Alexander; Garrett, Lillian; Hans, Wolfgang; Hoelter, Sabine M.; Janas, Eva; Moreth, Kristin; Prehn, Cornelia; Puk, Oliver; Rathkolb, Birgit; Rozman, Jan; Adamski, Jerzy; Bekeredjian, Raffi; Busch, Dirk H.; Graw, Jochen; Klingenspor, Martin; Klopstock, Thomas; Neff, Frauke; Ollert, Markus; Stoeger, Tobias; Yildrim, Ali Oender; Eickelberg, Oliver; Wolf, Eckhard; Wurst, Wolfgang; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Lufkin, Thomas; Stanton, Lawrence W.			Pleiotropic Functions for Transcription Factor Zscan10	PLOS ONE			English	Article							CELL FATE; STEM-CELLS; SOX2; GENE; EXPRESSION; EYE; PAX6; LINE; DLX1; DIFFERENTIATION	The transcription factor Zscan10 had been attributed a role as a pluripotency factor in embryonic stem cells based on its interaction with Oct4 and Sox2 in in vitro assays. Here we suggest a potential role of Zscan10 in controlling progenitor cell populations in vivo. Mice homozygous for a Zscan10 mutation exhibit reduced weight, mild hypoplasia in the spleen, heart and long bones and phenocopy an eye malformation previously described for Sox2 hypomorphs. Phenotypic abnormalities are supported by the nature of Zscan10 expression in midgestation embryos and adults suggesting a role for Zscan10 in either maintaining progenitor cell subpopulation or impacting on fate choice decisions thereof.	[Kraus, Petra; Sivakamasundari, V; Yu, Hong Bing; Xing, Xing; Lim, Siew Lan; Lufkin, Thomas; Stanton, Lawrence W.] Genome Inst Singapore, Singapore, Singapore; [Kraus, Petra; Lufkin, Thomas] Clarkson Univ, Dept Biol, Potsdam, NY 13699 USA; [Adler, Thure; Pimentel, Juan Antonio Aguilar; Becker, Lore; Bohla, Alexander; Garrett, Lillian; Hans, Wolfgang; Hoelter, Sabine M.; Janas, Eva; Moreth, Kristin; Prehn, Cornelia; Puk, Oliver; Rathkolb, Birgit; Rozman, Jan; Adamski, Jerzy; Bekeredjian, Raffi; Busch, Dirk H.; Graw, Jochen; Klingenspor, Martin; Klopstock, Thomas; Neff, Frauke; Ollert, Markus; Stoeger, Tobias; Yildrim, Ali Oender; Eickelberg, Oliver; Wolf, Eckhard; Wurst, Wolfgang; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, German Mouse Clin, Neuherberg, Germany; [Adler, Thure; Pimentel, Juan Antonio Aguilar; Becker, Lore; Hans, Wolfgang; Moreth, Kristin; Prehn, Cornelia; Rozman, Jan; Adamski, Jerzy; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany; [Garrett, Lillian; Hoelter, Sabine M.; Puk, Oliver; Graw, Jochen; Wurst, Wolfgang] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Janas, Eva; Neff, Frauke] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany; [Rathkolb, Birgit; Wolf, Eckhard] Univ Munich, Chair Mol Anim Breeding & Biotechnol, Gene Ctr, Munich, Germany; [Bekeredjian, Raffi] Heidelberg Univ, Dept Med 3, Div Cardiol, Heidelberg, Germany; [Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr, Freising Weihenstephan, Germany; [Klopstock, Thomas] Tech Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80290 Munich, Germany; [Pimentel, Juan Antonio Aguilar; Ollert, Markus] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Dermatol & Allergol Biederstein, D-80290 Munich, Germany; [Bohla, Alexander; Stoeger, Tobias; Yildrim, Ali Oender; Eickelberg, Oliver] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Lung Biol & Dis, Comprehens Pneumol Ctr, Neuherberg, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Chair Expt Genet, Freising Weihenstephan, Germany; [Wurst, Wolfgang] Tech Univ Munich, Chair Dev Biol, Freising Weihenstephan, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang] Deutsch Inst Neurodegenerat Erkrankungen Site Mun, Munich, Germany; [Wurst, Wolfgang] Munich Cluster Syst Neurol, Munich, Germany	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Clarkson University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Ruprecht Karls University Heidelberg; Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Kraus, P (corresponding author), Genome Inst Singapore, Singapore, Singapore.	stantonl@gis.a-star.edu.sg	Lufkin, Thomas/B-5352-2011; Fuchs, Helmut/M-7347-2014; Klingenspor, Martin/K-5033-2019; Gailus-Durner, Valerie/M-7337-2014; Becker, Lore/E-3717-2010; Klingenspor, Martin/D-6930-2011; Becker, Lore/AAJ-1203-2020; Lufkin, Thomas/AAG-7476-2019; Graw, Jochen/D-9336-2013; de Angelis, Martin Hrabe/F-5531-2012; Hölter, Sabine M./N-5868-2014; Kraus, Petra/I-5849-2014; Rozman, Jan/A-2540-2010; Stöger, Tobias/M-9861-2014	Lufkin, Thomas/0000-0002-7902-4771; Fuchs, Helmut/0000-0002-5143-2677; Klingenspor, Martin/0000-0002-4502-6664; Becker, Lore/0000-0002-6890-4984; Lufkin, Thomas/0000-0002-7902-4771; de Angelis, Martin Hrabe/0000-0002-7898-2353; Hölter, Sabine M./0000-0003-4878-5241; Kraus, Petra/0000-0002-6716-5550; Rozman, Jan/0000-0002-8035-8904; Stöger, Tobias/0000-0002-2790-0389; Xing, Xing/0000-0001-9682-815X; Wurst, Wolfgang/0000-0003-4422-7410; Garrett, Lillian/0000-0003-4880-7076; Adamski, Jerzy/0000-0001-9259-0199; Ollert, Markus W./0000-0002-8055-0103; Prehn, Cornelia/0000-0002-1274-4715; Graw, Jochen/0000-0003-0298-9660; Wolf, Eckhard/0000-0002-0430-9510	Agency for Science Technology and Research (A*STAR) Singapore; German Federal Ministry of Education and Research [01KX1012]; German Center for Diabetes Research (DZD); German Center for Vertigo and Balance Disorders [01EO 0901]; Helmholtz Alliance for Mental Health in Ageing Society [HA-215]	Agency for Science Technology and Research (A*STAR) Singapore(Agency for Science Technology & Research (A*STAR)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Center for Diabetes Research (DZD); German Center for Vertigo and Balance Disorders; Helmholtz Alliance for Mental Health in Ageing Society	This work was supported by the Agency for Science Technology and Research (A*STAR) Singapore. GMC researchers were funded by the German Federal Ministry of Education and Research (Infrafrontier grant 01KX1012), the German Center for Diabetes Research (DZD), the German Center for Vertigo and Balance Disorders (grant 01EO 0901), and by the Helmholtz Alliance for Mental Health in Ageing Society (HA-215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Brendolan A, 2007, BIOESSAYS, V29, P166, DOI 10.1002/bies.20528; Chu SG, 2010, J THROMB HAEMOST, V8, P148, DOI 10.1111/j.1538-7836.2009.03584.x; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Dames P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-39; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; Fuchs H, 2000, MAMM GENOME, V11, P528, DOI 10.1007/s003350010101; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Geyer MA, 1999, PSYCHOPHARMACOLOGY, V147, P11, DOI 10.1007/s002130051130; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Hagstrom SA, 2005, AM J MED GENET A, V138A, P95, DOI 10.1002/ajmg.a.30803; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Hever AM, 2006, CLIN GENET, V69, P459, DOI 10.1111/j.1399-0004.2006.00619.x; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Holter SM, 2011, NEUROMETHODS, V61, P109, DOI 10.1007/978-1-61779-298-4_7; Hojo M, 2000, DEVELOPMENT, V127, P2515; Jacobson L, 2005, ENDOCRIN METAB CLIN, V34, P271, DOI 10.1016/j.ecl.2005.01.003; Jones DL, 2011, J NEUROPHYSIOL, V105, P1984, DOI 10.1152/jn.00056.2011; Jung YJ, 2012, STEM CELLS, V30, P42, DOI 10.1002/stem.727; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kelberman D, 2008, J CLIN ENDOCR METAB, V93, P1865, DOI 10.1210/jc.2007-2337; Kraus P, 2013, DEV BIOL, V376, P224, DOI 10.1016/j.ydbio.2013.01.035; Kraus Petra, 2012, BMC Res Notes, V5, P232, DOI 10.1186/1756-0500-5-232; Kraus P, 2010, GENESIS, V48, P394, DOI 10.1002/dvg.20627; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Liang Y, 2012, NUCLEIC ACIDS RES, V40, P8721, DOI 10.1093/nar/gks611; Madsen GF, 2013, AUTISM RES OFFICIAL; Malisch JL, 2007, PHYSIOL BIOCHEM ZOOL, V80, P146, DOI 10.1086/508828; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Mao R, 2009, J NEURODEV DISORD, V1, P224, DOI 10.1007/s11689-009-9025-8; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsushima D, 2011, DEVELOPMENT, V138, P443, DOI 10.1242/dev.055178; Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Petryniak MA, 2007, NEURON, V55, P417, DOI 10.1016/j.neuron.2007.06.036; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Puk O, 2006, MAMM GENOME, V17, P851, DOI 10.1007/s00335-006-0019-5; Puk O, 2013, MOL VIS, V19, P877; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Ragge NK, 2005, AM J MED GENET A, V135A, P1, DOI 10.1002/ajmg.a.30642; Rathkolb Birgit, 2013, Curr Protoc Mouse Biol, V3, P69, DOI 10.1002/9780470942390.mo130043; Robledo RF, 2002, GENE DEV, V16, P1089, DOI 10.1101/gad.988402; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Thon JN, 2012, BLOOD, V120, P1552, DOI 10.1182/blood-2012-04-408724; Tribioli C, 2002, MECH DEVELOP, V118, P161, DOI 10.1016/S0925-4773(02)00220-4; van der Loo B, 1999, ARTERIOSCL THROM VAS, V19, P672, DOI 10.1161/01.ATV.19.3.672; Wang B, 2011, J COMP NEUROL, V519, P2320, DOI 10.1002/cne.22618; Wang ZX, 2007, STEM CELLS, V25, P2173, DOI 10.1634/stemcells.2007-0085; Wang ZX, 2007, J BIOL CHEM, V282, P12822, DOI 10.1074/jbc.M611814200; Watala C, 2005, PHARMACOL REP, V57, P42; Yoshikawa T, 2006, GENE EXPR PATTERNS, V6, P213, DOI 10.1016/j.modgep.2005.06.003; Yu HB, 2009, J BIOL CHEM, V284, P31327, DOI 10.1074/jbc.M109.016162; Zenteno JC, 2005, CLIN GENET, V68, P564, DOI 10.1111/j.1399-0004.2005.00518.x; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	63	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104568	10.1371/journal.pone.0104568	http://dx.doi.org/10.1371/journal.pone.0104568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111779	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100075
J	Merabishvili, M; Vandenheuvel, D; Kropinski, AM; Mast, J; De Vos, D; Verbeken, G; Noben, JP; Lavigne, R; Vaneechoutte, M; Pirnay, JP				Merabishvili, Maia; Vandenheuvel, Dieter; Kropinski, Andrew M.; Mast, Jan; De Vos, Daniel; Verbeken, Gilbert; Noben, Jean-Paul; Lavigne, Rob; Vaneechoutte, Mario; Pirnay, Jean-Paul			Characterization of Newly Isolated Lytic Bacteriophages Active against Acinetobacter baumannii	PLOS ONE			English	Article							MULTIDRUG-RESISTANT ACINETOBACTER; MICROBIAL GENE IDENTIFICATION; TRANSFER-RNA GENES; GENOMIC ANALYSIS; BETA-LACTAMASE; INFECTIONS; SEQUENCE; DEFINITION; ALIGNMENTS; CASUALTIES	Based on genotyping and host range, two newly isolated lytic bacteriophages, myovirus vB_AbaM_Acibel004 and podovirus vB_AbaP_Acibel007, active against Acinetobacter baumannii clinical strains, were selected from a new phage library for further characterization. The complete genomes of the two phages were analyzed. Both phages are characterized by broad host range and essential features of potential therapeutic phages, such as short latent period (27 and 21 min, respectively), high burst size (125 and 145, respectively), stability of activity in liquid culture and low frequency of occurrence of phage-resistant mutant bacterial cells. Genomic analysis showed that while Acibel004 represents a novel bacteriophage with resemblance to some unclassified Pseudomonas aeruginosa phages, Acibel007 belongs to the well-characterized genus of the Phikmvlikevirus. The newly isolated phages can serve as potential candidates for phage cocktails to control A. baumannii infections.	[Merabishvili, Maia; De Vos, Daniel; Verbeken, Gilbert; Pirnay, Jean-Paul] Queen Astrid Mil Hosp, Lab Mol & Cellular Technol LabMCT, Brussels, Belgium; [Merabishvili, Maia] Eliava Inst Bacteriophage Microbiol & Virol, Tbilisi, Georgia; [Merabishvili, Maia; Vaneechoutte, Mario] Univ Ghent, Fac Med & Hlth Sci, LBR, B-9000 Ghent, Belgium; [Vandenheuvel, Dieter; Lavigne, Rob] Katholieke Univ Leuven, Fac Biosci Engn, Lab Gene Technol, Leuven, Belgium; [Kropinski, Andrew M.] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Guelph, ON, Canada; [Kropinski, Andrew M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Mast, Jan] Vet & Agrochem Res Ctr, Electron Microscopy Unit, Brussels, Belgium; [Noben, Jean-Paul] Univ Ghent, Dept Pathol Bacteriol & Poultry Dis, Merelbeke, Belgium	Queen Astrid Military Hospital; Ghent University; KU Leuven; Public Health Agency of Canada; University of Guelph; Ghent University	Merabishvili, M (corresponding author), Queen Astrid Mil Hosp, Lab Mol & Cellular Technol LabMCT, Brussels, Belgium.	maia.merabishvili@mil.be	Kropinski, Andrew M/H-7130-2016; Merabishvili, Maia/GLU-4387-2022; Vaneechoutte, Mario/A-6189-2009; Noben, Jean-Paul/E-8066-2011	Kropinski, Andrew M/0000-0002-6871-6799; Merabishvili, Maia/0000-0002-2566-0772; Vaneechoutte, Mario/0000-0002-4586-203X; Noben, Jean-Paul/0000-0003-3368-5686; Vandenheuvel, Dieter/0000-0002-4398-1916; Mast, Jan/0000-0002-4879-3367; Lavigne, Rob/0000-0001-7377-1314; Pirnay, Jean-Paul/0000-0002-6863-5219	Royal Higher Institute for Defense of Belgium [MED 12]; FWO Vlaanderen [WO.022.09]; Agency for Innovation by Science and Technology (IWT) Flanders	Royal Higher Institute for Defense of Belgium; FWO Vlaanderen(FWO); Agency for Innovation by Science and Technology (IWT) Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by the Royal Higher Institute for Defense of Belgium (grant MED 12). The authors would like to acknowledge the Research community "Phagebiotics'' (WO.022.09) grant from the FWO Vlaanderen. The research of DV was funded by a Ph.D. grant of the Agency for Innovation by Science and Technology (IWT) Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott I, 2013, EXPERT REV ANTI-INFE, V11, P395, DOI [10.1586/ERI.13.21, 10.1586/eri.13.21]; Adams M., 1959, BACTERIOPHAGES, P443; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1980, SOV GUID PROD LIQ ST; [Anonymous], 1982, SOV GUID PROD COMB L; Appelmans R, 1921, CR SOC BIOL, V85, P1098; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailly-Bechet M, 2007, GENOME RES, V17, P1486, DOI 10.1101/gr.6649807; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Boo TW, 2009, J MED MICROBIOL, V58, P839, DOI 10.1099/jmm.0.008904-0; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks084; Carvalho KR, 2011, MEM I OSWALDO CRUZ, V106, P505, DOI 10.1590/S0074-02762011000400020; Ceyssens PJ, 2006, J BACTERIOL, V188, P6924, DOI 10.1128/JB.00831-06; Chang KC, 2011, GENOMICS, V97, P249, DOI 10.1016/j.ygeno.2011.01.002; Davis KA, 2005, EMERG INFECT DIS, V11, P1218, DOI 10.3201/1108.050103; Debarbieux L, 2010, J INFECT DIS, V201, P1096, DOI 10.1086/651135; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dizbay M, 2008, INT J ANTIMICROB AG, V32, P29, DOI 10.1016/j.ijantimicag.2008.02.016; Doi Y, 2012, INFECT CONT HOSP EP, V33, P642, DOI 10.1086/665713; Fishbain J, 2010, CLIN INFECT DIS, V51, P79, DOI 10.1086/653120; Gautheret D, 2001, J MOL BIOL, V313, P1003, DOI 10.1006/jmbi.2001.5102; Gundi VAKB, 2009, MICROBIOL-SGM, V155, P2333, DOI 10.1099/mic.0.026054-0; Hanlon GW, 2005, LETT APPL MICROBIOL, V41, P375, DOI 10.1111/j.1472-765X.2005.01791.x; Higgins PG, 2013, ANTIMICROB AGENTS CH, V57, P2121, DOI 10.1128/AAC.02413-12; Higgins PG, 2012, J MED MICROBIOL, V61, P137, DOI 10.1099/jmm.0.036046-0; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Huang GT, 2013, CURR MICROBIOL, V66, P535, DOI 10.1007/s00284-013-0308-7; Imberechts H, 1996, MICROB PATHOGENESIS, V21, P183, DOI 10.1006/mpat.1996.0053; Jeon J, 2012, J VIROL, V86, P12437, DOI 10.1128/JVI.02132-12; Jin J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-156; Jones A, 2006, LANCET INFECT DIS, V6, P317, DOI 10.1016/S1473-3099(06)70471-6; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kropinski AM, 2009, ENVIRON MICROBIOL, V11, P2775, DOI 10.1111/j.1462-2920.2009.01970.x; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lavigne R, 2006, MICROBIOL-SGM, V152, P529, DOI 10.1099/mic.0.28431-0; Lavigne R, 2004, BIOINFORMATICS, V20, P629, DOI 10.1093/bioinformatics/btg456; Lee B Y, 2011, Clin Microbiol Infect, V17, P1691, DOI 10.1111/j.1469-0691.2011.03491.x; Lee CN, 2011, APPL ENVIRON MICROB, V77, P6755, DOI 10.1128/AEM.05116-11; Li PZ, 2012, GENE, V507, P125, DOI 10.1016/j.gene.2012.07.029; Lin NT, 2010, RES MICROBIOL, V161, P308, DOI 10.1016/j.resmic.2010.03.007; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062933; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Manchanda V, 2010, J GLOB INFECT DIS, V2, P291, DOI 10.4103/0974-777X.68538; Meipariani A, 2003, Georgian patent, Patent No. [20,063,943 B, 20063943]; Merabishvili M, 2007, RES MICROBIOL, V158, P572, DOI 10.1016/j.resmic.2007.06.002; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Mihu MR, 2011, VIRULENCE, V2, P97, DOI 10.4161/viru.2.2.15061; Mikoulinskaia GV, 2007, DOKL BIOCHEM BIOPHYS, V412, P15, DOI 10.1134/S160767290701005X; Moak M, 2004, MOL MICROBIOL, V51, P1169, DOI 10.1046/j.1365-2958.2003.03894.x; Morello E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016963; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; Navon-Venezia S, 2007, J ANTIMICROB CHEMOTH, V59, P772, DOI 10.1093/jac/dkm018; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Petersen K, 2007, ANN SURG, V245, P803, DOI 10.1097/01.sla.0000251707.32332.c1; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pogue JM, 2013, EXPERT REV ANTI-INFE, V11, P383, DOI [10.1586/ERI.13.14, 10.1586/eri.13.14]; Popova AV, 2012, FEMS MICROBIOL LETT, V332, P40, DOI 10.1111/j.1574-6968.2012.02573.x; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Sambrook J, 2001, MOL CLONING LAB MANU; Shen GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046537; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; Uchiyama J, 2012, ARCH VIROL, V157, P733, DOI 10.1007/s00705-011-1210-x; Voroshilova N, 1992, Russian patent, Patent No. [2,036,232 C1, 2036232]; WEISS SB, 1968, P NATL ACAD SCI USA, V61, P114, DOI 10.1073/pnas.61.1.114; Yang HY, 2009, YONSEI MED J, V50, P764, DOI 10.3349/ymj.2009.50.6.764	73	67	69	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104853	10.1371/journal.pone.0104853	http://dx.doi.org/10.1371/journal.pone.0104853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111143	Green Submitted, Green Published, gold			2022-12-27	WOS:000341105100106
J	Brown, HH; Borchelt, DR				Brown, Hilda H.; Borchelt, David R.			Analysis of Mutant SOD1 Electrophoretic Mobility by Blue Native Gel Electrophoresis; Evidence for Soluble Multimeric Assemblies	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE 1; MOTOR-NEURON DEGENERATION; MOLECULAR-WEIGHT COMPLEXES; MONOMER-MISFOLDED SOD1; COPPER-BINDING-SITE; ALPHA-B-CRYSTALLIN; TRANSGENIC MICE; FAMILIAL ALS; WILD-TYPE	Mutations in superoxide dismutase 1 (SOD1) cause familial forms of amyotrophic lateral sclerosis (fALS). Disease causing mutations have diverse consequences on the activity and half-life of the protein, ranging from complete inactivity and short half-life to full activity and long-half-life. Uniformly, disease causing mutations induce the protein to misfold and aggregate and such aggregation tendencies are readily visualized by over-expression of the proteins in cultured cells. In the present study we have investigated the potential of using immunoblotting of proteins separated by Blue-Native gel electrophoresis (BNGE) as a means to identify soluble multimeric forms of mutant protein. We find that over-expressed wild-type human SOD1 (hSOD1) is generally not prone to form soluble high molecular weight entities that can be separated by BNGE. For ALS mutant SOD1, we observe that for all mutants examined (A4V, G37R, G85R, G93A, and L126Z), immunoblots of BN-gels separating protein solubilized by digitonin demonstrated varied amounts of high molecular weight immunoreactive entities. These entities lacked reactivity to ubiquitin and were partially dissociated by reducing agents. With the exception of the G93A mutant, these entities were not reactive to the C4F6 conformational antibody. Collectively, these data demonstrate that BNGE can be used to assess the formation of soluble multimeric assemblies of mutant SOD1.	[Brown, Hilda H.; Borchelt, David R.] Univ Florida, Coll Med,McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis,Dept Neurosci, SantaFe HealthCare Alzheimers Dis Res Ctr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Borchelt, DR (corresponding author), Univ Florida, Coll Med,McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis,Dept Neurosci, SantaFe HealthCare Alzheimers Dis Res Ctr, Gainesville, FL 32611 USA.	drb1@ufl.edu			National Institute of Neurological Disorders and Stroke [P01 NS049134]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS049134] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke - Grant number P01 NS049134. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers J, 2014, J NEUROCHEM, V128, P305, DOI 10.1111/jnc.12451; Ayers JI, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-55; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Choi JS, 2004, BIOCHEM BIOPH RES CO, V321, P574, DOI 10.1016/j.bbrc.2004.07.010; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; FRIDOVICH I, 1974, ADV ENZYMOL RAMB, V41, P35; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Jain MR, 2008, PROTEOM CLIN APPL, V2, P670, DOI 10.1002/prca.200780023; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2010, ARCH BIOCHEM BIOPHYS, V503, P175, DOI 10.1016/j.abb.2010.07.027; Karch CM, 2010, J NEUROCHEM, V113, P1092, DOI 10.1111/j.1471-4159.2010.06572.x; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; NISHIDA CR, 1994, P NATL ACAD SCI USA, V91, P9906, DOI 10.1073/pnas.91.21.9906; Ogihara NL, 1996, BIOCHEMISTRY-US, V35, P2316, DOI 10.1021/bi951930b; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Prudencio M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-77; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Rakhit R, 2007, NAT MED, V13, P754, DOI 10.1038/nm1559; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Roberts BLT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047838; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Seetharaman SV, 2010, BIOCHEMISTRY-US, V49, P5714, DOI 10.1021/bi100314n; Shi YH, 2012, PROTEIN SCI, V21, P1197, DOI 10.1002/pro.2107; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2005, HUM MOL GENET, V14, P2335, DOI 10.1093/hmg/ddi236; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Watanabe Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003497; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104; Zetterstrom P, 2013, NEUROMOL MED, V15, P147, DOI 10.1007/s12017-012-8204-z; Zetterstrom P, 2011, J BIOL CHEM, V286, P20130, DOI 10.1074/jbc.M111.218842; Zhang FJ, 2006, BBA-GEN SUBJECTS, V1760, P404, DOI 10.1016/j.bbagen.2005.11.024; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200	48	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104583	10.1371/journal.pone.0104583	http://dx.doi.org/10.1371/journal.pone.0104583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121776	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000045
J	van Dijk, JH; Moss, WJ; Hamangaba, F; Munsanje, B; Sutcliffe, CG				van Dijk, Janneke H.; Moss, William J.; Hamangaba, Francis; Munsanje, Bornface; Sutcliffe, Catherine G.			Scaling-Up Access to Antiretroviral Therapy for Children: A Cohort Study Evaluating Care and Treatment at Mobile and Hospital-Affiliated HIV Clinics in Rural Zambia	PLOS ONE			English	Article							TREATMENT PROGRAM; DECENTRALIZATION; PROVISION; ADHERENCE; SERVICES; AFRICA; MODEL	Background: Travel time and distance are barriers to care for HIV-infected children in rural sub-Saharan Africa. Decentralization of care is one strategy to scale-up access to antiretroviral therapy (ART), but few programs have been evaluated. We compared outcomes for children receiving care in mobile and hospital-affiliated HIV clinics in rural Zambia. Methods: Outcomes were measured within an ongoing cohort study of HIV-infected children seeking care at Macha Hospital, Zambia from 2007 to 2012. Children in the outreach clinic group received care from the Macha HIV clinic and transferred to one of three outreach clinics. Children in the hospital-affiliated clinic group received care at Macha HIV clinic and reported Macha Hospital as the nearest healthcare facility. Results: Seventy-seven children transferred to the outreach clinics and were included in the analysis. Travel time to the outreach clinics was significantly shorter and fewer caretakers used public transportation, resulting in lower transportation costs and fewer obstacles accessing the clinic. Some caretakers and health care providers reported inferior quality of service provision at the outreach clinics. Sixty-eight children received ART at the outreach clinics and were compared to 41 children in the hospital-affiliated clinic group. At ART initiation, median age, weight-for-age z-scores (WAZ) and CD4(+) T-cell percentages were similar for children in the hospital-affiliated and outreach clinic groups. Children in both groups experienced similar increases in WAZ and CD4(+) T-cell percentages. Conclusions: HIV care and treatment can be effectively delivered to HIV-infected children at rural health centers through mobile ART teams, removing potential barriers to uptake and retention. Outreach teams should be supported to increase access to HIV care and treatment in rural areas.	[van Dijk, Janneke H.; Hamangaba, Francis; Munsanje, Bornface] Macha Res Trust, Macha Hosp, Choma, Zambia; [van Dijk, Janneke H.] Erasmus Univ, Dept Immunol & Infect Dis, Rotterdam, Netherlands; [Moss, William J.; Sutcliffe, Catherine G.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA	Erasmus University Rotterdam; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sutcliffe, CG (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	csutcli1@jhu.edu		Sutcliffe, Catherine/0000-0001-8512-8326	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC), Global AIDS Program [5U2GPS001930-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC), Global AIDS Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was made possible by support from the President's Emergency Plan for AIDS Relief (PEPFAR) through Cooperative Agreement 5U2GPS001930-05 from the Department of Health and Human Services (DHHS)/Centers for Disease Control and Prevention (CDC), Global AIDS Program. The findings and conclusions included in its content are solely the responsibility of the author (s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention/Agency for Toxic Substances and Disease Registry. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NAT MOB HIV SERV GUI; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Barth RE, 2008, EUR J CLIN MICROBIOL, V27, P977, DOI 10.1007/s10096-008-0534-2; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bock P, 2008, T ROY SOC TROP MED H, V102, P905, DOI 10.1016/j.trstmh.2008.06.010; Bolton-Moore C, 2007, JAMA-J AM MED ASSOC, V298, P1888, DOI 10.1001/jama.298.16.1888; Boyer S, 2012, HEALTH POLICY PLANN, V27, P301, DOI 10.1093/heapol/czr039; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; DHS, 2002, 200102 DHS; Fatti G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012888; Fayorsey RN, 2013, JAIDS-J ACQ IMM DEF, V62, pE124, DOI 10.1097/QAI.0b013e3182869558; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Haberer JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018505; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Harries AD, 2008, T ROY SOC TROP MED H, V102, P310, DOI 10.1016/j.trstmh.2008.01.005; Humphreys CP, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-229; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Janssen N, 2010, ARCH DIS CHILD, V95, P414, DOI 10.1136/adc.2009.169367; Kipp W, 2010, CURR HIV RES, V8, P179, DOI 10.2174/157016210790442722; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; McGuire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038044; Ministry of Health Republic of Zambia, 2010, ZAMB GUID ANT THER H; Morris MB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-5; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; National AIDS Council Zambia Ministry of Health, 2012, ZAMB COUNTR REP MON; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Sutcliffe CG, 2010, PEDIATR INFECT DIS J, V29, P849, DOI 10.1097/INF.0b013e3181e753a8; Tene G, 2013, PEDIAT INFECT DIS J; Torpey KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002204; United Nations Development Program, 2011, PROJ DOC SCAL UP PRE; van Dijk JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019006; van Dijk JH, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-169; van Griensven J, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-39; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; WHO Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA, DOI 10.1093/tropej/fmn002; WHO/UNAIDS/UNICEF, 2012, GLOBAL HIV AIDS RESP; World Health Organisation, 2006, ANT THER HIV INF INF; World Health Organization, 2008, TASK SHIFT RAT RED T	41	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104884	10.1371/journal.pone.0104884	http://dx.doi.org/10.1371/journal.pone.0104884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122213	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000069
J	Yang, SS; Murphy, RL; Morishige, DT; Klein, PE; Rooney, WL; Mullet, JE				Yang, Shanshan; Murphy, Rebecca L.; Morishige, Daryl T.; Klein, Patricia E.; Rooney, William L.; Mullet, John E.			Sorghum Phytochrome B Inhibits Flowering in Long Days by Activating Expression of SbPRR37 and SbGHD7, Repressors of SbEHD1, SbCN8 and SbCN12	PLOS ONE			English	Article							PSEUDO-RESPONSE-REGULATOR; PHOTOPERIOD SENSITIVITY; NATURAL VARIATION; ARABIDOPSIS; GENE; LIGHT; PROTEIN; TIME; CONSTANS; GROWTH	Light signaling by phytochrome B in long days inhibits flowering in sorghum by increasing expression of the long day floral repressors PSEUDORESPONSE REGULATOR PROTEIN (SbPRR37, Ma1) and GRAIN NUMBER, PLANT HEIGHT AND HEADING DATE 7 (SbGHD7, Ma6). SbPRR37 and SbGHD7 RNA abundance peaks in the morning and in the evening of long days through coordinate regulation by light and output from the circadian clock. 58 M, a phytochrome B deficient (phyB-1, ma3(R)) genotype, flowered similar to 60 days earlier than 100 M (PHYB, Ma3) in long days and similar to 11 days earlier in short days. Populations derived from 58 M (Ma1, ma3(R), Ma5, ma6) and R. 07007 (Ma1, Ma3, ma5, Ma6) varied in flowering time due to QTL aligned to PHYB/phyB-1 (Ma3), Ma5, and GHD7/ghd7-1 (Ma6). PHYC was proposed as a candidate gene for Ma5 based on alignment and allelic variation. PHYB and Ma5 (PHYC) were epistatic to Ma1 and Ma6 and progeny recessive for either gene flowered early in long days. Light signaling mediated by PhyB was required for high expression of the floral repressors SbPRR37 and SbGHD7 during the evening of long days. In 100 M (PHYB) the floral activators SbEHD1, SbCN8 and SbCN12 were repressed in long days and de-repressed in short days. In 58 M (phyB-1) these genes were highly expressed in long and short days. Furthermore, SbCN15, the ortholog of rice Hd3a (FT), is expressed at low levels in 100 M but at high levels in 58 M (phyB-1) regardless of day length, indicating that PhyB regulation of SbCN15 expression may modify flowering time in a photoperiod-insensitive manner.	[Yang, Shanshan; Murphy, Rebecca L.; Morishige, Daryl T.; Mullet, John E.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Klein, Patricia E.] Texas A&M Univ, Dept Hort Sci, College Stn, TX 77843 USA; [Klein, Patricia E.] Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX USA; [Rooney, William L.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Mullet, JE (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	jmullet@neo.tamu.edu	Yang, Shanshan/G-9513-2018	Murphy, Rebecca/0000-0002-1156-4560	Pioneer Hi-Bred International, Inc.; Ceres Inc.; Perry Adkisson Chair in Agricultural Biology	Pioneer Hi-Bred International, Inc.; Ceres Inc.; Perry Adkisson Chair in Agricultural Biology	This research was supported by Pioneer Hi-Bred International, Inc., Ceres Inc., and the Perry Adkisson Chair in Agricultural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; [Anonymous], 1974, SORGHUM IMPROVEMENT; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Childs KL, 1997, PLANT PHYSIOL, V113, P611, DOI 10.1104/pp.113.2.611; CHURCHILL GA, 1994, GENETICS, V138, P963; Clack T, 2009, PLANT CELL, V21, P786, DOI 10.1105/tpc.108.065227; Danilevskaya ON, 2008, PLANT PHYSIOL, V146, P250, DOI 10.1104/pp.107.109538; Distelfeld A, 2010, MOL GENET GENOMICS, V283, P223, DOI 10.1007/s00438-009-0510-2; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Greenup A, 2009, ANN BOT-LONDON, V103, P1165, DOI 10.1093/aob/mcp063; Hanumappa M, 1999, PLANT PHYSIOL, V119, P1033, DOI 10.1104/pp.119.3.1033; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; Itoh H, 2010, NAT GENET, V42, P635, DOI 10.1038/ng.606; Izawa T, 2002, GENE DEV, V16, P2006, DOI 10.1101/gad.999202; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Koo BH, 2013, MOL PLANT, V6, P1877, DOI 10.1093/mp/sst088; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Mace ES, 2013, THEOR APPL GENET, V126, P1377, DOI 10.1007/s00122-013-2059-z; Meng X, 2011, PLANT CELL, V23, P942, DOI 10.1105/tpc.110.081406; Monte E, 2003, PLANT CELL, V15, P1962, DOI 10.1105/tpc.012971; Morgan PW, 2000, WILEY SERIES CROP SC, P240; Morishige DT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-448; Murphy RL, 2011, P NATL ACAD SCI USA, V108, P16469, DOI 10.1073/pnas.1106212108; Murphy RL, 2014, PLANT GENOM IN PRESS; Nagatani A, 2010, CURR OPIN PLANT BIOL, V13, P565, DOI 10.1016/j.pbi.2010.07.002; Nakamichi N, 2010, PLANT CELL, V22, P594, DOI 10.1105/tpc.109.072892; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Olson SN, 2012, BIOFUEL BIOPROD BIOR, V6, P640, DOI 10.1002/bbb.1357; Osugi A, 2011, PLANT PHYSIOL, V157, P1128, DOI 10.1104/pp.111.181792; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pruneda-Paz JL, 2010, TRENDS PLANT SCI, V15, P259, DOI 10.1016/j.tplants.2010.03.003; QUAIL PH, 1994, PLANT CELL, V6, P468, DOI 10.1105/tpc.6.4.468; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; Rooney WL, 1999, CROP SCI, V39, P397, DOI 10.2135/cropsci1999.0011183X0039000200016x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Srikanth A, 2011, CELL MOL LIFE SCI, V68, P2013, DOI 10.1007/s00018-011-0673-y; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tsuji H, 2011, CURR OPIN PLANT BIOL, V14, P45, DOI 10.1016/j.pbi.2010.08.016; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Vigouroux Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019563; Wang S, 2012, WINDOWS QTL CARTOGRA; Welch SM, 2004, MOD GEN NETW CONTR T, P1; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yang SS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-148; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473	54	39	44	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105352	10.1371/journal.pone.0105352	http://dx.doi.org/10.1371/journal.pone.0105352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122453	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000118
J	Heng, LJ; Huang, B; Guo, H; Ma, LT; Yuan, WX; Song, J; Wang, P; Xu, GZ; Gao, GD				Heng, Li-Jun; Huang, Bo; Guo, Heng; Ma, Lian-Ting; Yuan, Wei-Xin; Song, Jian; Wang, Peng; Xu, Guo-Zheng; Gao, Guo-Dong			Blocking TRPV1 in Nucleus Accumbens Inhibits Persistent Morphine Conditioned Place Preference Expression in Rats	PLOS ONE			English	Article							SYNAPTIC-TRANSMISSION; DOPAMINERGIC-NEURONS; GLUTAMATE RELEASE; MESSENGER-RNA; ION-CHANNEL; NULL MICE; RECEPTOR; CAPSAICIN; ACTIVATION; HEROIN	The function of TRPV1 (transient receptor potential vanilloid subfamily, member 1) in the central nervous system is gradually elucidated. It has been recently proved to be expressed in nucleus accumbens (NAc), a region playing an essential role in mediating opioid craving and taking behaviors. Based on the general role of TRPV1 antagonist in blocking neural over-excitability by both pre- and post-synaptic mechanisms, TRPV1 antagonist capsazepine (CPZ) was tested for its ability to prohibit persistent opioid craving in rats. In the present study, we assessed the expression of TRPV1 in nucleus accumbens and investigated the effect of CPZ in bilateral nucleus accumbens on persistent morphine conditioned place preference (mCPP) in rats. We also evaluated the side-effect of CPZ on activity by comparing cross-beam times between groups. We found that morphine conditioned place preference increased the TRPV1 expression and CPZ attenuated morphine conditioned place preference in a dose-dependent and target-specific manner after both short-and long-term spontaneous withdrawal, reflected by the reduction of the increased time in morphine-paired side. CPZ (10 nM) could induce prolonged and stable inhibition of morphine conditioned place preference expression. More importantly, CPZ did not cause dysfunction of activity in the subjects tested, which indicates the inhibitory effect was not obtained at the sacrifice of regular movement. Collectively, these results indicated that injection of TRPV1 antagonist in nucleus accumbens is capable of attenuating persistent morphine conditioned place preference without affecting normal activity. Thus, TRPV1 antagonist is one of the promising therapeutic drugs for the treatment of opioid addiction.	[Heng, Li-Jun; Huang, Bo; Yuan, Wei-Xin; Wang, Peng; Gao, Guo-Dong] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China; [Heng, Li-Jun; Ma, Lian-Ting; Song, Jian; Wang, Peng; Xu, Guo-Zheng] Guangzhou Mil Command, Wuhan Gen Hosp, Dept Neurosurg, Wuhan, Hubei, Peoples R China; [Guo, Heng] PLA Chengdu Gen Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China	Air Force Military Medical University	Xu, GZ (corresponding author), Guangzhou Mil Command, Wuhan Gen Hosp, Dept Neurosurg, Wuhan, Hubei, Peoples R China.	xu-gz@163.com; gaogd@outlook.com			National Natural Science Foundation of China [31070940, 31100778]; Military 12th Five-year Program of China [BWS11J006]; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State Education Ministry [SRFROCS1711]; Tangdu Outstanding Talents Surporting Project [Tangdu5084]; China Postdoctoral Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Military 12th Five-year Program of China; Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry; Tangdu Outstanding Talents Surporting Project; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work is supported by National Natural Science Foundation of China (31070940 to GDG, 31100778 to LJH), Military 12th Five-year Program of China (BWS11J006 to GZX), Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (SRFROCS1711 to LJH), Tangdu Outstanding Talents Surporting Project (Tangdu5084 to LJH) and China Postdoctoral Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk P, 2012, BRAIN RES, V1444, P45, DOI 10.1016/j.brainres.2012.01.030; Aguiar DC, 2009, PSYCHOPHARMACOLOGY, V205, P217, DOI 10.1007/s00213-009-1532-5; Alcantara AA, 2011, SYNAPSE, V65, P309, DOI 10.1002/syn.20849; Badiani A, 2011, NAT REV NEUROSCI, V12, P685, DOI 10.1038/nrn3104; Bajo M, 2006, J NEUROSCI RES, V83, P532, DOI 10.1002/jnr.20756; Benninger F, 2008, NEUROCHEM INT, V52, P89, DOI 10.1016/j.neuint.2007.06.008; Bossert JM, 2006, NEUROPSYCHOPHARMACOL, V31, P2197, DOI 10.1038/sj.npp.1300977; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cristino L, 2006, NEUROSCIENCE, V139, P1405, DOI 10.1016/j.neuroscience.2006.02.074; de Lago E, 2004, BRAIN RES, V1007, P152, DOI 10.1016/j.brainres.2004.02.016; Di Marzo V, 2001, EUR J PHARMACOL, V420, P123, DOI 10.1016/S0014-2999(01)01012-3; Esmaeili MH, 2012, PHARMACOL BIOCHEM BE, V102, P249, DOI 10.1016/j.pbb.2012.04.015; Gass JT, 2008, BIOCHEM PHARMACOL, V75, P218, DOI 10.1016/j.bcp.2007.06.039; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Ho Karen W, 2012, Am J Neurodegener Dis, V1, P1; Jin YH, 2004, J NEUROSCI, V24, P4709, DOI 10.1523/JNEUROSCI.0753-04.2004; Koya E, 2006, J NEUROCHEM, V98, P905, DOI 10.1111/j.1471-4159.2006.03917.x; Kuntz KL, 2008, PHARMACOL BIOCHEM BE, V90, P349, DOI 10.1016/j.pbb.2008.03.019; LaLumiere RT, 2008, J NEUROSCI, V28, P3170, DOI 10.1523/JNEUROSCI.5129-07.2008; Lee J, 2006, NEUROPHARMACOLOGY, V51, P557, DOI 10.1016/j.neuropharm.2006.04.016; Li DP, 2004, J NEUROPHYSIOL, V92, P1807, DOI 10.1152/jn.00171.2004; Li YQ, 2008, J NEUROSCI, V28, P13248, DOI 10.1523/JNEUROSCI.3027-08.2008; Ma YY, 2007, EXP NEUROL, V203, P309, DOI 10.1016/j.expneurol.2006.08.014; Marinelli S, 2005, NEUROPSYCHOPHARMACOL, V30, P864, DOI 10.1038/sj.npp.1300615; Marinelli S, 2003, J NEUROSCI, V23, P3136; Marinelli S, 2002, J PHYSIOL-LONDON, V543, P531, DOI 10.1113/jphysiol.2002.022863; Matta JA, 2011, CURR PHARM BIOTECHNO, V12, P95; Mezey E, 2000, P NATL ACAD SCI USA, V97, P3655, DOI 10.1073/pnas.060496197; Micale V, 2009, NEUROBIOL DIS, V36, P70, DOI 10.1016/j.nbd.2009.06.015; Milekic MH, 2006, J NEUROSCI, V26, P3010, DOI 10.1523/JNEUROSCI.4818-05.2006; Mori F, 2012, J NEUROSCI, V32, P873, DOI 10.1523/JNEUROSCI.2531-11.2012; Musella A, 2009, MOL CELL NEUROSCI, V40, P89, DOI 10.1016/j.mcn.2008.09.001; Nguyen TL, 2010, BRIT J ANAESTH, V105, P668, DOI 10.1093/bja/aeq212; OBrien CP, 1997, SCIENCE, V278, P66, DOI 10.1126/science.278.5335.66; Panlilio LV, 2009, PSYCHOPHARMACOLOGY, V203, P529, DOI 10.1007/s00213-008-1399-x; Roberts JC, 2004, BRAIN RES, V995, P176, DOI 10.1016/j.brainres.2003.10.001; Sasamura T, 1998, NEUROREPORT, V9, P2045, DOI 10.1097/00001756-199806220-00025; Shen HW, 2011, P NATL ACAD SCI USA, V108, P19407, DOI 10.1073/pnas.1112052108; Siggins GR, 2003, ANN NY ACAD SCI, V1003, P196, DOI 10.1196/annals.1300.012; Szallasi A, 1999, PHARMACOL REV, V51, P159; Tian YH, 2010, NEUROSCI LETT, V472, P61, DOI 10.1016/j.neulet.2010.01.058; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; Tzavara ET, 2006, BIOL PSYCHIAT, V59, P508, DOI 10.1016/j.biopsych.2005.08.019; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Wu XB, 2012, J NEUROSCI RES, V90, P1270, DOI 10.1002/jnr.23025; Xing JH, 2007, J NEUROPHYSIOL, V97, P503, DOI 10.1152/jn.01023.2006; Yokoyama T, 2010, J NEUROSCI, V30, P876, DOI 10.1523/JNEUROSCI.2986-09.2010; Yuan WX, 2013, BRAIN RES, V1531, P102, DOI 10.1016/j.brainres.2013.07.047	48	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104546	10.1371/journal.pone.0104546	http://dx.doi.org/10.1371/journal.pone.0104546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118895	Green Published, gold			2022-12-27	WOS:000340900600066
J	Layer, EH; Kennedy, CE; Beckham, SW; Mbwambo, JK; Likindikoki, S; Davis, WW; Kerrigan, DL; Brahmbhatt, H				Layer, Erica H.; Kennedy, Caitlin E.; Beckham, Sarah W.; Mbwambo, Jessie K.; Likindikoki, Samuel; Davis, Wendy W.; Kerrigan, Deanna L.; Brahmbhatt, Heena		LTC Tanzania Collaborat Study Team	Multi-Level Factors Affecting Entry into and Engagement in the HIV Continuum of Care in Iringa, Tanzania	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; HEALTH-CARE; HOUSEHOLD MEMBERS; HIV/AIDS STIGMA; SOCIAL STIGMA; SOUTH-AFRICA; BARRIERS; PEOPLE; INFECTION	Progression through the HIV continuum of care, from HIV testing to lifelong retention in antiretroviral therapy (ART) care and treatment programs, is critical to the success of HIV treatment and prevention efforts. However, significant losses occur at each stage of the continuum and little is known about contextual factors contributing to disengagement at these stages. This study sought to explore multi-level barriers and facilitators influencing entry into and engagement in the continuum of care in Iringa, Tanzania. We used a mixed-methods study design including facility-based assessments and interviews with providers and clients of HIV testing and treatment services; interviews, focus group discussions and observations with community-based providers and clients of HIV care and support services; and longitudinal interviews with men and women living with HIV to understand their trajectories in care. Data were analyzed using narrative analysis to identify key themes across levels and stages in the continuum of care. Participants identified multiple compounding barriers to progression through the continuum of care at the individual, facility, community and structural levels. Key barriers included the reluctance to engage in HIV services while healthy, rigid clinic policies, disrespectful treatment from service providers, stock-outs of supplies, stigma and discrimination, alternate healing systems, distance to health facilities and poverty. Social support from family, friends or support groups, home-based care providers, income generating opportunities and community mobilization activities facilitated engagement throughout the HIV continuum. Findings highlight the complex, multi-dimensional dynamics that individuals experience throughout the continuum of care and underscore the importance of a holistic and multi-level perspective to understand this process. Addressing barriers at each level is important to promoting increased engagement throughout the continuum.	[Layer, Erica H.; Kerrigan, Deanna L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA; [Kennedy, Caitlin E.; Beckham, Sarah W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Mbwambo, Jessie K.; Likindikoki, Samuel] Muhimbili Univ Hlth & Allied Sci, Dept Psychiat, Dar Es Salaam, Tanzania; [Davis, Wendy W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Brahmbhatt, Heena] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Muhimbili University of Health & Allied Sciences; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Layer, EH (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA.	erica.layer@gmail.com	Beckham, S Wilson/AAD-1992-2021; Harding, Richard/G-9729-2012	Beckham, S Wilson/0000-0002-9694-3091; 	USAID; US Agency for International Development [GHH-I-00-07-00032-00]; President's Emergency Plan for AIDS Relief; Open Access Promotion Fund of the Johns Hopkins University Libraries; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI102623] Funding Source: NIH RePORTER	USAID(United States Agency for International Development (USAID)); US Agency for International Development(United States Agency for International Development (USAID)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Open Access Promotion Fund of the Johns Hopkins University Libraries; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by USAID vertical bar Project SEARCH, Task Order No. 2, funded by the US Agency for International Development under Contract No. GHH-I-00-07-00032-00, beginning 30 September 2008, and supported by the President's Emergency Plan for AIDS Relief. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, 2013 UNAIDS REP GLOB; [Anonymous], 2013, 2012 TANZ POP HOUS C; Apondi R, 2007, JAIDS-J ACQ IMM DEF, V44, P71, DOI 10.1097/01.qai.0000243113.29412.dd; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Bogart LM, 2008, AIDS BEHAV, V12, P244, DOI 10.1007/s10461-007-9231-x; Bogart LM, 2013, AIDS CARE, V25, P843, DOI 10.1080/09540121.2012.729808; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Campbell C, 2011, INT J NURS STUD, V48, P175, DOI 10.1016/j.ijnurstu.2010.07.019; CIA, WORLD FACTBOOK; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; d'Oliveira AFPL, 2002, LANCET, V359, P1681, DOI 10.1016/S0140-6736(02)08592-6; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; Feldacker C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050871; Ferguson L, 2012, TROP MED INT HEALTH, V17, P564, DOI 10.1111/j.1365-3156.2012.02958.x; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Govindasamy D, 2011, JAIDS-J ACQ IMM DEF, V58, P344, DOI 10.1097/QAI.0b013e31822e0c4c; Harding R, 2013, PALLIATIVE MED, V28, P9; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jewkes R, 1998, SOC SCI MED, V47, P1781, DOI 10.1016/S0277-9536(98)00240-8; Kimaiyo S, 2010, East Afr Med J, V87, P100; Kipp W, 2010, CURR HIV RES, V8, P179, DOI 10.2174/157016210790442722; Kohler PK, 2011, AIDS, V25, P1657, DOI 10.1097/QAD.0b013e32834957fd; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Lessells RJ, 2011, JAIDS-J ACQ IMM DEF, V56, pE79, DOI 10.1097/QAI.0b013e3182075ae2; Lugada E, 2010, JAIDS-J ACQ IMM DEF, V55, P245, DOI 10.1097/QAI.0b013e3181e9e069; MacPherson P, 2013, HOME ASSESSMENT INIT; MacPherson P, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.18020; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Manongi RN, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-50; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Mpiima D, 2012, SUCCESSFUL COMMUNITY; Mshana GH, 2006, AIDS PATIENT CARE ST, V20, P649, DOI 10.1089/apc.2006.20.649; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Muhamadi L, 2010, HEALTH POLICY, V97, P187, DOI 10.1016/j.healthpol.2010.06.003; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; Naar-King S, 2007, AIDS PATIENT CARE ST, V21, pS40, DOI 10.1089/apc.2007.9988; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Prachakul W, 2007, J ASSOC NURSE AIDS C, V18, P67, DOI 10.1016/j.jana.2007.08.002; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Rintamaki LS, 2006, AIDS PATIENT CARE ST, V20, P359, DOI 10.1089/apc.2006.20.359; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Sayles JN, 2007, J URBAN HEALTH, V84, P814, DOI 10.1007/s11524-007-9220-4; Schouten Erik J, 2011, J Int AIDS Soc, V14 Suppl 1, pS4, DOI 10.1186/1758-2652-14-S1-S4; Sengupta S, 2011, AIDS BEHAV, V15, P1075, DOI 10.1007/s10461-010-9847-0; Stangl AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18734; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Tanzania Ministry of Health and Social Welfare National AIDS Control Program, 2012, NAT GUID MAN HIV AID; Tayler-Smith K, 2010, T ROY SOC TROP MED H, V104, P313, DOI 10.1016/j.trstmh.2010.01.007; Tomori C, 2013, AIDS CARE; Topp Stephanie M, 2012, J Int AIDS Soc, V15, P17352, DOI 10.7448/IAS.15.2.17352; Tsai AC, 2013, ANN BEHAV MED, V46, P285, DOI 10.1007/s12160-013-9514-6; Tumwebaze H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051620; Turan JM, 2011, AIDS BEHAV, V15, P1111, DOI 10.1007/s10461-010-9798-5; UNAIDS, 2013, GETT ZER HIV E SO AF; Vanable PA, 2006, AIDS BEHAV, V10, P473, DOI 10.1007/s10461-006-9099-1; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; Were WA, 2006, JAIDS-J ACQ IMM DEF, V43, P91, DOI 10.1097/01.qai.0000225021.81384.28; Wools-Kaloustian KK, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-22; Wynberg E, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18809; Yakong VN, 2010, J ADV NURS, V66, P2431, DOI 10.1111/j.1365-2648.2010.05404.x	63	99	100	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104961	10.1371/journal.pone.0104961	http://dx.doi.org/10.1371/journal.pone.0104961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9BM	25119665	Green Submitted, gold, Green Published			2022-12-27	WOS:000340900600107
J	Wang, CZ; Chen, YJ; Wang, YH; Yeh, ML; Huang, MH; Ho, ML; Liang, JI; Chen, CH				Wang, Chau-Zen; Chen, Yi-Jen; Wang, Yan-Hsiung; Yeh, Ming-Long; Huang, Mao-Hsiung; Ho, Mei-Ling; Liang, Jen-I; Chen, Chia-Hsin			Low-Level Laser Irradiation Improves Functional Recovery and Nerve Regeneration in Sciatic Nerve Crush Rat Injury Model	PLOS ONE			English	Article							ELECTRICAL-STIMULATION PROMOTES; NON-SERRATED CLAMP; MORPHOLOGICAL ASSESSMENT; AXONAL REGENERATION; SCHWANN-CELLS; 780 NM; THERAPY; INDEX; REPAIR; PHOTOTHERAPY	The development of noninvasive approaches to facilitate the regeneration of post-traumatic nerve injury is important for clinical rehabilitation. In this study, we investigated the effective dose of noninvasive 808-nm low-level laser therapy (LLLT) on sciatic nerve crush rat injury model. Thirty-six male Sprague Dawley rats were divided into 6 experimental groups: a normal group with or without 808-nm LLLT at 8 J/cm(2) and a sciatic nerve crush injury group with or without 808-nm LLLT at 3, 8 or 15 J/cm(2). Rats were given consecutive transcutaneous LLLT at the crush site and sacrificed 20 days after the crush injury. Functional assessments of nerve regeneration were analyzed using the sciatic functional index (SFI) and hindlimb range of motion (ROM). Nerve regeneration was investigated by measuring the myelin sheath thickness of the sciatic nerve using transmission electron microscopy (TEM) and by analyzing the expression of growth-associated protein 43 (GAP43) in sciatic nerve using western blot and immunofluorescence staining. We found that sciatic-injured rats that were irradiated with LLLT at both 3 and 8 J/cm(2) had significantly improved SFI but that a significant improvement of ROM was only found in rats with LLLT at 8 J/cm(2). Furthermore, the myelin sheath thickness and GAP43 expression levels were significantly enhanced in sciatic nerve-crushed rats receiving 808-nm LLLT at 3 and 8 J/cm(2). Taken together, these results suggest that 808-nm LLLT at a low energy density (3 J/cm(2) and 8 J/cm(2)) is capable of enhancing sciatic nerve regeneration following a crush injury.	[Wang, Chau-Zen; Ho, Mei-Ling] Kaohsiung Med Univ, Dept Physiol, Kaohsiung, Taiwan; [Wang, Chau-Zen; Wang, Yan-Hsiung; Ho, Mei-Ling; Chen, Chia-Hsin] Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Chen, Yi-Jen; Huang, Mao-Hsiung; Chen, Chia-Hsin] Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Yi-Jen; Chen, Chia-Hsin] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Wang, Yan-Hsiung] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung, Taiwan; [Yeh, Ming-Long; Liang, Jen-I] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Huang, Mao-Hsiung; Chen, Chia-Hsin] Kaohsiung Med Univ, Coll Med, Dept Phys Med & Rehabil, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; National Cheng Kung University; Kaohsiung Medical University	Chen, CH (corresponding author), Kaohsiung Med Univ, Orthopaed Res Ctr, Kaohsiung, Taiwan.	chchen@kmu.edu.tw	Wang, Yan-Hsiung/ABD-4004-2020	Wang, Yan-Hsiung/0000-0001-8161-7472; Chen, Yi-Jen/0000-0002-5178-2335; Chen, Chia-Hsin/0000-0002-6557-9848; Ho, Mei-Ling/0000-0001-8064-8488	National Health Research Institutes (NHRI-EX) [102-9914EC]; National Science Council [101-2314-B-037-002-MY3]; Kaohsiung Medical University Research Foundation, Taiwan [KMU-Q98007]	National Health Research Institutes (NHRI-EX); National Science Council(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Research Foundation, Taiwan	This work was supported by grants from the National Health Research Institutes (NHRI-EX 102-9914EC), the National Science Council (101-2314-B-037-002-MY3) and the Kaohsiung Medical University Research Foundation (KMU-Q98007), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Majed AA, 2000, J NEUROSCI, V20, P2602; Allodi I, 2012, PROG NEUROBIOL, V98, P16, DOI 10.1016/j.pneurobio.2012.05.005; Bae CS, 2004, IN VIVO, V18, P489; Bagis S, 2003, LASER MED SCI, V18, P83, DOI 10.1007/s10103-003-0258-6; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Bannaga Ahmed, 2002, J Huazhong Univ Sci Technolog Med Sci, V22, P135; Barbosa RI, 2010, LASER MED SCI, V25, P423, DOI 10.1007/s10103-009-0750-8; Brosseau L., 2005, COCHRANE DB SYST REV, V19; Chen YS, 2005, MICROSURG, V25, P83, DOI 10.1002/micr.20079; Chow RT, 2009, LANCET, V374, P1897, DOI 10.1016/S0140-6736(09)61522-1; Colen Kari L, 2009, Plast Reconstr Surg, V124, pe386, DOI 10.1097/PRS.0b013e3181bf8430; Camara CND, 2011, ACTA CIR BRAS, V26, P12, DOI 10.1590/S0102-86502011000100004; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Erba P, 2010, J PLAST RECONSTR AES, V63, P20; Geremia NM, 2007, EXP NEUROL, V205, P347, DOI 10.1016/j.expneurol.2007.01.040; Gigo-Benato D, 2005, MUSCLE NERVE, V31, P694, DOI 10.1002/mus.20305; Gigo-Benato D, 2004, LASER MED SCI, V19, P57, DOI 10.1007/s10103-004-0300-3; Gigo-Benato D, 2010, LASER SURG MED, V42, P673, DOI 10.1002/lsm.20978; Gordon T, 2009, MOTOR CONTROL, V13, P412, DOI 10.1123/mcj.13.4.412; Gravvanis AI, 2007, ACTA NEUROCHIR SUPPL, V100, P51; Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002; Gungormus M, 2009, PHOTOMED LASER SURG, V27, P895, DOI 10.1089/pho.2008.2431; Kokai LE, 2011, TISSUE ENG PT A, V17, P1263, DOI [10.1089/ten.tea.2010.0507, 10.1089/ten.TEA.2010.0507]; Kupers R, 1998, PAIN, V76, P45, DOI 10.1016/S0304-3959(98)00022-0; Lin FM, 1996, J RECONSTR MICROSURG, V12, P173, DOI 10.1055/s-2007-1006472; Luis AL, 2007, J NEUROSCI METH, V163, P92, DOI 10.1016/j.jneumeth.2007.02.017; Madduri S, 2010, J PERIPHER NERV SYST, V15, P93, DOI 10.1111/j.1529-8027.2010.00257.x; Medalha CC, 2012, LASER MED SCI, V27, P629, DOI 10.1007/s10103-011-1008-9; MEIRI KF, 1986, P NATL ACAD SCI USA, V83, P3537, DOI 10.1073/pnas.83.10.3537; Moges H, LASERS SURG MED, V43, P901; Mohammed IFR, 2007, PHOTOMED LASER SURG, V25, P107, DOI 10.1089/pho.2006.1090; Monte-Raso VV, 2008, J NEUROSCI METH, V170, P255, DOI 10.1016/j.jneumeth.2008.01.022; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Rochkind S, 2007, PHOTOMED LASER SURG, V25, P436, DOI 10.1089/pho.2007.2093; Shen CC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/175629; Shen Ninjiang, 1995, Microsurgery, V16, P552, DOI 10.1002/micr.1920160809; SHENAQ JM, 1989, MICROSURG, V10, P214, DOI 10.1002/micr.1920100315; Shin DH, 2003, NEUROSCI LETT, V344, P71, DOI 10.1016/S0304-3940(03)00354-9; Tumilty S, 2010, PHOTOMED LASER SURG, V28, P3, DOI 10.1089/pho.2008.2470; VANBREUGEL HHFI, 1993, J NEUROCYTOL, V22, P185, DOI 10.1007/BF01246357; Varejao ASP, 2004, J NEUROTRAUM, V21, P1652, DOI 10.1089/neu.2004.21.1652; Varejao ASP, 2004, NEUROL RES, V26, P186, DOI 10.1179/016164104225013833; Varejao ASP, 2002, MUSCLE NERVE, V26, P630, DOI 10.1002/mus.10242; Xu QG, 2008, NEUROSCIENCE, V152, P877, DOI 10.1016/j.neuroscience.2008.01.060; Yu W, 2000, J PERIPHER NERV SYST, V5, P209, DOI 10.1046/j.1529-8027.2000.00024.x	45	56	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103348	10.1371/journal.pone.0103348	http://dx.doi.org/10.1371/journal.pone.0103348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119457	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600021
J	Yang, HX; Liu, H; Xu, D; Zhao, LD; Wang, Q; Leng, XM; Zheng, WJ; Zhang, FC; Tang, FL; Zhang, X				Yang, Huaxia; Liu, Hui; Xu, Dong; Zhao, Lidan; Wang, Qian; Leng, Xiaomei; Zheng, Wenjie; Zhang, Fengchun; Tang, Fulin; Zhang, Xuan			Pregnancy-Related Systemic Lupus Erythematosus: Clinical Features, Outcome and Risk Factors of Disease Flares - A Case Control Study	PLOS ONE			English	Article							WOMEN	Objective: To investigate the clinical features, outcome, and risk factors of disease flares in patients with pregnancy-related lupus (PRL). Methods: Medical charts of 155 consecutive PRL inpatients were systematically reviewed, including demographic data, clinical features, laboratory findings, treatment, complications, and outcome. Results: PRL cases were divided into active (a-PRL) (n = 82, 53.0%) and stable lupus (s-PRL) (n = 73, 47.0%). Compared with nonpregnant active female systemic lupus erythematosus (SLE) patients, a-PRL including new-onset lupus (n-PRL) and flare lupus (f-PRL) (n = 41 respectively), had a higher incidence of renal and hematological involvement but less mucocutaneous and musculoskeletal involvement (p<0.05). The incidence of preeclampsia/eclampsia, fetal loss, and preterm birth were significantly higher in a-PRL than in s-PRL (p<0.05). Despite receiving a more vigorous glucocorticoid treatment, a-PRL mothers had a poorer prognosis (p<0.001). Five (6.1%) of them died and 13 (15.9%) developed severe irreversible organ failure, whereas none of these events was observed in the s-PRL group. Multivariate logistic analysis indicated that a history of lupus flares and serological activity (hypocomplementemia and/or anti-dsDNA positivity) at the time of conception were associated with lupus flares in PRL mothers. Conclusions: SLE patients with a flare history and serological activity at the time of conception were at an increased risk of disease flares during pregnancy and puerperium. a-PRL patients were more prone to renal and hematological involvement, pregnancy complications, and a poorer prognosis despite more vigorous glucocorticoid treatment.	[Yang, Huaxia; Xu, Dong; Zhao, Lidan; Wang, Qian; Leng, Xiaomei; Zheng, Wenjie; Zhang, Fengchun; Tang, Fulin; Zhang, Xuan] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Rheumatol, Beijing 100730, Peoples R China; [Liu, Hui] Beijing Univ Chinese Med, Dongfang Hosp, Clin Med Coll 2, Dept Rheumatol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Beijing University of Chinese Medicine	Zhang, X (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Rheumatol, Beijing 100730, Peoples R China.	zxpumch2003@sina.com	zhang, xuan/GQO-8953-2022; zhang, xu/GRX-9733-2022; huaxia, yang/AAP-7126-2020; zhang, xuan/AAN-9914-2020	zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699; yang, huaxia/0000-0001-6811-0255	National Natural Science Foundation of China [81325019, 81172859, 81273312]; Beijing Municipal Natural Science Foundation [7141008]; Research Special Fund for Public Welfare Industry of Health [20120217]; Capital Health Research and Development of Special [2011-4001-02]; Youth Foundation of Peking Union Medical College Hospital [20110110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Research Special Fund for Public Welfare Industry of Health; Capital Health Research and Development of Special; Youth Foundation of Peking Union Medical College Hospital	This work was partly supported by the grants from the National Natural Science Foundation of China (81325019, 81172859, and 81273312), Beijing Municipal Natural Science Foundation (7141008), the Research Special Fund for Public Welfare Industry of Health (20120217), the Capital Health Research and Development of Special (2011-4001-02), and the Youth Foundation of Peking Union Medical College Hospital (20110110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade R, 2008, CLIN EXP RHEUMATOL, V26, P268; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Calixto OJ, 2014, AUTOIMMUN REV; Clark CA, 2005, J RHEUMATOL, V32, P1709; Doria A, 2006, ANN NY ACAD SCI, V1069, P247, DOI 10.1196/annals.1351.022; HAYSLETT JP, 1991, AM J KIDNEY DIS, V17, P123, DOI 10.1016/S0272-6386(12)81115-2; Khamashta MA, 1997, RHEUM DIS CLIN N AM, V23, P15, DOI 10.1016/S0889-857X(05)70312-4; Kwok LW, 2011, LUPUS, V20, P829, DOI 10.1177/0961203310397967; Marker-Hermann E, 2010, CURR OPIN OBSTET GYN, V22, P458, DOI 10.1097/GCO.0b013e3283404d67; Ruiz-Irastorza G, 2004, LUPUS, V13, P679, DOI 10.1191/0961203304lu1099oa; Shand AW, 2013, ANN RHEUM DIS, V72, P547, DOI 10.1136/annrheumdis-2011-201210; Shen BY, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/270878; Sibai BM, 2007, OBSTET GYNECOL, V109, P956, DOI 10.1097/01.AOG.0000258281.22296.de; Stojan G, 2012, EXPERT REV CLIN IMMU, V8, P439, DOI [10.1586/eci.12.36, 10.1586/ECI.12.36]; Tarr Tuende, 2012, Orvosi Hetilap, V153, P454, DOI 10.1556/OH.2012.29323; Yan Yuen Sai, 2008, Open Rheumatol J, V2, P89, DOI 10.2174/1874312900802010089; Zhao CM, 2013, CLIN RHEUMATOL, V32, P815, DOI 10.1007/s10067-013-2180-z	17	50	55	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104375	10.1371/journal.pone.0104375	http://dx.doi.org/10.1371/journal.pone.0104375			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118692	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600052
J	Hiroshima, Y; Maawy, A; Hassanein, MK; Menen, R; Momiyama, M; Murakami, T; Miwa, S; Yamamoto, M; Uehara, F; Yano, S; Mori, R; Matsuyama, R; Chishima, T; Tanaka, K; Ichikawa, Y; Bouvet, M; Endo, I; Hoffman, RM				Hiroshima, Yukihiko; Maawy, Ali; Hassanein, Mohamed K.; Menen, Rhiana; Momiyama, Masashi; Murakami, Takashi; Miwa, Shinji; Yamamoto, Mako; Uehara, Fuminari; Yano, Shuya; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Bouvet, Michael; Endo, Itaru; Hoffman, Robert M.			The Tumor-Educated-Macrophage Increase of Malignancy of Human Pancreatic Cancer Is Prevented by Zoledronic Acid	PLOS ONE			English	Article							NUDE-MOUSE MODEL; SALMONELLA-TYPHIMURIUM; POTENTIAL TARGETS; COLON-CANCER; STEM-LIKE; CELLS; MICE; ANGIOGENESIS; GROWTH; DEPLETION	We previously defined macrophages harvested from the peritoneal cavity of nude mice with subcutaneous human pancreatic tumors as "tumor-educated-macrophages'' (Edu) and macrophages harvested from mice without tumors as "naive-macrophages'' (Naive), and demonstrated that Edu-macrophages promoted tumor growth and metastasis. In this study, Edu- and Naive-macrophages were compared for their ability to enhance pancreatic cancer malignancy at the cellular level in vitro and in vivo. The inhibitory efficacy of Zoledronic acid (ZA) on Edu-macrophage-enhanced metastasis was also determined. XPA1 human pancreatic cancer cells in Gelfoam co-cultured with Edu-macrophages proliferated to a greater extent compared to XPA1 cells cultured with Naive-macrophages (P = 0.014). XPA1 cells exposed to conditioned medium harvested from Edu culture significantly increased proliferation (P = 0.016) and had more migration stimulation capability (P < 0.001) compared to cultured cancer cells treated with the conditioned medium from Naive. The mitotic index of the XPA1 cells, expressing GFP in the nucleus and RFP in the cytoplasm, significantly increased in vivo in the presence of Edu-compared to Naive-macrophages (P = 0.001). Zoledronic acid (ZA) killed both Edu and Naive in vitro. Edu promoted tumor growth and metastasis in an orthotopic mouse model of the XPA1 human pancreatic cancer cell line. ZA reduced primary tumor growth (P = 0.006) and prevented metastasis (P = 0.025) promoted by Edu-macrophages. These results indicate that ZA inhibits enhanced primary tumor growth and metastasis of human pancreatic cancer induced by Edu-macrophages.	[Hiroshima, Yukihiko; Hassanein, Mohamed K.; Menen, Rhiana; Miwa, Shinji; Yamamoto, Mako; Uehara, Fuminari; Yano, Shuya; Hoffman, Robert M.] AntiCanc Inc, San Diego, CA 92111 USA; [Hiroshima, Yukihiko; Maawy, Ali; Hassanein, Mohamed K.; Miwa, Shinji; Yamamoto, Mako; Uehara, Fuminari; Yano, Shuya; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Momiyama, Masashi; Murakami, Takashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan	AntiCancer, Inc.; University of California System; University of California San Diego; Yokohama City University	Hoffman, RM (corresponding author), AntiCanc Inc, San Diego, CA 92111 USA.	all@anticancer.com	Yano, Shuya/AAL-8028-2020; Miwa, Shinji/AAI-9309-2020	Miwa, Shinji/0000-0002-5962-8287; UEHARA, FUMINARI/0000-0001-6567-2113; Murakami, Takashi/0000-0002-9429-5705	National Cancer Institute [CA132971]; JSPS KAKENHI Grant [26830081, 26462070, 24592009]; NATIONAL CANCER INSTITUTE [R01CA132971] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24592009] Funding Source: KAKEN	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by National Cancer Institute grant CA132971 and JSPS KAKENHI Grant Numbers 26830081 to Y.H., 26462070 to I. E. and 24592009 to K. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoh Y, 2006, ANTICANCER RES, V26, P3237; Baay M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/565187; Bouvet M, 2002, CANCER RES, V62, P1534; Bouvet M, 2006, CANCER RES, V66, P11293, DOI 10.1158/0008-5472.CAN-06-2662; Cao HST, 2009, J CELL BIOCHEM, V107, P328, DOI 10.1002/jcb.22128; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; FURUKAWA T, 1993, CANCER RES, V53, P3070; Hassanein MK, 2011, J CELL BIOCHEM, V112, P3549, DOI 10.1002/jcb.23282; Hiroshima Y, 2013, CELL CYCLE, V12, P2774, DOI 10.4161/cc.25872; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Cao HST, 2009, J PANCREAS, V10, P152; Jiang P, 2006, CELL CYCLE, V5, P1198, DOI 10.4161/cc.5.11.2795; Karnevi E, 2014, IMMUNOL CELL BIOL, V92, P543, DOI 10.1038/icb.2014.22; Kurahara H, 2011, J SURG RES, V167, pE211, DOI 10.1016/j.jss.2009.05.026; Lee CH, 2008, CLIN CANCER RES, V14, P1423, DOI 10.1158/1078-0432.CCR-07-1712; Maerten A, 2007, J IMMUNOTHER, V30, P370; McElroy M, 2008, CELL CYCLE, V7, P2916, DOI 10.4161/cc.7.18.6682; McElroy MK, 2009, MOL CANCER THER, V8, P1779, DOI 10.1158/1535-7163.MCT-09-0122; Menen RS, 2012, IN VIVO, V26, P565; Murphy EA, 2010, P NATL ACAD SCI USA, V107, P4299, DOI 10.1073/pnas.0909299107; Nagakura C, 2009, ANTICANCER RES, V29, P1873; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Rietkotter E, 2013, ONCOTARGET, V4, P1449, DOI 10.18632/oncotarget.1201; Rogers TL, 2013, CELL ONCOL, V36, P505, DOI 10.1007/s13402-013-0156-2; Rogers TL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-177; Snyder CS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-106; Tsuji K, 2006, J PANCREAS, V7, P193; Uchugonova A, 2011, CELL CYCLE, V10, P2017, DOI 10.4161/cc.10.12.15895; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yamauchi K, 2012, ANTICANCER RES, V32, P39; Yang M, 2004, CANCER RES, V64, P8651, DOI 10.1158/0008-5472.CAN-04-3118; Yang M, 2009, J CELL BIOCHEM, V106, P279, DOI 10.1002/jcb.21999; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904	36	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103382	10.1371/journal.pone.0103382	http://dx.doi.org/10.1371/journal.pone.0103382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116261	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400016
J	Joshi, H; Dave, R; Venugopalan, VP				Joshi, Hiren; Dave, Rachna; Venugopalan, Vayalam P.			Protein as Chemical Cue: Non-Nutritional Growth Enhancement by Exogenous Protein in Pseudomonas putida KT2440	PLOS ONE			English	Article							BACILLUS-SUBTILIS; AERUGINOSA; SECRETION; IRON; COLONIZATION; COMMUNITIES; COMPETITION; PLASMID; BIOAUGMENTATION; METAPROTEOMICS	Research pertaining to microbe-microbe and microbe-plant interactions has been largely limited to small molecules like quorum sensing chemicals. However, a few recent reports have indicated the role of complex molecules like proteins and polysaccharides in microbial communication. Here we demonstrate that exogenous proteins present in culture media can considerably accelerate the growth of Pseudomonas putida KT2440, even when such proteins are not internalized by the cells. The growth enhancement is observed when the exogenous protein is not used as a source of carbon or nitrogen. The data show non-specific nature of the protein inducing growth; growth enhancement was observed irrespective of the protein type. It is shown that growth enhancement is mediated via increased siderophore secretion in response to the exogenous protein, leading to better iron uptake. We highlight the ecological significance of the observation and hypothesize that exogenous proteins serve as chemical cues in the case of P. putida and are perceived as indicator of the presence of competitors in the environment. It is argued that enhanced siderophore secretion in response to exogenous protein helps P. putida establish numerical superiority over competitors by way of enhanced iron assimilation and quicker utilization of aromatic substrates.	[Joshi, Hiren; Dave, Rachna; Venugopalan, Vayalam P.] Bhabha Atom Res Ctr, Water & Steam Chem Div, Biofouling & Biofilm Proc Sect, Kalpakkam, Tamil Nadu, India	Bhabha Atomic Research Center (BARC)	Venugopalan, VP (corresponding author), Bhabha Atom Res Ctr, Water & Steam Chem Div, Biofouling & Biofilm Proc Sect, Kalpakkam, Tamil Nadu, India.	vpv@igcar.gov.in	Joshi, Hiren/AGJ-2262-2022	Joshi, Hiren/0000-0002-2774-7695				Antoniuk L P, 2006, Mikrobiologiia, V75, P544; Badri DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046640; Badri DV, 2009, CURR OPIN BIOTECH, V20, P642, DOI 10.1016/j.copbio.2009.09.014; Be'er A, 2010, P NATL ACAD SCI USA, V107, P6258, DOI 10.1073/pnas.1001062107; Beauregard PB, 2013, P NATL ACAD SCI USA, V110, pE1621, DOI 10.1073/pnas.1218984110; Charmont S, 2005, PHYTOCHEMISTRY, V66, P453, DOI 10.1016/j.phytochem.2004.12.013; De-La-Pena C, 2008, J BIOL CHEM, V283, P25247, DOI 10.1074/jbc.M801967200; De-la-Pena C, 2010, J BIOL CHEM, V285, P30654, DOI 10.1074/jbc.M110.119040; Dinkla IJT, 2001, APPL ENVIRON MICROB, V67, P3406, DOI 10.1128/AEM.67.8.3406-3412.2001; Fernandez-Pinar R, 2011, RES MICROBIOL, V162, P773, DOI 10.1016/j.resmic.2011.06.013; Folse HJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00338; Gallio M, 2002, P NATL ACAD SCI USA, V99, P12208, DOI 10.1073/pnas.192138799; Gaonkar T, 2012, SCI WORLD J, DOI 10.1100/2012/857249; Hammond A, 2010, J SURG RES, V159, P735, DOI 10.1016/j.jss.2008.09.003; Han SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029192; Harrison F, 2008, ISME J, V2, P49, DOI 10.1038/ismej.2007.96; Hettich RL, 2012, CURR OPIN MICROBIOL, V15, P373, DOI 10.1016/j.mib.2012.04.008; Ingmer H, 2009, RES MICROBIOL, V160, P704, DOI 10.1016/j.resmic.2009.08.017; Jeong BR, 2009, ANNU PLANT REV, V34, P48, DOI 10.1111/b.9781405175326.2009.00003.x; Jin CW, 2008, PLANT SIGNAL BEHAV, V3, P60; Jin CW, 2010, ANN BOT-LONDON, V105, P835, DOI 10.1093/aob/mcq071; Joshi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006065; Kim J, 2005, MICROBIOL-SGM, V151, P3575, DOI 10.1099/mic.0.28277-0; Kruczek C, 2012, MICROBIOL-SGM, V158, P353, DOI 10.1099/mic.0.053371-0; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Martinez-Bueno MA, 2002, ENVIRON MICROBIOL, V4, P842, DOI 10.1046/j.1462-2920.2002.00371.x; Matilla MA, 2007, ENVIRON MICROBIOL, V9, P1842, DOI 10.1111/j.1462-2920.2007.01286.x; Mohan SV, 2009, BIORESOURCE TECHNOL, V100, P1746, DOI 10.1016/j.biortech.2008.09.048; Molina MA, 2006, ENVIRON MICROBIOL, V8, P639, DOI 10.1111/j.1462-2920.2005.00940.x; Molina MA, 2005, ENVIRON MICROBIOL, V7, P443, DOI 10.1111/j.1462-2920.2005.00720.x; Muller J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00146; Nancharaiah YV, 2008, CHEMOSPHERE, V71, P30, DOI 10.1016/j.chemosphere.2007.10.062; Nobrega FM, 2005, PLANT SOIL, V272, P223, DOI 10.1007/s11104-004-4954-1; Parales RE, 2002, CURR OPIN MICROBIOL, V5, P266, DOI 10.1016/S1369-5274(02)00320-X; Preston GM, 2004, PHILOS T R SOC B, V359, P907, DOI 10.1098/rstb.2003.1384; Rendueles O, 2012, FEMS MICROBIOL REV, V36, P972, DOI 10.1111/j.1574-6976.2012.00328.x; Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928; Schneider T, 2010, PROTEOMICS, V10, P785, DOI 10.1002/pmic.200900450; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Siddiqui IA, 2005, APPL ENVIRON MICROB, V71, P5646, DOI 10.1128/AEM.71.9.5646-5649.2005; Smith DR, 2010, MBIO, V1, DOI 10.1128/mBio.00131-10; Sytnikov DM, 2007, RUSS J PLANT PHYSL+, V54, P366, DOI 10.1134/S1021443707030119; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Tokuda M, 1996, INFECT IMMUN, V64, P4067, DOI 10.1128/IAI.64.10.4067-4073.1996; Traidej M, 2003, INVEST OPHTH VIS SCI, V44, P190, DOI 10.1167/iovs.02-0458; Venturi V, 2009, HFSP J, V3, P105, DOI 10.2976/1.3065673; Wen FS, 2007, PLANT PHYSIOL, V143, P773, DOI 10.1104/pp.106.091637; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Wilmes P, 2006, TRENDS MICROBIOL, V14, P92, DOI 10.1016/j.tim.2005.12.006; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044; Yu FB, 2010, J HAZARD MATER, V176, P20, DOI 10.1016/j.jhazmat.2009.06.006; Zocchi G, 2007, J EXP BOT, V58, P993, DOI 10.1093/jxb/erl259	53	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103730	10.1371/journal.pone.0103730	http://dx.doi.org/10.1371/journal.pone.0103730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117434	Green Submitted, gold, Green Published			2022-12-27	WOS:000341230400021
J	Li, WC; Jin, HY; Sui, XK; Zhao, ZZ; Yang, CH; Wang, WQ; Li, JP; Li, G				Li, Wenchao; Jin, Hongyan; Sui, Xiukun; Zhao, Zhanzhong; Yang, Chenghuai; Wang, Wenquan; Li, Junping; Li, Gang			Self-Assembly and Release of Peste des Petits Ruminants Virus-Like Particles in an Insect Cell-Baculovirus System and Their Immunogenicity in Mice and Goats	PLOS ONE			English	Article							IMMUNE-RESPONSES; EXPRESSION SYSTEM; FUSION PROTEINS; MATRIX PROTEIN; VACCINE; NUCLEOPROTEIN; MORBILLIVIRUS; GLYCOPROTEIN; REQUIREMENTS; COEXPRESSION	Peste des petits ruminants (PPR) is an acute, febrile, viral disease of small ruminants that has a significant economic impact. For many viral diseases, vaccination with virus-like particles (VLPs) has shown considerable promise as a prophylactic approach; however, the processes of assembly and release of peste des petits ruminants virus (PPRV) VLPs are not well characterized, and their immunogenicity in the host is unknown. In this study, VLPs of PPRV were generated in a baculovirus system through simultaneous expression of PPRV matrix (M) protein and hemaglutin in (H) or fusion (F) protein. The released VLPs showed morphology similar to that of the native virus particles. Subcutaneous injection of these VLPs (PPRV-H, PPRV-F) into mice and goats elicited PPRV specific IgG production, increased the levels of virus neutralizing antibodies, and promoted lymphocyte proliferation. Without adjuvants, the immune response induced by the PPRV H VLPs was comparable to that obtained using equivalent amounts of PPRV vaccine. Thus, our results demonstrated that VLPs containing PPRV-M protein and H or F protein are potential "differentiating infected from vaccinated animals'' (DIVA) vaccine candidates for the surveillance and eradication of PPR.	[Li, Wenchao; Jin, Hongyan; Sui, Xiukun; Zhao, Zhanzhong; Li, Gang] Chinese Acad Agr Sci, Beijing Inst Anim Sci & Vet Med, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Li, Wenchao; Jin, Hongyan; Sui, Xiukun; Zhao, Zhanzhong; Li, Gang] Minist Agr, Beijing Sci Observat, Beijing 100193, Peoples R China; [Li, Wenchao; Jin, Hongyan; Sui, Xiukun; Zhao, Zhanzhong; Li, Gang] Minist Agr, Expt Stn Vet Drug & Vet Biotechnol, Beijing 100193, Peoples R China; [Yang, Chenghuai; Li, Junping] China Inst Vet Drug Control, Beijing, Peoples R China; [Wang, Wenquan] Beijing CevaHuadu Biol Co Ltd, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs; China Institute of Veterinary Drug Control	Li, JP (corresponding author), China Inst Vet Drug Control, Beijing, Peoples R China.	lijunping03@163.com; gli358@gmail.com			National Science and Technology Support Program of China [2013BAD12B05]; National Natural Science Foundation of China [31172342]; National Commonweal Project of China [200903037]; Fundamental Research Funds for the Central Public Welfare Research of Beijing Institute of Animal Science and Veterinary Medicine [2014ywf-yb-6]	National Science and Technology Support Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Commonweal Project of China; Fundamental Research Funds for the Central Public Welfare Research of Beijing Institute of Animal Science and Veterinary Medicine	This study was supported by the National Science and Technology Support Program of China (NO. 2013BAD12B05) http://program.most.gov.cn/, the National Natural Science Foundation of China (NO. 31172342) http://www.nsfc.gov.cn/, the National Commonweal Project of China (NO. 200903037) http://www.kjs.moa.gov.cn/, and the Fundamental Research Funds for the Central Public Welfare Research of Beijing Institute of Animal Science and Veterinary Medicine (2014ywf-yb-6) http://www.iascaas.net.cn/sites/IAS/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; BARRETT T, 1987, BIOCHEM SOC SYMP, P25; Berhe G, 2003, J VIROL, V77, P1571, DOI 10.1128/JVI.77.2.1571-1577.2003; Brun A, 2011, VIRUS RES, V157, P1, DOI 10.1016/j.virusres.2011.02.006; Chandran D, 2010, INDIAN J MICROBIOL, V50, P266, DOI 10.1007/s12088-010-0026-9; Chen WY, 2010, VACCINE, V28, P4742, DOI 10.1016/j.vaccine.2010.04.102; Chinnakannan SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057063; Choi JG, 2013, VET MICROBIOL, V162, P623, DOI 10.1016/j.vetmic.2012.11.035; Coronel EC, 1999, J VIROL, V73, P7035, DOI 10.1128/JVI.73.8.7035-7038.1999; Cox MMJ, 2012, VACCINE, V30, P1759, DOI 10.1016/j.vaccine.2012.01.016; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; GIBBS EPJ, 1979, INTERVIROLOGY, V11, P268, DOI 10.1159/000149044; Harrison MS, 2010, INT J BIOCHEM CELL B, V42, P1416, DOI 10.1016/j.biocel.2010.04.005; Herzog C, 2009, VACCINE, V27, P4381, DOI 10.1016/j.vaccine.2009.05.029; Hu YC, 2000, CHEM ENG SCI, V55, P3991, DOI 10.1016/S0009-2509(99)00579-5; Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083; Lamb R, 2007, PARAMYXOVIRIDAE VIRU, V5th; Li M, 2009, J VIROL, V83, P7261, DOI 10.1128/JVI.00421-09; LI Y, 1993, J VIROL, V67, P4415, DOI 10.1128/JVI.67.7.4415-4420.1993; LIBEAU G, 1995, RES VET SCI, V58, P50, DOI 10.1016/0034-5288(95)90088-8; Liu FX, 2014, RES VET SCI, V96, P213, DOI 10.1016/j.rvsc.2013.10.012; Liu FX, 2013, PROTEIN EXPRES PURIF, V90, P104, DOI 10.1016/j.pep.2013.05.009; Liu FX, 2013, COMP IMMUNOL MICROB, V36, P343, DOI 10.1016/j.cimid.2013.02.002; Ma HL, 2012, J VIROL, V86, P1789, DOI 10.1128/JVI.06003-11; Martelli P, 2011, VET MICROBIOL, V149, P339, DOI 10.1016/j.vetmic.2010.12.008; McGinnes LW, 2010, J VIROL, V84, P4513, DOI 10.1128/JVI.01931-09; Mortola E, 2004, FEBS LETT, V576, P174, DOI 10.1016/j.febslet.2004.09.009; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; OIE, 2013, MANUAL DIAGNOSTIC TE; Pantua HD, 2006, J VIROL, V80, P11062, DOI 10.1128/JVI.00726-06; Patch JR, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-1; Pushko P, 2005, VACCINE, V23, P5751, DOI 10.1016/j.vaccine.2005.07.098; Pyo HM, 2012, VACCINE, V30, P1297, DOI 10.1016/j.vaccine.2011.12.083; Rahman MM, 2003, VIROLOGY, V317, P36, DOI 10.1016/j.virol.2003.08.022; Renukaradhya GJ, 2002, VIRUS RES, V90, P171, DOI 10.1016/S0168-1702(02)00151-X; Saravanan P, 2010, BIOLOGICALS, V38, P479, DOI 10.1016/j.biologicals.2010.02.003; Schmitt AP, 2002, J VIROL, V76, P3952, DOI 10.1128/JVI.76.8.3952-3964.2002; Sinnathamby G, 2001, VACCINE, V19, P4816, DOI 10.1016/S0264-410X(01)00210-9; Sokolenko S, 2012, BIOTECHNOL ADV, V30, P766, DOI 10.1016/j.biotechadv.2012.01.009; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Takimoto T, 2001, J VIROL, V75, P11384, DOI 10.1128/JVI.75.23.11384-11391.2001; Vieira HLA, 2005, J BIOTECHNOL, V120, P72, DOI 10.1016/j.jbiotec.2005.03.026; Wang Y, 2013, J VIROL METHODS, V193, P525, DOI 10.1016/j.jviromet.2013.07.031; Wang Y, 2013, VET IMMUNOL IMMUNOP, V154, P1, DOI 10.1016/j.vetimm.2013.05.002; Wang ZL, 2009, EMERG INFECT DIS, V15, P299, DOI 10.3201/eid1502.080817	45	14	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104791	10.1371/journal.pone.0104791	http://dx.doi.org/10.1371/journal.pone.0104791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117931	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230400087
J	Reaz, R; Bayzid, MS; Rahman, MS				Reaz, Rezwana; Bayzid, Md Shamsuzzoha; Rahman, M. Sohel			Accurate Phylogenetic Tree Reconstruction from Quartets: A Heuristic Approach	PLOS ONE			English	Article							GENE TREES; SPECIES TREES; EVOLUTIONARY TREES; JOINING METHOD; DNA-SEQUENCES; ALGORITHM; MAXCUT; AVES; PROBABILITIES; CONCORDANCE	Supertree methods construct trees on a set of taxa (species) combining many smaller trees on the overlapping subsets of the entire set of taxa. A 'quartet' is an unrooted tree over 4 taxa, hence the quartet-based supertree methods combine many 4-taxon unrooted trees into a single and coherent tree over the complete set of taxa. Quartet-based phylogeny reconstruction methods have been receiving considerable attentions in the recent years. An accurate and efficient quartet-based method might be competitive with the current best phylogenetic tree reconstruction methods (such as maximum likelihood or Bayesian MCMC analyses), without being as computationally intensive. In this paper, we present a novel and highly accurate quartet-based phylogenetic tree reconstruction method. We performed an extensive experimental study to evaluate the accuracy and scalability of our approach on both simulated and biological datasets.	[Reaz, Rezwana; Bayzid, Md Shamsuzzoha; Rahman, M. Sohel] BUET, Dept Comp Sci & Engn, Dhaka, Bangladesh	Bangladesh University of Engineering & Technology (BUET)	Reaz, R (corresponding author), BUET, Dept Comp Sci & Engn, Dhaka, Bangladesh.	rimpi@cse.buet.ac.bd	Rahman, Mohammad Saifur/GZM-5483-2022; Rahman, Mohammad Sohelur/AAJ-7376-2020	Rahman, Mohammad Saifur/0000-0002-9887-4456; Rahman, Mohammad Sohelur/0000-0002-4489-2202; Rahman, M. Sohel/0000-0001-9419-6478				Allman ES, 2011, J MATH BIOL, V62, P833, DOI 10.1007/s00285-010-0355-7; BAUM BR, 2004, COMPU BIOL, V4, P17; BROWN JKM, 1994, SYST BIOL, V43, P78, DOI 10.2307/2413582; Christidis L, 1997, AUST J ZOOL, V45, P113, DOI 10.1071/ZO96068; Christidis L, 1999, AUST J ZOOL, V47, P113, DOI 10.1071/ZO98054; Christidis L, 2010, MOL PHYLOGENET EVOL, V57, P868, DOI 10.1016/j.ympev.2010.08.029; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Degnan JH, 2013, SYST BIOL, V62, P574, DOI 10.1093/sysbio/syt023; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Degnan JH, 2005, EVOLUTION, V59, P24; Donnellan SC, 2009, EMU, V109, P143, DOI 10.1071/MU07011; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fiduccia C. M., 1982, P 19 IEEE DES AUT C, V19, P175, DOI DOI 10.1109/DAC.1982.1585498; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; HARDING E, 1971, ADV APPL PROBAB, P44; Hodkinson TR, 2010, RECONSTRUCTING TREE; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Lee JY, 2011, SYSTEMATIC BIOL; LINDER C, 2005, HDB COMPUTATIONAL MO; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Morgado A, 2010, FUND INFORM, V102, P363, DOI 10.3233/FI-2010-311; Nichols R, 2001, TRENDS ECOL EVOL, V16, P358, DOI 10.1016/S0169-5347(01)02203-0; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Ranwez V, 2001, MOL BIOL EVOL, V18, P1103, DOI 10.1093/oxfordjournals.molbev.a003881; Regan MA, 1992, BIOSYSTEMS, V28, P47; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Rosenberg NA, 2002, THEOR POPUL BIOL, V61, P225, DOI 10.1006/tpbi.2001.1568; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanderson Michael J., 1994, American Journal of Botany, V81, P183; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Snir S, 2008, J COMPUT BIOL, V15, P91, DOI 10.1089/cmb.2007.0103; Snir S, 2012, MOL PHYLOGENET EVOL, V62, P1, DOI 10.1016/j.ympev.2011.06.021; Snir S, 2010, IEEE ACM T COMPUT BI, V7, P704, DOI 10.1109/TCBB.2008.133; STEEL M, 1992, J CLASSIF, V9, P91, DOI 10.1007/BF02618470; Steel M, 2001, MATH BIOSCI, V170, P91, DOI 10.1016/S0025-5564(00)00061-4; Strimmer K, 1997, MOL BIOL EVOL, V14, P210, DOI 10.1093/oxfordjournals.molbev.a025756; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Swenson MS, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-7; TAJIMA F, 1983, GENETICS, V105, P437; TAKAHATA N, 1985, GENETICS, V110, P325; Xin L, 2007, LECT NOTES COMPUT SC, V4598, P40; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306	43	68	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104008	10.1371/journal.pone.0104008	http://dx.doi.org/10.1371/journal.pone.0104008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117474	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400027
J	Vacca, M; D'Amore, S; Graziano, G; D'Orazio, A; Cariello, M; Massafra, V; Salvatore, L; Martelli, N; Murzilli, S; Lo Sasso, G; Mariani-Costantini, R; Moschetta, A				Vacca, Michele; D'Amore, Simona; Graziano, Giusi; D'Orazio, Andria; Cariello, Marica; Massafra, Vittoria; Salvatore, Lorena; Martelli, Nicola; Murzilli, Stefania; Lo Sasso, Giuseppe; Mariani-Costantini, Renato; Moschetta, Antonio			Clustering Nuclear Receptors in Liver Regeneration Identifies Candidate Modulators of Hepatocyte Proliferation and Hepatocarcinoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; X-RECEPTOR; GLUCOCORTICOID-RECEPTOR; HEPATIC REGENERATION; PARTIAL-HEPATECTOMY; VARIABLE IMPORTANCE; CELL-PROLIFERATION; ADAPTIVE RESPONSE; CIRCADIAN CLOCK; GENE-EXPRESSION	Background & Aims: Liver regeneration (LR) is a valuable model for studying mechanisms modulating hepatocyte proliferation. Nuclear receptors (NRs) are key players in the control of cellular functions, being ideal modulators of hepatic proliferation and carcinogenesis. Methods & Results: We used a previously validated RT-qPCR platform to profile modifications in the expression of all 49 members of the NR superfamily in mouse liver during LR. Twenty-nine NR transcripts were significantly modified in their expression during LR, including fatty acid (peroxisome proliferator-activated receptors, PPARs) and oxysterol (liver X receptors, Lxrs) sensors, circadian masters RevErb alpha and RevErb beta, glucocorticoid receptor (Gr) and constitutive androxane receptor (Car). In order to detect the NRs that better characterize proliferative status vs. proliferating liver, we used the novel Random Forest (RF) analysis to selected a trio of down-regulated NRs (thyroid receptor alpha, Tr alpha; farsenoid X receptor beta, Fxr beta; Ppar delta) as best discriminators of the proliferating status. To validate our approach, we further studied PPAR delta role in modulating hepatic proliferation. We first confirmed the suppression of PPAR delta both in LR and human hepatocellular carcinoma at protein level, and then demonstrated that PPAR delta agonist GW501516 reduces the proliferative potential of hepatoma cells. Conclusions: Our data suggest that NR transcriptome is modulated in proliferating liver and is a source of biomarkers and bona fide pharmacological targets for the management of liver disease affecting hepatocyte proliferation.	[Vacca, Michele; D'Orazio, Andria; Massafra, Vittoria; Salvatore, Lorena; Martelli, Nicola; Murzilli, Stefania; Lo Sasso, Giuseppe] Fdn Mario Negri Sud, Chieti, Italy; [Vacca, Michele; Mariani-Costantini, Renato] Gabriele DAnnunzio Univ & Fdn, Aging Res Ctr CeSI, Unit Gen Pathol, Chieti, Italy; [Vacca, Michele; Moschetta, Antonio] Aldo Moro Univ Bari, Interdisciplinary Dept Med, Bari, Italy; [D'Amore, Simona; Graziano, Giusi; Cariello, Marica; Moschetta, Antonio] IRCCS Oncol Giovanni Paolo II, Natl Canc Inst, Bari, Italy	G d'Annunzio University of Chieti-Pescara; Universita degli Studi di Bari Aldo Moro; IRCCS Istituto Tumori Bari Giovanni Paolo II	Moschetta, A (corresponding author), Aldo Moro Univ Bari, Interdisciplinary Dept Med, Bari, Italy.	antonio.moschetta@uniba.it	Moschetta, Antonio/K-6211-2016; Graziano, Giusi/J-9083-2016; Vacca, Michele/B-4736-2013; Moschetta, Antonio/AAC-5295-2022; Mariani-Costantini, Renato/B-6637-2012; Cariello, Marica/K-4064-2018	Graziano, Giusi/0000-0002-3347-8049; Vacca, Michele/0000-0002-1973-224X; Mariani-Costantini, Renato/0000-0002-4440-1848; D'Amore, Simona/0000-0002-5432-8808; Moschetta, Antonio/0000-0003-2123-6074	Italian Association for Cancer Research (AIRC, Milan, Italy) [IG 14732, IG 9168]; Italian Ministry of University and Education (Finanziamenti per la Ricerca di Base IDEAS) [RBID08C9N7, PRIN 2010FHH32M-002]; Italian Ministry of Health [GR-2008-1143546, GR-2010- 2314703]; Apulian Region - Italy (POR Strategic Projects) [CIP PS_101]; University of Bari - Italy [ORBA 08WEZJ, 07X7Q1, 06BXVC, IDEA GRBA0802SJ]; CariSPAQ (L'Aquila, Italy); Societa Italiana di Medicina Interna (SIMI, Premio di Ricerca "Uliveto''); Fondazione "Umberto Veronesi'' (fellowship); MRC-HNR; AIRC; Medical Research Council [MC_UP_A090_1006, MC_PC_13030] Funding Source: researchfish; MRC [MC_PC_13030, MC_UP_A090_1006] Funding Source: UKRI	Italian Association for Cancer Research (AIRC, Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Education (Finanziamenti per la Ricerca di Base IDEAS); Italian Ministry of Health(Ministry of Health, Italy); Apulian Region - Italy (POR Strategic Projects); University of Bari - Italy; CariSPAQ (L'Aquila, Italy); Societa Italiana di Medicina Interna (SIMI, Premio di Ricerca "Uliveto''); Fondazione "Umberto Veronesi'' (fellowship)(Fondazione Umberto Veronesi); MRC-HNR(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AIRC(Fondazione AIRC per la ricerca sul cancro); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Italian Association for Cancer Research (AIRC, Milan, Italy IG 14732 to A. M. and IG 9168 to R.M.C.), Italian Ministry of University and Education (Finanziamenti per la Ricerca di Base IDEAS RBID08C9N7 and PRIN 2010FHH32M-002 to A.M.), Italian Ministry of Health (GR-2008-1143546; GR-2010-2314703), Apulian Region - Italy (POR Strategic Projects, CIP PS_101 to G.P.), University of Bari - Italy (ORBA 08WEZJ, 07X7Q1, 06BXVC, IDEA GRBA0802SJ), CariSPAQ (L'Aquila, Italy), Societa Italiana di Medicina Interna (SIMI, Premio di Ricerca "Uliveto'' 2012). M. Vacca is supported by the Fondazione "Umberto Veronesi'' (fellowship) and MRC-HNR. Lo Sasso was a fellow of AIRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen WD, 2010, HEPATOLOGY, V51, P953, DOI 10.1002/hep.23390; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Columbano A, 2003, CELL DEATH DIFFER, V10, pS19, DOI 10.1038/sj.cdd.4401113; Columbano A, 2001, HEPATOLOGY, V34, P262, DOI 10.1053/jhep.2001.26172; Columbano A, 1996, FASEB J, V10, P1118, DOI 10.1096/fasebj.10.10.8751714; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Dai GL, 2008, HEPATOLOGY, V47, P1277, DOI 10.1002/hep.22129; Datta B, 2009, BBA-REV CANCER, V1796, P281, DOI 10.1016/j.bbcan.2009.08.002; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Fang C, 2004, BIOCHEM PHARMACOL, V67, P1389, DOI 10.1016/j.bcp.2003.12.012; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; FAUSTO N, 1999, AM J PHYSIOL-GASTR L, V277, pG917; FIELD FJ, 1985, AM J PHYSIOL, V249, pG679, DOI 10.1152/ajpgi.1985.249.6.G679; Galli A, 2010, HEPATOLOGY, V52, P493, DOI 10.1002/hep.23669; Gazit V, 2012, HEPATOLOGY, V56, P1489, DOI 10.1002/hep.25880; Girish V, 2004, Indian J Cancer, V41, P47; Glinghammar B, 2003, BIOCHEM BIOPH RES CO, V308, P361, DOI 10.1016/S0006-291X(03)01384-6; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; HABER BA, 1995, J CLIN INVEST, V95, P832, DOI 10.1172/JCI117733; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hollingshead HE, 2007, CARCINOGENESIS, V28, P2641, DOI 10.1093/carcin/bgm183; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Imai T, 2001, P NATL ACAD SCI USA, V98, P4581, DOI 10.1073/pnas.071056098; Kanetaka K, 2001, J HEPATOL, V35, P637, DOI 10.1016/S0168-8278(01)00183-0; Karabelyos C, 1999, Pathol Oncol Res, V5, P107, DOI 10.1053/paor.1999.0168; Kim HJ, 2009, CIRC RES, V105, P16, DOI 10.1161/CIRCRESAHA.108.189159; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Kino T, 2007, EUR J CLIN INVEST, V37, P425, DOI 10.1111/j.1365-2362.2007.01796.x; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; Ledda-Columbano GM, 1998, ONCOGENE, V17, P1039, DOI 10.1038/sj.onc.1202018; Leu JI, 2001, MOL CELL BIOL, V21, P414, DOI 10.1128/MCB.21.2.414-424.2001; Levy-Nissenbaum O, 2003, ONCOGENE, V22, P7649, DOI 10.1038/sj.onc.1206971; LIDDLE C, 1993, J GASTROEN HEPATOL, V8, P524, DOI 10.1111/j.1440-1746.1993.tb01646.x; Lien HC, 2008, HISTOPATHOLOGY, V52, P314, DOI 10.1111/j.1365-2559.2007.02953.x; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047202; Liu HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065644; Liu QZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S1; Lo Sasso G, 2010, HEPATOLOGY, V51, P1334, DOI 10.1002/hep.23436; Lopez-Fontal R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008710; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Meier Volker, 2006, Comp Hepatol, V5, P2, DOI 10.1186/1476-5926-5-2; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Modica S, 2009, GASTROENTEROLOGY; Mueller KM, 2011, HEPATOLOGY, V54, P1398, DOI 10.1002/hep.24509; Newberry EP, 2008, HEPATOLOGY, V48, P1097, DOI 10.1002/hep.22473; Okochi-Takada E, 2013, ONCOGENE; Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9; Pibiri M, 2001, FASEB J, V15, P1006, DOI 10.1096/fj.00-0416com; Qin XM, 2008, HEPATOLOGY, V48, P432, DOI 10.1002/hep.22334; Rao MS, 2002, HEPATOL RES, V22, P52, DOI 10.1016/S1386-6346(01)00119-X; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; ROSA JL, 1992, BIOCHEM J, V287, P113, DOI 10.1042/bj2870113; SANDGREN EP, 1991, CELL, V66, P245, DOI 10.1016/0092-8674(91)90615-6; Sanefuji K, 2010, ONCOLOGY-BASEL, V79, P229, DOI 10.1159/000322374; SCEARCE LM, 1993, J BIOL CHEM, V268, P8855; Shi Yiwu, 2004, Genomics Proteomics & Bioinformatics, V2, P47; Skrtic S, 2005, LIVER INT, V25, P33, DOI 10.1111/j.1478-3231.2004.0998.x; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Suh HN, 2008, CELL PHYSIOL BIOCHEM, V22, P673, DOI 10.1159/000185551; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Trauner M, 2011, GASTROENTEROLOGY, V140, P1120, DOI 10.1053/j.gastro.2011.02.044; Turmelle YP, 2006, FASEB J, V20, P2609, DOI 10.1096/fj.06-6511fje; Vacca M, 2013, GASTROENTEROLOGY, V144, P1518, DOI 10.1053/j.gastro.2013.02.027; Vacca M, 2013, MOL CELL ENDOCRINOL, V368, P108, DOI 10.1016/j.mce.2012.06.025; Xu LH, 2006, CANCER RES, V66, P11859, DOI 10.1158/0008-5472.CAN-06-1445; Yamaguchi Y, 2006, BBA-MOL CELL RES, V1763, P844, DOI 10.1016/j.bbamcr.2006.03.012; Yamamoto Y, 2008, J GASTROEN HEPATOL, V23, P930, DOI 10.1111/j.1440-1746.2008.05370.x; Yang XX, 2010, AM J PATHOL, V176, P733, DOI 10.2353/ajpath.2010.090524; Zabielski P, 2010, PROSTAG OTH LIPID M, V93, P120, DOI 10.1016/j.prostaglandins.2010.09.001; Zhang H, 2013, EXP THER MED, V5, P119, DOI 10.3892/etm.2012.750; Zhu XS, 2012, ONCOL RES, V20, P377, DOI 10.3727/096504013X13657689383012; Zingarelli B, 2010, AM J PATHOL, V177, P1834, DOI 10.2353/ajpath.2010.091010	80	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104449	10.1371/journal.pone.0104449	http://dx.doi.org/10.1371/journal.pone.0104449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116592	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400051
J	Fawcett, JA; Iida, T; Takuno, S; Sugino, RP; Kado, T; Kugou, K; Mura, S; Kobayashi, T; Ohta, K; Nakayama, J; Innan, H				Fawcett, Jeffrey A.; Iida, Tetsushi; Takuno, Shohei; Sugino, Ryuichi P.; Kado, Tomoyuki; Kugou, Kazuto; Mura, Sachiko; Kobayashi, Takehiko; Ohta, Kunihiro; Nakayama, Jun-ichi; Innan, Hideki			Population Genomics of the Fission Yeast Schizosaccharomyces pombe	PLOS ONE			English	Article							GENETIC-VARIATION; DNA; RECOMBINATION; SEQUENCE; ELEMENTS; FORMAT; OLD	The fission yeast Schizosaccharomyces pombe has been widely used as a model eukaryote to study a diverse range of biological processes. However, population genetic studies of this species have been limited to date, and we know very little about the evolutionary processes and selective pressures that are shaping its genome. Here, we sequenced the genomes of 32 worldwide S. pombe strains and examined the pattern of polymorphisms across their genomes. In addition to introns and untranslated regions ( UTRs), intergenic regions also exhibited lower levels of nucleotide diversity than synonymous sites, suggesting that a considerable amount of noncoding DNA is under selective constraint and thus likely to be functional. A number of genomic regions showed a reduction of nucleotide diversity probably caused by selective sweeps. We also identified a region close to the end of chromosome 3 where an extremely high level of divergence was observed between 5 of the 32 strains and the remain 27, possibly due to introgression, strong positive selection, or that region being responsible for reproductive isolation. Our study should serve as an important starting point in using a population genomics approach to further elucidate the biology of this important model organism.	[Fawcett, Jeffrey A.; Takuno, Shohei; Sugino, Ryuichi P.; Kado, Tomoyuki; Innan, Hideki] Grad Univ Adv Studies, Hayama, Kanagawa, Japan; [Iida, Tetsushi; Kobayashi, Takehiko] Natl Inst Genet, Mishima, Shizuoka 411, Japan; [Sugino, Ryuichi P.] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Kugou, Kazuto; Mura, Sachiko; Ohta, Kunihiro] Univ Tokyo, Dept Life Sci, Tokyo, Japan; [Nakayama, Jun-ichi] Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi, Japan	Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyushu University; University of Tokyo; Nagoya City University	Fawcett, JA (corresponding author), Grad Univ Adv Studies, Hayama, Kanagawa, Japan.	fawcett@soken.ac.jp; jnakayam@nsc.nagoya-cu.ac.jp; innan_hideki@soken.ac.jp	Nakayama, Jun-ichi/C-6003-2011; Iida, Tetsushi/R-6136-2019	Nakayama, Jun-ichi/0000-0002-5597-8239; Fawcett, Jeffrey/0000-0003-3907-2135; Kugou, Kazuto/0000-0002-7690-1249; Innan, Hideki/0000-0001-6375-9231; Takuno, Shohei/0000-0001-9538-7487	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [23114001, 23114002, 23114003, 23114004, 23114005]; Platform for Dynamic Approaches to Living System from MEXT	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform for Dynamic Approaches to Living System from MEXT	This work was supported by a Grant-in-Aid for Scientic Research on Innovative Areas to T. K., K. O., J. N. and H. I. (23114001, 23114002, 23114003, 23114004, 23114005) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT). This work was also supported by Platform for Dynamic Approaches to Living System from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bergstrom A, 2014, MOL BIOL EVOL, V31, P872, DOI 10.1093/molbev/msu037; Brown WRA, 2014, P NATL ACAD SCI USA, V111, P1903, DOI 10.1073/pnas.1216934111; Brown WRA, 2011, G3-GENES GENOM GENET, V1, P615, DOI 10.1534/g3.111.001123; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Falush D, 2003, GENETICS, V164, P1567; Ganley ARD, 2005, P NATL ACAD SCI USA, V102, P11787, DOI 10.1073/pnas.0504905102; Goto DB, 2012, DEV GROWTH DIFFER, V54, P129, DOI 10.1111/j.1440-169X.2011.01310.x; Goya A, 2011, CYTOSKELETON, V68, P69, DOI 10.1002/cm.20500; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Klar AJS, 1986, CELL, V46; Klar AJS, 2007, ANNU REV GENET, V41, P213, DOI 10.1146/annurev.genet.39.073103.094316; Kupfer DM, 2004, EUKARYOT CELL, V3, P1088, DOI 10.1128/EC.3.5.1088-1100.2004; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; McVean GAT, 2002, GENETICS, V162, P987; NEI M, 1986, MOL BIOL EVOL, V3, P418; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Phadnis N, 2011, TRENDS GENET, V27, P411, DOI 10.1016/j.tig.2011.06.007; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Vader G, 2011, NATURE, V477, P115, DOI 10.1038/nature10331; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	34	33	33	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104241	10.1371/journal.pone.0104241	http://dx.doi.org/10.1371/journal.pone.0104241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111393	Green Published, gold			2022-12-27	WOS:000341105100044
J	Engi, SA; Cruz, FC; Leao, RM; Spolidorio, LC; Planeta, CS; Crestani, CC				Engi, Sheila A.; Cruz, Fabio C.; Leao, Rodrigo M.; Spolidorio, Luis C.; Planeta, Cleopatra S.; Crestani, Carlos C.			Cardiovascular Complications following Chronic Treatment with Cocaine and Testosterone in Adolescent Rats	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; ANABOLIC-ANDROGENIC STEROIDS; CORONARY-HEART-DISEASE; DRUG-USE; UNANESTHETIZED RATS; BAROREFLEX FUNCTION; BLOOD-PRESSURE; UNITED-STATES; ADULT RATS; BRAIN	Concomitant use of anabolic androgenic steroids and cocaine has increased in the last years. However, the effects of chronic exposure to these substances during adolescence on cardiovascular function are unknown. Here, we investigated the effects of treatment for 10 consecutive days with testosterone and cocaine alone or in combination on basal cardiovascular parameters, baroreflex activity, hemodynamic responses to vasoactive agents, and cardiac morphology in adolescent rats. Administration of testosterone alone increased arterial pressure, reduced heart rate (HR), and exacerbated the tachycardiac baroreflex response. Cocaine-treated animals showed resting bradycardia without changes in arterial pressure and baroreflex activity. Combined treatment with testosterone and cocaine did not affect baseline arterial pressure and HR, but reduced baroreflex-mediated tachycardia. None of the treatments affected arterial pressure response to either vasoconstrictor or vasodilator agents. Also, heart to body ratio and left and right ventricular wall thickness were not modified by drug treatments. However, histological analysis of left ventricular sections of animals subjected to treatment with testosterone and cocaine alone and combined showed a greater spacing between cardiac muscle fibers, dilated blood vessels, and fibrosis. These data show important cardiovascular changes following treatment with testosterone in adolescent rats. However, the results suggest that exposure to cocaine alone or combined with testosterone during adolescence minimally affect cardiovascular function.	[Engi, Sheila A.; Planeta, Cleopatra S.; Crestani, Carlos C.] UNESP, Sch Pharmaceut Sci, Dept Nat Act Principles & Toxicol, Pharmacol Lab, Araraquara, SP, Brazil; [Engi, Sheila A.; Planeta, Cleopatra S.; Crestani, Carlos C.] UNESP, Grad Program Physiol Sci, Joint UFSCar, Sao Carlos, SP, Brazil; [Cruz, Fabio C.; Leao, Rodrigo M.] NIDA, Behav Neurosci Branch, Intramural Res Program, US NIH,Dept Hlth & Human Serv, Baltimore, MD USA; [Spolidorio, Luis C.] UNESP, Sch Dent Araraquara, Dept Physiol & Pathol, Araraquara, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Universidade Estadual Paulista	Crestani, CC (corresponding author), UNESP, Sch Pharmaceut Sci, Dept Nat Act Principles & Toxicol, Pharmacol Lab, Araraquara, SP, Brazil.	cccrestani@yahoo.com.br	ENGI, SHEILA A/O-2141-2013; Spolidorio, Luís Carlos/G-1857-2012; Crestani, Carlos C/E-4161-2012; Planeta, Cleopatra/Z-5255-2019; Scavone, Cristoforo/C-1580-2012; Leao, Rodrigo/J-4400-2015	ENGI, SHEILA A/0000-0002-5025-0177; Spolidorio, Luís Carlos/0000-0002-0592-542X; Crestani, Carlos C/0000-0002-1942-858X; Planeta, Cleopatra/0000-0002-1378-6327; Scavone, Cristoforo/0000-0002-1206-0882; Leao, Rodrigo/0000-0001-9865-7649	Sao Paulo Research Foundation (FAPESP) [2010/16192-8, 2012/14376-0, 2012/50549-6]; PADC-School of Pharmaceutical Sciences-Sao Paulo State University	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PADC-School of Pharmaceutical Sciences-Sao Paulo State University	This work was supported by Sao Paulo Research Foundation (FAPESP) grant#2010/16192-8, 2012/14376-0 and 2012/50549-6; and PADC-School of Pharmaceutical Sciences-Sao Paulo State University. CSP is a CNPq research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achar S, 2010, AM J CARDIOL, V106, P893, DOI 10.1016/j.amjcard.2010.05.013; ANTHONY JC, 1995, DRUG ALCOHOL DEPEN, V40, P9, DOI 10.1016/0376-8716(95)01194-3; Aquaro GD, 2011, HEART, V97, P2056, DOI 10.1136/hrt.2011.226977; Badanich KA, 2008, DEV PSYCHOBIOL, V50, P127, DOI 10.1002/dev.20252; Badanich KA, 2006, EUR J PHARMACOL, V550, P95, DOI 10.1016/j.ejphar.2006.08.034; Beutel A, 2005, J STEROID BIOCHEM, V93, P43, DOI 10.1016/j.jsbmb.2004.11.003; Beveridge TJR, 2004, NEUROSCI LETT, V370, P201, DOI 10.1016/j.neulet.2004.08.021; Brecklin CS, 1998, AM J HYPERTENS, V11, P1279, DOI 10.1016/S0895-7061(98)00135-6; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; Chambers RA, 2003, AM J PSYCHIAT, V160, P1041, DOI 10.1176/appi.ajp.160.6.1041; Chocyk A, 2006, BRAIN RES, V1090, P58, DOI 10.1016/j.brainres.2006.03.045; Coimbra LS, 2014, J CLIN PERIODONTOL, V41, P295, DOI 10.1111/jcpe.12203; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Crestani CC, 2011, EUR J PHARMACOL, V670, P527, DOI 10.1016/j.ejphar.2011.09.030; Crestani CC, 2010, NEUROSCI RES, V67, P317, DOI 10.1016/j.neures.2010.05.001; Cruz FC, 2013, NEUROSCIENCE, V253, P29, DOI 10.1016/j.neuroscience.2013.08.034; Cruz FC, 2012, J PSYCHOPHARMACOL, V26, P1366, DOI 10.1177/0269881112453210; DeWit DJ, 1997, HEALTH EDUC BEHAV, V24, P746, DOI 10.1177/109019819702400609; DURANT RH, 1993, NEW ENGL J MED, V328, P922, DOI 10.1056/NEJM199304013281304; DURANT RH, 1995, PEDIATRICS, V96, P23; DYER AR, 1980, AM J EPIDEMIOL, V112, P736, DOI 10.1093/oxfordjournals.aje.a113046; Engi SA, 2012, J CARDIOVASC PHARM, V59, P231, DOI 10.1097/FJC.0b013e31823cc58b; Fanton L, 2009, EXP TOXICOL PATHOL, V61, P317, DOI 10.1016/j.etp.2008.09.007; Goldstein RA, 2009, SEMIN DIAGN PATHOL, V26, P10, DOI 10.1053/j.semdp.2008.12.001; Grant BF, 1997, J STUD ALCOHOL, V58, P464, DOI 10.15288/jsa.1997.58.464; Grassi G, 2006, PROG CARDIOVASC DIS, V48, P407, DOI 10.1016/j.pcad.2006.03.002; Grassi G, 2004, CURR PHARM DESIGN, V10, P3579, DOI 10.2174/1381612043382756; Hassan AF, 2013, INT J HEALTH SCI-IJH, V7, P47, DOI 10.12816/0006020; HEAD GA, 1987, J AUTONOM NERV SYST, V21, P203, DOI 10.1016/0165-1838(87)90023-3; Honzikova N, 2009, PHYSIOL RES, V58, P605, DOI 10.33549/physiolres.931700; Johansson-Steensland P, 2002, EUR J NEUROSCI, V15, P539, DOI 10.1046/j.0953-816x.2001.01877.x; Kandel D, 1997, DRUG ALCOHOL DEPEN, V44, P11, DOI 10.1016/S0376-8716(96)01315-4; KLONER RA, 1992, CIRCULATION, V85, P407, DOI 10.1161/01.CIR.85.2.407; Lattanzio FA, 2005, CARDIOVASC TOXICOL, V5, P377, DOI 10.1385/CT:5:4:377; Macey DJ, 2004, PSYCHOPHARMACOLOGY, V172, P384, DOI 10.1007/s00213-003-1676-7; Maraj S, 2010, CLIN CARDIOL, V33, P264, DOI 10.1002/clc.20746; McCormick CM, 2010, BRAIN COGNITION, V72, P73, DOI 10.1016/j.bandc.2009.06.003; Olivares EL, 2014, PHYSIOL BEHAV, V126, P15, DOI 10.1016/j.physbeh.2013.12.006; Palatini P, 1997, J HUM HYPERTENS, V11, pS19; Phillis BD, 2000, EUR J PHARMACOL, V398, P263, DOI 10.1016/S0014-2999(00)00294-6; Reboussin BA, 2006, NEUROPSYCHOPHARMACOL, V31, P2055, DOI 10.1038/sj.npp.1301037; Riezzo I, 2011, MINI-REV MED CHEM, V11, P409, DOI 10.2174/138955711795445862; Romero Vecchione E, 2002, ACTA CIENT VENEZ, V53, P225; Rosa F, 2005, PHARMACOLOGY, V75, P5, DOI 10.1159/000085771; Salas-Ramirez KY, 2008, HORM BEHAV, V53, P378, DOI 10.1016/j.yhbeh.2007.11.004; Schramm-Sapyta NL, 2009, PSYCHOPHARMACOLOGY, V206, P1, DOI 10.1007/s00213-009-1585-5; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Sullivan ML, 1998, PROG CARDIOVASC DIS, V41, P1, DOI 10.1016/S0033-0620(98)80019-4; Tang EHC, 2010, PFLUG ARCH EUR J PHY, V459, P995, DOI 10.1007/s00424-010-0786-4; Tella SR, 1999, EUR J PHARMACOL, V383, P57, DOI 10.1016/S0014-2999(99)00582-8; Tirelli E, 2003, NEUROSCI BIOBEHAV R, V27, P163, DOI 10.1016/S0149-7634(03)00018-6; Togna GI, 2003, THROMB RES, V109, P195, DOI 10.1016/S0049-3848(03)00184-1; TSENG YT, 1994, FUND APPL TOXICOL, V22, P113, DOI 10.1006/faat.1994.1014; van Amsterdam J, 2010, REGUL TOXICOL PHARM, V57, P117, DOI 10.1016/j.yrtph.2010.02.001; Wong WC, 2013, J NEUROSCI, V33, P4913, DOI 10.1523/JNEUROSCI.1371-12.2013; Zombeck JA, 2009, PSYCHOPHARMACOLOGY, V201, P589, DOI 10.1007/s00213-008-1327-0	56	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105172	10.1371/journal.pone.0105172	http://dx.doi.org/10.1371/journal.pone.0105172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121974	Green Submitted, Green Published, gold			2022-12-27	WOS:000341017000102
J	Obanda, V; Omondi, GP; Chiyo, PI				Obanda, Vincent; Omondi, George Paul; Chiyo, Patrick Ilukol			The Influence of Body Mass Index, Age and Sex on Inflammatory Disease Risk in Semi-Captive Chimpanzees	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; PLATELET-DERIVED MICROPARTICLES; SERUM CLINICAL-CHEMISTRY; TUMOR-NECROSIS-FACTOR; BLOOD-CELL COUNT; LYMPHOCYTE RATIO; CAPTIVE CHIMPANZEES; CALORIC RESTRICTION; GENDER-DIFFERENCES	Obesity and ageing are emerging issues in the management of captive primates, including Chimpanzees, Pan troglodytes. Studies on humans show that obesity and old age can independently increase the risk of inflammatory-associated diseases indicated by elevated levels of pro-inflammatory cells and proteins in the blood of older or obese compared to levels in younger or non-obese individuals. In humans, sex can influence the outcomes of these risks. Health management of these problems in chimpanzee populations requires an understanding of similarities and differences of factors influencing inflammatory disease risks in humans and in chimpanzees. We examined the relationship between age, sex and Body Mass Index (BMI) with hematological biomarkers of inflammatory disease risk established for humans which include the neutrophil to lymphocyte ratio (NLR), and neutrophil, white blood cell (WBC), platelet microparticle and platelet counts. We found that higher values of NLR, neutrophil count and platelet microparticle count were associated with higher BMI values and older age indicating increased inflammation risk in these groups; a similar pattern to humans. There was a strong sex by age interaction on inflammation risk, with older males more at risk than older females. In contrast to human studies, total WBC count was not influenced by BMI, but like humans, WBC and platelet counts were lower in older individuals compared to younger individuals. Our findings are similar to those of humans and suggest that further insight on managing chimpanzees can be gained from extensive studies of ageing and obesity in humans. We suggest that managing BMI should be an integral part of health management in captive chimpanzee populations in order to partially reduce the risk of diseases associated with inflammation. These results also highlight parallels in inflammation risk between humans and chimpanzees and have implications for understanding the evolution of inflammation related diseases in apes.	[Obanda, Vincent] Kenya Wildlife Serv, Vet Serv Dept, Nairobi, Kenya; [Obanda, Vincent; Omondi, George Paul] Univ Nairobi, Fac Vet Med, Nairobi, Kenya; [Omondi, George Paul] Ol Pejeta Conservancy, Nanyuki, Kenya; [Chiyo, Patrick Ilukol] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Chiyo, Patrick Ilukol] Duke Univ, Dept Biol, Durham, NC USA	University of Nairobi; University of Notre Dame; Duke University	Chiyo, PI (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	pchiyo@gmail.com		Omondi, George/0000-0003-2041-4457	Arcus Foundation US [10OC-32]	Arcus Foundation US	Funding for the health examinations and laboratory analysis of blood samples was provided by the Arcus Foundation US grant number 10OC-32. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Rodriguez L, 2012, CELL IMMUNOL, V273, P124, DOI 10.1016/j.cellimm.2012.01.001; Amat JA, 2007, ECOL RES, V22, P282, DOI 10.1007/s11284-006-0022-z; Bauer SA, 2012, LAB ANIM-UK, V46, P193, DOI 10.1258/la.2012.011120; Bauer SA, 2011, COMPARATIVE MED, V61, P514; BERCOVITCH FB, 1992, HORM BEHAV, V26, P272, DOI 10.1016/0018-506X(92)90047-Y; Berkley KJ, 2006, AM J PHYSIOL-REG I, V291, pR241, DOI 10.1152/ajpregu.00287.2006; Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054289; Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212; Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Buyukkaya E, 2014, CLIN APPL THROMB-HEM, V20, P159, DOI 10.1177/1076029612459675; Cartier A, 2009, METABOLISM, V58, P1452, DOI 10.1016/j.metabol.2009.04.025; Casimir GJA, 2010, SHOCK, V34, P23, DOI 10.1097/SHK.0b013e3181ce2c3d; Casimir GJA, 2010, SHOCK, V33, P258, DOI 10.1097/SHK.0b013e3181b2b36b; Chakravarti A, 2009, LAB INVEST, V89, P1084, DOI 10.1038/labinvest.2009.74; Charles LE, 2007, OBESITY, V15, P2846, DOI 10.1038/oby.2007.338; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Colman RJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4557; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Dayal S, 2013, CIRCULATION, V127, P1308, DOI 10.1161/CIRCULATIONAHA.112.000966; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Diodato MD, 2001, CYTOKINE, V14, P162, DOI 10.1006/cyto.2001.0861; Dixon JB, 2006, OBES SURG, V16, P251, DOI 10.1381/096089206776116453; Duarte D, 2013, ALLERGY, V68, P1073, DOI 10.1111/all.12190; El Kebir D, 2010, THESCIENTIFICWORLDJO, V10, P1731, DOI 10.1100/tsw.2010.169; Ely JJ, 2013, ZOO BIOL, V32, P79, DOI 10.1002/zoo.21044; Enoch S., 2005, SURGERY, V23, P37, DOI DOI 10.1016/J.MPSUR.2007.11.005; Farhangi MA, 2013, J HEALTH POPUL NUTR, V31, P58; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; Gilbert-Diamond D, 2012, NUTR METAB CARDIOVAS, V22, P244, DOI 10.1016/j.numecd.2010.06.001; Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12; Goodchild Sarah, 2008, IZN International Zoo News, V55, P353; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Herndon JG, 2001, COMPARATIVE MED, V51, P60; Ho JE, 2005, J WOMENS HEALTH, V14, P117, DOI 10.1089/jwh.2005.14.117; Horstman LL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-10; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Howell S, 2003, COMPARATIVE MED, V53, P413; Ihrig M, 2001, COMPARATIVE MED, V51, P30; Imtiaz Fauzia, 2012, Int Arch Med, V5, P2, DOI 10.1186/1755-7682-5-2; Jayachandran M, 2011, J CARDIOVASC TRANSL, V4, P811, DOI 10.1007/s12265-011-9296-9; Jousilahti P, 1999, CIRCULATION, V99, P1165, DOI 10.1161/01.cir.99.9.1165; Kastman EK, 2012, J NEUROSCI, V32, P11897, DOI 10.1523/JNEUROSCI.2553-12.2012; Kaya H, 2014, CLIN APPL THROMB-HEM, V20, P221, DOI 10.1177/1076029613499821; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kubota K, 1991, Nihon Ronen Igakkai Zasshi, V28, P509; Lammey ML, 2008, J AM ASSOC LAB ANIM, V47, P56; Lefevre N, 2012, SHOCK, V38, P37, DOI 10.1097/SHK.0b013e3182571e46; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Li W, 2013, AGEING RES REV, V12, P1005, DOI 10.1016/j.arr.2013.05.006; Licastro Federico, 2005, Immun Ageing, V2, P8; Liu ZJ, 2010, ENCY EYE, P99; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Milagro FI, 2006, OBESITY, V14, P1118, DOI 10.1038/oby.2006.128; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Murakami T, 2007, THROMB RES, V119, P45, DOI 10.1016/j.thromres.2005.12.013; Nicoletti A, 1999, CARDIOVASC RES, V41, P532, DOI 10.1016/S0008-6363(98)00305-8; Nunamaker EA, 2012, COMPARATIVE MED, V62, P131; Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004; Obanda V, 2012, AFR J ECOL, V50, P60, DOI 10.1111/j.1365-2028.2011.01294.x; Ogawa K, 2008, IMMUN AGEING, V5, P135; Okyay GU, 2013, RENAL FAILURE, V35, P29, DOI 10.3109/0886022X.2012.734429; Park CS, 2010, AM J CARDIOL, V105, P1284, DOI 10.1016/j.amjcard.2009.12.045; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Robinson DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002149; Sampson AP, 2000, CLIN EXP ALLERGY, V30, P22; Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009; Schwitzer C, 2001, ZOO BIOL, V20, P261, DOI 10.1002/zoo.1026; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Seiler BM, 2009, J MED PRIMATOL, V38, P51, DOI 10.1111/j.1600-0684.2008.00307.x; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shaw AC, 2011, AGEING RES REV, V10, P346, DOI 10.1016/j.arr.2010.10.007; Sherwood Edward R, 2004, Best Pract Res Clin Anaesthesiol, V18, P385, DOI 10.1016/j.bpa.2003.12.002; Shiga S, 1990, Rinsho Byori, V38, P93; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Stowe RP, 2010, J GERONTOL A-BIOL, V65, P429, DOI 10.1093/gerona/glp198; Thavanati PKR, 2008, J GERONTOL A-BIOL, V63, P360, DOI 10.1093/gerona/63.4.360; Ueba T, 2008, THROMB HAEMOSTASIS, V100, P280, DOI 10.1160/TH07-11-0668; Ueba T, 2010, THROMB RES, V125, pE329, DOI 10.1016/j.thromres.2010.03.004; Uzenbaeva L.B., 2013, ADV GERONTOL, V3, P61; Varol E, 2013, ANGIOLOGY; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; Videan EN, 2008, AM J PRIMATOL, V70, P327, DOI 10.1002/ajp.20494; Videan EN, 2007, ZOO BIOL, V26, P93, DOI 10.1002/zoo.20122; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Visser M, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.1.e13; Wang R, 2011, INT J SPORTS MED, V32, P982, DOI 10.1055/s-0031-1283185; Warnberg J, 2006, AM J CLIN NUTR, V84, P505; Watkins LR, 1995, PAIN, V63, P289, DOI 10.1016/0304-3959(95)00186-7; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weiss EP, 2011, AM J PHYSIOL-HEART C, V301, pH1205, DOI 10.1152/ajpheart.00685.2011; Willette AA, 2012, DIABETES, V61, P1036, DOI 10.2337/db11-1187; Wisse BE, 2004, J AM SOC NEPHROL, V15, P2792, DOI 10.1097/01.ASN.0000141966.69934.21; Xu JZ, 2010, MECH AGEING DEV, V131, P487, DOI 10.1016/j.mad.2010.04.007; Yang Y, 2011, J GERONTOL A-BIOL, V66, P493, DOI 10.1093/gerona/glr003; Zahorec R, 2001, Bratisl Lek Listy, V102, P5; Zhang RX, 2010, HYPERTENSION, V55, P953, DOI 10.1161/HYPERTENSIONAHA.109.140608; Zihlman A, 2004, P NATL ACAD SCI USA, V101, P10541, DOI 10.1073/pnas.0402635101; Zihlman AL, 2007, J ZOOL, V273, P63, DOI 10.1111/j.1469-7998.2007.00301.x	107	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104602	10.1371/journal.pone.0104602	http://dx.doi.org/10.1371/journal.pone.0104602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121995	Green Published, gold			2022-12-27	WOS:000341017000046
J	Podobed, PS; Alibhai, FJ; Chow, CW; Martino, TA				Podobed, Peter S.; Alibhai, Faisal J.; Chow, Chi-Wing; Martino, Tami A.			Circadian Regulation of Myocardial Sarcomeric Titin-cap (Tcap, Telethonin): Identification of Cardiac Clock-Controlled Genes Using Open Access Bioinformatics Data	PLOS ONE			English	Article							HISTONE ACETYLTRANSFERASE; CARDIOVASCULAR-DISEASE; CONTRACTILE FUNCTION; Z-DISC; EXPRESSION; HEART; PROTEIN; RHYTHMS; HYPERTROPHY; METABOLISM	Circadian rhythms are important for healthy cardiovascular physiology and are regulated at the molecular level by a circadian clock mechanism. We and others previously demonstrated that 9-13% of the cardiac transcriptome is rhythmic over 24 h daily cycles; the heart is genetically a different organ day versus night. However, which rhythmic mRNAs are regulated by the circadian mechanism is not known. Here, we used open access bioinformatics databases to identify 94 transcripts with expression profiles characteristic of CLOCK and BMAL1 targeted genes, using the CircaDB website and JTK_Cycle. Moreover, 22 were highly expressed in the heart as determined by the BioGPS website. Furthermore, 5 heart-enriched genes had human/mouse conserved CLOCK: BMAL1 promoter binding sites (E-boxes), as determined by UCSC table browser, circadian mammalian promoter/enhancer database PEDB, and the European Bioinformatics Institute alignment tool (EMBOSS). Lastly, we validated findings by demonstrating that Titin cap (Tcap, telethonin) was targeted by transcriptional activators CLOCK and BMAL1 by showing 1) Tcap mRNA and TCAP protein had a diurnal rhythm in murine heart; 2) cardiac Tcap mRNA was rhythmic in animals kept in constant darkness; 3) Tcap and control Per2 mRNA expression and cyclic amplitude were blunted in Clock D19/D19 hearts; 4) BMAL1 bound to the Tcap promoter by ChIP assay; 5) BMAL1 bound to Tcap promoter E-boxes by biotinylated oligonucleotide assay; and 6) CLOCK and BMAL1 induced tcap expression by luciferase reporter assay. Thus this study identifies circadian regulated genes in silico, with validation of Tcap, a critical regulator of cardiac Z-disc sarcomeric structure and function.	[Podobed, Peter S.; Alibhai, Faisal J.; Martino, Tami A.] Univ Guelph, Dept Biomed Sci, Cardiovasc Res Grp, Guelph, ON N1G 2W1, Canada; [Chow, Chi-Wing] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	University of Guelph; Yeshiva University; Albert Einstein College of Medicine	Martino, TA (corresponding author), Univ Guelph, Dept Biomed Sci, Cardiovasc Res Grp, Guelph, ON N1G 2W1, Canada.	tmartino@uoguelph.ca		Alibhai, Faisal/0000-0002-8145-4682	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Canadian Institutes of Health Research (CIHR) to TAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibhai FJ, 2014, CIRC RES, V114, P1713, DOI 10.1161/CIRCRESAHA.114.302995; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Candasamy AJ, 2014, J BIOL CHEM, V289, P1282, DOI 10.1074/jbc.M113.479030; Collins HE, 2010, CIRC RES, V106, P1244, DOI 10.1161/CIRCRESAHA.109.213942; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Davidson AJ, 2005, CLIN EXP HYPERTENS, V27, P307, DOI 10.1081/CEH-200048933; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; Grimaldi B, 2009, INT J BIOCHEM CELL B, V41, P81, DOI 10.1016/j.biocel.2008.08.035; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Ibrahim M, 2013, HUM MOL GENET, V22, P372, DOI 10.1093/hmg/dds434; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; Kumaki Y, 2008, P NATL ACAD SCI USA, V105, P14946, DOI 10.1073/pnas.0802636105; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Leibetseder V, 2009, CHRONOBIOL INT, V26, P621, DOI 10.1080/07420520902924939; Linke WA, 2014, CIRC RES, V114, P1052, DOI 10.1161/CIRCRESAHA.114.301286; Lutzner N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042166; Martino T, 2004, J MOL MED, V82, P256, DOI 10.1007/s00109-003-0520-1; Martino TA, 2007, HYPERTENSION, V49, P1104, DOI 10.1161/HYPERTENSIONAHA.106.083568; Martino TA, 2009, CIRC RES, V105, P1047, DOI 10.1161/CIRCRESAHA.109.206201; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Nakahata Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-1; Paquet ER, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040038; Paschos GK, 2010, CIRC RES, V106, P833, DOI 10.1161/CIRCRESAHA.109.211706; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Podobed P, 2014, AM J PHYSL REGUL INT; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JA, 2000, GENE DEV, V14, P679; Roenneberg T, 2005, NAT REV MOL CELL BIO, V6, P965, DOI 10.1038/nrm1766; Sachan N, 2011, CIRC RES, V108, P437, DOI 10.1161/CIRCRESAHA.110.235309; Sole MJ, 2009, J APPL PHYSIOL, V107, P1318, DOI 10.1152/japplphysiol.00426.2009; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Tsimakouridze EV, 2012, CHRONOBIOL INT, V29, P810, DOI 10.3109/07420528.2012.691145; Valle G, 1997, FEBS LETT, V415, P163, DOI 10.1016/S0014-5793(97)01108-3; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yang F, 2013, J ATHEROSCLER THROMB, V20, P267, DOI 10.5551/jat.14381; Yang TTC, 2012, METHODS MOL BIOL, V809, P75, DOI 10.1007/978-1-61779-376-9_5; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoshitane H, 2014, MOL CELL BIOL, V34, P1776, DOI 10.1128/MCB.01465-13; Young ME, 2001, CIRC RES, V89, P1199, DOI 10.1161/hh2401.100741; Young ME, 2001, CIRC RES, V88, P1142, DOI 10.1161/hh1101.091190; Young ME, 2014, J BIOL RHYTHM; Zielinski T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096462; Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343	60	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104907	10.1371/journal.pone.0104907	http://dx.doi.org/10.1371/journal.pone.0104907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121604	Green Submitted, Green Published, gold			2022-12-27	WOS:000341017000072
J	Regina, VR; Lokanathan, AR; Modrzynski, JJ; Sutherland, DS; Meyer, RL				Regina, Viduthalai R.; Lokanathan, Arcot R.; Modrzynski, Jakub J.; Sutherland, Duncan S.; Meyer, Rikke L.			Surface Physicochemistry and Ionic Strength Affects eDNA's Role in Bacterial Adhesion to Abiotic Surfaces	PLOS ONE			English	Article							BIOFILM FORMATION; EXTRACELLULAR DNA; SUSPENDED PARTICLES; ORGANIC-MATTER; STAPHYLOCOCCUS-XYLOSUS; SUBSTRATUM SURFACES; PLASMID DNA; IV PILI; FORCES; CHARGE	Extracellular DNA (eDNA) is an important structural component of biofilms formed by many bacteria, but few reports have focused on its role in initial cell adhesion. The aim of this study was to investigate the role of eDNA in bacterial adhesion to abiotic surfaces, and determine to which extent eDNA-mediated adhesion depends on the physicochemical properties of the surface and surrounding liquid. We investigated eDNA alteration of cell surface hydrophobicity and zeta potential, and subsequently quantified the effect of eDNA on the adhesion of Staphylococcus xylosus to glass surfaces functionalised with different chemistries resulting in variable hydrophobicity and charge. Cell adhesion experiments were carried out at three different ionic strengths. Removal of eDNA from S. xylosus cells by DNase treatment did not alter the zeta potential, but rendered the cells more hydrophilic. DNase treatment impaired adhesion of cells to glass surfaces, but the adhesive properties of S. xylosus were regained within 30 minutes if DNase was not continuously present, implying a continuous release of eDNA in the culture. Removal of eDNA lowered the adhesion of S. xylosus to all surfaces chemistries tested, but not at all ionic strengths. No effect was seen on glass surfaces and carboxyl-functionalised surfaces at high ionic strength, and a reverse effect occurred on amine-functionalised surfaces at low ionic strength. However, eDNA promoted adhesion of cells to hydrophobic surfaces irrespective of the ionic strength. The adhesive properties of eDNA in mediating initial adhesion of S. xylosus is thus highly versatile, but also dependent on the physicochemical properties of the surface and ionic strength of the surrounding medium.	[Regina, Viduthalai R.; Lokanathan, Arcot R.; Modrzynski, Jakub J.; Sutherland, Duncan S.; Meyer, Rikke L.] Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark; [Meyer, Rikke L.] Aarhus Univ, Dept Biosci, Aarhus C, Denmark; [Lokanathan, Arcot R.] Aalto Univ, Dept Forest Prod Technol, Aalto, Finland; [Modrzynski, Jakub J.] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg C, Denmark	Aarhus University; Aarhus University; Aalto University; University of Copenhagen	Meyer, RL (corresponding author), Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark.	rikke.meyer@inano.au.dk	Meyer, Rikke Louise/AAB-5377-2021; Modrzynski, Jakub/C-5667-2015; Sutherland, Duncan S/E-4385-2010	Meyer, Rikke Louise/0000-0002-6485-5134; Modrzynski, Jakub/0000-0001-6297-5741; Sutherland, Duncan S/0000-0002-5045-9915	Danish Strategic Research Council [2106-07-0013]; Alfa Laval; Lundbeck Foundation; Carlsberg Foundation; Lundbeck Foundation [R44-2009-4427] Funding Source: researchfish	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Alfa Laval; Lundbeck Foundation(Lundbeckfonden); Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden)	The authors gratefully acknowledge the Danish Strategic Research Council (Grant No. 2106-07-0013), Alfa Laval, the Lundbeck Foundation, and the Carlsberg Foundation for funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; BECKETT R, 1990, COLLOID SURFACE, V44, P35, DOI 10.1016/0166-6622(90)80185-7; Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0; Busscher HJ, 2008, APPL ENVIRON MICROB, V74, P2559, DOI 10.1128/AEM.02839-07; BUSSCHER HJ, 1984, APPL ENVIRON MICROB, V48, P980, DOI 10.1128/AEM.48.5.980-983.1984; Callow Maureen E., 2002, Biologist (London), V49, P10; Cebula TA, 2011, MICROBIAL FORENSICS, 2ND EDITION, P29, DOI 10.1016/B978-0-12-382006-8.00003-7; Chen Y, 2011, APPL ENVIRON MICROB, V77, P5065, DOI 10.1128/AEM.00502-11; Corbett JCW, 2012, COLLOID SURFACE A, V396, P169, DOI 10.1016/j.colsurfa.2011.12.065; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Das T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058299; Das T, 2011, LANGMUIR, V27, P10113, DOI 10.1021/la202013m; Das T, 2011, SOFT MATTER, V7, P2927, DOI 10.1039/c0sm01142h; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Fletcher M., 1991, BIOFOULING, V4, P129, DOI [10.1080/08927019109378203, DOI 10.1080/08927019109378203]; Fredheim EGA, 2009, J CLIN MICROBIOL, V47, P1172, DOI 10.1128/JCM.01891-08; Goodman SD, 2011, MUCOSAL IMMUNOL, V4, P625, DOI 10.1038/mi.2011.27; Granhall U, 2010, J IND MICROBIOL BIOT, V37, P1061, DOI 10.1007/s10295-010-0754-1; Harmsen M, 2010, APPL ENVIRON MICROB, V76, P2271, DOI 10.1128/AEM.02361-09; Heijstra BD, 2009, ANTON LEEUW INT J G, V95, P343, DOI 10.1007/s10482-009-9320-0; Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6; HUNTER KA, 1982, LIMNOL OCEANOGR, V27, P322, DOI 10.4319/lo.1982.27.2.0322; HUNTER KA, 1979, NATURE, V282, P823, DOI 10.1038/282823a0; Huub HMR, 1995, COLLOIDS SURFACES B, V4; Jurcisek JA, 2007, J BACTERIOL, V189, P3868, DOI 10.1128/JB.01935-06; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Lata S, 2011, J CORROSION SCI ENG, V14; Liu Y, 2009, BIOFOULING, V25, P241, DOI 10.1080/08927010802713414; Lyubchenko YL, 2011, MICRON, V42, P196, DOI 10.1016/j.micron.2010.08.011; Mackey-Lawrence NM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-61; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Marchand S, 2012, COMPR REV FOOD SCI F, V11, P133, DOI 10.1111/j.1541-4337.2011.00183.x; Marino M, 2011, J APPL MICROBIOL, V110, P550, DOI 10.1111/j.1365-2672.2010.04909.x; Moschetti G, 1997, SYST APPL MICROBIOL, V20, P432, DOI 10.1016/S0723-2020(97)80012-4; Nguyen TH, 2007, ENVIRON SCI TECHNOL, V41, P5370, DOI 10.1021/es070425m; Nur A, 2013, J APPL MICROBIOLOGY; Perreten V, 1998, SYST APPL MICROBIOL, V21, P113, DOI 10.1016/S0723-2020(98)80014-3; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Reid G, 1999, INT J ANTIMICROB AG, V11, P223, DOI 10.1016/S0924-8579(99)00020-5; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Roberts AP, 2010, EXPERT REV ANTI-INFE, V8, P1441, DOI 10.1586/ERI.10.106; Robinson H, 2000, NUCLEIC ACIDS RES, V28, P1760, DOI 10.1093/nar/28.8.1760; ROMANOWSKI G, 1991, APPL ENVIRON MICROB, V57, P1057, DOI 10.1128/AEM.57.4.1057-1061.1991; Seu KJ, 2007, BIOPHYS J, V92, P2445, DOI 10.1529/biophysj.106.099721; Sondergaard AK, 2002, INT J FOOD MICROBIOL, V75, P99, DOI 10.1016/S0168-1605(01)00729-2; Stoodley P, 2011, CURR ORTHOP PRACT, V22, P558, DOI 10.1097/BCO.0b013e318230efcf; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; VANLOOSDRECHT MCM, 1989, MICROBIAL ECOL, V17, P1, DOI 10.1007/BF02025589; VANLOOSDRECHT MCM, 1990, AQUAT SCI, V52, P103, DOI 10.1007/BF00878244; VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7; VernozyRozand C, 1996, INT J FOOD MICROBIOL, V30, P271, DOI 10.1016/0168-1605(96)00952-X; Weiss L, 1972, PROGR SURFACE SCI, V1, P355; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Zita A, 1997, APPL ENVIRON MICROB, V63, P1168, DOI 10.1128/AEM.63.3.1168-1170.1997	55	20	22	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105033	10.1371/journal.pone.0105033	http://dx.doi.org/10.1371/journal.pone.0105033			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122477	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000091
J	Wagg, AS; Newman, DK; Leichsenring, K; van Houten, P				Wagg, Adrian S.; Newman, Diane K.; Leichsenring, Kai; van Houten, Paul			Developing an Internationally-Applicable Service Specification for Continence Care: Systematic Review, Evidence Synthesis and Expert Consensus	PLOS ONE			English	Review							QUALITY-OF-LIFE; URINARY-INCONTINENCE; COST-EFFECTIVENESS; GENERAL-PRACTITIONERS; NURSE-PRACTITIONER; ADULT PATIENTS; PREVALENCE; WOMEN; UROGYNAECOLOGY; EPIDEMIOLOGY	Background: Global demographic trends suggest that the incidence of both urinary and faecal incontinence will rise in the coming years, bringing significant health and economic implications for both patients and payers. There is limited organisational evidence to guide payers and providers about service configuration which will deliver efficient guideline-compliant, high-quality patient care. Objectives: To create, using evidence from a systematic review, qualitative data and expert consensus an internationally applicable service specification for continence care. Method: Evidence was obtained from a systematic and grey literature review of published randomised controlled trials and quasi-experimental studies reporting efficacy of continence service design at the level of the community dwelling patient with either bladder or bowel incontinence, governmental reports and policy frameworks supplemented by data from 47 semi-structured interviews with clinicians, patients, patient-representatives and policy experts from four geographies broadly representative of different healthcare systems. Results: A number of themes related to current and potential future organisation of continence care were identified from the data. A modular service specification with eight core components was created including case detection, initial assessment and treatment, case co-ordination, caregiver support, community-based support, specialist assessment and treatment, use of containment products, and use of technology. Within this framework important key recommendations are: ensure robust referral pathways, shift assessment for case coordination to nurses specializing in continence care, promote self-management and technology, use comprehensive assessment tools and service performance targets based on outcome and operational measures. Conclusions: This study has defined practice gaps in the provision of continence services and described eight core components of a service specification for incontinence that commissioners and payers of health and social care could consider using to provide high-quality continence care. A shift towards a community-delivered, nurse-led model appears to be associated with clinical and cost-effective care for people with bladder and bowel incontinence.	[Wagg, Adrian S.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Newman, Diane K.] Univ Penn, Div Urol, Philadelphia, PA USA; [Leichsenring, Kai] European Ctr Social Welf Policy & Res, Vienna, Austria; [van Houten, Paul] Zonnhuisgroep Amstelland, Elderly Med, Amstelveen, Netherlands	University of Alberta; University of Pennsylvania	Wagg, AS (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	adrian.wagg@ualberta.ca	Leichsenring, Kai/J-5943-2014	Leichsenring, Kai/0000-0002-4448-1585	SCA (Svenska Cellulosa Aktiebolaget)	SCA (Svenska Cellulosa Aktiebolaget)	The study was funded by SCA (Svenska Cellulosa Aktiebolaget). The funders had no role in the design and conduct of the study, collection, management, analysis and interpretation of data, or preparation, review and approval of the manuscript.	Abrams P, 2013, INCONTINENCE, P1895; Albers-Heitner CP, 2012, NEUROUROL URODYNAM, V31, P526, DOI 10.1002/nau.21204; Albers-Heitner P, 2011, WHO CARES STUDYING V; Albers-Heitner P, 2008, J EVAL CLIN PRACT, V14, P807, DOI 10.1111/j.1365-2753.2007.00925.x; Albers-Heitner P, 2013, SCAND J CARING SCI, V27, P253, DOI 10.1111/j.1471-6712.2012.01023.x; Albers-Heitner P, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-84; All-Party Parliamentary Group for Bladder and Bowel Continence Care, 2011, COST EFF COMM CONT C; Appleby I, 2013, INCONTINENCE AUSTR; Berg M, 2012, CONTRACTING VALUE SH; Borrie MJ, 2002, CAN MED ASSOC J, V166, P1267; Coyne KS, 2009, BJU INT, V104, P352, DOI 10.1111/j.1464-410X.2009.08427.x; de Bruin M, 2013, NEW EHEALTH SERVICE; Deglise C, 2012, J TELEMED TELECARE, V18, P273, DOI 10.1258/jtt.2012.110810; Du Moulin MFMT, 2009, SCAND J CARING SCI, V23, P222, DOI 10.1111/j.1471-6712.2008.00610.x; Ebbesen MH, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-27; Farrell SA, 2009, J OBSTET GYNAECOL CA, V31, P247, DOI 10.1016/S1701-2163(16)34123-8; Gawande A., 2009, COST CONUNDRUM NEW Y; Gemmill Robin, 2010, Urol Nurs, V30, P336; Georgiou EX, 2011, J OBSTET GYNAECOL, V31, P156, DOI 10.3109/01443615.2010.541569; Ginsburg PB, 2012, HEALTH AFFAIR, V31, P1977, DOI 10.1377/hlthaff.2012.0350; Gotoh M, 2009, NEUROUROL URODYNAM, V28, P492, DOI 10.1002/nau.20675; GRIMBY A, 1993, AGE AGEING, V22, P82, DOI 10.1093/ageing/22.2.82; Harari D, 2013, CONTINENCE CARE SERV; Horng SS, 2013, NEUROUROL URODYNAM, V32, P371, DOI 10.1002/nau.22302; Hsiao CJ, 2014, AM J MED QUAL, V29, P44, DOI 10.1177/1062860613483870; Imamura M, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14400; Kaplan RS, 2011, HARVARD BUS REV, V89, P46; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Krissovich M, 1998, GERIATR NURS, V19, P91, DOI 10.1016/S0197-4572(98)90045-3; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lee YS, 2011, WORLD J UROL, V29, P185, DOI 10.1007/s00345-009-0490-1; Lugtenberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025987; Matharu G S, 2004, Br J Nurs, V13, P140; McClurg D, 2013, NEUROUROL URODYNAM, V32, P224, DOI 10.1002/nau.22284; McFall S, 1997, ARCH FAM MED, V6, P114, DOI 10.1001/archfami.6.2.114; Milsom I., 2017, INCONTINENCE, V6th ed., P15; Moore K, 2013, INCONTINENCE, P1831; Moore KH, 2003, BJOG-INT J OBSTET GY, V110, P649, DOI 10.1046/j.1471-0528.2003.02264.x; MT Ho, 2012, AUSTR NZ CONTINENCE, V18; Munneke M, 2010, LANCET NEUROL, V9, P46, DOI 10.1016/S1474-4422(09)70327-8; National Collaborating Centre for Women's & Children's Health, 2006, UR INC MAN UR INC WO; Newman D, 2013, INCONTINENCE; Newman D, 2006, TXB FEMALE UROLOGY U, P91; NICE, 2007, FAEC INC MAN FAEC IN, P6; NICE, 2013, INT METH GUID DEV SE; Noimark D, 2009, NEUROUROL URODYNAM, V28, P567; O'Donnell Maire, 2007, Eur J Gen Pract, V13, P20, DOI 10.1080/14017430601049381; Oliver R, 2009, INT UROGYNECOL J, V20, P913, DOI 10.1007/s00192-009-0878-x; Paterson J, 2003, DISABIL REHABIL, V25, P955, DOI 10.1080/096382809210142211; Paterson J, 2006, CONSULTATION C UNPUB; Ploeg J, 2010, WORLDV EVID-BASED NU, V7, P238, DOI 10.1111/j.1741-6787.2010.00202.x; Porter ME, 2009, NEW ENGL J MED, V361, P109, DOI 10.1056/NEJMp0904131; Reuben DB, 2013, J AM GERIATR SOC, V61, P857, DOI 10.1111/jgs.12268; Rice KL, 2010, AM J RESP CRIT CARE, V182, P890, DOI 10.1164/rccm.200910-1579OC; Roberts M., 2008, GETTING HLTH REFORM, DOI DOI 10.1093/ACPROF:OSO/9780195371505.001.0001; Royal College of Physicians, 2012, NAT AUD CONT CAR NAC; Schultz Susan E, 2003, Health Rep, V14, P41; Shaw C, 2000, J CLIN NURS, V9, P574, DOI 10.1046/j.1365-2702.2000.00414.x; Shaw C, 2007, FAM PRACT, V24, P461, DOI 10.1093/fampra/cmm041; Sirls LT, 2013, J UROLOGY, V189, P204, DOI 10.1016/j.juro.2012.09.050; Stephen K, 2012, INT C TEL TEL LOND U; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Stothers L, 2008, CAN J UROL, V15, P4084; Swanson JG, 2002, CAN FAM PHYSICIAN, V48, P86; Tarricone R, 2010, EC INCONTINENCE; Tennstedt SL, 2008, AM J EPIDEMIOL, V167, P390, DOI 10.1093/aje/kwm356; Thomas P, 2004, INT J GERIATR PSYCH, V19, P127, DOI 10.1002/gps.1039; van der Veen R, 2011, QUALITY LIFE CARERS; Viktrup Lars, 2004, BMC Fam Pract, V5, P13, DOI 10.1186/1471-2296-5-13; Wagg A, 2005, J EVAL CLIN PRACT, V11, P525, DOI 10.1111/j.1365-2753.2005.00570.x; Wagg A, 2009, AGE AGEING, V38, P730, DOI 10.1093/ageing/afp177; Wicks P, 2014, QUAL LIFE RES, V23, P195, DOI 10.1007/s11136-013-0458-x; Williams KS, 2005, BRIT J GEN PRACT, V55, P696; Wilson L, 2001, OBSTET GYNECOL, V98, P398, DOI 10.1016/S0029-7844(01)01464-8	74	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104129	10.1371/journal.pone.0104129	http://dx.doi.org/10.1371/journal.pone.0104129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO0QT	25121511	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000029
J	Boyle, DS; McNerney, R; Low, HT; Leader, BT; Perez-Osorio, AC; Meyer, JC; O'Sullivan, DM; Brooks, DG; Piepenburg, O; Forrest, MS				Boyle, David S.; McNerney, Ruth; Low, Hwee Teng; Leader, Brandon Troy; Perez-Osorio, Ailyn C.; Meyer, Jessica C.; O'Sullivan, Denise M.; Brooks, David G.; Piepenburg, Olaf; Forrest, Matthew S.			Rapid Detection of Mycobacterium tuberculosis by Recombinase Polymerase Amplification	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; POINT-OF-CARE; RIFAMPIN RESISTANCE; MICROSCOPY CENTERS; INSERTION-SEQUENCE; IS6110; IDENTIFICATION; DIAGNOSIS; COMPLEX; COPY	Improved access to effective tests for diagnosing tuberculosis (TB) has been designated a public health priority by the World Health Organisation. In high burden TB countries nucleic acid based TB tests have been restricted to centralised laboratories and specialised research settings. Requirements such as a constant electrical supply, air conditioning and skilled, computer literate operators prevent implementation of such tests in many settings. Isothermal DNA amplification technologies permit the use of simpler, less energy intensive detection platforms more suited to low resource settings that allow the accurate diagnosis of a disease within a short timeframe. Recombinase Polymerase Amplification (RPA) is a rapid, low temperature isothermal DNA amplification reaction. We report here RPA-based detection of Mycobacterium tuberculosis complex (MTC) DNA in <20 minutes at 39 degrees C. Assays for two MTC specific targets were investigated, IS6110 and IS1081. When testing purified MTC genomic DNA, limits of detection of 6.25 fg (IS6110) and 20 fg (IS1081) were consistently achieved. When testing a convenience sample of pulmonary specimens from suspected TB patients, RPA demonstrated superior accuracy to indirect fluorescence microscopy. Compared to culture, sensitivities for the IS1081 RPA and microscopy were 91.4% (95%CI: 85, 97.9) and 86.1% (95%CI: 78.1, 94.1) respectively (n = 71). Specificities were 100% and 88.6% (95%CI: 80.8, 96.1) respectively. For the IS6110 RPA and microscopy sensitivities of 87.5% (95%CI: 81.7, 93.2) and 70.8% (95%CI: 62.9, 78.7) were obtained (n = 90). Specificities were 95.4 (95%CI: 92.3,98.1) and 88% (95%CI: 83.6, 92.4) respectively. The superior specificity of RPA for detecting tuberculosis was due to the reduced ability of fluorescence microscopy to distinguish Mtb complex from other acid fast bacteria. The rapid nature of the RPA assay and its low energy requirement compared to other amplification technologies suggest RPA-based TB assays could be of use for integration into a point-of-care test for use in resource constrained settings.	[Boyle, David S.; Leader, Brandon Troy] Program Appropriate Technol Hlth, Seattle, WA USA; [McNerney, Ruth; Low, Hwee Teng; O'Sullivan, Denise M.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Perez-Osorio, Ailyn C.] Washington State Dept Hlth, Publ Hlth Labs, Shoreline, WA USA; [Meyer, Jessica C.; Brooks, David G.; Piepenburg, Olaf; Forrest, Matthew S.] TwistDx Ltd, Cambridge, England	University of London; London School of Hygiene & Tropical Medicine	Forrest, MS (corresponding author), TwistDx Ltd, Cambridge, England.	m.forrest@twistdx.co.uk		Forrest, Matthew/0000-0002-2141-0303	National Institutes of Health (NIAID) [R01AI097038]; Technology Strategy Board (UK) [TP130268]; TwistDx in the form of salaries; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097038] Funding Source: NIH RePORTER	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Technology Strategy Board (UK); TwistDx in the form of salaries; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	DSB & BTL were supported by National Institutes of Health (NIAID R01AI097038) and a variety of discretionary donors to PATH for early studies (http://www.nih.gov/ and http://www.path.org/). RM, HTL, DOS, JCM, DGB, OP, and MSF gratefully acknowledge the Technology Strategy Board (UK) for their support of this work (Project No: TP130268, https://www.innovateuk.org/). JCM, DGB, OP, and MSF were also supported by TwistDx in the form of salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abd El Wahed A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071642, 10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364]; Abebe G, 2011, J MICROBIOL METH, V84, P155, DOI 10.1016/j.mimet.2010.11.014; Alonso H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-422; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ao WY, 2012, J CLIN MICROBIOL, V50, P2433, DOI 10.1128/JCM.00208-12; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Boyle DS, 2013, MBIO, V4, DOI 10.1128/mBio.00135-13; Castan P, 2014, J CLIN MICROBIOL, V52, P502, DOI 10.1128/JCM.02209-13; Clinical and Laboratory Standards Institute (CLSI), 2008, M48A CLSI; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLLINS DM, 1991, FEMS MICROBIOL LETT, V83, P11; Denkinger CM, 2013, EUR RESPIR J, V42, P544, DOI 10.1183/09031936.00081113; Denkinger CM, 2011, LANCET INFECT DIS; Drain PK, 2013, LANCET INFECT DIS; EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977; Fang RD, 2009, J CLIN MICROBIOL, V47, P845, DOI 10.1128/JCM.01528-08; Flores LL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-55; FOMUKONG NG, 1994, TUBERCLE LUNG DIS, V75, P435, DOI 10.1016/0962-8479(94)90117-1; Huyen MNT, 2013, INT J TUBERC LUNG D, V17, P1479, DOI 10.5588/ijtld.13.0149; LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; McNerney R, 2011, NAT REV MICROBIOL, V9, P204, DOI 10.1038/nrmicro2521; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; Mitarai S, 2011, INT J TUBERC LUNG D, V15, P1211, DOI 10.5588/ijtld.10.0629; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; Niemz A, 2012, EXPERT REV MOL DIAGN, V12, P687, DOI [10.1586/ERM.12.71, 10.1586/erm.12.71]; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Nikam C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051121; Pai NP, 2012, DISCOV MED, V13, P35; Perez-Osorio AC, 2012, J CLIN MICROBIOL, V50, P326, DOI 10.1128/JCM.05570-11; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Savelkoul PHM, 2006, J MICROBIOL METH, V66, P177, DOI 10.1016/j.mimet.2005.12.003; Seki M, 2009, VACCINE, V27, P1710, DOI 10.1016/j.vaccine.2009.01.034; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; THIERRY D, 1990, J CLIN MICROBIOL, V28, P2668, DOI 10.1128/JCM.28.12.2668-2673.1990; UNITAID, 2012, TUB DIAGN TECHN MARK; Van Deun A, 2004, INT J TUBERC LUNG D, V8, P816; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1992, J CLIN MICROBIOL, V30, P1772, DOI 10.1128/JCM.30.7.1772-1777.1992; WHO, 2009, GLOB TUB REP; WHO, 2010, STRAT TECHN ADV GROU; World Health Organization, 2021, 10 THREATS GLOB HLTH	43	106	128	5	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103091	10.1371/journal.pone.0103091	http://dx.doi.org/10.1371/journal.pone.0103091			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118698	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000340900600016
J	Chaturvedi, AK; Hameed, RS; Wozniak, KL; Hole, CR; Wager, CML; Weintraub, ST; Lopez-Ribot, JL; Wormley, FL				Chaturvedi, Ashok K.; Hameed, Rumanasma S.; Wozniak, Karen L.; Hole, Camaron R.; Wager, Chrissy M. Leopold; Weintraub, Susan T.; Lopez-Ribot, Jose L.; Wormley, Floyd L., Jr.			Vaccine-Mediated Immune Responses to Experimental Pulmonary Cryptococcus gattii Infection in Mice	PLOS ONE			English	Article							T-CELL RESPONSES; CANDIDA-ALBICANS; NEOFORMANS INFECTION; BRITISH-COLUMBIA; 2 VARIETIES; WALL; HEAT-SHOCK-PROTEIN-60; IDENTIFICATION; PROTEINS; ANTIGENS	Cryptococcus gattii is a fungal pathogen that can cause life-threatening respiratory and disseminated infections in immune-competent and immune-suppressed individuals. Currently, there are no standardized vaccines against cryptococcosis in humans, underlying an urgent need for effective therapies and/or vaccines. In this study, we evaluated the efficacy of intranasal immunization with C. gattii cell wall associated (CW) and/or cytoplasmic (CP) protein preparations to induce protection against experimental pulmonary C. gattii infection in mice. BALB/c mice immunized with C. gattii CW and/or CP protein preparations exhibited a significant reduction in pulmonary fungal burden and prolonged survival following pulmonary challenge with C. gattii. Protection was associated with significantly increased pro-inflammatory and Th1-type cytokine recall responses, in vitro and increased C. gattii-specific antibody production in immunized mice challenged with C. gattii. A number of immunodominant proteins were identified following immunoblot analysis of C. gattii CW and CP protein preparations using sera from immunized mice. Immunization with a combined CW and CP protein preparation resulted in an early increase in pulmonary T cell infiltrates following challenge with C. gattii. Overall, our studies show that C. gattii CW and CP protein preparations contain antigens that may be included in a subunit vaccine to induce prolonged protection against pulmonary C. gattii infection.	[Chaturvedi, Ashok K.; Hameed, Rumanasma S.; Wozniak, Karen L.; Hole, Camaron R.; Wager, Chrissy M. Leopold; Lopez-Ribot, Jose L.; Wormley, Floyd L., Jr.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Chaturvedi, Ashok K.; Hameed, Rumanasma S.; Wozniak, Karen L.; Hole, Camaron R.; Wager, Chrissy M. Leopold; Lopez-Ribot, Jose L.; Wormley, Floyd L., Jr.] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX USA; [Weintraub, Susan T.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio	Wormley, FL (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	floyd.wormley@utsa.edu	Lopez-Ribot, Jose L/D-2048-2010	Hole, Camaron/0000-0002-9363-3020; Lopez-Ribot, Jose/0000-0003-1992-3270; Leopold Wager, Chrissy/0000-0002-3828-055X; Wozniak, Karen/0000-0003-1798-2146	Army Research Office of the Department of Defense [W911NF-11-1-0136]; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) [2RO1 AI071752, R21 AI083718]; UTHSCSA; NIH [1 S10 RR021160-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR021160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083718, R01AI071752] Funding Source: NIH RePORTER	Army Research Office of the Department of Defense; National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UTHSCSA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Army Research Office of the Department of Defense under Contract No. W911NF-11-1-0136 awarded to FW and JL (http://www.defense. gov/) and grants 2RO1 AI071752 and R21 AI083718 from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded to FW (http://www.nih.gov/). Protein identifications were accomplished at the Institutional Mass Spectrometry Laboratory at The University of Texas Health Science Center at San Antonio with support by UTHSCSA and NIH (1 S10 RR021160-01) awarded to SW (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster P, 2009, CBE-LIFE SCI EDUC, V8, P203, DOI 10.1187/cbe.09-03-0025; Soares RDA, 2008, INFECT IMMUN, V76, P4214, DOI 10.1128/IAI.00753-07; Biondo C, 2005, INFECT IMMUN, V73, P7348, DOI 10.1128/IAI.73.11.7348-7355.2005; Byrnes EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005851; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Chaffin WL, 1998, MICROBIOL MOL BIOL R, V62, P130, DOI 10.1128/MMBR.62.1.130-180.1998; Chaturvedi AK, 2013, PROTEOMICS, V13, P3429, DOI 10.1002/pmic.201300213; Chaturvedi AK, 2013, EXPERT REV VACCINES, V12, P1261, DOI 10.1586/14760584.2013.840094; Cheng PY, 2009, INFECT IMMUN, V77, P4284, DOI 10.1128/IAI.00628-09; Datta K., 2009, Interdisciplinary Perspectives on Infectious Diseases, V2009, P176532, DOI 10.1155/2009/176532; Datta K, 2009, EMERG INFECT DIS, V15, P1185, DOI 10.3201/eid1508.081384; De Groot PWJ, 2005, FUNGAL GENET BIOL, V42, P657, DOI 10.1016/j.fgb.2005.04.002; DeBess E., 2010, Morbidity and Mortality Weekly Report, V59, P865; Deepe GS, 2002, INFECT IMMUN, V70, P3759, DOI 10.1128/IAI.70.7.3759-3767.2002; DONG ZM, 1995, INFECT IMMUN, V63, P2632, DOI 10.1128/IAI.63.7.2632-2644.1995; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Galanis E, 2010, EMERG INFECT DIS, V16, P251, DOI [10.3201/eid1602.090900, 10.3201/eid1601.090900]; GOMEZ FJ, 1995, INFECT IMMUN, V63, P2587, DOI 10.1128/IAI.63.7.2587-2595.1995; Hagen F, 2012, EMERG INFECT DIS, V18, P1618, DOI 10.3201/eid1810.120068; Harrison TS, 1997, J IMMUNOL, V158, P459; Hole CR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00291; HOY JF, 1989, J INFECT DIS, V159, P116, DOI 10.1093/infdis/159.1.116; Huang C, 2002, INFECT IMMUN, V70, P5485, DOI 10.1128/IAI.70.10.5485-5493.2002; Huang HB, 2012, J IMMUNOL, V189, P312, DOI 10.4049/jimmunol.1200603; Jarvis JN, 2008, SEMIN RESP CRIT CARE, V29, P141, DOI 10.1055/s-2008-1063853; Kakeya H, 1999, CLIN EXP IMMUNOL, V115, P485; Kakeya H, 1997, INFECT IMMUN, V65, P1653, DOI 10.1128/IAI.65.5.1653-1658.1997; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kronstad JW, 2011, NAT REV MICROBIOL, V9, P193, DOI 10.1038/nrmicro2522; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; Levitz SM, 2001, P NATL ACAD SCI USA, V98, P10422, DOI 10.1073/pnas.181331398; Li WQ, 2011, VACCINE, V29, P5526, DOI 10.1016/j.vaccine.2011.05.030; Litvintseva AP, 2005, J INFECT DIS, V192, P888, DOI 10.1086/432486; LopezRibot JL, 1996, INFECT IMMUN, V64, P3333; LopezRibot JL, 1996, J BACTERIOL, V178, P4724, DOI 10.1128/jb.178.15.4724-4726.1996; Martinez-Lopez R, 2008, PROTEOMICS, V8, P2651, DOI 10.1002/pmic.200701056; McCulloh RJ, 2011, PEDIATR INFECT DIS J, V30, P1111, DOI 10.1097/INF.0b013e31822d14fd; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Montagnoli C, 2003, EUR J IMMUNOL, V33, P1193, DOI 10.1002/eji.200323790; MURPHY JW, 1988, INFECT IMMUN, V56, P424, DOI 10.1128/IAI.56.2.424-431.1988; Murphy JW, 1998, INFECT IMMUN, V66, P2632, DOI 10.1128/IAI.66.6.2632-2639.1998; Ngamskulrungroj P, 2012, MBIO, V3, DOI 10.1128/mBio.00103-12; Nussbaum G, 1996, J EXP MED, V183, P1905, DOI 10.1084/jem.183.4.1905; Olszewski MA, 2010, FUTURE MICROBIOL, V5, P1269, DOI [10.2217/fmb.10.93, 10.2217/FMB.10.93]; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Specht CA, 2007, J INFECT DIS, V196, P796, DOI 10.1086/520536; Vibhagool A, 2003, CLIN INFECT DIS, V36, P1329, DOI 10.1086/374849; Walraven CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028625; Wozniak KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017204; Wozniak KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006854; Wright L, 2002, MICROBES INFECT, V4, P1427, DOI 10.1016/S1286-4579(02)00024-2; Yauch LE, 2006, PLOS PATHOG, V2, P1060, DOI 10.1371/journal.ppat.0020120; Young M, 2009, PROTEOMICS, V9, P2578, DOI 10.1002/pmic.200800713; Yuan RR, 1998, INFECT IMMUN, V66, P1057, DOI 10.1128/IAI.66.3.1057-1062.1998; YUAN RR, 1995, J IMMUNOL, V154, P1810	55	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104316	10.1371/journal.pone.0104316	http://dx.doi.org/10.1371/journal.pone.0104316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119981	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600049
J	Chuang, CY; Chen, LY; Fu, RH; Chen, SM; Ho, MH; Huang, JM; Hsu, CC; Wang, CC; Chen, MS; Tsai, RT				Chuang, Cheng-Yi; Chen, Ling-Yun; Fu, Ru-Huei; Chen, Shih-Ming; Ho, Ming-Hua; Huang, Jie-Mau; Hsu, Chia-Chi; Wang, Chien-Cheng; Chen, Meng-Shian; Tsai, Rong-Tzong			Involvement of the Carboxyl-Terminal Region of the Yeast Peroxisomal Half ABC Transporter Pxa2p in Its Interaction with Pxa1p and in Transporter Function	PLOS ONE			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; BINDING CASSETTE TRANSPORTERS; CHAIN FATTY-ACIDS; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; AMINO-ACIDS; GENE; METABOLISM; EXPRESSION; MECHANISM	Background: The peroxisome is a single membrane-bound organelle in eukaryotic cells involved in lipid metabolism, including beta-oxidation of fatty acids. The human genetic disorder X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1 gene (encoding ALDP, a peroxisomal half ATP-binding cassette [ABC] transporter). This disease is characterized by defective peroxisomal beta-oxidation and a large accumulation of very long-chain fatty acids in brain white matter, adrenal cortex, and testis. ALDP forms a homodimer proposed to be the functional transporter, whereas the peroxisomal transporter in yeast is a heterodimer comprising two half ABC transporters, Pxa1p and Pxa2p, both orthologs of human ALDP. While the carboxyl-terminal domain of ALDP is engaged in dimerization, it remains unknown whether the same region is involved in the interaction between Pxa1p and Pxa2p. Methods/Principal Findings: Using a yeast two-hybrid assay, we found that the carboxyl-terminal region (CT) of Pxa2p, but not of Pxa1p, is required for their interaction. Further analysis indicated that the central part of the CT (designated CT2) of Pxa2p was indispensable for its interaction with the carboxyl terminally truncated Pxa1_NBD. An interaction between the CT of Pxa2p and Pxa1_NBD was not detected, but could be identified in the presence of Pxa2_NBD-CT1. A single mutation of two conserved residues (aligned with X-ALD-associated mutations at the same positions in ALDP) in the CT2 of the Pxa2_NBD-CT protein impaired its interaction with Pxa1_NBD or Pxa1_NBD-CT, resulting in a mutant protein that exhibited a proteinase K digestion profile different from that of the wild-type protein. Functional analysis of these mutant proteins on oleate plates indicated that they were defective in transporter function. Conclusions/Significance: The CT of Pxa2p is involved in its interaction with Pxa1p and in transporter function. This concept may be applied to human ALDP studies, helping to establish the pathological mechanism for CT-related X-ALD disease.	[Chuang, Cheng-Yi; Chen, Shih-Ming; Ho, Ming-Hua; Huang, Jie-Mau; Hsu, Chia-Chi; Wang, Chien-Cheng; Chen, Meng-Shian; Tsai, Rong-Tzong] Chung Shan Med Univ, Coll Med, Inst Biochem & Biotechnol, Taichung, Taiwan; [Chen, Ling-Yun; Tsai, Rong-Tzong] Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan; [Fu, Ru-Huei] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; China Medical University Taiwan	Tsai, RT (corresponding author), Chung Shan Med Univ, Coll Med, Inst Biochem & Biotechnol, Taichung, Taiwan.	rttsai@csmu.edu.tw		Hsu, Chia-Chi/0000-0003-1532-7017; Fu, Ru-Huei/0000-0001-9367-1759	National Science Council (Taiwan) (NSC) [96-3111-B-040-001-, 97-2311-B-040-002-MY3]; Chung Shan Medical University [CSMU-INT-101-22]	National Science Council (Taiwan) (NSC); Chung Shan Medical University	This work was supported by the National Science Council (Taiwan) (NSC 96-3111-B-040-001-; 97-2311-B-040-002-MY3) and Chung Shan Medical University (CSMU-INT-101-22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 1999, EUR J BIOCHEM, V265, P719, DOI 10.1046/j.1432-1327.1999.00772.x; Bordignon E, 2010, MOL MICROBIOL, V77, P1354, DOI 10.1111/j.1365-2958.2010.07319.x; BOSSIER P, 1994, YEAST, V10, P681, DOI 10.1002/yea.320100512; de Wet H, 2010, FEBS J, V277, P2654, DOI [10.1111/j.1742-4658.2010.07675.x, 10.1111/j.1742-464X.2010.07675.x]; Dubois-Dalcq M, 1999, TRENDS NEUROSCI, V22, P4, DOI 10.1016/S0166-2236(98)01319-8; Genin EC, 2011, J BIOL CHEM, V286, P8075, DOI 10.1074/jbc.M110.211912; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V237, P152, DOI 10.1006/bbrc.1997.7102; JINKSROBERTSON S, 1993, MOL CELL BIOL, V13, P3937, DOI 10.1128/MCB.13.7.3937; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; KAMIJO K, 1992, BIOCHIM BIOPHYS ACTA, V1129, P323, DOI 10.1016/0167-4781(92)90510-7; Kemp S, 2012, BBA-MOL BASIS DIS, V1822, P1465, DOI 10.1016/j.bbadis.2012.03.012; Korenke GC, 1998, HUM MUTAT, pS204; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; MOSSER J, 1994, HUM MOL GENET, V3, P265, DOI 10.1093/hmg/3.2.265; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nyathi Y, 2010, J BIOL CHEM, V285, P29892, DOI 10.1074/jbc.M110.151225; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Pasyk EA, 1998, J BIOL CHEM, V273, P31759, DOI 10.1074/jbc.273.48.31759; Perria CL, 2006, J BIOL CHEM, V281, P39839, DOI 10.1074/jbc.M605492200; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Roerig P, 2001, FEBS LETT, V492, P66, DOI 10.1016/S0014-5793(01)02235-9; Rucktaschel R, 2009, J BIOL CHEM, V284, P20885, DOI 10.1074/jbc.M109.016584; Samanta S, 2003, J BIOL CHEM, V278, P35265, DOI 10.1074/jbc.M301171200; Shani N, 1996, P NATL ACAD SCI USA, V93, P11901, DOI 10.1073/pnas.93.21.11901; SHANI N, 1995, P NATL ACAD SCI USA, V92, P6012, DOI 10.1073/pnas.92.13.6012; Smith KD, 1999, NEUROCHEM RES, V24, P521, DOI 10.1023/A:1022535930009; Swartzman EE, 1996, J CELL BIOL, V132, P549, DOI 10.1083/jcb.132.4.549; Tsai RT, 2005, GENE DEV, V19, P2991, DOI 10.1101/gad.1377405; Tung MC, 2013, PROSTATE, V73, P1281, DOI 10.1002/pros.22670; van Roermund CWT, 2012, J BIOL CHEM, V287, P20144, DOI 10.1074/jbc.M111.332833; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wanders RJA, 2007, PFLUG ARCH EUR J PHY, V453, P719, DOI 10.1007/s00424-006-0142-x; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Yamada M, 2005, J MOL CELL CARDIOL, V39, P1, DOI 10.1016/j.yjmcc.2004.11.022; Zhang H, 2010, J BIOL CHEM, V285, P38324, DOI 10.1074/jbc.M110.131540	41	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104892	10.1371/journal.pone.0104892	http://dx.doi.org/10.1371/journal.pone.0104892			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118695	gold, Green Submitted, Green Published			2022-12-27	WOS:000340900600100
J	Chuang, HC; Yang, LP; Fitzgerald, AL; Osman, A; Woo, SH; Myers, JN; Skinner, HD				Chuang, Hui-Ching; Yang, Liang Peng; Fitzgerald, Alison L.; Osman, Abdullah; Woo, Sang Hyeok; Myers, Jeffrey N.; Skinner, Heath D.			The p53-Reactivating Small Molecule RITA Induces Senescence in Head and Neck Cancer Cells	PLOS ONE			English	Article							CELLULAR SENESCENCE; GROWTH ARREST; ACTIVATED P53; TUMOR-CELL; IN-VIVO; APOPTOSIS; THERAPY; SIRT1; INHIBITION; CHK2	TP53 is the most commonly mutated gene in head and neck cancer (HNSCC), with mutations being associated with resistance to conventional therapy. Restoring normal p53 function has previously been investigated via the use of RITA (reactivation of p53 and induction of tumor cell apoptosis), a small molecule that induces a conformational change in p53, leading to activation of its downstream targets. In the current study we found that RITA indeed exerts significant effects in HNSCC cells. However, in this model, we found that a significant outcome of RITA treatment was accelerated senescence. RITA-induced senescence in a variety of p53 backgrounds, including p53 null cells. Also, inhibition of p53 expression did not appear to significantly inhibit RITA-induced senescence. Thus, this phenomenon appears to be partially p53-independent. Additionally, RITA-induced senescence appears to be partially mediated by activation of the DNA damage response and SIRT1 (Silent information regulator T1) inhibition, with a synergistic effect seen by combining either ionizing radiation or SIRT1 inhibition with RITA treatment. These data point toward a novel mechanism of RITA function as well as hint to its possible therapeutic benefit in HNSCC.	[Chuang, Hui-Ching; Fitzgerald, Alison L.; Osman, Abdullah; Woo, Sang Hyeok; Myers, Jeffrey N.] Univ Texas MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA; [Chuang, Hui-Ching] Kaohsiung Chang Gung Mem Hosp, Dept Otolaryngol, Kaohsiung, Taiwan; [Chuang, Hui-Ching] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Yang, Liang Peng; Skinner, Heath D.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Fitzgerald, Alison L.; Myers, Jeffrey N.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Chang Gung Memorial Hospital; Chang Gung University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Skinner, HD (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	hskinner@mdanderson.org	Skinner, Heath/A-1669-2012	Skinner, Heath/0000-0003-1836-151X	The University of Texas MD Anderson Head and Neck Cancer SPORE Career Development Award; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	The University of Texas MD Anderson Head and Neck Cancer SPORE Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The University of Texas MD Anderson Head and Neck Cancer SPORE Career Development Award (HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Ahmed A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.42; Aliouat-Denis CM, 2005, MOL CANCER RES, V3, P627, DOI 10.1158/1541-7786.MCR-05-0121; Back JH, 2011, J BIOL CHEM; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Chan CH, 2011, J MOL MED, V89, P857, DOI 10.1007/s00109-011-0766-y; Chen CR, 2005, CANCER RES, V65, P6017, DOI 10.1158/0008-5472.CAN-05-0677; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; de Lange J, 2012, CELL DEATH DIFFER, V19, P980, DOI 10.1038/cdd.2011.182; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Espinoza-Fonseca LM, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-38; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Gadhikar MA, 2013, MOL CANCER THER, V12, P1860, DOI 10.1158/1535-7163.MCT-13-0157; Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259; Grinkevich VV, 2009, CANCER CELL, V15, P441, DOI 10.1016/j.ccr.2009.03.021; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Lehmann S, 2012, J CLIN ONCOL, V30, P3633, DOI 10.1200/JCO.2011.40.7783; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Loyo M, 2013, HEAD NECK-J SCI SPEC, V35, P454, DOI 10.1002/hed.23100; Lu C, 2009, APOPTOSIS, V14, P597, DOI 10.1007/s10495-009-0330-1; Mirzayans R, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/170325; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Portmann S, 2013, MOL CANCER THER, V12, P499, DOI 10.1158/1535-7163.MCT-12-0700; Roh JL, 2012, CANCER LETT, V325, P35, DOI 10.1016/j.canlet.2012.05.020; Roh JL, 2011, ORAL ONCOL, V47, P8, DOI 10.1016/j.oraloncology.2010.10.011; Roninson IB, 2003, CANCER RES, V63, P2705; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Shay JW, 2004, ONCOGENE, V23, P2919, DOI 10.1038/sj.onc.1207518; Skinner HD, 2012, CLIN CANCER RES, V18, P290, DOI 10.1158/1078-0432.CCR-11-2260; Spinnler C, 2011, CELL DEATH DIFFER, V18, P1736, DOI 10.1038/cdd.2011.45; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Wu P. C., 2012, Experimental Oncology, V34, P298; Yigitbasi OG, 2004, CANCER RES, V64, P7977, DOI 10.1158/0008-5472.CAN-04-1477; Yoo GH, 2009, ARCH OTOLARYNGOL, V135, P869, DOI 10.1001/archoto.2009.122; Zhang Y, 2011, ACTA PHARMACOL SIN, V32, P1199, DOI 10.1038/aps.2011.108; Zhao CY, 2010, CELL CYCLE, V9, P1847, DOI 10.4161/cc.9.9.11545; Zhao M, 2011, CLIN CANCER RES, V17, P7248, DOI 10.1158/1078-0432.CCR-11-0690	41	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104821	10.1371/journal.pone.0104821	http://dx.doi.org/10.1371/journal.pone.0104821			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119136	Green Submitted, gold, Green Published			2022-12-27	WOS:000340900600091
J	Gao, YX; Li, Y; Yu, XZ; Guo, SG; Ji, X; Sun, TW; Lan, C; Lavergne, V; Ghannoum, M; Li, L				Gao, Yanxia; Li, Yi; Yu, Xuezhong; Guo, Shigong; Ji, Xu; Sun, Tongwen; Lan, Chao; Lavergne, Valery; Ghannoum, Marc; Li, Li			The Impact of Various Platelet Indices as Prognostic Markers of Septic Shock	PLOS ONE			English	Article							DISTRIBUTION WIDTH; APACHE-II; VOLUME; SEPSIS; SEVERITY; COUNT; SIZE	Introduction: Platelet indices, including mean platelet volume (MPV), are readily available blood tests, although their prognostic value in patients with septic shock has not been fully explored. Current evidence has found contradictory results. This study aims to explore the behavior of platelet indices in septic shock and their clinical prognostic value. Methods: Charts of septic shock patients from January to December 2012 in a tertiary medical center in Northern China were reviewed retrospectively. Platelet indices were recorded during the first five consecutive days after admission, as well as the penultimate and the last day of hospital stay. The data were compared between surviving and non-surviving patients. Results: A total of 124 septic shock patients were enrolled. Thirty-six of the patients survived and 88 of them expired. MPV in the non-survivor group was higher than that of the survivor group, especially on the last day. PDW and PLCR showed increased trends, while PCT and PLT decreased in the non-survivor group. Among the PLT indices, MPV had the highest area under the receiver operating characteristic curve (0.81) with a precision rate of 75.6% at a cut-off of 10.5. Compared with other more usual septic shock prognostic markers, MPV is second only to lactate for the highest area under the curve. Conclusion: A statistically significant difference was seen between survivors and non-survivors for platelet indices which make them easily available and useful prognostic markers for patients in septic shock.	[Gao, Yanxia; Lan, Chao; Li, Li] Zhengzhou Univ, Affiliated Hosp 1, Emergency Dept, Zhengzhou 450052, Peoples R China; [Li, Yi; Yu, Xuezhong] Peking Union Med Coll Hosp, Emergency Dept, Beijing, Peoples R China; [Guo, Shigong] St Marys Hosp, London, England; [Ji, Xu] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China; [Sun, Tongwen] Zhengzhou Univ, Affiliated Hosp 1, Integrated Intens Care unit, Zhengzhou 450052, Peoples R China; [Lavergne, Valery] Univ Montreal, Sacre Coeur Hosp, Dept Med Biol, Montreal, PQ, Canada; [Ghannoum, Marc] Univ Montreal, Verdun Hosp, Dept Specialized Med, Montreal, PQ, Canada	Zhengzhou University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Imperial College London; Chinese People's Liberation Army General Hospital; Zhengzhou University; Universite de Montreal; Universite de Montreal	Li, L (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Emergency Dept, Zhengzhou 450052, Peoples R China.	lililovechina2013@163.com	li, li/AAT-2097-2020; li, li/HII-4157-2022; LI, LI QING/GRR-8855-2022; Sun, Tongwen/AAQ-7741-2020; Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022; li, li/GPX-3938-2022		National Natural Science Foundation of China [81370364]; Innovative investigators project grant from the Health Bureau of Henan Province; Program Grant for Science & Technology Innovation Talents in Universities of Henan Province [2012HASTIT001]; Henan provincial science and technology achievement transformation project [122102310581]; Henan province of medical scientific research project, China [201203027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative investigators project grant from the Health Bureau of Henan Province; Program Grant for Science & Technology Innovation Talents in Universities of Henan Province; Henan provincial science and technology achievement transformation project; Henan province of medical scientific research project, China	This study was supported by the National Natural Science Foundation of China (Grant No. 81370364), Innovative investigators project grant from the Health Bureau of Henan Province, Program Grant for Science & Technology Innovation Talents in Universities of Henan Province (2012HASTIT001), Henan provincial science and technology achievement transformation project (122102310581), Henan province of medical scientific research project (201203027), China. This funding was used to support collection, analysis, and interpretation of data our study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu S, 2005, J TROP PEDIATRICS, V51, P388, DOI 10.1093/tropej/fmi031; Aydemir H, 2015, PLATELETS, V26, P331, DOI 10.3109/09537104.2012.701027; Babu E, 2004, Indian J Pathol Microbiol, V47, P202; BESSMAN JD, 1985, BLOOD CELLS, V11, P127; BESSMAN JD, 1983, SURG GYNECOL OBSTET, V156, P177; Bilici S, 2011, AFR HEALTH SCI, V11, P427; Chandra S, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.009; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Farias MG, 2010, CLIN CHEM LAB MED, V48, P255, DOI 10.1515/CCLM.2010.035; Giamarellos-Bourboulis EJ, 2012, CRIT CARE, V16, DOI 10.1186/cc11463; Giovanetti Thayse Vanessa, 2011, Rev. Bras. Hematol. Hemoter., V33, P164, DOI 10.5581/1516-8484.20110040; Guida JD, 2003, PEDIATRICS, V111, P1411, DOI 10.1542/peds.111.6.1411; Gunebakmaz O, 2010, INT J INFECT DIS, V14, pE982, DOI 10.1016/j.ijid.2010.05.019; Haslett C, 2001, DAVIDSONS PRINCIPLES; Irmak K, 2006, VET RES COMMUN, V30, P497, DOI 10.1007/s11259-006-3258-8; JACKSON SR, 1993, BLOOD REV, V7, P104, DOI 10.1016/S0268-960X(05)80020-7; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Levi M, 2006, CRIT CARE, V10, DOI 10.1186/cc4975; Mavrommatis AC, 2000, CRIT CARE MED, V28, P451, DOI 10.1097/00003246-200002000-00027; Miguel-Bayarri V, 2012, MED INTENSIVA, V36, P556, DOI 10.1016/j.medin.2012.01.014; Mimidis K, 2004, PANCREATOLOGY, V4, P22, DOI 10.1159/000077024; ROBBINS G, 1983, J CLIN PATHOL, V36, P1320, DOI 10.1136/jcp.36.11.1320-a; VANDERLELIE J, 1983, J CLIN PATHOL, V36, P693, DOI 10.1136/jcp.36.6.693; Vasse M, 2012, THROMB RES, V130, P559, DOI 10.1016/j.thromres.2012.04.014; Yilmaz Z, 2008, VET CLIN PATH, V37, P159, DOI 10.1111/j.1939-165X.2008.00023.x; Zakynthinos SG, 2004, CRIT CARE MED, V32, P1004, DOI 10.1097/01.CCM.0000121433.61546.A0	26	55	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103761	10.1371/journal.pone.0103761	http://dx.doi.org/10.1371/journal.pone.0103761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118886	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600030
J	Han, FL; Zheng, WJ; Hu, DY; Xu, X; Barrett, PM				Han, Fenglu; Zheng, Wenjie; Hu, Dongyu; Xu, Xing; Barrett, Paul M.			A New Basal Ankylosaurid (Dinosauria: Ornithischia) from the Lower Cretaceous Jiufotang Formation of Liaoning Province, China	PLOS ONE			English	Article							SKELETAL RECONSTRUCTION; NODOSAURID ANKYLOSAUR; EUOPLOCEPHALUS-TUTUS; REDESCRIPTION; SKULL; DIVERSITY; MONTANA; ARMOR	A new ankylosaurid, Chuanqilong chaoyangensis gen. et sp. nov., is described here based on a nearly complete skeleton from the Lower Cretaceous Jiufotang Formation of Baishizui Village, Lingyuan City, Liaoning Province, China. Chuanqilong chaoyangensis can be diagnosed on the basis of two autapomorphies (glenoid fossa for quadrate at same level as the dentary tooth row; distally tapering ischium with constricted midshaft) and also a unique combination of character states (slender, wedge-like lacrimal; long retroarticular process; humerus with strongly expanded proximal end; ratio of humerus to femur length = 0.88). Although a phylogenetic analysis places Chuanqilong chaoyangensis as the sister taxon of the sympatric Liaoningosaurus near the base of the Ankylosauridae, the two taxa can be distinguished on the basis of many features, such as tooth morphology and ischial shape, which are not ontogeny-related. Chuanqilong chaoyangensis represents the fourth ankylosaurid species reported from the Cretaceous of Liaoning, China, suggesting a relatively high diversity in Cretaceous Liaoning.	[Han, Fenglu] China Univ Geosci, Fac Earth Sci, Wuhan 430074, Peoples R China; [Han, Fenglu; Zheng, Wenjie; Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Zheng, Wenjie] Univ Chinese Acad Sci, Beijing, Peoples R China; [Hu, Dongyu] Shenyang Normal Univ, Inst Paleontol, Shenyang, Peoples R China; [Barrett, Paul M.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	China University of Geosciences; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shenyang Normal University; Natural History Museum London	Han, FL (corresponding author), China Univ Geosci, Fac Earth Sci, Wuhan 430074, Peoples R China.	hfl0501@gmail.com	Barrett, Paul M/A-2648-2010	Barrett, Paul M/0000-0003-0412-3000; , Fenglu/0000-0003-3399-4008	National Natural Science Foundation of China [41120124002, 41172026]; 973 program [2012CB821900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China)	This project was supported by the National Natural Science Foundation of China (41120124002; 41172026) and 973 program (2012CB821900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour VM, 2013, CRETACEOUS RES, V46, P24, DOI 10.1016/j.cretres.2013.08.008; Arbour VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062421; Arbour VM, 2013, ACTA PALAEONTOL POL, V58, P55, DOI 10.4202/app.2011.0081; Arbour VM, 2009, J VERTEBR PALEONTOL, V29, P1117, DOI 10.1671/039.029.0405; Brown B, 1908, B AM MUS NAT HIST, V24, P187; Burns M.E., 2011, NEW MEXICO MUSEUM NA, V53, P169; Burns ME, 2011, NEW MEXICO MUSEUM NA, V53, P179; Campione NE, 2013, PALAEOBIO PALAEOENV, V93, P65, DOI 10.1007/s12549-012-0097-1; Carpenter K, 2004, CAN J EARTH SCI, V41, P961, DOI 10.1139/E04-043; Carpenter K., 1986, Journal of Vertebrate Paleontology, V6, P251; Carpenter K, 2011, PALAEONTOGR ABT A, V294, P1; Carpenter K, 2001, LIFE O PAST, P455; Carpenter K, 2001, LIFE O PAST, P211; Carpenter K, 1998, NATURE, V393, P782, DOI 10.1038/31684; CARPENTER K, 1984, CAN J EARTH SCI, V21, P1491, DOI 10.1139/e84-154; CARPENTER K, 1995, J VERTEBR PALEONTOL, V15, P275, DOI 10.1080/02724634.1995.10011230; Carpenter K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079887; Carpenter K, 2008, J VERTEBR PALEONTOL, V28, P1089, DOI 10.1671/0272-4634-28.4.1089; Coombs W.P. Jr, 1990, P456; COOMBS W P JR, 1978, Palaeontology (Oxford), V21, P143; Coombs W.P. Jr, 1986, Journal of Vertebrate Paleontology, V6, P162; COOMBS WP, 1979, J PALEONTOL, V53, P666; COOMBS WP, 1995, J VERTEBR PALEONTOL, V15, P298, DOI 10.1080/02724634.1995.10011231; Currie PJ, 2011, ACTA PALAEONTOL POL, V56, P489, DOI 10.4202/app.2010.0055; Dong Z.-M., 2002, VERTEBRAT PALASIATIC, V40, P276; Dong Zhiming, 2001, P237; Galton P.M., 1983, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V182, P1; Garcia G, 2003, J VERTEBR PALEONTOL, V23, P156, DOI 10.1671/0272-4634(2003)23[156:ANSOSD]2.0.CO;2; Godefroit Pascal, 2000, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V69, P17; Goloboff P, 2008, CLADISTICS, V24, P91; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020792; Hill RV, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)395<0001:ANSOPG>2.0.CO;2; Jacobs LL, 1996, DINOSAUR EGGS BABIES, P337; Kilbourne B, 2005, NEUES JAHRB GEOL P-A, V237, P111, DOI 10.1127/njgpa/237/2005/111; Kirkland JI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080405; Kirkland James I., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P271; Kirkland James I., 1998, Modern Geology, V23, P145; Kirkland James I., 1994, Brigham Young University Geology Studies, V40, P25; Lu JC, 2007, ACTA GEOL SIN-ENGL, V81, P883; Lu JC, 2007, ACTA GEOL SIN-ENGL, V81, P344; Maleev E.A., 1956, T PALEONTOL I AKAD N, V62, P51; Maryanska T, 1971, PALAEONTOLOGIA POLON, V25, P45; Maryaska T., 1977, PALAEONTOLOGIA POLON, V37, P85; Miles CA, 2009, CURR SCI INDIA, V96, P65; MOLNAR R E, 1980, Memoirs of the Queensland Museum, V20, P77; Molnar Ralph E., 1996, Memoirs of the Queensland Museum, V39, P653; Molnar RE, 2001, LIFE O PAST, P341; Nopcsa FB., 1915, COMMUNICATIONS YB RO, V23, P1; Osi A, 2009, PALAEONTOL Z, V83, P227, DOI 10.1007/s12542-009-0017-5; Osborn H. F., 1923, American Museum Novitates, V95, P1; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Pang QQ, 1998, PROG NAT SCI, V8, P326; Penkalski P, 2001, LIFE O PAST, P261; Pereda-Suberbiola X, 1994, PALAEONTOGRAPH A, V232, P133; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Stanford R, 2011, J PALEONTOL, V85, P916, DOI 10.1666/10-113.1; Suberbiola XP, 1999, SPEC PAP PALAEONTOL, P177; Thompson RS, 2012, J SYST PALAEONTOL, V10, P301, DOI 10.1080/14772019.2011.569091; Tumanova T.A., 1987, Trudy Sessii Vsesoyuznogo Paleontologicheskogo Obshchestva, V32, P1; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Vickaryous MK, 2003, ZOOL J LINN SOC-LOND, V137, P157, DOI 10.1046/j.1096-3642.2003.00045.x; Vickaryous MK, 2001, CAN J EARTH SCI, V38, P1767, DOI 10.1139/e01-051; WILKINSON M, 1994, SYST BIOL, V43, P343, DOI 10.2307/2413673; Xing X, 2006, GEOL J, V41, P419, DOI 10.1002/gj.1044; Xu Li, 2007, Dizhi Xuebao, V81, P433; Xu X, 2001, NATURWISSENSCHAFTEN, V88, P297, DOI 10.1007/s001140100233; 董枝明, 1993, 古脊椎动物学报, V31, P257	67	9	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104551	10.1371/journal.pone.0104551	http://dx.doi.org/10.1371/journal.pone.0104551			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118986	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600067
J	Klammer, M; Dybowski, JN; Hoffmann, D; Schaab, C				Klammer, Martin; Dybowski, J. Nikolaj; Hoffmann, Daniel; Schaab, Christoph			Identification of Significant Features by the Global Mean Rank Test	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; SPIKE-IN DATASET; MICROARRAY EXPERIMENTS; PHOSPHOPROTEOMICS; PHOSPHORYLATION; BIOCONDUCTOR; POWERFUL; PACKAGE; PROTEIN	With the introduction of omics-technologies such as transcriptomics and proteomics, numerous methods for the reliable identification of significantly regulated features (genes, proteins, etc.) have been developed. Experimental practice requires these tests to successfully deal with conditions such as small numbers of replicates, missing values, non-normally distributed expression levels, and non-identical distributions of features. With the MeanRank test we aimed at developing a test that performs robustly under these conditions, while favorably scaling with the number of replicates. The test proposed here is a global one-sample location test, which is based on the mean ranks across replicates, and internally estimates and controls the false discovery rate. Furthermore, missing data is accounted for without the need of imputation. In extensive simulations comparing MeanRank to other frequently used methods, we found that it performs well with small and large numbers of replicates, feature dependent variance between replicates, and variable regulation across features on simulation data and a recent two-color microarray spike-in dataset. The tests were then used to identify significant changes in the phosphoproteomes of cancer cells induced by the kinase inhibitors erlotinib and 3-MB-PP1 in two independently published mass spectrometry-based studies. MeanRank outperformed the other global rank-based methods applied in this study. Compared to the popular Significance Analysis of Microarrays and Linear Models for Microarray methods, MeanRank performed similar or better. Furthermore, MeanRank exhibits more consistent behavior regarding the degree of regulation and is robust against the choice of preprocessing methods. MeanRank does not require any imputation of missing values, is easy to understand, and yields results that are easy to interpret. The software implementing the algorithm is freely available for academic and commercial use.	[Klammer, Martin; Dybowski, J. Nikolaj; Schaab, Christoph] Evotec Munchen GmbH, Dept Bioinformat, Martinsried, Germany; [Hoffmann, Daniel] Univ Duisburg Essen, Ctr Med Biotechnol, Essen, Germany; [Schaab, Christoph] Max Planck Inst Biochem, Dept Proteom & Signal Transduct, D-82152 Martinsried, Germany	Evotec; University of Duisburg Essen; Max Planck Society	Schaab, C (corresponding author), Evotec Munchen GmbH, Dept Bioinformat, Martinsried, Germany.	christoph.schaab@evotec.com	Hoffmann, Daniel/B-1314-2018; Hoffmann, Daniel/P-5624-2019	Hoffmann, Daniel/0000-0003-2973-7869; Hoffmann, Daniel/0000-0003-2973-7869	Federal German Ministry of Education and Research [0315011]	Federal German Ministry of Education and Research	This work is based on a project supported by the Federal German Ministry of Education and Research (0315011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Cao J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-5; Eidhammer I., 2007, COMPUTATIONAL METHOD; Geiger T., 2012, MOL CELL PROTEOMICS, V11; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hochberg Y., 1987, MULTIPLE COMP PROCED; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Klammer M, 2012, MOL CELL PROTEOMICS, V11, P651, DOI 10.1074/mcp.M111.016410; Liew AWC, 2011, BRIEF BIOINFORM, V12, P498, DOI 10.1093/bib/bbq080; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Oppermann FS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.012351; R Core Team, 2012, R LANG ENV STAT COMP; SALCINI AE, 1994, ONCOGENE, V9, P2827; Schaab C, 2011, METHODS MOL BIOL, V696, P41, DOI 10.1007/978-1-60761-987-1_3; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; Weber C, 2012, J PROTEOMICS, V75, P1343, DOI 10.1016/j.jprot.2011.11.004; Zhang SP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-230; Zhou YY, 2007, BIOINFORMATICS, V23, P2073, DOI 10.1093/bioinformatics/btm292; Zhu QQ, 2011, BIOINFORMATICS, V27, P1284, DOI 10.1093/bioinformatics/btr135; Zhu QQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-285	26	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104504	10.1371/journal.pone.0104504	http://dx.doi.org/10.1371/journal.pone.0104504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119995	gold, Green Published			2022-12-27	WOS:000340900600062
J	Martinez, EA; Angel, MA; Cuello, C; Sanchez-Osorio, J; Gomis, J; Parrilla, I; Vila, J; Colina, I; Diaz, M; Reixach, J; Vazquez, JL; Vazquez, JM; Roca, J; Gil, MA				Martinez, Emilio A.; Angel Angel, Miguel; Cuello, Cristina; Sanchez-Osorio, Jonatan; Gomis, Jesus; Parrilla, Inmaculada; Vila, Jordi; Colina, Ignaci; Diaz, Marta; Reixach, Josep; Luis Vazquez, Jose; Maria Vazquez, Juan; Roca, Jordi; Antonia Gil, Maria			Successful Non-Surgical Deep Uterine Transfer of Porcine Morulae after 24 Hour Culture in a Chemically Defined Medium	PLOS ONE			English	Article							EMBRYO-TRANSFER; IN-VITRO; DNA FRAGMENTATION; BOAR SPERMATOZOA; STORAGE; OOCYTES; VIVO; PIGS; 4-DEGREES-C; SUPEROVULATION	Excellent fertility and prolificacy have been reported after non-surgical deep uterine transfers of fresh in vivo-derived porcine embryos. Unfortunately, when this technology is used with vitrified embryos, the reproductive performance of recipients is low. For this reason and because the embryos must be stored until they are transferred to the recipient farms, we evaluated the potential application of non-surgical deep uterine transfers with in vivo-derived morulae cultured for 24 h in liquid stage. In Experiment 1, two temperatures (25 degrees C and 37 degrees C) and two media (one fully defined and one semi-defined) were assessed. Morulae cultured in culture medium supplemented with bovine serum albumin and fetal calf serum at 38.5 degrees C in 5% CO2 in air were used as controls. Irrespective of medium, the embryo viability after 24 h of culture was negatively affected (P<0.05) at 25 degrees C but not at 37 degrees C compared with the controls. Embryo development was delayed in all experimental groups compared with the control group (P<0.001). Most of the embryos (95.7%) cultured at 37 degrees C achieved the full or expanded blastocyst stage, and unlike the controls, none of them hatched at the end of culture. In Experiment 2, 785 morulae were cultured in the defined medium at 37 degrees C for 24 h, and the resulting blastocysts were transferred to the recipients (n = 24). Uncultured embryos collected at the blastocyst stage (n = 750) were directly transferred to the recipients and used as controls (n = 25). No differences in farrowing rates (91.7% and 92.0%) or litter sizes (9.0 +/- 0.6 and 9.4 +/- 0.8) were observed between the groups. This study demonstrated, for the first time, that high reproductive performance can be achieved after non-surgical deep uterine transfers with short-term cultured morulae in a defined medium, which opens new possibilities for the sanitary, safe national and international trade of porcine embryos and the commercial use of embryo transfer in pigs.	[Martinez, Emilio A.; Angel Angel, Miguel; Cuello, Cristina; Sanchez-Osorio, Jonatan; Gomis, Jesus; Parrilla, Inmaculada; Luis Vazquez, Jose; Maria Vazquez, Juan; Roca, Jordi; Antonia Gil, Maria] Univ Murcia, Dept Anim Med & Surg, Murcia, Spain; [Vila, Jordi; Colina, Ignaci; Diaz, Marta; Reixach, Josep] Selecc Batalle SA, Dept Res & Dev, Girona, Spain	University of Murcia	Martinez, EA (corresponding author), Univ Murcia, Dept Anim Med & Surg, Murcia, Spain.	emilio@um.es	Parrilla, Inmaculada/I-1045-2015; Martinez, Emilio A/I-1901-2015; GIL, MARIA A/H-6753-2015; ANGEL, MIGUEL/GVS-9068-2022; Roca, Jordi/H-9365-2015; Gomis, Jesús/ABD-4389-2020; Cuello, Cristina/H-9986-2015; Angel, Miguel/GZN-2443-2022	Martinez, Emilio A/0000-0003-1260-9721; GIL, MARIA A/0000-0002-6955-7750; Roca, Jordi/0000-0002-4213-3093; Gomis, Jesús/0000-0001-8349-1607; Cuello, Cristina/0000-0002-6202-5946; Vazquez, Juan Maria/0000-0002-8674-6350; Parrilla, Inmaculada/0000-0002-5121-758X	Centro para el Desarrollo Tecnologico e Industrial (CDTI/Seleccion Batalle), Madrid, Spain [20090686]; Ministerio de Ciencia e Innovacion-FEDER, Madrid, Spain [AGL2009-12091]; Ministerio de Economia y Competitividad-FEDER, Madrid, Spain [AGL2012-38621]; Fundacion Seneca, Murcia, Spain [GERM 04543/07]; Seleccion Batalle S.A.	Centro para el Desarrollo Tecnologico e Industrial (CDTI/Seleccion Batalle), Madrid, Spain; Ministerio de Ciencia e Innovacion-FEDER, Madrid, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Economia y Competitividad-FEDER, Madrid, Spain; Fundacion Seneca, Murcia, Spain(Fundacion Seneca); Seleccion Batalle S.A.	This experimental study was supported by: Centro para el Desarrollo Tecnologico e Industrial (CDTI/Seleccion Batalle; 20090686), Madrid, Spain; Ministerio de Ciencia e Innovacion-FEDER (AGL2009-12091), Madrid, Spain; Ministerio de Economia y Competitividad-FEDER (AGL2012-38621), Madrid, Spain; Fundacion Seneca (GERM 04543/07), Murcia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors JV, IC, MD, and JR are employed by Seleccion Batalle S.A. Seleccion Batalle S.A. provided support in the form of salaries for authors JV, IC, MD, and JR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abeydeera LR, 2000, THERIOGENOLOGY, V54, P787, DOI 10.1016/S0093-691X(00)00390-3; Alminana C, 2010, ANIM REPROD SCI, V121, P145, DOI 10.1016/j.anireprosci.2010.05.004; ANDERSON GB, 1975, J ANIM SCI, V40, P900, DOI 10.2527/jas1975.405900x; Angel MA, 2014, THERIOGENOLOGY, V81, P832, DOI 10.1016/j.theriogenology.2013.12.017; Gil MA, 2012, MOL REPROD DEV, V79, P651, DOI 10.1002/mrd.22071; Baguisi A, 1997, THERIOGENOLOGY, V48, P1017, DOI 10.1016/S0093-691X(97)00328-2; BLUMRECKOW B, 1991, J ANIM SCI, V69, P3335; CAMERON RDA, 1989, AUST VET J, V66, P314, DOI 10.1111/j.1751-0813.1989.tb09714.x; CLARK KE, 1987, J ANIM SCI, V65, P534; Cuello C, 2007, THERIOGENOLOGY, V68, P258, DOI 10.1016/j.theriogenology.2007.05.039; Cuello C, 2004, THERIOGENOLOGY, V61, P843, DOI 10.1016/S0093-691X(03)00257-7; Day BN, 2000, ANIM REPROD SCI, V60, P161, DOI 10.1016/S0378-4320(00)00079-8; Hourcade JD, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-62; Funahashi H, 2000, BIOL REPROD, V63, P1437, DOI 10.1095/biolreprod63.5.1437; Furstoss V, 2012, ANIM REPROD SCI, V134, P177, DOI 10.1016/j.anireprosci.2012.08.019; Gil MA, 2013, THERIOGENOLOGY, V79, P392, DOI 10.1016/j.theriogenology.2012.10.012; Gomis J, 2012, THERIOGENOLOGY, V78, P1339, DOI 10.1016/j.theriogenology.2012.05.035; Guerin B, 1997, THERIOGENOLOGY, V47, P33, DOI 10.1016/S0093-691X(96)00337-8; Hazeleger W, 2000, THERIOGENOLOGY, V53, P1063, DOI 10.1016/S0093-691X(00)00252-1; Hazeleger W, 2001, THERIOGENOLOGY, V56, P1321, DOI 10.1016/S0093-691X(01)00633-1; Ideta A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01173; LINDNER GM, 1983, THERIOGENOLOGY, V20, P311, DOI 10.1016/0093-691X(83)90064-X; LONGENEC.DE, 1968, J ANIM SCI, V27, P709; Machaty Z, 1998, BIOL REPROD, V59, P451, DOI 10.1095/biolreprod59.2.451; Martinez EA, 2004, THERIOGENOLOGY, V61, P137, DOI 10.1016/S0093-691X(03)00190-0; Martinez EA, 2001, J REP FER S, P301; Martinez EA, 2013, CONTROL FIG REPROD, P101; MENINO AR, 1982, J ANIM SCI, V54, P583, DOI 10.2527/jas1982.543583x; NIEMANN H, 1989, THERIOGENOLOGY, V31, P525, DOI 10.1016/0093-691X(89)90237-9; Otoi T, 1999, MOL REPROD DEV, V54, P342, DOI 10.1002/(SICI)1098-2795(199912)54:4&lt;342::AID-MRD4&gt;3.0.CO;2-7; PETTERS RM, 1993, J REPROD FERTIL, P61; Pomar FJR, 2004, THERIOGENOLOGY, V61, P147, DOI 10.1016/S0093-691X(03)00204-8; Prather RS, 1998, THERIOGENOLOGY, V49, P23, DOI 10.1016/S0093-691X(97)00399-3; PURSEL VG, 1975, J ANIM SCI, V40, P99, DOI 10.2527/jas1975.40199x; Sakurai T, 2005, MOL HUM REPROD, V11, P325, DOI 10.1093/molehr/gah166; Stringfellow D. A, 1998, MANUAL INT EMBRYO TR, P79; Takeo T, 2010, J AM ASSOC LAB ANIM, V49, P415; WRATHALL AE, 1995, THERIOGENOLOGY, V43, P81, DOI 10.1016/0093-691X(94)00009-J; Wright J.M., 1998, MANUAL INT EMBRYO TR, P167; WRIGHT RW, 1977, J ANIM SCI, V44, P854, DOI 10.2527/jas1977.445854x	40	39	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104696	10.1371/journal.pone.0104696	http://dx.doi.org/10.1371/journal.pone.0104696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118944	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600078
J	Stevanovic, A; Coburn, M; Menon, A; Rossaint, R; Heyland, D; Schalte, G; Werker, T; Wonisch, W; Kiehntopf, M; Goetzenich, A; Rex, S; Stoppe, C				Stevanovic, Ana; Coburn, Mark; Menon, Ares; Rossaint, Rolf; Heyland, Daren; Schaelte, Gereon; Werker, Thilo; Wonisch, Willibald; Kiehntopf, Michael; Goetzenich, Andreas; Rex, Steffen; Stoppe, Christian			The Importance of Intraoperative Selenium Blood Levels on Organ Dysfunction in Patients Undergoing Off-Pump Cardiac Surgery: A Randomised Controlled Trial	PLOS ONE			English	Article							ARTERY-BYPASS SURGERY; CARDIOPULMONARY BYPASS; ASYMMETRIC DIMETHYLARGININE; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; SYSTEMIC INFLAMMATION; WHOLE-BLOOD; ANTIOXIDANT; SERUM	Introduction: Cardiac surgery is accompanied by an increase of oxidative stress, a significantly reduced antioxidant (AOX) capacity, postoperative inflammation, all of which may promote the development of organ dysfunction and an increase in mortality. Selenium is an essential co-factor of various antioxidant enzymes. We hypothesized a less pronounced decrease of circulating selenium levels in patients undergoing off-pump coronary artery bypass (OPCAB) surgery due to less intraoperative oxidative stress. Methods: In this prospective randomised, interventional trial, 40 patients scheduled for elective coronary artery bypass grafting were randomly assigned to undergo either on-pump or OPCAB-surgery, if both techniques were feasible for the single patient. Clinical data, myocardial damage assessed by myocard specific creatine kinase isoenzyme (CK-MB), circulating whole blood levels of selenium, oxidative stress assessed by asymmetric dimethylarginine (ADMA) levels, antioxidant capacity determined by glutathionperoxidase (GPx) levels and perioperative inflammation represented by interleukin-6 (IL-6) levels were measured at predefined perioperative time points. Results: At end of surgery, both groups showed a comparable decrease of circulating selenium concentrations. Likewise, levels of oxidative stress and IL-6 were comparable in both groups. Selenium levels correlated with antioxidant capacity (GPx: r = 0.720; p<0.001) and showed a negative correlation to myocardial damage (CK-MB: r = -0.571, p<0.001). Low postoperative selenium levels had a high predictive value for the occurrence of any postoperative complication. Conclusions: OPCAB surgery is not associated with less oxidative stress and a better preservation of the circulating selenium pool than on-pump surgery. Low postoperative selenium levels are predictive for the development of complications.	[Stevanovic, Ana; Coburn, Mark; Rossaint, Rolf; Schaelte, Gereon; Werker, Thilo; Stoppe, Christian] Rhein Westfal TH Aachen, Univ Hosp, Dept Anaesthesiol, D-52062 Aachen, Germany; [Menon, Ares; Goetzenich, Andreas; Stoppe, Christian] Rhein Westfal TH Aachen, Univ Hosp, Dept Thorac Cardiac & Vasc Surg, D-52062 Aachen, Germany; [Heyland, Daren] Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada; [Wonisch, Willibald] Med Univ Graz, Ctr Physiol Med, Inst Physiol Chem, Graz, Austria; [Wonisch, Willibald] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Kiehntopf, Michael] Univ Jena, Inst Clin Chem, Jena, Germany; [Rex, Steffen] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Anaesthesiol, Leuven, Belgium; [Rex, Steffen] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Cardiovasc Sci, Leuven, Belgium; [Stoppe, Christian] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Queens University - Canada; Medical University of Graz; Medical University of Graz; Friedrich Schiller University of Jena; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; RWTH Aachen University	Rex, S (corresponding author), Katholieke Univ Leuven, Univ Hosp Leuven, Dept Anaesthesiol, Leuven, Belgium.	steffen.rex@uzleuven.be; Christian.stoppe@gmail.com		Rex, Steffen/0000-0002-3536-9321; Coburn, Mark/0000-0002-7930-0270				Barta E, 1991, Bratisl Lek Listy, V92, P174; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Biglioli P, 2003, EUR J CARDIO-THORAC, V24, P260, DOI 10.1016/S1010-7940(03)00295-1; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Caputo M, 2005, ANN THORAC SURG, V80, P982, DOI 10.1016/j.athoracsur.2005.03.062; Cavalca V, 2006, ANN THORAC SURG, V81, P562, DOI 10.1016/j.athoracsur.2005.08.019; Chandrasena LG, 2009, ANN CLIN LAB SCI, V39, P372; Diegeler A, 2000, CIRCULATION, V102, P95; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Forceville X, 2009, EUR SURG RES, V43, P338, DOI 10.1159/000239763; Franke A, 2005, EUR J CARDIO-THORAC, V28, P569, DOI 10.1016/j.ejcts.2005.07.007; Frass OM, 2001, CHEST, V120, P1599, DOI 10.1378/chest.120.5.1599; Gerritsen Wim B, 2006, Interact Cardiovasc Thorac Surg, V5, P27; Huang TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054431; Karu I, 2006, SCAND CARDIOVASC J, V40, P363, DOI 10.1080/14017430600983648; Karu I, 2010, SCAND CARDIOVASC J, V44, P119, DOI 10.3109/14017430903490981; KHARAZMI A, 1989, J THORAC CARDIOV SUR, V98, P381; Lamy A, 2012, NEW ENGL J MED, V366, P1489, DOI 10.1056/NEJMoa1200388; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Loukanov T, 2008, CLIN RES CARDIOL, V97, P383, DOI 10.1007/s00392-008-0645-x; Manzanares W, 2009, INTENS CARE MED, V35, P882, DOI 10.1007/s00134-008-1356-5; McDonald CI, 2012, ASAIO J, V58, P217, DOI 10.1097/MAT.0b013e31824cc856; McDonald CI, 2014, EUR J CARDIOTHORAC S; Mediratta N, 2013, EUR J CARDIO-THORAC, V43, P1014, DOI 10.1093/ejcts/ezs459; Mei YQ, 2007, BIOL PHARM BULL, V30, P410, DOI 10.1248/bpb.30.410; OSTER O, 1988, BIOL TRACE ELEM RES, V15, P23, DOI 10.1007/BF02990125; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Raja SG, 2007, J CARDIAC SURG, V22, P445, DOI 10.1111/j.1540-8191.2007.00447.x; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Schulze F, 2004, CLIN CHEM LAB MED, V42, P1377, DOI 10.1515/CCLM.2004.257; Sohn N, 2009, PERFUSION-UK, V24, P231, DOI 10.1177/0267659109351218; Stoppe C, 2013, ANTIOXID REDOX SIGN, V19, P231, DOI 10.1089/ars.2012.5015; Stoppe C, 2013, NUTRITION, V29, P158, DOI 10.1016/j.nut.2012.05.013; Stoppe C, 2011, CRIT CARE MED, V39, P1879, DOI 10.1097/CCM.0b013e3182190d48; Storti S, 2004, EUR J CARDIO-THORAC, V26, P682, DOI 10.1016/j.ejcts.2004.06.001; Stuhlinger MC, 2001, CIRCULATION, V104, P2569, DOI 10.1161/hc4601.098514; TIRAN B, 1993, J TRACE ELEM ELECT H, V7, P211; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Winnefeld K, 1999, MED KLIN, V94, P101, DOI 10.1007/BF03042205	42	14	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104222	10.1371/journal.pone.0104222	http://dx.doi.org/10.1371/journal.pone.0104222			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118980	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600042
J	Suktitipat, B; Naktang, C; Mhuantong, W; Tularak, T; Artiwet, P; Pasomsap, E; Jongjaroenprasert, W; Fuchareon, S; Mahasirimongkol, S; Chantratita, W; Yimwadsana, B; Charoensawan, V; Jinawath, N				Suktitipat, Bhoom; Naktang, Chaiwat; Mhuantong, Wuttichai; Tularak, Thitima; Artiwet, Paramita; Pasomsap, Ekawat; Jongjaroenprasert, Wallaya; Fuchareon, Suthat; Mahasirimongkol, Surakameth; Chantratita, Wasan; Yimwadsana, Boonsit; Charoensawan, Varodom; Jinawath, Natini			Copy Number Variation in Thai Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; STRUCTURAL VARIATION; GENETIC-VARIATION; DATABASE	Copy number variation (CNV) is a major genetic polymorphism contributing to genetic diversity and human evolution. Clinical application of CNVs for diagnostic purposes largely depends on sufficient population CNV data for accurate interpretation. CNVs from general population in currently available databases help classify CNVs of uncertain clinical significance, and benign CNVs. Earlier studies of CNV distribution in several populations worldwide showed that a significant fraction of CNVs are population specific. In this study, we characterized and analyzed CNVs in 3,017 unrelated Thai individuals genotyped with the Illumina Human610, Illumina HumanOmniexpress, or Illumina HapMap550v3 platform. We employed hidden Markov model and circular binary segmentation methods to identify CNVs, extracted 23,458 CNVs consistently identified by both algorithms, and cataloged these high confident CNVs into our publicly available Thai CNV database. Analysis of CNVs in the Thai population identified a median of eight autosomal CNVs per individual. Most CNVs (96.73%) did not overlap with any known chromosomal imbalance syndromes documented in the DECIPHER database. When compared with CNVs in the 11 HapMap3 populations, CNVs found in the Thai population shared several characteristics with CNVs characterized in HapMap3. Common CNVs in Thais had similar frequencies to those in the HapMap3 populations, and all high frequency CNVs (>20%) found in Thai individuals could also be identified in HapMap3. The majorities of CNVs discovered in the Thai population, however, were of low frequency, or uniquely identified in Thais. When performing hierarchical clustering using CNV frequencies, the CNV data were clustered into Africans, Europeans, and Asians, in line with the clustering performed with single nucleotide polymorphism (SNP) data. As CNV data are specific to origin of population, our population-specific reference database will serve as a valuable addition to the existing resources for the investigation of clinical significance of CNVs in Thais and related ethnicities.	[Suktitipat, Bhoom] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok 10400, Thailand; [Naktang, Chaiwat; Charoensawan, Varodom] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Mhuantong, Wuttichai] Natl Ctr Genet Engn & Biotechnol BIOTEC, Enzyme Technol Lab, Bioresources Technol Unit, Pathum Thani, Thailand; [Tularak, Thitima; Artiwet, Paramita; Yimwadsana, Boonsit] Mahidol Univ, Fac Informat & Commun Technol, Phutthamonthon, Nakhon Prathom, Thailand; [Pasomsap, Ekawat; Chantratita, Wasan] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol,Div Virol & Mol Microbiol, Bangkok 10400, Thailand; [Jongjaroenprasert, Wallaya] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med,Endocrine & Metab Unit, Bangkok 10400, Thailand; [Fuchareon, Suthat] Mahidol Univ, Inst Mol Biosci, Thalassemia Res Ctr, Salaya, Nakhon Prathom, Thailand; [Mahasirimongkol, Surakameth] Natl Inst Hlth, Dept Med Sci, Med Genet Sect, Minist Publ Hlth, Nonthaburi, Thailand; [Jinawath, Natini] Mahidol Univ, Ramathibodi Hosp, Fac Med, Res Ctr, Bangkok 10400, Thailand; [Suktitipat, Bhoom; Yimwadsana, Boonsit; Charoensawan, Varodom; Jinawath, Natini] Mahidol Univ, Integrat Computat BioSci Ctr ICBS, Phutthamonthon, Nakhon Prathom, Thailand	Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Mahidol University; Mahidol University; Mahidol University; Ministry of Public Health - Thailand; Mahidol University; Mahidol University	Jinawath, N (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Res Ctr, Bangkok 10400, Thailand.	jnatini@hotmail.com	Yimwadsana, Boonsit/Y-4536-2019; Suktitipat, Bhoom/H-4239-2019	Suktitipat, Bhoom/0000-0001-8034-7757; Charoensawan, Varodom/0000-0002-2199-4126	Thailand Research Fund; Commission on Higher Education; Mahidol University (TRF-CHE-MU) [MRG 5480183]; "Chalermphrakiat'' grant, Faculty of Medicine Siriraj Hospital, Mahidol University	Thailand Research Fund(Thailand Research Fund (TRF)); Commission on Higher Education; Mahidol University (TRF-CHE-MU); "Chalermphrakiat'' grant, Faculty of Medicine Siriraj Hospital, Mahidol University	The current project was supported by the Thailand Research Fund (http://www.trf.or.th), the Commission on Higher Education, and Mahidol University (TRF-CHE-MU grant number MRG 5480183) to NJ. BS is supported by "Chalermphrakiat'' grant, Faculty of Medicine Siriraj Hospital, Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Chantarangsu S, 2011, CLIN INFECT DIS, V53, P341, DOI 10.1093/cid/cir403; Chen WT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023087; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Gai XW, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-74; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Hattirat S, 2010, COMM COM INF SC, V115, P130, DOI 10.1007/978-3-642-16750-8_12; Jongjaroenprasert W, 2012, J HUM GENET, V57, P301, DOI 10.1038/jhg.2012.20; Kearney HM, 2011, GENET MED, V13, P680, DOI 10.1097/GIM.0b013e3182217a3a; Lou HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027341; MacDonald JR, 2014, NUCLEIC ACIDS RES, V42, pD986, DOI 10.1093/nar/gkt958; Mahasirimongkol S, 2006, J HUM GENET, V51, P896, DOI 10.1007/s10038-006-0041-1; Mahasirimongkol S, 2012, J HUM GENET, V57, P363, DOI 10.1038/jhg.2012.35; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; Ngamphiw C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021451; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Tsuang DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014456; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wangsomboonsiri W, 2010, CLIN INFECT DIS, V50, P597, DOI 10.1086/650003; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006; Yim SH, 2010, HUM MOL GENET, V19, P1001, DOI 10.1093/hmg/ddp564	26	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104355	10.1371/journal.pone.0104355	http://dx.doi.org/10.1371/journal.pone.0104355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118596	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600051
J	Dang, YL; Xu, YS; Wu, WT; Li, WY; Sun, YR; Yang, J; Zhu, Y; Zhang, C				Dang, Yalong; Xu, Yongsheng; Wu, Wentao; Li, Weiyi; Sun, Yanran; Yang, Jing; Zhu, Yu; Zhang, Chun			Tetrandrine Suppresses Lipopolysaccharide-Induced Microglial Activation by Inhibiting NF-kappa B and ERK Signaling Pathways in BV2 Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RETINAL GANGLION-CELLS; OPTIC-NERVE HEAD; MOUSE MODEL; NEURONAL INJURY; GENE-EXPRESSION; TNF-ALPHA; ISCHEMIA; NEUROPROTECTION; INVOLVEMENT	Background and Objective: Tetrandrine (TET) is a bisbenzylisoquinoline alkaloid extracted from Stephania tetrandra Moore. Recent studies have suggested that TET can reduce the inflammatory response in microglia, but the mechanisms remain unclear. The aim of this study is to investigate whether TET can inhibit lipopolysaccharide (LPS)-induced microglial activation and clarify its possible mechanisms. Study Design/Materials and Methods: Cell viability assays and cell apoptosis assays were used to determine the working concentrations of TET. Then, BV2 cells were seeded and pretreated with TET for 2 h. LPS was then added and incubated for an additional 24 hours. qRT-PCR and ELISA were used to measure the mRNA or protein levels of IL1 beta and TNF alpha. Western blotting was utilized to quantify the expression of CD11b and cell signaling proteins. Results: TET at optimal concentrations (0.1 mu M, 0.5 mu M or 1 mu M) did not affect the cell viability. After TET pretreatment, the levels of IL1 beta and TNF alpha (both in transcription and translation) were significantly inhibited in a dose-dependent manner. Further studies indicated that phospho-p65, phospho-IKK, and phospho-ERK 1/2 expression were also suppressed by TET. Conclusions: Our results indicate that TET can effectively suppress microglial activation and inhibit the production of IL1 beta and TNF alpha by regulating the NF-kappa B and ERK signaling pathways. Together with our previous studies, we suggest that TET would be a promising candidate to effectively suppress overactivated microglia and alleviate neurodegeneration in glaucoma.	[Dang, Yalong; Yang, Jing; Zhu, Yu] Zhengzhou Univ, Affiliated Hosp 1, Dept Ophthalmol, Zhengzhou 450052, Henan Province, Peoples R China; [Dang, Yalong; Xu, Yongsheng; Wu, Wentao; Li, Weiyi; Zhang, Chun] Peking Univ, Hosp 3, Clin Stem Cell Res Ctr, Beijing 100871, Peoples R China; [Dang, Yalong; Xu, Yongsheng; Li, Weiyi; Sun, Yanran; Zhang, Chun] Peking Univ, Hosp 3, Dept Ophthalmol, Beijing 100871, Peoples R China	Zhengzhou University; Peking University; Peking University	Zhu, Y (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Ophthalmol, Zhengzhou 450052, Henan Province, Peoples R China.	asiadragon@163.com; zhangc1@yahoo.com			National Natural Science Foundation of China [81371017]; Key Project of Science Research of Henan Province Education Committee [13A320427]; Henan Province [2013GH11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science Research of Henan Province Education Committee; Henan Province	This study was supported by the National Natural Science Foundation of China (No. 81371017), the Key Project of Science Research of Henan Province Education Committee (No. 13A320427) and the International cooperation project of Henan Province (2013GH11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Balaiya S, 2011, CLIN OPHTHALMOL, V5, P553, DOI 10.2147/OPTH.S19453; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Chen YJ, 2002, ACTA PHARMACOL SIN, V23, P1102; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Chintala SK, 2002, J BIOL CHEM, V277, P47461, DOI 10.1074/jbc.M204824200; Colak D, 2012, INVEST OPHTH VIS SCI, V53, P5899, DOI 10.1167/iovs.12-9634; CREASEY WA, 1976, BIOCHEM PHARMACOL, V25, P1887, DOI 10.1016/0006-2952(76)90194-5; Dong XQ, 2013, IRAN J PHARM RES, V12, P165; Fourgeaud L, 2007, CELL, V131, P1034, DOI 10.1016/j.cell.2007.11.031; Gao F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054114; Halpern D Lynn, 2002, Ophthalmol Clin North Am, V15, P61, DOI 10.1016/S0896-1549(01)00012-8; Han QD, 2014, BRAIN RES, V1542, P176, DOI 10.1016/j.brainres.2013.10.026; He FQ, 2011, INT IMMUNOPHARMACOL, V11, P1220, DOI 10.1016/j.intimp.2011.03.023; Ho LJ, 2004, BRIT J PHARMACOL, V143, P919, DOI 10.1038/sj.bjp.0706000; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; Huang P, 2011, J GLAUCOMA, V20, P183, DOI 10.1097/IJG.0b013e3181d7882a; Huang P, 2010, J GLAUCOMA, V19, P324, DOI 10.1097/IJG.0b013e3181b4cac7; Imai F, 2007, J CEREBR BLOOD F MET, V27, P488, DOI 10.1038/sj.jcbfm.9600362; Jeong JW, 2010, INT IMMUNOPHARMACOL, V10, P1580, DOI 10.1016/j.intimp.2010.09.011; Jeong YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087030; Jung WK, 2010, BRIT J PHARMACOL, V159, P1274, DOI 10.1111/j.1476-5381.2009.00615.x; Kim M, 2013, BMB REP, V46, P398, DOI 10.5483/BMBRep.2013.46.8.237; King A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3518; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lambertsen KL, 2009, J NEUROSCI, V29, P1319, DOI 10.1523/JNEUROSCI.5505-08.2009; Levin LA, 1999, SURV OPHTHALMOL, V43, pS98, DOI 10.1016/S0039-6257(99)00027-2; Li WY, 2014, DRUG DES DEV THER, V8, P327, DOI 10.2147/DDDT.S55407; Liu Bing-Ci, 1994, Biomedical and Environmental Sciences, V7, P199; Mookherjee S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-99; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Neufeld AH, 1999, ARCH OPHTHALMOL-CHIC, V117, P1050; Neufeld AH, 1999, P NATL ACAD SCI USA, V96, P9944, DOI 10.1073/pnas.96.17.9944; Polazzi E, 2010, PROG NEUROBIOL, V92, P293, DOI 10.1016/j.pneurobio.2010.06.009; Roh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040065; Seitz R, 2013, CELL TISSUE RES, V353, P339, DOI 10.1007/s00441-013-1666-y; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Su XH, 2014, INT IMMUNOPHARMACOL, V19, P88, DOI 10.1016/j.intimp.2014.01.004; Tezel G, 2000, J NEUROSCI, V20, P8693; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Walton NM, 2006, GLIA, V54, P815, DOI 10.1002/glia.20419; Wang CY, 2012, MOL VIS, V18, P779; Wang HL, 2002, ACTA PHARMACOL SIN, V23, P1114; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Wang QS, 2014, J BIOMED MAT RES A, V2014; Xue Y, 2008, ACTA PHARMACOL SIN, V29, P245, DOI 10.1111/j.1745-7254.2008.00734.x; Yanagisawa D, 2008, BIOL PHARM BULL, V31, P1121, DOI 10.1248/bpb.31.1121; Yang F, 2013, OCUL IMMUNOL INFLAMM, V21, P378, DOI 10.3109/09273948.2013.806989; Yang XJ, 2011, INVEST OPHTH VIS SCI, V52, P8442, DOI 10.1167/iovs.11-8152; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.3.CO;2-V; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104; Zhang F, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/680545; Zhao LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079671; Zhou XH, 2005, J BIOL CHEM, V280, P31240, DOI 10.1074/jbc.M502641200; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	59	31	35	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e102522	10.1371/journal.pone.0102522	http://dx.doi.org/10.1371/journal.pone.0102522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115855	gold, Green Submitted, Green Published			2022-12-27	WOS:000341230400005
J	Mizuki, I; Sato, A; Matsuo, A; Suyama, Y; Suzuki, JI; Makita, A				Mizuki, Inoue; Sato, Ayaka; Matsuo, Ayumi; Suyama, Yoshihisa; Suzuki, Jun-Ichirou; Makita, Akifumi			Clonal Structure, Seed Set, and Self-Pollination Rate in Mass-Flowering Bamboo Species during Off-Year Flowering Events	PLOS ONE			English	Article							POPULATION; REGENERATION; EVOLUTION; ECOLOGY; SHRUB	Bamboos are typical examples of highly synchronized semelparous species. Their mass-flowering events occur at supra-annual intervals but they sometimes flower on a small scale in off-years. If some bamboo ramets (culms) of a genet flower and die in off-years, whereas other culms of the same genet do not flower synchronously, the genet can still survive blooming in an off-year and could participate in the next mass-flowering event. At genet level, the effect might be similar to that achieved by synchronously reproducing iteroparous plants. In addition, if multiple genets flower simultaneously in off-years, cross-pollination will be promoted. However, it is not known whether all the culms in a genet flower synchronously and whether multiple genets flower in off-years. We determined the clonal structure of three temperate dwarf bamboo species, i.e., Sasa senanensis, S. kurilensis, and S. palmata, at 24 off-year flowering sites and the surrounding areas in northern Japan using seven microsatellite markers. We also estimated seed set at seven of the sites and self-pollination rates at five sites to determine off-year reproductive success. Next, we investigated whether seed sets at the culm level were related to flowering area and/or number of flowering genets, using generalized linear mixed-effect models (GLMMs). Multiple genets flowered at 9/24 flowering sites. We found that 40/96 of the genets identified had some flowering culms. Non-flowering culms were present in 24/40 flowering genets. Seed set was in the range 2.2%-12.5% and the self-pollination rate was 96.3%. In the best GLMM, seed set increased with flowering area. Seeds were produced in off-years, but cross-pollination was rare in off-years. We suggest that some dwarf bamboos may exhibit iteroparity or imperfectly synchronized semelparity at the genet level, a characteristic similar to that of other reproductively synchronous plants. We also found synchronous flowering of a few genets even in off-years.	[Mizuki, Inoue; Sato, Ayaka; Makita, Akifumi] Akita Prefectural Univ, Fac Bioresource Sci, Lab Forest Sci, Akita, Japan; [Matsuo, Ayumi; Suzuki, Jun-Ichirou] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan; [Suyama, Yoshihisa] Tohoku Univ, Grad Sch Agr Sci, Sendai, Miyagi 980, Japan	Akita Prefectural University; Tokyo Metropolitan University; Tohoku University	Makita, A (corresponding author), Akita Prefectural Univ, Fac Bioresource Sci, Lab Forest Sci, Akita, Japan.	makita@akita-pu.ac.jp	Suyama, Yoshihisa/H-6115-2017	Suyama, Yoshihisa/0000-0002-3136-5489; MIZUKI, INOUE/0000-0001-7390-3655	Ministry of Education, Science, Sports, and Culture [20380092, 23380088]	Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Ministry of Education, Science, Sports, and Culture Grant-in-Aid for Scientific Research (20380092, 23380088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2012, ECOL RES, V27, P625, DOI 10.1007/s11284-012-0933-9; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; AUGSPURGER CK, 1981, ECOLOGY, V62, P775, DOI 10.2307/1937745; BANIK R L, 1988, Indian Forester, V114, P576; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brzyski JR, 2011, CONSERV GENET, V12, P1323, DOI 10.1007/s10592-011-0233-x; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; CHARLESWORTH D, 1989, NATURE, V338, P21, DOI 10.1038/338021a0; de Carvalho AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054852, 10.1371/journal.pone.0059736]; IMS RA, 1990, TRENDS ECOL EVOL, V5, P135, DOI 10.1016/0169-5347(90)90218-3; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Kelly D, 2000, OIKOS, V90, P477, DOI 10.1034/j.1600-0706.2000.900306.x; KELLY JK, 1994, THEOR POPUL BIOL, V46, P32, DOI 10.1006/tpbi.1994.1018; Kitamura K, 2011, J PLANT RES, V124, P683, DOI 10.1007/s10265-010-0398-2; Kitamura K, 2009, MOL ECOL RESOUR, V9, P1470, DOI 10.1111/j.1755-0998.2009.02675.x; Kitamura K, 2009, J PLANT RES, V122, P299, DOI 10.1007/s10265-009-0220-1; KOENIG WD, 1994, ECOLOGY, V75, P99, DOI 10.2307/1939386; LLOYD M, 1966, EVOLUTION, V20, P133, DOI 10.1111/j.1558-5646.1966.tb03350.x; MAKITA A, 1993, ECOL RES, V8, P215, DOI 10.1007/BF02348534; MAKITA A, 1992, ECOL RES, V7, P245, DOI 10.1007/BF02347093; Makita A, 1997, LINNEAN SOC, P135; Makita A, 1993, REP FUJI BAMBOO GARD, V37, P42; Makita A., 1989, REP FUJI BAMBOO GARD, V33, P50; Makita Akifumi, 1998, Plant Species Biology, V13, P85, DOI 10.1111/j.1442-1984.1998.tb00251.x; Matsuo Ayumi, 2010, Japanese Journal of Ecology (Otsu), V60, P81; McClure, 1966, BAMBOOS FRESH PERSPE; Miyazaki Y, 2009, J PLANT RES, V122, P523, DOI 10.1007/s10265-009-0241-9; Miyazaki Y, 2009, CONSERV GENET, V10, P585, DOI 10.1007/s10592-008-9575-4; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nagao A, 1998, FOREST PESTS, V47, P11; NAKASHIZUKA T, 1988, Ecological Research, V3, P21, DOI 10.1007/BF02348692; Nishiwaki A., 1990, BAMBOO J, V8, P17; Nishiwaki A, 1998, BAMBOO J, V15, P1; PARKS JC, 1993, AM J BOT, V80, P537, DOI 10.2307/2445369; Poncet BN, 2009, OECOLOGIA, V159, P527, DOI 10.1007/s00442-008-1233-5; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Raffaele E, 2007, J VEG SCI, V18, P371, DOI 10.1658/1100-9233(2007)18[371:IEOIHA]2.0.CO;2; Ramanayake SMSD, 1998, ANN BOT-LONDON, V82, P779, DOI 10.1006/anbo.1998.0754; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; SIMMONDS N W, 1980, Kew Bulletin, V35, P235, DOI 10.2307/4114566; Suyama Y, 2000, MOL ECOL, V9, P901, DOI 10.1046/j.1365-294x.2000.00943.x; Tanimoto Takeo, 1998, Journal of Japanese Botany, V73, P42; TAYLOR AH, 1988, AM J BOT, V75, P1065, DOI 10.2307/2443774; Watanabe M., 1982, Journal of the Japanese Forestry Society, V64, P107; WILLIAMS KS, 1995, ANNU REV ENTOMOL, V40, P269, DOI 10.1146/annurev.en.40.010195.001413; Yamazaki K, 2005, BAMBOO J, V22, P93; Yoshimura J, 1997, AM NAT, V149, P112, DOI 10.1086/285981	48	18	18	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e105051	10.1371/journal.pone.0105051	http://dx.doi.org/10.1371/journal.pone.0105051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115953	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230400116
J	Mora, MDE; Steeg, C; Tartz, S; Heussler, V; Sparwasser, T; Link, A; Fleischer, B; Jacobs, T				Mora, Maria del Rosario Espinoza; Steeg, Christiane; Tartz, Susanne; Heussler, Volker; Sparwasser, Tim; Link, Andreas; Fleischer, Bernhard; Jacobs, Thomas			Depletion of Regulatory T Cells Augments a Vaccine-Induced T Effector Cell Response against the Liver-Stage of Malaria but Fails to Increase Memory	PLOS ONE			English	Article							PLASMODIUM-BERGHEI; ADENYLATE-CYCLASE; CIRCUMSPOROZOITE PROTEIN; PROTRACTED PROTECTION; BORDETELLA-PERTUSSIS; IMMUNE-RESPONSES; IMMUNIZATION; INDUCTION; AUTOIMMUNITY; SUPPRESSION	Regulatory T cells (T-reg) have been shown to restrict vaccine-induced T cell responses in different experimental models. In these studies CD4(+)CD25(+) T-reg were depleted using monoclonal antibodies against CD25, which might also interfere with CD25 on non-regulatory T cell populations and would have no effect on Foxp3(+)CD25(-) T-reg. To obtain more insights in the specific function of T-reg during vaccination we used mice that are transgenic for a bacterial artificial chromosome expressing a diphtheria toxin (DT) receptor-eGFP fusion protein under the control of the foxp3 gene locus (depletion of regulatory T cell mice; DEREG). As an experimental vaccine-carrier recombinant Bordetella adenylate cyclase toxoid fused with a MHC-class I-restricted epitope of the circumsporozoite protein (ACT-CSP) of Plasmodium berghei (Pb) was used. ACT-CSP was shown by us previously to introduce the CD8(+) epitope of Pb-CSP into the MHC class I presentation pathway of professional antigen-presenting cells (APC). Using this system we demonstrate here that the number of CSP-specific T cells increases when T-reg are depleted during prime but also during boost immunization. Importantly, despite this increase of T effector cells no difference in the number of antigen-specific memory cells was observed.	[Mora, Maria del Rosario Espinoza; Steeg, Christiane; Tartz, Susanne; Heussler, Volker; Fleischer, Bernhard; Jacobs, Thomas] Bernhard Nocht Inst Tropenmed, Immunol Abt, Hamburg, Germany; [Mora, Maria del Rosario Espinoza; Link, Andreas] Univ Saarlandes Kliniken, Klin Innere Med 3, Homburg, Germany; [Sparwasser, Tim] TWINCORE, Zentrum Expt & Klin Infekt Forsch, Inst Infekt Immunol, Hannover, Germany	Bernhard Nocht Institut fur Tropenmedizin; Universitatsklinikum des Saarlandes; Helmholtz Association; Helmholtz-Center for Infection Research	Mora, MDE (corresponding author), Bernhard Nocht Inst Tropenmed, Immunol Abt, Hamburg, Germany.	Rosario.Espinoza@t-online.de	Sparwasser, Tim D/AAA-4306-2022; Heussler, Volker/H-9322-2019; Sparwasser, Tim/AAF-7085-2019	Heussler, Volker/0000-0001-8028-9825; Sparwasser, Tim/0000-0001-5645-902X	German Research Foundation [SFB 841]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a Grant of the German Research Foundation (SFB 841) to T.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp CEM, 1996, EUR J IMMUNOL, V26, P1951, DOI 10.1002/eji.1830260841; Balam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051875; Butler NS, 2010, J IMMUNOL, V184, P2528, DOI 10.4049/jimmunol.0903529; Chaturvedi V, 2011, J IMMUNOL, V186, P6661, DOI 10.4049/jimmunol.1100315; Chuang CM, 2009, VACCINE, V27, P684, DOI 10.1016/j.vaccine.2008.11.042; Collison LW, 2009, J IMMUNOL, V182, P6121, DOI 10.4049/jimmunol.0803646; Couper KN, 2007, J IMMUNOL, V178, P4136, DOI 10.4049/jimmunol.178.7.4136; Couper KN, 2009, J IMMUNOL, V182, P3985, DOI 10.4049/jimmunol.0803053; D'Elia R, 2009, J IMMUNOL, V182, P2340, DOI 10.4049/jimmunol.0802767; Furuichi Y, 2005, WORLD J GASTROENTERO, V11, P3772, DOI 10.3748/wjg.v11.i24.3772; Good MF, 1999, CURR OPIN IMMUNOL, V11, P412, DOI 10.1016/S0952-7915(99)80069-7; Gruner AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001371; Hansen Wiebke, 2008, Inflammation & Allergy Drug Targets, V7, P217, DOI 10.2174/187152808786848360; Haque A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001221; Jobe O, 2007, J INFECT DIS, V196, P599, DOI 10.1086/519743; Kearley J, 2008, J ALLERGY CLIN IMMUN, V122, P617, DOI 10.1016/j.jaci.2008.05.048; Krzych U, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00370; Lahl K, 2011, METHODS MOL BIOL, V707, P157, DOI 10.1007/978-1-61737-979-6_10; Mahnke Karsten, 2008, V94, P29, DOI 10.1159/000154854; Mauduit M, 2010, INFECT IMMUN, V78, P2182, DOI 10.1128/IAI.01415-09; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Moore AC, 2005, J IMMUNOL, V175, P7264, DOI 10.4049/jimmunol.175.11.7264; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Piccirillo CA, 2008, CURR OPIN IMMUNOL, V20, P655, DOI 10.1016/j.coi.2008.09.006; Plebanski M, 1998, EUR J IMMUNOL, V28, P4345, DOI 10.1002/(SICI)1521-4141(199812)28:12&lt;4345::AID-IMMU4345&gt;3.0.CO;2-P; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Rech AJ, 2009, ANN NY ACAD SCI, V1174, P99, DOI 10.1111/j.1749-6632.2009.04939.x; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sakaguchi S, 2011, METHODS MOL BIOL, V707, P3, DOI 10.1007/978-1-61737-979-6_1; Schildknecht A, 2010, P NATL ACAD SCI USA, V107, P199, DOI 10.1073/pnas.0910620107; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Schneider J, 1999, IMMUNOL REV, V170, P29, DOI 10.1111/j.1600-065X.1999.tb01326.x; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Shanker A, 2010, IMMUNOL LETT, V131, P107, DOI 10.1016/j.imlet.2010.04.002; Simsova M, 2004, INT J MED MICROBIOL, V293, P571, DOI 10.1078/1438-4221-00291; Steeg C, 2009, J IMMUNOL, V183, P7014, DOI 10.4049/jimmunol.0901422; Tang QZ, 2006, CURR OPIN IMMUNOL, V18, P496, DOI 10.1016/j.coi.2006.05.007; Tartz S, 2006, INFECT IMMUN, V74, P2277, DOI 10.1128/IAI.74.4.2277-2285.2006; Tartz S, 2008, VACCINE, V26, P5935, DOI 10.1016/j.vaccine.2008.08.057; Taylor MD, 2009, EUR J IMMUNOL, V39, P192, DOI 10.1002/eji.200838727; Trimnell A, 2009, J IMMUNOL, V183, P5870, DOI 10.4049/jimmunol.0900302; Vignali DAA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00191; Witney AA, 2001, MOL BIOCHEM PARASIT, V118, P233, DOI 10.1016/S0166-6851(01)00372-3	45	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104627	10.1371/journal.pone.0104627	http://dx.doi.org/10.1371/journal.pone.0104627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115805	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230400061
J	Pomper, U; Brincker, J; Harwood, J; Prikhodko, I; Senkowski, D				Pomper, Ulrich; Brincker, Jana; Harwood, James; Prikhodko, Ivan; Senkowski, Daniel			Taking a Call Is Facilitated by the Multisensory Processing of Smartphone Vibrations, Sounds, and Flashes	PLOS ONE			English	Article							RACE MODEL INEQUALITY; EVOKED BRAIN ACTIVITY; AUDIOVISUAL INTEGRATION; REACTION-TIME; ATTENTION; RESPONSES; HUMANS	Many electronic devices that we use in our daily lives provide inputs that need to be processed and integrated by our senses. For instance, ringing, vibrating, and flashing indicate incoming calls and messages in smartphones. Whether the presentation of multiple smartphone stimuli simultaneously provides an advantage over the processing of the same stimuli presented in isolation has not yet been investigated. In this behavioral study we examined multisensory processing between visual (V), tactile (T), and auditory (A) stimuli produced by a smartphone. Unisensory V, T, and A stimuli as well as VA, AT, VT, and trisensory VAT stimuli were presented in random order. Participants responded to any stimulus appearance by touching the smartphone screen using the stimulated hand (Experiment 1), or the non-stimulated hand (Experiment 2). We examined violations of the race model to test whether shorter response times to multisensory stimuli exceed probability summations of unisensory stimuli. Significant violations of the race model, indicative of multisensory processing, were found for VA stimuli in both experiments and for VT stimuli in Experiment 1. Across participants, the strength of this effect was not associated with prior learning experience and daily use of smartphones. This indicates that this integration effect, similar to what has been previously reported for the integration of semantically meaningless stimuli, could involve bottom-up driven multisensory processes. Our study demonstrates for the first time that multisensory processing of smartphone stimuli facilitates taking a call. Thus, research on multisensory integration should be taken into consideration when designing electronic devices such as smartphones.	[Pomper, Ulrich; Brincker, Jana; Harwood, James; Prikhodko, Ivan; Senkowski, Daniel] Charite, St Hedwig Hosp, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Senkowski, D (corresponding author), Charite, St Hedwig Hosp, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany.	daniel.senkowski@charite.de	Senkowski, Daniel/G-6100-2012	Pomper, Ulrich/0000-0002-6534-968X; Senkowski, Daniel/0000-0002-1467-8264	ERC starting grant from the European Union [ERC-2010-StG-20091209]	ERC starting grant from the European Union	This work was supported by an ERC starting grant to Daniel Senkowski from the European Union (ERC-2010-StG-20091209, http://erc.europa.eu/ starting-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cappe C, 2009, NEUROPSYCHOLOGIA, V47, P1045, DOI 10.1016/j.neuropsychologia.2008.11.003; Colonius H, 2006, PSYCHOL REV, V113, P148, DOI 10.1037/0033-295X.113.1.148; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; Doehrmann O, 2008, BRAIN RES, V1242, P136, DOI 10.1016/j.brainres.2008.03.071; Forster B, 2002, EXP BRAIN RES, V143, P480, DOI 10.1007/s00221-002-1017-9; Gondan M, 2005, PERCEPT PSYCHOPHYS, V67, P713, DOI 10.3758/BF03193527; Hein G, 2007, J NEUROSCI, V27, P7881, DOI 10.1523/JNEUROSCI.1740-07.2007; Kiesel A, 2007, BEHAV RES METHODS, V39, P539, DOI 10.3758/BF03193024; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; MILLER J, 1982, COGNITIVE PSYCHOL, V14, P247, DOI 10.1016/0010-0285(82)90010-X; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Murray MM, 2005, CEREB CORTEX, V15, P963, DOI 10.1093/cercor/bhh197; Sella I, 2014, INT J PSYCHOPHYSIOL, V93, P45, DOI 10.1016/j.ijpsycho.2013.11.003; Senkowski D, 2007, NEUROIMAGE, V36, P877, DOI 10.1016/j.neuroimage.2007.01.053; Senkowski D, 2011, NEUROIMAGE, V56, P2200, DOI 10.1016/j.neuroimage.2011.03.075; Sperdin HF, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/neuro.01.009.2010; Sperdin HF, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.002.2009; Stein BE., 1993, MERGING SENSES; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; Stevenson RA, 2012, BRAIN TOPOGR, V25, P308, DOI 10.1007/s10548-012-0220-7; Stevenson RA, 2011, NEUROIMAGE, V55, P1339, DOI 10.1016/j.neuroimage.2010.12.063; Talsma D, 2005, J COGNITIVE NEUROSCI, V17, P1098, DOI 10.1162/0898929054475172; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008	23	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103238	10.1371/journal.pone.0103238	http://dx.doi.org/10.1371/journal.pone.0103238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LJ	25116195	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400015
J	Roth-Walter, F; Pacios, LF; Gomez-Casado, C; Hofstetter, G; Roth, GA; Singer, J; Diaz-Perales, A; Jensen-Jarolim, E				Roth-Walter, Franziska; Pacios, Luis F.; Gomez-Casado, Cristina; Hofstetter, Gerlinde; Roth, Georg A.; Singer, Josef; Diaz-Perales, Araceli; Jensen-Jarolim, Erika			The Major Cow Milk Allergen Bos d 5 Manipulates T-Helper Cells Depending on Its Load with Siderophore-Bound Iron	PLOS ONE			English	Article							BETA-LACTOGLOBULIN; VITAMIN-A; LIPOCALIN; BINDING; DEFICIENCY; APOPTOSIS; EXPRESSION; EPITOPES; LUTEOLIN; RETINOL	The mechanisms of allergic sensitization to milk are still elusive. The major allergen Bos d 5 belongs to the lipocalin-family and thus is able to transport numerous ligands. In this study we investigated its ability to bind to iron-siderophore complexes and tested the immune-modulatory properties of Bos d 5 in either forms. Structural and in silico docking analysis of Bos d 5 revealed that Bos d 5 is able to bind to iron via catechol-based flavonoids (quercetin, myricetin, luteolin) that act as siderophores as confirmed by spectral-analysis and iron staining. Calculated dissociation constants of docking analyses were below 1 mu M by virtual addition of iron. When incubated with human peripheral blood mononuclear cells (PBMCs), only the apo-form of Bos d 5 led to an increase of CD4+positive cells and significantly elevated IL13 and IFN gamma-levels. In contrast, holo-Bos d 5 decreased numbers of CD4 expressing cells and induced apoptosis. Taken together, our data give evidence that Bos d 5 is capable of binding iron via siderophores. Moreover, our data support for the first time the notion that the form of application (apo- or holo-form) is decisive for the subsequent immune response. The apo-form promotes Th2 cells and inflammation, whereas the holo-form appears to be immunosuppressive.	[Roth-Walter, Franziska; Hofstetter, Gerlinde; Jensen-Jarolim, Erika] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria; [Roth-Walter, Franziska; Hofstetter, Gerlinde; Jensen-Jarolim, Erika] Univ Vienna, Vienna, Austria; [Pacios, Luis F.; Gomez-Casado, Cristina; Diaz-Perales, Araceli] Tech Univ Madrid, Ctr Plant Biotechnol & Gen, Dept Biotechnol, Madrid, Spain; [Roth, Georg A.] Med Univ Vienna, Gen Intens Care & Pain Med, Dept Anesthesiol, Vienna, Austria; [Singer, Josef; Jensen-Jarolim, Erika] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; Universidad Politecnica de Madrid; Medical University of Vienna; Medical University of Vienna	Jensen-Jarolim, E (corresponding author), Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria.	Erika.jensen-jarolim@meduniwien.ac.at	Jensen-Jarolim, Erika/C-5120-2018; Roth-Walter, Franziska/V-4651-2017; Gomez-Casado, Cristina/AAE-4826-2021; Pacios, Luis F/I-5164-2015; Díaz-Perales, Araceli/D-8433-2016; Pacios, Luis F./AAL-6124-2021; Gomez-Casado, Cristina/K-4031-2016	Jensen-Jarolim, Erika/0000-0003-4019-5765; Roth-Walter, Franziska/0000-0001-5005-9228; Pacios, Luis F/0000-0002-0585-4289; Díaz-Perales, Araceli/0000-0002-1093-3627; Pacios, Luis F./0000-0002-0585-4289; Gomez-Casado, Cristina/0000-0002-7707-6367; Roth, Georg/0000-0002-3984-3107	Austrian Science Fund FWF [F4606-B19]; Spanish Government (MICINN/MINECO) [BES-2010-034628]; FWF [W1205-B09, P23398-B11]	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Spanish Government (MICINN/MINECO); FWF(Austrian Science Fund (FWF))	This work was supported by the F4606-B19 of the Austrian Science Fund FWF. CGC was financially supported with the grant BES-2010-034628of the FPI Programme from the Spanish Government (MICINN/MINECO). JS was financially supported by FWF grants W1205-B09 (PhD program CCHD) and P23398-B11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Belatik A, 2012, J BIOMOL STRUCT DYN, V30, P437, DOI 10.1080/07391102.2012.682209; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Elgersma A, 2006, ANIM FEED SCI TECH, V131, P207, DOI 10.1016/j.anifeedsci.2006.06.012; Escobar D, 2011, J DAIRY SCI, V94, P1201, DOI 10.3168/jds.2010-3870; Fiocchi A, 2010, PEDIAT ALLERG IMM-UK, V21, P1, DOI [10.1097/WOX.0b013e3181defeb9, 10.1111/j.1399-3038.2010.01068.x]; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Gomez-Casado C, 2013, J MOL GRAPH MODEL, V45, P111, DOI 10.1016/j.jmgm.2013.08.013; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; Host A, 1994, Pediatr Allergy Immunol, V5, P1; Illi S, 2014, ANN ALLERG ASTHMA IM, V112, P132, DOI 10.1016/j.anai.2013.11.019; Jang JT, 2000, J NUTR, V130, P1291; Jarvinen KM, 2002, J ALLERGY CLIN IMMUN, V110, P293, DOI 10.1067/mai.2002.126080; KALDJIAN E, 1988, FASEB J, V2, P2801, DOI 10.1096/fasebj.2.12.3261700; Kehrer JP, 2010, CELL BIOL TOXICOL, V26, P83, DOI 10.1007/s10565-009-9119-9; Keppler JK, 2014, BIOCH BIOPHYSICA ACT; Kontopidis G, 2002, J MOL BIOL, V318, P1043, DOI 10.1016/S0022-2836(02)00017-7; Kuhnen S, 2014, J SCI FOOD AGR; Luyt D, 2014, CLIN EXPT ALLERGY J; Miean KH, 2001, J AGR FOOD CHEM, V49, P3106, DOI 10.1021/jf000892m; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Muresan S, 2001, J AGR FOOD CHEM, V49, P2609, DOI 10.1021/jf0012188; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Parviainen S, 2013, SCAND J IMMUNOL, V77, P171, DOI 10.1111/sji.12023; Riihimaki LH, 2008, J AGR FOOD CHEM, V56, P7721, DOI 10.1021/jf801120a; Rosales FJ, 1999, J NUTR, V129, P1223, DOI 10.1093/jn/129.6.1223; Roth-Walter F, 2008, ALLERGY, V63, P882, DOI 10.1111/j.1398-9995.2008.01673.x; Roth-Walter F, 2014, J BIOL CHEM; Saarinen KM, 2005, J ALLERGY CLIN IMMUN, V116, P869, DOI 10.1016/j.jaci.2005.06.018; Sanchez D, 2003, MOL BIOL EVOL, V20, P775, DOI 10.1093/molbev/msg079; Shimoi K, 1998, FEBS LETT, V438, P220, DOI 10.1016/S0014-5793(98)01304-0; Srinivasan G, 2012, J IMMUNOL, V189, P1911, DOI 10.4049/jimmunol.1200892; SUHARNO D, 1993, LANCET, V342, P1325, DOI 10.1016/0140-6736(93)92246-P; Symonowicz M, 2012, ACTA POL PHARM, V69, P381; Tordesillas L, 2009, MOL IMMUNOL, V46, P722, DOI 10.1016/j.molimm.2008.10.018; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van Hemelen D, 2011, J IMMUNOL METHODS, V371, P114, DOI 10.1016/j.jim.2011.06.019; Wang X, 2014, J DAIRY SCI; Waser M, 2007, CLIN EXP ALLERGY, V37, P661, DOI 10.1111/j.1365-2222.2006.02640.x; Xu G, 2012, J BIOL CHEM, V287, P4808, DOI 10.1074/jbc.M111.275719; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zhou J, 2012, J DAIRY SCI, V95, P4230, DOI 10.3168/jds.2011-5282; ZURERACOSANO G, 1994, FOOD CHEM, V51, P75, DOI 10.1016/0308-8146(94)90050-7	46	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104803	10.1371/journal.pone.0104803	http://dx.doi.org/10.1371/journal.pone.0104803			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117976	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400088
J	Varner, J; Dearing, MD				Varner, Johanna; Dearing, M. Denise			The Importance of Biologically Relevant Microclimates in Habitat Suitability Assessments	PLOS ONE			English	Article							PIKA OCHOTONA-PRINCEPS; SMALL-MAMMAL COMMUNITIES; CLIMATE-CHANGE; AMERICAN PIKA; SIERRA-NEVADA; REFUGIA; MODELS; MICROREFUGIA; TEMPERATURE; DISPERSAL	Predicting habitat suitability under climate change is vital to conserving biodiversity. However, current species distribution models rely on coarse scale climate data, whereas fine scale microclimate data may be necessary to assess habitat suitability and generate predictive models. Here, we evaluate disparities between temperature data at the coarse scale from weather stations versus fine-scale data measured in microhabitats required for a climate-sensitive mammal, the American pika (Ochotona princeps). We collected two years of temperature data in occupied talus habitats predicted to be suitable (high elevation) and unsuitable (low elevation) by the bioclimatic envelope approach. At low elevations, talus surface and interstitial microclimates drastically differed from ambient temperatures measured on-site and at a nearby weather station. Interstitial talus temperatures were frequently decoupled from high ambient temperatures, resulting in instantaneous disparities of over 30 degrees C between these two measurements. Microhabitat temperatures were also highly heterogeneous, such that temperature measurements within the same patch of talus were not more correlated than measurements at distant patches. An experimental manipulation revealed that vegetation cover may cool the talus surface by up to 10 degrees C during the summer, which may contribute to this spatial heterogeneity. Finally, low elevation microclimates were milder and less variable than typical alpine habitat, suggesting that, counter to species distribution model predictions, these seemingly unsuitable habitats may actually be better refugia for this species under climate change. These results highlight the importance of fine-scale microhabitat data in habitat assessments and underscore the notion that some critical refugia may be counterintuitive.	[Varner, Johanna; Dearing, M. Denise] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Varner, J (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	johanna.varner@utah.edu		Varner, Johanna/0000-0001-9431-0760	National Science Foundation Graduate Research Fellowship [0750758]; National Science Foundation award [1111533]; University of Utah Global Change and Sustainability Center; Society for Integrative and Comparative Biology; Oregon Zoo Future for Wildlife Fund; Wilderness Society Gloria Barron Scholarship; American Society of Mammalogists	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation award(National Science Foundation (NSF)); University of Utah Global Change and Sustainability Center; Society for Integrative and Comparative Biology; Oregon Zoo Future for Wildlife Fund; Wilderness Society Gloria Barron Scholarship; American Society of Mammalogists	J.V. is supported by a National Science Foundation Graduate Research Fellowship (#0750758). Field assistants were supported by a REU supplement to National Science Foundation award #1111533 (PI: T. Schmid). Additional funding for dataloggers and fieldwork was provided by: University of Utah Global Change and Sustainability Center, Society for Integrative and Comparative Biology, The Oregon Zoo Future for Wildlife Fund, The Wilderness Society Gloria Barron Scholarship and American Society of Mammalogists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcroft MB, 2012, GLOBAL CHANGE BIOL, V18, P1866, DOI 10.1111/j.1365-2486.2012.02661.x; Ashcroft MB, 2010, J BIOGEOGR, V37, P1407, DOI 10.1111/j.1365-2699.2010.02300.x; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Beever EA, 2013, ECOLOGY, V94, P1563, DOI 10.1890/12-2174.1; Beever EA, 2011, GLOBAL CHANGE BIOL, V17, P2054, DOI 10.1111/j.1365-2486.2010.02389.x; Beever EA, 2010, ECOL APPL, V20, P164, DOI 10.1890/08-1011.1; Beringer J, 2001, J CLIMATE, V14, P3324, DOI 10.1175/1520-0442(2001)014<3324:TROASI>2.0.CO;2; Buckley LB, 2012, ANNU REV ECOL EVOL S, V43, P205, DOI 10.1146/annurev-ecolsys-110411-160516; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Dearing MD, 1997, J MAMMAL, V78, P1156, DOI 10.2307/1383058; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; DUPLESSIS A, 1992, ACTA THERIOL, V37, P351, DOI 10.4098/AT.arch.92-36; Erb LP, 2014, ECOL APPL, V24, P429, DOI 10.1890/13-1072.1; Erb LP, 2011, ECOLOGY, V92, P1730, DOI 10.1890/11-0175.1; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Graae BJ, 2012, OIKOS, V121, P3, DOI 10.1111/j.1600-0706.2011.19694.x; Grayson DK, 2000, J MAMMAL, V81, P1100, DOI 10.1644/1545-1542(2000)081<1100:BIORLE>2.0.CO;2; HAFNER DJ, 1993, QUATERNARY RES, V39, P373, DOI 10.1006/qres.1993.1044; Janis MJ, 2004, PHYS GEOGR, V25, P513, DOI 10.2747/0272-3646.25.6.513; Jeffress MR, 2013, ECOL APPL IN PRESS; Johnson SR, 1970, THERMAL REGULATION M; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Keppel G, 2012, GLOBAL CHANGE BIOL, V18, P2389, DOI 10.1111/j.1365-2486.2012.02729.x; Li H, 2013, BUILD ENVIRON, V59, P536, DOI 10.1016/j.buildenv.2012.10.014; MACARTHUR RA, 1974, CAN J ZOOL, V52, P353, DOI 10.1139/z74-042; Millar CI, 2010, ARCT ANTARCT ALP RES, V42, P76, DOI 10.1657/1938-4246-42.1.76; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Mote PW, 2009, 21 C CLIM VAR CHANG; Parker Geoffrey G., 1995, P73; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pike DA, 2013, ANIM CONSERV, V16, P694, DOI 10.1111/acv.12049; Potter KA, 2013, GLOBAL CHANGE BIOL, V19, P2932, DOI [10.1111/, 10.1111/gcb.12257]; Qiu GY, 2013, J INTEGR AGR, V12, P1307, DOI 10.1016/S2095-3119(13)60543-2; R Core Development Team, 2011, R LANG ENV STAT COMP; Rambo TR, 2008, NORTHWEST SCI, V82, P259, DOI 10.3955/0029-344X-82.4.259; Ray C, 2009, N AM PIK C JACKS WY; Rowe RJ, 2011, ECOLOGY, V92, P1366, DOI 10.1890/10-1634.1; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Sheldon KS, 2011, ECOL LETT, V14, P1191, DOI 10.1111/j.1461-0248.2011.01689.x; Shenbrot G, 2002, J ARID ENVIRON, V51, P265, DOI 10.1006/jare.2001.0945; Simpson WG, 2009, WEST N AM NATURALIST, V69, P243, DOI 10.3398/064.069.0213; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; SMITH A T, 1990, Mammalian Species, P1, DOI 10.2307/3504319; Smith A.T., 2004, SPECIES, V41, P4; SMITH AT, 1974, ECOLOGY, V55, P1368, DOI 10.2307/1935464; SMITH AT, 1974, ECOLOGY, V55, P1112, DOI 10.2307/1940361; Smith Felisa A., 1997, Mammalian Species, V564, P1; STARK HE, 1963, ECOLOGY, V44, P663, DOI 10.2307/1933012; Stewart JAE, 2012, WILDLIFE SOC B, V36, P759, DOI 10.1002/wsb.220; STONE PH, 1979, J ATMOS SCI, V36, P415, DOI 10.1175/1520-0469(1979)036<0415:ALRRAT>2.0.CO;2; Suggitt AJ, 2011, OIKOS, V120, P1, DOI 10.1111/j.1600-0706.2010.18270.x; Sumbera R, 2004, J ZOOL, V263, P409, DOI 10.1017/S095283690400545X; Varner J, 2014, J MAMMAL, V95, P72, DOI 10.1644/13-MAMM-A-099.1; Yang XS, 2013, BUILD ENVIRON, V60, P93, DOI 10.1016/j.buildenv.2012.11.008; Zechmeister HG, 1995, J BRYOL, V18, P455, DOI 10.1179/jbr.1995.18.3.455	57	65	66	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104648	10.1371/journal.pone.0104648	http://dx.doi.org/10.1371/journal.pone.0104648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115894	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400065
J	Chen, CH; Tang, SC; Tsai, LK; Hsieh, MJ; Yeh, SJ; Huang, KY; Jeng, JS				Chen, Chih-Hao; Tang, Sung-Chun; Tsai, Li-Kai; Hsieh, Ming-Ju; Yeh, Shin-Joe; Huang, Kuang-Yu; Jeng, Jiann-Shing			Stroke Code Improves Intravenous Thrombolysis Administration in Acute Ischemic Stroke	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; TO-NEEDLE TIMES; IN-HOSPITAL MORTALITY; SAFE IMPLEMENTATION; GUIDELINES-STROKE; CASE-FATALITY; ADMISSION; TAIWAN; IMPACT; CARE	Background and Purpose: Timely intravenous (IV) thrombolysis for acute ischemic stroke is associated with better clinical outcomes. Acute stroke care implemented with "Stroke Code'' (SC) may increase IV tissue plasminogen activator (tPA) administration. The present study aimed to investigate the impact of SC on thrombolysis. Methods: The study period was divided into the "pre-SC era'' (January 2006 to July 2010) and "SC era'' (August 2010 to July 2013). Demographics, critical times (stroke symptom onset, presentation to the emergency department, neuroimaging, thrombolysis), stroke severity, and clinical outcomes were recorded and compared between the two eras. Results: During the study period, 5957 patients with acute ischemic stroke were admitted; of these, 1301 (21.8%) arrived at the emergency department within 3 h of stroke onset and 307 (5.2%) received IV-tPA. The number and frequency of IV-tPA treatments for patients with an onset-to-door time of <3 h increased from the pre-SC era (n = 91, 13.9%) to the SC era (n = 216, 33.3%) (P < 0.001). SC also improved the efficiency of IV-tPA administration; the median door-to-needle time decreased (88 to 51 min, P < 0.001) and the percentage of door-to-needle times <= 60 min increased (14.3% to 71.3%, P < 0.001). The SC era group tended to have more patients with good outcome (modified Rankin Scale <= 2) at discharge (49.5 vs. 39.6%, P = 0.11), with no difference in symptomatic hemorrhage events or in-hospital mortality. Conclusion: The SC protocol increases the percentage of acute ischemic stroke patients receiving IV-tPA and decreases door-to-needle time.	[Chen, Chih-Hao; Tang, Sung-Chun; Tsai, Li-Kai; Yeh, Shin-Joe; Huang, Kuang-Yu; Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan; [Chen, Chih-Hao; Tang, Sung-Chun; Tsai, Li-Kai; Yeh, Shin-Joe; Huang, Kuang-Yu; Jeng, Jiann-Shing] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Chen, Chih-Hao] Far Eastern Mem Hosp, Dept Internal Med, Div Neurol, New Taipei City, Taiwan; [Hsieh, Ming-Ju] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Hsieh, Ming-Ju] Natl Taiwan Univ, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Jeng, JS (corresponding author), Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan.	jsjeng@ntu.edu.tw	Chen, Chih-Hao/AAA-7297-2022; yeh, shin-joe/HGV-0244-2022	Chen, Chih-Hao/0000-0002-1258-8775; Yeh, Shin-Joe/0000-0003-1511-6295; HSIEH, MING-JU/0000-0003-3636-6250; Tang, Sung-Chun/0000-0003-3731-5973; JENG, JIANN-SHING/0000-0002-1456-3686; Tsai, Li-Kai/0000-0001-8420-6951	National Taiwan University Hospital [A116]	National Taiwan University Hospital(National Taiwan University)	The work was supported by grant A116 from National Taiwan University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JE, 2007, STROKE, V38, P3097, DOI 10.1161/STROKEAHA.107.186094; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Albright KC, 2012, CEREBROVASC DIS, V34, P424, DOI 10.1159/000345077; [Anonymous], TAIW GUID MAN STROK; Arora S, 2005, STROKE, V36, P1232, DOI 10.1161/01.STR.0000165902.18021.5b; Balami JS, 2013, BRAIN, V136, P3528, DOI 10.1093/brain/awt201; Dalloz MA, 2012, J NEUROL SCI, V314, P120, DOI 10.1016/j.jns.2011.10.009; de la Ossa NP, 2008, NEUROLOGY, V70, P1238, DOI 10.1212/01.wnl.0000291008.63002.a5; Etgen T, 2011, ACTA NEUROL SCAND, V123, P390, DOI 10.1111/j.1600-0404.2010.01413.x; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Fonarow GC, 2011, STROKE, V42, P2983, DOI 10.1161/STROKEAHA.111.621342; Fonarow GC, 2011, CIRCULATION, V123, P750, DOI 10.1161/CIRCULATIONAHA.110.974675; Ford AL, 2012, STROKE, V43, P3395, DOI 10.1161/STROKEAHA.112.670687; Gladstone DJ, 2009, STROKE, V40, P3841, DOI 10.1161/STROKEAHA.108.540377; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hacke Werner, 2008, N Engl J Med, V359, P1317, DOI 10.1056/NEJMoa0804656; Hamidon BB, 2007, J CLIN NEUROSCI, V14, P831, DOI 10.1016/j.jocn.2006.03.029; Hasegawa Y, 2005, CEREBROVASC DIS, V20, P325, DOI 10.1159/000087932; Heo JH, 2010, STROKE, V41, P1978, DOI 10.1161/STROKEAHA.110.583591; Heuschmann PU, 2003, STROKE, V34, P1106, DOI 10.1161/01.STR.0000065198.80347.C5; Hoh BL, 2010, STROKE, V41, P2323, DOI 10.1161/STROKEAHA.110.591081; Hsieh CY, 2014, J FORMOS MED ASSOC, V113, P929, DOI 10.1016/j.jfma.2013.11.012; Hsieh FI, 2010, CIRCULATION, V122, P1116, DOI 10.1161/CIRCULATIONAHA.110.936526; Kim SK, 2009, EUR J NEUROL, V16, P1331, DOI 10.1111/j.1468-1331.2009.02762.x; Lee HY, 2010, STROKE, V41, P739, DOI 10.1161/STROKEAHA.109.573543; Lin CB, 2012, CIRC-CARDIOVASC QUAL, V5, P514, DOI 10.1161/CIRCOUTCOMES.112.965210; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Nazir FS, 2009, J CLIN NEUROSCI, V16, P21, DOI 10.1016/j.jocn.2008.02.004; Ogbu UC, 2011, J NEUROL NEUROSUR PS, V82, P8, DOI 10.1136/jnnp.2009.202176; Reeves MJ, 2009, STROKE, V40, P569, DOI 10.1161/STROKEAHA.108.519355; Rizos T, 2009, STROKE, V40, P3547, DOI 10.1161/STROKEAHA.109.562769; Ruff IM, 2014, STROKE, V45, P504, DOI 10.1161/STROKEAHA.113.004073; Saposnik G, 2007, STROKE, V38, P1211, DOI 10.1161/01.STR.0000259622.78616.ea; Saposnik G, 2012, STROKE, V43, P1315, DOI 10.1161/STROKEAHA.111.646265; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Seshadri S, 2007, LANCET NEUROL, V6, P1106, DOI 10.1016/S1474-4422(07)70291-0; Sobesky J, 2007, CEREBROVASC DIS, V24, P56, DOI 10.1159/000103117; Summers D, 2009, STROKE, V40, P2911, DOI 10.1161/STROKEAHA.109.192362; Sung Sheng-Feng, 2010, Acta Neurol Taiwan, V19, P246; Tai YJ, 2012, INTERN MED J, V42, P1316, DOI 10.1111/j.1445-5994.2011.02709.x; Truelsen T, 2005, EUR J NEUROL, V12, P78, DOI 10.1111/j.1468-1331.2005.01199.x; Tung YC, 2009, MED CARE, V47, P1018, DOI 10.1097/MLR.0b013e3181a81144; Tveiten A, 2009, EMERG MED J, V26, P324, DOI 10.1136/emj.2008.063610; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wahlgren N, 2008, STROKE, V39, P3316, DOI 10.1161/STROKEAHA.107.510768; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Yip PK, 1997, STROKE, V28, P2507, DOI 10.1161/01.STR.28.12.2507	47	32	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104862	10.1371/journal.pone.0104862	http://dx.doi.org/10.1371/journal.pone.0104862			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111200	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100107
J	Chen, X				Chen, Xi			Gift-Giving and Network Structure in Rural China: Utilizing Long-Term Spontaneous Gift Records	PLOS ONE			English	Article							SOCIAL NETWORKS; IDENTIFICATION; CENTRALITY; POWER	The tradition of keeping written records of gift received during household ceremonies in many countries offers researchers an underutilized means of data collection for social network analysis. This paper first summarizes unique features of the gift record data that circumvent five prevailing sampling and measurement issues in the literature, and we discuss their advantages over existing studies at both the individual level and the dyadic link level using previous data sources. We then document our research project in rural China that implements a multiple wave census-type household survey and a long-term gift record collection. The pattern of gift-giving in major household social events and its recent escalation is analyzed. There are significantly positive correlations between gift network centrality and various forms of informal insurance. Finally, economic inequality and competitive marriage market are among the main demographic and socioeconomic determinants of the observed gift network structure.	Yale Univ, Dept Econ, Inst Social & Policy Studies, Sch Publ Hlth, New Haven, CT 06520 USA	Yale University	Chen, X (corresponding author), Yale Univ, Dept Econ, Inst Social & Policy Studies, Sch Publ Hlth, New Haven, CT 06520 USA.	xi.chen@yale.edu			International Food Policy Research Institute; China Academy of Agricultural Sciences; Guizhou University	International Food Policy Research Institute(CGIAR); China Academy of Agricultural Sciences; Guizhou University	Data collection support provided by International Food Policy Research Institute, China Academy of Agricultural Sciences, and Guizhou University is acknowledged. I appreciate the valuable comments from the editor and the three anonymous referees of the journal. I am grateful to Kevin Chen, Shenggen Fan, Robert Frank, Ravi Kanbur, David Sahn, Xiaobo Zhang for encouragement, guidance, helpful comments and discussions. The views expressed herein and any remaining errors are the author's and do not represent any official agency.	AKERLOF G, 1976, Q J ECON, V90, P599, DOI 10.2307/1885324; [Anonymous], AGR INNOVATION UNPUB; [Anonymous], 2013, ECONOMIST; [Anonymous], 2004, INSURANCE POVERTY; BASU K, 1986, OXFORD ECON PAP, V38, P259, DOI 10.1093/oxfordjournals.oep.a041740; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Brown PH, 2011, J DEV ECON, V96, P139, DOI 10.1016/j.jdeveco.2010.05.007; Cameron AC, 2011, J BUS ECON STAT, V29, P238, DOI 10.1198/jbes.2010.07136; Chen X, 2012, 2012070 UNUWIDER; Chen X., 2012, 8777 CEPR; Conley TG, 2010, AM ECON REV, V100, P35, DOI 10.1257/aer.100.1.35; Dekker M, 2004, CSAE C GROWTH POV RE; Durlauf S., 2005, SOCIAL CAPITAL HDB E; Fafchamps M, 2007, J DEV ECON, V83, P326, DOI 10.1016/j.jdeveco.2006.05.005; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Genicot G, 2000, ENDOGENOUS GRO UNPUB; Goyal S., 2009, CONNECTIONS INTRO EC; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Hogset H, 2010, ECON DEV CULT CHANGE, V58, P563, DOI 10.1086/650424; Jackson Mathew O., 2007, MISSING LINKS FORMAT; Krishnan P, 2005, 0462 CWPE U CAMBR; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Murgai R, 2000, LOCALIZED INCO UNPUB; Narayan D, 1999, ECON DEV CULT CHANGE, V47, P871, DOI 10.1086/452436; Santos P., 2008, NOT MUCH 0501; Simpson W., 2001, P N AM STATA USERSGR; The Economist, 2012, ECONOMIST; Udry C, 2005, SOCIAL EC POVERTY ID; Waldfogel J, 2002, ECON INQ, V40, P415, DOI 10.1093/ei/40.3.415; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wei SJ, 2011, J POLIT ECON, V119, P511, DOI 10.1086/660887; Xing L, 2009, CHINA ECON REV, V20, P338, DOI 10.1016/j.chieco.2008.10.006; Yan Yunxiang, 1996, FLOW GIFTS RECIPROCI; Zhang XB, 2011, CHINA ECON REV, V22, P542, DOI 10.1016/j.chieco.2011.07.002; Zhao L, 2013, WORKING PAPER	37	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e102104	10.1371/journal.pone.0102104	http://dx.doi.org/10.1371/journal.pone.0102104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WB	25111696	Green Submitted, gold, Green Published			2022-12-27	WOS:000341105100008
J	Huang, XW; Guo, JH; Wang, XL; Yan, M; Kang, YJ; Yu, H				Huang, Xiwei; Guo, Jinhong; Wang, Xiaolong; Yan, Mei; Kang, Yuejun; Yu, Hao			A Contact-Imaging Based Microfluidic Cytometer with Machine-Learning for Single-Frame Super-Resolution Processing	PLOS ONE			English	Article							CELLS	Lensless microfluidic imaging with super-resolution processing has become a promising solution to miniaturize the conventional flow cytometer for point-of-care applications. The previous multi-frame super-resolution processing system can improve resolution but has limited cell flow rate and hence low throughput when capturing multiple subpixel-shifted cell images. This paper introduces a single-frame super-resolution processing with on-line machine-learning for contact images of cells. A corresponding contact-imaging based microfluidic cytometer prototype is demonstrated for cell recognition and counting. Compared with commercial flow cytometer, less than 8% error is observed for absolute number of microbeads; and 0.10 coefficient of variation is observed for cell-ratio of mixed RBC and HepG2 cells in solution.	[Huang, Xiwei; Wang, Xiaolong; Yan, Mei; Yu, Hao] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore; [Guo, Jinhong; Kang, Yuejun] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kang, YJ (corresponding author), Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.	yuejun.kang@ntu.edu.sg; haoyu@ntu.edu.sg	kang, yue/GYA-2003-2022; Yu, Hao/C-1289-2010; yan, mei/AAA-1379-2022; Huang, Xiwei/M-8280-2015; Kang, Yuejun/C-4119-2009	Yu, Hao/0000-0001-8747-3203; Kang, Yuejun/0000-0002-1021-0349	National Research Foundation Singapore [NRF2011NRF-POCO01-050]	National Research Foundation Singapore(National Research Foundation, Singapore)	Authors gratefully acknowledge the support from National Research Foundation Proof-of-Concept Grant (NRF2011NRF-POCO01-050) Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2012, IEEE IMAGE PROC, P2209, DOI 10.1109/ICIP.2012.6467333; Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Bernabini C, 2011, LAB CHIP, V11, P407, DOI [10.1039/c0lc00099j, 10.1039/c01c00099j]; Brown M, 2000, CLIN CHEM, V46, P1221; Chen YC, 2014, LAB CHIP, V14, P916, DOI 10.1039/c3lc51139a; Freeman W. T., 1999, Proceedings of the Seventh IEEE International Conference on Computer Vision, P1182, DOI 10.1109/ICCV.1999.790414; Givan A. L., 2001, FLOW CYTOMETRY 1 PRI; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Heng X, 2006, LAB CHIP, V6, P1274, DOI 10.1039/b604676b; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Huh D, 2005, PHYSIOL MEAS, V26, pR73, DOI 10.1088/0967-3334/26/3/R02; Isikman SO, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3548564; Ji HH, 2007, IEEE T CIRCUITS-I, V54, P1698, DOI 10.1109/TCSI.2007.902409; Lee SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022312; Lin SC, 2012, LAB CHIP, V12, P3135, DOI 10.1039/c2lc40246g; Lipton AJ, 1998, FOURTH IEEE WORKSHOP ON APPLICATIONS OF COMPUTER VISION - WACV'98, PROCEEDINGS, P8, DOI 10.1109/ACV.1998.732851; Mao XL, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3701566; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Moon S, 2009, BIOSENS BIOELECTRON, V24, P3208, DOI 10.1016/j.bios.2009.03.037; Myers FB, 2008, LAB CHIP, V8, P2015, DOI 10.1039/b812343h; Ozcan A, 2008, LAB CHIP, V8, P98, DOI 10.1039/b713695a; Piccardi M, 2004, IEEE SYS MAN CYBERN, P3099, DOI 10.1109/ICSMC.2004.1400815; Schonbrun E, 2012, LAB CHIP, V12, P268, DOI 10.1039/c1lc20843h; Seo S, 2009, LAB CHIP, V9, P777, DOI 10.1039/b813943a; Shapiro HM, 2003, PRACTICAL FLOW CYTOM; Su TW, 2009, BIOTECHNOL BIOENG, V102, P856, DOI 10.1002/bit.22116; Wang T, 2012, P IEEE BIOM CIRC SYS, P388; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wei QS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01699; Wlodkowic D, 2011, METHOD CELL BIOL, V102, P105, DOI 10.1016/B978-0-12-374912-3.00005-5; Wyss HM, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.061402; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yang CH, 2009, OPTOFLUIDICS OPTOFLU; Zhang WY, 2004, PROC IEEE MICR ELECT, P741, DOI 10.1109/MEMS.2004.1290691; Zheng GA, 2010, LAB CHIP, V10, P3125, DOI [10.1039/c01c00213e, 10.1039/c0lc00213e]; Zhu HY, 2013, LAB CHIP, V13, P51, DOI [10.1039/c2lc40864c, 10.1039/c21c40864c]	37	41	45	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104539	10.1371/journal.pone.0104539	http://dx.doi.org/10.1371/journal.pone.0104539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111497	gold, Green Published			2022-12-27	WOS:000341105100072
J	Paech, D; Zaiss, M; Meissner, JE; Windschuh, J; Wiestler, B; Bachert, P; Neumann, JO; Kickingereder, P; Schlemmer, HP; Wick, W; Nagel, AM; Heiland, S; Ladd, ME; Bendszus, M; Radbruch, A				Paech, Daniel; Zaiss, Moritz; Meissner, Jan-Eric; Windschuh, Johannes; Wiestler, Benedikt; Bachert, Peter; Neumann, Jan Oliver; Kickingereder, Philipp; Schlemmer, Heinz-Peter; Wick, Wolfgang; Nagel, Armin Michael; Heiland, Sabine; Ladd, Mark Edward; Bendszus, Martin; Radbruch, Alexander			Nuclear Overhauser Enhancement Mediated Chemical Exchange Saturation Transfer Imaging at 7 Tesla in Glioblastoma Patients	PLOS ONE			English	Article							MAGNETIZATION-TRANSFER; THERAPEUTIC RESPONSE; TRANSFER CEST; IN-VIVO; BRAIN; TUMORS; PEPTIDES; PROTEINS; CRITERIA; CANCER	Background and Purpose: Nuclear Overhauser Enhancement (NOE) mediated chemical exchange saturation transfer (CEST) is a novel magnetic resonance imaging (MRI) technique on the basis of saturation transfer between exchanging protons of tissue proteins and bulk water. The purpose of this study was to evaluate and compare the information provided by three dimensional NOE mediated CEST at 7 Tesla (7T) and standard MRI in glioblastoma patients. Patients and Methods: Twelve patients with newly diagnosed histologically proven glioblastoma were enrolled in this prospective ethics committee-approved study. NOE mediated CEST contrast was acquired with a modified three-dimensional gradient-echo sequence and asymmetry analysis was conducted at 3.3ppm (B1 = 0.7 mu T) to calculate the magnetization transfer ratio asymmetry (MTRasym). Contrast enhanced T1 (CE-T1) and T2-weighted images were acquired at 3T and used for data co-registration and comparison. Results: Mean NOE mediated CEST signal based on MTRasym values over all patients was significantly increased (p<0.001) in CE-T1 tumor (-1.99 +/- 1.22%), tumor necrosis (-1.36 +/- 1.30%) and peritumoral CEST hyperintensities (PTCH) within T2 edema margins (-3.56 +/- 1.24%) compared to contralateral normal appearing white matter (-8.38 +/- 1.19%). In CE-T1 tumor (p = 0.015) and tumor necrosis (p<0.001) mean MTRasym values were significantly higher than in PTCH. Extent of the surrounding tumor hyperintensity was smaller in eight out of 12 patients on CEST than on T2-weighted images, while four displayed at equal size. In all patients, isolated high intensity regions (0.40 +/- 2.21%) displayed on CEST within the CE-T1 tumor that were not discernible on CE-T1 or T2-weighted images. Conclusion: NOE mediated CEST Imaging at 7T provides additional information on the structure of peritumoral hyperintensities in glioblastoma and displays isolated high intensity regions within the CE-T1 tumor that cannot be acquired on CE-T1 or T2-weighted images. Further research is needed to determine the origin of NOE mediated CEST and possible clinical applications such as therapy assessment or biopsy planning.	[Paech, Daniel; Kickingereder, Philipp; Heiland, Sabine; Bendszus, Martin; Radbruch, Alexander] Heidelberg Univ, Dept Neuroradiol, Med Ctr, Heidelberg, Germany; [Paech, Daniel; Radbruch, Alexander] Deutsch Krebsforschungszentrum DKFZ, Dept Radiol, Heidelberg, Germany; [Zaiss, Moritz; Meissner, Jan-Eric; Windschuh, Johannes; Bachert, Peter; Nagel, Armin Michael; Ladd, Mark Edward] Deutsch Krebsforschungszentrum DKFZ, Dept Med Phys Radiol, Heidelberg, Germany; [Wiestler, Benedikt; Wick, Wolfgang] Heidelberg Univ, Dept Neurooncol, Med Ctr, Heidelberg, Germany; [Neumann, Jan Oliver] Heidelberg Univ, Dept Neurosurg, Med Ctr, Heidelberg, Germany; [Schlemmer, Heinz-Peter] Deutsch Krebsforschungszentrum DKFZ, Dept Radiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Radbruch, A (corresponding author), Heidelberg Univ, Dept Neuroradiol, Med Ctr, Heidelberg, Germany.	a.radbruch@dkfz.de	Wick, Wolfgang/AAA-2545-2020; Vollmuth, Philipp/AAK-3267-2021; Radbruch, Alexander/ABA-6277-2021; Nagel, Armin M/C-4671-2016	Wick, Wolfgang/0000-0002-6171-634X; Nagel, Armin M/0000-0003-0948-1421; Paech, Daniel/0000-0001-5755-6833; Vollmuth (ne Kickingereder), Philipp/0000-0002-6224-0064; Wiestler, Benedikt/0000-0002-2963-7772; Zaiss, Moritz/0000-0001-9780-3616; Ladd, Mark/0000-0002-4128-9440; Radbruch, Alexander/0000-0001-6238-6525	German Cancer Research Center	German Cancer Research Center(Helmholtz Association)	This study was supported by a grant from the "Intramurales Forderprogramm'' of the German Cancer Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BODSCH W, 1987, J NEUROSURG, V67, P250, DOI 10.3171/jns.1987.67.2.0250; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; GRIFFITHS JR, 1991, BRIT J CANCER, V64, P425, DOI 10.1038/bjc.1991.326; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Jia GA, 2011, J MAGN RESON IMAGING, V33, P647, DOI 10.1002/jmri.22480; Jin T, 2013, MAGN RESON MED, V69, P760, DOI 10.1002/mrm.24315; Jones CK, 2013, NEUROIMAGE, V77, P114, DOI 10.1016/j.neuroimage.2013.03.047; Liu DP, 2013, MAGN RESON MED, V70, P1070, DOI 10.1002/mrm.24560; Liu GS, 2013, NMR BIOMED, V26, P810, DOI 10.1002/nbm.2899; Nelson SJ, 2011, NMR BIOMED, V24, P734, DOI 10.1002/nbm.1669; Radbruch A, 2012, NEURO-ONCOLOGY, V14, P222, DOI 10.1093/neuonc/nor200; Rivlin M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03045; Sagiyama K, 2014, P NATL ACAD SCI USA, V111, P4542, DOI 10.1073/pnas.1323855111; Schmitt B, 2011, RADIOLOGY, V260, P257, DOI 10.1148/radiol.11101841; Scott JN, 2002, NEUROLOGY, V59, P947, DOI 10.1212/WNL.59.6.947; Sorensen AG, 2008, NAT CLIN PRACT ONCOL, V5, P634, DOI 10.1038/ncponc1204; Stancanello J, 2008, CONTRAST MEDIA MOL I, V3, P136, DOI 10.1002/cmmi.240; Tietze A, 2014, NMR BIOMED, V27, P163, DOI 10.1002/nbm.3048; van Zijl PCM, 2003, MAGNET RESON MED, V49, P440, DOI 10.1002/mrm.10398; VAUPEL P, 1989, CANCER RES, V49, P6449; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wen ZB, 2010, NEUROIMAGE, V51, P616, DOI 10.1016/j.neuroimage.2010.02.050; Zaiss M, 2013, NMR BIOMEDICINE; Zaiss M, 2013, PHYS MED BIOL, V58, pR221, DOI 10.1088/0031-9155/58/22/R221; Zhou JY, 2013, J MAGN RESON IMAGING, V38, P1119, DOI 10.1002/jmri.24067; Zhou JY, 2013, MAGN RESON MED, V70, P320, DOI 10.1002/mrm.24784; Zhou Jinyuan, 2011, Nat Med, V17, P130, DOI 10.1038/nm.2268; Zhou JY, 2003, MAGNET RESON MED, V50, P1120, DOI 10.1002/mrm.10651; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907	29	48	48	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104181	10.1371/journal.pone.0104181	http://dx.doi.org/10.1371/journal.pone.0104181			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111650	gold, Green Published			2022-12-27	WOS:000341105100034
J	Canal, D; Serrano, D; Potti, J				Canal, David; Serrano, David; Potti, Jaime			Exploring Heterozygosity-Survival Correlations in a Wild Songbird Population: Contrasting Effects between Juvenile and Adult Stages	PLOS ONE			English	Article							FLYCATCHERS FICEDULA-HYPOLEUCA; FITNESS CORRELATIONS; INBREEDING DEPRESSION; MULTILOCUS HETEROZYGOSITY; LINKAGE DISEQUILIBRIUM; PIED FLYCATCHER; MATE CHOICE; AGE; MICROSATELLITES; DISPERSAL	The relationship between genetic diversity and fitness, a major issue in evolutionary and conservation biology, is expected to be stronger in traits affected by many loci and those directly influencing fitness. Here we explore the influence of heterozygosity measured at 15 neutral markers on individual survival, one of the most important parameters determining individual fitness. We followed individual survival up to recruitment and during subsequent adult life of 863 fledgling pied flycatchers born in two consecutive breeding seasons. Mark-recapture analyses showed that individual heterozygosity did not influence juvenile or adult survival. In contrast, the genetic relatedness of parents was negatively associated with the offspring's survival during the adult life, but this effect was not apparent in the juvenile (from fledgling to recruitment) stage. Stochastic factors experienced during the first year of life in this long-distance migratory species may have swamped a relationship between heterozygosity and survival up to recruitment.	[Canal, David; Potti, Jaime] CSIC, Dept Evolutionary Ecol, Donana Biol Stn, E-41080 Seville, Spain; [Serrano, David] CSIC, Dept Conservat Biol, Donana Biol Stn, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Canal, D (corresponding author), CSIC, Dept Evolutionary Ecol, Donana Biol Stn, E-41080 Seville, Spain.	davidcanal@ebd.csic.es	Canal, David/E-4401-2013; Serrano, David/B-5352-2013; Potti, Jaime/H-3113-2019	Canal, David/0000-0003-2875-2987; Serrano, David/0000-0001-6205-386X; Potti, Jaime/0000-0002-2284-0022	Spanish Government [PAC05-006-2, CGL2009-10652, CGL2011-29694]; Ministry of Education and Science [I3P-BDP2005]	Spanish Government(Spanish GovernmentEuropean Commission); Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by projects PAC05-006-2, CGL2009-10652 and CGL2011-29694 from the Spanish Government. DC was supported by a grant from the Ministry of Education and Science (I3P-BDP2005), and also thanks Paola Laiolo for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie LG, 2009, MOL ECOL RESOUR, V9, P1375, DOI 10.1111/j.1755-0998.2009.02746.x; Acevedo-Whitehouse K, 2006, MOL ECOL, V15, P1973, DOI 10.1111/j.1365-294X.2006.02903.x; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Balakrishnan CN, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-29; Balloux F, 2004, MOL ECOL, V13, P3021, DOI 10.1111/j.1365-294X.2004.02318.x; Brouwer L, 2007, MOL ECOL, V16, P3134, DOI 10.1111/j.1365-294X.2007.03370.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Camacho C, 2013, ECOL EVOL, V3, P4841, DOI 10.1002/ece3.563; Canal D, 2012, BEHAV ECOL SOCIOBIOL, V66, P67, DOI 10.1007/s00265-011-1253-8; Canal D, 2011, BEHAVIOUR, V148, P691, DOI 10.1163/000579511X573917; Chapman JR, 2011, J EVOLUTION BIOL, V24, P1715, DOI 10.1111/j.1420-9101.2011.02295.x; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Charlesworth B, 1996, P NATL ACAD SCI USA, V93, P6140, DOI 10.1073/pnas.93.12.6140; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Chernetsov Nikita, 2009, Avian Ecology and Behaviour, V16, P11; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Cohas A, 2009, MOL ECOL, V18, P1491, DOI 10.1111/j.1365-294X.2009.04116.x; Coltman DW, 2003, EVOLUTION, V57, P971, DOI 10.1111/j.0014-3820.2003.tb00309.x; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Da Silva A, 2009, EVOLUTION, V63, P403, DOI 10.1111/j.1558-5646.2008.00542.x; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; David P, 2007, MOL ECOL, V16, P2474, DOI 10.1111/j.1365-294X.2007.03330.x; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Eeva T, 2006, BIOL LETT-UK, V2, P298, DOI 10.1098/rsbl.2006.0443; Ellegren H, 1996, P ROY SOC B-BIOL SCI, V263, P1635, DOI 10.1098/rspb.1996.0239; Escobar JS, 2008, GENETICS, V180, P1593, DOI 10.1534/genetics.108.092718; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Forstmeier W, 2012, MOL ECOL, V21, P3237, DOI 10.1111/j.1365-294X.2012.05593.x; Gillingham MAF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081118; Grueber CE, 2010, CONSERV BIOL, V24, P1617, DOI 10.1111/j.1523-1739.2010.01549.x; Hansson B, 2001, P ROY SOC B-BIOL SCI, V268, P1287, DOI 10.1098/rspb.2001.1640; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Harrison XA, 2011, MOL ECOL, V20, P4786, DOI 10.1111/j.1365-294X.2011.05283.x; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Houle D, 1996, GENETICS, V143, P1467; Huk T, 2006, P R SOC B, V273, P1681, DOI 10.1098/rspb.2006.3485; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Jensen H, 2007, MOL ECOL, V16, P4066, DOI 10.1111/j.1365-294X.2007.03452.x; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Keller L, 2002, CONSERV BIOL, V17, P19, DOI DOI 10.1016/S0169-5347(02)02489-8; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Leder EH, 2008, MOL ECOL RESOUR, V8, P874, DOI 10.1111/j.1755-0998.2008.02096.x; Lesbarreres D, 2005, MOL ECOL, V14, P311, DOI 10.1111/j.1365-294X.2004.02394.x; Lundberg A, 1992, PIED FLYCATCHER; Lynch M., 1998, GENETICS ANAL QUANTI; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Martin TE, 1995, J APPL STAT, V22, P863, DOI 10.1080/02664769524676; Miller JM, 2014, HEREDITY, V112, P240, DOI 10.1038/hdy.2013.99; MONTALVO S, 1992, ORNIS SCAND, V23, P491, DOI 10.2307/3676681; Olano-Marin J, 2011, EVOLUTION, V65, P3175, DOI 10.1111/j.1558-5646.2011.01369.x; Olano-Marin J, 2011, MOL ECOL, V20, P4028, DOI 10.1111/j.1365-294X.2011.05177.x; POTTI J, 1991, ORNIS SCAND, V22, P45, DOI 10.2307/3676620; POTTI J, 1991, ARDEA, V79, P419; Potti J, 2013, J EVOLUTION BIOL, V26, P1445, DOI 10.1111/jeb.12145; Price T, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P202; Ralls K., 1986, P35; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Richardson DS, 2004, EVOLUTION, V58, P2037, DOI 10.1111/j.0014-3820.2004.tb00488.x; Rijks JM, 2008, HEREDITY, V100, P587, DOI 10.1038/hdy.2008.18; Ryder TB, 2010, BEHAV ECOL, V21, P203, DOI 10.1093/beheco/arp176; Sandercock BK, 2006, J WILDLIFE MANAGE, V70, P1504, DOI 10.2193/0022-541X(2006)70[1504:EODPFL]2.0.CO;2; Skalski J, 1993, TESTING SIGNIFICANCE, P9; Slate J, 2004, HEREDITY, V93, P255, DOI 10.1038/sj.hdy.6800485; Szulkin M, 2007, J EVOLUTION BIOL, V20, P1531, DOI 10.1111/j.1420-9101.2007.01325.x; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; Taylor SS, 2010, MOL ECOL, V19, P4454, DOI 10.1111/j.1365-294X.2010.04824.x; Von Hardenberg A, 2007, MOL ECOL, V16, P1969, DOI 10.1111/j.1365-294X.2006.03221.x; Wetzel DP, 2012, MOL ECOL, V21, P406, DOI 10.1111/j.1365-294X.2011.05380.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM	76	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105020	10.1371/journal.pone.0105020	http://dx.doi.org/10.1371/journal.pone.0105020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122217	Green Published, gold			2022-12-27	WOS:000341017000090
J	Chen, CH; Lin, TX; Zhou, Y; Li, DD; Xu, KW; Li, ZH; Fan, XX; Zhong, GZ; He, W; Chen, X; He, XY; Huang, J				Chen, Changhao; Lin, Tianxin; Zhou, Yu; Li, Doudou; Xu, Kewei; Li, Zhihua; Fan, Xinxiang; Zhong, Guangzheng; He, Wang; Chen, Xu; He, Xianyin; Huang, Jian			Adjuvant and Salvage Radiotherapy after Prostatectomy: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							POSITIVE SURGICAL MARGINS; RADICAL PROSTATECTOMY; RADIATION-THERAPY; POSTOPERATIVE RADIOTHERAPY; CANCER PATIENTS; PROGNOSTIC-SIGNIFICANCE; OUTCOME ANALYSIS; RISK; POSTPROSTATECTOMY; FAILURE	Purpose: In men with adverse prognostic factors (APFs) after radical prostatectomy (RP), the most appropriate timing to administer radiotherapy remains a subject for debate. We conducted a systemic review and meta-analysis to evaluate the therapeutic strategies: adjuvant radiotherapy (ART) and salvage radiotherapy (SRT). Materials and Methods: We comprehensively searched PubMed, EMBASE, Web of Science and the Cochrane Library and performed the meta-analysis of all randomized controlled trials (RCTs) and retrospective comparative studies assessing the prognostic factors of ART and SRT. Results: Between May 1998 and July 2012, 2 matched control studies and 16 retrospective studies including a total of 2629 cases were identified (1404 cases for ART and 1185 cases for SRT). 5-year biochemical failure free survival (BFFS) for ART was longer than that for SRT (Hazard Ratio [HR]: 0.37; 95% CI, 0.30-0.46; p<0.00001, I-2 = 0%). 3-year BFFS was significantly longer in the ART (HR: 0.38; 95% CI, 0.28-0.52; p<0.00001, I-2 = 0%). Overall survival (OS) was also better in the ART (RR: 0.53; 95% CI, 0.41-0.68; p<0.00001, I-2 = 0%), as did disease free survival (DFS) (RR: 0.53; 95% CI, 0.43-0.66; p<0.00001, I-2 = 0%). Exploratory subgroup analysis and sensitivity analysis revealed the similar results with original analysis. Conclusion: ART therapy offers a safe and efficient alternative to SRT with longer 3-year and 5-year BFFS, better OS and DFS. Our recommendation is to suggest ART for patients with APFs and may reduce the need for SRT. Given the inherent limitations of the included studies, future well-designed RCTs are awaited to confirm and update this analysis.	[Chen, Changhao; Lin, Tianxin; Xu, Kewei; Fan, Xinxiang; Zhong, Guangzheng; He, Wang; Chen, Xu; Huang, Jian] Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Zhou, Yu] Sun Yat Sen Mem Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China; [Li, Doudou; Li, Zhihua] Sun Yat Sen Mem Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [He, Xianyin] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Huang, J (corresponding author), Sun Yat Sen Mem Hosp, Dept Urol, Guangzhou, Guangdong, Peoples R China.	914259296@qq.com		Fan, Xinxiang/0000-0001-8495-6488	State Key Clinical Department of Urology; National Natural Science Foundation of China-Guangdong [U1301221]; National Natural Science Foundation of China [81001138, 81071688, 81172431, 81272808, 81101519, 81101935]; Guangdong Province Natural Scientific Foundation [07117336, 10151008901000024]	State Key Clinical Department of Urology; National Natural Science Foundation of China-Guangdong(National Natural Science Foundation of China (NSFC)National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Natural Scientific Foundation	This study was funded by the State Key Clinical Department of Urology, the Key Projects of National Natural Science Foundation of China-Guangdong Joint Fund (U1301221), the National Natural Science Foundation of China (Grant No. 81001138, 81071688, 81172431, 81272808, 81101519, 81101935), and Guangdong Province Natural Scientific Foundation (Grant No. 07117336, 10151008901000024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura Nobuaki, 2001, Hokkaido Journal of Medical Science, V76, P375; Anscher MS, 2004, JAMA-J AM MED ASSOC, V291, P1380, DOI 10.1001/jama.291.11.1380; Ayrapetov MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026064; Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Budiharto T, 2010, RADIOTHER ONCOL, V97, P474, DOI 10.1016/j.radonc.2010.07.008; Buskirk SJ, 2006, J UROLOGY, V176, P985, DOI 10.1016/j.juro.2006.04.083; Catton C, 2001, RADIOTHER ONCOL, V59, P51, DOI 10.1016/S0167-8140(01)00302-4; Cozzarini C, 2011, CURR OPIN UROL, V21, P206, DOI 10.1097/MOU.0b013e3283449e06; Detti B, 2013, J CANCER RES CLIN, V139, P147, DOI 10.1007/s00432-012-1309-9; Do LV, 2002, AM J CLIN ONCOL-CANC, V25, P1, DOI 10.1097/00000421-200202000-00001; Erickson BK, 2014, GYNECOL ONCOL; Hagan M, 2004, INT J RADIAT ONCOL, V59, P329, DOI 10.1016/j.ijrobp.2003.11.038; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Hudson E, 2008, CLIN ONCOL-UK, V20, P353, DOI 10.1016/j.clon.2008.02.008; Jereczek-Fossa BA, 2009, INT J RADIAT ONCOL, V74, P115, DOI 10.1016/j.ijrobp.2008.07.057; Jereczek-Fossa BA, 2007, RADIOTHER ONCOL, V84, P197, DOI 10.1016/j.radonc.2007.04.013; King CR, 2011, INT J RADIAT ONCOL, V80, P1, DOI 10.1016/j.ijrobp.2010.10.073; Kupelian PA, 1997, INT J RADIAT ONCOL, V37, P1043, DOI 10.1016/S0360-3016(96)00590-1; Lee HM, 2004, UROLOGY, V64, P84, DOI 10.1016/j.urology.2004.02.004; Lennernas B, 2003, SCAND J UROL NEPHROL, V37, P10, DOI 10.1080/00365590310008613; Lowe BA, 1997, J UROLOGY, V158, P1452, DOI 10.1016/S0022-5347(01)64240-X; Macdonald OK, 2008, UROL ONCOL-SEMIN ORI, V26, P271, DOI 10.1016/j.urolonc.2007.04.006; Mayer R, 2002, UROLOGY, V59, P732, DOI 10.1016/S0090-4295(02)01502-9; Nudell DM, 1999, UROLOGY, V54, P1049, DOI 10.1016/S0090-4295(99)00299-X; OHORI M, 1995, J UROLOGY, V154, P1818, DOI 10.1016/S0022-5347(01)66792-2; Ohri N, 2012, EUR J CANCER, V48, P837, DOI 10.1016/j.ejca.2011.08.013; Ospina JD, 2013, LECT NOTES COMPUT SC, V8150, P387, DOI 10.1007/978-3-642-40763-5_48; Ost P, 2011, INT J RADIAT ONCOL, V80, P1316, DOI 10.1016/j.ijrobp.2010.04.039; Pacholke HD, 2004, UROLOGY, V64, P982, DOI 10.1016/j.urology.2004.06.020; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; PARTIN AW, 1993, UROL CLIN N AM, V20, P713; Sasaki T, 2006, ANTICANCER RES, V26, P2367; Sasaki T, 2006, JPN J CLIN ONCOL, V36, P649, DOI 10.1093/jjco/hyl079; Schild SE, 1998, SEMIN RADIAT ONCOL, V8, P132, DOI 10.1016/S1053-4296(98)80009-X; Schild SE, 2001, INT J CANCER, V96, P94, DOI 10.1002/ijc.1012; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; STEIN A, 1992, J UROLOGY, V147, P942, DOI 10.1016/S0022-5347(17)37429-3; Stephenson AJ, 2004, JAMA-J AM MED ASSOC, V291, P1325, DOI 10.1001/jama.291.11.1325; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Swanson GP, 2007, UROL ONCOL-SEMIN ORI, V25, P110, DOI 10.1016/j.urolonc.2006.06.003; Swindle P, 2005, J UROLOGY, V174, P903, DOI 10.1097/01.ju.0000169475.00949.78; Taylor N, 2003, INT J RADIAT ONCOL, V56, P755, DOI 10.1016/S0360-3016(03)00069-5; Thompson IM, 2013, J UROLOGY, V190, P441, DOI 10.1016/j.juro.2013.05.032; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Thompson IM, 2006, JAMA-J AM MED ASSOC, V296, P2329, DOI 10.1001/jama.296.19.2329; Trabulsi EJ, 2008, UROLOGY, V72, P1298, DOI 10.1016/j.urology.2008.05.057; Tsien C, 2003, UROLOGY, V62, P93, DOI 10.1016/S0090-4295(03)00127-4; Valicenti RK, 1998, INT J RADIAT ONCOL, V42, P501, DOI 10.1016/S0360-3016(98)00270-3; Vassilikos EJK, 2000, CLIN BIOCHEM, V33, P115, DOI 10.1016/S0009-9120(99)00099-5; Vicini FA, 1999, UROLOGY, V54, P111, DOI 10.1016/S0090-4295(99)00219-8; Wadasaki K, 2007, INT J CLIN ONCOL, V12, P37, DOI 10.1007/s10147-006-0622-1; WALSH PC, 1994, J UROLOGY, V152, P1831, DOI 10.1016/S0022-5347(17)32396-0; Wiegel T, 2009, J CLIN ONCOL, V27, P2924, DOI 10.1200/JCO.2008.18.9563; Won MS, 2009, BIOCHEM BIOPH RES CO, V385, P16, DOI 10.1016/j.bbrc.2009.05.022	55	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104918	10.1371/journal.pone.0104918	http://dx.doi.org/10.1371/journal.pone.0104918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121769	gold, Green Submitted, Green Published			2022-12-27	WOS:000341017000073
J	Gouspillou, G; Sgarioto, N; Norris, B; Barbat-Artigas, S; Aubertin-Leheudre, M; Morais, JA; Burelle, Y; Taivassalo, T; Hepple, RT				Gouspillou, Gilles; Sgarioto, Nicolas; Norris, Brandon; Barbat-Artigas, Sebastien; Aubertin-Leheudre, Mylene; Morais, Jose A.; Burelle, Yan; Taivassalo, Tanja; Hepple, Russell T.			The Relationship between Muscle Fiber Type-Specific PGC-1 alpha Content and Mitochondrial Content Varies between Rodent Models and Humans	PLOS ONE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; RECEPTOR-GAMMA COACTIVATOR-1; SKELETAL-MUSCLE; ANATOMIC CAPILLARIZATION; OXIDATIVE CAPACITY; LIPID-CONTENT; ANGIOGENESIS; EXPRESSION; SIRT1; BIOGENESIS	PGC-1 alpha regulates critical processes in muscle physiology, including mitochondrial biogenesis, lipid metabolism and angiogenesis. Furthermore, PGC-1 alpha was suggested as an important regulator of fiber type determination. However, whether a muscle fiber type-specific PGC-1 alpha content exists, whether PGC-1 alpha content relates to basal levels of mitochondrial content, and whether such relationships are preserved between humans and classically used rodent models are all questions that have been either poorly addressed or never investigated. To address these issues, we investigated the fiber type-specific content of PGC-1 alpha and its relationship to basal mitochondrial content in mouse, rat and human muscles using in situ immunolabeling and histochemical methods on muscle serial cross-sections. Whereas type IIa fibers exhibited the highest PGC-1 alpha in all three species, other fiber types displayed a hierarchy of type IIx>I>IIb in mouse, type I = IIx>IIb in rat, and type IIx>I in human. In terms of mitochondrial content, we observed a hierarchy of IIa>IIx>I>IIb in mouse, IIa>I>IIx>IIb in rat, and I>IIa>IIx in human skeletal muscle. We also found in rat skeletal muscle that type I fibers displayed the highest capillarization followed by type IIa>IIx>IIb. Finally, we found in human skeletal muscle that type I fibers display the highest lipid content, followed by type IIa>IIx. Altogether, our results reveal that (i) the fiber type-specific PGC-1 alpha and mitochondrial contents were only matched in mouse, (ii) the patterns of PGC-1 alpha and mitochondrial contents observed in mice and rats do not correspond to that seen in humans in several respects, and (iii) the classical phenotypes thought to be regulated by PGC-1 alpha do not vary exclusively as a function of PGC-1 alpha content in rat and human muscles.	[Gouspillou, Gilles; Sgarioto, Nicolas; Hepple, Russell T.] McGill Univ, Ctr Hlth, Dept Crit Care, Montreal, PQ, Canada; [Gouspillou, Gilles; Sgarioto, Nicolas; Hepple, Russell T.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Gouspillou, Gilles; Barbat-Artigas, Sebastien; Aubertin-Leheudre, Mylene] Univ Quebec, Fac Sci, Dept Kinanthropol, Montreal, PQ H3C 3P8, Canada; [Norris, Brandon; Taivassalo, Tanja; Hepple, Russell T.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Morais, Jose A.] McGill Univ, Ctr Hlth, Div Geriatr Med, Montreal, PQ, Canada; [Burelle, Yan] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	McGill University; McGill University; University of Quebec; University of Quebec Montreal; McGill University; McGill University; Universite de Montreal	Gouspillou, G (corresponding author), McGill Univ, Ctr Hlth, Dept Crit Care, Montreal, PQ, Canada.	gouspillou.gilles@uqam.ca; russell.hepple@mcgill.ca	Burelle, Yan/AAF-8104-2021; aubertin, rebeckah/R-6437-2017	Burelle, Yan/0000-0001-9379-146X; aubertin, rebeckah/0000-0002-0558-7571; Hepple, Russell/0000-0003-3640-486X; Gouspillou, Gilles/0000-0002-8543-3619	Canadian Institutes for Health Research [MOP 119583, MOP 57808]; Canadian Foundation for Innovation; Ministere du Developpement economique, innovation et exportation Quebec; McGill University Health Center	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ministere du Developpement economique, innovation et exportation Quebec; McGill University Health Center	This work was supported by operating grants from the Canadian Institutes for Health Research (MOP 119583 and MOP 57808) and infrastructure grants from the Canadian Foundation for Innovation and the Ministere du Developpement economique, innovation et exportation Quebec, held by R.T. Hepple. G. Gouspillou was supported by a postdoctoral fellowship from the McGill University Health Center. The images of the present manuscript were collected in the McGill University Life Sciences Complex Imaging Facility. Purchase of equipment in this facility was made possible with funding from the Canadian Foundation for Innovation and the Ministere du Developpement economique, innovation et exportation Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chabi B, 2009, J APPL PHYSIOL, V107, P1730, DOI 10.1152/japplphysiol.91451.2008; Chin ER, 2005, J APPL PHYSIOL, V99, P414, DOI 10.1152/japplphysiol.00015.2005; Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Gavin TP, 2009, EXERC SPORT SCI REV, V37, P86, DOI 10.1097/JES.0b013e31819c2e9b; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Goodpaster BH, 2000, METABOLISM, V49, P467, DOI 10.1016/S0026-0495(00)80010-4; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Hepple RT, 2004, J APPL PHYSIOL, V96, P2257, DOI 10.1152/japplphysiol.01309.2003; Hepple RT, 1997, CAN J APPL PHYSIOL, V22, P11, DOI 10.1139/h97-002; INGJER F, 1979, EUR J APPL PHYSIOL, V40, P197, DOI 10.1007/BF00426942; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lindblad-Toh K, 2004, NATURE, V428, P475, DOI 10.1038/428475a; Lundberg TR, 2014, ACTA PHYSL OXF; Mathieu-Costello O, 2002, EXERC SPORT SCI REV, V30, P80, DOI 10.1097/00003677-200204000-00007; Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283; Mormeneo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029985; Murgia M, 2000, NAT CELL BIOL, V2, P142, DOI 10.1038/35004013; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Perez-Schindler J, 2012, MOL CELL BIOL, V32, P4913, DOI 10.1128/MCB.00877-12; Picard M, 2012, AM J PHYSIOL-CELL PH, V302, pC629, DOI 10.1152/ajpcell.00368.2011; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rehman J, 2012, FASEB J, V26, P2175, DOI 10.1096/fj.11-196543; ROSENBLATT JD, 1987, STAIN TECHNOL, V62, P85, DOI 10.3109/10520298709107973; Rowe GC, 2013, CELL REP; Rowe GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041817; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Scott W, 2001, PHYS THER, V81, P1810, DOI 10.1093/ptj/81.11.1810; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; Shen TS, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/989263; Shortreed KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007293; Suwa M, 2008, METABOLISM, V57, P986, DOI 10.1016/j.metabol.2008.02.017; Taivassalo T, 2006, BRAIN, V129, P3391, DOI 10.1093/brain/awl282; Thom R, 2014, J BIOL CHEM, V289, P8810, DOI 10.1074/jbc.M114.554394; Twig G, 2011, ANTIOXID REDOX SIGN, V14, P1939, DOI 10.1089/ars.2010.3779; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wong LE, 2009, J APPL PHYSIOL, V106, P1660, DOI 10.1152/japplphysiol.91233.2008; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Ydfors M, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.140; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348	61	82	85	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103044	10.1371/journal.pone.0103044	http://dx.doi.org/10.1371/journal.pone.0103044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121500	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000008
J	Xia, XM; Yu, YX; Weidmann, M; Pan, YJ; Yan, SL; Wang, YJ				Xia, Xiaoming; Yu, Yongxin; Weidmann, Manfred; Pan, Yingjie; Yan, Shuling; Wang, Yongjie			Rapid Detection of Shrimp White Spot Syndrome Virus by Real Time, Isothermal Recombinase Polymerase Amplification Assay	PLOS ONE			English	Article							CRAB SCYLLA-SERRATA; ENVELOPE PROTEIN; MONOCLONAL-ANTIBODY; HISTORIC EMERGENCE; PENAEID SHRIMP; PCR ASSAY; WSSV; DNA; PATHOGENS; INFECTION	White spot syndrome virus (WSSV) causes large economic losses to the shrimp aquaculture industry, and thus far there are no efficient therapeutic treatments available against this lethal virus. In this study, we present the development of a novel real time isothermal recombinase polymerase amplification (RPA) assay for WSSV detection on a small ESEQuant Tube Scanner device. The RPA sensitivity, specificity and rapidity were evaluated by using a plasmid standard as well as viral and shrimp genomic DNAs. Compared with qPCR, the RPA assay revealed more satisfactory performance. It reached a detection limit up to 10 molecules in 95% of cases as determined by probit analysis of 8 independent experiments within 6.41 +/- 0.17 min at 39 degrees C. Consequently, this rapid RPA method has great application potential for field use or point of care diagnostics.	[Xia, Xiaoming; Yu, Yongxin; Pan, Yingjie; Yan, Shuling; Wang, Yongjie] Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stor, Shanghai, Peoples R China; [Xia, Xiaoming; Yu, Yongxin; Pan, Yingjie; Yan, Shuling; Wang, Yongjie] Shanghai Engn Res Ctr Aquat Prod Proc & Preservat, Shanghai, Peoples R China; [Xia, Xiaoming; Yu, Yongxin; Pan, Yingjie; Yan, Shuling; Wang, Yongjie] Shanghai Ocean Univ, Coll Food Sci & Technol, Shanghai, Peoples R China; [Weidmann, Manfred] Univ Stirling, Inst Aquaculture, Stirling FK9 4LA, Scotland; [Yan, Shuling] Univ Gottingen, Inst Biochem & Mol Cell Biol, D-37073 Gottingen, Germany	Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; University of Stirling; University of Gottingen	Wang, YJ (corresponding author), Minist Agr, Lab Qual & Safety Risk Assessment Aquat Prod Stor, Shanghai, Peoples R China.	yjwang@shou.edu.cn	Weidmann, Manfred/G-1817-2015	Weidmann, Manfred/0000-0002-7063-7491; Wang, Yongjie/0000-0002-7209-585X	National Natural Science Foundation of China [41376135]; Doctoral Fund of Ministry of Education of China [20133104110006]; Innovation Program of Shanghai Municipal Education Commission, China [14ZZ144]; Construction Program of Shanghai Committee of Science and Technology, China [11DZ2280300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Innovation Program of Shanghai Municipal Education Commission, China(Innovation Program of Shanghai Municipal Education Commission); Construction Program of Shanghai Committee of Science and Technology, China	This work was supported by the National Natural Science Foundation of China (No. 41376135), Doctoral Fund of Ministry of Education of China (20133104110006), Innovation Program of Shanghai Municipal Education Commission (14ZZ144), China, and Construction Program of Shanghai Committee of Science and Technology (11DZ2280300), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AM, 2004, ANNU REV PHYTOPATHOL, V42, P339, DOI 10.1146/annurev.phyto.42.040803.140329; Briese T, 2005, EMERG INFECT DIS, V11, P310, DOI 10.3201/eid1102.040492; Chaivisuthangkura Parin, 2004, ScienceAsia, V30, P359, DOI 10.2306/scienceasia1513-1874.2004.30.359; Chaivisuthangkura P, 2010, AQUACULTURE, V299, P15, DOI 10.1016/j.aquaculture.2009.12.005; Chen LL, 2000, DIS AQUAT ORGAN, V40, P157, DOI 10.3354/dao040157; Chou HY, 1995, DIS AQUAT ORGAN, V23, P165, DOI 10.3354/dao023165; Chou PH, 2011, J VIROL METHODS, V173, P67, DOI 10.1016/j.jviromet.2011.01.009; Euler M, 2013, J CLIN MICROBIOL, V51, P1110, DOI 10.1128/JCM.02704-12; Euler M, 2012, J CLIN VIROL, V54, P308, DOI 10.1016/j.jcv.2012.05.006; Euler M, 2012, J CLIN MICROBIOL, V50, P2234, DOI 10.1128/JCM.06504-11; Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004; Hou Chong-lin, 2011, Virologica Sinica, V26, P260, DOI 10.1007/s12250-011-3202-0; INOUYE K, 1994, FISH PATHOL, V29, P149, DOI 10.3147/jsfp.29.149; Jang IK, 2009, AQUACULTURE, V287, P40, DOI 10.1016/j.aquaculture.2008.10.038; Jaroenrama W, 2009, MOL CELL PROBE, V23, P65, DOI 10.1016/j.mcp.2008.12.003; Kiatpathomchai W, 2005, J VIROL METHODS, V130, P79, DOI 10.1016/j.jviromet.2005.06.006; King AM, 2012, 9 REPORT INT COMMITT, P770; Leu JH, 2009, CURR TOP MICROBIOL, V328, P197; Lightner DV, 2012, J INVERTEBR PATHOL, V110, P174, DOI 10.1016/j.jip.2012.03.006; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Lutz S, 2010, LAB CHIP, V10, P887, DOI 10.1039/b921140c; Mekata T, 2009, LETT APPL MICROBIOL, V48, P25, DOI 10.1111/j.1472-765X.2008.02479.x; Mendoza-Cano F, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-186; Meng XH, 2010, AQUACULTURE, V310, P32, DOI 10.1016/j.aquaculture.2010.10.010; Mrotzek G, 2010, J VIROL METHODS, V168, P262, DOI 10.1016/j.jviromet.2010.05.010; Nadala ECB, 2000, J VIROL METHODS, V84, P175, DOI 10.1016/S0166-0934(99)00140-8; Natividad KDT, 2008, J VIROL METHODS, V149, P28, DOI 10.1016/j.jviromet.2008.01.013; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Samanman S, 2011, J VIROL METHODS, V173, P75, DOI 10.1016/j.jviromet.2011.01.010; Sanchez-Paz A, 2010, VET RES, V41, DOI 10.1051/vetres/2010015; Seetang-Nun Y, 2013, MOL CELL PROBE, V27, P71, DOI 10.1016/j.mcp.2012.11.005; Shih Hsiu-Hui, 2004, Taiwania, V49, P159; Supamattaya K, 1998, DIS AQUAT ORGAN, V32, P79, DOI 10.3354/dao032079; Tsai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045278; Tsai YL, 2012, J VIROL METHODS, V181, P134, DOI 10.1016/j.jviromet.2012.01.017; van Hulten MCW, 2000, VIROLOGY, V266, P227, DOI 10.1006/viro.1999.0088; Wonteerasupaya C, 1995, DIS AQUAT ORGAN, V21, P69; Yi GH, 2004, J BIOCHEM MOL BIOL, V37, P726; You ZO, 2002, DIS AQUAT ORGAN, V51, P77, DOI 10.3354/dao051077	39	58	77	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104667	10.1371/journal.pone.0104667	http://dx.doi.org/10.1371/journal.pone.0104667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121957	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000053
J	Latif, N; Barbosa, AV; Vatiokiotis-Bateson, E; Castelhano, MS; Munhall, KG				Latif, Nida; Barbosa, Adriano V.; Vatiokiotis-Bateson, Eric; Castelhano, Monica S.; Munhall, K. G.			Movement Coordination during Conversation	PLOS ONE			English	Article							EYE-MOVEMENTS; SOCIAL-BEHAVIOR; BODY MOVEMENT; THIN SLICES; PERCEPTION; CONVERGENCE; SYNCHRONY; SPEAKERS; CUES; INDIVIDUALS	Behavioral coordination and synchrony contribute to a common biological mechanism that maintains communication, cooperation and bonding within many social species, such as primates and birds. Similarly, human language and social systems may also be attuned to coordination to facilitate communication and the formation of relationships. Gross similarities in movement patterns and convergence in the acoustic properties of speech have already been demonstrated between interacting individuals. In the present studies, we investigated how coordinated movements contribute to observers' perception of affiliation (friends vs. strangers) between two conversing individuals. We used novel computational methods to quantify motor coordination and demonstrated that individuals familiar with each other coordinated their movements more frequently. Observers used coordination to judge affiliation between conversing pairs but only when the perceptual stimuli were restricted to head and face regions. These results suggest that observed movement coordination in humans might contribute to perceptual decisions based on availability of information to perceivers.	[Latif, Nida; Castelhano, Monica S.; Munhall, K. G.] Queens Univ, Dept Psychol, Kingston, ON, Canada; [Barbosa, Adriano V.] Univ Fed Minas Gerais, Dept Psychol, Belo Horizonte, MG, Brazil; [Vatiokiotis-Bateson, Eric] Univ British Columbia, Dept Linguist, Vancouver, BC V5Z 1M9, Canada; [Munhall, K. G.] Queens Univ, Dept Otolaryngol, Kingston, ON, Canada	Queens University - Canada; Universidade Federal de Minas Gerais; University of British Columbia; Queens University - Canada	Latif, N (corresponding author), Queens Univ, Dept Psychol, Kingston, ON, Canada.	n.latif@queensu.ca		Castelhano, Monica/0000-0002-1097-9721; Latif, Nida/0000-0003-1084-252X; Barbosa, Adriano/0000-0003-1083-8256	Natural Sciences and Engineering Research Council of Canada; Queen's University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Queen's University	This research was supported by the Natural Sciences and Engineering Research Council of Canada and Queen's University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; AMBADY N, 1993, J PERS SOC PSYCHOL, V64, P431, DOI 10.1037/0022-3514.64.3.431; Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; Babel M, 2012, J PHONETICS, V40, P177, DOI 10.1016/j.wocn.2011.09.001; Barbosa AV, 2008, AUDITORY VISUAL SPEE, P173; Berger D, 2006, INTRO RESAMPLING TEC; Birmingham E, 2008, VIS COGN, V16, P341, DOI 10.1080/13506280701434532; BOYLE EA, 1994, LANG SPEECH, V37, P1, DOI 10.1177/002383099403700101; Bull Matthew, 1998, P 5 INT C SPOK LANG, P1175; Campbell R, 1997, BRAIN, V120, P1793, DOI 10.1093/brain/120.10.1793; CAPPELLA JN, 1981, HUM COMMUN RES, V7, P117, DOI 10.1111/j.1468-2958.1981.tb00564.x; Chartrand TL, 2009, ADV EXP SOC PSYCHOL, V41, P219, DOI 10.1016/S0065-2601(08)00405-X; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Clark H.H., 1996, USING LANGUAGE; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; COLE RA, 1974, Q J EXP PSYCHOL, V26, P1, DOI 10.1080/14640747408400381; Connor RC, 2006, ANIM BEHAV, V72, P1371, DOI 10.1016/j.anbehav.2006.03.014; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; De Ruiter JP, 2006, LANGUAGE, V82, P515, DOI 10.1353/lan.2006.0130; DEPAULO BM, 1992, PSYCHOL BULL, V111, P203, DOI 10.1037/0033-2909.111.2.203; Dunne M, 1994, J LANG SOC PSYCHOL, V13, P45, DOI DOI 10.1177/0261927X94131004; Fast NJ, 2009, PSYCHOL SCI, V20, P904, DOI 10.1111/j.1467-9280.2009.02387.x; FEYEREISEN P, 1994, BEHAV PROCESS, V33, P189, DOI 10.1016/0376-6357(94)90066-3; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Garrod S, 2004, TRENDS COGN SCI, V8, P8, DOI 10.1016/j.tics.2003.10.016; Grahe JE, 1999, J NONVERBAL BEHAV, V23, P253, DOI 10.1023/A:1021698725361; Grammer K, 1999, J PERS SOC PSYCHOL, V77, P487, DOI 10.1037/0022-3514.77.3.487; HADAR U, 1984, HUM MOVEMENT SCI, V3, P237, DOI 10.1016/0167-9457(84)90018-6; Hay J., 1999, ICPHS, V14, P1389; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Kamachi M, 2001, PERCEPTION, V30, P875, DOI 10.1068/p3131; Keysar B, 2000, PSYCHOL SCI, V11, P32, DOI 10.1111/1467-9280.00211; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; Kim Midam, 2011, Lab Phonol, V2, P125; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Knoblich G, 2003, J EXP PSYCHOL LEARN, V29, P1006, DOI 10.1037/0278-7393.29.5.1006; Lander K, 1999, MEM COGNITION, V27, P974, DOI 10.3758/BF03201228; MCHUGO GJ, 1985, J PERS SOC PSYCHOL, V49, P1513; Meltzoff A. N, 2002, THE IMITATIVE MIND D, V6; Miles LK, 2011, EXP BRAIN RES, V211, P495, DOI 10.1007/s00221-011-2641-z; Mitani JC, 1998, BEHAVIOUR, V135, P1041, DOI 10.1163/156853998792913483; Munhall KG, 2004, PSYCHOL SCI, V15, P133, DOI 10.1111/j.0963-7214.2004.01502010.x; Pardo JS, 2006, J ACOUST SOC AM, V119, P2382, DOI 10.1121/1.2178720; Ramseyer F, 2011, J CONSULT CLIN PSYCH, V79, P284, DOI 10.1037/a0023419; Richardson D., 2008, EMBODIED COMMUNICATI, P75, DOI DOI 10.1093/ACPROF:OSO/9780199231751.003.0004; Richardson DC, 2007, PSYCHOL SCI, V18, P407, DOI 10.1111/j.1467-9280.2007.01914.x; Richardson DC, 2005, COGNITIVE SCI, V29, P1045, DOI 10.1207/s15516709cog0000_29; Riley MA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00038; Rosenblum LD, 1996, J SPEECH HEAR RES, V39, P1159, DOI 10.1044/jshr.3906.1159; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Schmid M, 2004, HUM MOVEMENT SCI, V23, P105, DOI 10.1016/j.humov.2004.06.001; SCHMIDT RC, 1993, J EXP PSYCHOL HUMAN, V19, P397, DOI 10.1037/0096-1523.19.2.397; Seyfarth RM, 2012, ANNU REV PSYCHOL, V63, P153, DOI 10.1146/annurev-psych-120710-100337; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; Shepherd SV, 2012, J NEUROSCI, V32, P6105, DOI 10.1523/JNEUROSCI.6136-11.2012; Shockley K, 2003, J EXP PSYCHOL HUMAN, V29, P326, DOI 10.1037/0096-1523.29.2.326; Stalnaker R, 2002, LINGUIST PHILOS, V25, P701, DOI 10.1023/A:1020867916902; Tyack PL, 2008, J COMP PSYCHOL, V122, P319, DOI 10.1037/a0013087; Weisbuch M., 2010, SOCIAL VISION, P28; WILSON TP, 1986, DISCOURSE PROCESS, V9, P375, DOI 10.1080/01638538609544649; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; Yehia HC, 2002, J PHONETICS, V30, P555, DOI 10.1006/jpho.2002.0165	64	37	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105036	10.1371/journal.pone.0105036	http://dx.doi.org/10.1371/journal.pone.0105036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9BM	25119189	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600116
J	Nikhil, K; Sharan, S; Singh, AK; Chakraborty, A; Roy, P				Nikhil, Kumar; Sharan, Shruti; Singh, Abhimanyu K.; Chakraborty, Ajanta; Roy, Partha			Anticancer Activities of Pterostilbene-Isothiocyanate Conjugate in Breast Cancer Cells: Involvement of PPAR gamma	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; SIGNALING PATHWAY; INDUCE APOPTOSIS; INHIBITS GROWTH; TUMOR-GROWTH; COLON-CANCER; IN-VITRO; LIGANDS; DIFFERENTIATION; PROLIFERATION	Trans-3,5-dimethoxy-4'-hydroxystilbene (PTER), a natural dimethylated analog of resveratrol, preferentially induces certain cancer cells to undergo apoptosis and could thus have a role in cancer chemoprevention. Peroxisome proliferator-activated receptor gamma (PPAR gamma), a member of the nuclear receptor superfamily, is a ligand-dependent transcription factor whose activation results in growth arrest and/or apoptosis in a variety of cancer cells. Here we investigated the potential of PTER-isothiocyanate (ITC) conjugate, a novel class of hybrid compound (PTER-ITC) synthesized by appending an ITC moiety to the PTER backbone, to induce apoptotic cell death in hormone-dependent (MCF-7) and -independent (MDA-MB-231) breast cancer cell lines and to elucidate PPAR gamma involvement in PTER-ITC action. Our results showed that when pre-treated with PPAR gamma antagonists or PPAR gamma siRNA, both breast cancer cell lines suppressed PTER-ITC-induced apoptosis, as determined by annexin V/propidium iodide staining and cleaved caspase-9 expression. Furthermore, PTER-ITC significantly increased PPAR gamma mRNA and protein levels in a dose-dependent manner and modulated expression of PPARc-related genes in both breast cancer cell lines. This increase in PPARc activity was prevented by a PPARc-specific inhibitor, in support of our hypothesis that PTER-ITC can act as a PPARc activator. PTER-ITC-mediated upregulation of PPAR gamma was counteracted by coincubation with p38 MAPK or JNK inhibitors, suggesting involvement of these pathways in PTER-ITC action. Molecular docking analysis further suggested that PTER-ITC interacted with 5 polar and 8 non-polar residues within the PPARc ligand-binding pocket, which are reported to be critical for its activity. Collectively, our observations suggest potential applications for PTER-ITC in breast cancer prevention and treatment through modulation of the PPAR gamma activation pathway.	[Nikhil, Kumar; Sharan, Shruti; Chakraborty, Ajanta; Roy, Partha] Indian Inst Technol Roorkee, Dept Biotechnol, Mol Endocrinol Lab, Roorkee, Uttar Pradesh, India; [Singh, Abhimanyu K.] CSIC, Ctr Nacl Biotecnol, Dept Macromolecular Structures, Madrid, Spain	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Roy, P (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Mol Endocrinol Lab, Roorkee, Uttar Pradesh, India.	paroyfbs@iitr.ernet.in	Singh, Abhimanyu K./C-2243-2019; Singh, Abhimanyu K./U-5881-2019	Singh, Abhimanyu K./0000-0002-9998-020X; Singh, Abhimanyu K./0000-0002-9998-020X; SHARAN, SHRUTI/0000-0003-0405-8560; NIKHIL, KUMAR/0000-0002-9438-6578	Council for Scientific and Industrial Research and Ministry of Human Resources and Development (MHRD), Government of India	Council for Scientific and Industrial Research and Ministry of Human Resources and Development (MHRD), Government of India	This work was supported by research grants from Council for Scientific and Industrial Research and Ministry of Human Resources and Development (MHRD), Government of India as research fellowships to KN and project assistantship to PR, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2002, EUR J PHARMACOL, V436, P7, DOI 10.1016/S0014-2999(01)01577-1; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Chakraborty A, 2012, MOL CELL ENDOCRINOL, V355, P25, DOI 10.1016/j.mce.2012.01.009; Chakraborty A, 2010, TOXICOL IN VITRO, V24, P1215, DOI 10.1016/j.tiv.2010.02.007; Chamras H, 2002, J NUTR BIOCHEM, V13, P711, DOI 10.1016/S0955-2863(02)00230-9; Chang TH, 2000, CANCER RES, V60, P1129; Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8; Chu EC, 2004, BIOCHEM BIOPH RES CO, V320, P875, DOI 10.1016/j.bbrc.2004.06.036; Cui YH, 2007, EUR J CANCER, V43, P2590, DOI 10.1016/j.ejca.2007.08.015; de Ruiter MB, 2012, HUM BRAIN MAPP, V33, P2971, DOI 10.1002/hbm.21422; Elrod HA, 2008, PPAR RES, V489, P641; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gardner OS, 2005, MOL PHARMACOL, V68, P933, DOI 10.1124/mol.105.012260; Gardner OS, 2003, J BIOL CHEM, V278, P46261, DOI 10.1074/jbc.M307827200; Girroir EE, 2008, TOXICOLOGY, V243, P236, DOI 10.1016/j.tox.2007.10.023; Han S, 2007, ANTI-CANCER DRUG, V18, P237, DOI 10.1097/CAD.0b013e328011e67d; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Kim EJ, 2003, J PHARMACOL EXP THER, V307, P505, DOI 10.1124/jpet.103.053876; Kim KY, 2006, BIOCHEM PHARMACOL, V72, P530, DOI 10.1016/j.bcp.2006.05.009; Kim SH, 2006, TOXICOL APPL PHARM, V215, P198, DOI 10.1016/j.taap.2006.03.001; Kramer DK, 2005, DIABETES, V54, P1157, DOI 10.2337/diabetes.54.4.1157; Kubota T, 1998, CANCER RES, V58, P3344; Kumar AP, 2009, CANCER RES, V69, P8636, DOI 10.1158/0008-5472.CAN-09-0219; Lea MA, 2004, ANTICANCER RES, V24, P2765; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Lennon AM, 2002, J BIOL CHEM, V277, P29681, DOI 10.1074/jbc.M201517200; Li K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057542; Li MY, 2005, J CELL BIOCHEM, V96, P760, DOI 10.1002/jcb.20474; Liu H, 2003, BREAST CANCER RES TR, V79, P63, DOI 10.1023/A:1023366117157; Ma J., 2013, BREAST CANC METASTAS, P1, DOI DOI 10.1007/978-1-4614-5647-6_1; McCormack D, 2012, J SURG RES, V173, pE53, DOI 10.1016/j.jss.2011.09.054; Mena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044524; Mills N, 2006, J AM CHEM SOC, V128, P13649, DOI 10.1021/ja0697875; Mody M, 2007, ENDOCR-RELAT CANCER, V14, P305, DOI 10.1677/ERC-06-0003; Moore Susan, 2007, Semin Oncol Nurs, V23, pS23, DOI 10.1016/j.soncn.2007.10.005; Motomura W, 2005, BIOCHEM BIOPH RES CO, V332, P89, DOI 10.1016/j.bbrc.2005.04.095; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Munster PN, 2001, CANCER RES, V61, P8492; Munster PN, 2001, CANCER RES, V61, P2945; Nikhil K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093335; Nikhil K, 2014, EXP CELL RES, V320, P311, DOI 10.1016/j.yexcr.2013.10.015; Odle Teresa G, 2014, Radiol Technol, V85, p297M; Oyekan A, 2011, CLIN EXP HYPERTENS, V33, P287, DOI 10.3109/10641963.2010.531845; Padilla J, 2000, J IMMUNOL, V165, P6941, DOI 10.4049/jimmunol.165.12.6941; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Papageorgiou E, 2007, EXPERT OPIN THER TAR, V11, P1071, DOI 10.1517/14728222.11.8.1071; Payre B, 2008, MOL CANCER THER, V7, P3707, DOI 10.1158/1535-7163.MCT-08-0507; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Pighetti GM, 2001, ANTICANCER RES, V21, P825; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Sauer LA, 2005, J NUTR, V135, P2124, DOI 10.1093/jn/135.9.2124; Schmidt MV, 2010, THESCIENTIFICWORLDJO, V10, P2181, DOI 10.1100/tsw.2010.213; Seargent JM, 2004, BRIT J PHARMACOL, V143, P933, DOI 10.1038/sj.bjp.0705973; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Sertznig P, 2007, J CELL PHYSIOL, V212, P1, DOI 10.1002/jcp.20998; Shan ZZ, 2004, J BIOL CHEM, V279, P37939, DOI 10.1074/jbc.M402424200; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Sjovall K, 2010, EUR J ONCOL NURS, V14, P147, DOI 10.1016/j.ejon.2009.09.002; Suh N, 1999, CANCER RES, V59, P5671; Sun H, 2008, CANCER RES, V68, P2912, DOI 10.1158/0008-5472.CAN-07-2305; Tachibana K, 2008, PPAR RES, V2008, DOI 10.1155/2008/102737; Talbert DR, 2008, BREAST CANCER RES TR, V108, P23, DOI 10.1007/s10549-007-9575-y; Teruel T, 2003, J BIOL CHEM, V278, P263, DOI 10.1074/jbc.M207200200; Vasudevan KM, 2004, MOL CELL BIOL, V24, P1007, DOI 10.1128/MCB.24.3.1007-1021.2004; Venkatachalam G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S5; Wilding JPH, 2012, DIABETES OBES METAB, V14, P973, DOI 10.1111/j.1463-1326.2012.01601.x; Woo CC, 2011, BIOCHEM PHARMACOL, V82, P464, DOI 10.1016/j.bcp.2011.05.030; Xu LH, 2006, CANCER RES, V66, P11859, DOI 10.1158/0008-5472.CAN-06-1445; Yin F, 2001, BIOCHEM BIOPH RES CO, V286, P916, DOI 10.1006/bbrc.2001.5491; Zhang GY, 2005, BRIT J CANCER, V92, P113, DOI 10.1038/sj.bjc.6602244; Zhou J, 2009, INT J BIOCHEM CELL B, V41, P2334, DOI 10.1016/j.biocel.2009.06.007	79	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104592	10.1371/journal.pone.0104592	http://dx.doi.org/10.1371/journal.pone.0104592			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119466	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600070
J	Dubots, E; Cottier, S; Peeli-Gulli, MP; Jaquenoud, M; Bontron, S; Schneiter, R; De Virgilio, C				Dubots, Emmanuelle; Cottier, Stephanie; Peli-Gulli, Marie-Pierre; Jaquenoud, Malika; Bontron, Severine; Schneiter, Roger; De Virgilio, Claudio			TORC1 Regulates Pah1 Phosphatidate Phosphatase Activity via the Nem1/Spo7 Protein Phosphatase Complex	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; ACID PHOSPHATASE; LIPID-SYNTHESIS; MEMBRANE BIOGENESIS; GLOBAL ANALYSIS; YEAST; PHOSPHORYLATION; GENE; METABOLISM; GROWTH	The evolutionarily conserved target of rapamycin complex 1 (TORC1) controls growth-related processes such as protein, nucleotide, and lipid metabolism in response to growth hormones, energy/ATP levels, and amino acids. Its deregulation is associated with cancer, type 2 diabetes, and obesity. Among other substrates, mammalian TORC1 directly phosphorylates and inhibits the phosphatidate phosphatase lipin-1, a central enzyme in lipid metabolism that provides diacylglycerol for the synthesis of membrane phospholipids and/or triacylglycerol as neutral lipid reserve. Here, we show that yeast TORC1 inhibits the function of the respective lipin, Pah1, to prevent the accumulation of triacylglycerol. Surprisingly, TORC1 regulates Pah1 in part indirectly by controlling the phosphorylation status of Nem1 within the Pah1-activating, heterodimeric Nem1-Spo7 protein phosphatase module. Our results delineate a hitherto unknown TORC1 effector branch that controls lipin function in yeast, which, given the recent discovery of Nem1-Spo7 orthologous proteins in humans, may be conserved.	[Dubots, Emmanuelle; Cottier, Stephanie; Peli-Gulli, Marie-Pierre; Jaquenoud, Malika; Bontron, Severine; Schneiter, Roger; De Virgilio, Claudio] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland	University of Fribourg	De Virgilio, C (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	Claudio.DeVirgilio@unifr.ch	De Virgilio, Claudio/B-4707-2012	Schneiter, Roger/0000-0002-9102-8396; De Virgilio, Claudio/0000-0001-8826-4323	Swiss National Science Foundation; Canton of Fribourg (Switzerland)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canton of Fribourg (Switzerland)	This work was suppirted by the Swiss National Science Foundation and Canton of Fribourg (Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brachmann CB, 1998, YEAST, V14, P115; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Chae M, 2013, J BIOL CHEM, V288, P6427, DOI 10.1074/jbc.M112.449629; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kohlwein SD, 2013, GENETICS, V193, P1, DOI 10.1534/genetics.112.143362; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lamming DW, 2013, CELL METAB, V18, P465, DOI 10.1016/j.cmet.2013.08.002; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Mockli N, 2007, BIOTECHNIQUES, V42, P725, DOI 10.2144/000112455; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Reue K, 2009, CURR OPIN LIPIDOL, V20, P165, DOI 10.1097/MOL.0b013e32832adee5; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Wormann ME, 2011, MOL MICROBIOL, V79, P566, DOI 10.1111/j.1365-2958.2010.07472.x; Wu R, 2011, BIOCHEMISTRY-US, V50, P3045, DOI 10.1021/bi200336b; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	55	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104194	10.1371/journal.pone.0104194	http://dx.doi.org/10.1371/journal.pone.0104194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117580	Green Published, gold			2022-12-27	WOS:000341230400035
J	Yang, LL; Wang, JJ; Sun, XS; Cao, YZ; Ning, SW; Zhang, HX; Chen, LX; Li, RH; Tian, QH; Wang, LH; Wang, WZ; Li, X				Yang, Lili; Wang, Jianjian; Sun, Xuesong; Cao, Yuze; Ning, Shangwei; Zhang, Huixue; Chen, Lixia; Li, Ronghong; Tian, Qinghua; Wang, Lihua; Wang, Weizhi; Li, Xia			Identifying a Polymorphic 'Switch' That Influences miRNAs' Regulation of a Myasthenia Gravis Risk Pathway	PLOS ONE			English	Article							MICRORNA TARGET PREDICTION; MEDIATED REGULATION; EPITHELIAL-CELLS; DATABASE; GENE; IDENTIFICATION; SITES; SNPS; EXPRESSION; HETEROGENEITY	The significant roles of genetic variants in myasthenia gravis (MG) pathogenesis have been demonstrated in many studies, and recently it has been revealed that aberrant level/regulation of microRNAs (miRNAs) might contribute to the initiation and progression of MG. However, the dysfunction of miRNA associated with single nucleotide polymorphisms (miRSNPs) has not been well investigated in MG. In this study, we created a contemporary catalog of 89 MG risk genes via manual literature-mining. Based on this risk gene catalog, we obtained 18 MG risk pathways. Furthermore, we identified 93 miRNAs that target MG risk pathways and revealed the miRSNPs 'switches' in miRNA regulation in the MG risk pathways by integrating the database information of miRSNPs. We also constructed a miRNA-mediated SNP switching pathway network (MSSPN) to intuitively analyze miRNA regulation of MG risk pathways and the relationship of the polymorphism 'switch' with these changes in regulation. Moreover, we carried out in-depth dissection on the correlation between hsa05200 (pathway in cancer) and MG development, and elaborated the significance of 4 high-risk genes. By network analysis and literature mining, we proposed a potential mechanism of miRSNPs -> gene -> pathway effects on MG pathogenesis, especially for rs28457673 (miR-15/16/195/424/497 family)-> IGF1R -> hsa05200 (pathway in cancer). Therefore, our studies have revealed a functional role for genetic modulators in MG pathogenesis at a systemic level, which could be informative for further miRNA and miRSNPs studies in MG.	[Yang, Lili; Wang, Jianjian; Sun, Xuesong; Cao, Yuze; Zhang, Huixue; Chen, Lixia; Tian, Qinghua; Wang, Lihua; Wang, Weizhi] Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin, Heilongjiang Pr, Peoples R China; [Ning, Shangwei; Li, Ronghong; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University	Wang, LH (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin, Heilongjiang Pr, Peoples R China.	wanglh211@163.com; wwz_h2013@163.com; lixia@hrbmu.edu.cn	li, xia/HHZ-7468-2022		National Natural Science Foundation of China [81171122, 81371324]; Natural Science Foundation of Heilongjiang Province [ZD201208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported in part by the National Natural Science Foundation of China grant nos. 81171122 and 81371324, and Natural Science Foundation of Heilongjiang Province (grant nos ZD201208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyi MV, 2012, J NEUROIMMUNOL; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bandyopadhyay S, 2009, BIOINFORMATICS, V25, P2625, DOI 10.1093/bioinformatics/btp503; Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bruno AE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-44; Chatzikyriakidou A, 2010, JOINT BONE SPINE, V77, P411, DOI 10.1016/j.jbspin.2010.05.013; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Cheng Z, 2012, J CLIN IMMUNOL; Chu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050338; Colombara M, 2005, J IMMUNOL, V175, P7021, DOI 10.4049/jimmunol.175.10.7021; COMPSTON DAS, 1980, BRAIN, V103, P579, DOI 10.1093/brain/103.3.579; Evans SC, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/43670; Giraud M, 2001, NEUROLOGY, V57, P1555, DOI 10.1212/WNL.57.9.1555; Giraud M, 2008, ANN NY ACAD SCI, V1132, P180, DOI 10.1196/annals.1405.027; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Guo ST, 2013, ONCOGENE, V32, P1910, DOI 10.1038/onc.2012.214; Hariharan M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-108; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang L, 2012, INT IMMUNOPHARMACOL, V14, P217, DOI 10.1016/j.intimp.2012.07.003; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kaminski HJ, CURRENT CLIN NEUROLO, P105; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kotani A, 2002, EUR J HAEMATOL, V69, P318, DOI 10.1034/j.1600-0609.2002.02789.x; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li CQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp667; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Li X, 2012, BRIEF BIOINFORM, V13, P175, DOI 10.1093/bib/bbr043; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu CX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-661; Liu DF, 2012, ASIAN PAC J CANCER P, V13, P3313, DOI 10.7314/APJCP.2012.13.7.3313; Lu J, 2013, NEUROSCI LETT; Luo XB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002128; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marinova TT, 2008, APMIS, V116, P50, DOI 10.1111/j.1600-0463.2008.00666.x; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Pal J, 2011, J NEUROIMMUNOL, V231, P43, DOI 10.1016/j.jneuroim.2010.10.020; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Reshmi G, 2011, GENOMICS, V98, P189, DOI 10.1016/j.ygeno.2011.06.005; Salakou S, 2001, EUR J CARDIO-THORAC, V20, P712, DOI 10.1016/S1010-7940(01)00776-X; Satoh J, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-17; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Singh R, 2012, J CELL SCI, V125, P1568, DOI 10.1242/jcs.095976; SZOBOR A, 1989, ACTA MED HUNG, V46, P13; Wang HL, 2012, TRANSL RES, V160, P198, DOI 10.1016/j.trsl.2012.04.002; Wang J, 2013, J NEUROIMMUNE PHARM, V8, P1287, DOI 10.1007/s11481-013-9498-9; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wolfe GI, 2012, ANN NY ACAD SCI, V1275, pVII, DOI 10.1111/nyas.12013; Yu W, 2010, BIOINFORMATICS, V26, P145, DOI 10.1093/bioinformatics/btp618; Ziebarth JD, 2012, NUCLEIC ACIDS RES, V40, pD216, DOI 10.1093/nar/gkr1026; Zorc M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030737	58	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104827	10.1371/journal.pone.0104827	http://dx.doi.org/10.1371/journal.pone.0104827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25118158	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400093
J	Burgstaller, JM; Jenni, BF; Steurer, J; Held, U; Wertli, MM				Burgstaller, Jakob M.; Jenni, Boris F.; Steurer, Johann; Held, Ulrike; Wertli, Maria M.			Treatment Efficacy for Non-Cardiovascular Chest Pain: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE PATIENTS; CHIROPRACTIC TREATMENT; PRIMARY PREVENTION; SYMPTOM RESPONSE; SELF-MANAGEMENT; NATURAL-HISTORY; PANIC DISORDER; CLINICAL-TRIAL	Background: Non-cardiovascular chest pain (NCCP) leads to impaired quality of life and is associated with a high disease burden. Upon ruling out cardiovascular disease, only vague recommendations exist for further treatment. Objectives: To summarize treatment efficacy for patients presenting with NCCP. Methods: Systematic review and meta-analysis. In July 2013, Medline, Web of Knowledge, Embase, EBSCOhost, Cochrane Reviews and Trials, and Scopus were searched. Hand and bibliography searches were also conducted. Randomized controlled trials (RCTs) evaluating non-surgical treatments in patients with NCCP were included. Exclusion criteria were poor study quality and small sample size (< 10 patients per group). Results: Thirty eligible RCT's were included. Most studies assessed PPI efficacy for gastroesophageal reflux disorders (GERD, n = 10). Two RCTs included musculoskeletal chest pain, seven psychotropic drugs, and eleven various psychological interventions. Study quality was high in five RCTs and acceptable in 25. PPI treatment in patients with GERD (5 RCTs, 192 patients) was more effective than placebo [pooled OR 11.7 (95% CI 5.5 to 25.0, heterogeneity I-2 = 6.1%)]. The pooled OR in GERD negative patients (4 RCTs, 156 patients) was 0.8 (95% CI 0.2 to 2.8, heterogeneity I-2 = 50.4%). In musculoskeletal NCCP (2 RCTs, 229 patients) manual therapy was more effective than usual care but not than home exercise [pooled mean difference 0.5 (95% CI -0.3 to 1.3, heterogeneity I-2 = 46.2%)]. The findings for cognitive behavioral treatment, serotonin reuptake inhibitors, tricyclic antidepressants were mixed. Most evidence was available for cognitive behavioral treatment interventions. Limitations: Only a small number of studies were available. Conclusions: Timely diagnostic evaluation and treatment of the disease underlying NCCP is important. For patients with suspected GERD, high-dose treatment with PPI is effective. Only limited evidence was available for most prevalent diseases manifesting with chest pain. In patients with idiopathic NCCP, treatments based on cognitive behavioral principles might be considered.	[Burgstaller, Jakob M.; Jenni, Boris F.; Steurer, Johann; Held, Ulrike; Wertli, Maria M.] Univ Zurich, Dept Internal Med, Horten Ctr Patient Oriented Res & Knowledge Trans, Zurich, Switzerland; [Wertli, Maria M.] Cantonal Hosp Winterthur, Winterthur, Switzerland	University of Zurich	Burgstaller, JM (corresponding author), Univ Zurich, Dept Internal Med, Horten Ctr Patient Oriented Res & Knowledge Trans, Zurich, Switzerland.	jakob.burgstaller@usz.ch	Held, Ulrike/O-8328-2019; Wertli, Maria/Q-3349-2017	Burgstaller, Jakob M./0000-0001-7976-6997; Wertli, Maria/0000-0001-6347-0198				Achem SR, 1997, DIGEST DIS SCI, V42, P2138, DOI 10.1023/A:1018843223263; Arnold J, 2009, BMJ BRIT MED J OVERS, V338, P700, DOI DOI 10.1136/BMJ.B541; Bautista J, 2004, ALIMENT PHARM THER, V19, P1123, DOI 10.1111/j.1365-2036.2004.01941.x; Blatchford O, 1999, BRIT J GEN PRACT, V49, P551; Bosner S, 2010, FAM PRACT, V27, P363, DOI 10.1093/fampra/cmq024; Buntinx F, 2001, FAM PRACT, V18, P586, DOI 10.1093/fampra/18.6.586; CANNON RO, 1994, NEW ENGL J MED, V330, P1411, DOI 10.1056/NEJM199405193302003; Cayley WE, 2005, AM FAM PHYSICIAN, V72, P2012; Copas J, 2013, BIOSTATISTICS; Cossentino MJ, 2012, ALIMENT PHARM THER, V35, P1036, DOI 10.1111/j.1365-2036.2012.05068.x; Cox ID, 1998, EUR HEART J, V19, P250, DOI 10.1053/euhj.1997.0615; Cremonini F, 2005, AM J GASTROENTEROL, V100, P1226, DOI 10.1111/j.1572-0241.2005.41657.x; Dickman R, 2005, ALIMENT PHARM THER, V22, P547, DOI 10.1111/j.1365-2036.2005.02620.x; Doraiswamy P Murali, 2006, Psychopharmacol Bull, V39, P15; Dore MP, 2007, DIGEST DIS SCI, V52, P463, DOI 10.1007/s10620-006-9573-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M., 2008, SYSTEMATIC REV HLTH; Esler JL, 2003, BEHAV THER, V34, P129, DOI 10.1016/S0005-7894(03)80009-6; Eslick GD, 2008, NEUROGASTROENT MOTIL, V20, P989, DOI 10.1111/j.1365-2982.2008.01133.x; Eslick GD, 2000, MED J AUSTRALIA, V173, P233, DOI 10.5694/j.1326-5377.2000.tb125626.x; Eslick GD, 2004, ALIMENT PHARM THER, V20, P909, DOI 10.1111/j.1365-2036.2004.02175.x; Eslick GD, 2002, ALIMENT PHARM THERAP, V16, P1217, DOI 10.1046/j.1365-2036.2002.01296.x; Fass R, 1998, GASTROENTEROLOGY, V115, P42, DOI 10.1016/S0016-5085(98)70363-4; Fleet RP, 1996, AM J MED, V101, P371, DOI 10.1016/S0002-9343(96)00224-0; Gasiorowska A, 2009, ALIMENT PHARM THER, V29, P126, DOI 10.1111/j.1365-2036.2008.03859.x; Hershcovici T, 2012, ALIMENT PHARM THER, V35, P5, DOI 10.1111/j.1365-2036.2011.04904.x; Hess EP, 2012, CIRC-CARDIOVASC QUAL, V5, P251, DOI 10.1161/CIRCOUTCOMES.111.964791; Jones H, 2006, GUT, V55, P1403, DOI 10.1136/gut.2005.086694; Jonsbu E, 2011, J PSYCHOSOM RES, V70, P117, DOI 10.1016/j.jpsychores.2010.09.013; Kahn SE, 2000, ARCH PATHOL LAB MED, V124, P1418; Kahrilas PJ, 2011, GUT, V60, P1473, DOI 10.1136/gut.2011.241307; Katerndahl DA, 1997, J FAM PRACTICE, V45, P54; Keefe FJ, 2011, PAIN, V152, P730, DOI 10.1016/j.pain.2010.08.040; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Kunz R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000012.pub2; Lahmann C, 2008, PSYCHOSOMATICS, V49, P378, DOI 10.1176/appi.psy.49.5.378; Lehtola V., 2010, INT MUSCULOSKELET ME, V32, P25, DOI [10.1179/175361410X12652805807558, DOI 10.1179/175361410X12652805807558]; Lind T, 1997, SCAND J GASTROENTERO, V32, P974, DOI 10.3109/00365529709011212; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Maradey-Romero Carla, 2014, Curr Gastroenterol Rep, V16, P390, DOI 10.1007/s11894-014-0390-4; Mayou R, 2002, PSYCHOL MED, V32, P699, DOI 10.1017/S0033291702005536; Mayou RA, 1997, PSYCHOL MED, V27, P1021, DOI 10.1017/S0033291797005254; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nilsson S, 2003, BRIT J GEN PRACT, V53, P378; Pandak WM, 2002, J CLIN GASTROENTEROL, V35, P307, DOI 10.1097/00004836-200210000-00006; Potts SG, 1999, QJM-MON J ASSOC PHYS, V92, P81, DOI 10.1093/qjmed/92.2.81; R Core Team, 2021, R LANGUAGE ENV STAT; Rao SSC, 2007, AM J GASTROENTEROL, V102, P930, DOI 10.1111/j.1572-0241.2007.01112.x; Robertson N, 2008, HEART, V94, DOI 10.1136/hrt.2006.100537; Rosengren A, 1998, INT J EPIDEMIOL, V27, P962, DOI 10.1093/ije/27.6.962; Rosengren A, 1998, J INTERN MED, V244, P495, DOI 10.1111/j.1365-2796.1998.00394.x; Roshanaei-Moghaddam B, 2011, DEPRESS ANXIETY, V28, P560, DOI 10.1002/da.20829; Sanders D, 1997, PSYCHOL MED, V27, P1033, DOI 10.1017/S0033291797005266; Smeijers L, 2014, PSYCHOL HEALTH, V29, P253, DOI 10.1080/08870446.2013.843681; Stochkendahl MJ, 2012, J MANIP PHYSIOL THER, V35, P254, DOI 10.1016/j.jmpt.2012.04.003; Stochkendahl MJ, 2012, J MANIP PHYSIOL THER, V35, P7, DOI 10.1016/j.jmpt.2010.11.004; Stochkendahl MJ, 2010, MED CLIN N AM, V94, P259, DOI 10.1016/j.mcna.2010.01.007; Svavarsdottir AE, 1996, CAN FAM PHYSICIAN, V42, P1122; Van Peski-Oosterbaan AS, 1999, PSYCHOTHER PSYCHOSOM, V68, P214, DOI 10.1159/000012335; van Peski-Oosterbaan AS, 1999, AM J MED, V106, P424, DOI 10.1016/S0002-9343(99)00049-2; Varia I, 2000, AM HEART J, V140, P367, DOI 10.1067/mhj.2000.108514; Verdon F, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-51; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Webster R, 2012, EMERG MED J, V29, P267, DOI 10.1136/emermed-2011-200526; Wertli MM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-239; White KS, 2008, J CONSULT CLIN PSYCH, V76, P422, DOI 10.1037/0022-006X.76.3.422; WILCOX RG, 1981, BRIT MED J, V282, P431, DOI 10.1136/bmj.282.6262.431; Wilhelmsen L, 1998, CLIN CARDIOL, V21, P477, DOI 10.1002/clc.4960210706; Wulsin L, 2002, ANN EMERG MED, V39, P139, DOI 10.1067/mem.2002.121484; Xia HHX, 2003, ALIMENT PHARM THER, V17, P369, DOI 10.1046/j.1365-2036.2003.01436.x	70	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104722	10.1371/journal.pone.0104722	http://dx.doi.org/10.1371/journal.pone.0104722			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111147	Green Accepted, Green Published, gold			2022-12-27	WOS:000341105100093
J	Greenwood, MP; Greenwood, M; Paton, JFR; Murphy, D				Greenwood, Michael P.; Greenwood, Mingkwan; Paton, Julian F. R.; Murphy, David			Salt Appetite Is Reduced by a Single Experience of Drinking Hypertonic Saline in the Adult Rat	PLOS ONE			English	Article							CONDITIONED TASTE-AVERSION; VASOPRESSIN GENE-EXPRESSION; SODIUM-CHLORIDE INTAKE; SUPRAOPTIC NUCLEUS; WATER-DEPRIVATION; ANGIOTENSIN-II; SUBFORNICAL ORGAN; SPRAGUE-DAWLEY; NACL SOLUTIONS; MESSENGER-RNA	Salt appetite, the primordial instinct to favorably ingest salty substances, represents a vital evolutionary important drive to successfully maintain body fluid and electrolyte homeostasis. This innate instinct was shown here in Sprague-Dawley rats by increased ingestion of isotonic saline (IS) over water in fluid intake tests. However, this appetitive stimulus was fundamentally transformed into a powerfully aversive one by increasing the salt content of drinking fluid from IS to hypertonic saline (2% w/v NaCl, HS) in intake tests. Rats ingested HS similar to IS when given no choice in one-bottle tests and previous studies have indicated that this may modify salt appetite. We thus investigated if a single 24 h experience of ingesting IS or HS, dehydration (DH) or 4% high salt food (HSD) altered salt preference. Here we show that 24 h of ingesting IS and HS solutions, but not DH or HSD, robustly transformed salt appetite in rats when tested 7 days and 35 days later. Using two-bottle tests rats previously exposed to IS preferred neither IS or water, whereas rats exposed to HS showed aversion to IS. Responses to sweet solutions (1% sucrose) were not different in two-bottle tests with water, suggesting that salt was the primary aversive taste pathway recruited in this model. Inducing thirst by subcutaneous administration of angiotensin II did not overcome this salt aversion. We hypothesised that this behavior results from altered gene expression in brain structures important in thirst and salt appetite. Thus we also report here lasting changes in mRNAs for markers of neuronal activity, peptide hormones and neuronal plasticity in supraoptic and paraventricular nuclei of the hypothalamus following rehydration after both DH and HS. These results indicate that a single experience of drinking HS is a memorable one, with long-term changes in gene expression accompanying this aversion to salty solutions.	[Greenwood, Michael P.; Greenwood, Mingkwan; Murphy, David] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Paton, Julian F. R.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Murphy, David] Univ Malaya, Dept Physiol, Kuala Lumpur, Malaysia	University of Bristol; University of Bristol; Universiti Malaya	Greenwood, MP (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.	mike.greenwood@bristol.ac.uk	Paton, Julian/AAM-2121-2020; Murphy, David/C-3967-2012	Paton, Julian/0000-0001-7410-2913; Greenwood, Michael/0000-0003-0565-2748; Murphy, David/0000-0003-2946-0353; Greenwood, Mingkwan/0000-0003-0463-6615	Biotechnology and Biological Sciences Research Council, BBSRC [BB/G006156/1, BB/J01515/1]; University of Malaya [H-20001-E000086]; Biotechnology and Biological Sciences Research Council [BB/J015415/1, BB/G006156/1] Funding Source: researchfish; British Heart Foundation [RG/12/6/29670] Funding Source: researchfish; BBSRC [BB/J015415/1, BB/G006156/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Malaya(Universiti Malaya); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors gratefully acknowledge the support of the Biotechnology and Biological Sciences Research Council, BBSRC (BB/G006156/1, MPG, JFRP, DM; BB/J01515/1, MG, JFRP, DM), and the University of Malaya (HIR award H-20001-E000086, DM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya F, 2001, NEUROENDOCRINOLOGY, V73, P185, DOI 10.1159/000054635; Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; ARNAULD E, 1993, NEUROSCI LETT, V149, P177, DOI 10.1016/0304-3940(93)90765-D; BERNSTEIN IL, 1992, BEHAV NEUROSCI, V106, P722, DOI 10.1037/0735-7044.106.4.722; BLACKBURN RE, 1992, AM J PHYSIOL, V263, pR1347, DOI 10.1152/ajpregu.1992.263.6.R1347; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; CHAN RKW, 1993, J NEUROSCI, V13, P5126, DOI 10.1523/JNEUROSCI.13-12-05126.1993; CONTRERAS RJ, 1983, J NUTR, V113, P1051, DOI 10.1093/jn/113.5.1051; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Curtis KS, 2004, AM J PHYSIOL-REG I, V286, pR1043, DOI 10.1152/ajpregu.00582.2003; Curtis KS, 2004, PHYSIOL BEHAV, V80, P657, DOI 10.1016/j.physbeh.2003.11.007; Curtis KS, 2001, PHYSIOL BEHAV, V72, P743, DOI 10.1016/S0031-9384(01)00422-X; Davis JD, 2002, PHYSIOL BEHAV, V75, P7, DOI 10.1016/S0031-9384(01)00626-6; De Luca LA, 2010, PHYSIOL BEHAV, V100, P535, DOI 10.1016/j.physbeh.2010.02.028; Denton DA, 2009, CONSCIOUS COGN, V18, P500, DOI 10.1016/j.concog.2008.06.009; DEVENPORT LD, 1973, J COMP PHYSIOL PSYCH, V83, P98, DOI 10.1037/h0034316; Flynn FW, 2003, PHYSIOL BEHAV, V78, P689, DOI 10.1016/S0031-9384(03)00062-3; Flynn FW, 2002, AM J PHYSIOL-REG I, V282, pR1236, DOI 10.1152/ajpregu.00181.2001; FRANK M, 1973, J GEN PHYSIOL, V61, P588, DOI 10.1085/jgp.61.5.588; FREGLY MJ, 1992, PHYSIOL BEHAV, V51, P915, DOI 10.1016/0031-9384(92)90070-I; FREGLY MJ, 1987, BRAIN RES BULL, V18, P245; Golden GJ, 2011, CHEM SENSES, V36, P811, DOI 10.1093/chemse/bjr056; Gottlieb HB, 2006, AM J PHYSIOL-REG I, V290, pR1251, DOI 10.1152/ajpregu.00727.2005; Greenwood M, 2014, J NEUROSCI, V34, P3810, DOI 10.1523/JNEUROSCI.4343-13.2014; Hindmarch C, 2006, P NATL ACAD SCI USA, V103, P1609, DOI 10.1073/pnas.0507450103; Hiyama TY, 2004, J NEUROSCI, V24, P9276, DOI 10.1523/JNEUROSCI.2795-04.2004; Johnson AK, 2007, MED SCI SPORT EXER, V39, P1388, DOI 10.1249/mss.0b013e3180686de8; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Liedtke WB, 2011, P NATL ACAD SCI USA, V108, P12509, DOI 10.1073/pnas.1109199108; LIGHTMAN SL, 1987, J PHYSIOL-LONDON, V394, P23, DOI 10.1113/jphysiol.1987.sp016858; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu B, 2012, REGUL PEPTIDES, V179, P15, DOI 10.1016/j.regpep.2012.07.004; Lu B, 2009, PHYSIOL BEHAV, V97, P463, DOI 10.1016/j.physbeh.2009.03.022; McKinley MJ, 2004, J NEUROENDOCRINOL, V16, P340, DOI 10.1111/j.0953-8194.2004.01184.x; McKinley MJ, 2004, NEWS PHYSIOL SCI, V19, P1, DOI 10.1152/nips.01470.2003; MIDKIFF EE, 1985, AM J PHYSIOL, V249, pR438, DOI 10.1152/ajpregu.1985.249.4.R438; MIDKIFF EE, 1983, DEV PSYCHOBIOL, V16, P385, DOI 10.1002/dev.420160504; Morris MJ, 2008, PHYSIOL BEHAV, V94, P709, DOI 10.1016/j.physbeh.2008.04.008; Morris MJ, 2002, BRAIN RES, V949, P42, DOI 10.1016/S0006-8993(02)02963-3; Mutsuga N, 2005, ENDOCRINOLOGY, V146, P1254, DOI 10.1210/en.2004-1202; Na ES, 2007, BRAIN RES, V1171, P104, DOI 10.1016/j.brainres.2007.07.033; Noda M, 2006, NEUROSCIENTIST, V12, P80, DOI 10.1177/1073858405279683; Oka Y, 2013, NATURE, V494, P472, DOI 10.1038/nature11905; Osborn JW, 2007, CURR HYPERTENS REP, V9, P228, DOI 10.1007/s11906-007-0041-3; PRIEHS TW, 1991, AM J PHYSIOL, V261, pR52, DOI 10.1152/ajpregu.1991.261.1.R52; ROWLAND NE, 1995, PHYSIOL BEHAV, V57, P753, DOI 10.1016/0031-9384(94)00321-1; Scordalakes EM, 2008, PROG BRAIN RES, V170, P43, DOI 10.1016/S0079-6123(08)00404-4; Smith PL, 2010, PHYSIOL BEHAV, V99, P324, DOI 10.1016/j.physbeh.2009.11.008; Sollars SI, 1996, PHYSIOL BEHAV, V60, P65, DOI 10.1016/0031-9384(95)02235-X; Stamler J, 1997, AM J CLIN NUTR, V65, P626, DOI 10.1093/ajcn/65.2.626S; Stephan FK, 1999, PHYSIOL BEHAV, V68, P221, DOI 10.1016/S0031-9384(99)00179-1; Ueta Y, 2002, MICROSC RES TECHNIQ, V56, P158, DOI 10.1002/jemt.10020; YAMAMOTO T, 1994, CHEM SENSES, V19, P209, DOI 10.1093/chemse/19.3.209; Yue CM, 2006, CELL MOL NEUROBIOL, V26, P959, DOI 10.1007/s10571-006-9017-0	54	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104802	10.1371/journal.pone.0104802	http://dx.doi.org/10.1371/journal.pone.0104802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111786	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100100
J	Narihiro, T; Tamaki, H; Akiba, A; Takasaki, K; Nakano, K; Kamagata, Y; Hanada, S; Maji, T				Narihiro, Takashi; Tamaki, Hideyuki; Akiba, Aya; Takasaki, Kazuto; Nakano, Koichiro; Kamagata, Yoichi; Hanada, Satoshi; Maji, Taizo			Microbial Community Structure of Relict Niter-Beds Previously Used for Saltpeter Production	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; BIOFILM REACTOR; ARCHAEA; AMOA; ABUNDANCE; SOILS; NITRIFICATION; POPULATION; ESTUARINE; DIVERSITY	From the 16th to the 18th centuries in Japan, saltpeter was produced using a biological niter-bed process and was formed under the floor of gassho-style houses in the historic villages of Shirakawa-go and Gokayama, which are classified as United Nations Educational, Scientific and Cultural Organization (UNESCO) World Heritage Sites. The relict niter-beds are now conserved in the underfloor space of gassho-style houses, where they are isolated from destabilizing environmental factors and retain the ability to produce nitrate. However, little is known about the nitrifying microbes in such relict niter-bed ecosystems. In this study, the microbial community structures within nine relict niter-bed soils were investigated using 454 pyrotag analysis targeting the 16S rRNA gene and the bacterial and archaeal ammonia monooxygenase gene (amoA). The 16S rRNA gene pyrotag analysis showed that members of the phyla Proteobacteria, Actinobacteria, Bacteroidetes, Chloroflexi, Firmicutes, Gemmatimonadetes, and Planctomycetes were major microbial constituents, and principal coordinate analysis showed that the NO3-, Cl-, K+, and Na+ contents were potential determinants of the structures of entire microbial communities in relict niter-bed soils. The bacterial and archaeal amoA libraries indicated that members of the Nitrosospira-type ammonia-oxidizing bacteria (AOB) and "Ca. Nitrososphaera''-type ammonia-oxidizing archaea (AOA), respectively, predominated in relict niter-bed soils. In addition, soil pH and organic carbon content were important factors for the ecological niche of AOB and AOA in relict niter-bed soil ecosystems.	[Narihiro, Takashi; Tamaki, Hideyuki; Akiba, Aya; Kamagata, Yoichi; Hanada, Satoshi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Takasaki, Kazuto; Nakano, Koichiro] FASMAC Co Ltd, Atsgui, Kanagawa, Japan; [Kamagata, Yoichi] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Sapporo, Hokkaido, Japan; [Maji, Taizo] Shubun Univ, Ichinomiya, Aichi, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST)	Narihiro, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan.	t.narihiro@aist.go.jp	Tamaki, Hideyuki/M-9863-2016; Narihiro, Takashi/L-8617-2016	Narihiro, Takashi/0000-0003-2936-7204	JSPS KAKENHI [23760512]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid for Young Scientists (B) (Grant Number 23760512) from JSPS KAKENHI. http://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1912, NATURE, V88, P330; [Anonymous], 1912, J IND ENG CHEM-US, V4, P687; Avrahami S, 2011, APPL ENVIRON MICROB, V77, P7329, DOI 10.1128/AEM.05864-11; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bollmann A, 2005, APPL ENVIRON MICROB, V71, P1276, DOI 10.1128/AEM.71.3.1276-1282.2005; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Colwell RK, 2013, ESTIMATES STAT ESTIM; Corneo PE, 2013, FEMS MICROBIOL ECOL, V84, P588, DOI 10.1111/1574-6941.12087; Dang HY, 2008, MICROBIOL-SGM, V154, P2084, DOI 10.1099/mic.0.2007/013581-0; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eilmus S, 2007, ENVIRON POLLUT, V146, P478, DOI 10.1016/j.envpol.2006.07.008; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Fukushima T, 2013, APPL MICROBIOL BIOT, V97, P6513, DOI 10.1007/s00253-012-4436-y; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Grossman JM, 2010, MICROB ECOL, V60, P192, DOI 10.1007/s00248-010-9689-3; Gubry-Rangin C, 2010, FEMS MICROBIOL ECOL, V74, P566, DOI 10.1111/j.1574-6941.2010.00971.x; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Jimura T, 2011, TOURISM MANAGE, V32, P288, DOI 10.1016/j.tourman.2010.02.005; Kunnas J, 2007, SCAND J HIST, V32, P281, DOI 10.1080/03468750701395419; Kyeser K, 1967, UMSCHRIFT UBERSETZUN; Kyeser K, 1967, FACSIMILE AUSGABE PE; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Li XR, 2012, J ZHEJIANG UNIV-SC B, V13, P769, DOI 10.1631/jzus.B1200013; Lockyer WJS, 1908, NATURE, V77, P513; Maji T, 2007, UNKNOWN HIST SHIRAKA; Maji T, 2005, KAGAKUSHI, V32, P137; Maji T, 2006, KAGAKUSHI, V33, P1; Maji T, 2005, KAGAKUSHI, V32, P75; Maji T, 2009, SCI REP FAC ED GIFU, V33, P103; Maji T, 2009, ANN REP FAC ED GIFU, V57, P121; Mao YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024750; Mintie AT, 2003, APPL ENVIRON MICROB, V69, P3129, DOI 10.1128/AEM.69.6.3129-3136.2003; Moin NS, 2009, APPL ENVIRON MICROB, V75, P7461, DOI 10.1128/AEM.01001-09; MULTHAUF RP, 1971, TECHNOL CULT, V12, P163, DOI 10.2307/3102523; Park HD, 2006, APPL ENVIRON MICROB, V72, P5643, DOI 10.1128/AEM.00402-06; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Pester M, 2012, ENVIRON MICROBIOL, V14, P525, DOI 10.1111/j.1462-2920.2011.02666.x; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shen JP, 2008, ENVIRON MICROBIOL, V10, P1601, DOI 10.1111/j.1462-2920.2008.01578.x; Shore JL, 2012, BIORESOURCE TECHNOL, V112, P51, DOI 10.1016/j.biortech.2012.02.045; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarre S, 2007, WATER SCI TECHNOL, V55, P363, DOI 10.2166/wst.2007.278; Thorpe TE, 1917, NATURE, V99, P447, DOI 10.1038/099447a0; Van Horn DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066103; Ward BB, 2007, ENVIRON MICROBIOL, V9, P2522, DOI 10.1111/j.1462-2920.2007.01371.x; WATSON SW, 1971, ARCH MIKROBIOL, V75, P179, DOI 10.1007/BF00408979; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Williams A. R., 1975, AMBIX, V22, P125; Xue K, 2013, APPL ENVIRON MICROB, V79, P1284, DOI 10.1128/AEM.03393-12; Yasuda T, 2013, J APPL MICROBIOL, V114, P746, DOI 10.1111/jam.12091; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108	60	3	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104752	10.1371/journal.pone.0104752	http://dx.doi.org/10.1371/journal.pone.0104752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111392	Green Submitted, gold, Green Published			2022-12-27	WOS:000341105100096
J	Halliez, S; Jaumain, E; Huor, A; Douet, JY; Lugan, S; Cassard, H; Lacroux, C; Beringue, V; Andreoletti, O; Vilette, D				Halliez, Sophie; Jaumain, Emilie; Huor, Alvina; Douet, Jean-Yves; Lugan, Severine; Cassard, Herve; Lacroux, Caroline; Beringue, Vincent; Andreoletti, Olivier; Vilette, Didier			White Blood Cell-Based Detection of Asymptomatic Scrapie Infection by Ex Vivo Assays	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; PRION INFECTIVITY; VARIANT; TRANSFUSION; COMPONENTS; PROTEIN; SHEEP; PRPSC; VCJD	Prion transmission can occur by blood transfusion in human variant Creutzfeldt-Jakob disease and in experimental animal models, including sheep. Screening of blood and its derivatives for the presence of prions became therefore a major public health issue. As infectious titer in blood is reportedly low, highly sensitive and robust methods are required to detect prions in blood and blood derived products. The objectives of this study were to compare different methods - in vitro, ex vivo and in vivo assays - to detect prion infectivity in cells prepared from blood samples obtained from scrapie infected sheep at different time points of the disease. Protein misfolding cyclic amplification (PMCA) and bioassays in transgenic mice expressing the ovine prion protein were the most efficient methods to identify infected animals at any time of the disease (asymptomatic to terminally-ill stages). However scrapie cell and cerebellar organotypic slice culture assays designed to replicate ovine prions in culture also allowed detection of prion infectivity in blood cells from asymptomatic sheep. These findings confirm that white blood cells are appropriate targets for preclinical detection and introduce ex vivo tools to detect blood infectivity during the asymptomatic stage of the disease.	[Halliez, Sophie; Jaumain, Emilie; Beringue, Vincent] INRA, UR892, Jouy En Josas, France; [Huor, Alvina; Douet, Jean-Yves; Lugan, Severine; Cassard, Herve; Lacroux, Caroline; Andreoletti, Olivier; Vilette, Didier] Ecole Natl Vet Toulouse, UMR INRA ENVT 1225, Toulouse, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse	Vilette, D (corresponding author), Ecole Natl Vet Toulouse, UMR INRA ENVT 1225, Toulouse, France.	d.vilette@envt.fr	Halliez, Sophie/ABA-1356-2020; DOUET, Jean Yves/F-8208-2011	Halliez, Sophie/0000-0002-6173-9752; DOUET, Jean Yves/0000-0002-0426-4957	DIM Malinf (Paris, France) [110208]; Alliance Biosecure Foundation (SafeCJD project); EU FP7 project "PRIORITY''; CONCOTSA	DIM Malinf (Paris, France); Alliance Biosecure Foundation (SafeCJD project); EU FP7 project "PRIORITY''; CONCOTSA	This work was supported by grants from DIM Malinf (Paris, France, grant no. 110208), the Alliance Biosecure Foundation (SafeCJD project), the EU FP7 project "PRIORITY'' and CONCOTSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002782; Andreoletti O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001285; Arellano-Anaya ZE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020563; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Beringue V, 2012, SCIENCE, V335, P472, DOI 10.1126/science.1215659; Bishop MT, 2013, BRAIN, V136, P1139, DOI 10.1093/brain/awt032; Bons N, 2002, TRANSFUSION, V42, P513, DOI 10.1046/j.1537-2995.2002.00098.x; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; Dassanayake RP, 2012, J GEN VIROL, V93, P1127, DOI 10.1099/vir.0.039032-0; Douet JY, 2014, EMERG INFECT DIS, V20, P114, DOI 10.3201/eid2001.130353; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Gill ON, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5675; Holada K, 2002, J VIROL, V76, P4649, DOI 10.1128/JVI.76.9.4649-4650.2002; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Johnson CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035383; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Lacroux C, 2012, J VIROL, V86, P2056, DOI 10.1128/JVI.06532-11; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Makarava N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1730; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2010, J VIROL, V84, P5097, DOI 10.1128/JVI.02169-09; McCutcheon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023169; Moudjou M, 2014, MBIO, V5, DOI 10.1128/mBio.00829-13; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Rubenstein R, 2010, J GEN VIROL, V91, P1883, DOI 10.1099/vir.0.020164-0; Segarra C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069632; Tattum MH, 2010, TRANSFUSION, V50, P996, DOI 10.1111/j.1537-2995.2010.02595.x; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	41	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104287	10.1371/journal.pone.0104287	http://dx.doi.org/10.1371/journal.pone.0104287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122456	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000034
J	Rafalowska, J; Sulejczak, D; Chrapusta, SJ; Gadamski, R; Dziewulska, D				Rafalowska, Janina; Sulejczak, Dorota; Chrapusta, Stanislaw J.; Gadamski, Roman; Dziewulska, Dorota			Diverse Expression of Selected SMN Complex Proteins in Humans with Sporadic Amyotrophic Lateral Sclerosis and in a Transgenic Rat Model of Familial Form of the Disease	PLOS ONE			English	Article							SURVIVAL MOTOR-NEURON; SOD1; COMPONENT; IDENTIFICATION; GEMIN2	Background and Objective: There is circumstantial evidence linking sporadic amyotrophic lateral sclerosis (ALS) cases to a malfunction or deficit of a multimeric SMN complex that scrutinizes cellular RNAs; the core of this complex is survival motor neuron (SMN, or gemin 1) protein. We intended to verify this hypothesis by comparing the expression of both SMN and several other functionally associated gemins in the anterior horn motoneurons of patients who died of sporadic ALS (sALS), of transgenic rats with overexpression of the mutated human superoxide dismutase 1 gene (SOD1(G93A)) that represent a model of familial ALS (fALS), and of the respective controls. Methods: Using archival material of paraffin blocks with samples of human and rat spinal cords, immunohistochemical reactions with antibodies against SMN and gemins 2, 3, and 4 were performed and assessed by light microscopy. Results: The expression of SMN and all other studied gemins was observed in motoneurons of sALS patients, fALS rats, and in all controls, although the intensity varied. The immunolabeling was most intense in sALS patients with relatively fast disease course, and decreased with increasing disease duration in both the human sALS and rat fALS material. Irrespective of the disease stage, sALS material showed no or very low gemin 2 immunoreactivity, while clear gemin 2 immnoreactivity was observed in all fALS rats and control material. Conclusion: The deficient expression of gemin 2 in spinal cord motoneurons in human sALS may lead to a dysfunction and loss of neuroprotective action of the SMN complex.	[Rafalowska, Janina; Gadamski, Roman; Dziewulska, Dorota] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Expt & Clin Neuropathol, Warsaw, Poland; [Sulejczak, Dorota; Chrapusta, Stanislaw J.] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Expt Pharmacol, Warsaw, Poland; [Dziewulska, Dorota] Med Univ Warsaw, Dept Neurol, Warsaw, Poland	Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Medical University of Warsaw	Sulejczak, D (corresponding author), Polish Acad Sci, Mossakowski Med Res Ctr, Dept Expt & Clin Neuropathol, Warsaw, Poland.	dsulejczak@imdik.pan.pl	Chrapusta, Stanisław/GLS-1363-2022; Chrapusta, Stanisław/AAA-3076-2020; Dziewulska, Dorota/M-5336-2018	Dziewulska, Dorota/0000-0003-3491-9819; Chrapusta, Stanislaw Jonatan/0000-0001-5219-8993; Sulejczak, Dorota/0000-0002-1697-8164	Ministry of Science and Higher Education of Poland [NN 401 014 640]; Mossakowski Research Institute Polish Academy of Science	Ministry of Science and Higher Education of Poland(Ministry of Science and Higher Education, Poland); Mossakowski Research Institute Polish Academy of Science	This study was supported by grant #NN 401 014 640 from the Ministry of Science and Higher Education of Poland and by statutory funds from the Mossakowski Research Institute Polish Academy of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Battle DJ, 2006, COLD SPRING HARB SYM, V71, P313, DOI 10.1101/sqb.2006.71.001; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Corcia P, 2009, AMYOTROPH LATERAL SC, V10, P436, DOI 10.3109/17482960902759162; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Fidzianska A, 2006, FOLIA NEUROPATHOL, V44, P175; Gertz B, 2012, J NEUROPATH EXP NEUR, V71, P162, DOI 10.1097/NEN.0b013e318244b635; Hao LT, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-28; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jablonka S, 2002, P NATL ACAD SCI USA, V99, P10126, DOI 10.1073/pnas.152318699; Kirby J, 2005, BRAIN, V128, P1686, DOI 10.1093/brain/awh503; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Rafalowska J, 2006, FOLIA NEUROPATHOL, V44, P162; Rafalowska J, 2012, FOLIA NEUROPATHOL, V50, P390, DOI 10.5114/fn.2012.32373; Rafalowska J, 2011, FOLIA NEUROPATHOL, V49, P301; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Turner BJ, 2014, NEUROBIOL AGING, V35, P906, DOI 10.1016/j.neurobiolaging.2013.09.030; Yamazaki T, 2012, CELL REP, V2, P799, DOI 10.1016/j.celrep.2012.08.025; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006	22	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104614	10.1371/journal.pone.0104614	http://dx.doi.org/10.1371/journal.pone.0104614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122454	gold, Green Submitted, Green Published			2022-12-27	WOS:000341017000048
J	West, PT; Li, Q; Ji, LX; Eichten, SR; Song, JW; Vaughn, MW; Schmitz, RJ; Springer, NM				West, Patrick T.; Li, Qing; Ji, Lexiang; Eichten, Steven R.; Song, Jawon; Vaughn, Matthew W.; Schmitz, Robert J.; Springer, Nathan M.			Genomic Distribution of H3K9me2 and DNA Methylation in a Maize Genome	PLOS ONE			English	Article							GENE ENRICHMENT; MESSENGER-RNA; ARABIDOPSIS; WIDE; HETEROCHROMATIN; LIBRARIES; EPIGENOME; REGIONS; METHYLTRANSFERASES; VARIABILITY	DNA methylation and dimethylation of lysine 9 of histone H3 (H3K9me2) are two chromatin modifications that can be associated with gene expression or recombination rate. The maize genome provides a complex landscape of interspersed genes and transposons. The genome-wide distribution of DNA methylation and H3K9me2 were investigated in seedling tissue for the maize inbred B73 and compared to patterns of these modifications observed in Arabidopsis thaliana. Most maize transposons are highly enriched for DNA methylation in CG and CHG contexts and for H3K9me2. In contrast to findings in Arabidopsis, maize CHH levels in transposons are generally low but some sub-families of transposons are enriched for CHH methylation and these families exhibit low levels of H3K9me2. The profile of modifications over genes reveals that DNA methylation and H3K9me2 is quite low near the beginning and end of genes. Although elevated CG and CHG methylation are found within gene bodies, CHH and H3K9me2 remain low. Maize has much higher levels of CHG methylation within gene bodies than observed in Arabidopsis and this is partially attributable to the presence of transposons within introns for some maize genes. These transposons are associated with high levels of CHG methylation and H3K9me2 but do not appear to prevent transcriptional elongation. Although the general trend is for a strong depletion of H3K9me2 and CHG near the transcription start site there are some putative genes that have high levels of these chromatin modifications. This study provides a clear view of the relationship between DNA methylation and H3K9me2 in the maize genome and how the distribution of these modifications is shaped by the interplay of genes and transposons.	[West, Patrick T.; Li, Qing; Eichten, Steven R.; Springer, Nathan M.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Ji, Lexiang; Schmitz, Robert J.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Ji, Lexiang] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Song, Jawon; Vaughn, Matthew W.] Univ Texas Austin, Texas Adv Comp Ctr, Austin, TX 78712 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University of Texas System; University of Texas Austin	Springer, NM (corresponding author), Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA.	springer@umn.edu	Song, Jawon/AAA-4318-2020; Schmitz, Robert/AAY-7659-2020	Song, Jawon/0000-0002-9916-3816; Schmitz, Robert/0000-0001-7538-6663; Eichten, Steven/0000-0003-2268-395X; Vaughn, Matthew/0000-0002-1384-4283	National Science Foundation [IOS-1237931, DBI-0735191, IOS-1339194]; University of Georgia; Direct For Biological Sciences [1237931] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Georgia; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research was supported by a grant from the National Science Foundation (IOS-1237931) to MWV and NMS. This work also used resources or cyberinfrastructure provided by iPlant Collaborative. The iPlant Collaborative is funded by a grant from the National Science Foundation (DBI-0735191; www.iplantcollaborative.org). Start-up funds from the University of Georgia and a research grant from the National Science Foundation (IOS-1339194) to RJS supported aspects of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; BENNETZEN JL, 1994, GENOME, V37, P565, DOI 10.1139/g94-081; Cao XF, 2000, P NATL ACAD SCI USA, V97, P4979, DOI 10.1073/pnas.97.9.4979; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; Eichten SR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002372; Eichten SR, 2013, PLANT CELL, V25, P2783, DOI 10.1105/tpc.113.114793; Eichten SR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003127; Emberton J, 2005, GENOME RES, V15, P1441, DOI 10.1101/gr.3362105; Gent JI, 2012, NUCLEIC ACIDS RES, V40, P1550, DOI 10.1093/nar/gkr862; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jin WW, 2008, CHROMOSOME RES, V16, P1203, DOI 10.1007/s10577-008-1269-8; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Law JA, 2013, NATURE, V498, P385, DOI 10.1038/nature12178; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Messing J, 2006, CURR OPIN PLANT BIOL, V9, P157, DOI 10.1016/j.pbi.2006.01.009; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Papa CM, 2001, PLANT CELL, V13, P1919, DOI 10.1105/tpc.13.8.1919; Parkin IAP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r77; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rabinowicz PD, 2003, CURR OPIN PLANT BIOL, V6, P150, DOI 10.1016/S1369-5266(03)00008-6; Regulski M, 2013, GENOME RES, V23, P1651, DOI 10.1101/gr.153510.112; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Saze H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3301; Schmitz RJ, 2013, GENOME RES, V23, P1663, DOI 10.1101/gr.152538.112; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schnable JC, 2012, GENOME BIOL EVOL, V4, P265, DOI 10.1093/gbe/evs009; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schultz MD, 2012, TRENDS GENET, V28, P583, DOI 10.1016/j.tig.2012.10.012; Sekhon RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061005; Shi JH, 2006, GENETICS, V173, P1571, DOI 10.1534/genetics.106.056853; Springer NM, 2009, MAYDICA, V54, P417; Stroud H, 2014, NAT STRUCT MOL BIOL, V21, P64, DOI 10.1038/nsmb.2735; Stroud H, 2013, CELL, V152, P352, DOI 10.1016/j.cell.2012.10.054; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Whitelaw CA, 2003, SCIENCE, V302, P2118, DOI 10.1126/science.1090047; Yuan YN, 2002, GENOME RES, V12, P1345, DOI 10.1101/gr.185902; Zemach A, 2013, CELL, V153, P193, DOI 10.1016/j.cell.2013.02.033; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhou JL, 2010, PLANT MOL BIOL, V72, P585, DOI 10.1007/s11103-009-9594-7	48	87	88	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105267	10.1371/journal.pone.0105267	http://dx.doi.org/10.1371/journal.pone.0105267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122127	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000110
J	Kaya, GA; Coskun, AN; Yilmaz, V; Oflazer, P; Gulsen-Parman, Y; Aysal, F; Disci, R; Direskeneli, H; Marx, A; Deymeer, F; Saruhan-Direskeneli, G				Kaya, Gizem A.; Coskun, Ayse N.; Yilmaz, Vuslat; Oflazer, Piraye; Gulsen-Parman, Yesim; Aysal, Fikret; Disci, Rian; Direskeneli, Haner; Marx, Alexander; Deymeer, Feza; Saruhan-Direskeneli, Guher			The Association of PTPN22 R620W Polymorphism Is Stronger with Late-Onset AChR-Myasthenia Gravis in Turkey	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE PTPN22; ACETYLCHOLINE-RECEPTOR; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; GENE POLYMORPHISM; AUTOANTIBODIES; ANTIBODY; ALLELE; MUSK; FREQUENCY	A functional single nucleotide polymorphism (SNP) of the PTPN22 gene encoding a protein tyrosine phosphatase has been associated with autoimmune disorders including myasthenia gravis (MG). As the PTPN22 R620W polymorphism has a wide variation of allele frequencies among different populations, this polymorphism was investigated in MG in Turkey. An emphasis is put on MG subgroups according to autoantibody (Abs) production and presence of thymoma. DNA samples from 416 patients with clinically diagnosed generalized MG (231 with Abs to acetylcholine receptor, AChR-MG), 53 with Abs to muscle-specific kinase (MuSK-MG), 55 patients with no detectable Abs (SN-MG), 77 patients with thymoma (TAMG) and 293 healthy controls (HC) were genotyped for the SNP (PTPN22 R620W, C1858T, rs2476601). The PTPN22 T allele was increased in AChR-MG patients (odds ratio [OR]: 2.5, 95%CI: 1.2-5.1). The association was stronger in late disease-onset AChR (LOMG, OR: 3.1, 95%CI: 1.2-8.2). MuSK-MG, SN-MG and TAMG groups did not carry the variant allele more frequently than the HC. In contrast to findings in other autoimmune diseases, the distribution of the PTPN22 polymorphism in this population provides a susceptibility marker for AChR-MG. The strongest association is detected in patients with LOMG.	[Kaya, Gizem A.] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey; [Coskun, Ayse N.; Yilmaz, Vuslat; Saruhan-Direskeneli, Guher] Istanbul Univ, Istanbul Fac Med, Dept Physiol, Istanbul, Turkey; [Oflazer, Piraye; Gulsen-Parman, Yesim; Deymeer, Feza] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkey; [Aysal, Fikret] Bakirkoy Hosp Psychiat & Neurol Dis, Istanbul, Turkey; [Disci, Rian] Istanbul Univ, Istanbul Fac Med, Dept Biostat, Istanbul, Turkey; [Direskeneli, Haner] Marmara Univ, Fac Med, Div Rheumatol, Istanbul, Turkey; [Marx, Alexander] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany	Istanbul University; Istanbul University; Istanbul University; Istanbul Bakirkoy Mental Health & Neurology Training & Research Hospital; Istanbul University; Marmara University; Ruprecht Karls University Heidelberg	Saruhan-Direskeneli, G (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Physiol, Istanbul, Turkey.	gsaruhan@istanbul.edu.tr	Direskeneli, Haner/AAS-5508-2020; YILMAZ, VUSLAT/AAB-9205-2020; DISÇI, RIAN/L-3788-2018; DİŞÇİ, RIAN/ABG-2356-2021	DISÇI, RIAN/0000-0002-5569-0913; DİŞÇİ, RIAN/0000-0002-5569-0913; , Piraye/0000-0001-8202-5313	TUBITAK/BMBF IntenC programme [TUBITAK-110S297, BMBF-01DL12027]; Istanbul University Research Fund (BAP)	TUBITAK/BMBF IntenC programme(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Istanbul University Research Fund (BAP)(Istanbul University)	This study is supported by the joint TUBITAK/BMBF IntenC programme, grants TUBITAK-110S297 (G.S.D.), BMBF-01DL12027 (A.M.) and by Istanbul University Research Fund (BAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarli JA, 2003, ANN NY ACAD SCI, V998, P424, DOI 10.1196/annals.1254.055; Alahgholi-Hajibehzad M, 2013, HUM IMMUNOL, V74, P1633, DOI 10.1016/j.humimm.2013.08.271; Ates A, 2011, TISSUE ANTIGENS, V78, P56, DOI 10.1111/j.1399-0039.2011.01675.x; Bartoccioni E, 2009, NEUROLOGY, V72, P195, DOI 10.1212/01.wnl.0000339103.08830.86; Chuang WY, 2009, GENES IMMUN, V10, P667, DOI 10.1038/gene.2009.64; Chuang WY, 2013, J AUTOIMMUN, P1; COMPSTON DAS, 1980, BRAIN, V103, P579, DOI 10.1093/brain/103.3.579; Dempfle Astrid, 2007, BMC Proc, V1 Suppl 1, pS73; Fousteri G, 2013, CLIN IMMUNOL, V149, P556, DOI 10.1016/j.clim.2013.10.006; Gregersen PK, 2012, ANN NEUROL, V72, P927, DOI 10.1002/ana.23691; Greve B, 2009, HUM IMMUNOL, V70, P540, DOI 10.1016/j.humimm.2009.04.027; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Huang DR, 1999, J NEUROIMMUNOL, V101, P197, DOI 10.1016/S0165-5728(99)00140-X; Ishii W, 2007, J CLIN NEUROSCI, V14, P110, DOI 10.1016/j.jocn.2005.11.048; Janer M, 1999, HUM IMMUNOL, V60, P909, DOI 10.1016/S0198-8859(99)00062-2; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; Lefvert AK, 2008, J NEUROIMMUNOL, V197, P110, DOI 10.1016/j.jneuroim.2008.04.004; LINDSTROM JM, 1976, NEUROLOGY, V26, P1054, DOI 10.1212/WNL.26.11.1054; Maniaol AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036603; MARROSU MG, 1988, NEUROLOGY, V38, P1749, DOI 10.1212/WNL.38.11.1749; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Pevzner A, 2012, J NEUROL, V259, P427, DOI 10.1007/s00415-011-6194-7; Pierer M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1945; Provenzano C, 2012, NEUROMUSCULAR DISORD, V22, P131, DOI 10.1016/j.nmd.2011.09.003; Romi F, 2003, ANN NY ACAD SCI, V998, P481, DOI 10.1196/annals.1254.062; Sahin N, 2008, RHEUMATOLOGY, V47, P634, DOI 10.1093/rheumatology/ken106; Sahin N, 2009, RHEUMATOL INT, V30, P81, DOI 10.1007/s00296-009-0919-2; SaruhanDireskeneli G, 1997, HUM IMMUNOL, V55, P59, DOI 10.1016/S0198-8859(97)00086-4; Somnier FE, 1999, EUR J NEUROL, V6, P555, DOI 10.1046/j.1468-1331.1999.650555.x; Strobel P, 2007, J PATHOL, V211, P563, DOI 10.1002/path.2141; Vandiedonck C, 2006, ANN NEUROL, V59, P404, DOI 10.1002/ana.20751; Vang T, 2007, AUTOIMMUNITY, V40, P453, DOI 10.1080/08916930701464897; VINCENT A, 1985, J NEUROL NEUROSUR PS, V48, P1246, DOI 10.1136/jnnp.48.12.1246; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091816; Zhang B, 2012, ARCH NEUROL-CHICAGO, V69, P445, DOI 10.1001/archneurol.2011.2393	39	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104760	10.1371/journal.pone.0104760	http://dx.doi.org/10.1371/journal.pone.0104760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119822	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600084
J	Mondragon, A; Davidsson, D; Kyriakoudi, S; Bertling, A; Gomes-Faria, R; Cohen, P; Rothery, S; Chabosseau, P; Rutter, GA; Xavier, GD				Mondragon, Angeles; Davidsson, Daniel; Kyriakoudi, Styliana; Bertling, Annika; Gomes-Faria, Rosa; Cohen, Patrizia; Rothery, Stephen; Chabosseau, Pauline; Rutter, Guy A.; Xavier, Gabriela da Silva			Divergent Effects of Liraglutide, Exendin-4, and Sitagliptin on Beta-Cell Mass and Indicators of Pancreatitis in a Mouse Model of Hyperglycaemia	PLOS ONE			English	Article							INCRETIN-BASED THERAPIES; TYPE-2 DIABETES-MELLITUS; RECEPTOR ACTIVATION; MICE; EXENATIDE; AGONISTS; SAFETY; INHIBITORS; ENDOCRINE; PATHWAYS	Aims: Glucagon-like peptide-1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP4) inhibitors improve glucose tolerance by still incompletely understood mechanisms. Each class of antihyperglycemic drugs has also been proposed to increase pancreatitis risk. Here, we compare systematically the effects of two widely-used GLP-1 analogues, liraglutide and exendin-4, and the DPP4 inhibitor, sitagliptin, in the mouse. Methods: C57BL6 mice were maintained for 131 days on a normal diet (ND) or a diet comprising 60% fat (HFD) before measurements of fasting blood glucose and insulin, and intraperitoneal glucose tolerance. Beta- and alpha- cell volume, and Reg3b immunoreactivity, were measured by immunohistochemical analysis of pancreatic slices. Results: Whereas liraglutide (200 mu g/kg) and exendin-4 (10 mu g/kg) treatment reduced body weight and/or improved glucose tolerance, sitagliptin (10 mg/kg) was without effect on either parameter. Liraglutide caused a sharp reduction in beta-cell mass in both ND and HFD mice, whereas exendin-4 exerted no effect. By contrast, sitagliptin unmasked an action of high fat diet to increase beta-cell mass. Reg3B positive area was augmented by all three agents in normal chow-fed mice, whilst sitagliptin and exendin-4, but not liraglutide, affected this parameter in HFD animals. Correspondingly sitagliptin, but not the GLP-1 analogues, increased circulating amylase levels in ND and HFD mice. Conclusions: Liraglutide improves glucose tolerance in the mouse whilst exerting relatively modest effects on pancreatitis risk. Conversely, exendin-4 and sitagliptin, at doses which exert, respectively, minor or no effects on metabolic parameters, lead to signs of pancreatitis.	[Mondragon, Angeles; Davidsson, Daniel; Kyriakoudi, Styliana; Bertling, Annika; Gomes-Faria, Rosa; Chabosseau, Pauline; Rutter, Guy A.; Xavier, Gabriela da Silva] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Div Diabet Endocrinol & Metab,Sect Cell Biol, London, England; [Cohen, Patrizia] St Marys Hosp, Imperial Coll Healthcare NHS Trust, Dept Pathol, London, England; [Rothery, Stephen] Univ London Imperial Coll Sci Technol & Med, FILM, London, England	Imperial College London; Imperial College London; Imperial College London	Xavier, GD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Med, Div Diabet Endocrinol & Metab,Sect Cell Biol, London, England.	g.dasilva-xavier@imperial.ac.uk		Rutter, Guy/0000-0001-6360-0343; da Silva Xavier, Gabriela/0000-0002-0678-012X	European Foundation for the Studies of Diabetes (Diabetes and Cancer grant scheme); Diabetes U. K. (Diabetes UK Alec and Beryl Warren Award) [13/0004672]; Wellcome Trust [WT098424AIA]; MRC (UK) [MR/J0003042/1]; Royal Society Wolfson Research Merit Award; MRC [MR/K001981/1] Funding Source: UKRI; Diabetes UK [13/0004672] Funding Source: researchfish; Medical Research Council [MR/K001981/1] Funding Source: researchfish	European Foundation for the Studies of Diabetes (Diabetes and Cancer grant scheme); Diabetes U. K. (Diabetes UK Alec and Beryl Warren Award)(Diabetes UK); Wellcome Trust(Wellcome TrustEuropean Commission); MRC (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Wolfson Research Merit Award(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to this report was funded by grants to GdSX and GAR from the European Foundation for the Studies of Diabetes (Diabetes and Cancer grant scheme 2012), and Diabetes U. K. (Diabetes UK Alec and Beryl Warren Award, Project grant 13/0004672), and to GAR from the Wellcome Trust (Senior Investigator Award WT098424AIA), and MRC (UK) (Programme Grant MR/J0003042/1). GAR is the recipient of a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 1997, METABOLISM, V46, P97, DOI 10.1016/S0026-0495(97)90175-X; Aroda VR, 2011, DIABETES-METAB RES, V27, P528, DOI 10.1002/dmrr.1202; Arulmozhi DK, 2006, EUR J PHARM SCI, V28, P96, DOI 10.1016/j.ejps.2006.01.003; Aston-Mourney K, 2013, AM J PHYSIOL-ENDOC M, V305, pE475, DOI 10.1152/ajpendo.00025.2013; Bhanot UK, 2009, LAB INVEST, V89, P489, DOI 10.1038/labinvest.2009.19; Butler PC, 2010, DIABETOLOGIA, V53, P1, DOI 10.1007/s00125-009-1591-5; Butler PC, 2013, DIABETES CARE, V36, P2118, DOI 10.2337/dc12-2713; Butler PC, 2010, DIABETES CARE, V33, P453, DOI 10.2337/dc09-1902; Chadwick KD, 2014, DIABETES, V63, P1303, DOI 10.2337/db13-1268; Dai Y, 2013, CARDIOVASC DRUG THER, V27, P371, DOI 10.1007/s10557-013-6463-z; Denker PS, 2006, DIABETES CARE, V29, P471, DOI 10.2337/diacare.29.02.06.dc05-2043; Drucker DJ, 2011, J CLIN ENDOCR METAB, V96, P2027, DOI 10.1210/jc.2011-0599; Drucker DJ, 2010, DIABETES CARE, V33, P428, DOI 10.2337/dc09-1499; Elashoff M, 2011, GASTROENTEROLOGY, V141, P150, DOI 10.1053/j.gastro.2011.02.018; Ellenbroek JH, 2013, DIABETOLOGIA, V56, P1980, DOI 10.1007/s00125-013-2957-2; Engel SS, 2010, INT J CLIN PRACT, V64, P984, DOI 10.1111/j.1742-1241.2010.02382.x; Forest T, 2014, ENDOCRINOLOGY, V155, P783, DOI 10.1210/en.2013-1781; Franks AS, 2012, ANN PHARMACOTHER, V46, P1547, DOI 10.1345/aph.1Q789; Garg R, 2010, DIABETES CARE, V33, P2349, DOI 10.2337/dc10-0482; Garg SK, 2010, DIABETES TECHNOL THE, V12, P11, DOI 10.1089/dia.2009.0127; Gaspari T, 2013, DIABETES VASC DIS RE, V10, P353, DOI 10.1177/1479164113481817; Gier B, 2012, DIABETES, V61, P1250, DOI 10.2337/db11-1109; Iyer Shridhar N, 2012, Endocr Pract, V18, pe10, DOI 10.4158/EP11264.CR; Jeong KH, 2011, INT J CLIN PHARM-NET, V33, P740, DOI 10.1007/s11096-011-9552-8; Jura N, 2005, CELL RES, V15, P72, DOI 10.1038/sj.cr.7290269; Knezevich E, 2012, AM J HEALTH-SYST PH, V69, P386, DOI 10.2146/ajhp110221; Koehler JA, 2009, DIABETES, V58, P2148, DOI 10.2337/db09-0626; Lando HM, 2012, ENDOCR PRACT, V18, P472, DOI 10.4158/EP11290.OR; Lee Phillip H, 2011, Ann Pharmacother, V45, pe22, DOI 10.1345/aph.1P714; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; LOWENFELS AB, 1993, NEW ENGL J MED, V328, P1433, DOI 10.1056/NEJM199305203282001; Marathe CS, 2013, PEPTIDES, V44, P75, DOI 10.1016/j.peptides.2013.01.014; Matveyenko AV, 2009, DIABETES, V58, P1604, DOI 10.2337/db09-0058; Monami M, 2011, CURR MED RES OPIN, V27, P57, DOI 10.1185/03007995.2011.602964; Nachnani JS, 2010, DIABETOLOGIA, V53, P153, DOI 10.1007/s00125-009-1515-4; Nauck MA, 1997, AM J PHYSIOL-ENDOC M, V273, pE981, DOI 10.1152/ajpendo.1997.273.5.E981; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Nyborg NCB, 2012, DIABETES, V61, P1243, DOI 10.2337/db11-0936; Peters KR, 2013, AM J THER, V20, P178, DOI 10.1097/MJT.0b013e3182204c16; Poucher SM, 2012, DIABETES OBES METAB, V14, P918, DOI 10.1111/j.1463-1326.2012.01619.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Singh S, 2013, JAMA INTERN MED, V173, P534, DOI 10.1001/jamainternmed.2013.2720; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; Tatarkiewicz K, 2014, DIABETES OBES METAB, V16, P376, DOI 10.1111/dom.12237; Tripathy N R, 2008, J Assoc Physicians India, V56, P987; Turner RC, 1998, DIABETES CARE, V21, pC35, DOI 10.2337/diacare.21.3.C35; van der Worp HB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000245; Vrang N, 2012, AM J PHYSIOL-ENDOC M, V303, pE253, DOI 10.1152/ajpendo.00182.2012; Wideman RD, 2009, TRENDS ENDOCRIN MET, V20, P280, DOI 10.1016/j.tem.2009.02.005; Xavier GD, 2012, DIABETOLOGIA, V55, P2667, DOI 10.1007/s00125-012-2600-7	50	22	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104873	10.1371/journal.pone.0104873	http://dx.doi.org/10.1371/journal.pone.0104873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119717	gold, Green Submitted, Green Published			2022-12-27	WOS:000340900600095
J	Pinheiro, D; Chang, YM; Bryant, H; Sziadovits, B; Daiessandri, T; Davison, LJ; Yallop, E; Mills, E; Leo, C; Lara, A; Stell, A; Polton, G; Garden, OA				Pinheiro, Dammy; Chang, Yu-Mei; Bryant, Hannah; Sziadovits, Balazs; Daiessandri, Tim; Davison, Lucy J.; Yallop, Elizabeth; Mills, Emily; Leo, Chiara; Lara, Ana; Stell, Anneliese; Polton, Gerry; Garden, Oliver A.			Dissecting the Regulatory Microenvironment of a Large Animal Model of Non-Hodgkin Lymphoma: Evidence of a Negative Prognostic Impact of FOXP3(+) T Cells in Canine B Cell Lymphoma	PLOS ONE			English	Article							LOW-DOSE CYCLOPHOSPHAMIDE; NEEDLE-ASPIRATION-CYTOLOGY; FOLLICULAR LYMPHOMA; MALIGNANT-LYMPHOMAS; MULTICENTRIC LYMPHOSARCOMA; TUMOR MICROENVIRONMENT; GERMINAL CENTER; HIGH NUMBERS; HUMAN CANCER; DOGS	The cancer microenvironment plays a pivotal role in oncogenesis, containing a number of regulatory cells that attenuate the anti-neoplastic immune response. While the negative prognostic impact of regulatory T cells (Tregs) in the context of most solid tissue tumors is well established, their role in lymphoid malignancies remains unclear. T cells expressing FOXP3 and Helios were documented in the fine needle aspirates of affected lymph nodes of dogs with spontaneous multicentric B cell lymphoma (BCL), proposed to be a model for human non-Hodgkin lymphoma. Multivariable analysis revealed that the frequency of lymph node FOXP3(+) T cells was an independent negative prognostic factor, impacting both progression-free survival (hazard ratio 1.10; p = 0.01) and overall survival (hazard ratio 1.61; p = 0.01) when comparing dogs showing higher than the median FOXP3 expression with those showing the median value of FOXP3 expression or less. Taken together, these data suggest the existence of a population of Tregs operational in canine multicentric BCL that resembles thymic Tregs, which we speculate are co-opted by the tumor from the periphery. We suggest that canine multicentric BCL represents a robust large animal model of human diffuse large BCL, showing clinical, cytological and immunophenotypic similarities with the disease in man, allowing comparative studies of immunoregulatory mechanisms.	[Pinheiro, Dammy; Bryant, Hannah; Daiessandri, Tim; Garden, Oliver A.] Royal Vet Coll, Immune Regulat Lab, Dept Clin Sci & Serv, London, England; [Chang, Yu-Mei] Royal Vet Coll, Res Off, London, England; [Sziadovits, Balazs] Royal Vet Coll, Dept Pathol & Pathogen Biol, Hatfield, Herts, England; [Davison, Lucy J.] Univ Oxford, Ctr Cellular & Mol Physiol, Oxford, England; [Davison, Lucy J.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Yallop, Elizabeth; Mills, Emily] Royal Vet Coll, Clin Investigat Ctr, Hatfield, Herts, England; [Leo, Chiara; Lara, Ana; Stell, Anneliese; Garden, Oliver A.] Royal Vet Coll, Queen Mother Hosp Animals, Dept Clin Sci & Serv, Hatfield, Herts, England; [Polton, Gerry] North Downs Specialist Referrals, Oncol Serv, Surrey, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of Oxford; University of Cambridge; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College	Garden, OA (corresponding author), Royal Vet Coll, Immune Regulat Lab, Dept Clin Sci & Serv, London, England.	ogarden@rvc.ac.uk	Polton, Gerry A./AAM-1760-2020	Polton, Gerry A./0000-0002-9357-944X; Dalessandri, Tim/0000-0001-5690-295X; LARA-GARCIA, ANA/0000-0003-3672-5460; Pinheiro, Damilola/0000-0003-0294-9423	Petplan Charitable Trust [10-19]; Wellcome Trust Veterinary Postdoctoral Fellowship [WT/096398/Z/11/Z]; Biotechnology and Biological Sciences Research Council [BB/F011180/1] Funding Source: researchfish; BBSRC [BB/F011180/1] Funding Source: UKRI	Petplan Charitable Trust; Wellcome Trust Veterinary Postdoctoral Fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was generously funded by the Petplan Charitable Trust, grant number 10-19, URL: http://www.petplantrust.org/. LJD is supported by a Wellcome Trust Veterinary Postdoctoral Fellowship (WT/096398/Z/11/Z). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeegbe DO, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00190; Akimova T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024226; Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Aresu L, 2015, VET COMP ONCOL, V13, P348, DOI 10.1111/vco.12048; Armand P, 2013, BRIT J HAEMATOL, V160, P608, DOI 10.1111/bjh.12176; Becker JC, 2013, CANCER IMMUNOL IMMUN, V62, P1137, DOI 10.1007/s00262-013-1434-6; Burton JH, 2011, J VET INTERN MED, V25, P920, DOI 10.1111/j.1939-1676.2011.0753.x; Camisaschi C, 2013, CANCER IMMUNOL IMMUN, V62, P897, DOI 10.1007/s00262-013-1397-7; Carreras J, 2006, BLOOD, V108, P2957, DOI 10.1182/blood-2006-04-018218; CARTER RF, 1987, J AM ANIM HOSP ASSOC, V23, P587; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Chun R, 2009, TOP COMPANION ANIM M, V24, P157, DOI 10.1053/j.tcam.2009.03.003; Coupland SE, 2011, HISTOPATHOLOGY, V58, P69, DOI 10.1111/j.1365-2559.2010.03706.x; Das DK, 1999, DIAGN CYTOPATHOL, V21, P240, DOI 10.1002/(SICI)1097-0339(199910)21:4<240::AID-DC3>3.0.CO;2-Z; Dehghani M, 2012, MED ONCOL, V29, P2364, DOI 10.1007/s12032-012-0176-1; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Dobrzanski MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00063; Dobson JM, 2001, J SMALL ANIM PRACT, V42, P377, DOI 10.1111/j.1748-5827.2001.tb02485.x; Dovat S, 2005, J IMMUNOL, V175, P3508, DOI 10.4049/jimmunol.175.6.3508; Felcht M, 2012, BRIT J DERMATOL, V167, P348, DOI 10.1111/j.1365-2133.2012.10987.x; Fields PA, 2012, BRIT J HAEMATOL, V157, P159, DOI 10.1111/j.1365-2141.2011.09011.x; Flammiger A, 2013, EUR J CANCER, V49, P1273, DOI 10.1016/j.ejca.2012.11.035; Fournel-Fleury C, 2002, VET PATHOL, V39, P92, DOI 10.1354/vp.39-1-92; FournelFleury C, 1997, J COMP PATHOL, V117, P35, DOI 10.1016/S0021-9975(97)80065-5; Frantz AM, 2013, VET PATHOL, V50, P693, DOI 10.1177/0300985812465325; Fridman WH, 2013, CANCER MICROENVIRON, V6, P117, DOI 10.1007/s12307-012-0124-9; Fujii K, 2003, BRIT J HAEMATOL, V120, P986, DOI 10.1046/j.1365-2141.2003.04216.x; Gallimore A, 2008, IMMUNOLOGY, V123, P157, DOI 10.1111/j.1365-2567.2007.02748.x; Garden OA, 2011, INT IMMUNOPHARMACOL, V11, P576, DOI 10.1016/j.intimp.2010.11.003; Gordon I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000161; GREENLEE PG, 1990, CANCER-AM CANCER SOC, V66, P480, DOI 10.1002/1097-0142(19900801)66:3&lt;480::AID-CNCR2820660314&gt;3.0.CO;2-X; Gribben JG, 2010, CURR OPIN ONCOL, V22, P424, DOI 10.1097/CCO.0b013e32833d5938; Guerard EJ, 2012, DM-DIS MON, V58, P208, DOI 10.1016/j.disamonth.2012.01.010; Hansen W, 2012, J EXP MED, V209, P2001, DOI 10.1084/jem.20111497; Head E, 2013, BBA-MOL BASIS DIS, V1832, P1384, DOI 10.1016/j.bbadis.2013.03.016; Hudnall SD, 2008, CYTOM PART B-CLIN CY, V74B, P1, DOI 10.1002/cyto.b.20376; Jagielski D, 2002, J VET MED A, V49, P419, DOI 10.1046/j.1439-0442.2002.00458.x; KELLER ET, 1993, J VET INTERN MED, V7, P289, DOI 10.1111/j.1939-1676.1993.tb01021.x; Kelley TW, 2007, AM J CLIN PATHOL, V128, P958, DOI 10.1309/NB3947K383DJ0LQ2; Khanna C, 1998, J AM VET MED ASSOC, V213, P985; Koch K, 2012, HUM PATHOL, V43, P2274, DOI 10.1016/j.humpath.2012.03.025; Kol A, 2015, VET COMP ONCOL, V13, P255, DOI 10.1111/vco.12041; Koreishi AF, 2010, APPL IMMUNOHISTO M M, V18, P206, DOI 10.1097/PAI.0b013e3181c7138b; Kryczek I, 2009, CANCER RES, V69, P3995, DOI 10.1158/0008-5472.CAN-08-3804; Lanca T, 2012, ONCOIMMUNOLOGY, V1, P717, DOI 10.4161/onci.20068; Landgren O, 2004, HEMATOL J, V5, P69, DOI 10.1038/sj.thj.6200316; Lee NR, 2008, LEUKEMIA LYMPHOMA, V49, P247, DOI 10.1080/10428190701824536; Lee S, 2013, ACTA ONCOL, V52, P73, DOI 10.3109/0284186X.2012.731520; Lin XH, 2013, INT J CLIN EXP PATHO, V6, P116; Lindau D, 2013, IMMUNOLOGY, V138, P105, DOI 10.1111/imm.12036; Lindqvist CA, 2012, IMMUNOLOGY, V135, P255, DOI 10.1111/j.1365-2567.2011.03539.x; Liu P, 2010, J IMMUNOTHER, V33, P53, DOI 10.1097/CJI.0b013e3181b56af4; Lurie DM, 2008, VET IMMUNOL IMMUNOP, V125, P102, DOI 10.1016/j.vetimm.2008.05.009; MACEWEN EG, 1985, J BIOL RESP MODIF, V4, P427; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Mao R, 2013, BIOCHEM PHARMACOL, V85, P1513, DOI 10.1016/j.bcp.2013.03.013; Marconato L, 2013, VET J, V197, P776, DOI 10.1016/j.tvjl.2013.05.003; Marconato L, 2013, HEMATOL ONCOL, V31, P1, DOI 10.1002/hon.2017; Marconato L, 2011, VET J, V188, P34, DOI 10.1016/j.tvjl.2010.04.027; Marshall NA, 2004, BLOOD, V103, P1755, DOI 10.1182/blood-2003-07-2594; Mey U, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13511; Miller AG, 2009, J VET INTERN MED, V23, P116, DOI [10.1111/j.1939-1676.2008.0210.x, 10.1111/j.1939-1676.2008.00210.x]; Mitchell L, 2012, VET IMMUNOL IMMUNOP, V145, P597, DOI 10.1016/j.vetimm.2012.01.006; Mizuno T, 2009, J VET MED SCI, V71, P1561, DOI 10.1292/jvms.001561; Modiano JF, 2005, CANCER RES, V65, P5654, DOI 10.1158/0008-5472.CAN-04-4613; Moniuszko M, 2010, INFLAMMATION, V33, P415, DOI 10.1007/s10753-010-9200-9; Mooney M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061088; Narendra BL, 2013, INFLAMM RES, V62, P823, DOI 10.1007/s00011-013-0645-9; O'Connor OA, 2005, LEUKEMIA LYMPHOMA, V46, P973, DOI 10.1080/10428190500083193; Oleinika K, 2013, CLIN EXP IMMUNOL, V171, P36, DOI 10.1111/j.1365-2249.2012.04657.x; Onoe T, 2011, J IMMUNOL, V187, P3895, DOI 10.4049/jimmunol.1100394; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Pastor M, 2009, J VET INTERN MED, V23, P301, DOI 10.1111/j.1939-1676.2008.0255.x; Perry JA, 2011, VET COMP ONCOL, V9, P55, DOI 10.1111/j.1476-5829.2010.00235.x; Pinheiro D, 2011, IMMUNOLOGY, V132, P111, DOI 10.1111/j.1365-2567.2010.03346.x; Ponce F, 2004, VET J, V167, P158, DOI 10.1016/j.tvjl.2003.10.009; Ponce F, 2010, VET PATHOL, V47, P414, DOI 10.1177/0300985810363902; Potschka H, 2013, EPILEPSIA, V54, P571, DOI 10.1111/epi.12138; PRICE GS, 1991, J VET INTERN MED, V5, P259, DOI 10.1111/j.1939-1676.1991.tb03131.x; Ranieri G, 2013, CRIT REV ONCOL HEMAT, V88, P187, DOI 10.1016/j.critrevonc.2013.03.005; Rao S, 2011, J VET INTERN MED, V25, P1097, DOI 10.1111/j.1939-1676.2011.0767.x; Richards KL, 2013, CANCER RES, V73, P5029, DOI 10.1158/0008-5472.CAN-12-3546; Rico M. J., 2012, Experimental Oncology, V34, P38; Rimsza LM, 2007, LEUKEMIA LYMPHOMA, V48, P542, DOI 10.1080/10428190601078605; Rimsza LM, 2004, BLOOD, V103, P4251, DOI 10.1182/blood-2003-07-2365; Ruslander DA, 1997, IN VIVO, V11, P169; Sato M, 2013, VET J, V195, P319, DOI 10.1016/j.tvjl.2012.07.013; Sbiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024345; Schiavoni G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00090; Schreck S, 2009, HEMATOL ONCOL, V27, P31, DOI 10.1002/hon.878; Shankland KR, 2012, LANCET, V380, P848, DOI 10.1016/S0140-6736(12)60605-9; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Su YH, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-2; Tanchot C, 2013, CANCER MICROENVIRON, V6, P147, DOI 10.1007/s12307-012-0122-y; TESKE E, 1994, J AM VET MED ASSOC, V205, P1722; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tsai KL, 2007, MAMM GENOME, V18, P444, DOI 10.1007/s00335-007-9037-1; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; UK CR, 2013, CANC STAT REP NONH L; Vail DM, 2010, VET COMP ONCOL, V8, P28, DOI 10.1111/j.1476-5829.2009.00200.x; Valli VE, 2013, VET PATHOL, V50, P738, DOI 10.1177/0300985813478210; Valli VE, 2011, VET PATHOL, V48, P198, DOI 10.1177/0300985810379428; Veelken H, 2007, ANN ONCOL, V18, P931, DOI 10.1093/annonc/mdm012; Vigliar Elena, 2012, Infez Med, V20 Suppl 3, P39; Wahlin BE, 2010, CLIN CANCER RES, V16, P637, DOI 10.1158/1078-0432.CCR-09-2487; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Webster JD, 2011, VET PATHOL, V48, P7, DOI 10.1177/0300985810377187; WELLER RE, 1982, J AM VET MED ASSOC, V181, P891; Whiteside TL, 2012, EXPERT OPIN BIOL TH, V12, P1383, DOI 10.1517/14712598.2012.707184; Wiedemann AL, 2005, J SMALL ANIM PRACT, V46, P185, DOI 10.1111/j.1748-5827.2005.tb00309.x; Wilkerson MJ, 2005, VET IMMUNOL IMMUNOP, V106, P179, DOI 10.1016/j.vetimm.2005.02.020; Yang ZZ, 2006, CANCER RES, V66, P10145, DOI 10.1158/0008-5472.CAN-06-1822; Yang ZZ, 2009, CANCER RES, V69, P5522, DOI 10.1158/0008-5472.CAN-09-0266; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; Zen M, 2011, AUTOIMMUN REV, V10, P305, DOI 10.1016/j.autrev.2010.11.009; Zhang Z, 2007, BLOOD, V109, P2190, DOI 10.1182/blood-2005-01-031930; Zhao J, 2010, CANCER RES, V70, P4850, DOI 10.1158/0008-5472.CAN-10-0283	117	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105027	10.1371/journal.pone.0105027	http://dx.doi.org/10.1371/journal.pone.0105027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119018	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600115
J	Song, NN; Zhong, X; Li, B; Li, JM; Wei, DP; Ma, YB				Song, Ningning; Zhong, Xu; Li, Bo; Li, Jumei; Wei, Dongpu; Ma, Yibing			Development of a Multi-Species Biotic Ligand Model Predicting the Toxicity of Trivalent Chromium to Barley Root Elongation in Solution Culture	PLOS ONE			English	Article							ACUTE COPPER TOXICITY; ACUTE ZINC TOXICITY; DAPHNIA-MAGNA; MAGNESIUM; SOIL; VALIDATION; POTASSIUM; CALCIUM; SODIUM; WHEAT	Little knowledge is available about the influence of cation competition and metal speciation on trivalent chromium (Cr(III)) toxicity. In the present study, the effects of pH and selected cations on the toxicity of trivalent chromium (Cr(III)) to barley (Hordeum vulgare) root elongation were investigated to develop an appropriate biotic ligand model (BLM). Results showed that the toxicity of Cr(III) decreased with increasing activity of Ca2+ and Mg2+ but not with K+ and Na+. The effect of pH on Cr(III) toxicity to barley root elongation could be explained by H+ competition with Cr3+ bound to a biotic ligand (BL) as well as by the concomitant toxicity of CrOH2+ in solution culture. Stability constants were obtained for the binding of Cr3+, CrOH2+, Ca2+, Mg2+ and H+ with binding ligand: log K-CrBL 7.34, log K-CrOHBL 5.35, log K-CaBL 2.64, log K-MgBL 2.98, and log K-HBL 4.74. On the basis of those estimated parameters, a BLM was successfully developed to predict Cr(III) toxicity to barley root elongation as a function of solution characteristics.	[Song, Ningning; Zhong, Xu; Li, Bo; Li, Jumei; Wei, Dongpu; Ma, Yibing] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Soil Fertil & Fertilizer Effects Long Term M, Beijing 100193, Peoples R China; [Li, Bo] Liaoning Acad Agr Sci, Inst Plant Nutr & Environm Resources, Shenyang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Ma, YB (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Natl Soil Fertil & Fertilizer Effects Long Term M, Beijing 100193, Peoples R China.	mayibing@caas.cn			National Natural Science Foundation of China [40971262]; China Postdoctoral Science Foundation [2013M530783]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The work was financially supported by National Natural Science Foundation of China (grant number 40971262) and China Postdoctoral Science Foundation (grant number 2013M530783). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2012, J HAZARD MATER, V203, P69, DOI 10.1016/j.jhazmat.2011.11.085; Bolan NS, 2003, J ENVIRON QUAL, V32, P120, DOI 10.2134/jeq2003.0120; Carbonaro RF, 2005, ANAL CHEM, V77, P155, DOI 10.1021/ac048860b; Chen CP, 2010, PLANT SOIL, V334, P299, DOI 10.1007/s11104-010-0383-5; Cremazy A, 2013, ENVIRON SCI TECHNOL, V47, P2408, DOI 10.1021/es3038388; De Schamphelaere KAC, 2002, ENVIRON SCI TECHNOL, V36, P48, DOI 10.1021/es000253s; Di Toro DM, 2001, ENVIRON TOXICOL CHEM, V20, P2383, DOI 10.1002/etc.5620201034; Guo XY, 2010, CHEM SPEC BIOAVAILAB, V22, P51, DOI 10.3184/095422910X12632121425090; Heijerick DG, 2002, ENVIRON TOXICOL CHEM, V21, P1309, DOI [10.1897/1551-5028(2002)021<1309:PAZTFD>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;1309:PAZTFD&gt;2.0.CO;2]; Jo HJ, 2009, TOXICOL ENV HEALTH, V2, P141; Jo HJ, 2010, CHEMOSPHERE, V81, P1301, DOI 10.1016/j.chemosphere.2010.08.037; Kinraide TB, 2004, PLANT SOIL, V259, P201, DOI 10.1023/B:PLSO.0000020972.18777.99; Kopittke PM, 2011, ENVIRON SCI TECHNOL, V45, P4966, DOI 10.1021/es1041404; LAUREN DJ, 1985, J COMP PHYSIOL B, V155, P635, DOI 10.1007/BF00694455; Le TTY, 2012, ENVIRON TOXICOL CHEM, V31, P355, DOI 10.1002/etc.736; Li B, 2009, ECOTOX ENVIRON SAFE, V72, P1760, DOI 10.1016/j.ecoenv.2009.05.003; Lock K, 2007, ENVIRON POLLUT, V147, P626, DOI 10.1016/j.envpol.2006.10.003; Lock K, 2006, SOIL BIOL BIOCHEM, V38, P1924, DOI 10.1016/j.soilbio.2005.12.014; Lopez-Luna J, 2009, J HAZARD MATER, V163, P829, DOI 10.1016/j.jhazmat.2008.07.034; Ma YiBing, 2010, Trace elements in soils, P461; Oorts K, 2006, ENVIRON TOXICOL CHEM, V25, P836, DOI 10.1897/04-672R.1; Pedler JF, 2004, PLANT SOIL, V259, P191, DOI 10.1023/B:PLSO.0000020958.42158.f5; Santore RC, 2001, ENVIRON TOXICOL CHEM, V20, P2397, DOI [10.1002/etc.5620201035, 10.1897/1551-5028(2001)020&lt;2397:BLMOTA&gt;2.0.CO;2]; Shanker AK, 2005, ENVIRON INT, V31, P739, DOI 10.1016/j.envint.2005.02.003; Sivakumar S, 2005, ECOTOX ENVIRON SAFE, V62, P93, DOI 10.1016/j.ecoenv.2004.08.006; Stewart MA, 2003, J ENVIRON QUAL, V32, P129, DOI 10.2134/jeq2003.0129; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; Thakali S, 2006, ENVIRON SCI TECHNOL, V40, P7094, DOI 10.1021/es061173c; Thakali S, 2006, ENVIRON SCI TECHNOL, V40, P7085, DOI 10.1021/es061171s; Vilar VJP, 2012, CHEM ENG J, V200, P140, DOI 10.1016/j.cej.2012.06.023; Wang P, 2012, J EXP BOT, V63, P659, DOI 10.1093/jxb/err254; Wang XD, 2012, CHEMOSPHERE, V89, P89, DOI 10.1016/j.chemosphere.2012.04.022; Wang XD, 2010, ECOTOX ENVIRON SAFE, V73, P1272, DOI 10.1016/j.ecoenv.2010.05.016; Wang XD, 2009, ENVIRON TOXICOL CHEM, V28, P662, DOI 10.1897/07-641.1; Yu PF, 2004, PLANT SOIL, V258, P333, DOI 10.1023/B:PLSO.0000016562.58948.b3; Yun YS, 2001, ENVIRON SCI TECHNOL, V35, P4353, DOI 10.1021/es010866k	36	17	21	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105174	10.1371/journal.pone.0105174	http://dx.doi.org/10.1371/journal.pone.0105174			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119269	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600128
J	Bonnet, C; Rusz, J; Megrelishvili, M; Sieger, T; Matouskova, O; Okujava, M; Brozova, H; Nikolai, T; Hanuska, J; Kapianidze, M; Mikeladze, N; Botchorishvili, N; Khatiashvili, I; Janelidze, M; Serranova, T; Fiala, O; Roth, J; Bergquist, J; Jech, R; Rivaud-Pechoux, S; Gaymard, B; Ruzicka, E				Bonnet, Cecilia; Rusz, Jan; Megrelishvili, Marika; Sieger, Tomas; Matouskova, Olga; Okujava, Michael; Brozova, Hana; Nikolai, Tomas; Hanuska, Jaromir; Kapianidze, Mariam; Mikeladze, Nina; Botchorishvili, Nazi; Khatiashvili, Irine; Janelidze, Marina; Serranova, Tereza; Fiala, Ondrej; Roth, Jan; Bergquist, Jonas; Jech, Robert; Rivaud-Pechoux, Sophie; Gaymard, Bertrand; Ruzicka, Evzen			Eye Movements in Ephedrone-Induced Parkinsonism	PLOS ONE			English	Article							SQUARE-WAVE JERKS; VISUALLY-GUIDED SACCADES; SUBTHALAMIC NUCLEUS; NEURONAL-ACTIVITY; MANGANESE; DISEASE; IMPAIRMENT; MOTOR; ANTISACCADES; DYSTONIA	Patients with ephedrone parkinsonism (EP) show a complex, rapidly progressive, irreversible, and levodopa non-responsive parkinsonian and dystonic syndrome due to manganese intoxication. Eye movements may help to differentiate parkinsonian syndromes providing insights into which brain networks are affected in the underlying disease, but they have never been systematically studied in EP. Horizontal and vertical eye movements were recorded in 28 EP and compared to 21 Parkinson's disease (PD) patients, and 27 age- and gender-matched healthy subjects using standardized oculomotor tasks with infrared videooculography. EP patients showed slow and hypometric horizontal saccades, an increased occurrence of square wave jerks, long latencies of vertical antisaccades, a high error rate in the horizontal antisaccade task, and made more errors than controls when pro-and antisaccades were mixed. Based on oculomotor performance, a direct differentiation between EP and PD was possible only by the velocity of horizontal saccades. All remaining metrics were similar between both patient groups. EP patients present extensive oculomotor disturbances probably due to manganese-induced damage to the basal ganglia, reflecting their role in oculomotor system.	[Bonnet, Cecilia; Rusz, Jan; Sieger, Tomas; Matouskova, Olga; Brozova, Hana; Nikolai, Tomas; Hanuska, Jaromir; Serranova, Tereza; Fiala, Ondrej; Roth, Jan; Jech, Robert; Ruzicka, Evzen] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Bonnet, Cecilia; Rusz, Jan; Sieger, Tomas; Matouskova, Olga; Brozova, Hana; Nikolai, Tomas; Hanuska, Jaromir; Serranova, Tereza; Fiala, Ondrej; Roth, Jan; Jech, Robert; Ruzicka, Evzen] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Bonnet, Cecilia; Rusz, Jan; Sieger, Tomas; Brozova, Hana; Nikolai, Tomas; Hanuska, Jaromir; Serranova, Tereza; Fiala, Ondrej; Roth, Jan; Jech, Robert; Ruzicka, Evzen] Gen Univ Hosp, Prague, Czech Republic; [Rusz, Jan] Czech Tech Univ, Fac Elect Engn, Dept Circuit Theory, CR-16635 Prague, Czech Republic; [Megrelishvili, Marika; Kapianidze, Mariam; Mikeladze, Nina; Botchorishvili, Nazi; Khatiashvili, Irine; Janelidze, Marina] S Khechinashvili Univ Clin, Dept Neurol, Tbilisi, Georgia; [Megrelishvili, Marika] Ilia State Univ, Inst Med Res, Tbilisi, Georgia; [Sieger, Tomas] Czech Tech Univ, Fac Elect Engn, Dept Cybernet, CR-16635 Prague, Czech Republic; [Okujava, Michael] Res Inst Clin Med, Tbilisi, Georgia; [Matouskova, Olga] Charles Univ Prague, Fac Med 1, Inst Pharmacol, Prague, Czech Republic; [Bergquist, Jonas] Uppsala Univ, Biomed Ctr, Dept Chem, Uppsala, Sweden; [Bergquist, Jonas] Uppsala Univ, SciLife Lab, Uppsala, Sweden; [Rivaud-Pechoux, Sophie; Gaymard, Bertrand] UPMC, Pitie Salpetriere Hosp, CNRS, INSERM,CRICM,ICM,UMR S975,UMR7225, Paris, France; [Gaymard, Bertrand] Univ Paris 06, Paris, France	Charles University Prague; Charles University Prague; General University Hospital Prague; Czech Technical University Prague; Ilia State University; Czech Technical University Prague; Charles University Prague; Uppsala University; SciLifeLab; Uppsala University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Ruzicka, E (corresponding author), Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic.	eruzi@lf1.cuni.cz	Rusz, Jan/X-5427-2019; Serranová, Tereza/AAY-2386-2021; Jech, Robert/HHY-7342-2022; Nikolai, Tomas/G-4883-2017; Rusz, Jan/S-2054-2018; Okujava, Michael/R-3667-2019; Nikolai, Tomas/AAL-6666-2021; Bartosova, Olga/J-8036-2017; May, Jaromir/AAR-4514-2020; Růžička, Evžen/F-9299-2017; Sieger, Tomas/AAD-9342-2019; Roth, Jan/O-1817-2017; Brozova, Hana/AAM-9717-2021; Bergquist, Jonas/C-5894-2015	Rusz, Jan/0000-0002-1036-3054; Serranová, Tereza/0000-0001-6525-3971; Jech, Robert/0000-0002-9732-8947; Nikolai, Tomas/0000-0002-0104-7228; Rusz, Jan/0000-0002-1036-3054; Okujava, Michael/0000-0002-3559-9485; Nikolai, Tomas/0000-0002-0104-7228; Bartosova, Olga/0000-0002-3427-5198; Růžička, Evžen/0000-0002-4893-9661; Roth, Jan/0000-0002-5247-7746; Brozova, Hana/0000-0003-3383-7117; Bergquist, Jonas/0000-0002-4597-041X; May, Jaromir/0000-0001-9925-338X; Sieger, Tomas/0000-0003-4960-1934	Czech Ministry of Health [IGA MZ ACER NT/12288-5/2011, IGA MZ ACER NT12282-5/2011]; Grant Agency of Charles University in Prague [GA UK 441611]; Embassy of the Czech Republic Tbilisi, Republic of Georgia; JSC Bank Republic Tbilisi Georgia; Czech Science Foundation [GACR 102/12/2230]; Czech Ministry of Education [MSM 6840770012]; Swedish Research Council [621-2011-4423]	Czech Ministry of Health(Ministry of Health, Czech Republic); Grant Agency of Charles University in Prague; Embassy of the Czech Republic Tbilisi, Republic of Georgia; JSC Bank Republic Tbilisi Georgia; Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by the Czech Ministry of Health (IGA MZ ACER NT/12288-5/2011 and IGA MZ ACER NT12282-5/2011), Grant Agency of Charles University in Prague (GA UK 441611), the Embassy of the Czech Republic Tbilisi, Republic of Georgia, JSC Bank Republic Tbilisi Georgia. JRu is supported by the Czech Science Foundation (GACR 102/12/2230). TSi is supported by Czech Ministry of Education, MSM 6840770012 Trans-disciplinary Research in the Area of Biomedical Engineering II. JB is supported by the Swedish Research Council (621-2011-4423). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVANZINI G, 1979, J NEUROL NEUROSUR PS, V42, P581, DOI 10.1136/jnnp.42.7.581; Averbuch-Heller L, 1999, NEUROLOGY, V52, P185, DOI 10.1212/WNL.52.1.185; Barton EJ, 2003, J NEUROPHYSIOL, V90, P372, DOI 10.1152/jn.01041.2002; Benko W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022410; Bonnet C, 2013, CLIN NEUROPHYSIOL, V124, P2216, DOI 10.1016/j.clinph.2013.05.002; Chen Athena L, 2010, Front Neurol, V1, P147, DOI 10.3389/fneur.2010.00147; Cherkasova MV, 2002, EXP BRAIN RES, V144, P528, DOI 10.1007/s00221-002-1075-z; de Bie RMA, 2007, ARCH NEUROL-CHICAGO, V64, P886, DOI 10.1001/archneur.64.6.886; Delinte A, 2002, NEUROSCI RES, V42, P21, DOI 10.1016/S0168-0102(01)00300-5; Fridley J, 2013, STEREOT FUNCT NEUROS, V91, P113, DOI 10.1159/000343200; GAYMARD B, 1990, ANN NEUROL, V28, P622, DOI 10.1002/ana.410280504; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Guilarte TR, 2006, EXP NEUROL, V202, P381, DOI 10.1016/j.expneurol.2006.06.015; Guilarte TR, 2010, ENVIRON HEALTH PERSP, V118, P1071, DOI [10.1289/ehp.0901748, 10.1590/S1413-81232011001200028]; Guilarte TR, 2008, J NEUROCHEM, V107, P1236, DOI 10.1111/j.1471-4159.2008.05695.x; GUPTA SK, 1980, TOXICOL LETT, V6, P17, DOI 10.1016/0378-4274(80)90095-8; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Husain M, 2003, NAT NEUROSCI, V6, P117, DOI 10.1038/nn1005; Kaneko CRS, 2006, J NEUROPHYSIOL, V95, P3698, DOI 10.1152/jn.01292.2005; Komaki H, 1999, BRAIN DEV-JPN, V21, P122, DOI 10.1016/S0387-7604(98)00074-6; KOMPF D, 1979, BRAIN, V102, P527, DOI 10.1093/brain/102.3.527; Levin OS, 2005, Z NEVROL PSIKHIATRII, V105, P12; MacAskill MR, 2012, NEUROPSYCHOLOGIA, V50, P3338, DOI 10.1016/j.neuropsychologia.2012.09.025; McMillan DE, 1999, NEUROTOXICOLOGY, V20, P499; Meral H, 2007, NEUROLOGIST, V13, P92, DOI 10.1097/01.nrl.0000253089.20746.a8; Mosimann UP, 2005, BRAIN, V128, P1267, DOI 10.1093/brain/awh484; O'Sullivan JD, 2003, J CLIN NEUROSCI, V10, P181, DOI 10.1016/S0967-5868(02)00125-X; Payan CAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022293; Perneczky R, 2011, NEUROBIOL DIS, V43, P79, DOI 10.1016/j.nbd.2011.01.032; PIERROTDESEILLIGNY C, 1989, BRAIN, V112, P471, DOI 10.1093/brain/112.2.471; Ploner CJ, 2005, BIOL PSYCHIAT, V57, P1159, DOI 10.1016/j.biopsych.2005.02.017; Pretegiani E, 2013, NEUROLOGY, V80; Quadri M, 2012, AM J HUM GENET, V90, P467, DOI 10.1016/j.ajhg.2012.01.017; RASCOL O, 1991, J NEUROL NEUROSUR PS, V54, P599, DOI 10.1136/jnnp.54.7.599; Reuter B, 2006, BIOL PSYCHOL, V72, P88, DOI 10.1016/j.biopsycho.2005.08.005; Rivaud-Pechoux S, 2000, J NEUROL NEUROSUR PS, V68, P381, DOI 10.1136/jnnp.68.3.381; Rivaud-Pechoux S, 2007, BRAIN, V130, P256, DOI 10.1093/brain/awl315; Rusz J, 2014, J NEURAL TRANSM, V121, P655, DOI 10.1007/s00702-014-1158-6; Sanotsky Y, 2007, MOVEMENT DISORD, V22, P1337, DOI 10.1002/mds.21378; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Selikhova M, 2008, MOVEMENT DISORD, V23, P2224, DOI 10.1002/mds.22290; Shaikh AG, 2011, BRIT J OPHTHALMOL, V95, P705, DOI 10.1136/bjo.2010.179630; SHARPE JA, 1984, CAN J NEUROL SCI, V11, P426, DOI 10.1017/S0317167100045959; Sieger T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078581; Sikk K, 2007, ACTA NEUROL SCAND, V115, P385, DOI 10.1111/j.1600-0404.2007.00818.x; Sikk K, 2010, ACTA NEUROL SCAND, V121, P237, DOI 10.1111/j.1600-0404.2009.01189.x; Stepens A, 2008, NEW ENGL J MED, V358, P1009, DOI 10.1056/NEJMoa072488; Terao Y, 2011, NEUROPSYCHOLOGIA, V49, P1794, DOI 10.1016/j.neuropsychologia.2011.03.002; Troost B T, 1976, Trans Am Neurol Assoc, V101, P60; Yamamoto K, 1992, Rinsho Shinkeigaku, V32, P1261; Yoshida A, 2009, CEREB CORTEX, V19, P206, DOI 10.1093/cercor/bhn069; ZEE DS, 1979, ANN NEUROL, V5, P405, DOI 10.1002/ana.410050502; Zee LJa, 2006, NEUROLOGY EYE MOVEME	55	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104784	10.1371/journal.pone.0104784	http://dx.doi.org/10.1371/journal.pone.0104784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117825	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230400084
J	Marconi, GD; Zara, S; De Colli, M; Di Valerio, V; Rapino, M; Zaramella, P; Dedja, A; Macchi, V; De Caro, R; Porzionato, A				Marconi, Guya Diletta; Zara, Susi; De Colli, Marianna; Di Valerio, Valentina; Rapino, Monica; Zaramella, Patrizia; Dedja, Arben; Macchi, Veronica; De Caro, Raffaele; Porzionato, Andrea			Postnatal Hyperoxia Exposure Differentially Affects Hepatocytes and Liver Haemopoietic Cells in Newborn Rats	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; INDUCED LUNG INJURY; MODERATE HYPEROXIA; OXIDATIVE STRESS; PARTIAL-HEPATECTOMY; DEVELOPING BRAIN; CEREBRAL-CORTEX; OXYGEN-TENSION	Premature newborns are frequently exposed to hyperoxic conditions and experimental data indicate modulation of liver metabolism by hyperoxia in the first postnatal period. Conversely, nothing is known about possible modulation of growth factors and signaling molecules involved in other hyperoxic responses and no data are available about the effects of hyperoxia in postnatal liver haematopoiesis. The aim of the study was to analyse the effects of hyperoxia in the liver tissue (hepatocytes and haemopoietic cells) and to investigate possible changes in the expression of Vascular Endothelial Growth Factor (VEGF), Matrix Metalloproteinase 9 (MMP-9), Hypoxia-Inducible Factor-1 alpha (HIF-1 alpha), endothelial Nitric Oxide Synthase (eNOS), and Nuclear Factor-kB (NF-kB). Experimental design of the study involved exposure of newborn rats to room air (controls), 60% O-2 (moderate hyperoxia), or 95% O-2 (severe hyperoxia) for the first two postnatal weeks. Immunohistochemical and Western blot analyses were performed. Severe hyperoxia increased hepatocyte apoptosis and MMP-9 expression and decreased VEGF expression. Reduced content in reticular fibers was found in moderate and severe hyperoxia. Some other changes were specifically produced in hepatocytes by moderate hyperoxia, i.e., upregulation of HIF-1 alpha and downregulation of eNOS and NF-kB. Postnatal severe hyperoxia exposure increased liver haemopoiesis and upregulated the expression of VEGF (both moderate and severe hyperoxia) and eNOS (severe hyperoxia) in haemopoietic cells. In conclusion, our study showed different effects of hyperoxia on hepatocytes and haemopoietic cells and differential involvement of the above factors. The involvement of VEGF and eNOS in the liver haemopoietic response to hyperoxia may be hypothesized.	[Marconi, Guya Diletta; Zara, Susi; De Colli, Marianna] Univ G dAnnunzio, Dept Pharm, Chieti, Italy; [Di Valerio, Valentina] Univ G dAnnunzio, Dept Med & Ageing Sci, Chieti, Italy; [Rapino, Monica] Inst Mol Genet CNR, Unit Chieti, Chieti, Italy; [Zaramella, Patrizia; Dedja, Arben] Univ Padua, Womens & Childrens Hlth Dept, Neonatal Intens Care Unit, Padua, Italy; [Macchi, Veronica; De Caro, Raffaele; Porzionato, Andrea] Univ Padua, Dept Mol Med, Padua, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Padua; University of Padua	De Caro, R (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	rdecaro@unipd.it	Dedja, Arben/J-2138-2018; Macchi, Veronica/AAV-4514-2020	Dedja, Arben/0000-0003-3535-598X; Macchi, Veronica/0000-0003-2335-6897; Zara, Susi/0000-0003-1705-6943				Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Atochin DN, 2003, J CEREBR BLOOD F MET, V23, P1219, DOI 10.1097/01.WCB.0000089601.87125.E4; Balasubramaniam V, 2007, AM J PHYSIOL-LUNG C, V292, pL1073, DOI 10.1152/ajplung.00347.2006; Ban R, 2002, FREE RADICAL RES, V36, P933, DOI 10.1080/107156021000006644; Benderro GF, 2012, BRAIN RES, V1471, P46, DOI 10.1016/j.brainres.2012.06.055; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Buonocore G, 2001, BIOL NEONATE, V79, P180; Chen CM, 2007, PEDIATR RES, V62, P128, DOI 10.1203/PDR.0b013e3180987202; Corne J, 2000, J CLIN INVEST, V106, P783, DOI 10.1172/JCI9674; Couroucli XI, 2002, MOL PHARMACOL, V61, P507, DOI 10.1124/mol.61.3.507; Curatola AM, 2011, ANGIOGENESIS, V14, P267, DOI 10.1007/s10456-011-9211-7; D'Angio CT, 2002, FRONT BIOSCI-LANDMRK, V7, pD1609, DOI 10.2741/angio; Deuber C, 2011, J PERINAT NEONAT NUR, V25, P268, DOI 10.1097/JPN.0b013e318226ee2c; Deulofeut R, 2006, J PERINATOL, V26, P700, DOI 10.1038/sj.jp.7211608; Duong TQ, 2001, MAGN RESON MED, V45, P61, DOI 10.1002/1522-2594(200101)45:1<61::AID-MRM1010>3.0.CO;2-8; Felderhoff-Mueser U, 2005, ANN NEUROL, V57, P50, DOI 10.1002/ana.20322; Felderhoff-Mueser U, 2004, NEUROBIOL DIS, V17, P273, DOI 10.1016/j.nbd.2004.07.019; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gerondakis S, 2012, IMMUNOL REV, V246, P272, DOI 10.1111/j.1600-065X.2011.01090.x; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Grisafi D, 2013, PEDIATR PULM, V48, P1070, DOI 10.1002/ppul.22791; Grisafi D, 2012, LUNG, V190, P419, DOI 10.1007/s00408-012-9382-z; Hu XM, 2003, INT J DEV NEUROSCI, V21, P371, DOI 10.1016/S0736-5748(03)00089-3; Hughes SJ, 2004, CELL TRANSPLANT, V13, P801, DOI 10.3727/000000004783983413; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; Kawada S, 2008, J STRENGTH COND RES, V22, P66, DOI 10.1519/JSC.0b013e31815eefa2; Kim CH, 2010, J BLOOD MED, V1, P13, DOI 10.2147/JBM.S7224; Klekamp JG, 1999, AM J PATHOL, V154, P823, DOI 10.1016/S0002-9440(10)65329-1; Koistinen P, 2001, LEUKEMIA, V15, P1433, DOI 10.1038/sj.leu.2402217; Lejbkowicz F, 2005, ACTA HISTOCHEM, V106, P405, DOI 10.1016/j.acthis.2004.11.003; Li WL, 2000, J CELL SCI, V113, P1525; Macak-Safranko Z, 2011, EXP TOXICOL PATHOL, V63, P345, DOI 10.1016/j.etp.2010.02.009; Malleske DT, 2006, TOXICOL APPL PHARM, V215, P109, DOI 10.1016/j.taap.2006.02.002; Mei Y, 2011, HEPATOLOGY, V54, P1777, DOI 10.1002/hep.24560; Miralles C, 2000, FEBS LETT, V476, P253, DOI 10.1016/S0014-5793(00)01748-8; Miralles C, 2000, EUR J BIOCHEM, V267, P5580, DOI 10.1046/j.1432-1327.2000.01627.x; Moorthy B, 2000, J PHARMACOL EXP THER, V292, P553; Moorthy B, 1997, TOXICOL LETT, V90, P67, DOI 10.1016/S0378-4274(96)03832-5; OKAMOTO T, 1993, BIOCHEM BIOPH RES CO, V197, P878, DOI 10.1006/bbrc.1993.2561; Olle EW, 2006, HEPATOLOGY, V44, P540, DOI 10.1002/hep.21314; Pogach MS, 2007, J CELL BIOCHEM, V100, P1415, DOI 10.1002/jcb.21142; Porzionato A, 2014, BRAIN STRUC IN PRESS; Porzionato A, 2013, RESP PHYSIOL NEUROBI, V187, P41, DOI 10.1016/j.resp.2013.02.018; Porzionato A, 2012, HISTOL HISTOPATHOL, V27, P1599, DOI 10.14670/HH-27.1599; Potter CF, 1999, PEDIATR RES, V45, P8, DOI 10.1203/00006450-199901000-00003; Ram M, 2006, J CLIN IMMUNOL, V26, P299, DOI 10.1007/s10875-006-9022-6; Rogers LK, 2010, PEDIATR RES, V67, P144, DOI 10.1203/PDR.0b013e3181c2df4f; Rubini A, 2013, LUNG, V191, P459, DOI 10.1007/s00408-013-9488-y; Saugstad OD, 2005, BIOL NEONATE, V88, P228, DOI 10.1159/000087586; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; SHAPIRO SD, 1994, AM J RESP CRIT CARE, V150, pS160, DOI 10.1164/ajrccm/150.6_Pt_2.S160; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STURMAN JA, 1970, SCIENCE, V169, P74, DOI 10.1126/science.169.3940.74; Sweet DG, 2004, ACTA PAEDIATR, V93, P791, DOI 10.1111/j.1651-2227.2004.tb03020.x; Taglialatela G, 1998, FREE RADICAL BIO MED, V25, P936, DOI 10.1016/S0891-5849(98)00131-2; Tang JR, 2010, AM J PHYSIOL-LUNG C, V299, pL735, DOI 10.1152/ajplung.00153.2010; Thom SR, 2002, J NEUROBIOL, V51, P85, DOI 10.1002/neu.10044; WEBSTER NR, 1987, BRIT J ANAESTH, V59, P760, DOI 10.1093/bja/59.6.760; Wen ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075383; Wikenheiser J, 2009, DEV DYNAM, V238, P2688, DOI 10.1002/dvdy.22089; Wong YL, 2001, TOXICOL LETT, V123, P179, DOI 10.1016/S0378-4274(01)00397-6; Zaghloul N, 2012, FEBS J, V279, P871, DOI 10.1111/j.1742-4658.2012.08478.x; Zara S, 2012, EUR J HISTOCHEM, V56, P7, DOI 10.4081/ejh.2012.e2; Zara S, 2013, HISTOCHEM CELL BIOL, V140, P575, DOI 10.1007/s00418-013-1092-y	66	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e105005	10.1371/journal.pone.0105005	http://dx.doi.org/10.1371/journal.pone.0105005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115881	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400112
J	Molinar-Toribio, E; Perez-Jimenez, J; Ramos-Romero, S; Lluis, L; Sanchez-Martos, V; Taltavull, N; Romeu, M; Pazos, M; Mendez, L; Miranda, A; Cascante, M; Medina, I; Torres, JL				Molinar-Toribio, Eunice; Perez-Jimenez, Jara; Ramos-Romero, Sara; Lluis, Laura; Sanchez-Martos, Vanessa; Taltavull, Nuria; Romeu, Marta; Pazos, Manuel; Mendez, Lucia; Miranda, Anibal; Cascante, Marta; Medina, Isabel; Lluis Torres, Josep			Cardiovascular Disease-Related Parameters and Oxidative Stress in SHROB Rats, a Model for Metabolic Syndrome	PLOS ONE			English	Article							MESENTERIC RESISTANCE ARTERIES; INSULIN-RESISTANCE; NONSENSE MUTATION; LEPTIN RECEPTOR; KOLETSKY RATS; PROTEIN; FAT; INFLAMMATION; GLUTATHIONE; CATALASE	SHROB rats have been suggested as a model for metabolic syndrome (MetS) as a situation prior to the onset of CVD or type-2 diabetes, but information on descriptive biochemical parameters for this model is limited. Here, we extensively evaluate parameters related to CVD and oxidative stress (OS) in SHROB rats. SHROB rats were monitored for 15 weeks and compared to a control group of Wistar rats. Body weight was recorded weekly. At the end of the study, parameters related to CVD and OS were evaluated in plasma, urine and different organs. SHROB rats presented statistically significant differences from Wistar rats in CVD risk factors: total cholesterol, LDL-cholesterol, triglycerides, apoA1, apoB100, abdominal fat, insulin, blood pressure, C-reactive protein, ICAM-1 and PAI-1. In adipose tissue, liver and brain, the endogenous antioxidant systems were activated, yet there was no significant oxidative damage to lipids (MDA) or proteins (carbonylation). We conclude that SHROB rats present significant alterations in parameters related to inflammation, endothelial dysfunction, thrombotic activity, insulin resistance and OS measured in plasma as well as enhanced redox defence systems in vital organs that will be useful as markers of MetS and CVD for nutrition interventions.	[Molinar-Toribio, Eunice; Perez-Jimenez, Jara; Ramos-Romero, Sara; Lluis Torres, Josep] CSIC, IQAC, Inst Adv Chem Catalonia, Barcelona, Spain; [Ramos-Romero, Sara] CIBER BBN, Biomed Res Networking Ctr Bioengn Biomat & Nanome, Zaragoza, Spain; [Lluis, Laura; Sanchez-Martos, Vanessa; Taltavull, Nuria; Romeu, Marta] Univ Rovira & Virgili, Fac Med & Ciencias Salut, Unidad Farmacol, E-43201 Reus, Spain; [Pazos, Manuel; Mendez, Lucia; Medina, Isabel] CSIC, IIM, Vigo, Spain; [Miranda, Anibal; Cascante, Marta] Univ Barcelona, Fac Biol, IBUB, Dept Biochem & Mol Biol, Barcelona, Spain; [Miranda, Anibal; Cascante, Marta] Univ Barcelona, Fac Biol, Unit Associated CSIC, Barcelona, Spain; [Miranda, Anibal; Cascante, Marta] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universitat Rovira i Virgili; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Perez-Jimenez, J (corresponding author), CSIC, IQAC, Inst Adv Chem Catalonia, Barcelona, Spain.	jara.perez@ictan.csic.es	CASCANTE, MARTA/AAG-4355-2022; CASCANTE, MARTA/AFK-5991-2022; Pazos, Manuel/N-5007-2014; Méndez, Lucía/T-7016-2017; ROMEU, MARTA/A-8468-2014; ROMEU, MARTA/O-7129-2019; Torres, Josep Lluís/N-7256-2013; Ramos-Romero, Sara/AAH-6209-2020; Perez-Jimenez, Jara/B-3989-2009; Méndez, Lucía/AAA-9264-2020; MEDINA, ISABEL/AAL-4012-2021; Ramos-Romero, Sara/K-8301-2017	CASCANTE, MARTA/0000-0002-2062-4633; CASCANTE, MARTA/0000-0002-2062-4633; Pazos, Manuel/0000-0003-1571-5730; Méndez, Lucía/0000-0002-9711-2994; ROMEU, MARTA/0000-0002-2131-1858; ROMEU, MARTA/0000-0002-2131-1858; Torres, Josep Lluís/0000-0002-5072-8265; Perez-Jimenez, Jara/0000-0002-2811-4558; Méndez, Lucía/0000-0002-9711-2994; Ramos-Romero, Sara/0000-0002-9293-4454; Taltavull, Nuria/0000-0002-3340-2650; MEDINA, ISABEL/0000-0002-1854-3359	Spanish Ministries of Science and Innovation and of Economy and Competitiveness [AGL2009-12374-C03-01, AGL2009-12374-C03-02, AGL2009-12374-C03-03, AGL2013-49079-C2-1-R, AGL2013-49079-C2-2-R]; Generalitat de Catalunya regional authorities [2009SGR-1308]; European Union [FP7-KBBE-222639]; ICREA Foundation of the Generalitat de Catalunya; Panamanian Government (SENACYT/IFRHU); Spanish Ministry of Science and Innovation; ISCIII; Xunta de Galicia [CD09/00068]	Spanish Ministries of Science and Innovation and of Economy and Competitiveness; Generalitat de Catalunya regional authorities; European Union(European Commission); ICREA Foundation of the Generalitat de Catalunya(ICREA); Panamanian Government (SENACYT/IFRHU); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII(Instituto de Salud Carlos III); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This research was supported by the Spanish Ministries of Science and Innovation and of Economy and Competitiveness (Grants AGL2009-12374-C03-01, -02 and -03; AGL2013-49079-C2-1,2-R; respectively) and in part by the Generalitat de Catalunya regional authorities (2009SGR-1308). M. C. acknowledges ETHERPATHS (FP7-KBBE-222639) funded by the European Union and "ICREA Academia'' award for excellence in research, funded by the ICREA Foundation of the Generalitat de Catalunya. The Panamanian Government (SENACYT/IFRHU) and the Spanish Ministry of Science and Innovation awarded graduate fellowships to E. M.-T. and L. M., respectively. The ISCIII and the Xunta de Galicia are also acknowledged for "Sara Borrell'' and "Isidro Parga Pondal'' postdoctoral contracts to J.P.-J. (CD09/00068) and M. P., respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Armutcu F, 2008, CLIN CHEM LAB MED, V46, P785, DOI 10.1515/CCLM.2008.166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buege J A, 1978, Methods Enzymol, V52, P302; BUNAG RD, 1973, J APPL PHYSIOL, V34, P279, DOI 10.1152/jappl.1973.34.2.279; Cao GH, 1998, AM J CLIN NUTR, V68, P1081, DOI 10.1093/ajcn/68.5.1081; Castell-Auvi A, 2012, J NUTR BIOCHEM, V23, P1565, DOI 10.1016/j.jnutbio.2011.10.010; Chaudhuri AR, 2006, MECH AGEING DEV, V127, P849, DOI 10.1016/j.mad.2006.08.006; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; COHEN G, 1970, ANAL BIOCHEM, V34, P30, DOI 10.1016/0003-2697(70)90083-7; Drabkin DL, 1935, J BIOL CHEM, V112, P51; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Ernsberger P, 1999, ANN NY ACAD SCI, V892, P315, DOI 10.1111/j.1749-6632.1999.tb07806.x; Ernsberger Paul, 2012, GLUCOSE TOLERANCE; Fellmann L, 2013, PHARMACOL THERAPEUT, V137, P331, DOI 10.1016/j.pharmthera.2012.11.004; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Goldberg DM., 1983, METHODS ENZYM ANAL, V3, P258, DOI DOI 10.1016/B978-0-12-091302-2.X5001-4; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Guclu F, 2004, BIOMED PHARMACOTHER, V58, P614, DOI 10.1016/j.biopha.2004.09.005; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Imig JD, 2012, EXP BIOL MED, V237, P1402, DOI 10.1258/ebm.2012.012225; Ishizuka T, 1998, J NUTR, V128, P2299, DOI 10.1093/jn/128.12.2299; Kimura T, 2007, J AGR FOOD CHEM, V55, P5869, DOI 10.1021/jf062680g; KOLETSKY S, 1973, EXP MOL PATHOL, V19, P53, DOI 10.1016/0014-4800(73)90040-3; KOLETSKY S, 1975, AM J PATHOL, V81, P463; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mendez L, 2014, J PROTEOMICS, V106, P246, DOI 10.1016/j.jprot.2014.04.036; Mendez L, 2013, FREE RADICAL BIO MED, V55, P8, DOI 10.1016/j.freeradbiomed.2012.11.004; Mendizabal Y, 2013, LIFE SCI, V93, P1023, DOI 10.1016/j.lfs.2013.10.021; Mendizabal Y, 2011, AM J PHYSIOL-HEART C, V301, pH1319, DOI 10.1152/ajpheart.01280.2010; Milne GL, 2007, NAT PROTOC, V2, P221, DOI 10.1038/nprot.2006.375; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Papazzo A, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-98; Poudyal H, 2010, BRIT J NUTR, V104, P1322, DOI 10.1017/S0007114510002308; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Takaya K, 1996, NAT GENET, V14, P130, DOI 10.1038/ng1096-130; WHEELER CR, 1990, ANAL BIOCHEM, V184, P193, DOI 10.1016/0003-2697(90)90668-Y; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	44	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104637	10.1371/journal.pone.0104637	http://dx.doi.org/10.1371/journal.pone.0104637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115868	Green Published, gold			2022-12-27	WOS:000341230400064
J	Hanawa, K; Ito, K; Aizawa, K; Shindo, T; Nishimiya, K; Hasebe, Y; Tuburaya, R; Hasegawa, H; Yasuda, S; Kanai, H; Shimokawa, H				Hanawa, Kenichiro; Ito, Kenta; Aizawa, Kentaro; Shindo, Tomohiko; Nishimiya, Kensuke; Hasebe, Yuhi; Tuburaya, Ryuji; Hasegawa, Hideyuki; Yasuda, Satoshi; Kanai, Hiroshi; Shimokawa, Hiroaki			Low-Intensity Pulsed Ultrasound Induces Angiogenesis and Ameliorates Left Ventricular Dysfunction in a Porcine Model of Chronic Myocardial Ischemia	PLOS ONE			English	Article							SHOCK-WAVE THERAPY; CORONARY-ARTERY-DISEASE; PIGS IN-VIVO; ENDOTHELIAL-CELLS; SHEAR-STRESS; STIMULATION; IMPROVES; SWINE	Background: Although a significant progress has been made in the management of ischemic heart disease (IHD), the number of severe IHD patients is increasing. Thus, it is crucial to develop new, non-invasive therapeutic strategies. In the present study, we aimed to develop low-intensity pulsed ultrasound (LIPUS) therapy for the treatment of IHD. Methods and Results: We first confirmed that in cultured human endothelial cells, LIPUS significantly up-regulated mRNA expression of vascular endothelial growth factor (VEGF) with a peak at 32-cycle (P < 0.05). Then, we examined the in vivo effects of LIPUS in a porcine model of chronic myocardial ischemia with reduced left ventricular ejection fraction (LVEF) (n = 28). The heart was treated with either sham (n = 14) or LIPUS (32-cycle with 193 mW/cm(2) for 20 min, n = 14) at 3 different short axis levels. Four weeks after the treatment, LVEF was significantly improved in the LIPUS group (46 +/- 4 to 57 +/- 5%, P < 0.05) without any adverse effects, whereas it remained unchanged in the sham group (46 +/- 5 to 47 +/- 6%, P = 0.33). Capillary density in the ischemic region was significantly increased in the LIPUS group compared with the control group (1084 +/- 175 vs. 858 +/- 151/mm(2), P < 0.05). Regional myocardial blood flow was also significantly improved in the LIPUS group (0.78 +/- 0.2 to 1.39 +/- 0.4 ml/min/g, P < 0.05), but not in the control group (0.84 +/- 0.3 to 0.97 +/- 0.4 ml/min/g). Western blot analysis showed that VEGF, eNOS and bFGF were all significantly up-regulated only in the LIPUS group. Conclusions: These results suggest that the LIPUS therapy is promising as a new, non-invasive therapy for IHD.	[Hanawa, Kenichiro; Ito, Kenta; Aizawa, Kentaro; Shindo, Tomohiko; Nishimiya, Kensuke; Hasebe, Yuhi; Tuburaya, Ryuji; Shimokawa, Hiroaki] Tohoku Univ Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi, Japan; [Hasegawa, Hideyuki; Kanai, Hiroshi] Tohoku Univ, Grad Sch Biomed Engn, Div Biomed Measurements & Diagnost, Sendai, Miyagi 980, Japan; [Hasegawa, Hideyuki; Kanai, Hiroshi] Tohoku Univ, Dept Elect Engn, Grad Sch Engn, Sendai, Miyagi 980, Japan; [Yasuda, Satoshi] Natl Cerebral & Cardiovasc Ctr, Osaka, Japan	Tohoku University; Tohoku University; Tohoku University; National Cerebral & Cardiovascular Center - Japan	Shimokawa, H (corresponding author), Tohoku Univ Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi, Japan.	shimo@cardio.med.tohoku.ac.jp	Ito, Kenta/AAX-4906-2020	Ito, Kenta/0000-0002-9725-399X; Kanai, Hiroshi/0000-0002-6567-1687; Shimokawa, Hiroaki/0000-0001-7534-4826	Special Funds for Education and Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan; Regional Innovation Strategy Support Program	Special Funds for Education and Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan; Regional Innovation Strategy Support Program	This study was supported in part by the Grant-in-Aid (Regional Innovation Strategy Support Program) and the Special Funds for Education and Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzelai S, 2006, ULTRASOUND MED BIOL, V32, P139, DOI 10.1016/j.ultrasmedbio.2005.08.010; Bir SC, 2012, CARDIOVASC RES, V95, P7, DOI 10.1093/cvr/cvs143; Fu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024342; Fukumoto Y, 2006, CORONARY ARTERY DIS, V17, P63, DOI 10.1097/00019501-200602000-00011; Garin G, 2005, CIRC RES, V97, P955, DOI 10.1161/01.RES.0000193566.65262.d8; Hassan MA, 2010, DRUG DISCOV TODAY, V15, P892, DOI 10.1016/j.drudis.2010.08.005; Hata J, 2013, CIRC J, V77, P1923, DOI 10.1253/circj.CJ-13-0786; Hayashi D, 2012, WOUND REPAIR REGEN, V20, P887, DOI 10.1111/j.1524-475X.2012.00851.x; Ito K, 2011, AM J CARDIOVASC DRUG, V11, P295, DOI 10.2165/11592760-000000000-00000; Ito K, 2009, TOHOKU J EXP MED, V219, P1, DOI 10.1620/tjem.219.1; Ito Y, 2010, CORONARY ARTERY DIS, V21, P304, DOI 10.1097/MCA.0b013e32833aec62; Kikuchi Y, 2010, CIRC J, V74, P589, DOI 10.1253/circj.CJ-09-1028; Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154; Mizrahi N, 2007, ULTRASOUND MED BIOL, V33, P1818, DOI 10.1016/j.ultrasmedbio.2007.05.007; Nakamura T, 2011, ANN BIOMED ENG, V39, P2964, DOI 10.1007/s10439-011-0408-0; Nishida T, 2004, CIRCULATION, V110, P3055, DOI 10.1161/01.CIR.0000148849.51177.97; O'Konski M S, 1987, Am J Cardiovasc Pathol, V1, P69; Prinzen FW, 2000, CARDIOVASC RES, V45, P13, DOI 10.1016/S0008-6363(99)00252-7; Przybylski M, 2009, J Wound Care, V18, P516; Ramli R, 2009, INT J ORAL MAX IMPL, V24, P591; Reher P, 1999, CYTOKINE, V11, P416, DOI 10.1006/cyto.1998.0444; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; ROTH DM, 1987, AM J PHYSIOL, V253, pH1279, DOI 10.1152/ajpheart.1987.253.5.H1279; Ruff CT, 2011, NAT REV CARDIOL, V8, P140, DOI 10.1038/nrcardio.2010.199; Serizawa F, 2011, EUR J VASC ENDOVASC, V42, P254, DOI 10.1016/j.ejvs.2011.02.029; Serizawa F, 2012, CIRC J, V76, P1486, DOI 10.1253/circj.CJ-11-1216; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; ter Haar G, 2007, PROG BIOPHYS MOL BIO, V93, P111, DOI 10.1016/j.pbiomolbio.2006.07.005; Toyama Y, 2012, CARDIOVASC RES, V95, P448, DOI 10.1093/cvr/cvs173; Uwatoku T, 2007, CORONARY ARTERY DIS, V18, P397, DOI 10.1097/MCA.0b013e328089f19b; WEAVER ME, 1986, CARDIOVASC RES, V20, P907, DOI 10.1093/cvr/20.12.907; Xu P, 2012, BIOTECHNOL LETT, V34, P1965, DOI 10.1007/s10529-012-0984-6; Yamaya S, 2014, J NEUROSURG IN PRESS; Yu J, 2006, J CLIN INVEST, V116, P1284, DOI 10.1172/JCI27100; Zaragoza C, 2012, CURR OPIN LIPIDOL, V23, P446, DOI 10.1097/MOL.0b013e328357e837; Zhang M, 2014, CARDIOVASC RES, V102, P249, DOI 10.1093/cvr/cvu050; 2006, CIRC J, V70, P1256	37	59	69	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104863	10.1371/journal.pone.0104863	http://dx.doi.org/10.1371/journal.pone.0104863			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111309	Green Published, gold			2022-12-27	WOS:000341105100108
J	Mainguy, V; Malenfant, S; Neyron, AS; Saey, D; Maltais, F; Bonnet, S; Provencher, S				Mainguy, Vincent; Malenfant, Simon; Neyron, Anne-Sophie; Saey, Didier; Maltais, Francois; Bonnet, Sebastien; Provencher, Steeve			Alternatives to the Six-Minute Walk Test in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							MUSCLE DYSFUNCTION; EXERCISE; TREADMILL; REPEATABILITY; VENTILATION; RESPONSES; CAPACITY; SURVIVAL	Introduction: The physiological response during the endurance shuttle walk test (ESWT), the cycle endurance test (CET) and the incremental shuttle walk test (ISWT) remains unknown in PAH. We tested the hypothesis that endurance tests induce a near-maximal physiological demand comparable to incremental tests. We also hypothesized that differences in respiratory response during exercise would be related to the characteristics of the exercise tests. Methods: Within two weeks, twenty-one PAH patients (mean age: 54(15) years; mean pulmonary arterial pressure: 42(12) mmHg) completed two cycling exercise tests (incremental cardiopulmonary cycling exercise test (CPET) and CET) and three field tests (ISWT, ESWT and six-minute walk test (6MWT)). Physiological parameters were continuously monitored using the same portable telemetric device. Results: Peak oxygen consumption (VO2peak) was similar amongst the five exercise tests (p = 0.90 by ANOVA). Walking distance correlated markedly with the VO2peak reached during field tests, especially when weight was taken into account. At 100% exercise, most physiological parameters were similar between incremental and endurance tests. However, the trends overtime differed. In the incremental tests, slopes for these parameters rose steadily over the entire duration of the tests, whereas in the endurance tests, slopes rose sharply from baseline to 25% of maximum exercise at which point they appeared far less steep until test end. Moreover, cycling exercise tests induced higher respiratory exchange ratio, ventilatory demand and enhanced leg fatigue measured subjectively and objectively. Conclusion: Endurance tests induce a maximal physiological demand in PAH. Differences in peak respiratory response during exercise are related to the modality (cycling vs. walking) rather than the progression (endurance vs. incremental) of the exercise tests.	[Mainguy, Vincent; Malenfant, Simon; Neyron, Anne-Sophie; Saey, Didier; Maltais, Francois; Bonnet, Sebastien; Provencher, Steeve] Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Pulm Hypertens Res Grp, Quebec City, PQ, Canada	Laval University	Provencher, S (corresponding author), Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Pulm Hypertens Res Grp, Quebec City, PQ, Canada.	steve.provencher@criucpq.ulaval.ca	Saey, Didier/F-7963-2014; Malenfant, Simon/AAQ-5587-2020	Malenfant, Simon/0000-0002-3911-3702	Fonds de recherche du Quebec-Sante (FRQS)	Fonds de recherche du Quebec-Sante (FRQS)	Financial support was provided by Fonds de recherche du Quebec-Sante (FRQS). The FRQS was not otherwise involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Casas A, 2005, CHEST, V128, P55, DOI 10.1378/chest.128.1.55; CASEY K, 1987, J PHYSIOL-LONDON, V391, P13, DOI 10.1113/jphysiol.1987.sp016722; Chuang ML, 2001, RESP MED, V95, P618, DOI 10.1053/rmed.2001.1115; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; DALONZO GE, 1987, CHEST, V92, P57, DOI 10.1378/chest.92.1.57; Deboeck G, 2005, EUR RESPIR J, V26, P667, DOI 10.1183/09031936.05.00031505; Dyer CAE, 2002, THORAX, V57, P34, DOI 10.1136/thorax.57.1.34; Eaton T, 2006, Chron Respir Dis, V3, P3, DOI 10.1191/1479972306cd077oa; Eiser N, 2003, RESP MED, V97, P407, DOI 10.1053/rmed.2002.1462; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384, DOI 10.1164/ajrccm.158.5.9710086; Galie N, 2009, EUR HEART J, V30, P394, DOI 10.1093/eurheartj/ehp022; Groepenhoff H, 2008, MED SCI SPORT EXER, V40, P1725, DOI 10.1249/MSS.0b013e31817c92c0; GUYATT GH, 1984, THORAX, V39, P818, DOI 10.1136/thx.39.11.818; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; KELSEY CJ, 1992, EUR J APPL PHYSIOL, V65, P480, DOI 10.1007/BF00243518; Mainguy V, 2013, EUR RESPIR J, V42, P425, DOI 10.1183/09031936.00107012; Mainguy V, 2010, THORAX, V65, P113, DOI 10.1136/thx.2009.117168; McGoon M, 2004, CHEST, V126, p14S, DOI 10.1378/chest.126.1_suppl.14S; Meyer FJ, 2005, EUR RESPIR J, V25, P125, DOI 10.1183/09031936.04.00095804; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; PAGE E, 1994, CHEST, V106, P1002, DOI 10.1378/chest.106.4.1002; Palange P, 2000, J APPL PHYSIOL, V88, P1715, DOI 10.1152/jappl.2000.88.5.1715; Potus F, 2014, AM J RESP CRIT CARE; Revill SM, 1999, THORAX, V54, P213, DOI 10.1136/thx.54.3.213; Riley MS, 2000, EUR J APPL PHYSIOL, V83, P63, DOI 10.1007/s004210000240; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; Saey D, 2003, AM J RESP CRIT CARE, V168, P425, DOI 10.1164/rccm.200208-856OC; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; Sun XG, 2001, CIRCULATION, V104, P429, DOI 10.1161/hc2901.093198; TAKANO N, 1988, J PHYSIOL-LONDON, V396, P389, DOI 10.1113/jphysiol.1988.sp016968; Tolle J, 2008, MED SCI SPORT EXER, V40, P3, DOI 10.1249/mss.0b013e318159d1b8; Valli G, 2007, EUR J APPL PHYSL; Verkindre C, 2006, RESPIRATION, V73, P420, DOI 10.1159/000089655; Wensel R, 2002, CIRCULATION, V106, P319, DOI 10.1161/01.CIR.0000022687.18568.2A	37	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e103626	10.1371/journal.pone.0103626	http://dx.doi.org/10.1371/journal.pone.0103626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111294	Green Submitted, Green Published, gold			2022-12-27	WOS:000341105100017
J	Murugan, R				Murugan, Rajamanickam			Theory on the Dynamics of Oscillatory Loops in the Transcription Factor Networks	PLOS ONE			English	Article							NEGATIVE FEEDBACK; RESPONSE-TIMES; GENE; FLUCTUATIONS; ROBUST; DELAY	We develop a detailed theoretical framework for various types of transcription factor gene oscillators. We further demonstrate that one can build genetic-oscillators which are tunable and robust against perturbations in the critical control parameters by coupling two or more independent Goodwin-Griffith oscillators through either -OR- or -AND- type logic. Most of the coupled oscillators constructed in the literature so far seem to be of -OR- type. When there are transient perturbations in one of the -OR- type coupled-oscillators, then the overall period of the system remains constant (period-buffering) whereas in case of -AND- type coupling the overall period of the system moves towards the perturbed oscillator. Though there is a period-buffering, the amplitudes of oscillators coupled through -OR- type logic are more sensitive to perturbations in the parameters associated with the promoter state dynamics than -AND- type. Further analysis shows that the period of -AND- type coupled dual-feedback oscillators can be tuned without conceding on the amplitudes. Using these results we derive the basic design principles governing the robust and tunable synthetic gene oscillators without compromising on their amplitudes.	Indian Inst Technol, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Chennai 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Murugan, R (corresponding author), Indian Inst Technol, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Chennai 600036, Tamil Nadu, India.	rmurugan@gmail.com	Murugan, Rajamanickam/A-9700-2008	Murugan, Rajamanickam/0000-0002-5454-3540				ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; ALON U, 2006, INTRO SYSTEMS BIOL; Amir A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100113; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fall CP., 2002, COMPUTATIONAL CELL B; Forger DB, 2005, P NATL ACAD SCI USA, V102, P321, DOI 10.1073/pnas.0408465102; Francois P, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031908; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; Guantes R, 2006, PLOS COMPUT BIOL, V2, P188, DOI 10.1371/journal.pcbi.0020030; Lewin B., 2004, GENES; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; MONOD J, 1952, BIOCHIM BIOPHYS ACTA, V9, P648, DOI 10.1016/0006-3002(52)90227-8; Murugan R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011901; Murugan R, 2010, BIOPHYS J, V99, P353, DOI 10.1016/j.bpj.2010.04.026; Murugan R, 2010, J PHYS A, V43; Murugan R, 2010, J PHYS A, V43; Murugan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041027; Murugan R, 2011, BIOPHYS J, V101, P1297, DOI 10.1016/j.bpj.2011.08.005; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Press W.H., 2007, NUMERICAL RECIPES C, V3rd; PTASHNE M, 2002, GENES SIGNALS; Purcell O, 2010, J R SOC INTERFACE, V7, P1503, DOI 10.1098/rsif.2010.0183; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Routh E., 1877, TREATISE STABILITY M; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Shahrezaei V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.31; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Smolen P, 2002, BIOPHYS J, V83, P2349, DOI 10.1016/S0006-3495(02)75249-1; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Strogatz S., 2000, NONLINEAR DYNAMICS C; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tyson JJ, 2008, J R SOC INTERFACE, V5, pS1, DOI 10.1098/rsif.2008.0179.focus; Wagner R, 2000, TRANSCRIPTION REGULA	42	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104328	10.1371/journal.pone.0104328	http://dx.doi.org/10.1371/journal.pone.0104328			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111803	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100049
J	Scholz, CFP; Jensen, A; Lomholt, HB; Bruggemann, H; Kilian, M				Scholz, Christian F. P.; Jensen, Anders; Lomholt, Hans B.; Brueggemann, Holger; Kilian, Mogens			A Novel High-Resolution Single Locus Sequence Typing Scheme for Mixed Populations of Propionibacterium acnes In Vivo	PLOS ONE			English	Article							INFECTION; DIVERSITY; TISSUE	The Gram-positive anaerobic bacterium Propionibacterium acnes is a prevalent member of the normal skin microbiota of human adults. In addition to its suspected role in acne vulgaris it is involved in a variety of opportunistic infections. Multi-locus sequence-typing (MLST) schemes identified distinct phylotypes associated with health and disease. Being based on 8 to 9 house-keeping genes these MLST schemes have a high discriminatory power, but their application is time-and cost-intensive. Here we describe a single-locus sequence typing (SLST) scheme for P. acnes. The target locus was identified with a genome mining approach that took advantage of the availability of representative genome sequences of all known phylotypes of P. acnes. We applied this SLST on a collection of 188 P. acnes strains and demonstrated a resolution comparable to that of existing MLST schemes. Phylogenetic analysis applied to the SLST locus resulted in clustering patterns identical to a reference tree based on core genome sequences. We further demonstrate that SLST can be applied to detect multiple phylotypes in complex microbial communities by a metagenomic pyrosequencing approach. The described SLST strategy may be applied to any bacterial species with a basically clonal population structure to achieve easy typing and mapping of multiple phylotypes in complex microbiotas.	[Scholz, Christian F. P.; Jensen, Anders; Lomholt, Hans B.; Brueggemann, Holger; Kilian, Mogens] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University	Scholz, CFP (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	christian.scholz@microbiology.au.dk	Scholz, Christian Brink/H-4463-2019; Jensen, Anders/B-1968-2016; Scholz, Christian/F-4499-2012	Scholz, Christian Brink/0000-0002-8894-1782; Jensen, Anders/0000-0003-1185-3343; Scholz, Christian/0000-0002-8894-1782; Bruggemann, Holger/0000-0001-7433-0190; Kilian, Mogens/0000-0002-5861-0472	Danish Medical Research council [DFF-1331-00241]; Aarhus University Health Faculty	Danish Medical Research council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Aarhus University Health Faculty	This study was supported by grant # DFF-1331-00241 to HB from the Danish Medical Research council and by an Aarhus University Health Faculty PhD stipend to CFPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert HB, 2013, EUR SPINE J, V22, P690, DOI 10.1007/s00586-013-2674-z; Alexeyev OA, 2007, J CLIN MICROBIOL, V45, P3721, DOI 10.1128/JCM.01543-07; Bek-Thomsen M, 2008, J CLIN MICROBIOL, V46, P3355, DOI 10.1128/JCM.00799-08; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CAUGANT DA, 1981, GENETICS, V98, P467; Dessinioti C, 2010, CLIN DERMATOL, V28, P2, DOI 10.1016/j.clindermatol.2009.03.012; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fehri LF, 2011, INT J MED MICROBIOL, V301, P69, DOI 10.1016/j.ijmm.2010.08.014; Fitz-Gibbon S, 2013, J INVEST DERMATOL, V133, P2152, DOI 10.1038/jid.2013.21; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hohwy J, 2001, INFECT IMMUN, V69, P6055, DOI 10.1128/IAI.69.10.6055-6063.2001; Holland C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-230; Kilian M, 2012, J CLIN MICROBIOL, V50, P1158, DOI 10.1128/JCM.r06129-11; LAUNDER WJ, 1981, CLIN ORTHOP RELAT R, P170; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Mak TN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-640; McDowell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070897; McDowell A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041480; McDowell A, 2011, MICROBIOL-SGM, V157, P1990, DOI 10.1099/mic.0.049676-0; Niazi SA, 2010, J CLIN MICROBIOL, V48, P3859, DOI 10.1128/JCM.01326-10; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/ERI.11.137, 10.1586/eri.11.137]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shaheen B, 2011, BRIT J DERMATOL, V165, P474, DOI 10.1111/j.1365-2133.2011.10375.x; Shirodkar AR, 2012, AM J OPHTHALMOL, V153, P391, DOI 10.1016/j.ajo.2011.08.029; Sperling JW, 2001, CLIN ORTHOP RELAT R, P206, DOI 10.1097/00003086-200101000-00028; Stirling A, 2001, LANCET, V357, P2024, DOI 10.1016/S0140-6736(00)05109-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomida S, 2013, MBIO, V4, DOI 10.1128/mBio.00003-13; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; Williams HC, 2012, LANCET, V379, P361, DOI 10.1016/S0140-6736(11)60321-8	32	88	98	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104199	10.1371/journal.pone.0104199	http://dx.doi.org/10.1371/journal.pone.0104199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111794	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100036
J	Bjerknes, S; Skogseid, IM; Saehle, T; Dietrichs, E; Toft, M				Bjerknes, Silje; Skogseid, Inger Marie; Saehle, Terje; Dietrichs, Espen; Toft, Mathias			Surgical Site Infections after Deep Brain Stimulation Surgery: Frequency, Characteristics and Management in a 10-Year Period	PLOS ONE			English	Article							HARDWARE-RELATED INFECTIONS; SMALL-COLONY VARIANTS; OF-THE-LITERATURE; STAPHYLOCOCCUS-AUREUS; SINGLE-CENTER; DEVICE INFECTIONS; BIOFILM; COMPLICATIONS; IMPLANTATION; EFFICACY	Background/Aims: Deep brain stimulation (DBS) implant infection is a feared complication, as it is difficult to manage and leads to increased patient morbidity. We wanted to assess the frequency and possible risk factors of DBS related infections at our centre. In the purpose of evaluating treatment options, we also analyzed treatment, and the clinical and microbiological characteristics of the infections. Methods: Electronic medical records of all patients undergoing DBS surgery at our centre, from 2001 through 2010, were retrospectively reviewed. Results: Of the 588 procedures performed 33 (5.6%) led to an infection. Some patients underwent several procedures, thus 32 out of totally 368 patients (8.7%), and 19 out of 285 patients (6.7%) who received primary lead implantation, developed an infection. Most infections (52%) developed within the first month and 79% within three months. In the majority of the infections (79%) hardware removal was performed. Staphylococcus aureus infections were the most frequent (36%), and more likely to have earlier onset, pus formation, a more aggressive development and lead to hardware removal. No risk factors were identified. Conclusions: Our results indicate that infections with more severe symptoms and growth of staphylococcus aureus should be treated with local hardware removal and antibiotic therapy. In other infections, an initial trial of antibiotic treatment could be considered. New knowledge about the microbiology of DBS related infections may lead to more effective antimicrobial treatment.	[Bjerknes, Silje; Skogseid, Inger Marie; Dietrichs, Espen; Toft, Mathias] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Saehle, Terje] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Dietrichs, Espen] Univ Oslo, Fac Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Bjerknes, S (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	sbbjsk@ous-hf.no	Dietrichs, Espen/AAB-4573-2021; Toft, Mathias/AAY-5212-2021	Bjerknes, Silje/0000-0003-2672-2397; Saehle, Terje/0000-0003-0518-0357; Toft, Mathias/0000-0002-6723-6865	Research Council of Norway; South-Eastern Norway Regional Health Authority	Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	The study has been supported by the Research Council of Norway (http://www.forskningsradet.no/en/Home_page/1177315753906) and the South-Eastern Norway Regional Health Authority (http://www.helse-sorost.no/fagfolk/forskning/Sider/side.aspx?utm_source=alias&utm_medium=url&utm_campaig = nhn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RJ, 2012, NEUROSCI BIOBEHAV R, V36, P1920, DOI 10.1016/j.neubiorev.2012.06.001; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Bhatia R, 2011, BRIT J NEUROSURG, V25, P625, DOI 10.3109/02688697.2011.566384; Bhatia S, 2010, STEREOT FUNCT NEUROS, V88, P147, DOI 10.1159/000303528; Blomstedt P, 2012, STEREOT FUNCT NEUROS, V90, P92, DOI 10.1159/000335712; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Brooks JL, 2012, ADV APPL MICROBIOL, V81, P63, DOI 10.1016/B978-0-12-394382-8.00002-2; Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062, DOI 10.1177/039139880502801103; Cutting K, 1994, Nurs Times, V90, P62; Cutting K, 1994, NURS TIMES, V90, P62; Cutting Keith F, 2004, Br J Community Nurs, V9, pS6; Elstrom P, 2012, J HOSP INFECT, V80, P36, DOI 10.1016/j.jhin.2011.10.004; Falowski S, 2012, STEREOT FUNCT NEUROS, V90, P173, DOI 10.1159/000338254; Fenoy AJ, 2012, J NEUROSURG, V116, P1324, DOI 10.3171/2012.1.JNS111798; Gandhi T, 2012, INFECT DIS CLIN N AM, V26, P57, DOI 10.1016/j.idc.2011.09.001; Gorgulho A, 2009, J NEUROSURG, V110, P239, DOI 10.3171/2008.6.17603; Kiedrowski MR, 2011, ANN NY ACAD SCI, V1241, P104, DOI 10.1111/j.1749-6632.2011.06281.x; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Pepper J, 2013, STEREOT FUNCT NEUROS, V91, P56, DOI 10.1159/000343202; Piacentino M, 2011, ACTA NEUROCHIR, V153, P2337, DOI 10.1007/s00701-011-1130-2; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Sillay KA, 2008, NEUROSURGERY, V62, P360, DOI 10.1227/01.neu.0000316002.03765.33; Skogseid IM, 2012, EUR J NEUROL, V19, P610, DOI 10.1111/j.1468-1331.2011.03591.x; Stenehjem E, 2012, INFECT DIS CLIN N AM, V26, P89, DOI 10.1016/j.idc.2011.09.006; Taghva AS, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.10.068; Thompson A, 2012, INT REV NEUROBIOL, V107, P253, DOI 10.1016/B978-0-12-404706-8.00014-0; Toba FA, 2011, J THORAC CARDIOV SUR, V141, P1259, DOI 10.1016/j.jtcvs.2010.07.016; Toft M, 2011, MOVEMENT DISORD, V26, P1931, DOI 10.1002/mds.23817; Voges J, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.081232; Von Eiff C, 2007, INT J ARTIF ORGANS, V30, P778, DOI 10.1177/039139880703000906; von Eiff C, 2008, INT J ANTIMICROB AG, V31, P507, DOI 10.1016/j.ijantimicag.2007.10.026	31	89	89	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105288	10.1371/journal.pone.0105288	http://dx.doi.org/10.1371/journal.pone.0105288			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122445	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000111
J	Hillary, FG; Rajtmajer, SM; Roman, CA; Medaglia, JD; Slocomb-Dluzen, JE; Calhoun, VD; Good, DC; Wylie, GR				Hillary, Frank G.; Rajtmajer, Sarah M.; Roman, Cristina A.; Medaglia, John D.; Slocomb-Dluzen, Julia E.; Calhoun, Vincent D.; Good, David C.; Wylie, Glenn R.			The Rich Get Richer: Brain Injury Elicits Hyperconnectivity in Core Subnetworks	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; WORKING-MEMORY DYSFUNCTION; GRAPH-THEORETICAL ANALYSIS; FUNCTIONAL MRI DATA; DEFAULT MODE; LOW-FREQUENCY; CONNECTIVITY; NETWORKS; DEFICITS; MILD	There remains much unknown about how large-scale neural networks accommodate neurological disruption, such as moderate and severe traumatic brain injury (TBI). A primary goal in this study was to examine the alterations in network topology occurring during the first year of recovery following TBI. To do so we examined 21 individuals with moderate and severe TBI at 3 and 6 months after resolution of posttraumatic amnesia and 15 age- and education-matched healthy adults using functional MRI and graph theoretical analyses. There were two central hypotheses in this study: 1) physical disruption results in increased functional connectivity, or hyperconnectivity, and 2) hyperconnectivity occurs in regions typically observed to be the most highly connected cortical hubs, or the "rich club". The current findings generally support the hyperconnectivity hypothesis showing that during the first year of recovery after TBI, neural networks show increased connectivity, and this change is disproportionately represented in brain regions belonging to the brain's core subnetworks. The selective increases in connectivity observed here are consistent with the preferential attachment model underlying scale-free network development. This study is the largest of its kind and provides the unique opportunity to examine how neural systems adapt to significant neurological disruption during the first year after injury.	[Hillary, Frank G.; Roman, Cristina A.; Medaglia, John D.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Rajtmajer, Sarah M.] Penn State Univ, Dept Math, University Pk, PA 16802 USA; [Slocomb-Dluzen, Julia E.; Good, David C.] Hershey Med Ctr, Dept Neurol, Hershey, PA USA; [Calhoun, Vincent D.] Mind Res Network, Albuquerque, NM USA; [Wylie, Glenn R.] Kessler Fdn Res Ctr, W Orange, NJ USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Lovelace Respiratory Research Institute; Kessler Institute for Rehabilitation	Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, University Pk, PA 16802 USA.	fhillary@psu.edu; gwylie@kesslerfoundation.org	Hillary, Frank/AAN-8622-2021		New Jersey Commission for Brain Injury Research [09.001.BIR1]; Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania	New Jersey Commission for Brain Injury Research; Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania	This work was funded in part by the New Jersey Commission for Brain Injury Research (09.001.BIR1) and the Social Sciences Research Institute at Pennsylvania State University in University Park, Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elseoud A, 2010, HUM BRAIN MAPP, V31, P1207, DOI 10.1002/hbm.20929; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Allen EA, 2012, NEUROIMAGE, V59, P4141, DOI 10.1016/j.neuroimage.2011.10.010; Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; [Anonymous], [No title captured]; Army Individual Test Battery, 1990, MAN DIR SCOR; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Benedict RHB, 2008, MULT SCLER J, V14, P940, DOI 10.1177/1352458508090923; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun Vince D, 2012, IEEE Rev Biomed Eng, V5, P60, DOI 10.1109/RBME.2012.2211076; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Castellanos NP, 2010, BRAIN, V133, P2365, DOI 10.1093/brain/awq174; Cayley A, 1875, BER DTSCH CHEM GES, V8, P1056; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Di Perri C, 2013, NEUROLOGY, V81, P1417, DOI 10.1212/WNL.0b013e3182a43b78; Du Y, 2014, P ORG HUM BRAIN MAPP; English SW, 2013, NEUROCRIT CARE, V18, P131, DOI 10.1007/s12028-012-9748-3; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; GAZZANIGA MS, 1984, BRAIN, V107, P145, DOI 10.1093/brain/107.1.145; GAZZANIGA MS, 1979, BRAIN, V102, P805, DOI 10.1093/brain/102.4.805; Harriger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046497; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hillary FG, 2007, CLIN NEUROPSYCHOL, V21, P58, DOI 10.1080/13854040601064542; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2014, NEUROPSYCHOLOGY; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hillary FG, 2006, HUM BRAIN MAPP, V27, P837, DOI 10.1002/hbm.20226; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; JENSEN AR, 1966, ACTA PSYCHOL, V25, P36, DOI 10.1016/0001-6918(66)90004-7; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Kiviniemi V, 2009, HUM BRAIN MAPP, V30, P3865, DOI 10.1002/hbm.20813; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Lin QH, 2010, HUM BRAIN MAPP, V31, P1076, DOI 10.1002/hbm.20919; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Mantini D, 2011, J NEUROSCI, V31, P12954, DOI 10.1523/JNEUROSCI.2318-11.2011; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCauley SR, 2013, J NEUROTRAUM, V30, P1506, DOI 10.1089/neu.2013.2925; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Micheloyannis S, 2006, NEUROSCI LETT, V402, P273, DOI 10.1016/j.neulet.2006.04.006; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Palacios EM, 2013, JAMA NEUROL, P1; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pouratian Nader, 2003, Neurosurg Focus, V15, pE2; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Reitan RM, 1985, HALSTEAD REITAN NEUR; Scott J., 2000, SOCIAL STRUCTURE, V2nd; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Shimamura M, 2005, NEUROSCIENCE, V131, P87, DOI 10.1016/j.neuroscience.2004.10.041; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Sidlauskaite J, 2014, NEUROIMAGE; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stibick DL, 2001, J NEUROTRAUM, V18, P303, DOI 10.1089/08977150151070955; Strigel RM, 2005, AM J NEURORADIOL, V26, P578; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sylvester J, 1878, NATURE, V17, P284, DOI [10.1038/017284a0, DOI 10.1038/017284A0]; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; TEASDALE G, 1974, LANCET, V2, P81; Trenerry M. R., 1989, PROFESSIONAL MANUAL; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; Vul E, 2012, NEUROIMAGE, V62, P945, DOI 10.1016/j.neuroimage.2012.01.027; Walker WC, 2013, CEPHALALGIA, V33, P998, DOI 10.1177/0333102413482197; Wechsler D, 1997, ADM SCORING MANUAL; Wu HM, 2004, NEUROSURGERY, V55, P1306, DOI 10.1227/01.NEU.0000143028.08719.42; Xu JS, 2013, NEUROIMAGE, V79, P62, DOI 10.1016/j.neuroimage.2013.04.038; Ystad Martin A, 2009, BMC Med Imaging, V9, P17, DOI 10.1186/1471-2342-9-17; Yu QB, 2013, SCHIZOPHR RES, V143, P165, DOI 10.1016/j.schres.2012.11.001; Yu QB, 2011, FRONT SYST NEUROSCI, V5, DOI [10.3389/fnsys.2011.00007, 10.3389/fnsys.2011.00103]	97	92	92	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104021	10.1371/journal.pone.0104021	http://dx.doi.org/10.1371/journal.pone.0104021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121760	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000024
J	Lien, GS; Wu, MS; Bien, MY; Chen, CH; Lin, CH; Chen, BC				Lien, Gi-Shih; Wu, Ming-Shun; Bien, Mauo-Ying; Chen, Chien-Hsin; Lin, Chien-Huang; Chen, Bing-Chang			Epidermal Growth Factor Stimulates Nuclear Factor-kappa B Activation and Heme Oxygenase-1 Expression via c-Src, NADPH Oxidase, PI3K, and Akt in Human Colon Cancer Cells	PLOS ONE			English	Article							LUNG EPITHELIAL-CELLS; COLORECTAL-CANCER; REACTIVE OXYGEN; ENDOTHELIAL-CELLS; FACTOR RECEPTOR; TRANSCRIPTION FACTOR; MEDIATED APOPTOSIS; GENE-EXPRESSION; PATHWAYS; KINASE	Previous report showed that epidermal growth factor (EGF) promotes tumor progression. Several studies demonstrated that growth factors can induce heme oxygenase (HO)-1 expression, protect against cellular injury and cancer cell proliferation. In this study, we investigated the involvement of the c-Src, NADPH oxidase, reactive oxygen species (ROS), PI3K/Akt, and NF-kappa B signaling pathways in EGF-induced HO-1 expression in human HT-29 colon cancer cells. Treatment of HT-29 cells with EGF caused HO-1 to be expressed in concentration-and time-dependent manners. Treatment of HT-29 cells with AG1478 (an EGF receptor (EGFR) inhibitor), small interfering RNA of EGFR (EGFR siRNA), a dominant negative mutant of c-Src (c-Src DN), DPI (an NADPH oxidase inhibitor), glutathione (an ROS inhibitor), LY294002 (a PI3K inhibitor), and an Akt DN inhibited EGF-induced HO-1 expression. Stimulation of cells with EGF caused an increase in c-Src phosphorylation at Tyr406 in a time-dependent manner. Treatment of HT-29 cells with EGF induced an increase in p47(phox) translocation from the cytosol to membranes. The EGF-induced ROS production was inhibited by DPI. Stimulation of cells with EGF resulted in an increase in Akt phosphorylation at Ser473, which was inhibited by c-Src DN, DPI, and LY 294002. Moreover, treatment of HT-29 cells with a dominant negative mutant of I kappa B (I kappa B alpha M) inhibited EGF-induced HO-1 expression. Stimulation of cells with EGF induced p65 translocation from the cytosol to nuclei. Treatment of HT-29 cells with EGF induced an increase in kappa B-luciferase activity, which was inhibited by a c-Src DN, LY 294002, and an Akt DN. Furthermore, EGF-induced colon cancer cell proliferation was inhibited by Sn(IV) protoporphyrin-IX (snPP, an HO-1 inhibitor). Taken together, these results suggest that the c-Src, NADPH oxidase, PI3K, and Akt signaling pathways play important roles in EGF-induced NF-kappa B activation and HO-1 expression in HT-29 cells. Moreover, overexpression of HO-1 mediates EGF-induced colon cancer cell proliferation.	[Lien, Gi-Shih; Wu, Ming-Shun] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Gastroenterol, Taipei, Taiwan; [Wu, Ming-Shun] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Bien, Mauo-Ying; Chen, Bing-Chang] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Bien, Mauo-Ying] Taipei Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Chen, Chien-Hsin] Taipei Med Univ, Wan Fang Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan; [Lin, Chien-Huang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Chen, BC (corresponding author), Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan.	bcchen@tmu.edu.tw		Lin, Chien-Huang/0000-0002-0916-8737	Taipei Medical University-Wan Fang Hospital [101TMU-WFH-02-1, 102TMU-WFH-01-1, 103TMU-WFH-02-1]	Taipei Medical University-Wan Fang Hospital	This study was supported by grants (101TMU-WFH-02-1, 102TMU-WFH-01-1, and 103TMU-WFH-02-1) from Taipei Medical University-Wan Fang Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2003, J CELL BIOCHEM, V90, P1098, DOI 10.1002/jcb.10736; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Becker JC, 2007, SCAND J GASTROENTERO, V42, P852, DOI 10.1080/00365520701192383; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Brady RRW, 2011, CARCINOGENESIS, V32, P1069, DOI 10.1093/carcin/bgr077; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Brunton VG, 1997, ONCOGENE, V14, P283, DOI 10.1038/sj.onc.1200827; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chen JZ, 2014, CLIN COLORECTAL CANC, V13, P5, DOI 10.1016/j.clcc.2013.10.003; Dal-Cim T, 2012, NEUROCHEM INT, V61, P397, DOI 10.1016/j.neuint.2012.05.021; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Feliers D, 2006, AM J PHYSIOL-RENAL, V290, pF927, DOI 10.1152/ajprenal.00331.2005; Furfaro AL, 2013, BIOCHIM BIOPHYS ACTA, V1842, P613; Gialeli C, 2013, INVEST NEW DRUG, V31, P516, DOI 10.1007/s10637-012-9875-x; He MH, 2013, INVEST OPHTH VIS SCI, V54, P4092, DOI 10.1167/iovs.13-12004; Kuroda H, 2010, LUNG CANCER, V67, P31, DOI 10.1016/j.lungcan.2009.03.015; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; LAVROVSKY Y, 1994, P NATL ACAD SCI USA, V91, P5987, DOI 10.1073/pnas.91.13.5987; Lee HY, 2010, INT J ONCOL, V36, P941, DOI 10.3892/ijo_00000573; Lee HJ, 2008, J ORAL PATHOL MED, V37, P278, DOI 10.1111/j.1600-0714.2007.00616.x; Li DY, 2013, INVEST OPHTH VIS SCI, V54, P5661, DOI 10.1167/iovs.13-12473; Li M, 2005, WORLD J GASTROENTERO, V11, P4685, DOI 10.3748/wjg.v11.i30.4685; Lin CC, 2007, EUR J PHARMACOL, V560, P101, DOI 10.1016/j.ejphar.2007.01.025; Lin CH, 2006, J IMMUNOL, V177, P3427, DOI 10.4049/jimmunol.177.5.3427; Liu JF, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3815; MAINES MD, 1986, J BIOL CHEM, V261, P411; Garcia-Martinez JM, 2010, CELL SIGNAL, V22, P415, DOI 10.1016/j.cellsig.2009.10.013; Do MT, 2013, TOXICOL APPL PHARM, V271, P229, DOI 10.1016/j.taap.2013.05.010; Montezano AC, 2008, ARTERIOSCL THROM VAS, V28, P1511, DOI 10.1161/ATVBAHA.108.168021; Park HS, 2004, MOL CELL BIOL, V24, P4384, DOI 10.1128/MCB.24.10.4384-4394.2004; Qi WT, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-219; Ramana KV, 2010, MOL CANCER THER, V9, P813, DOI 10.1158/1535-7163.MCT-09-0795; Regmi SC, 2014, FREE RADICAL BIO MED, V69, P377, DOI 10.1016/j.freeradbiomed.2014.02.003; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P587, DOI 10.1089/15230860260220085; Shih RH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-104; Singh MM, 2012, CANCER-AM CANCER SOC, V118, P3433, DOI 10.1002/cncr.26621; Takeya R, 2003, J BIOL CHEM, V278, P25234, DOI 10.1074/jbc.M212856200; Tesoriere L., 2013, BR J NUTR, P1; Tsai JR, 2012, CELL ONCOL, V35, P461, DOI 10.1007/s13402-012-0105-5; Was H, 2010, CURR DRUG TARGETS, V11, P1551, DOI 10.2174/1389450111009011551; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yarom N, 2011, DISCOV MED, V11, P95; Zheng S, 2013, CELL PHYSIOL BIOCHEM, V32, P972, DOI 10.1159/000354500; Zhou SY, 1997, P NATL ACAD SCI USA, V94, P11345, DOI 10.1073/pnas.94.21.11345	50	43	43	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104891	10.1371/journal.pone.0104891	http://dx.doi.org/10.1371/journal.pone.0104891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122478	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000070
J	Chiou, SY; Wang, RY; Roberts, RE; Wu, YT; Lu, CF; Liao, KK; Yang, YR				Chiou, Shin-Yi; Wang, Ray-Yau; Roberts, R. Edward; Wu, Yu-Te; Lu, Chia-Feng; Liao, Kwong-Kum; Yang, Yea-Ru			Fractional Anisotropy in Corpus Callosum Is Associated with Facilitation of Motor Representation during Ipsilateral Hand Movements	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CEREBRAL WHITE-MATTER; EVOKED-POTENTIALS; VOLUNTARY CONTRACTION; DIFFUSION; CORTEX; MUSCLE; BRAIN; RELIABILITY; MICROSTRUCTURE	Background: Coactivation of primary motor cortex ipsilateral to a unilateral movement (M1(ipsilateral)) has been observed, and the magnitude of activation is influenced by the contracting muscles. It has been suggested that the microstructural integrity of the callosal motor fibers (CMFs) connecting M1 regions may reflect the observed response. However, the association between the structural connectivity of CMFs and functional changes in M1(ipsilateral) remains unclear. The purpose of this study was to investigate the relationship between functional changes within M1(ipsilateral) during unilateral arm or leg movements and the microstructure of the CMFs connecting both homotopic representations (arm or leg). Methods: Transcranial magnetic stimulation was used to assess changes in motor evoked potentials (MEP) in an arm muscle during unilateral movements compared to rest in fifteen healthy adults. Functional magnetic resonance imaging was then used to identify regions of M1 associated with either arm or leg movements. Diffusion-weighted imaging data was acquired to generate CMFs for arm and leg areas using the areas of activation from the functional imaging as seed masks. Individual values of regional fractional anisotropy (FA) of arm and leg CMFs was then calculated by examining the overlap between CMFs and a standard atlas of corpus callosum. Results: The change in the MEP was significantly larger in the arm movement compared to the leg movement. Additionally, regression analysis revealed that FA in the arm CMFs was positively correlated with the change in MEP during arm movement, whereas a negative correlation was observed during the leg movement. However, there was no significant relationship between FA in the leg CMF and the change in MEP during the movements. Conclusions: These findings suggest that individual differences in interhemispheric structural connectivity may be used to explain a homologous muscle-dominant effect within M1(ipsilateral) hand representation during unilateral movement with topographical specificity.	[Chiou, Shin-Yi; Wang, Ray-Yau; Lu, Chia-Feng; Yang, Yea-Ru] Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan; [Roberts, R. Edward] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp Campus, Acad Dept Neurootol, London, England; [Wu, Yu-Te] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Lu, Chia-Feng] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Liao, Kwong-Kum] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan	National Yang Ming Chiao Tung University; Imperial College London; National Yang Ming Chiao Tung University; Taipei City Hospital; Taipei Veterans General Hospital	Yang, YR (corresponding author), Natl Yang Ming Univ, Dept Phys Therapy & Assist Technol, Taipei 112, Taiwan.	yryang@ym.edu.tw		Roberts, Ed/0000-0002-3656-5906	National Science Council [NSC96-2628-B-010-007-MY2]; Brain Research Center of National Yang-Ming University; Ministry of Education, Aim for the Top University Plan of National Yang-Ming University, Taiwan [98A-C-D160]	National Science Council(Ministry of Science and Technology, Taiwan); Brain Research Center of National Yang-Ming University; Ministry of Education, Aim for the Top University Plan of National Yang-Ming University, Taiwan	This project was supported by grants from National Science Council (NSC96-2628-B-010-007-MY2), from Brain Research Center of National Yang-Ming University and from Ministry of Education, Aim for the Top University Plan (98A-C-D160) of National Yang-Ming University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; Chiou SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072231; Chiou SY, 2013, CLIN NEUROPHYSIOL, V124, P1353, DOI 10.1016/j.clinph.2013.02.001; Christie A, 2007, J NEUROSCI METH, V164, P320, DOI 10.1016/j.jneumeth.2007.05.011; Debaere F, 2003, NEUROIMAGE, V19, P764, DOI 10.1016/S1053-8119(03)00148-4; Deutsch GK, 2005, CORTEX, V41, P354, DOI 10.1016/S0010-9452(08)70272-7; Doeltgen SH, 2009, J NEUROSCI METH, V178, P134, DOI 10.1016/j.jneumeth.2008.12.005; Harris-Love ML, 2007, J NEUROPHYSIOL, V97, P2511, DOI 10.1152/jn.01331.2006; HESS CW, 1986, J NEUROL, V233, P83, DOI 10.1007/BF00313852; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hortobagyi T, 2003, J NEUROPHYSIOL, V90, P2451, DOI 10.1152/jn.01001.2002; Hortobagyi T, 2011, MED SCI SPORT EXER, V43, P1188, DOI 10.1249/MSS.0b013e31820a94b8; Hubers A, 2012, BRAIN STIMUL, V5, P297, DOI 10.1016/j.brs.2011.03.008; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Kamen G, 2004, MED SCI SPORT EXER, V36, P1574, DOI 10.1249/01.MSS.0000139804.02576.6A; Kiebel S., 2003, HUMAN BRAIN FUNCTION, P725; Kloppel S, 2008, NEUROIMAGE, V40, P1782, DOI 10.1016/j.neuroimage.2008.01.019; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Madden DJ, 2004, NEUROIMAGE, V21, P1174, DOI 10.1016/j.neuroimage.2003.11.004; Malcolm MP, 2006, CLIN NEUROPHYSIOL, V117, P1037, DOI 10.1016/j.clinph.2006.02.005; MEYER BU, 1995, BRAIN, V118, P429, DOI 10.1093/brain/118.2.429; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P344, DOI 10.1016/S1388-2457(99)00243-6; Oguri T, 2013, NEUROIMAGE, V78, P353, DOI 10.1016/j.neuroimage.2013.04.026; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Pfefferbaum A, 2003, J MAGN RESON IMAGING, V18, P427, DOI 10.1002/jmri.10377; Roberts RE, 2013, NEUROSCIENTIST, V19, P8, DOI 10.1177/1073858411421218; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Stedman A, 1998, MUSCLE NERVE, V21, P1033, DOI 10.1002/(SICI)1097-4598(199808)21:8<1033::AID-MUS7>3.0.CO;2-9; Stinear CM, 2001, EXP BRAIN RES, V139, P101, DOI 10.1007/s002210100758; Stippich C, 2007, NEUROIMAGE, V34, P1227, DOI 10.1016/j.neuroimage.2006.08.046; Tazoe T, 2007, EXP BRAIN RES, V177, P419, DOI 10.1007/s00221-006-0686-1; Thomalla G, 2014, BRAIN, V137, P122, DOI 10.1093/brain/awt288; Tinazzi M, 1998, NEUROSCI LETT, V244, P121, DOI 10.1016/S0304-3940(98)00150-5; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; Wolbers T, 2006, CEREB CORTEX, V16, P857, DOI 10.1093/cercor/bhj029; Zarei M, 2006, J ANAT, V209, P311, DOI 10.1111/j.1469-7580.2006.00615.x	48	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104218	10.1371/journal.pone.0104218	http://dx.doi.org/10.1371/journal.pone.0104218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118828	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600041
J	Flynn, D; Ford, GA; Rodgers, H; Price, C; Steen, N; Thomson, RG				Flynn, Darren; Ford, Gary A.; Rodgers, Helen; Price, Christopher; Steen, Nick; Thomson, Richard G.			A Time Series Evaluation of the FAST National Stroke Awareness Campaign in England	PLOS ONE			English	Article							WARNING SIGNS; RISK-FACTORS; THROMBOLYSIS; EXPERIENCE; ALTEPLASE	Objective: In February 2009, the Department of Health in England launched the Face, Arm, Speech, and Time (FAST) mass media campaign, to raise public awareness of stroke symptoms and the need for an emergency response. We aimed to evaluate the impact of three consecutive phases of FAST using population-level measures of behaviour in England. Methods: Interrupted time series (May 2007 to February 2011) assessed the impact of the campaign on: access to a national stroke charity's information resources (Stroke Association [SA]); emergency hospital admissions with a primary diagnosis of stroke (Hospital Episode Statistics for England); and thrombolysis activity from centres in England contributing data to the Safe Implementation of Thrombolysis in Stroke UK database. Results: Before the campaign, emergency admissions (and patients admitted via accident and emergency [A&E]) and thrombolysis activity was increasing significantly over time, whereas emergency admissions via general practitioners (GPs) were decreasing significantly. SA webpage views, calls to their helpline and information materials dispatched increased significantly after phase one. Website hits/views, and information materials dispatched decreased after phase one; these outcomes increased significantly during phases two and three. After phase one there were significant increases in overall emergency admissions (505, 95% CI = 75 to 935) and patients admitted via A&E (451, 95% CI = 26 to 875). Significantly fewer monthly emergency admissions via GPs were reported after phase three (219, 95% CI = 229 to 29). Thrombolysis activity per month significantly increased after phases one (3, 95% CI = 1 to 6), and three (3, 95% CI = 1 to 4). Conclusions: Phase one had a statistically significant impact on information seeking behaviour and emergency admissions, with additional impact that may be attributable to subsequent phases on information seeking behaviour, emergency admissions via GPs, and thrombolysis activity. Future campaigns should be a0ccompanied by evaluation of impact on clinical outcomes such as reduced stroke-related morbidity and mortality.	[Flynn, Darren; Steen, Nick; Thomson, Richard G.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Ford, Gary A.; Rodgers, Helen] Newcastle Univ, Fac Med Sci, Inst Ageing & Hlth, Stroke Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Price, Christopher] Wansbeck Gen Hosp, Northumbria Healthcare NHS Fdn Trust, Ashington, England	Newcastle University - UK; Newcastle University - UK	Flynn, D (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	darren.flynn@ncl.ac.uk	Ford, Gary/AAY-6405-2020	Ford, Gary/0000-0001-8719-4968; Flynn, Darren/0000-0001-7390-632X; Price, Christopher/0000-0003-3566-3157	Boehringer Ingelheim; National Institute for Health Research [RP-PG-0606-1241, NF-SI-0512-10089, NF-SI-0507-10249] Funding Source: researchfish; Stroke Association [TSAPMF2013/02] Funding Source: researchfish	Boehringer Ingelheim(Boehringer Ingelheim); National Institute for Health Research(National Institute for Health Research (NIHR)); Stroke Association	The authors have read the journal's policy and have the following conflicts - DF, GAF, HR, CP and RGT have been involved in developing a computerised decision aid for thrombolytic treatment in acute stroke care. GAF has received personal remuneration for educational and advisory work from Boehringer Ingelheim (manufacturer of Alteplase) and Lundbeck. GAF's previous institution has received research grants from Boehringer Ingelheim, and honoraria from Lundbeck for stroke-related activities. GAF developed the Face Arm Speech Test for use by ambulance paramedics in England. This does not alter their adherence to PLOS ONE policies on sharing data and materials.	Bray JE, 2010, INT J STROKE, V5, P440, DOI 10.1111/j.1747-4949.2010.00484.x; Care Quality Commission, 2009, CAR PAT STROK TRANS; Department of Health, 2007, NAT STROK STRAT; Department of Health, 2009, STROK ACT F A S T AW; Dombrowski SU, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-915; Fitzsimmons PR, 2010, EUR STROK C BARC SPA; Fuel, STROK CAMP DIAGN; Grilli R, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000389, DOI 10.1002/14651858.CD000389]; Grimshaw J, 2000, FAM PRACT, V17, pS11, DOI 10.1093/fampra/17.suppl_1.S11; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hodgson C, 2007, STROKE, V38, P2115, DOI 10.1161/STROKEAHA.107.484071; Kleindorfer D, 2009, STROKE, V40, P2502, DOI 10.1161/STROKEAHA.109.551861; Lecouturier J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-157; Lees KR, 2008, QJM-INT J MED, V101, P863, DOI 10.1093/qjmed/hcn102; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Mackay J, 2004, ATLAS HEART DIS STRO; Mackintosh JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046124; Mellon L, 2014, EMERG MED J, V31, P536, DOI 10.1136/emermed-2012-202280; Mikulik R, 2011, CEREBROVASC DIS, V32, P342, DOI 10.1159/000330339; National Audit Office, 2005, RED BRAIN DAM FAST A; National Audit Office, 2010, PROGR IMPR STROK CAR; National Collaborating Centre for Chronic Conditions (UK), 2008, STROK NAT CLIN GUID; NHS Networks, 2014, LAT FIG SHOW ANN ACT; Reeves MJ, 2008, CEREBROVASC DIS, V25, P385, DOI 10.1159/000121338; Robinson TG, 2013, EMERG MED J, V30, P467, DOI 10.1136/emermed-2012-201471; Royal College of Physicians, 2013, CLIN EFF EV UN BEH I; SAVIN NE, 1977, ECONOMETRICA, V45, P1989, DOI 10.2307/1914122; Trobbiani K, 2013, INT J STROKE, V8, P28, DOI 10.1111/j.1747-4949.2012.00917.x; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wellcome Trust, 2012, FOC STROK MAK CAMP O; Wolfe C, 2007, BURDEN STROKE WHITE; Wood E, 2010, CEREBROVASC DIS, V29	33	57	57	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104289	10.1371/journal.pone.0104289	http://dx.doi.org/10.1371/journal.pone.0104289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119714	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000340900600047
J	Mensel, B; Kuehn, JP; Hoene, A; Hosten, N; Puls, R				Mensel, Birger; Kuehn, Jens-Peter; Hoene, Andreas; Hosten, Norbert; Puls, Ralf			Endovascular Repair of Arterial Iliac Vessel Wall Lesions with a Self-Expandable Nitinol Stent Graft System	PLOS ONE			English	Article							ANEURYSMS; ANGIOPLASTY	Objective: To assess the therapeutic outcome after endovascular repair of iliac arterial lesions (IALs) using a self-expandable Nitinol stent graft system. Methods: Between July 2006 and March 2013, 16 patients (13 males, mean age: 68 years) with a self-expandable Nitinol stent graft. A total of 19 lesions were treated: nine true aneurysms, two anastomotic aneurysms, two dissections, one arteriovenous fistula, two type 1B endoleaks after endovascular aneurysm repair, one pseudoaneurysm, and two perforations after angioplasty. Pre-, intra-, and postinterventional imaging studies and the medical records were analyzed for technical and clinical success and postinterventional complications. Results: The primary technical and clinical success rate was 81.3% (13/16 patients) and 75.0% (12/16), respectively. Two patients had technical failure due to persistent type 1A endoleak and another patient due to acute stent graft thrombosis. One patient showed severe stent graft kinking on the first postinterventional day. In two patients, a second intervention was performed. The secondary technical and clinical success rate was 87.5% (14/16) and 93.8% (15/16). The minor complication rate was 6.3% (patient with painful hematoma at the access site). The major complication rate was 6.3% (patient with ipsilateral deep vein thrombosis). During median follow-up of 22.4 months, an infection of the aneurysm sac in one patient and a stent graft thrombosis in another patient were observed. Conclusion: Endovascular repair of various IALs with a self-expandable Nitinol stent graft is safe and effective.	[Mensel, Birger; Kuehn, Jens-Peter; Hosten, Norbert] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Hoene, Andreas] Univ Med Greifswald, Dept Vasc Surg, Greifswald, Germany; [Puls, Ralf] Helios Hosp Erfurt, Erfurt, Germany	Greifswald Medical School; Greifswald Medical School	Mensel, B (corresponding author), Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany.	birger.mensel@uni-greifswald.de						Akpinar B, 2009, DIAGN INTERV RADIOL, V15, P303, DOI 10.4261/1305-3825.DIR.1018-07.4; BRUNKWALL J, 1989, J VASC SURG, V10, P381, DOI 10.1067/mva.1989.13733; Chaikof EL, 2002, J VASC SURG, V35, P1048, DOI 10.1067/mva.2002.123763; Dolmatch BL, 2012, J VASC INTERV RADIOL, V23, P479, DOI 10.1016/j.jvir.2011.12.024; Formichi M, 1998, J ENDOVASC SURG, V5, P37, DOI 10.1583/1074-6218(1998)005<0037:ROTEIA>2.0.CO;2; Hirai Shinji, 2002, Ann Thorac Cardiovasc Surg, V8, P180; Janjua Nazli, 2008, J Vasc Interv Neurol, V1, P5; Ludwig T, 2010, ROFO-FORTSCHR RONTG, V182, P717, DOI 10.1055/s-0029-1245356; Parsons RE, 1999, J VASC SURG, V30, P915, DOI 10.1016/S0741-5214(99)70017-0; Patel NV, 2009, J VASC SURG, V49, P1147, DOI 10.1016/j.jvs.2008.11.101; Pitoulias GA, 2007, J VASC SURG, V46, P648, DOI 10.1016/j.jvs.2007.05.047; Rosenthal D, 1998, J ENDOVASC SURG, V5, P142, DOI 10.1583/1074-6218(1998)005<0142:IVTCBC>2.0.CO;2; Sakamoto I, 2005, RADIOGRAPHICS, V25, pS213, DOI 10.1148/rg.25si055517; Sanada J, 2005, CARDIOVASC INTER RAD, V28, P83, DOI 10.1007/s00270-004-0005-9; Scheinert D, 2000, CIRCULATION, V102, P253; Uberoi R, 2011, CARDIOVASC INTER RAD, V34, P3, DOI 10.1007/s00270-010-0055-0; Wolf F, 2008, EUR J RADIOL, V65, P491, DOI 10.1016/j.ejrad.2007.04.004	17	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103980	10.1371/journal.pone.0103980	http://dx.doi.org/10.1371/journal.pone.0103980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119346	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600033
J	Raza, SI; Muhammad, D; Jan, A; Ali, RH; Hassan, M; Ahmad, W; Rashid, S				Raza, Syed Irfan; Muhammad, Dost; Jan, Abid; Ali, Raja Hussain; Hassan, Mubashir; Ahmad, Wasim; Rashid, Sajid			In Silico Analysis of Missense Mutations in LPAR6 Reveals Abnormal Phospholipid Signaling Pathway Leading to Hypotrichosis	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE HYPOTRICHOSIS; PROTEIN-COUPLED RECEPTOR; HAIR FOLLICLE DEVELOPMENT; LYSOPHOSPHATIDIC ACID; UCSF CHIMERA; WOOLLY HAIR; P2RY5; FAMILIES; GROWTH; LIPH	Autosomal recessive hypotrichosis is a rare genetic irreversible hair loss disorder characterized by sparse scalp hair, sparse to absent eyebrows and eyelashes, and sparse axillary and body hair. The study, presented here, established genetic linkage in four families showing similar phenotypes to lysophosphatidic acid receptor 6 (LPAR6) gene on chromosome 13q14.11-q21.32. Subsequently, sequence analysis of the gene revealed two previously reported missense mutations including p.D63V in affected members of one and p.I188F in three other families. Molecular modeling and docking analysis was performed to investigate binding of a ligand oleoyl-L-alpha-lysophosphatidic acid (LPA) to modeled protein structures of normal and mutated (D63V, G146R, I188F, N248Y, S3T, L277P) LPAR6 receptors. The mutant receptors showed a complete shift in orientation of LPA at the binding site. In addition, hydropathy analysis revealed a significant change in the membrane spanning topology of LPAR6 helical segments. The present study further substantiated involvement of LPAR6-LPA signaling in the pathogenesis of hypotrichosis/woolly hair and provided additional insight into the molecular mechanism of hair development.	[Raza, Syed Irfan; Muhammad, Dost; Jan, Abid; Ali, Raja Hussain; Ahmad, Wasim] Quaid I Azam Univ, Fac Biol Sci, Dept Biochem, Islamabad, Pakistan; [Hassan, Mubashir; Rashid, Sajid] Quaid I Azam Univ, Fac Biol Sci, Natl Ctr Bioinformat, Islamabad, Pakistan; [Raza, Syed Irfan] NUST, Army Med Coll, Islamabad, Pakistan	Quaid I Azam University; Quaid I Azam University; National University of Sciences & Technology - Pakistan	Rashid, S (corresponding author), Quaid I Azam Univ, Fac Biol Sci, Natl Ctr Bioinformat, Islamabad, Pakistan.	sajidrwp@yahoo.co.uk	Hassan, Mubashir/V-8187-2017; JAN, Abid/AAA-1209-2019; Ahmad, Wasim/GSD-8904-2022; Rashid, Sajid/K-8640-2019	Hassan, Mubashir/0000-0003-2532-1866; ali, raja/0000-0003-0305-7363				Alexandrescu DT, 2009, DERMATOLOGY ONLINE J, V3, P1; Azeem Z, 2008, HUM GENET, V123, P515, DOI 10.1007/s00439-008-0507-7; Basit S, 2010, HUM GENET, V128, P213, DOI 10.1007/s00439-010-0847-y; Betz RC, 2012, J INVEST DERMATOL, V132, P906, DOI 10.1038/jid.2011.408; Bibi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070843; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Doma E, 2013, INT J MOL SCI, V14, P19361, DOI 10.3390/ijms141019361; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Eswar N, 2006, CURR PROTOC BIOINFOR, V2006; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Fujimoto A, 2012, J INVEST DERMATOL, V132, P2342, DOI 10.1038/jid.2012.154; Horev L, 2010, J EUR ACAD DERMATOL, V24, P858, DOI 10.1111/j.1468-3083.2009.03514.x; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; JALINK K, 1995, BIOCHEM J, V307, P609, DOI 10.1042/bj3070609; JALINK K, 1990, J BIOL CHEM, V265, P12232; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Khan S, 2011, CLIN EXP DERMATOL, V36, P652, DOI 10.1111/j.1365-2230.2011.04014.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Naz G, 2010, HUM GENET, V127, P395, DOI 10.1007/s00439-009-0784-9; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pasternack SM, 2009, J INVEST DERMATOL, V129, P2772, DOI 10.1038/jid.2009.154; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Petukhova L, 2008, GENOMICS, V92, P273, DOI 10.1016/j.ygeno.2008.06.009; Shimomura Y, 2008, NAT GENET, V40, P335, DOI 10.1038/ng.100; Shimomura Y, 2010, AM J HUM GENET, V86, P632, DOI 10.1016/j.ajhg.2010.02.025; Shimomura Y, 2009, J DERMATOL SCI, V56, P205, DOI 10.1016/j.jdermsci.2009.08.005; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Tariq M, 2009, BRIT J DERMATOL, V160, P1006, DOI 10.1111/j.1365-2133.2009.09046.x; Tramontano A, 1998, METHODS, V14, P293, DOI 10.1006/meth.1998.0585; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wasif N, 2011, HUM GENET, V129, P419, DOI 10.1007/s00439-010-0938-9; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200	36	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104756	10.1371/journal.pone.0104756	http://dx.doi.org/10.1371/journal.pone.0104756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119526	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600082
J	Gageler, R; Bonner, M; Kirchhof, G; Amos, M; Robinson, N; Schmidt, S; Shoo, LP				Gageler, Rose; Bonner, Mark; Kirchhof, Gunnar; Amos, Mark; Robinson, Nicole; Schmidt, Susanne; Shoo, Luke P.			Early Response of Soil Properties and Function to Riparian Rainforest Restoration	PLOS ONE			English	Article							FINE-ROOT BIOMASS; WATER INFILTRATION; CARBON STOCKS; NITROGEN MINERALIZATION; PASTURE; LAND; DEFORESTATION; MACROPORES; INDICATORS; VEGETATION	Reforestation of riparian zones is increasingly practiced in many regions for purposes of biodiversity conservation, bank stabilisation, and improvement in water quality. This is in spite of the actual benefits of reforestation for recovering underlying soil properties and function remaining poorly understood. Here we compare remnant riparian rainforest, pasture and reforestation plantings aged 2-20 years in an Australian subtropical catchment on ferrosols to determine the extent to which reforestation restores key soil properties. Of the nine soil attributes measured (total nitrogen, nitrate and ammonium concentrations, net nitrification and ammonification rates, organic carbon, bulk density, fine root biomass and water infiltration rates), only infiltration rates were significantly lower in pasture than remnant riparian rainforest. Within reforestation plantings, bulk density decreased up to 1.4-fold and infiltration rates increased up to 60-fold with time post-reforestation. Our results suggest that the main outcome of belowground processes of early reforestation is the recovery of the soils' physical structure, with potential beneficial ecosystem services including reduced runoff, erosion and associated sediment and nutrient loads in waterways. We also demonstrate differential impacts of two commonly planted tree species on a subset of soil properties suggesting that preferential planting of select species could accelerate progress on specific restoration objectives.	[Gageler, Rose; Bonner, Mark; Kirchhof, Gunnar; Robinson, Nicole; Schmidt, Susanne] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Amos, Mark] Lake Baroon Catchment Care Grp, Maleny, Australia; [Shoo, Luke P.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Schmidt, S (corresponding author), Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia.	Susanne.Schmidt@uq.edu.au	Shoo, Luke P/A-2715-2009; Kirchhof, Gunnar/I-9146-2012; Schmidt, Susanne/B-2780-2009	Kirchhof, Gunnar/0000-0002-9480-6579; Schmidt, Susanne/0000-0001-8369-1238	Australian Government's National Environmental Research Program (Tropical Ecosystems and Environmental Decisions Hubs)	Australian Government's National Environmental Research Program (Tropical Ecosystems and Environmental Decisions Hubs)(Australian Government)	LPS was supported by funding from the Australian Government's National Environmental Research Program (Tropical Ecosystems and Environmental Decisions Hubs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2011, CENS; Bell LW, 2011, SOIL TILL RES, V113, P19, DOI 10.1016/j.still.2011.02.003; BEVEN K, 1982, WATER RESOUR RES, V18, P1311, DOI 10.1029/WR018i005p01311; Bezemer TM, 2006, J ECOL, V94, P893, DOI 10.1111/j.1365-2745.2006.01158.x; Bharati L, 2002, AGROFOREST SYST, V56, P249, DOI 10.1023/A:1021344807285; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Catterall C.P., 2006, RAINFOREST RESTORATI; Catterall CP, 2004, CONSERVATION OF AUTRALIA'S, SECOND EDITION, P359; Charron I, 2008, RIVER RES APPL, V24, P617, DOI 10.1002/rra.1133; Claus A, 2005, CAN J FOREST RES, V35, P1617, DOI 10.1139/x05-079; Colloff MJ, 2010, RESTOR ECOL, V18, P65, DOI 10.1111/j.1526-100X.2010.00667.x; Connor S, 2013, AGR ECOSYST ENVIRON, V180, P111, DOI 10.1016/j.agee.2011.12.006; DeForest JL, 2011, SOIL TEXTURE HYDROME; ELLISON L, 1954, ECOLOGY, V35, P380, DOI 10.2307/1930102; Finer L, 2011, FOREST ECOL MANAG, V261, P265, DOI 10.1016/j.foreco.2010.10.016; Griscom HP, 2009, RESTOR ECOL, V17, P117, DOI 10.1111/j.1526-100X.2007.00342.x; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Jimenez EM, 2009, BIOGEOSCIENCES, V6, P2809, DOI 10.5194/bg-6-2809-2009; KANDELER E, 1988, BIOL FERT SOILS, V6, P68, DOI 10.1007/BF00257924; Kanowski J, 2003, FOREST ECOL MANAG, V183, P265, DOI 10.1016/S0378-1127(03)00109-9; Kanowski John, 2010, Ecological Management & Restoration, V11, P119, DOI 10.1111/j.1442-8903.2010.00529.x; LAMB D, 1980, OECOLOGIA, V47, P257, DOI 10.1007/BF00346829; Laub BG, 2013, RESTOR ECOL, P1; Maloney KO, 2008, RESTOR ECOL, V16, P503, DOI 10.1111/j.1526-100X.2007.00324.x; MCINTYRE DS, 1976, AUST J SOIL RES, V14, P227, DOI 10.1071/SR9760227; Meynendonckx J, 2006, HYDROL EARTH SYST SC, V10, P913, DOI 10.5194/hess-10-913-2006; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Murty D, 2002, GLOBAL CHANGE BIOL, V8, P105, DOI 10.1046/j.1354-1013.2001.00459.x; Naiman RJ, 2005, RIPARIA ECOLOGY CONS; Nakamura A, 2007, J INSECT CONSERV, V11, P177, DOI 10.1007/s10841-006-9034-9; Nakamura Akihiro, 2003, Ecological Management & Restoration, V4, pS20, DOI 10.1046/j.1442-8903.4.s.3.x; Neris J, 2012, CATENA, V98, P55, DOI 10.1016/j.catena.2012.06.006; Orzetti LL, 2010, J AM WATER RESOUR AS, V46, P473, DOI 10.1111/j.1752-1688.2009.00414.x; Paul M, 2010, FOREST ECOL MANAG, V260, P370, DOI 10.1016/j.foreco.2010.04.029; Paul M, 2010, FOREST ECOL MANAG, V259, P2083, DOI 10.1016/j.foreco.2010.02.019; Penuela MC, 2004, RESTOR ECOL, V12, P516, DOI 10.1111/j.1061-2971.2004.00395.x; PERROUX KM, 1988, SOIL SCI SOC AM J, V52, P1205, DOI 10.2136/sssaj1988.03615995005200050001x; PICCOLO MC, 1994, PLANT SOIL, V162, P61, DOI 10.1007/BF01416090; Powers JS, 2013, BIOTROPICA, V45, P1, DOI 10.1111/j.1744-7429.2012.00881.x; R Core Team, 2021, R LANGUAGE ENV STAT; Radke J. K., 1993, American Journal of Alternative Agriculture, V8, P164, DOI 10.1017/S0889189300005385; Rasiah V, 2004, GEODERMA, V120, P35, DOI 10.1016/j.geoderma.2003.08.008; REINERS WA, 1994, ECOL APPL, V4, P363, DOI 10.2307/1941940; Robertson GP, 1999, LT EC RES NETWK SER, V2, P258; Nogueira LR, 2011, FOREST SYST, V20, P536, DOI 10.5424/fs/20112003-11844; Russo TA, 2012, J HYDROL, V432, P98, DOI 10.1016/j.jhydrol.2012.02.022; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; Schultz RC, 2004, AGROFOREST SYST, V61-2, P35, DOI 10.1023/B:AGFO.0000028988.67721.4d; Scott SJ, 2010, J ZOOL, V280, P371, DOI 10.1111/j.1469-7998.2009.00670.x; Smith I, 2001, BIODIVERS CONSERV, P81; Sweeney BW, 2004, P NATL ACAD SCI USA, V101, P14132, DOI 10.1073/pnas.0405895101; Vidon P, 2012, HYDROL PROCESS, V26, P3207, DOI 10.1002/hyp.8258; Wickham JD, 2011, LANDSCAPE ECOL, V26, P605, DOI 10.1007/s10980-011-9591-5; Willmott W., 2007, ROCKS LANDSCAPES SUN, V2nd ed.; WOOD HB, 1977, SOIL SCI SOC AM J, V41, P132, DOI 10.2136/sssaj1977.03615995004100010035x; Zhu BB, 2010, ECOL RES, V25, P531, DOI 10.1007/s11284-009-0683-5	56	22	25	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104198	10.1371/journal.pone.0104198	http://dx.doi.org/10.1371/journal.pone.0104198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117589	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400036
J	Jain, P; Calvert, M; Cockwell, P; McManus, RJ				Jain, Poorva; Calvert, Melanie; Cockwell, Paul; McManus, Richard J.			The Need for Improved Identification and Accurate Classification of Stages 3-5 Chronic Kidney Disease in Primary Care: Retrospective Cohort Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; CKD-EPI; PREVALENCE; RISK; UK; STRATIFICATION; MANAGEMENT; EQUATION; TRENDS	Background: Around ten percent of the population have been reported as having Chronic Kidney Disease (CKD), which is associated with increased cardiovascular mortality. Few previous studies have ascertained the chronicity of CKD. In the UK, a payment for performance (P4P) initiative incentivizes CKD (stages 3-5) recognition and management in primary care, but the impact of this has not been assessed. Methods and Findings: Using data from 426 primary care practices (population 2,707,130), the age standardised prevalence of stages 3-5 CKD was identified using two consecutive estimated Glomerular Filtration Rates (eGFRs) seven days apart. Additionally the accuracy of practice CKD registers and the relationship between accurate identification of CKD and the achievement of P4P indicators was determined. Between 2005 and 2009, the prevalence of stages 3-5 CKD increased from 0.3% to 3.9%. In 2009, 30,440 patients (1.1% unadjusted) fulfilled biochemical criteria for CKD but were not on a practice CKD register (uncoded CKD) and 60,705 patients (2.2% unadjusted) were included on a practice CKD register but did not fulfil biochemical criteria (miscoded CKD). For patients with confirmed CKD, inclusion in a practice register was associated with increasing age, male sex, diabetes, hypertension, cardiovascular disease and increasing CKD stage (p<0.0001). Uncoded CKD patients compared to miscoded patients were less likely to achieve performance indicators for blood pressure (OR 0.84, 95% CI 0.82-0.86 p<0.001) or recorded albumin-creatinine ratio (OR 0.73, 0.70-0.76, p<0.001). Conclusions: The prevalence of stages 3-5 CKD, using two laboratory reported eGFRs, was lower than estimates from previous studies. Clinically significant discrepancies were identified between biochemically defined CKD and appearance on practice registers, with misclassification associated with sub-optimal care for some people with CKD.	[Jain, Poorva; Calvert, Melanie] Univ Birmingham, NIHR Sch Primary Care Res, Birmingham, W Midlands, England; [Cockwell, Paul] Queen Elizabeth Hosp, Univ Hosp Birmingham, Dept Renal Med, Birmingham B15 2TH, W Midlands, England; [Cockwell, Paul] Univ Birmingham, Sch Med, Div Immun & Infect, Birmingham, W Midlands, England; [McManus, Richard J.] Univ Oxford, NIHR Sch Primary Care Res, Dept Primary Care Hlth Sci, Oxford, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Oxford	Jain, P (corresponding author), Univ Birmingham, NIHR Sch Primary Care Res, Birmingham, W Midlands, England.	p.jain@bham.ac.uk	Calvert, Melanie/F-7055-2011	Calvert, Melanie/0000-0002-1856-837X; Cockwell, Paul/0000-0003-1975-266X	NIHR Career Development Fellowship; National Institute for Health Research [NIHR-RP-02-12-015, CDF/01/017] Funding Source: researchfish	NIHR Career Development Fellowship; National Institute for Health Research(National Institute for Health Research (NIHR))	RJM and PJ were funded as part of an NIHR Career Development Fellowship awarded to RJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this paper are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; [Anonymous], 2013, KIDNEY INT S, V3, P19; Arellano FM, 2006, PHARMACOEPIDEM DR S, V15, P861, DOI 10.1002/pds.1343; Aresu M, 2010, HLTH SURV ENGL 2009; Blundell R, 1997, HEALTH ECON, V6, P439; Calvert M, 2009, BMJ, V338; Calvert MJ, 2009, FAM PRACT, V26, P145, DOI 10.1093/fampra/cmn105; Carter JL, 2011, QJM-INT J MED, V104, P839, DOI 10.1093/qjmed/hcr077; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS27, DOI 10.1053/j.ajkd.2008.07.055; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; de Lusignan S, 2011, NEPHRON CLIN PRACT, V117, pC213, DOI 10.1159/000320341; DoH, 2005, NAT SERV FRAM REN 2; Gardiner JC, 2009, STAT MED, V28, P221, DOI 10.1002/sim.3478; Gifford FJ, 2011, QJM-INT J MED, V104, P1045, DOI 10.1093/qjmed/hcr122; Glynn L G, 2009, Ir Med J, V102, P285; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan SI, 2006, J AM SOC NEPHROL, V17, P2275, DOI 10.1681/ASN.2005121273; HAYNES RB, 1978, NEW ENGL J MED, V299, P741, DOI 10.1056/NEJM197810052991403; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; JOHNSTON ME, 1984, J CHRON DIS, V37, P417, DOI 10.1016/0021-9681(84)90025-0; Joint Specialty Committee on Renal Medicine of the Royal College of Physicians of London and the Renal Association, 2006, JAMA; Kerr M, 2012, NEPHROL DIAL TRANSPL, V27, P73, DOI 10.1093/ndt/gfs269; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mackenzie F, 2011, NOTES BIRMINGHAM QUA; NHS Information Centre, 2010, KIDNEY INT; NHS Primary Care Commissioning, 2009, BMJ; O'Callaghan CA, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000308; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; Office for National Statistics, 2012, ALL REL POP EST UK; Office for National Statistics, 2012, DROP; Office for National Statistics, 2004, CENS 2001 NAT REP EN; Stevens PE, 2007, KIDNEY INT, V72, P92, DOI 10.1038/sj.ki.5002273; Tonelli M, 2011, ANN INTERN MED, V154, P12, DOI 10.7326/0003-4819-154-1-201101040-00003; Walker N, 2011, BRIT J GEN PRACT, V61, P203, DOI 10.3399/bjgp11X561212	37	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e100831	10.1371/journal.pone.0100831	http://dx.doi.org/10.1371/journal.pone.0100831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115813	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400003
J	Matheny, ME; Peterson, JF; Eden, SK; Hung, AM; Speroff, T; Abdel-Kader, K; Parr, SK; Ikizler, TA; Siew, ED				Matheny, Michael E.; Peterson, Josh F.; Eden, Svetlana K.; Hung, Adriana M.; Speroff, Theodore; Abdel-Kader, Khaled; Parr, Sharidan K.; Ikizler, T. Alp; Siew, Edward D.			Laboratory Test Surveillance following Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; DISEASE; RISK; MORTALITY; CARE; OUTCOMES; CLASSIFICATION; NEPHROLOGISTS; PROGRESSION; METABOLISM	Background: Patients with hospitalized acute kidney injury (AKI) are at increased risk for accelerated loss of kidney function, morbidity, and mortality. We sought to inform efforts at improving post-AKI outcomes by describing the receipt of renal-specific laboratory test surveillance among a large high-risk cohort. Methods: We acquired clinical data from the Electronic health record (EHR) of 5 Veterans Affairs (VA) hospitals to identify patients hospitalized with AKI from January 1 st, 2002 to December 31 st, 2009, and followed these patients for 1 year or until death, enrollment in palliative care, or improvement in renal function to estimated GFR (eGFR) >= 60 L/min/1.73 m(2). Using demographic data, administrative codes, and laboratory test data, we evaluated the receipt and timing of outpatient testing for serum concentrations of creatinine and any as well as quantitative proteinuria recommended for CKD risk stratification. Additionally, we reported the rate of phosphorus and parathyroid hormone (PTH) monitoring recommended for chronic kidney disease (CKD) patients. Results: A total of 10,955 patients admitted with AKI were discharged with an eGFR < 60 mL/min/1.73 m(2). During outpatient follow-up at 90 and 365 days, respectively, creatinine was measured on 69% and 85% of patients, quantitative proteinuria was measured on 6% and 12% of patients, PTH or phosphorus was measured on 10% and 15% of patients. Conclusions: Measurement of creatinine was common among all patients following AKI. However, patients with AKI were infrequently monitored with assessments of quantitative proteinuria or mineral metabolism disorder, even for patients with baseline kidney disease.	[Matheny, Michael E.; Hung, Adriana M.; Speroff, Theodore] Vet Hlth Adm, TVHS, GRECC, Nashville, TN 37212 USA; [Matheny, Michael E.; Peterson, Josh F.] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Matheny, Michael E.; Peterson, Josh F.; Speroff, Theodore] Vanderbilt Univ, Sch Med, Dept Med, Div Gen Internal Med, Nashville, TN 37212 USA; [Matheny, Michael E.; Eden, Svetlana K.; Speroff, Theodore] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Hung, Adriana M.; Abdel-Kader, Khaled; Parr, Sharidan K.; Ikizler, T. Alp; Siew, Edward D.] Vanderbilt Univ, Sch Med, Dept Med, Div Nephrol, Nashville, TN 37212 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Matheny, ME (corresponding author), Vet Hlth Adm, TVHS, GRECC, Nashville, TN 37212 USA.	michael@matheny.info	Matheny, Michael E/B-3541-2008; abdel-kader, khaled/AAF-3925-2020; Abdel-Kader, Khaled/ABE-7370-2021	Matheny, Michael E/0000-0003-3217-4147; Abdel-Kader, Khaled/0000-0002-6412-8498; Ikizler, Talat/0000-0002-5717-4218; Siew, Edward/0000-0003-1343-8784; Parr, Sharidan/0000-0002-4596-3818	Veterans Administration HSR&D Career Development Award [CDA-08-020]; Veterans Administration HSR&D Investigator Initiated Research [IIR-11-292]; National Institutes of Health Grant [5K23 DK088964-02]; Veterans Administration CSR&D Career Development Award [2-031-09S]; National Library of Medicine [R01 LM009965-01]; National Institute of Diabetes, Digestive and Kidney Diseases [U01DK82192]; Clinical Translational Science Award from the National Center for Research Resources [1UL-1RR024975]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK090304, K23DK088964, U01DK082192] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009965] Funding Source: NIH RePORTER	Veterans Administration HSR&D Career Development Award; Veterans Administration HSR&D Investigator Initiated Research; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration CSR&D Career Development Award; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Diabetes, Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Clinical Translational Science Award from the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was partially funded through a number of research grants. MEM was supported by Veterans Administration HSR&D Career Development Award CDA-08-020 and Veterans Administration HSR&D Investigator Initiated Research IIR-11-292, which also includes TS as co-investigator. EDS was supported by National Institutes of Health Grant 5K23 DK088964-02. AH was supported by Veterans Administration CSR&D Career Development Award 2-031-09S. JFP was supported by National Library of Medicine R01 LM009965-01. TAI was supported by U01DK82192 from the National Institute of Diabetes, Digestive and Kidney Diseases, and Clinical Translational Science Award 1UL-1RR024975 from the National Center for Research Resources. The views presented in this work are solely those of the authors and do not necessarily represent the position or the policy of the U.S. Department of Veterans Affairs or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN O, 1978, ANN STAT, V6, P534, DOI 10.1214/aos/1176344198; Chan MR, 2007, AM J MED, V120, P1063, DOI 10.1016/j.amjmed.2007.04.024; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Chow KM, 2008, PERITON DIALYSIS INT, V28, P371; Coca S. G., 2011, KIDNEY INT; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Drawz PE, 2013, J AM GERIATR SOC, V61, P762, DOI 10.1111/jgs.12223; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Grams ME, 2011, AM J KIDNEY DIS, V57, P44, DOI 10.1053/j.ajkd.2010.05.013; Grams ME, 2010, J AM SOC NEPHROL, V21, P1757, DOI 10.1681/ASN.2010010128; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hoy T, 2007, AM J MANAG CARE, V13, P620; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Hsu RK, 2013, J AM SOC NEPHROL, V24, P37, DOI 10.1681/ASN.2012080800; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Jafar TH, 2001, KIDNEY INT, V60, P1131, DOI 10.1046/j.1523-1755.2001.0600031131.x; Kalbfleish J., 1980, STAT ANAL FAILURE TI; Kausz AT, 2005, J AM SOC NEPHROL, V16, P3092, DOI 10.1681/ASN.2004110910; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Khan SS, 2005, KIDNEY INT, V67, P1038, DOI 10.1111/j.1523-1755.2005.00168.x; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Levey AS, 2000, J AM SOC NEPHROL, V11, pA0828; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Moe S, 2006, KIDNEY INT, V69, P1945, DOI 10.1038/sj.ki.5000414; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; O'Hare AM, 2012, AM J KIDNEY DIS, V59, P513, DOI 10.1053/j.ajkd.2011.11.044; Philipneri MD, 2008, CLIN EXP NEPHROL, V12, P41, DOI 10.1007/s10157-007-0016-3; Plantinga LC, 2009, HYPERTENSION, V54, P47, DOI 10.1161/HYPERTENSIONAHA.109.129841; Ruggenenti P, 2001, J AM SOC NEPHROL, V12, P2832, DOI 10.1681/ASN.V12122832; Siew ED, 2012, CLIN J AM SOC NEPHRO, V7, P712, DOI 10.2215/CJN.10821011; Siew ED, 2012, J AM SOC NEPHROL, V23, P305, DOI 10.1681/ASN.2011030315; Siew ED, 2010, KIDNEY INT, V77, P536, DOI 10.1038/ki.2009.479; Singh JA, 2009, PREV CHRONIC DIS, V6; Tangri N, 2012, J AM SOC NEPHROL, V23, P351, DOI 10.1681/ASN.2011070663; Thakar CV, 2011, CLIN J AM SOC NEPHRO, V6, P2567, DOI 10.2215/CJN.01120211; Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9; Tuot DS, 2012, AM J NEPHROL, V35, P191, DOI 10.1159/000335935; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uhlig K, 2010, AM J KIDNEY DIS, V55, P773, DOI 10.1053/j.ajkd.2010.02.340; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Winkelmayer WC, 2003, KIDNEY INT, V63, P1836, DOI 10.1046/j.1523-1755.2003.00930.x; Winkelmayer WC, 2003, J AM SOC NEPHROL, V14, P486, DOI 10.1097/01.ASN.0000046047.66958.C3; Zhang M, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-21	48	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103746	10.1371/journal.pone.0103746	http://dx.doi.org/10.1371/journal.pone.0103746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117447	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400022
J	Saha, S; Pashov, A; Siegel, ER; Murali, R; Kieber-Emmons, T				Saha, Somdutta; Pashov, Anastas; Siegel, Eric R.; Murali, Ramachandran; Kieber-Emmons, Thomas			Defining the Recognition Elements of Lewis Y-Reactive Antibodies	PLOS ONE			English	Article							ZONE B-CELLS; V-H GENES; MARGINAL ZONE; ANTICARBOHYDRATE ANTIBODIES; IMMUNE-RESPONSE; CAPSULAR POLYSACCHARIDE; MONOCLONAL-ANTIBODIES; MOLECULAR RECOGNITION; CARBOHYDRATE ANTIGEN; AFFINITY MATURATION	Antibody response to carbohydrate antigens is often independent of T cells and the process of affinity/specificity improvement is considered strictly dependent on the germinal centers. Antibodies induced during a T cell-independent type 2 (TI-2) response are less variable and less functionally versatile than those induced with T cell help. The antigen specificity consequences of accumulation of somatic mutations in antibodies during TI-2 responses of Marginal Zone (MZ) B cells is a fact that still needs explanation. Germline genes that define carbohydrate-reactive antibodies are known to sculpt antibody-combining sites containing innate, key side-chain contacts that define the antigen recognition step. However, substitutions associated with MZ B cell derived antibodies might affect the mobility and polyspecificity of the antibody. To examine this hypothesis, we analyzed antibodies reactive with the neolactoseries antigen Lewis Y (LeY) to define the residue subset required for the reactive repertoire for the LeY antigen. Our molecular simulation studies of crystallographically determined and modeled antibody-LeY complexes suggests that the heavy-chain germline gene VH7183.a13.20 and the light-chain V kappa cr1 germline gene are sufficient to account for the recognition of the trisaccharide-H determinant Types 1-4, while the specificity for LeY is driven by the CDR3 backbone conformation of the heavy chain and not the side chain interactions. These results confirm that these monoclonals use germline-encoded amino acids to recognize simple carbohydrate determinants like trisaccharide-H but relies on somatic mutations in the periphery of the combining site to modify affinity for LeY through electrostatic interactions that leads to their optimized binding. These observations bring further attention to the role of mutations in T-cell independent antibodies to distinguish self from non-self carbohydrate antigens.	[Saha, Somdutta] Univ Arkansas Med Sci, Univ Arkansas, Bioinformat Grad Program, Little Rock, AR 72205 USA; [Murali, Ramachandran] Cedars Sinai Med Ctr, Dept Sci Biol, Div Immunol Res, Los Angeles, CA USA; [Pashov, Anastas] Bulgarian Acad Sci, Stephan Angelov Inst Microbiol, Sofia, Bulgaria; [Siegel, Eric R.; Kieber-Emmons, Thomas] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University of Arkansas Medical Sciences; Cedars Sinai Medical Center; Bulgarian Academy of Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Kieber-Emmons, T (corresponding author), Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA.	tke@uams.edu	Pashov, Anastas/AAE-7997-2019; Murali, Ramachandran/D-1132-2009; Saha, Somdutta/H-3766-2019	Saha, Somdutta/0000-0002-1313-3588; Siegel, Eric/0000-0001-9824-6612; Murali, Ramachandran/0000-0002-8384-2793; Pashov, Anastas/0000-0002-6033-3566	Department of Defense Breast Cancer Program [W81XWH-06-1-0542]	Department of Defense Breast Cancer Program(United States Department of Defense)	This work was supported by a Clinical Translational Award from the Department of Defense Breast Cancer Program (W81XWH-06-1-0542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDERSON EE, 1993, J CLIN INVEST, V91, P2734, DOI 10.1172/JCI116514; Agresti A., 1996, INTRO CATEGORICAL DA; Almagro JC, 2011, PROTEINS, V79, P3050, DOI 10.1002/prot.23130; Benatuil L, 2008, J IMMUNOL, V180, P3839, DOI 10.4049/jimmunol.180.6.3839; BlaszczykThurin M, 1996, PROTEIN ENG, V9, P447, DOI 10.1093/protein/9.5.447; Brooks CL, 2008, J MOL BIOL, V377, P450, DOI 10.1016/j.jmb.2008.01.018; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carey JB, 2008, J EXP MED, V205, P2043, DOI 10.1084/jem.20080559; CHANG B, 1994, IMMUNOL TODAY, V15, P367, DOI 10.1016/0167-5699(94)90175-9; Chen ZC, 2000, MOL IMMUNOL, V37, P455, DOI 10.1016/S0161-5890(00)00064-X; Evans DW, 2011, GLYCOBIOLOGY, V21, P1049, DOI 10.1093/glycob/cwr041; Gerstenbruch S, 2010, GLYCOBIOLOGY, V20, P461, DOI 10.1093/glycob/cwp198; Harms MJ, 2013, NAT REV GENET, V14, P559, DOI 10.1038/nrg3540; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; HIRASHIMA K, 1990, J IMMUNOL, V145, P224; IMANISHI T, 1974, J EXP MED, V140, P1498, DOI 10.1084/jem.140.6.1498; Insel R A, 1992, Int Rev Immunol, V9, P25, DOI 10.3109/08830189209061781; JEFFREY PD, 1995, NAT STRUCT BIOL, V2, P466, DOI 10.1038/nsb0695-466; Kadirvelraj R, 2008, J AM CHEM SOC, V130, P16933, DOI 10.1021/ja8039663; Kang J, 2008, MOL IMMUNOL, V45, P304, DOI 10.1016/j.molimm.2007.07.007; Kannagi R, 2004, CANCER SCI, V95, P377, DOI 10.1111/j.1349-7006.2004.tb03219.x; Kieber-Emmons T, 2000, J IMMUNOL, V165, P623, DOI 10.4049/jimmunol.165.2.623; KITAMURA K, 1994, P NATL ACAD SCI USA, V91, P12957, DOI 10.1073/pnas.91.26.12957; Liu IM, 1996, BIOMETRICS, V52, P1223, DOI 10.2307/2532838; Lossos IS, 2000, J IMMUNOL, V165, P5122, DOI 10.4049/jimmunol.165.9.5122; Luo P, 2000, J BIOL CHEM, V275, P16146, DOI 10.1074/jbc.M909121199; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Murali R, 1997, J MOL RECOGNIT, V10, P269, DOI 10.1002/(SICI)1099-1352(199711/12)10:6<269::AID-JMR370>3.0.CO;2-9; Nguyen HP, 2003, NAT STRUCT BIOL, V10, P1019, DOI 10.1038/nsb1014; Nozawa S, 2001, TRANSPLANTATION, V72, P147, DOI 10.1097/00007890-200107150-00028; Oliva B, 1998, J MOL BIOL, V279, P1193, DOI 10.1006/jmbi.1998.1847; Oliver AM, 1999, J IMMUNOL, V162, P7198; PERLMUTTER RM, 1985, J EXP MED, V162, P1998, DOI 10.1084/jem.162.6.1998; Phan TG, 2005, J IMMUNOL, V174, P4567, DOI 10.4049/jimmunol.174.8.4567; Puga I., 2011, NAT IMMUNOL; Raghunathan G, 2012, J MOL RECOGNIT, V25, P103, DOI 10.1002/jmr.2158; Ramsland PA, 2004, J MOL BIOL, V340, P809, DOI 10.1016/j.jmb.2004.05.037; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; Sagawa T, 2003, MOL IMMUNOL, V39, P801, DOI 10.1016/S0161-5890(02)00282-1; Schelonka RL, 2007, EUR J IMMUNOL, V37, P1010, DOI 10.1002/eji.200636569; Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P2262, DOI 10.1073/pnas.96.5.2262; Sethi DK, 2006, IMMUNITY, V24, P429, DOI 10.1016/j.immuni.2006.02.010; SHER A, 1972, EUR J IMMUNOL, V2, P319, DOI 10.1002/eji.1830020405; Shirai H, 1996, FEBS LETT, V399, P1, DOI 10.1016/S0014-5793(96)01252-5; Smithson SL, 1999, MOL IMMUNOL, V36, P113, DOI 10.1016/S0161-5890(99)00024-3; Spassova MK, 2005, J ORG CHEM, V70, P3383, DOI 10.1021/jo048016l; Thomson CA, 2008, EMBO J, V27, P2592, DOI 10.1038/emboj.2008.179; Toellner KM, 2002, J EXP MED, V195, P383, DOI 10.1084/jem.20011112; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weller S, 2005, EUR J IMMUNOL, V35, P2789, DOI 10.1002/eji.200535446; WELLER S, 2004, BLOOD; Weller S, 2008, J EXP MED, V205, P1331, DOI 10.1084/jem.20071555; Weller S, 2012, BLOOD, V120, P4992, DOI 10.1182/blood-2012-07-440776; Willenbrock K, 2005, EUR J IMMUNOL, V35, P3002, DOI 10.1002/eji.200535134; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; YELTON DE, 1995, J IMMUNOL, V155, P1994	58	2	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104208	10.1371/journal.pone.0104208	http://dx.doi.org/10.1371/journal.pone.0104208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117628	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400037
J	Tsuji, N; Ninov, N; Delawary, M; Osman, S; Roh, AS; Gut, P; Stainier, DYR				Tsuji, Naoki; Ninov, Nikolay; Delawary, Mina; Osman, Sahar; Roh, Alex S.; Gut, Philipp; Stainier, Didier Y. R.			Whole Organism High Content Screening Identifies Stimulators of Pancreatic Beta-Cell Proliferation	PLOS ONE			English	Article							ZEBRAFISH; ENDODERM; GLUCOSE; APOPTOSIS; DYNAMICS; ABLATION; INSULIN; MASS	Inducing beta-cell mass expansion in diabetic patients with the aim to restore glucose homeostasis is a promising therapeutic strategy. Although several in vitro studies have been carried out to identify modulators of beta-cell mass expansion, restoring endogenous beta-cell mass in vivo has yet to be achieved. To identify potential stimulators of beta-cell replication in vivo, we established transgenic zebrafish lines that monitor and allow the quantification of cell proliferation by using the fluorescent ubiquitylation-based cell cycle indicator (FUCCI) technology. Using these new reagents, we performed an unbiased chemical screen, and identified 20 small molecules that markedly increased beta-cell proliferation in vivo. Importantly, these structurally distinct molecules, which include clinically-approved drugs, modulate three specific signaling pathways: serotonin, retinoic acid and glucocorticoids, showing the high sensitivity and robustness of our screen. Notably, two drug classes, retinoic acid and glucocorticoids, also promoted beta-cell regeneration after beta-cell ablation. Thus, this study establishes a proof of principle for a high-throughput small molecule-screen for beta-cell proliferation in vivo, and identified compounds that stimulate beta-cell proliferation and regeneration.	[Tsuji, Naoki; Ninov, Nikolay; Delawary, Mina; Osman, Sahar; Roh, Alex S.; Gut, Philipp; Stainier, Didier Y. R.] Univ Calif San Francisco, Ctr Diabet, Inst Regenerat Med, Dept Biochem & Biophys,Programs Dev & Stem Cell B, San Francisco, CA 94143 USA; [Tsuji, Naoki; Ninov, Nikolay; Delawary, Mina; Osman, Sahar; Roh, Alex S.; Gut, Philipp; Stainier, Didier Y. R.] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; [Ninov, Nikolay; Stainier, Didier Y. R.] Max Planck Inst Heart & Lung Res, Dept Dev Genet, Bad Nauheim, Germany; [Ninov, Nikolay] Tech Univ Dresden, DFG Res Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany; [Ninov, Nikolay] German Ctr Diabet Res, Paul Langerhans Inst Dresden, Dresden, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Max Planck Society; Technische Universitat Dresden; Technische Universitat Dresden	Stainier, DYR (corresponding author), Univ Calif San Francisco, Ctr Diabet, Inst Regenerat Med, Dept Biochem & Biophys,Programs Dev & Stem Cell B, San Francisco, CA 94143 USA.	didier.stainier@mpi-bn.mpg.de		Gut, Philipp/0000-0002-0689-9518; Ninov, Nikolay/0000-0003-3286-6100; Stainier, Didier/0000-0002-0382-0026	Canadian Diabetes Association; National Institutes of Health [R01 DK075032, U01 DK089541]; Packard Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075032, U01DK089541] Funding Source: NIH RePORTER	Canadian Diabetes Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a postdoctoral fellowship from the Canadian Diabetes Association (http://www.diabetes.ca/) (N.N.), as well as grants from the National Institutes of Health (R01 DK075032 and U01 DK089541)(http://www.nih.gov/) and the Packard Foundation (http://www.packard.org/) to D. Y. R. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson O, 2012, CELL METAB, V15, P885, DOI 10.1016/j.cmet.2012.04.018; Annes JP, 2012, P NATL ACAD SCI USA, V109, P3915, DOI 10.1073/pnas.1201149109; Bernard C, 1999, FASEB J, V13, P1195, DOI 10.1096/fasebj.13.10.1195; Borowiak M, 2009, CURR OPIN CELL BIOL, V21, P727, DOI 10.1016/j.ceb.2009.08.006; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cai J, 2010, J MOL CELL BIOL, V2, P50, DOI 10.1093/jmcb/mjp037; Curado S, 2007, DEV DYNAM, V236, P1025, DOI 10.1002/dvdy.21100; Eames SC, 2010, ZEBRAFISH, V7, P205, DOI 10.1089/zeb.2009.0640; Gut P, 2013, NAT CHEM BIOL, V9, P97, DOI [10.1038/NCHEMBIO.1136, 10.1038/nchembio.1136]; Jia J, 2014, CYTOTECHNOLOGY, V66, P687, DOI 10.1007/s10616-013-9622-y; Jiang Z, 2008, PLOS BIOL, V6, P2450, DOI 10.1371/journal.pbio.0060293; Jurczyk A, 2011, GEN COMP ENDOCR, V170, P334, DOI 10.1016/j.ygcen.2010.10.010; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; Ng KY, 2011, STEM CELL REV REP, V7, P53, DOI 10.1007/s12015-010-9146-1; Ninov N, 2013, CURR BIOL, V23, P1242, DOI 10.1016/j.cub.2013.05.037; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; Ohta Y, 2011, DIABETES, V60, P3208, DOI 10.2337/db10-1192; Ostrom M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002841; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Rafacho A, 2009, AM J PHYSIOL-ENDOC M, V296, pE681, DOI 10.1152/ajpendo.90931.2008; Rovira M, 2011, P NATL ACAD SCI USA, V108, P19264, DOI 10.1073/pnas.1113081108; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shen W, 2013, J AM CHEM SOC, V135, P1669, DOI 10.1021/ja309304m; Shi Y, 2005, STEM CELLS, V23, P656, DOI 10.1634/stemcells.2004-0241; Stafford D, 2006, DEVELOPMENT, V133, P949, DOI 10.1242/dev.02263; Stafford D, 2004, DEV GENES EVOL, V214, P432, DOI 10.1007/s00427-004-0420-6; STAINIER DYR, 1993, DEVELOPMENT, V119, P31; Sugiyama M, 2009, P NATL ACAD SCI USA, V106, P20812, DOI 10.1073/pnas.0906464106; SWENNE I, 1982, DIABETES, V31, P754, DOI 10.2337/diab.31.9.754; Tamplin OJ, 2012, WIRES DEV BIOL, V1, P459, DOI 10.1002/wdev.37; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Walpita D, 2012, J BIOMOL SCREEN, V17, P509, DOI 10.1177/1087057111430253	34	58	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104112	10.1371/journal.pone.0104112	http://dx.doi.org/10.1371/journal.pone.0104112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117518	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400031
J	van Atteveldt, NM; van Aalderen-Smeets, SI; Jacobi, C; Ruigrok, N				van Atteveldt, Nienke M.; van Aalderen-Smeets, Sandra I.; Jacobi, Carina; Ruigrok, Nel			Media Reporting of Neuroscience Depends on Timing, Topic and Newspaper Type	PLOS ONE			English	Article							EDUCATION; BRAIN; COVERAGE; QUALITY; SCIENCE; DECADE; PRESS; HYPE	The rapid developments in neuroscientific techniques raise high expectations among the general public and therefore warrant close monitoring of the translation to the media and daily-life applications. The need of empirical research into neuroscience communication is emphasized by its susceptibility to evoke misconceptions and polarized beliefs. As the mass media are the main sources of information about (neuro-) science for a majority of the general public, the objective of the current research is to quantify how critically and accurately newspapers report on neuroscience as a function of the timing of publication (within or outside of periods of heightened media attention to neuroscience, termed "news waves''), the topic of the research (e.g. development, health, law) and the newspaper type (quality, popular, free newspapers). The results show that articles published during neuroscience news waves were less neutral and more optimistic, but not different in accuracy. Furthermore, the overall tone and accuracy of articles depended on the topic; for example, articles on development often had an optimistic tone whereas articles on law were often skeptical or balanced, and articles on health care had highest accuracy. Average accuracy was rather low, but articles in quality newspapers were relatively more accurate than in popular and free newspapers. Our results provide specific recommendations for researchers and science communicators, to improve the translation of neuroscience findings through the media: 1) Caution is warranted during periods of heightened attention (news waves), as reporting tends to be more optimistic; 2) Caution is also warranted not to follow topic-related biases in optimism (e.g., development) or skepticism (e.g., law); 3) Researchers should keep in mind that overall accuracy of reporting is low, and especially articles in popular and free newspapers provide a minimal amount of details. This indicates that researchers themselves may need to be more active in preventing misconceptions to arise.	[van Atteveldt, Nienke M.] Vrije Univ Amsterdam, Fac Psychol & Educ & Inst Learn, Dept Educ Neurosci, Amsterdam, Netherlands; [van Atteveldt, Nienke M.] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [van Aalderen-Smeets, Sandra I.] Univ Twente, Fac Behav Sci, Ctr Sci Educ & Talent Dev SETD, NL-7500 AE Enschede, Netherlands; [Jacobi, Carina; Ruigrok, Nel] Erasmus Univ, Dept Media & Commun, Rotterdam, Netherlands; [Jacobi, Carina] Univ Vienna, Dept Commun, Vienna, Austria	Vrije Universiteit Amsterdam; Maastricht University; University of Twente; Erasmus University Rotterdam; University of Vienna	van Atteveldt, NM (corresponding author), Vrije Univ Amsterdam, Fac Psychol & Educ & Inst Learn, Dept Educ Neurosci, Amsterdam, Netherlands.	n.m.van.atteveldt@vu.nl	van Atteveldt, Nienke M/K-2124-2014	van Atteveldt, Nienke M/0000-0002-3387-6151	Dutch Organization for Scientific Research (NWO) [451-07-020]	Dutch Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Dutch Organization for Scientific Research (NWO, grant 451-07-020 to NvA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari D, 2011, EDUC PHILOS THEORY, V43, P37, DOI 10.1111/j.1469-5812.2010.00705.x; Bakker P, 2011, COMMUNICATIEKAART NE; Bann CM, 2004, DEPRESS ANXIETY, V20, P114, DOI 10.1002/da.20036; Beck DM, 2010, PERSPECT PSYCHOL SCI, V5, P762, DOI 10.1177/1745691610388779; Borgelt EL, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00293; Brechman J, 2009, SCI COMMUN, V30, P453, DOI 10.1177/1075547009332649; Brown N, 2003, TECHNOL ANAL STRATEG, V15, P3, DOI 10.1080/0953732032000046024; Bubela TM, 2004, CAN MED ASSOC J, V170, P1399, DOI 10.1503/cmaj.1030762; Connell I, 1998, JAVNOST-PUBLIC, V5, P11, DOI 10.1080/13183222.1998.11008680; Cyranoski D, 2011, NATURE, V469, P148, DOI 10.1038/469148a; De Swert, 2012, CALCULATING INTERCOD; Dekker S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00429; Devonshire IM, 2010, NEUROSCIENTIST, V16, P349, DOI 10.1177/1073858410370900; Dijkstra K-J, 1998, DOCUMENTATIECENTRUM, P258; Gonon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044275; Gonon F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014618; Goswami U, 2006, NAT REV NEUROSCI, V7, P406, DOI 10.1038/nrn1907; Green EGT, 2008, BRIT J SOC PSYCHOL, V47, P497, DOI 10.1348/014466607X248912; Herculano-Houzel S, 2002, NEUROSCIENTIST, V8, P98, DOI 10.1177/107385840200800206; Hijmans E, 2003, SCI COMMUN, V25, P153, DOI 10.1177/1075547003259559; Holtzman NA, 2005, COMMUNITY GENET, V8, P133, DOI 10.1159/000086756; Hook CJ, 2013, J COGNITIVE NEUROSCI, V25, P1397, DOI 10.1162/jocn_a_00407; Hughes S, 2013, TEACH PSYCHOL, V40, P31, DOI 10.1177/0098628312465861; Illes J, 2008, J PSYCHIATR RES, V43, P107, DOI 10.1016/j.jpsychires.2008.02.008; Illes J, 2010, NAT REV NEUROSCI, V11, P61, DOI 10.1038/nrn2773; Jones OD, 2013, J NEUROSCI, V33, P17624, DOI 10.1523/JNEUROSCI.3254-13.2013; Kandel ER, 2013, NAT REV NEUROSCI, V14, P659, DOI 10.1038/nrn3578; Kleinnijenhuis J, 1989, ACTA POLIT, V24, P433; Kroon A, TIJDSCHRIFT IN PRESS; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Moran JM, 2013, J COGNITIVE NEUROSCI, V25, P834, DOI 10.1162/jocn_a_00380; Nelkin D, 1995, SELLING SCI PRESS CO; Netherland J, 2011, SOCIOLOGICAL REFLECT, P153; O'Connor C, 2013, PUBLIC UNDERST SCI, V22, P254, DOI 10.1177/0963662513476812; O'Connor C, 2012, NEURON, V74, P220, DOI 10.1016/j.neuron.2012.04.004; Partridge BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028416; Pescosolido BA, 2010, AM J PSYCHIAT, V167, P1321, DOI 10.1176/appi.ajp.2010.09121743; Pickering SJ, 2007, MIND BRAIN EDUC, V1, P109, DOI 10.1111/j.1751-228X.2007.00011.x; Racine E, 2005, NAT REV NEUROSCI, V6, P159, DOI 10.1038/nrn1609; Racine E, 2006, SCI COMMUN, V28, P122, DOI 10.1177/1075547006291990; Racine E, 2010, SOC SCI MED, V71, P725, DOI 10.1016/j.socscimed.2010.05.017; Rodder S, 2010, COMMUNICATIONS-GER, V35, P249, DOI 10.1515/COMM.2010.014; Rose SPR, 2003, BIOCHEM SOC T, V31, P307, DOI 10.1042/BST0310307; Ruigrok N, 2009, TIJDSCHR COMMUNWET, V73, P238; Sacchet MD, 2013, NEUROIMAGE, V66, P270, DOI 10.1016/j.neuroimage.2012.10.056; Satel S., 2013, BRAINWASHED SEDUCTIV; Schleim S, 2012, INT J LAW PSYCHIAT, V35, P104, DOI 10.1016/j.ijlp.2012.01.001; Schleim S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.063.2009; Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164; Singh I, 2009, NATURE, V460, P202, DOI 10.1038/460202a; Thompson RA, 2001, AM PSYCHOL, V56, P5, DOI 10.1037//0003-066X.56.1.5; Vasterman PLM, 2005, EUR J COMMUN, V20, P508, DOI 10.1177/0267323105058254; Wardlaw JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025829; Weisberg DS, 2008, J COGNITIVE NEUROSCI, V20, P470, DOI 10.1162/jocn.2008.20040; Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308	55	15	15	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104780	10.1371/journal.pone.0104780	http://dx.doi.org/10.1371/journal.pone.0104780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO3LJ	25117741	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400082
J	Wu, MM; Chen, HC; Chen, CL; You, SL; Cheng, WF; Chen, CA; Lee, TC; Chen, CJ				Wu, Meei-Maan; Chen, Hui-Chi; Chen, Chi-Ling; You, San-Lin; Cheng, Wen-Fang; Chen, Chi-An; Lee, Te-Chang; Chen, Chien-Jen			A Prospective Study of Gynecological Cancer Risk in Relation to Adiposity Factors: Cumulative Incidence and Association with Plasma Adipokine Levels	PLOS ONE			English	Article							BODY-MASS-INDEX; EPITHELIAL OVARIAN-CANCER; ENDOMETRIAL CANCER; ANTHROPOMETRIC MEASURES; ALCOHOL-CONSUMPTION; ADIPONECTIN; OBESITY; LEPTIN; WOMEN; EPIDEMIOLOGY	Background: Associations of obesity and obesity-related metabolic factors (adiposity factors) with uterine corpus cancer (UCC) and ovarian cancer (OVC) risk have been described. Still, a cause-effect relationship and the underlying mediators remain unclear, particularly for low-incidence populations. We aimed to prospectively determine whether adiposity factors could predict the development of UCC and OVC in Taiwanese women. To explore the biological mediators linking adiposity factors to cancer risk, we examined the association of two adipokines, leptin and adiponectin, with the gynecological cancers. Methods: Totally, 11,258 women, aged 30-65, were recruited into the Community-Based Cancer Screening Program (CBCSP) study during 1991-1993, and were followed for UCC and OVC cases until December 31, 2011. Cox proportional hazard models were used to estimate hazard ratios (HRs). Adiposity factors and risk covariates were assessed at recruitment. Newly-developed cancer cases were determined from data in the government's National Cancer Registry and Death Certification System. For adipokienes study, a nested case-control study was conducted within the cohort. Baseline plasma samples of 40 incident gynecological cancer cases and 240 age-menopause-matched controls were assayed for adipokines levels. Findings: There were 38 and 30 incident cases of UCC and OVC, respectively, diagnosed during a median 19.9 years of follow-up. Multivariate analysis showed that alcohol intake (HR = 16.00, 95% = 4.83-53.00), high triglyceride levels (HR = 2.58, 95% = 1.28-5.17), and years of endogenous estrogen exposure per 5-year increment (HR = 1.91, 95% = 1.08-3.38) were associated with increased UCC risk. High body mass index (BMI >= 27 kg/m(2), HR = 2.90, 95% = 1.30-6.46) was associated with increased OVC risk. Analysis further showed an independent effect of adipokines on UCC and OVC risk after adjustment of the risk covariates. Conclusion: We provided evidence that alcohol intake, high triglyceride levels and long endogenous estrogen exposure increase UCC risk, whereas obesity positively predicts OVC risk. Circulating adipokines may mediate the link of adiposity factors to gynecological cancer risk.	[Wu, Meei-Maan; Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan; [Wu, Meei-Maan; Chen, Hui-Chi; You, San-Lin; Chen, Chien-Jen] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Wu, Meei-Maan] Taipei Med Univ, Sch Publ Hlth, Taipei, Taiwan; [Chen, Chi-Ling] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Cheng, Wen-Fang; Chen, Chi-An] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Lee, Te-Chang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Taipei Medical University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan	Wu, MM (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan.	mmwu@tmu.edu.tw; wenfangcheng@yahoo.com	Chen, Chien-Jen/N-4723-2019; Chen, Chien-Jen/C-6976-2008	CHENG, WEN-FANG/0000-0002-3282-6304; CHEN, CHI-AN/0000-0001-6670-7939; You, San-Lin/0000-0002-3192-3356	National Science Council, Executive Yuan [NSC 98-2628-B-002-083-MY3, NSC 98-2811-B-002-054, NSC 99-2811-B-002-187, NSC 100-2811-B-002-144]; National Science Council [NSC 97-2314-B-001-001-MY3, NSC 100-2314-B-001-003-MY3]	National Science Council, Executive Yuan(Ministry of Science and Technology, Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This research was funded by grants from the National Science Council, Executive Yuan (NSC 98-2628-B-002-083-MY3, NSC 98-2811-B-002-054, NSC 99-2811-B-002-187, NSC 100-2811-B-002-144). Additional supports were received from the grants of the National Science Council (NSC 97-2314-B-001-001-MY3, NSC 100-2314-B-001-003-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Ashizawa N, 2010, GYNECOL ONCOL, V119, P65, DOI 10.1016/j.ygyno.2010.07.007; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beral V, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001200; Bjorge T, 2010, AM J EPIDEMIOL, V171, P892, DOI 10.1093/aje/kwq006; BOHP, 2008, CANC REG ANN REP; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Canchola AJ, 2010, CANCER CAUSE CONTROL, V21, P2241, DOI 10.1007/s10552-010-9647-x; CASAGRANDE JT, 1979, LANCET, V2, P170; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen HC, 2011, JNCI-J NATL CANCER I, V103, P1387, DOI 10.1093/jnci/djr283; Colombo N, 2006, CRIT REV ONCOL HEMAT, V60, P159, DOI 10.1016/j.critrevonc.2006.03.004; Cramer DW, 2012, HEMATOL ONCOL CLIN N, V26, P1, DOI 10.1016/j.hoc.2011.10.009; Cust AE, 2007, J CLIN ENDOCR METAB, V92, P255, DOI 10.1210/jc.2006-1371; Cymbaluk A, 2008, EUR J OBSTET GYN R B, V136, P74, DOI 10.1016/j.ejogrb.2006.08.012; Fader AN, 2009, GYNECOL ONCOL, V114, P121, DOI 10.1016/j.ygyno.2009.03.039; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Grossmann ME, 2010, CANCER METAST REV, V29, P641, DOI 10.1007/s10555-010-9252-1; IARC, 2007, CANC INCIDENCE 5 CON, pIX; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lahmann PH, 2010, INT J CANCER, V126, P2404, DOI 10.1002/ijc.24952; Lin CH, 2012, INT J CANCER, V130, P2629, DOI 10.1002/ijc.26249; Lindemann K, 2009, INT J CANCER, V124, P2938, DOI 10.1002/ijc.24285; Luhn P, 2013, CANCER EPIDEM BIOMAR, V22, P1304, DOI 10.1158/1055-9965.EPI-13-0258; Ma X, 2013, BRIT J CANCER, V109, P751, DOI 10.1038/bjc.2013.384; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Mok SC, 2007, DIS MARKERS, V23, P367, DOI 10.1155/2007/474320; Niwa Y, 2005, J OBSTET GYNAECOL RE, V31, P452, DOI 10.1111/j.1447-0756.2005.00319.x; Olsen CM, 2007, EUR J CANCER, V43, P690, DOI 10.1016/j.ejca.2006.11.010; Olsen CM, 2013, ENDOCR-RELAT CANCER, V20, P251, DOI 10.1530/ERC-12-0395; Petridou E, 2003, J CLIN ENDOCR METAB, V88, P993, DOI 10.1210/jc.2002-021209; Purohit V, 1998, ALCOHOL CLIN EXP RES, V22, P994, DOI 10.1111/j.1530-0277.1998.tb03694.x; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Rockhill B, 1998, AM J EPIDEMIOL, V147, P826, DOI 10.1093/oxfordjournals.aje.a009535; Rzepka-Gorska I, 2008, EUR J GYNAECOL ONCOL, V29, P594; Schouten LJ, 2008, CANCER EPIDEM BIOMAR, V17, P902, DOI 10.1158/1055-9965.EPI-07-2524; Setiawan VW, 2008, INT J CANCER, V122, P634, DOI 10.1002/ijc.23072; Sharma D, 2010, HEPATOLOGY, V52, P1713, DOI 10.1002/hep.23892; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yang HP, 2012, INT J CANCER, V131, P938, DOI 10.1002/ijc.26469; Zhang Y, 2010, GYNECOL ONCOL, V117, P41, DOI 10.1016/j.ygyno.2009.12.029	42	14	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104630	10.1371/journal.pone.0104630	http://dx.doi.org/10.1371/journal.pone.0104630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115836	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400062
J	Liu, M; Wang, S; Pan, L; Yang, DQ; Xie, F; Liu, P; Guo, JJ; Zhang, JQ; Zhou, B				Liu, Miao; Wang, Shu; Pan, Lu; Yang, Deqi; Xie, Fei; Liu, Peng; Guo, Jiajia; Zhang, Jiaqing; Zhou, Bo			A New Model for Predicting Non-Sentinel Lymph Node Status in Chinese Sentinel Lymph Node Positive Breast Cancer Patients	PLOS ONE			English	Article							METASTASIS-SUPPRESSOR GENE; NONSENTINEL AXILLARY NODES; BIOPSY; INVOLVEMENT; DISSECTION; CARCINOMA; VALIDATION; NOMOGRAM; KISS-1; WOMEN	Background: Our goal is to validate the Memorial Sloan-Kettering Cancer Center (MSKCC) nomogram and Stanford Online Calculator (SOC) for predicting non-sentinel lymph node (NSLN) metastasis in Chinese patients, and develop a new model for better prediction of NSLN metastasis. Methods: The MSKCC nomogram and SOC were used to calculate the probability of NSLN metastasis in 120 breast cancer patients. Univariate and multivariate analyses were performed to evaluate the relationship between NSLN metastasis and clinicopathologic factors, using the medical records of the first 80 breast cancer patients. A new model predicting NSLN metastasis was developed from the 80 patients. Results: The MSKCC and SOC predicted NSLN metastasis in a series of 120 patients with an area under the receiver operating characteristic curve (AUC) of 0.688 and 0.734, respectively. For predicted probability cut-off points of 10%, the false-negative (FN) rates of MSKCC and SOC were both 4.4%, and the negative predictive value (NPV) 75.0% and 90.0%, respectively. Tumor size, Kiss-1 expression in positive SLN and size of SLN metastasis were independently associated with NSLN metastasis (p<0.05). A new model (Peking University People's Hospital, PKUPH) was developed using these three variables. The MSKCC, SOC and PKUPH predicted NSLN metastasis in the second 40 patients from the 120 patients with an AUC of 0.624, 0.679 and 0.795, respectively. Conclusion: MSKCC nomogram and SOC did not perform as well as their original researches in Chinese patients. As a new predictor, Kiss-1 expression in positive SLN correlated independently with NSLN metastasis strongly. PKUPH model achieved higher accuracy than MSKCC and SOC in predicting NSLN metastasis in Chinese patients.	[Liu, Miao; Wang, Shu; Pan, Lu; Yang, Deqi; Xie, Fei; Liu, Peng; Guo, Jiajia; Zhang, Jiaqing; Zhou, Bo] Peking Univ, Peoples Hosp, Breast Dis Ctr, Beijing 100871, Peoples R China	Peking University	Zhou, B (corresponding author), Peking Univ, Peoples Hosp, Breast Dis Ctr, Beijing 100871, Peoples R China.	zhoubo@pkuph.edu.cn						Barranger E, 2005, BREAST CANCER RES TR, V91, P113, DOI 10.1007/s10549-004-5781-z; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Chu KU, 1999, ANN SURG, V229, P536, DOI 10.1097/00000658-199904000-00013; Fan L, 2009, BREAST CANCER RES TR, V117, P409, DOI 10.1007/s10549-008-0303-z; Farshid G, 2004, BREAST, V13, P494, DOI 10.1016/j.breast.2004.08.005; Giuliano AE, 1997, J CLIN ONCOL, V15, P2345, DOI 10.1200/JCO.1997.15.6.2345; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Hessman CJ, 2011, ARCH SURG-CHICAGO, V146, P1035, DOI 10.1001/archsurg.2011.201; Houvenaeghel G, 2009, EJSO-EUR J SURG ONC, V35, P690, DOI 10.1016/j.ejso.2008.10.003; Hwang RF, 2003, ANN SURG ONCOL, V10, P248, DOI 10.1245/ASO.2003.05.020; Joseph KA, 2004, ARCH SURG-CHICAGO, V139, P648, DOI 10.1001/archsurg.139.6.648; Kamath VJ, 2001, ARCH SURG-CHICAGO, V136, P688, DOI 10.1001/archsurg.136.6.688; Kim T, 2006, CANCER-AM CANCER SOC, V106, P4, DOI 10.1002/cncr.21568; Klar M, 2008, BREAST CANCER RES TR, V112, P523, DOI 10.1007/s10549-007-9884-1; Kohrt HE, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-66; Kostadima L, 2007, ANTICANCER RES, V27, P2499; Krag D, 1998, NEW ENGL J MED, V339, P941, DOI 10.1056/NEJM199810013391401; Lambert LA, 2006, ANN SURG ONCOL, V13, P310, DOI 10.1245/ASO.2006.03.078; Lee JH, 1997, CANCER RES, V57, P2384; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Mitchell DC, 2006, J BIOL CHEM, V281, P51, DOI 10.1074/jbc.M506245200; Moghaddam Y, 2010, BRIT J SURG, V97, P1646, DOI 10.1002/bjs.7181; Ozmen V, 2006, BREAST CANCER RES TR, V95, P1, DOI 10.1007/s10549-005-9007-9; Pal A, 2008, BRIT J SURG, V95, P302, DOI 10.1002/bjs.5943; Ponzone R, 2007, AM J SURG, V193, P686, DOI 10.1016/j.amjsurg.2006.09.031; Rahusen FD, 2001, ARCH SURG-CHICAGO, V136, P1059, DOI 10.1001/archsurg.136.9.1059; Sachdev U, 2002, AM J SURG, V183, P213, DOI 10.1016/S0002-9610(02)00794-8; Saidi RF, 2004, AM SURGEON, V70, P101; Scow JS, 2009, CANCER, V9, P4064; Specht MC, 2012, ANN SURG ONCOL, V8, P654; Stark AM, 2005, J CANCER RES CLIN, V131, P191, DOI 10.1007/s00432-004-0629-9; Van Zee KJ, 2003, ANN SURG ONCOL, V10, P1140, DOI 10.1245/ASO.2003.03.015; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Veronesi U, 1997, LANCET, V349, P1864, DOI 10.1016/S0140-6736(97)01004-0; Weiser MR, 2001, ANN SURG ONCOL, V8, P145, DOI 10.1007/s10434-001-0145-y; Wong SL, 2001, ARCH SURG-CHICAGO, V136, P563, DOI 10.1001/archsurg.136.5.563; Xie F, 2012, SENSORS-BASEL, V12, P9936, DOI 10.3390/s120709936	37	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104117	10.1371/journal.pone.0104117	http://dx.doi.org/10.1371/journal.pone.0104117			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111296	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100031
J	Rodriguez-Ferreiro, J; Andreu, L; Sanz-Torrent, M				Rodriguez-Ferreiro, Javier; Andreu, Llorenc; Sanz-Torrent, Monica			Argument Structure and the Representation of Abstract Semantics	PLOS ONE			English	Article							HEMISPHERIC-ASYMMETRY; CONTEXT AVAILABILITY; GRAMMATICAL CLASS; LEXICAL DECISION; VERB PRODUCTION; CONCRETE WORDS; DEEP DYSPHASIA; IMPAIRMENT; RETRIEVAL; COMPREHENSION	According to the dual coding theory, differences in the ease of retrieval between concrete and abstract words are related to the exclusive dependence of abstract semantics on linguistic information. Argument structure can be considered a measure of the complexity of the linguistic contexts that accompany a verb. If the retrieval of abstract verbs relies more on the linguistic codes they are associated to, we could expect a larger effect of argument structure for the processing of abstract verbs. In this study, sets of length-and frequency-matched verbs including 40 intransitive verbs, 40 transitive verbs taking simple complements, and 40 transitive verbs taking sentential complements were presented in separate lexical and grammatical decision tasks. Half of the verbs were concrete and half were abstract. Similar results were obtained in the two tasks, with significant effects of imageability and transitivity. However, the interaction between these two variables was not significant. These results conflict with hypotheses assuming a stronger reliance of abstract semantics on linguistic codes. In contrast, our data are in line with theories that link the ease of retrieval with availability and robustness of semantic information.	[Rodriguez-Ferreiro, Javier; Sanz-Torrent, Monica] Univ Barcelona, Dept Psicol Basica, Barcelona, Spain; [Rodriguez-Ferreiro, Javier] Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Spain; [Andreu, Llorenc] Univ Oberta Catalunya, IN3, Cognit Neurosci & Informat Technol Res Program, Barcelona, Spain	University of Barcelona; University of Barcelona; UOC Universitat Oberta de Catalunya	Rodriguez-Ferreiro, J (corresponding author), Univ Barcelona, Dept Psicol Basica, Barcelona, Spain.	rodriguezferreiro@ub.edu	Andreu, Llorenç/P-2099-2019; Rodríguez-Ferreiro, Javier/B-5232-2011; Andreu, Llorenç/K-4286-2015	Andreu, Llorenç/0000-0001-8568-2511; Rodríguez-Ferreiro, Javier/0000-0001-9828-8302; Andreu, Llorenç/0000-0001-8568-2511; Sanz-Torrent, Monica/0000-0002-2012-1956	Universitat de Barcelona [PUB2011A]; national funding program (MICINN) [SEJ2007-62743]; UOC; UB	Universitat de Barcelona; national funding program (MICINN)(Ministry of Science and Innovation, Spain (MICINN)); UOC; UB	This research was supported by grant Ajuda a la recerca en ciencies socials i humanitats from the Universitat de Barcelona (PUB2011A) and grant SEJ2007-62743 by the national funding program (MICINN). Article publication was funded by UOC and UB programs supporting open access. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorni R, 2012, NEUROPSYCHOLOGIA, V50, P880, DOI 10.1016/j.neuropsychologia.2012.01.028; ANDREU L, 2012, J LANG COMMUN DISORD, V47, P637; Andreu L, 2012, J COMMUN DISORD, V45, P20, DOI 10.1016/j.jcomdis.2011.09.003; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Binder JR, 2005, J COGNITIVE NEUROSCI, V17, P905, DOI 10.1162/0898929054021102; BJORKLUND DF, 1987, DEV REV, V7, P93, DOI 10.1016/0273-2297(87)90007-4; BOLAND JE, 1993, J PSYCHOLINGUIST RES, V22, P133; BREEDIN SD, 1994, COGNITIVE NEUROPSYCH, V11, P617, DOI 10.1080/02643299408251987; CHUMBLEY JI, 1984, MEM COGNITION, V12, P590, DOI 10.3758/BF03213348; Colman KSF, 2009, CORTEX, V45, P930, DOI 10.1016/j.cortex.2008.12.010; COLTHEART M, 1980, DEEP DYSLEXIA, P22; Davis CJ, 2005, BEHAV RES METHODS, V37, P665, DOI 10.3758/BF03192738; Duchon A, 2013, BEHAV RES METHODS, V45, P1246, DOI 10.3758/s13428-013-0326-1; Fiebach CJ, 2004, NEUROPSYCHOLOGIA, V42, P62, DOI 10.1016/S0028-3932(03)00145-3; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Garbin G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045091; Goodglass H, 1969, Cortex, V5, P104; Grimshaw Jane., 2005, WORDS STRUCTURE; Grossman M, 2002, HUM BRAIN MAPP, V15, P124, DOI 10.1002/hbm.10117; *GRUP SINT ESP, 2012, BAS DAT SINT ESP ACT; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Hinojosa JA, 2001, BRAIN LANG, V78, P128, DOI 10.1006/brln.2001.2455; Jackendoff R. S., 2002, FDN LANGUAGE BRAIN M; JAMES CT, 1975, J EXP PSYCHOL HUMAN, V104, P130, DOI 10.1037/0096-1523.1.2.130; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Joordens S, 1997, J EXP PSYCHOL LEARN, V23, P1083, DOI 10.1037/0278-7393.23.5.1083; Kambanaros M, 2013, J NEUROLINGUIST, V26, P160, DOI 10.1016/j.jneuroling.2012.07.003; KATZ RB, 1990, BRAIN LANG, V39, P153, DOI 10.1016/0093-934X(90)90009-6; Kauschke C, 2008, J PSYCHOLINGUIST RES, V37, P443, DOI 10.1007/s10936-008-9073-3; Kemmerer D, 2008, BRAIN LANG, V107, P16, DOI 10.1016/j.bandl.2007.09.003; Kiehl KA, 1999, HUM BRAIN MAPP, V7, P225, DOI 10.1002/(SICI)1097-0193(1999)7:4<225::AID-HBM1>3.0.CO;2-P; KOUNIOS J, 1994, J EXP PSYCHOL LEARN, V20, P804, DOI 10.1037/0278-7393.20.4.804; KROLL JF, 1986, J EXP PSYCHOL LEARN, V12, P92, DOI 10.1037/0278-7393.12.1.92; Levin Beth, 1995, UNACCUSATIVITY SYNTA; MARTIN N, 1992, BRAIN LANG, V43, P240, DOI 10.1016/0093-934X(92)90130-7; MCMULLEN PA, 1987, BRAIN LANG, V31, P11, DOI 10.1016/0093-934X(87)90057-5; Morey R. D., 2014, BAYESFACTOR COMPUTAT; Morrison CM, 2000, BRIT J PSYCHOL, V91, P167, DOI 10.1348/000712600161763; Nieto A, 1999, BRAIN LANG, V70, P421, DOI 10.1006/brln.1999.2180; Noppeney U, 2004, NEUROIMAGE, V22, P164, DOI 10.1016/j.neuroimage.2003.12.010; PAIVIO A, 1991, CAN J PSYCHOL, V45, P255, DOI 10.1037/h0084295; Paivio A., 1978, INT J PSYCHOLINGUIST, V5, P31; Perani D, 1999, BRAIN, V122, P2337, DOI 10.1093/brain/122.12.2337; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Recchia G, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00315; Rodriguez-Ferreiro J, 2011, J COGNITIVE NEUROSCI, V23, P106, DOI 10.1162/jocn.2010.21414; Ruschemeyer SA, 2007, J COGNITIVE NEUROSCI, V19, P855, DOI 10.1162/jocn.2007.19.5.855; Sabsevitz DS, 2005, NEUROIMAGE, V27, P188, DOI 10.1016/j.neuroimage.2005.04.012; Sadoski M., 2004, THEORETICAL MODELS P, V5th, P1329, DOI DOI 10.1598/0872075028.47; Sanchez-Casas R, 2012, SPAN J PSYCHOL, V15, P891, DOI 10.5209/rev_SJOP.2012.v15.n3.39382; SCHWANENFLUGEL PJ, 1989, READ RES QUART, V24, P114, DOI 10.2307/748013; SCHWANENFLUGEL PJ, 1983, J EXP PSYCHOL LEARN, V9, P82, DOI 10.1037/0278-7393.9.1.82; SCHWANENFLUGEL PJ, 1991, PSYCHOLOGY OF WORD MEANINGS, P223; Sebastian N., 2000, LEXESP LEXICO INFORM; SHAPIRO LP, 1990, BRAIN LANG, V38, P21, DOI 10.1016/0093-934X(90)90100-U; STRAIN E, 1995, J EXP PSYCHOL LEARN, V21, P1140, DOI 10.1037/0278-7393.21.5.1140; Thompson CK, 1997, APHASIOLOGY, V11, P473, DOI 10.1080/02687039708248485; Thompson CK, 2003, J NEUROLINGUIST, V16, P151, DOI 10.1016/S0911-6044(02)00014-3; THOMSON CK, 2007, J COGNITIVE NEUROSCI, V11, P1753; van Hell JG, 1998, Q J EXP PSYCHOL-A, V51, P41, DOI 10.1080/713755752; Vigliocco G, 2008, BRAIN LANG, V105, P175, DOI 10.1016/j.bandl.2007.10.003; WARRINGTON EK, 1975, Q J EXP PSYCHOL, V27, P635, DOI 10.1080/14640747508400525; Wetzels R., ENCY CLIN PSYCHOL; Xiao X, 2012, BRAIN LANG, V120, P251, DOI 10.1016/j.bandl.2011.09.006; ZINGESER LB, 1990, BRAIN LANG, V39, P14, DOI 10.1016/0093-934X(90)90002-X	66	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104645	10.1371/journal.pone.0104645	http://dx.doi.org/10.1371/journal.pone.0104645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WB	25111701	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100086
J	Saboisky, JP; Stashuk, DW; Hamilton-Wright, A; Trinder, J; Nandedkar, S; Malhotra, A				Saboisky, Julian P.; Stashuk, Daniel W.; Hamilton-Wright, Andrew; Trinder, John; Nandedkar, Sanjeev; Malhotra, Atul			Effects of Aging on Genioglossus Motor Units in Humans	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; UPPER AIRWAY; HUMAN TONGUE; QUANTITATIVE-ANALYSIS; DIAGNOSTIC YIELD; NEEDLE EMG; MACRO EMG; OLDER-MEN; MUSCLE; AGE	The genioglossus is a major upper airway dilator muscle thought to be important in obstructive sleep apnea pathogenesis. Aging is a risk factor for obstructive sleep apnea although the mechanisms are unclear and the effects of aging on motor unit remodeled in the genioglossus remains unknown. To assess possible changes associated with aging we compared quantitative parameters related to motor unit potential morphology derived from EMG signals in a sample of older (n = 11; >55 years) versus younger (n = 29; <55 years) adults. All data were recorded during quiet breathing with the subjects awake. Diagnostic sleep studies (Apnea Hypopnea Index) confirmed the presence or absence of obstructive sleep apnea. Genioglossus EMG signals were analyzed offline by automated software (DQEMG), which estimated a MUP template from each extracted motor unit potential train (MUPT) for both the selective concentric needle and concentric needle macro (CNMACRO) recorded EMG signals. 2074 MUPTs from 40 subjects (mean +/- 95% CI; older AHI 19.6 +/- 9.9 events/hr versus younger AHI 30.1 +/- 6.1 events/hr) were extracted. MUPs detected in older adults were 32% longer in duration (14.7 +/- 0.5 ms versus 11.1 +/- 0.2 ms; P = 0.05), with similar amplitudes (395.2 +/- 25.1 mu V versus 394.6 +/- 13.7 mu V). Amplitudes of CNMACRO MUPs detected in older adults were larger by 22% (62.7 +/- 6.5 mu V versus 51.3 +/- 3.0 mu V; P<0.05), with areas 24% larger (160.6 +/- 18.6 mu V.ms versus 130.0 +/- 7.4 mu V.ms; P<0.05) than those detected in younger adults. These results confirm that remodeled motor units are present in the genioglossus muscle of individuals above 55 years, which may have implications for OSA pathogenesis and aging related upper airway collapsibility.	[Saboisky, Julian P.; Malhotra, Atul] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Saboisky, Julian P.; Malhotra, Atul] Harvard Univ, Sch Med, Boston, MA USA; [Saboisky, Julian P.] Neurosci Res Australia, Sydney, NSW, Australia; [Saboisky, Julian P.] Univ New S Wales, Fac Med, Prince Wales Clin Sch, Sydney, NSW, Australia; [Stashuk, Daniel W.] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada; [Hamilton-Wright, Andrew] Mt Allison Univ, Sackville, NB E0A 3C0, Canada; [Trinder, John] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia; [Nandedkar, Sanjeev] Natus Med Inc, Middleton, WI USA; [Malhotra, Atul] Univ Calif San Diego, La Jolla, CA 92093 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Neuroscience Research Australia; University of New South Wales Sydney; University of Waterloo; Mount Allison University; University of Melbourne; University of California System; University of California San Diego	Saboisky, JP (corresponding author), Brigham & Womens Hosp, Div Sleep Med, 75 Francis St, Boston, MA 02115 USA.	J.SABOISKY@neura.edu.au	Saboisky, Julian/P-5782-2014; Hamilton-Wright, Andrew/A-1054-2008	Saboisky, Julian/0000-0002-9450-6023; Hamilton-Wright, Andrew/0000-0002-7459-656X	National Institutes of Health [5K24HL093218-02, 5R01HL090897-02]; National Health Medical Research Council of Australia [GNT1036576]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL093218, R01HL085188, R01HL090897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from: National Institutes of Health 5K24HL093218-02 and 5R01HL090897-02 and Julian Saboisky is funded through National Health Medical Research Council of Australia, Early Career Fellowships: GNT1036576. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Malek S, 1938, J ANAT, V73, P15; Anderson R J, 1881, J Anat Physiol, V15, P382; ANIANSSON A, 1992, J APPL PHYSIOL, V73, P812, DOI 10.1152/jappl.1992.73.3.812; BISCHOFF C, 1991, ELECTROEN CLIN NEURO, V81, P304, DOI 10.1016/0168-5597(91)90017-R; Browne HAK, 2003, EUR RESPIR J, V21, P523, DOI 10.1183/09031936.03.00039002; Browne HAK, 2001, J APPL PHYSIOL, V90, P1074, DOI 10.1152/jappl.2001.90.3.1074; BUCHTHAL F, 1977, Acta Neurologica (Naples), V32, P1; BUCHTHAL F, 1954, ACTA PHYSIOL SCAND, V32, P200, DOI 10.1111/j.1748-1716.1954.tb01167.x; BUCHTHAL F, 1982, MUSCLE NERVE, V5, P265, DOI 10.1002/mus.880050403; BUCHTHAL F, 1980, PHYSIOL REV, V60, P90, DOI 10.1152/physrev.1980.60.1.90; BURGER CD, 1992, AM REV RESPIR DIS, V145, P846, DOI 10.1164/ajrccm/145.4_Pt_1.846; Calder KM, 2008, J NEUROSCI METH, V168, P483, DOI 10.1016/j.jneumeth.2007.10.008; Carlisle T, 2014, EUROPEAN RESP J; Carrera M, 1999, AM J RESP CRIT CARE, V159, P1960, DOI 10.1164/ajrccm.159.6.9809052; Cheng S, 2008, J PHYSIOL-LONDON, V586, P4283, DOI 10.1113/jphysiol.2008.156430; Chowdhuri S, 2008, RESP PHYSIOL NEUROBI, V160, P65, DOI 10.1016/j.resp.2007.08.007; CURTO FS, 1980, EAR NOSE THROAT J, V59, P94; Eastwood PR, 2003, J APPL PHYSIOL, V94, P1849, DOI 10.1152/japplphysiol.01017.2002; Edwards BA, 2010, SEMIN RESP CRIT CARE, V31, P618, DOI 10.1055/s-0030-1265902; Eikermann M, 2007, CHEST, V131, P1702, DOI 10.1378/chest.06-2653; FAWCETT PRW, 1985, J NEUROL SCI, V69, P67, DOI 10.1016/0022-510X(85)90008-5; Fenrich K, 2004, CAN J NEUROL SCI, V31, P142, DOI 10.1017/S0317167100053798; Finsterer J, 1997, J NEUROL NEUROSUR PS, V63, P175, DOI 10.1136/jnnp.63.2.175; FITZGERALD MJT, 1958, J ANAT, V92, P178; Fogel RB, 2003, J PHYSIOL-LONDON, V553, P533, DOI 10.1113/jphysiol.2003.045708; FUGLSANGFREDERIKSEN A, 1977, J NEUROL NEUROSUR PS, V40, P544, DOI 10.1136/jnnp.40.6.544; Goff EA, 2008, SLEEP, V31, P1009; Goff EA, 2012, J SLEEP RES, V21, P718, DOI 10.1111/j.1365-2869.2012.01019.x; Goff EA, 2010, CLIN AUTON RES, V20, P175, DOI 10.1007/s10286-009-0027-0; Hiiemae KM, 2003, CRIT REV ORAL BIOL M, V14, P413, DOI 10.1177/154411130301400604; HOCH CC, 1990, SLEEP, V13, P502, DOI 10.1093/sleep/13.6.502; JABRE JF, 1991, MUSCLE NERVE, V14, P820, DOI 10.1002/mus.880140904; Kollias I, 1999, EUR J ORTHODONT, V21, P333, DOI 10.1093/ejo/21.4.333; Malhotra A., 2006, AM J MED, V119, p72.; Martic V, 2008, MUSCLE NERVE, V38, P939, DOI 10.1002/mus.21011; Martin SE, 1997, EUR RESPIR J, V10, P2087, DOI 10.1183/09031936.97.10092087; Mayer P, 1996, EUR RESPIR J, V9, P1801, DOI 10.1183/09031936.96.09091801; Mayer P, 1999, AM J RESP CRIT CARE, V159, P213, DOI 10.1164/ajrccm.159.1.9709051; McClung JR, 2000, ANAT REC, V260, P378, DOI 10.1002/1097-0185(20001201)260:4<378::AID-AR70>3.0.CO;2-A; MCCOMAS AJ, 1971, J NEUROL NEUROSUR PS, V34, P453, DOI 10.1136/jnnp.34.4.453; Mehra R, 2009, ARCH INTERN MED, V169, P1147, DOI 10.1001/archinternmed.2009.138; Morrell MJ, 2012, EUR RESPIR J, V40, P386, DOI 10.1183/09031936.00177411; Mu LC, 2000, ANAT REC, V260, P308, DOI 10.1002/1097-0185(20001101)260:3<308::AID-AR70>3.0.CO;2-N; Mu LC, 2010, CLIN ANAT, V23, P777, DOI 10.1002/ca.21011; NANDEDKAR S, 1983, ELECTROEN CLIN NEURO, V56, P52, DOI 10.1016/0013-4694(83)90006-8; NANDEDKAR SD, 1984, IEEE T BIO-MED ENG, V31, P220, DOI 10.1109/TBME.1984.325332; NANDEDKAR SD, 1988, ELECTROEN CLIN NEURO, V69, P561, DOI 10.1016/0013-4694(88)90168-X; NANDEDKAR SD, 1988, ELECTROEN CLIN NEURO, V70, P177, DOI 10.1016/0013-4694(88)90117-4; Nashed J, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-39; Saboisky JP, 2006, J NEUROPHYSIOL, V95, P2213, DOI 10.1152/jn.00940.2005; Saboisky JP, 2007, J PHYSIOL-LONDON, V585, P135, DOI 10.1113/jphysiol.2007.139584; Saboisky JP, 2007, J NEUROSCI METH, V162, P287, DOI 10.1016/j.jneumeth.2007.01.006; Saboisky JP, 2012, AM J RESP CRIT CARE, V185, P322, DOI 10.1164/rccm.201106-1058OC; Saboisky JP, 2010, J APPL PHYSIOL, V109, P1939, DOI 10.1152/japplphysiol.00812.2010; SACCO G, 1962, ARCH NEUROL-CHICAGO, V6, P366, DOI 10.1001/archneur.1962.00450230028004; Saigusa H, 2001, ANN OTO RHINOL LARYN, V110, P779, DOI 10.1177/000348940111000815; SAUERLAND EK, 1976, EXP NEUROL, V51, P160, DOI 10.1016/0014-4886(76)90061-3; Song MK, 2012, PSYCHIAT INVEST, V9, P65, DOI 10.4306/pi.2012.9.1.65; Sonoo M, 2002, MUSCLE NERVE, pS98, DOI 10.1002/mus.10154; STALBERG E, 1989, MUSCLE NERVE, V12, P382, DOI 10.1002/mus.880120508; STALBERG E, 1986, J CLIN NEUROPHYSIOL, V3, P313; STALBERG E, 1982, MUSCLE NERVE, V5, pS135; Stashuk DW, 1999, MED ENG PHYS, V21, P389, DOI 10.1016/S1350-4533(99)00064-8; Svanborg E, 2005, RESP PHYSIOL NEUROBI, V147, P263, DOI 10.1016/j.resp.2005.06.012; Takeda N, 2000, LARYNGOSCOPE, V110, P1018, DOI 10.1097/00005537-200006000-00025; Takemoto H, 2001, J SPEECH LANG HEAR R, V44, P95, DOI 10.1044/1092-4388(2001/009); Tishler PV, 2003, JAMA-J AM MED ASSOC, V289, P2230, DOI 10.1001/jama.289.17.2230; Tsuiki S, 2000, EUR RESPIR J, V15, P906, DOI 10.1034/j.1399-3003.2000.15e16.x; VOGT T, 1990, J NEUROL NEUROSUR PS, V53, P331, DOI 10.1136/jnnp.53.4.331; Wellman A, 2007, J PHYSIOL-LONDON, V581, P291, DOI 10.1113/jphysiol.2006.126409; Wilkinson V, 2008, SLEEP, V31, P525, DOI 10.1093/sleep/31.4.525; Worsnop C, 2000, J APPL PHYSIOL, V88, P1831, DOI 10.1152/jappl.2000.88.5.1831; Yamaguchi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092808; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zalewska E, 2004, CLIN NEUROPHYSIOL, V115, P543, DOI 10.1016/j.clinph.2003.10.031; ZALEWSKA E, 1995, IEEE T BIO-MED ENG, V42, P616, DOI 10.1109/10.387201	76	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104572	10.1371/journal.pone.0104572	http://dx.doi.org/10.1371/journal.pone.0104572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111799	Green Published, gold			2022-12-27	WOS:000341105100076
J	You, YS; Lee, CY; Li, C; Lee, SH; Kim, K; Jung, H				You, Yong Sung; Lee, Chang Yeol; Li, Chengguo; Lee, Sung Ho; Kim, Kibom; Jung, Hyungil			An Arched Micro-Injector (ARCMI) for Innocuous Subretinal Injection	PLOS ONE			English	Article							MACULAR DEGENERATION; GANCICLOVIR IMPLANT; TOWER MICRONEEDLE; DRUG-DELIVERY	Several critical ocular diseases that can lead to blindness are due to retinal disorders. Subretinal drug delivery has been developed recently for the treatment of retinal disorders such as hemorrhage because of the specific ocular structure, namely, the blood retinal barrier (BRB). In the present study, we developed an Arched Micro-injector (ARCMI) for subretinal drug delivery with minimal retinal tissue damage. ARCMIs were fabricated using three major techniques: reverse drawing lithography, controlled air flow, and electroplating. In order to achieve minimal retinal tissue damage, ARCMIs were fabricated with specific features such as a 0.15 mm(-1) curvature, 45 degrees tip bevel, 5 mm length, inner diameter of 40 mu m, and an outer diameter of 100 mu m. These specific features were optimized via in-vitro experiments in artificial ocular hemispherical structures and subretinal injection of indocyanine green in porcine eye ex-vivo. We confirmed that the ARCMI was capable of delivering ocular drugs by subretinal injection without unusual subretinal tissue damage, including hemorrhage.	[You, Yong Sung] Nune Eye Hosp, Seoul, South Korea; [Lee, Chang Yeol; Li, Chengguo; Jung, Hyungil] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea; [Lee, Sung Ho; Kim, Kibom] Lumieye Genet Co Ltd, Seoul, South Korea	Yonsei University	Jung, H (corresponding author), Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea.	hijung@yonsei.ac.kr			Korean Health Technology R& D Project, Ministry for Health, Welfare, Republic of Korea [A102003]; Public Welfare & Safety Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Education, Science, and Technology [2010-0020772]	Korean Health Technology R& D Project, Ministry for Health, Welfare, Republic of Korea; Public Welfare & Safety Research Program through the National Research Foundation of Korea (NRF) - the Ministry of Education, Science, and Technology	This study was supported by a grant from the Korean Health Technology R& D Project, Ministry for Health, Welfare, Republic of Korea (A102003) and the Public Welfare & Safety Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2010-0020772). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2000, INVEST OPHTH VIS SCI, V41, P1186; Baba T, 2010, AM J PATHOL, V176, P3085, DOI 10.2353/ajpath.2010.090989; Hillenkamp J, 2010, GRAEF ARCH CLIN EXP, V248, P5, DOI 10.1007/s00417-009-1158-7; Janoria KG, 2007, EXPERT OPIN DRUG DEL, V4, P371, DOI 10.1517/17425247.4.4.371; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; LAM TT, 1991, GRAEF ARCH CLIN EXP, V229, P389, DOI 10.1007/BF00170699; Lee CY, 2013, BIOMED MICRODEVICES, V15, P841, DOI 10.1007/s10544-013-9771-y; Lee CY, 2013, ADV HEALTHC MATER, V2, P812, DOI 10.1002/adhm.201200239; MARTIN DF, 1994, ARCH OPHTHALMOL-CHIC, V112, P1531, DOI 10.1001/archopht.1994.01090240037023; Olivier S, 2004, OPHTHALMOLOGY, V111, P1201, DOI 10.1016/j.ophtha.2003.10.020; Sharma RK, 1999, SURV OPHTHALMOL, V43, P427, DOI 10.1016/S0039-6257(99)00006-5; Srivastava S, 2004, OPHTHAL SURG LAS IM, V35, P254, DOI 10.3928/1542-8877-20040501-16; Stanzel BV, 2012, INVEST OPHTH VIS SCI, V53, P490, DOI 10.1167/iovs.11-8260; Suesskind D, 2014, GRAEF ARCH CLIN EXP, V252, P873, DOI 10.1007/s00417-013-2512-3	14	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104145	10.1371/journal.pone.0104145	http://dx.doi.org/10.1371/journal.pone.0104145			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111562	Green Submitted, gold, Green Published			2022-12-27	WOS:000341105100033
J	Joo, YB; Bang, SY; Kim, TH; Shim, SC; Lee, S; Joo, KB; Kim, JH; Min, HJ; Rahman, P; Inman, RD				Joo, Young Bin; Bang, So-Young; Kim, Tae-Hwan; Shim, Seung-Cheol; Lee, Seunghun; Joo, Kyung Bin; Kim, Jong Heon; Min, Hye Joon; Rahman, Proton; Inman, Robert D.			Bone Morphogenetic Protein 6 Polymorphisms Are Associated with Radiographic Progression in Ankylosing Spondylitis	PLOS ONE			English	Article							GENETIC POLYMORPHISMS; DISEASE SEVERITY; CLINICAL-TRIALS; DAMAGE; SPONDYLOARTHRITIS; SUSCEPTIBILITY; SYNDESMOPHYTES; RISK; SPONDYLARTHRITIS; IDENTIFICATION	Background and Object: Nearly 25 genetic loci associated with susceptibility to ankylosing spondylitis (AS) have been identified by several large studies. However, there have been limited studies to identify the genes associated with radiographic severity of the disease. Thus we investigated which genes involved in bone formation pathways might be associated with radiographic severity in AS. Methods: A total of 417 Korean AS patients were classified into two groups based on the radiographic severity as defined by the modified Stoke' Ankylosing Spondylitis Spinal Score (mSASSS) system. Severe AS was defined by the presence of syndesmophytes and/or fusion in the lumbar or cervical spine (n = 195). Mild AS was defined by the absence of any syndesmophyte or fusion (n = 170). A total of 251 single nucleotide polymorphisms (SNPs) within 52 genes related to bone formation were selected and genotyped. Odds ratios (OR) and 95% confidence interval (95% CI) were analysed by multivariate logistic regression controlling for age at onset of symptoms, sex, disease duration, and smoking status as covariates. Results: We identified new loci of bone morphogenetic protein 6 (BMP6) associated with radiographic severity in patients with AS that passed false discovery rate threshold. Two SNPs in BMP6 were significantly associated with radiologic severity [rs270378 (OR 1.97, p = 6.74x10(-4)) and rs1235192 [OR 1.92, p = 1.17x10(-3)]) adjusted by covariates. Conclusion: This is the first study to demonstrate that BMP6 is associated with radiographic severity in AS, supporting the role wingless-type like/BMP pathway on radiographic progression in AS.	[Joo, Young Bin; Bang, So-Young; Kim, Tae-Hwan] Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133791, South Korea; [Shim, Seung-Cheol] Chungnam Natl Univ Hosp, Daejeon Rheumatoid & Degenerat Arthrit Ctr, Div Rheumatol, Taejon, South Korea; [Lee, Seunghun; Joo, Kyung Bin] Hanyang Univ, Hosp Rheumat Dis, Dept Radiol, Seoul 133791, South Korea; [Kim, Jong Heon] Hanyang Univ, Hosp Rheumat Dis, Dept Orthoped, Seoul 133791, South Korea; [Min, Hye Joon] Cornell Univ, Dept Anthropol, Ithaca, NY USA; [Rahman, Proton] Mem Univ Newfoundland, St Clares Mercy Hosp, Dept Rheumatol, St John, NF, Canada; [Inman, Robert D.] Univ Toronto, Toronto Western Hosp, Div Rheumatol, Toronto, ON M5T 2S8, Canada	Hanyang University; Chungnam National University; Chungnam National University Hospital; Hanyang University; Hanyang University; Cornell University; Memorial University Newfoundland; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Kim, TH (corresponding author), Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133791, South Korea.	thkim@hanyang.ac.kr		Shim, Seung cheol/0000-0002-3199-359X; Inman, Robert/0000-0002-4750-1422				Appel H, 2009, ARTHRITIS RHEUM-US, V60, P3257, DOI 10.1002/art.24888; Ashley-Koch AE, 2008, BLOOD, V111, P5721, DOI 10.1182/blood-2007-02-074849; Baldwin C, 2005, BLOOD, V106, P372, DOI 10.1182/blood-2005-02-0548; Bandarian F, 2013, LIPIDS, V48, P1207, DOI 10.1007/s11745-013-3847-6; Baraliakos X, 2007, ANN RHEUM DIS, V66, P910, DOI 10.1136/ard.2006.066415; Baraliakos X, 2009, J RHEUMATOL, V36, P997, DOI 10.3899/jrheum.080871; Bartolome N, 2012, RHEUMATOLOGY, V51, P1471, DOI 10.1093/rheumatology/kes056; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bobacz K, 2003, ARTHRITIS RHEUM-US, V48, P2501, DOI 10.1002/art.11248; Brophy S, 2004, J RHEUMATOL, V31, P1775; Brown MA, 2008, RHEUMATOLOGY, V47, P132, DOI 10.1093/rheumatology/kem269; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; CARETTE S, 1983, ARTHRITIS RHEUM, V26, P186, DOI 10.1002/art.1780260210; Carter S, 2012, THER ADV MUSCULOSKEL, V4, P293, DOI 10.1177/1759720X12444175; Chen HA, 2011, SEMIN ARTHRITIS RHEU, V40, P552, DOI 10.1016/j.semarthrit.2010.07.008; Chen HA, 2010, J RHEUMATOL, V37, P2126, DOI 10.3899/jrheum.100200; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Creemers MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503; Dougados M, 2012, ARTHRIT CARE RES, V64, P290, DOI 10.1002/acr.20671; Edmondson AC, 2011, CIRC-CARDIOVASC GENE, V4, P145, DOI 10.1161/CIRCGENETICS.110.957563; GITELMAN SE, 1994, J CELL BIOL, V126, P1595, DOI 10.1083/jcb.126.6.1595; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Haroon N, 2012, ARTHRITIS RHEUM-US, V64, P1119, DOI 10.1002/art.33430; Heiland GR, 2012, ANN RHEUM DIS, V71, P572, DOI 10.1136/annrheumdis-2011-200216; Jane JA, 2002, MOL THER, V6, P464, DOI 10.1006/mthe.2002.0691; Khan MA, 2002, BEST PRACT RES CL RH, V16, P675, DOI 10.1053/BERH.2002.0243; Kroon F, 2012, ANN RHEUM DIS, V71, P1623, DOI 10.1136/annrheumdis-2012-201370; Lian ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061527; Lories RJU, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2642; Lories RJU, 2005, J CLIN INVEST, V115, P1571, DOI 10.1172/JCI23738; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Maksymowych WP, 2007, ARTHRITIS RHEUM-US, V56, P1846, DOI 10.1002/art.22589; Park MC, 2008, SCAND J RHEUMATOL, V37, P200, DOI 10.1080/03009740701774941; Pimentel-Santos FM, 2012, J RHEUMATOL, V39, P131, DOI 10.3899/jrheum.110681; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; Ramiro S, 2014, ANN RHEUM DIS; Schett G, 2010, BEST PRACT RES CL RH, V24, P363, DOI 10.1016/j.berh.2010.01.005; Seo JS, 2005, RHEUMATOLOGY, V44, P1299, DOI 10.1093/rheumatology/kei013; Slattery ML, 2013, INT J CANCER, V132, P2928, DOI 10.1002/ijc.27960; Szczypiorska M, 2011, RHEUMATOLOGY, V50, P1969, DOI 10.1093/rheumatology/ker229; Ulug P, 2009, ANN HEMATOL, V88, P803, DOI 10.1007/s00277-008-0659-5; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; van der Heijde D, 2008, ARTHRITIS RHEUM-US, V58, P1324, DOI 10.1002/art.23471; van der Heijde D, 2005, J RHEUMATOL, V32, P2048; van der Heijde D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2794; van Tubergen A, 2012, ANN RHEUM DIS, V71, P518, DOI 10.1136/annrheumdis-2011-200411; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wanders AJB, 2004, ARTHRITIS RHEUM-US, V50, P2622, DOI 10.1002/art.20446; Wang CM, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3855; Ward MM, 2009, ARTHRIT RHEUM-ARTHR, V61, P859, DOI 10.1002/art.24585	50	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104966	10.1371/journal.pone.0104966	http://dx.doi.org/10.1371/journal.pone.0104966			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121767	Green Submitted, Green Published, gold			2022-12-27	WOS:000341017000080
J	Mathur, A; Abd Elmageed, ZY; Liu, XC; Kostochka, ML; Zhang, HT; Abdel-Mageed, AB; Mondal, D				Mathur, Aditi; Abd Elmageed, Zakaria Y.; Liu, Xichun; Kostochka, Mikhail L.; Zhang, Haitao; Abdel-Mageed, Asim B.; Mondal, Debasis			Subverting ER-Stress towards Apoptosis by Nelfinavir and Curcumin Coexposure Augments Docetaxel Efficacy in Castration Resistant Prostate Cancer Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM-STRESS; HIV-1 PROTEASE INHIBITOR; IN-VITRO; AKT PHOSPHORYLATION; DOWN-REGULATION; GROWTH ARREST; COMBINATION; TRIB3; GRP78; SENSITIZATION	Despite its side-effects, docetaxel (DTX) remains a first-line treatment against castration resistant prostate cancer (CRPC). Therefore, strategies to increase its anti-tumor efficacy and decrease its side effects are critically needed. Targeting of the constitutive endoplasmic reticulum (ER) stress in cancer cells is being investigated as a chemosensitization approach. We hypothesized that the simultaneous induction of ER-stress and suppression of PI3K/AKT survival pathway will be a more effective approach. In a CRPC cell line, C4-2B, we observed significant (p<0.005) enhancement of DTX-induced cytotoxicity following coexposure to thapsigargin and an AKT-inhibitor. However, since these two agents are not clinically approved, we investigated whether a combination of nelfinavir (NFR) and curcumin (CUR), known to target both these metabolic pathways, can similarly increase DTX cytotoxicity in CRPC cells. Within 24 hrs post-exposure to physiologic concentrations of NFR (5 mM) and CUR (5 mM) a significantly (p<0.005) enhanced cytotoxicity was evident with low concentration of DTX (10 nM). This 3-drug combination rapidly increased apoptosis in aggressive C4-2B cells, but not in RWPE-1 cells or in primary prostate epithelial cells (PrEC). Comparative molecular studies revealed that this 3-drug combination caused a more pronounced suppression of phosphorylated-AKT and higher induction in phosphorylated-eIF2 alpha in C4-2B cells, as compared to RWPE-1 cells. Acute exposure (3-9 hrs) to this 3-drug combination intensified ER-stress induced pro-apoptotic markers, i.e. ATF4, CHOP, and TRIB3. At much lower concentrations, chronic (3 wks) exposures to these three agents drastically reduced colony forming units (CFU) by C4-2B cells. In vivo studies using mice containing C4-2B tumor xenografts showed significant (p<0.05) enhancement of DTX's (10 mg/kg) anti-tumor efficacy following coexposure to NFR (20 mg/kg) & CUR (100 mg/kg). Immunohistochemical (IHC) analyses of tumor sections indicated decreased Ki-67 staining and increased TUNEL intensity in mice exposed to the 3-drug combination. Therefore, subverting ER-stress towards apoptosis using adjuvant therapy with NFR and CUR can chemosensitize the CRPC cells to DTX therapy.	[Mathur, Aditi; Mondal, Debasis] Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA; [Abd Elmageed, Zakaria Y.; Abdel-Mageed, Asim B.] Tulane Univ, Sch Med, Dept Urol, New Orleans, LA 70112 USA; [Liu, Xichun; Zhang, Haitao] Tulane Univ, Sch Med, Dept Pathol, New Orleans, LA 70112 USA; [Kostochka, Mikhail L.] Tulane Univ, Sch Med, Peptide Res Labs, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University; Tulane University	Mondal, D (corresponding author), Tulane Univ, Sch Med, Dept Pharmacol, New Orleans, LA 70112 USA.	dmondal@tulane.edu	Elmageed, Zakaria Y Abd/O-3456-2018	Elmageed, Zakaria Y Abd/0000-0003-4031-0348; Abdel-Mageed, Asim/0000-0001-8590-783X	Department of Defense [PC080811, PC081598]; Louisiana Cancer Research Consortium (LCRC)	Department of Defense(United States Department of Defense); Louisiana Cancer Research Consortium (LCRC)	These studies were supported by grants from the Department of Defense, to D.M. (#PC080811) and to A.B.A. (#PC081598), and funds from the Louisiana Cancer Research Consortium (LCRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2008, CANCER LETT, V267, P133, DOI 10.1016/j.canlet.2008.03.025; [Anonymous], 2003, METH MOL B; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Baril Jean-Guy, 2003, Can J Infect Dis, V14, P201; Basile V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053664; Bernstein WB, 2008, CURR OPIN HIV AIDS, V3, P666, DOI 10.1097/COH.0b013e328313915d; Bruning A, 2011, METHOD ENZYMOL, V491, P127, DOI 10.1016/B978-0-12-385928-0.00008-0; Bruning A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-19; Chen TC, 2011, CANCER LETT, V302, P100, DOI 10.1016/j.canlet.2010.11.008; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; DYKES DJ, 1995, INVEST NEW DRUG, V13, P1, DOI 10.1007/BF02614214; Funk MB, 1999, AIDS, V13, P1653, DOI 10.1097/00002030-199909100-00008; Galsky MD, 2010, ANN ONCOL, V21, P2135, DOI 10.1093/annonc/mdq050; Gills J, 2007, CLIN CANCER RES, V13, P5183, DOI 10.1158/1078-0432.CCR-07-0161; Gupta AK, 2007, NEOPLASIA, V9, P271, DOI 10.1593/neo.07124; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; He HN, 2010, CANCER LETT, V295, P38, DOI 10.1016/j.canlet.2010.02.011; Healy SJM, 2009, EUR J PHARMACOL, V625, P234, DOI 10.1016/j.ejphar.2009.06.064; Higano CS, 2011, UROL ONCOL-SEMIN ORI, V29, pS1, DOI 10.1016/j.urolonc.2011.08.013; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Ikezoe T, 2004, CANCER RES, V64, P7426, DOI 10.1158/0008-5472.CAN-03-2677; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Kosaka T, 2011, J UROLOGY, V185, P2376, DOI 10.1016/j.juro.2011.02.016; Lee HK, 2008, NEURO-ONCOLOGY, V10, P236, DOI 10.1215/15228517-2008-006; Lin SS, 2008, CANCER LETT, V272, P77, DOI 10.1016/j.canlet.2008.06.031; Liu CF, 2013, PROSTATE, V73, P418, DOI 10.1002/pros.22583; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mhaidat N, 2008, APOPTOSIS, V13, P1505, DOI 10.1007/s10495-008-0276-8; Morgan D M, 1998, Methods Mol Biol, V79, P179; Musende AG, 2010, PROSTATE, V70, P1437, DOI 10.1002/pros.21179; Nicoletti-Carvalho JE, 2010, J ENDOCRINOL, V206, P183, DOI 10.1677/JOE-09-0356; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Pai VB, 1999, ANN PHARMACOTHER, V33, P325, DOI 10.1345/aph.18089; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Prudente S, 2012, ENDOCR REV, V33, P526, DOI 10.1210/er.2011-1042; Qian B, 2008, J ENDOCRINOL, V199, P407, DOI 10.1677/JOE-08-0331; Qian DZ, 2010, PROSTATE, V70, P433, DOI 10.1002/pros.21077; Schonthal Axel H, 2012, Front Biosci (Schol Ed), V4, P412; Schwarze SR, 2008, PROSTATE, V68, P1615, DOI 10.1002/pros.20828; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; Shim JS, 2012, JNCI-J NATL CANCER I, V104, P1576, DOI 10.1093/jnci/djs396; SHIMIZU K, 2012, PRIMATE RES, V28, P1, DOI DOI 10.2354/psj.28.008; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Tan SS, 2011, J PATHOL, V223, P81, DOI 10.1002/path.2795; Tang YX, 2011, NEOPLASIA, V13, P108, DOI 10.1593/neo.101092; Wang L, 2009, MOL PHARMACOL, V76, P1238, DOI 10.1124/mol.109.059105; Woo JH, 2003, CARCINOGENESIS, V24, P1199, DOI 10.1093/carcin/bgg082; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Wu Y, 2009, CANCER BIOL THER, V8, P146, DOI 10.4161/cbt.8.2.7087; Yang Y, 2005, CANCER SCI, V96, P425, DOI 10.1111/j.1349-7006.2005.00063.x; Yang Y, 2006, BRIT J CANCER, V95, P1653, DOI 10.1038/sj.bjc.6603435; Yap TA, 2011, NAT REV CLIN ONCOL, V8, P597, DOI 10.1038/nrclinonc.2011.117; Yin HT, 2012, ACTA BIOCH BIOPH SIN, V44, P147, DOI 10.1093/abbs/gmr106; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080071	56	42	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103109	10.1371/journal.pone.0103109	http://dx.doi.org/10.1371/journal.pone.0103109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121735	Green Published, gold			2022-12-27	WOS:000341017000010
J	Smith, BN; Burton, LJ; Henderson, V; Randle, DD; Morton, DJ; Smith, BA; Taliaferro-Smith, L; Nagappan, P; Yates, C; Zayzafoon, M; Chung, LWK; Odero-Marah, VA				Smith, Bethany N.; Burton, Liza J.; Henderson, Veronica; Randle, Diandra D.; Morton, Derrick J.; Smith, Basil A.; Taliaferro-Smith, Latonia; Nagappan, Peri; Yates, Clayton; Zayzafoon, Majd; Chung, Leland W. K.; Odero-Marah, Valerie A.			Snail Promotes Epithelial Mesenchymal Transition in Breast Cancer Cells in Part via Activation of Nuclear ERK2	PLOS ONE			English	Article							PROSTATE-CANCER; TRANSCRIPTION FACTORS; EXPRESSION; PHOSPHORYLATION; PATHWAY; RESISTANCE; MAPK; LOCALIZATION; PROGRESSION; INHIBITOR	Snail transcription factor is up-regulated in several cancers and associated with increased tumor migration and invasion via induction of epithelial-to-mesenchymal transition (EMT). MAPK (ERK1/2) signaling regulates cellular processes including cell motility, adhesion, and invasion. We investigated the regulation of ERK1/2 by Snail in breast cancer cells. ERK1/2 activity (p-ERK) was higher in breast cancer patient tissue as compared to normal tissue. Snail and p-ERK were increased in several breast cancer cell lines as compared to normal mammary epithelial cells. Snail knockdown in MDA-MB-231 and T47-D breast cancer cells decreased or re-localized p-ERK from the nuclear compartment to the cytoplasm. Snail overexpression in MCF-7 breast cancer cells induced EMT, increased cell migration, decreased cell adhesion and also increased tumorigenicity. Snail induced nuclear translocation of p-ERK, and the activation of its subcellular downstream effector, Elk-1. Inhibiting MAPK activity with UO126 or knockdown of ERK2 isoform with siRNA in MCF-7 Snail cells reverted EMT induced by Snail as shown by decreased Snail and vimentin expression, decreased cell migration and increased cell adhesion. Overall, our data suggest that ERK2 isoform activation by Snail in aggressive breast cancer cells leads to EMT associated with increased cell migration and decreased cell adhesion. This regulation is enhanced by positive feedback regulation of Snail by ERK2. Therefore, therapeutic targeting of ERK2 isoform may be beneficial for breast cancer.	[Smith, Bethany N.; Burton, Liza J.; Henderson, Veronica; Randle, Diandra D.; Morton, Derrick J.; Smith, Basil A.; Nagappan, Peri; Odero-Marah, Valerie A.] Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA; [Smith, Bethany N.; Burton, Liza J.; Henderson, Veronica; Randle, Diandra D.; Morton, Derrick J.; Smith, Basil A.; Nagappan, Peri; Odero-Marah, Valerie A.] Clark Atlanta Univ, Dept Biol Sci, Atlanta, GA 30314 USA; [Taliaferro-Smith, Latonia] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Taliaferro-Smith, Latonia] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Yates, Clayton] Tuskegee Univ, Dept Biol, Tuskegee, AL 36088 USA; [Yates, Clayton] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Chung, Leland W. K.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Med, Urooncol Res Program, Los Angeles, CA 90048 USA	Clark Atlanta University; Clark Atlanta University; Emory University; Emory University; Tuskegee University; University of Alabama System; University of Alabama Birmingham; Cedars Sinai Medical Center	Odero-Marah, VA (corresponding author), Clark Atlanta Univ, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA.	vodero_marah@cau.edu	Smith, Bethany/GYT-9168-2022		NIH grants [P20MD002285-01, G12RR003062-22]; NATIONAL CANCER INSTITUTE [P01CA098912, U54CA118623, U54CA118948] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003062] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007590, P20MD002285] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by NIH grants P20MD002285-01 (VOM) and G12RR003062-22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves-Luquero CI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006124; American Cancer Society, 2012, BREAST CANC FACTS FI; Aziz SW, 2013, BREAST CANC METASTAS, P47; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Franco DL, 2010, J CELL SCI, V123, P3467, DOI 10.1242/jcs.068692; Hsu YL, 2013, ONCOGENE, V32, P4436, DOI 10.1038/onc.2012.444; Kuo HT, 2013, POL J PATHOL, V64, P163, DOI 10.5114/PJP.2013.38132; Lacroix M, 2004, ONCOL REP, V12, P701; Lee S, 2007, GYNECOL ONCOL, V104, P338, DOI 10.1016/j.ygyno.2006.08.040; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Neal CL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-336; Neal CL, 2011, CELL ADHES MIGR, V5, P249, DOI 10.4161/cam.5.3.15618; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Normanno N, 2006, J CELL PHYSIOL, V207, P420, DOI 10.1002/jcp.20588; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Shukla A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-314; Silvers AL, 2003, NEOPLASIA, V5, P319, DOI 10.1016/S1476-5586(03)80025-8; Smith AP, 2009, ONCOGENE, V28, P422, DOI 10.1038/onc.2008.395; Smith BN, 2012, CELL ADHES MIGR, V6, P433, DOI 10.4161/cam.21687; Smith ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009295; Svensson S, 2005, ONCOGENE, V24, P4370, DOI 10.1038/sj.onc.1208626; Vantaggiato Chiara, 2006, J Biol, V5, P14, DOI 10.1186/jbiol38; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; von Thun A, 2012, J CELL SCI, V125, P1465, DOI 10.1242/jcs.092916; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Yamasaki H, 2005, GENES CELLS, V10, P455, DOI 10.1111/j.1365-2443.2005.00850.x; Yang ZB, 2005, CANCER RES, V65, P3179, DOI 10.1158/0008-5472.CAN-04-3480; Yook JI, 2005, J BIOL CHEM, V280, P11740, DOI 10.1074/jbc.M413878200; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	38	80	87	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104987	10.1371/journal.pone.0104987	http://dx.doi.org/10.1371/journal.pone.0104987			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122124	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000082
J	Bell, S; Britton, A; Kubinova, R; Malyutina, S; Pajak, A; Nikitin, Y; Bobak, M				Bell, Steven; Britton, Annie; Kubinova, Ruzena; Malyutina, Sofia; Pajak, Andrzej; Nikitin, Yuri; Bobak, Martin			Drinking Pattern, Abstention and Problem Drinking as Risk Factors for Depressive Symptoms: Evidence from Three Urban Eastern European Populations	PLOS ONE			English	Article							ALCOHOL-USE DISORDERS; MAJOR DEPRESSION; GENERAL-POPULATION; MENTAL-HEALTH; PSYCHOLOGICAL BENEFITS; CAGE QUESTIONNAIRE; GENDER-DIFFERENCES; NATIONAL SURVEY; HEART-DISEASE; BIRTH COHORT	Purpose: To examine whether the frequency and amount of alcohol consumed in binge drinking sessions, total annual volume of alcohol consumed, problem drinking and abstaining from alcohol are associated with depressive symptoms in Eastern Europe. Subjects and Methods: Cross-sectional data from a total of 24,381 participants from general population samples of the Czech Republic (N = 7,601), Russia (N = 6,908) and Poland (N = 9,872) aged 45-69 years in 2002-2005. Depressive symptoms were defined as >= 16 points on the Centre for Epidemiological Studies - Depression (CES-D) scale. Several alcohol related measures were derived using responses from the graduated frequency questionnaire. Binge drinking was defined at several sex-specific thresholds (ranging from 60+ to 140+ g of ethanol) and two frequencies (at least monthly or weekly). Total annual alcohol intake in grams was also extracted. Problem drinking was defined as >= 2 positive answers on the CAGE questionnaire. Results: Problem drinking was consistently associated with approximately a 2-fold increase in odds of depressive symptoms across all countries and in both sexes. Abstaining from alcohol was typically associated with increased odds of depressive symptoms. Analyses separating lifelong abstainers and former drinkers in the Russian cohort revealed that this increased odds was driven by former drinkers. Amongst men, heavy frequent binge drinking was associated with increased odds of depressive symptoms in the Czech Republic and Poland. In women, heavy infrequent binge drinking was associated with increased odds of depressive symptoms in Russia and Poland. Only in Polish men was higher annual volume of alcohol intake associated with increased odds of depressive symptoms. Conclusion: Abstaining from alcohol and problem drinking were associated with increased odds of depressive symptoms in these Eastern European populations. Annual volume of alcohol intake as well as frequency and amount of alcohol consumed in a binge drinking session were less consistently associated with depressive symptoms.	[Bell, Steven; Britton, Annie; Bobak, Martin] UCL, Res Dept Epidemiol & Publ Hlth, London, England; [Kubinova, Ruzena] Natl Inst Publ Hlth, Prague, Czech Republic; [Malyutina, Sofia; Nikitin, Yuri] Inst Internal & Prevent Med, Novosibirsk, Russia; [Malyutina, Sofia] Novosibirsk State Med Univ, Novosibirsk, Russia; [Pajak, Andrzej] Jagiellonian Univ, Inst Publ Hlth, Krakow, Poland	University of London; University College London; National Institute of Public Health (SZU) - Czech Republic; Novosibirsk State Medical University; Jagiellonian University; Collegium Medicum Jagiellonian University	Bell, S (corresponding author), UCL, Res Dept Epidemiol & Publ Hlth, London, England.	steven.bell@ucl.ac.uk	Nikitin, Yuri/D-2774-2018; Malyutina, Sofia/J-1651-2018	Nikitin, Yuri/0000-0002-3932-2299; Malyutina, Sofia/0000-0001-6539-0466; Bobak, Martin/0000-0002-2633-6851; Bell, Steven/0000-0001-6774-3149	UK Economic and Social Research Council; European Research Council [309337]; Wellcome Trust [064947/Z, 081081/Z]; US National Institute of Aging [1R01 AG23522]; MacArthur Foundation; NATIONAL INSTITUTE ON AGING [R01AG023522] Funding Source: NIH RePORTER; ESRC [ES/J023299/1] Funding Source: UKRI; MRC [MR/K013351/1] Funding Source: UKRI; Economic and Social Research Council [ES/J023299/1] Funding Source: researchfish; Medical Research Council [MR/K013351/1] Funding Source: researchfish	UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); US National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MacArthur Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	SB was supported by a UK Economic and Social Research Council PhD Studentship. Both SB and AB are currently funded by the European Research Council (309337, PI: Britton, http://www.ucl.ac.uk/alcohol-lifecourse). The HAPIEE study was supported by grants from the Wellcome Trust (064947/Z, 081081/Z), the US National Institute of Aging (1R01 AG23522) and the MacArthur Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P., 2012, ALC EUR UN CONS HARM; Averina M, 2005, SOC PSYCH PSYCH EPID, V40, P511, DOI 10.1007/s00127-005-0918-x; BAUMBAICKER C, 1985, DRUG ALCOHOL DEPEN, V15, P305, DOI 10.1016/0376-8716(85)90008-0; Becker AE, 2013, NEW ENGL J MED, V369, P66, DOI 10.1056/NEJMra1110827; Beekman ATF, 1995, J AFFECT DISORDERS, V36, P65, DOI 10.1016/0165-0327(95)00061-5; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Bell S, 2011, TREND UROL MENS HEAL, V2, P9, DOI 10.1002/tre.206; Bell S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-91; Bjelland I, 2008, SOC SCI MED, V66, P1334, DOI 10.1016/j.socscimed.2007.12.019; Bobak M, 2006, BRIT J PSYCHIAT, V188, P359, DOI 10.1192/bjp.188.4.359; Bobak M, 2004, J EPIDEMIOL COMMUN H, V58, P238, DOI 10.1136/jech.2003.011825; Bobak M, 1999, ADDICTION, V94, P857, DOI 10.1046/j.1360-0443.1999.9468579.x; Bobrova N, 2010, ALCOHOL ALCOHOLISM, V45, P573, DOI 10.1093/alcalc/agq069; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Boden JM, 2010, BRIT J PSYCHIAT, V196, P440, DOI 10.1192/bjp.bp.109.065912; Bolton JM, 2009, J AFFECT DISORDERS, V115, P367, DOI 10.1016/j.jad.2008.10.003; Boschloo L, 2012, PSYCHOL MED, V42, P695, DOI 10.1017/S0033291711001681; Boschloo L, 2012, BRIT J PSYCHIAT, V201, P326, DOI 10.1192/bjp.201.4.326a; Boschloo L, 2012, BRIT J PSYCHIAT, V200, P476, DOI 10.1192/bjp.bp.111.097550; BRESLAU N, 1985, PSYCHIAT RES, V15, P219, DOI 10.1016/0165-1781(85)90079-4; Bulloch A, 2012, DEPRESS ANXIETY, V29, P1058, DOI 10.1002/da.22001; Burns L, 2002, DRUG ALCOHOL DEPEN, V68, P299, DOI 10.1016/S0376-8716(02)00220-X; Caldwell TM, 2006, ALCOHOL ALCOHOLISM, V41, P650, DOI 10.1093/alcalc/agl088; Chikritzhs T, 2009, DRUG ALCOHOL REV, V28, P441, DOI 10.1111/j.1465-3362.2009.00052.x; Dissing AS, 2013, ADDICTION, V108, P1905, DOI 10.1111/add.12257; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fergusson DM, 2009, ARCH GEN PSYCHIAT, V66, P260, DOI 10.1001/archgenpsychiatry.2008.543; Ferketich AK, 2000, ARCH INTERN MED, V160, P1261, DOI 10.1001/archinte.160.9.1261; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Fillmore KM, 2007, ANN EPIDEMIOL, V17, pS16, DOI 10.1016/j.annepidem.2007.01.005; FILLMORE KM, 1987, BRIT J ADDICT, V82, P77; Flensborg-Madsen T, 2009, COMPR PSYCHIAT, V50, P307, DOI 10.1016/j.comppsych.2008.09.003; Graham K, 2007, ALCOHOL CLIN EXP RES, V31, P78, DOI 10.1111/j.1530-0277.2006.00274.x; GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P197, DOI 10.1016/0376-8716(95)01160-4; Greenfield TK, 2000, J SUBST ABUSE, V12, P33, DOI 10.1016/S0899-3289(00)00039-0; Grittner U, 2013, EUR J PUBLIC HEALTH, V23, P332, DOI 10.1093/eurpub/cks044; Haynes JC, 2005, BRIT J PSYCHIAT, V187, P544, DOI 10.1192/bjp.187.6.544; Hu YY, 2015, AGE AGEING, V44, P84, DOI 10.1093/ageing/afu083; Kerr WC, 2010, J STUD ALCOHOL DRUGS, V71, P515, DOI 10.15288/jsad.2010.71.515; Laatikainen T, 2002, ALCOHOL ALCOHOLISM, V37, P282, DOI 10.1093/alcalc/37.3.282; Leon DA, 2009, ADDICTION, V104, P1630, DOI 10.1111/j.1360-0443.2009.02655.x; Lucas N, 2010, ALCOHOL ALCOHOLISM, V45, P95, DOI 10.1093/alcalc/agp080; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MAYFIELD D, 1974, AM J PSYCHIAT, V131, P1121; Merrick EL, 2008, J AM GERIATR SOC, V56, P214, DOI 10.1111/j.1532-5415.2007.01539.x; Meyer RE, 1986, PSYCHOPATHOLOGY ADDI; Mueser KT, 1998, ADDICT BEHAV, V23, P717, DOI 10.1016/S0306-4603(98)00073-2; MYERS JK, 1980, AM J PSYCHIAT, V137, P1081; Naimi TS, 2005, AM J PREV MED, V28, P369, DOI 10.1016/j.amepre.2005.01.011; O'Malley PM, 2004, ALCOHOL RES HEALTH, V28, P202; Paljarvi T, 2009, ADDICTION, V104, P1168, DOI 10.1111/j.1360-0443.2009.02577.x; Patel V, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001226; Peasey A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-255; Peele S, 2000, DRUG ALCOHOL DEPEN, V60, P221, DOI 10.1016/S0376-8716(00)00112-5; Peirce RS, 2000, HEALTH PSYCHOL, V19, P28, DOI 10.1037/0278-6133.19.1.28; Pikhartova J, 2009, INT J PUBLIC HEALTH, V54, P283, DOI 10.1007/s00038-009-8029-1; Popova S, 2007, ALCOHOL ALCOHOLISM, V42, P465, DOI 10.1093/alcalc/agl124; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rehm J, 1998, ALCOHOL CLIN EXP RES, V22, p4S, DOI 10.1111/j.1530-0277.1998.tb04368.x; Room R, 2005, INT J EPIDEMIOL, V34, P788, DOI 10.1093/ije/dyi117; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; SHAPER AG, 1988, LANCET, V2, P1267; Smith GW, 2008, ALCOHOL ALCOHOLISM, V43, P590, DOI 10.1093/alcalc/agn041; StataCorp, 2013, STAT STAT SOFTW REL; Stockwell T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2276; Swendsen JD, 1998, COMPR PSYCHIAT, V39, P176, DOI 10.1016/S0010-440X(98)90058-X; Van de Velde S, 2010, SOC SCI MED, V71, P305, DOI 10.1016/j.socscimed.2010.03.035; Wang JL, 2002, DEPRESS ANXIETY, V15, P42, DOI 10.1002/da.1084; Wang JL, 2001, CAN J PSYCHIAT, V46, P632, DOI 10.1177/070674370104600708; Zhan W., 2012, J ADDICTION RES THER, V03, P1, DOI [10.4172/2155-6105.1000124, DOI 10.4172/2155-6105.1000124]	71	17	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104384	10.1371/journal.pone.0104384	http://dx.doi.org/10.1371/journal.pone.0104384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9BM	25118714	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600053
J	Berlincourt, M; Arnould, JPY				Berlincourt, Maud; Arnould, John P. Y.			At-Sea Associations in Foraging Little Penguins	PLOS ONE			English	Article							EUDYPTULA-MINOR; DIVING BEHAVIOR; ADELIE PENGUINS; BASS STRAIT; GROUP-SIZE; PREDATION; RISK	Prey distribution, patch size, and the presence of conspecifics are important factors influencing a predator's feeding tactics, including the decision to feed individually or socially. Little is known about group behaviour in seabirds as they spend most of their lives in the marine environment where it is difficult to observe their foraging activities. In this study, we report on at-sea foraging associations of little penguins (Eudyptula minor) during the breeding season. Individuals could be categorised as (1) not associating; (2) associating when departing from and/or returning to the colony; or (3) at sea when travelling, diving or performing synchronised dives. Out of 84 separate foraging tracks, 58 (69.0%) involved associations with conspecifics. Furthermore, in a total of 39 (46.4%), individuals were found to dive during association and in 32 (38.1%), individuals were found to exhibit synchronous diving. These behaviours suggest little penguins forage in groups, could synchronise their underwater movements and potentially cooperate to concentrate their small schooling prey.	[Berlincourt, Maud; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia	Deakin University	Berlincourt, M (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia.	mberlinc@deakin.edu.au			ANZ Trustees Foundation - Holsworth Wildlife Research Endowment [RM23947]; MA Ingram Trust Application [RM25024]; Birds Australia [RM23896]	ANZ Trustees Foundation - Holsworth Wildlife Research Endowment; MA Ingram Trust Application; Birds Australia	Support was provided by: 1. ANZ Trustees Foundation - Holsworth Wildlife Research Endowment (grant RM23947) [http://www.anz.com/personal/private-bank-trustees/trustees/granting/granting-programs/small-grants/]. 2. MA Ingram Trust Application (grant RM25024) [https://www.statetrustees.com.au/uploads/content/142-MA_Ingram_Trust_Guidelines_Application_Form.pdf]. 3. Birds Australia (grant RM23896) [http://birdlife.org.au/who-we-are/ourorganisation/awards-scholarships]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINLEY DG, 1972, IBIS, V114, P388, DOI 10.1111/j.1474-919X.1972.tb00836.x; [Anonymous], 1993, HDB AUSTR NZ ANTARCT; Arnould JPY, 2004, EMU, V104, P261, DOI 10.1071/MU04035; Ashmole N.P, 1971, AVIAN BIOL, VI, P223; Chiaradia Andre F., 1999, Marine Ornithology, V27, P13; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; Daniel TA, 2007, ANIM BEHAV, V74, P1241, DOI 10.1016/j.anbehav.2007.01.029; DAVIS LS, 1990, PENGUIN BIOL; Grand TC, 1999, ANIM BEHAV, V58, P443, DOI 10.1006/anbe.1999.1174; Hoskins AJ, 2008, MAR ECOL PROG SER, V366, P293, DOI 10.3354/meps07507; Kokubun N, 2013, POLAR BIOL, V36, P1857, DOI 10.1007/s00300-013-1400-y; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; MANTEL N, 1967, CANCER RES, V27, P209; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Mori Y, 2001, BEHAVIOUR, V138, P1451, DOI 10.1163/156853901317367690; Orians G.H., 1979, P155; PACKER C, 1988, AM NAT, V132, P159, DOI 10.1086/284844; Pitcher T. J., 1993, BEHAV TELEOST FISHES, DOI [10.1007/978-94-011-1578-0_12, DOI 10.1007/978-94-011-1578-0_12, DOI 10.1007/978-94-011-1578-0_]; Putz K, 2005, MAR BIOL, V147, P281, DOI 10.1007/s00227-005-1577-x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; REILLY PN, 1981, EMU, V81, P1, DOI 10.1071/MU9810001; SIEGFRIED W R, 1975, Zoologica Africana, V10, P87; Stahel C., 1987, LITTLE PENGUIN FAIRY; Sumner MD, 2012, 2012 TRIP SPATIAL AN; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Takahashi A, 2004, J ETHOL, V22, P5, DOI 10.1007/s10164-003-0111-1; Takahashi A, 2008, POLAR BIOL, V31, P1291, DOI 10.1007/s00300-008-0502-4; Tremblay Y, 1999, CONDOR, V101, P179, DOI 10.2307/1370462; Vabo R, 1997, FISH OCEANOGR, V6, P155, DOI 10.1046/j.1365-2419.1997.00037.x; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Wilson R.P., 1990, P181; WILSON RP, 1986, ETHOLOGY, V72, P338	33	23	24	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105065	10.1371/journal.pone.0105065	http://dx.doi.org/10.1371/journal.pone.0105065			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119718	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600120
J	Bonfa, G; Benevides, L; Souza, MD; Fonseca, DM; Mineo, TWP; Rossi, MA; Silva, NM; Silva, JS; Cardoso, CRD				Bonfa, Giuliano; Benevides, Luciana; Souza, Maria do Carmo; Fonseca, Denise Morais; Patriarca Mineo, Tiago Wilson; Rossi, Marcos Antonio; Silva, Neide Maria; Silva, Joao Santana; de Barros Cardoso, Cristina Ribeiro			CCR5 Controls Immune and Metabolic Functions during Toxoplasma gondii Infection	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; INTESTINAL EPITHELIAL-CELLS; INFLAMMATORY-BOWEL-DISEASE; CD1D-RESTRICTED NKT CELLS; REGULATORY T-CELLS; DENDRITIC CELLS; NITRIC-OXIDE; FATTY-ACIDS; IFN-GAMMA; MICE	CCR5, an important receptor related to cell recruitment and inflammation, is expressed during experimental Toxoplasma gondii infection. However, its role in the immunopathology of toxoplasmosis is not clearly defined yet. Thus, we inoculated WT and CCR5(-/-) mice with a sub lethal dose of the parasite by oral route. CCR5(-/-) mice were extremely susceptible to infection, presenting higher parasite load and lower tissue expression of IL-12p40, IFN-gamma, TNF, IL-6, iNOS, Foxp3, T-bet, GATA-3 and PPAR alpha. Although both groups presented inflammation in the liver with prominent neutrophil infiltration, CCR5(-/-) mice had extensive tissue damage with hepatocyte vacuolization, steatosis, elevated serum triglycerides and transaminases. PPAR alpha agonist Gemfibrozil improved the vacuolization but did not rescue CCR5(-/-) infected mice from high serum triglycerides levels and enhanced mortality. We also found intense inflammation in the ileum of CCR5(-/-) infected mice, with epithelial ulceration, augmented CD4 and decreased frequency of NK cells in the gut lamina propria. Most interestingly, these findings were accompanied by an outstanding accumulation of neutrophils in the ileum, which seemed to be involved in the gut immunopathology, once the depletion of these cells was accompanied by reduced local damage. Altogether, these data demonstrated that CCR5 is essential to the control of T. gondii infection and to maintain the metabolic, hepatic and intestinal integrity. These findings add novel information on the disease pathogenesis and may be relevant for directing future approaches to the treatment of multi-deregulated diseases.	[Bonfa, Giuliano; Benevides, Luciana; Souza, Maria do Carmo; Fonseca, Denise Morais; Silva, Joao Santana] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, BR-14049 Ribeirao Preto, SP, Brazil; [Rossi, Marcos Antonio] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Patol, BR-14049 Ribeirao Preto, SP, Brazil; [de Barros Cardoso, Cristina Ribeiro] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, SP, Brazil; [Patriarca Mineo, Tiago Wilson; Silva, Neide Maria] Univ Fed Uberlandia, Inst Ciencias Biomed, BR-38400 Uberlandia, MG, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Uberlandia	Cardoso, CRD (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, SP, Brazil.	cristina@fcfrp.usp.br	SILVA, NEIDE MARIA/AAQ-7995-2020; Ribeiro de Barros Cardoso, Cristina/AGO-5764-2022; Mineo, Tiago W. P./B-4153-2009; Benevides, Luciana/D-2715-2012; Bonfá, Giuliano/D-4932-2013; Fonseca, Denise/E-7419-2012; de Barros Cardoso, Cristina Ribeiro/L-8396-2017; Silva, Joao/A-4484-2008; Silva, Neide/C-7813-2013	Ribeiro de Barros Cardoso, Cristina/0000-0002-6156-3144; Mineo, Tiago W. P./0000-0002-2339-2743; Fonseca, Denise/0000-0001-8310-0186; de Barros Cardoso, Cristina Ribeiro/0000-0002-6156-3144; Silva, Joao/0000-0002-3410-3927; Silva, Neide/0000-0002-3615-1340; Bonfa, Giuliano/0000-0003-2257-5502; Benevides, Luciana/0000-0003-3439-4266	Sao Paulo Research Foundation (FAPESP) [2012/14524-9, 2013/08216-2]; University of Sao Paulo NAP-DIN [11.1.21625.01.0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); University of Sao Paulo NAP-DIN; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research leading to these results received support and funding from the Sao Paulo Research Foundation (FAPESP) under grant agreements no. 2012/14524-9 (Thematic Project), 2013/08216-2 (Center for Research in Inflammatory Disease), from the University of Sao Paulo NAP-DIN under grant agreement no 11.1.21625.01.0. and from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 2005, J IMMUNOL, V174, P8027, DOI 10.4049/jimmunol.174.12.8027; Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Algood HMS, 2004, J IMMUNOL, V173, P3287; Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Bagaeva LV, 2003, J NEUROIMMUNOL, V137, P109, DOI 10.1016/S0165-5728(03)00079-1; Belnoue E, 2003, BLOOD, V101, P4253, DOI 10.1182/blood-2002-05-1493; Benevides L, 2008, AM J PATHOL, V173, P741, DOI 10.2353/ajpath.2008.080129; Benevides L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075138; Bliss SK, 1999, J IMMUNOL, V163, P2081; Boaventura VS, 2010, EUR J IMMUNOL, V40, P2830, DOI 10.1002/eji.200940115; Brunet LR, 2001, INT IMMUNOPHARMACOL, V1, P1457, DOI 10.1016/S1567-5769(01)00090-X; Buzoni-Gatel D, 2001, GASTROENTEROLOGY, V120, P914, DOI 10.1053/gast.2001.22432a; Del Rio L, 2001, J IMMUNOL, V167, P6503, DOI 10.4049/jimmunol.167.11.6503; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Egan CE, 2012, IMMUNOL CELL BIOL, V90, P668, DOI 10.1038/icb.2011.93; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; French AR, 2006, CYTOKINE, V35, P229, DOI 10.1016/j.cyto.2006.08.006; GUYGRAND D, 1978, J EXP MED, V148, P1661, DOI 10.1084/jem.148.6.1661; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Hsu HC, 2001, J LAB CLIN MED, V137, P414, DOI 10.1067/mlc.2001.114991; HUNTER CA, 1994, INFECT IMMUN, V62, P2818, DOI 10.1128/IAI.62.7.2818-2824.1994; Ishida Y, 2012, J CLIN INVEST, V122, P711, DOI 10.1172/JCI43027; ISSEMANN I, 1993, J MOL ENDOCRINOL, V11, P37, DOI 10.1677/jme.0.0110037; Jones JL, 2007, AM J TROP MED HYG, V77, P405, DOI 10.4269/ajtmh.2007.77.405; Kasper L, 2004, INT J PARASITOL, V34, P401, DOI 10.1016/j.ijpara.2003.11.023; Khan IA, 2006, PLOS PATHOG, V2, P484, DOI 10.1371/journal.ppat.0020049; LAUDET V, 1992, EMBO J, V11, P1003, DOI 10.1002/j.1460-2075.1992.tb05139.x; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1999, PARASITE IMMUNOL, V21, P365, DOI 10.1046/j.1365-3024.1999.00237.x; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Luangsay S, 2003, GASTROENTEROLOGY, V125, P491, DOI 10.1016/S0016-5085(03)00903-X; Mack M, 1999, ARTHRITIS RHEUM, V42, P981, DOI 10.1002/1529-0131(199905)42:5<981::AID-ANR17>3.0.CO;2-4; McKeage K, 2011, DRUGS, V71, P1917, DOI 10.2165/11208090-000000000-00000; Mennechet FJD, 2002, J IMMUNOL, V168, P2988, DOI 10.4049/jimmunol.168.6.2988; Moreira AP, 2008, J IMMUNOL, V180, P3049, DOI 10.4049/jimmunol.180.5.3049; Moreno C, 2005, HEPATOLOGY, V42, P854, DOI 10.1002/hep.20865; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Munoz M, 2011, IMMUNOL REV, V240, P269, DOI 10.1111/j.1600-065X.2010.00992.x; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Schlecker E, 2012, J IMMUNOL, V189, P5602, DOI 10.4049/jimmunol.1201018; Schulthess J, 2012, IMMUNITY, V37, P108, DOI 10.1016/j.immuni.2012.05.013; Scott P, 2002, CURR OPIN IMMUNOL, V14, P466, DOI 10.1016/S0952-7915(02)00353-9; Sullivan NL, 2011, J IMMUNOL, V187, P1358, DOI 10.4049/jimmunol.1100033; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; TRINDER P, 1969, J CLIN PATHOL, V22, P158, DOI 10.1136/jcp.22.2.158; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wang CR, 2003, CLIN EXP IMMUNOL, V132, P371, DOI 10.1046/j.1365-2249.2003.02126.x; Woitas RP, 2002, GASTROENTEROLOGY, V122, P1721, DOI 10.1053/gast.2002.33660; Yarovinsky F, 2008, J IMMUNOL, V181, P8478, DOI 10.4049/jimmunol.181.12.8478; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; Yurchenko E, 2006, J EXP MED, V203, P2451, DOI 10.1084/jem.20060956; Zhong MX, 2004, INFECT IMMUN, V72, P1057, DOI 10.1128/IAI.72.2.1057-1064.2004; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	59	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104736	10.1371/journal.pone.0104736	http://dx.doi.org/10.1371/journal.pone.0104736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119429	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600081
J	Gupta, H; Schiros, CG; Denney, TS				Gupta, Himanshu; Schiros, Chun G.; Denney, Thomas S., Jr.			Modified Treatment Approach Using Cardiovascular Disease Risk Calculator for Primary Prevention	PLOS ONE			English	Article								Background: The recent guidelines for preventing atherosclerotic cardiovascular events are an important advancement. For primary prevention, statins are recommended if the ten-year risk is >= 5% (consideration for therapy) or >= 7.5% (definitive treatment unless contraindication after discussion). We rationalized that a significant cohort with ten-year risk below the treatment thresholds would predictably surpass them within the recommended 4-6 year window for reassessing the ten-year risk. As atherosclerosis is a progressive disease, these individuals may therefore benefit with more aggressive therapies even at baseline. Methods and Findings: We used publicly available NHANES dataset for ten-year risk calculation. There were 1805 participants. To evaluate the ten-year risk change at five years, we considered two scenarios: no change in the baseline parameters except increased age by five (No Change) and alternatively 10% improvement in systolic BP, total and HDL-c, no smoking with five-year increase in age (Reduced Risk Profile). Amongst non-diabetics with <5% risk at baseline, 35% reached or exceeded 5% risk in five years (5% reached or exceed the 7.5% risk) with No Change and 9% reached or exceeded 5% risk in five years (none reached 7.5% risk) with Reduced Risk Profile; furthermore, 94% of the non-diabetic cohort with baseline risk between 3.5%-5% would exceed the 5% and/or 7.5% boundary limit with No Change. Amongst non-diabetics with 5-7.5% baseline risks, 87% reached or exceeded 7.5% with No Change while 30% reached or exceeded 7.5% risk with Reduced Risk Profile. Conclusions: A significant population cohort at levels below the treatment thresholds will predictably exceed these limits with time with or without improvement in modifiable risk factors and may benefit with more aggressive therapy at baseline. We provide an improved risk calculator that allows for integrating expected risk modification into discussion with an individual. This needs to be prospectively tested in clinical trials.	[Gupta, Himanshu; Schiros, Chun G.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35233 USA; [Gupta, Himanshu] VA Med Ctr, Birmingham, AL USA; Auburn Univ, Dept Elect & Comp Engn, Auburn, AL 36849 USA	University of Alabama System; University of Alabama Birmingham; Auburn University System; Auburn University	Gupta, H (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35233 USA.	hgupta@uab.edu		Denney, Thomas/0000-0002-6695-4777	NIH [NHLBI R01-HL104018]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by NIH NHLBI R01-HL104018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Goff D. C., 2013, CIRCULATION; Office of Management and Budget, 1997, FED REG, V62, P58781; Stone NJ, 2013, CIRCULATION	3	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104478	10.1371/journal.pone.0104478	http://dx.doi.org/10.1371/journal.pone.0104478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119719	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600060
J	Hilgartner, R; Stahl, D; Zinner, D				Hilgartner, Roland; Stahl, Daniel; Zinner, Dietmar			Impact of Supplementary Feeding on Reproductive Success of White Storks	PLOS ONE			English	Article							CICONIA-CICONIA; BREEDING SUCCESS; FOOD SUPPLEMENTATION; POPULATION-DYNAMICS; HABITAT STRUCTURE; RUBBISH DUMPS; PRODUCTIVITY; SIZE; DENSITY; CONSERVATION	European white stork (Ciconia ciconia) populations have been object to several conservation measures such as reintroduction programs, habitat improvement or supplementary feeding in the last decades. Although recent white stork censuses revealed an upward trend of most of the western populations, evaluations of the relative importance of certain conservation measures are still scarce or even lacking. In our study we analyzed the effect of supplementary feeding on the reproductive success of white storks in conjunction with other factors such as weather or nest site characteristics. We present data of 569 breeding events at 80 different nest sites located in variable distances to an artificial feeding site at Affenberg Salem (south-western Germany) collected from 1990-2012. A multilevel Poisson regression revealed that in our study population (1) reproductive success was negatively affected by monthly precipitation in April, May and June, (2) pairs breeding on power poles had a lower reproductive success than pairs breeding on platforms or trees and (3) reproductive success was significantly higher in pairs breeding in close distance to the feeding site. The number of fledglings per nest decreased by 8% per kilometer distance to the feeding site. Our data suggest that supplementary feeding increases fledgling populations which may be a tool to attenuate population losses caused by factors such as habitat deterioration or unfavorable conditions in wintering habitats.	[Hilgartner, Roland] Affenberg Salem, Salem, Germany; [Stahl, Daniel] Univ London, Kings Coll London, Inst Psychiat, Dept Biostat, London SW3 6LX, England; [Zinner, Dietmar] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany	University of London; King's College London; Deutsches Primatenzentrum (DPZ)	Hilgartner, R (corresponding author), Affenberg Salem, Salem, Germany.	hilgartner@gmx.de	Stahl, Daniel/B-9713-2011	Stahl, Daniel/0000-0001-7987-6619; Chiaradia, Andre/0000-0002-6178-4211				ALONSO JC, 1991, CAN J ZOOL, V69, P1957, DOI 10.1139/z91-270; Bairlein F, 1991, BIRD POPULATION STUD, P207; Barbraud C, 1999, IBIS, V141, P469, DOI 10.1111/j.1474-919X.1999.tb04416.x; Berthold P, 2007, VOGELZUG; Berthold P, 2006, VOGEL FUTTERN ABER R; Bloesch M., 1980, Ornithologische Beobachter, V77, P167; Bohning Gaese K, 1992, J ORNITHOL, V133, P61; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CARRASCAL LM, 1993, BIOL CONSERV, V65, P83, DOI 10.1016/0006-3207(93)90200-K; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Cortes-Avizanda A, 2010, BIOL CONSERV, V143, P1707, DOI 10.1016/j.biocon.2010.04.016; DALLINGA J.H., 1989, WHITE STORK STATUS C, P231; Denac D, 2006, ARDEA, V94, P233; Djerdali S, 2008, ETHOL ECOL EVOL, V20, P361, DOI 10.1080/08927014.2008.9522517; Doligez B., 2004, Animal Biodiversity and Conservation, V27, P387; Dziewiaty Krista, 2002, Vogelwarte, V41, P221; Elliott GP, 2001, BIOL CONSERV, V99, P121, DOI 10.1016/S0006-3207(00)00191-9; Elston DA, 2001, PARASITOLOGY, V122, P563, DOI 10.1017/S0031182001007740; Fiedler G, 1980, OKOL VOGEL, P59; Hancock J., 1992, STORKS IBISES SPOONB; Heath SR, 2008, BIOL CONSERV, V141, P2506, DOI 10.1016/j.biocon.2008.07.011; Hinde J., 1982, GLIM 82, P109; Hoodless AN, 1999, J APPL ECOL, V36, P147, DOI 10.1046/j.1365-2664.1999.00388.x; Johst K, 2001, ECOL APPL, V11, P60, DOI 10.1890/1051-0761(2001)011[0060:FIAPAD]2.0.CO;2; Jonkers DA, 1989, WEISSSTORCH, P231; Jonsson P, 2002, EVOL ECOL, V16, P455, DOI 10.1023/A:1020854525220; Jovani R, 2004, ECOGRAPHY, V27, P611, DOI 10.1111/j.0906-7590.2004.03925.x; Kruszyk R, 2010, EUR J WILDLIFE RES, V56, P83, DOI 10.1007/s10344-009-0313-0; Lakeberg H, 1993, THESIS U TUBINGEN TU; Lenz E, 1990, BERICHTE BAYRISCHEN, V4, P141; Lopez-Bao JV, 2010, ANIM CONSERV, V13, P35, DOI 10.1111/j.1469-1795.2009.00300.x; Gonzalez L, 2006, BIOL CONSERV, V129, P477, DOI 10.1016/j.biocon.2005.11.014; Martinez Rodriguez E, 1995, P INT S WHIT STORK W, P155; Martinez-Abrain A, 2013, BIOL CONSERV, V159, P539, DOI 10.1016/j.biocon.2012.10.020; Massemin-Challet S, 2006, IBIS, V148, P503, DOI 10.1111/j.1474-919X.2006.00550.x; Meijer T, 2013, OECOLOGIA, V173, P439, DOI 10.1007/s00442-013-2641-8; Moritzi M, 2001, ARDEA, V89, P457; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nevoux M, 2008, CONDOR, V110, P55, DOI 10.1525/cond.2008.110.1.55; Nowakowski JJ, 2003, ACTA ORNITHOL, V38, P39, DOI 10.3161/068.038.0109; O'Connor R.J., 1984, GROWTH DEV BIRDS; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; PFEIFER R, 1991, Ornithologischer Anzeiger, V30, P159; Reinhard Ute, 2007, Vogelwarte, V45, P81; Rickett J, 2013, EMU, V113, P62, DOI 10.1071/MU12053; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Royle N, 2000, J AVIAN BIOL, V31, P335, DOI 10.1111/j.0908-8857.2000.310309.x; Schaub M, 2004, BIOL CONSERV, V119, P105, DOI 10.1016/j.biocon.2003.11.002; Schierer A, 1967, LIEN ORNITHOL ALSACE, V12, P5; Schoech SJ, 2008, BIOL CONSERV, V141, P162, DOI 10.1016/j.biocon.2007.09.009; Schoenmakers S, 1985, COLON WATERBIRD, V10, P167; Schulz H, 1999, P INT S WHIT STORK H; Schulz H., 1988, WEISSSTORCHZUG OKOLO; Schuz E., 1975, Vogelwarte, V28, P61; Skov H, 1999, WEIBSTORCH AUFWIND W, P111; Thomsen Kai-Michael, 2006, P493; Tortosa FS, 2003, ARDEOLA, V50, P39; Tortosa FS, 2003, BIRD STUDY, V50, P112, DOI 10.1080/00063650309461302; Tortosa FS, 2002, WATERBIRDS, V25, P39, DOI 10.1675/1524-4695(2002)025[0039:EORDOB]2.0.CO;2; Tryjanowski P, 2005, WATERBIRDS, V28, P378, DOI 10.1675/1524-4695(2005)028[0378:EOWLAL]2.0.CO;2; Tryjanowski P, 2002, ARDEA, V90, P213; Tryjanowski P, 2009, ANN ZOOL FENN, V46, P34, DOI 10.5735/086.046.0104; Vergara P, 2007, J AVIAN BIOL, V38, P573, DOI 10.1111/j.2007.0908-8857.03983.x; ZINK GERHARDT, 1967, PROC INT ORNITHOL CONGR, V14, P191	64	17	19	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104276	10.1371/journal.pone.0104276	http://dx.doi.org/10.1371/journal.pone.0104276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119566	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600046
J	Kato, Y; Akasaki, S; Muto-Haenuki, Y; Fujieda, S; Matsushita, K; Yoshimoto, T				Kato, Yukinori; Akasaki, Shoko; Muto-Haenuki, Yoko; Fujieda, Shigeharu; Matsushita, Kazufumi; Yoshimoto, Tomohiro			Nasal Sensitization with Ragweed Pollen Induces Local-Allergic-Rhinitis-Like Symptoms in Mice	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; MAST-CELLS; IGE PRODUCTION; INFLAMMATION; ABSENCE; IL-33; MANAGEMENT; RESPONSES; DISEASE; ENTOPY	Recently, the concept of local allergic rhinitis (LAR) was established, namely rhinitis symptoms with local IgE production and negative serum antigen-specific IgE. However, the natural course of LAR development and the disease pathogenesis is poorly understood. This study investigated the pathophysiology of mice with allergic rhinitis that initially sensitized with ragweed pollen through the nasal route. Mice were nasally administrated ragweed pollen over consecutive days without prior systemic immunization of the allergen. Serial nasal sensitization of ragweed pollen induced an allergen-specific increase in sneezing, eosinophilic infiltration, and the production of local IgE by day 7, but serum antigen-specific IgE was not detected. Th2 cells accumulated in nose and cervical lymph nodes as early as day 3. These symptoms are characteristic of human LAR. Continual nasal exposure of ragweed pollen for 3 weeks resulted in the onset of classical AR with systemic atopy and adversely affected lung inflammation when the allergen was instilled into the lung. Fcer1a(-/-) mice were defective in sneezing but developed normal eosinophilic infiltration. Contrary, Rag2(-/-) mice were defective in both sneezing and eosinophilic infiltration, suggesting that T cells play a central role in the pathogenesis of the disease. These observations demonstrate nasal allergen sensitization to non-atopic individuals can induce LAR. Because local Th2 cell accumulation is the first sign and Th2 cells have a central role in the disease, a T-cell-based approach may aid the diagnosis and treatment of LAR.	[Kato, Yukinori; Akasaki, Shoko; Muto-Haenuki, Yoko; Matsushita, Kazufumi; Yoshimoto, Tomohiro] Hyogo Coll Med, Inst Adv Med Sci, Lab Allerg Dis, Nishinomiya, Hyogo, Japan; [Kato, Yukinori; Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Fukui 910, Japan; [Muto-Haenuki, Yoko] Kyoto Prefectural Univ Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Yoshimoto, Tomohiro] Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo, Japan	Hyogo College of Medicine; University of Fukui; Kyoto Prefectural University of Medicine; Hyogo College of Medicine	Yoshimoto, T (corresponding author), Hyogo Coll Med, Inst Adv Med Sci, Lab Allerg Dis, Nishinomiya, Hyogo, Japan.	tomo@hyo-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities [S1001055]; Japan Society for the Promotion of Science (JSPS) [24390253, 24790484]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities (S1001055); the Grant-in-Aid for Scientific Research B(24390253) from the Japan Society for the Promotion of Science (JSPS); the Grant-in-Aid for Young Scientists B (24790484) from JSPS, and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow JL, 2012, J ALLERGY CLIN IMMUN, V129, P191, DOI 10.1016/j.jaci.2011.09.041; Borish L, 2003, J ALLERGY CLIN IMMUN, V112, P1021, DOI 10.1016/j.jaci.2003.09.015; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Das AM, 1998, J LEUKOCYTE BIOL, V64, P156, DOI 10.1002/jlb.64.2.156; Elishmereni M, 2013, ALLERGY, V68, P171, DOI 10.1111/all.12059; Fokkens WJ, 2007, ALLERGY, V62, P1078, DOI 10.1111/j.1398-9995.2007.01522.x; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; HIRANO T, 1983, INT ARCH ALLER A IMM, V71, P182, DOI 10.1159/000233385; Incorvaia C, 2013, WORLD ALLERGY ORGAN, V6, DOI 10.1186/1939-4551-6-11; Kaiser HB, 2007, J ALLERGY CLIN IMMUN, V119, P1430, DOI 10.1016/j.jaci.2007.02.022; Kim HY, 2012, J ALLERGY CLIN IMMUN, V129, P216, DOI 10.1016/j.jaci.2011.10.036; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; Matsuba-Kitamura S, 2010, INT IMMUNOL, V22, P479, DOI 10.1093/intimm/dxq035; Minai-Fleminger Y, 2009, INFLAMM RES, V58, P631, DOI 10.1007/s00011-009-0042-6; Miyahara S, 2008, J ALLERGY CLIN IMMUN, V121, P718, DOI 10.1016/j.jaci.2007.11.002; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Powe DG, 2010, CLIN EXP ALLERGY, V40, P987, DOI 10.1111/j.1365-2222.2010.03536.x; Powe DG, 2003, CLIN EXP ALLERGY, V33, P1374, DOI 10.1046/j.1365-2222.2003.01737.x; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Rondon C, 2008, ALLERGY, V63, P1352, DOI 10.1111/j.1398-9995.2008.01695.x; Rondon C, 2012, ALLERGY, V67, P1282, DOI 10.1111/all.12002; Rondon C, 2010, J INVEST ALLERG CLIN, V20, P364; Rondon C, 2007, J ALLERGY CLIN IMMUN, V119, P899, DOI 10.1016/j.jaci.2007.01.006; Rondon C, 2014, J ALLERGY CLIN IMMUN, V133, P1026, DOI 10.1016/j.jaci.2013.10.034; Rondon C, 2012, J ALLERGY CLIN IMMUN, V129, P1460, DOI 10.1016/j.jaci.2012.02.032; Rondon C, 2009, J ALLERGY CLIN IMMUN, V123, P1098, DOI 10.1016/j.jaci.2009.02.018; Ryu JH, 2013, J ALLERGY CLIN IMMUN, V131, P549, DOI 10.1016/j.jaci.2012.07.050; Sarin S, 2006, J ALLERGY CLIN IMMUN, V118, P999, DOI 10.1016/j.jaci.2006.09.013; Shiraishi Y, 2013, J IMMUNOL, V190, P539, DOI 10.4049/jimmunol.1202049; Skoner DR, 2001, J ALLERGY CLIN IMMUN, V108, pS2, DOI 10.1067/mai.2001.115569; Tran NP, 2011, ALLERGY ASTHMA IMMUN, V3, P148, DOI 10.4168/aair.2011.3.3.148; Wallace DV, 2008, J ALLERGY CLIN IMMUN, V122, pS1, DOI 10.1016/j.jaci.2008.06.003; Wopfner N, 2005, INT ARCH ALLERGY IMM, V138, P337, DOI 10.1159/000089188; YOSHIMOTO T, 1995, P NATL ACAD SCI USA, V92, P11931, DOI 10.1073/pnas.92.25.11931	38	28	30	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103540	10.1371/journal.pone.0103540	http://dx.doi.org/10.1371/journal.pone.0103540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119881	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600024
J	Mackenbach, JD; Ringoot, AP; van der Ende, J; Verhulst, FC; Jaddoe, VWV; Hofman, A; Jansen, PW; Tiemeier, HW				Mackenbach, Joreintje D.; Ringoot, Ank P.; van der Ende, Jan; Verhulst, Frank C.; Jaddoe, Vincent W. V.; Hofman, Albert; Jansen, Pauline W.; Tiemeier, Henning W.			Exploring the Relation of Harsh Parental Discipline with Child Emotional and Behavioral Problems by Using Multiple Informants. The Generation R Study	PLOS ONE			English	Article							PHYSICAL DISCIPLINE; ANTISOCIAL-BEHAVIOR; MALTREATMENT; MOTHERS; PERCEPTIONS; SCALES; RISK	Parental harsh disciplining, like corporal punishment, has consistently been associated with adverse mental health outcomes in children. It remains a challenge to accurately assess the consequences of harsh discipline, as researchers and clinicians generally rely on parent report of young children's problem behaviors. If parents rate their parenting styles and their child's behavior this may bias results. The use of child self-report on problem behaviors is not common but may provide extra information about the relation of harsh parental discipline and problem behavior. We examined the independent contribution of young children's self-report above parental report of emotional and behavioral problems in a study of maternal and paternal harsh discipline in a birth cohort. Maternal and paternal harsh discipline predicted both parent reported behavioral and parent reported emotional problems, but only child reported behavioral problems. Associations were not explained by pre-existing behavioral problems at age 3. Importantly, the association with child reported outcomes was independent from parent reported problem behavior. These results suggest that young children's self-reports of behavioral problems provide unique information on the effects of harsh parental discipline. Inclusion of child self-reports can therefore help estimate the effects of harsh parental discipline more accurately.	[Mackenbach, Joreintje D.; Ringoot, Ank P.; Jaddoe, Vincent W. V.] Erasmus MC, Univ Med Ctr, Generat R Study Grp, Rotterdam, Netherlands; [Mackenbach, Joreintje D.; Ringoot, Ank P.; van der Ende, Jan; Verhulst, Frank C.; Jaddoe, Vincent W. V.; Jansen, Pauline W.; Tiemeier, Henning W.] Erasmus MC, Univ Med Ctr, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands; [Hofman, Albert; Tiemeier, Henning W.] Erasmus MC, Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Jaddoe, Vincent W. V.] Erasmus MC, Univ Med Ctr, Dept Pediat, Rotterdam, Netherlands; [Tiemeier, Henning W.] Erasmus MC, Univ Med Ctr, Dept Psychiat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Tiemeier, HW (corresponding author), Erasmus MC, Univ Med Ctr, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands.	h.tiemeier@erasmusmc.nl	Mackenbach, Joreintje Dingena/U-9131-2019; Tiemeier, Henning/H-6534-2019	Mackenbach, Joreintje Dingena/0000-0002-2783-721X; Tiemeier, Henning/0000-0002-4395-1397; Jansen, Pauline/0000-0001-7747-5803	Erasmus Medical Center; Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw); Netherlands Organization for Scientific Research (NWO ZonMW VIDI) [017.106.370]	Erasmus Medical Center; Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research (NWO ZonMW VIDI)	The first phase of the Generation R Study was made possible by financial support from: Erasmus Medical Center, Rotterdam, Erasmus University Rotterdam, and the Netherlands Organization for Health Research and Development (ZonMw). The present study was supported by an additional grant from the Netherlands Organization for Scientific Research to Henning Tiemeier (NWO ZonMW VIDI; grant no. 017.106.370). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T. M., 2001, MANUAL ASEBA PRESCHO; ANDERSON KE, 1986, DEV PSYCHOL, V22, P604, DOI 10.1037/0012-1649.22.5.604; Arseneault L, 2005, J ABNORM CHILD PSYCH, V33, P537, DOI 10.1007/s10802-005-6736-5; Arseneault L, 2003, J CHILD PSYCHOL PSYC, V44, P832, DOI 10.1111/1469-7610.00168; Avakame E F, 1998, Violence Vict, V13, P301; Berger LM, 2005, CHILD ABUSE NEGLECT, V29, P107, DOI 10.1016/j.chiabu.2004.02.006; Bolger KE, 2001, DEV PSYCHOPATHOL, V13, P913, DOI 10.1017/S0954579401004096; Boss MW, 1991, PSYCHOL ASSESSMENT J, V3, P433, DOI [10.1037/1040-3590.3.3.433, DOI 10.1037/1040-3590.3.3.433]; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Chang L, 2003, J FAM PSYCHOL, V17, P598, DOI 10.1037/0893-3200.17.4.598; Davis-Kean PE, 2008, CHILD DEV, V79, P1257, DOI 10.1111/j.1467-8624.2008.01187.x; Day RD, 1998, J MARRIAGE FAM, V60, P79, DOI 10.2307/353443; Fox RA, 1995, J GENET PSYCHOL, V156, P431, DOI 10.1080/00221325.1995.9914835; Harter S., 1990, THRESHOLD DEV ADOLES, P352; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Jansen PW, 2012, FAM RELAT, V61, P253, DOI 10.1111/j.1741-3729.2011.00691.x; Kraemer HC, 2003, AM J PSYCHIAT, V160, P1566, DOI 10.1176/appi.ajp.160.9.1566; Lansford JE, 2004, J CHILD PSYCHOL PSYC, V45, P801, DOI 10.1111/j.1469-7610.2004.00273.x; Lansford JE, 2005, CHILD DEV, V76, P1234, DOI 10.1111/j.1467-8624.2005.00847.x; Larzelere R E, 2000, Clin Child Fam Psychol Rev, V3, P199, DOI 10.1023/A:1026473020315; Luby JL, 2007, CHILD PSYCHIAT HUM D, V38, P321, DOI 10.1007/s10578-007-0063-8; MCLEOD JD, 1994, SOC FORCES, V73, P575, DOI 10.2307/2579822; Measelle JR, 1998, CHILD DEV, V69, P1556, DOI 10.2307/1132132; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Prinzie P, 2006, INT J BEHAV DEV, V30, P444, DOI 10.1177/0165025406071901; REID JB, 1987, J ABNORM CHILD PSYCH, V15, P457, DOI 10.1007/BF00916461; Rescorla L, 2007, J EMOT BEHAV DISORD, V15, P130, DOI 10.1177/10634266070150030101; Ringoot AP, 2013, PSYCHOL ASSESSMENT, V25, P1273, DOI 10.1037/a0033976; Sachs-Ericsson N, 2006, J AFFECT DISORDERS, V93, P71, DOI 10.1016/j.jad.2006.02.014; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Sidebotham P, 2001, CHILD ABUSE NEGLECT, V25, P1177, DOI 10.1016/S0145-2134(01)00261-7; Straus MA, 1998, CHILD ABUSE NEGLECT, V22, P249, DOI 10.1016/S0145-2134(97)00174-9; Taylor CA, 2010, PEDIATRICS, V125, pE1057, DOI 10.1542/peds.2009-2678; Teicher MH, 2006, AM J PSYCHIAT, V163, P993, DOI 10.1176/appi.ajp.163.6.993; Tick NT, 2007, J AM ACAD CHILD PSY, V46, P1333, DOI 10.1097/chi.0b013e3181337532; van der Valk JC, 2003, J AM ACAD CHILD PSY, V42, P1212, DOI 10.1097/00004583-200310000-00012; vandenOord EJCG, 1996, J ABNORM PSYCHOL, V105, P349, DOI 10.1037/0021-843X.105.3.349; Verlinden M, 2014, PSYCHOL ASSESSMENT, V26, P628, DOI 10.1037/a0035571; Vostanis P, 2006, SOC PSYCH PSYCH EPID, V41, P509, DOI 10.1007/s00127-006-0061-3; Walter S, 2009, EUR J EPIDEMIOL, V24, P733, DOI 10.1007/s10654-009-9411-2; Wolke D, 2009, BRIT J PSYCHIAT, V195, P249, DOI 10.1192/bjp.bp.108.053751; Zwirs B, 2012, PSYCHOL CRIME LAW, V18, P335, DOI 10.1080/1068316X.2010.493888	42	23	26	4	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104793	10.1371/journal.pone.0104793	http://dx.doi.org/10.1371/journal.pone.0104793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9BM	25120014	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600086
J	Zhou, LL; Yu, LJ; Wang, Y; Lu, ZQ; Tian, LH; Tan, L; Shi, Y; Nie, SF; Liu, L				Zhou, Lingling; Yu, Lijing; Wang, Ying; Lu, Zhouqin; Tian, Lihong; Tan, Li; Shi, Yun; Nie, Shaofa; Liu, Li			A Hybrid Model for Predicting the Prevalence of Schistosomiasis in Humans of Qianjiang City, China	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; TIME-SERIES ANALYSIS; REPUBLIC-OF-CHINA; TRANSMISSION; JAPONICUM; METAANALYSIS; ELIMINATION; REGRESSION; STRATEGY; OUTCOMES	Backgrounds/Objective: Schistosomiasis is still a major public health problem in China, despite the fact that the government has implemented a series of strategies to prevent and control the spread of the parasitic disease. Advanced warning and reliable forecasting can help policymakers to adjust and implement strategies more effectively, which will lead to the control and elimination of schistosomiasis. Our aim is to explore the application of a hybrid forecasting model to track the trends of the prevalence of schistosomiasis in humans, which provides a methodological basis for predicting and detecting schistosomiasis infection in endemic areas. Methods: A hybrid approach combining the autoregressive integrated moving average (ARIMA) model and the nonlinear autoregressive neural network (NARNN) model to forecast the prevalence of schistosomiasis in the future four years. Forecasting performance was compared between the hybrid ARIMA-NARNN model, and the single ARIMA or the single NARNN model. Results: The modelling mean square error (MSE), mean absolute error (MAE) and mean absolute percentage error (MAPE) of the ARIMA-NARNN model was 0.1869x10(-4), 0.0029, 0.0419 with a corresponding testing error of 0.9375x10(-4), 0.0081, 0.9064, respectively. These error values generated with the hybrid model were all lower than those obtained from the single ARIMA or NARNN model. The forecasting values were 0.75%, 0.80%, 0.76% and 0.77% in the future four years, which demonstrated a no-downward trend. Conclusion: The hybrid model has high quality prediction accuracy in the prevalence of schistosomiasis, which provides a methodological basis for future schistosomiasis monitoring and control strategies in the study area. It is worth attempting to utilize the hybrid detection scheme in other schistosomiasis-endemic areas including other infectious diseases.	[Zhou, Lingling; Yu, Lijing; Wang, Ying; Lu, Zhouqin; Tian, Lihong; Tan, Li; Shi, Yun; Nie, Shaofa; Liu, Li] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Nie, SF (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China.	sf_nie@mails.tjmu.edu.cn; gracefulliuly@gmail.com						Aladag CH, 2009, APPL MATH LETT, V22, P1467, DOI 10.1016/j.aml.2009.02.006; Allard R, 1998, B WORLD HEALTH ORGAN, V76, P327; Allende H, 2002, KYBERNETIKA, V38, P685; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P81; Araujo P, 2011, J ENVIRON MONITOR, V13, P35, DOI 10.1039/c0em00478b; Barbounis TG, 2006, IEEE T ENERGY CONVER, V21, P273, DOI 10.1109/TEC.2005.847954; Barbour AD, 1996, AM J TROP MED HYG, V55, P135, DOI 10.4269/ajtmh.1996.55.135; Box George E. P, 2008, TIME SERIES ANAL FOR; Chen ZM, 2010, ACTA TROP, V115, P119, DOI 10.1016/j.actatropica.2010.02.012; China MohotPsRo, 2007, GB159762006, P1; Collins C, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-8; CONNOR JT, 1994, IEEE T NEURAL NETWOR, V5, P240, DOI 10.1109/72.279188; DOYLE HR, 1994, ANN SURG, V219, P408, DOI 10.1097/00000658-199404000-00012; Fan KW, 2012, AM J PUBLIC HEALTH, V102, P2231, DOI 10.2105/AJPH.2012.300809; Faruk DO, 2010, ENG APPL ARTIF INTEL, V23, P586, DOI 10.1016/j.engappai.2009.09.015; Gao SJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-141; Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166; Gomez-Elipe A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-129; Gray DJ, 2010, LANCET INFECT DIS, V10, P733, DOI 10.1016/S1473-3099(10)70099-2; Gray DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004058; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Gryseels B, 2012, INFECT DIS CLIN N AM, V26, P383, DOI 10.1016/j.idc.2012.03.004; Guan P, 2004, WORLD J GASTROENTERO, V10, P3579, DOI 10.3748/wjg.v10.i24.3579; Hoad KA, 2009, MATH BIOSCI, V218, P98, DOI 10.1016/j.mbs.2009.01.002; HORNIK K, 1993, NEURAL NETWORKS, V6, P1069, DOI 10.1016/S0893-6080(09)80018-X; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Hu WN, 2007, ANN EPIDEMIOL, V17, P679, DOI 10.1016/j.annepidem.2007.03.020; Kaastra I, 1996, NEUROCOMPUTING, V10, P215, DOI 10.1016/0925-2312(95)00039-9; Khashei M, 2012, EXPERT SYST APPL, V39, P4344, DOI 10.1016/j.eswa.2011.09.157; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Lee YS, 2011, KNOWL-BASED SYST, V24, P66, DOI 10.1016/j.knosys.2010.07.006; McManus DP, 2010, CLIN MICROBIOL REV, V23, P442, DOI 10.1128/CMR.00044-09; Medina DC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000276; Moreno JJM, 2011, PSICOTHEMA, V23, P322; Ren YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042055; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Seto EYW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001372; Shafie-khah M, 2011, ENERG CONVERS MANAGE, V52, P2165, DOI 10.1016/j.enconman.2010.10.047; Sousa SIV, 2006, CHEMOSPHERE, V64, P1141, DOI 10.1016/j.chemosphere.2005.11.051; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Sun LP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-243; Tseng FM, 2002, TECHNOL FORECAST SOC, V69, P71, DOI 10.1016/S0040-1625(00)00113-X; Wan C, 2013, ACTA TROP, V126, P256, DOI 10.1016/j.actatropica.2013.02.012; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Wedding DK, 1996, NEUROCOMPUTING, V10, P149, DOI 10.1016/0925-2312(95)00021-6; Xu JF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002123; Yan WR, 2010, JPN J INFECT DIS, V63, P264; Yolcu U, 2013, DECIS SUPPORT SYST, V54, P1340, DOI 10.1016/j.dss.2012.12.006; Zhang DF, 2011, DESIGN ARTIFICIAL NU; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang Z, 2008, PARASITOL INT, V57, P121, DOI 10.1016/j.parint.2007.09.008; Zheng Hao, 2012, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V24, P621; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	54	16	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104875	10.1371/journal.pone.0104875	http://dx.doi.org/10.1371/journal.pone.0104875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119882	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600096
J	Barrett, HL; Kubala, MH; Romero, KS; Denny, KJ; Woodruff, TM; Mcintyre, HD; Caiiaway, LK; Nitert, MD				Barrett, Helen L.; Kubala, Marta H.; Romero, Katherin Scholz; Denny, Kerina J.; Woodruff, Trent M.; Mcintyre, H. David; Caiiaway, Leonie K.; Nitert, Marioes Dekker			Placental Lipases in Pregnancies Complicated by Gestational Diabetes Mellitus (GDM)	PLOS ONE			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; NORMAL GLUCOSE-TOLERANCE; FATTY-ACID TRANSPORT; FULL-TERM PLACENTA; LIPOPROTEIN-LIPASE; LIPID-METABOLISM; HYDROLASE ACTIVITIES; ADIPOCYTE LIPOLYSIS; ENDOTHELIAL LIPASE; GENE-EXPRESSION	Infants of women with gestational diabetes mellitus (GDM) are more likely to be born large for gestational age with a higher percentage body fat. Elevated maternal lipids may contribute to this. Placental lipases such as lipoprotein lipase (LPL), endothelial lipase (EL) and hormone sensitive lipase (HSL) are involved in transferring lipids from mother to fetus. Previous studies of expression of these lipases in placentae in women with diabetes in pregnancy have reported divergent results. Intracellular lipases such as adipose triglyceride lipase (ATGL), and HSL are central to lipid droplet metabolism. The activities of these lipases are both influenced by Perilipin 1, and ATGL is also activated by a co-factor comparative gene identification-58 (CGI-58) and inhibited by G(0)/G(1) switch gene 2 (GS02). None of these modifying factors or ATGL have been examined previously in placenta. The purpose of this study was therefore to examine the expression of ATGL, HSL, LPL, EL, as well as Perilipin 1, GS02 and CGI-58 in term pregnancies complicated by GDM. mRNA and protein expression of the lipases were measured in placentae from 17 women with GDM and 17 normoglycaemic pregnancies, matched for maternal BMI and gestational age of delivery. ATGL mRNA expression was increased and HSL mRNA expression reduced in placentae from GDM although there was no differences in protein expression of any of the lipases. All lipases were localised to trophoblasts and endothelial cells. The expression of Perilipin 1 and CGI-58 mRNA was increased and GS02 not altered in GDM. These results suggest that there is no difference in expression in these four lipases between GDM and normoglycaemic placentae, and therefore altered lipid transfer via these lipases does not contribute to large for gestational age in infants of women with GDM.	[Barrett, Helen L.; Kubala, Marta H.; Romero, Katherin Scholz; Nitert, Marioes Dekker] Univ Queensland, UQ Ctr Clin Res, Herston, Qld, Australia; [Barrett, Helen L.; Caiiaway, Leonie K.] Royal Brisbane & Womens Hosp, Herston, Qld, Australia; [Barrett, Helen L.; Mcintyre, H. David; Caiiaway, Leonie K.; Nitert, Marioes Dekker] Univ Queensland, Sch Med, Herston, Qld, Australia; [Mcintyre, H. David] Univ Queensland, Inst Mat Res, Brisbane, Qld, Australia; [Denny, Kerina J.; Woodruff, Trent M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia	University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; University of Queensland; University of Queensland	Barrett, HL (corresponding author), Univ Queensland, UQ Ctr Clin Res, Herston, Qld, Australia.	h.barrett@uq.edu.au	Woodruff, Trent/AAS-4629-2020; McIntyre, Harold D/F-1888-2010; Denny, Kerina/F-5237-2017	Woodruff, Trent/0000-0003-1382-911X; McIntyre, Harold D/0000-0001-8819-5794; Denny, Kerina/0000-0001-9901-5736; Callaway, Leonie/0000-0002-0137-9935; Barrett, Helen L/0000-0001-7141-2086	Pfizer Australia; Cardiovascular Lipid Research grant; National Health and Medical Research Council project grant [APP 569693]; Royal Brisbane and Women's Hospital foundation grant; National Health and Medical Research Council; Patricia Dukes Fellowship from the Royal Brisbane and Women's Hospital foundation grant	Pfizer Australia(PfizerPfizer Australia); Cardiovascular Lipid Research grant; National Health and Medical Research Council project grant(National Health and Medical Research Council (NHMRC) of Australia); Royal Brisbane and Women's Hospital foundation grant; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Patricia Dukes Fellowship from the Royal Brisbane and Women's Hospital foundation grant	Project funding for this analysis was obtained from Pfizer Australia with a Cardiovascular Lipid Research grant (www.pfizer.com.au), a National Health and Medical Research Council project grant (www.nhmrc.gov.au, APP 569693), and a Royal Brisbane and Women's Hospital foundation grant (www.rbwhfoundation.com.au). HLB is supported by a National Health and Medical Research Council medical and dental PhD scholarship. MDN is supported by a Patricia Dukes Fellowship from the Royal Brisbane and Women's Hospital foundation grant (www.rbwhfoundation.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt J, 2008, EXP CLIN ENDOCR DIAB, V116, P203, DOI 10.1055/s-2007-993148; Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Butte NF, 2000, AM J CLIN NUTR, V71, p1256S, DOI 10.1093/ajcn/71.5.1256s; Di Cianni G, 2005, DIABETIC MED, V22, P21, DOI 10.1111/j.1464-5491.2004.01336.x; Dube E, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105619; Dube E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.098095; Durnwald C, 2004, AM J OBSTET GYNECOL, V191, P804, DOI 10.1016/j.ajog.2003.11.033; Gardosi J, 2013, GROW CUSTOMISED WEIG; Gauster M, 2007, J CLIN ENDOCR METAB, V92, P2256, DOI 10.1210/jc.2006-2403; Gauster M, 2011, DIABETES, V60, P2457, DOI 10.2337/db10-1434; Gil-Sanchez A, 2012, CURR OPIN CLIN NUTR, V15, P265, DOI 10.1097/MCO.0b013e3283523b6e; Helps SC, 2012, APPL IMMUNOHISTO M M, V20, P82, DOI 10.1097/PAI.0b013e31821fc8cd; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Herrera E, 2010, BEST PRACT RES CL EN, V24, P515, DOI 10.1016/j.beem.2010.05.006; Hoffman L, 1998, MED J AUSTRALIA, V169, P93, DOI 10.5694/j.1326-5377.1998.tb140192.x; Huter O, 1997, PLACENTA, V18, P707, DOI 10.1016/S0143-4004(97)90013-8; KAMINSKY S, 1991, PEDIATR RES, V30, P541, DOI 10.1203/00006450-199112000-00009; Lager S, 2006, PLACENTA, V27, pA35; Lager S, 2011, PLACENTA, V32, P121, DOI 10.1016/j.placenta.2010.10.012; Lampidonis AD, 2011, GENE, V477, P1, DOI 10.1016/j.gene.2011.01.007; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lawlor DA, 2010, DIABETOLOGIA, V53, P89, DOI 10.1007/s00125-009-1560-z; Lindegaard MLS, 2006, J LIPID RES, V47, P2581, DOI 10.1194/jlr.M600236-JLR200; Lindegaard MLS, 2005, J LIPID RES, V46, P2339, DOI 10.1194/jlr.M500277-JLR200; Magnusson AL, 2004, J CLIN ENDOCR METAB, V89, P4607, DOI 10.1210/jc.2003-032234; Magnusson-Olsson AL, 2006, J LIPID RES, V47, P2551, DOI 10.1194/jlr.M600098-JLR200; Magnusson-Olsson AL, 2007, AM J PHYSIOL-ENDOC M, V293, pE24, DOI 10.1152/ajpendo.00571.2006; Mairal A, 2006, DIABETOLOGIA, V49, P1629, DOI 10.1007/s00125-006-0272-x; Nielsen TS, 2012, J CLIN ENDOCR METAB, V97, pE1348, DOI 10.1210/jc.2012-1159; Ray H, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-58; Schaefer-Graf UM, 2008, DIABETES CARE, V31, P1858, DOI 10.2337/dc08-0039; Scholler M, 2012, J CLIN ENDOCR METAB, V97, P437, DOI 10.1210/jc.2011-1942; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Son GH, 2010, ACTA OBSTET GYN SCAN, V89, P700, DOI 10.3109/00016341003605677; Wang YX, 2003, OBES RES, V11, P930, DOI 10.1038/oby.2003.128; Waterman IJ, 1998, BBA-LIPID LIPID MET, V1394, P169, DOI 10.1016/S0005-2760(98)00105-2; Woollett LA, 2011, PLACENTA, V32, pS218, DOI 10.1016/j.placenta.2011.01.011; Yang XY, 2013, MOL ENDOCRINOL, V27, P116, DOI 10.1210/me.2012-1178	38	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104826	10.1371/journal.pone.0104826	http://dx.doi.org/10.1371/journal.pone.0104826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25118138	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400092
J	Leng, L; Yuan, YM; Chen, Q; Shen, MX; Ma, QK; Lin, BB; Zhu, DX; Qu, J; Lu, F				Leng, Lin; Yuan, Yimin; Chen, Qi; Shen, Meixiao; Ma, Qingkai; Lin, Beibei; Zhu, Dexi; Qu, Jia; Lu, Fan			Biometry of Anterior Segment of Human Eye on Both Horizontal and Vertical Meridians during Accommodation Imaged with Extended Scan Depth Optical Coherence Tomography	PLOS ONE			English	Article							CRYSTALLINE LENS; IN-VIVO; CURVATURE; CHAMBER; PRESBYOPIA; DIAMETER; RADII; VITRO	Purpose: To determine the biometry of anterior segment dimensions of the human eye on both horizontal and vertical meridians with extended scan depth optical coherence tomography (OCT) during accommodation. Methods: Twenty pre-presbyopic volunteers, aged between 24 and 30, were recruited. The ocular anterior segment of each subject was imaged using an extended scan depth OCT under non-and 3.0 diopters (D) of accommodative demands on both horizontal and vertical meridians. All the images were analyzed to yield the following parameters: pupil diameter (PD), anterior chamber depth (ACD), anterior and posterior surface curvatures of the crystalline lens (ASC and PSC) and the lens thickness (LT). Two consecutive measurements were performed to assess the repeatability and reproducibility of this OCT. They were evaluated by calculating the within-subject standard deviation (SD), a paired t-test, intra-class correlation coefficients (ICC) and the coefficient of repeatability/reproducibility (CoR). Results: There were no significant differences between two consecutive measurements on either horizontal or vertical meridians under both two different accommodative statuses (P>0.05). The ICC for all parameters ranged from 0.775 to 0.998, except for the PSC (0.550) on the horizontal meridian under the non-accommodative status. In addition, the CoR for most of the parameters were excellent (0.004% to 4.89%). In all the parameters, only PD and PSC were found different between the horizontal and vertical meridians under both accommodative statuses (P<0.05). PD, ACD, ASC and PSC under accommodative status were significantly smaller than those under the non-accommodative status, except that the PSC at the vertical meridian did not change. In addition, LT was significantly increased when accommodation. Conclusion: The extended scan depth OCT successfully measured the dimensions of the anterior eye during accommodation with good repeatability and reproducibility on both horizontal and vertical meridians. The asymmetry of lens posterior surface and oval-shaped pupil were found during accommodation.	[Leng, Lin; Yuan, Yimin; Chen, Qi; Shen, Meixiao; Ma, Qingkai; Lin, Beibei; Zhu, Dexi; Qu, Jia; Lu, Fan] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University	Lu, F (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	lufan62@mail.eye.ac.cn		Leng, Lin/0000-0001-9947-1352	National Natural Science Foundation of China [81170869, 81200672]; Wenzhou Science and Technology program [Y20120151]; National Basic Research Program (973 Program) of China [2011CB504601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Science and Technology program; National Basic Research Program (973 Program) of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (Grant No. 81170869 to Lu; Grant No. 81200672 to Chen), Wenzhou Science and Technology program (Grant No. Y20120151 to Chen), and National Basic Research Program (973 Program) of China (2011CB504601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American National Standards Institute Inc, 2007, AM NAT STAND SAF US; Baikoff G, 2005, J CATARACT REFR SURG, V31, P1722, DOI 10.1016/j.jcrs.2005.02.030; BROWN N, 1974, EXP EYE RES, V19, P175, DOI 10.1016/0014-4835(74)90034-7; Charman WN, 2008, CLIN EXP OPTOM, V91, P207, DOI 10.1111/j.1444-0938.2008.00256.x; Charman WN, 2009, OPHTHAL PHYSL OPT, V29, P72, DOI 10.1111/j.1475-1313.2008.00611.x; Chien Chang-Hai M., 2003, Comprehensive Therapy, V29, P245; Croft MA, 2001, INT OPHTHALMOL CLIN, V41, P33, DOI 10.1097/00004397-200104000-00005; Dawczynski J, 2007, GRAEF ARCH CLIN EXP, V245, P423, DOI 10.1007/s00417-006-0383-6; Dick HB, 2005, J CATARACT REFR SURG, V31, P302, DOI 10.1016/j.jcrs.2004.04.040; GILMARTIN B, 1995, OPHTHAL PHYSL OPT, V15, P431, DOI 10.1016/0275-5408(95)00095-U; Goldsmith JA, 2005, OPHTHALMOLOGY, V112, P238, DOI 10.1016/j.ophtha.2004.09.019; Helmhotz H, 1855, AKKOMMODATION AUGES, P1; Hermans EA, 2009, INVEST OPHTH VIS SCI, V50, P281, DOI 10.1167/iovs.08-2124; Hurmeric Volkan, 2010, Ophthalmic Surg Lasers Imaging, V41 Suppl, pS109, DOI 10.3928/15428877-20101031-08; Ishikawa Hiroshi, 2004, Ophthalmol Clin North Am, V17, P7, DOI 10.1016/j.ohc.2003.12.001; IZATT JA, 1994, ARCH OPHTHALMOL-CHIC, V112, P1584, DOI 10.1001/archopht.1994.01090240090031; Kasprzak HT, 2000, OPHTHAL PHYSL OPT, V20, P31, DOI 10.1016/S0275-5408(99)00031-9; Khanani AM, 2004, J CATARACT REFR SURG, V30, P2557, DOI 10.1016/j.jcrs.2004.05.029; Kirschkamp T, 2004, OPHTHAL PHYSL OPT, V24, P65, DOI 10.1046/j.1475-1313.2003.00168.x; Koretz JF, 1997, INVEST OPHTH VIS SCI, V38, P569; Ortiz S, 2012, BIOMED OPT EXPRESS, V3, P2471, DOI 10.1364/BOE.3.002471; ROHEN JW, 1979, INVEST OPHTH VIS SCI, V18, P133; Rosales P, 2006, J VISION, V6, P1057, DOI 10.1167/6.10.5; Rosales P, 2009, J REFRACT SURG, V25, P421, DOI 10.3928/1081597X-20090422-04; Rosen AM, 2006, VISION RES, V46, P1002, DOI 10.1016/j.visres.2005.10.019; Schachar RA, 2004, OPHTHALMOLOGY, V111, P1699, DOI 10.1016/j.ophtha.2004.03.033; Shen MX, 2010, EYE CONTACT LENS, V36, P73, DOI 10.1097/ICL.0b013e3181d0423e; Soliman W, 2012, ACTA OPHTHALMOL, V90, P461, DOI 10.1111/j.1755-3768.2010.01994.x; Strenk SA, 1990, INVEST OPHTH VIS SCI, V40, P1162; Subbaram MV, 2002, OPHTHAL PHYSL OPT, V22, P312, DOI 10.1046/j.1475-1313.2002.00037.x; Tsorbatzoglou A, 2007, J CATARACT REFR SURG, V33, P1597, DOI 10.1016/j.jcrs.2007.05.021; Wolffsohn JS, 2006, CLIN EXP OPTOM, V89, P205, DOI 10.1111/j.1444-0938.2006.00065.x; Wyatt HJ, 1995, EYE, V9, P772, DOI 10.1038/eye.1995.193; Yan PS, 2010, OPHTHALMOLOGY, V117, P2301, DOI 10.1016/j.ophtha.2010.03.027; Yuan YM, 2012, EYE CONTACT LENS, V38, P102, DOI 10.1097/ICL.0b013e318243e795	35	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104775	10.1371/journal.pone.0104775	http://dx.doi.org/10.1371/journal.pone.0104775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117696	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400081
J	Chirakul, S; Bartpho, T; Wongsurawat, T; Taweechaisupapong, S; Karoonutaisiri, N; Talaat, AM; Wongratanacheewin, S; Ernst, RK; Sermswan, RW				Chirakul, Sunisa; Bartpho, Thanatchaporn; Wongsurawat, Thidathip; Taweechaisupapong, Suwimol; Karoonutaisiri, Nitsara; Talaat, Adel M.; Wongratanacheewin, Surasakdi; Ernst, Robert K.; Sermswan, Rasana W.			Characterization of BPSS1521 (bprD), a Regulator of Burkholderia pseudomallei Virulence Gene Expression in the Mouse Model	PLOS ONE			English	Article							SECRETION SYSTEM; IMMUNE-RESPONSE; VI SECRETION; MELIOIDOSIS; INFECTION; PROTEIN; SURVIVAL; INSIGHTS; CLUSTER; VECTOR	The Gram-negative saprophytic bacterium Burkholderia pseudomallei is the causative agent of melioidosis, a severe infectious disease of both humans and animals. Severity of the disease is thought to be dependent on both the health status of the host, including diabetes mellitus and kidney disease, and bacterial-derived factors. To identify the bacterial factors important during an acute infection, gene expression profiles in the spleen, lung, and liver of BALB/c (Th2 prototype) and C57BL/6 mice (Th1 prototype) were determined using DNA microarrays. This analysis identified BPSS1521 (bprD), a predicted transcriptional regulator located in the type III secretion system (T3SS-3) operon, to be up regulated, specifically in C57BL/6 mice. BALB/c mice infected with a bprD mutant showed a shorter time to death and increased inflammation, as determined by histopathological analysis and enumeration of bacteria in the spleen. Elevated numbers of multinucleated giant cells (MNGCs), which is the hallmark of melioidosis, were detected in both the wild-type and the bprD mutants; a similar elevation occurs in melioidosis patients. One striking observation was the increased expression of BPSS1520 (bprC), located downstream of bprD, in the bprD mutant. BprC is a regulator of T6SS-1 that is required for the virulence of B. pseudomallei in murine infection models. Deletion of bprD led to the overexpression of bprC and a decreased time to death. bprD expression was elevated in C57BL/6 -as compared to BALB/c-mice, suggesting a role for BprD in the natural resistance of C57BL/6 mice to B. pseudomallei. Ultimately, this analysis using mice with different immune backgrounds may enhance our understanding of the outcomes of infection in a variety of models.	[Chirakul, Sunisa; Bartpho, Thanatchaporn; Wongratanacheewin, Surasakdi; Sermswan, Rasana W.] Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand; [Chirakul, Sunisa; Sermswan, Rasana W.] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand; [Wongsurawat, Thidathip; Karoonutaisiri, Nitsara] Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Taweechaisupapong, Suwimol] Khon Kaen Univ, Biofilm Res Grp, Fac Dent, Khon Kaen, Thailand; [Talaat, Adel M.] Univ Wisconsin, Dept Pathobiol, SVM, Madison, WI USA; [Wongratanacheewin, Surasakdi] Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand; [Ernst, Robert K.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA	Khon Kaen University; Khon Kaen University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Khon Kaen University; University of Wisconsin System; University of Wisconsin Madison; Khon Kaen University; University System of Maryland; University of Maryland Baltimore	Sermswan, RW (corresponding author), Khon Kaen Univ, Melioidosis Res Ctr, Khon Kaen, Thailand.	rasanaw@gmail.com	Simawaranon Bartpho, Theeraya/GYI-9839-2022; Taweechaisupapong, suwimol/F-6759-2010; Wongsurawat, Thidathip/K-5590-2019; Wongratanacheewin, Surasakdi/F-7324-2010	Simawaranon Bartpho, Theeraya/0000-0001-9803-3588; Wongratanacheewin, Surasakdi/0000-0003-2921-2536; Ernst, Robert/0000-0001-5016-8694	Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0166/2549]; Commission on Higher Education (CHE) Thailand; Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand	Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Commission on Higher Education (CHE) Thailand(Office of Higher Education Commission (OHEC)); Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand	This research work was supported by the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (Grant no. PHD/0166/2549) to SC and RW, the Commission on Higher Education (CHE) Thailand, and Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; AuCoin DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035386; Barnes JL, 2001, IMMUNOL CELL BIOL, V79, P490, DOI 10.1046/j.1440-1711.2001.01038.x; Bartpho T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037762; Burtnick MN, 2010, INFECT IMMUN, V78, P88, DOI 10.1128/IAI.00985-09; CHAOWAGUL W, 1989, J INFECT DIS, V159, P890, DOI 10.1093/infdis/159.5.890; Chen YH, 2011, INFECT IMMUN, V79, P3064, DOI 10.1128/IAI.05148-11; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cuccui J, 2012, INFECT IMMUN, V80, P1209, DOI 10.1128/IAI.05805-11; Currie BJ, 2001, AM J TROP MED HYG, V65, P177, DOI 10.4269/ajtmh.2001.65.177; Dance DAB, 2000, ACTA TROP, V74, P115, DOI 10.1016/S0001-706X(99)00059-5; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gan YH, 2005, J INFECT DIS, V192, P1845, DOI 10.1086/497382; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Hoppe I, 1999, INFECT IMMUN, V67, P2891, DOI 10.1128/IAI.67.6.2891-2900.1999; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; Kespichayawattana W, 2000, INFECT IMMUN, V68, P5377, DOI 10.1128/IAI.68.9.5377-5384.2000; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Le Negrate G, 2008, J IMMUNOL, V180, P5045, DOI 10.4049/jimmunol.180.7.5045; Lopez CM, 2009, APPL ENVIRON MICROB, V75, P6496, DOI 10.1128/AEM.01669-09; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Muller CM, 2012, INFECT IMMUN, V80, P3247, DOI 10.1128/IAI.00178-12; Pappas G, 2006, INFECT DIS CLIN N AM, V20, P395, DOI 10.1016/j.idc.2006.02.002; PRUKSACHARTVUTHI S, 1990, J MED MICROBIOL, V31, P109, DOI 10.1099/00222615-31-2-109; Sarkar-Tyson M, 2007, J MED MICROBIOL, V56, P1005, DOI 10.1099/jmm.0.47043-0; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Songsri J, 2012, SE ASIAN J TROP MED, V43, P124; Stevens MP, 2003, J BACTERIOL, V185, P4992, DOI 10.1128/JB.185.16.4992-4996.2003; Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x; Sun GW, 2010, TRENDS MICROBIOL, V18, P561, DOI 10.1016/j.tim.2010.09.002; Sun GW, 2010, MOL MICROBIOL, V76, P677, DOI 10.1111/j.1365-2958.2010.07124.x; Suputtamongkol Y, 1999, CLIN INFECT DIS, V29, P408, DOI 10.1086/520223; Talaat AM, 2000, NAT BIOTECHNOL, V18, P679, DOI 10.1038/76543; Talaat AM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf103; Tan KS, 2010, J IMMUNOL, V184, P5160, DOI 10.4049/jimmunol.0902663; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tuanyok A, 2006, INFECT IMMUN, V74, P5465, DOI 10.1128/IAI.00737-06; Ulett GC, 2000, ACTA TROP, V74, P229, DOI 10.1016/S0001-706X(99)00075-3; Ulett GC, 2000, INFECT IMMUN, V68, P2034, DOI 10.1128/IAI.68.4.2034-2042.2000; van Schaik E, 2008, MICROBES INFECT, V10, P1291, DOI 10.1016/j.micinf.2008.07.028; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; WONG KT, 1995, HISTOPATHOLOGY, V26, P51, DOI 10.1111/j.1365-2559.1995.tb00620.x	48	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104313	10.1371/journal.pone.0104313	http://dx.doi.org/10.1371/journal.pone.0104313			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111708	Green Submitted, Green Published, gold			2022-12-27	WOS:000341105100047
J	Edele, F; Dudda, JC; Bachtanian, E; Jakob, T; Pircher, H; Martin, SF				Edele, Fanny; Dudda, Jan C.; Bachtanian, Eva; Jakob, Thilo; Pircher, Hanspeter; Martin, Stefan F.			Efficiency of Dendritic Cell Vaccination against B16 Melanoma Depends on the Immunization Route	PLOS ONE			English	Article							CD8 T-CELLS; HOMING RECEPTOR PATTERNS; CANCER-IMMUNOTHERAPY; IMMUNE-RESPONSES; VIRAL-INFECTION; LYMPH-NODES; IN-VIVO; BYSTANDER ACTIVATION; TUMOR-IMMUNOTHERAPY; ANTIGEN	Dendritic cells (DC) presenting tumor antigens are crucial to induce potent T cell-mediated anti-tumor immune responses. Therefore DC-based cancer vaccines have been established for therapy, however clinical outcomes are often poor and need improvement. Using a mouse model of B16 melanoma, we found that the route of preventive DC vaccination critically determined tumor control. While repeated DC vaccination did not show an impact of the route of DC application on the prevention of tumor growth, a single DC vaccination revealed that both the imprinting of skin homing receptors and an enhanced proliferation state of effector T cells was seen only upon intracutaneous but not intravenous or intraperitoneal immunization. Tumor growth was prevented only by intracutaneous DC vaccination. Our results indicate that under suboptimal conditions the route of DC vaccination crucially determines the efficiency of tumor defense. DC-based strategies for immunotherapy of cancer should take into account the immunization route in order to optimize tissue targeting of tumor antigen specific T cells.	[Edele, Fanny; Dudda, Jan C.; Bachtanian, Eva; Jakob, Thilo; Martin, Stefan F.] Univ Freiburg, Med Ctr, Dept Dermatol, Allergy Res Grp, Freiburg, Germany; [Pircher, Hanspeter] Univ Freiburg, Med Ctr, Inst Med Microbiol & Hyg, Freiburg, Germany	University of Freiburg; University of Freiburg	Martin, SF (corresponding author), Univ Freiburg, Med Ctr, Dept Dermatol, Allergy Res Grp, Freiburg, Germany.	stefan.martin@uniklinik-freiburg.de			Deutsche Forschungsgemeinschaft (DFG) [MA1567/8-1, ED203/2-1]; Forschungskommission der Medizinischen Fakultat, Medical Center - University of Freiburg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Forschungskommission der Medizinischen Fakultat, Medical Center - University of Freiburg	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG) MA1567/8-1 (S. F. M. and F. E.) & ED203/2-1 (F. E.) and a grant from the Forschungskommission der Medizinischen Fakultat, Medical Center - University of Freiburg (S. F. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abastado JP, 2012, CANCER RES, V72, P2159, DOI 10.1158/0008-5472.CAN-11-3538; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Brinkman CC, 2008, J IMMUNOL, V181, P1814, DOI 10.4049/jimmunol.181.3.1814; Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Calzascia T, 2005, IMMUNITY, V22, P175, DOI 10.1016/j.immuni.2004.12.008; de Vries IJM, 2003, CLIN CANCER RES, V9, P5091; Dhodapkar MV, 2000, J CLIN INVEST, V105, pR9, DOI 10.1172/JCI9051; Dhodapkar MV, 1999, J CLIN INVEST, V104, P173, DOI 10.1172/JCI6909; Dudda JC, 2005, EUR J IMMUNOL, V35, P1056, DOI 10.1002/eji.200425817; Dudda JC, 2004, TRENDS IMMUNOL, V25, P417, DOI 10.1016/j.it.2004.05.008; Dudda JC, 2004, J IMMUNOL, V172, P857, DOI 10.4049/jimmunol.172.2.857; Edele F, 2008, J IMMUNOL, V181, P3745, DOI 10.4049/jimmunol.181.6.3745; Fong L, 2001, J IMMUNOL, V166, P4254, DOI 10.4049/jimmunol.166.6.4254; Fong L, 2001, P NATL ACAD SCI USA, V98, P8809, DOI 10.1073/pnas.141226398; Frankenberger B, 2012, EUR J CELL BIOL, V91, P53, DOI 10.1016/j.ejcb.2011.01.012; Grover A, 2006, CLIN CANCER RES, V12, P5801, DOI 10.1158/1078-0432.CCR-05-2421; Hammerschmidt SI, 2008, J EXP MED, V205, P2483, DOI 10.1084/jem.20080039; Hsu FJ, 1996, NAT MED, V2, P52, DOI 10.1038/nm0196-52; Kalinski P, 2013, EXPERT REV VACCINES, V12, P285, DOI [10.1586/erv.13.22, 10.1586/ERV.13.22]; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Molenaar R, 2009, J IMMUNOL, V183, P6395, DOI 10.4049/jimmunol.0900311; Morse MA, 2009, EXPERT OPIN BIOL TH, V9, P331, DOI 10.1517/14712590802715756 ; Moutsopoulos NM, 2008, CURR OPIN IMMUNOL, V20, P234, DOI 10.1016/j.coi.2008.04.003; Mullins DW, 2006, J IMMUNOL, V176, P4535, DOI 10.4049/jimmunol.176.8.4535; Mullins DW, 2003, J EXP MED, V198, P1023, DOI 10.1084/jem.20021348; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murali-Krishna K, 1998, ADV EXP MED BIOL, V452, P123; Nestle FO, 1998, NAT MED, V4, P328, DOI 10.1038/nm0398-328; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Sheasley-O'Neill SL, 2007, J IMMUNOL, V178, P1512, DOI 10.4049/jimmunol.178.3.1512; Sims RB, 2012, VACCINE, V30, P4394, DOI 10.1016/j.vaccine.2011.11.058; Thurner B, 1999, J EXP MED, V190, P1669, DOI 10.1084/jem.190.11.1669; Timmerman JM, 2002, BLOOD, V99, P1517, DOI 10.1182/blood.V99.5.1517; Xu GS, 2008, J CANCER RES CLIN, V134, P1043, DOI 10.1007/s00432-008-0393-3; Yoneyama H, 2005, INT J HEMATOL, V81, P204, DOI 10.1532/IJH97.04164; Zimmermann C, 1996, J EXP MED, V183, P1367, DOI 10.1084/jem.183.4.1367; Zitvogel L, 1996, J EXP MED, V183, P87, DOI 10.1084/jem.183.1.87	44	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105266	10.1371/journal.pone.0105266	http://dx.doi.org/10.1371/journal.pone.0105266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121970	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000109
J	Joshi, R; Alim, M; Kengne, AP; Jan, S; Maulik, PK; Peiris, D; Patel, AA				Joshi, Rohina; Alim, Mohammed; Kengne, Andre Pascal; Jan, Stephen; Maulik, Pallab K.; Peiris, David; Patel, Anushka A.			Task Shifting for Non-Communicable Disease Management in Low and Middle Income Countries - A Systematic Review	PLOS ONE			English	Review							PRIMARY-HEALTH-CARE; NONPHYSICIAN CLINICIAN; CONTROLLED-TRIAL; CERVIX CANCER; ORAL-CANCER; WORKERS; INDIA; INTERVENTION; FEASIBILITY; DEPRESSION	Background: One potential solution to limited healthcare access in low and middle income countries (LMIC) is task-shifting-the training of non-physician healthcare workers (NPHWs) to perform tasks traditionally undertaken by physicians. The aim of this paper is to conduct a systematic review of studies involving task-shifting for the management of non-communicable disease (NCD) in LMIC. Methods: A search strategy with the following terms "task-shifting'', "non-physician healthcare workers'', "community healthcare worker'', "hypertension'', "diabetes'', "cardiovascular disease'', "mental health'', "depression'', "chronic obstructive pulmonary disease'', "respiratory disease'', "cancer'' was conducted using Medline via Pubmed and the Cochrane library. Two reviewers independently reviewed the databases and extracted the data. Findings: Our search generated 7176 articles of which 22 were included in the review. Seven studies were randomised controlled trials and 15 were observational studies. Tasks performed by NPHWs included screening for NCDs and providing primary health care. The majority of studies showed improved health outcomes when compared with usual healthcare, including reductions in blood pressure, increased uptake of medications and lower depression scores. Factors such as training of NPHWs, provision of algorithms and protocols for screening, treatment and drug titration were the main enablers of the task-shifting intervention. The main barriers identified were restrictions on prescribing medications and availability of medicines. Only two studies described cost-effective analyses, both of which demonstrated that task-shifting was cost-effective. Conclusions: Task-shifting from physicians to NPHWs, if accompanied by health system re-structuring is a potentially effective and affordable strategy for improving access to healthcare for NCDs. Since the majority of study designs reviewed were of inadequate quality, future research methods should include robust evaluations of such strategies.	[Joshi, Rohina; Jan, Stephen; Peiris, David; Patel, Anushka A.] George Inst Global Hlth, Sydney, NSW, Australia; [Joshi, Rohina; Jan, Stephen; Peiris, David; Patel, Anushka A.] Univ Sydney, Sydney, NSW 2006, Australia; [Alim, Mohammed; Maulik, Pallab K.] George Inst Global Hlth, Hyderabad, Andhra Pradesh, India; [Kengne, Andre Pascal] MRC, Cape Town, South Africa; [Maulik, Pallab K.] Univ Oxford, Oxford, England	George Institute for Global Health; University of Sydney; University of Sydney; University of Oxford	Joshi, R (corresponding author), George Inst Global Hlth, Sydney, NSW, Australia.	rjoshi@thegeorgeinstitute.org	Jan, Stephen/AAG-3333-2021; Kengne, Andre Pascal/ABB-3696-2020; Mohammed, Alim/L-2831-2018	Maulik, Pallab Kumar/0000-0001-6835-6175; Patel, Anushka/0000-0003-3825-4092; Jan, Stephen/0000-0003-2839-1405; Joshi, Rohina/0000-0002-3374-401X; Peiris, David/0000-0002-6898-3870; Mohammed, Alim/0000-0002-1802-2203; Kengne, Andre Pascal/0000-0002-5183-131X	DBT-Wellcome Trust India Alliance [IA/I/13/1/500879] Funding Source: Medline	DBT-Wellcome Trust India Alliance(Wellcome Trust DBT India Alliance)		Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; Adams JL, 2012, INT J PSYCHIAT MED, V43, P105, DOI 10.2190/PM.43.2.a; Australian Institute for Health and Welfare, 2011, CARD DIS SER; Babigumira JB, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-192; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Berhanu S, 2009, SEIZURE, V18, DOI [10.1016/j.seizure.2008.1007.1002, DOI 10.1016/J.SEIZURE.2008.1007.1002]; Bhanbhro S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-330; Bloom DE, 2011, GLOBAL EC BURDEN NON; Buttorff C, 2012, B WORLD HEALTH ORGAN, V90, P813, DOI 10.2471/BLT.12.104133; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Chibanda D, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-1111-1828, DOI 10.1186/1471-2458-1111-1828]; Coleman R, 1998, B WORLD HEALTH ORGAN, V76, P633; Confederation of Medical Associations in Asia and Oceania, 2011, CMAAO STAT TASK SHIF; Dinshaw K, 2007, ONCOLOGY-BASEL, V73, P154, DOI 10.1159/000126498; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; FEKSI AT, 1991, LANCET, V337, P406, DOI 10.1016/0140-6736(91)91176-U; Gajalakshmi CK, 1996, CANCER CAUSE CONTROL, V7, P520, DOI 10.1007/BF00051884; Grumbach K, 1998, JAMA-J AM MED ASSOC, V280, P825, DOI 10.1001/jama.280.9.825; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Joshi R, 2008, J AM COLL C IN PRESS; Joshi R, 2012, J AM COLL CARDIOL, V59, P1188, DOI 10.1016/j.jacc.2011.10.901; Kar Sitanshu Sekhar, 2008, Indian Heart J, V60, P19; Kaufman JA, 2013, AIDS CARE, V25, P430, DOI 10.1080/09540121.2012.712661; Kengne AP, 2010, EPILEPSIA, V51, P931, DOI 10.1111/j.1528-1167.2009.02414.x; Kengne AP, 2009, J CLIN HYPERTENS, V11, P564, DOI 10.1111/j.1751-7176.2009.00165.x; Kengne AP, 2008, J ASTHMA, V45, P437, DOI 10.1080/02770900802032933; Kengne AP, 2009, PRIM CARE DIABETES, V3, P181, DOI 10.1016/j.pcd.2009.08.005; Kengne AP, 2009, PAN AFR MED J, V3; Labhardt ND, 2011, TROP MED INT HEALTH, V16, P1276, DOI 10.1111/j.1365-3156.2011.02827.x; Labhardt ND, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-339; Lekoubou A, 2010, INT J ENV RES PUB HE, V7, P353, DOI 10.3390/ijerph7020353; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Mathew B, 1997, BRIT J CANCER, V76, P390, DOI 10.1038/bjc.1997.396; McCollum ED, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009626; Mdege ND, 2013, HEALTH POLICY PLANN, V28, P223, DOI 10.1093/heapol/czs058; Ministry of Health and Family Welfare, 2010, RUR HLTH STAT B MARC; Mittra I, 2010, INT J CANCER, V126, P976, DOI 10.1002/ijc.24840; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Organization WH, 2016, GLOBAL STATUS REPORT; Patel V, 2011, BRIT J PSYCHIAT, V199, P459, DOI 10.1192/bjp.bp.111.092155; Petersen I, 2012, COMMUNITY MENT HLT J, V48, P336, DOI 10.1007/s10597-011-9429-2; Pisani P, 2006, INT J CANCER, V118, P149, DOI 10.1002/ijc.21343; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Sankaranarayanan R, 2005, LANCET, V365, P1927, DOI 10.1016/S0140-6736(05)66658-5; Subramanian S, 2009, B WORLD HEALTH ORGAN, V87, P198, DOI 10.2471/BLT.08.053231; WARNAKULASURIYA KAAS, 1984, B WORLD HEALTH ORGAN, V62, P243; World Health Organization, 2008, TASK SHIFT RAT RED T; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; World Medical Association, 2009, WMA RES TASK SHIFT M; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	50	285	286	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e103754	10.1371/journal.pone.0103754	http://dx.doi.org/10.1371/journal.pone.0103754			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121789	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000018
J	Oynebraten, I; Hinkula, J; Fredriksen, AB; Bogen, B				Oynebraten, Inger; Hinkula, Jorma; Fredriksen, Agnete B.; Bogen, Bjarne			Increased Generation of HIV-1 gp120-Reactive CD8(+) T Cells by a DNA Vaccine Construct Encoding the Chemokine CCL3	PLOS ONE			English	Article							TARGETING DENDRITIC CELLS; IMMUNE-RESPONSE; IN-VIVO; TUMOR-ANTIGEN; ANTIBODY; FUSION; EXPRESSION; RECEPTORS; MOLECULES; MOUSE	DNA vaccines based on subunits from pathogens have several advantages over other vaccine strategies. DNA vaccines can easily be modified, they show good safety profiles, are stable and inexpensive to produce, and the immune response can be focused to the antigen of interest. However, the immunogenicity of DNA vaccines which is generally quite low needs to be improved. Electroporation and co-delivery of genetically encoded immune adjuvants are two strategies aiming at increasing the efficacy of DNA vaccines. Here, we have examined whether targeting to antigen-presenting cells (APC) could increase the immune response to surface envelope glycoprotein (Env) gp120 from Human Immunodeficiency Virus type 1 (HIV- 1). To target APC, we utilized a homodimeric vaccine format denoted vaccibody, which enables covalent fusion of gp120 to molecules that can target APC. Two molecules were tested for their efficiency as targeting units: the antibody-derived single chain Fragment variable (scFv) specific for the major histocompatilibility complex (MHC) class II I-E molecules, and the CC chemokine ligand 3 (CCL3). The vaccines were delivered as DNA into muscle of mice with or without electroporation. Targeting of gp120 to MHC class II molecules induced antibodies that neutralized HIV-1 and that persisted for more than a year after one single immunization with electroporation. Targeting by CCL3 significantly increased the number of HIV-1 gp120-reactive CD8(+) T cells compared to non-targeted vaccines and gp120 delivered alone in the absence of electroporation. The data suggest that chemokines are promising molecular adjuvants because small amounts can attract immune cells and promote immune responses without advanced equipment such as electroporation.	[Oynebraten, Inger; Fredriksen, Agnete B.; Bogen, Bjarne] Univ Oslo, Dept Immunol, Oslo, Norway; [Oynebraten, Inger; Fredriksen, Agnete B.; Bogen, Bjarne] Oslo Univ Hosp, Rikshosp, Oslo, Norway; [Oynebraten, Inger; Fredriksen, Agnete B.; Bogen, Bjarne] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Hinkula, Jorma] Linkoping Univ, Dept Clin & Expt Med, Div Mol Virol, Linkoping, Sweden; [Bogen, Bjarne] Univ Oslo, KG Jebsen Ctr Res Influenza Vaccines, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; Linkoping University; University of Oslo	Oynebraten, I (corresponding author), Oslo Univ Hosp, Rikshosp, Dept Pathol, Oslo, Norway.	inger.oynebraten@rr-research.no; bjarne.bogen@medisin.uio.no	Hinkula, Jorma/P-6849-2018; Øynebråten, Inger/W-3369-2019	Øynebråten, Inger/0000-0001-8914-5676	Research Council of Norway; Odd Fellow	Research Council of Norway(Research Council of Norway); Odd Fellow	The study was supported by grants from the Research Council of Norway and Odd Fellow (http://www.oddfellow.no/). The funders had no role in study design, data collection or analyses, decision to publish, or preparation of the manuscript.	Aliberti J, 2000, NAT IMMUNOL, V1, P83, DOI 10.1038/76957; Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Barouch DH, 2002, J IMMUNOL, V168, P562, DOI 10.4049/jimmunol.168.2.562; Bergman PJ, 2006, VACCINE, V24, P4582, DOI 10.1016/j.vaccine.2005.08.027; Biragyn A, 2002, BLOOD, V100, P1153, DOI 10.1182/blood-2002-01-0086; Biragyn A, 1999, NAT BIOTECHNOL, V17, P253, DOI 10.1038/6995; Biragyn A, 2007, J IMMUNOL, V179, P1381, DOI 10.4049/jimmunol.179.2.1381; Borroni EM, 2010, PHARMACOL THERAPEUT, V127, P1, DOI 10.1016/j.pharmthera.2010.04.006; BROLIDEN PA, 1990, J VIROL, V64, P936, DOI 10.1128/JVI.64.2.936-940.1990; CARAYANNIOTIS G, 1987, NATURE, V327, P59, DOI 10.1038/327059a0; Charmoy M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000755; Cheong C, 2010, BLOOD, V116, P3828, DOI 10.1182/blood-2010-06-288068; Coban C, 2013, HUM VACC IMMUNOTHER, V9, P2216, DOI 10.4161/hv.25893; Cohn L, 2013, J EXP MED, V210, P1049, DOI 10.1084/jem.20121251; Compeer EB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00037; Cruz LJ, 2012, NANOMEDICINE-UK, V7, P1591, DOI [10.2217/NNM.12.131, 10.2217/nnm.12.131]; D'Ambrosio D, 2003, J IMMUNOL METHODS, V273, P3, DOI 10.1016/S0022-1759(02)00414-3; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334; Flingai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00354; Fredriksen AB, 2006, MOL THER, V13, P776, DOI 10.1016/j.ymthe.2005.10.019; Fredriksen AB, 2007, BLOOD, V110, P1797, DOI 10.1182/blood-2006-06-032938; Froyland M, 2011, EUR J HAEMATOL, V86, P385, DOI 10.1111/j.1600-0609.2011.01590.x; Garver KA, 2005, DIS AQUAT ORGAN, V64, P13, DOI 10.3354/dao064013; Grodeland G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080008; Grodeland G, 2013, J IMMUNOL, V191, P3221, DOI 10.4049/jimmunol.1300504; Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; Iwasaki A, 1997, J IMMUNOL, V158, P4591; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Karpus WJ, 1997, J IMMUNOL, V158, P4129; KAWAMURA H, 1986, J IMMUNOL, V136, P58; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kim JJ, 1997, J IMMUNOL, V158, P816; Kreutz M, 2013, BLOOD, V121, P2836, DOI 10.1182/blood-2012-09-452078; Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x; Liu WL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002295; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; MALISSEN M, 1984, CELL, V37, P1101, DOI 10.1016/0092-8674(84)90444-6; Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019; McKay PF, 2004, EUR J IMMUNOL, V34, P1011, DOI 10.1002/eji.200324840; McMichael AJ, 2014, NAT IMMUNOL, V15, P319, DOI 10.1038/ni.2844; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; NEUBERGER MS, 1981, P NATL ACAD SCI-BIOL, V78, P1138, DOI 10.1073/pnas.78.2.1138; Norderhaug L, 1997, J IMMUNOL METHODS, V204, P77, DOI 10.1016/S0022-1759(97)00034-3; Oynebraten I, 2012, SCAND J IMMUNOL; OZATO K, 1980, J IMMUNOL, V124, P533; Peng BW, 2007, VACCINE, V25, P2064, DOI 10.1016/j.vaccine.2006.11.042; Qin H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/860160; Qin L, 2007, J VIROL, V81, P10606, DOI 10.1128/JVI.01000-07; Roos AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007226; Ruffini PA, 2010, VACCINE, V29, P191, DOI 10.1016/j.vaccine.2010.10.057; Santra S, 2000, J IMMUNOL, V165, P6791, DOI 10.4049/jimmunol.165.12.6791; Sardesai NY, 2011, CURR OPIN IMMUNOL, V23, P421, DOI 10.1016/j.coi.2011.03.008; Schiavo R, 2006, BLOOD, V107, P4597, DOI 10.1182/blood-2005-08-3207; Schiffner T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-72; Schjetne KW, 2007, J IMMUNOL, V178, P4169, DOI 10.4049/jimmunol.178.7.4169; Smed-Sorensen A, 2013, ADV EXP MED BIOL, V762, P263, DOI 10.1007/978-1-4614-4433-6_10; Snider DP, 1997, IMMUNOLOGY, V90, P323, DOI 10.1111/j.1365-2567.1997.00323.x; Song RJ, 2007, MOL THER, V15, P1007, DOI 10.1038/mt.sj.6300129; Spang HCL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045393; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Stephenson KE, 2013, IMMUNOL REV, V254, P295, DOI 10.1111/imr.12073; Tacken PJ, 2011, SEMIN IMMUNOL, V23, P12, DOI 10.1016/j.smim.2011.01.001; TAKAHASHI H, 1992, SCIENCE, V255, P333, DOI 10.1126/science.1372448; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; XIANG ZQ, 1995, IMMUNITY, V2, P129, DOI 10.1016/S1074-7613(95)80001-8	69	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104814	10.1371/journal.pone.0104814	http://dx.doi.org/10.1371/journal.pone.0104814			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122197	Green Submitted, Green Published, gold			2022-12-27	WOS:000341017000062
J	Srivastava, A; Sinha, S				Srivastava, Ashutosh; Sinha, Somdatta			Thermostability of In Vitro Evolved Bacillus subtilis Lipase A: A Network and Dynamics Perspective	PLOS ONE			English	Article							PROTEIN THERMAL-STABILITY; MOLECULAR-DYNAMICS; DIRECTED EVOLUTION; STRUCTURAL BASIS; HYDROGEN-BONDS; RESIDUES	Proteins in thermophilic organisms remain stable and function optimally at high temperatures. Owing to their important applicability in many industrial processes, such thermostable proteins have been studied extensively, and several structural factors attributed to their enhanced stability. How these factors render the emergent property of thermostability to proteins, even in situations where no significant changes occur in their three-dimensional structures in comparison to their mesophilic counter-parts, has remained an intriguing question. In this study we treat Lipase A from Bacillus subtilis and its six thermostable mutants in a unified manner and address the problem with a combined complex network-based analysis and molecular dynamic studies to find commonality in their properties. The Protein Contact Networks (PCN) of the wild-type and six mutant Lipase A structures developed at a mesoscopic scale were analyzed at global network and local node (residue) level using network parameters and community structure analysis. The comparative PCN analysis of all proteins pointed towards important role of specific residues in the enhanced thermostability. Network analysis results were corroborated with finer-scale molecular dynamics simulations at both room and high temperatures. Our results show that this combined approach at two scales can uncover small but important changes in the local conformations that add up to stabilize the protein structure in thermostable mutants, even when overall conformation differences among them are negligible. Our analysis not only supports the experimentally determined stabilizing factors, but also unveils the important role of contacts, distributed throughout the protein, that lead to thermostability. We propose that this combined mesoscopic-network and fine-grained molecular dynamics approach is a convenient and useful scheme not only to study allosteric changes leading to protein stability in the face of negligible over-all conformational changes due to mutations, but also in other molecular networks where change in function does not accompany significant change in the network structure.	[Srivastava, Ashutosh] Ctr Cellular & Mol Biol, CSIR, Hyderabad, Andhra Pradesh, India; [Sinha, Somdatta] Indian Inst Sci Educ & Res Mohali, Manauli, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Indian Institute of Science Education & Research (IISER) - Mohali	Sinha, S (corresponding author), Indian Inst Sci Educ & Res Mohali, Manauli, India.	ssinha@iisermohali.ac.in		Srivastava, Ashutosh/0000-0001-9820-720X	CSIR India; DST India	CSIR India(Council of Scientific & Industrial Research (CSIR) - India); DST India(Department of Science & Technology (India))	AS acknowledges financial support from CSIR India. SS thanks DST India for the JC Bose Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2004, J MOL BIOL, V341, P1271, DOI 10.1016/j.jmb.2004.06.059; Ahmad S, 2008, J MOL BIOL, V381, P324, DOI 10.1016/j.jmb.2008.05.063; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Babu MM, 2012, SCIENCE, V337, P1460, DOI 10.1126/science.1228775; Bagler G, 2005, PHYSICA A, V346, P27, DOI 10.1016/j.physa.2004.08.046; Bagler G, 2007, BIOINFORMATICS, V23, P1760, DOI 10.1093/bioinformatics/btm257; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Chan CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021624; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Development Core Team R, 2010, R FDN STAT COMPUT, V1, P409; Di Paola L, 2013, CHEM REV, V113, P1598, DOI 10.1021/cr3002356; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Essman U, 1995, J CHEM PHYS, V102, P31; Facchiano AM, 1999, PROTEIN ENG, V12, P893, DOI 10.1093/oxfordjournals.protein.a029825; Giver L, 1998, P NATL ACAD SCI USA, V95, P12809, DOI 10.1073/pnas.95.22.12809; Gonzalez-Blasco G, 2000, J BIOL CHEM, V275, P13708, DOI 10.1074/jbc.275.18.13708; Gromiha MM, 2013, PROTEINS, V81, P715, DOI 10.1002/prot.24232; Gromiha MM, 2004, PROG BIOPHYS MOL BIO, V86, P235, DOI 10.1016/j.pbiomolbio.2003.09.003; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Haney P, 1997, PROTEINS, V28, P117, DOI 10.1002/(SICI)1097-0134(199705)28:1<117::AID-PROT12>3.0.CO;2-M; Hansia P, 2009, MOL BIOSYST, V5, P1860, DOI 10.1039/b903807h; Hashem Y, 2009, METHODS, V47, P187, DOI 10.1016/j.ymeth.2008.09.020; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kamal MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035188; Kamal MZ, 2011, J MOL BIOL, V413, P726, DOI 10.1016/j.jmb.2011.09.002; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P67; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; Lehmann M, 2000, BBA-PROTEIN STRUCT M, V1543, P408, DOI 10.1016/S0167-4838(00)00238-7; Liszka MJ, 2012, ANNU REV CHEM BIOMOL, V3, P77, DOI 10.1146/annurev-chembioeng-061010-114239; Matsumura I, 1999, PROTEIN SCI, V8, P731; MATSUMURA M, 1989, NATURE, V342, P291, DOI 10.1038/342291a0; NICHOLSON H, 1988, NATURE, V336, P651, DOI 10.1038/336651a0; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; PJURA P, 1993, PROTEIN SCI, V2, P2226, DOI 10.1002/pro.5560021222; Polyansky AA, 2004, RUSS J BIOORG CHEM+, V30, P421, DOI 10.1023/B:RUBI.0000043784.51859.41; Pouderoyen G, 2001, J MOL BIOL, V309, P215; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Purmonen M, 2007, PROTEIN ENG DES SEL, V20, P551, DOI 10.1093/protein/gzm056; Russell RJM, 1997, BIOCHEMISTRY-US, V36, P9983, DOI 10.1021/bi9705321; Salminen T, 1996, PROTEIN SCI, V5, P1014; Stephens DE, 2007, J BIOTECHNOL, V127, P348, DOI 10.1016/j.jbiotec.2006.06.015; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Vogt G, 1997, FOLD DES, V2, pS40, DOI 10.1016/S1359-0278(97)00062-X; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Watanabe K, 1998, J MOL CATAL B-ENZYM, V4, P167, DOI 10.1016/S1381-1177(97)00031-3; WATANABE K, 1994, EUR J BIOCHEM, V226, P277, DOI 10.1111/j.1432-1033.1994.tb20051.x; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhao HM, 1999, PROTEIN ENG, V12, P47, DOI 10.1093/protein/12.1.47	59	20	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e102856	10.1371/journal.pone.0102856	http://dx.doi.org/10.1371/journal.pone.0102856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122499	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000007
J	Yang, GX; Xu, YY; Fan, YP; Wang, J; Chen, XL; Zhang, YD; Wu, JH				Yang, Guang-xia; Xu, Yu-yin; Fan, Ya-ping; Wang, Jing; Chen, Xiao-lan; Zhang, Yi-de; Wu, Jian-hua			A Maladaptive Role for EP4 Receptors in Mouse Mesangial Cells	PLOS ONE			English	Article							PROSTAGLANDIN E-2; PROSTANOID RECEPTORS; CYCLOOXYGENASE-2; EXPRESSION; INHIBITION; ACTIVATION; SYNTHASE; INJURY	Roles of the prostaglandin E2 E-prostanoid 4 receptor (EP4) on extracellular matrix (ECM) accumulation induced by TGF-beta 1 in mouse glomerular mesangial cells (GMCs) remain unknown. Previously, we have identified that TGF-beta 1 stimulates the expression of FN and Col I in mouse GMCs. Here we asked whether stimulation of EP4 receptors would exacerbate renal fibrosis associated with enhanced glomerular ECM accumulation. We generated EP4(Flox/Flox) and EP4(+/-) mice, cultured primary WT, EP4(Flox/Flox) and EP4(+/-) GMCs, AD-EP4 transfected WT GMCs (EP4 overexpression) and AD-Cre transfected EP4(Flox/Flox) GMCs (EP4 deleted). We found that TGF-beta 1-induced cAMP and PGE2 synthesis decreased in EP4 deleted GMCs and increased in EP4 overexpressed GMCs. Elevated EP4 expression in GMCs augmented the coupling of TGF-beta 1 to FN, Col I expression and COX2/PGE2 signaling, while TGF-beta 1 induced FN, Col I expression and COX2/PGE2 signaling were down-regulated in EP4 deficiency GMCs. 8 weeks after 5/6 nephrectomy (Nx), WT and EP4(+/-) mice exhibited markedly increased accumulation of ECM compared with sham-operated controls. Albuminuria, blood urea nitrogen and creatinine (BUN and Cr) concentrations were significantly increased in WT mice as compared to those of EP4(+/-) mice. Urine osmotic pressure was dramatically decreased after 5/6 Nx surgery in WT mice as compared to EP4(+/-) mice. The pathological changes in kidney of EP4(+/-) mice was markedly alleviated compared with WT mice. Immunohistochemical analysis showed significant reductions of Col I and FN in the kidney of EP4(+/-) mice compared with WT mice. Collectively, this investigation established EP4 as a potent mediator of the pro-TGF-beta 1 activities elicited by COX2/PGE2 in mice GMCs. Our findings suggested that prostaglandin E2, acting via EP4 receptors contributed to accumulation of ECM in GMCs and promoted renal fibrosis.	[Yang, Guang-xia; Xu, Yu-yin; Fan, Ya-ping; Chen, Xiao-lan; Zhang, Yi-de; Wu, Jian-hua] Nantong Univ, Affiliated Hosp, Dept Nephrol, Nantong, Jiangsu, Peoples R China; [Yang, Guang-xia] Jiangnan Univ, Wuxi Peoples Hosp 4, Affiliated Hosp, Dept Rheumatol, Wuxi, Jiangsu, Peoples R China; [Wang, Jing] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Nantong University; Jiangnan University; Shanghai Jiao Tong University	Chen, XL (corresponding author), Nantong Univ, Affiliated Hosp, Dept Nephrol, Nantong, Jiangsu, Peoples R China.	chenxl8448@sina.com			National Natural Science Fundation of China [81170656]; Jiangsu Basic Research Program [BK2008185]; Science Foundation of Nantong City, Jiangsu province, China [HS2011021]	National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Basic Research Program; Science Foundation of Nantong City, Jiangsu province, China	This research was supported by fundings from: National Natural Science Fundation of China (No. 81170656), Jiangsu Basic Research Program (BK2008185) and the Science Foundation of Nantong City, Jiangsu province, China (No. HS2011021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boor P, 2012, KIDNEY INT, V82, P132, DOI 10.1038/ki.2012.125; Breyer MD, 2000, AM J PHYSIOL-RENAL, V279, pF12, DOI 10.1152/ajprenal.2000.279.1.F12; Cheng HF, 2007, J AM SOC NEPHROL, V18, P551, DOI 10.1681/ASN.2006090990; Das F, 2010, FEBS LETT, V584, P4268, DOI 10.1016/j.febslet.2010.09.010; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; FUNK CD, 1993, J BIOL CHEM, V268, P26767; Gilbert RD, 2009, KIDNEY INT, V75, P415, DOI 10.1038/ki.2008.573; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Jo YI, 2007, NEPHRON EXP NEPHROL, V107, P87, DOI 10.1159/000108653; Jung GS, 2009, J AM SOC NEPHROL, V20, P2162, DOI 10.1681/ASN.2008121232; Kotnik P, 2005, AM J PHYSIOL-RENAL, V288, pF1053, DOI 10.1152/ajprenal.00114.2004; Kudo I, 2005, J BIOCHEM MOL BIOL, V38, P633; Lopez-Novoa JM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-13; Morath R, 1999, J AM SOC NEPHROL, V10, P1851; Nabrdalik K, 2013, ARCH MED SCI, V9, P230, DOI 10.5114/aoms.2013.34418; Nguyen MT, 2002, J IMMUNOL, V169, P4586, DOI 10.4049/jimmunol.169.8.4586; Raymond C, 2013, T AM CLIN CLIMAT ASS, V124, P139; Sankaran D, 2007, AM J PHYSIOL-RENAL, V293, pF821, DOI 10.1152/ajprenal.00257.2006; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; Stitt-Cavanagh EM, 2010, J AM SOC NEPHROL, V21, P1678, DOI 10.1681/ASN.2009121234; Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001; Vukicevic S, 2006, KIDNEY INT, V70, P1099, DOI 10.1038/sj.ki.5001715; Wahab NA, 2002, J AM SOC NEPHROL, V13, P2437, DOI 10.1097/01.ASN.0000031828.58276.02; Wang JL, 2000, KIDNEY INT, V57, P2334, DOI 10.1046/j.1523-1755.2000.00093.x; Yamamoto E, 2010, HISTOL HISTOPATHOL, V25, P995, DOI 10.14670/HH-25.995; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100	27	11	12	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104091	10.1371/journal.pone.0104091	http://dx.doi.org/10.1371/journal.pone.0104091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122504	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000028
J	Clements, J; Galek, R; Kozak, B; Michalczyk, DJ; Piotrowicz-Cieslak, AI; Sawicka-Sienkiewicz, E; Stawinski, S; Zalewski, D				Clements, Jon; Galek, Renata; Kozak, Bartosz; Michalczyk, Dariusz Jan; Piotrowicz-Cieslak, Agnieszka Iwona; Sawicka-Sienkiewicz, Ewa; Stawinski, Stanislaw; Zalewski, Dariusz			Diversity of Selected Lupinus angustifolius L. Genotypes at the Phenotypic and DNA Level with Respect to Microscopic Seed Coat Structure and Thickness	PLOS ONE			English	Article							DOMESTICATION GENES; POD WALL; ISSR; GERMPLASM; IDENTIFICATION; ENVIRONMENT; COLLECTION; CULTIVARS; AFLP; RAPD	The paper investigates seed coat characteristics (as a percentage of overall seed diameter) in Lupinus angustifolius L., a potential forage crop. In the study ten L. angustifolius genotypes, including three Polish cultivars, two Australian cultivars, three mutants originated from cv. 'Emir', and one Belarusian and one Australian breeding line were evaluated. The highest seed coat percentage was recorded in cultivars 'Sonet' and 'Emir'. The lowest seed coat thickness percentage (below 20%) was noted for breeding lines 11257-19, LAG24 and cultivar 'Zeus' (17.87%, 18.91% 19.60%, respectively). Despite having low seed weight, the Australian line no. 11257-19 was characterized by a desirable proportion of seed coat to the weight of seeds. In general, estimation of the correlation coefficient indicated a tendency that larger seeds had thinner coats. Scanning Electron Microscopy images showed low variation of seed coat sculpture and the top of seeds covered with a cuticle. Most of the studied genotypes were characterized by a cristatepapillate seed coat surface, formed by elongated polygonal cells. Only breeding line no. 11267-19 had a different shape of the cells building the surface layer of the coat. In order to illustrate genetic diversity among the genotypes tested, 24 ISSR primers were used. They generated a total of 161 polymorphic amplification products in 10 evaluated narrow-leaved lupin genotypes.	[Galek, Renata; Kozak, Bartosz; Sawicka-Sienkiewicz, Ewa; Zalewski, Dariusz] Wroclaw Univ Environm & Life Sci, Dept Genet Plant Breeding & Seed Prod, Wroclaw, Lower Silesia, Poland; [Michalczyk, Dariusz Jan; Piotrowicz-Cieslak, Agnieszka Iwona] Univ Warmia & Mazury, Dept Plant Physiol & Biotechnol, Olsztyn, Warmian Masuria, Poland; [Clements, Jon] Univ Western Australia, Ctr Plant Genet & Breeding, Crawley, WA, Australia; [Stawinski, Stanislaw] HR Smolice Sp Grupa IHAR Przebedowo, Plant Breeding Stn, Greater Poland, Poland	Wroclaw University of Environmental & Life Sciences; University of Warmia & Mazury; University of Western Australia	Kozak, B (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Genet Plant Breeding & Seed Prod, Wroclaw, Lower Silesia, Poland.	bartosz.kozak@up.wroc.pl	Galek, Renata/D-5029-2017; , Piotrowicz-Cieslak/AAA-8413-2021; Kozak, Bartosz/AAG-8466-2019	, Piotrowicz-Cieslak/0000-0001-8356-6373; Kozak, Bartosz/0000-0001-6472-3273; Clements, Jon/0000-0003-0494-9531; Michalczyk, Dariusz/0000-0002-3927-8806; Galek, Renata/0000-0002-0102-1335	HR Smolice Sp. z o. o. Grupa IHAR	HR Smolice Sp. z o. o. Grupa IHAR	HR Smolice Sp. z o. o. Grupa IHAR provided support in the form of salaries for author Stanislaw Stawinski. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MOL BIOL BIOTECHNOLO; Boersma JG, 2005, CELL MOL BIOL LETT, V10, P331; Clements JC, 2005, AUST J AGR RES, V56, P75, DOI 10.1071/AR03114; Clements JC, 2002, AUST J AGR RES, V53, P1147, DOI 10.1071/AR01156; Clements JC, 2001, P 4 EUR C GRAIN LEG, P293; Dolata A, 2007, ROSLINY STRACZKOWE, P79; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Fang DQ, 1997, THEOR APPL GENET, V95, P408, DOI 10.1007/s001220050577; Li X, 2012, MOL BREEDING, V29, P361, DOI 10.1007/s11032-011-9552-3; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Mera M, 2004, AUST J AGR RES, V55, P397, DOI 10.1071/AR03129; Michalczyk DJ, 2006, ACTA BIOL CRACOV BOT, V48, P59; Moreno S, 1998, EUPHYTICA, V101, P117, DOI 10.1023/A:1018379805873; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nelson MN, 2006, THEOR APPL GENET, V113, P225, DOI 10.1007/s00122-006-0288-0; Perisse P, 2004, SEED SCI TECHNOL, V32, P69, DOI 10.15258/sst.2004.32.1.08; Planchuelo A. M., 2006, Mexico, where old and new world lupins meet. Proceedings of the 11th International Lupin Conference, Guadalajara, Jalisco, Mexico, 4-9 May 2005, P35; Prusinski J., 2007, ZESZ PROBL POST NAUK, V522, P23; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; ROHLF F. J., 2009, NTSYSPC NUMERICAL TA; Sawicka-Sienkiewicz E, 2006, P 11 INT LUP C, P20; Sawicka-Sienkiewicz E, 2004, ROZPRAWY MONOGRAFIE, V11, P403; Sbabou L, 2010, INT J AGRIC BIOL, V12, P26; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Stawinski S, 2007, ROSLINY STRACZKOWE N, P25; Talhinhas P, 2006, GENET RESOUR CROP EV, V53, P563, DOI 10.1007/s10722-004-2684-0; Talhinhas P, 2003, PLANT BREEDING, V122, P507, DOI 10.1111/j.1439-0523.2003.00892.x; VANDEPEER Y, 1994, COMPUT APPL BIOSCI, V10, P569; Yang H, 2012, BMC GENOMICS, P13; Yorgancilar M, 2009, AFR J BIOTECHNOL, V8, P3524; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	31	11	12	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e102874	10.1371/journal.pone.0102874	http://dx.doi.org/10.1371/journal.pone.0102874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119983	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600014
J	Song, Y; McLoughlin, IV; Dai, LR				Song, Yan; McLoughlin, Ian Vince; Dai, Li-Rong			Local Coding Based Matching Kernel Method for Image Classification	PLOS ONE			English	Article								This paper mainly focuses on how to effectively and efficiently measure visual similarity for local feature based representation. Among existing methods, metrics based on Bag of Visual Word (BoV) techniques are efficient and conceptually simple, at the expense of effectiveness. By contrast, kernel based metrics are more effective, but at the cost of greater computational complexity and increased storage requirements. We show that a unified visual matching framework can be developed to encompass both BoV and kernel based metrics, in which local kernel plays an important role between feature pairs or between features and their reconstruction. Generally, local kernels are defined using Euclidean distance or its derivatives, based either explicitly or implicitly on an assumption of Gaussian noise. However, local features such as SIFT and HoG often follow a heavy-tailed distribution which tends to undermine the motivation behind Euclidean metrics. Motivated by recent advances in feature coding techniques, a novel efficient local coding based matching kernel (LCMK) method is proposed. This exploits the manifold structures in Hilbert space derived from local kernels. The proposed method combines advantages of both BoV and kernel based metrics, and achieves a linear computational complexity. This enables efficient and scalable visual matching to be performed on large scale image sets. To evaluate the effectiveness of the proposed LCMK method, we conduct extensive experiments with widely used benchmark datasets, including 15-Scenes, Caltech101/256, PASCAL VOC 2007 and 2011 datasets. Experimental results confirm the effectiveness of the relatively efficient LCMK method.	[Song, Yan; McLoughlin, Ian Vince; Dai, Li-Rong] Univ Sci & Technol China, Natl Engn Lab Speech & Language Informat Proc, Hefei 230026, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Song, Y (corresponding author), Univ Sci & Technol China, Natl Engn Lab Speech & Language Informat Proc, Hefei 230026, Peoples R China.	songy@ustc.edu.cn	McLoughlin, Ian/AAS-9081-2020; McLoughlin, Ian V/A-3674-2011	McLoughlin, Ian/0000-0001-7111-2008; McLoughlin, Ian V/0000-0001-7111-2008	National Nature Science Foundation of China [61172158]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grant No. 61172158, National Nature Science Foundation of China (http://www.nsfc.gov.co/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arandjelovic R, 2012, PROC CVPR IEEE, P2911, DOI 10.1109/CVPR.2012.6248018; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Bishop Christopher M., 2006, PATTERN RECOGNITION; Boiman O, 2008, PROC CVPR IEEE, P1992, DOI 10.1109/CVPR.2008.4587598; Boureau Y-L., 2010, P 27 INT C MACH LEAR, P111, DOI DOI 10.5555/3104322.3104338; BOUREAU YL, 2010, PROC CVPR IEEE, P2559, DOI DOI 10.1109/CVPR.2010.5539963; Carreira J, 2012, LECT NOTES COMPUT SC, V7578, P430, DOI 10.1007/978-3-642-33786-4_32; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chatfield K, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.76; Cuturi M, 2004, P ADV NEUR INF PROC; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Doersch Carl, 2013, NIPS; Everingham M., PASCAL VISUAL OBJECT; Gao SH, 2010, PROC CVPR IEEE, P3555, DOI 10.1109/CVPR.2010.5539943; Griffin G., 2007, 7694 CALT; Haussler D, 1999, CONVOLUTION KERNELS, P95; He X, 2004, P ADV NEUR INF PROC, V103; Jegou H, 2010, PROC CVPR IEEE, P3304, DOI 10.1109/CVPR.2010.5540039; Jia Y., 2011, ADV NEURAL INFORM PR, V24, P397; Jia YQ, 2012, PROC CVPR IEEE, P3370, DOI 10.1109/CVPR.2012.6248076; Jiashi Feng, 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2697, DOI 10.1109/CVPR.2011.5995370; Juneja M, 2013, PROC CVPR IEEE, P923, DOI 10.1109/CVPR.2013.124; Lazebnik S., 2006, P IEEE INT C COMP VI, V2, P2169, DOI DOI 10.1109/CVPR.2006.68; Lew MS, 2000, PROC CVPR IEEE, P58, DOI 10.1109/CVPR.2000.854737; Liu LQ, 2011, IEEE I CONF COMP VIS, P2486, DOI 10.1109/ICCV.2011.6126534; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Lyu S, 2005, P IEEE C COMP VIS PA; Moreno PJ, 2003, P ADV NEUR INF PROC; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Parsana M, 2007, P ADV NEUR INF PROC; Perronnin F, 2010, PROC CVPR IEEE, P2297, DOI 10.1109/CVPR.2010.5539914; Pontil M, 1998, IEEE T PATTERN ANAL, V20, P637, DOI 10.1109/34.683777; Rematas K, 2012, ACCV, V7724, P176; Sanchez J, 2013, INT J COMPUT VISION, V105, P222, DOI 10.1007/s11263-013-0636-x; Shashua A, 2005, P ADV NEUR INF PROC; Sminchisescu C, 2009, NEURIPS, P135; van Gemert JC, 2010, IEEE T PATTERN ANAL, V32, P1271, DOI 10.1109/TPAMI.2009.132; Vedaldi A., 2008, VLFEAT OPEN PORTABLE; Vedaldi A, 2012, IEEE T PATTERN ANAL, V34, P480, DOI 10.1109/TPAMI.2011.153; Wang J., 2010, COMPUTER VISION PATT, DOI DOI 10.1109/CVPR.2010.5540018; Wang J, IEEE T MULTIMEDIA, V14, P986; Wu JX, 2009, IEEE I CONF COMP VIS, P630, DOI 10.1109/ICCV.2009.5459178; Yan SY, 2012, LECT NOTES COMPUT SC, V7575, P473, DOI 10.1007/978-3-642-33765-9_34; Yan YP, 2013, IEEE INT CON MULTI; Yanagawa A, 2007, TECHNICAL REPORT; Yang Jun, 2009, Proceedings of the 2009 2nd International Congress on Image and Signal Processing (CISP), DOI 10.1109/CISP.2009.5304123; Yu Kai, 2009, ADV NEURAL INFORM PR, P2223; Zhou X, 2010, LECT NOTES COMPUT SC, V6315, P141, DOI 10.1007/978-3-642-15555-0_11	50	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103575	10.1371/journal.pone.0103575	http://dx.doi.org/10.1371/journal.pone.0103575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119982	gold, Green Submitted, Green Published			2022-12-27	WOS:000340900600025
J	Zhang, ML; Dong, MQ; Liu, W; Wang, L; Luo, YC; Li, ZC; Jin, FG				Zhang, Minlong; Dong, Mingqing; Liu, Wei; Wang, Li; Luo, Ying; Li, Zhichao; Jin, Faguang			1 alpha, 25-Dihydroxyvitamin D-3 Ameliorates Seawater Aspiration-Induced Acute Lung Injury via NF-kappa B and RhoA/Rho Kinase Pathways	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; RHO-KINASE; ENDOTHELIAL-CELLS; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; INHIBITION; ACTIVATION; EXPRESSION; MYOSIN; PHOSPHORYLATION; PREVENTION	Introduction: Inflammation and pulmonary edema are involved in the pathogenesis of seawater aspiration-induced acute injury (ALI). Although several studies have reported that 1 alpha, 25-Dihydroxyvitamin D-3 (calcitriol) suppresses inflammation, it has not been confirmed to be effective in seawater aspiration-induced ALI. Thus, we investigated the effect of calcitriol on seawater aspiration-induced ALI and explored the probable mechanism. Methods: Male SD rats receiving different doses of calcitriol or not, underwent seawater instillation. Then lung samples were collected at 4 h for analysis. In addition, A549 cells and rat pulmonary microvascular endothelial cells (RPMVECs) were cultured with calcitriol or not and then stimulated with 25% seawater for 40 min. After these treatments, cells samples were collected for analysis. Results: Results from real-time PCR showed that seawater stimulation up-regulated the expression of vitamin D receptor in lung tissues, A549 cells and RPMVECs. Seawater stimulation also activates NF-kappa B and RhoA/Rho kinase pathways. However, we found that pretreatment with calcitriol significantly inhibited the activation of NF-kappa B and RhoA/Rho kinase pathways. Meanwhile, treatment of calcitriol also improved lung histopathologic changes, reduced inflammation, lung edema and vascular leakage. Conclusions: These results demonstrated that NF-kappa B and RhoA/Rho kinase pathways are critical in the development of lung inflammation and pulmonary edema and that treatment with calcitriol could ameliorate seawater aspiration-induced ALI, which was probably through the inhibition of NF-kappa B and RhoA/Rho kinase pathways.	[Zhang, Minlong; Liu, Wei; Wang, Li; Jin, Faguang] Fourth Mil Med Univ, Tangdu Hosp, Dept Respirat, Xian 710032, Peoples R China; [Dong, Mingqing; Luo, Ying; Li, Zhichao] Fourth Mil Med Univ, Dept Pathol & Pathophysiol, Xian 710032, Peoples R China; [Dong, Mingqing; Liu, Wei; Luo, Ying; Li, Zhichao; Jin, Faguang] Fourth Mil Med Univ, Lung Injury & Repair Ctr, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Li, ZC (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Respirat, Xian 710032, Peoples R China.	lizhic@fmmu.edu.cn; jinfag@fmmu.edu.cn			National Nature Science Foundation of China [81270124]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation of China (No. 81270124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; BAKER AR, 1988, P NATL ACAD SCI USA, V85, P3294, DOI 10.1073/pnas.85.10.3294; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V292, pL924, DOI 10.1152/ajplung.00395.2006; CHEN SF, 1995, MICROVASC RES, V50, P119, DOI 10.1006/mvre.1995.1044; Chen WG, 2008, AM J PHYSIOL-LUNG C, V295, pL575, DOI 10.1152/ajplung.00428.2007; Clements RT, 2005, AM J PHYSIOL-LUNG C, V288, pL294, DOI 10.1152/ajplung.00213.2004; Ding XM, 2006, PHARMACOL RES, V53, P372, DOI 10.1016/j.phrs.2006.01.006; Dong XY, 2003, J BIOL CHEM, V278, P49378, DOI 10.1074/jbc.M308448200; Ecklund MM, 2012, CRIT CARE NURS CLIN, V24, P601, DOI 10.1016/j.ccell.2012.07.002; Essler M, 2000, J IMMUNOL, V164, P6543, DOI 10.4049/jimmunol.164.12.6543; Fan QX, 2011, PULM PHARMACOL THER, V24, P673, DOI 10.1016/j.pupt.2011.07.002; Fukuoka M, 1998, BRIT J PHARMACOL, V124, P1433, DOI 10.1038/sj.bjp.0701988; Gorovoy M, 2007, CIRC RES, V101, P50, DOI 10.1161/CIRCRESAHA.106.145847; Han F, 2012, RESP PHYSIOL NEUROBI, V182, P71, DOI 10.1016/j.resp.2012.05.012; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Ibsen LM, 2002, CRIT CARE MED, V30, pS402, DOI 10.1097/00003246-200211001-00004; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Konrad FM, 2012, AM J PHYSIOL-LUNG C, V303, pL425, DOI 10.1152/ajplung.00387.2011; Li JH, 2011, RESP PHYSIOL NEUROBI, V176, P39, DOI 10.1016/j.resp.2011.01.005; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Ma LJ, 2013, RESP PHYSIOL NEUROBI, V185, P608, DOI 10.1016/j.resp.2012.11.016; Matsumura F, 2008, BIOCHEM BIOPH RES CO, V369, P149, DOI 10.1016/j.bbrc.2007.12.090; Montaner S, 1998, J BIOL CHEM, V273, P12779, DOI 10.1074/jbc.273.21.12779; Penna G, 2009, PROSTATE, V69, P480, DOI 10.1002/pros.20896; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Rostkowska-Nadolska B, 2010, ADV MED SCI-POLAND, V55, P86, DOI 10.2478/v10039-010-0012-9; Salomez F, 2004, RESUSCITATION, V63, P261, DOI 10.1016/j.resuscitation.2004.06.007; Schmeck B, 2003, INFLAMMATION, V27, P89, DOI 10.1023/A:1023278600596; Segain JP, 2003, GASTROENTEROLOGY, V124, P1180, DOI 10.1016/S0016-5085(03)00283-X; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Takahashi K, 2002, IMMUNOPHARM IMMUNOT, V24, P1, DOI 10.1081/IPH-120003399; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takano Y, 2011, STEROIDS, V76, P1305, DOI 10.1016/j.steroids.2011.06.009; Tasaka S, 2005, AM J RESP CELL MOL, V32, P504, DOI 10.1165/rcmb.2004-0009OC; van Beeck EF, 2005, B WORLD HEALTH ORGAN, V83, P853; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2; Xie XY, 2011, EXP LUNG RES, V37, P482, DOI 10.3109/01902148.2011.594144; You QH, 2010, J SURG RES, V162, P110, DOI 10.1016/j.jss.2009.01.019; Zhang Y, 2011, BIOL PHARM BULL, V34, P1052, DOI 10.1248/bpb.34.1052; Zheng C, 2011, CELL RES, V21, P183, DOI 10.1038/cr.2010.171	44	19	26	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104507	10.1371/journal.pone.0104507	http://dx.doi.org/10.1371/journal.pone.0104507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118599	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600063
J	Basson, A; Swart, R; Jordaan, E; Mazinu, M; Watermeyer, G				Basson, Abigail; Swart, Rina; Jordaan, Esme; Mazinu, Mikateko; Watermeyer, Gillian			The Association between Race and Crohn's Disease Phenotype in the Western Cape Population of South Africa, Defined by the Montreal Classification System	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LONG-TERM PROGNOSIS; JAPANESE PATIENTS; CLINICAL-FEATURES; CHINESE PATIENTS; BLACK PATIENTS; INCREASING INCIDENCE; ULCERATIVE-COLITIS; GENETIC-STRUCTURE; NOD2/CARD15 GENE	Background: Inter-racial differences in disease characteristics and in the management of Crohn's disease (CD) have been described in African American and Asian subjects, however for the racial groups in South Africa, no such recent literature exists. Methods: A cross sectional study of all consecutive CD patients seen at 2 large inflammatory bowel disease (IBD) referral centers in the Western Cape, South Africa between September 2011 and January 2013 was performed. Numerous demographic and clinical variables at diagnosis and date of study enrolment were identified using an investigator administered questionnaire as well as clinical examination and patient case notes. Using predefined definitions, disease behavior was stratified as 'complicated' or 'uncomplicated'. Results: One hundred and ninety four CD subjects were identified; 35 (18%) were white, 152 (78%) were Cape Coloured and 7 (4%) were black. On multiple logistic regression analysis Cape Coloureds were significantly more likely to develop 'complicated' CD (60% vs. 9%, p = 0.023) during the disease course when compared to white subjects. In addition, significantly more white subjects had successfully discontinued cigarette smoking at study enrolment (31% vs. 7% reduction, p = 0.02). No additional inter-racial differences were found. A low proportion of IBD family history was observed among the non-white subjects. Conclusions: Cape Coloured patients were significantly more likely to develop 'complicated' CD over time when compared to whites.	[Basson, Abigail; Swart, Rina] Univ Western Cape, Dietet Dept, ZA-7535 Bellville, Western Cape, South Africa; [Jordaan, Esme; Mazinu, Mikateko] Med Res Council South Afr, Biostat Unit, Parow, Western Cape, South Africa; [Jordaan, Esme] Univ Western Cape, Stat & Populat Studies Dept, ZA-7535 Bellville, Western Cape, South Africa; [Watermeyer, Gillian] Groote Schuur Hosp, Dept Gastroenterol, ZA-7925 Cape Town, Western Cape, South Africa; [Watermeyer, Gillian] Univ Cape Town, Dept Med, ZA-7925 Cape Town, Western Cape, South Africa	University of the Western Cape; University of the Western Cape; University of Cape Town; University of Cape Town	Basson, A (corresponding author), Univ Western Cape, Dietet Dept, ZA-7535 Bellville, Western Cape, South Africa.	abbasson@uwc.ac.za	Swart, Elizabeth/O-9619-2014	Swart, Elizabeth/0000-0002-7786-3117; Basson, Abigail/0000-0002-8369-919X	Scholarship in Gastroenterology; AstraZeneca/South African Gastroenterology Society (SAGES)	Scholarship in Gastroenterology; AstraZeneca/South African Gastroenterology Society (SAGES)	This research was supported by the 2011 Scholarship in Gastroenterology; a grant from the AstraZeneca/South African Gastroenterology Society (SAGES). http://www.sages.co.za/D_AN_ScholTravel.asp. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhous MC, 2010, FRONTLINE GASTROENTE, V1, P156, DOI 10.1136/fg.2010.001487; Ayodele OE, 2010, NEPHROLOGY, V15, P482, DOI 10.1111/j.1440-1797.2010.01290.x; Basu D, 2005, AM J GASTROENTEROL, V100, P2254, DOI 10.1111/j.1572-0241.2005.00233.x; Bayless TM, 1996, GASTROENTEROLOGY, V111, P573, DOI 10.1053/gast.1996.v111.pm8780559; CALKINS BM, 1984, DIGEST DIS SCI, V29, P913, DOI 10.1007/BF01312480; Cao Q, 2005, CHINESE MED J-PEKING, V118, P747; Chow DKL, 2008, INFLAMM BOWEL DIS, V14, P536, DOI 10.1002/ibd.20335; Chow DKL, 2009, INFLAMM BOWEL DIS, V15, P551, DOI 10.1002/ibd.20804; Chu KM, 2013, INFLAMM BOWEL DIS, V19, P614, DOI 10.1097/MIB.0b013e31827f27f4; Chua KH, 2009, J DIGEST DIS, V10, P124, DOI 10.1111/j.1751-2980.2009.00374.x; Croucher PJP, 2003, EUR J HUM GENET, V11, P6, DOI 10.1038/sj.ejhg.5200897; Epstein D, 2007, ALIMENT PHARM THER, V25, P1373, DOI 10.1111/j.1365-2036.2007.03332.x; Freeman HJ, 2009, WORLD J GASTROENTERO, V15, P1315, DOI 10.3748/wjg.15.1315; GOLDMAN CD, 1986, DIS COLON RECTUM, V29, P317, DOI 10.1007/BF02554120; Guo QS, 2004, WORLD J GASTROENTERO, V10, P1069; Hisabe T, 2003, J GASTROENTEROL, V38, P121, DOI 10.1007/s005350300020; Hofmeister A, 1997, SURGERY, V122, P173, DOI 10.1016/S0039-6060(97)90006-4; Hou JK, 2009, AM J GASTROENTEROL, V104, P2100, DOI 10.1038/ajg.2009.190; Inoue N, 2002, GASTROENTEROLOGY, V123, P86, DOI 10.1053/gast.2002.34155; Ishige T, 2010, J GASTROENTEROL, V45, P911, DOI 10.1007/s00535-010-0223-7; Jiang L, 2006, INFLAMM BOWEL DIS, V12, P212, DOI 10.1097/01.MIB.0000201098.26450.ae; Karlinger K, 2000, EUR J RADIOL, V35, P154, DOI 10.1016/S0720-048X(00)00238-2; KURATA JH, 1992, GASTROENTEROLOGY, V102, P1940, DOI 10.1016/0016-5085(92)90317-R; Lawrance IC, 2004, AM J GASTROENTEROL, V99, P2186, DOI 10.1111/j.1572-0241.2004.40486.x; Leong RWL, 2006, AM J GASTROENTEROL, V101, P1024, DOI 10.1111/j.1572-0241.2006.00503.x; Leong RWL, 2003, ALIMENT PHARM THER, V17, P1465, DOI 10.1046/j.1365-2036.2003.01607.x; Li M, 2008, WORLD J GASTROENTERO, V14, P4923, DOI 10.3748/wjg.14.4923; Loftus EV, 2002, GASTROENTEROL CLIN N, V31, P1, DOI 10.1016/S0889-8553(01)00002-4; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Loftus EV, 1998, GASTROENTEROLOGY, V114, P1161, DOI 10.1016/S0016-5085(98)70421-4; MEKHJIAN HS, 1979, GASTROENTEROLOGY, V77, P898; MENDELOF.AI, 1966, GASTROENTEROLOGY, V51, P748; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Mosley E Jr, 1977, J Natl Med Assoc, V69, P219; NOVIS BH, 1975, S AFR MED J, V49, P693; ORHOLM M, 1991, NEW ENGL J MED, V324, P84, DOI 10.1056/NEJM199101103240203; Oriuchi T, 2003, J GASTROENTEROL, V38, P942, DOI 10.1007/s00535-003-1177-9; Patterson N, 2010, HUM MOL GENET, V19, P411, DOI 10.1093/hmg/ddp505; PAUL H, 1990, J NATL MED ASSOC, V82, P709; Peeters M, 1996, GASTROENTEROLOGY, V111, P597, DOI 10.1053/gast.1996.v111.pm8780562; Pugazhendhi Srinivasan, 2008, Indian J Gastroenterol, V27, P201; Risch N, 2006, NEW ENGL J MED, V354, P408, DOI 10.1056/NEJMe058265; ROGERS B H G, 1971, Journal of Chronic Diseases, V24, P743, DOI 10.1016/0021-9681(71)90087-7; SAMUELS AD, 1974, AM J DIG DIS, V19, P156, DOI 10.1007/BF01072627; Shin DH, 2011, DIGEST DIS SCI, V56, P1154, DOI 10.1007/s10620-010-1403-2; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; SIMSEK H, 1989, J CLIN GASTROENTEROL, V11, P294, DOI 10.1097/00004836-198906000-00010; Small K., 2008, DEMOGRAPHIC SO UNPUB; Song XM, 2011, DIS COLON RECTUM, V54, P1147, DOI 10.1097/DCR.0b013e318222ddc3; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Statistics South Africa, 2012, CENS 2011 STAT REL R; Straus WL, 2000, AM J GASTROENTEROL, V95, P479; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; Thia KT, 2008, AM J GASTROENTEROL, V103, P3167, DOI 10.1111/j.1572-0241.2008.02158.x; Thia KTJ, 2006, INFLAMM BOWEL DIS, V12, P57, DOI 10.1097/01.MIB.0000195390.11645.7d; Vind I, 2006, AM J GASTROENTEROL, V101, P1274, DOI 10.1111/j.1572-0241.2006.00552.x; Wadee S, 2007, RHEUMATOLOGY, V46, P1487, DOI 10.1093/rheumatology/kem180; WRIGHT JP, 1983, S AFR MED J, V63, P226; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; Yang SK, 2008, AM J GASTROENTEROL, V103, P1437, DOI 10.1111/j.1572-0241.2007.01752.x; Yang SK, 2008, INFLAMM BOWEL DIS, V14, P542, DOI 10.1002/ibd.20310; Ye BD, 2010, SCAND J GASTROENTERO, V45, P1178, DOI 10.3109/00365521.2010.497936; Zaahl MG, 2005, MOL CELL PROBE, V19, P278, DOI 10.1016/j.mcp.2005.03.001; Zaahl MG, 2006, INT J COLORECTAL DIS, V21, P402, DOI 10.1007/s00384-005-0019-z	65	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104859	10.1371/journal.pone.0104859	http://dx.doi.org/10.1371/journal.pone.0104859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25118187	Green Published, gold			2022-12-27	WOS:000341230400097
J	Naskar, S; Datta, K; Mitra, A; Pathak, K; Datta, R; Bansal, T; Sarkar, S				Naskar, Shaon; Datta, Kaberi; Mitra, Arkadeep; Pathak, Kanchan; Datta, Ritwik; Bansal, Trisha; Sarkar, Sagartirtha			Differential and Conditional Activation of PKC-Isoforms Dictates Cardiac Adaptation during Physiological to Pathological Hypertrophy	PLOS ONE			English	Article							KINASE-C-DELTA; APOPTOTIC RESPONSE; ANGIOTENSIN-II; MYOCYTE GROWTH; PROTEIN; ALPHA; CELLS; HEART; INHIBITION; PHOSPHORYLATION	A cardiac hypertrophy is defined as an increase in heart mass which may either be beneficial (physiological hypertrophy) or detrimental (pathological hypertrophy). This study was undertaken to establish the role of different protein kinase-C (PKC) isoforms in the regulation of cardiac adaptation during two types of cardiac hypertrophy. Phosphorylation of specific PKC-isoforms and expression of their downstream proteins were studied during physiological and pathological hypertrophy in 24 week male Balb/c mice (Mus musculus) models, by reverse transcriptase-PCR, western blot analysis and M-mode echocardiography for cardiac function analysis. PKC-delta was significantly induced during pathological hypertrophy while PKC-alpha was exclusively activated during physiological hypertrophy in our study. PKC-delta activation during pathological hypertrophy resulted in cardiomyocyte apoptosis leading to compromised cardiac function and on the other hand, activation of PKC-alpha during physiological hypertrophy promoted cardiomyocyte growth but down regulated cellular apoptotic load resulting in improved cardiac function. Reversal in PKC-isoform with induced activation of PKC-delta and simultaneous inhibition of phospho-PKC-alpha resulted in an efficient myocardium to deteriorate considerably resulting in compromised cardiac function during physiological hypertrophy via augmentation of apoptotic and fibrotic load. This is the first report where PKC-alpha and -delta have been shown to play crucial role in cardiac adaptation during physiological and pathological hypertrophy respectively thereby rendering compromised cardiac function to an otherwise efficient heart by conditional reversal of their activation.	[Naskar, Shaon; Datta, Kaberi; Mitra, Arkadeep; Pathak, Kanchan; Datta, Ritwik; Bansal, Trisha; Sarkar, Sagartirtha] Univ Calcutta, Dept Zool, Genet & Mol Cardiol Lab, Kolkata, India	University of Calcutta	Sarkar, S (corresponding author), Univ Calcutta, Dept Zool, Genet & Mol Cardiol Lab, Kolkata, India.	sagartirtha.sarkar@gmail.com	Mitra, Arkadeep/J-4163-2019; Bansal, Trisha/HGA-8082-2022; Datta, Ritwik/AFS-6077-2022	Mitra, Arkadeep/0000-0002-9257-0427; NASKAR, SHAON/0000-0001-7732-5864	Council of Scientific and Industrial Research [37(1393)/10/EMR-II]; Department of Science and Technology, Govt. of India [SR/SO/HS-100/2009]; University Grants Commission	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); University Grants Commission(University Grants Commission, India)	This work was funded by grants from Council of Scientific and Industrial Research [Grant#37(1393)/10/EMR-II]; Department of Science and Technology, Govt. of India [Grant#F.No.SR/SO/HS-100/2009] to S. Sarkar. S. Naskar was supported by Research Fellowship from University Grants Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhowmick R, 2012, J BIOL CHEM, V287, P35004, DOI 10.1074/jbc.M112.369595; Braz JC, 2002, J CELL BIOL, V156, P905, DOI 10.1083/jcb.200108062; Catalucci D, 2008, FRONT BIOSCI-LANDMRK, V13, P312, DOI 10.2741/2681; Chatterjee A, 2011, J CELL PHYSIOL, V226, P2543, DOI 10.1002/jcp.22599; Chintalgattu V, 2009, BIOCHEM BIOPH RES CO, V386, P612, DOI 10.1016/j.bbrc.2009.06.076; Churchill E, 2008, ANNU REV PHARMACOL, V48, P569, DOI 10.1146/annurev.pharmtox.48.121806.154902; Cuadrado I, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.113; Datta R, 1997, J BIOL CHEM, V272, P20317, DOI 10.1074/jbc.272.33.20317; Dave KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022057; Dong YZ, 2011, NAT PROD REP, V28, P529, DOI 10.1039/c0np00035c; Duquesnes N, 2011, J MOL CELL CARDIOL, V51, P665, DOI 10.1016/j.yjmcc.2011.07.013; Ellison GM, 2012, HEART, V98, P5, DOI 10.1136/heartjnl-2011-300639; Endo K, 2000, J BIOL CHEM, V275, P18476, DOI 10.1074/jbc.M002266200; Evangelista FS, 2003, BRAZ J MED BIOL RES, V36, P1751, DOI 10.1590/S0100-879X2003001200018; Fagard Robert H., 1997, Cardiology Clinics, V15, P397; Galindo Cristi L., 2009, BMC Physiology, V9, P23, DOI 10.1186/1472-6793-9-23; Garciarena CD, 2009, HYPERTENSION, V53, P708, DOI 10.1161/HYPERTENSIONAHA.108.126805; He Y, 2007, J CELL BIOCHEM, V101, P1210, DOI 10.1002/jcb.21243; Jin HK, 2000, AM J PHYSIOL-HEART C, V279, pH2994, DOI 10.1152/ajpheart.2000.279.6.H2994; Kato K, 2009, AM J PHYSIOL-HEART C, V297, pH2253, DOI 10.1152/ajpheart.00274.2009; Koide Y, 2003, HYPERTENS RES, V26, P421, DOI 10.1291/hypres.26.421; Lee SW, 2011, MOL MED, V17, P1095, DOI 10.2119/molmed.2011.00106; Liu JH, 2003, MOL CANCER RES, V1, P892; Liu QH, 2011, J MOL CELL CARDIOL, V51, P474, DOI 10.1016/j.yjmcc.2010.10.004; Matassa A, 2003, CELL DEATH DIFFER, V10, P269, DOI 10.1038/sj.cdd.4401149; Mir SA, 2012, J BIOL CHEM, V287, P2666, DOI 10.1074/jbc.M111.246173; Mitra A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.114; Mut M, 2010, TURK NEUROSURG, V20, P277, DOI 10.5137/1019-5149.JTN.3008-10.1; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Partovian C, 2004, CELL SIGNAL, V16, P951, DOI 10.1016/j.cellsig.2004.01.008; Pathak M, 2001, HYPERTENSION, V37, P833, DOI 10.1161/01.HYP.37.3.833; Putinski C, 2013, P NATL ACAD SCI USA, V110, pE4079, DOI 10.1073/pnas.1315587110; Sarkar S, 2004, AM J PHYSIOL-HEART C, V287, pH107, DOI 10.1152/ajpheart.00763.2003; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sil P, 1998, CIRC RES, V82, P1173, DOI 10.1161/01.RES.82.11.1173; Sil P, 1997, HYPERTENSION, V30, P209; STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2; Steinberg SF, 2012, PHYSIOLOGY, V27, P130, DOI 10.1152/physiol.00009.2012; Takeishi Y, 2000, CIRC RES, V86, P1218, DOI 10.1161/01.RES.86.12.1218; Tanaka Y, 2003, J BIOL CHEM, V278, P33753, DOI 10.1074/jbc.M303313200; Weeks KL, 2011, PHYSIOLOGY, V26, P97, DOI 10.1152/physiol.00043.2010; Zhao M, 2012, ARCH IMMUNOL THER EX, V60, P361, DOI 10.1007/s00005-012-0188-8	42	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104711	10.1371/journal.pone.0104711	http://dx.doi.org/10.1371/journal.pone.0104711			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116170	gold, Green Submitted, Green Published			2022-12-27	WOS:000341230400073
J	Song, LL; Tu, YY; Xia, L; Wang, WW; Wei, W; Ma, CM; Wen, DH; Lei, H; Xu, HZ; Wu, YL				Song, Li-Li; Tu, Yao-Yao; Xia, Li; Wang, Wei-Wei; Wei, Wei; Ma, Chun-Min; Wen, Dong-Hua; Lei, Hu; Xu, Han-Zhang; Wu, Ying-Li			Targeting Catalase but Not Peroxiredoxins Enhances Arsenic Trioxide-Induced Apoptosis in K562 Cells	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; DOWN-REGULATION; IN-VITRO; BCR-ABL; INHIBITION; PROTEIN; AS2O3; DEGRADATION; ACTIVATION	Despite considerable efficacy of arsenic trioxide (As2O3) in acute promyelocytic leukemia (APL) treatment, other non-APL leukemias, such as chronic myeloid leukemia (CML), are less sensitive to As2O3 treatment. However, the underlying mechanism is not well understood. Here we show that relative As2O3-resistant K562 cells have significantly lower ROS levels than As2O3-sensitive NB4 cells. We compared the expression of several antioxidant enzymes in these two cell lines and found that peroxiredoxin 1/2/6 and catalase are expressed at high levels in K562 cells. We further investigated the possible role of peroxirdoxin 1/2/6 and catalase in determining the cellular sensitivity to As2O3. Interestingly, knockdown of peroxiredoxin 1/2/6 did not increase the susceptibility of K562 cells to As2O3. On the contrary, knockdown of catalase markedly enhanced As2O3-induced apoptosis. In addition, we provide evidence that overexpression of BCR/ABL cannot increase the expression of PRDX 1/2/6 and catalase. The current study reveals that the functional role of antioxidant enzymes is cellular context and treatment agents dependent; targeting catalase may represent a novel strategy to improve the efficacy of As2O3 in CML treatment.	[Song, Li-Li; Tu, Yao-Yao; Xia, Li; Wang, Wei-Wei; Wei, Wei; Ma, Chun-Min; Wen, Dong-Hua; Lei, Hu; Xu, Han-Zhang; Wu, Ying-Li] Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol Chem Biol,Chinese Minist Educ, Div Shanghai Univ E Inst,Key Lab Cell Differentia, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Xu, HZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pathophysiol Chem Biol,Chinese Minist Educ, Div Shanghai Univ E Inst,Key Lab Cell Differentia, Shanghai 200030, Peoples R China.	smollyxu@126.com; wuyingli@shsmu.edu.cn	Lei, Hu/AAR-7795-2021	Lei, Hu/0000-0003-3288-5205	National Basic Research Program of China (973 Program) [2010CB912104]; National Natural Science Foundation of China [91313303, 81272886, 31100980]; Science and Technology Committee of Shanghai [11JC1406500]; Shanghai Talent Development Project of Shanghai Human Resource and Social Security Bureau	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of Shanghai(Shanghai Science & Technology Committee); Shanghai Talent Development Project of Shanghai Human Resource and Social Security Bureau	This work was supported in part by grants from National Basic Research Program of China (973 Program) (NO. 2010CB912104), National Natural Science Foundation of China (91313303, 81272886, 31100980), Science and Technology Committee of Shanghai (11JC1406500), Shanghai Talent Development Project of Shanghai Human Resource and Social Security Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal-Singh S, 2012, BLOOD, V119, P2346, DOI 10.1182/blood-2011-06-358705; Akao Y, 1998, BRIT J HAEMATOL, V102, P1055, DOI 10.1046/j.1365-2141.1998.00869.x; Binet F, 2006, BRIT J HAEMATOL, V132, P349, DOI 10.1111/j.1365-2141.2005.05866.x; Chen GQ, 1996, BLOOD, V88, P1052; Chou WC, 2005, CURR OPIN HEMATOL, V12, P1, DOI 10.1097/01.moh.0000148552.93303.45; Coe E, 2008, LEUKEMIA LYMPHOMA, V49, P1976, DOI 10.1080/10428190802353617; Dai J, 1999, BLOOD, V93, P268, DOI 10.1182/blood.V93.1.268.401a21_268_277; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Eguchi R, 2011, J CELL PHYSIOL, V226, P762, DOI 10.1002/jcp.22397; Goussetis DJ, 2012, BLOOD, V120, P3555, DOI 10.1182/blood-2012-01-402578; Jeanne M, 2010, CANCER CELL, V18, P88, DOI 10.1016/j.ccr.2010.06.003; Juul T, 2010, J BIOL CHEM, V285, P21411, DOI 10.1074/jbc.M110.103564; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Kwong YL, 1997, BLOOD, V89, P3487, DOI 10.1182/blood.V89.9.3487; Lallemand-Breitenbach V, 2012, TRENDS MOL MED, V18, P36, DOI 10.1016/j.molmed.2011.10.001; LANEUVILLE P, 1994, CANCER RES, V54, P1360; LANOTTE M, 1991, BLOOD, V77, P1080; Liu CX, 2013, EXP CELL RES, V319, P170, DOI 10.1016/j.yexcr.2012.06.013; Liu CX, 2012, NAT CHEM BIOL, V8, P486, DOI [10.1038/NCHEMBIO.935, 10.1038/nchembio.935]; Moen MD, 2007, DRUGS, V67, P299, DOI 10.2165/00003495-200767020-00010; Nimmanapalli R, 2003, CANCER RES, V63, P7950; Nystrom T, 2012, GENE DEV, V26, P2001, DOI 10.1101/gad.200006.112; Poole Leslie B, 2011, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0709s49; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Roboz GJ, 2000, BLOOD, V96, P1525, DOI 10.1182/blood.V96.4.1525.h8001525_1525_1530; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; SPERANZA MJ, 1993, J BIOL CHEM, V268, P19039; Vivas-Mejia PE, 2009, INT J CANCER, V125, P264, DOI 10.1002/ijc.24341; Wang XS, 2008, EXP TOXICOL PATHOL, V60, P481, DOI 10.1016/j.etp.2008.04.011; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Waxman S, 2001, ONCOLOGIST, V6, P3, DOI 10.1634/theoncologist.6-suppl_2-3; Wei W, 2013, APOPTOSIS, V18, P1060, DOI 10.1007/s10495-013-0854-2; Yuan HF, 2012, BLOOD, V119, P1904, DOI 10.1182/blood-2011-06-361691; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615; Zhang XW, 2010, SCIENCE, V328, P240, DOI 10.1126/science.1183424	35	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104985	10.1371/journal.pone.0104985	http://dx.doi.org/10.1371/journal.pone.0104985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115845	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400110
J	Sun, S; Guo, MA; Zhang, JB; Ha, A; Yokoyama, KK; Chiu, RH				Sun, Shan; Guo, Mian; Zhang, James Beiji; Ha, Albert; Yokoyama, Kazunari K.; Chiu, Robert H.			Cyclophilin A (CypA) Interacts with NF-kappa B Subunit, p65/RelA, and Contributes to NF-kappa B Activation Signaling	PLOS ONE			English	Article							CYCLOSPORINE-A; NUCLEAR TRANSLOCATION; BINDING-PROTEIN; INFLAMMATION; EXPRESSION; DIFFERENTIATION; ISOMERIZATION; INDUCTION; CANCER; FK506	Background: Peptidyl-prolyl isomerase cyclophilin A (CypA) plays important roles in signaling, protein translocation, inflammation, and cancer formation. However, little is known about the mechanisms by which CypA exerts its effects. C57BL/6 Ppia (encoding CypA)-deficient embryonic fibroblasts show reduced activation of the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B), the p65/RelA subunit, suggesting that CypA may mediate modulation of NF-kappa B activity to exert its biological effects. Methodology: Western blotting and qRT-PCR analyses were used to evaluate the association of CypA deficiency with reduced activation of NF-kappa B/p65 at the protein level. GST pull-down and co-immunoprecipitation were used to examine interactions between CypA and p65/RelA. Truncation mutants and site-directed mutagenesis were used to determine the sequences of p65/RelA required for interactions with CypA. Enhancement of p65/RelA nuclear translocation by CypA was assessed by co-transfection and immunofluorescent imaging. Treatment of cells with cycloheximide that were harvested at various time points for Western blot analyses was carried out to evaluate p65/RelA protein stability. The functional activity of NF-kappa B was assessed by electrophoretic mobility-shift assays (EMSA), luciferase assays, and changes in expression levels of target genes. Results: GST pull-down assays in vitro and co-immunoprecipitation analyses in vivo provided evidence for protein-protein interactions. These interactions were further supported by identification of a CypA-binding consensus-like sequence within NF-kappa B subunit p65 at the N-terminal 170-176 amino acid residues. Significantly, CypA provided stability for NF-kappa B p65 and promoted NF-kappa B p65 nuclear translocation, resulting in increased nuclear accumulation and enhanced NF-kappa B activity. Conclusions: Our findings revealed important mechanisms that regulate NF-kappa B activation, and offer new insights into the role of CypA in aberrant activation of NF-kappa B-mediated signaling for altered expression of its target genes, resulting in pathological effects in various diseases.	[Sun, Shan; Guo, Mian; Zhang, James Beiji; Ha, Albert; Chiu, Robert H.] Univ Calif Los Angeles, Dent & Craniofacial Res Inst, Los Angeles, CA 90095 USA; [Sun, Shan; Zhang, James Beiji; Ha, Albert; Chiu, Robert H.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Guo, Mian] Harbin Med Univ, Affiliated Hosp 2, Dept Neurosurg, Harbin, Peoples R China; [Yokoyama, Kazunari K.] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Chiu, Robert H.] Univ Calif Los Angeles, Surg Oncol & Jonsson Comprehens Canc Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Harbin Medical University; Kaohsiung Medical University; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Chiu, RH (corresponding author), Univ Calif Los Angeles, Dent & Craniofacial Res Inst, Los Angeles, CA 90095 USA.	rchiu@dentistry.ucla.edu		Guo, Mian/0000-0002-1475-1935	UCLA Dental and Craniofacial Research Institute	UCLA Dental and Craniofacial Research Institute	This work was supported in part by a research fund from the UCLA Dental and Craniofacial Research Institute. No additional funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Bauer K, 2009, ONCOGENE, V28, P2784, DOI 10.1038/onc.2009.142; BRAM RJ, 1993, MOL CELL BIOL, V13, P4760, DOI 10.1128/MCB.13.8.4760; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Chan HM, 2001, J CELL SCI, V114, P2363; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Chen S, 2008, CANCER CHEMOTH PHARM, V61, P459, DOI 10.1007/s00280-007-0491-y; Chiu R, 2003, CELL MOL NEUROBIOL, V23, P929, DOI 10.1023/B:CEMN.0000005321.11544.cc; Colgan J, 2005, J IMMUNOL, V174, P6030, DOI 10.4049/jimmunol.174.10.6030; Colgan J, 2004, IMMUNITY, V21, P189, DOI 10.1016/j.immuni.2004.07.005; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Cui Y, 2002, J CELL BIOCHEM, V86, P630, DOI 10.1002/jcb.10253; Du SQ, 2009, J IMMUNOL, V182, P7201, DOI 10.4049/jimmunol.0801772; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kasza A, 2013, CYTOKINE, V62, P22, DOI 10.1016/j.cyto.2013.02.007; Kim H, 2005, CLIN IMMUNOL, V116, P217, DOI 10.1016/j.clim.2005.05.004; KRUSE M, 1995, J BIOL CHEM, V270, P2588, DOI 10.1074/jbc.270.6.2588; Lee J, 2010, ARCH PHARM RES, V33, P181, DOI 10.1007/s12272-010-0200-y; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Mamane Y, 2000, IMMUNITY, V12, P129, DOI 10.1016/S1074-7613(00)80166-1; Nishiyama S, 2005, INT IMMUNOPHARMACOL, V5, P699, DOI 10.1016/j.intimp.2004.11.018; Obchoei S, 2009, MED SCI MONITOR, V15, pRA221; Pan H, 2008, J BIOL CHEM, V283, P623, DOI 10.1074/jbc.M704934200; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Song J, 2004, J BIOL CHEM, V279, P24414, DOI 10.1074/jbc.M311406200; Sun S, 2011, J NEURO-ONCOL, V101, P1, DOI 10.1007/s11060-010-0220-y; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wu ZQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018157; Xu J, 2005, CURR PROTOC MOL BIOL, V28, P2811; Zhu CL, 2007, J EXP MED, V204, P1741, DOI 10.1084/jem.20070193; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	39	30	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e96211	10.1371/journal.pone.0096211	http://dx.doi.org/10.1371/journal.pone.0096211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25119989	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230400001
J	Chen, S; Wang, DY; Xu, CM; Ji, CL; Zhang, XG; Zhao, X; Zhang, XF; Chauhan, BS				Chen, Song; Wang, Danying; Xu, Chunmei; Ji, Chenglin; Zhang, Xiaoguo; Zhao, Xia; Zhang, Xiufu; Chauhan, Bhagirath Singh			Responses of Super Rice (Oryza sativa L.) to Different Planting Methods for Grain Yield and Nitrogen-Use Efficiency in the Single Cropping Season	PLOS ONE			English	Article							HYBRID RICE; NO-TILLAGE; TRANSPLANTED RICE; GROWTH; FERTILIZATION; PROGRESS; TRENDS; CHINA; WATER	To break the yield ceiling of rice production, a super rice project was developed in 1996 to breed rice varieties with super high yield. A two-year experiment was conducted to evaluate yield and nitrogen (N)-use response of super rice to different planting methods in the single cropping season. A total of 17 rice varieties, including 13 super rice and four non-super checks (CK), were grown under three N levels [0 (N0), 150 (N150), and 225 (N225) kg ha(-1)] and two planting methods [transplanting (TP) and direct-seeding in wet conditions (WDS)]. Grain yield under WDS (7.69 kg ha(-1)) was generally lower than TP (8.58 kg ha(-1)). However, grain yield under different planting methods was affected by N rates as well as variety groups. In both years, there was no difference in grain yield between super and CK varieties at N150, irrespective of planting methods. However, grain yield difference was dramatic in japonica groups at N225, that is, there was an 11.3% and 14.1% average increase in super rice than in CK varieties in WDS and TP, respectively. This suggests that high N input contributes to narrowing the yield gap in super rice varieties, which also indicates that super rice was bred for high fertility conditions. In the japonica group, more N was accumulated in super rice than in CK at N225, but no difference was found between super and CK varieties at N0 and N150. Similar results were also found for N agronomic efficiency. The results suggest that super rice varieties have an advantage for N-use efficiency when high N is applied. The response of super rice was greater under TP than under WDS. The results suggest that the need to further improve agronomic and other management practices to achieve high yield and N-use efficiency for super rice varieties in WDS.	[Chen, Song; Wang, Danying; Xu, Chunmei; Ji, Chenglin; Zhang, Xiaoguo; Zhao, Xia; Zhang, Xiufu] Chinese Acad Agr Sci, China Natl Rice Res Inst, Hangzhou, Zhejiang, Peoples R China; [Chauhan, Bhagirath Singh] Univ Queensland, QAAFI, Toowoomba, Qld, Australia	Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; University of Queensland	Zhang, XF (corresponding author), Chinese Acad Agr Sci, China Natl Rice Res Inst, Hangzhou, Zhejiang, Peoples R China.	chais.zju@gmail.com; b.chauhan@uq.edu.au	wang, danying/GQY-7371-2022; Chauhan, Bhagirath/G-8892-2014	Chauhan, Bhagirath/0000-0003-1540-4668	'Five-twelfth' National Science and Technology Support Program [2012BAD04B00]; National Natural Science Foundation of China [31301255, 3117150156]; MOA Special Fund for Agro-Scientific Research in the Public Interest of China [201203096]	'Five-twelfth' National Science and Technology Support Program(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOA Special Fund for Agro-Scientific Research in the Public Interest of China	This research was partly supported by grants from the 'Five-twelfth' National Science and Technology Support Program (2012BAD04B00), the National Natural Science Foundation of China (31301255&3117150156), and the MOA Special Fund for Agro-Scientific Research in the Public Interest of China (201203096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 1996, JPN J CROP SCI, V65, P16, DOI 10.1626/jcs.65.16; Arromratana U., 2002, JIRCAS Working Report, P129; Bhushan L, 2007, AGRON J, V99, P1288, DOI 10.2134/agronj2006.0227; Bremner JM, 1982, AGRONOMY, P595, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C31; Chen S., 2013, ROUTLEDGE HDB SPORT, P33; Chen Song, 2012, Australian Journal of Crop Science, V6, P1630; Chen S, 2011, COMMUN SOIL SCI PLAN, V42, P1324, DOI 10.1080/00103624.2011.571737; Chen S, 2009, RICE SCI, V16, P143, DOI 10.1016/S1672-6308(08)60071-2; Chen S, 2007, RICE SCI, V14, P283, DOI 10.1016/S1672-6308(08)60006-2; Cheng SH, 2007, ANN BOT-LONDON, V100, P959, DOI 10.1093/aob/mcm121; Cheng SH, 2007, J INTEGR PLANT BIOL, V49, P805, DOI [10.1111/j.1744-7909.2007.00514.x, 10.1111/j.1672-9072.2007.00514.x]; Dawe D, 2005, PLANT PROD SCI, V8, P221, DOI 10.1626/pps.8.221; Derpsch R., 2009, 4 WORLD C CONS AGR N 4 WORLD C CONS AGR N; DINGKUHN M, 1990, CROP SCI, V30, P1284, DOI 10.2135/cropsci1990.0011183X003000060025x; Farooq M, 2011, SOIL TILL RES, V111, P87, DOI 10.1016/j.still.2010.10.008; Huang M, 2011, EUR J AGRON, V34, P278, DOI 10.1016/j.eja.2011.02.005; Katsura K, 2007, FIELD CROP RES, V103, P170, DOI 10.1016/j.fcr.2007.06.001; LIN X, 2002, CHINA RICE, V2, P10; Mae T, 1997, PLANT NUTR SUSTAINAB, P51; Naklang K, 1996, FIELD CROP RES, V48, P115, DOI 10.1016/S0378-4290(96)01029-5; Normile D, 2008, SCIENCE, V321, P330, DOI 10.1126/science.321.5887.330; PANDEY S, 2002, DIRECT SEEDING RES S, P139; Peng S, 1999, CROP SCI, V39, P1552, DOI 10.2135/cropsci1999.3961552x; Peng S., 2004, P 4 INT CROP SCI C; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; [彭少兵 Peng Shaobing], 2002, [中国农业科学, Scientia Agricultura Sinica], V35, P1095; SCHNIER HF, 1990, CROP SCI, V30, P1276, DOI 10.2135/cropsci1990.0011183X003000060024x; Shi HongRu, 2008, Acta Agronomica Sinica, V34, P1985; Shi LiHong, 2010, Scientia Agricultura Sinica, V43, P1274; Song GuiYun, 2007, Soil and Fertilizer Sciences in China, P44; WADA G, 1986, JARQ-JPN AGR RES Q, V20, P135; Wang Xi, 2002, Chinese Journal of Rice Science, V16, P38; Ying JF, 1998, FIELD CROP RES, V57, P71, DOI 10.1016/S0378-4290(98)00077-X; Yuan L., 1996, HYBRID RICE, V11, P1; Zhu DF, 2000, BRIDGING RICE YIELD, P69; Zong S., 2000, J NANJING AGR TECH C, V16, P8; [Zou Yingbin 邹应斌], 2003, [湖南农业大学学报, Journal of Hunan Agricultural University], V29, P78	37	5	9	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104950	10.1371/journal.pone.0104950	http://dx.doi.org/10.1371/journal.pone.0104950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111805	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100114
J	Di, CL; Yang, XH; Wang, XC				Di, Chongli; Yang, Xiaohua; Wang, Xiaochao			A Four-Stage Hybrid Model for Hydrological Time Series Forecasting	PLOS ONE			English	Article							NEURAL-NETWORKS; WATER-RESOURCES; NOISE-REDUCTION; WAVELET; STREAMFLOW; FLOW; DECOMPOSITION; VARIABILITY; SIMULATION; PREDICTION	Hydrological time series forecasting remains a difficult task due to its complicated nonlinear, non-stationary and multi-scale characteristics. To solve this difficulty and improve the prediction accuracy, a novel four-stage hybrid model is proposed for hydrological time series forecasting based on the principle of 'denoising, decomposition and ensemble'. The proposed model has four stages, i.e., denoising, decomposition, components prediction and ensemble. In the denoising stage, the empirical mode decomposition (EMD) method is utilized to reduce the noises in the hydrological time series. Then, an improved method of EMD, the ensemble empirical mode decomposition (EEMD), is applied to decompose the denoised series into a number of intrinsic mode function (IMF) components and one residual component. Next, the radial basis function neural network (RBFNN) is adopted to predict the trend of all of the components obtained in the decomposition stage. In the final ensemble prediction stage, the forecasting results of all of the IMF and residual components obtained in the third stage are combined to generate the final prediction results, using a linear neural network (LNN) model. For illustration and verification, six hydrological cases with different characteristics are used to test the effectiveness of the proposed model. The proposed hybrid model performs better than conventional single models, the hybrid models without denoising or decomposition and the hybrid models based on other methods, such as the wavelet analysis (WA)-based hybrid models. In addition, the denoising and decomposition strategies decrease the complexity of the series and reduce the difficulties of the forecasting. With its effective denoising and accurate decomposition ability, high prediction precision and wide applicability, the new model is very promising for complex time series forecasting. This new forecast model is an extension of nonlinear prediction models.	[Di, Chongli; Yang, Xiaohua] Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China; [Wang, Xiaochao] Beihang Univ, State Key Lab Virtual Real Technol & Syst, Beijing 100191, Peoples R China	Beijing Normal University; Beihang University	Yang, XH (corresponding author), Beijing Normal Univ, Sch Environm, State Key Lab Water Environm Simulat, Beijing 100875, Peoples R China.	xiaohuayang@bnu.edu.cn		Wang, Xiaochao/0000-0001-7852-2106	Funds for Creative Research Groups of China [51121003]; Project of National Basic Research Program of China [2010CB951104]; National Natural Foundation of China [51379013]; Specialized Research Fund for the Doctoral Program of Higher Education [20100003110024]	Funds for Creative Research Groups of China(Science Fund for Creative Research Groups); Project of National Basic Research Program of China(National Basic Research Program of China); National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the Funds for Creative Research Groups of China (No. 51121003), the Project of National Basic Research Program of China (No. 2010CB951104), the Project of National Natural Foundation of China (No. 51379013), and the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20100003110024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudu S, 2011, J HYDROL ENG, V16, P384, DOI 10.1061/(ASCE)HE.1943-5584.0000322; Adarnowski JF, 2008, J HYDROL, V353, P247, DOI 10.1016/j.jhydrol.2008.02.013; Akrami S, 2013, WATER RESOUR MANAG, V27, P3507, DOI 10.1007/s11269-013-0361-9; An XL, 2012, COMMUN NONLINEAR SCI, V17, P1036, DOI 10.1016/j.cnsns.2011.06.003; BALDI PF, 1995, IEEE T NEURAL NETWOR, V6, P837, DOI 10.1109/72.392248; Bao AM, 2011, HYDROL PROCESS, V25, P3506, DOI 10.1002/hyp.8078; Boudraa A. O., 2004, INT J SIGNAL PROCESS, V1, P33; Chellali F, 2010, RENEW ENERG, V35, P1214, DOI 10.1016/j.renene.2009.10.010; Chen CS, 2008, HYDROL PROCESS, V22, P3697, DOI 10.1002/hyp.6973; Colominas MA, 2012, ADV DATA SCI ADAPT, V4, DOI 10.1142/S1793536912500252; Coulibaly P, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002667; Flandrin P, 2005, HIBERT HUANG TRANSFO; Grimaldi S, 2004, J HYDROL ENG, V9, P383, DOI 10.1061/(ASCE)1084-0699(2004)9:5(383); Guo J, 2011, EXPERT SYST APPL, V38, P13073, DOI 10.1016/j.eswa.2011.04.114; Hanson RT, 2004, J HYDROL, V287, P252, DOI 10.1016/j.jhydrol.2003.10.006; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Jain A, 2007, APPL SOFT COMPUT, V7, P585, DOI 10.1016/j.asoc.2006.03.002; Jansen M, 2001, IEEE T SIGNAL PROCES, V49, P1113, DOI 10.1109/78.923292; Jayawardena AW, 2000, J HYDROL, V228, P242, DOI 10.1016/S0022-1694(00)00142-6; Kisi O, 2009, HYDROL PROCESS, V23, P3583, DOI 10.1002/hyp.7461; Kisi O, 2011, WATER RESOUR MANAG, V25, P579, DOI 10.1007/s11269-010-9715-8; Kisi O, 2011, J HYDROL, V399, P132, DOI 10.1016/j.jhydrol.2010.12.041; Kopsinis Y, 2009, IEEE T SIGNAL PROCES, V57, P1351, DOI 10.1109/TSP.2009.2013885; Koutsoyiannis D, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005592; Labat D, 2000, J HYDROL, V238, P149, DOI 10.1016/S0022-1694(00)00322-X; Lee T, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012801; Li XL, 2006, PHYS LETT A, V356, P237, DOI 10.1016/j.physleta.2006.03.045; Liu LW, 2012, CHEM PHYS LETT, V530, P107, DOI 10.1016/j.cplett.2012.01.061; Maier HR, 2000, ENVIRON MODELL SOFTW, V15, P101, DOI 10.1016/S1364-8152(99)00007-9; Mallat S., 1999, WAVELET TOUR SIGNAL, DOI 10.1016/B978-012466606-1/50008-8; Massei N, 2010, INT J CLIMATOL, V30, P2146, DOI 10.1002/joc.2022; McMillan H, 2010, HYDROL PROCESS, V24, P1270, DOI 10.1002/hyp.7587; Mehrsai A, 2013, NEUROCOMPUTING, V101, P82, DOI 10.1016/j.neucom.2012.07.028; Montanari A, 2000, WATER RESOUR RES, V36, P1249, DOI 10.1029/2000WR900012; Nourani V, 2009, WATER RESOUR MANAG, V23, P2877, DOI 10.1007/s11269-009-9414-5; Peugeot C, 2003, J HYDROL, V279, P224, DOI 10.1016/S0022-1694(03)00181-1; Pinnegar CR, 2003, FLUCT NOISE LETT, V3, pL357, DOI 10.1142/S0219477503001439; Sahoo GB, 2009, J HYDROL, V378, P325, DOI 10.1016/j.jhydrol.2009.09.037; Sang YF, 2013, WATER RESOUR MANAG, V27, P2807, DOI 10.1007/s11269-013-0316-1; Sang YF, 2013, HYDROL PROCESS, V27, P2021, DOI 10.1002/hyp.9356; Sang YF, 2009, J HYDROL, V368, P165, DOI 10.1016/j.jhydrol.2009.01.042; SCHREIBER T, 1993, PHYS REV E, V47, P2401, DOI 10.1103/PhysRevE.47.2401; Shrestha RR, 2009, J HYDROL ENG, V14, P1309, DOI 10.1061/(ASCE)HE.1943-5584.0000123; Smith LC, 1998, HYDROL PROCESS, V12, P233, DOI 10.1002/(SICI)1099-1085(199802)12:2<233::AID-HYP573>3.0.CO;2-3; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wang H, 2012, GRAPH MODELS, V74, P173, DOI 10.1016/j.gmod.2012.04.005; Wang J, 2013, ADV MECH ENG, DOI 10.1155/2013/258506; Wang W, 2006, J HYDROL, V324, P383, DOI 10.1016/j.jhydrol.2005.09.032; Wei Y, 2012, TRANSPORT RES C-EMER, V21, P148, DOI 10.1016/j.trc.2011.06.009; Wu XJ, 2013, NEURAL COMPUT APPL, V22, P947, DOI 10.1007/s00521-011-0787-z; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Yang CG, 2010, J HYDROMETEOROL, V11, P810, DOI 10.1175/2009JHM1145.1; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang X, 2008, ENERG ECON, V30, P905, DOI 10.1016/j.eneco.2007.02.012; ZIV J, 1977, IEEE T INFORM THEORY, V23, P337, DOI 10.1109/TIT.1977.1055714	55	73	77	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104663	10.1371/journal.pone.0104663	http://dx.doi.org/10.1371/journal.pone.0104663			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111782	Green Published, gold			2022-12-27	WOS:000341105100087
J	Houghton, LA; Gray, AR; Harper, MJ; Winichagoon, P; Pongcharoen, T; Gowachirapant, S; Gibson, RS				Houghton, Lisa A.; Gray, Andrew R.; Harper, Michelle J.; Winichagoon, Pattanee; Pongcharoen, Tippawan; Gowachirapant, Sueppong; Gibson, Rosalind S.			Vitamin D Status among Thai School Children and the Association with 1,25-Dihydroxyvitamin D and Parathyroid Hormone Levels	PLOS ONE			English	Article							RECEPTOR GENE POLYMORPHISM; SERUM 25-HYDROXYVITAMIN-D CONCENTRATIONS; BONE-MINERAL DENSITY; D DEFICIENCY; CALCIUM REQUIREMENTS; HEALTHY-CHILDREN; SUN EXPOSURE; PREVALENCE; METABOLISM; HEIGHT	In several low latitude countries, vitamin D deficiency is emerging as a public health issue. Adequate vitamin D is essential for bone health in rapidly growing children. In the Thai population, little is known about serum 25-hydroxyvitamin D [25(OH)D] status of infants and children. Moreover, the association between 25(OH)D and the biological active form of 1,25-dihydroxyvitamin D [1,25(OH)](2)D is not clear. The specific aims of this study were to characterize circulating serum 25(OH)D, 1,25(OH)(2)D and their determinants including parathyroid hormone (PTH), age, sex, height and body mass index (BMI) in 529 school-aged Thai children aged 6-14 y. Adjusted linear regression analysis was performed to examine the impact of age and BMI, and its interaction with sex, on serum 25(OH)D concentrations and 1,25(OH)(2)D concentrations. Serum 25(OH)D, 1,25(OH)(2)D and PTH concentrations (geometric mean +/- geometric SD) were 72.7 +/- 1.2 nmol/L, 199.1 +/- 1.3 pmol/L and 35.0 +/- 1.5 ng/L, respectively. Only 4% (21 of 529) participants had a serum 25(OH)D level below 50 nmol/L. There was statistically significant evidence for an interaction between sex and age with regard to 25(OH)D concentrations. Specifically, 25(OH)D concentrations were 19% higher in males. Moreover, females experienced a statistically significant 4% decline in serum 25(OH)D levels for each increasing year of age (P = 0.001); no decline was seen in male participants with increasing age (P = 0.93). When BMI, age, sex, height and serum 25(OH)D were individually regressed on 1,25(OH)(2)D, height and sex were associated with 1,25(OH)(2)D with females exhibiting statistically significantly higher serum 1,25(OH)(2)D levels compared with males (P<0.001). Serum 1,25(OH)(2)D among our sample of children exhibiting fairly sufficient vitamin D status were higher than previous reports suggesting an adaptive mechanism to maximize calcium absorption.	[Houghton, Lisa A.; Harper, Michelle J.; Gibson, Rosalind S.] Univ Otago, Dept Human Nutr, Dunedin, New Zealand; [Gray, Andrew R.] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Winichagoon, Pattanee; Pongcharoen, Tippawan; Gowachirapant, Sueppong] Mahidol Univ, Inst Nutr, Salaya, Thailand	University of Otago; University of Otago; Mahidol University	Houghton, LA (corresponding author), Univ Otago, Dept Human Nutr, Dunedin, New Zealand.	lisa.houghton@otago.ac.nz	Gray, Andrew Robert/L-9161-2015; Houghton, Lisa A/F-5305-2011	Gray, Andrew Robert/0000-0003-4299-2194; Houghton, Lisa A/0000-0002-2276-6205; Gowachirapant, Sueppong/0000-0001-9619-2534	Micronutrient Initiative Fund, Ottawa, Canada; Institute of Nutrition, Mahidol University, Salaya, Thailand; University of Otago Research Grants	Micronutrient Initiative Fund, Ottawa, Canada; Institute of Nutrition, Mahidol University, Salaya, Thailand; University of Otago Research Grants	This study was supported by the Micronutrient Initiative Fund, Ottawa, Canada; the Institute of Nutrition, Mahidol University, Salaya, Thailand; and University of Otago Research Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghamdi MA, 2012, PUBLIC HEALTH NUTR, V15, P1845, DOI 10.1017/S1368980011003612; Ameri P, 2013, CLIN ENDOCRINOL, V79, P457, DOI 10.1111/cen.12268; Anderson PH, 2010, J STEROID BIOCHEM, V121, P71, DOI 10.1016/j.jsbmb.2010.03.021; Aspray TJ, 2005, BONE, V36, P710, DOI 10.1016/j.bone.2005.01.002; BATCHELOR AJ, 1983, BRIT J NUTR, V49, P213, DOI 10.1079/BJN19830027; Carpenter TO, 2012, AM J CLIN NUTR, V95, P137, DOI 10.3945/ajcn.111.018721; Chailurkit LO, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-853; CHUSILP K, 1992, EUR J CLIN NUTR, V46, P475; CLEMENTS MR, 1992, CLIN ENDOCRINOL, V37, P17, DOI 10.1111/j.1365-2265.1992.tb02278.x; CLEMENTS MR, 1987, NATURE, V325, P62, DOI 10.1038/325062a0; d'Alesio A, 2005, HUM MOL GENET, V14, P3539, DOI 10.1093/hmg/ddi382; Davies M, 1997, J CLIN ENDOCR METAB, V82, P209, DOI 10.1210/jc.82.1.209; Farrell CJ, 2013, BEST PRACT RES CL EN, V27, P675, DOI 10.1016/j.beem.2013.06.001; Gibson RS, 2007, BRIT J NUTR, V97, P167, DOI 10.1017/S0007114507250445; Gordon CM, 2008, ARCH PEDIAT ADOL MED, V162, P505, DOI 10.1001/archpedi.162.6.505; HALLORAN BP, 1986, J CLIN INVEST, V78, P622, DOI 10.1172/JCI112619; Harkness Laura S, 2005, J Adolesc Health, V37, P75, DOI 10.1016/j.jadohealth.2004.07.015; HEANEY RP, 1991, AM J CLIN NUTR, V53, P745, DOI 10.1093/ajcn/53.3.745; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Jang Han Byul, 2013, Osong Public Health Res Perspect, V4, P179, DOI 10.1016/j.phrp.2013.06.004; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Khor GL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-95; Krobtrakulchai W, 2013, ALLERGY ASTHMA IMMUN, V5, P289, DOI 10.4168/aair.2013.5.5.289; Kumar Juhi, 2009, Pediatrics, V124, pe362, DOI 10.1542/peds.2009-0051; Laillou A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063979; Lee WTK, 2008, ASIA PAC J CLIN NUTR, V17, P33; Lewis RD, 2013, J CLIN ENDOCR METAB, V98, P4816, DOI 10.1210/jc.2013-2728; Lips P, 2006, PROG BIOPHYS MOL BIO, V92, P4, DOI 10.1016/j.pbiomolbio.2006.02.016; Lorentzon M, 2000, J CLIN ENDOCR METAB, V85, P1666, DOI 10.1210/jc.85.4.1666; LUND B, 1980, ACTA ENDOCRINOL-COP, V94, P426, DOI 10.1530/acta.0.0940426; Mahachoklertwattana Pat, 2002, Journal of the Medical Association of Thailand, V85, pS1127; Manger MS, 2008, AM J CLIN NUTR, V87, P1715, DOI 10.1093/ajcn/87.6.1715; Marwaha RK, 2005, AM J CLIN NUTR, V82, P477, DOI 10.1093/ajcn/82.2.477; Maunsell Z, 2005, CLIN CHEM, V51, P1683, DOI 10.1373/clinchem.2005.052936; Moon HW, 2012, CLIN BIOCHEM, V45, P326, DOI 10.1016/j.clinbiochem.2011.12.025; Nakavachara P, 2013, PEDIATR BLOOD CANCER, V60, P1683, DOI 10.1002/pbc.24614; Neyestani TR, 2012, PUBLIC HEALTH NUTR, V15, P324, DOI 10.1017/S1368980011000188; Park CY, 2010, J NUTR, V140, P2139, DOI 10.3945/jn.110.124891; Razzaghy-Azar M, 2010, ANN HUM BIOL, V37, P692, DOI 10.3109/03014460903527348; Rockell JE, 2005, J NUTR, V135, P2602, DOI 10.1093/jn/135.11.2602; Rojroongwasinkul N, 2013, BRIT J NUTR, V110, pS36, DOI 10.1017/S0007114513002110; Ross A. C., 2010, Dietary reference intakes for calcium and vitamin D; Ryan LM, 2012, PEDIATRICS, V130, pE553, DOI 10.1542/peds.2012-0134; Saintonge S, 2009, PEDIATRICS, V123, P797, DOI 10.1542/peds.2008-1195; Schottker B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048774; Shaw NJ, 2013, ARCH DIS CHILD, V98, P368, DOI 10.1136/archdischild-2012-302585; Steingrimsdottir L, 2005, JAMA-J AM MED ASSOC, V294, P2336, DOI 10.1001/jama.294.18.2336; Suarez F, 1997, J CLIN ENDOCR METAB, V82, P2966, DOI 10.1210/jc.82.9.2966; Telfer SV, 1926, Q J MED, V20, P1; Tempark T, 2012, PHOTODERMATOL PHOTO, V28, P200, DOI 10.1111/j.1600-0781.2012.00671.x; van der Sluis IM, 2003, CALCIFIED TISSUE INT, V73, P332, DOI 10.1007/s00223-002-2130-2; VANHOOF HJC, 1994, CALCIFIED TISSUE INT, V55, P417, DOI 10.1007/BF00298554; Weng FL, 2007, AM J CLIN NUTR, V86, P150, DOI 10.1093/ajcn/86.1.150; WHO, WHO CHILD GROWTH STA; Winichagoon P, 2006, J NUTR, V136, P1617, DOI 10.1093/jn/136.6.1617; World Health Organization and Food and Agriculture Organization of the United Nations, 2004, CALC VIT MIN REQ HUM; Wu L, 2010, J BONE MINER RES, V25, P1842, DOI 10.1002/jbmr.76	57	14	15	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104825	10.1371/journal.pone.0104825	http://dx.doi.org/10.1371/journal.pone.0104825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111832	Green Submitted, gold, Green Published			2022-12-27	WOS:000341105100102
J	Ortiz, MC; Borghese, MFA; Balonga, SE; Lavagna, A; Filipuzzi, AL; Elesgaray, R; Costa, MA; Majowicz, MP				Ortiz, Maria C.; Albertoni Borghese, Maria F.; Balonga, Sabrina E.; Lavagna, Agustina; Filipuzzi, Ana L.; Elesgaray, Rosana; Costa, Maria A.; Majowicz, Monica P.			Renal Response to L-Arginine in Diabetic Rats. A Possible Link between Nitric Oxide System and Aquaporin-2	PLOS ONE			English	Article							OXIDATIVE STRESS; MEMBRANE INSERTION; SYNTHASE ACTIVITY; EXPRESSION; VASOPRESSIN; MEDULLA; SUPPLEMENTATION; HYPERGLYCEMIA; KIDNEYS; NITRATE	The aim of this study was to evaluate whether L-Arginine (L-Arg) supplementation modifies nitric oxide (NO) system and consequently aquaporin-2 (AQP2) expression in the renal outer medulla of streptozotocin-diabetic rats at an early time point after induction of diabetes. Male Wistar rats were divided in four groups: Control, Diabetic, Diabetic treated with L-Arginine and Control treated with L-Arginine. Nitric oxide synthase (NOS) activity was estimated by [C-14] L-citrulline production in homogenates of the renal outer medulla and by NADPH-diaphorase staining in renal outer medullary tubules. Western blot was used to detect the expression of AQP2 and NOS types I and III; real time PCR was used to quantify AQP2 mRNA. The expression of both NOS isoforms, NOS I and NOS III, was decreased in the renal outer medulla of diabetic rats and L-Arg failed to prevent these decreases. However, L-Arg improved NO production, NADPH-diaphorase activity in collecting ducts and other tubular structures, and NOS activity in renal homogenates from diabetic rats. AQP2 protein and mRNA were decreased in the renal outer medulla of diabetic rats and L-Arg administration prevented these decreases. These results suggest that the decreased NOS activity in collecting ducts of the renal outer medulla may cause, at least in part, the decreased expression of AQP2 in this model of diabetes and constitute additional evidence supporting a role for NO in contributing to renal water reabsorption through the modulation of AQP2 expression in this pathological condition. However, we cannot discard that another pathway different from NOS also exists that links L-Arg to AQP2 expression.	[Ortiz, Maria C.; Albertoni Borghese, Maria F.; Balonga, Sabrina E.; Lavagna, Agustina; Filipuzzi, Ana L.; Majowicz, Monica P.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Ciencias Biol, Catedra Biol Celular & Mol, RA-1113 Buenos Aires, DF, Argentina; [Elesgaray, Rosana; Costa, Maria A.] Univ Buenos Aires, Fac Farm & Bioquim, Dept Ciencias Biol, Catedra Fisiol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Majowicz, MP (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Dept Ciencias Biol, Catedra Biol Celular & Mol, RA-1113 Buenos Aires, DF, Argentina.	mmajow@ffyb.uba.ar			UBACYT from Universidad de Buenos Aires, (Buenos Aires, Argentina) [20020110200353, UBACYT B087]	UBACYT from Universidad de Buenos Aires, (Buenos Aires, Argentina)	This study was partially supported by grants: UBACYT B087 and UBACYT Number 20020110200353 from Universidad de Buenos Aires, (Buenos Aires, Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borghese MFA, 2011, NEPHRON EXTRA, V1, P124, DOI 10.1159/000333066; Altinova AE, 2007, J CLIN ENDOCR METAB, V92, P1881, DOI 10.1210/jc.2006-2643; Baylis C, 1998, CURR OPIN NEPHROL HY, V7, P59, DOI 10.1097/00041552-199801000-00010; Boone M, 2010, NEPHROL DIAL TRANSPL, V25, P48, DOI 10.1093/ndt/gfp409; Borghese MFA, 2007, NEPHRON PHYSIOL, V107, pP77, DOI 10.1159/000109822; Bouley R, 2000, J CLIN INVEST, V106, P1115, DOI 10.1172/JCI9594; Bouley R, 2005, AM J PHYSIOL-RENAL, V288, pF1103, DOI 10.1152/ajprenal.00337.2004; Cherla G, 2004, J NUTR, V134, p2801S, DOI 10.1093/jn/134.10.2801S; Cipriani P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00176; Costa MA, 2006, LIFE SCI, V78, P1543, DOI 10.1016/j.lfs.2005.07.024; Dioguardi FS, 2011, J NUTRIGENET NUTRIGE, V4, P90, DOI 10.1159/000327777; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Feraille E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087239; Garvin JL, 2011, ANNU REV PHYSIOL, V73, P359, DOI 10.1146/annurev-physiol-012110-142247; Gonzalez-Zulueta M, 2001, CURR PROTOC TOXICOL, DOI [10.1002/047114086.tx041006501., DOI 10.1002/047114086.TX041006501]; Hasler U, 2006, AM J PHYSIOL-RENAL, V290, pF177, DOI 10.1152/ajprenal.00056.2005; Hyndman KA, 2013, HYPERTENSION, V62, P91, DOI 10.1161/HYPERTENSIONAHA.113.01291; Kato T, 2011, J CARDIOL, V58, P131, DOI 10.1016/j.jjcc.2011.06.003; Klokkers J, 2009, AM J PHYSIOL-RENAL, V297, pF693, DOI 10.1152/ajprenal.00136.2009; Komers R, 2003, AM J PHYSIOL-RENAL, V284, pF1121, DOI 10.1152/ajprenal.00265.2002; Kotsonis P, 2000, BIOCHEM J, V346, P767, DOI 10.1042/0264-6021:3460767; Lee DL, 2005, AM J PHYSIOL-RENAL, V288, pF82, DOI 10.1152/ajprenal.00127.2004; Leung JC, 2005, NEPHROLOGY, V10, P63, DOI 10.1111/j.1440-1797.2005.00359.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomas-Soria C, 2011, INT J MOL SCI, V12, P8431, DOI 10.3390/ijms12128431; Lubec B, 1997, FREE RADICAL BIO MED, V22, P355, DOI 10.1016/S0891-5849(96)00386-3; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Martin PY, 2002, AM J PHYSIOL-RENAL, V283, pF559, DOI 10.1152/ajprenal.00309.2001; Mohamadin AMA, 2007, CLIN EXP PHARMACOL P, V34, P586, DOI 10.1111/j.1440-1681.2007.04622.x; Morishita T, 2005, P NATL ACAD SCI USA, V102, P10616, DOI 10.1073/pnas.0502236102; Morris BJ, 1997, NEUROPHARMACOLOGY, V36, P1589, DOI 10.1016/S0028-3908(97)00159-7; Mount PF, 2006, ACTA PHYSIOL, V187, P433, DOI 10.1111/j.1748-1716.2006.01582.x; Nejsum LN, 2005, CELL MOL LIFE SCI, V62, P1692, DOI 10.1007/s00018-005-4549-x; Nejsum LN, 2001, AM J PHYSIOL-RENAL, V280, pF715, DOI 10.1152/ajprenal.2001.280.4.F715; Palm F, 2008, AM J PHYSIOL-RENAL, V294, pF30, DOI 10.1152/ajprenal.00166.2007; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pieper GM, 1998, HYPERTENSION, V31, P1047, DOI 10.1161/01.HYP.31.5.1047; Popov D, 2002, CELL TISSUE RES, V308, P109, DOI 10.1007/s00441-001-0509-4; Prabhakar SS, 2004, SEMIN NEPHROL, V24, P333, DOI 10.1016/j.semnephrol.2004.04.005; Rothe F, 1998, NEUROSCIENCE, V83, P259, DOI 10.1016/S0306-4522(97)00373-4; Roxas B, 2002, BIOCHEM BIOPH RES CO, V296, P755, DOI 10.1016/S0006-291X(02)00896-3; Rusai K, 2008, CLIN EXP PHARMACOL P, V35, P1183, DOI 10.1111/j.1440-1681.2008.04976.x; Schuhmacher S, 2011, DIABETES, V60, P2608, DOI 10.2337/db10-1395; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Shin SJ, 1999, KIDNEY INT, V56, P2191, DOI 10.1046/j.1523-1755.1999.00795.x; Shin SJ, 2000, DIABETOLOGIA, V43, P649, DOI 10.1007/s001250051354; Song J, 2003, AM J PHYSIOL-RENAL, V285, pF1125, DOI 10.1152/ajprenal.00143.2003; VERDON CP, 1995, ANAL BIOCHEM, V224, P502, DOI 10.1006/abio.1995.1079; Ward DT, 2001, J AM SOC NEPHROL, V12, P779, DOI 10.1681/ASN.V124779; Yagihashi N, 1996, DIABETOLOGIA, V39, P793, DOI 10.1007/s001250050512	50	9	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104923	10.1371/journal.pone.0104923	http://dx.doi.org/10.1371/journal.pone.0104923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111608	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100111
J	Pinzon-Latorre, D; Deyholos, MK				Pinzon-Latorre, David; Deyholos, Michael K.			Pectinmethylesterases (PME) and Pectinmethylesterase Inhibitors (PMEI) Enriched during Phloem Fiber Development in Flax (Linum usitatissimum)	PLOS ONE			English	Article							PECTIN METHYLESTERASE INHIBITORS; CELL-WALL; METHYL ESTERASE; ARABIDOPSIS; GENE; EXPRESSION; IDENTIFICATION; GROWTH; FRUIT; STEM	Flax phloem fibers achieve their length by intrusive-diffusive growth, which requires them to penetrate the extracellular matrix of adjacent cells. Fiber elongation therefore involves extensive remodelling of cell walls and middle lamellae, including modifying the degree and pattern of methylesterification of galacturonic acid (GalA) residues of pectin. Pectin methylesterases (PME) are important enzymes for fiber elongation as they mediate the demethylesterification of GalA in muro, in either a block-wise fashion or in a random fashion. Our objective was to identify PMEs and PMEIs that mediate phloem fiber elongation in flax. For this purpose, we measured transcript abundance of candidate genes at nine different stages of stem and fiber development and found sets of genes enriched during fiber elongation and maturation as well as during xylem development. We expressed one of the flax PMEIs in E. coli and demonstrated that it was able to inhibit most of the native PME activity in the upper portion of the flax stem. These results identify key genetic components of the intrusive growth process and define targets for fiber engineering and crop improvement.	[Pinzon-Latorre, David; Deyholos, Michael K.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	University of Alberta	Pinzon-Latorre, D (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	david.pinzon@ualberta.ca			Genome Canada	Genome Canada(Genome Canada)	This work was funded by the Genome Canada project: Total Utilization of Flax Genomics (TUFGEN) www.genomecanada.ca. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ageeva MV, 2005, PLANTA, V222, P565, DOI 10.1007/s00425-005-1536-2; Al-Qsous S, 2004, PLANTA, V219, P369, DOI 10.1007/s00425-004-1246-1; De-la-Pena C, 2008, BBA-GEN SUBJECTS, V1780, P773, DOI 10.1016/j.bbagen.2007.12.013; Dedeurwaerder S, 2009, PLANTA, V229, P311, DOI 10.1007/s00425-008-0831-0; Downie B, 1998, ANAL BIOCHEM, V264, P149, DOI 10.1006/abio.1998.2847; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Esau K., 1977, ANATOMY SEED PLANTS; Francis KE, 2006, PLANT PHYSIOL, V142, P1004, DOI 10.1104/pp.106.085274; GIOVANE A, 1990, PHYTOCHEMISTRY, V29, P2821, DOI 10.1016/0031-9422(90)87083-7; Gorshkova TA, 2003, IND CROP PROD, V18, P213, DOI 10.1016/S0926-6690(03)00043-8; Hongo S, 2012, PLANT CELL, V24, P2624, DOI 10.1105/tpc.112.099325; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; KOCH JL, 1989, PLANT PHYSIOL, V91, P816, DOI 10.1104/pp.91.3.816; LINERS F, 1989, PLANT PHYSIOL, V91, P1419, DOI 10.1104/pp.91.4.1419; Mareck A, 2012, PLANT SIGNAL BEHAV, V7, P59, DOI 10.4161/psb.7.1.18632; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pinzon-Latorre D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-742; Raiola A, 2004, FEBS LETT, V557, P199, DOI 10.1016/S0014-5793(03)01491-1; RILLO L, 1992, J AGR FOOD CHEM, V40, P591, DOI 10.1021/jf00016a012; Roger D, 2001, PLANT SCI, V160, P713, DOI 10.1016/S0168-9452(00)00456-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senechal F, 2014, ANN BOT; Siedlecka A, 2008, PLANT PHYSIOL, V146, P554, DOI 10.1104/pp.107.111963; To L, 2013, GENETICS SEED COAT S; Wolf S, 2003, FEBS LETT, V555, P551, DOI 10.1016/S0014-5793(03)01344-9; Wolf S, 2009, PLANT J, V58, P361, DOI 10.1111/j.1365-313X.2009.03784.x	27	11	12	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105386	10.1371/journal.pone.0105386	http://dx.doi.org/10.1371/journal.pone.0105386			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121600	gold, Green Published, Green Submitted			2022-12-27	WOS:000341017000121
J	Rojas-Caraballo, J; Lopez-Aban, J; del Villar, LP; Vizcaino, C; Vicente, B; Fernandez-Soto, P; del Olmo, E; Patarroyo, MA; Muro, A				Rojas-Caraballo, Jose; Lopez-Aban, Julio; Perez del Villar, Luis; Vizcaino, Carolina; Vicente, Belen; Fernandez-Soto, Pedro; del Olmo, Esther; Alfonso Patarroyo, Manuel; Muro, Antonio			In Vitro and In Vivo Studies for Assessing the Immune Response and Protection-Inducing Ability Conferred by Fasciola hepatica-Derived Synthetic Peptides Containing B- and T-Cell Epitopes	PLOS ONE			English	Article							CATHEPSIN-L PROTEINASES; SCHISTOSOMA-MANSONI; HELMINTH INFECTION; VACCINE ADJUVANTS; SHEEP; CATTLE; FLUKE; ANTIGENS; ANTIBODY; MICE	Fasciolosis is considered the most widespread trematode disease affecting grazing animals around the world; it is currently recognised by the World Health Organisation as an emergent human pathogen. Triclabendazole is still the most effective drug against this disease; however, resistant strains have appeared and developing an effective vaccine against this disease has increasingly become a priority. Several bioinformatics tools were here used for predicting B- and T-cell epitopes according to the available data for Fasciola hepatica protein amino acid sequences. BALB/c mice were immunised with the synthetic peptides by using the ADAD vaccination system and several immune response parameters were measured (antibody titres, cytokine levels, T-cell populations) to evaluate their ability to elicit an immune response. Based on the immunogenicity results so obtained, seven peptides were selected to assess their protection-inducing ability against experimental infection with F. hepatica metacercariae. Twenty-four B- or T-epitope-containing peptides were predicted and chemically synthesised. Immunisation of mice with peptides so-called B1, B2, B5, B6, T14, T15 and T16 induced high levels of total IgG, IgG1 and IgG2a (p<0.05) and a mixed Th1/Th2/Th17/Treg immune response, according to IFN-gamma, IL-4, IL-17 and IL-10 levels, accompanied by increased CD62L(+) T-cell populations. A high level of protection was obtained in mice vaccinated with peptides B2, B5, B6 and T15 formulated in the ADAD vaccination system with the AA0029 immunomodulator. The bioinformatics approach used in the present study led to the identification of seven peptides as vaccine candidates against the infection caused by Fasciola hepatica (a liver-fluke trematode). However, vaccine efficacy must be evaluated in other host species, including those having veterinary importance.	[Rojas-Caraballo, Jose; Lopez-Aban, Julio; Perez del Villar, Luis; Vicente, Belen; Fernandez-Soto, Pedro; Muro, Antonio] Univ Salamanca IBSAL CIETUS, Trop Dis Res Ctr, Parasite & Mol Immunol Lab, Salamanca, Spain; [Rojas-Caraballo, Jose; Vizcaino, Carolina; Alfonso Patarroyo, Manuel] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [del Olmo, Esther] Univ Salamanca IBSAL CIETUS, Trop Dis Res Ctr, Dept Pharmaceut Chem, Salamanca, Spain; [Alfonso Patarroyo, Manuel] Univ Rosario, Sch Med & Hlth Sci, Dept Basic Sci, Bogota, Colombia	Universidad del Rosario	Muro, A (corresponding author), Univ Salamanca IBSAL CIETUS, Trop Dis Res Ctr, Parasite & Mol Immunol Lab, Salamanca, Spain.	ama@usal.es	Patarroyo, Manuel A/I-8046-2016; del Olmo, Esther/L-5803-2014; López-Abán, Julio/B-3557-2015	Patarroyo, Manuel A/0000-0002-4751-2500; del Olmo, Esther/0000-0002-3965-3290; López-Abán, Julio/0000-0001-8509-0727; Muro, Antonio/0000-0003-0244-4740	Fundacion Ramon Areces (Madrid, Spain) [XV-2010-2013]	Fundacion Ramon Areces (Madrid, Spain)	This study was supported by Fundacion Ramon Areces (Madrid, Spain). Reference: XV-2010-2013 (www.fundacionareces.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Arnon R, 2003, INT IMMUNOPHARMACOL, V3, P1195, DOI 10.1016/S1567-5769(03)00016-X; Arnon R, 2000, IMMUNOLOGY, V101, P555, DOI 10.1046/j.1365-2567.2000.00139.x; Artis D, 1999, J EXP MED, V190, P953, DOI 10.1084/jem.190.7.953; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bustamante JM, 2008, NAT MED, V14, P542, DOI 10.1038/nm1744; Caoili SEC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/910524; Cardoso FC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000308; Dalton JP, 1996, INFECT IMMUN, V64, P5066, DOI 10.1128/IAI.64.12.5066-5074.1996; Dalton JP, 2003, INT J PARASITOL, V33, P1173, DOI 10.1016/S0020-7519(03)00171-1; de Aluja AS, 2005, VACCINE, V23, P4062, DOI 10.1016/j.vaccine.2004.11.076; De Groot AS, 2006, DRUG DISCOV TODAY, V11, P203, DOI 10.1016/S1359-6446(05)03720-7; De Groot AS, 2004, METHODS, V34, P425, DOI 10.1016/j.ymeth.2004.06.004; del Olmo E, 2006, BIOORG MED CHEM LETT, V16, P6091, DOI 10.1016/j.bmcl.2006.08.113; Deleage G, 2001, COMPUT BIOL MED, V31, P259, DOI 10.1016/S0010-4825(01)00008-7; Espino AM, 2005, EXP PARASITOL, V110, P374, DOI 10.1016/j.exppara.2005.03.029; Espino AM, 2010, VET PARASITOL, V169, P82, DOI 10.1016/j.vetpar.2009.12.018; Fairweather I, 2011, VET PARASITOL, V180, P133, DOI 10.1016/j.vetpar.2011.05.034; Farias LP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000597; Flynn RJ, 2008, INT J PARASITOL, V38, P1673, DOI 10.1016/j.ijpara.2008.05.008; Gause WC, 2003, TRENDS IMMUNOL, V24, P269, DOI 10.1016/S1471-4906(03)00101-7; HAGAN P, 1993, PARASITE IMMUNOL, V15, P1, DOI 10.1111/j.1365-3024.1993.tb00565.x; Hans Dhiraj, 2006, Med Chem, V2, P627; Harmsen MM, 2004, INT J PARASITOL, V34, P675, DOI 10.1016/j.ijpara.2003.12.011; HAROUN EM, 1986, VET PARASITOL, V20, P63, DOI 10.1016/0304-4017(86)90093-2; Hillyer GV, 2005, J HELMINTHOL, V79, P241, DOI 10.1079/JOH2005304; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Hoyle DV, 2003, PARASITE IMMUNOL, V25, P221, DOI 10.1046/j.1365-3024.2003.00627.x; Jayaraj R, 2009, VET PARASITOL, V160, P230, DOI 10.1016/j.vetpar.2008.10.099; Jezek J, 2008, BIOPOLYMERS, V90, P349, DOI 10.1002/bip.20788; Kaplan R M, 2001, Vet Ther, V2, P40; Kensil CR, 1996, CRIT REV THER DRUG, V13, P1; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lopez-Aban J, 2007, J PARASITOL, V93, P428, DOI 10.1645/GE-838R1.1; Madhumathi J, 2010, VACCINE, V28, P5038, DOI 10.1016/j.vaccine.2010.05.012; Martinez-Fernandez AR, 2004, VET PARASITOL, V126, P287, DOI 10.1016/j.vetpar.2004.07.023; Mas-Coma S, 2005, J HELMINTHOL, V79, P207, DOI 10.1079/JOH2005296; Mas-Coma S, 2009, VET PARASITOL, V163, P264, DOI 10.1016/j.vetpar.2009.03.024; McCole DF, 1999, PARASITE IMMUNOL, V21, P1, DOI 10.1046/j.1365-3024.1999.00188.x; McGonigle L, 2008, INT J PARASITOL, V38, P149, DOI 10.1016/j.ijpara.2007.10.007; McManus DP, 2006, PARASITOLOGY, V133, pS43, DOI 10.1017/S0031182006001806; MERRIFIELD RB, 1969, ADV ENZYMOL RAMB, V32, P221; Mulcahy G, 1999, RES VET SCI, V67, P27, DOI 10.1053/rvsc.1998.0270; Mulcahy G, 1998, VACCINE, V16, P932, DOI 10.1016/S0264-410X(97)00289-2; Negrao-Correa Deborah, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P291, DOI 10.1590/S0036-46652001000500011; Patarroyo ME, 2008, J CELL MOL MED, V12, P1915, DOI 10.1111/j.1582-4934.2008.00174.x; Piacenza L, 1999, INFECT IMMUN, V67, P1954; Prowse RK, 2002, PARASITE IMMUNOL, V24, P57, DOI 10.1046/j.0141-9838.2001.00438.x; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Read AJ, 2009, VACCINE, V27, P1024, DOI 10.1016/j.vaccine.2008.11.096; Robinson K, 1995, IMMUNOLOGY, V86, P495; Rutitzky LI, 2009, EUR J IMMUNOL, V39, P2470, DOI 10.1002/eji.200939325; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Totte P, 2010, DEV COMP IMMUNOL, V34, P177, DOI 10.1016/j.dci.2009.09.005; Vilar MM, 2003, VACCINE, V22, P137, DOI 10.1016/S0264-410X(03)00300-1; Villa-Mancera A, 2012, VET J, V194, P108, DOI 10.1016/j.tvjl.2012.03.003; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wedrychowicz H, 2007, VET PARASITOL, V147, P77, DOI 10.1016/j.vetpar.2007.03.023; World Health Organization (WHO), 2011, IN EST GLOB BURD FOO; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108; ZIMMERMAN GL, 1983, J PARASITOL, V69, P473, DOI 10.2307/3281356	64	23	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105323	10.1371/journal.pone.0105323	http://dx.doi.org/10.1371/journal.pone.0105323			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122166	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000117
J	Williams, CML; Cheah, ESG; Malkin, J; Patel, H; Otu, J; Mlaga, K; Sutherland, JS; Antonio, M; Perera, N; Woltmann, G; Haldar, P; Garton, NJ; Barer, MR				Williams, Caroline M. L.; Cheah, Eddy S. G.; Malkin, Joanne; Patel, Hemu; Otu, Jacob; Mlaga, Kodjovi; Sutherland, Jayne S.; Antonio, Martin; Perera, Nelun; Woltmann, Gerrit; Haldar, Pranabashis; Garton, Natalie J.; Barer, Michael R.			Face Mask Sampling for the Detection of Mycobacterium tuberculosis in Expelled Aerosols	PLOS ONE			English	Article							AIRBORNE TRANSMISSION; PULMONARY TUBERCULOSIS; INFECTION; VARIABILITY; RESISTANCE; BACILLI	Background: Although tuberculosis is transmitted by the airborne route, direct information on the natural output of bacilli into air by source cases is very limited. We sought to address this through sampling of expelled aerosols in face masks that were subsequently analyzed for mycobacterial contamination. Methods: In series 1, 17 smear microscopy positive patients wore standard surgical face masks once or twice for periods between 10 minutes and 5 hours; mycobacterial contamination was detected using a bacteriophage assay. In series 2, 19 patients with suspected tuberculosis were studied in Leicester UK and 10 patients with at least one positive smear were studied in The Gambia. These subjects wore one FFP30 mask modified to contain a gelatin filter for one hour; this was subsequently analyzed by the Xpert MTB/RIF system. Results: In series 1, the bacteriophage assay detected live mycobacteria in 11/17 patients with wearing times between 10 and 120 minutes. Variation was seen in mask positivity and the level of contamination detected in multiple samples from the same patient. Two patients had non-tuberculous mycobacterial infections. In series 2, 13/20 patients with pulmonary tuberculosis produced positive masks and 0/9 patients with extrapulmonary or non-tuberculous diagnoses were mask positive. Overall, 65% of patients with confirmed pulmonary mycobacterial infection gave positive masks and this included 3/6 patients who received diagnostic bronchoalveolar lavages. Conclusion: Mask sampling provides a simple means of assessing mycobacterial output in non-sputum expectorant. The approach shows potential for application to the study of airborne transmission and to diagnosis.	[Williams, Caroline M. L.; Cheah, Eddy S. G.; Malkin, Joanne; Haldar, Pranabashis; Garton, Natalie J.; Barer, Michael R.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Malkin, Joanne; Patel, Hemu; Perera, Nelun; Barer, Michael R.] Univ Hosp Leicester NHS Trust, Dept Clin Microbiol, Leicester, Leics, England; [Otu, Jacob; Mlaga, Kodjovi; Sutherland, Jayne S.; Antonio, Martin] MRC Unit, Banjul, Gambia; [Woltmann, Gerrit; Haldar, Pranabashis] Glenfield Hosp, Dept Resp Med, Leicester, Leics, England; [Haldar, Pranabashis] Glenfield Hosp, Resp Biomed Res Unit, Natl Inst Hlth Res, Leicester, Leics, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; University of London; London School of Hygiene & Tropical Medicine; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Barer, MR (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	mrb19@le.ac.uk	Mlaga, Kodjovi D./AAL-3472-2020; Cheah, Eddy Seong Guan/T-1754-2017	Cheah, Eddy Seong Guan/0000-0002-4555-167X; Woltmann, Gerrit/0000-0002-9253-6034; Sutherland, Jayne/0000-0002-7083-4997; Haldar, Pranabashis/0000-0002-1572-5421; Barer, Michael/0000-0002-0377-3100	Henry Smith Charity; Edith Murphy Foundation; Medical Research Council [MC_UP_A900_1122, MC_U190071468, G0300403] Funding Source: researchfish; MRC [MC_UP_A900_1122, MC_U190071468, G0300403] Funding Source: UKRI	Henry Smith Charity; Edith Murphy Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MRB and ESGC received funding from the Henry Smith Charity (www.henrysmithcharity.org.uk) and the Edith Murphy Foundation (www.edithmurphy.co.uk). CMLW held a UK National Institute for Health Research Academic Clinical Fellowship (www.nihr.ac.uk) during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkerman OW, 2013, J CLIN MICROBIOL, V51, P3505, DOI 10.1128/JCM.00843-13; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Boston LN, 1901, J AMER MED ASSOC, V37, P685; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Cheah ESG, 2010, J MOL DIAGN, V12, P250, DOI 10.2353/jmoldx.2010.090030; Dharmadhikari AS, 2011, TUBERCULOSIS, V91, P329, DOI 10.1016/j.tube.2011.03.002; Escombe AR, 2007, CLIN INFECT DIS, V44, P1349, DOI 10.1086/515397; FEIGIN RD, 1982, NEW ENGL J MED, V307, P1255, DOI 10.1056/NEJM198211113072007; Fennelly KP, 2007, CLIN INFECT DIS, V44, P1358, DOI 10.1086/516617; Fennelly KP, 2012, AM J RESP CRIT CARE, V186, P450, DOI 10.1164/rccm.201203-0444OC; Fennelly KP, 2004, AM J RESP CRIT CARE, V169, P604, DOI 10.1164/rccm.200308-1101OC; Friedrich SO, 2013, LANCET RESP MED, V1, P462, DOI 10.1016/S2213-2600(13)70119-X; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hernandez-Garduno E, 2004, THORAX, V59, P286, DOI 10.1136/thx.2003.011759; Huynh KN, 2008, CLIN INFECT DIS, V46, P93, DOI 10.1086/523000; Jones-Lopez EC, 2013, AM J RESP CRIT CARE, V187, P1007, DOI 10.1164/rccm.201208-1422OC; Mole R, 2007, J MED MICROBIOL, V56, P1334, DOI 10.1099/jmm.0.46936-0; Mukamolova GV, 2010, AM J RESP CRIT CARE, V181, P174, DOI 10.1164/rccm.200905-0661OC; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; RILEY RL, 1959, AM J HYG, V70, P185, DOI 10.1093/oxfordjournals.aje.a120069; Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051; Sepkowitz KA, 1996, CLIN INFECT DIS, V23, P954, DOI 10.1093/clinids/23.5.954; STEINBERG P, 1969, AM J EPIDEMIOL, V89, P62, DOI 10.1093/oxfordjournals.aje.a120916; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wurie Fatima, 2013, F1000Res, V2, P14, DOI 10.12688/f1000research.2-14.v1	26	16	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104921	10.1371/journal.pone.0104921	http://dx.doi.org/10.1371/journal.pone.0104921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122163	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000075
J	Engen, SA; Rukke, HV; Becattini, S; Jarrossay, D; Blix, IJ; Petersen, FC; Sallusto, F; Schenck, K				Engen, Stian Andre; Rukke, Hakon Valen; Becattini, Simone; Jarrossay, David; Blix, Inger Johanne; Petersen, Fernanda Cristina; Sallusto, Federica; Schenck, Karl			The Oral Commensal Streptococcus mitis Shows a Mixed Memory Th Cell Signature That Is Similar to and Cross-Reactive with Streptococcus pneumoniae	PLOS ONE			English	Article							PNEUMOCOCCAL CARRIAGE; INTERLEUKIN 22; HUMAN INFANTS; IDENTIFICATION; ANTIBODIES; RESPONSES; IMMUNITY; DISEASE; SUBSET; COLONIZATION	Background: Carriage of and infection with Streptococcus pneumoniae is known to predominantly induce T helper 17 (Th17) responses in humans, but the types of Th cells showing reactivity towards commensal streptococci with low pathogenic potential, such as the oral commensals S. mitis and S. salivarius, remain uncharacterized. Methods: Memory CD4(+) T helper (Th) cell subsets were isolated from healthy human blood donors according to differential expression of chemokine receptors, expanded in vitro using polyclonal stimuli and characterized for reactivity against different streptococcal strains. Results: Th cells responding to S. mitis, S. salivarius and S. pneumoniae were predominantly in a CCR6(+)CXCR3(+) subset and produced IFN-gamma, and in a CCR6(+)CCR4(+) subset and produced IL-17 and IL-22. Frequencies of S. pneumoniae-reactive Th cells were higher than frequencies of S. mitis-and S. salivarius-specific Th cells. S. mitis and S. pneumoniae isogenic capsule knockout mutants and a S. mitis mutant expressing the serotype 4 capsule of S. pneumoniae showed no different Th cell responses as compared to wild type strains. S. mitis-specific Th17 cells showed cross-reactivity with S. pneumoniae. Conclusions: As Th17 cells partly control clearance of S. pneumoniae, cross-reactive Th17 cells that may be induced by commensal bacterial species may influence the immune response, independent of capsule expression.	[Engen, Stian Andre; Rukke, Hakon Valen; Blix, Inger Johanne; Petersen, Fernanda Cristina; Schenck, Karl] Univ Oslo, Dept Oral Biol, Oslo, Norway; [Becattini, Simone; Jarrossay, David; Sallusto, Federica] Univ Svizzera Italiana, Inst Biomed Res, Bellinzona, Switzerland; [Blix, Inger Johanne] Univ Oslo, Dept Periodontol, Oslo, Norway	University of Oslo; Universita della Svizzera Italiana; University of Oslo	Engen, SA (corresponding author), Univ Oslo, Dept Oral Biol, Oslo, Norway.	s.a.engen@odont.uio.no	Petersen, Fernanda Cristina/AAQ-1107-2020	Petersen, Fernanda Cristina/0000-0003-4649-247X; Becattini, Simone/0000-0001-5985-0403; Valen, Hakon/0000-0002-9038-4153	European Research Council [323183 PREDICT]; Helmut Horten Foundation	European Research Council(European Research Council (ERC)European Commission); Helmut Horten Foundation	This work was supported by the European Research Council grant number 323183 PREDICT (to FS). The Institute for Research in Biomedicine, Bellinzona, is supported by the Helmut Horten Foundation (http://www.helmut-hortenstiftung.org/en/homepage.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Belkaid Y, 2013, TRENDS IMMUNOL, V34, P299, DOI 10.1016/j.it.2013.03.003; Brandtzaeg P, 2001, ACTA ODONTOL SCAND, V59, P235, DOI 10.1080/00016350152509265; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cosmi L, 2010, J ALLERGY CLIN IMMUN, V125, P222, DOI 10.1016/j.jaci.2009.10.012; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Glennie SJ, 2013, CLIN INFECT DIS, V56, P291, DOI 10.1093/cid/cis842; Granat SM, 2009, J INFECT DIS, V200, P99, DOI 10.1086/599364; Ivanov S, 2013, J VIROL, V87, P6911, DOI 10.1128/JVI.02943-12; Kalka-Moll WM, 2002, J IMMUNOL, V169, P6149, DOI 10.4049/jimmunol.169.11.6149; Kirchherr JL, 2005, CLIN DIAGN LAB IMMUN, V12, P1184, DOI 10.1128/CDLI.12.10.1184-1190.2005; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lefkovits I., 1999, LIMITING DILUTION AN; Lipsitch M, 2005, PLOS MED, V2, P62, DOI 10.1371/journal.pmed.0020015; Lundgren A, 2012, VACCINE, V30, P3897, DOI 10.1016/j.vaccine.2012.03.082; Moffitt KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043445; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Paats MS, 2013, THORAX, V68, P468, DOI 10.1136/thoraxjnl-2012-202168; Pido-Lopez J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002396; Pletz MW, 2008, INT J ANTIMICROB AG, V32, P199, DOI 10.1016/j.ijantimicag.2008.01.021; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Rapola S, 2000, J INFECT DIS, V182, P1146, DOI 10.1086/315822; Rukke HV, 2012, MOL ORAL MICROBIOL, V27, P95, DOI 10.1111/j.2041-1014.2011.00635.x; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Velez CD, 2009, IMMUNOLOGY, V127, P73, DOI 10.1111/j.1365-2567.2008.02924.x; Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x; Wirth KA, 2008, ISME J, V2, P728, DOI 10.1038/ismej.2008.26; Wright AKA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003274; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zielinski CE, 2011, IMMUNOL REV, V240, P40, DOI 10.1111/j.1600-065X.2010.01000.x	38	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104306	10.1371/journal.pone.0104306	http://dx.doi.org/10.1371/journal.pone.0104306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119879	Green Published, gold			2022-12-27	WOS:000340900600048
J	Galukande, M; Duffy, K; Bitega, JP; Wooding, N				Galukande, Moses; Duffy, Kevin; Bitega, Jean Paul; Wooding, Nick			Skills Training of Health Workers in the Use of a Non Surgical Device (PrePex) for Adult Safe Male Circumcision	PLOS ONE			English	Article							HIV PREVENTION; EXPERT; MEN	Background: Safe Male Circumcision (SMC) is a proven approach for partial protection of men from acquisition of HIV infection. Several sub-Saharan African countries have a target to circumcise 80% of males aged 15 to 49. The use of devices such as PrePex would aid scaling up of SMC. Since most health workers would have no prior experience with use of devices, skills training is needed. This paper explores a skills transfer model at an urban site in Uganda. Objective: To assess the practicability and feasibility of rapid short duration training for safe PrePex device use. Methods: A prospective study, conducted over 8 weeks (August-October 2012) at International Hospital Kampala, an urban Kampala hospital, examining the performance of various health worker cadres after training in the use of a non-surgical device (PrePex). The prospective study obtained approval from the Makerere School of Medicine Research and Ethics Committee and the Uganda National Council of Science and Technology. If eligible, and after the subject signed the informed consent form, they were enrolled into the study. Results: Ten health workers were successfully trained in use of PrePex during a 3 day non-residential on-the-job training course. After the first three days of training, the trained health workers performed 561 placements and 529 device removals successfully. Over all adverse events (AE) rates were below <= 2%; however, there were some differences in AE rates across the cadres trained but not significant (p>0.25 for moderate AEs). Conclusion: Rapid training for safe use of the PrePex device is feasible for the range of health workers available for SMC in resource limited settings, but among those with past SMC experience.	[Galukande, Moses] Int Hosp Kampala, Kampala, Uganda; [Galukande, Moses] Mulago Hosp, Dept Surg, Kampala, Uganda; [Duffy, Kevin] Int Med Grp, Kampala, Uganda; [Bitega, Jean Paul] Kanombe Hosp, Kigali, Rwanda; [Wooding, Nick] Int Hlth Sci Univ, Kampala, Uganda	Mulago National Referral Hospital	Galukande, M (corresponding author), Int Hosp Kampala, Kampala, Uganda.	mosesg@img.co.ug	Wooding, Nicholas/L-7934-2019		International Medical Group	International Medical Group	Funding was from International Medical Group as the internal source. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, GUIDELINES USE DEVIC; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Benjamin Larry, 2002, Community Eye Health, V15, P19; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Ericsson K.A., 1991, GEN THEORY EXPERTISE; Ericsson K Anders, 2007, ANS Adv Nurs Sci, V30, pE58; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Fitts PM., 1967, HUM PERFORM; Galukande M, 2014, PLOS ONE, V9, DOI 101371/journal.p.one.0086631; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Haluck RS, 2000, ARCH SURG-CHICAGO, V135, P786, DOI 10.1001/archsurg.135.7.786; Kopta J A, 1971, Clin Orthop Relat Res, V75, P80, DOI 10.1097/00003086-197103000-00011; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Reznick RK, 2006, NEW ENGL J MED, V355, P2664, DOI 10.1056/NEJMra054785; SHANTEAU J, 1992, ORGAN BEHAV HUM DEC, V53, P95, DOI 10.1016/0749-5978(92)90057-E; Smith Valerie, 2012, Nurse Educ Pract, V12, P242, DOI 10.1016/j.nepr.2012.04.012; Tache S, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-64; Uganda AIDS Commission, 2011, NAT PRIOR ACT PLAN	20	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104893	10.1371/journal.pone.0104893	http://dx.doi.org/10.1371/journal.pone.0104893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN9BM	25118716	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600101
J	Gonzalez-Ortiz, G; Bronsoms, S; Van Ufford, HCQ; Halkes, SBA; Virkola, R; Liskamp, RMJ; Beukelman, CJ; Pieters, RJ; Perez, JF; Martin-Orue, SM				Gonzalez-Ortiz, Gemma; Bronsoms, Silvia; Van Ufford, H. C. Quarles; Halkes, S. Bart A.; Virkola, Ritva; Liskamp, Rob M. J.; Beukelman, Cees J.; Pieters, Roland J.; Francisco Perez, Jose; Maria Martin-Orue, Susana			A Proteinaceous Fraction of Wheat Bran May Interfere in the Attachment of Enterotoxigenic E. Coli K88 (F4+) to Porcine Epithelial Cells	PLOS ONE			English	Article							ESCHERICHIA-COLI; ADHESION; EXPRESSION; COMPONENTS; RESISTANCE; GLOBULIN; FIMBRIAE; GENE; FOOD	Wheat bran (WB) from Triticum aestivum has many beneficial effects on human health. To the best of our knowledge, very little has been published about its ability to prevent pathogenic bacterial adhesion in the intestine. Here, a WB extract was fractionated using different strategies, and the obtained fractions were tested in different in vitro methodologies to evaluate their interference in the attachment of enterotoxigenic Escherichia coli (ETEC) K88 to intestinal porcine epithelial cells (IPEC-J2) with the aim of identifying the putative anti-adhesive molecules. It was found that a proteinaceous compound in the >300-kDa fraction mediates the recognition of ETEC K88 to IPEC-J2. Further fractionation of the >300-kDa sample by size-exclusion chromatography showed several proteins below 90 kDa, suggesting that the target protein belongs to a high-molecular-weight (MW) multi-component protein complex. The identification of some relevant excised bands was performed by mass spectrometry (MS) and mostly revealed the presence of various protease inhibitors (PIs) of low MW: Serpin-Z2B, Class II chitinase, endogenous alpha-amylase/subtilisin inhibitor and alpha-amylase/trypsin inhibitor CM3. Furthermore, an incubation of the WB extract with ETEC K88 allowed for the identification of a 7S storage protein globulin of wheat, Globulin 3 of 66 kDa, which may be one of the most firmly attached WB proteins to ETEC K88 cells. Further studies should be performed to gain an understanding of the molecular recognition of the blocking process that takes place. All gathered information can eventually pave the way for the development of novel anti-adhesion therapeutic agents to prevent bacterial pathogenesis.	[Gonzalez-Ortiz, Gemma; Francisco Perez, Jose; Maria Martin-Orue, Susana] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Serv Nutr Benestar Anim SNiBA, E-08193 Barcelona, Spain; [Bronsoms, Silvia] Univ Autonoma Barcelona, Serv Prote & Biol Estruct, E-08193 Barcelona, Spain; [Van Ufford, H. C. Quarles; Halkes, S. Bart A.; Liskamp, Rob M. J.; Beukelman, Cees J.; Pieters, Roland J.] Univ Utrecht, Dept Med Chem & Chem Biol, Utrecht, Netherlands; [Virkola, Ritva] Univ Helsinki, Dept Biosci Gen Microbiol, Helsinki, Finland	Autonomous University of Barcelona; Autonomous University of Barcelona; Utrecht University; University of Helsinki	Gonzalez-Ortiz, G (corresponding author), Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Serv Nutr Benestar Anim SNiBA, E-08193 Barcelona, Spain.	gemma.gonzalez.ortiz@gmail.com	Martín-Orúe, Susana María/AAB-9235-2019; Gonzalez, Gemma/AAM-8318-2021; Martín-Orúe, Susana M./C-5065-2014; Perez, Jose F/G-4373-2014; Liskamp, Rob M/I-5889-2012; Pieters, Roland J/A-9254-2008	Martín-Orúe, Susana María/0000-0001-5266-0906; Martín-Orúe, Susana M./0000-0001-5266-0906; Perez, Jose F/0000-0001-8853-8945; Liskamp, Rob M/0000-0001-8897-8975; Pieters, Roland J/0000-0003-4723-3584; Gonzalez-Ortiz, Gemma/0000-0003-4181-5524; Bronsoms, Silvia/0000-0001-9763-762X	Spanish Ministry of Education and Science [AGL 2009-07328]; Spanish Ministry of Education and Science	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Education and Science(Spanish Government)	This work was supported by a public research project of the Spanish Ministry of Education and Science (Project AGL 2009-07328). Gemma Gonzalez-Ortiz was supported by a mobility scholarship from the Spanish Ministry of Education and Science, which she enjoyed in Utrecht Universiteit. The funders had no role in study study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, 9 2 SAS; Badia R, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-4; Becker PM, 2007, J APPL MICROBIOL, V103, P2686, DOI 10.1111/j.1365-2672.2007.03524.x; Becker PM, 2008, J SCI FOOD AGR, V88, P2026, DOI 10.1002/jsfa.3324; BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6; Blanco M, 1997, J CLIN MICROBIOL, V35, P2958, DOI 10.1128/JCM.35.11.2958-2963.1997; Eeckhaut V, 2008, POULTRY SCI, V87, P2329, DOI 10.3382/ps.2008-00193; Gonzalez-Ortiz G, 2013, VET MICROBIOL, V167, P494, DOI 10.1016/j.vetmic.2013.07.035; Gonzalez-Ortiz G, 2014, BRIT J NUTR, V111, P633, DOI 10.1017/S0007114513003024; Gouin SG, 2009, CHEMMEDCHEM, V4, P749, DOI 10.1002/cmdc.200900034; Guo GF, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-147; Hermes RG, 2013, BRIT J NUTR, V109, P1001, DOI 10.1017/S0007114512002978; Joensuu JJ, 2006, TRANSGENIC RES, V15, P359, DOI 10.1007/s11248-006-0010-7; Kitajima S, 1999, J BIOCHEM, V125, P1, DOI 10.1093/oxfordjournals.jbchem.a022244; LANE JI, 2010, TEMPORAL BONE, P1, DOI DOI 10.1016/J.IJF00DMICR0.2010.05.027; Lengsfeld C, 2004, J AGR FOOD CHEM, V52, P1495, DOI 10.1021/jf030666n; Liu Y, 2008, COLLOID SURFACE B, V65, P35, DOI 10.1016/j.colsurfb.2008.02.012; Malmstrom E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000698; Molist F, 2010, LIVEST SCI, V133, P214, DOI 10.1016/j.livsci.2010.06.067; Gasa FM, 2010, BRIT J NUTR, V103, P879, DOI 10.1017/S0007114509992637; Olaya-Abril A, 2014, J PROTEOMICS, V97, P164, DOI 10.1016/j.jprot.2013.03.035; Oldach KH, 2001, MOL PLANT MICROBE IN, V14, P832, DOI 10.1094/MPMI.2001.14.7.832; Osman AO, 2013, J DAIRY RES, V80, P174, DOI 10.1017/S0022029913000095; Pieters RJ, 2011, ADV EXP MED BIOL, V715, P227, DOI 10.1007/978-94-007-0940-9_14; Ray S, 2003, PLANT MOL BIOL, V53, P741, DOI 10.1023/B:PLAN.0000019120.74610.52; Rehault-Godbert S, 2013, J BIOL CHEM, V288, P17285, DOI 10.1074/jbc.M113.469759; Rosenfelder P, 2013, ANIM FEED SCI TECH, V185, P107, DOI 10.1016/j.anifeedsci.2013.07.011; Satinder Kaur, 2011, Asian Journal of Food and Agro-Industry, V4, P122; Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008; Shin SY, 2008, J EXP BOT, V59, P2371, DOI 10.1093/jxb/ern103; Shmuely H, 2012, CURR OPIN BIOTECH, V23, P148, DOI 10.1016/j.copbio.2011.10.009; Shoaf-Sweeney KD, 2009, ADV FOOD NUTR RES, V55, P101, DOI 10.1016/S1043-4526(08)00402-6; SLIFKIN M, 1990, CLIN MICROBIOL REV, V3, P197, DOI 10.1128/CMR.3.3.197-218.1990; Snellings NJ, 1997, INFECT IMMUN, V65, P2462, DOI 10.1128/IAI.65.6.2462-2467.1997; Teodorowicz M, 2014, J APPL MICROBIOL, V116, P424, DOI 10.1111/jam.12358; Teodorowicz M, 2013, EUR J NUTR, V52, P1927, DOI 10.1007/s00394-013-0494-x; VIRKOLA R, 1993, INFECT IMMUN, V61, P4480, DOI 10.1128/IAI.61.10.4480-4484.1993; Westerlund-Wikstrom B, 1997, PROTEIN ENG, V10, P1319, DOI 10.1093/protein/10.11.1319; Wittschier N, 2007, J PHARM PHARMACOL, V59, P777, DOI 10.1211/jpp.59.6.0004	39	4	4	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104258	10.1371/journal.pone.0104258	http://dx.doi.org/10.1371/journal.pone.0104258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119298	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600044
J	Ivanov, DP; Parker, TL; Walker, DA; Alexander, C; Ashford, MB; Gellert, PR; Garnett, MC				Ivanov, Delyan P.; Parker, Terry L.; Walker, David A.; Alexander, Cameron; Ashford, Marianne B.; Gellert, Paul R.; Garnett, Martin C.			Multiplexing Spheroid Volume, Resazurin and Acid Phosphatase Viability Assays for High-Throughput Screening of Tumour Spheroids and Stem Cell Neurospheres	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; DRUG DISCOVERY; STATISTICAL PARAMETER; MALIGNANT GLIOMA; ETOPOSIDE; CULTURE; TISSUE; MEDULLOBLASTOMA; BIOLOGY; MODELS	Three-dimensional cell culture has many advantages over monolayer cultures, and spheroids have been hailed as the best current representation of small avascular tumours in vitro. However their adoption in regular screening programs has been hindered by uneven culture growth, poor reproducibility and lack of high-throughput analysis methods for 3D. The objective of this study was to develop a method for a quick and reliable anticancer drug screen in 3D for tumour and human foetal brain tissue in order to investigate drug effectiveness and selective cytotoxic effects. Commercially available ultra-low attachment 96-well round-bottom plates were employed to culture spheroids in a rapid, reproducible manner amenable to automation. A set of three mechanistically different methods for spheroid health assessment (Spheroid volume, metabolic activity and acid phosphatase enzyme activity) were validated against cell numbers in healthy and drug-treated spheroids. An automated open-source ImageJ macro was developed to enable high-throughput volume measurements. Although spheroid volume determination was superior to the other assays, multiplexing it with resazurin reduction and phosphatase activity produced a richer picture of spheroid condition. The ability to distinguish between effects on malignant and the proliferating component of normal brain was tested using etoposide on UW228-3 medulloblastoma cell line and human neural stem cells. At levels below 10 mu M etoposide exhibited higher toxicity towards proliferating stem cells, whereas at concentrations above 10 mM the tumour spheroids were affected to a greater extent. The high-throughput assay procedures use ready-made plates, open-source software and are compatible with standard plate readers, therefore offering high predictive power with substantial savings in time and money.	[Ivanov, Delyan P.; Alexander, Cameron; Garnett, Martin C.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England; [Parker, Terry L.] Univ Nottingham, Queens Med Ctr, Sch Med, Nottingham NG7 2RD, England; [Walker, David A.] Univ Nottingham, Queens Med Ctr, Childrens Brain Tumour Res Ctr, Nottingham NG7 2RD, England; [Ashford, Marianne B.; Gellert, Paul R.] AstraZeneca, Macclesfield, Cheshire, England	University of Nottingham; University of Nottingham; University of Nottingham; AstraZeneca	Garnett, MC (corresponding author), Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.	martin.garnett@nottingham.ac.uk	Garnett, Martin/K-3265-2012; Alexander, Cameron/N-7729-2014	Garnett, Martin/0000-0002-4365-4499; Alexander, Cameron/0000-0001-8337-1875; Gellert, Paul/0000-0001-7492-7210; Ivanov, Delyan/0000-0001-5515-5251	EPSRC; AstraZeneca [EP/I01375X/1]; Engineering and Physical Sciences Research Council [975344] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); AstraZeneca(AstraZeneca); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by EPSRC and AstraZeneca under grant EP/I01375X/1: Centre for Doctoral Training in Targeted Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Arrowsmith J, 2012, NAT REV DRUG DISCOV, V11, P17, DOI 10.1038/nrd3630; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; BOWEN ID, 1980, HISTOCHEMISTRY, V65, P173, DOI 10.1007/BF00493166; BREGMAN CL, 1994, TOXICOL PATHOL, V22, P528, DOI 10.1177/019262339402200508; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Campos LS, 2004, J NEUROSCI RES, V78, P761, DOI 10.1002/jnr.20333; Chan GKY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063583; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Conroy S, 2010, CANCER CHEMOTH PHARM, V65, P1173, DOI 10.1007/s00280-009-1127-1; Doublier S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-4; Eastwood BJ, 2006, J BIOMOL SCREEN, V11, P253, DOI 10.1177/1087057105285611; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Fleischhack G, 2001, BRIT J CANCER, V84, P1453, DOI 10.1054/bjoc.2001.1841; Fortin D, 2000, NEUROSURGERY, V47, P199, DOI 10.1097/00006123-200007000-00041; Friedrich J, 2007, J BIOMOL SCREEN, V12, P925, DOI 10.1177/1087057107306839; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Fu XA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002009; Green JA, 2007, ADV DRUG DELIVER REV, V59, P1293, DOI 10.1016/j.addr.2007.08.005; Hamer PCDW, 2008, ONCOGENE, V27, P2091, DOI 10.1038/sj.onc.1210850; Hande KR, 1998, EUR J CANCER, V34, P1514, DOI 10.1016/S0959-8049(98)00228-7; Hardelauf H, 2011, LAB CHIP, V11, P419, DOI 10.1039/c0lc00089b; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Johnson JI, 2001, BRIT J CANCER, V84, P1424, DOI 10.1054/bjoc.2001.1796; Katayama M, 2007, CELL DEATH DIFFER, V14, P548, DOI 10.1038/sj.cdd.4402030; Keles GE, 1995, ONCOL RES, V7, P493; Krzywinski M, 2013, NAT METHODS, V10, P1139, DOI 10.1038/nmeth.2738; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Meng W, 2006, EVALUATION NANPARTIC; Messner S, 2013, ARCH TOXICOL, V87, P209, DOI 10.1007/s00204-012-0968-2; Mikhail AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062630; Monazzam A, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-32; Moors M, 2009, ENVIRON HEALTH PERSP, V117, P1131, DOI 10.1289/ehp.0800207; Moreno L, 2013, EXPERT OPIN DRUG DIS, V8, P363, DOI 10.1517/17460441.2013.768984; Mori H, 2006, J NEUROSCI RES, V84, P1682, DOI 10.1002/jnr.21082; Mutterer J, IMAGEJ MACRO LANGUAG, V46d, P1; OGASAWARA H, 1992, J NEURO-ONCOL, V13, P111; Page H, 2013, CELL TISSUE RES, V352, P123, DOI 10.1007/s00441-012-1441-5; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pizer B, 2008, ARCH DIS CHILDHOOD-E, V93, P137, DOI 10.1136/adc.2007.136655; Puri S, 2007, NOVEL FUNCTIONALIZED; Rahman CV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077435; Rodriguez-Enriquez S, 2008, J CELL PHYSIOL, V216, P189, DOI 10.1002/jcp.21392; Sakai Y, 2010, CELLS TISSUES ORGANS, V191, P281, DOI 10.1159/000272316; Sittampalam G.S., 2004, ASSAY GUIDANCE MANUA; Sittampalam GS, 1997, J BIOMOL SCREEN, V2, P159, DOI 10.1177/108705719700200306; Slavc I, 2003, J NEURO-ONCOL, V64, P239, DOI 10.1023/A:1025633704071; SPEARS CP, 1984, MED PEDIATR ONCOL, V12, P212, DOI 10.1002/mpo.2950120314; Sung KW, 2013, NEURO-ONCOLOGY, V15, P352, DOI 10.1093/neuonc/nos304; SUTHERLAND RM, 1971, JNCI-J NATL CANCER I, V46, P113; Toffoli G, 2004, CLIN PHARMACOKINET, V43, P441, DOI 10.2165/00003088-200443070-00002; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Walenta S, 2000, J HISTOCHEM CYTOCHEM, V48, P509, DOI 10.1177/002215540004800409; WALENTA S, 1990, EUR J CELL BIOL, V52, P389; Wartenberg M, 2003, FASEB J, V17, P503, DOI 10.1096/fj.02-0358fje; Wartenberg M, 2001, FASEB J, V15, P995, DOI 10.1096/fj.00-0350com; Xiao J, 2010, APPL BIOCHEM BIOTECH, V162, P1996, DOI 10.1007/s12010-010-8975-3; YEN JC, 1995, IEEE T IMAGE PROCESS, V4, P370, DOI 10.1109/83.366472; Zamaraeva MV, 2005, CELL DEATH DIFFER, V12, P1390, DOI 10.1038/sj.cdd.4401661; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zurich MG, 2013, TOXICOL IN VITRO, V27, P1416, DOI 10.1016/j.tiv.2012.06.018	67	131	132	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103817	10.1371/journal.pone.0103817	http://dx.doi.org/10.1371/journal.pone.0103817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119185	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600032
J	Li, MX; Ho, PWL; Pang, SYY; Tse, ZHM; Kung, MHW; Sham, PC; Ho, SL				Li, Miaoxin; Ho, Philip Wing-Lok; Pang, Shirley Yin-Yu; Tse, Zero Ho-Man; Kung, Michelle Hiu-Wai; Sham, Pak-Chung; Ho, Shu-Leong			PMCA4 (ATP2B4) Mutation in Familial Spastic Paraplegia	PLOS ONE			English	Article							LIPID RAFTS; CALCIUM; FRAMEWORK; DISEASES	Familial spastic paraplegia (FSP) is a heterogeneous group of disorders characterized primarily by progressive lower limb spasticity and weakness. More than 50 disease loci have been described with different modes of inheritance. In this study, we identified a novel missense mutation (c.803G>A, p.R268Q) in the plasma membrane calcium ATPase (PMCA4, or ATP2B4) gene in a Chinese family with autosomal dominant FSP using whole-exome sequencing and confirmed with Sanger sequencing. This mutation co-segregated with the phenotype in the six family members studied and is predicted to be pathogenic when multiple deleteriousness predictions were combined. This novel R268Q mutation was not present in over 7,000 subjects in public databases, and over 1,000 Han Chinese in our database. Prediction of potential functional consequence of R268Q mutation on PMCA4 by computational modeling revealed that this mutation is located in protein aggregation-prone segment susceptible to protein misfolding. Analysis for thermodynamic protein stability indicated that this mutation destabilizes the PMCA4 protein structure with higher folding free energy. As PMCA4 functions to maintain neuronal calcium homeostasis, our result showed that calcium dysregulation may be associated with the pathogenesis of FSP.	[Li, Miaoxin; Sham, Pak-Chung] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Li, Miaoxin; Sham, Pak-Chung] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Li, Miaoxin; Sham, Pak-Chung] Univ Hong Kong, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Ho, Philip Wing-Lok; Pang, Shirley Yin-Yu; Tse, Zero Ho-Man; Kung, Michelle Hiu-Wai; Ho, Shu-Leong] Univ Hong Kong, Dept Med, Div Neurol, Hong Kong, Hong Kong, Peoples R China; [Ho, Philip Wing-Lok; Ho, Shu-Leong] Univ Hong Kong, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Sham, PC (corresponding author), Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	pcsham@hku.hk; slho@hku.hk	Ho, Shu-Leong/AFK-8146-2022; Ho, Philip Wing-Lok/K-5814-2013	Ho, Philip Wing-Lok/0000-0001-7794-0146	Henry G. Leong Professorship in Neurology; Donation Fund for Neurology Research; Hong Kong Research Grants Council (GRF) [HKU 776412M]; European Community Seventh Framework Program Grant on European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI); HKU Seed Funding Program [201302159006]	Henry G. Leong Professorship in Neurology; Donation Fund for Neurology Research; Hong Kong Research Grants Council (GRF)(Hong Kong Research Grants Council); European Community Seventh Framework Program Grant on European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI); HKU Seed Funding Program	This study was financially supported by the Henry G. Leong Professorship in Neurology (SLH) and the Donation Fund for Neurology Research (SLH). The authors also thank Hong Kong Research Grants Council (GRF HKU 776412M); European Community Seventh Framework Program Grant on European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI); the HKU Seed Funding Program for Basic Research (201302159006) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bettencourt C, 2012, HUM MUTAT, V33, P1315, DOI 10.1002/humu.22148; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; Gleichmann M, 2011, ANTIOXID REDOX SIGN, V14, P1261, DOI 10.1089/ars.2010.3386; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li MX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003143; Li MX, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1257; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sepulveda MR, 2006, J BIOL CHEM, V281, P447, DOI 10.1074/jbc.M506950200; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Strehler EE, 2013, J PHARM PHARM SCI, V16, P190, DOI 10.18433/J3Z011; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359	23	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104790	10.1371/journal.pone.0104790	http://dx.doi.org/10.1371/journal.pone.0104790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119969	gold, Green Submitted, Green Published			2022-12-27	WOS:000340900600085
J	Li, M; Jurado, KA; Lin, SQ; Engelman, A; Craigie, R				Li, Min; Jurado, Kellie A.; Lin, Shiqiang; Engelman, Alan; Craigie, Robert			Engineered Hyperactive Integrase for Concerted HIV-1 DNA Integration	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PROTOTYPE FOAMY VIRUS; VIRAL-DNA; IN-VITRO; STRAND TRANSFER; SYNAPTIC COMPLEX; STABLE COMPLEX; PROTEIN; INHIBITION; ENDS	The DNA cutting and joining reactions of HIV-1 integration are catalyzed by integrase (IN), a viral protein that functions as a tetramer bridging the two viral DNA ends (intasome). Two major obstacles for biochemical and structural studies of HIV-1 intasomes are 1) the low efficiency of assembly with oligonucleotide DNA substrates, and 2) the non-specific aggregation of both intasomes and free IN in the reaction mixture. By fusing IN with a small non-specific DNA binding protein, Sulfolobus solfataricus chromosomal protein Sso7d (PDB: 1BNZ), we have engineered a highly soluble and hyperactive IN. Unlike wildtype IN, it efficiently catalyzes intasome assembly and concerted integration with oligonucleotide DNA substrates. The fusion IN protein also functions to integrate viral reverse transcripts during HIV-infection. The hyperactive HIV-1 IN may assist in facilitating future biochemical and structural studies of HIV-1 intasomes. Understanding the mechanistic basis of the Sso7d-IN fusion protein could provide insight into the factors that have hindered biophysical studies of wild-type HIV-1 IN and intasomes.	[Li, Min; Lin, Shiqiang; Craigie, Robert] Natl Inst Hlth, Natl Inst Diabet & Digest & Kidney Dis, Mol Biol Lab, Bethesda, MD 20892 USA; [Jurado, Kellie A.; Engelman, Alan] Harvard Med Sch, Dana Farber Canc Inst & Dept Med, Dept Canc Immunol & AIDS, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Harvard Medical School	Craigie, R (corresponding author), Natl Inst Hlth, Natl Inst Diabet & Digest & Kidney Dis, Mol Biol Lab, Bethesda, MD 20892 USA.	bobc@helix.nih.gov		Lin, Shiqiang/0000-0001-7181-4261	Intramural Program of NIDDK, NIH; AIDS Targeted Antiviral Program of the Office of the Director of the NIH; NIH [AI070042]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036169] Funding Source: NIH RePORTER	Intramural Program of NIDDK, NIH; AIDS Targeted Antiviral Program of the Office of the Director of the NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Intramural Program of NIDDK, NIH, by the AIDS Targeted Antiviral Program of the Office of the Director of the NIH (to R. C.), and by NIH grant AI070042 (to A.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bera S, 2009, J MOL BIOL, V389, P183, DOI 10.1016/j.jmb.2009.04.007; Brown P. O., 1997, P161; ELLISON V, 1994, P NATL ACAD SCI USA, V91, P7316, DOI 10.1073/pnas.91.15.7316; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Gao YG, 1998, NAT STRUCT BIOL, V5, P782, DOI 10.1038/1822; Gupta K, 2012, STRUCTURE, V20, P1918, DOI 10.1016/j.str.2012.08.023; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Hindmarsh P, 1999, J VIROL, V73, P2994, DOI 10.1128/JVI.73.4.2994-3003.1999; Johnson BC, 2013, J MOL BIOL, V425, P2133, DOI 10.1016/j.jmb.2013.03.027; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Krishnan L, 2012, J BIOL CHEM, V287, P40858, DOI 10.1074/jbc.R112.397760; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li M, 2005, J BIOL CHEM, V280, P29334, DOI 10.1074/jbc.M505367200; Li M, 2012, PROTEIN SCI, V21, P249, DOI 10.1002/pro.2010; Li M, 2009, METHODS, V47, P237, DOI 10.1016/j.ymeth.2009.02.001; Lu R, 2004, J VIROL, V78, P12735, DOI 10.1128/JVI.78.23.12735-12746.2004; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Nilsen BM, 1996, J VIROL, V70, P1580, DOI 10.1128/JVI.70.3.1580-1587.1996; Sinha S, 2005, J VIROL, V79, P8208, DOI 10.1128/JVI.79.13.8208-8216.2005; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; VINK C, 1994, NUCLEIC ACIDS RES, V22, P4103, DOI 10.1093/nar/22.20.4103; Wang Y, 2004, NUCLEIC ACIDS RES, V32, P1197, DOI 10.1093/nar/gkh271; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Wu XY, 1997, EMBO J, V16, P5113, DOI 10.1093/emboj/16.16.5113	27	21	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105078	10.1371/journal.pone.0105078	http://dx.doi.org/10.1371/journal.pone.0105078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119883	Green Published, gold			2022-12-27	WOS:000340900600121
J	Wang, GF; Liu, BJ; Cao, YX; Du, YJ; Zhang, HY; Luo, QL; Li, B; Wu, JF; Lv, YB; Sun, J; Jin, HL; Wei, K; Zhao, ZX; Kong, LW; Zhou, XM; Miao, Q; Wang, G; Zhou, QW; Dong, JC				Wang, Genfa; Liu, Baojun; Cao, Yuxue; Du, Yijie; Zhang, Hongying; Luo, Qingli; Li, Bei; Wu, Jinfeng; Lv, Yubao; Sun, Jing; Jin, Hualiang; Wei, Kai; Zhao, Zhengxiao; Kong, Lingwen; Zhou, Xianmei; Miao, Qing; Wang, Gang; Zhou, Qingwei; Dong, Jingcheng			Effects of Two Chinese Herbal Formulae for the Treatment of Moderate to Severe Stable Chronic Obstructive Pulmonary Disease: A Multicenter, Double-Blind, Randomized Controlled Trial	PLOS ONE			English	Article							INHALED CORTICOSTEROIDS; COPD; METAANALYSIS; MEDICINE; TGF-BETA(1); PNEUMONIA; 4-CENTER; THERAPY; PATHWAY; UPDATE	Objective: The study aims to evaluate the efficacy and safety of two Chinese herbal formulae for the treatment of stable COPD. Methods: A multicenter, double-blind, double-dummy, and randomized controlled trial (RCT) was conducted. All groups were treated with additional conventional medicines. There were a 6-month treatment and a 12-month follow-up for 5 times. Primary outcomes included lung function test, exacerbation frequency, score of SGRQ. Second outcomes consisted of 6MWD, BODE index, psychological field score, inflammatory factors and cortisol. Results: A total of 331 patients were randomly divided into two active treatment groups (Bushen Yiqi (BY) granule group, n = 109; Bushen Fangchuan (BF) tablet group, n = 109) and a placebo group (n = 113). Finally 262 patients completed the study. BY granule & BF tablet increased the values of VC, FEV1 (%) and FEV1/FVC (%), compared with placebo. BY granule improved PEF. Both treatments reduced acute exacerbation frequency (P = 0.067), BODE index and psychological field score, while improved 6MWD. In terms of descent rang of SGRQ score, both treatments increased (P = 0.01). Both treatments decreased inflammatory cytokines, such as IL-8, and IL-17(P = 0.0219). BY granule obviously descended IL-17(P<0.05), IL-1 beta (P = 0.05), IL-6, compared with placebo. They improved the level of IL-10 and cortisol. BY granule raised cortisol (P = 0.07) and decreased TNF-alpha. Both treatments slightly descended TGF-beta 1. In terms of safety, subject compliance and drug combination, there were no differences (P>0.05) among three groups. Conclusions: BY granule and BF tablet were positively effective for the treatment of COPD, and the former performed better in general.	[Wang, Genfa; Liu, Baojun; Cao, Yuxue; Du, Yijie; Zhang, Hongying; Luo, Qingli; Li, Bei; Wu, Jinfeng; Lv, Yubao; Sun, Jing; Jin, Hualiang; Wei, Kai; Zhao, Zhengxiao; Kong, Lingwen; Dong, Jingcheng] Fudan Univ, Huashan Hosp, Dept Integrated Tradit Chinese & Western Med, Shanghai 200433, Peoples R China; [Wang, Genfa; Liu, Baojun; Cao, Yuxue; Du, Yijie; Zhang, Hongying; Luo, Qingli; Li, Bei; Wu, Jinfeng; Lv, Yubao; Sun, Jing; Jin, Hualiang; Wei, Kai; Zhao, Zhengxiao; Kong, Lingwen; Dong, Jingcheng] Fudan Univ, Inst Integrated Tradit Chinese & Western Med, Shanghai, Peoples R China; [Zhou, Xianmei] Nanjing Univ TCM, Jiangsu Prov Hosp TCM, Resp Dept, Nanjing, Jiangsu, Peoples R China; [Miao, Qing] CACMS, Xiyuan Hosp, Resp Dept, Beijing, Peoples R China; [Wang, Gang] Sichuan Univ, West China Hosp, Resp Dept, Chengdu, Peoples R China; [Zhou, Qingwei] Henan Univ TCM, Affiliated Hosp 1, Resp Dept, Zhengzhou, Peoples R China	Fudan University; Fudan University; Nanjing University of Chinese Medicine; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; Sichuan University; Henan University of Traditional Chinese Medicine	Dong, JC (corresponding author), Fudan Univ, Huashan Hosp, Dept Integrated Tradit Chinese & Western Med, Shanghai 200433, Peoples R China.	jcdong2004@126.com		Wu, Jinfeng/0000-0002-9579-9163; Dong, Jingcheng/0000-0002-5194-367X	China National Basic Research Program (China National 973 Program) [2009 CB 523000]; National Natural Science Foundation of China [81173390, 81102541, 81302931]	China National Basic Research Program (China National 973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from China National Basic Research Program (China National 973 Program) (2009 CB 523000) and National Natural Science Foundation of China (81173390, 81102541, 81302931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An XD, 2012, J ALTERN COMPLEM MED, V18, P731, DOI 10.1089/acm.2011.0389; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Bohy ME, 2010, ARCH MED SCI, V6, P71; Cafarella PA, 2012, RESPIROLOGY, V17, P627, DOI 10.1111/j.1440-1843.2012.02148.x; Calverley PMA, 2011, CHEST, V139, P505, DOI 10.1378/chest.09-2992; Celik P, 2005, RESP MED, V99, P444, DOI 10.1016/j.rmed.2004.09.008; Chen R, 2010, EVID-BASED COMPL ALT, V7, P3, DOI 10.1093/ecam/nen017; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Drummond MB, 2008, JAMA-J AM MED ASSOC, V300, P2407, DOI 10.1001/jama.2008.717; Gao JX, 2012, MOL MED REP, V6, P1155, DOI 10.3892/mmr.2012.1059; George J, 2004, MED J AUSTRALIA, V181, P248, DOI 10.5694/j.1326-5377.2004.tb06262.x; Guo R, 2006, EUR RESPIR J, V28, P330, DOI 10.1183/09031936.06.00119905; Hothersall E, 2006, THORAX, V61, P729, DOI 10.1136/thx.2005.057976; Kinoshita M, 2012, RESPIROLOGY, V17, P379, DOI 10.1111/j.1440-1843.2011.02107.x; Kucich U, 2002, AM J RESP CELL MOL, V26, P183, DOI 10.1165/ajrcmb.26.2.4666; Li JS, 2012, J ETHNOPHARMACOL, V141, P584, DOI 10.1016/j.jep.2011.08.060; Li SY, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-197; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meyer KC, 2013, J AM PHARM ASSOC, V53, pE219, DOI 10.1331/JAPhA.2013.13535; Nathell L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-89; Puhan MA, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-2; Rabe KF, 2011, BRIT J PHARMACOL, V163, P53, DOI 10.1111/j.1476-5381.2011.01218.x; Ram A, 2011, FITOTERAPIA, V82, P141, DOI 10.1016/j.fitote.2010.09.005; Ren S, 2013, J TRADIT CHIN MED, V33, P413, DOI 10.1016/S0254-6272(13)60189-2; Singh S, 2009, ARCH INTERN MED, V169, P219, DOI 10.1001/archinternmed.2008.550; Stoll P, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-116; Tonnesen P, 2013, EUR RESPIR REV, V22, P37, DOI 10.1183/09059180.00007212; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Xu CQ, 2010, EUR J PHARMACOL, V642, P146, DOI 10.1016/j.ejphar.2010.05.012; Zhang AH, 2009, EXP TOXICOL PATHOL, V61, P461, DOI 10.1016/j.etp.2008.10.010	31	16	19	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e103168	10.1371/journal.pone.0103168	http://dx.doi.org/10.1371/journal.pone.0103168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118962	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600018
J	Wu, PY; Chen, MY; Hsieh, SM; Sun, HY; Tsai, MS; Lee, KY; Liu, WC; Yang, SP; Luo, YZ; Zhang, JY; Sheng, WH; Hung, CC				Wu, Pei-Ying; Chen, Mao-Yuan; Hsieh, Szu-Min; Sun, Hsin-Yun; Tsai, Mao-Song; Lee, Kuan-Yeh; Liu, Wen-Chun; Yang, Shan-Ping; Luo, Yu-Zhen; Zhang, Jun-Yu; Sheng, Wang-Huei; Hung, Chien-Ching			Comorbidities among the HIV-Infected Patients Aged 40 Years or Older in Taiwan	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; BONE-MINERAL DENSITY; DIABETES-MELLITUS; RISK-FACTORS; GENERAL-POPULATION; DRUG-INTERACTIONS; POSITIVE PATIENTS; MORTALITY TRENDS; COHORT; PREVALENCE	Background: With the widespread use of combination antiretroviral therapy (cART), life expectancy of HIV-infected patients has significantly prolonged. An increasing number of HIV-infected patients are aging and concurrent use of medications are not uncommon for management of metabolic complications and cardiovascular diseases related to aging and prolonged exposure to cART. Methods: We reviewed medical records of all HIV-infected patients aged 40 years or older who had been followed at a university hospital for HIV care in Taiwan between January and December 2013. A standardized case record form was used to collect information on demographics and clinical characteristics, comorbidity, cART, and concurrent medications. Results: During the study period, 610 patients aged 40 to 49 years (mean, 44.1) and 310 aged 50 years or older (mean, 58.8) sought HIV care at this hospital. Compared with patients aged 40 to 49 years, those aged 50 years or older were significantly more likely to be female (15.9% vs 3.8%); to have received cART (97.7% vs 94.8%) and a lower plasma HIV RNA load (1.6 vs 1.7 log(10) copies/ml); and to have diabetes mellitus (18.4% vs 4.6%), hypertension (31.0% vs 10.8%), hyperlipidemia (29.4% vs 11.6%), coronary artery disease (6.8% vs 0.5%), and an estimated glomerular filtration rate <60 ml/min/1.73 m(2) (11.5% vs 2.7%); and were significantly less likely to have syphilis. Other than HIV infection, patients aged 50 years or older were more likely to have been receiving two or more concurrent medications than those aged 40 to 49 years (22.9% vs 6.4%). Conclusions: Our findings show a significant proportion of the HIV-infected patients aged 50 years or older have multiple comorbidities that may increase the risk for cardiovascular and renal complications. Issues of poly-pharmacy among the HIV-infected patients who are aging should be addressed to ensure adherence and minimize drug-drug interactions.	[Wu, Pei-Ying; Yang, Shan-Ping; Luo, Yu-Zhen; Zhang, Jun-Yu; Sheng, Wang-Huei] Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan; [Chen, Mao-Yuan; Hsieh, Szu-Min; Sun, Hsin-Yun; Liu, Wen-Chun; Sheng, Wang-Huei; Hung, Chien-Ching] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chen, Mao-Yuan; Hsieh, Szu-Min; Sun, Hsin-Yun; Liu, Wen-Chun; Sheng, Wang-Huei; Hung, Chien-Ching] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Tsai, Mao-Song] Far Eastern Mem Hosp, Dept Internal Med, New Taipei City, Taiwan; [Lee, Kuan-Yeh] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan; [Hung, Chien-Ching] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hung, Chien-Ching] China Med Univ, Taichung, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Sheng, WH (corresponding author), Natl Taiwan Univ Hosp, Ctr Infect Control, Taipei, Taiwan.	whsheng@ntu.edu.tw; hcc0401@ntu.edu.tw		SUN, HSIN-YUN/0000-0003-0074-7721; Hung, Chien-Ching/0000-0001-7345-0836; SHENG, WANG-HUEI/0000-0002-5605-7853; HSIEH, SZU-MIN/0000-0002-1879-4086	Taiwan Centers for Disease Control [DOH-102-DC-1401]	Taiwan Centers for Disease Control	Taiwan Centers for Disease Control (DOH-102-DC-1401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bonjoch A, 2010, AIDS, V24, P2827, DOI 10.1097/QAD.0b013e328340a28d; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Butt AA, 2009, AIDS, V23, P1227, DOI 10.1097/QAD.0b013e32832bd7af; Capeau J, 2012, AIDS, V26, P303, DOI 10.1097/QAD.0b013e32834e8776; Centers for Disease Control ROC, 2013, TAIW STAT HIV AIDS; Chang YH, 2013, J MICROBIOL IMMUNOL; Chu C, 2011, J URBAN HEALTH, V88, P507, DOI 10.1007/s11524-010-9540-7; de Coul ELMO, 2014, INT J STD AIDS, V25, P40, DOI 10.1177/0956462413491736; De Wit S, 2008, DIABETES CARE, V31, P1224, DOI 10.2337/dc07-2013; Gleason LJ, 2013, CLIN INTERV AGING, V8, P749, DOI 10.2147/CIA.S37738; Gregg EW, 2007, ANN INTERN MED, V147, P149, DOI 10.7326/0003-4819-147-3-200708070-00167; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hsieh M-H, 2013, J MICROBIOL IMMUNOL; Huang YF, 2013, J FORMOS MED ASSOC, V112, P369, DOI 10.1016/j.jfma.2012.10.018; Hung CC, 2014, CLIN INFECT DIS, V58, P1625, DOI 10.1093/cid/ciu127; Ibrahim F, 2012, NEPHROL DIAL TRANSPL, V27, P2291, DOI 10.1093/ndt/gfr657; Jiang YD, 2012, J FORMOS MED ASSOC, V111, P599, DOI 10.1016/j.jfma.2012.09.014; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Lazarus JV, 2010, HIV MED, V11, P479, DOI 10.1111/j.1468-1293.2009.00810.x; Ledergerber B, 2007, CLIN INFECT DIS, V45, P111, DOI 10.1086/518619; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li HY, 2012, J FORMOS MED ASSOC, V111, P645, DOI 10.1016/j.jfma.2012.09.013; Linley L, 2012, AM J PUBLIC HEALTH, V102, P1527, DOI 10.2105/AJPH.2011.300431; Lo YC, 2009, HIV MED, V10, P302, DOI 10.1111/j.1468-1293.2008.00687.x; Manrique L, 2010, JAIDS-J ACQ IMM DEF, V54, P332, DOI 10.1097/QAI.0b013e3181d2eef1; Marzolini C, 2011, J ANTIMICROB CHEMOTH, V66, P2107, DOI 10.1093/jac/dkr248; Nachega Jean B, 2012, AIDS, V26 Suppl 1, pS39; Onen NF, 2010, HIV CLIN TRIALS, V11, P100, DOI 10.1310/hct1102-100; Oursler KK, 2011, AIDS PATIENT CARE ST, V25, P13, DOI 10.1089/apc.2010.0242; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Rasmussen LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044575; Sterne JAC, 2005, LANCET, V366, P378, DOI 10.1016/S0140-6736(05)67022-5; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Sun HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090194; Sun HY, 2012, J CLIN MICROBIOL, V50, P781, DOI 10.1128/JCM.06014-11; Tien PC, 2007, AIDS, V21, P1739, DOI 10.1097/QAD.0b013e32827038d0; Torres TS, 2013, BRAZ J INFECT DIS, V17, P324, DOI 10.1016/j.bjid.2012.10.024; Tsai MS, 2014, J MICROBIOL IMMUNOL, V47, P109, DOI 10.1016/j.jmii.2012.08.026; Tseng A, 2013, ANN PHARMACOTHER, V47, P1429, DOI 10.1177/1060028013504075; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; Vance DE, 2011, J ASSOC NURSE AIDS C, V22, P17, DOI 10.1016/j.jana.2010.04.002; Wallrauch C, 2010, SAMJ S AFR MED J, V100, P812, DOI 10.7196/SAMJ.4181; Wu PY, 2012, J ANTIMICROB CHEMOTH, V67, P1001, DOI 10.1093/jac/dkr558; Yanagisawa N, 2011, NEPHRON CLIN PRACT, V118, pC285, DOI 10.1159/000322278; Yang CH, 2008, HIV MED, V9, P535, DOI 10.1111/j.1468-1293.2008.00600.x	48	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104945	10.1371/journal.pone.0104945	http://dx.doi.org/10.1371/journal.pone.0104945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119532	Green Published, gold, Green Submitted			2022-12-27	WOS:000340900600106
J	Yamanaka, K; Nakanishi, T; Saito, H; Maruyama, J; Isoda, K; Yokochi, A; Imanaka-Yoshida, K; Tsuda, K; Kakeda, M; Okamoto, R; Fujita, S; Iwakura, Y; Suzuki, N; Ito, M; Maruyama, K; Gabazza, EC; Yoshida, T; Shimaoka, M; Mizutani, H				Yamanaka, Keiichi; Nakanishi, Takehisa; Saito, Hiromitsu; Maruyama, Junko; Isoda, Kenichi; Yokochi, Ayumu; Imanaka-Yoshida, Kyoko; Tsuda, Kenshiro; Kakeda, Masato; Okamoto, Ryuji; Fujita, Satoshi; Iwakura, Yoichiro; Suzuki, Noboru; Ito, Masaaki; Maruyama, Kazuo; Gabazza, Esteban C.; Yoshida, Toshimichi; Shimaoka, Motomu; Mizutani, Hitoshi			Persistent Release of IL-1s from Skin Is Associated with Systemic Cardio-Vascular Disease, Emaciation and Systemic Amyloidosis: The Potential of Anti-IL-1 Therapy for Systemic Inflammatory Diseases	PLOS ONE			English	Article							INHERITED EPIDERMOLYSIS-BULLOSA; MICE; RISK; ATHEROSCLEROSIS; INTERLEUKIN-1; DERMATITIS; IL-1-BETA; PSORIASIS; SIMPLEX	The skin is an immune organ that contains innate and acquired immune systems and thus is able to respond to exogenous stimuli producing large amount of proinflammatory cytokines including IL-1 and IL-1 family members. The role of the epidermal IL-1 is not limited to initiation of local inflammatory responses, but also to induction of systemic inflammation. However, association of persistent release of IL-1 family members from severe skin inflammatory diseases such as psoriasis, epidermolysis bullosa, atopic dermatitis, blistering diseases and desmoglein-1 deficiency syndrome with diseases in systemic organs have not been so far assessed. Here, we showed the occurrence of severe systemic cardiovascular diseases and metabolic abnormalities including aberrant vascular wall remodeling with aortic stenosis, cardiomegaly, impaired limb and tail circulation, fatty tissue loss and systemic amyloid deposition in multiple organs with liver and kidney dysfunction in mouse models with severe dermatitis caused by persistent release of IL-1s from the skin. These morbid conditions were ameliorated by simultaneous administration of anti-IL-1 alpha and IL-1 beta antibodies. These findings may explain the morbid association of arteriosclerosis, heart involvement, amyloidosis and cachexia in severe systemic skin diseases and systemic autoinflammatory diseases, and support the value of anti-IL-1 therapy for systemic inflammatory diseases.	[Yamanaka, Keiichi; Nakanishi, Takehisa; Isoda, Kenichi; Tsuda, Kenshiro; Kakeda, Masato; Mizutani, Hitoshi] Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan; [Saito, Hiromitsu; Suzuki, Noboru] Mie Univ, Life Sci Res Ctr, Funct Genom Inst, Dept Anim Genom, Tsu, Mie, Japan; [Maruyama, Junko] Suzuka Univ Med Sci, Dept Clin Engn, Suzuka, Mie, Japan; [Yokochi, Ayumu; Imanaka-Yoshida, Kyoko; Okamoto, Ryuji; Fujita, Satoshi; Ito, Masaaki; Maruyama, Kazuo; Gabazza, Esteban C.; Yoshida, Toshimichi; Shimaoka, Motomu] Mie Univ, Grad Sch Med, Tsu, Mie 514, Japan; [Imanaka-Yoshida, Kyoko; Yoshida, Toshimichi] Mie Univ, Res Ctr Matrix Biol, Tsu, Mie, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Div Expt Anim Immunol, Noda, Chiba 278, Japan	Mie University; Mie University; Mie University; Mie University; Tokyo University of Science	Yamanaka, K (corresponding author), Mie Univ, Grad Sch Med, Dept Dermatol, Tsu, Mie 514, Japan.	yamake@clin.medic.mie-u.ac.jp	Iwakura, Yoichiro/E-5457-2011; Yoshida, Toshimichi/H-6204-2013	Iwakura, Yoichiro/0000-0002-9934-5775; Yoshida, Toshimichi/0000-0001-8935-8217; Nakanishi, Takehisa/0000-0002-4035-1695; Kakeda, Masato/0000-0001-9011-3655; Gabazza, Esteban/0000-0001-5748-1499	Ministry of Education, Culture, Sports, Science and Technology, Japan [26461690, 24591647]; Grants-in-Aid for Scientific Research [26461690] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	K. Yamanaka (26461690) and H. Mizutani (24591647) received grants for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Ahlehoff O, 2013, J INTERN MED, V273, P197, DOI 10.1111/j.1365-2796.2012.02593.x; Akdogan A, 2006, J AM COLL CARDIOL, V48, P2351, DOI 10.1016/j.jacc.2006.09.013; Davidovici BB, 2010, J INVEST DERMATOL, V130, P1785, DOI 10.1038/jid.2010.103; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Fine JD, 2008, BRIT J DERMATOL, V159, P677, DOI 10.1111/j.1365-2133.2008.08697.x; Fine JD, 2004, AM J KIDNEY DIS, V44, P651, DOI 10.1053/j.ajkd.2004.06.007; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Herrero L, 2010, P NATL ACAD SCI USA, V107, P240, DOI 10.1073/pnas.0905310107; Horai R, 1998, J EXP MED, V187, P1463, DOI 10.1084/jem.187.9.1463; Konishi H, 2002, P NATL ACAD SCI USA, V99, P11340, DOI 10.1073/pnas.152337799; Malkinson FD, 1999, ARCH DERMATOL, V135, P997, DOI 10.1001/archderm.135.8.997; Maruyama J, 1999, J APPL PHYSIOL, V86, P1687, DOI 10.1152/jappl.1999.86.5.1687; Merhi-Soussi F, 2005, CARDIOVASC RES, V66, P583, DOI 10.1016/j.cardiores.2005.01.008; Nishioka T, 2007, J CARDIOVASC PHARM, V49, P261, DOI 10.1097/FJC.0b013e318033dfd4; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Samavedam UKSRL, 2013, J AUTOIMMUN, V40, P74, DOI 10.1016/j.jaut.2012.08.002; Samuelov L, 2013, NAT GENET, V45, P1244, DOI 10.1038/ng.2739; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Tsoli M, 2012, TRENDS ENDOCRINOLOGY; Veien NK, 2000, ARCH DERMATOL, V136, P424, DOI 10.1001/archderm.136.3.424-a; Wally V, 2013, J INVEST DERMATOL, V133, P1901, DOI 10.1038/jid.2013.31; WATANABE N, 1994, CYTOKINE, V6, P597, DOI 10.1016/1043-4666(94)90046-9; Yamanaka K, 2000, J IMMUNOL, V165, P997, DOI 10.4049/jimmunol.165.2.997; Yu AP, 2009, CURR MED RES OPIN, V25, P2429, DOI 10.1185/03007990903185557	26	37	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104479	10.1371/journal.pone.0104479	http://dx.doi.org/10.1371/journal.pone.0104479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119884	Green Submitted, gold, Green Published			2022-12-27	WOS:000340900600061
J	Yao, YH; Song, XM; Cheng, H; Tang, GS; Hu, XX; Zhou, H; Wang, JM				Yao, Yonghua; Song, Xianmin; Cheng, Hui; Tang, Gusheng; Hu, Xiaoxia; Zhou, Hong; Wang, Jianmin			Dysfunction of Bone Marrow Vascular Niche in Acute Graft-Versus-Host Disease after MHC-Haploidentical Bone Marrow Transplantation	PLOS ONE			English	Article							HEMATOPOIETIC-STEM; ENDOTHELIAL-CELLS; PROGENITOR CELLS; FAS-LIGAND; T-CELLS; DONOR; RECONSTITUTION; PROLIFERATION; REGENERATION; APOPTOSIS	Acute graft-versus-host disease (aGvHD) is the most common complication of allogeneic hematopoietic stem cell transplantation (HSCT), which is often accompanied by impaired hematopoietic reconstitution. Sinusoidal endothelial cells (SECs) constitute bone marrow (BM) vascular niche that plays an important role in supporting self-renewal capacity and maintaining the stability of HSC pool. Here we provide evidences that vascular niche is a target of aGvHD in a major histocompatibility complex (MHC)-haploidentical matched murine HSCT model. The results demonstrated that hematopoietic cells derived from GvHD mice had the capacity to reconstitute hematopoiesis in healthy recipient mice. However, hematopoietic cells from healthy donor mice failed to reconstitute hematopoiesis in GvHD recipient mice, indicating that the BM niche was impaired by aGvHD in this model. We further demonstrated that SECs were markedly reduced in the BM of aGvHD mice. High level of Fas and caspase-3 expression and high rate of apoptosis were identified in SECs, indicating that SECs were destroyed by aGvHD in this murine HSCT model. Furthermore, high Fas ligand expression on engrafted donor CD4(+), but not CD8(+) T cells, and high level MHC-II but not MHC-I expression on SECs, suggested that SECs apoptosis was mediated by CD4(+) donor T cells through the Fas/FasL pathway.	[Yao, Yonghua; Song, Xianmin; Cheng, Hui; Tang, Gusheng; Hu, Xiaoxia; Zhou, Hong; Wang, Jianmin] Changhai Hosp, Inst Hematol, Dept Hematol, Shanghai, Peoples R China	Naval Medical University	Wang, JM (corresponding author), Changhai Hosp, Inst Hematol, Dept Hematol, Shanghai, Peoples R China.	jmwang@medmail.com.cn	wang, jian/GVS-0711-2022		National Natural Science Foundation of China [81070394, 81370601, 81090413, 81270567]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grants from National Natural Science Foundation of China (81070394, 81370601, 81090413, and 81270567). http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Baker MB, 1997, P NATL ACAD SCI USA, V94, P1366, DOI 10.1073/pnas.94.4.1366; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chute JP, 2007, BLOOD, V109, P2365, DOI 10.1182/blood-2006-05-022640; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Doan PL, 2012, LEUKEMIA, V26, P54, DOI 10.1038/leu.2011.236; Drobyski WR, 2001, BLOOD, V97, P2506, DOI 10.1182/blood.V97.8.2506; Hatfield K, 2006, INT J CANCER, V119, P2313, DOI 10.1002/ijc.22180; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hill GR, 1998, J CLIN INVEST, V102, P115, DOI 10.1172/JCI3132; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Iwasaki T, 1999, CELL IMMUNOL, V197, P30, DOI 10.1006/cimm.1999.1553; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim DH, 2008, BIOL BLOOD MARROW TR, V14, P1408, DOI 10.1016/j.bbmt.2008.09.022; Kopp HG, 2005, BLOOD, V106, P505, DOI 10.1182/blood-2004-11-4269; Li WM, 2000, CYTOKINE, V12, P1017, DOI 10.1006/cyto.1999.0678; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Maeda Y, 2005, BLOOD, V105, P2023, DOI 10.1182/blood-2004-08-3036; Min CK, 2006, BONE MARROW TRANSPL, V38, P149, DOI 10.1038/sj.bmt.1705410; Mori T, 1998, BLOOD, V92, P101, DOI 10.1182/blood.V92.1.101.413k14_101_107; Muramoto GG, 2006, BIOL BLOOD MARROW TR, V12, P530, DOI 10.1016/j.bbmt.2005.12.039; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Shono Y, 2010, BLOOD, V115, P5401, DOI 10.1182/blood-2009-11-253559; Slayton WB, 2007, STEM CELLS, V25, P2945, DOI 10.1634/stemcells.2007-0158; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	32	18	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104607	10.1371/journal.pone.0104607	http://dx.doi.org/10.1371/journal.pone.0104607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25119573	gold, Green Submitted, Green Published			2022-12-27	WOS:000340900600071
J	Hou, LF; Block, KE; Huang, HC				Hou, Lifei; Block, Katharine E.; Huang, Haochu			Artesunate Abolishes Germinal Center B Cells and Inhibits Autoimmune Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; ANTIMALARIAL AGENT ARTESUNATE; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; T-CELLS; INFLAMMATORY ARTHRITIS; QINGHAOSU ARTEMISININ; SYSTEMIC AUTOIMMUNITY; MOUSE MODEL; PATHWAY	The antimalarial drug artemisinin and its derivatives exhibit potent immunosuppressive activity in several autoimmune disease models, however the mechanisms are not well-understood. This study was designed to investigate the therapeutic effects and the underlying mechanisms of the artemisinin analog artesunate using the K/BxN mouse model of rheumatoid arthritis. The well-studied disease mechanisms of K/BxN model allowed us to pinpoint the effect of artesunate on disease. Artesunate treatment prevented arthritis development in young K/BxN mice by inhibiting germinal center (GC) formation and production of autoantibodies. In adult K/BxN mice with established arthritis, artesunate diminished GC B cells in a few days. However, artesunate did not affect the follicular helper T cells (Tfh). In contrast to the spontaneous K/BxN model, artesunate treatment exerted minor influence on K/BxN serum transfer induced arthritis suggesting that artesunate has minimal effect on inflammatory responses downstream of antibody production. Finally, we showed that artesunate preferentially inhibits proliferating GC B cells. These results identify GC B cells as a target of artesunate and provide a new rationale for using artemisinin analogues to treat autoimmune diseases mediated by autoantibodies.	[Hou, Lifei; Huang, Haochu] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Hou, Lifei; Huang, Haochu] Univ Chicago, Knapp Ctr Lupus & Immunol Res, Chicago, IL 60637 USA; [Block, Katharine E.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Huang, HC (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	hhuang@bsd.uchicago.edu		Block, Katharine/0000-0001-9488-3577; Hou, Lifei/0000-0001-8975-7795	National Institutes of Health NIAID Grant [R01-AI087645]; NIH/NIAID [R01-AI087645, 2T32AI007090]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087645] Funding Source: NIH RePORTER	National Institutes of Health NIAID Grant; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health NIAID Grant R01-AI087645 to Dr. Huang. K. Block was supported by NIH/NIAID Training Grant 2T32AI007090 and R01-AI087645. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block KE, 2013, J IMMUNOL, V191, P2948, DOI 10.4049/jimmunol.1301173; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Finnegan A, 2012, AUTOIMMUNITY, V45, P353, DOI 10.3109/08916934.2012.665526; Gregersen JW, 2012, NAT REV NEPHROL, V8, P505, DOI 10.1038/nrneph.2012.141; Hou LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032424; Hou LF, 2011, ARTHRITIS RHEUM-US, V63, P2445, DOI 10.1002/art.30392; Hou LF, 2009, INT IMMUNOPHARMACOL, V9, P1509, DOI 10.1016/j.intimp.2009.09.003; Huang HC, 2010, P NATL ACAD SCI USA, V107, P4658, DOI 10.1073/pnas.1001074107; Ji H, 2002, J EXP MED, V196, P77, DOI 10.1084/jem.20020439; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kelchtermans H, 2005, ARTHRITIS RES THER, V7, pR402, DOI 10.1186/ar1500; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Leandro MJ, 2011, BEST PRACT RES CL RH, V25, P535, DOI 10.1016/j.berh.2011.10.005; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074108; Li YM, 2013, TRANSL RES, V161, P89, DOI 10.1016/j.trsl.2012.06.001; Li Y, 2012, ACTA PHARMACOL SIN, V33, P1141, DOI 10.1038/aps.2012.104; LUO XD, 1987, MED RES REV, V7, P29, DOI 10.1002/med.2610070103; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Mirshafiey A, 2006, IMMUNOPHARM IMMUNOT, V28, P397, DOI 10.1080/08923970600927447; Monach Paul, 2007, V136, P269; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Paddon CJ, 2013, NATURE; Sanz I, 2010, NAT REV RHEUMATOL, V6, P326, DOI 10.1038/nrrheum.2010.68; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Wang JX, 2008, BRIT J PHARMACOL, V153, P1303, DOI 10.1038/bjp.2008.11; Wang JX, 2009, ACTA PHARMACOL SIN, V30, P1428, DOI 10.1038/aps.2009.138; Xu H, 2007, RHEUMATOLOGY, V46, P920, DOI 10.1093/rheumatology/kem014; Yang Z, 2012, CURR MED CHEM, V19, P4541, DOI 10.2174/092986712803251575; Yang ZS, 2005, J MED CHEM, V48, P4608, DOI 10.1021/jm048979c; Yang ZS, 2006, BIOORGAN MED CHEM, V14, P8043; Zhao YG, 2012, J IMMUNOL, V189, P4417, DOI 10.4049/jimmunol.1200919	34	34	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104762	10.1371/journal.pone.0104762	http://dx.doi.org/10.1371/journal.pone.0104762			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116436	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400078
J	Prince, LR; Maxwell, NC; Gill, SK; Dockrell, DH; Sabroe, I; McGreal, EP; Kotecha, S; Whyte, MK				Prince, Lynne R.; Maxwell, Nicola C.; Gill, Sharonjit K.; Dockrell, David H.; Sabroe, Ian; McGreal, Eamon P.; Kotecha, Sailesh; Whyte, Moira K.			Macrophage Phenotype Is Associated with Disease Severity in Preterm Infants with Chronic Lung Disease	PLOS ONE			English	Article							RABBIT ALVEOLAR MACROPHAGE; CD16+ BLOOD MONOCYTES; HLA-DR EXPRESSION; NEUTROPHIL APOPTOSIS; PNEUMOCOCCAL PNEUMONIA; VITRONECTIN RECEPTOR; TISSUE MACROPHAGES; ANIMAL DEVELOPMENT; INFLAMMATION; MATURATION	Background: The etiology of persistent lung inflammation in preterm infants with chronic lung disease of prematurity (CLD) is poorly characterized, hampering efforts to stratify prognosis and treatment. Airway macrophages are important innate immune cells with roles in both the induction and resolution of tissue inflammation. Objectives: To investigate airway innate immune cellular phenotypes in preterm infants with respiratory distress syndrome (RDS) or CLD. Methods: Bronchoalveolar lavage (BAL) fluid was obtained from term and preterm infants requiring mechanical ventilation. BAL cells were phenotyped by flow cytometry. Results: Preterm birth was associated with an increase in the proportion of non-classical CD14+/CD16+ monocytes on the day of delivery (58.9 +/- 5.8% of total mononuclear cells in preterm vs 33.0 +/- 6.1% in term infants, p = 0.02). Infants with RDS were born with significantly more CD36(+) macrophages compared with the CLD group (70.3 +/- 5.3% in RDS vs 37.6 +/- 8.9% in control, p = 0.02). At day 3, infants born at a low gestational age are more likely to have greater numbers of CD14(+) mononuclear phagocytes in the airway (p = 0.03), but fewer of these cells are functionally polarized as assessed by HLA-DR (p = 0.05) or CD36 (p = 0.05) positivity, suggesting increased recruitment of monocytes or a failure to mature these cells in the lung. Conclusions: These findings suggest that macrophage polarization may be affected by gestational maturity, that more immature macrophage phenotypes may be associated with the progression of RDS to CLD and that phenotyping mononuclear cells in BAL could predict disease outcome.	[Prince, Lynne R.; Gill, Sharonjit K.; Sabroe, Ian; Whyte, Moira K.] Univ Sheffield, Sheffield Teaching Hosp NHS Trust, Dept Infect & Immun, Acad Unit Resp Med, Sheffield, S Yorkshire, England; [Dockrell, David H.] Univ Sheffield, Sheffield Teaching Hosp NHS Trust, Dept Infect & Immun, Acad Unit Immunol & Infect Dis, Sheffield, S Yorkshire, England; [Maxwell, Nicola C.; McGreal, Eamon P.; Kotecha, Sailesh] Cardiff Univ, Dept Child Hlth, Cardiff CF10 3AX, S Glam, Wales	University of Sheffield; University of Sheffield; Cardiff University	Prince, LR (corresponding author), Univ Sheffield, Sheffield Teaching Hosp NHS Trust, Dept Infect & Immun, Acad Unit Resp Med, Sheffield, S Yorkshire, England.	l.r.prince@sheffield.ac.uk	Sabroe, Ian/AAE-5858-2019; Sabroe, Ian/I-5981-2013	Prince, Lynne/0000-0001-6133-9372; Sabroe, Ian/0000-0001-9750-8975; Kotecha, Sailesh/0000-0003-3535-7627; Dockrell, David/0000-0002-2718-4861	Wellcome Trust [075540/Z/04/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by The Wellcome Trust, ref: 075540/Z/04/Z, www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALENGHAT E, 1984, PEDIATRICS, V74, P221; Alexis NE, 2001, J ALLERGY CLIN IMMUN, V108, P577; ANDREESEN R, 1990, J LEUKOCYTE BIOL, V47, P490, DOI 10.1002/jlb.47.6.490; AntalSzalmas P, 1997, J LEUKOCYTE BIOL, V61, P721, DOI 10.1002/jlb.61.6.721; Asada K, 2004, AM J RESP CRIT CARE, V169, P195, DOI 10.1164/rccm.200207-740OC; BELLANTI JA, 1979, PEDIATRICS, V64, P726; Blackwell TS, 2011, J IMMUNOL, V187, P2740, DOI 10.4049/jimmunol.1101495; BOWDEN DH, 1984, ENVIRON HEALTH PERSP, V55, P327, DOI 10.2307/3429712; CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1; CHANTRY D, 1990, Cytokine, V2, P60, DOI 10.1016/1043-4666(90)90044-T; Currie AE, 2001, EUR RESPIR J, V18, P796, DOI 10.1183/09031936.01.00088201; Daigneault M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002814; Davies PL, 2010, THORAX, V65, P246, DOI 10.1136/thx.2009.116061; Dessardo NS, 2012, AM J PERINAT, V29, P133, DOI 10.1055/s-0031-1295654; Dhaliwal K, 2012, AM J RESP CRIT CARE, V186, P514, DOI 10.1164/rccm.201112-2132OC; Driscoll WS, 2013, CIRC RES, V113, P52, DOI 10.1161/CIRCRESAHA.112.300683; Fadok VA, 1998, J IMMUNOL, V161, P6250; FINGERLE G, 1993, BLOOD, V82, P3170; Forster-Waldl E, 2005, PEDIATR RES, V58, P121, DOI 10.1203/01.PDR.0000163397.53466.0F; GANZ T, 1985, AM REV RESPIR DIS, V132, P901; Genel F, 2010, J INFECTION, V60, P224, DOI 10.1016/j.jinf.2009.12.004; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; GRIGG JM, 1991, LANCET, V338, P720, DOI 10.1016/0140-6736(91)91443-X; Grip O, 2007, INFLAMM BOWEL DIS, V13, P566, DOI 10.1002/ibd.20025; Hallwirth U, 2004, PEDIAT ALLERG IMM-UK, V15, P513, DOI 10.1111/j.1399-3038.2004.00168.x; HASLETT C, 1992, CLIN SCI, V83, P639, DOI 10.1042/cs0830639; Huh HY, 1996, BLOOD, V87, P2020; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Kanakoudi-Tsakalidou F, 2001, CLIN EXP IMMUNOL, V123, P402, DOI 10.1046/j.1365-2249.2001.01471.x; Knapp S, 2003, AM J RESP CRIT CARE, V167, P171, DOI 10.1164/rccm.200207-698OC; KOTECHA S, 1995, ARCH DIS CHILD-FETAL, V72, pF90, DOI 10.1136/fn.72.2.F90; Kotecha S, 2003, THORAX, V58, P961, DOI 10.1136/thorax.58.11.961; Kotiranta-Ainamo A, 1999, CLIN EXP IMMUNOL, V115, P309, DOI 10.1046/j.1365-2249.1999.00795.x; KRADIN RL, 1986, J LEUKOCYTE BIOL, V40, P407, DOI 10.1002/jlb.40.4.407; Kramer BW, 2003, PEDIATR RES, V54, P52, DOI 10.1203/01.PDR.0000066621.11877.33; KURLAND G, 1988, PEDIATR RES, V23, P293, DOI 10.1203/00006450-198803000-00013; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Marriott HM, 2006, J IMMUNOL, V177, P6480, DOI 10.4049/jimmunol.177.9.6480; Parks BW, 2013, J LIPID RES, V54, P1114, DOI 10.1194/jlr.M035352; Renshaw SA, 2003, J IMMUNOL, V170, P1027, DOI 10.4049/jimmunol.170.2.1027; Rosseau S, 2000, AM J PHYSIOL-LUNG C, V279, pL25, DOI 10.1152/ajplung.2000.279.1.L25; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; UNANUE ER, 1980, NEW ENGL J MED, V303, P977, DOI 10.1056/NEJM198010233031706; Van Marter LJ, 2002, J PEDIATR-US, V140, P171, DOI 10.1067/mpd.2002.121381; ZELIGS BJ, 1977, PEDIATR RES, V11, P1208, DOI 10.1203/00006450-197712000-00008; ZELIGS BJ, 1977, PEDIATR RES, V11, P197, DOI 10.1203/00006450-197703000-00011; Zhang MJ, 2001, J BIOMED SCI, V8, P290, DOI 10.1159/000054045; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902; Zimmermann HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011049	51	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103059	10.1371/journal.pone.0103059	http://dx.doi.org/10.1371/journal.pone.0103059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115925	Green Published, gold, Green Accepted			2022-12-27	WOS:000341230400009
J	Schechter, MA; Hsieh, MKH; Njoroge, LW; Thompson, JW; Soderblom, EJ; Feger, BJ; Troupes, CD; Hershberger, KA; Ilkayeva, OR; Nagel, WL; Landinez, GP; Shah, KM; Burns, VA; Santacruz, L; Hirschey, MD; Foster, MW; Milano, CA; Moseley, MA; Piacentino, V; Bowles, DE				Schechter, Matthew A.; Hsieh, Michael K. H.; Njoroge, Linda W.; Thompson, J. Will; Soderblom, Erik J.; Feger, Bryan J.; Troupes, Constantine D.; Hershberger, Kathleen A.; Ilkayeva, Olga R.; Nagel, Whitney L.; Landinez, Gina P.; Shah, Kishan M.; Burns, Virginia A.; Santacruz, Lucia; Hirschey, Matthew D.; Foster, Matthew W.; Milano, Carmelo A.; Moseley, M. Arthur; Piacentino, Valentino, III; Bowles, Dawn E.			Phosphoproteomic Profiling of Human Myocardial Tissues Distinguishes Ischemic from Non-Ischemic End Stage Heart Failure	PLOS ONE			English	Article							PROTEIN-KINASE CK2; STROKE STATISTICS-2012 UPDATE; CASPASE RECRUITMENT DOMAIN; TRABECULAR MESHWORK CELLS; PYRUVATE-DEHYDROGENASE; PHOSPHORYLATION SITES; EXTRACELLULAR-MATRIX; APOPTOSIS REPRESSOR; DISEASE; ASSOCIATION	The molecular differences between ischemic (IF) and non-ischemic (NIF) heart failure are poorly defined. A better understanding of the molecular differences between these two heart failure etiologies may lead to the development of more effective heart failure therapeutics. In this study extensive proteomic and phosphoproteomic profiles of myocardial tissue from patients diagnosed with IF or NIF were assembled and compared. Proteins extracted from left ventricular sections were proteolyzed and phosphopeptides were enriched using titanium dioxide resin. Gel- and label-free nanoscale capillary liquid chromatography coupled to high resolution accuracy mass tandem mass spectrometry allowed for the quantification of 4,436 peptides (corresponding to 450 proteins) and 823 phosphopeptides (corresponding to 400 proteins) from the unenriched and phospho-enriched fractions, respectively. Protein abundance did not distinguish NIF from IF. In contrast, 37 peptides (corresponding to 26 proteins) exhibited a >= 2-fold alteration in phosphorylation state (p<0.05) when comparing IF and NIF. The degree of protein phosphorylation at these 37 sites was specifically dependent upon the heart failure etiology examined. Proteins exhibiting phosphorylation alterations were grouped into functional categories: transcriptional activation/RNA processing; cytoskeleton structure/function; molecular chaperones; cell adhesion/signaling; apoptosis; and energetic/metabolism. Phosphoproteomic analysis demonstrated profound post-translational differences in proteins that are involved in multiple cellular processes between different heart failure phenotypes. Understanding the roles these phosphorylation alterations play in the development of NIF and IF has the potential to generate etiology-specific heart failure therapeutics, which could be more effective than current therapeutics in addressing the growing concern of heart failure.	[Schechter, Matthew A.; Hsieh, Michael K. H.; Njoroge, Linda W.; Feger, Bryan J.; Troupes, Constantine D.; Nagel, Whitney L.; Landinez, Gina P.; Shah, Kishan M.; Santacruz, Lucia; Milano, Carmelo A.; Piacentino, Valentino, III; Bowles, Dawn E.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Thompson, J. Will; Soderblom, Erik J.; Moseley, M. Arthur] Duke Univ, Med Ctr, Duke Prote Core, Durham, NC 27710 USA; [Hershberger, Kathleen A.; Ilkayeva, Olga R.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Hershberger, Kathleen A.; Hirschey, Matthew D.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Burns, Virginia A.] Duke Univ, Med Ctr, Duke Translat Res Inst, Durham, NC 27710 USA; [Foster, Matthew W.] Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University	Bowles, DE (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	dawn.bowles@duke.edu	Bowles, Dawn/R-6153-2019; Hershberger, Kathleen/AAP-2098-2020	Hershberger, Kathleen/0000-0002-3349-6140; Hirschey, Matthew/0000-0003-4541-5376	Duke Department of Surgery; Duke School of Medicine; Duke Translational Medicine Institute (CTSA) [UL1RR024128]; Duke Cancer Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045351] Funding Source: NIH RePORTER	Duke Department of Surgery; Duke School of Medicine; Duke Translational Medicine Institute (CTSA); Duke Cancer Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Duke Department of Surgery funding (Bolognesi Award to DEB). We thank the Duke Proteomics Core Facility (http://www.genome.duke.edu/cores/proteomics/), which provided mass spectrometry proteomics service. The Duke Proteomics Core is funded in part by the Duke School of Medicine, the Duke Translational Medicine Institute (CTSA grant UL1RR024128), and the Duke Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argraves WS, 2009, HISTOCHEM CELL BIOL, V132, P559, DOI 10.1007/s00418-009-0628-7; Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Barallobre-Barreiro J, 2012, CIRCULATION, V125, P789, DOI 10.1161/CIRCULATIONAHA.111.056952; Bolanos-Garcia VM, 2006, TRENDS BIOCHEM SCI, V31, P654, DOI 10.1016/j.tibs.2006.10.005; Bujak M, 2007, CIRCULATION, V116, P2127, DOI 10.1161/CIRCULATIONAHA.107.704197; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; Clark R, 2013, MOL CELL PROTEOMICS, V12, P194, DOI 10.1074/mcp.M112.019745; Cui HY, 2012, BIOCHEM BIOPH RES CO, V419, P517, DOI 10.1016/j.bbrc.2012.02.049; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Eom GH, 2011, CIRCULATION, V123, P2392, DOI 10.1161/CIRCULATIONAHA.110.003665; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; Froese A, 2012, J CLIN INVEST, V122, P1119, DOI 10.1172/JCI59410; Gingold-Belfer R, 2011, INT J MOL MED, V27, P25, DOI 10.3892/ijmm.2010.558; Gonzalez A, 2009, REV ESP CARDIOL, V62, P305, DOI 10.1016/S0300-8932(09)70375-6; Hager HA, 2009, HISTOL HISTOPATHOL, V24, P777, DOI 10.14670/HH-24.777; Hauck L, 2008, NAT MED, V14, P315, DOI 10.1038/nm1729; Hu B, 2009, MOL CANCER RES, V7, P1756, DOI 10.1158/1541-7786.MCR-09-0207; Huet E, 2008, CONNECT TISSUE RES, V49, P175, DOI 10.1080/03008200802151722; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Kakimoto Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000565; Karpova T, 2003, BBA-PROTEINS PROTEOM, V1652, P126, DOI 10.1016/j.bbapap.2003.08.010; Kim JY, 2013, P NATL ACAD SCI USA, V110, P12414, DOI 10.1073/pnas.1220674110; Kim SO, 1999, BIOCHEM CELL BIOL, V77, P559, DOI 10.1139/bcb-77-6-559; Klawitter J, 2013, CARDIOVASC RES, V97, P66, DOI 10.1093/cvr/cvs302; Konecny F, 2012, CARDIOVASC RES, V94, P492, DOI 10.1093/cvr/cvs138; KOROTCHKINA LG, 1995, J BIOL CHEM, V270, P14297, DOI 10.1074/jbc.270.24.14297; Kostyukova AS, 2007, ARCH BIOCHEM BIOPHYS, V465, P227, DOI 10.1016/j.abb.2007.05.012; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Liebler DC, 2013, BIOCHEMISTRY-US, V52, P3797, DOI 10.1021/bi400110b; Lloyd-Jones DM, 2002, CIRCULATION, V106, P3068, DOI 10.1161/01.CIR.0000039105.49749.6F; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Margulies KB, 2009, J AM COLL CARDIOL, V53, P1752, DOI 10.1016/j.jacc.2008.12.064; Murtaza I, 2008, J BIOL CHEM, V283, P5996, DOI 10.1074/jbc.M706466200; Piacentino V, 2012, HUM GENE THER, V23, P635, DOI 10.1089/hum.2011.186; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosello-Lleti E, 2012, J CELL MOL MED, V16, P2471, DOI 10.1111/j.1582-4934.2012.01565.x; Russ PK, 2010, INVEST OPHTH VIS SCI, V51, P223, DOI 10.1167/iovs.09-3539; Sanger JM, 2010, CYTOSKELETON, V67, P808, DOI 10.1002/cm.20490; Sharma P, 2012, J PROTEOMICS; Soderblom EJ, 2011, ANAL CHEM, V83, P3758, DOI 10.1021/ac200213b; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Soubeyran P, 2003, BIOCHEM J, V370, P29, DOI 10.1042/BJ20021539; Tan WQ, 2008, CIRCULATION, V118, P2268, DOI 10.1161/CIRCULATIONAHA.107.750869; Veis A, 1997, CRIT REV ORAL BIOL M, V8, P360, DOI 10.1177/10454411970080040101; Vilahur G, 2012, EUR HEART J; Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Wilson MC, 2002, J BIOL CHEM, V277, P3666, DOI 10.1074/jbc.M109658200; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Zhang N, 2013, J BIOL CHEM, V288, P9396, DOI 10.1074/jbc.M112.395913	54	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104157	10.1371/journal.pone.0104157	http://dx.doi.org/10.1371/journal.pone.0104157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117565	Green Published, gold, Green Submitted			2022-12-27	WOS:000341230400034
J	Sher, EA; Sholto, AY; Shaklai, M; Shaklai, N				Sher, Elena A.; Sholto, Alan Y.; Shaklai, Mati; Shaklai, Nurith			Can Gas Replace Protein Function? CO Abrogates the Oxidative Toxicity of Myoglobin	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HEME OXYGENASE-1; HEMOGLOBIN; HAPTOGLOBIN; RHABDOMYOLYSIS; PATHOGENESIS; INVOLVEMENT; INDUCTION; IRON; PEROXIDATION	Outside their cellular environments, hemoglobin (Hb) and myoglobin (Mb) are known to wreak oxidative damage. Using haptoglobin (Hp) and hemopexin (Hx) the body defends itself against cell-free Hb, yet mechanisms of protection against oxidative harm from Mb are unclear. Mb may be implicated in oxidative damage both within the myocyte and in circulation following rhabdomyolysis. Data from the literature correlate rhabdomyolysis with the induction of Heme Oxygenase-1 (HO-1), suggesting that either the enzyme or its reaction products are involved in oxidative protection. We hypothesized that carbon monoxide (CO), a product, might attenuate Mb damage, especially since CO is a specific ligand for heme iron. Low density lipoprotein (LDL) was chosen as a substrate in circulation and myosin (My) as a myocyte component. Using oxidation targets, LDL and My, the study compared the antioxidant potential of CO in Mb-mediated oxidation with the antioxidant potential of Hp in Hb-mediated oxidation. The main cause of LDL oxidation by Hb was found to be hemin which readily transfers from Hb to LDL. Hp prevented heme transfer by sequestering hemin within the Hp-Hb complex. Hemin barely transferred from Mb to LDL, and oxidation appeared to stem from heme iron redox in the intact Mb. My underwent oxidative crosslinking by Mb both in air and under N-2. These reactions were fully arrested by CO. The data are interpreted to suit several circumstances, some physiological, such as high muscle activity, and some pathological, such as rhabdomyolysis, ischemia/reperfusion and skeletal muscle disuse atrophy. It appear that CO from HO-1 attenuates damage by temporarily binding to deoxy-Mb, until free oxygen exchanges with CO to restore the equilibrium.	[Sher, Elena A.; Sholto, Alan Y.; Shaklai, Mati] Tel Aviv Univ, Sackler Fac Med, Dept Human Genet & Biochem, IL-69978 Tel Aviv, Israel; [Shaklai, Nurith] Tel Aviv Univ, Sackler Fac Med, Dept Hematol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Shaklai, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Hematol, IL-69978 Tel Aviv, Israel.	nshaklai@post.tau.ac.il			Krawitz fund for hematology	Krawitz fund for hematology	This work was funded by the Krawitz fund for hematology to Mati Shaklai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Akamatsu Y, 2004, FASEB J, V18, P771, DOI 10.1096/fj.03-0921fje; Alayash AI, 2013, TRENDS BIOTECHNOL, V31, P2, DOI 10.1016/j.tibtech.2012.10.003; Antonini E., 1971, FRONTIERS BIOL, V21; BALLA G, 1990, J LAB CLIN MED, V116, P546; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Bamm VV, 2004, BIOCHEMISTRY-US, V43, P3899, DOI 10.1021/bi0362626; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Buehler PW, 2005, ANTIOXID REDOX SIGN, V7, P1755, DOI 10.1089/ars.2005.7.1755; BUNN HF, 1968, J BIOL CHEM, V243, P465; Chiabrando D, 2011, ACUTE PHASE PROTEINS - REGULATION AND FUNCTIONS OF ACUTE PHASE PROTEINS, P261; ESTERBAUER H, 1992, FREE RADICAL BIO MED, V13, P341, DOI 10.1016/0891-5849(92)90181-F; Ferenbach DA, 2010, NEPHRON EXP NEPHROL, V115, pE33, DOI 10.1159/000313828; Ferreira A, 2008, J MOL MED, V86, P1097, DOI 10.1007/s00109-008-0368-5; Ferreira A, 2011, CELL, V145, P398, DOI 10.1016/j.cell.2011.03.049; Grinshtein N, 2003, BIOCHEMISTRY-US, V42, P6977, DOI 10.1021/bi020647r; HANAN T, 1995, EUR J BIOCHEM, V233, P930, DOI 10.1111/j.1432-1033.1995.930_3.x; HEBBEL RP, 1988, P NATL ACAD SCI USA, V85, P237, DOI 10.1073/pnas.85.1.237; Huang JM, 2002, BIOCHEMISTRY-US, V41, P2466, DOI 10.1021/bi011470o; Hunter RB, 2001, AM J PHYSIOL-CELL PH, V281, pC1285, DOI 10.1152/ajpcell.2001.281.4.C1285; Ivanovic Z, 2009, J CELL PHYSIOL, V219, P271, DOI 10.1002/jcp.21690; Kamin-Belsky N, 1998, ADV EXP MED BIOL, V454, P219; Katori M, 2002, TRANSPLANTATION, V73, P287, DOI 10.1097/00007890-200201270-00023; Langlois MR, 1996, CLIN CHEM, V42, P1589; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lund MN, 2008, BIOCHEM J, V410, P565, DOI 10.1042/BJ20071107; Miller YI, 1997, BIOCHEMISTRY-US, V36, P12189, DOI 10.1021/bi970258a; MILLER YI, 1994, BIOCHEM MOL BIOL INT, V34, P1121; Mollan TL, 2013, ANTIOXID REDOX SIGN, V18, P2251, DOI 10.1089/ars.2013.5195; Moore KP, 1998, J BIOL CHEM, V273, P31731, DOI 10.1074/jbc.273.48.31731; Nagy E, 2010, ARTERIOSCL THROM VAS, V30, P1347, DOI 10.1161/ATVBAHA.110.206433; Natella F, 1998, FREE RADICAL RES, V29, P427, DOI 10.1080/10715769800300471; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Neuzil J, 1997, FREE RADICAL BIO MED, V22, P57, DOI 10.1016/S0891-5849(96)00224-9; Nielsen MJ, 2010, ANTIOXID REDOX SIGN, V12, P261, DOI 10.1089/ars.2009.2792; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Patel R, 2012, AM J SURG, V203, P488, DOI 10.1016/j.amjsurg.2011.05.005; Schaer CA, 2013, CELL DEATH DIFFER, V20, P1569, DOI 10.1038/cdd.2013.113; Schaer DJ, 2013, BLOOD, V121, P1276, DOI 10.1182/blood-2012-11-451229; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Sher EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033039; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tift MS, 2014, J EXP BIOL, V217, P1752, DOI 10.1242/jeb.100677; TONOMURA Y, 1966, BIOCHEMISTRY-US, V5, P515, DOI 10.1021/bi00866a017; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Umbreit J, 2007, AM J HEMATOL, V82, P134, DOI 10.1002/ajh.20738; VEDIE B, 1991, J LIPID RES, V32, P1359; VERCELLOTTI GM, 1994, ARTIF CELL BLOOD SUB, V22, P207, DOI 10.3109/10731199409117415; Vesely MJJ, 1999, FEBS LETT, V458, P257, DOI 10.1016/S0014-5793(99)01129-1; Warren JD, 2002, MUSCLE NERVE, V25, P332, DOI 10.1002/mus.10053; YUSA K, 1987, BIOCHEMISTRY-US, V26, P6684, DOI 10.1021/bi00395a018; Zager RA, 1996, KIDNEY INT, V49, P314, DOI 10.1038/ki.1996.48	53	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104075	10.1371/journal.pone.0104075	http://dx.doi.org/10.1371/journal.pone.0104075			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111140	Green Submitted, gold, Green Published			2022-12-27	WOS:000341105100029
J	Sun, SH; Jia, CX				Sun, Shi-Hua; Jia, Cun-Xian			Completed Suicide with Violent and Non-Violent Methods in Rural Shandong, China: A Psychological Autopsy Study	PLOS ONE			English	Article							VERSION; INTENT; AGE; PREVENTION; PESSIMISM; TAIWAN; GENDER; CHOICE; TRENDS	Background: This study aims to describe the specific characteristics of completed suicides by violent methods and nonviolent methods in rural Chinese population, and to explore the related factors for corresponding methods. Methods: Data of this study came from investigation of 199 completed suicide cases and their paired controls of rural areas in three different counties in Shandong, China, by interviewing one informant of each subject using the method of Psychological Autopsy (PA). Results: There were 78 (39.2%) suicides with violent methods and 121 (60.8%) suicides with non-violent methods. Ingesting pesticides, as a non-violent method, appeared to be the most common suicide method (103, 51.8%). Hanging (73 cases, 36.7%) and drowning (5 cases, 2.5%) were the only violent methods observed. Storage of pesticides at home and higher suicide intent score were significantly associated with choice of violent methods while committing suicide. Risk factors related to suicide death included negative life events and hopelessness. Conclusions: Suicide with violent methods has different factors from suicide with non-violent methods. Suicide methods should be considered in suicide prevention and intervention strategies.	[Sun, Shi-Hua; Jia, Cun-Xian] Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China; [Jia, Cun-Xian] Shandong Univ, Ctr Suicide Prevent Res, Jinan 250100, Peoples R China	Shandong University; Shandong University	Jia, CX (corresponding author), Shandong Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Jinan 250100, Peoples R China.	jiacunxian@sdu.edu.cn			National Natural Science Foundation of China (NSFC) [30972527]; Postdoctoral Innovative projects of Shandong Province [200703091]; Shandong University	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Postdoctoral Innovative projects of Shandong Province; Shandong University	This study was sponsored by National Natural Science Foundation of China (NSFC) [No: 30972527](http://www.nsfc.gov.cn/), the Postdoctoral Innovative projects of Shandong Province [No: 200703091], and the Distinguished Youth Cultivation Project of Shandong University. The sponsors of the research merely provided financial funding sources and were not involved in the design, conduction, data analyses, or the manuscript writing process.	Abrams RC, 2005, AM J PUBLIC HEALTH, V95, P1000, DOI 10.2105/AJPH.2004.037861; Ajdacic-Gross V, 2008, B WORLD HEALTH ORGAN, V86, P726, DOI 10.2471/BLT.07.043489; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; China MoH, 2011, 2011 CHIN HLTH STAT; Chung WSD, 2001, PSYCHIATR SERV, V52, P836, DOI 10.1176/appi.ps.52.6.836; Conner KR, 2005, PSYCHOL MED, V35, P1197, DOI 10.1017/S003329170500454X; Conwell Y, 1998, AM J GERIAT PSYCHIAT, V6, P122; Dai Y., 2006, SHANGHAI ARCHPSYCHIA, V18, P1, DOI DOI 10.3969/J.ISSN.1002-0829.2006.01.001; Denning DG, 2000, SUICIDE LIFE-THREAT, V30, P282; Fleischmann A, 2005, PSYCHOL MED, V35, P1467, DOI 10.1017/S0033291705005416; Gau SSF, 2009, SUICIDE LIFE-THREAT, V39, P332, DOI 10.1521/suli.2009.39.3.332; GRANT I, 1976, J PSYCHOSOM RES, V20, P141, DOI 10.1016/0022-3999(76)90041-6; Hunt IM, 2010, SUICIDE LIFE-THREAT, V40, P22, DOI 10.1521/suli.2010.40.1.22; Jenkins R, 2002, LANCET, V359, P813, DOI 10.1016/S0140-6736(02)07958-8; Ji Y. F., 1999, CHINESE MENTAL HLTH, V12, P318; Jia CX, 2011, J FORENSIC SCI, V56, P674, DOI 10.1111/j.1556-4029.2010.01695.x; Kamizato E, 2009, ACTA MED OKAYAMA, V63, P177; [李献云 LI Xian-Yun], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P250; Lin HC, 2008, NEUROPSYCHOBIOLOGY, V57, P32, DOI 10.1159/000129664; Lin JJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-6; Lin JJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-480; [刘慧 Liu Hui], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P867; Lu CF, 2012, OMEGA-J DEATH DYING, V66, P215, DOI 10.2190/OM.66.3.b; [路长飞 Lu Changfei], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P218; [路长飞 Lu Changfei], 2011, [中国公共卫生, China Public Health], V27, P312; Lumei T., 2006, PSYCHOL J EXPLOR, V2, P88, DOI DOI 10.3969/J.ISSN.1003-5184.2006.02.020; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Nordentoft M, 2007, DAN MED BULL, V54, P306; Organization WH, 2006, SAF ACC PEST COMM IN; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Paykel ES, 1997, PSYCHOL MED, V27, P301, DOI 10.1017/S0033291796004424; PAYKEL ES, 1971, ARCH GEN PSYCHIAT, V25, P340, DOI 10.1001/archpsyc.1971.01750160052010; Phillips MR, 2002, LANCET, V360, P1728, DOI 10.1016/S0140-6736(02)11681-3; Phillips MR, 2004, LANCET, V364, P1062, DOI 10.1016/S0140-6736(04)17061-X; Qin P, 2001, ACTA PSYCHIAT SCAND, V103, P117, DOI 10.1034/j.1600-0447.2001.00008.x; Runeson B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3222; SHEK DTL, 1993, SOC BEHAV PERSONAL, V21, P107, DOI 10.2224/sbp.1993.21.2.107; Spielberger C, 2010, CORSINI ENCY PSYCHOL; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Vijayakumar L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-850; Wang DongFang, 2011, Journal of Shandong University (Health Sciences), V49, P111; Wang X, 1999, HDB MENTAL HLTH RATI; Wang XinXin, 2011, Journal of Shandong University (Health Sciences), V49, P159; Xiao S., 1994, J CLIN PSYCHIAT, V4, P98, DOI DOI 10.1186/S12913-016-1423-5; Yang GH, 2005, BIOMED ENVIRON SCI, V18, P379; Yip PSF, 2010, BRIT J PSYCHIAT, V196, P241, DOI 10.1192/bjp.bp.109.065185; Zhai S-T, 2002, SHANGHAI ARCH PSYCHI, V14, P35; Zhang J, 2003, J NERV MENT DIS, V191, P450, DOI 10.1097/01.NMD.0000081613.03157.D9; Zhang J, 2002, SUICIDE LIFE-THREAT, V32, P370, DOI 10.1521/suli.32.4.370.22342; Zhang J, 2007, OMEGA-J DEATH DYING, V55, P255, DOI 10.2190/OM.55.4.a; Zhang J, 2011, J NERV MENT DIS, V199, P410, DOI 10.1097/NMD.0b013e31821d3ac7; Zhang X, 2008, BIOMED ENVIRON SCI, V21, P253, DOI 10.1016/S0895-3988(08)60038-0; [周莉 Zhou Li], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P19	53	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104333	10.1371/journal.pone.0104333	http://dx.doi.org/10.1371/journal.pone.0104333			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO1WB	25111835	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100050
J	Takenaka-Ninagawa, N; Kawabata, Y; Watanabe, S; Nagata, K; Torihashi, S				Takenaka-Ninagawa, Nana; Kawabata, Yuka; Watanabe, Shogo; Nagata, Kohzo; Torihashi, Shigeko			Generation of Rat-Induced Pluripotent Stem Cells from a New Model of Metabolic Syndrome	PLOS ONE			English	Article							ANIMAL-MODEL; MOUSE	We recently characterized DahlS.Z-Lepr(fa)/Lepr(fa) (DS/obese) rats, derived from a cross between Dahl salt-sensitive rats and Zucker rats, as a new animal model of metabolic syndrome (MetS). Although the phenotype of DS/obese rats is similar to that of humans with MetS, the pathophysiological and metabolic characteristics in each cell type remain to be clarified. Hence, the establishment of induced pluripotent stem cells (iPSCs) derived from MetS rats is essential for investigations of MetS in vitro. Reports of rat iPSCs (riPSCs), however, are few because of the difficulty of comparing to other rodents such as mouse. Recently, the advantage of using mesenchymal stromal cells (MSCs) as a cell source for generating iPSCs was described. We aimed to establish riPSCs from MSCs in adipose tissues of both DS/obese rats and their lean littermates, DahlS.Z-Lepr(+)/Lepr(+) (DS/lean) rats using lentivirus vectors with only three factors Oct4, Klf4, and Sox2 without c-Myc. The morphology, gene expression profiles, and protein expression of established colonies showed embryonic stem cell (ESCs)like properties, and the differentiation potential into cells from all three germ layers both in vitro and in vivo (teratomas). Both riPSCs became adipocytes after induction of adipogenesis by insulin, T3, and dexamethasone. Real-time PCR analysis also revealed that both riPSCs and the adipose tissue from DS/obese and DS/lean rats possess similar expression patterns of adipocyte differentiation-related genes. We succeeded in generating riPSCs effectively from MSCs of both DS/obese and DS/ lean rats. These riPSCs may well serve as highly effective tools for the investigation of MetS pathophysiology in vitro.	[Takenaka-Ninagawa, Nana; Kawabata, Yuka; Torihashi, Shigeko] Nagoya Univ, Dept Rehabil Sci, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Watanabe, Shogo; Nagata, Kohzo] Nagoya Univ, Dept Pathophysiol Lab Sci, Grad Sch Med, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Takenaka-Ninagawa, N (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan.	nana.takenaka@cira.kyoto-u.ac.jp			Japan Society for the Promotion of Sciences	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Grants-in-Aid for Scientific Research (B) http://www.jsps.go.jp/ and Grant-in-Aid from Japan Society for the Promotion of Sciences http://www.jsps.go.jp/ supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Chang MY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009838; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Hamanaka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022008; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hattori T, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2010.1; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; Jiang MG, 2013, J BIOL CHEM, V288, P27150, DOI 10.1074/jbc.M113.492900; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Kunisato A, 2010, STEM CELLS DEV, V19, P229, DOI 10.1089/scd.2009.0149; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Merkl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055170; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Murase T, 2012, HYPERTENSION, V59, P694, DOI 10.1161/HYPERTENSIONAHA.111.180976; Ninagawa N, 2011, DIFFERENTIATION, V82, P153, DOI 10.1016/j.diff.2011.07.001; Oda Y, 2010, J BIOL CHEM, V285, P29270, DOI 10.1074/jbc.M109.055889; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takatsu M, 2013, HYPERTENSION, V62, P957, DOI 10.1161/HYPERTENSIONAHA.113.02093; Tat PA, 2010, CELL TRANSPLANT, V19, P525, DOI 10.3727/096368910X491374; Veronique A, 2006, NATURE CELL BIOL, V8, P8	23	8	8	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104462	10.1371/journal.pone.0104462	http://dx.doi.org/10.1371/journal.pone.0104462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111735	Green Submitted, gold, Green Published			2022-12-27	WOS:000341105100061
J	Dyson, RM; Palliser, HK; Latter, JL; Chwatko, G; Glowacki, R; Wright, IMR				Dyson, Rebecca M.; Palliser, Hannah K.; Latter, Joanna L.; Chwatko, Grazyna; Glowacki, Rafal; Wright, Ian M. R.			A Role for H2S in the Microcirculation of Newborns: The Major Metabolite of H2S (Thiosulphate) Is Increased in Preterm Infants	PLOS ONE			English	Article							HYDROGEN-SULFIDE; BLOOD-FLOW; CREATININE EXCRETION; NITRIC-OXIDE; 1ST YEAR; MEDIATOR; RAT; INHIBITION; INDICATOR; APOPTOSIS	Excessive vasodilatation during the perinatal period is associated with cardiorespiratory instability in preterm neonates. Little evidence of the mechanisms controlling microvascular tone during circulatory transition exists. We hypothesised that hydrogen sulphide (H2S), an important regulator of microvascular reactivity and central cardiac function in adults and animal models, may contribute to the vasodilatation observed in preterm newborns. Term and preterm neonates (24-43 weeks gestational age) were studied. Peripheral microvascular blood flow was assessed by laser Doppler. Thiosulphate, a urinary metabolite of H2S, was determined by high performance liquid chromatography as a measure of 24 hr total body H2S turnover for the first 3 days of postnatal life. H2S turnover was greatest in very preterm infants and decreased with increasing gestational age (p = 0.0001). H2S turnover was stable across the first 72 hrs of life in older neonates. In very preterm neonates, H2S turnover increased significantly from day 1 to 3 ( p = 0.0001); and males had higher H2S turnover than females (p = 0.04). A significant relationship between microvascular blood flow and H2S turnover was observed on day 2 of postnatal life (p = 0.0004). H2S may play a role in maintaining microvascular tone in the perinatal period. Neonates at the greatest risk of microvascular dysfunction characterised by inappropriate peripheral vasodilatation - very preterm male neonates - are also the neonates with highest levels of total body H2S turnover suggesting that overproduction of this gasotransmitter may contribute to microvascular dysfunction in preterms. Potentially, H2S is a target to selectively control microvascular tone in the circulation of newborns.	[Dyson, Rebecca M.; Palliser, Hannah K.; Latter, Joanna L.; Wright, Ian M. R.] Mothers & Babies Res Ctr, Hunter Med Res Inst, New Lambton Hts, NSW, Australia; [Dyson, Rebecca M.; Wright, Ian M. R.] Univ Newcastle, Sch Med & Publ Hlth, Discipline Paediat & Child Hlth, Callaghan, NSW 2308, Australia; [Dyson, Rebecca M.; Wright, Ian M. R.] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Dyson, Rebecca M.; Wright, Ian M. R.] Univ Wollongong, Grad Sch Med, Wollongong, NSW, Australia; [Palliser, Hannah K.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Latter, Joanna L.] Univ Newcastle, Sch Med & Publ Hlth, Discipline Publ Hlth, Callaghan, NSW 2308, Australia; [Chwatko, Grazyna; Glowacki, Rafal] Univ Lodz, Fac Chem, Dept Environm Chem, PL-90131 Lodz, Poland; [Wright, Ian M. R.] John Hunter Childrens Hosp, Kaleidoscope Neonatal Intens Care Unit, New Lambton Hts, NSW, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Wollongong; University of Wollongong; University of Newcastle; University of Newcastle; University of Lodz	Wright, IMR (corresponding author), Mothers & Babies Res Ctr, Hunter Med Res Inst, New Lambton Hts, NSW, Australia.	iwright@uow.edu.au	Chwatko, Grażyna/R-8757-2016	Glowacki, Rafal/0000-0003-0071-1470; Palliser, Hannah/0000-0001-5783-9737; Dyson, Rebecca/0000-0003-2319-6897; Latter, Joanna/0000-0002-8499-0069; Chwatko, Grazyna/0000-0001-9247-5131; Wright, Ian/0000-0001-5337-0134	National Health and Medical Research Council [569285]; John Hunter Hospital Charitable Trust; Hunter Children's Research Foundation; University of Lodz	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); John Hunter Hospital Charitable Trust; Hunter Children's Research Foundation; University of Lodz	This study was funded by a National Health and Medical Research Council Project Grant awarded to IMRW (ID#569285; https://www.nhmrc.gov.au/) and John Hunter Hospital Charitable Trust Project Grants awarded to IMRW, HKP and RMD. RMD was supported by the Hunter Children's Research Foundation. The HPLC work performed by GC and RG was supported by the University of Lodz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba-Alejandre I, 2013, INT J PEDIAT, V2013, DOI 10.1155/2013/768784; Amey M, 2008, PEDIATR CRIT CARE ME, V9, P76, DOI 10.1097/01.PCC.0000298550.29453.7D; APPLEGARTH DA, 1975, CLIN CHIM ACTA, V64, P83, DOI 10.1016/0009-8981(75)90148-5; APPLEGARTH DA, 1968, CLIN CHIM ACTA, V22, P131, DOI 10.1016/0009-8981(68)90348-3; Baragatti B, 2013, AM J PHYSIOL-HEART C, V304, pH927, DOI 10.1152/ajpheart.00718.2012; BEAUCHAMP RO, 1984, CRC CR REV TOXICOL, V13, P25, DOI 10.3109/10408448409029321; Bhatia M, 2005, BRIT J PHARMACOL, V145, P141, DOI 10.1038/sj.bjp.0706186; Bhatia M, 2012, SCIENTIFICA, V2012, P12; Bhutani V. K., 1997, SEMINARS PERINATOLOG, V2, P1; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Chwatko G, 2009, TALANTA, V79, P229, DOI 10.1016/j.talanta.2009.03.040; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Collin M, 2005, SHOCK, V24, P595, DOI 10.1097/01.shk.0000188328.59770.25; Collin M, 2005, BRIT J PHARMACOL, V146, P498, DOI 10.1038/sj.bjp.0706367; Dasgupta SJ, 2003, ARCH DIS CHILD-FETAL, V88, pF450, DOI 10.1136/fn.88.6.F450; Du Junbao, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P102; Dyson RM, 2012, PEDIATR RES, V71, P20, DOI 10.1038/pr.2011.9; Elder DE, 1999, J PAEDIATR CHILD H, V35, P145, DOI 10.1046/j.1440-1754.1999.00308.x; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Evans N, 2002, ARCH DIS CHILD-FETAL, V87, P181; Hille ETM, 2007, PEDIATRICS, V120, pE587, DOI 10.1542/peds.2006-2407; Ji Y, 2008, EUR J PHARMACOL, V587, P1, DOI 10.1016/j.ejphar.2008.03.044; Jiang Hai-long, 2005, Di Yi Jun Yi Da Xue Xue Bao, V25, P951; Kage S, 1997, INT J LEGAL MED, V110, P220, DOI 10.1007/s004140050071; KANGAS J, 1987, CLIN CHIM ACTA, V164, P7, DOI 10.1016/0009-8981(87)90101-X; Kent AL, 2012, PEDIATRICS, V129, P124, DOI 10.1542/peds.2011-1578; Kimura H, 2005, ANTIOXID REDOX SIGN, V7, P795, DOI 10.1089/ars.2005.7.795; Kubli S, 2000, J CARDIOVASC PHARM, V36, P640, DOI 10.1097/00005344-200011000-00014; Leffler CW, 2011, AM J PHYSIOL-HEART C, V300, pH440, DOI 10.1152/ajpheart.00722.2010; Levonen AL, 2000, BIOCHEM J, V347, P291, DOI 10.1042/0264-6021:3470291; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Martin JA, 2007, CELL MOL BIOL NOIS S, V53; Minamishima S, 2009, CIRCULATION, V120, P888, DOI 10.1161/CIRCULATIONAHA.108.833491; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; Olson KR, 2006, J EXP BIOL, V209, P4011, DOI 10.1242/jeb.02480; Pan TT, 2006, J MOL CELL CARDIOL, V40, P119, DOI 10.1016/j.yjmcc.2005.10.003; Picker JD, 1993, HOMOCYSTINURIA CAUSE; Ritter JM, 2010, BRIT J CLIN PHARMACO, V69, P573, DOI 10.1111/j.1365-2125.2010.03690.x; Saukkonen K, 2010, SHOCK, V34, P558, DOI 10.1097/SHK.0b013e3181e14de9; Seri I, 2001, PEDIATRICS, V107, P1070, DOI 10.1542/peds.107.5.1070; Shaul PW, 1997, SEMIN PERINATOL, V21, P381, DOI 10.1016/S0146-0005(97)80004-3; Sodha NR, 2008, EUR J CARDIO-THORAC, V33, P906, DOI 10.1016/j.ejcts.2008.01.047; Stark MJ, 2008, ARCH DIS CHILD-FETAL, V93, pF271, DOI 10.1136/adc.2007.123539; Stark MJ, 2011, J MATERN-FETAL NEO M, V24, P1215, DOI 10.3109/14767058.2011.569618; Stark MJ, 2009, PEDIATRICS, V124, P277, DOI 10.1542/peds.2008-0877; Stark MJ, 2008, PEDIATR RES, V63, P415, DOI 10.1203/01.pdr.0000304937.38669.63; Toombs CF, 2010, BRIT J CLIN PHARMACO, V69, P626, DOI 10.1111/j.1365-2125.2010.03636.x; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wen YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053147; Yao LL, 2010, AM J PHYSIOL-HEART C, V298, pH1310, DOI 10.1152/ajpheart.00339.2009; Zhang HL, 2006, AM J PHYSIOL-LUNG C, V290, pL1193, DOI 10.1152/ajplung.00489.2005; Zhang L, 2010, MOL MED, V16, P417, DOI 10.2119/molmed.2010.00027; ZLOTKIN SH, 1982, PEDIATR RES, V16, P65; Zoccali C, 2009, NEPHROL DIAL TRANSPL, V24, P1394, DOI 10.1093/ndt/gfp053	54	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105085	10.1371/journal.pone.0105085	http://dx.doi.org/10.1371/journal.pone.0105085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121737	Green Submitted, gold, Green Published			2022-12-27	WOS:000341017000094
J	Rangaswamy, US; O'Flaherty, BM; Speck, SH				Rangaswamy, Udaya S.; O'Flaherty, Brigid M.; Speck, Samuel H.			Tyrosine 129 of the Murine Gammaherpesvirus M2 Protein Is Critical for M2 Function In Vivo	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; B-CELLS; KAPOSIS-SARCOMA; LATENT MEMBRANE-PROTEIN-1; VIRAL INTERLEUKIN-10; DENDRITIC CELLS; IL-10; INFECTION; GENE	A common strategy shared by all known gammaherpesviruses is their ability to establish a latent infection in lymphocytes - predominantly in B cells. In immunocompromised patients, such as transplant recipients or AIDS patients, gammaherpesvirus infections can lead to the development of lymphoproliferative disease and lymphoid malignancies. The human gamma-herpesviruses, EBV and KSHV, encode proteins that are capable of modulating the host immune signaling machinery, thereby subverting host immune responses. Murine gamma-herpesvirus 68 (MHV68) infection of laboratory strains of mice has proven to be useful small-animal model that shares important pathogenic strategies with the human gamma-herpesviruses. The MHV68 M2 protein is known to manipulate B cell signaling and, dependent on route and dose of virus inoculation, plays a role in both the establishment of latency and virus reactivation. M2 contains two tyrosines that are targets for phosphorylation, and have been shown to interact with the B cell signaling machinery. Here we describe in vitro and in vivo studies of M2 mutants which reveals that while both tyrosines Y120 and Y129 are required for M2 induction of IL-10 expression from primary murine B cells in vitro, only Y129 is critical for reactivation from latency and plasma cell differentiation in vivo.	[Rangaswamy, Udaya S.; O'Flaherty, Brigid M.] Emory Univ, Sch Med, Microbiol & Mol Genet Grad Program, Atlanta, GA 30322 USA; [Rangaswamy, Udaya S.; O'Flaherty, Brigid M.; Speck, Samuel H.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Speck, Samuel H.] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Speck, SH (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	sspeck@emory.edu	Speck, Samuel/L-5893-2019		National Institutes of Health (NIH) [R01 AI058057]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058057] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by grant number R01 AI058057 from the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; CARSETTI R, 1995, J EXP MED, V181, P2129, DOI 10.1084/jem.181.6.2129; Collins CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033230; Collins CM, 2009, J VIROL, V83, P6484, DOI 10.1128/JVI.00297-09; de Miranda MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001654; de Miranda MP, 2013, J BIOL CHEM, V288, P3858, DOI 10.1074/jbc.M112.439810; DeZalia M, 2008, J VIROL, V82, P7411, DOI 10.1128/JVI.00651-08; Ding YZ, 2003, J IMMUNOL, V170, P1383, DOI 10.4049/jimmunol.170.3.1383; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Flano E, 2000, J IMMUNOL, V165, P1074, DOI 10.4049/jimmunol.165.2.1074; Ganem D, 2006, ANNU REV PATHOL-MECH, V1, P273, DOI 10.1146/annurev.pathol.1.110304.100133; Herskowitz J, 2005, J VIROL, V79, P2261, DOI 10.1128/JVI.79.4.2261-2273.2005; Herskowitz JH, 2008, J VIROL, V82, P3295, DOI 10.1128/JVI.02234-07; Hornef MW, 1997, CLIN DIAGN LAB IMMUN, V4, P545, DOI 10.1128/CDLI.4.5.545-549.1997; Jacoby MA, 2002, J VIROL, V76, P1790, DOI 10.1128/JVI.76.4.1790-1801.2002; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; Krutzik PO, 2005, J IMMUNOL, V175, P2366, DOI 10.4049/jimmunol.175.4.2366; Lagunoff M, 1999, P NATL ACAD SCI USA, V96, P5704, DOI 10.1073/pnas.96.10.5704; Lambert SL, 2007, J IMMUNOL, V179, P8225, DOI 10.4049/jimmunol.179.12.8225; Liang XZ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000677; Madureira PA, 2005, J BIOL CHEM, V280, P37310, DOI 10.1074/jbc.M507478200; MIYAZAKI I, 1993, J EXP MED, V178, P439, DOI 10.1084/jem.178.2.439; MOORE KW, 1990, SCIENCE, V248, P1230, DOI 10.1126/science.2161559; Ouyang P, 2014, J GEN VIROL, V95, P245, DOI 10.1099/vir.0.058966-0; Punjabi AS, 2007, J VIROL, V81, P2449, DOI 10.1128/JVI.01769-06; Rangaswamy US, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003858; Rodrigues L, 2006, J VIROL, V80, P6123, DOI 10.1128/JVI.02700-05; Santarelli R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04241; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shair KHY, 2007, PLOS PATHOG, V3, P1669, DOI 10.1371/journal.ppat.0030166; Siegel AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000039; Siegel AM, 2010, J VIROL, V84, P674, DOI 10.1128/JVI.01306-09; Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002; Stinski MF, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P241; STUART AD, 1995, ONCOGENE, V11, P1711; Virgin HW, 1999, J VIROL, V73, P2321, DOI 10.1128/JVI.73.3.2321-2332.1999; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Vockerodt M, 2001, VIROLOGY, V280, P183, DOI 10.1006/viro.2000.0768; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Weck KE, 1999, J VIROL, V73, P4651, DOI 10.1128/JVI.73.6.4651-4661.1999; Weck KE, 1999, J VIROL, V73, P3273, DOI 10.1128/JVI.73.4.3273-3283.1999; Wehinger J, 1996, FEBS LETT, V394, P365, DOI 10.1016/0014-5793(96)00990-8; Welte T, 1999, SCIENCE, V283, P222, DOI 10.1126/science.283.5399.222; Willer DO, 2003, J VIROL, V77, P8310, DOI 10.1128/JVI.77.15.8310-8321.2003; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	46	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105197	10.1371/journal.pone.0105197	http://dx.doi.org/10.1371/journal.pone.0105197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122496	Green Submitted, Green Published, gold			2022-12-27	WOS:000341017000105
J	Wood, BA; Blair, HT; Gray, DI; Kemp, PD; Kenyon, PR; Morris, ST; Sewell, AM				Wood, Brennon A.; Blair, Hugh T.; Gray, David I.; Kemp, Peter D.; Kenyon, Paul R.; Morris, Steve T.; Sewell, Alison M.			Agricultural Science in the Wild: A Social Network Analysis of Farmer Knowledge Exchange	PLOS ONE			English	Article							INNOVATION SYSTEMS; MANAGEMENT; DIFFUSION	Responding to demands for transformed farming practices requires new forms of knowledge. Given their scale and complexity, agricultural problems can no longer be solved by linear transfers in which technology developed by specialists passes to farmers by way of extension intermediaries. Recent research on alternative approaches has focused on the innovation systems formed by interactions between heterogeneous actors. Rather than linear transfer, systems theory highlights network facilitation as a specialized function. This paper contributes to our understanding of such facilitation by investigating the networks in which farmers discuss science. We report findings based on the study of a pastoral farming experiment collaboratively undertaken by a group of 17 farmers and five scientists. Analysis of prior contact and alter sharing between the group's members indicates strongly tied and decentralized networks. Farmer knowledge exchanges about the experiment have been investigated using a mix of quantitative and qualitative methods. Network surveys identified who the farmers contacted for knowledge before the study began and who they had talked to about the experiment by 18 months later. Open-ended interviews collected farmer statements about their most valuable contacts and these statements have been thematically analysed. The network analysis shows that farmers talked about the experiment with 192 people, most of whom were fellow farmers. Farmers with densely tied and occupationally homogeneous contacts grew their networks more than did farmers with contacts that are loosely tied and diverse. Thematic analysis reveals three general principles: farmers value knowledge delivered by persons rather than roles, privilege farming experience, and develop knowledge with empiricist rather than rationalist techniques. Taken together, these findings suggest that farmers deliberate about science in intensive and durable networks that have significant implications for theorizing agricultural innovation. The paper thus concludes by considering the findings' significance for current efforts to rethink agricultural extension.	[Wood, Brennon A.; Gray, David I.; Kemp, Peter D.] Massey Univ, Inst Agr & Environm, Palmerston North, New Zealand; [Blair, Hugh T.; Kenyon, Paul R.; Morris, Steve T.] Massey Univ, Inst Vet Anim & Biol Sci, Palmerston North, New Zealand; [Sewell, Alison M.] Massey Univ, Inst Educ, Palmerston North, New Zealand	Massey University; Massey University; Massey University	Wood, BA (corresponding author), Massey Univ, Inst Agr & Environm, Palmerston North, New Zealand.	b.a.wood@massey.ac.nz	Morris, Steve/AAA-8539-2019; Kemp, Peter D/B-4639-2011	Kemp, Peter D/0000-0002-2239-2012; Kenyon, Paul/0000-0003-1131-0736	Gravida; New Zealand Centre for Research Excellence; International Sheep Research Centre	Gravida; New Zealand Centre for Research Excellence; International Sheep Research Centre	The project was funded in part by Gravida (http://www.gravida.org.nz/), a New Zealand Centre for Research Excellence, and the International Sheep Research Centre (http://www.sheepresearch.co.nz/). Other than the named authors, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannet ET, 1997, NEW LITERARY HIST, V28, P655; Barnes Barry, 2000, UNDERSTANDING AGENCY; Biggs C, 2010, 3 U MELB VICT EC INN; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Brannen J, 2005, INT J SOC RES METHOD, V8, P173, DOI [DOI 10.1080/13645570500154642, 10.1080/13645570500154642]; Burt R.S., 2017, SOCIAL CAPITAL, P31, DOI DOI 10.4324/9781315129457-2/STRUCTURAL-HOLES-VERSUS-NETWORK-CLOSURE-SOCIAL-CAPITAL-RONALD-BURT; Chambers R, 1989, FARMER 1 FARMER INNO; COLEMAN J, 1957, SOCIOMETRY, V20, P253, DOI 10.2307/2785979; Darnhofer I., 2012, FARMING SYSTEMS RES, P1, DOI [10.1007/978-94-007-4503-2_20, 10.1007/978-94-007-4503-2, DOI 10.1007/978-94-007-4503-2]; Eastwood CR, 2012, AGR SYST, V108, P10, DOI 10.1016/j.agsy.2011.12.005; Freeman LC, 2004, DEV SOCIAL NETWORK A; Gibbons M., 1994, EMPIRICA, V21, P259, DOI DOI 10.1007/BF01697408; Glaser B.G., 1968, DISCOV GROUNDED THEO; Harrison DA, 2007, ACAD MANAGE REV, V32, P1199, DOI 10.5465/AMR.2007.26586096; Hekkert MP, 2007, TECHNOL FORECAST SOC, V74, P413, DOI 10.1016/j.techfore.2006.03.002; HUTCHINS E., 1995, COGNITION WILD; Hutton PG, 2011, ANIM FEED SCI TECH, V164, P1, DOI 10.1016/j.anifeedsci.2010.11.014; Klerkx L, 2010, AGR SYST, V103, P390, DOI 10.1016/j.agsy.2010.03.012; Leeuwis C, 2011, J AGRIC EDUC EXT, V17, P21, DOI 10.1080/1389224X.2011.536344; Macdonald KM., 1995, SOCIOLOGY PROFESSION; McIntyre BD, 2009, AGR CROSSR GLOB REP; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Neef A, 2011, AGR HUM VALUES, V28, P179, DOI 10.1007/s10460-010-9272-z; Nooteboom B, 2008, MICROFOUNDATIONS INN, P199; Nuthall PL, 2012, AGR SYST, V107, P65, DOI 10.1016/j.agsy.2011.11.006; Oreszczyn S, 2010, J RURAL STUD, V26, P404, DOI 10.1016/j.jrurstud.2010.03.003; Prell C., 2012, SOCIAL NETWORK ANAL; Prell C, 2009, SOC NATUR RESOUR, V22, P501, DOI 10.1080/08941920802199202; PRETTY JN, 1994, FARMER 1 RURAL PEOPL, P182; QSR International Pty Ltd, 2010, NVIVO 9, P9; RICHARDS P, 2009, FARMER 1 REVISITED, P233; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Rothenberg R.B., 1995, CONNECTIONS, V18, P104; Scoones I., 1994, FARMER 1 RURAL PEOPL; Scoones I., 2009, FARMER 1 REVISITED I, P3; Sewell AM, 2014, AGR SYST, V125, P63, DOI 10.1016/j.agsy.2013.12.002; Simmel G., 1950, SOCIOLOGY G SIMMEL, P145; United Nations Conference on Sustainable Development, 2012, FUT WE WANT OUTC C; Valente T, 1995, NETWORK MODELS DIFFU; Valente T W, 1995, Sci Commun, V16, P242, DOI 10.1177/1075547095016003002	41	94	94	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105203	10.1371/journal.pone.0105203	http://dx.doi.org/10.1371/journal.pone.0105203			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AO0QT	25121487	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000106
J	Xu, Y; Wen, X; Wen, LS; Wu, LY; Deng, NY; Chou, KC				Xu, Yan; Wen, Xin; Wen, Li-Shu; Wu, Ling-Yun; Deng, Nai-Yang; Chou, Kuo-Chen			iNitro-Tyr: Prediction of Nitrotyrosine Sites in Proteins with General Pseudo Amino Acid Composition	PLOS ONE			English	Article							SECONDARY STRUCTURE-CONTENT; LABEL LEARNING CLASSIFIER; CHOUS PSEAAC FORMULATION; PROTEASE CLEAVAGE SITES; S-NITROSYLATION SITES; SUBCELLULAR-LOCALIZATION; SIGNAL PEPTIDES; STRUCTURAL CLASSES; MULTIPLE SITES; PHYSICOCHEMICAL PROPERTIES	Nitrotyrosine is one of the post-translational modifications (PTMs) in proteins that occurs when their tyrosine residue is nitrated. Compared with healthy people, a remarkably increased level of nitrotyrosine is detected in those suffering from rheumatoid arthritis, septic shock, and coeliac disease. Given an uncharacterized protein sequence that contains many tyrosine residues, which one of them can be nitrated and which one cannot? This is a challenging problem, not only directly related to in-depth understanding the PTM's mechanism but also to the nitrotyrosine-based drug development. Particularly, with the avalanche of protein sequences generated in the postgenomic age, it is highly desired to develop a high throughput tool in this regard. Here, a new predictor called "iNitro-Tyr'' was developed by incorporating the position-specific dipeptide propensity into the general pseudo amino acid composition for discriminating the nitrotyrosine sites from non-nitrotyrosine sites in proteins. It was demonstrated via the rigorous jackknife tests that the new predictor not only can yield higher success rate but also is much more stable and less noisy. A web-server for iNitro-Tyr is accessible to the public at http://app.aporc.org/iNitro-Tyr/. For the convenience of most experimental scientists, we have further provided a protocol of step-by-step guide, by which users can easily get their desired results without the need to follow the complicated mathematics that were presented in this paper just for the integrity of its development process. It has not escaped our notice that the approach presented here can be also used to deal with the other PTM sites in proteins.	[Xu, Yan; Wen, Xin] Univ Sci & Technol Beijing, Dept Informat & Comp Sci, Beijing 100083, Peoples R China; [Wen, Li-Shu] Liaoning Shiyou Univ, Coll Sci, Fushun, Peoples R China; [Wu, Ling-Yun] Chinese Acad Sci, Acad Math & Syst Sci, Inst Appl Math, Beijing, Peoples R China; [Deng, Nai-Yang] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China; [Chou, Kuo-Chen] King Abdulaziz Univ, CEGMR, Jeddah 21413, Saudi Arabia; [Chou, Kuo-Chen] Gordon Life Sci Inst, Boston, MA USA	University of Science & Technology Beijing; Liaoning Petrochemical University; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; China Agricultural University; King Abdulaziz University; Gordon Life Science Institute	Xu, Y (corresponding author), Univ Sci & Technol Beijing, Dept Informat & Comp Sci, Beijing 100083, Peoples R China.	xuyan@ustb.edu.cn	Wu, Ling-Yun/C-4222-2008; Chou, Kuo-Chen/A-8340-2009	Wu, Ling-Yun/0000-0001-9487-0215; Xu, Yan/0000-0001-9462-580X	National Natural Science Foundation of China [11301024, 11371365, 11101029, 31201002, 11071013]; National Natural Science Foundation of China [11301024, 11371365, 11101029, 31201002, 11071013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No. 11301024, No. 11371365, No. 11101029, No. 31201002, No. 11071013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Cao DS, 2013, BIOINFORMATICS, V29, P960, DOI 10.1093/bioinformatics/btt072; Casoni F, 2005, J BIOL CHEM, V280, P16295, DOI 10.1074/jbc.M413111200; Chen W, 2014, ANAL BIOCHEM, V462, P76, DOI 10.1016/j.ab.2014.06.022; Chen W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/623149; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047843; Chen YK, 2013, J THEOR BIOL, V318, P1, DOI 10.1016/j.jtbi.2012.10.033; CHOU JJ, 1993, BIOPOLYMERS, V33, P1405, DOI 10.1002/bip.360330910; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 1996, ANAL BIOCHEM, V233, P1, DOI 10.1006/abio.1996.0001; Chou KC, 2002, CURR PROTEIN PEPT SC, V3, P615, DOI 10.2174/1389203023380468; Chou KC, 2001, PEPTIDES, V22, P1973, DOI 10.1016/S0196-9781(01)00540-X; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEIN SCI, V4, P1365, DOI 10.1002/pro.5560040712; Chou KC, 2001, PROTEINS, V42, P136, DOI 10.1002/1097-0134(20010101)42:1<136::AID-PROT130>3.0.CO;2-F; CHOU KC, 1993, J BIOL CHEM, V268, P16938; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2001, PROTEIN ENG, V14, P75, DOI 10.1093/protein/14.2.75; Chou KC, 1999, J PROTEIN CHEM, V18, P473, DOI 10.1023/A:1020696810938; Chou KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Dekker F. F, 2012, CURR PROTOC PROTEIN; Ding H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/286419; Du PF, 2014, INT J MOL SCI, V15, P3495, DOI 10.3390/ijms15033495; Du PF, 2012, ANAL BIOCHEM, V425, P117, DOI 10.1016/j.ab.2012.03.015; Fan YN, 2014, INT J MOL SCI, V15, P4915, DOI 10.3390/ijms15034915; Feeney M. B., 2013, ANTIOXID REDOX SIGNA; Feng KY, 2005, BIOCHEM BIOPH RES CO, V334, P213, DOI 10.1016/j.bbrc.2005.06.075; Feng PM, 2013, ANAL BIOCHEM, V442, P118, DOI 10.1016/j.ab.2013.05.024; Georgiou D.N., 2013, OPEN BIOINF J, V7, P41, DOI DOI 10.2174/1875036201307010041; Ghesquiere B, 2009, MOL CELL PROTEOMICS, V8, P2642, DOI 10.1074/mcp.M900259-MCP200; Guo SH, 2014, BIOINFORMATICS, V30, P1522, DOI 10.1093/bioinformatics/btu083; Hajisharifi Z, 2014, J THEOR BIOL, V341, P34, DOI 10.1016/j.jtbi.2013.08.037; Huang C, 2013, J THEOR BIOL, V335, P205, DOI 10.1016/j.jtbi.2013.06.034; Jarmula A, 2013, J COMPUT AID MOL DES, V27, P45, DOI 10.1007/s10822-012-9624-4; Jia CZ, 2014, INT J MOL SCI, V15, P10410, DOI 10.3390/ijms150610410; Jiang Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/287019; Kandaswamy KK, 2011, J THEOR BIOL, V270, P56, DOI 10.1016/j.jtbi.2010.10.037; Khosravian M, 2013, PROTEIN PEPTIDE LETT, V20, P180, DOI 10.2174/092986613804725307; Kong L, 2014, J THEOR BIOL, V344, P12, DOI 10.1016/j.jtbi.2013.11.021; LIN SX, 2013, J BIOMED SCI JBISE, V6, P435, DOI DOI 10.4236/JBISE.2013.64054; Lin WZ, 2013, MOL BIOSYST, V9, P634, DOI 10.1039/c3mb25466f; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu WM, 1999, PROTEIN ENG, V12, P1041, DOI 10.1093/protein/12.12.1041; Liu ZX, 2011, MOL BIOSYST, V7, P1197, DOI 10.1039/c0mb00279h; Mei SY, 2012, J THEOR BIOL, V310, P80, DOI 10.1016/j.jtbi.2012.06.028; Mei SY, 2012, J THEOR BIOL, V293, P121, DOI 10.1016/j.jtbi.2011.10.015; Min JL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/701317; Mohabatkar H, 2013, MED CHEM, V9, P133, DOI 10.2174/157340613804488341; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohammad Beigi Majid, 2011, J Struct Funct Genomics, V12, P191, DOI 10.1007/s10969-011-9120-4; Nanni L, 2012, IEEE ACM T COMPUT BI, V9, P467, DOI 10.1109/TCBB.2011.117; Qiu WR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/947416; Qiu WR, 2014, INT J MOL SCI, V15, P1746, DOI 10.3390/ijms15021746; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Shen HB, 2005, BIOCHEM BIOPH RES CO, V334, P577, DOI 10.1016/j.bbrc.2005.06.128; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Sun XY, 2012, MOL BIOSYST, V8, P3178, DOI 10.1039/c2mb25280e; Wang M, 2005, J THEOR BIOL, V232, P7, DOI 10.1016/j.jtbi.2004.07.023; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Xiao X, 2013, J THEOR BIOL, V337, P71, DOI 10.1016/j.jtbi.2013.08.013; Xiao X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072234; Xiao X, 2013, ANAL BIOCHEM, V436, P168, DOI 10.1016/j.ab.2013.01.019; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xu Y, 2014, INT J MOL SCI, V15, P7594, DOI 10.3390/ijms15057594; Xu Y, 2013, PEERJ, V1, DOI 10.7717/peerj.171; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Zhan XQ, 2008, MOL CELL PROTEOMICS, V7, P864, DOI 10.1074/mcp.M700417-MCP200; Zia-ur-Rehman, 2012, PROTEIN PEPTIDE LETT, V19, P890	77	222	223	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e105018	10.1371/journal.pone.0105018	http://dx.doi.org/10.1371/journal.pone.0105018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121969	Green Submitted, Green Published, gold			2022-12-27	WOS:000341017000088
J	Zhong, WX; Hutchinson, TE; Chebolu, S; Darmani, NA				Zhong, Weixia; Hutchinson, Tarun E.; Chebolu, Seetha; Darmani, Nissar A.			Serotonin 5-HT3 Receptor-Mediated Vomiting Occurs via the Activation of Ca2+/CaMKII-Dependent ERK1/2 Signaling in the Least Shrew (Cryptotis parva)	PLOS ONE			English	Article							PROTEIN-KINASE-II; CALMODULIN-BINDING; INDUCED EMESIS; CA2+ CHANNELS; INTRACELLULAR CA2+; NG108-15 CELLS; NK1 RECEPTORS; ION CHANNELS; BRAIN-STEM; ANTAGONISTS	Stimulation of 5-HT3 receptors (5-HT(3)Rs) by 2-methylserotonin (2-Me-5-HT), a selective 5-HT3 receptor agonist, can induce vomiting. However, downstream signaling pathways for the induced emesis remain unknown. The 5-HT3R channel has high permeability to extracellular calcium (Ca2+) and upon stimulation allows increased Ca2+ influx. We examined the contribution of Ca (2+)/calmodulin-dependent protein kinase II alpha (Ca2+/CaMKII alpha), interaction of 5-HT3R with calmodulin, and extracellular signal-regulated kinase 1/2 (ERK1/2) signaling to 2-Me-5-HT-induced emesis in the least shrew. Using fluo-4 AM dye, we found that 2-Me-5-HT augments intracellular Ca2+ levels in brainstem slices and that the selective 5-HT3R antagonist palonosetron, can abolish the induced Ca2+ signaling. Pre-treatment of shrews with either: i) amlodipine, an antagonist of L-type Ca2+ channels present on the cell membrane; ii) dantrolene, an inhibitor of ryanodine receptors (RyRs) Ca2+-release channels located on the endoplasmic reticulum (ER); iii) a combination of their less-effective doses; or iv) inhibitors of CaMKII (KN93) and ERK1/2 (PD98059); dose-dependently suppressed emesis caused by 2-Me-5-HT. Administration of 2-Me-5-HT also significantly: i) enhanced the interaction of 5-HT3R with calmodulin in the brainstem as revealed by immunoprecipitation, as well as their colocalization in the area postrema (brainstem) and small intestine by immunohistochemistry; and ii) activated CaMKII alpha in brainstem and in isolated enterochromaffin cells of the small intestine as shown by Western blot and immunocytochemistry. These effects were suppressed by palonosetron. 2-Me-5-HT also activated ERK1/2 in brainstem, which was abrogated by palonosetron, KN93, PD98059, amlodipine, dantrolene, or a combination of amlodipine plus dantrolene. However, blockade of ER inositol-1, 4, 5-triphosphate receptors by 2-APB, had no significant effect on the discussed behavioral and biochemical parameters. This study demonstrates that Ca2+ mobilization via extracellular Ca2+ influx through 5-HT(3)Rs/L-type Ca2+ channels, and intracellular Ca2+ release via RyRs on ER, initiate Ca2+-dependent sequential activation of CaMKII alpha and ERK1/2, which contribute to the 5-HT3R-mediated, 2-Me-5-HT-evoked emesis.	[Zhong, Weixia; Hutchinson, Tarun E.; Chebolu, Seetha; Darmani, Nissar A.] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Dept Basic Med Sci, Pomona, CA 91766 USA	Western University of Health Sciences	Darmani, NA (corresponding author), Western Univ Hlth Sci, Coll Osteopath Med Pacific, Dept Basic Med Sci, Pomona, CA 91766 USA.	ndarmani@westernu.edu			COMP/WesternU	COMP/WesternU	The author (NAD) used start up funds from COMP/WesternU for this study. The funders had no role in study design, data collection and analysis, decission to publish, or preparation of the manuscript.	Alkam T, 2014, EUR J PHARMACOL, V722, P156, DOI 10.1016/j.ejphar.2013.09.080; Darmani NA, 2004, EUR J PHARMACOL, V488, P201, DOI 10.1016/j.ejphar.2004.02.018; Darmani NA, 1998, J NEURAL TRANSM, V105, P1143, DOI 10.1007/s007020050118; DARMANI NA, 1994, PHARMACOL BIOCHEM BE, V48, P383, DOI 10.1016/0091-3057(94)90542-8; Darmani NA, 1999, J NEURAL TRANSM, V106, P1045, DOI 10.1007/s007020050222; Darmani NA, 2014, EUR J PHARMACOL, V722, P2, DOI 10.1016/j.ejphar.2013.08.052; Darmani NA, 2013, EUR J PHARMACOL, V698, P161, DOI 10.1016/j.ejphar.2012.09.008; Darmani NA, 2011, PHARMACOL BIOCHEM BE, V99, P573, DOI 10.1016/j.pbb.2011.05.025; Darmani NA, 2009, CHEM REV, V109, P3158, DOI 10.1021/cr900117p; Darmani NA, 2009, BRAIN RES, V1248, P40, DOI 10.1016/j.brainres.2008.10.063; Day M, 2002, J NEUROPHYSIOL, V87, P2490, DOI 10.1152/jn.00843.2001; Endo T, 1999, RES COMMUN MOL PATH, V104, P145; Engleman EA, 2008, CNS NEUROL DISORD-DR, V7, P454, DOI 10.2174/187152708786927886; Glatzle J, 2002, GASTROENTEROLOGY, V123, P217, DOI 10.1053/gast.2002.34245; Glennon RA, 2000, J MED CHEM, V43, P1011, DOI 10.1021/jm990550b; Gustin RM, 2011, MOL CELL NEUROSCI, V47, P286, DOI 10.1016/j.mcn.2011.05.006; Hargreaves AC, 1996, MOL PHARMACOL, V50, P1284; Homma K, 2006, J NEUROSCI RES, V84, P316, DOI 10.1002/jnr.20894; Horn CC, 2014, AM J PHYSIOL-REG I, V306, pR341, DOI 10.1152/ajpregu.00413.2013; Hu WP, 2004, NEUROPHARMACOLOGY, V47, P833, DOI 10.1016/j.neuropharm.2004.06.015; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; ISMAIEL AM, 1990, J MED CHEM, V33, P755, DOI 10.1021/jm00164a046; Jones S, 1998, J PHYSIOL-LONDON, V510, P361, DOI 10.1111/j.1469-7793.1998.361bk.x; Orejarena MJ, 2011, INT J NEUROPSYCHOPH, V14, P927, DOI 10.1017/S1461145710001215; Katoh H, 2000, CIRC RES, V87, P106, DOI 10.1161/01.RES.87.2.106; King MV, 2004, NEUROPHARMACOLOGY, V47, P195, DOI 10.1016/j.neuropharm.2004.03.012; Kovalevskaya NV, 2013, PFLUG ARCH EUR J PHY, V465, P1507, DOI 10.1007/s00424-013-1278-0; Labasque M, 2008, MOL BIOL CELL, V19, P4640, DOI 10.1091/mbc.E08-04-0422; Lasheras B, 1996, ARZNEIMITTEL-FORSCH, V46, P401; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lu KK, 2005, AM J PHYSIOL-CELL PH, V289, pC1343, DOI 10.1152/ajpcell.00064.2005; Lucas JL, 2006, PHARM RES-DORDR, V23, P647, DOI 10.1007/s11095-006-9784-9; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; Minami M, 2003, PHARMACOL THERAPEUT, V99, P149, DOI 10.1016/S0163-7258(03)00057-3; Monti JM, 2011, BEHAV BRAIN RES, V216, P381, DOI 10.1016/j.bbr.2010.08.020; MS Al-Tikriti WK, 2012, DISTRIBUTION SEROTON; Muthalif MM, 2002, HYPERTENSION, V39, P704, DOI 10.1161/hy0202.103823; Niebert M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021395; O'Day DH, 2003, CELL SIGNAL, V15, P347, DOI 10.1016/S0898-6568(02)00116-X; Ray AP, 2009, PHARMACOL BIOCHEM BE, V94, P211, DOI 10.1016/j.pbb.2009.08.010; Ray AP, 2009, BEHAV NEUROSCI, V123, P701, DOI 10.1037/a0015733; Resende RR, 2010, STEM CELLS DEV, V19, P379, DOI 10.1089/scd.2008.0289; Romero G, 2006, BRIT J PHARMACOL, V148, P1133, DOI 10.1038/sj.bjp.0706827; Ronde P, 1997, CELL CALCIUM, V22, P357, DOI 10.1016/S0143-4160(97)90020-8; Ronde P, 1998, J NEUROCHEM, V70, P1094; Ronde P, 2000, J PHYSIOL-LONDON, V529, P307, DOI 10.1111/j.1469-7793.2000.00307.x; Schafermeyer A, 2004, ACTA PHYSIOL SCAND, V182, P53, DOI 10.1111/j.1365-201X.2004.01299.x; Schierberl K, 2011, J NEUROSCI, V31, P13562, DOI 10.1523/JNEUROSCI.2315-11.2011; Simms BA, 2013, PFLUGERS ARCH; Soderling TR, 2001, J BIOL CHEM, V276, P3719, DOI 10.1074/jbc.R000013200; Svensson CI, 2006, FEBS LETT, V580, P6629, DOI 10.1016/j.febslet.2006.11.012; Takenouchi T, 1998, NEUROSCI LETT, V246, P141, DOI 10.1016/S0304-3940(98)00253-5; TORII Y, 1991, N-S ARCH PHARMACOL, V344, P564; Trudeau MC, 2003, J BIOL CHEM, V278, P18705, DOI 10.1074/jbc.R300001200; Turner JH, 2005, J BIOL CHEM, V280, P30741, DOI 10.1074/jbc.M501696200; Turner JH, 2004, J BIOL CHEM, V279, P17027, DOI 10.1074/jbc.M313919200; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Vincent KM, 2011, NEUROGASTROENT MOTIL, V23, pE282, DOI 10.1111/j.1365-2982.2011.01673.x; Yadav PN, 2011, J PHARMACOL EXP THER, V339, P99, DOI 10.1124/jpet.111.183780; Young KA, 2005, J PHYSIOL-LONDON, V565, P349, DOI 10.1113/jphysiol.2004.081422; Zhong WX, 2014, PHARMACOL BIOCHEM BE, V120, P124, DOI 10.1016/j.pbb.2014.03.005; Ziviani E, 2011, EMBO J, V30, P194, DOI 10.1038/emboj.2010.279	63	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104718	10.1371/journal.pone.0104718	http://dx.doi.org/10.1371/journal.pone.0104718			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25121483	Green Published, Green Submitted, gold			2022-12-27	WOS:000341017000057
J	Asmussen, MJ; Zapallow, CM; Jacobs, MF; Lee, KGH; Tsang, P; Nelson, AJ				Asmussen, Michael J.; Zapallow, Christopher M.; Jacobs, Mark F.; Lee, Kevin G. H.; Tsang, Philemon; Nelson, Aimee J.			Modulation of Short-Latency Afferent Inhibition Depends on Digit and Task-Relevance	PLOS ONE			English	Article							FOCAL HAND DYSTONIA; SOMATOSENSORY CORTEX; SURROUND INHIBITION; PREFRONTAL CORTEX; MOTOR CORTEX; INTEGRATION; MOVEMENT; CIRCUITS; HUMANS; INITIATION	Short-latency afferent inhibition (SAI) occurs when a single transcranial magnetic stimulation (TMS) pulse delivered over the primary motor cortex is preceded by peripheral electrical nerve stimulation at a short inter-stimulus interval (similar to 20-28 ms). SAI has been extensively examined at rest, but few studies have examined how this circuit functions in the context of performing a motor task and if this circuit may contribute to surround inhibition. The present study investigated SAI in a muscle involved versus uninvolved in a motor task and specifically during three pre-movement phases; two movement preparation phases between a "warning'' and "go'' cue and one movement initiation phase between a "go'' cue and EMG onset. SAI was tested in the first dorsal interosseous (FDI) and abductor digiti minimi (ADM) muscles in twelve individuals. In a second experiment, the origin of SAI modulation was investigated by measuring H-reflex amplitudes from FDI and ADM during the motor task. The data indicate that changes in SAI occurred predominantly in the movement initiation phase during which SAI modulation depended on the specific digit involved. Specifically, the greatest reduction in SAI occurred when FDI was involved in the task. In contrast, these effects were not present in ADM. Changes in SAI were primarily mediated via supraspinal mechanisms during movement preparation, while both supraspinal and spinal mechanisms contributed to SAI reduction during movement initiation.	[Asmussen, Michael J.; Zapallow, Christopher M.; Jacobs, Mark F.; Lee, Kevin G. H.; Tsang, Philemon; Nelson, Aimee J.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	McMaster University	Nelson, AJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	nelsonaj@mcmaster.ca			Natural Sciences and Engineering Research Council [RGPIN-2009-371924]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Natural Sciences and Engineering Research Council to AJN. (RGPIN-2009-371924.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmussen MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060496; Beck S, 2009, J APPL PHYSIOL, V107, P1513, DOI 10.1152/japplphysiol.91580.2008; Beck S, 2008, J NEUROSCI, V28, P10363, DOI 10.1523/JNEUROSCI.3564-08.2008; Beck S, 2011, EXP BRAIN RES, V210, P165, DOI 10.1007/s00221-011-2610-6; BLAKEMOR.C, 1970, NATURE, V228, P37, DOI 10.1038/228037a0; Chen YS, 2010, J ELECTROMYOGR KINES, V20, P980, DOI 10.1016/j.jelekin.2009.11.003; Di Lazzaro V, 2007, CLIN NEUROPHYSIOL, V118, P2207, DOI 10.1016/j.clinph.2007.07.005; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V569, P315, DOI 10.1113/jphysiol.2005.092155; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V564, P661, DOI 10.1113/jphysiol.2004.061747; Di Lazzaro V, 2012, STROKE, V43, P250, DOI 10.1161/STROKEAHA.111.631085; Elbert T, 1998, NEUROREPORT, V9, P3571, DOI 10.1097/00001756-199811160-00006; Fischer M, 2011, BRAIN STIMUL, V4, P202, DOI 10.1016/j.brs.2010.10.005; Inghilleri A, 2003, CLIN NEUROPHYSIOL, V114, P1096, DOI 10.1016/S1388-2457(03)00056-7; KINOSHITA H, 1995, ERGONOMICS, V38, P1212; Kinoshita H, 1996, ERGONOMICS, V39, P243, DOI 10.1080/00140139608964455; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Knikou M, 2008, J NEUROSCI METH, V171, P1, DOI 10.1016/j.jneumeth.2008.02.012; McNeil CJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00152; Nelson AJ, 2009, ANN NEUROL, V66, P146, DOI 10.1002/ana.21626; Ni Z, 2011, J NEUROPHYSIOL, V105, P749, DOI 10.1152/jn.00640.2010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Reilmann R, 2001, EXP BRAIN RES, V140, P443, DOI 10.1007/s002210100838; Richardson SP, 2008, MUSCLE NERVE, V37, P358, DOI 10.1002/mus.20943; Rothwell J C, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P97; Sailer A, 2003, BRAIN, V126, P1883, DOI 10.1093/brain/awg183; SUTHERLING WW, 1992, NEUROLOGY, V42, P1020, DOI 10.1212/WNL.42.5.1020; SWANSON AB, 1964, SURG CLIN N AM, V44, P925; Tamburin S, 2005, EXP BRAIN RES, V167, P362, DOI 10.1007/s00221-005-0041-y; Tinazzi M, 2000, BRAIN, V123, P42, DOI 10.1093/brain/123.1.42; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; Udupa K, 2014, J NEUROPHYSIOL, V111, P1350, DOI 10.1152/jn.00613.2013; Udupa K, 2009, EXP BRAIN RES, V199, P177, DOI 10.1007/s00221-009-1997-9; Voller B, 2006, EXP BRAIN RES, V169, P226, DOI 10.1007/s00221-005-0140-9; Zikopoulos B, 2007, REV NEUROSCIENCE, V18, P417	34	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104807	10.1371/journal.pone.0104807	http://dx.doi.org/10.1371/journal.pone.0104807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118700	Green Published, Green Submitted, gold			2022-12-27	WOS:000340900600088
J	Srivastava, P; Khandokar, YB; Swarbrick, CMD; Roman, N; Himiari, Z; Sarker, S; Raidal, SR; Forwood, JK				Srivastava, Parul; Khandokar, Yogesh B.; Swarbrick, Crystall M. D.; Roman, Noelia; Himiari, Zainab; Sarker, Subir; Raidal, Shane R.; Forwood, Jade K.			Structural Characterization of a Gcn5-Related N-Acetyltransferase from Staphylococcus aureus	PLOS ONE			English	Article							METHICILLIN-RESISTANT; CATALYSIS	The Gcn5-related N-acetyltransferases (GNATs) are ubiquitously expressed in nature and perform a diverse range of cellular functions through the acetylation of small molecules and protein substrates. Using activated acetyl coenzyme A as a common acetyl donor, GNATs catalyse the transfer of an acetyl group to acceptor molecules including aminoglycoside antibiotics, glucosamine-6-phosphate, histones, serotonin and spermidine. There is often only very limited sequence conservation between members of the GNAT superfamily, in part, reflecting their capacity to bind a diverse array of substrates. In contrast, the secondary and tertiary structures are highly conserved, but then at the quaternary level there is further diversity, with GNATs shown to exist in monomeric, dimeric, or tetrameric states. Here we describe the X-ray crystallographic structure of a GNAT enzyme from Staphyloccocus aureus with only low sequence identity to previously solved GNAT proteins. It contains many of the classical GNAT motifs, but lacks other hallmarks of the GNAT fold including the classic beta-bulge splayed at the beta-sheet interface. The protein is likely to be a dimer in solution based on analysis of the asymmetric unit within the crystal structure, homology with related GNAT family members, and size exclusion chromatography. The study provides the first high resolution structure of this enzyme, providing a strong platform for substrate and cofactor modelling, and structural/functional comparisons within this diverse enzyme superfamily.	[Srivastava, Parul; Khandokar, Yogesh B.; Swarbrick, Crystall M. D.; Roman, Noelia; Himiari, Zainab; Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia; [Sarker, Subir; Raidal, Shane R.] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia	Charles Sturt University; Charles Sturt University	Forwood, JK (corresponding author), Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia.	jforwood@csu.edu.au	Raidal, Shane/C-4632-2008; Sarker, Subir/U-8444-2019	Raidal, Shane/0000-0001-7917-8976; Sarker, Subir/0000-0002-2685-8377; KHANDOKAR, YOGESH/0000-0002-4630-8508; Swarbrick, Crystall/0000-0002-9337-3361; Roman, Noelia/0000-0003-0856-2131; Forwood, Jade/0000-0003-3267-9997				Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bewley MC, 2006, P NATL ACAD SCI USA, V103, P2063, DOI 10.1073/pnas.0511008103; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Davies J, 1997, TRENDS MICROBIOL, V5, P234, DOI 10.1016/S0966-842X(97)01033-0; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Reith J, 2011, J BACTERIOL, V193, P5393, DOI 10.1128/JB.05519-11; Shittu AO, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-125; Stefani S, 2010, INT J INFECT DIS, V14, pS19, DOI 10.1016/j.ijid.2010.05.009; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Trautmann M, 2002, EUR J CLIN MICROBIOL, V21, P43, DOI 10.1007/s10096-001-0643-7; Vetting MW, 2008, PROTEIN SCI, V17, P1781, DOI 10.1110/ps.035899.108; Vetting MW, 2008, BIOCHEMISTRY-US, V47, P9825, DOI 10.1021/bi800664x; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003; Wolf E, 2002, J MOL BIOL, V317, P215, DOI 10.1006/jmbi.2001.5371	21	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e102348	10.1371/journal.pone.0102348	http://dx.doi.org/10.1371/journal.pone.0102348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118709	Green Published, gold			2022-12-27	WOS:000340900600005
J	Weltermann, BM; Markic, M; Thielmann, A; Gesenhues, S; Hermann, M				Weltermann, Birgitta M.; Markic, Marta; Thielmann, Anika; Gesenhues, Stefan; Hermann, Martin			Vaccination Management and Vaccination Errors: A Representative Online-Survey among Primary Care Physicians	PLOS ONE			English	Article							COLD CHAIN; STORAGE; IMMUNIZATION; KNOWLEDGE; MEASLES	Background: Effective immunizations require a thorough, multi-step process, yet few studies comprehensively addressed issues around vaccination management. Objectives: To assess variations in vaccination management and vaccination errors in primary care. Methods: A cross sectional, web-based questionnaire survey was performed among 1157 primary physicians from North Rhine-Westphalia, Germany: a representative 10% random sample of general practitioners (n = 946) and all teaching physicians from the University Duisburg-Essen (n = 211). Four quality aspects with three items each were included: patient-related quality (patient information, patient consent, strategies to increase immunization rates), vaccine-related quality (practice vaccine spectrum, vaccine pre-selection, vaccination documentation), personnel-related quality (recommendation of vaccinations, vaccine application, personnel qualification) and storage-related quality (storage device, temperature log, vaccine storage control). For each of the four quality aspects, "good quality" was reached if all three criteria per quality aspect were fulfilled. Good vaccination management was defined as fulfilling all twelve items. Additionally, physicians' experiences with errors and nearby-errors in vaccination management were obtained. Results: More than 20% of the physicians participated in the survey. Good vaccination management was reached by 19% of the practices. Patient-related quality was good in 69% of the practices, vaccine-related quality in 73%, personnel-related quality in 59% and storage-related quality in 41% of the practices. No predictors for error reporting and good vaccination management were identified. Conclusions: We identified good results for vaccine-and patient-related quality but need to improve issues that revolve around vaccine storage.	[Weltermann, Birgitta M.; Markic, Marta; Thielmann, Anika; Gesenhues, Stefan; Hermann, Martin] Univ Duisburg Essen, Essen Univ Hosp, Inst Gen Med, Essen, Germany	University of Duisburg Essen	Weltermann, BM (corresponding author), Univ Duisburg Essen, Essen Univ Hosp, Inst Gen Med, Essen, Germany.	birgitta.weltermann@uk-essen.de			ministry of innovation, science and research of North Rhine-Westphalia, Germany	ministry of innovation, science and research of North Rhine-Westphalia, Germany	The study was supported by an institutional grant from the ministry of innovation, science and research of North Rhine-Westphalia, Germany. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2013, AUSTR IMM HDB; [Anonymous], 2013, GEM BUND RICHTL GEM; [Anonymous], EPIDEMIOL B; [Anonymous], 2019, RUBELLA; Australian Government, 2005, NAT VACC STOR GUID S; Bailey HD, 1999, AUST NZ J PUBL HEAL, V23, P6, DOI 10.1111/j.1467-842X.1999.tb01198.x; Bell KN, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e100; Bundesinstitut fur Arzneimittel und Medizinprodukte (BfArM) & Paul-Ehrlich-Institut (PEI), 2012, B ARZN INF BFARM PEI; Bundy DG, 2009, VACCINE, V27, P3890, DOI 10.1016/j.vaccine.2009.04.005; Cohen NJ, 2003, PEDIATRICS, V111, P925, DOI 10.1542/peds.111.5.925; Gazmararian JA, 2002, AM J PREV MED, V23, P246, DOI 10.1016/S0749-3797(02)00512-3; Grabenstein JD, 2008, J AM PHARM ASSOC, V48, P105, DOI 10.1331/JAPhA.2008.08502; Kroger Andrew T., 2011, Morbidity and Mortality Weekly Report, V60, P3; Jacobson Vann JC, 2005, COCHRANE DB SYST REV, V3; Kommission fur Krankenhaushygiene und Infektionspravention Robert Koch Institute, 2011, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V54, P1135, DOI 10.1007/s00103-011-1352-8; LERMAN SJ, 1971, J AMER MED ASSOC, V216, P1311, DOI 10.1001/jama.216.8.1311; Lewis PR, 2001, AUST NZ J PUBL HEAL, V25, P547, DOI 10.1111/j.1467-842X.2001.tb00322.x; Martin M, 2012, OJ PEDIAT, V2, P228, DOI DOI 10.4236/OJPED.2012.23036; Matthias DM, 2007, VACCINE, V25, P3980, DOI 10.1016/j.vaccine.2007.02.052; Maurer W, 2000, VACCINE, V18, P1539, DOI 10.1016/S0264-410X(99)00435-1; McColloster P, 2011, AM J PUBLIC HEALTH, V101, P46, DOI 10.2105/AJPH.2009.179853; ONOJA AL, 1992, VACCINE, V10, P49, DOI 10.1016/0264-410X(92)90419-K; Page SL, 2008, AUST FAM PHYSICIAN, V37, P892; Robert Koch-Institut, 2007, EPIDEMIOLOGISCHES B, V25, P219; Salisbury D, 2006, IMMUNISATION INFECT, V3rd; Shaw JS, 2000, PEDIATRICS, V105, P978; Szilagyi PG, 2005, PREV MED, V40, P152, DOI 10.1016/j.ypmed.2004.05.010; WHO, 2006, TEMP SENS DIPHTH CON; WHO Unicef, 2013, GLOB IMM DAT; YUAN LL, 1995, CAN FAM PHYSICIAN, V41, P1169	30	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e105119	10.1371/journal.pone.0105119	http://dx.doi.org/10.1371/journal.pone.0105119			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	25118779	gold, Green Published, Green Submitted			2022-12-27	WOS:000340900600125
J	Ma, L; Wang, K; Shang, JY; Cao, CZ; Zhen, PP; Liu, X; Wang, W; Zhang, H; Du, YH; Liu, HR				Ma, Lu; Wang, Ke; Shang, Jianyu; Cao, Chengzhang; Zhen, Panpan; Liu, Xin; Wang, Wen; Zhang, Hui; Du, Yunhui; Liu, Huirong			Anti-Peroxynitrite Treatment Ameliorated Vasorelaxation of Resistance Arteries in Aging Rats: Involvement with NO-sGC-cGKs Pathway	PLOS ONE			English	Article							NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION; GUANYLYL CYCLASE; DEPENDENT VASODILATION; VASCULAR DYSFUNCTION; AEROBIC EXERCISE; SMOOTH-MUSCLE; BLOOD-FLOW; MICE; HYPERTENSION	Declined vasorelaxation function in aging resistance arteries is responsible for aging-related multiple organ dysfunctions. The aim of the present study is to explore the role of peroxynitrite (ONOO-) in aging resistance arterial vasorelaxation dysfunction and the possible mechanism. In the present study, young (3-4 months olds) and aging (20 months olds) male SD rats were randomized to receive vehicle (Saline) or FeTMPyP (ONOO- scavenger) for 2 weeks. The vasorelaxation of resistance arteries was determined in vitro; NOx level was tested by a colorimetric assay; the expression of nitrotyrosine (NT), soluble Guanylate Cyclase (sGC), vasodilator-stimulated phosphoprotein (VASP), phosphorylated VASP (P-VASP) and cGMP in resistance arteries were detected by immunohistochemical staining. In the present study, endothelium-dependent dilation in aging resistance arteries was lower than in those from young rats (young vs. aging: 68.0% +/- 4.5% vs. 50.4% +/- 2.9%, P < 0.01). And the endothelium-independent dilation remained constant. Compared with young rats, aging increased nitrative stress in resistance arteries, evidenced by elevated NOx production in serum (5.3 +/- 1.0 nmol/ml vs. 3.3 +/- 1.4 nmol/ml, P < 0.05) and increased NT expression (P < 0.05). ONOO- was responsible for the vasorelaxation dysfunction, evidenced by normalized vasorelaxation after inhibit ONOO- or its sources (P, 0.05) and suppressed NT expression after FeTMPyP treatment (P < 0.05). The expression of sGC was not significantly different between young and aging resistance arteries, but the cGMP level and P-VASP/VASP ratio (biochemical marker of NO-sGC-cGKs signaling) decreased, which was reversed by FeTMPyP treatment in vivo (P, 0.05). The present study suggested that ONOO- mediated the decline of endothelium-dependent vasorelaxation of aging resistance arteries by induction of the NO-sGC-cGKs pathway dysfunction.	[Ma, Lu; Wang, Ke; Shang, Jianyu; Liu, Xin; Wang, Wen; Zhang, Hui; Du, Yunhui; Liu, Huirong] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Cao, Chengzhang] Fujian Med Univ, Hosp Longyan 1, Dept Chest Surg, Fujian, Peoples R China; [Zhen, Panpan] Capital Med Univ, Luhe Hosp, Dept Pathol, Beijing, Peoples R China; [Liu, Huirong] Beijing Key Lab Metab Disturbance Related Cardiov, Beijing, Peoples R China	Capital Medical University; Fujian Medical University; Capital Medical University	Liu, HR (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China.	liuhr2000@126.com			National Natural Science Foundation of China [81270283, 30973163]; Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality [PHR201106112]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality	This research was supported by two funders: 1. National Natural Science Foundation of China (Grant NO. 81270283 and 30973163 to HL). http://www.nsfc.gov.cn/. 2. Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality (PHR201106112 to HL). http://www.bjedu.gov.cn/publish/portal0/tab40/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo J, 2012, EXP GERONTOL, V47, P734, DOI 10.1016/j.exger.2012.06.014; Bucci M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053319; Cabassi A, 2014, CIRC RES; Cau SBA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00218; Cernadas MR, 1998, CIRC RES, V83, P279, DOI 10.1161/01.RES.83.3.279; Cheng ZJ, 2011, BLOOD, V118, P1998, DOI 10.1182/blood-2011-01-333310; Csiszar A, 2002, CIRC RES, V90, P1159, DOI 10.1161/01.RES.0000020401.61826.EA; Daiber A, 2013, INT J MOL SCI, V14, P7542, DOI 10.3390/ijms14047542; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Fleenor BS, 2012, AGING CELL, V11, P269, DOI 10.1111/j.1474-9726.2011.00783.x; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Goettsch W, 2001, BIOCHEM BIOPH RES CO, V280, P908, DOI 10.1006/bbrc.2000.4180; Hong CW, 2013, J RAD RES; Idris-Khodja N, 2012, N-S ARCH PHARMACOL, V385, P749, DOI 10.1007/s00210-012-0749-8; James MA, 2006, HYPERTENSION, V47, P968, DOI 10.1161/01.HYP.0000209939.05482.61; Kloss S, 2005, HYPERTENSION, V45, P1200, DOI 10.1161/01.HYP.0000165674.58470.8f; Kloss S, 2000, HYPERTENSION, V35, P43; Leocadio Rodri Guez-Man As ME, 2009, AGING CELL; Lesniewski LA, 2013, EXP GERONTOL, V48, P1218, DOI 10.1016/j.exger.2013.08.001; Lesniewski LA, 2011, AM J PHYSIOL-HEART C, V301, pH1025, DOI 10.1152/ajpheart.01276.2010; Liu YP, 2002, CIRC RES, V91, P1070, DOI 10.1161/01.RES.0000046003.14031.98; Marasciulo FL, 2006, CURR MED CHEM, V13, P1655, DOI 10.2174/092986706777441968; Martinez-Ruiz A, 2011, FREE RADICAL BIO MED, V51, P17, DOI 10.1016/j.freeradbiomed.2011.04.010; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; Moreau P, 1998, CARDIOVASC RES, V37, P247, DOI 10.1016/S0008-6363(97)00225-3; Nardi GM, 2014, CRIT CARE MED; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; Palomares SM, 2012, J CEREBR BLOOD F MET, V32, P1035, DOI 10.1038/jcbfm.2012.14; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; Prisby RD, 2007, J BONE MINER RES, V22, P1280, DOI 10.1359/JBMR.070415; Radovits T, 2007, MECH AGEING DEV, V128, P173, DOI 10.1016/j.mad.2006.09.005; Sastry KVH, 2002, ANAL BIOCHEM, V306, P79, DOI 10.1006/abio.2002.5676; Schildknecht S, 2009, ARCH BIOCHEM BIOPHYS, V484, P183, DOI 10.1016/j.abb.2008.10.023; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Staehr M, 2011, AM J PHYSIOL-REG I, V301, pR412, DOI 10.1152/ajpregu.00823.2010; Stavniichuk R, 2014, DIABETES METAB RES R, DOI 10.10002/dmrr.2549; Stibingerova A, 2009, GEN PHYSL BIOPHYS, V28, P384; Tao L, 2003, CIRCULATION, V108, P2805, DOI 10.1161/01.CIR.0000097003.49585.5E; Tian J, 2010, ACTA PHARMACOL SIN, V31, P1324, DOI 10.1038/aps.2010.111; Toda N, 2011, EUR J PHARMACOL, V667, P41, DOI 10.1016/j.ejphar.2011.06.028; Wang PG, 2002, CHEM REV, V102, P1091, DOI 10.1021/cr000040l; Yan Z, 2010, BIOCHEM BIOPH RES CO, V393, P531, DOI 10.1016/j.bbrc.2010.02.049; Yoon HJ, 2010, MECH AGEING DEV, V131, P119, DOI 10.1016/j.mad.2009.12.010; Zhang HY, 2007, CIRC RES, V100, P730, DOI 10.1161/01.RES.0000260189.38975.35; Zhou XS, 2009, AM J PHYSIOL-HEART C, V297, pH2227, DOI 10.1152/ajpheart.00325.2009	45	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104788	10.1371/journal.pone.0104788	http://dx.doi.org/10.1371/journal.pone.0104788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25117910	Green Submitted, Green Published, gold			2022-12-27	WOS:000341230400086
J	Maluta, RP; Logue, CM; Casas, MRT; Meng, T; Guastalli, EAL; Rojas, TCG; Montelli, AC; Sadatsune, T; Ramos, MD; Nolan, LK; da Silveira, WD				Maluta, Renato Pariz; Logue, Catherine Mary; Tiba Casas, Monique Ribeiro; Meng, Ting; Lopes Guastalli, Elisabete Aparecida; Galvao Rojas, Thais Cabrera; Montelli, Augusto Cezar; Sadatsune, Terue; Ramos, Marcelo de Carvalho; Nolan, Lisa Kay; da Silveira, Wanderley Dias			Overlapped Sequence Types (STs) and Serogroups of Avian Pathogenic (APEC) and Human Extra-Intestinal Pathogenic (ExPEC) Escherichia coli Isolated in Brazil	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; VIRULENCE; STRAINS; POULTRY; RESISTANCE; ORIGIN; MEAT	Avian pathogenic Escherichia coli (APEC) strains belong to a category that is associated with colibacillosis, a serious illness in the poultry industry worldwide. Additionally, some APEC groups have recently been described as potential zoonotic agents. In this work, we compared APEC strains with extraintestinal pathogenic E. coli (ExPEC) strains isolated from clinical cases of humans with extra-intestinal diseases such as urinary tract infections (UTI) and bacteremia. PCR results showed that genes usually found in the ColV plasmid (tsh, iucA, iss, and hlyF) were associated with APEC strains while fyuA, irp-2, fepC sitD(chrom), fimH, crl, csgA, afa, iha, sat, hlyA, hra, cnf1, kpsMTII, clpV(Sakai) and malX were associated with human ExPEC. Both categories shared nine serogroups (O2, O6, O7, O8, O11, O19, O25, O73 and O153) and seven sequence types (ST10, ST88, ST93, ST117, ST131, ST155, ST359, ST648 and ST1011). Interestingly, ST95, which is associated with the zoonotic potential of APEC and is spread in avian E. coli of North America and Europe, was not detected among 76 APEC strains. When the strains were clustered based on the presence of virulence genes, most ExPEC strains (71.7%) were contained in one cluster while most APEC strains (63.2%) segregated to another. In general, the strains showed distinct genetic and fingerprint patterns, but avian and human strains of ST359, or ST23 clonal complex (CC), presented more than 70% of similarity by PFGE. The results demonstrate that some "zoonotic-related'' STs (ST117, ST131, ST10CC, ST23CC) are present in Brazil. Also, the presence of moderate fingerprint similarities between ST359 E. coli of avian and human origin indicates that strains of this ST are candidates for having zoonotic potential.	[Maluta, Renato Pariz; Galvao Rojas, Thais Cabrera; da Silveira, Wanderley Dias] State Univ Campinas UNICAMP, Inst Biol, Dept Genet Evolut & Bioagents, Bacterial Mol Biol Lab, Campinas, SP, Brazil; [Logue, Catherine Mary; Meng, Ting; Nolan, Lisa Kay] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA USA; [Tiba Casas, Monique Ribeiro] Adolfo Lutz Inst, Sao Paulo, Brazil; [Lopes Guastalli, Elisabete Aparecida] CAPTAA, Unidade Pesquisa & Desenvolvimento Bastos, Inst Biol, Bastos, SP, Brazil; [Montelli, Augusto Cezar] Univ Estadual Paulista, Fac Med, Dept Clin Med, Botucatu, SP, Brazil; [Sadatsune, Terue] Univ Estadual Paulista, Inst Biociencias, Dept Microbiol & Imunol, Botucatu, SP, Brazil; [Ramos, Marcelo de Carvalho] Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Iowa State University; Instituto Adolfo Lutz; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual de Campinas	da Silveira, WD (corresponding author), State Univ Campinas UNICAMP, Inst Biol, Dept Genet Evolut & Bioagents, Bacterial Mol Biol Lab, Campinas, SP, Brazil.	wds@unicamp.br	Tiba-Casas, Monique Ribeiro/AAT-1154-2021; Maluta, Renato/D-4997-2012	Maluta, Renato/0000-0003-3249-5127; Logue, Catherine/0000-0002-6098-2662	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/05073-3, 2013/09167-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [PNPD/CAPES 23038.042588/2008-11]; FAPESP [2012/04931-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Dean's Office College of Veterinary Medicine, Iowa State University (ISU); VPR Office, ISU	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Dean's Office College of Veterinary Medicine, Iowa State University (ISU); VPR Office, ISU	RPM (2012/05073-3) and TCGR (2013/09167-5) are fellows from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). This work was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PNPD/CAPES 23038.042588/2008-11) and FAPESP (2012/04931-6). WDS has a scientific fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). CML was supported by the Dean's Office College of Veterinary Medicine, Iowa State University (ISU) and VPR Office, ISU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeit Robert D., 1995, P190; Berman H, 2014, J CLIN MICROBIOLOGY; Borges CA, 2012, FOODBORNE PATHOG DIS, V9, P1119, DOI 10.1089/fpd.2012.1206; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Danzeisen JL, 2013, AVIAN DIS, V57, P104, DOI 10.1637/10218-042812-ResNote.1; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dissanayake DRA, 2014, VET MICROBIOL, V168, P403, DOI 10.1016/j.vetmic.2013.11.028; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; Ginns CA, 2000, INFECT IMMUN, V68, P1535, DOI 10.1128/IAI.68.3.1535-1541.2000; Giufre M, 2012, J ANTIMICROB CHEMOTH, V67, P860, DOI 10.1093/jac/dkr565; Hussein AHM, 2013, AVIAN DIS, V57, P602, DOI 10.1637/10503-012513-Reg.1; Johnson TJ, 2008, APPL ENVIRON MICROB, V74, P7043, DOI 10.1128/AEM.01395-08; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kawamura K, 2014, FOODBORNE PATHOG DIS, V11, P104, DOI 10.1089/fpd.2013.1608; Machado J, 2000, RES MICROBIOL, V151, P535, DOI 10.1016/S0923-2508(00)00223-0; Maluta RP, 2014, FOODBORNE PATHOG DIS, V11, P484, DOI 10.1089/fpd.2013.1719; Manges AR, 2012, CLIN INFECT DIS, V55, P712, DOI 10.1093/cid/cis502; Mellata M, 2013, FOODBORNE PATHOG DIS, V10, P916, DOI 10.1089/fpd.2013.1533; Minarini LAR, 2007, CURR MICROBIOL, V55, P524, DOI 10.1007/s00284-007-9026-3; Mora A, 2012, VET MICROBIOL, V156, P347, DOI 10.1016/j.vetmic.2011.10.033; Mora A, 2010, APPL ENVIRON MICROB, V76, P6991, DOI 10.1128/AEM.01112-10; Moreno E, 2006, EPIDEMIOL INFECT, V134, P1015, DOI 10.1017/S0950268806005917; Moulin-Schouleur M, 2007, J CLIN MICROBIOL, V45, P3366, DOI 10.1128/JCM.00037-07; ORSKOV F, 1984, METHOD MICROBIOL, V14, P43, DOI 10.1016/S0580-9517(08)70447-1; Peirano G, 2011, CLIN MICROBIOL INFEC, V17, P1039, DOI 10.1111/j.1469-0691.2010.03440.x; Pires-dos-Santos T, 2013, VET MICROBIOL, V162, P873, DOI 10.1016/j.vetmic.2012.11.008; Platell JL, 2011, VET MICROBIOL, V153, P99, DOI 10.1016/j.vetmic.2011.05.007; Rodriguez-Siek KE, 2005, MICROBIOL-SGM, V151, P2097, DOI 10.1099/mic.0.27499-0; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Smith JL, 2007, FOODBORNE PATHOG DIS, V4, P134, DOI 10.1089/fpd.2007.0087; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valverde A, 2009, ANTIMICROB AGENTS CH, V53, P5204, DOI 10.1128/AAC.01706-08; Vincent C, 2010, EMERG INFECT DIS, V16, P88, DOI 10.3201/eid1601.091118; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yamamoto S, 1997, J UROLOGY, V157, P1127, DOI 10.1016/S0022-5347(01)65154-1	39	113	120	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e105016	10.1371/journal.pone.0105016	http://dx.doi.org/10.1371/journal.pone.0105016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115913	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230400114
J	Moiroux, N; Damien, GB; Egrot, M; Djenontin, A; Chandre, F; Corbel, V; Killeen, GF; Pennetier, C				Moiroux, Nicolas; Damien, Georgia B.; Egrot, Marc; Djenontin, Armel; Chandre, Fabrice; Corbel, Vincent; Killeen, Gerry F.; Pennetier, Cedric			Human Exposure to Early Morning Anopheles funestus Biting Behavior and Personal Protection Provided by Long-Lasting Insecticidal Nets	PLOS ONE			English	Article							TREATED NETS; MALARIA; MOSQUITOS; INTERVENTIONS; TRANSMISSION; RESISTANCE; EFFICACY; WESTERN; AREA	A shift towards early morning biting behavior of the major malaria vector Anopheles funestus have been observed in two villages in south Benin following distribution of long-lasting insecticidal nets (LLINs), but the impact of these changes on the personal protection efficacy of LLINs was not evaluated. Data from human and An. funestus behavioral surveys were used to measure the human exposure to An. funestus bites through previously described mathematical models. We estimated the personal protection efficacy provided by LLINs and the proportions of exposure to bite occurring indoors and/or in the early morning. Average personal protection provided by using of LLIN was high (>= 80% of the total exposure to bite), but for LLIN users, a large part of remaining exposure occurred outdoors (45.1% in Tokoli-V and 68.7% in Lokohoue) and/or in the early morning (38.5% in Tokoli-V and 69.4% in Lokohoue). This study highlights the crucial role of LLIN use and the possible need to develop new vector control strategies targeting malaria vectors with outdoor and early morning biting behavior. This multidisciplinary approach that supplements entomology with social science and mathematical modeling illustrates just how important it is to assess where and when humans are actually exposed to malaria vectors before vector control program managers, policy-makers and funders conclude what entomological observations imply.	[Moiroux, Nicolas; Damien, Georgia B.; Egrot, Marc; Djenontin, Armel; Pennetier, Cedric] IRD, CNRS 5290, IRD 224, MIVEGEC,UM1 UM2, Cotonou, Benin; [Moiroux, Nicolas; Chandre, Fabrice; Corbel, Vincent] IRD, CNRS 5290, IRD 224, MIVEGEC,UM1 UM2, Montpellier, France; [Moiroux, Nicolas; Damien, Georgia B.; Egrot, Marc; Djenontin, Armel; Pennetier, Cedric] CREC, Minist Sante, Montpellier, France; [Djenontin, Armel] Univ dAbomey Calavi, Fac Sci & Tech, Montpellier, France; [Corbel, Vincent] Kasetsart Univ, Dept Entomol, Bangkok, Thailand; [Killeen, Gerry F.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania; [Killeen, Gerry F.] Univ Liverpool, Liverpool Sch Trop Med, Vector Biol Dept, Liverpool L3 5QA, Merseyside, England	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Kasetsart University; Ifakara Health Institute; Liverpool School of Tropical Medicine; University of Liverpool	Moiroux, N (corresponding author), IRD, CNRS 5290, IRD 224, MIVEGEC,UM1 UM2, Cotonou, Benin.	nicolas.moiroux@ird.fr	Chandre, Fabrice/Q-3429-2019; Moiroux, Nicolas/AFT-2925-2022; Pennetier, Cedric/K-2010-2016; Corbel, VIncent/G-9576-2016; Marc, Egrot/AAF-9581-2021	Chandre, Fabrice/0000-0002-1994-9705; Moiroux, Nicolas/0000-0001-6755-6167; Marc, Egrot/0000-0002-3871-280X; corbel, vincent/0000-0003-0995-3257; Pennetier, Cedric/0000-0002-3362-6371	Anopheles Biology and Control (ABC) Network; Institut de Recherche pour le Developpement; French Ministry of Foreign Affairs through the FSP project REFS [2006-22]	Anopheles Biology and Control (ABC) Network; Institut de Recherche pour le Developpement; French Ministry of Foreign Affairs through the FSP project REFS	This work was supported by the Anopheles Biology and Control (ABC) Network and by the Institut de Recherche pour le Developpement and the French Ministry of Foreign Affairs through the FSP project REFS No. 2006-22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coffinet T, 2009, Med Trop (Mars), V69, P109; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Corbel V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-113; Gillies B.B., 1968, PUBLICATION S AFR I, V343; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; Govella NJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00199; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Killeen GF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-161; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-97; Killeen GF, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-172; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Lindblade KA, 2013, INT J EPIDEMIOL, V42, P247, DOI 10.1093/ije/dyt004; Moiroux N, 2012, J INFECT DIS, V206, P1622, DOI 10.1093/infdis/jis565; Moiroux N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030558; Seyoum A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-101; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175; Yohannes M, 2012, MED VET ENTOMOL, V26, P103, DOI 10.1111/j.1365-2915.2011.00955.x	18	47	47	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104967	10.1371/journal.pone.0104967	http://dx.doi.org/10.1371/journal.pone.0104967			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25115830	Green Published, Green Accepted, gold			2022-12-27	WOS:000341230400109
J	Rieux, A; Soubeyrand, S; Bonnot, F; Klein, EK; Ngando, JE; Mehl, A; Ravigne, V; Carlier, J; de Bellaire, LD				Rieux, Adrien; Soubeyrand, Samuel; Bonnot, Francois; Klein, Etienne K.; Ngando, Josue E.; Mehl, Andreas; Ravigne, Virginie; Carlier, Jean; de Bellaire, Luc de Lapeyre			Long-Distance Wind-Dispersal of Spores in a Fungal Plant Pathogen: Estimation of Anisotropic Dispersal Kernels from an Extensive Field Experiment	PLOS ONE			English	Article							SEED DISPERSAL; POLLEN DISPERSAL; MECHANISTIC MODELS; GENETIC-STRUCTURE; SPATIAL-PATTERNS; AERIAL DISPERSAL; POPULATION; DISEASE; SPREAD; SCALES	Given its biological significance, determining the dispersal kernel (i.e., the distribution of dispersal distances) of spore-producing pathogens is essential. Here, we report two field experiments designed to measure disease gradients caused by sexually-and asexually-produced spores of the wind-dispersed banana plant fungus Mycosphaerella fijiensis. Gradients were measured during a single generation and over 272 traps installed up to 1000 m along eight directions radiating from a traceable source of inoculum composed of fungicide-resistant strains. We adjusted several kernels differing in the shape of their tail and tested for two types of anisotropy. Contrasting dispersal kernels were observed between the two types of spores. For sexual spores (ascospores), we characterized both a steep gradient in the first few metres in all directions and rare long-distance dispersal (LDD) events up to 1000 m from the source in two directions. A heavy-tailed kernel best fitted the disease gradient. Although ascospores distributed evenly in all directions, average dispersal distance was greater in two different directions without obvious correlation with wind patterns. For asexual spores (conidia), few dispersal events occurred outside of the source plot. A gradient up to 12.5 m from the source was observed in one direction only. Accordingly, a thin-tailed kernel best fitted the disease gradient, and anisotropy in both density and distance was correlated with averaged daily wind gust. We discuss the validity of our results as well as their implications in terms of disease diffusion and management strategy.	[Rieux, Adrien; Bonnot, Francois; Ravigne, Virginie; Carlier, Jean] CIRAD, UMR BGPI, Montpellier, France; [Soubeyrand, Samuel; Klein, Etienne K.] INRA, UR546 Biostat & Spatial Proc BioSP, Avignon, France; [Ngando, Josue E.] CARBAP, Njombe, Cameroon; [Mehl, Andreas] Bayer CropSci AG, Monheim, Germany; [de Bellaire, Luc de Lapeyre] CIRAD, UPR Syst Culture Bananiers Plantains Ananas, Montpellier, France	CIRAD; INRAE; Bayer AG; Bayer CropScience; CIRAD	Rieux, A (corresponding author), UCL, Fac Life Sci, Genet Inst, Dept Genet Evolut & Environm, London, England.	a.rieux@ucl.ac.uk	Ravigné, Virginie/AAC-5427-2020; RAVIGNE, Virginie/B-5876-2011	Ravigné, Virginie/0000-0002-4252-2574; RAVIGNE, Virginie/0000-0002-4252-2574; Soubeyrand, Samuel/0000-0003-2447-3067; de Lapeyre de Bellaire, Luc/0000-0003-1243-0887	CIFRE doctoral fellowship from Bayer CropScience; Agence Nationale de la Recherche et de la Technologie [ANRT-123/2008]; Agence Nationale de la Recherche [ANR 07-BDIV-003/Emerfundis, ANR 09-BLAN-0145-01/EMILE]; Europaid contract [ATF/UE-No146-762/786/798/801]; European Research Council (ERC) [260801]	CIFRE doctoral fellowship from Bayer CropScience; Agence Nationale de la Recherche et de la Technologie(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Europaid contract; European Research Council (ERC)(European Research Council (ERC)European Commission)	AR conducted this work during his PhD, which was supported by a CIFRE doctoral fellowship from Bayer CropScience. The funder provided support in the form of salaries for author AM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section. This work was also supported by the Agence Nationale de la Recherche et de la Technologie (ANRT-123/2008); the Agence Nationale de la Recherche (ANR 07-BDIV-003/Emerfundis, and ANR 09-BLAN-0145-01/EMILE); a Europaid contract ATF/UE-No146-762/786/798/801; and a European Research Council (ERC, grant number 260801). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amil AF, 2007, PHYTOPATHOLOGY, V97, P1451, DOI 10.1094/PHYTO-97-11-1451; ANDERSEN M, 1991, AM NAT, V137, P476, DOI 10.1086/285178; Austerlitz F, 2004, MOL ECOL, V13, P937, DOI 10.1111/j.1365-294X.2004.02100.x; Aylor DE, 2003, ECOLOGY, V84, P1989, DOI 10.1890/01-0619; Baguette M, 2003, ECOGRAPHY, V26, P153, DOI 10.1034/j.1600-0587.2003.03364.x; Bialozyt R, 2006, J EVOLUTION BIOL, V19, P12, DOI 10.1111/j.1420-9101.2005.00995.x; Broquet T, 2009, ANNU REV ECOL EVOL S, V40, P193, DOI 10.1146/annurev.ecolsys.110308.120324; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; Burie JB, 2011, ANN BOT-LONDON, V107, P885, DOI 10.1093/aob/mcq233; Burt P. J. A., 2003, MYCOSPHAERELLA LEAF, V1, P111; Burt P. J. A., 1998, AEROBIOLOGIA, V14, P209; Burt PJA, 1997, PLANT PATHOL, V46, P451, DOI 10.1046/j.1365-3059.1997.d01-32.x; Busi R, 2008, THEOR APPL GENET, V117, P1281, DOI 10.1007/s00122-008-0862-8; Champion J, 1963, BANANIER TECHNIQUES; Churchill ACL, 2011, MOL PLANT PATHOL, V12, P307, DOI 10.1111/j.1364-3703.2010.00672.x; Clark JS, 2001, AM NAT, V157, P537, DOI 10.1086/319934; Cox KD, 2001, PLANT DIS, V85, P955, DOI 10.1094/PDIS.2001.85.9.955; Darmency H, 2009, THEOR APPL GENET, V118, P1083, DOI 10.1007/s00122-009-0964-y; de Bellaire LD, 2010, FRUITS, V65, P327, DOI 10.1051/fruits/2010034; Devaux C, 2008, J APPL ECOL, V45, P803, DOI 10.1111/j.1365-2664.2007.01400.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fayard J, 2009, J EVOLUTION BIOL, V22, P2171, DOI 10.1111/j.1420-9101.2009.01832.x; Feller W, 1968, INTRO PROBABILITY TH, V1; Filipe JAN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002328; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fisher N., 1995, STAT ANAL CIRCULAR D; Forster GA, 2007, P NATL ACAD SCI USA, V104, P4984, DOI 10.1073/pnas.0607900104; Foure E, 1987, VARIETAL REACTIONS B; Freeland J., 2005, MOL ECOLOGY; Gauhl F, 1994, THESIS INIBAP MONTPE; Gilligan CA, 2008, PHILOS T R SOC B, V363, P741, DOI 10.1098/rstb.2007.2181; GREGORY PH, 1968, ANNU REV PHYTOPATHOL, V6, P189, DOI 10.1146/annurev.py.06.090168.001201; Grove GG, 2006, PLANT DIS, V90, P587, DOI 10.1094/PD-90-0587; Guest D., 1997, PLANT PATHOGENS PLAN; Herrmann I, 2011, ECOL MODEL, V222, P1333, DOI 10.1016/j.ecolmodel.2011.01.006; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Jones FA, 2008, J ECOL, V96, P642, DOI 10.1111/j.1365-2745.2008.01400.x; Jongejans E, 2008, PERSPECT PLANT ECOL, V9, P153, DOI 10.1016/j.ppees.2007.09.005; Katul GG, 2005, AM NAT, V166, P368, DOI 10.1086/432589; Keller MD, 2014, AEROBIOLOGIA, V30, P123, DOI 10.1007/s10453-013-9321-3; Kinlan BP, 2005, DIVERS DISTRIB, V11, P139, DOI 10.1111/j.1366-9516.2005.00158.x; Klein EK, 2003, ECOL MONOGR, V73, P131, DOI 10.1890/0012-9615(2003)073[0131:CPDQMM]2.0.CO;2; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Kuparinen A, 2007, OIKOS, V116, P966, DOI 10.1111/j.2006.0030-1299.15563.x; Kuparinen A, 2010, FOREST ECOL MANAG, V259, P1003, DOI 10.1016/j.foreco.2009.12.006; Largier JL, 2003, ECOL APPL, V13, pS71; Lenormand T, 1998, P ROY SOC B-BIOL SCI, V265, P1985, DOI 10.1098/rspb.1998.0529; Marchetto KM, 2010, ECOLOGY, V91, P2485, DOI 10.1890/09-1069.1; Marin DH, 2003, PLANT DIS, V87, P208, DOI 10.1094/PDIS.2003.87.3.208; Mundt CC, 2009, AM NAT, V173, P456, DOI 10.1086/597220; Nathan R, 2003, OIKOS, V103, P261, DOI 10.1034/j.1600-0706.2003.12146.x; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Nathan R, 2012, DISPERSAL KERNELS RE; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; Nathan R, 2011, THEOR ECOL-NETH, V4, P113, DOI 10.1007/s12080-011-0115-3; Nathan Ran, 2001, Trends in Ecology and Evolution, V16, P481, DOI 10.1016/S0169-5347(01)02272-8; NICHOLS RA, 1994, HEREDITY, V72, P312, DOI 10.1038/hdy.1994.41; Parisod C, 2008, HEREDITY, V101, P536, DOI 10.1038/hdy.2008.95; Pazos GE, 2013, J ECOL, V101, P889, DOI 10.1111/1365-2745.12103; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; Petit RJ, 2004, DIVERS DISTRIB, V10, P159, DOI 10.1111/j.1366-9516.2004.00084.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rapilly F, 1991, EPIDEMIOLOGIE PATHOL; Ray N, 2010, MOL ECOL RESOUR, V10, P902, DOI 10.1111/j.1755-0998.2010.02881.x; Revilla E, 2008, P NATL ACAD SCI USA, V105, P19120, DOI 10.1073/pnas.0801725105; Rieux A, 2013, Ecol Lett, V16, P721, DOI 10.1111/ele.12090; Rieux A, 2011, MOL ECOL, V20, P1661, DOI 10.1111/j.1365-294X.2011.05053.x; Rieux A, 2012, HEREDITY, V19; Robledo-Arnuncio JJ, 2004, MOL ECOL, V13, P2567, DOI 10.1111/j.1365-294X.2004.02251.x; Robledo-Arnuncio JJ, 2006, GENETICS, V173, P1033, DOI 10.1534/genetics.105.052035; Rohatgi V.K., 2003, STAT INFERENCE; Rousset Francois, 2001, P18; Rutter J., 1998, AEROBIOLOGIA, V14, P201; Saccheri IJ, 2008, P NATL ACAD SCI USA, V105, P16212, DOI 10.1073/pnas.0803785105; Sackett KE, 2005, PHYTOPATHOLOGY, V95, P983, DOI 10.1094/PHYTO-95-0983; Sapoukhina N, 2010, ECOL MODEL, V221, P2793, DOI 10.1016/j.ecolmodel.2010.08.020; Savage D, 2010, DIVERS DISTRIB, V16, P288, DOI 10.1111/j.1472-4642.2009.00634.x; Schurr FM, 2008, J ECOL, V96, P628, DOI 10.1111/j.1365-2745.2008.01371.x; SHAW MW, 1995, P ROY SOC B-BIOL SCI, V259, P243, DOI 10.1098/rspb.1995.0036; Siegel DA, 2003, MAR ECOL PROG SER, V260, P83, DOI 10.3354/meps260083; Skarpaas O, 2005, J APPL ECOL, V42, P731, DOI 10.1111/j.1365-2664.2005.01056.x; Soubeyrand S, 2007, PHYTOPATHOLOGY, V97, P1315, DOI 10.1094/PHYTO-97-10-1315; Soubeyrand S, 2009, ANN APPL BIOL, V154, P399, DOI 10.1111/j.1744-7348.2008.00310.x; Soubeyrand S, 2008, J R STAT SOC C-APPL, V57, P253, DOI 10.1111/j.1467-9876.2007.00612.x; Thompson SE, 2013, GLOBAL CHANGE BIOL, V19, P1720, DOI 10.1111/gcb.12173; Tufto J, 1997, THEOR POPUL BIOL, V52, P16, DOI 10.1006/tpbi.1997.1306; Van Houtan KS, 2007, ECOL LETT, V10, P219, DOI 10.1111/j.1461-0248.2007.01004.x; Vinatier F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021115; Willocquet L, 1998, PLANT PATHOL, V47, P234, DOI 10.1046/j.1365-3059.1998.00242.x; Wingen LU, 2007, GENETICS, V177, P435, DOI 10.1534/genetics.107.077206	94	62	63	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e103225	10.1371/journal.pone.0103225	http://dx.doi.org/10.1371/journal.pone.0103225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116080	Green Published, gold			2022-12-27	WOS:000341230400013
J	Xu, LM; Zheng, YJ; Wang, Y; Yang, Y; Cao, FF; Peng, B; Xu, XF; An, HZ; Zheng, AX; Zhang, DH; Uzan, G; Yu, YZ				Xu, Li-min; Zheng, Yue-juan; Wang, Ying; Yang, Yang; Cao, Fan-fan; Peng, Bin; Xu, Xiong-fei; An, Hua-zhang; Zheng, Ao-xiang; Zhang, Deng-hai; Uzan, Georges; Yu, Yi-zhi			Celastrol Inhibits Lung Infiltration in Differential Syndrome Animal Models by Reducing TNF-alpha and ICAM-1 Levels while Preserving Differentiation in ATRA-Induced Acute Promyelocytic Leukemia Cells	PLOS ONE			English	Article							RETINOIC ACID SYNDROME; NF-KAPPA-B; MOLECULES; APOPTOSIS; ADHESION; STRESS; ERK1/2	All-trans retinoic acid (ATRA) is a revolutionary agent for acute promyelocytic leukemia (APL) treatment via differentiation induction. However, ATRA treatment also increases cytokine, chemokine, and adhesive molecule (mainly ICAM-1) expression, which can cause clinical complications, including a severe situation known as differentiation syndrome (DS) which can cause death. Therefore, it is of clinical significance to find a strategy to specifically blunt inflammatory effects while preserving differentiation. Here we report that the natural compound, celastrol, could effectively block lung infiltrations in DS animal models created by loading ATRA-induced APL cell line NB4. In ATRA-treated NB4 cells, celastrol could potently inhibit ICAM-1 elevation and partially reduce TNF-alpha and IL-1 beta secretion, though treatment showed no effects on IL-8 and MCP-1 levels. Celastrol's effect on ICAM-1 in ATRA-treated NB4 was related to reducing MEK1/ERK1 activation. Strikingly and encouragingly, celastrol showed no obvious effects on ATRA-induced NB4 differentiation, as determined by morphology, enzymes, and surface markers. Our results show that celastrol is a promising and unique agent for managing the side effects of ATRA application on APL, and suggest that hyper-inflammatory ability is accompanied by, but not necessary for, APL differentiation. Thus we offered an encouraging novel strategy to further improve differentiation therapy.	[Xu, Li-min; Zheng, Yue-juan; Yang, Yang; Xu, Xiong-fei; An, Hua-zhang; Zheng, Ao-xiang; Yu, Yi-zhi] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai, Peoples R China; [Xu, Li-min; Zheng, Yue-juan; Yang, Yang; Xu, Xiong-fei; An, Hua-zhang; Zheng, Ao-xiang; Yu, Yi-zhi] Second Mil Med Univ, Inst Immunol, Shanghai, Peoples R China; [Xu, Li-min; Wang, Ying; Cao, Fan-fan; Peng, Bin; Zhang, Deng-hai; Uzan, Georges] Shanghai Gongli Hosp, Sino French Cooperat Cent Lab, Shanghai, Peoples R China; [Zheng, Yue-juan] Shanghai Univ Tradit Chinese Med, Dept Immunol & Microbiol, Shanghai, Peoples R China; [Zhang, Deng-hai; Uzan, Georges] Hop Paul Brousse, INSERM, U972, Paris, France	Naval Medical University; Naval Medical University; Shanghai University of Traditional Chinese Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Zhang, DH (corresponding author), Shanghai Gongli Hosp, Sino French Cooperat Cent Lab, Shanghai, Peoples R China.	shanghai_zhang@hotmail.com; yuyz88@126.com	Zheng, Yuejuan/AAF-5923-2020; Uzan, Georges/M-8199-2018; yu, yizhi/ADP-7854-2022	Uzan, Georges/0000-0002-0178-5386; Xu, Xiongfei/0000-0001-9532-4582	National Key Development Program for Basic Research of China [2010CB529901]; Key Project of Chinese Ministry of Health [2012ZX10002006-001-004]; Project of Excellent Academic Leader in Medicine of Shanghai [XBR2011054]; Medical Project of Shanghai Pudong District [PKJ2011-Y11]; National Natural Science Foundation of China [31100619]	National Key Development Program for Basic Research of China(National Basic Research Program of China); Key Project of Chinese Ministry of Health; Project of Excellent Academic Leader in Medicine of Shanghai; Medical Project of Shanghai Pudong District; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Key Development Program for Basic Research of China (No. 2010CB529901) and the Key Project of Chinese Ministry of Health (No. 2012ZX10002006-001-004) to YZY, the Project of Excellent Academic Leader in Medicine of Shanghai (No. XBR2011054) to DHZ, the Medical Project of Shanghai Pudong District (No. PKJ2011-Y11) to LMX, and the National Natural Science Foundation of China (No. 31100619) to YJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2001, PROG NEURO-PSYCHOPH, V25, P1341, DOI 10.1016/S0278-5846(01)00192-0; Cao FF, 2009, CYTOM PART A, V75A, P975, DOI 10.1002/cyto.a.20809; De Santis GC, 2007, HAEMATOLOGICA, V92, P1615, DOI 10.3324/haematol.10607; Dore AI, 2007, J LEUKOCYTE BIOL, V82, P1340, DOI 10.1189/jlb.0207095; Friedman MD, 2013, ONCOL REP, V30, P1645, DOI 10.3892/or.2013.2625; Grimwade D, 2010, CANCER TREAT RES, V145, P219, DOI 10.1007/978-0-387-69259-3_13; Harrison GM, 2001, CLIN DIAGN LAB IMMUN, V8, P397, DOI 10.1128/CDLI.8.2.397-401.2001; Hu YY, 2013, J ETHNOPHARMACOL, V149, P601, DOI 10.1016/j.jep.2013.07.030; Imran M, 2012, EUR J CANCER, V48, P2474, DOI 10.1016/j.ejca.2012.01.028; Jung HW, 2007, EXP MOL MED, V39, P715, DOI 10.1038/emm.2007.78; Kamimura T, 2011, CANCER SCI, V102, P1929, DOI 10.1111/j.1349-7006.2011.02045.x; Kannaiyan R, 2011, CANCER LETT, V303, P9, DOI 10.1016/j.canlet.2010.10.025; Kim Y, 2009, EUR J PHARMACOL, V612, P131, DOI 10.1016/j.ejphar.2009.03.071; Konopleva M, 2002, BLOOD, V99, P326, DOI 10.1182/blood.V99.1.326; LANOTTE M, 1991, BLOOD, V77, P1080; Larson RS, 2003, BEST PRACT RES CL HA, V16, P453, DOI 10.1016/S1521-6926(03)00043-4; Li YH, 2012, BRAIN RES, V1464, P8, DOI 10.1016/j.brainres.2012.04.054; Lo-Coco F, 2008, SEMIN ONCOL, V35, P401, DOI 10.1053/j.seminoncol.2008.04.010; Montesinos P, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.059; Nam NH, 2006, MINI-REV MED CHEM, V6, P945, DOI 10.2174/138955706777934937; Ninomiya M, 2004, LEUKEMIA, V18, P442, DOI 10.1038/sj.leu.2403284; Peng B, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-79; Persaud SD, 2013, CELL SIGNAL, V25, P19, DOI 10.1016/j.cellsig.2012.09.002; Rogers Jane E, 2012, J Oncol Pharm Pract, V18, P109, DOI 10.1177/1078155211399163; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; Wang WB, 2012, J CELL PHYSIOL, V227, P2196, DOI 10.1002/jcp.22956; Xu Li-min, 2007, Zhong Xi Yi Jie He Xue Bao, V5, P282; Yu XA, 2010, AM J HYPERTENS, V23, P895, DOI 10.1038/ajh.2010.75; Zhang DH, 2006, J LEUKOCYTE BIOL, V80, P309, DOI 10.1189/jlb.1005611; Zhang T, 2011, ANTI-CANCER DRUG, V22, P158, DOI 10.1097/CAD.0b013e3283409673; Zhu H, 2010, J PHARMACOL EXP THER, V334, P489, DOI 10.1124/jpet.110.165654	31	6	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e105131	10.1371/journal.pone.0105131	http://dx.doi.org/10.1371/journal.pone.0105131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	25116125	gold, Green Published, Green Submitted			2022-12-27	WOS:000341230400119
J	Debarre, D; Olivier, N; Supatto, W; Beaurepaire, E				Debarre, Delphine; Olivier, Nicolas; Supatto, Willy; Beaurepaire, Emmanuel			Mitigating Phototoxicity during Multiphoton Microscopy of Live Drosophila Embryos in the 1.0-1.2 mu m Wavelength Range	PLOS ONE			English	Article							INFRARED LASER-PULSES; HARMONIC-GENERATION MICROSCOPY; MORPHOGENETIC MOVEMENTS; CELLULAR-RESPONSE; TI-SAPPHIRE; LONG-TERM; CELLS; PHOTODAMAGE; MECHANISMS; DAMAGE	Light-induced toxicity is a fundamental bottleneck in microscopic imaging of live embryos. In this article, after a review of photodamage mechanisms in cells and tissues, we assess photo-perturbation under illumination conditions relevant for point-scanning multiphoton imaging of live Drosophila embryos. We use third-harmonic generation (THG) imaging of developmental processes in embryos excited by pulsed near-infrared light in the 1.0-1.2 mu m range. We study the influence of imaging rate, wavelength, and pulse duration on the short-term and long-term perturbation of development and define criteria for safe imaging. We show that under illumination conditions typical for multiphoton imaging, photodamage in this system arises through 2-and/or 3-photon absorption processes and in a cumulative manner. Based on this analysis, we derive general guidelines for improving the signal-to-damage ratio in two-photon (2PEF/SHG) or THG imaging by adjusting the pulse duration and/or the imaging rate. Finally, we report label-free time-lapse 3D THG imaging of gastrulating Drosophila embryos with sampling appropriate for the visualisation of morphogenetic movements in wild-type and mutant embryos, and long-term multiharmonic (THG-SHG) imaging of development until hatching.	[Debarre, Delphine; Olivier, Nicolas; Supatto, Willy; Beaurepaire, Emmanuel] Ecole Polytech, CNRS, Lab Opt & Biosci, UMR 7645, F-91128 Palaiseau, France; [Debarre, Delphine; Olivier, Nicolas; Supatto, Willy; Beaurepaire, Emmanuel] INSERM, U696, Palaiseau, France; [Debarre, Delphine] Univ Grenoble Alpes, LIPhy, Grenoble, France; [Debarre, Delphine] CNRS, LIPhy, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Institut Polytechnique de Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Debarre, D (corresponding author), Ecole Polytech, CNRS, Lab Opt & Biosci, UMR 7645, F-91128 Palaiseau, France.	delphine.debarre@ujf-grenoble.fr; emmanuel.beaurepaire@polytechnique.edu	Beaurepaire, Emmanuel/C-6343-2014; Olivier, Nicolas/AAM-4414-2021; Supatto, Willy/B-3720-2013	Beaurepaire, Emmanuel/0000-0002-2082-8214; Supatto, Willy/0000-0002-4562-9166; Debarre, Delphine/0000-0002-0513-6172; Olivier, Nicolas/0000-0001-9042-5456	Delegation Generale de l'Armement Agence Nationale de la Recherche [ANR-10-INBS-04, ANR-11-EQPX-0029]	Delegation Generale de l'Armement Agence Nationale de la Recherche(French National Research Agency (ANR))	Funding provided by Delegation Generale de l'Armement Agence Nationale de la Recherche (ANR-10-INBS-04, ANR-11-EQPX-0029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles-Espinosa R, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3477535; Barad Y, 1997, APPL PHYS LETT, V70, P922, DOI 10.1063/1.118442; Born M., 2000, PRINCIPLES OPTICS EL; Cain CP, 2005, GRAEF ARCH CLIN EXP, V243, P101, DOI 10.1007/s00417-004-0924-9; Cash TP, 2007, FREE RADICAL BIO MED, V43, P1219, DOI 10.1016/j.freeradbiomed.2007.07.001; Chen IH, 2002, OPT QUANT ELECTRON, V34, P1251, DOI 10.1023/A:1021303426482; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; CHENG LYL, 1979, FEBS LETT, V97, P124, DOI 10.1016/0014-5793(79)80066-6; Chu SW, 2003, OPT EXPRESS, V11, P3093, DOI 10.1364/OE.11.003093; Chu SW, 2003, OPT EXPRESS, V11, P933, DOI 10.1364/OE.11.000933; Chung SH, 2009, J BIOPHOTONICS, V2, P557, DOI 10.1002/jbio.200910053; Debarre D, 2005, OPT LETT, V30, P2134, DOI 10.1364/OL.30.002134; Debarre D, 2004, OPT LETT, V29, P2881, DOI 10.1364/OL.29.002881; Dela Cruz JM, 2010, BIOMED OPT EXPRESS, V1, P1320, DOI 10.1364/BOE.1.001320; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denton ML, 2006, J MICROSC-OXFORD, V221, P164, DOI 10.1111/j.1365-2818.2006.01557.x; Donnert G, 2007, NAT METHODS, V4, P81, DOI 10.1038/NMETH986; FORK RL, 1984, OPT LETT, V9, P150, DOI 10.1364/OL.9.000150; Friedman H, 1999, J PHOTOCH PHOTOBIO B, V11, P87; Herz J, 2010, BIOPHYS J, V98, P715, DOI 10.1016/j.bpj.2009.10.035; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; Hovhannisyan V, 2010, OPT EXPRESS, V18, P24037, DOI 10.1364/OE.18.024037; Hsieh CS, 2008, OPT EXPRESS, V16, P11574, DOI 10.1364/OE.16.011574; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Iwanaga S, 2006, OPT EXPRESS, V14, P717, DOI 10.1364/OPEX.14.000717; Ji N, 2008, NAT METHODS, V5, P197, DOI 10.1038/NMETH.1175; Jureller JE, 2006, OPT EXPRESS, V14, P3406, DOI 10.1364/OE.14.003406; Kalies S, 2011, BIOMED OPT EXPRESS, V2, P805, DOI 10.1364/BOE.2.000816; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; King A, 2004, PHOTOCHEM PHOTOBIOL, V79, P470, DOI 10.1562/LE-03-17.1; King BA, 2004, PHOTOCHEM PHOTOBIOL, V80, P1, DOI 10.1562/2004-03-01-RA-093.1; Kobat D, 2009, OPT EXPRESS, V17, P13354, DOI 10.1364/OE.17.013354; Koester HJ, 1999, BIOPHYS J, V77, P2226, DOI 10.1016/S0006-3495(99)77063-3; Konig K, 1996, OPT LETT, V21, P1090, DOI 10.1364/OL.21.001090; Konig K, 1997, OPT LETT, V22, P135, DOI 10.1364/OL.22.000135; Konig K, 1999, OPT LETT, V24, P113, DOI 10.1364/OL.24.000113; Konig K, 1996, J MICROSC-OXFORD, V183, P197; Konig K, 1996, HUM REPROD, V11, P2162; Lavi R, 2003, J BIOL CHEM, V278, P40917, DOI 10.1074/jbc.M303034200; Lecuit T, 2000, J CELL BIOL, V150, P849, DOI 10.1083/jcb.150.4.849; Leitz G, 2002, BIOPHYS J, V82, P2224, DOI 10.1016/S0006-3495(02)75568-9; Liu Y, 1996, BIOPHYS J, V71, P2158, DOI 10.1016/S0006-3495(96)79417-1; Lukinavicius G, 2013, NAT CHEM, V5, P132, DOI [10.1038/NCHEM.1546, 10.1038/nchem.1546]; Masters BR, 2004, J BIOMED OPT, V9, P1265, DOI 10.1117/1.1806135; Mavrakis M, 2014, NAT CELL BIOL, V16, P322, DOI 10.1038/ncb2921; Mitsunaga M, 2011, NAT MED, V17, P1685, DOI 10.1038/nm.2554; Mohanty SK, 2006, PHOTOCH PHOTOBIO SCI, V5, P134, DOI 10.1039/b506061c; Mohanty SK, 2002, RADIAT RES, V157, P378, DOI 10.1667/0033-7587(2002)157[0378:CAMODD]2.0.CO;2; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Nichols MG, 2005, PHOTOCHEM PHOTOBIOL, V81, P259, DOI 10.1562/2004-08-05-RA-263.1; Oehring H, 2000, SCANNING, V22, P263, DOI 10.1002/sca.4950220406; Ogawa K, 2008, ANTI-CANCER AGENT ME, V8, P269, DOI 10.2174/187152008783961860; Olivier N, 2010, SCIENCE, V329, P967, DOI 10.1126/science.1189428; PALMER KF, 1974, J OPT SOC AM, V64, P1107, DOI 10.1364/JOSA.64.001107; Saytashev I, 2012, J PHOTOCH PHOTOBIO B, V115, P42, DOI 10.1016/j.jphotobiol.2012.06.009; Schonle A, 1998, OPT LETT, V23, P325, DOI 10.1364/OL.23.000325; Shcherbakova DM, 2012, ANGEW CHEM INT EDIT, V51, P10724, DOI 10.1002/anie.201200408; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Squier JA, 1998, OPT EXPRESS, V3, P315, DOI 10.1364/OE.3.000315; Squirrell JM, 1999, NAT BIOTECHNOL, V17, P763, DOI 10.1038/11698; Stephens Jared, 2009, J Biomed Opt, V14, P054004, DOI 10.1117/1.3213601; Stevenson D, 2006, OPT EXPRESS, V14, P7125, DOI 10.1364/OE.14.007125; Sun CK, 2004, J STRUCT BIOL, V147, P19, DOI 10.1016/j.jsb.2003.10.017; Supatto W, 2005, P NATL ACAD SCI USA, V102, P1047, DOI 10.1073/pnas.0405316102; Supatto W, 2005, MED LASER APPL, V20, P207, DOI DOI 10.1016/j.mla.2005.07.001; Supatto W, 2009, NAT PROTOC, V4, P1397, DOI 10.1038/nprot.2009.130; SWEETON D, 1991, DEVELOPMENT, V112, P775; Thayil A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3569614; Tirlapur UK, 2001, EXP CELL RES, V263, P88, DOI 10.1006/excr.2000.5082; Trautlein D, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp932; Uchugonova A, 2008, OPT EXPRESS, V16, P9357, DOI 10.1364/OE.16.009357; Valencia A, 2008, J INVEST DERMATOL, V128, P214, DOI 10.1038/sj.jid.5700960; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Vogel A, 1999, APPL PHYS B-LASERS O, V68, P271, DOI 10.1007/s003400050617; Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n; Watanabe T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-38; Wieschaus E., 1998, DROSOPHILA PRACTICAL, P179; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166	83	41	45	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104250	10.1371/journal.pone.0104250	http://dx.doi.org/10.1371/journal.pone.0104250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111506	gold, Green Published, Green Submitted			2022-12-27	WOS:000341105100045
J	Watanabe, Y; Tanaka, H; Tsukabe, A; Kunitomi, Y; Nishizawa, M; Hashimoto, R; Yamamori, H; Fujimoto, M; Fukunaga, M; Tomiyama, N				Watanabe, Yoshiyuki; Tanaka, Hisashi; Tsukabe, Akio; Kunitomi, Yuki; Nishizawa, Mitsuo; Hashimoto, Ryota; Yamamori, Hidenaga; Fujimoto, Michiko; Fukunaga, Masaki; Tomiyama, Noriyuki			Neuromelanin Magnetic Resonance Imaging Reveals Increased Dopaminergic Neuron Activity in the Substantia Nigra of Patients with Schizophrenia	PLOS ONE			English	Article							ADULT READING TEST; PARKINSONS-DISEASE; JAPANESE VERSION; LOCUS-COERULEUS; PREMORBID IQ; INDIVIDUALS; DEPRESSION; RECEPTORS; PSYCHOSIS; CERULEUS	Purpose: The dopamine hypothesis suggests that excessive dopamine release results in the symptoms of schizophrenia. The purpose of this study was to elucidate the dopaminergic and noradrenergic neurons using 3-T neuromelanin magnetic resonance imaging (MRI) in patients with schizophrenia and healthy control subjects. Methods: We prospectively examined 52 patients with schizophrenia (M: F = 27: 25, mean age, 35 years) and age-and sex-matched healthy controls. Using a 3T MRI unit, we obtained oblique T1-weighted axial images perpendicular to the brainstem. We measured the signal intensity and area for the substantia nigra (SNc), midbrain tegmentum, locus ceruleus (LC), and pons. We then calculated the contrast ratios (CR) for the SNc (CRSN) and LC (CRLC), which were compared between patients and healthy controls using unpaired t-tests. Results: The SNc and LC were readily identified in both patients and healthy controls as areas with high signal intensities in the posterior part of the cerebral peduncle and in the upper pontine tegmentum. The CRSN values in patients were significantly higher than those in healthy controls (10.89 +/- 2.37 vs. 9.6 +/- 2.36, p<0.01). We observed no difference in the CRLC values between the patients and healthy controls (14.21 +/- 3.5 vs. 13.44 +/- 3.37, p = 0.25). Furthermore, there was no difference in area of the SNc and LC between schizophrenia patients and controls. Conclusions: Neuromelanin MRI might reveal increased signal intensity in the SNc of patients with schizophrenia. Our results indicate the presence of excessive dopamine products in the SNc of these patients.	[Watanabe, Yoshiyuki; Tanaka, Hisashi; Tsukabe, Akio; Kunitomi, Yuki; Nishizawa, Mitsuo; Tomiyama, Noriyuki] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; [Hashimoto, Ryota] Osaka Univ, United Grad Sch Child Dev, Res Ctr Childrens Mental Dev, Suita, Osaka, Japan; [Fukunaga, Masaki] Osaka Univ, Frontier Res Ctr, Dept Biofunct Imaging, Suita, Osaka, Japan; [Fukunaga, Masaki] Osaka Univ, Frontier Res Ctr, Dept Immunol, Suita, Osaka, Japan; [Hashimoto, Ryota; Yamamori, Hidenaga; Fujimoto, Michiko] Osaka Univ, Grad Sch Med, Dept Psychiat, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University	Watanabe, Y (corresponding author), Osaka Univ, Grad Sch Med, Suita, Osaka, Japan.	watanabe@radiol.med.osaka-u.ac.jp	Nishizawa, Mitsuo/AAT-4154-2021; Hashimoto, Ryota/AAE-3200-2019; Hashimoto, Ryota/P-8572-2014; Fukunaga, Masaki/F-6441-2013	Hashimoto, Ryota/0000-0002-5941-4238; Hashimoto, Ryota/0000-0002-5941-4238; Fukunaga, Masaki/0000-0003-1010-2644; Tanaka, Hisashi/0000-0002-6148-0672	KAKENHI, Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22390225, 23659565]; Japan Foundation for Neuroscience and Mental Health; Grants-in-Aid for Scientific Research [25861002] Funding Source: KAKEN	KAKENHI, Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Foundation for Neuroscience and Mental Health(Japan Foundation for Neuroscience and Mental Health); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from KAKENHI, 22390225-Grant-in-Aid for Scientific Research (B), 23659565-Grant-in-Aid for Challenging Exploratory Research and Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), and the Japan Foundation for Neuroscience and Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Bilder RM, 2006, J CLIN EXP NEUROPSYC, V28, P270, DOI 10.1080/13803390500360554; Committee JW-IP, 2006, JAP WECHSL AD INT SC; Fujino H, 2014, PSYCHIAT CLIN NEUROS; Gururajan A, 2012, AUST NZ J PSYCHIAT, V46, P1120, DOI 10.1177/0004867412455232; Heinz A, 2010, SCHIZOPHRENIA BULL, V36, P472, DOI 10.1093/schbul/sbq031; HIETALA J, 1995, LANCET, V346, P1130, DOI 10.1016/S0140-6736(95)91801-9; Howes OD, 2013, BRAIN, V136, P3242, DOI 10.1093/brain/awt264; Kashihara K, 2011, J CLIN NEUROSCI, V18, P1093, DOI 10.1016/j.jocn.2010.08.043; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2005, BIOL PSYCHIAT, V57, P688, DOI 10.1016/j.biopsych.2005.01.003; Lehericy S, 2012, MOVEMENT DISORD, V27, P822, DOI 10.1002/mds.25015; MANN DMA, 1974, BRAIN, V97, P489, DOI 10.1093/brain/97.1.489; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Matsuura K, 2013, EUR NEUROL, V70, P70, DOI 10.1159/000350291; Ogisu K, 2013, NEURORADIOLOGY, V55, P719, DOI 10.1007/s00234-013-1171-8; Ohtsuka C, 2013, NEUROSCI LETT, V541, P93, DOI 10.1016/j.neulet.2013.02.012; Ota T, 2013, INT J PSYCHIAT CLIN, V17, P10, DOI 10.3109/13651501.2011.653380; Sasaki M, 2006, NEUROREPORT, V17, P1215, DOI 10.1097/01.wnr.0000227984.84927.a7; Sasaki M, 2010, NEURORADIOLOGY, V52, P83, DOI 10.1007/s00234-009-0595-7; Sasaki M, 2008, NEUROREPORT, V19, P1649, DOI 10.1097/WNR.0b013e328315a637; Schwarz ST, 2011, MOVEMENT DISORD, V26, P1633, DOI 10.1002/mds.23722; Seeman Philip, 2010, Clin Schizophr Relat Psychoses, V4, P56, DOI 10.3371/CSRP.4.1.5; Shibata Eri, 2006, Magn Reson Med Sci, V5, P197, DOI 10.2463/mrms.5.197; Shibata E, 2008, BIOL PSYCHIAT, V64, P401, DOI 10.1016/j.biopsych.2008.03.021; Tanaka Makoto, 2011, Rinsho Shinkeigaku, V51, P14; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495; Woodberry KA, 2008, AM J PSYCHIAT, V165, P579, DOI 10.1176/appi.ajp.2008.07081242; Zahodne LB, 2008, DRUG AGING, V25, P665, DOI 10.2165/00002512-200825080-00004; Zucca FA, 2006, J NEURAL TRANSM, V113, P757, DOI 10.1007/s00702-006-0453-2	30	33	33	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e104619	10.1371/journal.pone.0104619	http://dx.doi.org/10.1371/journal.pone.0104619			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111500	Green Published, Green Submitted, gold			2022-12-27	WOS:000341105100084
J	Zhang, Y; Bai, XZ; Wang, YC; Li, N; Li, XQ; Han, F; Su, LL; Hu, DH				Zhang, Yue; Bai, Xiaozhi; Wang, Yunchuan; Li, Na; Li, Xiaoqiang; Han, Fei; Su, Linlin; Hu, Dahai			Role for Heat Shock Protein 90 alpha in the Proliferation and Migration of HaCaT Cells and in the Deep Second-Degree Burn Wound Healing in Mice	PLOS ONE			English	Article							HSP90; MOTILITY; HYPOXIA; DIFFERENTIATION; REGENERATION; MODULATION; MECHANISMS; EFFICACY; CANCER; REPAIR	Inflammation, proliferation, and tissue remodeling are essential steps for wound healing. The hypoxic wound microenvironment promotes cell migration through a hypoxia-heat shock protein 90 alpha (Hsp90 alpha)-low density lipoprotein receptor-related protein-1 (LRP-1) autocrine loop. To elucidate the role of this autocrine loop on burn wound healing, we investigated the expression profile of Hsp90 alpha at the edge of burn wounds and found a transient increase in both mRNA and protein levels. Experiments performed with a human keratinocyte cell line-HaCaT also confirmed above results. 17-dimethylaminoethylamino-17demethoxygeldanamycin hydrochloride (17-DMAG), an Hsp90 alpha inhibitor, was used to further evaluate the function of Hsp90 alpha in wound healing. Consistently, topical application of Hsp90 alpha in the early stage of deep second-degree burn wounds led to reduced inflammation and increased tissue granulation, with a concomitant reduction in the size of the wound at each time point tested (p<0.05). Consequently, epidermal cells at the wound margin progressed more rapidly causing an expedited healing process. In conclusion, these results provided a rationale for the therapeutic effect of Hsp90 alpha on the burn wound management.	[Zhang, Yue; Bai, Xiaozhi; Wang, Yunchuan; Li, Na; Li, Xiaoqiang; Han, Fei; Su, Linlin; Hu, Dahai] Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shannxi, Peoples R China	Air Force Military Medical University	Su, LL (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Shannxi, Peoples R China.	linlinsu@fmmu.edu.cn; hudhai@fmmu.edu.cn	Li, Xiao-Qiang/AAA-5094-2019		National Natural Science Foundation of China (NSFC) [81171811, 31101043]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (NSFC, Grant Number 81171811 to D. Hu and Grant Number 31101043 to L. Su). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 2009, BRIT J DERMATOL, V161, P326, DOI 10.1111/j.1365-2133.2009.09296.x; Akita S, 2008, WOUND REPAIR REGEN, V16, P635, DOI 10.1111/j.1524-475X.2008.00414.x; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Badillo AT, 2007, J SURG RES, V143, P35, DOI 10.1016/j.jss.2007.03.051; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Breitkreutz D, 1998, EUR J CELL BIOL, V75, P273, DOI 10.1016/S0171-9335(98)80123-4; Chen XD, 2013, INT J CLIN EXP PATHO, V6, P2280; Cheng C. Yan, 2008, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V8, P1, DOI 10.2174/187152208783790778; Cheng CF, 2011, J CLIN INVEST, V121, P4348, DOI 10.1172/JCI46475; Cheppudira B, 2013, EXPERT OPIN INV DRUG, V22, P1295, DOI 10.1517/13543784.2013.825249; Du J, 2013, GENE THER, V20, P1070, DOI 10.1038/gt.2013.32; Embil JM, 2000, WOUND REPAIR REGEN, V8, P162, DOI 10.1046/j.1524-475x.2000.00162.x; Ermolov AS, 2008, B EXP BIOL MED+, V146, P153, DOI 10.1007/s10517-008-0225-0; Hackl C, 2010, SURGERY, V147, P704, DOI 10.1016/j.surg.2009.10.061; HAGHDOOST F, 2013, EVID-BASED COMPL ALT, DOI DOI 10.1155/2013/893425; Hecker L, 2011, EXP CELL RES, V317, P1914, DOI 10.1016/j.yexcr.2011.03.016; Heo DN, 2013, J BIOMED NANOTECHNOL, V9, P511, DOI 10.1166/jbn.2013.1509; Hollingshead M, 2005, CANCER CHEMOTH PHARM, V56, P115, DOI 10.1007/s00280-004-0939-2; Hu DH, 2012, BURNS, V38, P702, DOI 10.1016/j.burns.2011.12.014; HUNT TK, 1972, ACTA CHIR SCAND, V138, P109; Li JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036389; Li W, 2004, HISTOL HISTOPATHOL, V19, P1311, DOI 10.14670/HH-19.1311; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Li W, 2012, BBA-MOL CELL RES, V1823, P730, DOI 10.1016/j.bbamcr.2011.09.009; NIINIKOSKI J, 1972, ANN SURG, V175, P588, DOI 10.1097/00000658-197204000-00020; O'Toole EA, 1997, J CLIN INVEST, V100, P2881, DOI 10.1172/JCI119837; Qu L, 2012, LASER SURG MED, V44, P517, DOI 10.1002/lsm.22055; RYLE CM, 1989, DIFFERENTIATION, V40, P42, DOI 10.1111/j.1432-0436.1989.tb00812.x; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Schreml S, 2010, J AM ACAD DERMATOL, V63, P866, DOI 10.1016/j.jaad.2009.10.048; Shakespeare P, 2001, BURNS, V27, P517, DOI 10.1016/S0305-4179(01)00017-1; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sun XP, 2013, J VIROL, V87, P10126, DOI 10.1128/JVI.01671-13; Tang QL, 2014, MOL MED REP; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; VARGHESE MC, 1986, ARCH DERMATOL, V122, P52, DOI 10.1001/archderm.122.1.52; Wang TT, 1998, INT J BIOCHEM CELL B, V30, P745, DOI 10.1016/S1357-2725(97)00133-7; Woodley DT, 2009, J CELL SCI, V122, P1495, DOI 10.1242/jcs.047894; Xing DM, 2011, WOUND REPAIR REGEN, V19, P205, DOI 10.1111/j.1524-475X.2010.00656.x; Zhou D, 2013, TOXICOL APPL PHARM, V273, P401, DOI 10.1016/j.taap.2013.09.018	40	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2014	9	8							e103723	10.1371/journal.pone.0103723	http://dx.doi.org/10.1371/journal.pone.0103723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO1WB	25111496	Green Published, gold, Green Submitted			2022-12-27	WOS:000341105100019
J	Zhang, ZL; Wang, J; Chen, SF; Wei, ZY; Li, ZT; Zhao, SW; Lu, WJ				Zhang, Zili; Wang, Jian; Chen, Sifan; Wei, Zhaoyu; Li, Zhengtu; Zhao, Siwen; Lu, Wenju			Comparison of Vegetarian Diets and Omnivorous Diets on Plasma Level of HDL-c: A Meta-Analysis	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; SERUM-LIPIDS; RISK-FACTORS; METABOLIC SYNDROME; CHOLESTEROL; ASSOCIATION; CONSUMPTION; PREVENTION	Low plasma level of high density lipoprotein cholesterol (HDL-c) was an independent risk factor for cardio vascular disorder, and associated with poor outcomes in pulmonary arterial hypertension. To compare the effects of vegetarian diets and omnivorous diets on HDL-c in plasma, we identified cross-sectional and cohort studies related to HDL-c listed on PubMed and ISI Web of Knowledge as well as the corresponding references (until Nov, 2013). Twelve studies with a total of 4177 individuals were selected for meta-analysis. This meta-analysis indicates that vegetarian diets did not alter plasma HDL-c concentrations, as it wasn't initially expected by the authors [Standardized Mean Difference (SMD) = 0.02 mmol/l; 95% confidence interval (CI): -0.19 to 0.22 mmol/l]. In Asia and Latin America countries, no significant differences in HDL-c levels between vegetarians and omnivores were found (SMD = -0.09 mmol/l; 95% CI: -0.43 to 0.25 mmol/l). In Europe and North America countries, the plasma level of HDL-c was also not different between the two diets (SMD = 0.09 mmol/l; 95% CI: 2 0.19 to 0.36 mmol/l). In light of this meta-analysis, we conclude that there is no evidence that plasma HDL-c levels differs in vegetarians and omnivores, even after adjusting for cultural circumstances.	[Zhang, Zili; Wang, Jian; Li, Zhengtu; Lu, Wenju] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Chen, Sifan] Sun Yat Sen Univ, Sch Publ Hlth, Dept Nutr, Guangzhou 510275, Guangdong, Peoples R China; [Wei, Zhaoyu] Guangzhou Med Univ, Dept Student Affairs, Guangzhou, Guangdong, Peoples R China; [Zhao, Siwen] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Sun Yat Sen University; Guangzhou Medical University; Guangzhou Medical University	Lu, WJ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	wlu92@yahoo.com	Zhao, Qiongyi/B-4106-2014; Zhang, Zong Hong/N-9126-2013; Wray, Naomi/C-8639-2015; Bauer, Denis/C-3903-2009	Zhao, Qiongyi/0000-0002-6341-0416; Jhaveri, Dhanisha/0000-0002-5615-3546; Zhang, Zong Hong/0000-0002-8056-891X; Wray, Naomi/0000-0001-7421-3357; Edson, Janette/0000-0002-1864-0095; Bauer, Denis/0000-0001-8033-9810; Narayanan, Ramesh/0000-0001-8171-474X	NIH [R01-HL093020]; National Natural Science Foundation of China [81070043, 81173112, 81170052, 81220108001]; Guangdong Natural Science Foundation Team Grant [1035101200300000]; Guangzhou Department of Education Yangcheng Scholarship [10A058S, 12A001S]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093020] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation Team Grant; Guangzhou Department of Education Yangcheng Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH (R01-HL093020), National Natural Science Foundation of China (81070043, 81173112, 81170052, 81220108001), Guangdong Natural Science Foundation Team Grant (1035101200300000), and Guangzhou Department of Education Yangcheng Scholarship (10A058S, 12A001S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander H, 1999, J AM COLL NUTR, V18, P127, DOI 10.1080/07315724.1999.10718840; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Assmann G, 1999, ARTERIOSCL THROM VAS, V19, P1819, DOI 10.1161/01.ATV.19.8.1819; Baer DJ, 2002, AM J CLIN NUTR, V75, P593, DOI 10.1093/ajcn/75.3.593; Barnard ND, 2000, AM J CARDIOL, V85, P969, DOI 10.1016/S0002-9149(99)00911-X; CASTELLI WP, 1977, CIRCULATION, V55, P767, DOI 10.1161/01.CIR.55.5.767; Chen CW, 2011, YONSEI MED J, V52, P13, DOI 10.3349/ymj.2011.52.1.13; CHOI SSY, 1994, J LIPID RES, V35, P848; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Craig WJ, 2009, J AM DIET ASSOC, V109, P1266, DOI 10.1016/j.jada.2009.05.027; De Biase SG, 2007, ARQ BRAS CARDIOL, V88, P35, DOI 10.1590/S0066-782X2007000100006; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Famodu AA, 1998, CLIN BIOCHEM, V31, P545, DOI 10.1016/S0009-9120(98)00067-8; Dourado KF, 2011, NUTR HOSP, V26, P959, DOI [10.3305/nh.2011.26.5.5108, 10.1590/S0212-16112011000500006]; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; HAMSTEN A, 1986, ATHEROSCLEROSIS, V60, P199, DOI 10.1016/0021-9150(86)90166-8; Harper CR, 1999, ARCH INTERN MED, V159, P1049, DOI 10.1001/archinte.159.10.1049; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; Heresi GA, 2010, AM J RESP CRIT CARE, V182, P661, DOI 10.1164/rccm.201001-0007OC; Hoffmann I, 2001, EUR J CLIN NUTR, V55, P887, DOI 10.1038/sj.ejcn.1601243; Kelley GA, 2012, CLIN NUTR, V31, P156, DOI 10.1016/j.clnu.2011.11.011; Krajcovicova-Kudlackova M, 2000, SCAND J CLIN LAB INV, V60, P657, DOI 10.1080/00365510050216385; Li D, 1999, EUR J CLIN NUTR, V53, P612, DOI 10.1038/sj.ejcn.1600817; Li D, 2001, CLIN SCI, V100, P25, DOI 10.1042/CS20000109; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; McCoy MG, 2002, J LIPID RES, V43, P921; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Teixeira RDMD, 2007, ARQ BRAS CARDIOL, V89, P237, DOI 10.1590/S0066-782X2007001600005; Papadaki A, 2008, PUBLIC HEALTH NUTR, V11, P1022, DOI 10.1017/S1368980007001498; PEKKANEN J, 1990, NEW ENGL J MED, V322, P1700, DOI 10.1056/NEJM199006143222403; Qin SC, 2000, J LIPID RES, V41, P269; Rader DJ, 1996, CURR OPIN LIPIDOL, V7, P117, DOI 10.1097/00041433-199606000-00002; Robinson F, 2002, J HUM NUTR DIET, V15, P323, DOI 10.1046/j.1365-277X.2002.00383.x; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rosengren A, 1997, EUR HEART J, V18, P754; SCOTT LW, 1994, ARCH INTERN MED, V154, P1261, DOI 10.1001/archinte.154.11.1261; SINCLAIR AJ, 1987, LIPIDS, V22, P523, DOI 10.1007/BF02540369; THOROGOOD M, 1987, BMJ-BRIT MED J, V295, P351, DOI 10.1136/bmj.295.6594.351; van der Gaag MS, 2001, J LIPID RES, V42, P2077; Vinagre JC, 2013, NUTR METAB CARDIOVAS, V23, P61, DOI 10.1016/j.numecd.2011.02.011; Vinagre JC, 2013, EUR J NUTR; WATTS GF, 1988, BMJ-BRIT MED J, V296, P235, DOI 10.1136/bmj.296.6617.235; Yoshikawa H, 1976, Rinsho Ketsueki, V17, P553; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	46	34	38	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 26	2014	9	3							e92609	10.1371/journal.pone.0092609	http://dx.doi.org/10.1371/journal.pone.0092609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SR	25119138	Green Published, gold, Green Submitted			2022-12-27	WOS:000333677000058
J	Thompson, MB; Tangen, JM				Thompson, Matthew B.; Tangen, Jason M.			The Nature of Expertise in Fingerprint Matching: Experts Can Do a Lot with a Little	PLOS ONE			English	Article							DECISION-MAKING; INFORMATION; IDENTIFICATION; RECOGNITION; ERROR	Expert decision making often seems impressive, even miraculous. People with genuine expertise in a particular domain can perform quickly and accurately, and with little information. In the series of experiments presented here, we manipulate the amount of "information'' available to a group of experts whose job it is to identify the source of crime scene fingerprints. In Experiment 1, we reduced the amount of information available to experts by inverting fingerprint pairs and adding visual noise. There was no evidence for an inversion effect-experts were just as accurate for inverted prints as they were for upright prints-but expert performance with artificially noisy prints was impressive. In Experiment 2, we separated matching and nonmatching print pairs in time. Experts were conservative, but they were still able to discriminate pairs of fingerprints that were separated by five-seconds, even though the task was quite different from their everyday experience. In Experiment 3, we separated the print pairs further in time to test the long-term memory of experts compared to novices. Long-term recognition memory for experts and novices was the same, with both performing around chance. In Experiment 4, we presented pairs of fingerprints quickly to experts and novices in a matching task. Experts were more accurate than novices, particularly for similar nonmatching pairs, and experts were generally more accurate when they had more time. It is clear that experts can match prints accurately when there is reduced visual information, reduced opportunity for direct comparison, and reduced time to engage in deliberate reasoning. These findings suggest that non-analytic processing accounts for a substantial portion of the variance in expert fingerprint matching accuracy. Our conclusion is at odds with general wisdom in fingerprint identification practice and formal training, and at odds with the claims and explanations that are offered in court during expert testimony.	[Thompson, Matthew B.; Tangen, Jason M.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia	University of Queensland	Thompson, MB (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	mbthompson@gmail.com; jtangen@psy.uq.edu.au	Thompson, Matthew/J-9922-2012; Tangen, Jason/ABH-8577-2020	Thompson, Matthew/0000-0002-5649-1203; Tangen, Jason/0000-0002-0649-2566; Poulsen, Mette Homann/0000-0003-2162-3007; Tarnow, Lise/0000-0002-8735-966X; Feidenhansl, Robert/0000-0002-7963-3649; Mathiesen, Joachim/0000-0002-5621-5487	Australian Research Council Linkage Grant to Tangen [LP120100063]; Fulbright Scholarship; Villum Fonden [00007172] Funding Source: researchfish	Australian Research Council Linkage Grant to Tangen(Australian Research Council); Fulbright Scholarship; Villum Fonden(Villum Fonden)	This research was supported by an Australian Research Council Linkage Grant to Tangen (LP120100063; www.arc.gov.au; see The Forensic Reasoning Project at ForensicReasoning. com), and a Fulbright Scholarship to Thompson (www.fulbright.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERNETHY B, 1991, INT J SPORT PSYCHOL, V22, P189; [Anonymous], 2009, STRENGTHENING FORENS; BARROWS HS, 1982, CLIN INVEST MED, V5, P49; Barton JJS, 2006, PERCEPTION, V35, P1089, DOI 10.1068/p5547; Brooks L, 1987, EMORY S COGNITION 1, P141; Brooks LR, 2005, CAN J EXP PSYCHOL, V59, P62, DOI 10.1037/h0087462; BROOKS LR, 1978, NON ANALYTIC CONCEPT; BUSEY T, 2011, J FORENSIC IDENTIF, V60, P61; Busey TA, 2005, VISION RES, V45, P431, DOI 10.1016/j.visres.2004.08.021; Busey TA, 2010, PSYCHON B REV, V17, P155, DOI 10.3758/PBR.17.2.155; CAMPBELL A, 2011, THE FINGERPRINT INQU, P790; Cole SA, 2009, LP R, V8, P233, DOI DOI 10.1093/LPR/MGP016; Cole SA, 2005, J CRIM LAW CRIM, V95, P985; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; DEGROOT AD, 1978, THOUGHT AND CHOICE I; Dodson CS, 1997, MEM COGNITION, V25, P129, DOI 10.3758/BF03201107; Dror I.E., 2006, J FORENSIC IDENTIFIC, V56, P600, DOI DOI 10.1016/S1355-0306(98)72118-5; Dror IE, 2006, FORENSIC SCI INT, V156, P74, DOI 10.1016/j.forsciint.2005.10.017; Dror IE, 2011, FORENSIC SCI INT, V208, P10, DOI 10.1016/j.forsciint.2010.10.013; Edmond G, 2015, LAW PROBAB RISK, V14, P1, DOI [10.1093/lpr/mgu018, 10.1093/lpr/mgt011]; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; ERICSSON KA, 1991, TOWARD A GENERAL THE; Evans KK, 2013, PSYCHON B REV, V20, P1170, DOI 10.3758/s13423-013-0459-3; Evans KK, 2011, PSYCHOL SCI, V22, P739, DOI 10.1177/0956797611407930; Evans KK, 2011, ATTEN PERCEPT PSYCHO, V73, P30, DOI 10.3758/s13414-010-0022-5; *FED BUR INV, 1984, THE SCIENCE OF FINGE; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gobet F, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P523; Greene MR, 2009, COGNITIVE PSYCHOL, V58, P137, DOI 10.1016/j.cogpsych.2008.06.001; HENRY ER, 1900, CLASSIFICATION AND U; Hughson AL, 2001, AUST J PSYCHOL, V53, P103, DOI 10.1080/00049530108255130; INTRAUB H, 1981, J EXP PSYCHOL HUMAN, V7, P604, DOI 10.1037/0096-1523.7.3.604; Joubert OR, 2007, VISION RES, V47, P3286, DOI 10.1016/j.visres.2007.09.013; Kahneman D., 2011, THINKING FAST AND SL; Kahneman D, 2009, AM PSYCHOL, V64, P515, DOI 10.1037/a0016755; Kassin SM, 2013, J APPL RES MEM COGN, V2, P42, DOI 10.1016/j.jarmac.2013.01.001; KLEIN GA, 1998, SOURCES OF POWER; Loftus EF, 2004, SCIENCE, V304, P959; Medin DL., 1989, ADV PSYCHOL HUMAN IN, P189, DOI [10.4324/9781315807768-13, DOI 10.4324/9781315807768-13]; Mnookin JL, 2011, UCLA LAW REV, V58, P725; MYLESWORSLEY M, 1988, J EXP PSYCHOL LEARN, V14, P553, DOI 10.1037/0278-7393.14.3.553; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Norman GR, 2010, MED EDUC, V44, P94, DOI 10.1111/j.1365-2923.2009.03507.x; Norman GR, 1997, ADV HEALTH SCI EDUC, V2, P173, DOI 10.1023/A:1009784330364; NORMAN GR, 1989, ARCH DERMATOL, V125, P1063, DOI 10.1001/archderm.125.8.1063; POTTER MC, 1975, NATURE, V253, P437, DOI 10.1038/253437a0; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Saks MJ, 2005, SCIENCE, V309, P892, DOI 10.1126/science.1111565; SEARSTON RA, PUTTING BIAS INTO CO; Spinney L, 2010, NATURE, V464, P344, DOI 10.1038/464344a; Tangen JM, 2011, PSYCHOL SCI, V22, P995, DOI 10.1177/0956797611414729; Thompson MB, 2014, LAW HUMAN BEHAV, V38, P84, DOI 10.1037/lhb0000051; Thompson MB, 2013, J FORENSIC SCI, V58, P1519, DOI 10.1111/1556-4029.12203; Ulery BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032800; Ulery BT, 2011, P NATL ACAD SCI USA, V108, P7733, DOI 10.1073/pnas.1018707108; Vokey JR, 2009, Q J EXP PSYCHOL, V62, P1023, DOI 10.1080/17470210802372987; Wilson T., 2002, STRANGERS TO OURSELV	58	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2014	9	12							e114759	10.1371/journal.pone.0114759	http://dx.doi.org/10.1371/journal.pone.0114759			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX9IA	25122138	gold, Green Submitted, Green Published			2022-12-27	WOS:000347215600026
J	Mishra, S; Singh, BR; Singh, A; Keswani, C; Naqvi, AH; Singh, HB				Mishra, Sandhya; Singh, Braj Raj; Singh, Akanksha; Keswani, Chetan; Naqvi, Alim H.; Singh, H. B.			Biofabricated Silver Nanoparticles Act as a Strong Fungicide against Bipolaris sorokiniana Causing Spot Blotch Disease in Wheat	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; EXTRACELLULAR BIOSYNTHESIS; PHOTOCATALYTIC ACTIVITY; CULTURE SUPERNATANT; ANTIFUNGAL ACTIVITY; BACTERIA; STRAIN; NANOCOMPOSITE; LIGNIFICATION; PROTECTION	The present study is focused on the extracellular synthesis of silver nanoparticles (AgNPs) using culture supernatant of an agriculturally important bacterium, Serratia sp. BHU-S4 and demonstrates its effective application for the management of spot blotch disease in wheat. The biosynthesis of AgNPs by Serratia sp. BHU-S4 (denoted as bsAgNPs) was monitored by UV-visible spectrum that showed the surface plasmon resonance (SPR) peak at 410 nm, an important characteristic of AgNPs. Furthermore, the structural, morphological, elemental, functional and thermal characterization of bsAgNPs was carried out using the X-ray diffraction (XRD), electron and atomic microscopies, energy dispersive X-ray (EDAX) spectrometer, FTIR spectroscopy and thermogravimetric analyzer (TGA), respectively. The bsAgNPs were spherical in shape with size range of similar to 10 to 20 nm. The XRD and EDAX analysis confirmed successful biosynthesis and crystalline nature of AgNPs. The bsAgNPs exhibited strong antifungal activity against Bipolaris sorokiniana, the spot blotch pathogen of wheat. Interestingly, 2, 4 and 10 mu g/ml concentrations of bsAgNPs accounted for complete inhibition of conidial germination, whereas in the absence of bsAgNPs, conidial germination was 100%. A detached leaf bioassay revealed prominent conidial germination on wheat leaves infected with B. sorokiniana conidial suspension alone, while the germination of conidia was totally inhibited when the leaves were treated with bsAgNPs. The results were further authenticated under green house conditions, where application of bsAgNPs significantly reduced B. sorokiniana infection in wheat plants. Histochemical staining revealed a significant role of bsAgNPs treatment in inducing lignin deposition in vascular bundles. In summary, our findings represent the efficient application of bsAgNPs in plant disease management, indicating the exciting possibilities of nanofungicide employing agriculturally important bacteria.	[Mishra, Sandhya; Singh, Akanksha; Keswani, Chetan; Singh, H. B.] Banaras Hindu Univ, Inst Agr Sci, Dept Mycol & Plant Pathol, Varanasi 221005, Uttar Pradesh, India; [Singh, Braj Raj; Naqvi, Alim H.] Aligarh Muslim Univ, ZH Coll Engn & Technol, Dept Appl Phys, Ctr Excellence Mat Sci Nanomat, Aligarh, Uttar Pradesh, India	Banaras Hindu University (BHU); Aligarh Muslim University; Zakir Husain College Of Engineering & Technology	Singh, HB (corresponding author), Banaras Hindu Univ, Inst Agr Sci, Dept Mycol & Plant Pathol, Varanasi 221005, Uttar Pradesh, India.	hbs1@rediffmail.com	KESWANI, CHETAN/I-4311-2014; De Groot, Annie/B-6221-2013	KESWANI, CHETAN/0000-0002-2786-121X; Singh, Akanksha/0000-0001-7206-3965; De Groot, Annie/0000-0001-5911-1459	NIAID NIH HHS [U19 AI082642] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bakshi M, 2014, CURR SCI INDIA, V106, P350; Balaji DS, 2009, COLLOID SURFACE B, V68, P88, DOI 10.1016/j.colsurfb.2008.09.022; Benhamou N, 2000, PHYTOPATHOLOGY, V90, P45, DOI 10.1094/PHYTO.2000.90.1.45; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRIC JM, 1991, APPL ENVIRON MICROB, V57, P535, DOI 10.1128/AEM.57.2.535-538.1991; Choi M, 2010, J COLLOID INTERF SCI, V341, P83, DOI 10.1016/j.jcis.2009.09.037; Domiciano GP, 2013, TROP PLANT PATHOL, V38, P258, DOI http://dx.doi.org/10.1590/s1982-56762013005000006; Dwivedi S, 2011, J HAZARD MATER, V185, P938, DOI 10.1016/j.jhazmat.2010.09.110; Ghormade V, 2011, BIOTECHNOL ADV, V29, P792, DOI 10.1016/j.biotechadv.2011.06.007; Gopinath V, 2013, SPECTROCHIM ACTA A, V106, P170, DOI 10.1016/j.saa.2012.12.087; He LL, 2011, MICROBIOL RES, V166, P207, DOI 10.1016/j.micres.2010.03.003; HOLT J. G., 1994, BERGEYS MANUAL DETER, P544; Hu C, 2006, J PHYS CHEM B, V110, P4066, DOI 10.1021/jp0564400; Jensen WA., 1962, BOT HISTOCHEMISTRY P; Jeyaraj M, 2013, J IND ENG CHEM, V19, P1299, DOI 10.1016/j.jiec.2012.12.031; KAMENSKY M, 2003, SOIL BOIL BIOCH, V79, P584; Kanchana A, 2011, DIG J NANOMATER BIOS, V6, P1741; Kasthuri J, 2009, COLLOID SURFACE B, V68, P55, DOI 10.1016/j.colsurfb.2008.09.021; Khan JA, 2014, CR CHIM, V17, P91, DOI 10.1016/j.crci.2013.08.006; Khan JA, 2013, SPECTROCHIM ACTA A, V109, P313, DOI 10.1016/j.saa.2013.03.011; Kim SW, 2009, J MICROBIOL BIOTECHN, V19, P760, DOI 10.4014/jmb.0812.649; KLEEMANN W, 1993, INT J MOD PHYS B, V7, P2469, DOI 10.1142/S0217979293002912; Koo SY, 2009, J MICROBIOL BIOTECHN, V19, P1431, DOI 10.4014/jmb.0904.04014; Krishnaraj C, 2012, SPECTROCHIM ACTA A, V93, P95, DOI 10.1016/j.saa.2012.03.002; Kumar CG, 2011, COLLOID SURFACE B, V84, P462, DOI 10.1016/j.colsurfb.2011.01.042; Kumar J, 2002, MOL PLANT PATHOL, V3, P185, DOI 10.1046/j.1364-3703.2002.00120.x; Kumar U, 2009, THEOR APPL GENET, V118, P783, DOI 10.1007/s00122-008-0938-5; Lee KJ, 2013, MATER LETT, V105, P128, DOI 10.1016/j.matlet.2013.04.076; Malhotra A, 2013, BIORESOURCE TECHNOL, V142, P727, DOI 10.1016/j.biortech.2013.05.109; Mandal S, 2007, PHYSIOL MOL PLANT P, V71, P201, DOI 10.1016/j.pmpp.2008.02.003; Mehta S, 2001, CURR MICROBIOL, V43, P51, DOI 10.1007/s002840010259; Mehta YR, 1994, MANEJO INTEGRADO ENF, P314; Mishra S, 2012, PLANT GROWTH REGUL, V66, P155, DOI 10.1007/s10725-011-9639-1; MOERSCHBACHER BM, 1990, PLANT PHYSIOL, V93, P465, DOI 10.1104/pp.93.2.465; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Musarrat J, 2010, BIORESOURCE TECHNOL, V101, P8772, DOI 10.1016/j.biortech.2010.06.065; Nair R, 2010, PLANT SCI, V179, P154, DOI 10.1016/j.plantsci.2010.04.012; Navrotsky A, 2000, J NANOPART RES, V2, P321, DOI 10.1023/A:1010007023813; Long NV, 2013, J NANOMATER, V2013, DOI 10.1155/2013/793125; Oves M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059140; Prakash P, 2013, COLLOID SURFACE B, V108, P255, DOI 10.1016/j.colsurfb.2013.03.017; Quester K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077486; Rao RAK, 2014, J ENVIRON CHEM ENG, V2, P199, DOI 10.1016/j.jece.2013.12.011; Saari E.E., 1998, HELMINTHOSPORIUM BLI, P37; Sarkar A, 2010, J PROTEOME RES, V9, P4565, DOI 10.1021/pr1002824; Shi HY, 2012, ACTA BIOCH BIOPH SIN, V44, P555, DOI 10.1093/abbs/gms035; Shivaji S, 2011, PROCESS BIOCHEM, V46, P1800, DOI 10.1016/j.procbio.2011.06.008; Shoeb M, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/035015; Siddique YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080944; Singh BR, 2012, BIOMATERIALS, V33, P5753, DOI 10.1016/j.biomaterials.2012.04.045; Singh RV, 1997, P INT WORKSH HELM BL, P59; Singh S, 2014, J MOL STRUCT, V1056, P194, DOI 10.1016/j.molstruc.2013.10.020; Tian J, 2007, CHEMMEDCHEM, V2, P129, DOI 10.1002/cmdc.200600171	53	123	139	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 19	2014	9	5							e97881	10.1371/journal.pone.0097881	http://dx.doi.org/10.1371/journal.pone.0097881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9SK	25111185	Green Submitted, Green Published, gold			2022-12-27	WOS:000340948600086
J	Wang, JF; Ruan, Z; Feng, Y; Fu, Y; Jiang, Y; Wang, HP; Yu, YS				Wang, Jianfeng; Ruan, Zhi; Feng, Ye; Fu, Ying; Jiang, Yan; Wang, Haiping; Yu, Yunsong			Species Distribution of Clinical Acinetobacter Isolates Revealed by Different Identification Techniques	PLOS ONE			English	Article							RPOB GENE; CARBAPENEM-RESISTANT; MASS-SPECTROMETRY; MULTIPLEX PCR; BAUMANNII; BLA(OXA-51-LIKE)	A total of 2582 non-duplicate clinical Acinetobacter spp. isolates were collected to evaluate the performance of four identification methods because it is important to identify Acinetobacter spp. accurately and survey the species distribution to determine the appropriate antimicrobial treatment. Phenotyping (VITEK 2 and VITEK MS) and genotyping (16S rRNA and rpoB gene sequencing) methods were applied for species identification, and antimicrobial susceptibility test of imipenem and meropenem was performed with a disk diffusion assay. Generally, the phenotypic identification results were quite different from the genotyping results, and their discrimination ability was unsatisfactory, whereas 16S rRNA and rpoB gene sequencing showed consistent typing results, with different resolution. Additionally, A. pittii, A. calcoaceticus and A. nosocomialis, which were phylogenetically close to A. baumannii, accounted for 85.5% of the non-A. baumannii isolates. One group, which could not be clustered with any reference strains, consisted of 11 isolates and constituted a novel Acinetobacter species that was entitled genomic species 33YU. None of the non-A. baumannii isolates harbored a bla(OXA-51)-like gene, and this gene was disrupted by ISAba19 in only one isolate; it continues to be appropriate as a genetic marker for A. baumannii identification. The resistance rate of non-A. baumannii isolates to imipenem and/or meropenem was only 2.6%, which was significantly lower than that of A. baumannii. Overall, rpoB gene sequencing was the most accurate identification method for Acinetobacter species. Except for A. baumannii, the most frequently isolated species from the nosocomial setting were A. pittii, A. calcoaceticus and A. nosocomialis.	[Wang, Jianfeng; Ruan, Zhi; Feng, Ye; Fu, Ying; Jiang, Yan; Wang, Haiping; Yu, Yunsong] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Feng, Ye] Zhejiang Univ, Inst Translat Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Yu, YS (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	yvys119@163.com	Yang, Ming/G-4705-2012; Ruan, Zhi/P-3987-2015; , CC. Zhou/AGI-1229-2022	Yang, Ming/0000-0002-7722-7487; Ruan, Zhi/0000-0001-8648-4592; RAJENDRA PRASAD, JANAPATLA/0000-0003-4331-0925	National Natural Science Foundation of China [NSFC81378158, NSFC81230039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. NSFC81378158 and NSFC81230039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2009, TRENDS MICROBIOL, V17, P37, DOI 10.1016/j.tim.2008.09.008; Adekambi T, 2008, INT J SYST EVOL MICR, V58, P1807, DOI 10.1099/ijs.0.65440-0; Alvarez-Buylla A, 2012, INFECT GENET EVOL, V12, P345, DOI 10.1016/j.meegid.2012.01.002; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bitrian M, 2012, INT MICROBIOL, V15, P79, DOI 10.2436/20.1501.01.161; Cockerill FR, 2012, PERFORMANCE STANDARD; GERISCHER U., 2008, ACINETOBACTER MOL BI; Gundi VAKB, 2009, MICROBIOL-SGM, V155, P2333, DOI 10.1099/mic.0.026054-0; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Kaase M, 2013, J ANTIMICROB CHEMOTH; Karah N, 2011, J ANTIMICROB CHEMOTH, V66, P738, DOI 10.1093/jac/dkq521; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Kiyota N, 2013, J MED MICROBIOL, V62, P610, DOI 10.1099/jmm.0.049072-0; La Scola B, 2006, J CLIN MICROBIOL, V44, P827, DOI 10.1128/JCM.44.3.827-832.2006; Lee MJ, 2014, DIAGN MICR INFEC DIS, V78, P29, DOI 10.1016/j.diagmicrobio.2013.07.013; Lee MJ, 2013, DIAGN MICROBIOL INFE; Lee YT, 2012, ANTIMICROB AGENTS CH, V56, P1124, DOI 10.1128/AAC.00622-11; Li Y, 2013, INT J SYST EVOL MICR, V63, P2963, DOI 10.1099/ijs.0.047274-0; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Patel R, 2013, CLIN INFECT DIS, V57, P564, DOI 10.1093/cid/cit247; Ruan Z, 2013, INT J ANTIMICROB AG, V42, P322, DOI 10.1016/j.ijantimicag.2013.06.019; Sahl JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054287; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sedo O, 2013, SYST APPL MICROBIOL, V36, P572, DOI 10.1016/j.syapm.2013.08.001; Sieniawski Karol, 2013, Pol Przegl Chir, V85, P483, DOI 10.2478/pjs-2013-0075; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Vaneechoutte M, 2008, INT J SYST EVOL MICR, V58, P937, DOI 10.1099/ijs.0.65129-0; Zander E, 2013, INT J MED MICROBIOL, V303, P88, DOI 10.1016/j.ijmm.2012.12.007	29	194	203	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2014	9	8							e104882	10.1371/journal.pone.0104882	http://dx.doi.org/10.1371/journal.pone.0104882			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN9BM	24722735	Green Submitted, Green Published, gold			2022-12-27	WOS:000340900600098
J	Li, MM; Wu, MQ; Xu, J; Du, J; Yan, CH				Li, Min-ming; Wu, Mei-qin; Xu, Jian; Du, Juan; Yan, Chong-huai			Body Burden of Hg in Different Bio-Samples of Mothers in Shenyang City, China	PLOS ONE			English	Article							BLOOD MERCURY LEVELS; UMBILICAL-CORD BLOOD; MATERNAL FISH INTAKE; PRENATAL EXPOSURE; METHYLMERCURY EXPOSURE; INORGANIC MERCURY; BREAST-MILK; GROWTH-RETARDATION; LACTATING WOMEN; PREGNANT-WOMEN	Hg is an accumulative and neuro-toxic heavy metal which has a wide range of adverse effects in human health. However, few studies are available on body burden of Hg level in different bio-samples of pregnant women in Chinese population. Therefore, this study evaluated Hg levels in different maternal bio-samples in Shenyang city, China and investigated the correlation of Hg levels in different bio-samples. From October to December 2008, 200 pregnant women about to deliver their babies at ShengJing Hospital (Shenyang city, northeast of China) participated in this study. The geometric mean (GM) of Hg levels in cord blood, maternal venous blood, breast milk, and maternal urine were 2.18 mu g/L, 1.17 mu g/L, 1.14 mu g/L, and 0.73 mu g/L, respectively, and the GM of maternal hair Hg level was 404.45 mu g/kg. There was a strong correlation between cord blood and maternal blood total Hg level (r = 0.713, P<0.001). Frequency of fish consumption more than or equal to 3 times per week during pregnancy was suggested as a significant risk factor of prenatal Hg exposure (unadjusted OR 3.5, adjusted OR 2.94, P<0.05). This study provides evidence about Hg burden of mothers and the risk factors of prenatal Hg exposure in Shenyang city, China.	[Li, Min-ming; Wu, Mei-qin; Xu, Jian; Yan, Chong-huai] Shanghai Jiao Tong Univ, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Sch Med, Shanghai 200030, Peoples R China; [Du, Juan] China Med Univ, Shengjing Hosp, Dept Gynecol & Obstet, Shenyang, Peoples R China	Shanghai Jiao Tong University; China Medical University	Yan, CH (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, MOE Shanghai Key Lab Childrens Environm Hlth, Sch Med, Shanghai 200030, Peoples R China.	yanch@shkeylab-ceh.org	Wu, Meiqin/HHS-2963-2022		Science and Technology Commission of Shanghai Municipality [09DZ2200900]; Natural Science Foundation of China [30872806]; Shanghai Municipal Health Bureau, China [SNXD 2011056]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Health Bureau, China	This work was supported by a grant from the Science and Technology Commission of Shanghai Municipality (09DZ2200900), Natural Science Foundation of China (Grant No. 30872806), and Shanghai Municipal Health Bureau, China (SNXD 2011056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrad DA, 2007, ENVIRON HEALTH PERSP, V115, P609, DOI 10.1289/ehp.9303; Bernhard D, 2005, IUBMB LIFE, V57, P805, DOI 10.1080/15216540500459667; Bose-O'Reilly S, 2010, CURR PROB PEDIATR AD, V40, P186, DOI 10.1016/j.cppeds.2010.07.002; Carrington CD, 2004, REGUL TOXICOL PHARM, V40, P272, DOI 10.1016/j.yrtph.2004.07.006; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P705; Cernichiari E, 1995, NEUROTOXICOLOGY, V16, P613; Chinese Nutrition Society, 2010, DIET GUID CHIN INH, V2010, P44; Counter SA, 2004, TOXICOL APPL PHARM, V198, P209, DOI 10.1016/j.taap.2003.11.032; Crinnion WJ, 2010, ALTERN MED REV, V15, P101; Dastoor AP, 2004, ATMOS ENVIRON, V38, P147, DOI 10.1016/j.atmosenv.2003.08.037; DOI R, 1984, B ENVIRON CONTAM TOX, V33, P69, DOI 10.1007/BF01625513; Dorea JG, 2004, BRIT J NUTR, V92, P21, DOI 10.1079/BJN20041163; Fok TF, 2007, ENVIRON INT, V33, P84, DOI 10.1016/j.envint.2006.08.002; Gao Y, 2007, ENVIRON RES, V105, P390, DOI 10.1016/j.envres.2007.05.015; Garcia-Esquinas E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-841; Goldman LR, 2001, PEDIATRICS, V108, P197, DOI 10.1542/peds.108.1.197; Grandjean P, 1998, ENVIRON RES, V77, P165, DOI 10.1006/enrs.1997.3804; Grandjean P, 2005, ENVIRON HEALTH PERSP, V113, P905, DOI 10.1289/ehp.7842; Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4; Grandjean P, 1999, AM J EPIDEMIOL, V150, P301, DOI 10.1093/oxfordjournals.aje.a010002; Gundacker C, 2002, PEDIATRICS, V110, P873, DOI 10.1542/peds.110.5.873; Guo BQ, 2013, TOXICOLOGY, V304, P57, DOI 10.1016/j.tox.2012.11.019; Halldorsson TI, 2007, AM J EPIDEMIOL, V166, P687, DOI 10.1093/aje/kwm133; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Jackson LW, 2011, HUM REPROD, V26, P2887, DOI 10.1093/humrep/der250; Jedrychowski W, 2006, ANN EPIDEMIOL, V16, P439, DOI 10.1016/j.annepidem.2005.06.059; Jo Eun Mi, 2010, J Prev Med Public Health, V43, P377, DOI 10.3961/jpmph.2010.43.5.377; Kim BM, 2011, SCI TOTAL ENVIRON, V410, P26, DOI 10.1016/j.scitotenv.2011.08.060; KIM DS, 2011, TOXICOL ENV HEALTH, V3, P254, DOI DOI 10.1007/s13530-011-0099-9; Kim NS, 2010, SCI TOTAL ENVIRON, V408, P4841, DOI 10.1016/j.scitotenv.2010.06.026; Kowalski R, 2009, ECOL CHEM ENG S, V16, P155; MASON HJ, 1994, OCCUP ENVIRON MED, V51, P287, DOI 10.1136/oem.51.4.287-a; Miao LJ, 2013, MODERN FOOD SCI TECH, V29, P687; Morrissette J, 2004, ENVIRON RES, V95, P363, DOI 10.1016/j.envres.2003.12.007; Morton J, 2004, BIOMARKERS, V9, P47, DOI 10.1080/13547500410001670312; Myers GJ, 2003, LANCET, V361, P1686, DOI 10.1016/S0140-6736(03)13371-5; Nesheim M, 2007, SEAFOOD CHOICES BALA, P67; Ng DKK, 2007, PEDIATR INT, V49, P80, DOI 10.1111/j.1442-200X.2007.02303.x; NRC (National Research Council), 2000, TOX EFF METH, P250; Office of Science and Technology Office of Water US EPA (United States Environmental Protection Agency), 2001, WAT QUAL CRIT PROC H, P18; Oken E, 2004, AM J EPIDEMIOL, V160, P774, DOI 10.1093/aje/kwh282; Oken E, 2008, AM J EPIDEMIOL, V167, P1171, DOI 10.1093/aje/kwn034; OLSTAD ML, 1987, J DENT RES, V66, P1179, DOI 10.1177/00220345870660061701; Oskarsson A, 1996, ARCH ENVIRON HEALTH, V51, P234, DOI 10.1080/00039896.1996.9936021; Pacyna EG, 2006, ATMOS ENVIRON, V40, P4048, DOI 10.1016/j.atmosenv.2006.03.041; Pesch A, 2002, J EXPO ANAL ENV EPID, V12, P252, DOI 10.1038/sj.jea.7500228; Ramirez GB, 2000, PEDIATRICS, V106, P774, DOI 10.1542/peds.106.4.774; Ramon R, 2008, SCI TOTAL ENVIRON, V392, P69, DOI 10.1016/j.scitotenv.2007.11.025; Ramon R, 2009, AM J CLIN NUTR, V90, P1047, DOI 10.3945/ajcn.2009.27944; Reus IS, 2003, J BIOCHEM MOL TOXIC, V17, P161, DOI 10.1002/jbt.10074; Rice DC, 2004, ENVIRON RES, V95, P406, DOI 10.1016/j.envres.2003.08.013; RICHARDSON RA, 1976, CLIN CHEM, V22, P1604; Rogers I, 2004, J EPIDEMIOL COMMUN H, V58, P486, DOI 10.1136/jech.2003.013565; Sakamoto M, 2004, ENVIRON SCI TECHNOL, V38, P3860, DOI 10.1021/es034983m; Sakamoto M, 2007, ENVIRON RES, V103, P106, DOI 10.1016/j.envres.2006.03.004; Schettler T, 2001, ENVIRON HEALTH PERSP, V109, P813, DOI 10.2307/3454643; Scheulhammer AM, 2007, AMBIO, V36, P12, DOI 10.1579/0044-7447(2007)36[12:EOEMOT]2.0.CO;2; Schober SE, 2003, JAMA-J AM MED ASSOC, V289, P1667, DOI 10.1001/jama.289.13.1667; Stern AH, 2003, ENVIRON HEALTH PERSP, V111, P1465, DOI 10.1289/ehp.6187; Steuerwald U, 2000, J PEDIATR-US, V136, P599, DOI 10.1067/mpd.2000.102774; Unuvar E, 2007, SCI TOTAL ENVIRON, V374, P60, DOI 10.1016/j.scitotenv.2006.11.043; US Department of Health and Human Services US Environmental Protection Agency, 2004, WHAT YOU NEED KNOW M; US EPA (United States Environmental Protection Agency), 1997, CHAR HUM HLTH WILDL, VVII; Vahter M, 2000, ENVIRON RES, V84, P186, DOI 10.1006/enrs.2000.4098; Weil M, 2005, JAMA-J AM MED ASSOC, V293, P1875, DOI 10.1001/jama.293.15.1875; Weiner R, 1996, S AFR MED J, V86, P943; Wilson SJ, 2006, ATMOS ENVIRON, V40, P4621, DOI 10.1016/j.atmosenv.2006.03.042; Wu MQ, 2013, J ENVIRON SCI-CHINA, V25, P386, DOI 10.1016/S1001-0742(12)60061-8; Wu Y, 2006, ENVIRON SCI TECHNOL, V40, P5312, DOI 10.1021/es060406x; Yoshida M, 2002, TOHOKU J EXP MED, V196, P79, DOI 10.1620/tjem.196.79; Zalups RK, 1997, J TOXICOL ENV HEALTH, V50, P173, DOI 10.1080/009841097160564; Zalups RK, 1999, CHEM-BIOL INTERACT, V123, P171, DOI 10.1016/S0009-2797(99)00135-0	72	26	29	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98121	10.1371/journal.pone.0098121	http://dx.doi.org/10.1371/journal.pone.0098121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	24858815	Green Published, gold, Green Submitted			2022-12-27	WOS:000336839400044
J	Liu, LY; Yu, YH; Hou, YS; Chai, JK; Duan, HJ; Chu, WL; Zhang, HJ; Hu, Q; Du, JD				Liu, Lingying; Yu, Yonghui; Hou, Yusen; Chai, Jiake; Duan, Hongjie; Chu, Wanli; Zhang, Haijun; Hu, Quan; Du, Jundong			Human Umbilical Cord Mesenchymal Stem Cells Transplantation Promotes Cutaneous Wound Healing of Severe Burned Rats	PLOS ONE			English	Article							BONE-MARROW; IN-VITRO; STROMAL CELLS; DIFFERENTIATION; THERAPY; REPAIR; INJURY	Background: Severe burns are a common and highly lethal trauma. The key step for severe burn therapy is to promote the wound healing as early as possible, and reports indicate that mesenchymal stem cell (MSC) therapy contributes to facilitate wound healing. In this study, we investigated effect of human umbilical cord MSCs (hUC-MSCs) could on wound healing in a rat model of severe burn and its potential mechanism. Methods: Adult male Wistar rats were randomly divided into sham, burn, and burn transplanted hUC-MSCs. GFP labeled hUC-MSCs or PBS was intravenous injected into respective groups. The rate of wound closure was evaluated by Image Pro Plus. GFP-labeled hUC-MSCs were tracked by in vivo bioluminescence imaging (BLI), and human-specific DNA expression in wounds was detected by PCR. Inflammatory cells, neutrophils, macrophages, capillaries and collagen types I/III in wounds were evaluated by histochemical staining. Wound blood flow was evaluated by laser Doppler blood flow meter. The levels of proinflammatory and anti-inflammatory factors, VEGF, collagen types I/III in wounds were analyzed using an ELISA. Results: We found that wound healing was significantly accelerated in the hUC-MSC therapy group. The hUC-MSCs migrated into wound and remarkably decreased the quantity of infiltrated inflammatory cells and levels of IL-1, IL-6, TNF-alpha and increased levels of IL-10 and TSG-6 in wounds. Additionally, the neovascularization and levels of VEGF in wounds in the hUC-MSC therapy group were markedly higher than those in other control groups. The ratio of collagen types I and III in the hUC-MSC therapy group were markedly higher than that in the burn group at indicated time after transplantation. Conclusion: The study suggests that hUC-MSCs transplantation can effectively improve wound healing in severe burned rat model. Moreover, these data might provide the theoretical foundation for the further clinical application of hUC-MSC in burn areas.	[Liu, Lingying; Yu, Yonghui; Hou, Yusen; Chai, Jiake; Duan, Hongjie; Chu, Wanli; Zhang, Haijun; Hu, Quan; Du, Jundong] Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Burn & Plast Surg, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Chai, JK (corresponding author), Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Burn & Plast Surg, Beijing, Peoples R China.	cjk304@126.com	Yu, Yonghui/AAZ-4093-2021; Duan, Hongjie/HCI-0703-2022		National Natural Science Foundation of China [81372052]; General Financial Grant from the China Postdoctoral Science Foundation [2013M532200]; First Affiliated Hospital [QN201207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Financial Grant from the China Postdoctoral Science Foundation; First Affiliated Hospital	This work was supported by the National Natural Science Foundation of China (81372052), General Financial Grant from the China Postdoctoral Science Foundation (2013M532200), and the First Affiliated Hospital to the PLA General Hospital Science Research Foundation of China (QN201207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZM, 2013, CHINESE MED J-PEKING, V126, P1890, DOI 10.3760/cma.j.issn.0366-6999.20130045; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Bernardo ME, 2012, BONE MARROW TRANSPL, V47, P164, DOI 10.1038/bmt.2011.81; Chen K, 2010, CLIN IMMUNOL, V135, P448, DOI 10.1016/j.clim.2010.01.015; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Chu Wan-li, 2012, Zhonghua Yi Xue Za Zhi, V92, P853; Fong CY, 2007, REPROD BIOMED ONLINE, V15, P708, DOI 10.1016/S1472-6483(10)60539-1; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Han YF, 2011, BIOCHEM BIOPH RES CO, V413, P561, DOI 10.1016/j.bbrc.2011.09.001; Hocking AM, 2010, EXP CELL RES, V316, P2213, DOI 10.1016/j.yexcr.2010.05.009; Johansson U, 2008, DIABETES, V57, P2393, DOI 10.2337/db07-0981; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Krasnodembskaya A, 2010, STEM CELLS, V28, P2229, DOI 10.1002/stem.544; Lau K, 2009, EXP DERMATOL, V18, P921, DOI 10.1111/j.1600-0625.2009.00942.x; Leclerc T, 2011, CELL PROLIFERAT, V44, P48, DOI 10.1111/j.1365-2184.2010.00727.x; Li J, 2012, J ASIA TEFL, V9, P1, DOI 10.1186/1476-9255-9-33; Li JX, 2008, CELL RES, V18, P360, DOI 10.1038/cr.2007.103; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Pillai SI, 2010, PHARM BIOL, V48, P1198, DOI 10.3109/13880200903578754; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Shi YH, 2012, BURNS, V38, P95, DOI 10.1016/j.burns.2010.06.002; Suzdaltseva YG, 2008, B EXP BIOL MED+, V145, P228, DOI 10.1007/s10517-008-0057-y; Tondreau T, 2009, CYTOTHERAPY, V11, P559, DOI 10.1080/14653240903051541; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Wang MJ, 2006, AM J PHYSIOL-REG I, V291, pR880, DOI 10.1152/ajpregu.00280.2006; Wang Y, 2009, SURGERY, V146, P198, DOI 10.1016/j.surg.2009.04.013; Yan H, 2013, CHINESE MED J-PEKING, V126, P1700, DOI 10.3760/cma.j.issn.0366-6999.20122728; Zhou YL, 2010, CHINESE MED J-PEKING, V123, P3282, DOI 10.3760/cma.j.issn.0366-6999.2010.22.021	30	153	168	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2014	9	2							e88348	10.1371/journal.pone.0088348	http://dx.doi.org/10.1371/journal.pone.0088348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3UC	24586314	Green Published, gold, Green Submitted			2022-12-27	WOS:000331714700013
J	Thomsen, M; Hernandez-Garcia, A; Mathiesen, J; Poulsen, M; Sorensen, DN; Tarnow, L; Feidenhansl, R				Thomsen, Maria; Hernandez-Garcia, Anier; Mathiesen, Joachim; Poulsen, Mette; Sorensen, Dan N.; Tarnow, Lise; Feidenhansl, Robert			Model Study of the Pressure Build-Up during Subcutaneous Injection	PLOS ONE			English	Article							INSULIN; INFUSION; TISSUE	In this study we estimate the subcutaneous tissue counter pressure during drug infusion from a series of injections of insulin in type 2 diabetic patients using a non-invasive method. We construct a model for the pressure evolution in subcutaneous tissue based on mass continuity and the flow laws of a porous medium. For equivalent injection forces we measure the change in the infusion rate between injections in air at atmospheric pressure and in tissue. From a best fit with our model, we then determine the flow permeability as well as the bulk modulus of the tissue, estimated to be of the order 10(-11) - 10(-10) m(2) and 10(5) Pa, respectively. The permeability is in good agreement with reported values for adipose porcine tissue. We suggest our model as a general way to estimate the pressure build-up in tissue during subcutaneous injection.	[Thomsen, Maria; Hernandez-Garcia, Anier; Mathiesen, Joachim; Feidenhansl, Robert] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Thomsen, Maria; Poulsen, Mette; Sorensen, Dan N.] Novo Nordisk AS, Hillerod, Denmark; [Tarnow, Lise] Nordsjae llands Hosp, Hillerod, Denmark; [Tarnow, Lise] Aarhus Univ Hosp, Klin Epidemiol Afdeling, DK-8000 Aarhus, Denmark; [Tarnow, Lise] Steno Diabet Ctr AS, Gentofte, Denmark	University of Copenhagen; Niels Bohr Institute; Novo Nordisk; Aarhus University; Steno Diabetes Center	Thomsen, M (corresponding author), Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	mariath@fys.ku.dk	Thompson, Matthew/J-9922-2012; Tangen, Jason/ABH-8577-2020	Thompson, Matthew/0000-0002-5649-1203; Tangen, Jason/0000-0002-0649-2566; Poulsen, Mette Homann/0000-0003-2162-3007; Tarnow, Lise/0000-0002-8735-966X; Feidenhansl, Robert/0000-0002-7963-3649; Mathiesen, Joachim/0000-0002-5621-5487	Villum Fonden [00007172] Funding Source: researchfish	Villum Fonden(Villum Fonden)		Agache PG, 2004, MEASURING SKIN; AUKLAND K, 1993, PHYSIOL REV, V73, P1, DOI 10.1152/physrev.1993.73.1.1; Comley KSC, 2010, THESIS U CAMBRIDGE E; Darcy H., 1856, FONTAINES PUBLIQUE V, DOI [10.2307/1467138, DOI 10.2307/1467138]; De Coninck C, 2010, J DIABETES, V2, P168, DOI 10.1111/j.1753-0407.2010.00077.x; Gentile S, 2011, ACTA DIABETOL, V48, P121, DOI 10.1007/s00592-009-0172-x; Heinemann L, 2013, DIABETES TECHNOL THE, V15, pS48, DOI 10.1089/dia.2013.1506; Holstein A, 2010, EXPERT OPIN DRUG SAF, V9, P225, DOI 10.1517/14740330903496402; Johansson UB, 2005, DIABETES CARE, V28, P2025, DOI 10.2337/diacare.28.8.2025; Johnsen O, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011301; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; Milan G, 2010, J CLIN ENDOCR METAB, V95, P3126, DOI 10.1210/jc.2009-2773; Omar Magdy A, 2011, BMC Res Notes, V4, P290, DOI 10.1186/1756-0500-4-290; Patte C, 2013, DIABETES TECHNOL THE, V15, P289, DOI 10.1089/dia.2012.0319; Pearson Teresa L, 2010, J Diabetes Sci Technol, V4, P522; Peteiro-Gonzalez D, 2011, DIABETES RES CLIN PR, V91, pE61, DOI 10.1016/j.diabres.2010.11.026; SPIEGELMAN M, 1993, J FLUID MECH, V247, P17, DOI 10.1017/S0022112093000369; STRANDEN E, 1982, MICROVASC RES, V24, P241, DOI 10.1016/0026-2862(82)90015-2; Strauss K, 2002, PRACT DIAB INT, P71, DOI 10.1002/pdi.314; Thomsen M, 2012, PHYS MED BIOL, V57, P7191, DOI 10.1088/0031-9155/57/21/7191; Vardar B, 2007, DIABETES RES CLIN PR, V77, P231, DOI 10.1016/j.diabres.2006.12.023; Wang H.F., 2000, PRI SER GEO; Wielandt JO, 2011, EXPERT OPIN DRUG DEL, V8, P1271, DOI 10.1517/17425247.2011.615308; Wiig H, 2003, ACTA ANAESTH SCAND, V47, P111, DOI 10.1034/j.1399-6576.2003.00050.x	24	51	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104054	10.1371/journal.pone.0104054	http://dx.doi.org/10.1371/journal.pone.0104054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	25122138	Green Published, gold			2022-12-27	WOS:000341017000026
J	Wang, JW; Wei, JY; Xu, XL; Pan, WT; Ge, YX; Zhou, CC; Liu, C; Gao, J; Yang, M; Mao, WM				Wang, Jiwen; Wei, Jinyu; Xu, Xiaoling; Pan, Wenting; Ge, Yunxia; Zhou, Changchun; Liu, Chao; Gao, Jia; Yang, Ming; Mao, Weimin			Replication Study of ESCC Susceptibility Genetic Polymorphisms Locating in the ADH1B-ADH1C-ADH7 Cluster Identified by GWAS	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; GENOME-WIDE ASSOCIATION; ESOPHAGEAL CANCER; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; VARIANTS CONTRIBUTE; CHINESE POPULATION; RISK-FACTORS; ALCOHOL; LOCI	China was one of the countries with highest esophageal squamous cell carcinoma (ESCC) incidence and mortality worldwide. Alcohol drinking has been identified as a major environmental risk-factor related to ESCC. The alcohol dehydrogenase (ADH) family are major enzymes involved in the alcohol-metabolizing pathways, including alcohol dehydrogenase 1B (ADH1B) and ADH1C. Interestingly, ADH1B and ADH1C genes locate tandemly with ADH7 in a genomic segment as a gene cluster, and are all polymorphic. Several ESCC susceptibility single nucleotide polymorphisms (SNPs) of the ADH1B-ADH1C-ADH7 cluster have been identified previously through a genome-wide association study (GWAS). In the study, we examined the association between five ADH1B-ADH1C-ADH7 cluster SNPs (rs1042026, rs17033, rs1614972, rs1789903 and rs17028973) and risk of developing ESCC. Genotypes were determined in two independent case-control sets from two regions of China. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by logistic regression. Our data demonstrated that these ADH1B-ADH1C-ADH7 cluster SNPs confer susceptibility to ESCC in these two case-control sets, which were consistent to results of the previous GWAS.	[Wang, Jiwen; Xu, Xiaoling; Mao, Weimin] Zhejiang Canc Hosp, Canc Res Inst, Hangzhou, Zhejiang, Peoples R China; [Wang, Jiwen; Mao, Weimin] Key Lab Diag & Treatment Technol Thorac Oncol, Hangzhou, Zhejiang, Peoples R China; [Wei, Jinyu; Pan, Wenting; Ge, Yunxia; Yang, Ming] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China; [Zhou, Changchun] Shandong Acad Med Sci, Shandong Canc Hosp, Clin Lab, Jinan, Shandong, Peoples R China; [Liu, Chao] Zhejiang Canc Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Gao, Jia] Chinese Acad Med Sci, Canc Inst & Hosp, Clin Lab, Beijing 100730, Peoples R China; [Gao, Jia] Peking Union Med Coll, Beijing 100021, Peoples R China; [Mao, Weimin] Zhejiang Canc Hosp, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Beijing University of Chemical Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Zhejiang Cancer Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Zhejiang Cancer Hospital	Yang, M (corresponding author), Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China.	yangm@mail.buct.edu.cn; weiminmao@126.com	Yang, Ming/G-4705-2012; Ruan, Zhi/P-3987-2015; , CC. Zhou/AGI-1229-2022	Yang, Ming/0000-0002-7722-7487; Ruan, Zhi/0000-0001-8648-4592; RAJENDRA PRASAD, JANAPATLA/0000-0003-4331-0925	Key Research Project of Medicine of Zhejiang Province [2011c13039-1]	Key Research Project of Medicine of Zhejiang Province	This work was supported by Key Research Project of Medicine of Zhejiang Province (2011c13039-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2012, HUM MOL GENET, V21, P2132, DOI 10.1093/hmg/dds029; Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Agrawal A, 2012, ALCOHOL RES-CURR REV, V34, P274; Akbari MR, 2009, CANCER RES, V69, P7994, DOI 10.1158/0008-5472.CAN-09-1149; Bass AJ, 2009, GASTROENTEROLOGY, V137, P1573, DOI 10.1053/j.gastro.2009.09.026; Chen W, 2013, BREAST CANCER RES TR, V142, P637, DOI 10.1007/s10549-013-2775-8; Chen YD, 2013, J NEURO-ONCOL, V111, P145, DOI 10.1007/s11060-012-1007-0; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; GAO YT, 1994, INT J CANCER, V58, P192, DOI 10.1002/ijc.2910580208; Hashibe M, 2008, NAT GENET, V40, P707, DOI 10.1038/ng.151; Hiyama T, 2007, INT J CANCER, V121, P1643, DOI 10.1002/ijc.23044; HU JF, 1994, INT J CANCER, V57, P38, DOI 10.1002/ijc.2910570108; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lewis SJ, 2005, CANCER EPIDEM BIOMAR, V14, P1967, DOI 10.1158/1055-9965.EPI-05-0196; Liu JB, 2013, BREAST CANCER RES TR, V140, P151, DOI 10.1007/s10549-013-2615-x; Liu L, 2013, EUR J CANCER, V49, P2143, DOI 10.1016/j.ejca.2013.01.028; Liu L, 2012, CARCINOGENESIS, V33, P119, DOI 10.1093/carcin/bgr250; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Lv Z, 2014, GENE, V538, P42, DOI 10.1016/j.gene.2014.01.025; McKay JD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001333; Ng D, 2008, INT J CANCER, V123, P1610, DOI 10.1002/ijc.23682; Oze I, 2009, CANCER EPIDEM BIOMAR, V18, P3097, DOI 10.1158/1055-9965.EPI-09-0499; Shi J, 2013, INT J CANCER, V132, P2799, DOI 10.1002/ijc.27959; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Wu HC, 2013, CARCINOGENESIS, V34, P2908, DOI 10.1093/carcin/bgt252; Wu M, 2013, INT J CANCER, V132, P1868, DOI 10.1002/ijc.27803; Yang Chun-Xia, 2005, Asian Pac J Cancer Prev, V6, P256; Yang M, 2008, CLIN CANCER RES, V14, P3230, DOI 10.1158/1078-0432.CCR-08-0177; Yang M, 2012, CANCER-AM CANCER SOC, V118, P4681, DOI 10.1002/cncr.27455; Yang M, 2011, INT J RADIAT ONCOL, V79, P1402, DOI 10.1016/j.ijrobp.2009.12.042; Yang M, 2009, HUM MUTAT, V30, P1320, DOI 10.1002/humu.21060; Yao JR, 2014, GENE, V533, P21, DOI 10.1016/j.gene.2013.09.054; Zhang XJ, 2013, CARCINOGENESIS, V34, P2309, DOI 10.1093/carcin/bgt213; Zheng J, 2013, CANCER RES, V73, P5151, DOI 10.1158/0008-5472.CAN-13-0395; Zheng J, 2012, INT J CANCER, V130, P1981, DOI 10.1002/ijc.26253; Zhong R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04147; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zhou LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064331; Zhou LQ, 2012, GENE, V506, P295, DOI 10.1016/j.gene.2012.07.007	41	194	203	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94096	10.1371/journal.pone.0094096	http://dx.doi.org/10.1371/journal.pone.0094096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24722735	Green Published, Green Submitted, gold			2022-12-27	WOS:000336909100038
J	Wang, ST; Sun, XL; Hoshino, Y; Yu, Y; Jia, B; Sun, ZW; Sun, MZ; Duan, XB; Zhu, YM				Wang, Sun-ting; Sun, Xiao-li; Hoshino, Yoichiro; Yu, Yang; Jia, Bei; Sun, Zhong-wen; Sun, Ming-zhe; Duan, Xiang-bo; Zhu, Yan-ming			MicroRNA319 Positively Regulates Cold Tolerance by Targeting OsPCF6 and OsTCP21 in Rice (Oryza sativa L.)	PLOS ONE			English	Article							APOPLASTIC OXIDATIVE BURST; PLANT MICRORNAS; TRANSCRIPTION FACTORS; LOW-TEMPERATURE; GENE-REGULATION; SMALL RNAS; STRESS; ARABIDOPSIS; EXPRESSION; LANCEOLATE	The microRNA319 (miR319) family is conserved among diverse plant species. In rice (Oryza sativa L.), the miR319 gene family is comprised of two members, Osa-miR319a and Osa-miR319b. We found that overexpressing Osa-miR319b in rice resulted in wider leaf blades and delayed development. Here, we focused on the biological function and potential molecular mechanism of the Osa-miR319b gene in response to cold stress in rice. The expression of Osa-miR319b was down-regulated by cold stress, and the overexpression of Osa-miR319b led to an enhanced tolerance to cold stress, as evidenced by higher survival rates and proline content. Also, the expression of a handful of cold stress responsive genes, such as DREB1A/B/C, DREB2A, TPP1/2, was increased in Osa-miR319b transgenic lines. Furthermore, we demonstrated the nuclear localization of the transcription factors, OsPCF6 and OsTCP21, which may be Osa-miR319b-targeted genes. We also showed that OsPCF6 and OsTCP21 expression was largely induced by cold stress, and the degree of induction was obviously repressed in plants overexpressing Osa-miR319b. As expected, the down-regulation of OsPCF6 and OsTCP21 resulted in enhanced tolerance to cold stress, partially by modifying active oxygen scavenging. Taken together, our findings suggest that Osa-miR319b plays an important role in plant response to cold stress, maybe by targeting OsPCF6 and OsTCP21.	[Wang, Sun-ting; Sun, Xiao-li; Yu, Yang; Jia, Bei; Sun, Zhong-wen; Sun, Ming-zhe; Duan, Xiang-bo; Zhu, Yan-ming] Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China; [Hoshino, Yoichiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Kita Ku, Sapporo, Hokkaido, Japan	Northeast Agricultural University - China; Hokkaido University	Zhu, YM (corresponding author), Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China.	ymzhu2001@neau.edu.cn	han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020; Hoshino, Yoichiro/A-5115-2012	Sun, Xiaoli/0000-0003-1134-3976; Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Mingzhe/0000-0001-7557-623X	National Natural Science Foundation of China [31171578]; "863" project [2008AA10Z153]; Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program [2011TD005]; National basic scientific talent training fund projects [J1210069]; Graduate student innovation research project in Heilongjiang province [YJSCX2012-047HLJ]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "863" project(National High Technology Research and Development Program of China); Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program; National basic scientific talent training fund projects; Graduate student innovation research project in Heilongjiang province	This work was supported by the National Natural Science Foundation of China (31171578), the "863" project (2008AA10Z153), Heilongjiang Provincial Higher School Science and Technology Innovation Team Building Program (2011TD005), National basic scientific talent training fund projects (J1210069), Graduate student innovation research project in Heilongjiang province (YJSCX2012-047HLJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2006, PLANT CELL REP, V25, P1263, DOI 10.1007/s00299-006-0204-8; Andaya VC, 2003, THEOR APPL GENET, V106, P1084, DOI 10.1007/s00122-002-1126-7; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Armengaud P, 2004, PHYSIOL PLANTARUM, V120, P442, DOI 10.1111/j.0031-9317.2004.00251.x; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Ben-Gera H, 2012, PLANT SIGNAL BEHAV, V7, P1255, DOI 10.4161/psb.21550; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Chinnusamy V, 2010, METHODS MOL BIOL, V639, P39, DOI 10.1007/978-1-60761-702-0_3; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Efroni I, 2008, PLANT CELL, V20, P2293, DOI 10.1105/tpc.107.057521; Eldem V, 2013, TURK J AGRIC FOR, V37, P1, DOI 10.3906/tar-1206-50; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; GLASZMANN JC, 1990, EUPHYTICA, V45, P95; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hsieh TH, 2002, PLANT PHYSIOL, V129, P1086, DOI 10.1104/pp.003442; Huang J, 2009, BIOCHEM BIOPH RES CO, V389, P556, DOI 10.1016/j.bbrc.2009.09.032; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Lou QJ, 2007, EUPHYTICA, V158, P87, DOI 10.1007/s10681-007-9431-5; Lv DK, 2010, GENE, V459, P39, DOI 10.1016/j.gene.2010.03.011; Ma QB, 2009, PLANT PHYSIOL, V150, P244, DOI 10.1104/pp.108.133454; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mao DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047275; Martin-Trillo M, 2010, TRENDS PLANT SCI, V15, P31, DOI 10.1016/j.tplants.2009.11.003; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Nonogaki H, 2010, PLANT CELL PHYSIOL, V51, P1840, DOI 10.1093/pcp/pcq154; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Ozhuner E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059543; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Peyman S, 2010, RICE SCI, V1, P77; Phillips JR, 2007, FEBS LETT, V581, P3592, DOI 10.1016/j.febslet.2007.04.007; Saini A., 2012, MICRORNAS PLANT DEV, P219, DOI [10.1016/j.tplants.2012.01.010, DOI 10.1016/J.TPLANTS.2012.01.010]; Schommer C., 2012, SIGNAL COMMUN PLANTS, V15, P29, DOI [DOI 10.1007/978-3-642-27384-1_2, 10.1007/978-3-642-27384-1_2]; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Sharma R., 2010, J PLANT MOL BIOL BIO, V1, P24; Song SY, 2011, PLANTA, V234, P331, DOI 10.1007/s00425-011-1403-2; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Suzuki N, 2006, PHYSIOL PLANTARUM, V126, P45, DOI 10.1111/j.0031-9317.2005.00582.x; Talmor-Neiman M, 2006, PLANT J, V47, P25, DOI 10.1111/j.1365-313X.2006.02768.x; Thiebaut F, 2012, PLANT CELL ENVIRON, V35, P502, DOI 10.1111/j.1365-3040.2011.02430.x; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Ueno M, 2003, PLANT J, V36, P215, DOI 10.1046/j.1365-313X.2003.01875.x; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Xin Z, 2000, PLANT CELL ENVIRON, V23, P893, DOI 10.1046/j.1365-3040.2000.00611.x; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yanai O, 2011, PLANT J, V68, P571, DOI 10.1111/j.1365-313X.2011.04716.x; Yang CH, 2013, PLANT CELL ENVIRON, V36, P2207, DOI 10.1111/pce.12130; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zhao K, 2013, PLANT CELL PHYSIOL, V54, P1415, DOI 10.1093/pcp/pct087	61	208	242	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 25	2014	9	3							e91357	10.1371/journal.pone.0091357	http://dx.doi.org/10.1371/journal.pone.0091357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE0SD	24667308	Green Published, Green Submitted, gold			2022-12-27	WOS:000333675600005
J	He, XL; Huang, X; Shen, YZ; Huang, ZJ				He, Xiaoliang; Huang, Xi; Shen, Yinzhu; Huang, Zhanjing			Wheat V-H+-ATPase Subunit Genes Significantly Affect Salt Tolerance in Arabidopsis thaliana	PLOS ONE			English	Article							PROTON TRANSPORT; NACL REGULATION; OSMOTIC-STRESS; EXPRESSION; PLANT; CLONING; MECHANISM; GROWTH; LEAVES	Genes for V-H+-ATPase subunits were identified and cloned from the salt-tolerant wheat mutant RH8706-49. Sequences of these genes are highly conserved in plants. Overexpression of these genes in Arabidopsis thaliana improved its salt tolerance, and increased the activities of V-H+-ATPase and Na+/H+ exchange, with the largest increase in plants carrying the c subunit of V-H+-ATPase. Results from quantitative RT-PCR analysis indicated that the mRNA level of each V-H+-ATPase subunit in the Arabidopsis increased under salt stress. Overall, our results suggest that each V-H+-ATPase subunit plays a key role in enhancing salt tolerance in plants.	[Huang, Xi; Shen, Yinzhu; Huang, Zhanjing] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Hebei, Peoples R China; [He, Xiaoliang] Hebei Univ Sci & Technol, Sch Biol Sci & Engn, Shijiazhuang, Hebei, Peoples R China	Hebei Normal University; Hebei University of Science & Technology	Huang, ZJ (corresponding author), Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Hebei, Peoples R China.	huangzhanjing@sohu.com	TANG, Rui/GRS-5116-2022	He, Xing/0000-0001-7676-9930	National Natural Science Fund [30971766]; Hebei Provincial Natural Science Fund [C2009000278]; Doctor Fund of Hebei University of Science and Technology [QD201046]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Hebei Provincial Natural Science Fund; Doctor Fund of Hebei University of Science and Technology	This work was supported by National Natural Science Fund (30971766), Hebei Provincial Natural Science Fund (No. C2009000278), and Doctor Fund of Hebei University of Science and Technology (QD201046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baisakh N, 2012, PLANT BIOTECHNOL J, V10, P453, DOI 10.1111/j.1467-7652.2012.00678.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dietz KJ, 2001, J EXP BOT, V52, P1969, DOI 10.1093/jexbot/52.363.1969; Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200; Forgac M, 2000, J EXP BIOL, V203, P71; Gao CQ, 2011, MOL BIOL REP, V38, P957, DOI 10.1007/s11033-010-0189-9; Ge RC, 2007, PLANT SCI, V173, P55, DOI 10.1016/j.plantsci.2007.04.005; Golldack D, 2001, PLANT PHYSIOL, V125, P1643, DOI 10.1104/pp.125.4.1643; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; He XL, 2012, PLANT MOL BIOL REP, V30, P807, DOI 10.1007/s11105-011-0390-6; Hou XN, 2013, PLANT MOL BIOL REP, V31, P791, DOI 10.1007/s11105-012-0549-9; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Kirsch M, 1996, PLANT MOL BIOL, V32, P543, DOI 10.1007/BF00019107; Lee S, 2004, PLANT CELL, V16, P1378, DOI 10.1105/tpc.021683; Lehr A, 1999, PLANT MOL BIOL, V39, P463, DOI 10.1023/A:1006158310891; Li PH, 2004, ACTA BOT SIN, V46, P93; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Muller ML, 1996, J BIOL CHEM, V271, P1916; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NARASIMHAN ML, 1991, PLANT PHYSIOL, V97, P562, DOI 10.1104/pp.97.2.562; NIU XM, 1993, PLANT PHYSIOL, V103, P713, DOI 10.1104/pp.103.3.713; Ratajczak R, 2000, BBA-BIOMEMBRANES, V1465, P17, DOI 10.1016/S0005-2736(00)00129-2; Sze H, 2002, TRENDS PLANT SCI, V7, P157, DOI 10.1016/S1360-1385(02)02240-9; Wang BS, 2001, J EXP BOT, V52, P2355, DOI 10.1093/jexbot/52.365.2355; Wang L, 2011, PLANTA, V234, P1, DOI 10.1007/s00425-011-1383-2; WARD JM, 1992, PLANT PHYSIOL, V99, P925, DOI 10.1104/pp.99.3.925; Xu CX, 2011, PLANT MOL BIOL REP, V29, P424, DOI 10.1007/s11105-010-0247-4; Xu T, 2000, J BIOL CHEM, V275, P22075, DOI 10.1074/jbc.M002983200; Zhao Q, 2009, PLANT MOL BIOL, V69, P33, DOI 10.1007/s11103-008-9403-8; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	30	96	108	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2014	9	1							e86982	10.1371/journal.pone.0086982	http://dx.doi.org/10.1371/journal.pone.0086982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302PJ	24498005	Green Submitted, Green Published, gold			2022-12-27	WOS:000330617100043
J	Wang, S; Han, XH; Wang, JF; Yao, JR; Shi, YK				Wang, Shuai; Han, Xiaohong; Wang, Jianfei; Yao, Jiarui; Shi, Yuankai			Antitumor Effects of a Novel Chromosome Region Maintenance 1 (CRM1) Inhibitor on Non-Small Cell Lung Cancer Cells In Vitro and in Mouse Tumor Xenografts	PLOS ONE			English	Article							NUCLEAR EXPORT SIGNAL; SELECTIVE INHIBITORS; PROGNOSTIC-FACTOR; TRANSPORT; RECEPTOR; APOPTOSIS; EGFR	Background: Chromosome Region Maintenance 1 (CRM1) is a nuclear exporter and its inhibitor has anti-tumor activity in various cancers. This study assessed the therapeutic efficiency of the novel CRM1 inhibitor KPT-185 on non-small cell lung cancer (NSCLC). Methods: NSCLC cell lines were treated with KPT-185 to assess changes in cell viability, cell cycle, apoptosis, and protein expression. NOD-SCID mice carrying NSCLC cell xenografts were orally treated with KPT-276, a clinical analog of KPT-185, to examine the efficacy and side effects of KPT-276 in vivo. Results: KPT-185 significantly reduced the viability of six NSCLC cell lines in a time-and dose-dependent manner, including epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI)-resistant H1975 and H1650GR cell lines. In addition, KPT-185 induced these NSCLC cells to arrest at G1 phase of the cell cycle and caused apoptosis in a dose-dependent manner. KPT-185 treatment also reduced CRM1 protein levels in six NSCLC cell lines, and the reduction could be completely abolished by the proteasome inhibitor bortezomib. KPT-185 activated caspase 3, 8, and 9, but inhibited survivin expression in NSCLC cells. In a mouse H1975 cell xenograft model, tumor growth was significantly inhibited by oral KPT-276 administration, and there was no significant mouse body weight loss or other side effects. Conclusions: The current study demonstrated the anti-tumor effects of KPT-185 in NSCLC cells, including EGFR-TKI-resistant NSCLC cell lines. Further studies will assess anti-tumor activity of KPT-185 in a clinical trial for NSCLC patients.	[Shi, Yuankai] Chinese Acad Med Sci, Dept Med Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China; Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shi, YK (corresponding author), Chinese Acad Med Sci, Dept Med Oncol, Canc Inst Hosp, Beijing 100730, Peoples R China.	syuankai@cicams.ac.cn	han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020; Hoshino, Yoichiro/A-5115-2012	Sun, Xiaoli/0000-0003-1134-3976; Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Mingzhe/0000-0001-7557-623X				Azmi AS, 2013, GASTROENTEROLOGY, V144, P447, DOI 10.1053/j.gastro.2012.10.036; Bartholomeusz G, 2006, MOL CARCINOGEN, V45, P73, DOI 10.1002/mc.20156; Bonazzi S, 2010, J AM CHEM SOC, V132, P1432, DOI 10.1021/ja9097093; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Etchin J, 2013, LEUKEMIA, V27, P66, DOI 10.1038/leu.2012.219; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9; Keller Shannon A., 2000, Blood, V96, P2537; Lo HW, 2006, J CELL BIOCHEM, V98, P1570, DOI 10.1002/jcb.20876; Meissner T, 2004, FEBS LETT, V576, P27, DOI 10.1016/j.febslet.2004.08.056; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Monecke T, 2009, SCIENCE, V324, P1087, DOI 10.1126/science.1173388; Murakami N, 2002, BIOORG MED CHEM LETT, V12, P2807, DOI 10.1016/S0960-894X(02)00624-8; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Newlands ES, 1996, BRIT J CANCER, V74, P648, DOI 10.1038/bjc.1996.415; Noske A, 2008, CANCER-AM CANCER SOC, V112, P1733, DOI 10.1002/cncr.23354; Noske A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-294; Phelps RM, 1996, J CELL BIOCHEM, P32; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Sakakibara K, 2011, BLOOD, V118, P3922, DOI 10.1182/blood-2011-01-333138; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Turner JG, 2012, BIOCHEM PHARMACOL, V83, P1021, DOI 10.1016/j.bcp.2011.12.016; Van Neck T, 2008, BIOORGAN MED CHEM, V16, P9487, DOI 10.1016/j.bmc.2008.09.051; Wach JY, 2010, BIOORG MED CHEM LETT, V20, P2843, DOI 10.1016/j.bmcl.2010.03.049; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Zhang KJ, 2013, EXP HEMATOL, V41, P67, DOI 10.1016/j.exphem.2012.09.002	31	208	242	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e89848	10.1371/journal.pone.0089848	http://dx.doi.org/10.1371/journal.pone.0089848			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24667308	gold, Green Published, Green Submitted			2022-12-27	WOS:000332475500025
J	Wang, SL; Yang, H; Yu, LJ; Jin, JL; Qian, L; Zhao, H; Xu, Y; Zhu, XL				Wang, Sulei; Yang, Hui; Yu, Linjie; Jin, Jiali; Qian, Lai; Zhao, Hui; Xu, Yun; Zhu, Xiaolei			Oridonin Attenuates A beta(1-42)-Induced Neuroinflammation and Inhibits NF-kappa B Pathway	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; IN-VITRO; PROINFLAMMATORY CYTOKINES; INFLAMMATION; ACTIVATION; HYPOTHESIS; PROTECTS; NEURONS	Neuroinflammation induced by beta-amyloid (A beta) plays a critical role in the pathogenesis of Alzheimer's disease (AD), and inhibiting A beta-induced neuroinflammation serves as a potential strategy for the treatment of AD. Oridonin (Ori), a compound of Rabdosia rubescens, has been shown to exert anti-inflammatory effects. In this study, we demonstrated that Ori inhibited glial activation and decreased the release of inflammatory cytokines in the hippocampus of A beta(1-42)-induced AD mice. In addition, Ori inhibited the NF-kappa B pathway and A beta(1-42)-induced apoptosis. Furthermore, Ori could attenuate memory deficits in A beta(1-42)-induced AD mice. In conclusion, our study demonstrated that Ori inhibited the neuroinflammation and attenuated memory deficits induced by A beta(1-42), suggesting that Ori might be a promising candidate for AD treatment.	[Wang, Sulei; Yang, Hui; Xu, Yun] Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Yu, Linjie; Jin, Jiali; Qian, Lai; Zhao, Hui; Xu, Yun; Zhu, Xiaolei] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University of Chinese Medicine; Nanjing University	Xu, Y (corresponding author), Nanjing Univ Chinese Med, Nanjing Drum Tower Hosp, Clin Coll Tradit Chinese & Western Med, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	xuyun20042001@aliyun.com; zhuquelee@126.com	han, xiao/HDN-9782-2022; Sun, Xiaoli/AAH-2265-2020; Hoshino, Yoichiro/A-5115-2012	Sun, Xiaoli/0000-0003-1134-3976; Hoshino, Yoichiro/0000-0003-3828-0696; Sun, Mingzhe/0000-0001-7557-623X	National Nature Science Foundation of China [81200839, 81230026, 81171085]; Natural Science Foundation [BL2012013]; Bureau of Health of the Jiangsu Province of China [LJ201101]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Bureau of Health of the Jiangsu Province of China	This study was supported by the National Nature Science Foundation of China (81200839, 81230026, and 81171085), the Natural Science Foundation (BL2012013) and the Bureau of Health (LJ201101) of the Jiangsu Province of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae S, 2014, INT J MOL MED, V33, P185, DOI 10.3892/ijmm.2013.1561; Batsch N., 2012, WORLD ALZHEIMER REPO; Boissiere F, 1997, NEUROREPORT, V8, P2849, DOI 10.1097/00001756-199709080-00009; Bu HQ, 2014, ONCOL REP, V31, P975, DOI 10.3892/or.2013.2888; Capiralla H, 2012, J NEUROCHEM, V120, P461, DOI 10.1111/j.1471-4159.2011.07594.x; Couturier J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-72; Fan H, 2013, J BIOMED RES, V27, P296, DOI 10.7555/JBR.27.20120100; Gubandru M, 2013, FOOD CHEM TOXICOL, V61, P209, DOI 10.1016/j.fct.2013.07.013; Han LJ, 2013, NEUROCHEM INT, V62, P913, DOI 10.1016/j.neuint.2013.03.003; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Huang Y, 2005, NEUROSCI LETT, V373, P115, DOI 10.1016/j.neulet.2004.09.074; Jaturapatporn D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006378.pub2; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim HG, 2014, NEUROTOXICOLOGY, V40, P23, DOI 10.1016/j.neuro.2013.10.004; Ku CM, 2013, FOOD CHEM, V141, P1104, DOI 10.1016/j.foodchem.2013.04.044; Kurt MA, 1997, NEUROSCI LETT, V239, P41, DOI 10.1016/S0304-3940(97)00876-8; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Leung CH, 2005, MOL PHARMACOL, V68, P286, DOI 10.1124/mol.105.012765; Llano DA, 2012, ALZ DIS ASSOC DIS, V26, P322, DOI 10.1097/WAD.0b013e31823b2728; Lyman M, 2014, NEUROSCI RES, V79, P1, DOI 10.1016/j.neures.2013.10.004; McGeer PL, 2013, ACTA NEUROPATHOL, V126, P479, DOI 10.1007/s00401-013-1177-7; Meng QH, 2013, PHARMAZIE, V68, P904, DOI 10.1691/ph.2013.3571; Overmyer M, 1999, DEMENT GERIATR COGN, V10, P252, DOI 10.1159/000017128; Paris D, 2007, NEUROSCI LETT, V415, P11, DOI 10.1016/j.neulet.2006.12.029; PRICE DL, 1995, CURR OPIN NEUROL, V8, P268, DOI 10.1097/00019052-199508000-00004; Rozemuller AJM, 2012, NEURODEGENER DIS, V10, P301, DOI 10.1159/000335380; Thangavel R, 2012, NEUROPATH APPL NEURO, V38, P572, DOI 10.1111/j.1365-2990.2011.01232.x; Valerio A, 2006, EUR J NEUROSCI, V23, P1711, DOI 10.1111/j.1460-9568.2006.04722.x; Wang C, 2011, NEUROSCI LETT, V491, P127, DOI 10.1016/j.neulet.2011.01.022; Wu J, 2011, BIOCHEM BIOPH RES CO, V408, P382, DOI 10.1016/j.bbrc.2011.04.013; Xu Y, 2009, INT IMMUNOPHARMACOL, V9, P360, DOI 10.1016/j.intimp.2009.01.002; Zhang J, 2013, BEHAV BRAIN RES, V244, P70, DOI 10.1016/j.bbr.2013.01.037; Zhang YY, 2013, CLIN INTERV AGING, V8, DOI 10.2147/CIA.S40405; Zhao H, 2013, CNS NEUROSCI THER, V19, P117, DOI 10.1111/cns.12043; Zhu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035823	37	208	242	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2014	9	8							e104745	10.1371/journal.pone.0104745	http://dx.doi.org/10.1371/journal.pone.0104745			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO0QT	24667308	Green Published, gold, Green Submitted			2022-12-27	WOS:000341017000058
J	He, X; Pu, GB; Tang, R; Zhang, DM; Pan, WQ				He, Xing; Pu, Guangbin; Tang, Rui; Zhang, Dongmei; Pan, Weiqing			Activation of Nuclear Factor Kappa B in the Hepatic Stellate Cells of Mice with Schistosomiasis Japonica	PLOS ONE			English	Article							MICRORNAS; LIVER; EXPRESSION; FIBROSIS; DISEASE; FIBROGENESIS	Schistosomiasis japonica is a serious tropical parasitic disease in humans, which causes inflammation and fibrosis of the liver. Hepatic stellate cells (HSCs) are known to play an important role in schistosome-induced fibrosis, but their role in schistosome-induced inflammation is still largely unknown. Here, we use a murine model of schistosomiasis japonica to investigate the role that nuclear factor kappa B (NF-kappa B), a critical mediator of inflammatory responses, plays in schistosome-induced inflammation. We revealed that NF-kappa B was significantly activated in HSCs at the early stage of infection, but not at later stages. We also show that the expression levels of several chemokines regulated by NF-kappa B signaling (Ccl2, Ccl3 and Ccl5) were similarly elevated at early infection. TLR4 signaling, one of the strongest known inducers of NF-kappa B activation, seemed not activated in HSCs post-infection. Importantly, we found that levels of miR-146 (a known negative regulator of NF-kappa B signaling) in HSCs opposed those of NF-kappa B signaling, elevating at later stage of infection. These results indicate that HSCs might play an important role in the progression of hepatic schistosomiasis japonica by linking liver inflammation to fibrosis via NF-kappa B signaling. Moreover, our work suggests that miR-146 appeared to regulate this process. These findings are significant and imply that manipulating the function of HSCs by targeting either NF-kappa B signaling or miR-146 expression may provide a novel method of treating hepatic schistosomiasis japonica.	[He, Xing; Pu, Guangbin; Tang, Rui; Zhang, Dongmei; Pan, Weiqing] Second Mil Med Univ, Dept Trop Infect Dis, Shanghai, Peoples R China	Naval Medical University	Zhang, DM (corresponding author), Second Mil Med Univ, Dept Trop Infect Dis, Shanghai, Peoples R China.	dmzhangcn@gmail.com; wqpan0912@aliyun.com	TANG, Rui/GRS-5116-2022	He, Xing/0000-0001-7676-9930	National Basic Research Program (973 Program) [2007CB513100]; National Science and Technology Program of China [2012ZX10004220]	National Basic Research Program (973 Program)(National Basic Research Program of China); National Science and Technology Program of China	This study was supported by grants from the National Basic Research Program (973 Program) (2007CB513100) and the National Science and Technology Program of China (2012ZX10004220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-60; Anthony BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068479; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartley PB, 2006, INT J PARASITOL, V36, P993, DOI 10.1016/j.ijpara.2006.04.015; Bataller R, 2003, J CLIN INVEST, V112, P1383, DOI 10.1172/JCI200318212; Burke ML, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000598; Cai PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067037; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; CHEEVER A W, 1968, Bulletin of the World Health Organization, V39, P328; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chuah C, 2014, TRENDS PARA IN PRESS; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Do H, 1999, J BIOL CHEM, V274, P19587, DOI 10.1074/jbc.274.28.19587; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; He X, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-272; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kelada S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003451; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Liang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042490; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Ramm GA, 2009, HEPATOLOGY, V49, P533, DOI 10.1002/hep.22637; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Wang ZX, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000596; Winau F, 2008, CURR OPIN IMMUNOL, V20, P68, DOI 10.1016/j.coi.2007.10.006	35	96	108	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 12	2014	9	8							e104323	10.1371/journal.pone.0104323	http://dx.doi.org/10.1371/journal.pone.0104323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3LJ	24498005	Green Published, Green Submitted, gold			2022-12-27	WOS:000341230400042
J	Wang, ZT; Akamatsu, T; Wang, KX; Wang, D				Wang, Zhitao; Akamatsu, Tomonari; Wang, Kexiong; Wang, Ding			The Diel Rhythms of Biosonar Behavior in the Yangtze Finless Porpoise (Neophocaena asiaeorientalis asiaeorientalis) in the Port of the Yangtze River: The Correlation between Prey Availability and Boat Traffic	PLOS ONE			English	Article							PANTROPICAL SPOTTED DOLPHINS; PHOCAENOIDES-ASIAEORIENTALIS; ECHOLOCATION BEHAVIOR; TEMPORAL PATTERNS; BEAKED-WHALES; FOOD-HABITS; CONSERVATION; SIGNALS; SONAR; MOVEMENTS	Information on the habitat use of the critically endangered Yangtze finless porpoise (Neophocaena asiaeorientalis asiaeorientalis) is critical for its conservation. The diel biosonar behavior of the porpoise in the port areas of the Yangtze River was examined along with simultaneous observations of fish density and boat traffic. Biosonar pulses from the porpoises were detected for 1233 min (5.77%) over a 21,380 min duration of effective observations. In total, 190 (5.63%) buzzes (an indication of prey capture attempts) were recorded among the 3372 identified click trains. Of the 168 echolocation encounters (bouts of click trains less than eight min apart), 150 (89.3%) involved single animals, indicating that solitary porpoises were frequently present and feeding in the port areas. Significant diel patterns were evident involving the biosonar behavior of the porpoises (including click trains and buzzes), fish density and boat traffic. The frequencies of the click trains and buzzes were significantly lower during the day than in the evening and at night, which suggests that porpoises in this region are primarily engaged in crepuscular and nocturnal foraging. The lack of a significant diel pattern in the echolocation encounters indicates the importance of the port in porpoise conservation. A forced feeding schedule may be associated with the lack of a significant correlation between porpoise acoustics and boat traffic. Overall, prey availability appears to be the primary factor that attracts porpoises. Additionally, porpoises tend to migrate or remain downstream in the morning and migrate or remain upstream in the evening, most likely to follow their prey. The findings of this study can be used to improve the conservation of the Yangtze finless porpoise.	[Wang, Zhitao; Wang, Kexiong; Wang, Ding] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wang, Zhitao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Akamatsu, Tomonari] Natl Res Inst Fisheries Engn, Fisheries Res Agcy, Ibaraki, Japan	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Japan Fisheries Research & Education Agency (FRA)	Wang, KX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	wangk@ihb.ac.cn; wangd@ihb.ac.cn	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-4]; National Natural Science Foundation of China [31170501, 31070347]; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China [201203086]; Ministry of Science and Technology of China [2011BAG07B05-3]; State Oceanic Administration of China [201105011-3]; CREST, Japan Science and Technology Agency; Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Oceanic Administration of China; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4), the National Natural Science Foundation of China (31170501 and 31070347), the Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China (201203086), Ministry of Science and Technology of China (2011BAG07B05-3), State Oceanic Administration of China (201105011-3), CREST, Japan Science and Technology Agency and the Ocean Park Conservation Foundation, Hong Kong (There is no grant code). The funders had no roles in designing the study, collecting and analyzing data or preparing and deciding where to publish the manuscript.	Akamatsu T, 2008, J ACOUST SOC AM, V123, P4403, DOI 10.1121/1.2912449; Akamatsu T, 2000, J ACOUST SOC AM, V108, P1353, DOI 10.1121/1.1287841; Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3, DOI 10.4031/002533205787443980; Akamatsu T, 2005, J ACOUST SOC AM, V117, P3325, DOI 10.1121/1.1893325; Akamatsu T, 2010, J EXP BIOL, V213, P146, DOI 10.1242/jeb.037655; Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Au W.W, 2008, PRINCIPLES MARINE BI; Au WWL, 2013, J ACOUST SOC AM, V133, P3119, DOI 10.1121/1.4798360; Baird RW, 2001, CAN J ZOOL, V79, P988, DOI 10.1139/cjz-79-6-988; Barros NB, 2002, RAFFLES B ZOOL, P115; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Carlstrom J, 2005, MAR MAMMAL SCI, V21, P1, DOI 10.1111/j.1748-7692.2005.tb01204.x; Dawson S, 2013, ENDANGER SPECIES RES, V21, P45, DOI 10.3354/esr00508; Dong Shou-Yue, 2012, Acta Hydrobiologica Sinica, V36, P246; Evans W.E., 1974, P385; Fabi G, 2002, ICES J MAR SCI, V59, pS309, DOI 10.1006/jmsc.2002.1194; FOOTE KG, 1987, J ACOUST SOC AM, V82, P981, DOI 10.1121/1.395298; Gannier Alexandre, 1999, Aquatic Mammals, V25, P123; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Henderson EE, 2012, MAR MAMMAL SCI, V28, P439, DOI 10.1111/j.1748-7692.2011.00498.x; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Kajimura H., 1981, FISH B-NOAA, V78, P951; Keenan SE, 2003, AM FISH S S, V36, P167; Kimura S, 2013, J ACOUST SOC AM, V133, P3128, DOI 10.1121/1.4796129; Kimura S, 2012, MAR MAMMAL SCI, V28, P308, DOI 10.1111/j.1748-7692.2011.00490.x; Kimura S, 2009, J ACOUST SOC AM, V125, P547, DOI 10.1121/1.3021302; Leeney RH, 2011, AQUAT MAMM, V37, P151, DOI 10.1578/AM.37.2.2011.151; Li S., 2008, BIOACOUSTICS, V17, P174, DOI [10.1080/09524622.2008.9753806, DOI 10.1080/09524622.2008.9753806]; Li SH, 2006, J ACOUST SOC AM, V120, P1803, DOI 10.1121/1.2335674; Li SH, 2010, WILDL PROT DESTR EXT, P343; Lin PC, 2013, J APPL ICHTHYOL, V29, P1402, DOI 10.1111/jai.12342; Linnenschmidt M, 2013, MAR MAMMAL SCI, V29, pE77, DOI 10.1111/j.1748-7692.2012.00592.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Payne NL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2363; Pilleri G., 1970, P27; Rasmussen MH, 2013, DEEP-SEA RES PT II, V88-89, P97, DOI 10.1016/j.dsr2.2012.07.011; Reubens JT, 2014, J SEA RES, V85, P214, DOI 10.1016/j.seares.2013.05.005; Richard S, 2010, SCIENCE, V329, P378; Robertson KM, 1997, FISH B-NOAA, V95, P334; Sasaki-Yamamoto Y, 2013, MAR MAMMAL SCI, V29, P589, DOI 10.1111/j.1748-7692.2012.00590.x; Scott MD, 2009, MAR MAMMAL SCI, V25, P137, DOI 10.1111/j.1748-7692.2008.00241.x; Shirakihara M, 2008, J MAMMAL, V89, P1248, DOI 10.1644/07-MAMM-A-264.1; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Wang D., 2013, NEOPHOCAENA ASIAEORI, V2013, DOI DOI 10.2305/IUCN.UK.2013-1.RLTS.T43205774A45893487.EN; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Wang KX, 2005, J ACOUST SOC AM, V118, P1180, DOI 10.1121/1.1945487; Wang ZT, 2014, INTEGRATIVE ZOOLOGY, V9; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Wei Zhou, 2003, Acta Zoologica Sinica, V49, P163; Xiao JQ, 2005, ZOO BIOL, V24, P531, DOI 10.1002/zoo.20070; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhao XJ, 2008, BIOL CONSERV, V141, P3006, DOI 10.1016/j.biocon.2008.09.005; Zimmer WM., 2011, PASSIVE ACOUSTIC MON, DOI 10.1017/CBO9780511977107	59	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97907	10.1371/journal.pone.0097907	http://dx.doi.org/10.1371/journal.pone.0097907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	25116432	Green Published, Green Submitted, gold			2022-12-27	WOS:000336369200137
J	Wang, ZL; Luo, XF; Li, MT; Xu, D; Zhou, S; Chen, HZ; Gao, N; Chen, Z; Zhang, LL; Zeng, XF				Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Chen, Hou-Zao; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng			Resveratrol Possesses Protective Effects in a Pristane-Induced Lupus Mouse Model	PLOS ONE			English	Article							INDUCED APOPTOSIS; BALB/C MICE; AUTOANTIBODIES; MECHANISMS; DIFFERENTIATION; DISEASE; CELLS; SIRT1	Background: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterized by the production of autoantibodies. To date, no therapy has been found to satisfactorily treat SLE. SIRT1 deficiency results in the development of an autoimmune syndrome in mice, including a high titer of anti-nuclear antibody in serum, immunoglobulin deposition in the kidney, and immune complex glomerulonephritis. Resveratrol is an activator of SIRT1 and possesses anti-inflammation and immune-regulatory properties. Objective: To evaluate the preventative effects of resveratrol on a pristane-induced lupus animal model and assess its putative immune modulation effects. Methods: BALB/c mice received a single intraperitoneal injection of 0.5 ml of pristane on day 1 and then various doses of resveratrol were given to the mice daily starting on day 2 and continuing for seven months. The autoantibodies in serum and supernatants were measured. Single cells isolated from spleen, isolated CD4+ T cells, and CD19+ B cells were cultured with or without resveratrol in vitro and assessed by flow cytometry. Results: Resveratrol attenuated proteinuria, immunoglobuin depositon in kidney, and glomerulonephritis as well as IgG1 and IgG2a in serum in pristane-induced lupus mice. Resveratrol also suppressed CD69 and CD71 expression on CD4+ T cells as well as CD4+ T cell proliferation, induced CD4+ T cell apoptosis, and decreased CD4 IFN gamma(+) Th1 cells and the ratio of Th1/Th2 cells in vitro. In vitro antibody production and proliferation of B cells were also inhibited. Conclusion: Resveratrol possesses protective effects in pristane-induced lupus mice and may represent a novel approach for the management of SLE.	[Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China; [Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Chinese Acad Med Sci, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100730, Peoples R China; [Chen, Hou-Zao] Peking Union Med Coll, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100021, Peoples R China; [Chen, Hou-Zao] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College	Zeng, XF (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China.	zengxfpumc@gmail.com	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Chinese National Key Technology R&D Program, Ministry of Science and Technology [2008BAI59B02]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2012AA02A513]; Young Investigator Project, Peking Union Medical College Hospital [I457200]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Chinese National Key Technology R&D Program, Ministry of Science and Technology; Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China); Young Investigator Project, Peking Union Medical College Hospital; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Chinese National Key Technology R&D Program, Ministry of Science and Technology (2008BAI59B02); the Chinese National High Technology Research and Development Program, Ministry of Science and Technology (2012AA02A513) and the Young Investigator Project, Peking Union Medical College Hospital (I457200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Danila MI, 2009, RHEUMATOLOGY, V48, P542, DOI 10.1093/rheumatology/kep012; Dorrie J, 2001, CANCER RES, V61, P4731; Gao XZ, 2012, ANN RHEUM DIS, V71, P129, DOI 10.1136/ard.2011.149831; He MX, 2013, CELL DEATH DIFFER, V20, P188, DOI 10.1038/cdd.2012.148; Hoffman RW, 2004, CLIN IMMUNOL, V113, P4, DOI 10.1016/j.clim.2004.05.001; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Izawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048798; Ko YC, 2011, CANCER LETT, V309, P46, DOI 10.1016/j.canlet.2011.05.014; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miyake K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/980286; Monneaux F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2711; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Richards HB, 1999, CLIN EXP IMMUNOL, V115, P547; Roman V, 2002, BRIT J HAEMATOL, V117, P842, DOI 10.1046/j.1365-2141.2002.03520.x; SATOH M, 1995, P NATL ACAD SCI USA, V92, P10934, DOI 10.1073/pnas.92.24.10934; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Savarese E, 2008, ARTHRITIS RHEUM, V58, P1107, DOI 10.1002/art.23407; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Sestak AL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2176; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Takahashi S, 1996, J CLIN INVEST, V97, P1597, DOI 10.1172/JCI118584; Wallace DJ, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-77; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]; Zou T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075139; Zunino SJ, 2009, J NUTR, V139, P1603, DOI 10.3945/jn.109.105064	39	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114792	10.1371/journal.pone.0114792	http://dx.doi.org/10.1371/journal.pone.0114792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25116432	Green Submitted, gold, Green Published			2022-12-27	WOS:000347146700054
J	Wang, Z; Li, Y; Childress, AR; Detre, JA				Wang, Ze; Li, Yin; Childress, Anna Rose; Detre, John A.			Brain Entropy Mapping Using fMRI	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; APPROXIMATE ENTROPY; COMPLEXITY ANALYSIS; SAMPLE ENTROPY; FUNCTIONAL MRI; DEFAULT MODE; NETWORKS; DISEASE; NOVELTY	Entropy is an important trait for life as well as the human brain. Characterizing brain entropy (BEN) may provide an informative tool to assess brain states and brain functions. Yet little is known about the distribution and regional organization of BEN in normal brain. The purpose of this study was to examine the whole brain entropy patterns using a large cohort of normal subjects. A series of experiments were first performed to validate an approximate entropy measure regarding its sensitivity, specificity, and reliability using synthetic data and fMRI data. Resting state fMRI data from a large cohort of normal subjects (n = 1049) from multi-sites were then used to derive a 3-dimensional BEN map, showing a sharp low-high entropy contrast between the neocortex and the rest of brain. The spatial heterogeneity of resting BEN was further studied using a data-driven clustering method, and the entire brain was found to be organized into 7 hierarchical regional BEN networks that are consistent with known structural and functional brain parcellations. These findings suggest BEN mapping as a physiologically and functionally meaningful measure for studying brain functions.	[Wang, Ze; Li, Yin; Childress, Anna Rose] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Wang, Ze; Detre, John A.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wang, Z (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	zewang@mail.med.upenn.edu	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	National Institutes of Health [R21DC011074, 8P41-EB015893, 5R33DA026114-04]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants: R21DC011074, and 8P41-EB015893, and 5R33DA026114-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2008, HUM BRAIN MAP POSTER, P496; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Baumgartner R, 2000, MAGN RESON IMAGING, V18, P845, DOI 10.1016/S0730-725X(00)00171-5; BERGSTROM R M, 1969, Developmental Psychobiology, V2, P139, DOI 10.1002/dev.420020304; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bruna R, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036007; Buxton R., 2002, INTRO FUNCTIONAL MAG; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Chen X, 2005, P ANN INT IEEE EMBS, P4212; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Araujo DB, 2003, NEUROIMAGE, V20, P311, DOI 10.1016/S1053-8119(03)00306-9; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fernandez A, 2010, ALZ DIS ASSOC DIS, V24, P182, DOI 10.1097/WAD.0b013e3181c727f7; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; HITCHCOCK DR, 1967, ICARUS, V7, P149, DOI 10.1016/0019-1035(67)90059-0; Hu ZH, 2006, IEEE IMAGE PROC, P2861, DOI 10.1109/ICIP.2006.313026; Hyvarinen A, 1998, ADV NEUR IN, V10, P273; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kolmogorov AN, 1998, THEOR COMPUT SCI, V207, P387, DOI 10.1016/S0304-3975(98)00075-9; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Li Z, 2012, JMRI; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liu CY, 2013, J MAGN RESON IMAGING, V38, P36, DOI 10.1002/jmri.23961; Lovelock James, 1979, GAIA NEW LOOK LIFE E; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Palazzolo JA, 1998, AM J PHYSIOL-HEART C, V274, pH1099, DOI 10.1152/ajpheart.1998.274.4.H1099; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pinker S., 1997, MIND WORKS; Poza J, 2008, ANN BIOMED ENG, V36, P141, DOI 10.1007/s10439-007-9402-y; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rezek IA, 1998, IEEE T BIO-MED ENG, V45, P1186, DOI 10.1109/10.709563; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sandler S.I, 2006, CHEM ENG THERMODYNAM; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Singer W, 2009, EUR REV, V17, P321, DOI 10.1017/S1062798709000751; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Sokunbi MO, 2011, IEEE T BIO-MED ENG, V58, P3206, DOI 10.1109/TBME.2011.2164793; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang Z., 2012, 3 BIENN C REST STAT, P208; Wang Z, 2012, 2012 ANN M ORG HUM B; Wang Z, 2007, NEUROIMAGE, V36, P1139, DOI 10.1016/j.neuroimage.2007.03.072; Wang Z, 2009, NEUROIMAGE, V46, P608, DOI 10.1016/j.neuroimage.2009.03.016; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Ze Wang A.M., 2013, 2013 ANN M INT SOC M, P4861; Ze Wang JS, 2013, 2013 ANN M SOC NEUR, P7491; Zhu HT, 2006, 9 INT C CONTR AUT RO, P1	57	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e89948	10.1371/journal.pone.0089948	http://dx.doi.org/10.1371/journal.pone.0089948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	25116432	Green Published, gold, Green Submitted			2022-12-27	WOS:000333355300008
